PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Inoue, K; Nakada, K; Ogura, A; Isobe, K; Goto, Y; Nonaka, I; Hayashi, JI				Inoue, K; Nakada, K; Ogura, A; Isobe, K; Goto, Y; Nonaka, I; Hayashi, JI			Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotes	NATURE GENETICS			English	Article							TRANSMITOCHONDRIAL MICE; PROTEIN-SYNTHESIS; CELL LINES; DNA; DISEASE; MUTATION; MYOPATHY; CHLORAMPHENICOL; MICROINJECTION; HETEROPLASMY	Mice carrying mitochondrial DNA (mtDNA) with pathogenic mutations would provide a system in which to study how mutant mtDNAs are transmitted and distributed in tissues, resulting in expression of mitochondrial diseases. However, no effective procedures are available for the generation of these mice. Isolation of mouse cells without mtDNA (rho(0)) enabled us to trap mutant mtDNA that had accumulated in somatic tissues into rho(0) cells repopulated with mtDNA (cybrids). We isolated respiration-deficient cybrids with mtDNA carrying a deletion and introduced this mtDNA into fertilized eggs. The mutant mtDNA was transmitted maternally, and its accumulation induced mitochondrial dysfunction in various tissues. Moreover, most of these mice died because of venal failure, suggesting the involvement of mtDNA mutations in the pathogeneses of new diseases.	Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 305, Japan; Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 305, Japan; Natl Inst Infect Dis, Dept Vet Sci, Tokyo, Japan; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Tokyo, Japan	University of Tsukuba; University of Tsukuba; National Institute of Infectious Diseases (NIID); National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan	Hayashi, JI (corresponding author), Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 305, Japan.		Ogura, Atsuo/J-3916-2014	Ogura, Atsuo/0000-0003-0447-1988				BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; CLAYTON DA, 1967, NATURE, V216, P652, DOI 10.1038/216652a0; DUNBAR DR, 1993, HUM MOL GENET, V2, P1619, DOI 10.1093/hmg/2.10.1619; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; HAYASHI JI, 1994, J CELL BIOL, V125, P43, DOI 10.1083/jcb.125.1.43; HOLTZWORTHMUNROE A, 1988, CLIN PSYCHOL REV, V8, P331, DOI 10.1016/0272-7358(88)90095-5; Inoue K, 1997, BIOCHEM BIOPH RES CO, V239, P257, DOI 10.1006/bbrc.1997.7446; Inoue K, 1997, J BIOL CHEM, V272, P15510, DOI 10.1074/jbc.272.24.15510; Irwin MH, 1999, TRANSGENIC RES, V8, P119, DOI 10.1023/A:1008925419758; Ito S, 1999, P NATL ACAD SCI USA, V96, P2099, DOI 10.1073/pnas.96.5.2099; Jansen JJ, 1997, J AM SOC NEPHROL, V8, P1118; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; Levy SE, 1999, TRANSGENIC RES, V8, P137, DOI 10.1023/A:1008967412955; Marchington DR, 1999, NAT MED, V5, P957, DOI 10.1038/11403; MIYABAYASHI S, 1984, BRAIN DEV-JPN, V6, P362, DOI 10.1016/S0387-7604(84)80112-6; NELSON I, 1993, MAMM GENOME, V4, P680, DOI 10.1007/BF00360907; Pinkert CA, 1997, TRANSGENIC RES, V6, P379, DOI 10.1023/A:1018431316831; POULTON J, 1989, LANCET, V1, P236; ROTIG A, 1992, AM J HUM GENET, V50, P364; Shitara H, 1998, GENETICS, V148, P851; SHITARA H, IN PRESS GENETICS; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SZABOLCS MJ, 1994, KIDNEY INT, V45, P1388, DOI 10.1038/ki.1994.181; Takai D, 1997, J BIOL CHEM, V272, P6028, DOI 10.1074/jbc.272.9.6028; TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769; VOLZLINGENHOHL A, 1992, P NATL ACAD SCI USA, V89, P11528, DOI 10.1073/pnas.89.23.11528; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Yamaoka M, 2000, GENETICS, V155, P301; YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699	34	303	312	0	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					176	181		10.1038/82826	http://dx.doi.org/10.1038/82826			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017072				2022-12-17	WOS:000089638800013
J	Honda, H; Oda, H; Nakamoto, T; Honda, Z; Sakai, R; Suzuki, T; Saito, T; Nakamura, K; Nakao, K; Ishikawa, T; Katsuki, M; Yazaki, Y; Hirai, H				Honda, H; Oda, H; Nakamoto, T; Honda, Z; Sakai, R; Suzuki, T; Saito, T; Nakamura, K; Nakao, K; Ishikawa, T; Katsuki, M; Yazaki, Y; Hirai, H			Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130(Cas)	NATURE GENETICS			English	Article							CRK-ASSOCIATED SUBSTRATE; TYROSINE PHOSPHORYLATION; MONOCLONAL-ANTIBODIES; CELL-TRANSFORMATION; STABLE ASSOCIATION; PROTEINS; GROWTH; MOLECULE; P130; DISRUPTION	p130(Cas) (Cas), the protein encoded by the Crkas gene (also known as Gas), is an adaptor molecule with a unique structure that contains a Src homology (SH)-3 domain followed by multiple YXXP motifs and a proline-rich region(1). Cas was originally cloned as a highly tyrosine-phosphorylated protein in cells transformed by v-Src (refs 2,3) or v-Crk (ref, 4) and has subsequently been implicated in a variety of biological processes including cell adhesion(5), cell migration(6), growth factor stimulation(7-9), cytokine receptor engagement(10,11) and bacterial infection(12,13). To determine its role in vivo, we generated mice lacking Gas. Cas-deficient embryos died in utero showing marked systemic congestion and growth retardation. Histologically, the heart was poorly developed and blood vessels were prominently dilated. Electron microscopic analysis of the heart revealed disorganization of myofibrils and disruption of Z-disks. In addition, actin stress fiber formation was severely impaired in Cas-deficient primary fibroblasts. Moreover, expression of activated Src in Cas-deficient primary fibroblasts did not induce a fully transformed phenotype, possibly owing to insufficient accumulation of actin cytoskeleton in podosomes. These findings have defined Cas function in cardiovascular development, actin filament assembly and Src-induced transformation.	Univ Tokyo, Fac Med, Dept Internal Med 3, Bunkyo Ku, Tokyo 113, Japan; Univ Tokyo, Fac Med, Dept Pathol, Bunkyo Ku, Tokyo 113, Japan; Univ Tokyo, Fac Med, Dept Internal Med & Phys Therapy, Bunkyo Ku, Tokyo 113, Japan; Univ Tokyo, Inst Med Sci, Dept DNA Embryol, Minato Ku, Tokyo 108, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Hirai, H (corresponding author), Univ Tokyo, Fac Med, Dept Internal Med 3, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.			Sakai, Ryuichi/0000-0001-6833-1103; zhong wei, he gui/0000-0002-3066-3564				Alexandropoulos K, 1996, SIN GENES DEV, V10, P1341; Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730; BOSCHEK CB, 1981, CELL, V24, P175, DOI 10.1016/0092-8674(81)90513-4; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; Casamassima A, 1997, J BIOL CHEM, V272, P9363; CHEN Z, 1994, GENE DEV, V8, P2293, DOI 10.1101/gad.8.19.2293; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Ingham RJ, 1996, J BIOL CHEM, V271, P32306, DOI 10.1074/jbc.271.50.32306; Ishino M, 1995, ONCOGENE, V11, P2331; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; KANNER SB, 1991, EMBO J, V10, P1689, DOI 10.1002/j.1460-2075.1991.tb07693.x; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; KWEE L, 1995, DEVELOPMENT, V121, P489; Law SF, 1996, MOL CELL BIOL, V16, P3327; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; MATSUDA M, 1990, SCIENCE, V248, P1537, DOI 10.1126/science.1694307; Minegishi M, 1996, J EXP MED, V184, P1365, DOI 10.1084/jem.184.4.1365; MORRISON DK, 1990, MOL CELL BIOL, V10, P2359, DOI 10.1128/MCB.10.5.2359; NOJIMA Y, 1995, J BIOL CHEM, V270, P15398, DOI 10.1074/jbc.270.25.15398; Ojaniemi M, 1997, J BIOL CHEM, V272, P25993, DOI 10.1074/jbc.272.41.25993; Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P3951, DOI 10.1128/MCB.9.9.3951; Ribon V, 1996, J BIOL CHEM, V271, P7375, DOI 10.1074/jbc.271.13.7375; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; SANGER JW, 1984, J CELL BIOL, V98, P825, DOI 10.1083/jcb.98.3.825; SCHRAW W, 1995, BIOCHEMISTRY-US, V34, P13760, DOI 10.1021/bi00042a006; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407	30	303	304	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1998	19	4					361	365		10.1038/1246	http://dx.doi.org/10.1038/1246			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697697				2022-12-17	WOS:000075107600019
J	Roselli, C; Chaffin, MD; Weng, LC; Aeschbacher, S; Ahlberg, G; Albert, CM; Almgren, P; Alonso, A; Anderson, CD; Aragam, KG; Arking, DE; Barnard, J; Bartz, TM; Benjamin, EJ; Bihlmeyer, NA; Bis, JC; Bloom, HL; Boerwinkle, E; Bottinger, EB; Brody, JA; Calkins, H; Campbell, A; Cappola, TP; Carlquist, J; Chasman, DI; Chen, LY; Chen, YDI; Choi, EK; Choi, SH; Christophersen, IE; Chung, MK; Cole, JW; Conen, D; Cook, J; Crijns, HJ; Cutler, MJ; Damrauer, SM; Daniels, BR; Darbar, D; Delgado, G; Denny, JC; Dichgans, M; Dorr, M; Dudink, EA; Dudley, SC; Esa, N; Esko, T; Eskola, M; Fatkin, D; Felix, SB; Ford, I; Franco, OH; Geelhoed, B; Grewal, RP; Gudnason, V; Guo, XQ; Gupta, N; Gustafsson, S; Gutmann, R; Hamsten, A; Harris, TB; Hayward, C; Heckbert, SR; Hernesniemi, J; Hocking, LJ; Hofman, A; Horimoto, ARVR; Huang, J; Huang, PL; Huffman, J; Ingelsson, E; Ipek, EG; Ito, K; Jimenez-Conde, J; Johnson, R; Jukema, JW; Kaab, S; Kahonen, M; Kamatani, Y; Kane, JP; Kastrati, A; Kathiresan, S; Katschnig-Winter, P; Kavousi, M; Kessler, T; Kietselaer, BL; Kirchhof, P; Kleber, ME; Knight, S; Krieger, JE; Kubo, M; Launer, LJ; Laurikka, J; Lehtimaki, T; Leineweber, K; Lemaitre, RN; Li, M; Lim, HE; Lin, HJ; Lin, HH; Lind, L; Lindgren, CM; Lokki, ML; London, B; Loos, RJF; Low, SK; Lu, YC; Lyytikainen, LP; Macfarlane, PW; Magnusson, PK; Mahajan, A; Malik, R; Mansur, AJ; Marcus, GM; Margolin, L; Margulies, KB; Marz, W; McManus, DD; Melander, O; Mohanty, S; Montgomery, JA; Morley, MP; Morris, AP; Muller-Nurasyid, M; Natale, A; Nazarian, S; Neumann, B; Newton-Cheh, C; Niemeijer, MN; Nikus, K; Nilsson, P; Noordam, R; Oellers, H; Olesen, MS; Orho-Melander, M; Padmanabhan, S; Pak, HN; Pare, G; Pedersen, NL; Pera, J; Pereira, A; Porteous, D; Psaty, BM; Pulit, SL; Pullinger, CR; Rader, DJ; Refsgaard, L; Ribases, M; Ridker, PM; Rienstra, M; Risch, L; Roden, DM; Rosand, J; Rosenberg, MA; Rost, N; Rotter, JI; Saba, S; Sandhu, RK; Schnabel, RB; Schramm, K; Schunkert, H; Schurman, C; Scott, SA; Seppala, I; Shaffer, C; Shah, S; Shalaby, AA; Shim, J; Shoemaker, MB; Siland, JE; Sinisalo, J; Sinner, MF; Slowik, A; Smith, AV; Smith, BH; Smith, JG; Smith, JD; Smith, NL; Soliman, EZ; Sotoodehnia, N; Stricker, BH; Sun, A; Sun, H; Svendsen, JH; Tanaka, T; Tanriverdi, K; Taylor, KD; Teder-Laving, M; Teumer, A; Theriault, S; Trompet, S; Tucker, NR; Tveit, A; Uitterlinden, AG; Van Der Harst, P; Van Gelder, IC; Van Wagoner, DR; Verweij, N; Vlachopoulou, E; Volker, U; Wang, BQ; Weeke, PE; Weijs, B; Weiss, R; Weiss, S; Wells, QS; Wiggins, KL; Wong, JA; Woo, D; Worrall, BB; Yang, PS; Yao, J; Yoneda, ZT; Zeller, T; Zeng, LY; Lubitz, SA; Lunetta, KL; Ellinor, PT				Roselli, Carolina; Chaffin, Mark D.; Weng, Lu-Chen; Aeschbacher, Stefanie; Ahlberg, Gustav; Albert, Christine M.; Almgren, Peter; Alonso, Alvaro; Anderson, Christopher D.; Aragam, Krishna G.; Arking, Dan E.; Barnard, John; Bartz, Traci M.; Benjamin, Emelia J.; Bihlmeyer, Nathan A.; Bis, Joshua C.; Bloom, Heather L.; Boerwinkle, Eric; Bottinger, Erwin B.; Brody, Jennifer A.; Calkins, Hugh; Campbell, Archie; Cappola, Thomas P.; Carlquist, John; Chasman, Daniel I.; Chen, Lin Y.; Chen, Yii-Der Ida; Choi, Eue-Keun; Choi, Seung Hoan; Christophersen, Ingrid E.; Chung, Mina K.; Cole, John W.; Conen, David; Cook, James; Crijns, Harry J.; Cutler, Michael J.; Damrauer, Scott M.; Daniels, Brian R.; Darbar, Dawood; Delgado, Graciela; Denny, Joshua C.; Dichgans, Martin; Doerr, Marcus; Dudink, Elton A.; Dudley, Samuel C.; Esa, Nada; Esko, Tonu; Eskola, Markku; Fatkin, Diane; Felix, Stephan B.; Ford, Ian; Franco, Oscar H.; Geelhoed, Bastiaan; Grewal, Raji P.; Gudnason, Vilmundur; Guo, Xiuqing; Gupta, Namrata; Gustafsson, Stefan; Gutmann, Rebecca; Hamsten, Anders; Harris, Tamara B.; Hayward, Caroline; Heckbert, Susan R.; Hernesniemi, Jussi; Hocking, Lynne J.; Hofman, Albert; Horimoto, Andrea R. V. R.; Huang, Jie; Huang, Paul L.; Huffman, Jennifer; Ingelsson, Erik; Ipek, Esra Gucuk; Ito, Kaoru; Jimenez-Conde, Jordi; Johnson, Renee; Jukema, J. Wouter; Kaeaeb, Stefan; Kahonen, Mika; Kamatani, Yoichiro; Kane, John P.; Kastrati, Adnan; Kathiresan, Sekar; Katschnig-Winter, Petra; Kavousi, Maryam; Kessler, Thorsten; Kietselaer, Bas L.; Kirchhof, Paulus; Kleber, Marcus E.; Knight, Stacey; Krieger, Jose E.; Kubo, Michiaki; Launer, Lenore J.; Laurikka, Jari; Lehtimaki, Terho; Leineweber, Kirsten; Lemaitre, Rozenn N.; Li, Man; Lim, Hong Euy; Lin, Henry J.; Lin, Honghuang; Lind, Lars; Lindgren, Cecilia M.; Lokki, Marja-Liisa; London, Barry; Loos, Ruth J. F.; Low, Siew-Kee; Lu, Yingchang; Lyytikainen, Leo-Pekka; Macfarlane, Peter W.; Magnusson, Patrik K.; Mahajan, Anubha; Malik, Rainer; Mansur, Alfredo J.; Marcus, Gregory M.; Margolin, Lauren; Margulies, Kenneth B.; Maerz, Winfried; McManus, David D.; Melander, Olle; Mohanty, Sanghamitra; Montgomery, Jay A.; Morley, Michael P.; Morris, Andrew P.; Mueller-Nurasyid, Martina; Natale, Andrea; Nazarian, Saman; Neumann, Benjamin; Newton-Cheh, Christopher; Niemeijer, Maartje N.; Nikus, Kjell; Nilsson, Peter; Noordam, Raymond; Oellers, Heidi; Olesen, Morten S.; Orho-Melander, Marju; Padmanabhan, Sandosh; Pak, Hui-Nam; Pare, Guillaume; Pedersen, Nancy L.; Pera, Joanna; Pereira, Alexandre; Porteous, David; Psaty, Bruce M.; Pulit, Sara L.; Pullinger, Clive R.; Rader, Daniel J.; Refsgaard, Lena; Ribases, Marta; Ridker, Paul M.; Rienstra, Michiel; Risch, Lorenz; Roden, Dan M.; Rosand, Jonathan; Rosenberg, Michael A.; Rost, Natalia; Rotter, Jerome I.; Saba, Samir; Sandhu, Roopinder K.; Schnabel, Renate B.; Schramm, Katharina; Schunkert, Heribert; Schurman, Claudia; Scott, Stuart A.; Seppala, Ilkka; Shaffer, Christian; Shah, Svati; Shalaby, Alaa A.; Shim, Jaemin; Shoemaker, M. Benjamin; Siland, Joylene E.; Sinisalo, Juha; Sinner, Moritz F.; Slowik, Agnieszka; Smith, Albert V.; Smith, Blair H.; Smith, J. Gustav; Smith, Jonathan D.; Smith, Nicholas L.; Soliman, Elsayed Z.; Sotoodehnia, Nona; Stricker, Bruno H.; Sun, Albert; Sun, Han; Svendsen, Jesper H.; Tanaka, Toshihiro; Tanriverdi, Kahraman; Taylor, Kent D.; Teder-Laving, Maris; Teumer, Alexander; Theriault, Sebastien; Trompet, Stella; Tucker, Nathan R.; Tveit, Arnljot; Uitterlinden, Andre G.; Van Der Harst, Pim; Van Gelder, Isabelle C.; Van Wagoner, David R.; Verweij, Niek; Vlachopoulou, Efthymia; Voelker, Uwe; Wang, Biqi; Weeke, Peter E.; Weijs, Bob; Weiss, Raul; Weiss, Stefan; Wells, Quinn S.; Wiggins, Kerri L.; Wong, Jorge A.; Woo, Daniel; Worrall, Bradford B.; Yang, Pil-Sung; Yao, Jie; Yoneda, Zachary T.; Zeller, Tanja; Zeng, Lingyao; Lubitz, Steven A.; Lunetta, Kathryn L.; Ellinor, Patrick T.			Multi-ethnic genome-wide association study for atrial fibrillation	NATURE GENETICS			English	Article							POLYMORPHIC VENTRICULAR-TACHYCARDIA; CARDIAC CONDUCTION; VARIANTS; LOCI; IDENTIFICATION; MUTATIONS; GENE; SUSCEPTIBILITY; ANNOTATION; IMPUTATION	Atrial fibrillation (AF) affects more than 33 million individuals worldwide(1) and has a complex heritability(2). We conducted the largest meta-analysis of genome-wide association studies (GWAS) for AF to date, consisting of more than half a million individuals, including 65,446 with AF. In total, we identified 97 loci significantly associated with AF, including 67 that were novel in a combined-ancestry analysis, and 3 that were novel in a European-specific analysis. We sought to identify AF-associated genes at the GWAS loci by performing RNA-sequencing and expression quantitative trait locus analyses in 101 left atrial samples, the most relevant tissue for AF. We also performed transcriptome-wide analyses that identified 57 AF-associated genes, 42 of which overlap with GWAS loci. The identified loci implicate genes enriched within cardiac developmental, electrophysiological, contractile and structural pathways. These results extend our understanding of the biological pathways underlying AF and may facilitate the development of therapeutics for AF.	[Roselli, Carolina; Chaffin, Mark D.; Weng, Lu-Chen; Anderson, Christopher D.; Aragam, Krishna G.; Chasman, Daniel I.; Choi, Seung Hoan; Christophersen, Ingrid E.; Daniels, Brian R.; Esko, Tonu; Gupta, Namrata; Kathiresan, Sekar; Margolin, Lauren; Newton-Cheh, Christopher; Pulit, Sara L.; Rosand, Jonathan; Rost, Natalia; Smith, J. Gustav; Tucker, Nathan R.; Lubitz, Steven A.; Ellinor, Patrick T.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Weng, Lu-Chen; Christophersen, Ingrid E.; Huang, Paul L.; Tucker, Nathan R.; Lubitz, Steven A.; Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Aeschbacher, Stefanie; Conen, David] Univ Hosp Basel, Basel, Switzerland; [Aeschbacher, Stefanie; Conen, David] Cardiovasc Res Inst Basel, Basel, Switzerland; [Ahlberg, Gustav; Olesen, Morten S.; Refsgaard, Lena; Svendsen, Jesper H.; Weeke, Peter E.] Copenhagen Univ Hosp, Dept Cardiol, Heart Ctr, Lab Mol Cardiol,Rigshosp, Copenhagen, Denmark; [Ahlberg, Gustav; Olesen, Morten S.; Refsgaard, Lena] Univ Copenhagen, Dept Biomed Sci, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Copenhagen, Denmark; [Ahlberg, Gustav; Olesen, Morten S.; Refsgaard, Lena; Svendsen, Jesper H.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Albert, Christine M.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent & Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Albert, Christine M.; Chasman, Daniel I.; Ridker, Paul M.] Harvard Med Sch, Boston, MA USA; [Almgren, Peter; Orho-Melander, Marju] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Alonso, Alvaro] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Anderson, Christopher D.; Aragam, Krishna G.; Kathiresan, Sekar; Newton-Cheh, Christopher; Rosand, Jonathan; Rosenberg, Michael A.] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Arking, Dan E.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Barnard, John; Chung, Mina K.; Smith, Jonathan D.; Sun, Han; Van Wagoner, David R.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH USA; [Barnard, John; Chung, Mina K.; Smith, Jonathan D.; Sun, Han; Van Wagoner, David R.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH USA; [Barnard, John; Chung, Mina K.; Smith, Jonathan D.; Sun, Han; Van Wagoner, David R.] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH USA; [Barnard, John; Chung, Mina K.; Smith, Jonathan D.; Sun, Han; Van Wagoner, David R.] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH USA; [Bartz, Traci M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit Dept, Seattle, WA 98195 USA; [Bartz, Traci M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Benjamin, Emelia J.; Lin, Honghuang; Lunetta, Kathryn L.] NHLBI, Framingham, MA USA; [Benjamin, Emelia J.; Lin, Honghuang; Lunetta, Kathryn L.] Boston Univ, Framingham Heart Study, Framingham, MA USA; [Benjamin, Emelia J.; Lin, Honghuang] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Benjamin, Emelia J.] Boston Univ, Dept Epidemiol, Sch Publ Hlth, Boston, MA USA; [Bihlmeyer, Nathan A.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Predoctoral Training Program Human Genet, Baltimore, MD USA; [Bis, Joshua C.; Brody, Jennifer A.; Lemaitre, Rozenn N.; Wiggins, Kerri L.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Bloom, Heather L.] Emory Univ, Div Cardiol, Atlanta, GA 30322 USA; [Bloom, Heather L.] Atlanta VA Med Ctr, Atlanta, GA USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Bottinger, Erwin B.; Loos, Ruth J. F.; Lu, Yingchang; Schurman, Claudia] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Bottinger, Erwin B.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Calkins, Hugh; Ipek, Esra Gucuk] Johns Hopkins Univ, Baltimore, MD USA; [Campbell, Archie; Porteous, David] Univ Edinburgh, Inst Genet & Mol Med, Ctr Genom & Expt Med, Generat Scotland, Edinburgh, Midlothian, Scotland; [Cappola, Thomas P.; Margulies, Kenneth B.; Morley, Michael P.] Univ Penn, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA; [Cappola, Thomas P.; Margulies, Kenneth B.; Morley, Michael P.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Carlquist, John; Cutler, Michael J.; Knight, Stacey] Intermt Med Ctr, Intermt Heart Inst, Murray, UT USA; [Carlquist, John] Univ Utah, Div Cardiovasc Med, Salt Lake City, UT USA; [Chasman, Daniel I.] Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Chasman, Daniel I.] Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Chasman, Daniel I.] Harvard Med Sch, Boston, MA USA; [Chen, Lin Y.] Univ Minnesota, Sch Med, Dept Med, Div Cardiovasc, Minneapolis, MN 55455 USA; [Chen, Yii-Der Ida; Guo, Xiuqing; Lin, Henry J.; Taylor, Kent D.; Yao, Jie] Harbor UCLA Med Ctr, Dept Pediat, LABioMed, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Choi, Eue-Keun] Seoul Natl Univ Hosp, Seoul, South Korea; [Christophersen, Ingrid E.; Tveit, Arnljot] Vestre Viken Hosp Trust, Baerum Hosp, Dept Med Res, Drammen, Norway; [Cole, John W.] Baltimore Vet Affairs Med Ctr, Dept Neurol, Baltimore, MD USA; [Cole, John W.] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Conen, David; Pare, Guillaume; Theriault, Sebastien] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Cook, James; Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England; [Crijns, Harry J.; Dudink, Elton A.; Kietselaer, Bas L.; Weijs, Bob] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Crijns, Harry J.; Dudink, Elton A.; Kietselaer, Bas L.; Weijs, Bob] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Cardiol, Maastricht, Netherlands; [Damrauer, Scott M.] Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Damrauer, Scott M.] Corporal Michael Crescenz VA Med Ctr, Dept Surg, Philadelphia, PA USA; [Darbar, Dawood] Univ Illinois, Chicago, IL USA; [Delgado, Graciela; Kleber, Marcus E.] Heidelberg Univ, Med Fac Mannheim, Dept Med 5, Heidelberg, Germany; [Denny, Joshua C.; Montgomery, Jay A.; Roden, Dan M.; Shaffer, Christian; Shoemaker, M. Benjamin; Weeke, Peter E.; Wells, Quinn S.; Yoneda, Zachary T.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Dichgans, Martin; Malik, Rainer] Univ Hosp, LMU Munich, Inst Stroke & Dementia Res ISD, Munich, Germany; [Dichgans, Martin] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Dichgans, Martin] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Doerr, Marcus; Felix, Stephan B.] Univ Med Greifswald, Dept Internal Med B, Greifswald, Germany; [Doerr, Marcus; Felix, Stephan B.; Teumer, Alexander; Voelker, Uwe; Weiss, Stefan] Partner Site Greifswald, DZHK German Ctr Cardiovasc Res, Greifswald, Germany; [Dudley, Samuel C.] Univ Minnesota, Div Cardiovasc, Minneapolis, MN 55455 USA; [Dudley, Samuel C.] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN USA; [Esa, Nada; McManus, David D.; Tanriverdi, Kahraman] Univ Massachusetts, Med Sch Worcester, Worcester, MA 01605 USA; [Esko, Tonu; Teder-Laving, Maris] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Eskola, Markku; Hernesniemi, Jussi; Nikus, Kjell] Tampere Univ Hosp, Dept Cardiol, Heart Ctr, Tampere, Finland; [Eskola, Markku; Hernesniemi, Jussi; Nikus, Kjell] Univ Tampere, Fac Med & Life Sci, Tampere, Finland; [Fatkin, Diane; Johnson, Renee] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Fatkin, Diane] St Vincent Hosp, Darlinghurst, NSW, Australia; [Fatkin, Diane] Univ New South Wales, Fac Med, Kensington, NSW, Australia; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Franco, Oscar H.; Hofman, Albert; Kavousi, Maryam; Niemeijer, Maartje N.] Erasmus Univ, Med Ctr Rotterdam, Dept Epidemiol, Rotterdam, Netherlands; [Geelhoed, Bastiaan; Rienstra, Michiel; Siland, Joylene E.; Van Der Harst, Pim; Van Gelder, Isabelle C.; Verweij, Niek] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Grewal, Raji P.] St Francis Med Ctr, Dept Neurosci, Trenton, NJ USA; [Grewal, Raji P.] Seton Hall Univ, Sch Hlth & Med Sci, S Orange, NJ USA; [Gudnason, Vilmundur; Smith, Albert V.] Icelandic Heart Assoc, Kopavogur, Iceland; [Gudnason, Vilmundur; Smith, Albert V.] Univ Iceland, Fac Med, Reykavik, Iceland; [Gustafsson, Stefan; Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Gutmann, Rebecca; London, Barry] Univ Iowa, Div Cardiovasc Med, Abboud Cardiovasc Res Ctr, Iowa City, IA USA; [Hamsten, Anders] Karolinska Inst, Dept Med Solna, Atherosclerosis Res Unit, Cardiovasc Genet & Genom Grp, Stockholm, Sweden; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Hayward, Caroline; Huffman, Jennifer] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Heckbert, Susan R.; Smith, Nicholas L.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Heckbert, Susan R.; Smith, Nicholas L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Heckbert, Susan R.; Psaty, Bruce M.; Smith, Nicholas L.] Kaiser Permanente, Washington Hlth Res Inst, Seattle, WA USA; [Hernesniemi, Jussi; Lehtimaki, Terho; Lyytikainen, Leo-Pekka; Seppala, Ilkka] Univ Tampere, Fac Med & Life Sci, Dept Clin Chem, Fimlab Labs, Tampere, Finland; [Hernesniemi, Jussi; Lehtimaki, Terho; Lyytikainen, Leo-Pekka; Seppala, Ilkka] Univ Tampere, Fac Med & Life Sci, Finnish Cardiovasc Res Ctr Tampere, Tampere, Finland; [Hocking, Lynne J.] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Horimoto, Andrea R. V. R.; Krieger, Jose E.] Univ Sao Paulo, Heart Inst, Lab Genet & Mol Cardiol, Sao Paulo, Brazil; [Huang, Jie] Boston VA Res Inst Inc, Boston, MA USA; [Ingelsson, Erik] Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Ito, Kaoru] RIKEN, Ctr Integrat Med Sci, Lab Cardiovasc Dis, Yokohama, Kanagawa, Japan; [Jimenez-Conde, Jordi] Inst Hosp Mar Invest Med, Hosp Mar, Dept Neurol, Neurovasc Res Grp IMIM, Barcelona, Spain; [Jimenez-Conde, Jordi] Univ Autonoma Barcelona, Med Dept, Barcelona, Spain; [Jukema, J. Wouter; Trompet, Stella] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Jukema, J. Wouter] Durrer Ctr Cardiogenet Res, Amsterdam, Netherlands; [Jukema, J. Wouter] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Kaeaeb, Stefan; Mueller-Nurasyid, Martina; Neumann, Benjamin; Schramm, Katharina; Sinner, Moritz F.] Ludwig Maximilians Univ Munchen, Univ Hosp Munich, Dept Med 1, Munich, Germany; [Kaeaeb, Stefan; Kastrati, Adnan; Mueller-Nurasyid, Martina; Schunkert, Heribert; Sinner, Moritz F.] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany; [Kahonen, Mika] Univ Tampere, Fac Med & Life Sci, Tampere Univ Hosp, Dept Clin Physiol, Tampere, Finland; [Kahonen, Mika] Univ Tampere, Fac Med & Life Sci, Finnish Cardiovasc Res Center Tampere, Tampere, Finland; [Kamatani, Yoichiro; Low, Siew-Kee] RIKEN, Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Kane, John P.; Pullinger, Clive R.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Kastrati, Adnan; Kessler, Thorsten; Schunkert, Heribert; Zeng, Lingyao] Tech Univ Munich, Klin Herz & Kreislauferkrankungen, Deutsch Herzzentrum Munchen, Munich, Germany; [Katschnig-Winter, Petra] Med Univ Graz, Dept Neurol, Graz, Austria; [Kirchhof, Paulus] Univ Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England; [Kirchhof, Paulus] Sandwell & West Birmingham Hosp NHS Trust, Birmingham, W Midlands, England; [Kirchhof, Paulus] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Kirchhof, Paulus] AFNET, Munster, Germany; [Knight, Stacey] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Laurikka, Jari] Univ Tampere, Fac Med & Life Sci, Tampere Univ Hosp, Heart Ctr,Dept Cardiothoracic Surg, Tampere, Finland; [Laurikka, Jari] Univ Tampere, Fac Med & Life Sci, Finnish Cardiovasc Res Center Tampere, Tampere, Finland; [Leineweber, Kirsten] Bayer, Dept Dis Genom, Wuppertal, Germany; [Li, Man] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Li, Man] Univ Utah, Sch Med, Div Nephrol & Hypertens Internal Med, Salt Lake City, UT USA; [Lim, Hong Euy] Korea Univ, Guro Hosp, Seoul, South Korea; [Lind, Lars] Uppsala Univ, Cardiovasc Epidemiol, Dept Med Sci, Uppsala, Sweden; [Lindgren, Cecilia M.; Mahajan, Anubha] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Lokki, Marja-Liisa; Vlachopoulou, Efthymia] Univ Helsinki, Medicum, Transplantat Lab, Helsinki, Finland; [Loos, Ruth J. F.; Lu, Yingchang; Schurman, Claudia] Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, New York, NY 10029 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY USA; [Macfarlane, Peter W.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Magnusson, Patrik K.; Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Mansur, Alfredo J.] Univ Sao Paulo, Heart Inst, Sao Paulo, Brazil; [Marcus, Gregory M.] Univ Calif San Francisco, Div Cardiol, San Francisco, CA 94143 USA; [Maerz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Maerz, Winfried] Synlab Serv GmbH, Synlab Acad, Mannheim, Germany; [Melander, Olle] Lund Univ, Dept Internal Med Clin Sci, Malmo, Sweden; [Mohanty, Sanghamitra; Natale, Andrea] St Davids Med Ctr, Texas Cardiac Arrhythmia Inst, Austin, TX USA; [Mohanty, Sanghamitra; Natale, Andrea] Dell Med Sch, Austin, TX USA; [Mueller-Nurasyid, Martina; Schramm, Katharina] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Genet Epidemiol, Neuherberg, Germany; [Nazarian, Saman] Univ Penn, Philadelphia, PA USA; [Nilsson, Peter] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Nilsson, Peter] Skane Univ Hosp, Malmo, Sweden; [Noordam, Raymond; Trompet, Stella] Leiden Univ, Med Ctr, Dept Internal Med, Sect Gerontol & Geriatr, Leiden, Netherlands; [Oellers, Heidi] Atrial Fibrillat NETwork, Munster, Germany; [Padmanabhan, Sandosh] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Pak, Hui-Nam; Yang, Pil-Sung] Yonsei Univ Hlth Syst, Seoul, South Korea; [Pare, Guillaume; Theriault, Sebastien] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Pera, Joanna; Slowik, Agnieszka] Jagiellonian Univ, Med Coll, Fac Med, Dept Neurol, Krakow, Poland; [Pereira, Alexandre] Univ Sao Paulo, Heart Inst, Lab Genet & Mol Biol, Sao Paulo, Brazil; [Pereira, Alexandre] Harvard Med Sch, Dept Genet, Boston, MA USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol & Hlth Serv, Seattle, WA 98195 USA; [Pulit, Sara L.] Univ Utrecht, Univ Med Ctr Utrecht, Ctr Mol Med, Dept Genet, Utrecht, Netherlands; [Pulit, Sara L.] Univ Oxford, Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England; [Rader, Daniel J.] Univ Penn, Perelman Sch Med, Dept Med, Div Cardiovasc Med, Philadelphia, PA USA; [Ribases, Marta] Univ Autonoma Barcelona, Vall dHebron Res Inst VHIR, Grp Psychiat Mental Hlth & Addict, Psychiatr Genet Unit, Barcelona, Spain; [Ribases, Marta] Hosp Univ Vall dHebron, Dept Psychiat, Barcelona, Spain; [Ribases, Marta] Inst Salud Carlos III, Biomed Network Res Ctr Mental Hlth CIBERSAM, Madrid, Spain; [Risch, Lorenz] Univ Bern, Univ Inst Clin Chem, Bern, Switzerland; [Risch, Lorenz] Lab Med Zentrum Dr Risch, Schaan, Liechtenstein; [Rosenberg, Michael A.] Univ Colorado, Sch Med, Aurora, CO USA; [Rost, Natalia] Massachusetts Gen Hosp, J Philip Kistler Stroke Res Ctr, Boston, MA 02114 USA; [Rotter, Jerome I.] Harbor UCLA Med Ctr, LABioMed, Inst Translat Genom & Populat Sci, Dept Pediat, Torrance, CA 90509 USA; [Rotter, Jerome I.] Harbor UCLA Med Ctr, LABioMed, Dept Med, Torrance, CA 90509 USA; [Saba, Samir; Shalaby, Alaa A.] Univ Pittsburgh, Div Cardiol, Pittsburgh, PA USA; [Sandhu, Roopinder K.] Univ Alberta, Div Cardiol, Edmonton, AB, Canada; [Schnabel, Renate B.; Zeller, Tanja] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Schnabel, Renate B.; Zeller, Tanja] DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany; [Scott, Stuart A.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Shah, Svati; Sun, Albert] Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC 27706 USA; [Shalaby, Alaa A.] Pittsburgh VA Healthcare Syst, Cardiol Div, Pittsburgh, PA USA; [Shim, Jaemin] Korea Univ, Anam Hosp, Seoul, South Korea; [Sinisalo, Juha] Univ Helsinki, Cent Hosp, Heart & Lung Ctr HUS, Helsinki, Finland; [Smith, Blair H.] Univ Dundee, Div Populat Hlth Sci, Dundee, Scotland; [Smith, J. Gustav] Lund Univ, Dept Cardiol Clin Sci, Lund, Sweden; [Smith, J. Gustav] Skane Univ Hosp, Lund, Sweden; [Soliman, Elsayed Z.] Wake Forest Sch Med, Epidemiol Cardiol Res Ctr EPICARE, Winston Salem, NC USA; [Sotoodehnia, Nona] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Sotoodehnia, Nona] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Stricker, Bruno H.; Uitterlinden, Andre G.] Erasmus Univ, Med Ctr Rotterdam, Dept Epidemiol & Internal Med, Rotterdam, Netherlands; [Stricker, Bruno H.] Inspectorate Hlth Care, Utrecht, Netherlands; [Tanaka, Toshihiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Div, Tokyo, Japan; [Teumer, Alexander] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Tveit, Arnljot] Univ Oslo, Inst Clin Med, Oslo, Norway; [Voelker, Uwe; Weiss, Stefan] Univ Med Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Gen, Greifswald, Germany; [Wang, Biqi; Lunetta, Kathryn L.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Weiss, Raul] Ohio State Univ, Div Cardiovasc Med, Columbus, OH 43210 USA; [Wong, Jorge A.] McMaster Univ, Div Cardiol Hamilton Hlth Sci, Hamilton, ON, Canada; [Woo, Daniel] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Worrall, Bradford B.] Univ Virginia Hlth Syst, Dept Neurol, Charlottesville, VA USA; [Worrall, Bradford B.] Univ Virginia Hlth Syst, Dept Publ Hlth Sci, Charlottesville, VA USA; [Lubitz, Steven A.; Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; University of Basel; Rigshospitalet; University of Copenhagen; Danmarks Grundforskningsfond; University of Copenhagen; University of Copenhagen; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Lund University; Emory University; Rollins School Public Health; Harvard University; Massachusetts General Hospital; Johns Hopkins University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Framingham Heart Study; Boston University; Boston University; Johns Hopkins University; University of Washington; University of Washington Seattle; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Baylor College of Medicine; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; University of Edinburgh; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Seoul National University (SNU); Seoul National University Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; University System of Maryland; University of Maryland Baltimore; McMaster University; Population Health Research Institute; University of Liverpool; Maastricht University; Maastricht University; University of Pennsylvania; Pennsylvania Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Ruprecht Karls University Heidelberg; Vanderbilt University; University of Munich; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Greifswald Medical School; German Centre for Cardiovascular Research; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Massachusetts System; University of Massachusetts Worcester; University of Tartu; Tampere University; Tampere University Hospital; Tampere University; Victor Chang Cardiac Research Institute; St Vincents Hospital Sydney; University of New South Wales Sydney; University of Glasgow; Erasmus University Rotterdam; Erasmus MC; University of Groningen; Seton Hall University; Icelandic Heart Association; University of Iceland; Uppsala University; University of Iowa; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Edinburgh; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kaiser Permanente; Tampere University; Tampere University; University of Aberdeen; Universidade de Sao Paulo; Stanford University; RIKEN; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Tampere University; Tampere University Hospital; Tampere University; RIKEN; University of California System; University of California San Francisco; German Heart Centre Munich; Technical University of Munich; Medical University of Graz; University of Birmingham; University of Birmingham; Utah System of Higher Education; University of Utah; RIKEN; Tampere University; Tampere University Hospital; Tampere University; Bayer AG; Johns Hopkins University; Utah System of Higher Education; University of Utah; Korea University; Korea University Medicine (KU Medicine); Uppsala University; University of Oxford; Wellcome Centre for Human Genetics; University of Helsinki; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Glasgow; Karolinska Institutet; Universidade de Sao Paulo; University of California System; University of California San Francisco; Medical University of Graz; SYNLAB Group; Lund University; Saint David's Medical Center; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Pennsylvania; Lund University; Lund University; Skane University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Glasgow; Yonsei University; Yonsei University Health System; McMaster University; Jagiellonian University; Collegium Medicum Jagiellonian University; Universidade de Sao Paulo; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Utrecht University; Utrecht University Medical Center; University of Oxford; University of Pennsylvania; Pennsylvania Medicine; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; University of Bern; University Hospital of Bern; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Massachusetts General Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alberta; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; Icahn School of Medicine at Mount Sinai; Duke University; Korea University; Korea University Medicine (KU Medicine); University of Helsinki; Helsinki University Central Hospital; University of Dundee; Lund University; Lund University; Skane University Hospital; Wake Forest University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Erasmus University Rotterdam; Erasmus MC; Tokyo Medical & Dental University (TMDU); Greifswald Medical School; University of Oslo; Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School; Boston University; University System of Ohio; Ohio State University; McMaster University; University System of Ohio; University of Cincinnati; University of Virginia; University of Virginia; Harvard University; Massachusetts General Hospital	Ellinor, PT (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA.; Ellinor, PT (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA.; Ellinor, PT (corresponding author), Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA 02114 USA.	ellinor@mgh.harvard.edu	Lin, Honghuang/A-3269-2019; Dudley, Samuel/AAR-7950-2021; Müller-Nurasyid, Martina/I-8735-2018; Risch, Lorenz/D-4629-2011; Porteous, David/AAA-3446-2021; Ribasés, Marta/B-5309-2019; Pare, Guillaume/T-9631-2018; Roden, Dan/ABD-5412-2021; Verweij, Niek/ABC-6249-2021; Choi, Eue-Keun/K-3752-2019; Smith, Blair H/G-2834-2012; Dudley, Samuel C/A-7085-2009; Pereira, Alexandre/HHN-1038-2022; Nazarian, Saman/ABC-8000-2020; Loos, Ruth J F/Q-2862-2016; Ford, Ian/ABE-6145-2020; Smith, Albert Vernon/AHC-3838-2022; Van Wagoner, David R/C-6783-2008; Laurikka, Jari/F-2010-2014; , Kastrati/Y-2389-2019; Kirchhof, Paulus/AAT-7074-2021; olesen, morten/AAC-5752-2021; Campbell, Archie/AAZ-1757-2021; Soliman, Elsayed Z/AAD-7135-2020; Bihlmeyer, Nathan/T-3939-2019; Loos, Ruth/GON-5877-2022; Sinner, Moritz/AAW-5043-2020; JIMENEZ-CONDE, JORDI/C-1941-2012; Lehtimäki, Terho/AAD-1094-2022; Dichgans, Martin/HCH-3247-2022; Teumer, Alexander/S-7438-2019; Dudink, Elton/AAC-9913-2019; Schnabel, Renate B/ABE-6668-2021; Li, Man/AAX-3400-2020; Denny, Josh/AAL-3359-2021; Benjamin, Emelia/E-7103-2011; Dörr, Marcus/F-1919-2010; Marcus, Gregory/AAN-8584-2021; Pera, Joanna/U-5552-2018; Ito, Kaoru/AAZ-3440-2021; Rotter, Jerome/AAY-6598-2021; Franco, Óscar H/ABE-2305-2020; Kessler, Thorsten/AAI-7292-2021; Choi, Eue-Keun/J-5968-2014; Gudnason, Vilmundur/AAE-7126-2019; Kavousi, Maryam/F-1174-2018; Jukema, J. Wouter/ABD-6503-2021; Aeschbacher, Stefanie/E-4935-2017; Alonso, Alvaro/A-4917-2010; Hernesniemi, Jussi/ABH-1842-2021; Kessler, Thorsten/O-7426-2015; Magnusson, Patrik KE/C-4458-2017; Svendsen, Jesper Hastrup/G-8573-2017; Nikus, Kjell/K-7813-2019; Pak, Hui-Nam/C-4266-2015; Smith, Jonathan D./H-9723-2013	Lin, Honghuang/0000-0003-3043-3942; Dudley, Samuel/0000-0001-5843-5961; Müller-Nurasyid, Martina/0000-0003-3793-5910; Risch, Lorenz/0000-0003-2692-6699; Porteous, David/0000-0003-1249-6106; Ribasés, Marta/0000-0003-1039-1116; Pare, Guillaume/0000-0002-6795-4760; Verweij, Niek/0000-0002-4303-7685; Smith, Blair H/0000-0002-5362-9430; Loos, Ruth J F/0000-0002-8532-5087; Smith, Albert Vernon/0000-0003-1942-5845; Van Wagoner, David R/0000-0001-8250-9828; Laurikka, Jari/0000-0001-7253-6048; Kirchhof, Paulus/0000-0002-1881-0197; Soliman, Elsayed Z/0000-0001-5632-8150; Lehtimäki, Terho/0000-0002-2555-4427; Dichgans, Martin/0000-0002-0654-387X; Teumer, Alexander/0000-0002-8309-094X; Schnabel, Renate B/0000-0001-7170-9509; Li, Man/0000-0002-3839-0281; Denny, Josh/0000-0002-3049-7332; Benjamin, Emelia/0000-0003-4076-2336; Dörr, Marcus/0000-0001-7471-475X; Marcus, Gregory/0000-0001-5197-7696; Pera, Joanna/0000-0001-6142-2969; Franco, Óscar H/0000-0002-4606-4929; Kessler, Thorsten/0000-0003-3326-1621; Choi, Eue-Keun/0000-0002-0411-6372; Gudnason, Vilmundur/0000-0001-5696-0084; Kavousi, Maryam/0000-0001-5976-6519; Jukema, J. Wouter/0000-0002-3246-8359; Alonso, Alvaro/0000-0002-2225-8323; Hernesniemi, Jussi/0000-0002-8111-6421; Magnusson, Patrik KE/0000-0002-7315-7899; Svendsen, Jesper Hastrup/0000-0001-8466-8515; Chen, Lin/0000-0002-0700-814X; Ahlberg, Gustav/0000-0003-0066-2779; Melander, Olle/0000-0002-2581-484X; Rosenberg, Michael/0000-0002-6708-1648; Knight, Stacey/0000-0003-0092-7327; Sinisalo, Juha/0000-0002-0169-5137; Chaffin, Mark/0000-0002-1234-5562; Lim, Hong Euy/0000-0001-8102-8352; Lindgren, Cecilia/0000-0002-4903-9374; Refsgaard, Lena/0000-0002-6560-9357; Johnson, Renee/0000-0002-8979-2096; Kietselaer, Bas/0000-0002-0096-8594; Huang, Paul/0000-0002-5436-8658; Albert, Christine/0000-0002-2081-1121; Wiggins, Kerri L/0000-0003-2749-1279; Olesen, Morten Salling/0000-0001-9477-5322; Scott, Stuart/0000-0001-5720-1864; Morley, Michael/0000-0002-0958-7376; Pak, Hui-Nam/0000-0002-3256-3620; Natale, Andrea/0000-0002-5487-0728; Zeller, Tanja/0000-0003-3379-2641; London, Barry/0000-0003-1506-3947; Weiss, Stefan/0000-0002-3553-4315; Pedersen, Nancy/0000-0001-8057-3543; Anderson, Christopher/0000-0002-0053-2002; Lunetta, Kathryn/0000-0002-9268-810X; Damrauer, Scott/0000-0001-8009-1632; Malik, Rainer/0000-0001-9212-2520; Kahonen, Mika/0000-0002-4510-7341; Bihlmeyer, Nathan/0000-0002-4415-7419; Smith, Jonathan D./0000-0002-0415-386X; Noordam, Raymond/0000-0001-7801-809X; Dudink, Elton/0000-0003-4572-3969; Tucker, Nathan/0000-0002-5071-4218; Padmanabhan, Sandosh/0000-0003-3869-5808; Theriault, Sebastien/0000-0003-1893-8307; Rienstra, Michiel/0000-0002-2581-070X; Pulit, Sara/0000-0002-2502-3669	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL130114, K24HL105780, R01HL116747, R01HL138737, R01HL092577, R01HL139731, R01HL111314, R01HL128914, K23HL127296, R01HL092217] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG007380] Funding Source: NIH RePORTER; American Heart Association-American Stroke Association [16EIA26410001] Funding Source: Medline; Doris Duke Charitable Foundation [2014105] Funding Source: Medline; Medical Research Council [MC_QA137853, MC_PC_17228] Funding Source: Medline; NHGRI NIH HHS [U01 HG007417] Funding Source: Medline; NHLBI NIH HHS [U01 HL130114, R01 HL092577, L30 HL123413, R01 HL092217, K24 HL105780, R01 HL116747, K23 HL127296, R01 HL111314, R01 HL090620, R01 HL105756, R01 HL120393, R01 HL139731, U01 HL120393, R01 HL138737, R01 HL128914] Funding Source: Medline; NIGMS NIH HHS [T32 GM007569] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Heart Association-American Stroke Association(American Heart Association); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI [10.1016/j.hrthm.2011.05.020, 10.1093/europace/eur245]; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; [Anonymous], 2016, NAT GENET, V48, P1279, DOI DOI 10.1038/ng.3643; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Auton A., 2015, NATURE, V7571, P68, DOI 10.1038/nature15393; Barbeira AN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03621-1; Bellenguez C, 2012, BIOINFORMATICS, V28, P134, DOI 10.1093/bioinformatics/btr599; Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416; Bycroft C., 2017, BIORXIV, DOI [DOI 10.1101/16629824, DOI 10.1101/166298]; Chanda P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068585; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Christophersen IE, 2017, NAT GENET, V49, P946, DOI 10.1038/ng.3843; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Corrado D, 2017, NEW ENGL J MED, V376, P61, DOI 10.1056/NEJMra1509267; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Delaneau O, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15452; den Hoed M, 2013, NAT GENET, V45, P621, DOI 10.1038/ng.2610; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Ernst J, 2015, NAT BIOTECHNOL, V33, P364, DOI 10.1038/nbt.3157; Fadista J, 2016, EUR J HUM GENET, V24, P1202, DOI 10.1038/ejhg.2015.269; Fay MP, 2010, J STAT SOFTW, V36, P1; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Goldstein JI, 2012, BIOINFORMATICS, V28, P2543, DOI 10.1093/bioinformatics/bts479; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; January CT, 2014, CIRCULATION, V130, pE270, DOI [10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000142, 10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022]; Kirchhof P, 2011, CIRC-CARDIOVASC GENE, V4, P123, DOI 10.1161/CIRCGENETICS.110.958058; Klarin D, 2017, NAT GENET, V49, P1392, DOI 10.1038/ng.3914; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lahat H, 2001, AM J HUM GENET, V69, P1378, DOI 10.1086/324565; Lahat H, 2001, CIRCULATION, V103, P2822; Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431; Low SK, 2017, NAT GENET, V49, P953, DOI 10.1038/ng.3842; Lu XF, 2015, HUM MOL GENET, V24, P865, DOI 10.1093/hmg/ddu478; Lubitz SA, 2010, JAMA-J AM MED ASSOC, V304, P2263, DOI 10.1001/jama.2010.1690; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; McNair WP, 2004, CIRCULATION, V110, P2163, DOI 10.1161/01.CIR.0000144458.58660.BB; Nadadur RD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf4891; Nielsen J. B, 2018, PREPRINT; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Pers TH, 2015, BIOINFORMATICS, V31, P418, DOI 10.1093/bioinformatics/btu655; Postma AV, 2008, CIRC RES, V102, P1433, DOI 10.1161/CIRCRESAHA.107.168294; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Rosand J, 2016, LANCET NEUROL, V15, P174, DOI 10.1016/S1474-4422(15)00338-5; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Sinner MF, 2008, EUR HEART J, V29, P907, DOI 10.1093/eurheartj/ehm619; Sinner MF, 2014, CIRCULATION, V130, P1225, DOI 10.1161/CIRCULATIONAHA.114.009892; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Syeda F, 2016, J AM COLL CARDIOL, V68, P1881, DOI 10.1016/j.jacc.2016.07.766; Tucker NR, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.117.001902; van Weerd JH, 2014, CIRC RES, V115, P432, DOI 10.1161/CIRCRESAHA.115.303591; Wang J, 2010, P NATL ACAD SCI USA, V107, P9753, DOI 10.1073/pnas.0912585107; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Welter Danielle, 2014, Nucleic Acids Res, V42, pD1001, DOI 10.1093/nar/gkt1229; Weng LC, 2018, CIRCULATION, V137, P1027, DOI 10.1161/CIRCULATIONAHA.117.031431; Weng LC, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.117.001838; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	73	302	303	5	63	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2018	50	9					1225	+		10.1038/s41588-018-0133-9	http://dx.doi.org/10.1038/s41588-018-0133-9			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GS0CH	29892015	Green Accepted, Green Submitted, Green Published			2022-12-17	WOS:000443151300012
J	Nikolaev, SI; Rimoldi, D; Iseli, C; Valsesia, A; Robyr, D; Gehrig, C; Harshman, K; Guipponi, M; Bukach, O; Zoete, V; Michielin, O; Muehlethaler, K; Speiser, D; Beckmann, JS; Xenarios, I; Halazonetis, TD; Jongeneel, CV; Stevenson, BJ; Antonarakis, SE				Nikolaev, Sergey I.; Rimoldi, Donata; Iseli, Christian; Valsesia, Armand; Robyr, Daniel; Gehrig, Corinne; Harshman, Keith; Guipponi, Michel; Bukach, Olesya; Zoete, Vincent; Michielin, Olivier; Muehlethaler, Katja; Speiser, Daniel; Beckmann, Jacques S.; Xenarios, Ioannis; Halazonetis, Thanos D.; Jongeneel, C. Victor; Stevenson, Brian J.; Antonarakis, Stylianos E.			Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma	NATURE GENETICS			English	Article							MALIGNANT-MELANOMA; GERMLINE MUTATIONS; MAPK PATHWAY; HUMAN BREAST; GENE; GENOME; BRAF; METASTASIS; MECHANISMS; BYPASS	We performed exome sequencing to detect somatic mutations in protein-coding regions in seven melanoma cell lines and donor-matched germline cells. All melanoma samples had high numbers of somatic mutations, which showed the hallmark of UV-induced DNA repair. Such a hallmark was absent in tumor sample specific mutations in two metastases derived from the same individual. Two melanomas with non-canonical BRAF mutations harbored gain-of-function MAP2K1 and MAP2K2 (MEK1 and MEK2, respectively) mutations, resulting in constitutive ERK phosphorylation and higher resistance to MEK inhibitors. Screening a larger cohort of individuals with melanoma revealed the presence of recurring somatic MAP2K1 and MAP2K2 mutations, which occurred at an overall frequency of 8%. Furthermore, missense and nonsense somatic mutations were frequently found in three candidate melanoma genes, FAT4, LRP1B and DSC1.	[Nikolaev, Sergey I.; Robyr, Daniel; Gehrig, Corinne; Guipponi, Michel; Antonarakis, Stylianos E.] Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland; [Rimoldi, Donata; Iseli, Christian; Valsesia, Armand; Michielin, Olivier; Muehlethaler, Katja; Speiser, Daniel; Jongeneel, C. Victor; Stevenson, Brian J.] Univ Lausanne, Ludwig Inst Canc Res, Lausanne, Switzerland; [Iseli, Christian; Zoete, Vincent; Michielin, Olivier; Xenarios, Ioannis; Jongeneel, C. Victor; Stevenson, Brian J.] Swiss Inst Bioinformat, Lausanne, Switzerland; [Valsesia, Armand; Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Harshman, Keith] Ctr Integrat Gen, Lausanne Genom Technol Facil, Lausanne, Switzerland; [Bukach, Olesya] Univ Geneva, Dept Micorbiol & Mol Med, Geneva, Switzerland; [Michielin, Olivier] CHU Vaudois, Multidisciplinary Oncol Ctr, Lausanne, Switzerland; [Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, Lausanne, Switzerland; [Halazonetis, Thanos D.] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Jongeneel, C. Victor] Univ Illinois, Natl Ctr Supercomp Applicat, Urbana, IL 61801 USA; [Jongeneel, C. Victor] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Antonarakis, Stylianos E.] Inst Genet & Genom Geneva iGE3, Geneva, Switzerland	University of Geneva; Ludwig Institute for Cancer Research; University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nikolaev, SI (corresponding author), Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland.	serg.nikolaev@gmail.com; donata.rimoldi@unil.ch; Stylianos.Antonarakis@unige.ch	Bukach, Olesya/GYT-9911-2022; Beckmann, Jacques S/A-9772-2008; Xenarios, Ioannis/ABD-5045-2021; Michielin, Olivier/ABE-7924-2020; Iseli, Christian/AAM-3878-2020; Nikolaev, Sergey/F-3148-2012; Speiser, Daniel E./F-2173-2013; Antonarakis, Stylianos E/N-8866-2014; Valsesia, Armand/F-1724-2010	Beckmann, Jacques S/0000-0002-9741-1900; Xenarios, Ioannis/0000-0002-3413-6841; Iseli, Christian/0000-0002-2296-2863; Antonarakis, Stylianos E/0000-0001-8907-5823; Valsesia, Armand/0000-0003-0746-9664; Jongeneel, Cornelis Victor/0000-0002-3922-1906	Ludwig Institute for Cancer Research; Hilton-Ludwig Cancer Metastasis Initiative; Conrad N. Hilton Foundation; Swiss National Science Foundation (SNF) National Centres of Competence in Research (NCCR) Frontiers in Genetics; European Research Council	Ludwig Institute for Cancer Research; Hilton-Ludwig Cancer Metastasis Initiative; Conrad N. Hilton Foundation; Swiss National Science Foundation (SNF) National Centres of Competence in Research (NCCR) Frontiers in Genetics(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission)	We thank E Schutz and P. Bady for statistical discussions, P. Descombes for high-throughput sequencing, D. Martinet for aCGH data and C. Rivolta for valuable comments on the manuscript. We thank A. Simpson and R. Strausberg for their constant support. Part of the computation was performed on the cluster at the Vital-IT computing center. This work was supported by the Ludwig Institute for Cancer Research (CI. and SEA.), the Hilton-Ludwig Cancer Metastasis Initiative, funded by the Conrad N. Hilton Foundation (DR.), the Swiss National Science Foundation (SNF) National Centres of Competence in Research (NCCR) Frontiers in Genetics (SEA.) and the European Research Council (ERC; S.E.A.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ANDERSEN LB, 1993, NAT GENET, V3, P118, DOI 10.1038/ng0293-118; Bentivegna S, 2008, HUM MUTAT, V29, P441, DOI 10.1002/humu.20672; Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Daniotti M, 2004, ONCOGENE, V23, P5968, DOI 10.1038/sj.onc.1207780; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Delaney AM, 2002, MOL CELL BIOL, V22, P7593, DOI 10.1128/MCB.22.21.7593-7602.2002; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Fecher LA, 2008, CURR OPIN ONCOL, V20, P183, DOI 10.1097/CCO.0b013e3282f5271c; Fischmann TO, 2009, BIOCHEMISTRY-US, V48, P2661, DOI 10.1021/bi801898e; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Gripp KW, 2007, AM J MED GENET A, V143A, P1472, DOI 10.1002/ajmg.a.31815; Haass NK, 2005, J INVEST DERM SYMP P, V10, P153, DOI 10.1111/j.1087-0024.2005.200407.x; Jeong YH, 2010, BIOCHEM BIOPH RES CO, V392, P495, DOI 10.1016/j.bbrc.2010.01.049; Li YH, 2001, MOL NEUROBIOL, V23, P53; Liu CX, 2000, CANCER RES, V60, P1961; Mao YP, 2011, DEVELOPMENT, V138, P947, DOI 10.1242/dev.057166; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Nystrom AM, 2008, J MED GENET, V45, P500, DOI 10.1136/jmg.2008.057653; O'Donovan PJ, 2010, CARCINOGENESIS, V31, P961, DOI 10.1093/carcin/bgq069; Oshiro MM, 2005, BREAST CANCER RES, V7, pR669, DOI 10.1186/bcr1273; Pages V, 2009, GENE DEV, V23, P1438, DOI 10.1101/gad.1793409; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Prickett TD, 2009, NAT GENET, V41, P1127, DOI 10.1038/ng.438; Qi C, 2009, INT J CANCER, V124, P793, DOI 10.1002/ijc.23775; Rane SG, 2002, MOL CELL BIOL, V22, P644, DOI 10.1128/MCB.22.2.644-656.2002; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Siegel DH, 2011, BRIT J DERMATOL, V164, P521, DOI 10.1111/j.1365-2133.2010.10122.x; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solit D, 2010, NATURE, V468, P902, DOI 10.1038/468902a; Sonoda I, 2004, CANCER RES, V64, P3741, DOI 10.1158/0008-5472.CAN-04-0172; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Timmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015661; Valsesia A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018369; Wei XM, 2011, HUM MUTAT, V32, pE2148, DOI 10.1002/humu.21477; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	43	302	311	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					133	139		10.1038/ng.1026	http://dx.doi.org/10.1038/ng.1026			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22197931				2022-12-17	WOS:000299664400009
J	Liu, XD; Invernizzi, P; Lu, Y; Kosoy, R; Lu, Y; Bianchi, I; Podda, M; Xu, C; Xie, G; Macciardi, F; Selmi, C; Lupoli, S; Shigeta, R; Ransom, M; Lleo, A; Lee, AT; Mason, AL; Myers, RP; Peltekian, KM; Ghent, CN; Bernuzzi, F; Zuin, M; Rosina, F; Borghesio, E; Floreani, A; Lazzari, R; Niro, G; Andriulli, A; Muratori, L; Muratori, P; Almasio, PL; Andreone, P; Margotti, M; Brunetto, M; Coco, B; Alvaro, D; Bragazzi, MC; Marra, F; Pisano, A; Rigamonti, C; Colombo, M; Marzioni, M; Benedetti, A; Fabris, L; Strazzabosco, M; Portincasa, P; Palmieri, VO; Tiribelli, C; Croce, L; Bruno, S; Rossi, S; Vinci, M; Prisco, C; Mattalia, A; Toniutto, P; Picciotto, A; Galli, A; Ferrari, C; Colombo, S; Casella, G; Morini, L; Caporaso, N; Colli, A; Spinzi, G; Montanari, R; Gregersen, PK; Heathcote, EJ; Hirschfield, GM; Siminovitch, KA; Amos, CI; Gershwin, ME; Seldin, MF				Liu, Xiangdong; Invernizzi, Pietro; Lu, Yue; Kosoy, Roman; Lu, Yan; Bianchi, Ilaria; Podda, Mauro; Xu, Chun; Xie, Gang; Macciardi, Fabio; Selmi, Carlo; Lupoli, Sara; Shigeta, Russell; Ransom, Michael; Lleo, Ana; Lee, Annette T.; Mason, Andrew L.; Myers, Robert P.; Peltekian, Kevork M.; Ghent, Cameron N.; Bernuzzi, Francesca; Zuin, Massimo; Rosina, Floriano; Borghesio, Elisabetta; Floreani, Annarosa; Lazzari, Roberta; Niro, Grazia; Andriulli, Angelo; Muratori, Luigi; Muratori, Paolo; Almasio, Piero L.; Andreone, Pietro; Margotti, Marzia; Brunetto, Maurizia; Coco, Barbara; Alvaro, Domenico; Bragazzi, Maria C.; Marra, Fabio; Pisano, Alessandro; Rigamonti, Cristina; Colombo, Massimo; Marzioni, Marco; Benedetti, Antonio; Fabris, Luca; Strazzabosco, Mario; Portincasa, Piero; Palmieri, Vincenzo O.; Tiribelli, Claudio; Croce, Lory; Bruno, Savino; Rossi, Sonia; Vinci, Maria; Prisco, Cleofe; Mattalia, Alberto; Toniutto, Pierluigi; Picciotto, Antonio; Galli, Andrea; Ferrari, Carlo; Colombo, Silvia; Casella, Giovanni; Morini, Lorenzo; Caporaso, Nicola; Colli, Agostino; Spinzi, Giancarlo; Montanari, Renzo; Gregersen, Peter K.; Heathcote, E. Jenny; Hirschfield, Gideon M.; Siminovitch, Katherine A.; Amos, Christopher I.; Gershwin, M. Eric; Seldin, Michael F.			Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis	NATURE GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; SPI-B; CELL; VARIANTS; RISK; TRANSCRIPTION; EXPRESSION; ASTHMA	A genome-wide association screen for primary biliary cirrhosis risk alleles was performed in an Italian cohort. The results from the Italian cohort replicated IL12A and IL12RB associations, and a combined meta-analysis using a Canadian dataset identified newly associated loci at SPIB (P = 7.9 x 10(-11), odds ratio (OR) = 1.46), IRF5-TNPO3 (P = 2.8 x 10(-10), OR = 1.63) and 17q12-21 (P = 1.7 x 10(-10), OR = 1.38).	[Invernizzi, Pietro; Kosoy, Roman; Selmi, Carlo; Shigeta, Russell; Ransom, Michael; Lleo, Ana; Gershwin, M. Eric; Seldin, Michael F.] Univ Calif Davis, Davis, CA 95616 USA; [Liu, Xiangdong; Lu, Yan; Xu, Chun; Xie, Gang; Heathcote, E. Jenny; Hirschfield, Gideon M.; Siminovitch, Katherine A.] Univ Hlth Network, Toronto, ON, Canada; [Invernizzi, Pietro; Bianchi, Ilaria; Podda, Mauro; Selmi, Carlo; Lleo, Ana; Bernuzzi, Francesca] IRCCS, Ist Clin Humanitas, Rozzano, Italy; [Lu, Yue; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Bianchi, Ilaria; Podda, Mauro; Macciardi, Fabio; Selmi, Carlo; Lleo, Ana; Bernuzzi, Francesca; Zuin, Massimo; Rigamonti, Cristina; Colombo, Massimo] Univ Milan, Milan, Italy; [Macciardi, Fabio] Univ Calif Irvine, Irvine, CA USA; [Lupoli, Sara] Ist Sci San Raffaele, I-20132 Milan, Italy; [Lee, Annette T.; Gregersen, Peter K.] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Mason, Andrew L.] Univ Alberta, Edmonton, AB, Canada; [Liu, Xiangdong; Myers, Robert P.] Univ Calgary, Calgary, AB, Canada; [Peltekian, Kevork M.] Dalhousie Univ, Halifax, NS, Canada; [Ghent, Cameron N.] London Hlth Sci Ctr, London, ON, Canada; [Rosina, Floriano; Borghesio, Elisabetta] Gradenigo Hosp, Turin, Italy; [Floreani, Annarosa; Lazzari, Roberta; Fabris, Luca] Univ Padua, Padua, Italy; [Niro, Grazia; Andriulli, Angelo] Casa Sollievo della Sofferenza Hosp, San Giovanni Rotondo, Italy; [Muratori, Luigi; Muratori, Paolo; Andreone, Pietro; Margotti, Marzia] Univ Bologna, Bologna, Italy; [Almasio, Piero L.] Univ Palermo, Palermo, Italy; [Brunetto, Maurizia; Coco, Barbara] Azienda Osped Univ Pisana, Pisa, Italy; [Alvaro, Domenico; Bragazzi, Maria C.] Univ Sapienza Rome, Rome, Italy; [Marra, Fabio; Pisano, Alessandro; Galli, Andrea] Univ Florence, Florence, Italy; [Marzioni, Marco; Benedetti, Antonio] Univ Politecn Marche, Ancona, Italy; [Strazzabosco, Mario] Yale Univ, New Haven, CT USA; [Strazzabosco, Mario] Univ Milano Bicocca, Monza, Italy; [Portincasa, Piero; Palmieri, Vincenzo O.] Univ Bari, Bari, Italy; [Tiribelli, Claudio; Croce, Lory] Univ Trieste, Trieste, Italy; [Bruno, Savino; Rossi, Sonia] Osped Fatebene Fratelli & Oftalm, Milan, Italy; [Vinci, Maria; Prisco, Cleofe] Osped Maggiore Niguarda, Milan, Italy; [Mattalia, Alberto] Santa Croce Carle Hosp, Cuneo, Italy; [Toniutto, Pierluigi] Univ Udine, I-33100 Udine, Italy; [Picciotto, Antonio] Univ Genoa, Genoa, Italy; [Ferrari, Carlo] Univ Parma, Azienda Osped, I-43100 Parma, Italy; [Colombo, Silvia] Treviglio Hosp, Treviglio, Italy; [Casella, Giovanni] Desio Hosp, Desio, Italy; [Morini, Lorenzo] Magenta Hosp, Magenta, Italy; [Caporaso, Nicola] Univ Naples Federico 2, Naples, Italy; [Colli, Agostino] AO Lecco, Dept Internal Med, Lecce, Italy; [Spinzi, Giancarlo] AO Valduce, Corno, Italy; [Montanari, Renzo] Osped Negrar, Verona, Italy; [Heathcote, E. Jenny; Hirschfield, Gideon M.; Siminovitch, Katherine A.] Univ Toronto, Toronto, ON, Canada; [Siminovitch, Katherine A.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of California System; University of California Davis; University of Toronto; University Toronto Affiliates; University Health Network Toronto; IRCCS Humanitas Research Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Milan; University of California System; University of California Irvine; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Northwell Health; University of Alberta; University of Calgary; Dalhousie University; London Health Sciences Centre; Humanitas Hospital Gradenigo; University of Padua; IRCCS Casa Sollievo Della Sofferenza; University of Bologna; University of Palermo; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Sapienza University Rome; University of Florence; Marche Polytechnic University; Yale University; University of Milano-Bicocca; Universita degli Studi di Bari Aldo Moro; University of Trieste; University of Udine; University of Genoa; University of Parma; University Hospital of Parma; University of Naples Federico II; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Seldin, MF (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.	mfseldin@ucdavis.edu	Hirschfield, Gideon M/M-2143-2015; Fabris, Luca/J-7565-2018; Ferrari, Carlo/D-5663-2017; Peltekian, Kevork M/D-1083-2010; bernuzzi, francesca/AAQ-7073-2020; Muratori, Luigi/I-3181-2012; Niro, Grazia G/Q-9087-2016; croce', lory saveria l/E-2565-2011; Andreone, Pietro/K-8050-2016; Selmi, Carlo/ABG-4899-2021; Mason, Andrew/D-2938-2013; Marzioni, Marco/A-8153-2011; Brunetto, Maurizia/AAU-2906-2020; Siminovitch, Katherine/K-1475-2013; Galli, Andrea/AAC-1623-2019; ALVARO, Domenico/J-8600-2018; Invernizzi, Pietro/AAB-8367-2022; Marra, Fabio/K-7263-2016; Andriulli, Angelo/B-5027-2017; Lleo, Ana/AAA-5759-2019; Macciardi, Fabio/N-3768-2014; Benedetti, Antonio/A-8189-2011; Bossa, Fabrizio/B-3078-2017; Tiribelli, Claudio/A-4716-2014	Hirschfield, Gideon M/0000-0002-6736-2255; Fabris, Luca/0000-0001-8538-6317; Ferrari, Carlo/0000-0002-5461-6842; Peltekian, Kevork M/0000-0002-9560-5576; Muratori, Luigi/0000-0002-8748-8031; Niro, Grazia G/0000-0002-6169-9586; croce', lory saveria l/0000-0001-9890-7011; Andreone, Pietro/0000-0002-4794-9809; Selmi, Carlo/0000-0002-0323-0376; Mason, Andrew/0000-0002-0470-9522; Marzioni, Marco/0000-0001-6014-6165; Brunetto, Maurizia/0000-0001-8364-9152; ALVARO, Domenico/0000-0003-3771-9644; Invernizzi, Pietro/0000-0003-3262-1998; Marra, Fabio/0000-0001-8629-0878; Andriulli, Angelo/0000-0001-8862-7083; Lleo, Ana/0000-0002-0561-7902; Macciardi, Fabio/0000-0003-0537-4266; Benedetti, Antonio/0000-0003-0280-4574; Galli, Andrea/0000-0001-5416-6290; Cadamuro, Massimiliano/0000-0002-0899-7613; Bruno, Savino/0000-0002-3887-864X; palmieri, vincenzo ostilio/0000-0002-7649-6028; Bernuzzi, Francesca/0000-0002-5008-7525; Bossa, Fabrizio/0000-0002-4518-9949; portincasa, piero/0000-0001-5359-1471; Ferrari, Carlo/0000-0002-7843-4963; Toniutto, Pierluigi/0000-0002-2566-3041; Zuin, Massimo/0000-0003-3906-4362; Tiribelli, Claudio/0000-0001-6596-7595	US National Institutes of Health [R01 DK056839, R01 DK80670, K23 DK68290, RO3 DK78527]; Canadian Institutes for Health Research [MOP 74621]; Ontario Research Fund [RE01-061]; Canadian Primary Biliary Cirrhosis Society; American Gastroenterological Association; A.J. and Sigismunda Palumbo Charitable Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK068290, R03DK078527, R01DK091823, R01DK080670, R01DK056839] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; Canadian Primary Biliary Cirrhosis Society; American Gastroenterological Association; A.J. and Sigismunda Palumbo Charitable Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the subjects and physicians who contributed DNA samples and clinical data for this study. This work was supported in part by the US National Institutes of Health (R01 DK056839, R01 DK80670, K23 DK68290 and RO3 DK78527), the Canadian Institutes for Health Research (MOP 74621), the Ontario Research Fund (RE01-061), the Canadian Primary Biliary Cirrhosis Society, the American Gastroenterological Association and the A.J. and Sigismunda Palumbo Charitable Trust.	Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Dontje W, 2006, BLOOD, V107, P2446, DOI 10.1182/blood-2005-05-2090; Garrett-Sinha LA, 1999, IMMUNITY, V10, P399, DOI 10.1016/S1074-7613(00)80040-0; Gershwin ME, 2008, HEPATOLOGY, V47, P737, DOI 10.1002/hep.22042; Guo FK, 2009, BLOOD, V114, P2909, DOI 10.1182/blood-2009-04-214676; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Invernizzi P, 2008, HEPATOLOGY, V48, P1906, DOI 10.1002/hep.22567; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Nguyen VT, 2000, J BIOL CHEM, V275, P23674, DOI 10.1074/jbc.M002482200; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Romero F, 1999, EMBO J, V18, P3419, DOI 10.1093/emboj/18.12.3419; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Sun J, 2003, J IMMUNOL, V170, P1699, DOI 10.4049/jimmunol.170.4.1699; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8	15	302	311	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2010	42	8					658	660		10.1038/ng.627	http://dx.doi.org/10.1038/ng.627			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	633RZ	20639880	Green Published, Green Accepted			2022-12-17	WOS:000280524000007
J	Silverberg, MS; Cho, JH; Rioux, JD; McGovern, DPB; Wu, J; Annese, V; Achkar, JP; Goyette, P; Scott, R; Xu, W; Barmada, MM; Klei, L; Daly, MJ; Abraham, C; Bayless, TM; Bossa, F; Griffiths, AM; Ippoliti, AF; Lahaie, RG; Latiano, A; Pare, P; Proctor, DD; Regueiro, MD; Steinhart, AH; Targan, SR; Schumm, LP; Kistner, EO; Lee, AT; Gregersen, PK; Rotter, JI; Brant, SR; Taylor, KD; Roeder, K; Duerr, RH				Silverberg, Mark S.; Cho, Judy H.; Rioux, John D.; McGovern, Dermot P. B.; Wu, Jing; Annese, Vito; Achkar, Jean-Paul; Goyette, Philippe; Scott, Regan; Xu, Wei; Barmada, M. Michael; Klei, Lambertus; Daly, Mark J.; Abraham, Clara; Bayless, Theodore M.; Bossa, Fabrizio; Griffiths, Anne M.; Ippoliti, Andrew F.; Lahaie, Raymond G.; Latiano, Anna; Pare, Pierre; Proctor, Deborah D.; Regueiro, Miguel D.; Steinhart, A. Hillary; Targan, Stephan R.; Schumm, L. Philip; Kistner, Emily O.; Lee, Annette T.; Gregersen, Peter K.; Rotter, Jerome I.; Brant, Steven R.; Taylor, Kent D.; Roeder, Kathryn; Duerr, Richard H.			Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; SUSCEPTIBILITY LOCI; SEQUENCE VARIANTS; GENE; EXPRESSION; MULTIPLE; PATHOGENESIS; REPLICATION; CONTRIBUTE	Ulcerative colitis is a chronic inflammatory disease of the colon that presents as diarrhea and gastrointestinal bleeding. We performed a genome-wide association study using DNA samples from 1,052 individuals with ulcerative colitis and preexisting data from 2,571 controls, all of European ancestry. In an analysis that controlled for gender and population structure, ulcerative colitis loci attaining genome-wide significance and subsequent replication in two independent populations were identified on chromosomes 1p36 (rs6426833, combined P = 5.1 x 10(-13), combined odds ratio OR = 0.73) and 12q15 (rs1558744, combined P = 2.5 x 10(-12), combined OR = 1.35). In addition, combined genome-wide significant evidence for association was found in a region spanning BTNL2 to HLA-DQB1 on chromosome 6p21 (rs2395185, combined P = 1.0 x 10(-16), combined OR = 0.66) and at the IL23R locus on chromosome 1p31 (rs11209026, combined P = 1.3 x 10(-8), combined OR = 0.56; rs10889677, combined P = 1.3 x 10(-8), combined OR = 1.29).	[Silverberg, Mark S.; Steinhart, A. Hillary] Univ Toronto, Mt Sinai Hosp, Inflammatory Bowel Dis Grp, Toronto, ON M5G 1X5, Canada; [Cho, Judy H.; Proctor, Deborah D.] Yale Univ, Sect Digest Dis, Dept Med, New Haven, CT 06520 USA; [Cho, Judy H.] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Rioux, John D.; Goyette, Philippe; Abraham, Clara] Univ Montreal, Montreal, PQ H1T 1C8, Canada; [Rioux, John D.; Goyette, Philippe] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [McGovern, Dermot P. B.; Ippoliti, Andrew F.; Targan, Stephan R.; Rotter, Jerome I.; Taylor, Kent D.] Cedars Sinai Med Ctr, Ctr Inflammatory Bowel Dis, Los Angeles, CA 90048 USA; [Wu, Jing; Roeder, Kathryn] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Annese, Vito; Bossa, Fabrizio; Latiano, Anna] IRCCS CSS Hosp, I-71013 San Giovanni Rotondo, FG, Italy; [Achkar, Jean-Paul] Cleveland Clin, Inst Digest Dis, Cleveland, OH 44195 USA; [Scott, Regan; Regueiro, Miguel D.; Duerr, Richard H.] Univ Pittsburgh, Dept Med, Div Gastroenterol Hepatol & Nutr, Sch Med,UPMC PUH, Pittsburgh, PA 15213 USA; [Xu, Wei] Univ Toronto, Princess Margaret Hosp, Dept Publ Hlth Sci, Toronto, ON M5G 2M9, Canada; [Barmada, M. Michael; Duerr, Richard H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Klei, Lambertus] Univ Pittsburgh, Med Ctr, Dept Psychiat, Pittsburgh, PA 15213 USA; [Daly, Mark J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02114 USA; [Bayless, Theodore M.; Brant, Steven R.] Johns Hopkins Univ, Sch Med, Dept Med, Harvey M & Lyn P Meyerhoff Infammatory Bowel Dis, Baltimore, MD 21287 USA; [Griffiths, Anne M.] Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Lahaie, Raymond G.] Univ Montreal, Dept Med, Montreal, PQ H2X 3J4, Canada; [Lahaie, Raymond G.] CHUM, Hop St Luc, Montreal, PQ H2X 3J4, Canada; [Pare, Pierre; Rotter, Jerome I.] Univ Laval, Dept Med, Div Gastroenterol, Quebec City, PQ G1K 7P4, Canada; [Pare, Pierre] CHAUQ Hop St Sacrement, Ste Foy, PQ G1S 4L8, Canada; [Schumm, L. Philip; Kistner, Emily O.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Lee, Annette T.; Gregersen, Peter K.] Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Taylor, Kent D.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Brant, Steven R.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21231 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Yale University; Yale University; Universite de Montreal; Universite de Montreal; Cedars Sinai Medical Center; Carnegie Mellon University; Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Massachusetts General Hospital; Johns Hopkins University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Universite de Montreal; Universite de Montreal; Laval University; Laval University; University of Chicago; Northwell Health; Cedars Sinai Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Duerr, RH (corresponding author), Univ Toronto, Mt Sinai Hosp, Inflammatory Bowel Dis Grp, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	duerr@pitt.edu	Daly, Mark J/B-2453-2017; Silverberg, Mark/B-4183-2008; Bossa, Fabrizio/B-3078-2017; Annese, Vito/AGW-4200-2022; Palmieri, Orazio/J-7697-2012; Latiano, Anna/R-1965-2016; Rioux, John D/A-9599-2015; Rotter, Jerome/AAY-6598-2021; Duerr, Richard H/B-4188-2009	Daly, Mark J/0000-0002-0949-8752; Bossa, Fabrizio/0000-0002-4518-9949; Annese, Vito/0000-0002-0082-892X; Palmieri, Orazio/0000-0002-0019-7929; Latiano, Anna/0000-0003-3719-2061; Rioux, John D/0000-0001-7560-8326; Duerr, Richard H/0000-0001-6586-3905; Roeder, Kathryn/0000-0002-8869-6254; Schumm, Phil/0000-0002-3050-2429; Barmada, M Michael/0000-0002-3604-6460	NIDDK IBD Genetics Consortium [DK062431, DK062422, DK062420, DK062432, DK062423, DK062413, DK062429]; Atran Foundation; Board of Governor's Chair in Medical Genetics at Cedars-Sinai Medical Center; Bohmfalk Funds for Medical Research; Burroughs Wellcome Medical Foundation; Crohn's and Colitis Foundation of America; Crohn's and Colitis Foundation of Canada; Feintech Chair in Immunobiology; Gale and Graham Wright Research Chair in Digestive Diseases; Harvey M. and Lyn P. Meyerhoff Inflammatory Bowel Disease Center; US National Institutes of Health [RR00052, DK077905, DK068112, DK072373, RR024139, DK076025, DK064869, MH057881, DK046763, RR00425]; Rainin IBD Genetics Research Fund; W. Buford Lewis family; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139, M01RR000425, M01RR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK068112, U01DK062423, R01DK064869, P30DK063491, U01DK062420, R01DK072373, U01DK062413, U01DK062429, R01DK076025, R01DK077905, P01DK046763, U01DK062422, U01DK062431, U01DK062432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057881, R01MH057881] Funding Source: NIH RePORTER	NIDDK IBD Genetics Consortium; Atran Foundation; Board of Governor's Chair in Medical Genetics at Cedars-Sinai Medical Center; Bohmfalk Funds for Medical Research; Burroughs Wellcome Medical Foundation(Burroughs Wellcome Fund); Crohn's and Colitis Foundation of America; Crohn's and Colitis Foundation of Canada; Feintech Chair in Immunobiology; Gale and Graham Wright Research Chair in Digestive Diseases; Harvey M. and Lyn P. Meyerhoff Inflammatory Bowel Disease Center; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rainin IBD Genetics Research Fund; W. Buford Lewis family; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Thanks to L. Wu Datta, J. Fultz and J. Stempak for coordinating study subject recruitment, to A. Andriulli and O. Palmieri for providing clinical data and to J. Lian, A. Liew and H. Khalili for technical support. The NIDDK IBD Genetics Consortium is funded by the following grants: DK062431 (S. R. B.), DK062422 (J. H. C.), DK062420 (R. H. D.), DK062432 (J. D. R.), DK062423 (M. S. S.), DK062413 (K. D. T.) and DK062429 (J. H. C.). The authors would also like to acknowledge additional support from the Atran Foundation (S. R. B.), Board of Governor's Chair in Medical Genetics at Cedars-Sinai Medical Center (J. I. R.), Bohmfalk Funds for Medical Research (J. H. C.), Burroughs Wellcome Medical Foundation (J. H. C.), Crohn's and Colitis Foundation of America (C. A., T. M. B., S. R. B., J. H. C., R. H. D., J. D. R.), Crohn's and Colitis Foundation of Canada (M. S. S.), Feintech Chair in Immunobiology (S. R. T.), Gale and Graham Wright Research Chair in Digestive Diseases (M. S. S.), Harvey M. and Lyn P. Meyerhoff Inflammatory Bowel Disease Center (T. M. B., S. R. B.), US National Institutes of Health grants RR00052 (S. R. B.), DK077905 (C. A.), DK068112 (J.-P. A.), DK072373 (J. H. C.), RR024139 H. C.), DK076025 (R. H. D.), DK064869 (J. D. R.), MH057881 (K. R.), DK046763 (J. I. R., S. R. T., K. D. T.) and RR00425 (K. D. T.), the Rainin IBD Genetics Research Fund (J.-P. A.) and the W. Buford Lewis family (S. R. B.).	Auja SJ, 2007, SEMIN IMMUNOL, V19, P377, DOI 10.1016/j.smim.2007.10.009; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; Murakami M, 2002, BIOCHEM BIOPH RES CO, V292, P689, DOI 10.1006/bbrc.2002.6716; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Stokkers PCF, 1999, GUT, V45, P395, DOI 10.1136/gut.45.3.395; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Suzuki N, 2000, J BIOL CHEM, V275, P5785, DOI 10.1074/jbc.275.8.5785; Teller I C, 2001, Expert Rev Mol Med, V3, P1, DOI 10.1017/S1462399401003623; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	28	302	313	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2009	41	2					216	220		10.1038/ng.275	http://dx.doi.org/10.1038/ng.275			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	403OG	19122664	Green Accepted, Green Submitted			2022-12-17	WOS:000263091300023
J	Tan, LB; Li, XR; Liu, FX; Sun, XY; Li, CG; Zhu, ZF; Fu, YC; Cai, HW; Wang, XK; Xie, DX; Sun, CQ				Tan, Lubin; Li, Xianran; Liu, Fengxia; Sun, Xianyou; Li, Chenggang; Zhu, Zuofeng; Fu, Yongcai; Cai, Hongwei; Wang, Xiangkun; Xie, Daoxin; Sun, Chuanqing			Control of a key transition from prostrate to erect growth in rice domestication	NATURE GENETICS			English	Article							ORYZA-RUFIPOGON; PLANT; GENE; GRAVITROPISM; EVOLUTION; PROTEIN; ORIGIN; MAIZE; LAZY1	The transition from the prostrate growth of ancestral wild rice (O. rufipogon Griff.) to the erect growth of Oryza sativa cultivars was one of the most critical events in rice domestication. This evolutionary step importantly improved plant architecture and increased grain yield. Here we find that prostrate growth of wild rice from Yuanjiang County in China is controlled by a semi-dominant gene, PROG1 (PROSTRATE GROWTH 1), on chromosome 7 that encodes a single Cys(2)-His(2) zinc-finger protein. prog1 variants identified in O. sativa disrupt the prog1 function and inactivate prog1 expression, leading to erect growth, greater grain number and higher grain yield in cultivated rice. Sequence comparison shows that 182 varieties of cultivated rice, including 87 indica and 95 japonica cultivars from 17 countries, carry identical mutations in the prog1 coding region that may have become fixed during rice domestication.	[Tan, Lubin; Li, Xianran; Liu, Fengxia; Sun, Xianyou; Li, Chenggang; Zhu, Zuofeng; Fu, Yongcai; Cai, Hongwei; Wang, Xiangkun; Sun, Chuanqing] China Agr Univ, Dept Genet & Plant Breeding, Natl Ctr Evaluat Agr Wild Plants Rice, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China; [Xie, Daoxin] Tsinghua Univ, Dept Biol Sci & Biotechnol, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China	China Agricultural University; Tsinghua University	Sun, CQ (corresponding author), China Agr Univ, Dept Genet & Plant Breeding, Natl Ctr Evaluat Agr Wild Plants Rice, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China.	daoxin@tsinghua.edu.cn; suncq@cau.edu.cn	Li, Xianran/I-5651-2012; xie, daoxin d/C-8646-2017; Li, Xianran/AAH-1070-2019; Tan, Lubin/H-9270-2017	Li, Xianran/0000-0002-4252-6911; Tan, Lubin/0000-0003-3775-7720	National Natural Science Foundation; Ministry of Agriculture; Ministry of Science and Technology of China	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We thank N. Harberd for comments on the manuscript, Y. Wang for assisting in cross sections, and the International Rice Research Institute, Chinese Rice Research Institute, Institute of Crop Sciences of Chinese Academy of Agricultural Sciences, Guangxi Academy of Agricultural Sciences and Guangdong Academy of Agricultural Sciences for providing the wild rice and cultivated rice samples. This research was supported by the National Natural Science Foundation, the Ministry of Agriculture and the Ministry of Science and Technology of China.	Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Hiratsu K, 2002, FEBS LETT, V514, P351, DOI 10.1016/S0014-5793(02)02435-3; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; Li XR, 2008, BIOTECHNOL LETT, V30, P555, DOI 10.1007/s10529-007-9558-4; Lin ZW, 2007, PLANTA, V226, P11, DOI 10.1007/s00425-006-0460-4; Scarpella E, 2003, DEVELOPMENT, V130, P645, DOI 10.1242/dev.00243; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Takatsuji H, 1999, PLANT MOL BIOL, V39, P1073, DOI 10.1023/A:1006184519697; Tan LB, 2007, J INTEGR PLANT BIOL, V49, P871, DOI 10.1111/j.1744-7909.2007.00497.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WAISEL Y, 1987, OECOLOGIA, V73, P630, DOI 10.1007/BF00379428; Yoshihara T, 2007, PLANT CELL PHYSIOL, V48, P678, DOI 10.1093/pcp/pcm042; Yu BS, 2007, PLANT J, V52, P891, DOI 10.1111/j.1365-313X.2007.03284.x; Yuan QP, 2003, NUCLEIC ACIDS RES, V31, P229, DOI 10.1093/nar/gkg059	21	302	364	15	228	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1360	1364		10.1038/ng.197	http://dx.doi.org/10.1038/ng.197			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18820699				2022-12-17	WOS:000260501500031
J	Dibbens, LM; Tarpey, PS; Hynes, K; Bayly, MA; Scheffer, IE; Smith, R; Bomar, J; Sutton, E; Vandeleur, L; Shoubridge, C; Edkins, S; Turner, SJ; Stevens, C; O'Meara, S; Tofts, C; Barthorpe, S; Buck, G; Cole, J; Halliday, K; Jones, D; Lee, R; Madison, M; Mironenko, T; Varian, J; West, S; Widaa, S; Wray, P; Teague, J; Dicks, E; Butler, A; Menzies, A; Jenkinson, A; Shepherd, R; Gusella, JF; Afawi, Z; Mazarib, A; Neufeld, MY; Kivity, S; Lev, D; Lerman-Sagie, T; Korczyn, AD; Derry, CP; Sutherland, GR; Friend, K; Shaw, M; Corbett, M; Kim, HG; Geschwind, DH; Thomas, P; Haan, E; Ryan, S; McKee, S; Berkovic, SF; Futreal, PA; Stratton, MR; Mulley, JC; Gecz, J				Dibbens, Leanne M.; Tarpey, Patrick S.; Hynes, Kim; Bayly, Marta A.; Scheffer, Ingrid E.; Smith, Raffaella; Bomar, Jamee; Sutton, Edwina; Vandeleur, Lucianne; Shoubridge, Cheryl; Edkins, Sarah; Turner, Samantha J.; Stevens, Claire; O'Meara, Sarah; Tofts, Calli; Barthorpe, Syd; Buck, Gemma; Cole, Jennifer; Halliday, Kelly; Jones, David; Lee, Rebecca; Madison, Mark; Mironenko, Tatiana; Varian, Jennifer; West, Sofie; Widaa, Sara; Wray, Paul; Teague, John; Dicks, Ed; Butler, Adam; Menzies, Andrew; Jenkinson, Andrew; Shepherd, Rebecca; Gusella, James F.; Afawi, Zaid; Mazarib, Aziz; Neufeld, Miriam Y.; Kivity, Sara; Lev, Dorit; Lerman-Sagie, Tally; Korczyn, Amos D.; Derry, Christopher P.; Sutherland, Grant R.; Friend, Kathryn; Shaw, Marie; Corbett, Mark; Kim, Hyung-Goo; Geschwind, Daniel H.; Thomas, Paul; Haan, Eric; Ryan, Stephen; McKee, Shane; Berkovic, Samuel F.; Futreal, P. Andrew; Stratton, Michael R.; Mulley, John C.; Gecz, Jozef			X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment	NATURE GENETICS			English	Article							CADHERIN SUPERFAMILY; CONVULSIVE DISORDER; FAMILIAL FORM; EXPRESSION; BRAIN; GENES; ORGANIZATION; DIVERSITY; MEMBERS	Epilepsy and mental retardation limited to females (EFMR) is a disorder with an X-linked mode of inheritance and an unusual expression pattern. Disorders arising from mutations on the X chromosome are typically characterized by affected males and unaffected carrier females. In contrast, EFMR spares transmitting males and affects only carrier females. Aided by systematic resequencing of 737 X chromosome genes, we identified different protocadherin 19 (PCDH19) gene mutations in seven families with EFMR. Five mutations resulted in the introduction of a premature termination codon. Study of two of these demonstrated nonsense-mediated decay of PCDH19 mRNA. The two missense mutations were predicted to affect adhesiveness of PCDH19 through impaired calcium binding. PCDH19 is expressed in developing brains of human and mouse and is the first member of the cadherin superfamily to be directly implicated in epilepsy or mental retardation.	[Dibbens, Leanne M.; Hynes, Kim; Bayly, Marta A.; Vandeleur, Lucianne; Shoubridge, Cheryl; Sutherland, Grant R.; Friend, Kathryn; Shaw, Marie; Corbett, Mark; Haan, Eric; Mulley, John C.; Gecz, Jozef] Womens & Childrens Hosp, Dept Med Genet, Adelaide, SA 5006, Australia; [Dibbens, Leanne M.; Sutherland, Grant R.; Mulley, John C.; Gecz, Jozef] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia; [Tarpey, Patrick S.; Smith, Raffaella; Edkins, Sarah; Stevens, Claire; O'Meara, Sarah; Tofts, Calli; Barthorpe, Syd; Buck, Gemma; Cole, Jennifer; Halliday, Kelly; Jones, David; Lee, Rebecca; Madison, Mark; Mironenko, Tatiana; Varian, Jennifer; West, Sofie; Widaa, Sara; Wray, Paul; Teague, John; Dicks, Ed; Butler, Adam; Menzies, Andrew; Jenkinson, Andrew; Shepherd, Rebecca; Futreal, P. Andrew; Stratton, Michael R.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Hynes, Kim; Sutton, Edwina; Sutherland, Grant R.; Thomas, Paul; Haan, Eric; Mulley, John C.; Gecz, Jozef] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Scheffer, Ingrid E.; Turner, Samantha J.; Derry, Christopher P.; Berkovic, Samuel F.] Univ Melbourne, Epilepsy Res Ctr, Heidelberg Repatriat Hosp, Heidelberg West, Vic 3081, Australia; [Scheffer, Ingrid E.; Turner, Samantha J.; Derry, Christopher P.; Berkovic, Samuel F.] Univ Melbourne, Dept Med, Heidelberg Repatriat Hosp, Heidelberg West, Vic 3081, Australia; [Scheffer, Ingrid E.] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Bomar, Jamee; Geschwind, Daniel H.] Univ Calif Los Angeles, Program Neurogenet & Neurobehav Genet, Dept Neurol, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Bomar, Jamee; Geschwind, Daniel H.] Univ Calif Los Angeles, Semel Inst Neurosci & Behav, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Gusella, James F.; Korczyn, Amos D.; Kim, Hyung-Goo] Massachusetts Gen Hosp, Mol Neurogenet Unit, Ctr Human Genet Res, Boston, MA 02114 USA; [Gusella, James F.; Korczyn, Amos D.; Kim, Hyung-Goo] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Afawi, Zaid; Mazarib, Aziz; Neufeld, Miriam Y.] Tel Aviv Sourasky Med Ctr, Dept Neurol, IL-64239 Tel Aviv, Israel; [Kivity, Sara] Schneider Childrens Med Ctr, Dept Neurol, IL-49202 Petaq Tikvah, Israel; [Lev, Dorit; Lerman-Sagie, Tally] Wolfson Med Ctr, Metab Neurogenet Clin, IL-58100 Holon, Israel; [Ryan, Stephen] AstraZeneca, Wilmington, DE 19803 USA; [McKee, Shane] Belfast City Hosp, No Ireland Reg Genet Serv, Belfast BT9 7AB, Antrim, North Ireland	Womens & Childrens Hospital Australia; University of Adelaide; Wellcome Trust Sanger Institute; University of Adelaide; University of Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; AstraZeneca; Belfast City Hospital	Dibbens, LM (corresponding author), Womens & Childrens Hosp, Dept Med Genet, Level 9 Rieger Bldg,72 King William Rd, Adelaide, SA 5006, Australia.	leanne.dibbens@cywhs.sa.gov.au; jozef.gecz@adelaide.edu.au	Gecz, Jozef/X-3469-2019; Scheffer, Ingrid E/G-1668-2013; Afawi, Zaid/AAE-7848-2022; Corbett, Mark/A-8063-2010; Bayly, Marta A/F-3977-2013; Shoubridge, Cheryl/A-1571-2016; Thomas, Paul Q/K-4497-2012; jiang, yu/HGU-0029-2022; Hynes, Kim/O-3874-2015; Korczyn, Amos/C-3461-2017	Gecz, Jozef/0000-0002-7884-6861; Scheffer, Ingrid E/0000-0002-2311-2174; Corbett, Mark/0000-0001-9298-3072; Shoubridge, Cheryl/0000-0002-0157-3084; Dibbens, Leanne/0000-0002-5824-3342; Jenkinson, Andrew/0000-0002-0703-6984; Buck, Gemma/0000-0001-5289-1050; Hynes, Kim/0000-0001-8679-4400; Korczyn, Amos/0000-0003-0125-2579; Bayly, Marta/0000-0002-6011-4478; Berkovic, Samuel/0000-0003-4580-841X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064547] Funding Source: NIH RePORTER; NICHD NIH HHS [N01-HD-4-3383, N01-HD-4-3368] Funding Source: Medline; NIGMS NIH HHS [GM061354, P01 GM061354] Funding Source: Medline; NIMH NIH HHS [R01 MH064547, R01 MH064547-02S1, R01 MH064547-03, R01 MH064547-02, R01 MH 64547, R01 MH064547-01, R01 MH064547-01S1, R01 MH064547-05, R01 MH064547-04] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Arnold AP, 2004, NAT REV NEUROSCI, V5, P701, DOI 10.1038/nrn1494; Bauer R, 2006, EXP MOL PATHOL, V81, P224, DOI 10.1016/j.yexmp.2006.07.002; Blanco P, 2000, MAMM GENOME, V11, P906, DOI 10.1007/s003350010177; Durand CM, 2006, AM J MED GENET B, V141B, P67, DOI 10.1002/ajmg.b.30229; FABISIAK K, 1990, CLIN GENET, V38, P353; Gaitan Y, 2006, GENE EXPR PATTERNS, V6, P893, DOI 10.1016/j.modgep.2006.03.001; JUBERG RC, 1971, J PEDIATR-US, V79, P726, DOI 10.1016/S0022-3476(71)80382-7; Kim SY, 2007, NEUROSCIENCE, V147, P996, DOI 10.1016/j.neuroscience.2007.03.052; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Morishita H, 2006, J BIOL CHEM, V281, P33650, DOI 10.1074/jbc.M603298200; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Ryan SG, 1997, NAT GENET, V17, P92, DOI 10.1038/ng0997-92; Scheffer IE, 2008, BRAIN, V131, P918, DOI 10.1093/brain/awm338; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Uemura M, 2007, NAT NEUROSCI, V10, P1151, DOI 10.1038/nn1960; Vanhalst K, 2005, CELL MOL LIFE SCI, V62, P1247, DOI 10.1007/s00018-005-5021-7; Wieland I, 2004, AM J HUM GENET, V74, P1209, DOI 10.1086/421532; Wilson LD, 2005, GENE EXPR PATTERNS, V5, P305, DOI 10.1016/j.modgep.2004.10.005; Wolverton T, 2001, GENOMICS, V76, P66, DOI 10.1006/geno.2001.6592; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yagi T, 2000, GENE DEV, V14, P1169; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506	24	302	323	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2008	40	6					776	781		10.1038/ng.149	http://dx.doi.org/10.1038/ng.149			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18469813	Green Accepted			2022-12-17	WOS:000256212000020
J	Visscher, PM				Visscher, Peter M.			Sizing up human height variation	NATURE GENETICS			English	Editorial Material							GENOME-WIDE ASSOCIATION; SEQUENCE VARIANTS; ADULT; RISK; LOCI	Genome-wide association studies have identified many variants affecting susceptibility to disease. Now, three studies use this approach to study adult height variation in a combined sample size of similar to 63,000 individuals and report a total of 54 validated variants influencing this trait.	Queensland Inst Med Res, Brisbane, Qld 4029, Australia	QIMR Berghofer Medical Research Institute	Visscher, PM (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4029, Australia.	peter.visscher@qimr.edu.au	Visscher, Peter/ABB-6151-2020	Visscher, Peter/0000-0002-2143-8760				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; GALTON F, 1886, NATURE, V33, P295; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Gunnell D, 2001, EPIDEMIOL REV, V23, P313, DOI 10.1093/oxfordjournals.epirev.a000809; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rebbeck TR, 2004, NAT REV GENET, V5, P589, DOI 10.1038/nrg1403; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407	15	302	312	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2008	40	5					489	490		10.1038/ng0508-489	http://dx.doi.org/10.1038/ng0508-489			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18443579				2022-12-17	WOS:000255366700003
J	Leitch, CC; Zaghloul, NA; Davis, EE; Stoetzel, C; Diaz-Font, A; Rix, S; Al-Fadhel, M; Lewis, RA; Eyaid, W; Banin, E; Dollfus, H; Beales, PL; Badano, JL; Katsanis, N				Leitch, Carmen C.; Zaghloul, Norann A.; Davis, Erica E.; Stoetzel, Corinne; Diaz-Font, Anna; Rix, Suzanne; Al-Fadhel, Majid; Lewis, Richard Alan; Eyaid, Wafaa; Banin, Eyal; Dollfus, Helene; Beales, Philip L.; Badano, Jose L.; Katsanis, Nicholas			Hypomorphic mutations in syndromic encephalocele genes are associated with Bardet-Biedl syndrome	NATURE GENETICS			English	Article							MECKEL-GRUBER-SYNDROME; BASAL BODY PROTEIN; JOUBERT-SYNDROME; BBS LOCUS; DISSECTION; DISRUPTION; RPGRIP1L; CILIUM; MKS3	Meckel-Gruber syndrome (MKS) is a genetically heterogeneous, neonatally lethal malformation and the most common form of syndromic neural tube defect (NTD). To date, several MKS-associated genes have been identified whose protein products affect ciliary function(1-5). Here we show that mutations in MKS1, MKS3 and CEP290 (also known as NPHP6) either can cause Bardet-Biedl syndrome (BBS) or may have a potential epistatic effect on mutations in known BBS-associated loci. Five of six families with both MKS1 and BBS mutations manifested seizures, a feature that is not a typical component of either syndrome. Functional studies in zebrafish showed that mks1 is necessary for gastrulation movements and that it interacts genetically with known bbs genes. Similarly, we found two families with missense or splice mutations in MKS3, in one of which the affected individual also bears a homozygous nonsense mutation in CEP290 that is likely to truncate the C terminus of the protein. These data extend the genetic stratification of ciliopathies and suggest that BBS and MKS, although distinct clinically, are allelic forms of the same molecular spectrum.	[Leitch, Carmen C.; Zaghloul, Norann A.; Davis, Erica E.; Badano, Jose L.; Katsanis, Nicholas] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Stoetzel, Corinne; Dollfus, Helene] Univ Strasbourg 1, Fac Med Strasbourg, Med Genet Lab, Equipe Avenir INSERM EA 34390, F-67085 Strasbourg, France; [Diaz-Font, Anna; Rix, Suzanne; Beales, Philip L.] UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; [Lewis, Richard Alan; Banin, Eyal] King Fahad Hosp, Dept Pediat, Riyadh 11426, Saudi Arabia; [Lewis, Richard Alan] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Lewis, Richard Alan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Banin, Eyal] Hadassah Hebrew Univ Hosp, Dept Ophthalmol, IL-91120 Jerusalem, Israel; [Badano, Jose L.] Inst Pasteur, Montevideo 11400, Uruguay	Johns Hopkins University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of London; University College London; King Saud Bin Abdulaziz University for Health Sciences; King Fahad Hospital - National Guard; Baylor College of Medicine; Baylor College of Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo	Katsanis, N (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, 733 N Broadway, Baltimore, MD 21205 USA.	katsanis@jhmi.edu	Katsanis, Nicholas/E-1837-2012; Beales, Philip L/C-7367-2009	Davis, Erica/0000-0002-2412-8397; Badano, Jose/0000-0002-0706-8652; Dollfus, Helene/0000-0002-2249-895X; Katsanis, Nicholas/0000-0002-2480-0171	Medical Research Council [G0801843] Funding Source: Medline; NICHD NIH HHS [R01HD04260] Funding Source: Medline; NIDDK NIH HHS [F32 DK079541-01, R01DK072301] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK079541, R01DK072301] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Beales PL, 1999, J MED GENET, V36, P437; Beales PL, 2003, AM J HUM GENET, V72, P1187, DOI 10.1086/375178; Davis EE, 2006, DEV CELL, V11, P9, DOI 10.1016/j.devcel.2006.06.009; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Helou J, 2007, J MED GENET, V44, P657, DOI 10.1136/jmg.2007.052027; Karmous-Benailly H, 2005, AM J HUM GENET, V76, P493, DOI 10.1086/428679; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Khaddour Rana, 2007, Hum Mutat, V28, P523, DOI 10.1002/humu.9489; Kyttala M, 2006, NAT GENET, V38, P155, DOI 10.1038/ng1714; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Stoetzel C, 2006, NAT GENET, V38, P521, DOI 10.1038/ng1771; Stoetzel C, 2007, AM J HUM GENET, V80, P1, DOI 10.1086/510256; Stone DL, 2000, NAT GENET, V25, P79, DOI 10.1038/75637; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715	28	302	312	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					443	448		10.1038/ng.97	http://dx.doi.org/10.1038/ng.97			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18327255				2022-12-17	WOS:000254388100015
J	Stiewe, T; Putzer, BM				Stiewe, T; Putzer, BM			Role of the p53-homologue p73 in EZF1-induced apoptosis	NATURE GENETICS			English	Article							P53; BINDING; PROTEIN; NEUROBLASTOMA; ACTIVATION; EXPRESSION; TARGET; GROWTH; E2F; RB	Most human cancers harbour aberrations of cell-cycle control(1), which result in deregulated activity of the E2F transcription factors with concomitant enhanced cell-cycle progression(2). Oncogenic signalling by E2F1 has recently been linked to stabilization and activation of the tumour suppressor p53 (refs 1,3,4). The p73 protein shares substantial sequence homology and functional similarity with p53 (refs 5-7). Hence, several previously considered p53-independent cellular activities may be attributable to p73. Here we provide evidence that E2F1 directly activates transcription of TP73, leading to activation of p53-responsive target genes and apoptosis. Disruption of p73 function by a tumour-derived p53 mutant reduced E2F1-mediated apoptosis. Thus, p73 activation by deregulated E2F1 activity might constitute a p53-independent, anti-tumorigenic safeguard mechanism.	Univ Essen Gesamthsch, Sch Med, Inst Mol Biol Canc Res, Essen, Germany	University of Duisburg Essen	Putzer, BM (corresponding author), Univ Essen Gesamthsch, Sch Med, Inst Mol Biol Canc Res, Essen, Germany.	brigitte.puetzer@uni-essen.de		Stiewe, Thorsten/0000-0003-0134-7826				BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Chiang SY, 1998, BIOCHEMISTRY-US, V37, P3109, DOI 10.1021/bi9721142; CRESS WD, 1993, MOL CELL BIOL, V13, P6314, DOI 10.1128/MCB.13.10.6314; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kalejta RF, 1997, CYTOMETRY, V29, P286, DOI 10.1002/(SICI)1097-0320(19971201)29:4<286::AID-CYTO4>3.0.CO;2-8; Kovalev S, 1998, CELL GROWTH DIFFER, V9, P897; Lee TA, 2000, ONCOGENE, V19, P2257, DOI 10.1038/sj.onc.1203556; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; Marin MC, 1998, MOL CELL BIOL, V18, P6316, DOI 10.1128/MCB.18.11.6316; Ng SW, 2000, ONCOGENE, V19, P1885, DOI 10.1038/sj.onc.1203512; ORMEROD MG, 1993, ACTA ONCOL, V32, P417, DOI 10.3109/02841869309093620; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Phillips AC, 1997, GENE DEV, V11, P1853, DOI 10.1101/gad.11.14.1853; Putzer BM, 2000, GENE THER, V7, P1317, DOI 10.1038/sj.gt.3301235; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Yokomizo A, 1999, ONCOGENE, V18, P1629, DOI 10.1038/sj.onc.1202474; Zeng XY, 2000, MOL CELL BIOL, V20, P1299, DOI 10.1128/MCB.20.4.1299-1310.2000; Zhu JH, 1998, CANCER RES, V58, P5061; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	28	302	306	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2000	26	4					464	469		10.1038/82617	http://dx.doi.org/10.1038/82617			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101847				2022-12-17	WOS:000165671700022
J	Gangloff, S; Soustelle, C; Fabre, F				Gangloff, S; Soustelle, C; Fabre, F			Homologous recombination is responsible for cell death in the absence of the Sgs1 and Srs2 helicases	NATURE GENETICS			English	Article							WERNERS-SYNDROME GENES; STRAND BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; BLOOMS-SYNDROME; DNA HELICASE; YEAST SGS1; MUTATIONS; RAD51; ALLELE; SEQUENCE	DNA helicases are involved in many aspects of DNA metabolism, including transcription, replication, recombination and repair. In the yeast Saccharomyces cerevisiae, the absence of the Sgs1 helicase results in genomic instability and accelerated ageing(1-4). In human cells, mutations in orthologues of SGS1 lead to Bloom (BS). Werner (WS) or Rothmund-Thomson (RTS) syndromes, which are rare, autosomal recessive diseases characterized by genetic instability associated with cancer predisposition(5-7). Although data concerning these human diseases are accumulating, there is still no clear idea of the function of the proteins involved. Here we show that sgs1 Delta mutants are deficient in DNA repair and are defective for induced recombination events that involve homologous chromosomes. The role of homologous recombination is further evidenced in haploid cells in which both Sgs1p and Srs2p are absent. Yeast SRS2 encodes another DNA helicase involved in the maintenance of genome integrity(8-10). Our data suggest that some defects observed in BS. WS or RTS are the consequence of unrestrained recombination.	CEA, UMR 217 CNRS, DSV, DRR,LERA, F-92265 Fontenay Aux Roses, France	CEA	Gangloff, S (corresponding author), CEA, UMR 217 CNRS, DSV, DRR,LERA, F-92265 Fontenay Aux Roses, France.	Serge.Gangloff@cea.fr; Francis.Fabre@cea.fr	Gangloff, Serge/B-2758-2008	Gangloff, Serge/0000-0003-1333-6091				ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Chanet R, 1996, MOL CELL BIOL, V16, P4782; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Frei C, 2000, GENE DEV, V14, P81; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Gangloff S, 1999, EMBO J, V18, P1701, DOI 10.1093/emboj/18.6.1701; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; KAYTOR MD, 1995, GENETICS, V140, P1441; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Lee SK, 1999, SCIENCE, V286, P2339, DOI 10.1126/science.286.5448.2339; Lu JA, 1996, NATURE, V383, P678, DOI 10.1038/383678a0; MILNE GT, 1995, GENETICS, V139, P1189; Murray JM, 1997, MOL CELL BIOL, V17, P6868, DOI 10.1128/MCB.17.12.6868; RONG L, 1991, GENETICS, V127, P75; RONG L, 1993, J BIOL CHEM, V268, P1252; Rothstein R, 1995, GENOME RES, V5, P421, DOI 10.1101/gr.5.5.421; Rothstein R, 2000, GENE DEV, V14, P1; SCHILD D, 1995, GENETICS, V140, P115; SHERMAN F, 1991, P21; Sinclair DA, 1997, SCIENCE, V277, P1313, DOI 10.1126/science.277.5330.1313; Smith J, 1999, GENETICS, V151, P447; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Watt PM, 1996, GENETICS, V144, P935; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	26	302	305	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2000	25	2					192	194		10.1038/76055	http://dx.doi.org/10.1038/76055			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	321ML	10835635				2022-12-17	WOS:000087459200019
J	Weil, D; Kussel, P; Blanchard, S; Levy, G; LeviAcobas, F; Drira, M; Ayadi, H; Petit, C				Weil, D; Kussel, P; Blanchard, S; Levy, G; LeviAcobas, F; Drira, M; Ayadi, H; Petit, C			The autosomal recessive isolated deafness, DFNB2, and the Usher 1B syndrome are allelic defects of the myosin-VIIA gene	NATURE GENETICS			English	Article							MUTATION; LOCALIZATION; EXPRESSION; HOMOLOG; PATIENT; PROTEIN; MOTOR; IV	Hereditary non-syndromic profound deafness affects about 1 in 2000 children prior to language acquisition. In 80% of the cases, the mode of transmission is autosomal recessive. The number of genes involved in these recessive forms of isolated deafness (DFNB genes) has been estimated to between 30 and 100. So far, ten DFNB genes have been mapped to human chromosomes, one of which has been isolated(2). By linkage analysis of a single family whose members were affected with profound deafness, some of them presenting with vestibular dysfunction, DFNB2 has been mapped to chromosome 11q13 (ref. 3), The gene responsible for a form of Usher syndrome type I, USH1B, has been assigned to the same chromosomal region(4). Usher syndrome associates profound congenital deafness and vestibular dysfunction with retinitis pigmentosa. In the homologous murine region are located the shaker-1 mutations responsible for deafness and vestibular dysfunction. It has been demonstrated that the murine shaker-1 and human USH1B phenotypes result from mutations in the gene encoding myosin-VIIA(5,6). Based on mapping data as well as on the similarities between the phenotypes of DFNB2-affected patients and shaker-1 mouse mutants, we have proposed that a defective myosin-VIIA may also be responsible for DFNB2 (ref. 1). Sequence analysis of each of the coding exons of the myosin-VIIA gene (MYO7A) was thus undertaken in the DFNB2-affected family. In the last nucleotide of exon 15, a G to A transition was detected, a type of mutation that is known to decrease the efficiency of splicing(7-14). Accordingly, this result shows that different mutations in MYO7A result in either an isolated or a syndromic form of deafness.	INST PASTEUR, CNRS URA 1968, UNITE GENET DEFICITS SENSORIELS, F-75724 PARIS 15, FRANCE; FAC MED, LAB IMMUNOL & BIOL MOL, SFAX 3029, TUNISIA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite de Sfax				Petit, Christine/0000-0002-9069-002X				ANDREWS LG, 1992, J BIOL CHEM, V267, P7834; Chaib H, 1996, HUM MOL GENET, V5, P1061, DOI 10.1093/hmg/5.7.1061; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; ElAmraoui A, 1996, HUM MOL GENET, V5, P1171, DOI 10.1093/hmg/5.8.1171; ENGLE LJ, 1994, GENOMICS, V19, P407, DOI 10.1006/geno.1994.1088; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; GUILFORD P, 1994, HUM MOL GENET, V3, P989, DOI 10.1093/hmg/3.6.989; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; KUIVANIEMI H, 1995, J INVEST DERMATOL, V105, P352, DOI 10.1111/1523-1747.ep12320704; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEMMINK HH, 1994, HUM MOL GENET, V3, P1269, DOI 10.1093/hmg/3.8.1269; Levy G, 1997, HUM MOL GENET, V6, P111, DOI 10.1093/hmg/6.1.111; LIND B, 1993, BLOOD, V82, P2423; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; SAHLY I, 1997, IN PRESS ANAT EMBRYO; SATOKATA I, 1995, HUM MOL GENET, V4, P1993, DOI 10.1093/hmg/4.10.1993; SMITH RJH, 1992, GENOMICS, V14, P995, DOI 10.1016/S0888-7543(05)80122-3; Tamagawa Y, 1996, HUM MOL GENET, V5, P849, DOI 10.1093/hmg/5.6.849; Vale Ronald D., 1993, P175; VIDAUD M, 1989, P NATL ACAD SCI USA, V86, P1041, DOI 10.1073/pnas.86.3.1041; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wayne S, 1996, HUM MOL GENET, V5, P1689, DOI 10.1093/hmg/5.10.1689; WEIL D, 1990, J BIOL CHEM, V265, P16007; WEIL D, 1989, J BIOL CHEM, V264, P16804; Weil D, 1996, P NATL ACAD SCI USA, V93, P3232, DOI 10.1073/pnas.93.8.3232; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0	28	302	316	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1997	16	2					191	193		10.1038/ng0697-191	http://dx.doi.org/10.1038/ng0697-191			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XB543	9171833				2022-12-17	WOS:A1997XB54300022
J	Sakamuro, D; Elliott, KJ; WechslerReya, R; Prendergast, GC				Sakamuro, D; Elliott, KJ; WechslerReya, R; Prendergast, GC			BIN1 is a novel MYC-interacting protein with features of a tumour suppressor	NATURE GENETICS			English	Article							TRANSCRIPTIONAL ACTIVATION DOMAIN; STIFF-MAN SYNDROME; C-MYC; BREAST-CANCER; TRANSACTIVATION DOMAIN; NUCLEAR-LOCALIZATION; GENE-EXPRESSION; TRANSGENIC MICE; ADENOVIRUS E1A; DNA-BINDING	BIN1 is a novel protein that interacts with the functionally critical Myc box regions at the N terminus of the MYC oncoprotein. BIN1 is structurally related to amphiphysin, a breast cancer-associated autoimmune antigen, and RVS167, a negative regulator of the yeast cell cycle, suggesting roles in malignancy and cell cycle control. Consistent with this likelihood, BIN1 inhibited malignant cell transformation by MYC. Although BIN1 is expressed in many normal cells, its levels were greatly reduced or undetectable in 14/27 carcinoma cell lines and 3/6 primary breast tumours. Deficits were functionally significant because ectopic expression of BIN1 inhibited the growth of tumour cells tacking endogenous message. We conclude that BIN1 is an MYC-interacting protein with features of a tumour suppressor.	WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104	The Wistar Institute					NCI NIH HHS [CA10815, CA66179, CA09171] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ASKEW DS, 1991, ONCOGENE, V6, P1915; BAUER F, 1993, MOL CELL BIOL, V13, P5070, DOI 10.1128/MCB.13.8.5070; BEIJERSBERGEN RL, 1994, EMBO J, V13, P4080, DOI 10.1002/j.1460-2075.1994.tb06725.x; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; BERNS EMJJ, 1992, CANCER RES, V52, P1107; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; BIANCHI MW, 1993, GENE, V134, P51, DOI 10.1016/0378-1119(93)90173-Z; BORN T, 1994, MOL CELL BIOL, V14, P5741; BROWN RH, 1994, PRINCIPLES INTERNAL, P1878; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cher ML, 1996, CANCER RES, V56, P3091; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; EVAN GI, 1993, CURR OPIN GENET DEV, V3, P44, DOI 10.1016/S0959-437X(05)80339-9; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FOLLI F, 1993, NEW ENGL J MED, V328, P546, DOI 10.1056/NEJM199302253280805; GAUBATZ S, 1994, MOL CELL BIOL, V14, P3853, DOI 10.1128/MCB.14.6.3853; GU W, 1994, SCIENCE, V264, P251, DOI 10.1126/science.8146655; GUPTA S, 1993, P NATL ACAD SCI USA, V90, P3216, DOI 10.1073/pnas.90.8.3216; HANSON KD, 1994, MOL CELL BIOL, V14, P5748, DOI 10.1128/MCB.14.9.5748; Harlow E LD, 1988, ANTIBODIES LAB MANUA; HAYATA I, 1983, CANCER RES, V43, P367; HEHIR DJ, 1993, J SURG ONCOL, V54, P207, DOI 10.1002/jso.2930540402; HEIKKILA R, 1987, NATURE, V328, P445, DOI 10.1038/328445a0; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; HOANG AT, 1995, MOL CELL BIOL, V15, P4031; HOLT JT, 1988, MOL CELL BIOL, V8, P963, DOI 10.1128/MCB.8.2.963; JAHNER D, 1991, MOL CELL BIOL, V11, P3682; KATO GJ, 1990, MOL CELL BIOL, V10, P5914, DOI 10.1128/MCB.10.11.5914; KELEKAR A, 1986, MOL CELL BIOL, V6, P7, DOI 10.1128/MCB.6.1.7; KREIPE H, 1993, CANCER RES, V53, P1956; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; LI LH, 1994, EMBO J, V13, P4070, DOI 10.1002/j.1460-2075.1994.tb06724.x; LICHTE B, 1992, EMBO J, V11, P2521, DOI 10.1002/j.1460-2075.1992.tb05317.x; LUTTERBACH B, 1994, MOL CELL BIOL, V14, P5510, DOI 10.1128/MCB.14.8.5510; MEICHLE A, 1992, BIOCHIM BIOPHYS ACTA, V1114, P129, DOI 10.1016/0304-419X(92)90011-M; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Negorev D, 1996, GENOMICS, V33, P329, DOI 10.1006/geno.1996.0205; NIMAN HL, 1983, P NATL ACAD SCI-BIOL, V80, P4949, DOI 10.1073/pnas.80.16.4949; PACKHAM G, 1995, BBA-REV CANCER, V1242, P11, DOI 10.1016/0304-419X(94)00015-T; PAPAS TS, 1985, NATURE, V318, P237, DOI 10.1038/318237a0; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PRENDERGAST GC, 1989, MOL CELL BIOL, V9, P124, DOI 10.1128/MCB.9.1.124; PRENDERGAST GC, 1991, EMBO J, V10, P757, DOI 10.1002/j.1460-2075.1991.tb08007.x; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; PRENDERGAST GC, 1992, GENE DEV, V6, P2429, DOI 10.1101/gad.6.12a.2429; PULVERER BJ, 1994, ONCOGENE, V9, P59; RAO L, 1992, P NATL ACAD SCI USA, V89, P7742, DOI 10.1073/pnas.89.16.7742; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; Sakamuro D, 1995, ONCOGENE, V11, P2411; SAWYERS CL, 1992, CELL, V70, P901, DOI 10.1016/0092-8674(92)90241-4; SETH A, 1993, MOL CELL BIOL, V13, P4125, DOI 10.1128/MCB.13.7.4125; SHIOZAWA M, 1990, GENE, V87, P299, DOI 10.1016/0378-1119(90)90317-K; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; SKLAR MD, 1991, MOL CELL BIOL, V11, P3699, DOI 10.1128/MCB.11.7.3699; STONE J, 1987, MOL CELL BIOL, V7, P1697, DOI 10.1128/MCB.7.5.1697; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WATSON PH, 1993, J NATL CANCER I, V85, P902, DOI 10.1093/jnci/85.11.902; YAMAMOTO R, 1995, HUM MOL GENET, V4, P265, DOI 10.1093/hmg/4.2.265; YANO T, 1993, ONCOGENE, V8, P2741	63	302	312	0	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1996	14	1					69	77		10.1038/ng0996-69	http://dx.doi.org/10.1038/ng0996-69			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VF611	8782822				2022-12-17	WOS:A1996VF61100023
J	Wang, MJ; Tu, LL; Yuan, DJ; Zhu, D; Shen, C; Li, JY; Liu, FY; Pei, LL; Wang, PC; Zhao, GN; Ye, ZX; Huang, H; Yan, FL; Ma, YZ; Zhang, L; Liu, M; You, JQ; Yang, YC; Liu, ZP; Huang, F; Li, BQ; Qiu, P; Zhang, QH; Zhu, LF; Jin, SX; Yang, XY; Min, L; Li, GL; Chen, LL; Zheng, HK; Lindsey, K; Lin, ZX; Udall, JA; Zhang, XL				Wang, Maojun; Tu, Lili; Yuan, Daojun; Zhu, De; Shen, Chao; Li, Jianying; Liu, Fuyan; Pei, Liuling; Wang, Pengcheng; Zhao, Guannan; Ye, Zhengxiu; Huang, Hui; Yan, Feilin; Ma, Yizan; Zhang, Lin; Liu, Min; You, Jiaqi; Yang, Yicheng; Liu, Zhenping; Huang, Fan; Li, Baoqi; Qiu, Ping; Zhang, Qinghua; Zhu, Longfu; Jin, Shuangxia; Yang, Xiyan; Min, Ling; Li, Guoliang; Chen, Ling-Ling; Zheng, Hongkun; Lindsey, Keith; Lin, Zhongxu; Udall, Joshua A.; Zhang, Xianlong			Reference genome sequences of two cultivated allotetraploid cottons, Gossypium hirsutum and Gossypium barbadense	NATURE GENETICS			English	Article							PROVIDES INSIGHTS; LINKAGE MAP; HI-C; POLYPLOIDIZATION; IDENTIFICATION; POPULATION; ALGORITHM; ALIGNMENT; GENES	Allotetraploid cotton species (Gossypium hirsutum and Gossypium barbadense) have long been cultivated world-wide for natural renewable textile fibers. The draft genome sequences of both species are available but they are highly fragmented and incomplete(1-4). Here we report reference-grade genome assemblies and annotations for G. hirsutum accession Texas Marker-1 (TM-1) and G. barbadense accession 3-79 by integrating single-molecule real-time sequencing, BioNano optical mapping and high-throughput chromosome conformation capture techniques. Compared with previous assembled draft genomes(1,3), these genome sequences show considerable improvements in contiguity and completeness for regions with high content of repeats such as centromeres. Comparative genomics analyses identify extensive structural variations that probably occurred after polyploidization, highlighted by large paracentric/pericentric inversions in 14 chromosomes. We constructed an introgression line population to introduce favorable chromosome segments from G. barbadense to G. hirsutum, allowing us to identify 13 quantitative trait loci associated with superior fiber quality. These resources will accelerate evolutionary and functional genomic studies in cotton and inform future breeding programs for fiber improvement.	[Wang, Maojun; Tu, Lili; Zhu, De; Shen, Chao; Li, Jianying; Pei, Liuling; Wang, Pengcheng; Zhao, Guannan; Ye, Zhengxiu; Huang, Hui; Yan, Feilin; Ma, Yizan; Zhang, Lin; You, Jiaqi; Yang, Yicheng; Liu, Zhenping; Huang, Fan; Li, Baoqi; Qiu, Ping; Zhang, Qinghua; Zhu, Longfu; Jin, Shuangxia; Yang, Xiyan; Zhang, Xianlong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [Yuan, Daojun; Min, Ling; Lin, Zhongxu] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Yuan, Daojun] Brigham Young Univ, Plant & Wildlife Sci Dept, Provo, UT 84602 USA; [Liu, Fuyan; Liu, Min; Zheng, Hongkun] Biomarker Technol Corp, Beijing, Peoples R China; [Li, Guoliang; Chen, Ling-Ling] Huazhong Agr Univ, Coll Informat, Hubei Key Lab Agr Bioinformat, Wuhan, Hubei, Peoples R China; [Lindsey, Keith] Univ Durham, Dept Biosci, Durham, England; [Udall, Joshua A.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA	Huazhong Agricultural University; Huazhong Agricultural University; Brigham Young University; Huazhong Agricultural University; Durham University; Iowa State University	Zhang, XL (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.; Lin, ZX (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China.; Lindsey, K (corresponding author), Univ Durham, Dept Biosci, Durham, England.; Udall, JA (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	keith.lindsey@durham.ac.uk; linzhongxu@mail.hzau.edu.cn; jaudall@gmail.com; xlzhang@mail.hzau.edu.cn	Chen, Ling-Ling/AAY-3547-2021; Lindsey, Keith/AAG-5228-2019; Udall, Joshua A/A-7298-2009; Yuan, Daojun/R-6048-2016; Yuan, Daojun/D-5555-2011; Li, Guoliang/D-8014-2012; Wang, Maojun/M-2587-2019; shen, chao/GZL-3987-2022	Lindsey, Keith/0000-0002-7992-6804; Udall, Joshua A/0000-0003-0978-4764; Yuan, Daojun/0000-0001-6007-5571; Li, Guoliang/0000-0003-1601-6640; Wang, Maojun/0000-0002-4791-3742; Li, Jianying/0000-0002-9825-672X; Jin, Shuangxia/0000-0002-1495-9154; Shen, Chao/0000-0001-5483-3348	National Natural Science Foundation of China [31830062]; National Transgenic Plant Research of China [2016ZX08005-001]; National Postdoctoral Program for Innovative Talents [BX201700094]; Young Elite Scientists Sponsorship Program by China Association for Science and Technology; National Science Foundation Plant Genome Research Program [1339412]; Cotton Incorporated	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transgenic Plant Research of China; National Postdoctoral Program for Innovative Talents; Young Elite Scientists Sponsorship Program by China Association for Science and Technology; National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Cotton Incorporated(Cotton R&D Corp)	We thank K. Wang (Institute of Cotton Research of the Chinese Academy of Agricultural Sciences, Anyang, China) for providing leaf samples of wild cotton species. This project was financially supported by the National Natural Science Foundation of China (31830062) and National Transgenic Plant Research of China (2016ZX08005-001) to X.Z. This project was also supported by National Postdoctoral Program for Innovative Talents (BX201700094) and the Young Elite Scientists Sponsorship Program by China Association for Science and Technology to M.W. Funding was also provided by the National Science Foundation Plant Genome Research Program (1339412) to J.U. Additional support was provided from Cotton Incorporated. We thank Rise Services for office accommodations in Orem, UT, USA.	Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Burton JN, 2013, NAT BIOTECHNOL, V31, P1119, DOI 10.1038/nbt.2727; Cao HZ, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-34; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Ciuladaite Z, 2014, CYTOGENET GENOME RES, V144, P109, DOI 10.1159/000368863; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Dixon JR, 2018, NAT GENET, V50, P1388, DOI 10.1038/s41588-018-0195-8; Du XM, 2018, NAT GENET, V50, P796, DOI 10.1038/s41588-018-0116-x; Falush D, 2003, GENETICS, V164, P1567; Fang L, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1167-5; Fransz P, 2016, PLANT J, V88, P159, DOI 10.1111/tpj.13262; Fu JJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3832; Harewood L, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1253-8; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Lam ET, 2012, NAT BIOTECHNOL, V30, P771, DOI 10.1038/nbt.2303; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Li Y, 2016, PLANT BIOTECHNOL J, V14, P951, DOI 10.1111/pbi.12450; Liu X, 2015, SCI REP-UK, V5, DOI [10.1038/srep14139, 10.1038/srep10007]; Ma J, 2015, GENOME, V58, P385, DOI 10.1139/gen-2015-0060; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Senchina DS, 2003, MOL BIOL EVOL, V20, P633, DOI 10.1093/molbev/msg065; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Soyk S, 2017, CELL, V169, P1142, DOI 10.1016/j.cell.2017.04.032; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valouev A, 2006, P NATL ACAD SCI USA, V103, P15770, DOI 10.1073/pnas.0604040103; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang MJ, 2018, NAT PLANTS, V4, P90, DOI 10.1038/s41477-017-0096-3; Wang MJ, 2018, NEW PHYTOL, V217, P163, DOI 10.1111/nph.14762; Wang MJ, 2017, NAT GENET, V49, P579, DOI 10.1038/ng.3807; Wang S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0678-1; Wang YP, 2012, NUCLEIC ACIDS RES, V40, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; Yu Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-15; Yuan DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17662; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang WP, 2014, GENOMICS, V104, P587, DOI 10.1016/j.ygeno.2014.09.002; Zhang YX, 2008, GENOME, V51, P534, DOI 10.1139/G08-033	43	301	327	14	154	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2019	51	2					224	+		10.1038/s41588-018-0282-x	http://dx.doi.org/10.1038/s41588-018-0282-x			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HJ6PM	30510239	Green Accepted, hybrid			2022-12-17	WOS:000457314300008
J	Le Gallo, M; O'Hara, AJ; Rudd, ML; Urick, ME; Hansen, NF; O'Neil, NJ; Price, JC; Zhang, S; England, BM; Godwin, AK; Sgroi, DC; Hieter, P; Mullikin, JC; Merino, MJ; Bell, DW				Le Gallo, Matthieu; O'Hara, Andrea J.; Rudd, Meghan L.; Urick, Mary Ellen; Hansen, Nancy F.; O'Neil, Nigel J.; Price, Jessica C.; Zhang, Suiyuan; England, Bryant M.; Godwin, Andrew K.; Sgroi, Dennis C.; Hieter, Philip; Mullikin, James C.; Merino, Maria J.; Bell, Daphne W.		NIH Intramural Sequencing Ctr NISC	Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes	NATURE GENETICS			English	Article							HISTONE DEACETYLASE; FREQUENT MUTATIONS; CARCINOMA; ARID1A; NURD; SUPPRESSOR; OVARIAN; AMPLIFICATION; SENSITIVITY; EXPRESSION	Endometrial cancer is the sixth most commonly diagnosed cancer in women worldwide, causing similar to 74,000 deaths annually(1). Serous endometrial cancers are a clinically aggressive subtype with a poorly defined genetic etiology(2-4). We used whole-exome sequencing to comprehensively search for somatic mutations within similar to 22,000 protein-encoding genes in 13 primary serous endometrial tumors. We subsequently resequenced 18 genes, which were mutated in more than 1 tumor and/or were components of an enriched functional grouping, from 40 additional serous tumors. We identified high frequencies of somatic mutations in CHD4 (17%), EP300 (8%), ARID1A (6%), TSPYL2 (6%), FBXW7 (29%), SPOP (8%), MAP3K4 (6%) and ABCC9 (6%). Overall, 36.5% of serous tumors had a mutated chromatin-remodeling gene, and 35% had a mutated ubiquitin ligase complex gene, implicating frequent mutational disruption of these processes in the molecular pathogenesis of one of the deadliest forms of endometrial cancer.	[Le Gallo, Matthieu; O'Hara, Andrea J.; Rudd, Meghan L.; Urick, Mary Ellen; Price, Jessica C.; England, Bryant M.; Bell, Daphne W.] NHGRI, Canc Genet Branch, US Natl Inst Hlth NIH, Bethesda, MD 20892 USA; [Hansen, Nancy F.; Zhang, Suiyuan; Mullikin, James C.] NHGRI, Genome Technol Branch, US NIH, Bethesda, MD 20892 USA; [O'Neil, Nigel J.; Hieter, Philip] Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada; [Sgroi, Dennis C.] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA USA; [Sgroi, Dennis C.] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Mullikin, James C.; NIH Intramural Sequencing Ctr NISC] NISC, US NIH, Bethesda, MD USA; [Merino, Maria J.] NCI, US NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of British Columbia; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bell, DW (corresponding author), NHGRI, Canc Genet Branch, US Natl Inst Hlth NIH, Bethesda, MD 20892 USA.	belldaph@mail.nih.gov	Sgroi, Dennis/AAV-2487-2021; O'Neil, Nigel/J-4012-2014; Le Gallo, Matthieu/F-7188-2012; Le Gallo, Matthieu/T-4181-2019	O'Neil, Nigel/0000-0002-1992-6976; Le Gallo, Matthieu/0000-0001-9085-8155; 	National Human Genome Research Institute, US NIH; NIH [R01CA112021, R01CA140323, CA016519]; Avon Foundation; Ovarian Cancer Fund; Canadian Institutes for Health Research [MOP-38096]; NATIONAL CANCER INSTITUTE [R01CA112021, ZIESC000853, R01CA140323, R01CA158162, P01CA016519] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196, ZIAHG200330, ZIAHG200338] Funding Source: NIH RePORTER	National Human Genome Research Institute, US NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Avon Foundation; Ovarian Cancer Fund; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The study was funded in part by the Intramural Program of the National Human Genome Research Institute, US NIH (D.W.B., J.C.M. and M.J.M.); NIH grant R01CA112021 (D.C.S.); the Avon Foundation (D.C.S.); NIH grant R01CA140323 (A.K.G.); and the Ovarian Cancer Fund (A.K.G.). P.H. is supported by grants from the NIH (CA016519) and by the Canadian Institutes for Health Research (MOP-38096).	Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Cassia R, 2003, J PATHOL, V201, P589, DOI 10.1002/path.1474; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Glaeser M, 2001, HORM METAB RES, V33, P121, DOI 10.1055/s-2001-14938; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hall JA, 2007, BIOCHEM CELL BIOL, V85, P463, DOI 10.1139/O07-063; Hamilton CA, 2006, BRIT J CANCER, V94, P642, DOI 10.1038/sj.bjc.6603012; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hayes MP, 2009, GYNECOL ONCOL, V113, P370, DOI 10.1016/j.ygyno.2008.12.021; HENDRICKSON M, 1982, AM J SURG PATHOL, V6, P93, DOI 10.1097/00000478-198203000-00002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang JM, 2007, GENE CHROMOSOME CANC, V46, P745, DOI 10.1002/gcc.20459; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kuhn E, 2012, JNCI-J NATL CANCER I, V104, P1503, DOI 10.1093/jnci/djs345; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Larsen DH, 2010, J CELL BIOL, V190, P731, DOI 10.1083/jcb.200912135; Li CP, 2011, EUR PHYS J-SPEC TOP, V193, P1, DOI 10.1140/epjst/e2011-01377-3; Li JW, 2002, GENE DEV, V16, P687, DOI 10.1101/gad.962502; McConechy MK, 2012, J PATHOL, V228, P20, DOI 10.1002/path.4056; McConechy MK, 2011, J PATHOL, V223, P567, DOI 10.1002/path.2848; National Cancer Institute, 2007, SEER SURVIVAL MONOGR; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Rudd ML, 2011, CLIN CANCER RES, V17, P1331, DOI 10.1158/1078-0432.CCR-10-0540; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shain AH, 2012, P NATL ACAD SCI USA, V109, pE252, DOI 10.1073/pnas.1114817109; Sherman ME, 2000, MODERN PATHOL, V13, P295, DOI 10.1038/modpathol.3880051; Shih IM, 2011, AM J PATHOL, V178, P1442, DOI 10.1016/j.ajpath.2011.01.009; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Spruck CH, 2002, CANCER RES, V62, P4535; Suehiro Y, 2008, CLIN CANCER RES, V14, P3354, DOI 10.1158/1078-0432.CCR-07-4609; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Urick ME, 2011, CANCER RES, V71, P4061, DOI 10.1158/0008-5472.CAN-11-0549; Van Houdt JKJ, 2012, NAT GENET, V44, P445, DOI 10.1038/ng.1105; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Wiegand KC, 2011, J PATHOL, V224, P328, DOI 10.1002/path.2911; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	59	301	304	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1310	1315		10.1038/ng.2455	http://dx.doi.org/10.1038/ng.2455			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23104009	Green Accepted			2022-12-17	WOS:000311713200007
J	Houlston, RS; Cheadle, J; Dobbins, SE; Tenesa, A; Jones, AM; Howarth, K; Spain, SL; Broderick, P; Domingo, E; Farrington, S; Prendergast, JGD; Pittman, AM; Theodoratou, E; Smith, CG; Olver, B; Walther, A; Barnetson, RA; Churchman, M; Jaeger, EEM; Penegar, S; Barclay, E; Martin, L; Gorman, M; Mager, R; Johnstone, E; Midgley, R; Niittymaki, I; Tuupanen, S; Colley, J; Idziaszczyk, S; Thomas, HJW; Lucassen, AM; Evans, DGR; Maher, ER; Maughan, T; Dimas, A; Dermitzakis, E; Cazier, JB; Aaltonen, LA; Pharoah, P; Kerr, DJ; Carvajal-Carmona, LG; Campbell, H; Dunlop, MG; Tomlinson, IPM				Houlston, Richard S.; Cheadle, Jeremy; Dobbins, Sara E.; Tenesa, Albert; Jones, Angela M.; Howarth, Kimberley; Spain, Sarah L.; Broderick, Peter; Domingo, Enric; Farrington, Susan; Prendergast, James G. D.; Pittman, Alan M.; Theodoratou, Evi; Smith, Christopher G.; Olver, Bianca; Walther, Axel; Barnetson, Rebecca A.; Churchman, Michael; Jaeger, Emma E. M.; Penegar, Steven; Barclay, Ella; Martin, Lynn; Gorman, Maggie; Mager, Rachel; Johnstone, Elaine; Midgley, Rachel; Niittymaki, Iina; Tuupanen, Sari; Colley, James; Idziaszczyk, Shelley; Thomas, Huw J. W.; Lucassen, Anneke M.; Evans, D. Gareth R.; Maher, Eamonn R.; Maughan, Timothy; Dimas, Antigone; Dermitzakis, Emmanouil; Cazier, Jean-Baptiste; Aaltonen, Lauri A.; Pharoah, Paul; Kerr, David J.; Carvajal-Carmona, Luis G.; Campbell, Harry; Dunlop, Malcolm G.; Tomlinson, Ian P. M.		COGENT Consortium; CORGI Consortium; COIN Collaborative Grp; COINB Collaborative Grp	Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33	NATURE GENETICS			English	Article							RISK; GENETICS; DISEASE; VARIANT; SCAN	Genome-wide association studies (GWAS) have identified ten loci harboring common variants that influence risk of developing colorectal cancer (CRC). To enhance the power to identify additional CRC risk loci, we conducted a meta-analysis of three GWAS from the UK which included a total of 3,334 affected individuals (cases) and 4,628 controls followed by multiple validation analyses including a total of 18,095 cases and 20,197 controls. We identified associations at four new CRC risk loci: 1q41 (rs6691170, odds ratio (OR) = 1.06, P = 9.55 x 10(-10) and rs6687758, OR = 1.09, P = 2.27 x 10(-9)), 3q26.2 (rs10936599, OR = 0.93, P = 3.39 x 10(-8)), 12q13.13 (rs11169552, OR = 0.92, P = 1.89 x 10(-10) and rs7136702, OR = 1.06, P = 4.02 x 10(-8)) and 20q13.33 (rs4925386, OR = 0.93, P = 1.89 x 10(-10)). In addition to identifying new CRC risk loci, this analysis provides evidence that additional CRC-associated variants of similar effect size remain to be discovered.	[Houlston, Richard S.; Dobbins, Sara E.; Broderick, Peter; Pittman, Alan M.; Olver, Bianca; Penegar, Steven] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Cheadle, Jeremy; Smith, Christopher G.; Colley, James; Idziaszczyk, Shelley] Cardiff Univ, Sch Med, Inst Med Genet, Cardiff, S Glam, Wales; [Tenesa, Albert; Farrington, Susan; Prendergast, James G. D.; Theodoratou, Evi; Barnetson, Rebecca A.; Dunlop, Malcolm G.] Univ Edinburgh, Inst Genet & Mol Med, Colon Canc Genet Grp, Edinburgh, Midlothian, Scotland; [Tenesa, Albert; Farrington, Susan; Prendergast, James G. D.; Theodoratou, Evi; Barnetson, Rebecca A.; Dunlop, Malcolm G.] MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Jones, Angela M.; Howarth, Kimberley; Spain, Sarah L.; Domingo, Enric; Walther, Axel; Churchman, Michael; Jaeger, Emma E. M.; Barclay, Ella; Martin, Lynn; Gorman, Maggie; Dimas, Antigone; Cazier, Jean-Baptiste; Carvajal-Carmona, Luis G.; Tomlinson, Ian P. M.] Wellcome Trust Ctr Human Genet, Oxford, England; [Mager, Rachel; Johnstone, Elaine; Midgley, Rachel; Kerr, David J.] Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HE, England; [Niittymaki, Iina; Tuupanen, Sari; Aaltonen, Lauri A.] Univ Helsinki, Biomedicum Helsinki, Genome Scale Biol Res Program, Dept Med Genet, Helsinki, Finland; [Thomas, Huw J. W.] St Marks Hosp, Colorectal Canc Unit, Harrow, Middx, England; [Lucassen, Anneke M.] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Evans, D. Gareth R.] St Marys Hosp, Manchester M13 0JH, Lancs, England; [Maher, Eamonn R.] Brigham & Womens Hosp, W Midlands Reg Genet Serv, Birmingham, W Midlands, England; [Maher, Eamonn R.] Univ Birmingham, Dept Med & Mol Genet, Sch Clin & Expt Med, Inst Biomed Res, Birmingham, W Midlands, England; [Maughan, Timothy] Cardiff Univ, Sch Med, Dept Oncol & Palliat Care, Cardiff, S Glam, Wales; [Dimas, Antigone; Dermitzakis, Emmanouil] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Pharoah, Paul] Univ Cambridge, Canc Res UK Labs, Strangeways Res Lab, Dept Oncol, Cambridge, England; [Kerr, David J.] Qatar Fdn, Sidra Med & Res Ctr, Doha, Qatar	University of London; Institute of Cancer Research - UK; Cardiff University; University of Edinburgh; University of Edinburgh; University of Oxford; Wellcome Centre for Human Genetics; Radcliffe Infirmary; University of Oxford; University of Helsinki; Imperial College London; University of Manchester; Birmingham Women's Hospital; University of Birmingham; Cardiff University; University of Geneva; Cancer Research UK; University of Cambridge; Qatar Foundation (QF); Sidra Medical & Research Center	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England.	richard.houlston@icr.ac.uk; malcolm.dunlop@hgu.mrc.ac.uk; iant@well.ox.ac.uk	MAHER, EAMONN R/A-9507-2008; van Wezel, Tom/Z-3092-2019; Maughan, Timothy/D-5032-2011; Dermitzakis, Emmanouil/B-7687-2013; Cazier, Jean-Baptiste/F-2369-2010; Theodoratou, Evropi/C-3430-2014; Evans, D Gareth/AAB-4308-2022; Farrington, Susan M/Q-2710-2019; Aaltonen, Lauri/A-5375-2010; Pittman, Alan/AAP-2534-2020; van Wezel, Tom/A-9599-2008; Farrington, Susan M/C-7319-2013; Cazier, Jean-Baptiste/GLR-2949-2022; Campbell, Harry/E-2959-2010; Carvajal-Carmona, Luis G/B-3882-2010; Pharoah, Paul/V-6658-2019; GenePool, The/D-8812-2012; Pittman, Alan M/D-6231-2012; Domingo, Enric/A-9099-2018; Dunlop, Malcolm G/F-1973-2011; Jones, Alan/F-3086-2015; Spain, Sarah/G-1968-2010; Lucassen, Anneke/D-7764-2017	MAHER, EAMONN R/0000-0002-6226-6918; van Wezel, Tom/0000-0001-5773-7730; Cazier, Jean-Baptiste/0000-0001-7581-9051; Theodoratou, Evropi/0000-0001-5887-9132; Evans, D Gareth/0000-0002-8482-5784; Farrington, Susan M/0000-0001-5955-7389; Aaltonen, Lauri/0000-0001-6839-4286; Pittman, Alan/0000-0002-8112-2987; van Wezel, Tom/0000-0001-5773-7730; Cazier, Jean-Baptiste/0000-0001-7581-9051; Campbell, Harry/0000-0002-6169-6262; Carvajal-Carmona, Luis G/0000-0001-7129-2918; Pharoah, Paul/0000-0001-8494-732X; Pittman, Alan M/0000-0002-8112-2987; Domingo, Enric/0000-0003-4390-8767; Dunlop, Malcolm G/0000-0002-3033-5851; Jones, Alan/0000-0002-3897-5626; Spain, Sarah/0000-0002-7591-8364; Broderick, Peter/0000-0002-8348-5829; Tenesa, Albert/0000-0003-4884-4475; Kerr, Rachel/0000-0002-7240-3269; Lucassen, Anneke/0000-0003-3324-4338; Penegar, Steven/0000-0002-3768-0236; Houlston, Richard/0000-0002-5268-0242; Prendergast, James/0000-0001-8916-018X; churchman, Michael/0000-0003-1958-7692	Cancer Research UK; Oxford Comprehensive Biomedical Research Centre; EU; Core infrastructure; Centre for Human Genetics, Oxford [075491/Z/04]; Medical Research Council [G0000657-53203]; CORE and Scottish Executive Chief Scientist's Office [K/OPR/2/2/D333, CZB/4/449]; Cancer Research UK [C31250/A10107]; Cancer Research Wales, Tenovus and Wales Gene Park; Academy of Finland; Finnish Cancer Society; Sigrid Juselius Foundation; MRC [MC_U122861325, MC_U127527198, G0301096] Funding Source: UKRI; Medical Research Council [MC_U122861325, G0301096, MC_U127527198] Funding Source: researchfish; Chief Scientist Office [CZB/4/449] Funding Source: researchfish; Tenovus Cancer Care [PhD2009/L27] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Oxford Comprehensive Biomedical Research Centre; EU(European Commission); Core infrastructure; Centre for Human Genetics, Oxford; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CORE and Scottish Executive Chief Scientist's Office; Cancer Research UK(Cancer Research UK); Cancer Research Wales, Tenovus and Wales Gene Park; Academy of Finland(Academy of Finland); Finnish Cancer Society; Sigrid Juselius Foundation(Sigrid Juselius Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; Tenovus Cancer Care; The Francis Crick Institute	Cancer Research UK provided principal funding for this study individually to I.P.M.T., M.G.D., R.S.H., P.P. and J. Cheadle. Additional funding was provided by the Oxford Comprehensive Biomedical Research Centre (to E. Domingo and I.P.M.T.) and the EU FP7 CHIBCHA grant (to L.G.C.-C. and I.P.M.T.). Core infrastructure support to the Wellcome Trust Centre for Human Genetics, Oxford was provided by grant 075491/Z/04. We are grateful to many colleagues within UK Clinical Genetics Departments (for CORGI) and to many collaborators who participated in the VICTOR and QUASAR2 trials. We also thank colleagues from the UK National Cancer Research Network (for NSCCG). Additional funding (to M.G.D.) was provided by the Medical Research Council (G0000657-53203), CORE and Scottish Executive Chief Scientist's Office (K/OPR/2/2/D333, CZB/4/449). We (Edinburgh) gratefully acknowledge the work of the COGS and SOCCS administrative teams; R. Cetnarskyj and the research nurse teams, who all recruited subjects to the studies; the Wellcome Trust Clinical Research Facility for sample preparation; and to all clinicians and pathologists throughout Scotland at the collaborating centres. E.T. was funded by a Cancer Research UK Fellowship (C31250/A10107). The study used the biological and data resources of Generation Scotland. COIN and COINB were funded by the UK Medical Research Council. COIN sample analysis (J. Cheadle) was also funded by Cancer Research Wales, Tenovus and Wales Gene Park. For the Helsinki study, the work was supported by grants from Academy of Finland (Finnish Centre of Excellence Program 2006-2011), the Finnish Cancer Society and the Sigrid Juselius Foundation. For the Cambridge study, we thank the SEARCH study team and all the participants in the study. P.P. is a Cancer Research UK Senior Clinical Research Fellow. This study made use of genotyping data from the 1958 Birth Cohort and NBS samples, kindly made available by the Wellcome Trust Case Control Consortium 2. A full list of the investigators who contributed to the generation of the data is available at http://www.wtccc.org.uk/. Finally, we would like to thank all individuals who participated in the study.	Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Houlston RS, 1996, QJM-INT J MED, V89, P737, DOI 10.1093/qjmed/89.10.737; Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1111/j.1572-0241.2001.04677.x; Jones AM, 2005, ONCOGENE, V24, P118, DOI 10.1038/sj.onc.1208194; Petitti Diana B., 1994, Annals of Epidemiology, V4, P115; Power C, 2006, J PEDIATR-US, V148, P54, DOI 10.1016/j.jpeds.2005.07.028; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Tomlinson IPM, 2010, BRIT J CANCER, V102, P447, DOI 10.1038/sj.bjc.6605338; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; ZUCMAN J, 1993, NAT GENET, V4, P341, DOI 10.1038/ng0893-341	14	301	306	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					973	U89		10.1038/ng.670	http://dx.doi.org/10.1038/ng.670			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20972440	Green Accepted, Green Published, Green Submitted			2022-12-17	WOS:000283540500014
J	Haiman, CA; Le Marchand, L; Yamamato, J; Stram, DO; Sheng, X; Kolonel, LN; Wu, AH; Reich, D; Henderson, BE				Haiman, Christopher A.; Le Marchand, Loic; Yamamato, Jennifer; Stram, Daniel O.; Sheng, Xin; Kolonel, Laurence N.; Wu, Anna H.; Reich, David; Henderson, Brian E.			A common genetic risk factor for colorectal and prostate cancer	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; WIDE ASSOCIATION; LOCUS; OCT4; 8Q24	Variants on chromosome 8q24 contribute risk for prostate cancer; here, we tested whether they also modulate risk for colorectal cancer. We studied 1,807 affected individuals and 5,511 controls and found that one variant, rs6983267, is also significantly associated with colorectal cancer ( odds ratio = 1.22; P = 4.4 x 10(-6)) and that the apportionment of risk among the variants differs significantly between the two cancers. Comprehensive testing in the region uncovered variants capturing significant additional risk. Our results show that variants at 8q24 have different effects on cancer development that depend on the tissue type.	Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; Univ Hawaii, Canc Res Ctr Hawaii, Program Epidemiol, Honolulu, HI 96813 USA; Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Haiman, CA (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA.	haiman@usc.edu			NATIONAL CANCER INSTITUTE [P01CA017054, R01CA063464, R01CA054281, U01CA063464, R01CA072520, R37CA054281, R01CA060987] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA054281, CA63464, R37 CA054281, P01 CA017054, CA72520, R01 CA060987, R01 CA072520, CA54281, R01 CA063464, CA60987, U01 CA063464, R01 CA063464-09S1, P01 CA17054] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Douglas EJ, 2004, CANCER RES, V64, P4817, DOI 10.1158/0008-5472.CAN-04-0328; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Sun JS, 2007, PROSTATE, V67, P692, DOI 10.1002/pros.20543; Suo GL, 2005, BIOCHEM BIOPH RES CO, V337, P1047, DOI 10.1016/j.bbrc.2005.09.157; VISAKORPI T, 1995, CANCER RES, V55, P342; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	13	301	312	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					954	956		10.1038/ng2098	http://dx.doi.org/10.1038/ng2098			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17618282	Green Accepted			2022-12-17	WOS:000248446900008
J	Yamanouchi, J; Rainbow, D; Serra, P; Howlett, S; Hunter, K; Garner, VES; Gonzalez-Munoz, A; Clark, J; Veijola, R; Cubbon, R; Chen, SL; Rosa, R; Cumiskey, AM; Serreze, DV; Gregory, S; Rogers, J; Lyons, PA; Healy, B; Smink, LJ; Todd, JA; Peterson, LB; Wicker, LS; Santamaria, P				Yamanouchi, Jun; Rainbow, Dan; Serra, Pau; Howlett, Sarah; Hunter, Kara; Garner, Valerie E. S.; Gonzalez-Munoz, Andrea; Clark, Jan; Veijola, Riitta; Cubbon, Rose; Chen, Show-Ling; Rosa, Raymond; Cumiskey, Anne Marie; Serreze, David V.; Gregory, Simon; Rogers, Jane; Lyons, Paul A.; Healy, Barry; Smink, Luc J.; Todd, John A.; Peterson, Laurence B.; Wicker, Linda S.; Santamaria, Pere			Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity	NATURE GENETICS			English	Article							NONOBESE DIABETIC MICE; ALPHA-CHAIN; NOD MICE; IL-2; REGION; LOCUS; ACTIVATION; EXPRESSION; DISEASE; COMPLEX	Autoimmune diseases are thought to result from imbalances in normal immune physiology and regulation. Here, we show that autoimmune disease susceptibility and resistance alleles on mouse chromosome 3 (Idd3) correlate with differential expression of the key immunoregulatory cytokine interleukin-2 (IL-2). In order to test directly that an approximately twofold reduction in IL-2 underpins the Idd3-linked destabilization of immune homeostasis, we show that engineered haplodeficiency of Il2 gene expression not only reduces T cell IL-2 production by twofold but also mimics the autoimmune dysregulatory effects of the naturally occurring susceptibility alleles of Il2. Reduced IL-2 production achieved by either genetic mechanism correlates with reduced function of CD4(+) CD25(+) regulatory T cells, which are critical for maintaining immune homeostasis.	Univ Calgary, Fac Med, JMDRC, Inst Inflammat Infect & Immun, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Dept Microbiol & Infect Dis, Inst Inflammat Infect & Immun, Calgary, AB T2N 4N1, Canada; Univ Cambridge, Cambridge Inst Med Genet, Dept Med Genet, Juvenile Diabet Res Fdn,Wellcome Trust Diabet & I, Cambridge CB2 2XY, England; Merck Res Labs, Rahway, NJ 07065 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England	University of Calgary; University of Calgary; University of Cambridge; Merck & Company; Jackson Laboratory; Wellcome Trust Sanger Institute	Wicker, LS (corresponding author), Univ Calgary, Fac Med, JMDRC, Inst Inflammat Infect & Immun, Calgary, AB T2N 4N1, Canada.	linda.wicker@cimr.cam.ac.uk; psantama@ucalgary.ca	Wicker, Linda S/F-7384-2010; Todd, John A/A-3542-2010; Santamaria, Pere/ABF-6823-2021	Todd, John A/0000-0003-2740-8148; Gregory, Simon/0000-0002-7805-1743	Wellcome Trust [061859] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adachi S, 2005, NUCLEIC ACIDS RES, V33, P3200, DOI 10.1093/nar/gki637; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Amrani A, 2002, IMMUNITY, V16, P719, DOI 10.1016/S1074-7613(02)00315-1; Anderson B, 1999, P NATL ACAD SCI USA, V96, P9311, DOI 10.1073/pnas.96.16.9311; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Cervino ACL, 2006, MAMM GENOME, V17, P565, DOI 10.1007/s00335-005-0170-4; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; DiLorenzo TP, 1998, P NATL ACAD SCI USA, V95, P12538, DOI 10.1073/pnas.95.21.12538; Encinas JA, 1999, NAT GENET, V21, P158, DOI 10.1038/5941; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Hurez V, 2003, J EXP MED, V198, P123, DOI 10.1084/jem.20022230; Kim HP, 2005, J BIOL CHEM, V280, P25291, DOI 10.1074/jbc.M501459200; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI200213605; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; LORD CJ, 1995, MAMM GENOME, V6, P563, DOI 10.1007/BF00352359; Lyons PA, 2000, GENOME RES, V10, P446, DOI 10.1101/gr.10.4.446; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; MCALEER MA, 1995, DIABETES, V44, P1186, DOI 10.2337/diabetes.44.10.1186; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Podolin PL, 2000, CYTOKINE, V12, P477, DOI 10.1006/cyto.1999.0609; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Samy ET, 2005, J EXP MED, V202, P771, DOI 10.1084/jem.20041033; Saparov A, 1999, IMMUNITY, V11, P271, DOI 10.1016/S1074-7613(00)80102-8; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sharfe N, 1997, P NATL ACAD SCI USA, V94, P3168, DOI 10.1073/pnas.94.7.3168; Smink LJ, 2005, NUCLEIC ACIDS RES, V33, pD544; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Teuscher C, 1996, J EXP MED, V183, P631, DOI 10.1084/jem.183.2.631; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Trudeau JD, 2003, J CLIN INVEST, V111, P217, DOI 10.1172/JCI200316409; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Verdaguer J, 1996, J IMMUNOL, V157, P4726; Wang L, 2005, BIOCHEM BIOPH RES CO, V331, P589, DOI 10.1016/j.bbrc.2005.03.216; WICKER LS, 1994, J EXP MED, V180, P1705, DOI 10.1084/jem.180.5.1705; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wolf M, 2001, EUR J IMMUNOL, V31, P1637, DOI 10.1002/1521-4141(200106)31:6<1637::AID-IMMU1637>3.0.CO;2-T; Yui MA, 2001, J IMMUNOL, V166, P1730, DOI 10.4049/jimmunol.166.3.1730; Zhang YQ, 2002, J IMMUNOL, V168, P1466, DOI 10.4049/jimmunol.168.3.1466	50	301	311	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2007	39	3					329	337		10.1038/ng1958	http://dx.doi.org/10.1038/ng1958			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17277778	Green Accepted			2022-12-17	WOS:000244480000014
J	Falck, J; Petrini, JHJ; Williams, BR; Lukas, J; Bartek, J				Falck, J; Petrini, JHJ; Williams, BR; Lukas, J; Bartek, J			The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways	NATURE GENETICS			English	Article							ATAXIA-TELANGIECTASIA; CHROMATIN ASSOCIATION; POLYMERASE-ALPHA; CELL-CYCLE; ATM; REPLICATION; COMPLEX; PHOSPHORYLATION; INITIATION; PROTEIN	To preserve genetic integrity, mammalian cells exposed to ionizing radiation activate the ATM kinase, which initiates a complex response including the S-phase checkpoint pathways to delay DNA replication(1,2). Defects in ATM or its substrates Nbs1 or Chk2 (ref. 3), the Nbs1-interacting Mre11 protein(4), or the Chk2-regulated Cdc25A-Cdk2 cascade all cause radio-resistant DNA synthesis (RDS)(5,6). It is unknown, however, whether these proteins operate in a common signaling cascade. Here we show that experimental blockade of either the Nbs1-Mre11 function or the Chk2-triggered events leads to a partial RDS phenotype in human cells. In contrast, concomitant interference with Nbs1-Mre11 and the Chk2-Cdc25A-Cdk2 pathways entirely abolishes inhibition of DNA synthesis induced by ionizing radiation, resulting in complete RDS analogous to that caused by defective ATM. In addition, Cdk2-dependent loading of Cdc45 onto replication origins, a prerequisite for recruitment of DNA polymerase(7,8), was prevented upon irradiation of normal or Nbs1/Mre11-defective cells but not cells with defective ATM. We conclude that in response to ionizing radiation, phosphorylations of Nbs1 and Chk2 by ATM trigger two parallel branches of the DNA damage-dependent S-phase checkpoint that cooperate by inhibiting distinct steps of DNA replication.	Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; Univ Wisconsin, Sch Med, Madison, WI 53706 USA	Danish Cancer Society; University of Wisconsin System; University of Wisconsin Madison	Bartek, J (corresponding author), Danish Canc Soc, Inst Canc Biol, Strandblvd 49, DK-2100 Copenhagen, Denmark.		Bartek, Jiri/G-5870-2014	Lukas, Jiri/0000-0001-9087-506X				Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Carr AM, 2000, SCIENCE, V287, P1765, DOI 10.1126/science.287.5459.1765; Costanzo V, 2000, MOL CELL, V6, P649, DOI 10.1016/S1097-2765(00)00063-0; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kukimoto I, 1999, EUR J BIOCHEM, V265, P936, DOI 10.1046/j.1432-1327.1999.00791.x; Larner JM, 1999, NUCLEIC ACIDS RES, V27, P803, DOI 10.1093/nar/27.3.803; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; Rotman G, 1999, ONCOGENE, V18, P6135, DOI 10.1038/sj.onc.1203124; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sorensen CS, 2000, MOL CELL BIOL, V20, P7613, DOI 10.1128/MCB.20.20.7613-7623.2000; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Takisawa H, 2000, CURR OPIN CELL BIOL, V12, P690, DOI 10.1016/S0955-0674(00)00153-8; Tao L, 2000, J CELL BIOCHEM, V78, P442, DOI 10.1002/1097-4644(20000901)78:3<442::AID-JCB9>3.0.CO;2-1; Trivedi A, 1998, DNA CELL BIOL, V17, P885, DOI 10.1089/dna.1998.17.885; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	30	301	308	1	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					290	294		10.1038/ng845	http://dx.doi.org/10.1038/ng845			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11850621				2022-12-17	WOS:000174157600013
J	Davuluri, RV; Grosse, I; Zhang, MQ				Davuluri, RV; Grosse, I; Zhang, MQ			Computational identification of promoters and first exons in the human genome	NATURE GENETICS			English	Article							CPG ISLANDS; DISCRIMINANT-ANALYSIS; DNA-SEQUENCE; BIOLOGY; REGIONS; GENES	The identification of promoters and first exons has been one of the most difficult problems in gene-finding. We present a set of discriminant functions that can recognize structural and compositional features such as CpG islands, promoter regions and first splice-donor sites. We explain the implementation of the discriminant functions into a decision tree that constitutes a new program called FirstEF. By using different models to predict CpG-related and non-CpG-related first exons, we showed by cross-validation that the program could predict 86% of the first exons with 17% false positives. We also demonstrated the prediction accuracy of FirstEF at the genome level by applying it to the finished sequences of human chromosomes 21 and 22 as well as by comparing the predictions with the locations of the experimentally verified first exons. Finally, we present the analysis of the predicted first exons for all of the 24 chromosomes of the human genome.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Zhang, MQ (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	mzhang@cshl.org	Davuluri, Ramana/D-7348-2011					Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Claverie JM, 2000, GENOME RES, V10, P1277, DOI 10.1101/gr.155500; CLEVERIE JM, 1997, HUM MOL GENET, V6, P1735; CROSS S, 1991, NUCLEIC ACIDS RES, V19, P1469, DOI 10.1093/nar/19.7.1469; CROSS SH, 1995, CURR OPIN GENET DEV, V5, P309, DOI 10.1016/0959-437X(95)80044-1; Davuluri RV, 2000, GENOME RES, V10, P1807, DOI 10.1101/gr.GR-1460R; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Galas DJ, 2001, SCIENCE, V291, P1257, DOI 10.1126/science.291.5507.1257; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Hong SJ, 2001, PATTERN RECOGN LETT, V22, P55, DOI 10.1016/S0167-8655(00)00099-4; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Maroni G, 1996, EVOL BIOL, V29, P1; Perier RC, 2000, NUCLEIC ACIDS RES, V28, P302, DOI 10.1093/nar/28.1.302; Scherf M, 2000, J MOL BIOL, V297, P599, DOI 10.1006/jmbi.2000.3589; SOLOVYEV VV, 1994, NUCLEIC ACIDS RES, V22, P5156, DOI 10.1093/nar/22.24.5156; Stormo GD, 2000, GENOME RES, V10, P394, DOI 10.1101/gr.10.4.394; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Zhang MQ, 1998, GENOME RES, V8, P319, DOI 10.1101/gr.8.3.319; Zhang MQ, 1997, P NATL ACAD SCI USA, V94, P565, DOI 10.1073/pnas.94.2.565; [No title captured]	24	301	327	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					412	417		10.1038/ng780	http://dx.doi.org/10.1038/ng780			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11726928				2022-12-17	WOS:000172507500016
J	VAN MEIR, EG; POLVERINI, PJ; CHAZIN, VR; HUANG, HJS; DETRIBOLET, N; CAVENEE, WK				VAN MEIR, EG; POLVERINI, PJ; CHAZIN, VR; HUANG, HJS; DETRIBOLET, N; CAVENEE, WK			RELEASE OF AN INHIBITOR OF ANGIOGENESIS UPON INDUCTION OF WILD-TYPE P53 EXPRESSION IN GLIOBLASTOMA CELLS	NATURE GENETICS			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; GENE AMPLIFICATION; SUPPRESSOR GENE; CYCLE CONTROL; CANCER; PROGRESSION; MUTATIONS; PROTEIN; PROMOTERS	The earliest genetic alteration in human astrocytoma progression is mutation of the p53 tumour suppressor gene, while one of the earliest phenotypic changes is the stimulation of neovascularization. Here, we tested the role of p53 in the angiogenic process by introducing a tetracycline-regulated wild type p53 gene into null glioblastoma cells. The parental cells expressed strong angiogenic activity while upon induction of wild type, but not mutant, p53 expression, the cells secreted a factor able to neutralize the angiogenicity of the factors produced by the parental cells as well as of basic fibroblast growth factor.	UNIV CALIF SAN DIEGO, LUDWIG INST CANC RES, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, CTR MOLEC GENET, LA JOLLA, CA 92093 USA; UNIV LAUSANNE HOSP, TUMOUR BIOL & GENET LAB, NEUROSURG SERV, CH-1011 LAUSANNE, SWITZERLAND; UNIV MICHIGAN, SCH DENT, ANN ARBOR, MI 48109 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Michigan System; University of Michigan			Polverini, Peter/AAJ-8392-2020	Van Meir, Erwin G./0000-0003-2444-7707	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039926] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL39926] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BREM S, 1972, J NATL CANCER I, V48, P347; CAVENEE WK, 1991, MUTAT RES, V247, P199, DOI 10.1016/0027-5107(91)90015-G; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FARMER G, 1992, NATURE, V358, P83, DOI 10.1038/358083a0; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FOLKMAN J, 1963, CANCER, V16, P453, DOI 10.1002/1097-0142(196304)16:4<453::AID-CNCR2820160407>3.0.CO;2-Y; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; GALL CM, 1991, ASTROCYTOMAS DIAGNOS, P241; GINSBERG D, 1991, P NATL ACAD SCI USA, V88, P9979, DOI 10.1073/pnas.88.22.9979; GLASER BM, 1980, NATURE, V288, P483, DOI 10.1038/288483a0; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; KASTAN MB, 1991, CANCER RES, V51, P6304; KEMP CJ, 1993, CELL, V74, P813, DOI 10.1016/0092-8674(93)90461-X; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; KLAGSBRUN M, 1991, ANNU REV PHYSIOL, V53, P217, DOI 10.1146/annurev.physiol.53.1.217; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MARTINEZ J, 1991, GENE DEV, V5, P151, DOI 10.1101/gad.5.2.151; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; RASTINEJAD F, 1989, CELL, V56, P345, DOI 10.1016/0092-8674(89)90238-9; Russell D., 1989, PATHOLOGY TUMORS NER; SCHWEIKI D, 1992, NATURE, V359, P843; SIDRANSKY D, 1992, NATURE, V355, P846, DOI 10.1038/355846a0; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; VAN MEIR EG, 1994, CANCER RES, V54, P649; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7	36	301	319	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1994	8	2					171	176		10.1038/ng1094-171	http://dx.doi.org/10.1038/ng1094-171			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PL123	7531056				2022-12-17	WOS:A1994PL12300019
J	ADAMS, MD; KERLAVAGE, AR; FIELDS, C; VENTER, JC				ADAMS, MD; KERLAVAGE, AR; FIELDS, C; VENTER, JC			3,400 NEW EXPRESSED SEQUENCE TAGS IDENTIFY DIVERSITY OF TRANSCRIPTS IN HUMAN BRAIN	NATURE GENETICS			English	Article							LIPOPROTEIN RECEPTOR; LDL-RECEPTOR; ZINC FINGERS; PROTEIN; ENCODES; GENE; FAMILY; VIRUS; TOOL	We present the results of the partial sequencing of over 3,400 expressed sequence tags (ESTs) from human brain cDNA clones, which increases the number of distinct genes expressed in the brain, that are represented by ESTs, to about 6,000. By choosing clones in an unbiased manner, it is possible to construct a profile of the transcriptional activity of the brain at different stages. Proteins that comprise the cytoskeleton are the most abundant; however, a large variety of regulatory proteins are also seen. About half of the ESTs predicted to contain a protein-coding region have no matches in the public peptide databases and may represent new gene families.	NINCDS,RECEPTOR BIOCHEM & MOLECU BIOL SECT,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	ADAMS, MD (corresponding author), INST GENOM RES,932 CLOPPER RD,GAITHERSBURG,MD 20878, USA.			Kerlavage, Anthony/0000-0002-3954-9653; Fields, Chris/0000-0002-4812-0744				ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ADAMS MD, IN PRESS NATURE GENE; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BORK P, 1992, NATURE, V358, P287, DOI 10.1038/358287a0; CHARDIN P, 1991, NUCLEIC ACIDS RES, V19, P1431, DOI 10.1093/nar/19.7.1431; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; DIBELLO PR, 1991, GENETICS, V129, P385; FIELDS CA, 1990, COMPUT APPL BIOSCI, V6, P263; HARRISON SD, 1990, EMBO J, V9, P207, DOI 10.1002/j.1460-2075.1990.tb08097.x; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; HOOG C, 1991, NUCLEIC ACIDS RES, V19, P6123, DOI 10.1093/nar/19.22.6123; HOWARD ST, 1991, VIROLOGY, V180, P633, DOI 10.1016/0042-6822(91)90077-O; KERLAVAGE A, 1993, 26TH P HAW INT C SYS, P585; KHAN AS, 1992, NAT GENET, V2, P180, DOI 10.1038/ng1192-180; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; MARTINGALLARDO A, 1992, NAT GENET, V1, P348; MCCOMBIE WR, 1992, NAT GENET, V1, P348, DOI 10.1038/ng0892-348; MCCOMBIE WR, 1992, NAT GENET, V1, P124, DOI 10.1038/ng0592-124; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; SODERLUND C, 1992, P HAWAII INT C SYSTE, P653; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; UPTON C, 1990, VIROLOGY, V179, P618, DOI 10.1016/0042-6822(90)90129-F; WATERSTON R, 1992, NAT GENET, V1, P114, DOI 10.1038/ng0592-114; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0	30	301	389	1	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1993	4	3					256	267		10.1038/ng0793-256	http://dx.doi.org/10.1038/ng0793-256			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	8358434				2022-12-17	WOS:A1993LJ84200013
J	Doring, A; Gieger, C; Mehta, D; Gohlke, H; Prokisch, H; Coassin, S; Fischer, G; Henke, K; Klopp, N; Kronenberg, F; Paulweber, B; Pfeufer, A; Rosskopf, D; Voelzke, H; Illig, T; Meitinger, T; Wichmann, HE; Meisinger, C				Doering, Angela; Gieger, Christian; Mehta, Divya; Gohlke, Henning; Prokisch, Holger; Coassin, Stefan; Fischer, Guido; Henke, Kathleen; Klopp, Norman; Kronenberg, Florian; Paulweber, Bernhard; Pfeufer, Arne; Rosskopf, Dieter; Voelzke, Henry; Illig, Thomas; Meitinger, Thomas; Wichmann, H-Erich; Meisinger, Christa			SLC2A9 influences uric acid concentrations with pronounced sex-specific effects	NATURE GENETICS			English	Article							GENE; ASSOCIATION; TRANSPORTER; POPULATION; FRUCTOSE; URATE; EXPRESSION; DISEASE; LINKAGE; FAMILY	Serum uric acid concentrations are correlated with gout and clinical entities such as cardiovascular disease and diabetes. In the genome-wide association study KORA (Kooperative Gesundheitsforschung in der Region Augsburg) F3 500K (n = 1,644), the most significant SNPs associated with uric acid concentrations mapped within introns 4 and 6 of SLC2A9, a gene encoding a putative hexose transporter (effects: -0.23 to -0.36 mg/dl per copy of the minor allele). We replicated these findings in three independent samples from Germany (KORA S4 and SHIP (Study of Health in Pomerania)) and Austria (SAPHIR; Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk), with P values ranging from 1.2 x 10(-8) to 1.0 x 10(-32). Analysis of whole blood RNA expression profiles from a KORA F3 500K subgroup (n = 117) showed a significant association between the SLC2A9 isoform 2 and urate concentrations. The SLC2A9 genotypes also showed significant association with self-reported gout. The proportion of the variance of serum uric acid concentrations explained by genotypes was about 1.2% in men and 6% in women, and the percentage accounted for by expression levels was 3.5% in men and 15% in women.	[Doering, Angela; Gieger, Christian; Gohlke, Henning; Fischer, Guido; Klopp, Norman; Illig, Thomas; Wichmann, H-Erich; Meisinger, Christa] German Res Ctr Environm Hlth, Inst Epidemiol, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Gieger, Christian; Klopp, Norman; Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, D-81377 Munich, Germany; [Mehta, Divya; Prokisch, Holger; Pfeufer, Arne; Meitinger, Thomas] German Res Ctr Environm Hlth, Inst Human Genet, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Prokisch, Holger; Pfeufer, Arne; Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-81765 Munich, Germany; [Coassin, Stefan; Kronenberg, Florian] Innsbruck Med Univ, Dept Med Genet, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [Henke, Kathleen; Rosskopf, Dieter] Ernst Moritz Arndt Univ Greifswald, Dept Pharmacol, D-17487 Greifswald, Germany; [Paulweber, Bernhard] Paracelsus Private Med Univ, Dept Internal Med 1, St Johann Spital, A-5020 Salzburg, Austria; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, D-17487 Greifswald, Germany; [Meisinger, Christa] KORA Kooperat Gesundheitsforsch Reg Augsburg Myoc, MONICA Monitoring Trends & Determinants Cardiovas, Cent Hosp Augsburg, D-86156 Augsburg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Medical University of Innsbruck; Ernst Moritz Arndt Universitat Greifswald; Paracelsus Private Medical University; Ernst Moritz Arndt Universitat Greifswald	Meisinger, C (corresponding author), German Res Ctr Environm Hlth, Inst Epidemiol, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany.	christa.meisinger@helmholtz-muenchen.de	Wichmann, Heinz Erich/AAA-5695-2022; Coassin, Stefan/J-2611-2018; Kronenberg, Florian/B-1736-2008; Meisinger, Christine/B-5358-2014; Prokisch, Holger/N-8964-2013; Pfeufer, Arne/B-6634-2013; Meitinger, Thomas/O-1318-2015; Mehta, Divya/ABD-4551-2021	Coassin, Stefan/0000-0001-5677-8979; Kronenberg, Florian/0000-0003-2229-1120; Mehta, Divya Deepak/0000-0002-7359-348X; Meisinger, Christa/0000-0002-9026-6544; Meitinger, Thomas/0000-0002-8838-8403; Mehta, Divya/0000-0001-7971-7255; Prokisch, Holger/0000-0003-2379-6286; Gieger, Christian/0000-0001-6986-9554				Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; BURANT CF, 1992, J BIOL CHEM, V267, P14523; Cheng LSC, 2004, AM J HUM GENET, V75, P498, DOI 10.1086/423429; Graessler J, 2006, ARTHRITIS RHEUM, V54, P292, DOI 10.1002/art.21499; HALLFRISCH J, 1990, FASEB J, V4, P2652, DOI 10.1096/fasebj.4.9.2189777; Heid IM, 2006, DIABETES, V55, P375, DOI 10.2337/diabetes.55.02.06.db05-0747; John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Keembiyehetty C, 2006, MOL ENDOCRINOL, V20, P686, DOI 10.1210/me.2005-0010; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Richardson S, 2003, OSTEOARTHR CARTILAGE, V11, P92, DOI 10.1053/joca.2002.0858; Roddy E, 2007, NAT CLIN PRACT RHEUM, V3, P443, DOI 10.1038/ncprheum0556; Scheepers A, 2005, MOL MEMBR BIOL, V22, P339, DOI 10.1080/09687860500166143; Shima Y, 2006, LIFE SCI, V79, P2234, DOI 10.1016/j.lfs.2006.07.030; STIRPE F, 1970, LANCET, V2, P1310; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Wilk JB, 2000, HUM GENET, V106, P355, DOI 10.1007/s004390051050; Yang Q, 2005, METABOLISM, V54, P1435, DOI 10.1016/j.metabol.2005.05.007; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	23	300	322	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2008	40	4					430	436		10.1038/ng.107	http://dx.doi.org/10.1038/ng.107			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18327256				2022-12-17	WOS:000254388100013
J	Boggs, BA; Cheung, P; Heard, E; Spector, DL; Chinault, AC; Allis, CD				Boggs, BA; Cheung, P; Heard, E; Spector, DL; Chinault, AC; Allis, CD			Differentially methylated forms of histone H3 show unique association patterns with inactive human X chromosomes	NATURE GENETICS			English	Article							FEMALE MAMMALS; ACETYLATION; CELLS; GENES	Studies of histone methylation have shown that H3 can be methylated at lysine 4 (Lys4) or lysine 9 (Lys9)(1.2). Whereas H3-Lys4 methylation has been correlated with active gene expression(3), H3-Lys9 methylation has been linked to gene silencing and assembly of heterochromatin in mouse and Schizosaccharomyces pombe(4-7). The chromodomain of mouse HP1 (and Swi6 in S. pombe) binds H3 methylated at Lys9, and methylation at this site is thought to mark and promote heterochromatin assembly. We have used a well-studied model of mammalian epigenetic silencing, the human inactive X chromosome, to show that enrichment for H3 methylated at Lys9 is also a distinguishing mark of facultative heterochromatin. In contrast, H3 methylated at Lys4 is depleted in the inactive X chromosome, except in three 'hot spots' of enrichment along its length. Chromatin immunoprecipitation analyses further show that Lys9 methylation is associated with promoters of inactive genes, whereas Lys4 methylation is associated with active genes on the X chromosome. These data demonstrate that differential methylation at two distinct sites of the H3 amino terminus correlates with contrasting gene activities and may be part of a 'histone code' involved in establishing and maintaining facultative heterochromatin.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Baylor College of Medicine; University of Virginia; Cold Spring Harbor Laboratory	Allis, CD (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.		Heard, Edith/D-7197-2017	Heard, Edith/0000-0001-8052-7117				Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BARR ML, 1962, ACTA CYTOL, V6, P34; Belyaev ND, 1996, HUM GENET, V97, P573; Boggs BA, 1996, CHROMOSOMA, V105, P303, DOI 10.1007/BF02524648; Carrel L, 1999, P NATL ACAD SCI USA, V96, P14440, DOI 10.1073/pnas.96.25.14440; Chadwick BP, 2001, HUM MOL GENET, V10, P1101, DOI 10.1093/hmg/10.10.1101; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; ELLIS N, 1987, SOMAT CELL MOLEC GEN, V13, P191, DOI 10.1007/BF01535202; FRANCKE U, 1994, CYTOGENET CELL GENET, V65, P206, DOI 10.1159/000133633; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; Gilbert SL, 1999, P NATL ACAD SCI USA, V96, P13825, DOI 10.1073/pnas.96.24.13825; HEARD E, IN PRESS CELL; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; MORISHIMA A, 1962, P NATL ACAD SCI USA, V48, P756, DOI 10.1073/pnas.48.5.756; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; NORRIS DP, 1991, MAMM GENOME, V1, P78, DOI 10.1007/BF02443782; Perche PY, 2000, CURR BIOL, V10, P1531, DOI 10.1016/S0960-9822(00)00832-0; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967	30	300	310	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2002	30	1					73	76		10.1038/ng787	http://dx.doi.org/10.1038/ng787			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11740495				2022-12-17	WOS:000173105600016
J	Haracska, L; Yu, SL; Johnson, RE; Prakash, L; Prakash, S				Haracska, L; Yu, SL; Johnson, RE; Prakash, L; Prakash, S			Efficient and accurate replication in the presence of 7,8-dihydro-8-oxoguanine by DNA polymerase eta	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; XERODERMA-PIGMENTOSUM; 8-OXO-GUANINE; TRANSVERSIONS; MUTAGENESIS; REQUIREMENT; FIDELITY; BYPASS; ASSAY; CELLS	Oxidative damage to DNA has been proposed to have a role in cancer and ageing(1). Oxygen-free radicals formed during normal aerobic cellular metabolism attack bases in DNA, and 7,8-dihydro-8-oxoguanine (8-oxoG) is one of the adducts formed(2,3). Eukaryotic replicative DNA polymerases replicate DNA containing 8-oxoG by inserting an adenine opposite the lesion(4); consequently. 8-oxoG is highly mutagenic and causes G:C to T:A transversions(5). Genetic studies in yeast have indicated a role for mismatch repair in minimizing the incidence of these mutations. In Saccharomyces cerevisiae, deletion of OGG1, encoding a DNA glycosylase that functions in the removal of 8-oxoG when paired with C, causes an increase in the rate of G:C to TA transversions(6). The ogg1 Delta msh2 Delta double mutant displays a higher rate of CAN1(S) to can1(r) forward mutations than the ogg1 Delta or msh2 Delta single mutants, and this enhanced mutagenesis is primarily due to C:C to T:A transversions(7). The gene RAD30 of S. cerevisiae encodes a DNA polymerase, Pol eta, that efficiently replicates DNA containing a cis-syn thymine-thymine (T-T) dimer by inserting two adenines across from the dimers. In humans, mutations in the yeast RAD30 counterpart, POLH, cause the variant form of xeroderma pigmentosum(9,10) (XP-V), and XP-V individuals suffer from a high incidence of sunlight-induced skin cancers. Here we show that yeast and human POL eta replicate DNA containing 8-oxoG efficiently and accurately by inserting a cytosine across from the lesion and by proficiently extending from this base pair. Consistent with these biochemical studies, a synergistic increase in the rate of spontaneous mutations occurs in the absence of POL eta in the yeast ogg1 Delta mutant. Our results suggest an additional role for Pol eta in the prevention of internal cancers in humans that would otherwise result from the mutagenic replication of 8-oxoG in DNA.	Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston	Prakash, S (corresponding author), Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77550 USA.		Prakash, Satya/C-6420-2013	Prakash, Satya/0000-0001-7228-1444; Prakash, Louise/0000-0001-9143-6261	NATIONAL CANCER INSTITUTE [R01CA080882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NCI NIH HHS [CA80882] Funding Source: Medline; NIEHS NIH HHS [P30-ES06676] Funding Source: Medline; NIGMS NIH HHS [GM19261] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Efrati E, 1999, J BIOL CHEM, V274, P15920, DOI 10.1074/jbc.274.22.15920; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288; HOFMANN H, 1978, B CANCER, V65, P347; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 1999, J BIOL CHEM, V274, P15975, DOI 10.1074/jbc.274.23.15975; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; MORIYA M, 1993, P NATL ACAD SCI USA, V90, P1122, DOI 10.1073/pnas.90.3.1122; Ni TT, 1999, MOL CELL, V4, P439, DOI 10.1016/S1097-2765(00)80346-9; Saparbaev M, 1996, GENETICS, V142, P727; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Thomas D, 1997, MOL GEN GENET, V254, P171, DOI 10.1007/s004380050405; Washington MT, 1999, J BIOL CHEM, V274, P36835, DOI 10.1074/jbc.274.52.36835	20	300	306	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2000	25	4					458	461		10.1038/78169	http://dx.doi.org/10.1038/78169			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	341WY	10932195				2022-12-17	WOS:000088615000026
J	Wagner, A				Wagner, A			Robustness against mutations in genetic networks of yeast	NATURE GENETICS			English	Article							FUNCTIONAL REDUNDANCY; SELECTIVE NEUTRALITY; EVOLUTION; GENOME; TRANSCRIPTION; TRANSPOSITION; DUPLICATION; DATABASE; FITNESS	There are two principal mechanisms that are responsible for the ability of an organism's physiological and developmental processes to compensate for mutations. In the first, genes have overlapping functions, and loss-of-function mutations in one gene will have little phenotypic effect if there are one or more additional genes with similar functions. The second mechanism has its origin in interactions between genes with unrelated functions, and has been documented in metabolic and regulatory gene networks. Here I analyse, on a genome-wide scale, which of these mechanisms of robustness against mutations is more prevalent. I used functional genomics data from the yeast Saccharomyces cerevisiae to test hypotheses related to the following: if gene duplications are mostly responsible for robustness, then a correlation is expected between the similarity of two duplicated genes and the effect of mutations in one of these genes. Wry results demonstrate that interactions among unrelated genes are the major cause of robustness against mutations. This type of robustness is probably an evolved response of genetic networks to stabilizing selection.	Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Santa Fe Inst, Albuquerque, NM USA	University of New Mexico; The Santa Fe Institute	Wagner, A (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	wagnera@unm.edu						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1984, AM NAT; BRADSHAW VA, 1989, MOL GEN GENET, V218, P465, DOI 10.1007/BF00332411; CADIGAN KM, 1994, P NATL ACAD SCI USA, V91, P6324, DOI 10.1073/pnas.91.14.6324; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Comeron JM, 1995, J MOL EVOL, V41, P1152, DOI 10.1007/BF00173196; Dayhoff M, 1978, ATLAS PROTEIN SEQ ST, P345; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DOOLITTLE RF, 1994, TRENDS BIOCHEM SCI, V19, P15, DOI 10.1016/0968-0004(94)90167-8; DUN RB, 1958, NATURE, V181, P1018, DOI 10.1038/1811018a0; DYKHUIZEN D, 1980, GENETICS, V96, P801; DYKHUIZEN DE, 1987, GENETICS, V115, P25; Edwards JS, 1999, J BIOL CHEM, V274, P17410, DOI 10.1074/jbc.274.25.17410; Fell D., 1997, UNDERSTANDING CONTRO; Galperin MY, 1998, GENOME RES, V8, P779, DOI 10.1101/gr.8.8.779; GONZALEZGAITAN M, 1994, P NATL ACAD SCI USA, V91, P8567, DOI 10.1073/pnas.91.18.8567; Goudet J., 2001, CLADISTICS; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; HARTL DL, 1985, GENETICS, V111, P655; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HOFFMANN FM, 1991, TRENDS GENET, V7, P351, DOI 10.1016/0168-9525(91)90254-F; Hubbard TJP, 1998, ACTA CRYSTALLOGR D, V54, P1147, DOI 10.1107/S0907444998009172; KACSER H, 1981, GENETICS, V97, P639; LI XL, 1994, NATURE, V367, P83, DOI 10.1038/367083a0; Nadeau JH, 1997, GENETICS, V147, P1259; PAQUIN CE, 1984, SCIENCE, V226, P53, DOI 10.1126/science.226.4670.53; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; RENDEL JM, 1959, EVOLUTION, V13, P425, DOI 10.2307/2406126; RENDEL JM, 1979, QUANTITATIVE GENETIC, P139; Rutherford SL, 1998, MOL BIOL CELL, V9, p433A; SAGA Y, 1992, GENE DEV, V6, P1821, DOI 10.1101/gad.6.10.1821; Seoighe C, 1999, CURR OPIN MICROBIOL, V2, P548, DOI 10.1016/S1369-5274(99)00015-6; Seoighe C, 1998, P NATL ACAD SCI USA, V95, P4447, DOI 10.1073/pnas.95.8.4447; Smith V, 1997, SCIENCE, V275, P464; Sokal R.R., 1981, BIOMETRY, V2nd ed.; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; TAUTZ D, 1992, BIOESSAYS, V14, P263, DOI 10.1002/bies.950140410; Thatcher JW, 1998, P NATL ACAD SCI USA, V95, P253, DOI 10.1073/pnas.95.1.253; Waddington C. H., 1959, STRATEGY GENES; Wagner A, 1999, J EVOLUTION BIOL, V12, P1, DOI 10.1046/j.1420-9101.1999.00008.x; Wagner A, 1996, EVOLUTION, V50, P1008, DOI 10.1111/j.1558-5646.1996.tb02342.x; Wagner A, 2000, GENETICS, V154, P1389; Wagner GP, 1997, EVOLUTION, V51, P329, DOI 10.1111/j.1558-5646.1997.tb02420.x; Wang YK, 1996, NATURE, V379, P823, DOI 10.1038/379823a0; WATERMAN MS, 1984, B MATH BIOL, V46, P473, DOI 10.1007/BF02459498; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711	48	300	307	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2000	24	4					355	361		10.1038/74174	http://dx.doi.org/10.1038/74174			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	299HK	10742097				2022-12-17	WOS:000086192800012
J	Grifa, A; Wagner, CA; D'Ambrosio, L; Melchionda, S; Bernardi, F; Lopez-Bigas, N; Rabionet, R; Arbones, M; Della Monica, M; Estivill, X; Zelante, L; Lang, F; Gasparini, P				Grifa, A; Wagner, CA; D'Ambrosio, L; Melchionda, S; Bernardi, F; Lopez-Bigas, N; Rabionet, R; Arbones, M; Della Monica, M; Estivill, X; Zelante, L; Lang, F; Gasparini, P			Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus	NATURE GENETICS			English	Letter							DEPENDENT JUNCTIONAL CONDUCTANCE; SENSORINEURAL DEAFNESS; CONNEXIN-26 MUTATIONS; EXPRESSION		IRCCS, Serv Genet Med, Osped CSS, San Giovanni Rotondo, Italy; Univ Tubingen, Inst Physiol, D-72076 Tubingen, Germany; Univ Ferrara, Dipartimento Biochim, I-44100 Ferrara, Italy; IRO, Hosp Duran & Reynals, Dept Mol Genet, Barcelona, Spain; Osped G Moscati, Serv Genet Med, Avellino, Italy	IRCCS Casa Sollievo Della Sofferenza; Eberhard Karls University of Tubingen; University of Ferrara; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; San Giuseppe Moscati Hospital	Gasparini, P (corresponding author), IRCCS, Serv Genet Med, Osped CSS, San Giovanni Rotondo, Italy.		bernardi, francesco/F-5443-2013; Rabionet, Raquel/C-8379-2009; Arbones, Maria/D-4668-2016; rabionet, raquel/A-7407-2009; Lopez-Bigas, Nuria/F-6193-2011; Estivill, Xavier/A-3125-2013; Estivill, Xavier/E-2957-2012; Gasparini, Paolo/B-6173-2014	Rabionet, Raquel/0000-0001-5006-8140; Arbones, Maria/0000-0002-6035-0235; rabionet, raquel/0000-0001-5006-8140; Lopez-Bigas, Nuria/0000-0003-4925-8988; Estivill, Xavier/0000-0002-0723-2256; Gasparini, Paolo/0000-0002-0859-0856; Della Monica, Matteo/0000-0001-8338-7949	Telethon [E.0813] Funding Source: Medline	Telethon(Fondazione Telethon)		Cohen M. M., 1995, HEREDITARY HEARING L, P9; Dahl E, 1996, J BIOL CHEM, V271, P17903, DOI 10.1074/jbc.271.30.17903; Denoyelle F, 1998, NATURE, V393, P319, DOI 10.1038/30639; EBIHARA L, 1992, METHOD ENZYMOL, V207, P376; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; HARRIS AL, 1981, J GEN PHYSIOL, V77, P95, DOI 10.1085/jgp.77.1.95; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kunzelmann P, 1999, GLIA, V25, P111, DOI 10.1002/(SICI)1098-1136(19990115)25:2<111::AID-GLIA2>3.0.CO;2-I; Lautermann J, 1998, CELL TISSUE RES, V294, P415, DOI 10.1007/s004410051192; Pusch M, 1995, NEURON, V15, P1455, DOI 10.1016/0896-6273(95)90023-3; SPRAY DC, 1981, J GEN PHYSIOL, V77, P77, DOI 10.1085/jgp.77.1.77; Stojkovic T, 1999, NEUROLOGY, V52, P1010, DOI 10.1212/WNL.52.5.1010; White TW, 1998, NATURE, V394, P630, DOI 10.1038/29202; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605	15	300	319	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1999	23	1					16	18		10.1038/12612	http://dx.doi.org/10.1038/12612			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	231XU	10471490				2022-12-17	WOS:000082337300008
J	Wang, JM; Wilhelmsson, H; Graff, C; Li, H; Oldfors, A; Rustin, P; Bruning, JC; Kahn, CR; Clayton, DA; Barsh, GS; Thoren, P; Larsson, NG				Wang, JM; Wilhelmsson, H; Graff, C; Li, H; Oldfors, A; Rustin, P; Bruning, JC; Kahn, CR; Clayton, DA; Barsh, GS; Thoren, P; Larsson, NG			Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression	NATURE GENETICS			English	Article							KEARNS-SAYRE SYNDROME; SKELETAL-MUSCLE; DEVELOPMENTAL REGULATION; MESSENGER-RNAS; IN-VIVO; DEFICIENCY; DELETIONS; DISEASE; MICE; TRANSCRIPTION	Mutations of mitochondrial DNA (mtDNA) cause several well-recognized human genetic syndromes with deficient oxidative phosphorytation(1-4) and may also have a role in ageing and acquired diseases of old age(5). We report here that hallmarks of mtDNA mutation disorders can be reproduced in the mouse using a conditional mutation strategy tl manipulate the expression of the gene encoding mitochondrial transcription factor A (Tfam, previously named mtTFA), which regulates transcription and replication of mtDNA (refs 6,7). Using a loxP-flanked Tfam allele (Tfam(loxP); ref. 8) in combination with a cre-recombinase transgene under control of the muscle creatinine kinase promoter(9,10), we have disrupted Tfam in heart and muscle. Mutant animals develop a mosaic cardiac-specific progressive respiratory chain deficiency, dilated cardiomyopathy, atrioventricular heart conduction blocks and die at 2-4 weeks of age. This animal model reproduces biochemical, morphological and physiological features of the dilated cardiomyopathy of Kearns-Sayre syndrome(1-4). Furthermore, our findings provide genetic evidence that the respiratory chain is critical for normal heart function.	Karolinska Hosp, Dept Mol Med, Ctr Mol Med L8 02, S-17176 Stockholm, Sweden; Karolinska Hosp, Dept Woman & Child Hlth, S-17176 Stockholm, Sweden; Sahlgrenska Hosp, Dept Pathol, S-41345 Gothenburg, Sweden; Hop Necker Enfants Malad, Unite Rech Handicaps Genet Enfant, INSERM U393, F-75015 Paris, France; Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Pediat & Genet, Stanford, CA 94305 USA; Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Sahlgrenska University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Stanford University; Karolinska Institutet	Larsson, NG (corresponding author), Karolinska Hosp, Dept Mol Med, Ctr Mol Med L8 02, S-17176 Stockholm, Sweden.	nils-goran.larsson@cmm.ki.se	graff, caroline/A-2545-2009; Larsson, Nils-Göran/GVS-5578-2022; Kahn, Ronald/AAY-2435-2021	Larsson, Nils-Göran/0000-0001-5100-996X; Kahn, Ronald/0000-0002-7583-9228; Graff, Caroline/0000-0002-9949-2951; Oldfors, Anders/0000-0002-5758-7397	NIGMS NIH HHS [R37-GM33088-28] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033088] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AXENBORG JE, 1993, COMPUT METH PROG BIO, V41, P55, DOI 10.1016/0169-2607(93)90065-S; BERENBERG RA, 1977, ANN NEUROL, V1, P37, DOI 10.1002/ana.410010104; CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321; Connor MK, 1996, ARCH BIOCHEM BIOPHYS, V333, P103, DOI 10.1006/abbi.1996.0369; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; GROVE D, 1969, CIRC RES, V25, P473, DOI 10.1161/01.RES.25.4.473; HAKULINEN T, 1987, APPL STAT-J ROY ST C, V36, P309; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; HOIT BD, 1995, CIRC RES, V77, P632, DOI 10.1161/01.RES.77.3.632; Johansson C, 1997, ACTA PHYSIOL SCAND, V160, P133, DOI 10.1046/j.1365-201X.1997.00134.x; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; LYONS GE, 1991, DEVELOPMENT, V113, P1017; MOORE GW, 1980, AM HEART J, V100, P610, DOI 10.1016/0002-8703(80)90224-0; MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359; MULLERHOCKER J, 1992, HUM PATHOL, V23, P1431, DOI 10.1016/0046-8177(92)90065-B; Munnich A, 1996, EUR J PEDIATR, V155, P262; OLDFORS A, 1992, J NEUROL SCI, V110, P169, DOI 10.1016/0022-510X(92)90025-G; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; SCHON EA, 1994, J BIOENERG BIOMEMBR, V26, P291, DOI 10.1007/BF00763100; SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A; TRASK RV, 1990, BIOCHIM BIOPHYS ACTA, V1049, P182, DOI 10.1016/0167-4781(90)90039-5; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; Weber K, 1997, AM J HUM GENET, V60, P373; ZAK R, 1974, CIRC RES, V35, P17	30	300	312	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1999	21	1					133	137		10.1038/5089	http://dx.doi.org/10.1038/5089			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	155RT	9916807				2022-12-17	WOS:000077960700025
J	Kong, DH; Suzuki, A; Zou, TT; Sakurada, A; Kemp, LW; Wakatsuki, S; Yokoyama, T; Yamakawa, H; Furukawa, T; Sato, M; Ohuchi, N; Sato, S; Yin, J; Wang, SN; Abraham, JM; Souza, RF; Smolinski, KN; Meltzer, SJ; Horii, A				Kong, DH; Suzuki, A; Zou, TT; Sakurada, A; Kemp, LW; Wakatsuki, S; Yokoyama, T; Yamakawa, H; Furukawa, T; Sato, M; Ohuchi, N; Sato, S; Yin, J; Wang, SN; Abraham, JM; Souza, RF; Smolinski, KN; Meltzer, SJ; Horii, A			PTEN1 is frequently mutated in primary endometrial carcinomas	NATURE GENETICS			English	Letter							ALLELIC LOSS; CANCERS		TOHOKU UNIV,SCH MED,DEPT MOL PATHOL,SENDAI,MIYAGI 98077,JAPAN; TOHOKU UNIV,SCH MED,DEPT SURG 2,SENDAI,MIYAGI 98077,JAPAN; TOHOKU UNIV,SCH MED,DEPT OBSTET & GYNECOL,SENDAI,MIYAGI 98077,JAPAN; TOHOKU UNIV,INST DEV AGING & CANC,DEPT THORAC SURG,SENDAI,MIYAGI 98077,JAPAN; UNIV MARYLAND,SCH MED,DEPT MED,GI DIV,BALTIMORE,MD 21205; UNIV MARYLAND,SCH MED,GREENEBAUM CANC CTR,BALTIMORE,MD 21205; UNIV MARYLAND,SCH MED,GRAD PROGRAM MOL & CELLULAR BIOL,BALTIMORE,MD 21205; UNIV MARYLAND,SCH MED,GRAD PROGRAM PATHOL,BALTIMORE,MD 21205; VET AFFAIRS MED CTR,BALTIMORE,MD 21205	Tohoku University; Tohoku University; Tohoku University; Tohoku University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA)			Horii, Akira/AAW-2839-2021; Furukawa, Toru/AAF-5596-2021	Horii, Akira/0000-0002-3967-3291; Furukawa, Toru/0000-0002-1083-2324	NATIONAL CANCER INSTITUTE [R01CA067497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047717] Funding Source: NIH RePORTER; NCI NIH HHS [CA67497] Funding Source: Medline; NIDDK NIH HHS [DK47717] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ENOMOTO T, 1990, CANCER RES, V50, P6139; FUJIMOTO I, 1993, CANC INCIDENCE MORTA, P49; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; MAYAMA T, IN PRESS EUR J SURG; OKAMOTO A, 1991, CANCER RES, V51, P5632; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Ouyang H, 1997, CANCER RES, V57, P1851; PEIFFER SL, 1995, CANCER RES, V55, P1922; ROBBOY SJ, 1995, ESSENTIAL PATHOLOGY, P516; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; SUZUKI H, 1994, CANCER RES, V54, P4841	12	300	306	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					143	144		10.1038/ng1097-143	http://dx.doi.org/10.1038/ng1097-143			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326929				2022-12-17	WOS:A1997XZ55500015
J	Wilson, RB; Roof, DM				Wilson, RB; Roof, DM			Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; FRIEDREICHS ATAXIA; CRITICAL REGION; PET MUTANTS; VITAMIN-E; PROTEIN; RNA; MUTATIONS; MENADIONE; MEDICINE	Friedreich's ataxia (FRDA) is an autosomal recessive degenerative disorder that primarily affects the nervous system and heart. Patients with FRDA have point mutations or trinucleotide repeat expansions in both alleles of FRDA, which encodes a protein termed frataxin. We show that the yeast frataxin homologue, which we have named YFH1, localizes to mitochondria and is required to maintain mitochondrial DNA, The YFH1-homologous domain of frataxin functions in yeast and a disease-associated missense mutation of this domain, or the corresponding domain in YFH1, reduces function. Our data suggest that mitochondrial dysfunction contributes to FRDA pathophysiology.	UNIV PENN,DEPT PHYSIOL,PHILADELPHIA,PA 19104	University of Pennsylvania	Wilson, RB (corresponding author), UNIV PENN,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104, USA.							Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; BARBEAU A, 1984, CAN J NEUROL SCI, V11, P646, DOI 10.1017/S0317167100035228; BARBEAU A, 1980, CAN J NEUROL SCI, V7, P455, DOI 10.1017/S0317167100023064; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Carvajal JJ, 1996, NAT GENET, V14, P157, DOI 10.1038/ng1096-157; CARVAJAL JJ, 1995, HUM MOL GENET, V4, P1411, DOI 10.1093/hmg/4.8.1411; DUCLOS F, 1994, HUM MOL GENET, V3, P909, DOI 10.1093/hmg/3.6.909; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; GARN H, 1994, J IMMUNOL METHODS, V168, P253, DOI 10.1016/0022-1759(94)90062-0; GENGA A, 1986, J BIOL CHEM, V261, P9328; JAHN B, 1995, J CLIN MICROBIOL, V33, P661, DOI 10.1128/JCM.33.3.661-667.1995; JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007; KOOBS DH, 1978, ARCH PATHOL LAB MED, V102, P66; LAMARCHE JB, 1980, CAN J NEUROL SCI, V7, P389, DOI 10.1017/S0317167100022927; LUFT R, 1995, BBA-MOL BASIS DIS, V1271, P1, DOI 10.1016/0925-4439(95)00002-L; Mastrogiacomo F, 1996, NEURODEGENERATION, V5, P27, DOI 10.1006/neur.1996.0004; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; MONTERMINI L, 1995, AM J HUM GENET, V57, P1061; MUELLER DM, 1987, CURR GENET, V11, P359, DOI 10.1007/BF00378178; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; ROSE MD, 1990, METHODS YEAST GENETI; ROTH MB, 1991, J CELL BIOL, V115, P587, DOI 10.1083/jcb.115.3.587; SANYAL A, 1995, MOL GEN GENET, V246, P56, DOI 10.1007/BF00290133; SIKORSKI RS, 1989, GENETICS, V122, P19; SIMON M, 1984, P NATL ACAD SCI-BIOL, V81, P8, DOI 10.1073/pnas.81.1.8; SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146; TAPPEL AL, 1972, ANN NY ACAD SCI, V203, P12, DOI 10.1111/j.1749-6632.1972.tb27851.x; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; ZEVIANI M, 1992, J INHERIT METAB DIS, V15, P456, DOI 10.1007/BF01799604; [No title captured]	33	300	312	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					352	357		10.1038/ng0897-352	http://dx.doi.org/10.1038/ng0897-352			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241271				2022-12-17	WOS:A1997XM90900016
J	Jenuth, JP; Peterson, AC; Shoubridge, EA				Jenuth, JP; Peterson, AC; Shoubridge, EA			Tissue-specific selection for different mtDNA genotypes in heteroplasmic mice	NATURE GENETICS			English	Article							MITOCHONDRIAL-DNA; TRANSCRIPTION; SEGREGATION	Mammalian mitochondrial DNA (mtDNA) is a highly polymorphic, high-copy-number genome that is maternally inherited. New mutations in mtDNA segregate rapidly in the female germline due to a genetic bottleneck in early oogenesis(1-3) and as a result most individuals are homoplasmic for a single species of mtDNA. Sequence variants thus accumulate along maternal lineages without genetic recombination. Most of the extant variation in mtDNA in mammalian populations has been assumed to be neutral with respect to selection(4); however, comparisons of the ratio of replacement to silent nucleotide substitutions between species suggest that the evolution of mammalian mtDNA is not strictly neutral(5). To test directly whether polymorphic mtDNAs behave as neutral variants, we examined the segregation of two different mtDNA genotypes in the tissues of heteroplasmic mice. We find evidence for random genetic drift in some tissues, but in others strong, tissue-specific and age-related, directional selection for different mtDNA genotypes in the same animal. These surprising data suggest that the coding sequence of mtDNA may represent a compromise between the competing demands of different tissues and point to the existence of unknown, tissue-specific nuclear genes important in the interaction between the nuclear and mitochondrial genomes.	MONTREAL NEUROL INST,MONTREAL,PQ H3A 2B4,CANADA; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ H3A 1B1,CANADA; MCGILL UNIV,MOL ONCOL GRP,MONTREAL,PQ H3A 1A1,CANADA	McGill University; McGill University; McGill University								ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; BIRKY CW, 1983, GENETICS, V103, P513; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; CLAYTON DA, 1992, INT REV CYTOL, V141, P217, DOI 10.1016/S0074-7696(08)62067-7; DESTORDEUR E, 1989, MOL GEN GENET, V220, P127, DOI 10.1007/BF00260866; DUKES KR, 1995, THESIS U FLORIDA; HARDING AE, 1992, AM J HUM GENET, V50, P629; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; KENNAWAY NG, 1990, PEDIATR RES, V28, P529; LI H, 1991, Methods (Orlando), V2, P49, DOI 10.1016/S1046-2023(05)80125-2; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807; Nachman MW, 1996, GENETICS, V142, P953; PONDER BAJ, 1985, NATURE, V313, P689, DOI 10.1038/313689a0; SHADEL GS, 1993, J BIOL CHEM, V268, P16083; ZAJICEK G, 1985, LIVER, V5, P293	21	300	313	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1997	16	1					93	95		10.1038/ng0597-93	http://dx.doi.org/10.1038/ng0597-93			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	9140402				2022-12-17	WOS:A1997WX02400029
J	BANFI, S; SERVADIO, A; CHUNG, MY; KWIATKOWSKI, TJ; MCCALL, AE; DUVICK, LA; SHEN, Y; ROTH, EJ; ORR, HT; ZOGHBI, HY				BANFI, S; SERVADIO, A; CHUNG, MY; KWIATKOWSKI, TJ; MCCALL, AE; DUVICK, LA; SHEN, Y; ROTH, EJ; ORR, HT; ZOGHBI, HY			IDENTIFICATION AND CHARACTERIZATION OF THE GENE CAUSING TYPE-1 SPINOCEREBELLAR ATAXIA	NATURE GENETICS			English	Article							ANDROGEN RECEPTOR GENE; MESSENGER-RNA; UNTRANSLATED REGION; MYOTONIC-DYSTROPHY; EXPRESSION; LINKAGE; HLA; TRANSCRIPTS; MUTATIONS; KINDREDS	Spinocerebellar ataxia type 1 (SCA1) is a neurodegenerative disorder caused by expansion of a CAG trinucleotide repeat. In this study, we describe the identification and characterization of the gene harbouring this repeat. The SCA1 transcript is 10,660 bases and is transcribed from both the wild type and SCA1 alleles. The CAG repeat, coding for a polyglutamine tract, lies within the coding region. The gene spans 450 kb of genomic DNA and is organized in nine exons. The first seven fall in the 5' untranslated region and the last two contain the coding region, and a 7,277 basepairs 3' untranslated region. The first four non-coding exons undergo alternative splicing in several tissues. These features suggest that the transcriptional and translational regulation of ataxin-1, the SCA1 encoded protein, may be complex.	BAYLOR COLL MED, DEPT PEDIAT, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT HUMAN GENET, HOUSTON, TX 77030 USA; UNIV MINNESOTA, INST HUMAN GENET, DEPT LAB MED & PATHOL, MINNEAPOLIS, MN 55455 USA; UNIV MINNESOTA, INST HUMAN GENET, DEPT BIOCHEM, MINNEAPOLIS, MN 55455 USA	Baylor College of Medicine; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities			Banfi, Sandro/K-3963-2018	Banfi, Sandro/0000-0002-6541-8833; Orr, Harry/0000-0001-6118-741X; Zoghbi, Huda/0000-0002-0700-3349; Chung, Ming-yi/0000-0003-2198-6860	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022920, R37NS022920, R01NS027699] Funding Source: NIH RePORTER; NINDS NIH HHS [NS27699, NS22920] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS MD, 1993, NAT GENET, V4, P256, DOI 10.1038/ng0793-256; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BANFI S, 1993, GENOMICS, V18, P627, DOI 10.1016/S0888-7543(05)80365-9; BANKIER AT, 1987, METHOD ENZYMOL, V155, P51; CRIPE LD, 1992, BIOCHEMISTRY-US, V31, P3777, DOI 10.1021/bi00130a007; CURRIER RD, 1972, NEUROLOGY, V22, P1040, DOI 10.1212/WNL.22.9.1040; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Frohman MA, 1990, PCR PROTOCOLS GUIDE; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; Greenfield JG, 1954, SPINOCEREBELLAR DEGE; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; HAINES JL, 1984, NEUROLOGY, V34, P1542, DOI 10.1212/WNL.34.12.1542; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; JODICE C, 1994, AM J HUM GENET, V54, P959; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KWIATKOWSKI TJ, 1993, AM J HUM GENET, V53, P391; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LIN BY, 1993, HUM MOL GENET, V2, P1541, DOI 10.1093/hmg/2.10.1541; LINK DC, 1992, ONCOGENE, V7, P877; LUDWIG EH, 1987, DNA-J MOLEC CELL BIO, V6, P363, DOI 10.1089/dna.1987.6.363; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MATILLA T, 1993, HUM MOL GENET, V2, P2123, DOI 10.1093/hmg/2.12.2123; MYERS RL, 1993, ONCOGENE, V8, P341; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; QUIGLEY CA, 1992, J CLIN ENDOCR METAB, V74, P927, DOI 10.1210/jc.74.4.927; RANUM LPW, 1994, AM J HUM GENET, V55, P244; RANUM LPW, 1991, AM J HUM GENET, V49, P31; RASTINEJAD F, 1993, CELL, V75, P1107, DOI 10.1016/0092-8674(93)90320-P; SABOURI LA, 1993, NAT GENET, V4, P233, DOI 10.1038/ng0793-233; SCHUT JW, 1950, ARCH NEURO PSYCHIATR, V63, P535, DOI 10.1001/archneurpsyc.1950.02310220002001; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; TILLEY WD, 1990, J BIOL CHEM, V265, P13776; TRIFIRO M, 1991, MOL CELL ENDOCRINOL, V75, P37, DOI 10.1016/0303-7207(91)90243-L; WAPENAAR MC, 1993, HUM MOL GENET, V2, P947, DOI 10.1093/hmg/2.7.947; ZOGHBI HY, 1988, AM J HUM GENET, V42, P877; ZOGHBI HY, 1988, ANN NEUROL, V23, P580, DOI 10.1002/ana.410230609; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23; ZOGHBI HY, 1991, CURRENT NEUROLOGY, P121	43	300	311	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1994	7	4					513	520		10.1038/ng0894-513	http://dx.doi.org/10.1038/ng0894-513			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA832	7951322				2022-12-17	WOS:A1994PA83200019
J	ABERDAM, D; GALLIANO, MF; VAILLY, J; PULKKINEN, L; BONIFAS, J; CHRISTIANO, AM; TRYGGVASON, K; UITTO, J; EPSTEIN, EH; ORTONNE, JP; MENEGUZZI, G				ABERDAM, D; GALLIANO, MF; VAILLY, J; PULKKINEN, L; BONIFAS, J; CHRISTIANO, AM; TRYGGVASON, K; UITTO, J; EPSTEIN, EH; ORTONNE, JP; MENEGUZZI, G			HERLITZS JUNCTIONAL EPIDERMOLYSIS-BULLOSA IS LINKED TO MUTATIONS IN THE GENE (LAMC2) FOR THE GAMMA-2 SUBUNIT OF NICEIN/KALININ (LAMININ-5)	NATURE GENETICS			English	Article							MONOCLONAL-ANTIBODY; BASEMENT-MEMBRANES; PROTEINS; PROBE	We have linked Herlitz's junctional epidermolysis bullosa (H-JEB) to the gene (LAMC2) encoding the gamma 2 subunit of nicein/kalinin, an isolaminin (laminin-5) expressed by basal keratinocytes. In four H-JEB kindreds, a maximum two-point lod score of 5.33 at theta=0 was observed between a microsatellite near LAMC2 at 1q25-31 and the disease. In one family, a homozygous point mutation leading to a premature stop codon (CGA to TGA) was identified in exon 3 of the gene. The segregation of the mutated allele implicates the mutation in the pathology of the disorder and corroborates the linkage results.	FAC MED NICE,INSERM,U385,F-06107 NICE 2,FRANCE; THOMAS JEFFERSON UNIV,DEPT DERMATOL,PHILADELPHIA,PA 19107; UNIV CALIF SAN FRANCISCO,SAN FRANCISCO GEN HOSP,DEPT DERMATOL,SAN FRANCISCO,CA 94110; UNIV OULU,BIOCTR,SF-90570 OULU,FINLAND; UNIV OULU,DEPT BIOCHEM,SF-90570 OULU,FINLAND	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Jefferson University; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu			Aberdam, Daniel/G-3299-2013	Aberdam, Daniel/0000-0002-4019-5418	NIAMS NIH HHS [R01-AR 41120, P01-AR38923] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041120, P01AR038923] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABERDAM D, IN PRESS MAMM GENOME; BARE JW, 1992, CANCER RES, V52, P1494; BAUDOIN C, IN PRESS J INVEST DE; BROWN DL, 1992, NUCLEIC ACIDS RES, V200, P141; BURGESON RE, 1993, J INVEST DERMATOL, V101, P252, DOI 10.1111/1523-1747.ep12365129; BURGESON RE, IN PRESS J CLIN INVE; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHRISTIANO AM, 1993, NAT GENET, V4, P62, DOI 10.1038/ng0593-62; ENGEL J, 1992, BIOCHEMISTRY-US, V31, P10643, DOI 10.1021/bi00159a001; EPSTEIN EH, 1992, SCIENCE, V256, P799, DOI 10.1126/science.1375393; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; FINE JD, 1986, INT J DERMATOL, V25, P143, DOI 10.1111/j.1365-4362.1986.tb02206.x; FINE JD, 1990, ARCH DERMATOL, V126, P1187, DOI 10.1001/archderm.126.9.1187; GERECKE D, IN PRESS J BIOL CHEM; GROUP NCC, 1992, SCIENCE, V258, P148; KALLUNKI P, 1992, J CELL BIOL, V119, P679, DOI 10.1083/jcb.119.3.679; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MARINKOVICH MP, 1992, J CELL BIOL, V119, P695, DOI 10.1083/jcb.119.3.695; Meneguzzi G, 1992, Exp Dermatol, V1, P221, DOI 10.1111/j.1600-0625.1992.tb00080.x; ORTONNE JP, 1990, J INVEST DERMATOL, V94, P400; PULKKINEN L, 1994, NAT GENET, V6, P293, DOI 10.1038/ng0394-293; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; SAKAI LI, 1986, J CELL BIOL, V114, P1567; Sambrook J., 1989, MOL CLONING LAB MANU; SIMON M, 1985, CELL, V40, P677, DOI 10.1016/0092-8674(85)90216-8; UITTO J, 1993, SEMIN DERMATOL, V12, P191; VAILLY J, 1994, EUR J BIOCHEM, V219, P209, DOI 10.1111/j.1432-1033.1994.tb19932.x; VAILLY J, IN PRESS GENOMICS; VERRANDO P, 1987, EXP CELL RES, V170, P116, DOI 10.1016/0014-4827(87)90121-2; VERRANDO P, 1993, J INVEST DERMATOL, V101, P738, DOI 10.1111/1523-1747.ep12371685; VERRANDO P, 1991, LAB INVEST, V64, P85; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WOODLEY DT, 1992, EPIDERMOLYSIS BULLOS, P19	35	300	308	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					299	304		10.1038/ng0394-299	http://dx.doi.org/10.1038/ng0394-299			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012394				2022-12-17	WOS:A1994MZ56200019
J	Barthel, FP; Wei, W; Tang, M; Martinez-Ledesma, E; Hu, X; Amin, SB; Akdemir, KC; Seth, S; Song, XZ; Wang, QH; Lichtenberg, T; Hu, J; Zhang, JH; Zheng, SY; Verhaak, RGW				Barthel, Floris P.; Wei, Wei; Tang, Ming; Martinez-Ledesma, Emmanuel; Hu, Xin; Amin, Samirkumar B.; Akdemir, Kadir C.; Seth, Sahil; Song, Xingzhi; Wang, Qianghu; Lichtenberg, Tara; Hu, Jian; Zhang, Jianhua; Zheng, Siyuan; Verhaak, Roel G. W.			Systematic analysis of telomere length and somatic alterations in 31 cancer types	NATURE GENETICS			English	Article							TERT PROMOTER MUTATIONS; RENAL-CELL CARCINOMA; REVERSE-TRANSCRIPTASE; CATALYTIC SUBUNIT; GENE-EXPRESSION; HUMAN TUMORS; RNA; METHYLATION; LANDSCAPE; CHROMATIN	Cancer cells survive cellular crisis through telomere maintenance mechanisms. We report telomere lengths in 18,430 samples, including tumors and non-neoplastic samples, across 31 cancer types. Telomeres were shorter in tumors than in normal tissues and longer in sarcomas and gliomas than in other cancers. Among 6,835 cancers, 73% expressed telomerase reverse transcriptase (TERT), which was associated with TERT point mutations, rearrangements, DNA amplifications and transcript fusions and predictive of telomerase activity. TERT promoter methylation provided an additional deregulatory TERT expression mechanism. Five percent of cases, characterized by undetectable TERT expression and alterations in ATRX or DAXX, demonstrated elongated telomeres and increased telomeric repeat-containing RNA (TERRA). The remaining 22% of tumors neither expressed TERT nor harbored alterations in ATRX or DAXX. In this group, telomere length positively correlated with TP53 and RB1 mutations. Our analysis integrates TERT abnormalities, telomerase activity and genomic alterations with telomere length in cancer.	[Barthel, Floris P.; Verhaak, Roel G. W.] Jackson Lab Genom Med, Farmington, CT 06032 USA; [Barthel, Floris P.] Vrije Univ Amsterdam, Med Ctr, Oncol Grad Sch Amsterdam, Amsterdam, Netherlands; [Barthel, Floris P.; Tang, Ming; Martinez-Ledesma, Emmanuel; Hu, Xin; Amin, Samirkumar B.; Akdemir, Kadir C.; Wang, Qianghu; Zheng, Siyuan; Verhaak, Roel G. W.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Wei, Wei] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Martinez-Ledesma, Emmanuel; Zheng, Siyuan] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Hu, Xin] Univ Texas Grad Sch Biomed Sci Houston, Program Biostat Bioinformat & Syst Biol, Houston, TX USA; [Amin, Samirkumar B.] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Seth, Sahil; Song, Xingzhi; Zhang, Jianhua] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Wang, Qianghu; Verhaak, Roel G. W.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Lichtenberg, Tara] Nationwide Childrens Hosp, Biopathol Ctr, Columbus, OH USA; [Hu, Jian] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	Jackson Laboratory; Vrije Universiteit Amsterdam; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University of Texas System; UTMD Anderson Cancer Center	Verhaak, RGW (corresponding author), Jackson Lab Genom Med, Farmington, CT 06032 USA.; Zheng, SY; Verhaak, RGW (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA.; Zheng, SY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA.; Verhaak, RGW (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA.	syzhenger@gmail.com; roel.verhaak@jax.org	Zheng, sy/GRS-3136-2022; Wei, Wei/AGP-5085-2022; Verhaak, Roel/ABE-7058-2020; Barthel, Floris P/I-4653-2014; Amin, Samirkumar B/H-3184-2019; Seth, Sahil/I-5809-2019; Barthel, Floris P/AHC-3558-2022	Barthel, Floris P/0000-0002-7425-4180; Amin, Samirkumar B/0000-0002-3207-9505; Seth, Sahil/0000-0003-4579-3959; Barthel, Floris P/0000-0002-7425-4180; Zheng, Siyuan/0000-0002-1031-9424; Tang, Ming/0000-0002-7739-8913; Martinez Ledesma, Juan Emmanuel/0000-0003-1191-7917	National Institutes of Health [R01CA190121, P01CA085878, P50CA127001, U24CA143883]; Cancer Prevention and Research Institute of Texas (CPRIT) [R140606]; Cancer Center Support Grants [P30CA16672, P30CA034196]; NATIONAL CANCER INSTITUTE [P30CA034196, P01CA085878, R01CA190121, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); Cancer Center Support Grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all patients who consented to have their samples analyzed by The Cancer Genome Atlas Network. We thank D. Jiao and D. Jackson at the High Performance Computing facility at MD Anderson Cancer Center for assistance with data downloading and storage. We thank I.R. Watson (McGill University) and T. Wu (MD Anderson Cancer Center) for insights on TCGA melanoma project, and D. Wheeler (Baylor College of Medicine) for insights on TCGA liver cancer project. We thank S. Borah and T.R. Cech (University of Colorado) for sharing telomerase enzymatic activity data of the 23 urothelial cancer cell lines. We thank D. Broccoli (Mercer University) for sharing the 14 gene signature from GSE20559. We thank X. Wang (Baylor College of Medicine) for help with CPTAC data and A. Barbo (MD Anderson Cancer Center) for statistical advice. We thank B. Murray (Broad Institute) for suggestions regarding the analysis of copy number data. This project is supported by grants from the National Institutes of Health (R01CA190121 and P01CA085878 to R.G.W.V., P50CA127001 to Z.S. and R.G.W.V. and U24CA143883) and the Cancer Prevention and Research Institute of Texas (CPRIT) (R140606) to R.G.W.V. This work was supported by Cancer Center Support Grants P30CA16672 and P30CA034196.	Albanell J, 1999, J NATL CANCER I, V91, P1321, DOI 10.1093/jnci/91.15.1321; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Borah S, 2015, SCIENCE, V347, P1006, DOI 10.1126/science.1260200; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Castelo-Branco P, 2013, LANCET ONCOL, V14, P534, DOI 10.1016/S1470-2045(13)70110-4; Chapon C, 1997, RNA, V3, P1337; Clynes D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8538; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Davis CF, 2014, CANCER CELL, V26, P319, DOI 10.1016/j.ccr.2014.07.014; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Dilley RL, 2015, TRENDS CANCER, V1, P145, DOI 10.1016/j.trecan.2015.07.007; Ding ZH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku181; Dlouha D, 2014, PHYSIOL RES, V63, pS343, DOI 10.33549/physiolres.932856; Feuerhahn S, 2010, FEBS LETT, V584, P3812, DOI 10.1016/j.febslet.2010.07.032; Flynn RL, 2015, SCIENCE, V347, P273, DOI 10.1126/science.1257216; Garcia-Cao M, 2002, NAT GENET, V32, P415, DOI 10.1038/ng1011; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Guo ZY, 2015, ADV ANAT PATHOL, V22, P283, DOI 10.1097/PAP.0000000000000086; Hackett JA, 2002, ONCOGENE, V21, P619, DOI 10.1038/sj.onc.1205061; Heaphy CM, 2011, AM J PATHOL, V179, P1608, DOI 10.1016/j.ajpath.2011.06.018; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Hrdlickova R, 2012, MOL CELL BIOL, V32, P4283, DOI 10.1128/MCB.00550-12; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Khan A, 2016, NUCLEIC ACIDS RES, V44, pD164, DOI 10.1093/nar/gkv1002; Khoury JD, 2013, J VIROL, V87, P8916, DOI 10.1128/JVI.00340-13; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lenders JWM, 2005, LANCET, V366, P665, DOI 10.1016/S0140-6736(05)67139-5; Martinez E, 2015, ONCOGENE, V34, P2732, DOI 10.1038/onc.2014.216; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Peifer M, 2015, NATURE, V526, P700, DOI 10.1038/nature14980; Porro A, 2010, MOL CELL BIOL, V30, P4808, DOI 10.1128/MCB.00460-10; Przybycin CG, 2011, AM J SURG PATHOL, V35, P962, DOI 10.1097/PAS.0b013e31821a455d; Ramamoorthy M, 2015, CANCER CELL, V28, P357, DOI 10.1016/j.ccell.2015.08.003; Reddel RR, 2000, CARCINOGENESIS, V21, P477, DOI 10.1093/carcin/21.3.477; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; Robin JD, 2014, GENE DEV, V28, P2464, DOI 10.1101/gad.251041.114; Rohde V, 2000, CLIN CANCER RES, V6, P4803; Sahin E, 2012, NAT REV MOL CELL BIO, V13, P397, DOI 10.1038/nrm3352; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Torres-Garcia W, 2014, BIOINFORMATICS, V30, P2224, DOI 10.1093/bioinformatics/btu169; Valentijn LJ, 2015, NAT GENET, V47, P1411, DOI 10.1038/ng.3438; Vinagre J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3185; Wong MS, 2014, TRENDS GENET, V30, P430, DOI 10.1016/j.tig.2014.07.006; Xi LH, 2014, NUCLEIC ACIDS RES, V42, P8565, DOI 10.1093/nar/gku560; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yoshihara K, 2015, ONCOGENE, V34, P4845, DOI 10.1038/onc.2014.406; Zhang AJ, 2000, CANCER RES, V60, P6230	61	299	301	5	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2017	49	3					349	357		10.1038/ng.3781	http://dx.doi.org/10.1038/ng.3781			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EL9CU	28135248	Green Accepted			2022-12-17	WOS:000394917800008
J	Nault, JC; Datta, S; Imbeaud, S; Franconi, A; Mallet, M; Couchy, G; Letouze, E; Pilati, C; Verret, B; Blanc, JF; Balabaud, C; Calderaro, J; Laurent, A; Letexier, M; Bioulac-Sage, P; Calvo, F; Zucman-Rossi, J				Nault, Jean-Charles; Datta, Shalini; Imbeaud, Sandrine; Franconi, Andrea; Mallet, Maxime; Couchy, Gabrielle; Letouze, Eric; Pilati, Camilla; Verret, Benjamin; Blanc, Jean-Frederic; Balabaud, Charles; Calderaro, Julien; Laurent, Alexis; Letexier, Melanie; Bioulac-Sage, Paulette; Calvo, Fabien; Zucman-Rossi, Jessica			Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas	NATURE GENETICS			English	Article							ADENOASSOCIATED VIRUS AAV; NEUTRALIZING ANTIBODIES; SOMATIC MUTATIONS; DEFECTIVE VIRUS; LIVER CANCERS; GENE-THERAPY; INTEGRATION; MECHANISMS; EXPRESSION; ALIGNMENT	Hepatocellular carcinomas (HCCs) are liver tumors related to various etiologies, including alcohol intake and infection with hepatitis B (HBV) or C (HCV) virus. Additional risk factors remain to be identified, particularly in patients who develop HCC without cirrhosis. We found clonal integration of adeno-associated virus type 2 (AAV2) in 11 of 193 HCCs. These AAV2 integrations occurred in known cancer driver genes, namely CCNA2 (cyclin A2; four cases), TERT (telomerase reverse transcriptase; one case), CCNE1 (cyclin E1; three cases), TNFSF10 (tumor necrosis factor superfamily member 10; two cases) and KMT2B (lysine-specific methyltransferase 2B; one case), leading to overexpression of the target genes. Tumors with viral integration mainly developed in non-cirrhotic liver (9 of 11 cases) and without known risk factors (6 of 11 cases), suggesting a pathogenic role for AAV2 in these patients. In conclusion, AAV2 is a DNA virus associated with oncogenic insertional mutagenesis in human HCC.	[Nault, Jean-Charles; Datta, Shalini; Imbeaud, Sandrine; Franconi, Andrea; Mallet, Maxime; Couchy, Gabrielle; Letouze, Eric; Pilati, Camilla; Verret, Benjamin; Calderaro, Julien; Calvo, Fabien; Zucman-Rossi, Jessica] INSERM, UMR 1162, Genom Fonct Tumeurs Solides, Equipe Labellisee Ligue Canc, Paris, France; [Nault, Jean-Charles; Datta, Shalini; Imbeaud, Sandrine; Franconi, Andrea; Mallet, Maxime; Couchy, Gabrielle; Letouze, Eric; Pilati, Camilla; Calderaro, Julien; Calvo, Fabien; Zucman-Rossi, Jessica] Univ Paris 05, Labex Immunooncol, Sorbonne Paris Cite, Paris, France; [Nault, Jean-Charles; Datta, Shalini; Imbeaud, Sandrine; Franconi, Andrea; Mallet, Maxime; Couchy, Gabrielle; Letouze, Eric; Pilati, Camilla; Calderaro, Julien; Calvo, Fabien; Zucman-Rossi, Jessica] Univ Paris 13, Sorbonne Paris Cite, UFR, SMHB, Bobigny, France; [Nault, Jean-Charles; Datta, Shalini; Imbeaud, Sandrine; Franconi, Andrea; Mallet, Maxime; Couchy, Gabrielle; Letouze, Eric; Pilati, Camilla; Verret, Benjamin; Calderaro, Julien; Calvo, Fabien; Zucman-Rossi, Jessica] Univ Paris Diderot, Inst Univ Hematol, Paris, France; [Nault, Jean-Charles] Hop Univ Paris Seine St Denis, AP HP, Pole Act Cancerol Specialisee, Serv Hepatol, Bondy, France; [Blanc, Jean-Frederic] Hop St Andre, Dept Hepatol, CHU Bordeaux, Bordeaux, France; [Blanc, Jean-Frederic; Balabaud, Charles; Bioulac-Sage, Paulette] INSERM, UMR 1053, Bordeaux, France; [Blanc, Jean-Frederic; Balabaud, Charles; Bioulac-Sage, Paulette] Univ Bordeaux, Bordeaux, France; [Calderaro, Julien] CHU Henri Mondor, AP HP, Dept Pathol, F-94010 Creteil, France; [Laurent, Alexis] CHU Henri Mondor, AP HP, Dept Digest & Hepatobiliary Surg, F-94010 Creteil, France; [Laurent, Alexis] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Letexier, Melanie] IntegraGen, Evry, France; [Bioulac-Sage, Paulette] CHU Bordeaux, Pellegrin Hosp, Dept Pathol, Bordeaux, France; [Calvo, Fabien] Inst Gustave Roussy, Core Europe, Villejuif, France; [Zucman-Rossi, Jessica] Hop Europeen Georges Pompidou, AP HP, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Zucman-Rossi, J (corresponding author), INSERM, UMR 1162, Genom Fonct Tumeurs Solides, Equipe Labellisee Ligue Canc, Paris, France.	jessica.zucman-rossi@inserm.fr	zucman-rossi, Jessica/B-5098-2009; Letouzé, Eric/AAP-9924-2020; j, zucman-rossi/AAV-3594-2021; Laurent, Alexis/O-3657-2016; Datta, Shalini/B-3408-2010; Imbeaud, Sandrine/P-8780-2017	zucman-rossi, Jessica/0000-0002-5687-0334; Letouzé, Eric/0000-0002-6369-2839; j, zucman-rossi/0000-0002-5687-0334; Laurent, Alexis/0000-0003-1372-0843; Pilati, Camilla/0000-0002-1781-5180; calvo, fabien/0000-0002-0298-7633; Imbeaud, Sandrine/0000-0001-8439-6732; nault, jean charles/0000-0002-4875-9353	Institut Nationale du Cancer (INCa); International Cancer Genome Consortium (ICGC); PAIR-CHC project NoFLIC (Association pour la Recherche sur le Cancer (ARC)); Ligue Nationale contre le Cancer; INCa; AERIO-Boehringer-Ingelheim; ARC	Institut Nationale du Cancer (INCa)(Institut National du Cancer (INCA) France); International Cancer Genome Consortium (ICGC); PAIR-CHC project NoFLIC (Association pour la Recherche sur le Cancer (ARC)); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); INCa(Institut National du Cancer (INCA) France); AERIO-Boehringer-Ingelheim; ARC(Australian Research Council)	We warmly thank L. Yost, E. Chevet and A. de Reynies for critical review of the manuscript and helpful discussion. We thank all the clinician surgeons and pathologists who have participated in this work: J. Saric, C. Laurent, L. Chiche, B. Le Bail and C. Castain (CHU Bordeaux) and Y. Allory, K. Leroy and D. Azoulay (CHU Henri Mondor). We also thank the Reseau National Centre de Ressources Biologiques (CRB) Foie and the tumor banks of CHU Bordeaux and CHU Henri Mondor for contributing to the tissue collection. This work was supported by Institut Nationale du Cancer (INCa) with the International Cancer Genome Consortium (ICGC) and the PAIR-CHC project NoFLIC (also funded by Association pour la Recherche sur le Cancer (ARC)). The group is supported by the Ligue Nationale contre le Cancer. J.-C.N., M.M., C.P. and A.F. were supported by fellowships from INCa, AERIO-Boehringer-Ingelheim, ARC and the Ligue Nationale contre le Cancer, respectively.	ATCHISON RW, 1965, SCIENCE, V149, P754, DOI 10.1126/science.149.3685.754; Baudard M, 1996, HUM GENE THER, V7, P1309, DOI 10.1089/hum.1996.7.11-1309; Bell P, 2006, MOL THER, V14, P34, DOI 10.1016/j.ymthe.2006.03.008; Berasain C, 1998, ONCOGENE, V16, P1277, DOI 10.1038/sj.onc.1201893; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Chandler RJ, 2015, J CLIN INVEST, V125, P870, DOI 10.1172/JCI79213; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Ding D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003065; Donsante A, 2007, SCIENCE, V317, P477, DOI 10.1126/science.1142658; Flotte TR, 2005, HUM GENE THER, V16, P401, DOI 10.1089/hum.2005.16.401; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Goncalves MAFV, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-43; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Haberman RP, 2000, J VIROL, V74, P8732, DOI 10.1128/JVI.74.18.8732-8739.2000; Halbert CL, 2006, HUM GENE THER, V17, P440, DOI 10.1089/hum.2006.17.440; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; KOTIN RM, 1990, P NATL ACAD SCI USA, V87, P2211, DOI 10.1073/pnas.87.6.2211; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Martin D, 2008, ONCOGENE, V27, P1844, DOI [10.1038/sj.onc.1210817, 10.1038/onc.2009.351]; McAlister VJ, 2007, J VIROL, V81, P9718, DOI 10.1128/JVI.00746-07; Moore PS, 2010, NAT REV CANCER, V10, P878, DOI 10.1038/nrc2961; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Nault JC, 2014, HEPATOLOGY, V60, P1983, DOI 10.1002/hep.27372; Nault JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3218; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; Paterlini-Brechot P, 2003, ONCOGENE, V22, P3911, DOI 10.1038/sj.onc.1206492; Pilati C, 2014, CANCER CELL, V25, P428, DOI 10.1016/j.ccr.2014.03.005; Rebouissou S, 2005, HUM MOL GENET, V14, P603, DOI 10.1093/hmg/ddi057; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Rosas LE, 2012, MOL THER, V20, P2098, DOI 10.1038/mt.2012.197; SAMULSKI RJ, 1991, EMBO J, V10, P3941, DOI 10.1002/j.1460-2075.1991.tb04964.x; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Smith RH, 2008, GENE THER, V15, P817, DOI 10.1038/gt.2008.55; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; WANG J, 1990, NATURE, V343, P555, DOI 10.1038/343555a0; Wang PR, 2012, P NATL ACAD SCI USA, V109, P11264, DOI 10.1073/pnas.1117032109	49	299	310	0	43	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2015	47	10					1187	+		10.1038/ng.3389	http://dx.doi.org/10.1038/ng.3389			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CS3JR	26301494				2022-12-17	WOS:000361969900014
J	Ford, CB; Lin, PL; Chase, MR; Shah, RR; Iartchouk, O; Galagan, J; Mohaideen, N; Ioerger, TR; Sacchettini, JC; Lipsitch, M; Flynn, JL; Fortune, SM				Ford, Christopher B.; Lin, Philana Ling; Chase, Michael R.; Shah, Rupal R.; Iartchouk, Oleg; Galagan, James; Mohaideen, Nilofar; Ioerger, Thomas R.; Sacchettini, James C.; Lipsitch, Marc; Flynn, JoAnne L.; Fortune, Sarah M.			Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection	NATURE GENETICS			English	Article							ISONIAZID PREVENTIVE THERAPY; DRUG-RESISTANCE; SURVIVAL; SPECTRUM; YEAST	Tuberculosis poses a global health emergency, which has been compounded by the emergence of drug-resistant Mycobacterium tuberculosis (Mtb) strains. We used whole-genome sequencing to compare the accumulation of mutations in Mtb isolated from cynomolgus macaques with active, latent or reactivated disease. We sequenced 33 Mtb isolates from nine macaques with an average genome coverage of 93% and an average read depth of 117x. Based on the distribution of SNPs observed, we calculated the mutation rates for these disease states. We found a similar mutation rate during latency as during active disease or in a logarithmically growing culture over the same period of time. The pattern of polymorphisms suggests that the mutational burden in vivo is because of oxidative DNA damage. We show that Mtb continues to acquire mutations during disease latency, which may explain why isoniazid monotherapy for latent tuberculosis is a risk factor for the emergence of isoniazid resistance(1,2).	[Ford, Christopher B.; Chase, Michael R.; Shah, Rupal R.; Lipsitch, Marc; Fortune, Sarah M.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Lin, Philana Ling] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Dept Pediat, Pittsburgh, PA 15213 USA; [Iartchouk, Oleg] Harvard Univ, Sch Med, Partners Healthcare Ctr Personalized Genet Med, Cambridge, MA 02138 USA; [Galagan, James] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Galagan, James] Boston Univ, Dept Microbiol, Boston, MA 02215 USA; [Galagan, James] Broad Inst MIT & Harvard, Cambridge, MA USA; [Mohaideen, Nilofar; Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Ioerger, Thomas R.] Texas A&M Univ, Dept Comp Sci & Engn, College Stn, TX 77843 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Epidemiol, Boston, MA 02115 USA; [Flynn, JoAnne L.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Harvard University; Harvard T.H. Chan School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Partners Healthcare System; Boston University; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Harvard University; Harvard T.H. Chan School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Fortune, SM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	sfortune@hsph.harvard.edu	Flynn, JoAnne/ABC-7371-2020; Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592; Fortune, Sarah/0000-0001-7565-9975; Galagan, James/0000-0003-0542-3291; Lipsitch, Marc/0000-0003-1504-9213	Director's Office of the National Institute of Health [DP2 0D001378]; National Institute for Allergy and Infectious Diseases (NIAID) [U19 AI076217]; US National Institutes of Health (NIH) [RO1 HL075845]; Bill and Melinda Gates Foundation; National Institute of Allergy and Infectious Disease, US NIH, US Department of Health and Human Services [HHSN266200400001C]; National Institute of General Medical Sciences [U54GM088558]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106804, R01HL075845, R33HL092883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI063101, U19AI076217, T32AI007638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001378] Funding Source: NIH RePORTER	Director's Office of the National Institute of Health; National Institute for Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of Allergy and Infectious Disease, US NIH, US Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a New Innovator's Award, DP2 0D001378 from the Director's Office of the National Institute of Health to S.M.F., by a subcontract from National Institute for Allergy and Infectious Diseases (NIAID) U19 AI076217 to S.M.F., by the US National Institutes of Health (NIH) RO1 HL075845 to J.L.F. and by the Bill and Melinda Gates Foundation (J.L.F.). The genome sequencing has been funded in part with federal funds from the National Institute of Allergy and Infectious Disease, US NIH, US Department of Health and Human Services, under contract no. HHSN266200400001C. The project described was supported in part by Award Number U54GM088558 to M.L. from the National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. We thank D. Gurgil and J. Xu of the Enterprise Research IS group at Partners Healthcare for their support and for provision of the HPC facilities and E. Klein for necropsy and pathology of the infected monkeys, as well as the veterinary technical staff for care of the animals. We also thank E. Rubin, C. Sassetti, B. Bloom, T. Rosebrock and B. Aldridge for helpful feedback.	Balcells ME, 2006, EMERG INFECT DIS, V12, P744; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Boshoff HIM, 2001, SCAND J INFECT DIS, V33, P101, DOI 10.1080/003655401753382567; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Cattamanchi A, 2009, CLIN INFECT DIS, V48, P179, DOI 10.1086/595689; Cohen T, 2006, P NATL ACAD SCI USA, V103, P7042, DOI 10.1073/pnas.0600349103; Denver DR, 2004, NATURE, V430, P679, DOI 10.1038/nature02697; Fenhalls G, 2002, INFECT IMMUN, V70, P6330, DOI 10.1128/IAI.70.11.6330-6338.2002; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; GUTIERREZVAZQUEZ JM, 1956, AM REV TUBERC PULM, V74, P50; Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Munoz-Elias F. I., 2005, INFECT IMMUN, V73, P546; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; PERRIENS JH, 1991, AM REV RESPIR DIS, V144, P750, DOI 10.1164/ajrccm/144.4.750; Saint-Ruf C, 2007, CRIT REV BIOCHEM MOL, V42, P259, DOI 10.1080/10409230701495599; SARKAR S, 1992, GENETICA, V85, P173, DOI 10.1007/BF00120324; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Werngren J, 2003, J CLIN MICROBIOL, V41, P1520, DOI 10.1128/JCM.41.4.1520-1524.2003	31	299	303	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2011	43	5					482	+		10.1038/ng.811	http://dx.doi.org/10.1038/ng.811			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	755XF	21516081	Green Accepted			2022-12-17	WOS:000289972600021
J	Mangold, E; Ludwig, KU; Birnbaum, S; Baluardo, C; Ferrian, M; Herms, S; Reutter, H; de Assis, NA; Al Chawa, T; Mattheisen, M; Steffens, M; Barth, S; Kluck, N; Paul, A; Becker, J; Lauster, C; Schmidt, G; Braumann, B; Scheer, M; Reich, RH; Hemprich, A; Potzsch, S; Blaumeiser, B; Moebus, S; Krawczak, M; Schreiber, S; Meitinger, T; Wichmann, HE; Steegers-Theunissen, RP; Kramer, FJ; Cichon, S; Propping, P; Wienker, TF; Knapp, M; Rubini, M; Mossey, PA; Hoffmann, P; Nothen, MM				Mangold, Elisabeth; Ludwig, Kerstin U.; Birnbaum, Stefanie; Baluardo, Carlotta; Ferrian, Melissa; Herms, Stefan; Reutter, Heiko; de Assis, Nilma Almeida; Al Chawa, Taofik; Mattheisen, Manuel; Steffens, Michael; Barth, Sandra; Kluck, Nadine; Paul, Anna; Becker, Jessica; Lauster, Carola; Schmidt, Guel; Braumann, Bert; Scheer, Martin; Reich, Rudolf H.; Hemprich, Alexander; Poetzsch, Simone; Blaumeiser, Bettina; Moebus, Susanne; Krawczak, Michael; Schreiber, Stefan; Meitinger, Thomas; Wichmann, Hans-Erich; Steegers-Theunissen, Regine P.; Kramer, Franz-Josef; Cichon, Sven; Propping, Peter; Wienker, Thomas F.; Knapp, Michael; Rubini, Michele; Mossey, Peter A.; Hoffmann, Per; Noethen, Markus M.			Genome-wide association study identifies two susceptibility loci for nonsyndromic cleft lip with or without cleft palate	NATURE GENETICS			English	Article							GENE	We conducted a genome-wide association study for nonsyndromic cleft lip with or without cleft palate (NSCL/P) in 401 affected individuals and 1,323 controls, with replication in an independent sample of 793 NSCL/P triads. We report two new loci associated with NSCL/P at 17q22 (rs227731, combined P = 1.07 x 10(-8), relative risk in homozygotes = 1.84, 95% CI 1.34-2.53) and 10q25.3 (rs7078160, combined P = 1.92 x 10(-8), relative risk in homozygotes = 2.17, 95% CI 1.32-3.56).	[Mangold, Elisabeth; Ludwig, Kerstin U.; Birnbaum, Stefanie; Herms, Stefan; Reutter, Heiko; de Assis, Nilma Almeida; Al Chawa, Taofik; Mattheisen, Manuel; Barth, Sandra; Kluck, Nadine; Becker, Jessica; Cichon, Sven; Propping, Peter; Hoffmann, Per; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Inst Human Genet, D-5300 Bonn, Germany; [Herms, Stefan; Mattheisen, Manuel; Barth, Sandra; Kluck, Nadine; Becker, Jessica; Cichon, Sven; Hoffmann, Per; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-5300 Bonn, Germany; [Baluardo, Carlotta; Ferrian, Melissa; Rubini, Michele] Univ Ferrara, Med Genet Unit, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy; [Mattheisen, Manuel; Steffens, Michael; Wienker, Thomas F.; Knapp, Michael] Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-5300 Bonn, Germany; [Paul, Anna] Asklepios Klin Altona, Dept Otolaryngol, Hamburg, Germany; [Lauster, Carola; Schmidt, Guel] Humboldt Univ, Dept Cleft Lip & Cleft Palate Surg, Berlin, Germany; [Braumann, Bert] Univ Cologne, Dept Orthodont, Cologne, Germany; [Scheer, Martin] Univ Cologne, Dept Oral & Maxillofacial Surg, Cologne, Germany; [Reich, Rudolf H.] Univ Bonn, Dept Oral & Maxillofacial Plast Surg, D-5300 Bonn, Germany; [Hemprich, Alexander] Univ Leipzig, Dept Oral & Maxillofacial Surg, Leipzig, Germany; [Poetzsch, Simone] Univ Magdeburg, D-39106 Magdeburg, Germany; [Blaumeiser, Bettina] Univ Antwerp Hosp, Dept Med Genet, Antwerp, Belgium; [Blaumeiser, Bettina] Univ Antwerp, B-2020 Antwerp, Belgium; [Moebus, Susanne] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Krawczak, Michael; Schreiber, Stefan] Univ Kiel, PopGen Biobank, Kiel, Germany; [Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Dept Human Genet, D-8000 Munich, Germany; [Wichmann, Hans-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Wichmann, Hans-Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, Hans-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Steegers-Theunissen, Regine P.] Univ Med Ctr, Erasmus Med Ctr, Dept Obstet & Gynecol, Rotterdam, Netherlands; [Steegers-Theunissen, Regine P.] Univ Med Ctr, Erasmus Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Steegers-Theunissen, Regine P.] Univ Med Ctr, Erasmus Med Ctr, Dept Pediat, Rotterdam, Netherlands; [Steegers-Theunissen, Regine P.] Univ Med Ctr, Erasmus Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Steegers-Theunissen, Regine P.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol, NL-6525 ED Nijmegen, Netherlands; [Kramer, Franz-Josef] Univ Gottingen, Dept Oral & Maxillofacial Surg, Gottingen, Germany; [Mossey, Peter A.] Univ Dundee, Dent Hosp & Sch, Dundee, Scotland	University of Bonn; University of Bonn; University of Ferrara; University of Bonn; Asklepios Klinik Altona; Humboldt University of Berlin; University of Cologne; University of Cologne; University of Bonn; Leipzig University; Otto von Guericke University; University of Antwerp; University of Antwerp; University of Duisburg Essen; University of Kiel; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; University of Gottingen; University of Dundee	Mangold, E (corresponding author), Univ Bonn, Life & Brain Ctr, Inst Human Genet, D-5300 Bonn, Germany.	e.mangold@uni-bonn.de	Cichon, Sven/B-9618-2014; Mattheisen, Manuel/B-4949-2012; Nöthen, Markus/B-2027-2009; Rubini, Michele/AFF-8477-2022; Mattheisen, Manuel/S-3725-2019; Hoffmann, Per/A-5149-2010; Herms, Stefan/J-1949-2014; Ludwig, Kerstin U/H-7828-2019; Cichon, Sven/H-8803-2013; Wichmann, Heinz Erich/AAA-5695-2022; Krawczak, Michael/A-8964-2010; Meitinger, Thomas/O-1318-2015	Cichon, Sven/0000-0002-9475-086X; Mattheisen, Manuel/0000-0002-8442-493X; Nöthen, Markus/0000-0002-8770-2464; Rubini, Michele/0000-0003-1448-9516; Mattheisen, Manuel/0000-0002-8442-493X; Hoffmann, Per/0000-0002-6573-983X; Herms, Stefan/0000-0002-2786-8200; Ludwig, Kerstin U/0000-0002-8541-2519; Cichon, Sven/0000-0002-9475-086X; Krawczak, Michael/0000-0003-2603-1502; Meitinger, Thomas/0000-0002-8838-8403; Steffens, Michael/0000-0002-6445-8593; Ferrian, Melissa/0000-0002-3746-4576; Mossey, Peter/0000-0002-9914-6901; Moebus, Susanne/0000-0002-0072-5410	Deutsche Forschungsgemeinschaft [FOR 423, MA 2546/3-1, KR 1912/7-1, NO 246/6-1, WI 1555/5-1]; Heinz Nixdorf Foundation, Germany; Ministry of Science, Economy and Transport of Schleswig-Holstein, Germany; German Federal Ministry of Education and Research; German Federal Ministry of Education and Research (BMBF); European Commission [QLG1-CT-2000-01019]; University of Ferrara, Italy [FAR-2008]; Conselho Nacional de Pesquisa (CNPq), Brasil; Ministry of Higher Education, Syrian Arab Republic	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heinz Nixdorf Foundation, Germany; Ministry of Science, Economy and Transport of Schleswig-Holstein, Germany; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre); University of Ferrara, Italy; Conselho Nacional de Pesquisa (CNPq), Brasil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Higher Education, Syrian Arab Republic	We thank all affected individuals and their families for their participation in this study as well as the German support group for people with cleft lip and/or palate (Deutsche Selbsthilfevereinigung fur Lippen-Gaumen-Fehlbildungen e. V.). We acknowledge our collaborating clinical partners, all colleagues who contributed to the European Collaboration on Craniofacial Anomalies (EUROCRAN) project, our laboratory technicians and colleagues responsible for database management (for a complete list of all individuals see Supplementary Note). The study was supported by the Deutsche Forschungsgemeinschaft (FOR 423 and individual grants MA 2546/3-1, KR 1912/7-1, NO 246/6-1 and WI 1555/5-1). The Heinz Nixdorf Recall cohort was established with the generous support of the Heinz Nixdorf Foundation, Germany (Chairman: G. Schmidt). POPGEN biobank is financed by the local Ministry of Science, Economy and Transport of Schleswig-Holstein, Germany. The Kooperative Gesundheitforschung in der Region Augsburg (KORA) research platform was initiated and financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the state of Bavaria. The work of KORA is supported by the German Federal Ministry of Education and Research (BMBF) in the context of the German National Genome Research Network (NGFN-2 and NGFN-plus). The EUROCRAN study was supported by the European Commission FP5 (contract no. QLG1-CT-2000-01019), and the ITALCLEFT study was supported by a FAR-2008 grant from the University of Ferrara, Italy. N. A. d. A. is supported by the Conselho Nacional de Pesquisa (CNPq), Brasil. T. A. C. is supported by a grant from the Ministry of Higher Education, Syrian Arab Republic. Additional acknowledgments are found in the	Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Drieschner N, 2007, GENE, V403, P110, DOI 10.1016/j.gene.2007.06.029; Goodnough LH, 2007, DEV DYNAM, V236, P1918, DOI 10.1002/dvdy.21195; Guo CY, 2009, GENET EPIDEMIOL, V33, P54, DOI 10.1002/gepi.20356; Hallonet M, 1999, GENE DEV, V13, P3106, DOI 10.1101/gad.13.23.3106; Magee AC, 1998, CLIN GENET, V54, P65; MULCAHY MT, 1982, CLIN GENET, V21, P33; Petersen B, 1998, AM J MED GENET, V77, P60, DOI 10.1002/(SICI)1096-8628(19980428)77:1<60::AID-AJMG13>3.3.CO;2-Z; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Suzuki S, 2009, AM J HUM GENET, V84, P406, DOI 10.1016/j.ajhg.2009.02.002; Vieira AR, 2005, PLOS GENET, V1, P651, DOI 10.1371/journal.pgen.0010064; Welsh IC, 2007, MECH DEVELOP, V124, P746, DOI 10.1016/j.mod.2007.06.007; YUNIS E, 1979, HUM GENET, V48, P241, DOI 10.1007/BF00286910; Zhang ZY, 2002, DEVELOPMENT, V129, P4135	14	299	320	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					24	26		10.1038/ng.506	http://dx.doi.org/10.1038/ng.506			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA	20023658	Bronze			2022-12-17	WOS:000273055100011
J	Gudmundsson, J; Sulem, P; Gudbjartsson, DF; Jonasson, JG; Sigurdsson, A; Bergthorsson, JT; He, HL; Blondal, T; Geller, F; Jakobsdottir, M; Magnusdottir, DN; Matthiasdottir, S; Stacey, SN; Skarphedinsson, OB; Helgadottir, H; Li, W; Nagy, R; Aguillo, E; Faure, E; Prats, E; Saez, B; Martinez, M; Eyjolfsson, GI; Bjornsdottir, US; Holm, H; Kristjansson, K; Frigge, ML; Kristvinsson, H; Gulcher, JR; Jonsson, T; Rafnar, T; Hjartarsson, H; Mayordomo, JI; de la Chapelle, A; Hrafnkelsson, J; Thorsteinsdottir, U; Kong, A; Stefansson, K				Gudmundsson, Julius; Sulem, Patrick; Gudbjartsson, Daniel F.; Jonasson, Jon G.; Sigurdsson, Asgeir; Bergthorsson, Jon T.; He, Huiling; Blondal, Thorarinn; Geller, Frank; Jakobsdottir, Margret; Magnusdottir, Droplaug N.; Matthiasdottir, Sigurborg; Stacey, Simon N.; Skarphedinsson, Oskar B.; Helgadottir, Hafdis; Li, Wei; Nagy, Rebecca; Aguillo, Esperanza; Faure, Eduardo; Prats, Enrique; Saez, Berta; Martinez, Mariano; Eyjolfsson, Gudmundur I.; Bjornsdottir, Unnur S.; Holm, Hilma; Kristjansson, Kristleifur; Frigge, Michael L.; Kristvinsson, Hoskuldur; Gulcher, Jeffrey R.; Jonsson, Thorvaldur; Rafnar, Thorunn; Hjartarsson, Hannes; Mayordomo, Jose I.; de la Chapelle, Albert; Hrafnkelsson, Jon; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari			Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations	NATURE GENETICS			English	Article							SEQUENCE VARIANTS; CLEFT-PALATE; CARCINOMA; RISK; SUSCEPTIBILITY; ASSOCIATION; EXPRESSION; NEOPLASIA; GENETICS; ICELAND	In order to search for sequence variants conferring risk of thyroid cancer we conducted a genome-wide association study in 192 and 37,196 Icelandic cases and controls, respectively, followed by a replication study in individuals of European descent. Here we show that two common variants, located on 9q22.33 and 14q13.3, are associated with the disease. Overall, the strongest association signals were observed for rs965513 on 9q22.33 ( OR = 1.75; P = 1.7 x 10(-27)) and rs944289 on 14q13.3 (OR = 1.37; P = 2.0 x 10(-9)). The gene nearest to the 9q22.33 locus is FOXE1 (TTF2) and NKX2-1 (TTF1) is among the genes located at the 14q13.3 locus. Both variants contribute to an increased risk of both papillary and follicular thyroid cancer. Approximately 3.7% of individuals are homozygous for both variants, and their estimated risk of thyroid cancer is 5.7-fold greater than that of noncarriers. In a study on a large sample set from the general population, both risk alleles are associated with low concentrations of thyroid stimulating hormone (TSH), and the 9q22.33 allele is associated with low concentration of thyroxin (T-4) and high concentration of triiodothyronine (T-3).	[Gudmundsson, Julius; Sulem, Patrick; Gudbjartsson, Daniel F.; Sigurdsson, Asgeir; Bergthorsson, Jon T.; Blondal, Thorarinn; Geller, Frank; Jakobsdottir, Margret; Magnusdottir, Droplaug N.; Matthiasdottir, Sigurborg; Stacey, Simon N.; Skarphedinsson, Oskar B.; Helgadottir, Hafdis; Holm, Hilma; Kristjansson, Kristleifur; Frigge, Michael L.; Gulcher, Jeffrey R.; Rafnar, Thorunn; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Jonasson, Jon G.] Landspitali Univ Hosp Hringbraut, Dept Pathol, IS-101 Reykjavik, Iceland; [Jonasson, Jon G.; Bjornsdottir, Unnur S.; Jonsson, Thorvaldur; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Jonasson, Jon G.] Iceland Canc Registry, IS-105 Reykjavik, Iceland; [Bergthorsson, Jon T.; Li, Wei; Nagy, Rebecca; de la Chapelle, Albert] Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA; [Aguillo, Esperanza; Faure, Eduardo] Univ Hosp, Div Endocrinol, Zaragoza 50009, Spain; [Prats, Enrique] Univ Hosp, Div Nucl Med, Zaragoza 50009, Spain; [Saez, Berta; Mayordomo, Jose I.] Nanotechnol Inst Aragon, Hlth Sci Inst, Zaragoza 50009, Spain; [Martinez, Mariano] Univ Hosp, Div Surg, Zaragoza 50009, Spain; [Eyjolfsson, Gudmundur I.] Lab Mjodd, IS-109 Reykjavik, Iceland; [Holm, Hilma] Emory Univ, Sch Med, Dept Internal Med, Div Cardiol, Atlanta, GA 30322 USA; [Kristvinsson, Hoskuldur; Jonsson, Thorvaldur] Landspitali Univ Hosp Hringbraut, Dept Surg, IS-101 Reykjavik, Iceland; [Hjartarsson, Hannes] Landspitali Univ Hosp Fossvogi, H&N Surg Dept, ORL, IS-108 Reykjavik, Iceland; [Mayordomo, Jose I.] Univ Zaragoza, Lozano Blesa Univ Hosp, Div Med Oncol, E-50009 Zaragoza, Spain; [Hrafnkelsson, Jon] Landspitali Univ Hosp Hringbraut, Dept Oncol, IS-101 Reykjavik, Iceland	University of Iceland; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Miguel Servet University Hospital; Miguel Servet University Hospital; Miguel Servet University Hospital; Emory University; Lozano Blesa University Clinical Hospital; University of Zaragoza	Stefansson, K (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	julius.gudmundsson@decode.is	Nagy, Rebecca Shrigley/E-4088-2011; Mayordomo, Jose/K-3453-2013; Stefansson, Kari/AAE-7187-2019; Pillay, Nischalan/F-9536-2012	Helgadottir, Hafdis/0000-0003-4352-152X; Bergthorsson, Jon Thor/0000-0002-0560-2639; Saez, Berta/0000-0003-0753-1165; Kong, Augustine/0000-0001-8193-5438; Gudbjartsson, Daniel/0000-0002-5222-9857; Geller, Frank/0000-0002-9238-3269; Jonasson, Jon G./0000-0002-2635-5032	US National Institutes of Health [CA16058, CA124570]; NATIONAL CANCER INSTITUTE [P30CA016058, P01CA124570] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the study participants whose contribution made this work possible. This project was funded in part by the following contract numbers: US National Institutes of Health CA16058 and CA124570.	Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Baida A, 2008, CANCER EPIDEM BIOMAR, V17, P1499, DOI 10.1158/1055-9965.EPI-07-0235; Clifton-Bligh RJ, 1998, NAT GENET, V19, P399, DOI 10.1038/1294; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; Dathan N, 2002, DEV DYNAM, V224, P450, DOI 10.1002/dvdy.10118; De Felice M, 1998, NAT GENET, V19, P395, DOI 10.1038/1289; Delellis RA, 2006, J SURG ONCOL, V94, P662, DOI 10.1002/jso.20700; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; He HL, 2009, CANCER RES, V69, P625, DOI 10.1158/0008-5472.CAN-08-1071; Hrafnkelsson J, 2001, J MED GENET, V38, P189, DOI 10.1136/jmg.38.3.189; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Kebebew E, 2005, CANCER-AM CANCER SOC, V103, P1330, DOI 10.1002/cncr.20936; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marx SJ, 2005, NAT REV CANCER, V5, P367, DOI 10.1038/nrc1610; Parlato R, 2004, DEV BIOL, V276, P464, DOI 10.1016/j.ydbio.2004.08.048; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Sequeira MJ, 2001, THYROID, V11, P995, DOI 10.1089/105072501753271662; Zhang P, 2006, PATHOL INT, V56, P240, DOI 10.1111/j.1440-1827.2006.01959.x	27	299	314	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					460	464		10.1038/ng.339	http://dx.doi.org/10.1038/ng.339			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19198613	Green Accepted			2022-12-17	WOS:000264659000021
J	Tamaru, H; Zhang, X; McMillen, D; Singh, PB; Nakayama, J; Grewal, SI; Allis, CD; Cheng, XD; Selker, EU				Tamaru, H; Zhang, X; McMillen, D; Singh, PB; Nakayama, J; Grewal, SI; Allis, CD; Cheng, XD; Selker, EU			Trimethylated lysine 9 of histone H3 is a mark for DNA methylation in Neurospora crassa	NATURE GENETICS			English	Article							INDUCED POINT MUTATION; METHYLTRANSFERASE ACTIVITY; PROTEIN; DOMAIN; PATTERNS; HP1; HETEROCHROMATIN; CHROMOSOME; ENHANCER; GENES	Besides serving to package nuclear DNA, histones carry information in the form of a diverse array of post-translational modifications. Methylation of histones H3 and H4 has been implicated in long-term epigenetic 'memory'(1). Dimethylation or trimethylation of Lys4 of histone H3 (H3 Lys4) has been found in expressible euchromatin of yeasts and mammals(2-4). In contrast, methylation of Lys9 of histone H3 (H3 Lys9) has been implicated in establishing and maintaining the largely quiescent heterochromatin of mammals, yeasts, Drosophila melanogaster and plants". we have previously shown that a DNA methylation mutant of Neurospora crassa, dim-5 (defective in methylation), has a nonsense mutation in the SET domain of an H3-specific histone methyltransferase and that substitutions of H3 Lys9 cause gross hypomethylation of DNA(10). Similarly, the KRYPTONITE histone methyltransferase is required for full DNA methylation in Arabidopsis thaliana(11). We used biochemical, genetic and immunological methods to investigate the specific mark for DNA methylation in N. crassa. Here we show that trimethylated H3 Lys9, but not dimethylated H3 Lys9, marks chromatin regions for cytosine methylation and that DIM-5 specifically creates this mark.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Roslin Inst, Div Gene Express & Dev, Nuc Reprogramming Lab, Roslin EH25 9PS, Midlothian, Scotland; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Oregon; Emory University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; Cold Spring Harbor Laboratory; University of Virginia	Selker, EU (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.		Singh, Prim/G-1088-2014; Nakayama, Jun-ichi/C-6003-2011	Singh, Prim/0000-0002-9571-0974; Nakayama, Jun-ichi/0000-0002-5597-8239				Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; Cowell IG, 2002, CHROMOSOMA, V111, P22, DOI 10.1007/s00412-002-0182-8; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; FOSS HM, 1993, SCIENCE, V262, P1737, DOI 10.1126/science.7505062; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Hays SM, 2002, GENETICS, V160, P961; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kouzminova E, 2001, EMBO J, V20, P4309, DOI 10.1093/emboj/20.15.4309; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Margolin BS, 1998, GENETICS, V149, P1787; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; SELKER EU, IN PRESS NATURE; SINGER MJ, 1995, MOL CELL BIOL, V15, P5586; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6	30	299	314	1	18	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2003	34	1					75	79		10.1038/ng1143	http://dx.doi.org/10.1038/ng1143			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12679815				2022-12-17	WOS:000182667900020
J	Olofsson, P; Holmberg, J; Tordsson, J; Lu, SM; Akerstrom, B; Holmdahl, R				Olofsson, P; Holmberg, J; Tordsson, J; Lu, SM; Akerstrom, B; Holmdahl, R			Positional identification of Ncf1 as a gene that regulates arthritis severity in rats	NATURE GENETICS			English	Article							CHRONIC GRANULOMATOUS-DISEASE; ADJUVANT-INDUCED ARTHRITIS; COLLAGEN-INDUCED ARTHRITIS; OLIGOMERIC MATRIX PROTEIN; PHAGOCYTE NADPH OXIDASE; OIL-INDUCED ARTHRITIS; GENOME-WIDE LINKAGE; RHEUMATOID-ARTHRITIS; AUTOIMMUNE ENCEPHALOMYELITIS; SUSCEPTIBILITY LOCUS	The identification of genes underlying quantitative-trait loci (QTL) for complex diseases, such as rheumatoid arthritis, is a challenging and difficult task for the human genome project. Through positional cloning of the Pia4 QTL in rats, we found that a naturally occurring polymorphism of Ncf1 (encoding neutrophil cytosolic factor 1, a component of the NADPH oxidase complex) regulates arthritis severity. The disease-related allele of Ncf1 has reduced oxidative burst response and promotes activation of arthritogenic T cells. Pharmacological treatment with substances that activate the NADPH oxidase complex is shown to ameliorate arthritis. Hence, Ncf1 is associated with a new autoimmune mechanism leading to severe destructive arthritis, notably similar to rheumatoid arthritis in humans.	Lund Univ, Sect Med Inflammat Res, S-22184 Lund, Sweden; Lund Univ, Dept Cell & Mol Biol, Sect Mol Pathogenesis, S-22184 Lund, Sweden	Lund University; Lund University	Holmdahl, R (corresponding author), Lund Univ, Sect Med Inflammat Res, Solvegatan 19,I11 BMC, S-22184 Lund, Sweden.		Lu, Shemin/AAI-6479-2021; Holmdahl, Rikard/AAI-7682-2020; Lu, Shemin/M-3350-2018	Lu, Shemin/0000-0002-5535-8320; Lu, Shemin/0000-0001-8250-850X; Olofsson, Peter/0000-0003-4849-8541				AKERSTROM B, 1985, J BIOL CHEM, V260, P4839; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Bergsteinsdottir K, 2000, J IMMUNOL, V164, P1564, DOI 10.4049/jimmunol.164.3.1564; CANNON GW, 1993, ARTHRITIS RHEUM, V36, P126, DOI 10.1002/art.1780360120; CASIMIR CM, 1991, P NATL ACAD SCI USA, V88, P2753, DOI 10.1073/pnas.88.7.2753; Cooper AM, 2000, INFECT IMMUN, V68, P1231, DOI 10.1128/IAI.68.3.1231-1234.2000; Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Dahlman I, 1999, J IMMUNOL, V162, P2581; DeSilva U, 2002, GENOME RES, V12, P3, DOI 10.1101/gr.214802; Geiszt M, 2001, J LEUKOCYTE BIOL, V69, P191; Gosele C, 2000, GENOMICS, V69, P287, DOI 10.1006/geno.2000.6352; Griffiths MM, 2000, ARTHRITIS RHEUM, V43, P1278, DOI 10.1002/1529-0131(200006)43:6<1278::AID-ANR10>3.0.CO;2-S; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; Holmdahl R, 2001, IMMUNOL REV, V184, P184, DOI 10.1034/j.1600-065x.2001.1840117.x; HOLMDAHL R, 1992, CLIN EXP IMMUNOL, V88, P96; Huang CK, 2000, J LEUKOCYTE BIOL, V67, P210, DOI 10.1002/jlb.67.2.210; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Lapouge K, 2002, J BIOL CHEM, V277, P10121, DOI 10.1074/jbc.M112065200; LOMAX KJ, 1989, SCIENCE, V245, P409, DOI 10.1126/science.2547247; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Mitchell TC, 2001, NAT IMMUNOL, V2, P397, DOI 10.1038/87692; Mizuki K, 1998, EUR J BIOCHEM, V251, P573, DOI 10.1046/j.1432-1327.1998.2510573.x; Morel L, 2000, Int Rev Immunol, V19, P423, DOI 10.3109/08830180009055506; Nordquist N, 2000, J AUTOIMMUN, V15, P425, DOI 10.1006/jaut.2000.0450; Olofsson P, 2002, ARTHRITIS RHEUM, V46, P259, DOI 10.1002/1529-0131(200201)46:1<259::AID-ART10035>3.0.CO;2-2; SAXNE T, 1992, BRIT J RHEUMATOL, V31, P583; Schneider SM, 2001, INFLAMMATION, V25, P17, DOI 10.1023/A:1007019510569; Shiose A, 2000, J BIOL CHEM, V275, P13793, DOI 10.1074/jbc.275.18.13793; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Sun SH, 1999, INT IMMUNOL, V11, P529, DOI 10.1093/intimm/11.4.529; Svelander L, 1997, IMMUNOLOGY, V91, P260, DOI 10.1046/j.1365-2567.1997.00251.x; TAUROG JD, 1983, CELL IMMUNOL, V80, P198, DOI 10.1016/0008-8749(83)90106-5; TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857; van der Veen RC, 2000, J IMMUNOL, V164, P5177, DOI 10.4049/jimmunol.164.10.5177; Vingsbo C, 1996, AM J PATHOL, V149, P1675; Vingsbo-Lundberg C, 1998, ARTHRITIS RHEUM, V41, P544, DOI 10.1002/1529-0131(199803)41:3<544::AID-ART21>3.0.CO;2-#; Vingsbo-Lundberg C, 1998, NAT GENET, V20, P401, DOI 10.1038/3887; VOLPP BD, 1989, P NATL ACAD SCI USA, V86, P7195, DOI 10.1073/pnas.86.18.7195; Wang YK, 1998, GENOMICS, V48, P163, DOI 10.1006/geno.1997.5182; Weis JJ, 1999, J IMMUNOL, V162, P948; Wishart MJ, 2001, CELL, V105, P817, DOI 10.1016/S0092-8674(01)00414-7; Woon PY, 1998, GENOMICS, V50, P306, DOI 10.1006/geno.1998.5319; Yang WY, 1997, P NATL ACAD SCI USA, V94, P604, DOI 10.1073/pnas.94.2.604; Zhang L, 1999, IMMUNOLOGY, V98, P267; Zheng CL, 2002, CLIN IMMUNOL, V103, P204, DOI 10.1006/clim.2002.5205; Zu YL, 1996, BLOOD, V87, P5287, DOI 10.1182/blood.V87.12.5287.bloodjournal87125287	50	299	309	2	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2003	33	1					25	32		10.1038/ng1058	http://dx.doi.org/10.1038/ng1058			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12461526				2022-12-17	WOS:000180136100013
J	El-Assal, SED; Alonso-Blanco, C; Peeters, AJM; Raz, V; Koornneef, M				El-Assal, SED; Alonso-Blanco, C; Peeters, AJM; Raz, V; Koornneef, M			A QTL for flowering time in Arabidopsis reveals a novel allele of CRY2	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCUS; THALIANA; TOMATO; PROTEINS; MUTANTS; GENE; PHOTORECEPTORS; AGROBACTERIUM; CRYPTOCHROMES; DEFICIENT	Variation of flowering time is found in the natural populations of many plant species. The underlying genetic variation, mostly of a quantitative nature, is presumed to reflect adaptations to different environments contributing to reproductive success. Analysis of natural variation for flowering time in Arabidopsis thaliana has identified several quantitative trait loci (QTL)(1), which have yet to be characterized at the molecular level. A major environmental factor that determines flowering time is photoperiod or day length, the length of the light period, which changes across the year differently with geographical latitude(2). We identified the EDI locus as a QTL partly accounting for the difference in flowering response to the photoperiod between two Arabidopsis accessions: the laboratory strain Landsberg erecta (Ler), originating in Northern Europe, and Cvi, collected in the tropical Cape Verde Islands(3). Positional cloning of the EDI QTL showed it to be a novel allele of CRY2, encoding the blue-light photoreceptor cryptochrome-2 that has previously been shown to promote flowering in long-day (LD) photoperiods(4). We show that the unique EDI flowering phenotype results from a single amino-acid substitution that reduces the light-induced downregulation of CRY2 in plants grown under Short photoperiods, leading to early flowering.	Univ Wageningen & Res Ctr, Genet Lab, NL-6703 HA Wageningen, Netherlands; Ctr Nacl Biotecnol, E-28049 Madrid, Spain; Univ Utrecht, Dept Plant Ecophysiol, NL-3584 CA Utrecht, Netherlands; Univ Wageningen & Res Ctr, Mol Biol Lab, NL-6703 HA Wageningen, Netherlands	Wageningen University & Research; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Utrecht University; Wageningen University & Research	Koornneef, M (corresponding author), Univ Wageningen & Res Ctr, Genet Lab, Dreijenlaan 2, NL-6703 HA Wageningen, Netherlands.	maarten.koornneef@genetics.dpw.wau.nl	Peeters, Anton J.M./B-9610-2011; Alonso-Blanco, Carlos/F-8864-2016	Alonso-Blanco, Carlos/0000-0002-4738-5556; Koornneef, Maarten/0000-0002-7759-4869				Ahmad M, 1998, PLANT CELL, V10, P197, DOI 10.1105/tpc.10.2.197; Alonso-Blanco C, 1998, GENETICS, V149, P749; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; BERNIER G, 1993, PLANT CELL, V5, P1147, DOI 10.1105/tpc.5.10.1147; Bradley D, 1997, SCIENCE, V275, P80, DOI 10.1126/science.275.5296.80; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chou IT, 1997, PLANT MOL BIOL, V35, P873, DOI 10.1023/A:1005930024796; Devlin PF, 2000, PLANT CELL, V12, P2499, DOI 10.1105/tpc.12.12.2499; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Fridman E, 2000, P NATL ACAD SCI USA, V97, P4718, DOI 10.1073/pnas.97.9.4718; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; JANSEN RC, 1995, THEOR APPL GENET, V91, P33, DOI 10.1007/BF00220855; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; KARLSSON BH, 1993, AM J BOT, V80, P646, DOI 10.2307/2445435; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; KOORNNEEF M, 1995, PHYSIOL PLANTARUM, V95, P260, DOI 10.1111/j.1399-3054.1995.tb00836.x; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Koornneef M, 1998, ANNU REV PLANT PHYS, V49, P345, DOI 10.1146/annurev.arplant.49.1.345; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; Maloof JN, 2001, NAT GENET, V29, P441, DOI 10.1038/ng777; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mizoguchi T, 2000, TRENDS PLANT SCI, V5, P409, DOI 10.1016/S1360-1385(00)01747-7; Mockler TC, 1999, DEVELOPMENT, V126, P2073; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; PETERS JL, 1992, PHOTOCHEM PHOTOBIOL, V56, P75, DOI 10.1111/j.1751-1097.1992.tb09605.x; Raz V, 1999, DEVELOPMENT, V126, P3661; SESSA G, 1995, PLANT MOL BIOL, V28, P537, DOI 10.1007/BF00020400; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Swarup K, 1999, PLANT J, V20, P67, DOI 10.1046/j.1365-313X.1999.00577.x; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Thomas B., 1997, PHOTOPERIODISM PLANT; VANTUINEN A, 1995, MOL GEN GENET, V246, P133, DOI 10.1007/BF00294675; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473	36	299	314	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2001	29	4					435	440		10.1038/ng767	http://dx.doi.org/10.1038/ng767			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11726930				2022-12-17	WOS:000172507500019
J	Bulman, MP; Kusumi, K; Frayling, TM; McKeown, C; Garrett, C; Lander, ES; Krumlauf, R; Hattersley, AT; Ellard, S; Turnpenny, PD				Bulman, MP; Kusumi, K; Frayling, TM; McKeown, C; Garrett, C; Lander, ES; Krumlauf, R; Hattersley, AT; Ellard, S; Turnpenny, PD			Mutations in the human Delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis	NATURE GENETICS			English	Article							EPIDERMAL GROWTH-FACTOR; ALAGILLE-SYNDROME; NOTCH-GENE; DROSOPHILA; EXPRESSION; SEGMENTATION; BOUNDARIES; PATTERN; COMPLEX; ENCODES	Spondylocostal dysostosis (SD, MIM 277300) is a group of vertebral malsegmentation syndromes with reduced stature resulting from axial skeletal defects. SD is characterized by mu[tiple hemivertebrae, rib fusions and deletions with a non-progressive kyphoscoliosis. Cases may be sporadic or familial, with both autosomal dominant and autosomal recessive modes of inheritance reported(1). Autosomal recessive SD maps to a 7.8cM interval on chromosome 19q13.1-q13.3 (ref, 2) that is homologous with a mouse region containing a gene encoding the Notch ligand delta-like 3 (DII3). DII3 is mutated(3) in the Xray-induced mouse mutant pudgy (pu), causing a variety of vertebrocostal defects similar to SD phenotypes. Here we have cloned and sequenced human DLL3 to evaluate it as a candidate gene for SD and identified mutations in three autosomal recessive SD families. Two of the mutations predict truncations within conserved extracellular domains. The third is a missense mutation in a highly conserved glycine residue of the fifth epidermal growth factor (EGF) repeat, which has revealed an important functional role for this domain. These represent the first mutations in a human Delta homologue, thus highlighting the critical role of the Notch signalling pathway and its components in patterning the mammalian axial skeleton.	Royal Devon & Exeter Hosp, Clin Genet, Exeter EX2 5DW, Devon, England; Sch Postgrad Med & Hlth Sci, Exeter, Devon, England; Natl Inst Med Res, Div Dev Neurobiol, London NW7 1AA, England; Birmingham Womens Hosp, Clin Genet Unit, Birmingham, W Midlands, England; Northwick Pk & St Marks Trust, Kennedy Galton Ctr, Harrow, Middx, England; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	University of Exeter; University of Exeter; MRC National Institute for Medical Research; Birmingham Women's Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute	Turnpenny, PD (corresponding author), Royal Devon & Exeter Hosp, Clin Genet, Barrack Rd, Exeter EX2 5DW, Devon, England.		Kusumi, Kenro/J-2626-2012; Krumlauf, Robb/AAH-5012-2019	Kusumi, Kenro/0000-0002-1458-4540; Krumlauf, Robb/0000-0001-9102-7927; Frayling, Timothy/0000-0001-8362-2603; Hattersley, Andrew/0000-0001-5620-473X; Ellard, Sian/0000-0002-7620-5526				ArtavanisTsakonas S, 1997, NAT GENET, V16, P212, DOI 10.1038/ng0797-212; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; BONAIME JL, 1978, PEDIATRIE, V33, P173; CASAMASSIMA AC, 1981, AM J MED GENET, V8, P117, DOI 10.1002/ajmg.1320080114; Cohen B, 1997, NAT GENET, V16, P283, DOI 10.1038/ng0797-283; CONLON RA, 1995, DEVELOPMENT, V121, P1533; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; DELGOFFE C, 1982, ANN PEDIATR-PARIS, V29, P135; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; GREENWALD I, 1994, CURR OPIN GENET DEV, V4, P556, DOI 10.1016/0959-437X(94)90072-B; Johnston SH, 1997, DEVELOPMENT, V124, P2245; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; KOPCZYNSKI CC, 1988, GENE DEV, V2, P1723, DOI 10.1101/gad.2.12b.1723; Kusumi K, 1998, NAT GENET, V19, P274, DOI 10.1038/961; LARDELLI M, 1993, EXP CELL RES, V204, P364, DOI 10.1006/excr.1993.1044; LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Mortier GR, 1996, AM J MED GENET, V61, P310, DOI 10.1002/(SICI)1096-8628(19960202)61:4<310::AID-AJMG3>3.0.CO;2-Y; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; ROBBINS J, 1992, J VIROL, V66, P2594, DOI 10.1128/JVI.66.4.2594-2599.1992; Sidow A, 1997, NATURE, V389, P722, DOI 10.1038/39587; SIMPSON JM, 1995, J MED GENET, V32, P633, DOI 10.1136/jmg.32.8.633; THOMAS U, 1991, DEVELOPMENT, V111, P749; TURNPENNY PD, 1991, J MED GENET, V28, P27, DOI 10.1136/jmg.28.1.27; Turnpenny PD, 1999, AM J HUM GENET, V65, P175, DOI 10.1086/302464; WEINMASTER G, 1991, DEVELOPMENT, V113, P931; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	30	299	315	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2000	24	4					438	441		10.1038/74307	http://dx.doi.org/10.1038/74307			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	299HK	10742114				2022-12-17	WOS:000086192800029
J	Stessman, HAF; Xiong, B; Coe, BP; Wang, TY; Hoekzema, K; Fenckova, M; Kvarnung, M; Gerdts, J; Trinh, S; Cosemans, N; Vives, L; Lin, J; Turner, TN; Santen, G; Ruivenkamp, C; Kriek, M; van Haeringen, A; Aten, E; Friend, K; Liebelt, J; Barnett, C; Haan, E; Shaw, M; Gecz, J; Anderlid, BM; Nordgren, A; Lindstrand, A; Schwartz, C; Kooy, RF; Vandeweyer, G; Helsmoortel, C; Romano, C; Alberti, A; Vinci, M; Avola, E; Giusto, S; Courchesne, E; Pramparo, T; Pierce, K; Nalabolu, S; Amaral, DG; Scheffer, IE; Delatycki, MB; Lockhart, PJ; Hormozdiari, F; Harich, B; Castells-Nobau, A; Xia, K; Peeters, H; Nordenskjold, M; Schenck, A; Bernier, RA; Eichler, EE				Stessman, Holly A. F.; Xiong, Bo; Coe, Bradley P.; Wang, Tianyun; Hoekzema, Kendra; Fenckova, Michaela; Kvarnung, Malin; Gerdts, Jennifer; Trinh, Sandy; Cosemans, Nele; Vives, Laura; Lin, Janice; Turner, Tychele N.; Santen, Gijs; Ruivenkamp, Claudia; Kriek, Marjolein; van Haeringen, Arie; Aten, Emmelien; Friend, Kathryn; Liebelt, Jan; Barnett, Christopher; Haan, Eric; Shaw, Marie; Gecz, Jozef; Anderlid, Britt-Marie; Nordgren, Ann; Lindstrand, Anna; Schwartz, Charles; Kooy, R. Frank; Vandeweyer, Geert; Helsmoortel, Celine; Romano, Corrado; Alberti, Antonino; Vinci, Mirella; Avola, Emanuela; Giusto, Stefania; Courchesne, Eric; Pramparo, Tiziano; Pierce, Karen; Nalabolu, Srinivasa; Amaral, David G.; Scheffer, Ingrid E.; Delatycki, Martin B.; Lockhart, Paul J.; Hormozdiari, Fereydoun; Harich, Benjamin; Castells-Nobau, Anna; Xia, Kun; Peeters, Hilde; Nordenskjold, Magnus; Schenck, Annette; Bernier, Raphael A.; Eichler, Evan E.			Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases	NATURE GENETICS			English	Article							DE-NOVO MUTATIONS; MILD INTELLECTUAL DISABILITY; OF-FUNCTION MUTATIONS; SPECTRUM DISORDER; SIMPLEX COLLECTION; LEARNING-DEFICITS; GRIN2B MUTATIONS; SCN2A MUTATION; FREQUENT CAUSE; WEST SYNDROME	Gene-disruptive mutations contribute to the biology of neurodevelopmental disorders (NDDs), but most of the related pathogenic genes are not known. We sequenced 208 candidate genes from >11,730 cases and >2,867 controls. We identified 91 genes, including 38 new NDD genes, with an excess of de novo mutations or private disruptive mutations in 5.7% of cases. Drosophila functional assays revealed a subset with increased involvement in NDDs. We identified 25 genes showing a bias for autism versus intellectual disability and highlighted a network associated with high-functioning autism (full-scale IQ >100). Clinical follow-up for NAA15, KMT5B, and ASH1L highlighted new syndromic and nonsyndromic forms of disease.	[Stessman, Holly A. F.; Xiong, Bo; Coe, Bradley P.; Hoekzema, Kendra; Vives, Laura; Lin, Janice; Turner, Tychele N.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Xiong, Bo] Huazhong Univ Sci & Technol, Dept Forens Med, Tongji Med Coll, Wuhan, Peoples R China; [Xiong, Bo] Huazhong Univ Sci & Technol, Inst Brain Res, Tongji Med Coll, Wuhan, Peoples R China; [Wang, Tianyun] Cent South Univ, Sch Life Sci, State Key Lab Med Genet, Changsha, Peoples R China; [Fenckova, Michaela; Schenck, Annette] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, Nijmegen, Netherlands; [Fenckova, Michaela; Harich, Benjamin; Castells-Nobau, Anna; Schenck, Annette] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Med Ctr, Nijmegen, Netherlands; [Kvarnung, Malin; Anderlid, Britt-Marie; Nordgren, Ann; Lindstrand, Anna] Karolinska Inst, Dept Mol Med & Surg, Ctr Mol Med, Stockholm, Sweden; [Kvarnung, Malin; Anderlid, Britt-Marie; Nordgren, Ann; Lindstrand, Anna; Nordenskjold, Magnus] Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden; [Trinh, Sandy; Bernier, Raphael A.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA USA; [Cosemans, Nele; Peeters, Hilde] Ctr Human Genet, KU Leuven & Leuven Autism Res LAuRes, Leuven, Belgium; [Ruivenkamp, Claudia; Kriek, Marjolein; van Haeringen, Arie] LUMC, Dept Clin Genet, Leiden, Netherlands; [Shaw, Marie] Univ Adelaide, Sch Med & Robinson Res Inst, Womens & Childrens Hosp, Adelaide, SA, Australia; [Friend, Kathryn; Gecz, Jozef] Genet & Mol Pathol, Adelaide, SA, Australia; [Barnett, Christopher] South Australian Clin Genet Serv, Adelaide, SA, Australia; [Gecz, Jozef] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Schwartz, Charles] Greenwood Genet Ctr, JC Self Res Inst Human Genet, Ctr Mol Studies, Greenwood, SC USA; [Kooy, R. Frank; Vandeweyer, Geert; Helsmoortel, Celine] Univ Antwerp, Dept Med Genet, Antwerp, Belgium; [Romano, Corrado; Alberti, Antonino; Avola, Emanuela] IRCCS Associaz Oasi Maria Santissima, Unit Pediat Med Genet, Troina, Italy; [Vinci, Mirella] IRCCS Associaz Oasi Maria Santissima, Lab Med Genet, Troina, Italy; [Giusto, Stefania] IRCCS Associaz Oasi Maria Santissima, Unit Neurol, Troina, Italy; [Pramparo, Tiziano; Pierce, Karen; Nalabolu, Srinivasa] Univ Calif San Diego, Sch Med, UC San Diego Autism Ctr, Dept Neurosci, La Jolla, CA USA; [Amaral, David G.] MIND Inst, Sacramento, CA USA; [Amaral, David G.] Univ Calif Davis, Sch Med, Sacramento, CA USA; [Scheffer, Ingrid E.; Delatycki, Martin B.; Lockhart, Paul J.] Univ Melbourne, Royal Childrens Hosp, Dept Pediat, Melbourne, Australia; [Scheffer, Ingrid E.] Univ Melbourne, Dept Med, Austin, Australia; [Scheffer, Ingrid E.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Delatycki, Martin B.] Victorian Clin Genet Serv, Parkville, Vic, Australia; [Delatycki, Martin B.; Lockhart, Paul J.] Murdoch Childrens Res Inst, Bruce Lefroy Ctr Genet Hlth Res, Parkville, Vic, Australia; [Hormozdiari, Fereydoun] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA USA; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Central South University; Radboud University Nijmegen; Radboud University Nijmegen; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Washington; University of Washington Seattle; Leiden University; Leiden University Medical Center (LUMC); Robinson Research Institute; University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI); Greenwood Genetic Center; University of Antwerp; University of California System; University of California San Diego; University of California System; University of California Davis; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Murdoch Children's Research Institute; University of California System; University of California Davis; Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Eichler, EE (corresponding author), Howard Hughes Med Inst, Seattle, WA USA.	eee@gs.washington.edu	Lockhart, Paul J/E-7753-2011; Gecz, Jozef/X-3469-2019; Avola, Emanuela/E-5435-2017; Nordgren, Ann C/N-4057-2013; Kooy, Frank/F-5276-2014; Nordgren, Ann/AAQ-9142-2021; Castells-Nobau, Anna/AAA-3846-2020; Fenckova, Michaela/AGY-9276-2022; Romano, Corrado/B-9695-2008; Alberti, Antonino/D-5653-2017; Lindstrand, Anna M/J-3566-2012; Schenck, Annette/E-4514-2012; Scheffer, Ingrid E/G-1668-2013; Castells-Nobau, Anna/AAL-1905-2021; XIA, KUN/AAO-3525-2020; Peeters, Hilde/AAA-7338-2020; Vinci, Mirella/K-8654-2016; Fenckova, Michaela/H-8622-2017; Lindstrand, Anna/AAT-9969-2021	Lockhart, Paul J/0000-0003-2531-8413; Gecz, Jozef/0000-0002-7884-6861; Avola, Emanuela/0000-0002-6740-665X; Nordgren, Ann C/0000-0003-3285-4281; Kooy, Frank/0000-0003-2024-0485; Nordgren, Ann/0000-0003-3285-4281; Fenckova, Michaela/0000-0002-5716-1652; Romano, Corrado/0000-0003-1049-0683; Alberti, Antonino/0000-0001-6742-7429; Lindstrand, Anna M/0000-0003-0806-5602; Schenck, Annette/0000-0002-6918-3314; Scheffer, Ingrid E/0000-0002-2311-2174; Vinci, Mirella/0000-0003-3026-8510; Fenckova, Michaela/0000-0002-5716-1652; Lindstrand, Anna/0000-0003-0806-5602; Stessman, Holly/0000-0002-0764-3493; Coe, Bradley/0000-0001-8471-4016; Castells-Nobau, Anna/0000-0002-6024-8353; Turner, Tychele/0000-0001-8246-6477; Peeters, Hilde/0000-0002-7295-3375; Xiong, Bo/0000-0002-2695-9100; Cosemans, Nele/0000-0002-9015-2803; Nordenskjold, Magnus/0000-0002-4974-425X	Simons Foundation Autism Research Initiative [SFARI 303241]; NIH [R01MH101221]; Netherlands Organization for Scientific Research [917-96-346, 912-12-109]; Horizon 2020 Marie SklodowskaCurie European Training Network (MiND) [643051]; NHGRI Interdisciplinary Training in Genome Science grant [T32HG00035]; Australian NHMRC [1091593, 1041920]; Channel 7 Children's Research Foundation; National Basic Research Program of China [2012CB517900]; National Natural Science Foundation of China [81330027, 81525007, 31400919]; China Scholarship Council [201406370028]; Fundamental Research Funds for the Central Universities [2012zzts110]; National Health and Medical Research Council of Australia [556759, 1044175, 1006110]; Jack Brockhoff Foundation; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC IRIISS; Swedish Brain Foundation; Swedish Research Council; Stockholm County Council; University of California, San Diego Clinical and Translational Research Institute [KL2TR00099, 1KL2TR001444]; Research FundFlanders (FWO); National Institute of Mental Health [1U24MH081810]; Senior Clinical Investigator of FWO; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000099, KL2TR001444] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH081810, R01MH101221] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Simons Foundation Autism Research Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Horizon 2020 Marie SklodowskaCurie European Training Network (MiND); NHGRI Interdisciplinary Training in Genome Science grant; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Channel 7 Children's Research Foundation; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Jack Brockhoff Foundation; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia); Swedish Brain Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); University of California, San Diego Clinical and Translational Research Institute; Research FundFlanders (FWO)(FWO); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Senior Clinical Investigator of FWO; Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the individuals and their families for participation in this study. We acknowledge the Vienna Drosophila Resource Center and Bloomington Drosophila Stock Center (NIH P40OD018537). This research was supported in part by the following: the Simons Foundation Autism Research Initiative (SFARI 303241) and NIH (R01MH101221) to E.E.E.; VIDI and TOP grants (917-96-346, 912-12-109) from the Netherlands Organization for Scientific Research and Horizon 2020 Marie SklodowskaCurie European Training Network (MiND, 643051) to A.S.; an NHGRI Interdisciplinary Training in Genome Science grant (T32HG00035) to H.A.F.S. and T.N.T.; Australian NHMRC grants 1091593 and 1041920 and Channel 7 Children's Research Foundation support to J.G.; the National Basic Research Program of China (2012CB517900) and the National Natural Science Foundation of China (81330027, 81525007 and 31400919) to K.X.; the China Scholarship Council (201406370028) and the Fundamental Research Funds for the Central Universities (2012zzts110) to T.W.; National Health and Medical Research Council of Australia Project grants (556759 and 1044175) to I.E.S., P.J.L., and M.B.D., and a Practitioner Fellowship (1006110) to I.E.S.; grants from the Jack Brockhoff Foundation and Perpetual Trustees, the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS, the Swedish Brain Foundation, the Swedish Research Council, and the Stockholm County Council; the University of California, San Diego Clinical and Translational Research Institute (KL2TR00099 and 1KL2TR001444) to T.P.; and the Research FundFlanders (FWO) to R.F.K. and G.V.D.W. We are grateful to all of the families at the participating SSC sites, as well as the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, R. Goin-Kochel, E. Hanson, D. Grice, A. Klin, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren, and E. Wijsman). We appreciate access to phenotypic data on SFARI Base. We gratefully acknowledge the resources provided by the Autism Genetic Resource Exchange (AGRE) Consortium and the participating AGRE families. AGRE is a program of Autism Speaks and is supported in part by grant 1U24MH081810 from the National Institute of Mental Health to C.M. Lajonchere. We thank N. Brown, K. Pereira, T. Vick, T. Desai, C. Green, A.L. Doebley, and L. Grillo for their valuable contributions as well as T. Brown for assistance in editing this manuscript. H.P. is supported as a Senior Clinical Investigator of FWO. E.E.E. is supported as an investigator of the Howard Hughes Medical Institute.	Adams DR, 2014, MOL GENET METAB, V113, P161, DOI 10.1016/j.ymgme.2014.04.001; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, V5th, DOI 10.1176/appi.books.9780890425596; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Attrill H, 2016, NUCLEIC ACIDS RES, V44, pD786, DOI 10.1093/nar/gkv1046; Ba W, 2016, HUM MOL GENET, V25, P892, DOI 10.1093/hmg/ddv618; Baasch AL, 2014, EPILEPSIA, V55, pE25, DOI 10.1111/epi.12554; BAIRD PA, 1988, AM J HUM GENET, V42, P677; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; BRAND AH, 1993, DEVELOPMENT, V118, P401; Busa T, 2015, EUR J PAEDIATR NEURO, V19, P188, DOI 10.1016/j.ejpn.2014.11.012; Buxbaum JD, 2007, AM J MED GENET B, V144B, P484, DOI 10.1002/ajmg.b.30493; Buxbaum JD, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-34; Cafiero C, 2015, EUR J HUM GENET, V23, P1499, DOI 10.1038/ejhg.2015.19; Cascio CJ, 2016, AUTISM RES, V9, P920, DOI 10.1002/aur.1612; Chan CB, 2014, P NATL ACAD SCI USA, V111, P1993, DOI 10.1073/pnas.1318185111; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chow ML, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002592; Coe BP, 2014, NAT GENET, V46, P1063, DOI 10.1038/ng.3092; Cotney J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7404; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; de Vries BBA, 2001, J MED GENET, V38, P145, DOI 10.1136/jmg.38.3.145; Dhamija R, 2013, PEDIATR NEUROL, V49, P486, DOI 10.1016/j.pediatrneurol.2013.07.004; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dimassi S, 2016, CLIN GENET, V89, P198, DOI 10.1111/cge.12636; Dinstein I, 2012, NEURON, V75, P981, DOI 10.1016/j.neuron.2012.07.026; Elliott C. D., 2007, DIFFERENTIAL ABILITY; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Esmaeeli-Nieh S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006022; Ethridge LE, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.48; Feenstra I, 2011, EUR J HUM GENET, V19, P1152, DOI 10.1038/ejhg.2011.120; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Freunscht I, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-20; Fukai R, 2015, J HUM GENET, V60, P277, DOI 10.1038/jhg.2015.13; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Green EW, 2014, NAT METHODS, V11, P222, DOI 10.1038/nmeth.2856; Griswold AJ, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0034-z; Hamdan FF, 2010, AM J HUM GENET, V87, P671, DOI 10.1016/j.ajhg.2010.09.017; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; Heinen CA, 2016, J MED GENET, V53, P330, DOI 10.1136/jmedgenet-2015-103233; Helsmoortel C, 2014, NAT GENET, V46, P380, DOI 10.1038/ng.2899; Herenger Y, 2015, EUR J MED GENET, V58, P479, DOI 10.1016/j.ejmg.2015.07.004; Hiatt JB, 2013, GENOME RES, V23, P843, DOI 10.1101/gr.147686.112; Homsy J, 2015, SCIENCE, V350, P1262, DOI 10.1126/science.aac9396; Hormozdiari F, 2015, GENOME RES, V25, P142, DOI 10.1101/gr.178855.114; Hoyer J, 2012, AM J HUM GENET, V90, P565, DOI 10.1016/j.ajhg.2012.02.007; Iossifov I, 2015, P NATL ACAD SCI USA, V112, pE5600, DOI 10.1073/pnas.1516376112; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kleefstra T, 2012, AM J HUM GENET, V91, P73, DOI 10.1016/j.ajhg.2012.05.003; Kleinhans NM, 2009, AM J PSYCHIAT, V166, P467, DOI 10.1176/appi.ajp.2008.07101681; Kramer JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000569; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Kuechler A, 2015, HUM GENET, V134, P97, DOI 10.1007/s00439-014-1498-1; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lemke JR, 2014, ANN NEUROL, V75, P147, DOI 10.1002/ana.24073; Liszczak G, 2013, NAT STRUCT MOL BIOL, V20, P1098, DOI 10.1038/nsmb.2636; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C., 2001, AUTISM DIAGNOSTIC OB; Lozano R, 2015, EUR J HUM GENET, V23, P1702, DOI 10.1038/ejhg.2015.66; Lugtenberg D, 2016, EUR J HUM GENET, V24, P1145, DOI 10.1038/ejhg.2015.282; Marchetto M.C, 2016, MOL PSYCHIAT; Matson JL, 2009, RES DEV DISABIL, V30, P1107, DOI 10.1016/j.ridd.2009.06.003; McNeill EM, 2011, DEV BIOL, V353, P331, DOI 10.1016/j.ydbio.2011.03.008; Merner N, 2016, AM J MED GENET A, V170, P1225, DOI 10.1002/ajmg.a.37566; Miyake F, 2015, J CHILD NEUROL, V30, P932, DOI 10.1177/0883073814541468; Myklebust LM, 2015, HUM MOL GENET, V24, P1956, DOI 10.1093/hmg/ddu611; Nakamura K, 2013, NEUROLOGY, V81, P992, DOI 10.1212/WNL.0b013e3182a43e57; Nijhof B, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004823; O'Roak BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6595; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Oortveld MAW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003911; Pellicano E, 2013, NEUROPSYCHOLOGIA, V51, P1504, DOI 10.1016/j.neuropsychologia.2013.03.021; Pescosolido MF, 2014, J MED GENET, V51, P587, DOI 10.1136/jmedgenet-2014-102444; Posthuma D, 2013, CURR OPIN NEUROL, V26, P111, DOI 10.1097/WCO.0b013e32835f19c3; Pramparo T, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156108; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ramaswami M, 2014, NEURON, V82, P1216, DOI 10.1016/j.neuron.2014.04.035; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; Rhodes Christopher T, 2016, Neuroepigenetics, V6, P10; Rope AF, 2011, AM J HUM GENET, V89, P28, DOI 10.1016/j.ajhg.2011.05.017; Rosenfeld JA, 2013, GENET MED, V15, P478, DOI 10.1038/gim.2012.164; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmid S, 2015, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00097; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; Shen MD, 2013, BRAIN, V136, P2825, DOI 10.1093/brain/awt166; Shoubridge C, 2010, NAT GENET, V42, P486, DOI 10.1038/ng.588; Sollis E, 2016, HUM MOL GENET, V25, P546, DOI 10.1093/hmg/ddv495; Stamberger H, 2016, NEUROLOGY, V86, P954, DOI 10.1212/WNL.0000000000002457; Stessman HA, 2014, CELL, V156, P872, DOI 10.1016/j.cell.2014.02.002; Stessman HAF, 2016, AM J HUM GENET, V98, P541, DOI 10.1016/j.ajhg.2016.02.004; Stoner R, 2014, NEW ENGL J MED, V370, P1209, DOI 10.1056/NEJMoa1307491; Stray-Pedersen A, 2016, AM J HUM GENET, V98, P202, DOI 10.1016/j.ajhg.2015.11.004; Sugathan A, 2014, P NATL ACAD SCI USA, V111, pE4468, DOI 10.1073/pnas.1405266111; Sugiura N, 2001, J BIOL CHEM, V276, P14257, DOI 10.1074/jbc.M100011200; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takeuchi A, 2015, EUR J MED GENET, V58, P369, DOI 10.1016/j.ejmg.2015.05.006; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tavassoli T, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-35; Torres F, 2016, J MED GENET, V53, P73, DOI 10.1136/jmedgenet-2015-103366; Tucci V, 2014, J CLIN INVEST, V124, P1468, DOI 10.1172/JCI70372; Turner TN, 2017, NUCLEIC ACIDS RES, V45, pD804, DOI 10.1093/nar/gkw865; Turner TN, 2016, AM J HUM GENET, V98, P58, DOI 10.1016/j.ajhg.2015.11.023; Turner TN, 2015, NATURE, V520, P51, DOI 10.1038/nature14186; van Bokhoven H, 2011, ANNU REV GENET, V45, P81, DOI 10.1146/annurev-genet-110410-132512; van Bon BWM, 2016, MOL PSYCHIATR, V21, P126, DOI 10.1038/mp.2015.5; van Bon BWM, 2013, HUM MOL GENET, V22, P3138, DOI 10.1093/hmg/ddt170; van Haelst MM, 2015, EUR J HUM GENET, V23, P135, DOI 10.1038/ejhg.2014.69; Vissers JHA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10368; Vulto-van Silfhout AT, 2013, HUM MUTAT, V34, P1679, DOI 10.1002/humu.22442; Wang TY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13316; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; White J, 2016, GENOME MED, V8, DOI 10.1186/s13073-015-0253-0; Willemsen MH, 2013, J MED GENET, V50, P507, DOI 10.1136/jmedgenet-2012-101490; Winczewska-Wiktor A, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0554-y; Witteveen JS, 2016, NAT GENET, V48, P877, DOI 10.1038/ng.3619; Zhu T, 2016, SCI REP-UK, V6, DOI 10.1038/srep26597	123	298	306	4	109	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2017	49	4					515	+		10.1038/ng.3792	http://dx.doi.org/10.1038/ng.3792			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EP8CO	28191889	Green Submitted, Green Accepted			2022-12-17	WOS:000397603700015
J	Qi, JJ; Liu, X; Shen, D; Miao, H; Xie, BY; Li, XX; Zeng, P; Wang, SH; Shang, Y; Gu, XF; Du, YC; Li, Y; Lin, T; Yuan, JH; Yang, XY; Chen, JF; Chen, HM; Xiong, XY; Huang, K; Fei, ZJ; Mao, LY; Tian, L; Stadler, T; Renner, SS; Kamoun, S; Lucas, WJ; Zhang, ZH; Huang, SW				Qi, Jianjian; Liu, Xin; Shen, Di; Miao, Han; Xie, Bingyan; Li, Xixiang; Zeng, Peng; Wang, Shenhao; Shang, Yi; Gu, Xingfang; Du, Yongchen; Li, Ying; Lin, Tao; Yuan, Jinhong; Yang, Xueyong; Chen, Jinfeng; Chen, Huiming; Xiong, Xingyao; Huang, Ke; Fei, Zhangjun; Mao, Linyong; Tian, Li; Staedler, Thomas; Renner, Susanne S.; Kamoun, Sophien; Lucas, William J.; Zhang, Zhonghua; Huang, Sanwen			A genomic variation map provides insights into the genetic basis of cucumber domestication and diversity	NATURE GENETICS			English	Article							WIDE PATTERNS; DRAFT GENOME; ARABIDOPSIS; SATIVUS; RICE; REVEALS; ORIGIN; WILD; LD	Most fruits in our daily diet are the products of domestication and breeding. Here we report a map of genome variation for a major fruit that encompasses similar to 3.6 million variants, generated by deep resequencing of 115 cucumber lines sampled from 3,342 accessions worldwide. Comparative analysis suggests that fruit crops underwent narrower bottlenecks during domestication than grain crops. We identified 112 putative domestication sweeps; 1 of these regions contains a gene involved in the loss of bitterness in fruits, an essential domestication trait of cucumber. We also investigated the genomic basis of divergence among the cultivated populations and discovered a natural genetic variant in a beta-carotene hydroxylase gene that could be used to breed cucumbers with enhanced nutritional value. The genomic history of cucumber evolution uncovered here provides the basis for future genomics-enabled breeding.	[Qi, Jianjian; Shen, Di; Miao, Han; Xie, Bingyan; Li, Xixiang; Wang, Shenhao; Shang, Yi; Gu, Xingfang; Du, Yongchen; Li, Ying; Lin, Tao; Yuan, Jinhong; Yang, Xueyong; Xiong, Xingyao; Zhang, Zhonghua; Huang, Sanwen] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Hort Crops, Sinodutch Joint Lab Hort Genom, Minist Agr,Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Liu, Xin; Zeng, Peng] BGI Shenzhen, Shenzhen, Peoples R China; [Chen, Jinfeng] Nanjing Agr Univ, Coll Hort, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Chen, Huiming] Hunan Acad Agr Sci, Hunan Vegetable Res Inst, Changsha, Hunan, Peoples R China; [Xiong, Xingyao; Huang, Ke] Hunan Agr Univ, Hort & Landscape Coll, Hunan Prov Key Lab Germplasm Innovat & Utilizat C, Changsha, Hunan, Peoples R China; [Fei, Zhangjun; Mao, Linyong] Robert W Holley Ctr Agr & Hlth, Boyce Thompson Inst Plant Res, USDA, Ithaca, NY USA; [Tian, Li] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Staedler, Thomas] ETH, Inst Integrat Biol, Zurich, Switzerland; [Renner, Susanne S.] Univ Munich, Dept Biol, Munich, Germany; [Kamoun, Sophien] Sainsbury Lab, Norwich, Norfolk, England; [Lucas, William J.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs; Beijing Genomics Institute (BGI); Nanjing Agricultural University; Hunan Academy of Agricultural Sciences; Hunan Agricultural University; Cornell University; Boyce Thompson Institute for Plant Research; United States Department of Agriculture (USDA); University of California System; University of California Davis; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Munich; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of California System; University of California Davis	Huang, SW (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Hort Crops, Sinodutch Joint Lab Hort Genom, Minist Agr,Inst Vegetables & Flowers, Beijing 100193, Peoples R China.	zhangzhonghua@caas.cn; huangsanwen@caas.cn	Kamoun, Sophien/B-3529-2009; Huang, Sanwen/ABE-9053-2020; Fei, Zhangjun/H-5152-2012; Städler, Thomas/B-7286-2009; Yuan, Jinhong/AAF-7715-2019	Kamoun, Sophien/0000-0002-0290-0315; Huang, Sanwen/0000-0002-8547-5309; Städler, Thomas/0000-0003-4513-8583; Yuan, Jinhong/0000-0002-5794-493X; Yang, Xueyong/0000-0003-0453-2023; Liu, Xin/0000-0003-3256-2940; zhang, zhonghua/0000-0002-1034-227X; Fei, Zhangjun/0000-0001-9684-1450	National Program on Key Basic Research Projects in China (the 973 Program) [2012CB113900]; National Natural Science Foundation of China (NSFC) [31225025]; National High-Tech Research Development Program in China (the 863 Program) [2010AA10A108, 2012AA100101]; NSFC [31030057, 30972011, 31101550, 31071797, 31171961, 31272161, 31322047]; Chinese Ministry of Agriculture [2008-Z42]; Chinese Ministry of Finance [1251610601001]; CAAS	National Program on Key Basic Research Projects in China (the 973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National High-Tech Research Development Program in China (the 863 Program)(National High Technology Research and Development Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); Chinese Ministry of Finance; CAAS	We thank J. Ross-Ibarra (University of California, Davis) and J.-Y. Li (Chinese Academy of Agricultural Sciences (CAAS)) for critical comments, D. DellaPenna (Michigan State University) for assistance in beta-carotene pathway analysis and the three anonymous referees for their constructive comments. We thank F. Cunningham (University of Maryland) for providing the pAC-BETA plasmid. This work was supported by funding from the National Program on Key Basic Research Projects in China (the 973 Program; 2012CB113900), the National Natural Science Foundation of China (NSFC; 31225025) the National High-Tech Research Development Program in China (the 863 Program; 2010AA10A108 and 2012AA100101), and other NSFC grants (31030057, 30972011, 31101550, 31071797, 31171961, 31272161 and 31322047), the Chinese Ministry of Agriculture (the 948 program; 2008-Z42), the Chinese Ministry of Finance (1251610601001) and CAAS (seed grant to S.H.).	Anderson M. J., 2003, PCO FORTRAN COMPUTER; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Balkema-Boomstra AG, 2003, J CHEM ECOL, V29, P225, DOI 10.1023/A:1021945101308; BARHAM WS, 1953, P AM SOC HORTIC SCI, V62, P441; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bo KL, 2012, MOL BREEDING, V30, P335, DOI 10.1007/s11032-011-9624-4; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Cunningham FX, 2007, PHOTOSYNTH RES, V92, P245, DOI 10.1007/s11120-007-9210-0; de Meeus T, 2007, INFECT GENET EVOL, V7, P731, DOI 10.1016/j.meegid.2007.07.005; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Gross BL, 2010, TRENDS PLANT SCI, V15, P529, DOI 10.1016/j.tplants.2010.05.008; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Horiguchi G, 2009, PLANT J, V60, P122, DOI 10.1111/j.1365-313X.2009.03940.x; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Jiao YP, 2012, NAT GENET, V44, P812, DOI 10.1038/ng.2312; Kang HX, 2011, THEOR APPL GENET, V122, P795, DOI 10.1007/s00122-010-1487-2; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li XueFeng, 2011, Acta Horticulturae Sinica, V38, P886; Li Z, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-540; Lv J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046919; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Qi C. Z., 1983, Acta Horticulturae Sinica, V10, P259; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; Ross-Ibarra J, 2009, GENETICS, V181, P1397, DOI 10.1534/genetics.108.097238; Sebastian P, 2010, P NATL ACAD SCI USA, V107, P14269, DOI 10.1073/pnas.1005338107; TAJIMA F, 1983, GENETICS, V105, P437; Tang HB, 2010, CURR OPIN PLANT BIOL, V13, P160, DOI 10.1016/j.pbi.2009.10.008; Tian L, 2001, PLANT MOL BIOL, V47, P379, DOI 10.1023/A:1011623907959; Walter MH, 2011, NAT PROD REP, V28, P663, DOI 10.1039/c0np00036a; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Xu ZL, 2007, BIOINFORMATICS, V23, P3254, DOI 10.1093/bioinformatics/btm426; Yang LM, 2012, PLANT J, V71, P895, DOI 10.1111/j.1365-313X.2012.05017.x	52	298	355	15	283	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1510	U149		10.1038/ng.2801	http://dx.doi.org/10.1038/ng.2801			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	24141363				2022-12-17	WOS:000327715800021
J	Wang, Z; Pascual-Anaya, J; Zadissa, A; Li, WQ; Niimura, Y; Huang, ZY; Li, CY; White, S; Xiong, ZQ; Fang, DM; Wang, B; Ming, Y; Chen, Y; Zheng, Y; Kuraku, S; Pignatelli, M; Herrero, J; Beal, K; Nozawa, M; Li, QY; Wang, J; Zhang, HY; Yu, LL; Shigenobu, S; Wang, JY; Liu, JN; Flicek, P; Searle, S; Wang, J; Kuratani, S; Yin, Y; Aken, B; Zhang, GJ; Irie, N				Wang, Zhuo; Pascual-Anaya, Juan; Zadissa, Amonida; Li, Wenqi; Niimura, Yoshihito; Huang, Zhiyong; Li, Chunyi; White, Simon; Xiong, Zhiqiang; Fang, Dongming; Wang, Bo; Ming, Yao; Chen, Yan; Zheng, Yuan; Kuraku, Shigehiro; Pignatelli, Miguel; Herrero, Javier; Beal, Kathryn; Nozawa, Masafumi; Li, Qiye; Wang, Juan; Zhang, Hongyan; Yu, Lili; Shigenobu, Shuji; Wang, Junyi; Liu, Jiannan; Flicek, Paul; Searle, Steve; Wang, Jun; Kuratani, Shigeru; Yin, Ye; Aken, Bronwen; Zhang, Guojie; Irie, Naoki			The draft genomes of soft-shell turtle and green sea turtle yield insights into the development and evolution of the turtle-specific body plan	NATURE GENETICS			English	Article							CARAPACIAL RIDGE; PHYLOTYPIC STAGE; DIVERGENCE TIMES; MOLECULAR CLOCK; SISTER GROUP; SEQUENCE; ALIGNMENT; GENES; TRANSCRIPTOME; BLAST	The unique anatomical features of turtles have raised unanswered questions about the origin of their unique body plan. We generated and analyzed draft genomes of the soft-shell turtle (Pelodiscus sinensis) and the green sea turtle (Chelonia mydas); our results indicated the close relationship of the turtles to the bird-crocodilian lineage, from which they split similar to 267.9-248.3 million years ago (Upper Permian to Triassic). We also found extensive expansion of olfactory receptor genes in these turtles. Embryonic gene expression analysis identified an hourglass-like divergence of turtle and chicken embryogenesis, with maximal conservation around the vertebrate phylotypic period, rather than at later stages that show the amniote-common pattern. Wnt5a expression was found in the growth zone of the dorsal shell, supporting the possible co-option of limb-associated Wnt signaling in the acquisition of this turtle-specific novelty. Our results suggest that turtle evolution was accompanied by an unexpectedly conservative vertebrate phylotypic period, followed by turtle-specific repatterning of development to yield the novel structure of the shell.	[Wang, Zhuo; Huang, Zhiyong; Xiong, Zhiqiang; Fang, Dongming; Wang, Bo; Ming, Yao; Chen, Yan; Zheng, Yuan; Li, Qiye; Wang, Juan; Yu, Lili; Wang, Junyi; Zhang, Guojie] BGI Shenzhen, Shenzhen, Peoples R China; [Pascual-Anaya, Juan; Kuraku, Shigehiro; Kuratani, Shigeru; Irie, Naoki] RIKEN Ctr Dev Biol, Kobe, Hyogo, Japan; [Zadissa, Amonida; White, Simon; Searle, Steve; Aken, Bronwen] Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Cambridge, England; [Li, Wenqi; Li, Chunyi; Zhang, Hongyan; Liu, Jiannan; Yin, Ye] BGI Japan, Kobe, Hyogo, Japan; [Niimura, Yoshihito] Tokyo Med & Dent Univ, Med Res Inst, Tokyo, Japan; [Pignatelli, Miguel; Herrero, Javier; Beal, Kathryn; Flicek, Paul] Wellcome Trust Genome Campus, European Bioinformat Inst, Cambridge, England; [Nozawa, Masafumi; Shigenobu, Shuji] NIBB, Natl Inst Basic Biol NIBB Core Res Facil, Okazaki, Aichi, Japan; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Zhang, Guojie] BGI Shenzhen, China Natl GeneBank, Shenzhen, Peoples R China; [Zhang, Guojie] Univ Copenhagen, Dept Biol, Ctr Social Evolut, Copenhagen, Denmark	Beijing Genomics Institute (BGI); RIKEN; Wellcome Trust Sanger Institute; Tokyo Medical & Dental University (TMDU); European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); University of Copenhagen; King Abdulaziz University; Beijing Genomics Institute (BGI); University of Copenhagen	Irie, N (corresponding author), RIKEN Ctr Dev Biol, Kobe, Hyogo, Japan.	yinye@genomics.cn; ba1@sanger.ac.uk; zhanggj@genomics.org.cn; asurain@cdb.riken.jp	Zhang, Guojie/B-6188-2014; Shigenobu, Shuji/B-6239-2011; Li, Qiye/C-1348-2015; wang, junyi/GYA-3213-2022; Pascual-Anaya, Juan/B-5043-2016; Kuraku, Shigehiro/B-2801-2009; Zhang, Guojie/J-7273-2019; Kuratani, Shigeru/J-4146-2014; Wang, Jun/A-7261-2013; yan, chen/AAS-4603-2021; Nozawa, Masafumi/S-9054-2019; Herrero, Javier/H-6971-2019; IRIE, NAOKI/G-5012-2014; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Zhang, Guojie/0000-0001-6860-1521; Shigenobu, Shuji/0000-0003-4640-2323; Li, Qiye/0000-0002-5993-0312; Pascual-Anaya, Juan/0000-0003-3429-9453; Kuraku, Shigehiro/0000-0003-1464-8388; Zhang, Guojie/0000-0001-6860-1521; Kuratani, Shigeru/0000-0001-9717-7221; Herrero, Javier/0000-0001-7313-717X; Wang, Zhuo/0000-0002-4069-9501; Wang, Jun/0000-0002-2113-5874; Aken, Bronwen/0000-0002-3032-4095; White, Simon/0000-0001-6375-2363; yu, lili/0000-0003-0435-0385; Flicek, Paul/0000-0002-3897-7955; Irie, Naoki/0000-0002-6720-381X; Wang, Jun/0000-0002-8540-8931; Zadissa, Amonida/0000-0001-5310-8830	Ministry of Education, Culture, Sports, Science & Technology, Japan [22128003, 22128001]; NIBB Cooperative Research Program (Next-generation DNA Sequencing Initiative) [11-730]; European Molecular Biology Laboratory; Wellcome Trust [WT095908, WT098051]; China National GeneBank at BGI-Shenzhen; Grants-in-Aid for Scientific Research [23770271, 24570243, 22128003] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science & Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIBB Cooperative Research Program (Next-generation DNA Sequencing Initiative); European Molecular Biology Laboratory; Wellcome Trust(Wellcome TrustEuropean Commission); China National GeneBank at BGI-Shenzhen; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to acknowledge the International Crocodilian Genomes Working Group, in particular, D.A. Ray of Mississippi State University, R.E. Green of the University of California at Santa Cruz and E.L. Braun of the University of Florida, for making their early drafts of the Crocodylus porosus (saltwater crocodile) and Alligator mississippiensis (American alligator) genomes available for the phylogenetic analysis. We acknowledge P. Martelli at Ocean Park Corporation Hong Kong for providing the green sea turtle samples and Daiwa-yoshoku Ltd. For providing the soft-shell turtle samples. We thank M. Noro, K. Yamanaka, K. Itomi and T. Kitazume for help collecting and sequencing the soft-shell turtle mRNA. The soft-shell turtle genome project was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science & Technology, Japan (22128003 and 22128001), the NIBB Cooperative Research Program (Next-generation DNA Sequencing Initiative, 11-730) and the European Molecular Biology Laboratory and the Wellcome Trust (grant numbers WT095908 and WT098051). The green sea turtle genome project was supported by the China National GeneBank at BGI-Shenzhen.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1966, VERTEBRATE PALEONTOL; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Brudno M, 2004, GENOME RES, V14, P685, DOI 10.1101/gr.2067704; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; BURKE AC, 1989, J MORPHOL, V199, P363, DOI 10.1002/jmor.1051990310; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen ZQ, 2012, NAT GEOSCI, V5, P375, DOI [10.1038/NGEO1475, 10.1038/ngeo1475]; Chiari Y, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-65; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; Domazet-Loso T, 2010, NATURE, V468, P815, DOI 10.1038/nature09632; DUBOULE D, 1994, DEVELOPMENT, P135; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Endres CS, 2009, J EXP BIOL, V212, P3823, DOI 10.1242/jeb.033068; Enright AJ, 2004, GENOME BIOL, V5; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Harris R.S., 2007, THESIS PENN STATE U; Hayden S, 2010, GENOME RES, V20, P1, DOI 10.1101/gr.099416.109; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; HEDGES SB, 1990, MOL BIOL EVOL, V7, P607; Irie N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1248; Irie N, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-1; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kalinka AT, 2010, NATURE, V468, P811, DOI 10.1038/nature09634; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Keller O, 2011, BIOINFORMATICS, V27, P757, DOI 10.1093/bioinformatics/btr010; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kishida T, 2007, BIOLOGY LETT, V3, P428, DOI 10.1098/rsbl.2007.0191; Kuraku S, 2005, EVOL DEV, V7, P3, DOI 10.1111/j.1525-142X.2005.05002.x; Kuratani S, 2011, EVOL DEV, V13, P1, DOI 10.1111/j.1525-142X.2010.00451.x; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Li C, 2008, NATURE, V456, P497, DOI 10.1038/nature07533; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lyson TR, 2012, BIOL LETTERS, V8, P104, DOI 10.1098/rsbl.2011.0477; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagashima H, 2007, DEVELOPMENT, V134, P2219, DOI 10.1242/dev.002618; Nagashima H, 2009, SCIENCE, V325, P193, DOI 10.1126/science.1173826; Niimura Y, 2012, CURR GENOMICS, V13, P103, DOI 10.2174/138920212799860706; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Quint M, 2012, NATURE, V490, P98, DOI 10.1038/nature11394; Raff A., 1996, SHAPE LIFE GENES DEV; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Richardson MK, 1998, TRENDS ECOL EVOL, V13, P158, DOI 10.1016/S0169-5347(98)01340-8; Rieppel O, 1996, NATURE, V384, P453, DOI 10.1038/384453a0; Rieppel O, 2001, BIOESSAYS, V23, P987, DOI 10.1002/bies.1143; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Toba G, 2000, GENE, V253, P179, DOI 10.1016/S0378-1119(00)00246-8; Tokita M, 2001, ZOOL SCI, V18, P705, DOI 10.2108/zsj.18.705; Tzika AC, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-19; von Baer K.E., 1828, ENTWICKELUNGSGESCHIC; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	68	298	305	9	212	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2013	45	6					701	+		10.1038/ng.2615	http://dx.doi.org/10.1038/ng.2615			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	152XA	23624526	hybrid, Green Accepted, Green Published			2022-12-17	WOS:000319563900021
J	Vaz, F; Hanenberg, H; Schuster, B; Barker, K; Wiek, C; Erven, V; Neveling, K; Endt, D; Kesterton, I; Autore, F; Fraternali, F; Freund, M; Hartmann, L; Grimwade, D; Roberts, RG; Schaal, H; Mohammed, S; Rahman, N; Schindler, D; Mathew, CG				Vaz, Fiona; Hanenberg, Helmut; Schuster, Beatrice; Barker, Karen; Wiek, Constanze; Erven, Verena; Neveling, Kornelia; Endt, Daniela; Kesterton, Ian; Autore, Flavia; Fraternali, Franca; Freund, Marcel; Hartmann, Linda; Grimwade, David; Roberts, Roland G.; Schaal, Heiner; Mohammed, Shehla; Rahman, Nazneen; Schindler, Detlev; Mathew, Christopher G.			Mutation of the RAD51C gene in a Fanconi anemia-like disorder	NATURE GENETICS			English	Article							MAMMALIAN-CELLS; GENOMIC STABILITY; RECOMBINATION; FAMILIES; REGISTRY; MUTANTS; CANCER; REPAIR; FANCD2; MICE	Fanconi anemia (FA) is a rare chromosomal-instability disorder associated with a variety of developmental abnormalities, bone marrow failure and predisposition to leukemia and other cancers(1). We have identified a homozygous missense mutation in the RAD51C gene in a consanguineous family with multiple severe congenital abnormalities characteristic of FA. RAD51C is a member of the RAD51-like gene family involved in homologous recombination-mediated DNA repair. The mutation results in loss of RAD51 focus formation in response to DNA damage and in increased cellular sensitivity to the DNA interstrand cross-linking agent mitomycin C and the topoisomerase-1 inhibitor camptothecin. Thus, biallelic germline mutations in a RAD51 paralog are associated with an FA-like syndrome.	[Vaz, Fiona; Grimwade, David; Roberts, Roland G.; Mathew, Christopher G.] Kings Coll London, Dept Med & Mol Genet, Sch Med, Guys Hosp, London WC2R 2LS, England; [Hanenberg, Helmut; Wiek, Constanze; Erven, Verena; Freund, Marcel] Univ Dusseldorf, Childrens Hosp, Dept Pediat Hematol Oncol & Clin Immunol, D-4000 Dusseldorf, Germany; [Hanenberg, Helmut] Indiana Univ Sch Med, Riley Hosp, Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN USA; [Schuster, Beatrice; Neveling, Kornelia; Endt, Daniela; Schindler, Detlev] Univ Wurzburg, Dept Human Genet, D-8700 Wurzburg, Germany; [Barker, Karen; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Kesterton, Ian] Guys Hosp, Guys & St Thomas NHS Fdn Trust, Genet Ctr, Cytogenet Lab, London SE1 9RT, England; [Autore, Flavia; Fraternali, Franca] Kings Coll London, Guys Hosp, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Hartmann, Linda; Schaal, Heiner] Univ Dusseldorf, Inst Virol, Dusseldorf, Germany; [Mohammed, Shehla] Guys Hosp, Guys & St Thomas NHS Fdn Trust, Dept Clin Genet, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Heinrich Heine University Dusseldorf; Indiana University System; Indiana University Bloomington; James Whitcomb Riley Hospital Children; University of Wurzburg; University of London; Institute of Cancer Research - UK; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Heinrich Heine University Dusseldorf; Guy's & St Thomas' NHS Foundation Trust	Mathew, CG (corresponding author), Kings Coll London, Dept Med & Mol Genet, Sch Med, Guys Hosp, London WC2R 2LS, England.	helmut.hanenberg@uni-duesseldorf.de; schindler@biozentrum.uni-wuerzburg.de; christopher.mathew@genetics.kcl.ac.uk	Mathew, Christopher G/G-3434-2015; Fraternali, Franca/D-4410-2011; Schaal, Heiner/A-5115-2008; Roberts, Roland G/C-3596-2009; Rahman, Nazneen/B-8890-2012; Fraternali, Franca/C-8912-2009; Rahman, Nazneen/D-2802-2013	Mathew, Christopher G/0000-0003-4178-1838; Fraternali, Franca/0000-0002-3143-6574; Roberts, Roland/0000-0001-6636-1579; Wiek, Constanze/0000-0003-2214-8148; Rahman, Nazneen/0000-0003-4376-0440	Medical Research Council UK; Daniel Ayling Trust; Forschungskommission of the Heinrich Heine University, Dusseldorf; Deutsche Forschungsgemeinschaft [SPP1230]; Bundesministerium fur Bildung und Forschung network for congenital bone marrow failure syndromes; Deutsche Fanconi Anaemie Hilfe; Aktionskreis Fanconi Anaemie; Schroeder Kurth Fund; Jurgen-Manchot-Stiftung; European Molecular Biology Organization [ASTF 177-2008]	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Daniel Ayling Trust; Forschungskommission of the Heinrich Heine University, Dusseldorf; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung network for congenital bone marrow failure syndromes; Deutsche Fanconi Anaemie Hilfe; Aktionskreis Fanconi Anaemie; Schroeder Kurth Fund; Jurgen-Manchot-Stiftung; European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	We thank affected individuals and their families for providing samples for this study and for donations to FA research. DNA from matched Pakistani controls was kindly provided by D. A. Khan (Department of Pathology, Army Medical College, Rawalpindi, Pakistan). We thank B. Xia (Department of Radiation Oncology, The Cancer Institute of New Jersey) for providing the PALB2 antibody, A. Sobeck for initial cloning of RAD51C cDNA and R. Kalb and E. Velleuer for constructing an early version of the RAD51C vector and for preliminary analysis. The Rad51c-deficient hamster irs3 cells were a kind gift from J. Thacker (Medical Research Council UK Radiation and Genome Stability Unit), provided by G. Illiakis (Institute of Medical Radiation Biology, University of Duisburg-Essen Medical School). We thank E. Manners for editorial assistance. We are indebted to R. Friedl for flow cytometry and to B. Gottwald and W. Kuss for expert technical assistance. Research in our laboratories was supported by the Medical Research Council UK and the Daniel Ayling Trust (F.V.), the Forschungskommission of the Heinrich Heine University, Dusseldorf (M.F., H.H.), the Deutsche Forschungsgemeinschaft SPP1230 (H.H.), the Bundesministerium fur Bildung und Forschung network for congenital bone marrow failure syndromes (H.H., H.S., D.S.), the Deutsche Fanconi Anaemie Hilfe, the Aktionskreis Fanconi Anaemie and the Schroeder Kurth Fund (D.S., H.H.), the Jurgen-Manchot-Stiftung (L.H., H.S.), Cancer Research UK (K. B., N.R.) and European Molecular Biology Organization fellowship ASTF 177-2008 (F.A.).	Abraham J, 2003, EMBO J, V22, P6137, DOI 10.1093/emboj/cdg580; AUERBACH AD, 1989, BLOOD, V73, P391; Badie S, 2009, J CELL BIOL, V185, P587, DOI 10.1083/jcb.200811079; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Casado JA, 2007, J MED GENET, V44, P241, DOI 10.1136/jmg.2006.044719; Daura X, 1998, J COMPUT CHEM, V19, P535, DOI 10.1002/(SICI)1096-987X(19980415)19:5<535::AID-JCC6>3.0.CO;2-N; Enders A, 2006, J IMMUNOL, V176, P5060, DOI 10.4049/jimmunol.176.8.5060; French CA, 2002, J BIOL CHEM, V277, P19322, DOI 10.1074/jbc.M201402200; Godthelp BC, 2002, NUCLEIC ACIDS RES, V30, P2172, DOI 10.1093/nar/30.10.2172; Hanenberg H, 1996, NAT MED, V2, P876, DOI 10.1038/nm0896-876; Hanenberg H, 1997, HUM GENE THER, V8, P2193, DOI 10.1089/hum.1997.8.18-2193; Hanenberg H, 2002, EXP HEMATOL, V30, P410, DOI 10.1016/S0301-472X(02)00782-8; Kalb R, 2007, AM J HUM GENET, V80, P895, DOI 10.1086/517616; Kuznetsov S, 2007, J CELL BIOL, V176, P581, DOI 10.1083/jcb.200608130; Kuznetsov SG, 2009, CANCER RES, V69, P863, DOI 10.1158/0008-5472.CAN-08-3057; Liu YL, 2007, J BIOL CHEM, V282, P1973, DOI 10.1074/jbc.M609066200; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; Livingston DM, 2009, SCIENCE, V324, P602, DOI 10.1126/science.1174839; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Rosenberg PS, 2008, HAEMATOLOGICA, V93, P511, DOI 10.3324/haematol.12234; Sandoval N, 1999, HUM MOL GENET, V8, P69, DOI 10.1093/hmg/8.1.69; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, P816, DOI 10.1093/nar/gki233; Singh TR, 2009, BLOOD, V114, P174, DOI 10.1182/blood-2009-02-207811; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Waltes R, 2009, AM J HUM GENET, V84, P605, DOI 10.1016/j.ajhg.2009.04.010	30	298	307	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2010	42	5					406	U63		10.1038/ng.570	http://dx.doi.org/10.1038/ng.570			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	589UK	20400963				2022-12-17	WOS:000277179500010
J	Rothenberg, ME; Spergel, JM; Sherrill, JD; Annaiah, K; Martin, LJ; Cianferoni, A; Gober, L; Kim, C; Glessner, J; Frackelton, E; Thomas, K; Blanchard, C; Liacouras, C; Verma, R; Aceves, S; Collins, MH; Brown-Whitehorn, T; Putnam, PE; Franciosi, JP; Chiavacci, RM; Grant, SFA; Abonia, JP; Sleiman, PMA; Hakonarson, H				Rothenberg, Marc E.; Spergel, Jonathan M.; Sherrill, Joseph D.; Annaiah, Kiran; Martin, Lisa J.; Cianferoni, Antonella; Gober, Laura; Kim, Cecilia; Glessner, Joseph; Frackelton, Edward; Thomas, Kelly; Blanchard, Carine; Liacouras, Chris; Verma, Ritu; Aceves, Seema; Collins, Margaret H.; Brown-Whitehorn, Terri; Putnam, Phil E.; Franciosi, James P.; Chiavacci, Rosetta M.; Grant, Struan F. A.; Abonia, J. Pablo; Sleiman, Patrick M. A.; Hakonarson, Hakon			Common variants at 5q22 associate with pediatric eosinophilic esophagitis	NATURE GENETICS			English	Article							EOTAXIN-3; CHILDREN	Eosinophilic esophagitis (EoE) is an allergic disorder characterized by the accumulation of eosinophils in the esophagus. We report association of EoE with variants at chromosome 5q22 encompassing TSLP and WDR36 (rs3806932, combined P = 3.19 x 10(-9)). TSLP is overexpressed in esophageal biopsies from individuals with EoE compared with unaffected individuals, whereas WDR36 expression is unaltered between the two groups. These data implicate the 5q22 locus in the pathogenesis of EoE and identify TSLP as the most likely candidate gene in the region.	[Spergel, Jonathan M.; Cianferoni, Antonella; Liacouras, Chris; Verma, Ritu; Brown-Whitehorn, Terri; Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Rothenberg, Marc E.; Sherrill, Joseph D.; Blanchard, Carine; Abonia, J. Pablo] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp, Div Allergy & Immunol,Med Ctr, Cincinnati, OH 45221 USA; [Spergel, Jonathan M.; Cianferoni, Antonella; Gober, Laura; Brown-Whitehorn, Terri] Childrens Hosp Philadelphia, Div Allergy & Immunol, Philadelphia, PA 19104 USA; [Annaiah, Kiran; Kim, Cecilia; Glessner, Joseph; Frackelton, Edward; Thomas, Kelly; Chiavacci, Rosetta M.; Grant, Struan F. A.; Sleiman, Patrick M. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Martin, Lisa J.] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp, Div Human Genet,Med Ctr, Cincinnati, OH 45221 USA; [Liacouras, Chris; Verma, Ritu] Childrens Hosp Philadelphia, Div Gastroenterol & Nutr, Philadelphia, PA 19104 USA; [Aceves, Seema] Univ Calif San Diego, Div Allergy & Immunol, Riley Hosp Children, San Diego, CA 92103 USA; [Collins, Margaret H.] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp, Div Pathol,Med Ctr, Cincinnati, OH 45221 USA; [Putnam, Phil E.; Franciosi, James P.] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp, Div Gastroenterol Hepatol & Nutr,Med Ctr, Cincinnati, OH 45221 USA; [Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of California System; University of California San Diego; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Hakonarson, H (corresponding author), Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA.	hakonarson@chop.edu	Martin, Lisa/E-2425-2016; Sherrill, Joseph/B-6662-2014	Martin, Lisa/0000-0001-8702-9946; Grant, Struan/0000-0003-2025-5302; Glessner, Joseph/0000-0001-5131-2811; Abonia, Juan/0000-0003-3788-6485; Spergel, Jonathan/0000-0002-4658-5353	US National Institutes of Health (NIH) [U19 AI070235, NIH R01 DK076893]; Food Allergy Project; Campaign Urging Research for Eosinophilic Disorders (CURED) Foundation; American Partnership for Eosinophilic Disorders (APFED); Children's Hospital of Philadelphia; Buckeye Foundation; Coltswold Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070235, R01AI083450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076893] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Food Allergy Project; Campaign Urging Research for Eosinophilic Disorders (CURED) Foundation; American Partnership for Eosinophilic Disorders (APFED); Children's Hospital of Philadelphia; Buckeye Foundation; Coltswold Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all of the participating families and subjects. We thank B. Buckmeier, A. Ahrens, S. Jameson, M. Palazzolo, H. Foote, M. Mingler, M. Shuker and E. Stucke for assistance with patient enrollment, DNA preparation and/or database management. This work was supported in part by US National Institutes of Health (NIH) U19 AI070235, NIH R01 DK076893, Food Allergy Project, Campaign Urging Research for Eosinophilic Disorders (CURED) Foundation, American Partnership for Eosinophilic Disorders (APFED), The Children's Hospital of Philadelphia Chair's Institutive, the Buckeye Foundation and the Coltswold Foundation. All genome-wide genotyping was funded by an Institute Development Award to the Center for Applied Genomics from the Children's Hospital of Philadelphia.	Akei HS, 2005, GASTROENTEROLOGY, V129, P985, DOI 10.1053/j.gastro.2005.06.027; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Blanchard C, 2007, J ALLERGY CLIN IMMUN, V120, P1292, DOI 10.1016/j.jaci.2007.10.024; Challa Pratap, 2008, Int Ophthalmol Clin, V48, P73, DOI 10.1097/IIO.0b013e318187e71a; Collins MH, 2008, CLIN GASTROENTEROL H, V6, P621, DOI 10.1016/j.cgh.2008.01.004; Furuta GT, 2007, GASTROENTEROLOGY, V133, P1342, DOI 10.1053/j.gastro.2007.08.017; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Konikoff MR, 2006, CLIN GASTROENTEROL H, V4, P1328, DOI 10.1016/j.cgh.2006.08.013; Liu YJ, 2009, ADV IMMUNOL, V101, P1, DOI 10.1016/S0065-2776(08)01001-8; Malerba G, 2000, AM J RESP CRIT CARE, V162, P1587, DOI 10.1164/ajrccm.162.4.9909031; Noel RJ, 2004, NEW ENGL J MED, V351, P940, DOI 10.1056/NEJM200408263510924; Oyoshi MK, 2009, ADV IMMUNOL, V102, P135, DOI 10.1016/S0065-2776(09)01203-6; Spergel JM, 2007, J ALLERGY CLIN IMMUN, V119, P509, DOI 10.1016/j.jaci.2006.11.016; Tonozuka Y, 2001, CYTOGENET CELL GENET, V93, P23, DOI 10.1159/000056941	14	298	309	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2010	42	4					289	291		10.1038/ng.547	http://dx.doi.org/10.1038/ng.547			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	576NE	20208534	Green Accepted			2022-12-17	WOS:000276150500006
J	Gudmundsson, J; Sulem, P; Rafnar, T; Bergthorsson, JT; Manolescu, A; Gudbjartsson, D; Agnarsson, BA; Sigurdsson, A; Benediktsdottir, KR; Blondal, T; Jakobsdottir, M; Stacey, SN; Kostic, J; Kristinsson, KT; Birgisdottir, B; Ghosh, S; Magnusdottir, DN; Thorlacius, S; Thorleifsson, G; Zheng, SL; Sun, J; Chang, BL; Elmore, JB; Breyer, JP; McReynolds, KM; Bradley, KM; Yaspan, BL; Wiklund, F; Stattin, P; Lindstrom, S; Adami, HO; McDonnell, SK; Schaid, DJ; Cunningham, JM; Wang, L; Cerhan, JR; St Sauver, JL; Isaacs, SD; Wiley, KE; Partin, AW; Walsh, PC; Polo, S; Ruiz-Echarri, M; Navarrete, S; Fuertes, F; Saez, B; Godino, J; Weijerman, PC; Swinkels, DW; Aben, KK; Witjes, JA; Suarez, BK; Helfand, BT; Frigge, ML; Kristjansson, K; Ober, C; Jonsson, E; Einarsson, GV; Xu, JF; Gronberg, H; Smith, JR; Thibodeau, SN; Isaacs, WB; Catalona, WJ; Mayordomo, JI; Kiemeney, LA; Barkardottir, RB; Gulcher, JR; Thorsteinsdottir, U; Kong, A; Stefansson, K				Gudmundsson, Julius; Sulem, Patrick; Rafnar, Thorunn; Bergthorsson, Jon T.; Manolescu, Andrei; Gudbjartsson, Daniel; Agnarsson, Bjarni A.; Sigurdsson, Asgeir; Benediktsdottir, Kristrun R.; Blondal, Thorarinn; Jakobsdottir, Margret; Stacey, Simon N.; Kostic, Jelena; Kristinsson, Kari T.; Birgisdottir, Birgitta; Ghosh, Shyamali; Magnusdottir, Droplaug N.; Thorlacius, Steinunn; Thorleifsson, Gudmar; Zheng, S. Lilly; Sun, Jielin; Chang, Bao-Li; Elmore, J. Bradford; Breyer, Joan P.; McReynolds, Kate M.; Bradley, Kevin M.; Yaspan, Brian L.; Wiklund, Fredrik; Stattin, Par; Lindstrom, Sara; Adami, Hans-Olov; McDonnell, Shannon K.; Schaid, Daniel J.; Cunningham, Julie M.; Wang, Liang; Cerhan, James R.; St Sauver, Jennifer L.; Isaacs, Sara D.; Wiley, Kathleen E.; Partin, Alan W.; Walsh, Patrick C.; Polo, Sonia; Ruiz-Echarri, Manuel; Navarrete, Sebastian; Fuertes, Fernando; Saez, Berta; Godino, Javier; Weijerman, Philip C.; Swinkels, Dorine W.; Aben, Katja K.; Witjes, J. Alfred; Suarez, Brian K.; Helfand, Brian T.; Frigge, Michael L.; Kristjansson, Kristleifur; Ober, Carole; Jonsson, Eirikur; Einarsson, Gudmundur V.; Xu, Jianfeng; Gronberg, Henrik; Smith, Jeffrey R.; Thibodeau, Stephen N.; Isaacs, William B.; Catalona, William J.; Mayordomo, Jose I.; Kiemeney, Lambertus A.; Barkardottir, Rosa B.; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari			Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer	NATURE GENETICS			English	Article							P75 NEUROTROPHIN RECEPTOR; PROTEIN; RISK; NRAGE	We conducted a genome-wide SNP association study on prostate cancer on over 23,000 Icelanders, followed by a replication study including over 15,500 individuals from Europe and the United States. Two newly identified variants were shown to be associated with prostate cancer: rs5945572 on Xp11.22 and rs721048 on 2p15 (odds ratios (OR) = 1.23 and 1.15; P = 3.9 x 10(-13) and 7.7 x 10(-9), respectively). The 2p15 variant shows a significantly stronger association with more aggressive, rather than less aggressive, forms of the disease.	[Gudmundsson, Julius; Sulem, Patrick; Rafnar, Thorunn; Bergthorsson, Jon T.; Manolescu, Andrei; Gudbjartsson, Daniel; Sigurdsson, Asgeir; Blondal, Thorarinn; Jakobsdottir, Margret; Stacey, Simon N.; Kostic, Jelena; Kristinsson, Kari T.; Birgisdottir, Birgitta; Ghosh, Shyamali; Magnusdottir, Droplaug N.; Thorlacius, Steinunn; Thorleifsson, Gudmar; Frigge, Michael L.; Kristjansson, Kristleifur; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Agnarsson, Bjarni A.; Benediktsdottir, Kristrun R.; Barkardottir, Rosa B.] Landspitali Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; [Zheng, S. Lilly; Sun, Jielin; Chang, Bao-Li; Xu, Jianfeng] Wake Forest Univ, Sch Med, Ctr Human Genome, Winston Salem, NC 27157 USA; [Elmore, J. Bradford; Breyer, Joan P.; McReynolds, Kate M.; Bradley, Kevin M.; Yaspan, Brian L.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN 37232 USA; [Lindstrom, Sara; Adami, Hans-Olov] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Stattin, Par] Umea Univ Hosp, Dept Urol, S-90185 Umea, Sweden; [Adami, Hans-Olov] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [McDonnell, Shannon K.; Schaid, Daniel J.; Cerhan, James R.; St Sauver, Jennifer L.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Cunningham, Julie M.; Wang, Liang; Thibodeau, Stephen N.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Isaacs, Sara D.; Wiley, Kathleen E.; Partin, Alan W.; Walsh, Patrick C.; Isaacs, William B.] Johns Hopkins Med Inst, Brady Urol Inst, Baltimore, MD 21209 USA; [Polo, Sonia] Quiron Hosp, Div Radiat Oncol, Zaragoza 50009, Spain; [Ruiz-Echarri, Manuel; Mayordomo, Jose I.] Univ Zaragoza, Lozano Blesa Univ Hosp, Div Med Oncol, E-50009 Zaragoza, Spain; [Navarrete, Sebastian; Fuertes, Fernando] Univ Zaragoza, Lozano Blesa Univ Hosp, Div Radiat Oncol, E-50009 Zaragoza, Spain; [Saez, Berta; Godino, Javier; Mayordomo, Jose I.] Hlth Sci Inst, Zaragoza 50009, Spain; [Saez, Berta; Mayordomo, Jose I.] Nanotechnol Inst Aragon, Zaragoza 50009, Spain; [Weijerman, Philip C.] Rijinstate Hosp, Dept Urol, NL-6800 TA Arnhem, Netherlands; [Swinkels, Dorine W.] Radboud Univ Nijmegen, Med Ctr, Dept Clin Chem, NL-6500 HB Nijmegen, Netherlands; [Aben, Katja K.; Kiemeney, Lambertus A.] Comprehens Canc Ctr E, NL-6501 BG Nijmegen, Netherlands; [Aben, Katja K.] Radboud Univ Nijmegen, Dept Epidemiol & Biostat, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Witjes, J. Alfred; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6500 HB Nijmegen, Netherlands; [Suarez, Brian K.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Helfand, Brian T.; Catalona, William J.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Jonsson, Eirikur; Einarsson, Gudmundur V.] Landspitali Univ Hosp, Dept Urol, Reykjavik 101, Iceland; [Smith, Jeffrey R.] VA Tennessee Valley Hlthcare Syst, Med Res Serv, Nashville, TN 37212 USA	Landspitali National University Hospital; Wake Forest University; Vanderbilt University; Karolinska Institutet; Umea University; Harvard University; Harvard T.H. Chan School of Public Health; Mayo Clinic; Mayo Clinic; Johns Hopkins University; Johns Hopkins Medicine; Lozano Blesa University Clinical Hospital; University of Zaragoza; Lozano Blesa University Clinical Hospital; University of Zaragoza; Rijnstate Hospital; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Washington University (WUSTL); Northwestern University; Feinberg School of Medicine; University of Chicago; Landspitali National University Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Gudmundsson, J (corresponding author), deCODE Genet, IS-101 Reykjavik, Iceland.	julius@decode.is; kstefans@decode.is	Witjes, Fred/N-9665-2013; Swinkels, Dorine W./H-8098-2014; Godino, Javier/M-3753-2018; Aben, Katja KH/G-9686-2016; Manolescu, Andrei/G-4565-2014; Stefansson, Kari/AAE-7187-2019; Mayordomo, Jose/K-3453-2013; Kiemeney, Lambertus A./D-3357-2009; Smith, Jeff/C-3484-2012	Swinkels, Dorine W./0000-0002-1040-9446; Godino, Javier/0000-0002-5653-2722; Aben, Katja KH/0000-0002-0214-2147; Manolescu, Andrei/0000-0002-0713-4664; Kiemeney, Lambertus A./0000-0002-2368-1326; Yaspan, Brian/0000-0002-3787-2510; Bergthorsson, Jon Thor/0000-0002-0560-2639; Kong, Augustine/0000-0001-8193-5438; Gudbjartsson, Daniel/0000-0002-5222-9857; Saez, Berta/0000-0003-0753-1165; St Sauver, Jennifer/0000-0002-9789-8544; McDonnell, Shannon/0000-0001-6201-369X; Smith, Jeffrey/0000-0001-8424-910X; Cerhan, James/0000-0002-7482-178X; Ober, Carole/0000-0003-4626-9809	NCI NIH HHS [U01 CA086323, CA105055, CA95052, CA86323, P50 CA058236, CA106523, R01 CA106523, R01 CA095052, R01 CA105055, CA112517, CA58236, R01 CA112517, R01 CA112517-01A1] Funding Source: Medline; NCRR NIH HHS [UL1 RR025741] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA112517, R01CA105055, U01CA086323, R01CA106523, P50CA058236, R01CA095052] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Dubois E, 2002, J BIOL CHEM, V277, P23755, DOI 10.1074/jbc.M202206200; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hidaka K, 2002, J BIOL CHEM, V277, P32730, DOI 10.1074/jbc.M205476200; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; Morrison BH, 2001, J BIOL CHEM, V276, P24965, DOI 10.1074/jbc.M101161200; NAROD SA, 1995, NAT MED, V1, P99, DOI 10.1038/nm0295-99; Salehi AH, 2000, NEURON, V27, P279, DOI 10.1016/S0896-6273(00)00036-2; Salehi AH, 2002, J BIOL CHEM, V277, P48043, DOI 10.1074/jbc.M205324200; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	13	298	316	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2008	40	3					281	283		10.1038/ng.89	http://dx.doi.org/10.1038/ng.89			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18264098	Green Accepted			2022-12-17	WOS:000253548400016
J	Cooper, MK; Wassif, CA; Krakowiak, PA; Taipale, J; Gong, RY; Kelley, RI; Porter, FD; Beachy, PA				Cooper, MK; Wassif, CA; Krakowiak, PA; Taipale, J; Gong, RY; Kelley, RI; Porter, FD; Beachy, PA			A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis	NATURE GENETICS			English	Article							LEMLI-OPITZ-SYNDROME; A REDUCTASE-ACTIVITY; FLOOR PLATE; INHIBITION; FIBROBLASTS; CYCLOPAMINE; BINDING; CYCLODEXTRINS; INDUCTION; PROTEINS	Smith-Lemli-Opitz syndrome (SLOS), desmosterolosis and lathosterolosis are human syndromes caused by defects in the final stages of cholesterol biosynthesis. Many of the developmental malformations in these syndromes occur in tissues and structures whose embryonic patterning depends on signaling by the Hedgehog (Hh) family of secreted proteins. Here we report that response to the Hh signal is compromised in mutant cells from mouse models of SLOS and lathosterolosis and in normal cells pharmacologically depleted of sterols. We show that decreasing levels of cellular sterols correlate with diminishing responsiveness to the Hh signal. This diminished response occurs at sterol levels sufficient for normal autoprocessing of Hh protein, which requires cholesterol as cofactor and covalent adduct. We further find that sterol depletion affects the activity of Smoothened (Smo), an essential component of the Hh signal transduction apparatus.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Howard Hughes Med Inst, Baltimore, MD 21205 USA; NICHHD, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA; Kennedy Krieger Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Kennedy Krieger Institute	Beachy, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.			Wassif, Christopher/0000-0002-2524-1420	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000139] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000139] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Beachy PA, 1997, COLD SPRING HARB SYM, V62, P191; BITTMAN R, 1972, P NATL ACAD SCI USA, V69, P3795, DOI 10.1073/pnas.69.12.3795; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Clayton P, 1996, LANCET, V348, P404, DOI 10.1016/S0140-6736(05)65020-9; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; DONNAI D, 1987, AM J MED GENET, V28, P741, DOI 10.1002/ajmg.1320280323; GIBSON KM, 1990, J LIPID RES, V31, P515; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Guy RK, 2000, P NATL ACAD SCI USA, V97, P7307, DOI 10.1073/pnas.97.13.7307; Incardona JP, 2000, DEV BIOL, V224, P440, DOI 10.1006/dbio.2000.9775; Ingham PW, 2001, SCIENCE, V294, P1879, DOI 10.1126/science.1064115; Kelley R I, 2000, Adv Pediatr, V47, P1; KELLEY RI, 1995, CLIN CHIM ACTA, V236, P45, DOI 10.1016/0009-8981(95)06038-4; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; MATSUNAGA E, 1977, TERATOLOGY, V16, P261, DOI 10.1002/tera.1420160304; Nowaczyk MJM, 2001, AM J MED GENET, V102, P18, DOI 10.1002/1096-8628(20010722)102:1<18::AID-AJMG1376>3.0.CO;2-E; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; PARNES S, 1990, AM J MED GENET, V35, P397, DOI 10.1002/ajmg.1320350317; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wassink TH, 2001, PSYCHIAT GENET, V11, P57, DOI 10.1097/00041444-200106000-00001	30	298	307	1	18	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					508	513		10.1038/ng1134	http://dx.doi.org/10.1038/ng1134			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12652302	Bronze			2022-12-17	WOS:000181928600023
J	Kurima, K; Peters, LM; Yang, YD; Riazuddin, S; Ahmed, ZM; Naz, S; Arnaud, D; Drury, S; Mo, JH; Makishima, T; Ghosh, M; Menon, PSN; Deshmukh, D; Oddoux, C; Ostrer, H; Khan, S; Riazuddin, S; Deininger, PL; Hampton, LL; Sullivan, SL; Battey, JF; Keats, BJB; Wilcox, ER; Friedman, TB; Griffith, AJ				Kurima, K; Peters, LM; Yang, YD; Riazuddin, S; Ahmed, ZM; Naz, S; Arnaud, D; Drury, S; Mo, JH; Makishima, T; Ghosh, M; Menon, PSN; Deshmukh, D; Oddoux, C; Ostrer, H; Khan, S; Riazuddin, S; Deininger, PL; Hampton, LL; Sullivan, SL; Battey, JF; Keats, BJB; Wilcox, ER; Friedman, TB; Griffith, AJ			Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function	NATURE GENETICS			English	Article							INNER-EAR; LOCUS DN; MOUSE; CHROMOSOME-19; SENSITIVITY; DFNB3; MICE	Positional cloning of hereditary deafness genes is a direct approach to identify molecules and mechanisms underlying auditory function. Here we report a locus for dominant deafness, DFNA36, which maps to human chromosome 9q13-21 in a region overlapping the DFNB7/B11 locus for recessive deafness. We identified eight mutations in a new gene, transmembrane cochlear-expressed gene 1 (TMC1), in a DFNA36 family and eleven DFNB7/B11 families. We detected a 1.6-kb genomic deletion encompassing exon 14 of Tmc1 in the recessive deafness (dn) mouse mutant, which lacks auditory responses and has hair-cell degeneration(1,2). TMC1 and TMC2 on chromosome 20p13 are members of a gene family predicted to encode transmembrane proteins. Tmc1 mRNA is expressed in hair cells of the postnatal mouse cochlea and vestibular end organs and is required for normal function of cochlear hair cells.	Natl Inst Deafness & Other Commun Disorders, Sect Gene Struct & Funct, Mol Genet Lab, NIH, Rockville, MD 20850 USA; Natl Inst Deafness & Other Commun Disorders, Sect Human Genet, Mol Genet Lab, NIH, Rockville, MD 20850 USA; Univ Punjab, Ctr Excellence Mol Biol, Lahore, Pakistan; Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA; All India Inst Med Sci, Dept Pediat, Genet Unit, New Delhi, India; Rotary Deaf Sch, Ichalkaranji Tilawani, Maharashtra, India; NYU, Sch Med, Dept Pediat, Human Genet Program, New York, NY USA; Tulane Univ, Med Ctr, Dept Environm Hlth Sci, New Orleans, LA USA; NINCDS, G Prot Coupled Receptors Sect, NIH, Bethesda, MD 20892 USA; Natl Inst Deafness & Other Commun Disorders, Mol Neurosci Sect, NIH, Rockville, MD 20850 USA; Natl Inst Deafness & Other Commun Disorders, Hearing Sect, NIH, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Punjab; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; All India Institute of Medical Sciences (AIIMS) New Delhi; New York University; Tulane University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Griffith, AJ (corresponding author), Natl Inst Deafness & Other Commun Disorders, Sect Gene Struct & Funct, Mol Genet Lab, NIH, 5 Res Court, Rockville, MD 20850 USA.		Naz, Sadaf/C-3911-2019; Makishima, Tomoko/L-2439-2019; naz, sadaf/F-4406-2015; Drury, Stacy/O-9181-2017; Peters, Linda/P-5370-2018	Naz, Sadaf/0000-0002-1912-0235; Makishima, Tomoko/0000-0003-3397-6395; Drury, Stacy/0000-0001-5950-0091; Deininger, Prescott/0000-0002-1067-3028; Peters, Linda/0000-0002-9961-4293	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000039, ZIADC000048, Z01DC000039, Z01DC000035, ZIADC000060, Z01DC000048, Z01DC000060] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; Ashmore JF, 2001, CURR OPIN NEUROBIOL, V11, P449, DOI 10.1016/S0959-4388(00)00233-6; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; BOCK GR, 1983, ACTA OTO-LARYNGOL, V96, P39, DOI 10.3109/00016488309132873; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; DEOL M. S., 1958, HEREDITY, V12, P463, DOI 10.1038/hdy.1958.46; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Griffith AJ, 1999, NAT GENET, V21, P347, DOI 10.1038/7668; Huang JM, 1998, HEARING RES, V117, P24, DOI 10.1016/S0378-5955(98)00005-7; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; JAIN PK, 1995, HUM MOL GENET, V4, P2391, DOI 10.1093/hmg/4.12.2391; KEATS BJB, 1995, MAMM GENOME, V6, P8, DOI 10.1007/BF00350886; Kiernan AE, 1999, J NEUROCYTOL, V28, P969, DOI 10.1023/A:1007090626294; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Liang Y, 1999, GENOMICS, V61, P243, DOI 10.1006/geno.1999.5976; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; PUJOL R, 1983, HEARING RES, V12, P57, DOI 10.1016/0378-5955(83)90118-1; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rivolta MN, 1998, P ROY SOC B-BIOL SCI, V265, P1595, DOI 10.1098/rspb.1998.0477; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; SASSOON DA, 1988, DEVELOPMENT, V104, P155; Scott DA, 2000, GENE, V246, P265, DOI 10.1016/S0378-1119(00)00090-1; Scott DA, 1996, AM J HUM GENET, V59, P385; STEEL KP, 1980, NATURE, V288, P159, DOI 10.1038/288159a0; Suzuki Y, 2000, GENOMICS, V64, P286, DOI 10.1006/geno.2000.6076; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Verpy E, 2001, NAT GENET, V29, P345, DOI 10.1038/ng726; Vinas AM, 1998, BBA-MOL BASIS DIS, V1407, P257, DOI 10.1016/S0925-4439(98)00050-7; Vreugde S, 2002, NAT GENET, V30, P257, DOI 10.1038/ng848; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8	36	298	319	2	32	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					277	284		10.1038/ng842	http://dx.doi.org/10.1038/ng842			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11850618	Green Published			2022-12-17	WOS:000174157600011
J	Brown, JR; Douady, CJ; Italia, MJ; Marshall, WE; Stanhope, MJ				Brown, JR; Douady, CJ; Italia, MJ; Marshall, WE; Stanhope, MJ			Universal trees based on large combined protein sequence data sets	NATURE GENETICS			English	Letter							ORIGIN; GENE; LIFE; CLASSIFICATION; MITOCHONDRIAL; EUKARYOTES; EVOLUTION; BACTERIA; SUPPORT; ARCHAEA	Universal trees of life based on small-subunit (SSU) ribosomal RNA (rRNA) support the separate mono/holophyly of the domains Archaea (archaebacteria), Bacteria (eubacteria) and Eucarya (eukaryotes) and the placement of extreme thermophiles at the base of the Bacteria(1-4). The concept of universal tree reconstruction recently has been upset by protein trees that show intermixing of species from different domains(5,6). Such tree topologies have been attributed to either extensive horizontal gene transfer(7) or degradation of phylogenetic signals because of saturation for amino acid substitutions(8). Here we use large combined alignments of 23 orthologous proteins conserved across 45 species from all domains to construct highly robust universal trees. Although individual protein trees are variable in their support of domain integrity, trees based on combined protein data sets strongly support separate monophyletic domains. Within the Bacteria, we placed spirochaetes as the earliest derived bacterial group. However, elimination from the combined protein alignment of nine protein data sets, which were likely candidates for horizontal gene transfer, resulted in trees showing thermophiles as the earliest evolved bacterial lineage. Thus, combined protein universal trees are highly congruent with SSU rRNA trees in their strong support for the separate monophyly of domains as well as the early evolution of thermophilic Bacteria.	GlaxoSmithKline, Antimicrobial Bioinformat Grp, Collegeville, PA 19426 USA	GlaxoSmithKline	Brown, JR (corresponding author), GlaxoSmithKline, Antimicrobial Bioinformat Grp, 1250 S Collegeville Rd,UP1345 POB 5089, Collegeville, PA 19426 USA.	James_R_Brown@gsk.com	Douady, Christophe/N-3069-2019; Douady, Christophe J/N-1357-2014; Puigbò, Pere/A-2214-2008	Douady, Christophe/0000-0002-4503-8040; Douady, Christophe J/0000-0002-4503-8040; Italia, Michael/0000-0002-6941-6181				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Bond JP, 2000, J MOL EVOL, V50, P339, DOI 10.1007/s002399910037; Brown JR, 1998, CURR BIOL, V8, pR365, DOI 10.1016/S0960-9822(98)70238-6; Brown JR, 1997, MICROBIOL MOL BIOL R, V61, P456, DOI 10.1128/.61.4.456-502.1997; Chihade JW, 2000, P NATL ACAD SCI USA, V97, P12153, DOI 10.1073/pnas.220388797; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; FELSENSTEIN J, 2000, PHYLIP PHYLONGENY IN; Forterre P, 1999, BIOESSAYS, V21, P871, DOI 10.1002/(SICI)1521-1878(199910)21:10<871::AID-BIES10>3.0.CO;2-Q; FOX GE, 1977, P NATL ACAD SCI USA, V74, P4537, DOI 10.1073/pnas.74.10.4537; Galtier N, 1999, SCIENCE, V283, P220, DOI 10.1126/science.283.5399.220; GOLDING GB, 1995, MOL BIOL EVOL, V12, P1; GRAY MW, 1992, INT REV CYTOL, V141, P233, DOI 10.1016/S0074-7696(08)62068-9; Hassanin A, 1998, CR ACAD SCI III-VIE, V321, P611, DOI 10.1016/S0764-4469(98)80464-2; Ibba M, 1997, SCIENCE, V278, P1119, DOI 10.1126/science.278.5340.1119; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; Logsdon JM, 1999, CURR BIOL, V9, pR747, DOI 10.1016/S0960-9822(99)80474-6; Miller SL, 1995, J MOL EVOL, V41, P689; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; PACE NR, 1991, CELL, V65, P531, DOI 10.1016/0092-8674(91)90082-A; RIVERA MC, 1992, SCIENCE, V257, P74, DOI 10.1126/science.1621096; Shah HN, 1997, REV MED MICROBIOL, V8, P103; Springer MS, 1999, SYST BIOL, V48, P65, DOI 10.1080/106351599260445; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; Teichmann SA, 1999, J MOL EVOL, V49, P98, DOI 10.1007/PL00006538; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Xiong J, 1998, P NATL ACAD SCI USA, V95, P14851, DOI 10.1073/pnas.95.25.14851	30	298	313	0	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2001	28	3					281	285		10.1038/90129	http://dx.doi.org/10.1038/90129			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431701				2022-12-17	WOS:000169656400023
J	Dawkins, JL; Hulme, DJ; Brahmbhatt, SB; Auer-Grumbach, M; Nicholson, GA				Dawkins, JL; Hulme, DJ; Brahmbhatt, SB; Auer-Grumbach, M; Nicholson, GA			Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I	NATURE GENETICS			English	Letter							SPHINGOLIPID SYNTHESIS; CHROMOSOME 9Q22.1-Q22.3; BIOSYNTHESIS; INHIBITION; APOPTOSIS; LINKAGE; ENZYME; CELLS; LOCI; GENE	Hereditary sensory neuropathy type I (HSN1) is the most common hereditary disorder of peripheral sensory neurons. HSN1 is an autosomal dominant progressive degeneration of dorsal root ganglia and motor neurons with onset in the second or third decades. Initial symptoms are sensory loss in the feet followed by distal muscle wasting and weakness. Loss of pain sensation leads to chronic: skin ulcers and distal amputations(1,2). The HSN1 locus has been mapped to chromosome 9q22.1-22.3 (refs. 3,4). Here we map the gene SPTLC1, encoding serine palmitoyltransferase. long chain base subunit-l. to this locus. Mutation screening revealed 3 different missense mutations resulting in changes to 2 amino acids in all affected members of 11 HSN1 families. We found two mutations to be located in exon 5 (C133Y and C133W) and one mutation to be located in exon 6 of SPTLC1 (V144D). All families showing definite or probable linkage to chromosome 9 had mutations in these two exons. These mutations are associated with increased de novo glucosyl ceramide synthesis in lymphoblast cell lines in affected individuals. Increased de novo ceramide synthesis triggers apoptosis(5,6) and is associated with massive cell death during neural tube closure(7), raising the possibility that neural degeneration in HSN1 is due to ceramide-induced apoptotic cell death.	Univ Sydney, Concord Hosp, Anzac Res Inst, Neurobiol Lab, Concord, NSW, Australia; Karl Franzens Univ Graz, Dept Neurol, Graz, Austria	Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; University of Graz	Nicholson, GA (corresponding author), Univ Sydney, Concord Hosp, Anzac Res Inst, Neurobiol Lab, Concord, NSW, Australia.		Research Institute, ANZAC/CAE-9030-2022; Ekanayake, Kanchana/P-8817-2016	Nicholson, Garth/0000-0001-9694-066X				AndreuttiZaugg C, 1997, CANCER RES, V57, P3288; Auer-Grumbach M, 2000, NEUROLOGY, V54, P45, DOI 10.1212/WNL.54.1.45; Bejaoui K, 1999, NEUROLOGY, V52, P510, DOI 10.1212/WNL.52.3.510; Blair IP, 1998, GENOMICS, V51, P277, DOI 10.1006/geno.1998.5373; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Dyck P. J., 1993, PERIPHERAL NEUROPATH, V3rd, P1065; Hanada K, 1997, J BIOL CHEM, V272, P32108, DOI 10.1074/jbc.272.51.32108; Herget T, 2000, J BIOL CHEM, V275, P30344, DOI 10.1074/jbc.M000714200; MATHEWS CK, 1990, BIOCHEMISTRY, V617; MEDLOCK KA, 1988, BIOCHEMISTRY-US, V27, P7079, DOI 10.1021/bi00418a061; Merrill AH, 1997, TOXICOL APPL PHARM, V142, P208, DOI 10.1006/taap.1996.8029; Nagiec MM, 1996, GENE, V177, P237, DOI 10.1016/0378-1119(96)00309-5; Nicholson GA, 1996, NAT GENET, V13, P101, DOI 10.1038/ng0596-101; Perry DK, 2000, J BIOL CHEM, V275, P9078, DOI 10.1074/jbc.275.12.9078; SARKAR G, 1992, GENOMICS, V13, P441, DOI 10.1016/0888-7543(92)90266-U; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; SNELL EE, 1970, CHEM PHYS LIPIDS, V5, P116, DOI 10.1016/0009-3084(70)90013-7; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; THOMAS PK, 1993, BRAIN PATHOL, V3, P157, DOI 10.1111/j.1750-3639.1993.tb00740.x; Weiss B, 1997, EUR J BIOCHEM, V249, P239, DOI 10.1111/j.1432-1033.1997.00239.x	20	298	311	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2001	27	3					309	312		10.1038/85879	http://dx.doi.org/10.1038/85879			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242114				2022-12-17	WOS:000167304200024
J	Xu, X; Toselli, PA; Russell, LD; Seldin, DC				Xu, X; Toselli, PA; Russell, LD; Seldin, DC			Globozoospermia in mice lacking the casein kinase II alpha ' catalytic subunit	NATURE GENETICS			English	Article							HEADED HUMAN SPERMATOZOA; DEFICIENT MICE; SPERMATOGENESIS; SPERMIOGENESIS; MANCHETTE; NUCLEAR; CELLS; GENE	Protein kinase casein kinase II (Ck2) is a cyclic-AMP and calcium-independent serine-threonine kinase that is composed of two catalytic subunits (alpha and alpha') and two regulatory beta-subunits. Ck2 is not a casein kinase in vivo, but over 100 substrates are known(1). The highly conserved amino acid sequences of its subunits(2, 3) and their broad expression suggest that Ck2 may have a fundamental role in cell function. Ck2 has been implicated in DNA replication, regulation of basal and inducible transcription, translation and control of metabolism. The Ck2 alpha and Ck2 alpha' isoforms (products of the genes Csnk2a1 and Csnk2a2, respectively) are highly homologous, but the reason for their redundancy and evolutionary conservation is unknown. We find here that Csnk2a2 is preferentially expressed in late stages of spermatogenesis, and male mice in which Csnk2a2 has been disrupted are infertile, with oligospermia and globozoospermia ('round-headed' spermatozoa). This is the first demonstration of a unique role for a Ck2 isoform in development. The primary spermatogenic defect in Csnk2a2(-/-) testis is a specific abnormality of anterior head shaping of elongating spermatids; this is the first defined gene that regulates sperm head morphogenesis. As the germ cells differentiate, they are capable of undergoing chromatin condensation, although many abnormal cells are deleted through apoptosis or Sertoli cell phagocytosis. The few that survive to populate the epididymis exhibit head abnormalities similar to those described in human globozoospermia, thus Csnk2a2 may be a candidate gene for these inherited syndromes.	Boston Med Ctr, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA	Boston Medical Center; Boston University; Southern Illinois University System; Southern Illinois University	Seldin, DC (corresponding author), Boston Med Ctr, Dept Med, Boston, MA 02118 USA.	dseldin@med-med1.bu.edu		Seldin, David C/0000-0003-0168-2333				Baccetti B, 1996, J SUBMICR CYTOL PATH, V28, P587; BACCETTI B, 1977, ANDROLOGIA, V9, P255; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; BURGOYNE PS, 1992, CELL, V71, P391, DOI 10.1016/0092-8674(92)90509-B; CASTELLANI L, 1978, ARCH ANDROLOGY, V1, P291, DOI 10.3109/01485017808988349; CHESTER N, 1995, J BIOL CHEM, V270, P7501, DOI 10.1074/jbc.270.13.7501; COLE A, 1988, BIOL REPROD, V38, P385, DOI 10.1095/biolreprod38.2.385; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; ESCALIER D, 1990, International Journal of Developmental Biology, V34, P287; FAWCETT DW, 1971, DEV BIOL, V26, P220, DOI 10.1016/0012-1606(71)90124-2; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Mudgal P, 1998, MOL REPROD DEV, V50, P178, DOI 10.1002/(SICI)1098-2795(199806)50:2&lt;178::AID-MRD8&gt;3.0.CO;2-H; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; Ross AJ, 1998, NAT GENET, V18, P251, DOI 10.1038/ng0398-251; Rubes J, 1998, FERTIL STERIL, V70, P715, DOI 10.1016/S0015-0282(98)00261-1; RUSSELL LD, 1991, AM J ANAT, V192, P97, DOI 10.1002/aja.1001920202; Russo R. O., 1990, Journal of Sustainable Agriculture, V1, P19, DOI 10.1300/J064v01n02_04; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; SINGH G, 1992, INT J FERTIL, V37, P99; Tawfic S, 1999, J CELL BIOCHEM, V72, P242; TOPPARI J, 1988, CYTOMETRY, V9, P456, DOI 10.1002/cyto.990090509; Toscani A, 1997, NATURE, V386, P713, DOI 10.1038/386713a0; TOSELLI P, 1994, LIFE SCI, V55, P621, DOI 10.1016/0024-3205(94)00488-9; VONBERNHARDI R, 1990, ANDROLOGIA, V22, P12; Ward WS, 1999, BIOL REPROD, V60, P702, DOI 10.1095/biolreprod60.3.702; Xu X, 1998, GENOMICS, V48, P79, DOI 10.1006/geno.1997.5154	26	298	314	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1999	23	1					118	121		10.1038/12729	http://dx.doi.org/10.1038/12729			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	231XU	10471512				2022-12-17	WOS:000082337300029
J	Cheng, SWG; Davies, KP; Yung, E; Beltran, RJ; Yu, J; Kalpana, GV				Cheng, SWG; Davies, KP; Yung, E; Beltran, RJ; Yu, J; Kalpana, GV			c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function	NATURE GENETICS			English	Article							TRANSCRIPTIONAL REPRESSION; PROTEIN; GROWTH; TRANSFORMATION; INTEGRASE; MACHINES; NETWORK; DOMAIN; SNF5	Chromatin organization plays a key role in the regulation of gene expression(1,2). The evolutionarily conserved SWI/SNF complex is one of several multiprotein complexes that activate transcription by remodelling chromatin in an ATP-dependent manner(3-5). SWI2/SNF2 is an ATPase whose homologues, BRG1 and hBRM, mediate cell-cycle arrest(6,7); the SNF5 homologue, INI1/hSNF5, appears to be a tumour suppressor(8,9). A search for INI1-interacting proteins using the two-hybrid system(10,11) led to the isolation of c-MYC, a transactivator(12,13). The c-MYC-INI1 interaction was observed both in vitro and in vivo. The c-MYC basic helix-loop-helix (bHLH) and leucine zipper (Zip) domains and the INI1 repeat 1 (Rpt1) region were required for this interaction. c-MYC-mediated transactivation was inhibited by a deletion fragment of INI1 and the ATPase mutant of BRG1/hSNF2 in a dominant-negative manner contingent upon the presence of the c-MYC bHLH-Zip domain. Our results suggest that the SWI/SNF complex is necessary for c-MYC-mediated transactivation and that the c-MYC-INI1 interaction helps recruit the complex.	Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA	Yeshiva University; Albert Einstein College of Medicine; Columbia University	Kalpana, GV (corresponding author), Albert Einstein Coll Med, Dept Mol Genet, 1300 Morris Pk Ave,U821, Bronx, NY 10461 USA.	kalpana@aecom.yu.edu		Yung, Eric/0000-0002-7328-7204; Davies, Kelvin/0000-0002-0201-9210; Kalpana, Ganjam/0000-0003-4111-0604	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI039951, R21AI039951, R01AI039951] Funding Source: NIH RePORTER; NIAID NIH HHS [AI39951] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Biegel JA, 1999, CANCER RES, V59, P74; Cairns BR, 1998, TRENDS BIOCHEM SCI, V23, P20, DOI 10.1016/S0968-0004(97)01160-2; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Facchini LM, 1998, FASEB J, V12, P633, DOI 10.1096/fasebj.12.9.633; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; KATO GJ, 1990, MOL CELL BIOL, V10, P5914, DOI 10.1128/MCB.10.11.5914; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kingston RE, 1996, GENE DEV, V10, P905, DOI 10.1101/gad.10.8.905; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Morozov A, 1998, P NATL ACAD SCI USA, V95, P1120, DOI 10.1073/pnas.95.3.1120; MUCHARDT C, 1995, NUCLEIC ACIDS RES, V23, P1127, DOI 10.1093/nar/23.7.1127; Peterson CL, 1996, CURR OPIN GENET DEV, V6, P171, DOI 10.1016/S0959-437X(96)80047-5; Rozenblatt-Rosen O, 1998, P NATL ACAD SCI USA, V95, P4152, DOI 10.1073/pnas.95.8.4152; Shanahan F, 1999, MOL CELL BIOL, V19, P1460; SHRIVASTAVA A, 1993, SCIENCE, V262, P1889, DOI 10.1126/science.8266081; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Young KH, 1998, BIOL REPROD, V58, P302, DOI 10.1095/biolreprod58.2.302	23	298	312	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1999	22	1					102	105		10.1038/8811	http://dx.doi.org/10.1038/8811			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192TU	10319872				2022-12-17	WOS:000080096300033
J	Prolla, TA; Baker, SM; Harris, AC; Tsao, EL; Yao, X; Bronner, CE; Zheng, BH; Gordon, M; Reneker, J; Arnheim, N; Shibata, D; Bradley, A; Liskay, RM				Prolla, TA; Baker, SM; Harris, AC; Tsao, EL; Yao, X; Bronner, CE; Zheng, BH; Gordon, M; Reneker, J; Arnheim, N; Shibata, D; Bradley, A; Liskay, RM			Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair	NATURE GENETICS			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; COLON-CANCER; MICROSATELLITE INSTABILITY; HEREDITARY; HOMOLOG; CELLS; MSH2	Germline mutations in the human MSH2, MLH1, PMS2 and PMS1 DNA mismatch repair (MMR) gene homologues appear to be responsible for most cases of hereditary non-polyposis colorectal cancer (HNPCC; refs 1-5). An important role for DNA replication errors in colorectal tumorigenesis has been suggested by the finding of frequent alterations in the length of specific mononucleotide tracts within genes controlling cell growth, including TGF-beta receptor type II (ref. 6), BAX (ref. 7) and APC (ref. 8). A broader role for MMR deficiency in human tumorigenesis is implicated by microsatellite instability in a fraction of sporadic tumours, including gastric, endometrial and colorectal malignancies(9). To better define the role of individual MMR genes in cancer susceptibility and MMR functions, we have generated mice deficient for the murine homologues of the human genes MLH1, PMS1 and PMS2. Surprisingly, we find that these mice show different tumour susceptibilities, most notably, to intestinal adenomas and adenocarcinomas, and different mutational spectra. Our results suggest that a general increase in replication errors may not be sufficient for intestinal tumour formation and that these genes share overlapping, but not identical functions.	Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Oregon Hlth Sci Univ, Dept Pathol, Portland, OR 97201 USA; Univ So Calif, Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; Univ So Calif, Dept Mol Biol, Los Angeles, CA 90089 USA	Oregon Health & Science University; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Oregon Health & Science University; University of Southern California; University of Southern California	Liskay, RM (corresponding author), Oregon Hlth Sci Univ, Dept Mol & Med Genet, L103,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	liskay@ohsu.edu		Arnheim, Norman/0000-0003-1247-1347; Bradley, Allan/0000-0002-2349-8839				Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; BOOTSMA D, 1994, MUTAT RES, V307, P15, DOI 10.1016/0027-5107(94)90273-9; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; GUPTA RS, 1980, MUTAT RES, V69, P113, DOI 10.1016/0027-5107(80)90181-5; Huang J, 1996, P NATL ACAD SCI USA, V93, P9049, DOI 10.1073/pnas.93.17.9049; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Karran P, 1996, SEMIN CANCER BIOL, V7, P15, DOI 10.1006/scbi.1996.0003; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; Luria SE, 1943, GENETICS, V28, P491; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Narayanan L, 1997, P NATL ACAD SCI USA, V94, P3122, DOI 10.1073/pnas.94.7.3122; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PROLLA TA, 1994, SCIENCE, V265, P1091, DOI 10.1126/science.8066446; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Reitmair AH, 1996, CANCER RES, V56, P3842; Shibata D, 1996, NAT MED, V2, P676, DOI 10.1038/nm0696-676; Tsao JL, 1997, AM J PATHOL, V151, P573; WATSON P, 1993, CANCER, V71, P677, DOI 10.1002/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#	24	298	304	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1998	18	3					276	279		10.1038/ng0398-276	http://dx.doi.org/10.1038/ng0398-276			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500552				2022-12-17	WOS:000072325000028
J	Rougeulle, C; Glatt, H; Lalande, M				Rougeulle, C; Glatt, H; Lalande, M			The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain	NATURE GENETICS			English	Letter									CHILDRENS HOSP,DIV GENET,BOSTON,MA 02115; CHILDRENS HOSP,HOWARD HUGHES MED INST,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School				Rougeulle, Claire/0000-0003-3861-4940	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD018658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030628] Funding Source: NIH RePORTER; NICHD NIH HHS [P01-HD18658] Funding Source: Medline; NINDS NIH HHS [R01-NS30628] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Greger V, 1997, AM J HUM GENET, V60, P574; JAY V, 1991, NEUROLOGY, V41, P416, DOI 10.1212/WNL.41.3.416; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; NAKAO M, 1994, HUM MOL GENET, V3, P309, DOI 10.1093/hmg/3.2.309; SadouletPuccio HM, 1996, HUM MOL GENET, V5, P489, DOI 10.1093/hmg/5.4.489; Yamamoto Y, 1997, GENOMICS, V41, P263, DOI 10.1006/geno.1997.4617	7	298	304	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1997	17	1					14	15		10.1038/ng0997-14	http://dx.doi.org/10.1038/ng0997-14			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288088				2022-12-17	WOS:A1997XU72400008
J	Mahtani, MM; Widen, E; Lehto, M; Thomas, J; McCarthy, M; Brayer, J; Bryant, B; Chan, GY; Daly, M; Forsblom, C; Kanninen, T; Kirby, A; Kruglyak, L; Munnelly, K; Parkkonen, M; ReeveDaly, MP; Weaver, A; Brettin, T; Duyk, G; Lander, ES; Groop, LC				Mahtani, MM; Widen, E; Lehto, M; Thomas, J; McCarthy, M; Brayer, J; Bryant, B; Chan, GY; Daly, M; Forsblom, C; Kanninen, T; Kirby, A; Kruglyak, L; Munnelly, K; Parkkonen, M; ReeveDaly, MP; Weaver, A; Brettin, T; Duyk, G; Lander, ES; Groop, LC			Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families	NATURE GENETICS			English	Letter							IMPAIRED GLUCOSE-TOLERANCE; BETA-CELL; CHROMOSOME 12Q; COMPLEX TRAITS; BREAST-CANCER; PIMA-INDIANS; LINKAGE; ONSET; MELLITUS; NIDDM		WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142; LUND UNIV,DEPT ENDOCRINOL,WALLENBERG LAB,MALMO,SWEDEN; MIT,DEPT BIOL,CAMBRIDGE,MA 02139; MILLENIUM PHARMACEUT INC,CAMBRIDGE,MA 02139; UNIV HELSINKI HOSP,DEPT MED,HELSINKI,FINLAND	Massachusetts Institute of Technology (MIT); Whitehead Institute; Lund University; Massachusetts Institute of Technology (MIT); Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; University of Helsinki; Helsinki University Central Hospital			McCarthy, Mark/M-3763-2015	McCarthy, Mark/0000-0002-4393-0510				BELL GI, 1991, P NATL ACAD SCI USA, V88, P1484, DOI 10.1073/pnas.88.4.1484; CERASI E, 1973, LANCET, V1, P794; CHARLES MA, 1991, DIABETES, V40, P796, DOI 10.2337/diabetes.40.7.796; COOK JTE, 1994, DIABETOLOGIA, V37, P1231, DOI 10.1007/s001250050240; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; ERIKSSON J, 1992, DIABETIC MED, V9, P654, DOI 10.1111/j.1464-5491.1992.tb01862.x; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; Galli J, 1996, NAT GENET, V12, P31, DOI 10.1038/ng0196-31; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAFFNER SM, 1990, METABOLISM, V39, P842, DOI 10.1016/0026-0495(90)90130-5; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; KING H, 1988, World Health Statistics Quarterly, V41, P190; KOBBERLING J, 1971, DIABETOLOGIA, V7, P46, DOI 10.1007/BF02346253; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LESAGE S, 1995, DIABETES, V44, P1243, DOI 10.2337/diabetes.44.10.1243; LILLIOJA S, 1988, NEW ENGL J MED, V318, P1217, DOI 10.1056/NEJM198805123181901; MENZEL S, 1995, DIABETES, V44, P1408, DOI 10.2337/diabetes.44.12.1408; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NEWMAN B, 1987, DIABETOLOGIA, V30, P763; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; ORAHILLY SP, 1986, LANCET, V2, P360; PELTOMAKI P, 1993, SCIENCE, V260, P810, DOI 10.1126/science.8484120; SAAD MF, 1988, NEW ENGL J MED, V319, P1500, DOI 10.1056/NEJM198812083192302; SARTOR G, 1980, DIABETES, V29, P41, DOI 10.2337/diabetes.29.1.41; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; VAXILLAIRE M, 1995, NAT GENET, V9, P418, DOI 10.1038/ng0495-418; VIRTARANTAKNOWLES K, 1991, HUM HERED, V41, P248, DOI 10.1159/000154009; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; *WHO, 1985, DIABETES MELLITUS RE; YKIJARVINEN H, 1990, DIABETOLOGIA, V33, P579, DOI 10.1007/BF00400200	39	298	305	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1996	14	1					90	94		10.1038/ng0996-90	http://dx.doi.org/10.1038/ng0996-90			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VF611	8782826				2022-12-17	WOS:A1996VF61100027
J	RANUM, LPW; SCHUT, LJ; LUNDGREN, JK; ORR, HT; LIVINGSTON, DM				RANUM, LPW; SCHUT, LJ; LUNDGREN, JK; ORR, HT; LIVINGSTON, DM			SPINOCEREBELLAR ATAXIA TYPE-5 IN A FAMILY DESCENDED FROM THE GRANDPARENTS OF PRESIDENT LINCOLN MAPS TO CHROMOSOME-11	NATURE GENETICS			English	Article							MACHADO-JOSEPH DISEASE; DOMINANT CEREBELLAR-ATAXIA; FRAGILE-X; MYOTONIC-DYSTROPHY; LARGE KINDREDS; CGG REPEAT; DNA REGION; GENE; LINKAGE; ONSET	Autosomal dominant ataxias are a genetically heterogeneous group of disorders for which spinocerebellar ataxia (SCA) loci on chromosomes 6p, 12q, 14q and 16q have been reported. We have examined 170 individuals (56 of whom were affected) from a previously unreported ten-generation kindred with a dominant ataxia that is clinically and genetically distinct from those previously mapped. The family has two major branches which both descend from the paternal grandparents of President Abraham Lincoln. Among those examined, 56 individuals have a generally non-life threatening cerebellar ataxia. Disease onset varies from 10-68 years and anticipation is evident. We have mapped this gene, spinocerebellar ataxia type 5 (SCAS), to the centromeric region of chromosome 11.	UNIV MINNESOTA,DEPT LAB MED,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT PATHOL,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT BIOCHEM,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,INST HUMAN GENET,MINNEAPOLIS,MN 55455	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	RANUM, LPW (corresponding author), UNIV MINNESOTA,DEPT NEUROL,420 DELAWARE ST SE,MINNEAPOLIS,MN 55455, USA.			Orr, Harry/0000-0001-6118-741X				BARBEAU A, 1984, CAN J NEUROL SCI, V11, P510, DOI 10.1017/S0317167100034983; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; BURKE JR, 1994, NAT GENET, V7, P521, DOI 10.1038/ng0894-521; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; DIAZ GO, 1990, NEUROLOGY, V40, P1369, DOI 10.1212/WNL.40.9.1369; FRONTALI M, 1992, BRAIN, V115, P1647, DOI 10.1093/brain/115.6.1647; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GARDNER K, 1994, NEUROLOGY, V44, pA361; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; GYACAY G, 1994, NAT GENET, V7, P246; HAINES JL, 1984, NEUROLOGY, V34, P1542, DOI 10.1212/WNL.34.12.1542; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HOFFMAN PM, 1971, NEUROLOGY, V21, P771, DOI 10.1212/WNL.21.8.771; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; JODICE C, 1994, AM J HUM GENET, V54, P956; KEATS BJB, 1991, GENOMICS, V9, P557, DOI 10.1016/0888-7543(91)90426-F; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; KWIATKOWSKI TJ, 1993, AM J HUM GENET, V53, P391; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NINO HE, 1980, NEUROLOGY, V30, P12, DOI 10.1212/WNL.30.1.12; ORR HT, 1993, NAT GENET, V4, P211; RANUM LPW, 1994, AM J HUM GENET, V55, P244; RANUM LPW, 1991, AM J HUM GENET, V49, P31; ROSENBERG RN, 1992, MOVEMENT DISORD, V7, P193, DOI 10.1002/mds.870070302; SCHUT JW, 1950, ARCH NEURO PSYCHIATR, V63, P535, DOI 10.1001/archneurpsyc.1950.02310220002001; STEVANIN G, 1994, AM J HUM GENET, V54, P11; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WEBER JL, 1993, AM J HUM GENET, V53, P1079; ZOGHBI HY, 1988, ANN NEUROL, V23, P580, DOI 10.1002/ana.410230609; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23; Zoghbi HY, 1991, CURR NEUROL, V11, P121; 1993, CELL, V72, P971	41	298	301	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1994	8	3					280	284		10.1038/ng1194-280	http://dx.doi.org/10.1038/ng1194-280			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PP765	7874171				2022-12-17	WOS:A1994PP76500019
J	Zhang, F; Khajavi, M; Connolly, AM; Towne, CF; Batish, SD; Lupski, JR				Zhang, Feng; Khajavi, Mehrdad; Connolly, Anne M.; Towne, Charles F.; Batish, Sat Dev; Lupski, James R.			The DNA replication FoSTeS/MMBIR mechanism can generate genomic, genic and exonic complex rearrangements in humans	NATURE GENETICS			English	Article							BREAK-INDUCED REPLICATION; STRUCTURAL VARIATION; COPY-NUMBER; FINE-SCALE; DUPLICATIONS; ARCHITECTURE; DISORDERS; GENES	We recently proposed a DNA replication-based mechanism of fork stalling and template switching (FoSTeS) to explain the complex genomic rearrangements associated with a dysmyelinating central nervous system disorder in humans(1). The FoSTeS mechanism has been further generalized and molecular mechanistic details have been provided in the microhomology-mediated break-induced replication (MMBIR) model that may underlie many structural variations in genomes from all domains of life(2). Here we provide evidence that human genomic rearrangements ranging in size from several megabases to a few hundred base pairs can be generated by FoSTeS/MMBIR. Furthermore, we show that FoSTeS/MMBIR-mediated rearrangements can occur mitotically and can result in duplication or triplication of individual genes or even rearrangements of single exons. The FoSTeS/MMBIR mechanism can explain both the gene duplication-divergence hypothesis(3) and exon shuffling(4), suggesting an important role in both genome and single-gene evolution.	[Zhang, Feng; Khajavi, Mehrdad; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Connolly, Anne M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Towne, Charles F.; Batish, Sat Dev] Athena Diagnost Inc, Worcester, MA USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Washington University (WUSTL); Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu	Connolly, Anne/GYD-3128-2022; Zhang, Feng/C-7735-2009	Zhang, Feng/0000-0003-4556-8276; Connolly, Anne/0000-0002-9193-2457	Charcot Marie Tooth Association and the National Institute of Neurological Disorders and Stroke (NINDS, NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529] Funding Source: NIH RePORTER	Charcot Marie Tooth Association and the National Institute of Neurological Disorders and Stroke (NINDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all participating subjects and families for their kind cooperation in the study. We also thank W. Bi, W. Gu, J. A. Lee and P. Stankiewicz for their critical reviews and C. M. B. Carvalho and M. A. Withers for their assistance. This work was supported in part by the Charcot Marie Tooth Association and the National Institute of Neurological Disorders and Stroke (NINDS, NIH).	Arlt MF, 2009, AM J HUM GENET, V84, P339, DOI 10.1016/j.ajhg.2009.01.024; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bi WM, 2009, NAT GENET, V41, P168, DOI 10.1038/ng.302; Carvalho CMB, 2009, HUM MOL GENET, V18, P2188, DOI 10.1093/hmg/ddp151; Chen JM, 2005, HUM MUTAT, V26, P125, DOI 10.1002/humu.20202; Doco-Fenzy M, 2008, AM J MED GENET A, V146A, P917, DOI 10.1002/ajmg.a.32195; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Flores M, 2007, P NATL ACAD SCI USA, V104, P6099, DOI 10.1073/pnas.0701631104; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jones JM, 2000, HUM MOL GENET, V9, P821, DOI 10.1093/hmg/9.5.821; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Long M, 2001, CURR OPIN GENET DEV, V11, P673, DOI 10.1016/S0959-437X(00)00252-5; Lupski JR, 2005, PERIPHERAL NEUROPATH, P1659, DOI DOI 10.1016/B978-0-7216-9491-7.50073-9; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Ohno S., 1970, EVOLUTION GENE DUPLI; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; van Rijk AAF, 1999, P NATL ACAD SCI USA, V96, P8074, DOI 10.1073/pnas.96.14.8074; Vissers LELM, 2007, HUM GENET, V121, P697, DOI 10.1007/s00439-007-0359-6; ZHANG F, TRENDS GENE IN PRESS	35	297	303	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					849	U115		10.1038/ng.399	http://dx.doi.org/10.1038/ng.399			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	19543269	Green Accepted			2022-12-17	WOS:000267786200019
J	Rea, SL; Wu, DQ; Cypser, JR; Vaupel, JW; Johnson, TE				Rea, SL; Wu, DQ; Cypser, JR; Vaupel, JW; Johnson, TE			A stress-sensitive reporter predicts longevity in isogenic populations of Caenorhabditis elegans	NATURE GENETICS			English	Article							LIFE-SPAN; GENE-EXPRESSION; C-ELEGANS; NEMATODES; HORMESIS; AGE	When both genotype and environment are held constant, 'chance' variation in the lifespan of individuals in a population is still quite large. Using isogenic populations of the nematode Caenorhabditis elegans, we show that, on the first day of adult life, chance variation in the level of induction of a green fluorescent protein (GFP) reporter coupled to a promoter from the gene hsp-16.2 predicts as much as a fourfold variation in subsequent survival. The same reporter is also a predictor of ability to withstand a subsequent lethal thermal stress. The level of induction of GFP is not heritable, and GFP expression levels in other reporter constructs are not associated with differences in longevity. HSP-16.2 itself is probably not responsible for the observed differences in survival but instead probably reflects a hidden, heterogeneous, but now quantifiable, physiological state that dictates the ability of an organism to deal with the rigors of living.	Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; Max Planck Inst Demog Res, D-18057 Rostock, Germany; Univ Colorado, Dept Integrat Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; Max Planck Society; University of Colorado System; University of Colorado Boulder	Johnson, TE (corresponding author), Univ Colorado, Inst Behav Genet, Box 447, Boulder, CO 80309 USA.	johnsont@colorado.edu	Rea, Shane/F-4073-2014	/0000-0001-7147-8237; CYPSER, JAMES/0000-0001-8436-6437; Vaupel, James/0000-0003-0783-3905	NATIONAL INSTITUTE ON AGING [R01AG016219, P01AG008761, P30AG034424] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG008761, R01 AG016219, P30 AG034424] Funding Source: Medline; NICHD NIH HHS [R03 HD050374] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BAKER GT, 1988, EXP GERONTOL, V23, P223, DOI 10.1016/0531-5565(88)90025-3; BRENNER S, 1974, GENETICS, V77, P71; Calabrese EJ, 2002, HUM EXP TOXICOL, V21, P91, DOI 10.1191/0960327102ht217oa; Cypser JR, 2002, J GERONTOL A-BIOL, V57, pB109, DOI 10.1093/gerona/57.3.B109; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fedoroff N, 2002, SCIENCE, V297, P1129, DOI 10.1126/science.1075988; Finch C, 2000, CHANCE DEV AGING; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Golden TR, 2004, AGING CELL, V3, P111, DOI 10.1111/j.1474-9728.2004.00095.x; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/BF02185763; JOHNSON TE, 1982, P NATL ACAD SCI-BIOL, V79, P6603, DOI 10.1073/pnas.79.21.6603; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; Johnson TE, 2000, EXP GERONTOL, V35, P687, DOI 10.1016/S0531-5565(00)00138-8; Kelly WG, 1997, GENETICS, V146, P227; Kenyon C, 1996, CELL, V84, P501, DOI 10.1016/S0092-8674(00)81024-7; Kirkwood TBL, 2005, MECH AGEING DEV, V126, P439, DOI 10.1016/j.mad.2004.09.008; Kirkwood TBL, 2002, NATURE, V419, P794, DOI 10.1038/419794a; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; MELOV S, 1995, NUCLEIC ACIDS RES, V23, P1419, DOI 10.1093/nar/23.8.1419; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; STREHLER BL, 1960, SCIENCE, V132, P14, DOI 10.1126/science.132.3418.14; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x	29	297	306	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2005	37	8					894	898		10.1038/ng1608	http://dx.doi.org/10.1038/ng1608			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	16041374	Green Accepted			2022-12-17	WOS:000230880400022
J	Sellick, GS; Barker, KT; Stolte-Dijkstra, I; Fleischmann, C; Coleman, RJ; Garrett, C; Gloyn, AL; Edghill, EL; Hattersley, AT; Wellauer, PK; Goodwin, G; Houlston, RS				Sellick, GS; Barker, KT; Stolte-Dijkstra, I; Fleischmann, C; Coleman, RJ; Garrett, C; Gloyn, AL; Edghill, EL; Hattersley, AT; Wellauer, PK; Goodwin, G; Houlston, RS			Mutations in PTF1A cause pancreatic and cerebellar agenesis	NATURE GENETICS			English	Article							NEONATAL DIABETES-MELLITUS; GLUCOKINASE DEFICIENCY; EXOCRINE; SUBUNIT; GENE; PTF1-P48; PROTEIN	Individuals with permanent neonatal diabetes mellitus usually present within the first three months of life and require insulin treatment(1,2). We recently identified a locus on chromosome 10p13-p12.1 involved in permanent neonatal diabetes mellitus associated with pancreatic and cerebellar agenesis in a genome-wide linkage search of a consanguineous Pakistani family(3). Here we report the further linkage analysis of this family and a second family of Northern European descent segregating an identical phenotype. Positional cloning identified the mutations 705insG and C886T in the gene PTF1A, encoding pancreas transcription factor 1alpha, as disease-causing sequence changes. Both mutations cause truncation of the expressed PTF1A protein C-terminal to the basic-helix-loop-helix domain. Reporter-gene studies using a minimal PTF1A deletion mutant indicate that the deleted region defines a new domain that is crucial for the function of this protein. PTF1A is known to have a role in mammalian pancreatic development(4,5), and the clinical phenotype of the affected individuals implicated the protein as a key regulator of cerebellar neurogenesis. The essential role of PTF1A in normal cerebellar development was confirmed by detailed neuropathological analysis of Ptf1a(-/-) mice.	Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Univ Groningen Hosp, Dept Clin Genet, NL-9700 RB Groningen, Netherlands; NW London Hosp NHS Trust, NW Thames Reg Genet Serv, Kennedy Galton Ctr, Harrow HA1 3UJ, Middx, England; Peninsula Med Sch, Exeter EX2 5AX, Devon, England; Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; Inst Canc Res, Sect Mol Carcinogenesis, Sutton SM2 5NG, Surrey, England	University of London; Institute of Cancer Research - UK; University of Groningen; University of Exeter; Swiss Institute Experimental Cancer Research; University of London; Institute of Cancer Research - UK	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England.	Richard.Houlston@icr.ac.uk		Hattersley, Andrew/0000-0001-5620-473X; Gloyn, Anna/0000-0003-1205-1844; Houlston, Richard/0000-0002-5268-0242				COCKELL M, 1989, MOL CELL BIOL, V9, P2464, DOI 10.1128/MCB.9.6.2464; Gentz J C, 1969, Adv Pediatr, V16, P345; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Hoveyda N, 1999, J MED GENET, V36, P700; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Krapp A, 1996, EMBO J, V15, P4317, DOI 10.1002/j.1460-2075.1996.tb00806.x; Krapp A, 1998, GENE DEV, V12, P3752, DOI 10.1101/gad.12.23.3752; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; Njolstad PR, 2001, NEW ENGL J MED, V344, P1588, DOI 10.1056/NEJM200105243442104; Njolstad PR, 2003, DIABETES, V52, P2854, DOI 10.2337/diabetes.52.11.2854; Obata J, 2001, GENES CELLS, V6, P345, DOI 10.1046/j.1365-2443.2001.00422.x; Rose SD, 2001, J BIOL CHEM, V276, P44018, DOI 10.1074/jbc.M106264200; Sellick GS, 2003, DIABETES, V52, P2636, DOI 10.2337/diabetes.52.10.2636; Shield JP, 1997, ARCH DIS CHILD-FETAL, V76, P39; Sigvardsson M, 2000, MOL CELL BIOL, V20, P3640, DOI 10.1128/MCB.20.10.3640-3654.2000; Zecchin E, 2004, DEV BIOL, V268, P174, DOI 10.1016/j.ydbio.2003.12.016	16	297	309	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2004	36	12					1301	1305		10.1038/ng1475	http://dx.doi.org/10.1038/ng1475			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	15543146				2022-12-17	WOS:000225354100018
J	Bergamaschi, D; Samuels, Y; O'Neil, NJ; Trigiante, G; Crook, T; Hsieh, JK; O'Connor, DJ; Zhong, S; Campargue, I; Tomlinson, ML; Kuwabara, PE; Lu, X				Bergamaschi, D; Samuels, Y; O'Neil, NJ; Trigiante, G; Crook, T; Hsieh, JK; O'Connor, DJ; Zhong, S; Campargue, I; Tomlinson, ML; Kuwabara, PE; Lu, X			iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR; CAENORHABDITIS-ELEGANS; DROSOPHILA P53; APOPTOSIS; HOMOLOG	We have previously shown that ASPP1 and ASPP2 are specific activators of p53; one mechanism by which wild-type p53 is tolerated in human breast carcinomas is through loss of ASPP activity. We have further shown that 53BP2, which corresponds to a C-terminal fragment of ASPP2, acts as a dominant negative inhibitor of p53 (ref. 1). Hence, an inhibitory form of ASPP resembling 53BP2 could allow cells to bypass the tumor-suppressor functions of p53 and the ASPP proteins. Here, we characterize such a protein, iASPP (inhibitory member of the ASPP family), encoded by PPP1R13L in humans and ape-1 in Caenorhabditis elegans. iASPP is an evolutionarily conserved inhibitor of p53; inhibition of iASPP by RNA-mediated interference or antisense RNA in C elegans or human cells, respectively, induces p53-dependent apoptosis. Moreover, iASPP is an oncoprotein that cooperates with Ras, E1A and E7, but not mutant p53, to transform cells in vitro. Increased expression of iASPP also confers resistance to ultraviolet radiation and to cisplatin-induced apoptosis. iASPP expression is upregulated in human breast carcinomas expressing wild-type p53 and normal levels of ASPP. Inhibition of iASPP could provide an important new strategy for treating tumors expressing wild-type p53.	Univ London Imperial Coll Sci & Technol, Sch Med, Ludwig Inst Canc Res, London W2 1PG, England; Wellcome Trust Sanger Inst, Cambridge, England	Imperial College London; Ludwig Institute for Cancer Research; Wellcome Trust Sanger Institute	Lu, X (corresponding author), Univ London Imperial Coll Sci & Technol, Sch Med, Ludwig Inst Canc Res, St Marys Campus,Norfolk Pl, London W2 1PG, England.		O'Neil, Nigel/J-4012-2014	O'Neil, Nigel/0000-0002-1992-6976; Lu, Xin/0000-0002-6587-1152; Samuels, Yardena/0000-0002-3349-7266; Bergamaschi, Daniele/0000-0002-3955-1091; Kuwabara, Patricia/0000-0002-1108-7776				Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; CROOK T, 1994, CELL, V79, P817, DOI 10.1016/0092-8674(94)90071-X; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gorina S, 1996, SCIENCE, V274, P1001, DOI 10.1126/science.274.5289.1001; Harlow E LD, 1988, ANTIBODIES LAB MANUA; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Yang JP, 1999, J BIOL CHEM, V274, P15662, DOI 10.1074/jbc.274.22.15662	12	297	354	1	29	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2003	33	2					162	167		10.1038/ng1070	http://dx.doi.org/10.1038/ng1070			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12524540				2022-12-17	WOS:000180773700013
J	Kielman, MF; Rindapaa, M; Gaspar, C; van Poppel, N; Breukel, C; van Leeuwen, S; Taketo, MM; Roberts, S; Smits, R; Fodde, R				Kielman, MF; Rindapaa, M; Gaspar, C; van Poppel, N; Breukel, C; van Leeuwen, S; Taketo, MM; Roberts, S; Smits, R; Fodde, R			Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling	NATURE GENETICS			English	Article							FAMILIAL ADENOMATOUS POLYPOSIS; COLON-CANCER; MOUSE MODEL; GENES; MUTATION; TUMORS; MICE; EXPRESSION; REGULATORS; ACTIVATION	The Wnt signal-transduction pathway induces the nuclear translocation of membrane-bound beta-catenin (Catnb) and has a key role in cell-fate determination. Tight somatic regulation of this signal is essential, as uncontrolled nuclear accumulation of beta-catenin can cause developmental defects and tumorigenesis in the adult organism. The adenomatous polyposis coli gene (APC) is a major controller of the Wnt pathway and is essential to prevent tumorigenesis in a variety of tissues and organs. Here, we have investigated the effect of different mutations in Apc on the differentiation potential of mouse embryonic stem (ES) cells. We provide genetic and molecular evidence that the ability and sensitivity of ES cells to differentiate into the three germ layers is inhibited by increased doses of beta-catenin by specific Apc mutations. These range from a severe differentiation blockade in Apc alleles completely deficient in beta-catenin regulation to more specific neuroectodermal, dorsal mesodermal and endodermal defects in more hypomorphic alleles. Accordingly, a targeted oncogenic mutation in Catnb also affects the differentiation potential of ES cells. Expression profiling of wildtype and Apc-mutated teratomas supports the differentiation defects at the molecular level and pinpoints a large number of downstream structural and regulating genes. Chimeric experiments showed that this effect is cell-autonomous. Our results imply that constitutive activation of the Apc/beta-catenin signaling pathway results in differentiation defects in tissue homeostasis, and possibly underlies tumorigenesis in the colon and other self-renewing tissues.	Leiden Univ, Med Ctr, Sylvius Lab, Ctr Human & Clin Genet, NL-2333 RA Leiden, Netherlands; Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan; Rosetta Inpharmat, Kirkland, WA USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Kyoto University; Merck & Company	Fodde, R (corresponding author), Leiden Univ, Med Ctr, Sylvius Lab, Ctr Human & Clin Genet, Wassenaarseweg 72, NL-2333 RA Leiden, Netherlands.		Gaspar, Claudia/I-6402-2013; Fodde, Riccardo/AAW-9394-2021	Gaspar, Claudia/0000-0003-1051-0998; Fodde, Riccardo/0000-0001-9839-4324				Boman BM, 2001, CANCER RES, V61, P8408; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chen JR, 2001, MOL CELL ENDOCRINOL, V177, P43, DOI 10.1016/S0303-7207(01)00456-7; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Fodde R, 2001, TRENDS MOL MED, V7, P369, DOI 10.1016/S1471-4914(01)02050-0; Fodde Riccardo, 1995, Critical Reviews in Oncogenesis, V6, P291; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; HAY ED, 1995, AM J KIDNEY DIS, V26, P678, DOI 10.1016/0272-6386(95)90610-X; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hu GZ, 2001, DEVELOPMENT, V128, P2373; Kim K, 2000, MOL BIOL CELL, V11, P3509, DOI 10.1091/mbc.11.10.3509; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; LAMIUM H, 1999, NAT MED, V5, P1071; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MOSER AR, 1992, J CELL BIOL, V116, P1517, DOI 10.1083/jcb.116.6.1517; MOSER AR, 1995, DEV DYNAM, V203, P422, DOI 10.1002/aja.1002030405; Polakis P, 2000, GENE DEV, V14, P1837; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Seidensticker MJ, 2000, BBA-MOL CELL RES, V1495, P168, DOI 10.1016/S0167-4889(99)00158-5; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Smits R, 2000, GENE CHROMOSOME CANC, V29, P229, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1033>3.0.CO;2-R; Smits R, 1998, GASTROENTEROLOGY, V114, P275, DOI 10.1016/S0016-5085(98)70478-0; Smits R, 1999, GENE DEV, V13, P1309, DOI 10.1101/gad.13.10.1309; Stevens L C, 1967, Adv Morphog, V6, P1; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yamada M, 2000, DEV BIOL, V228, P95, DOI 10.1006/dbio.2000.9927	36	297	312	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32	4					594	605		10.1038/ng1045	http://dx.doi.org/10.1038/ng1045			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12426568				2022-12-17	WOS:000179593000011
J	Jamin, SP; Arango, NA; Mishina, Y; Hanks, MC; Behringer, RR				Jamin, SP; Arango, NA; Mishina, Y; Hanks, MC; Behringer, RR			Requirement of Bmpr1a for Mullerian duct regression during male sexual development	NATURE GENETICS			English	Article							IBMP RECEPTOR BMPRIB; MOUSE EMBRYOGENESIS; II RECEPTOR; EXPRESSION; HORMONE; GASTRULATION; PATHWAY; ALK2; FAMILY; LIMB	Elimination of the developing female reproductive tract in male fetuses is an essential step in mammalian sexual differentiation(1). In males, the fetal testis produces the transforming growth factor beta (TGF-beta) family member anti-Mullerian hormone (Amh, also known as Mullerian-inhibiting substance (Mis)), which causes regression of the Mullerian ducts, the primordia of the oviducts, uterus and upper vagina(2). Amh induces regression by binding to a specific type II receptor (Amhr2) expressed in the mesenchyme surrounding the ductal epithelium(3-7). Mutations in AMH or AMHR2 in humans and mice disrupt signaling, producing male pseudohermaphrodites that possess oviducts and uteri(8-10). The type I receptor and Smad proteins that are required in vivo for Mullerian duct regression have not yet been identified(11-14). Here we show that targeted disruption of the widely expressed type I bone morphogenetic protein (BMP) receptor Bmpr1a (also known as Alk3) in the mesenchymal cells of the Mullerian ducts leads to retention of oviducts and uteri in males. These results identify Bmpr1a as a type I receptor for Amh-induced regression of Mullerian ducts. Because Bmpr1a is evolutionarily conserved, these findings indicate that a component of the BMP signaling pathway has been co-opted during evolution for male sexual development in amniotes.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; Procter & Gamble Co, Hlth Care Res Ctr, Mason, OH USA	University of Texas System; UTMD Anderson Cancer Center; Procter & Gamble	Behringer, RR (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA.		Jamin, Soazik P./K-1507-2019; Jamin, Soazik/F-6796-2015	Jamin, Soazik P./0000-0002-1688-0167; 				Ahn K, 2001, DEVELOPMENT, V128, P4449; Albrecht U, 1996, DEV BIOL, V180, P579, DOI 10.1006/dbio.1996.0330; Allard S, 2000, DEVELOPMENT, V127, P3349; Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; BAARENDS WM, 1994, DEVELOPMENT, V120, P189; BEHRINGER RR, 1994, CELL, V79, P415, DOI 10.1016/0092-8674(94)90251-8; Belville C, 1999, AM J MED GENET, V89, P218, DOI 10.1002/(SICI)1096-8628(19991229)89:4<218::AID-AJMG6>3.0.CO;2-E; Clarke TR, 2001, MOL ENDOCRINOL, V15, P946, DOI 10.1210/me.15.6.946; DICLEMENTE N, 1994, MOL ENDOCRINOL, V8, P1006, DOI 10.1210/me.8.8.1006; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Gaussin V, 2002, P NATL ACAD SCI USA, V99, P2878, DOI 10.1073/pnas.042390499; Gouedard L, 2000, J BIOL CHEM, V275, P27973; Gu ZY, 1998, GENE DEV, V12, P844, DOI 10.1101/gad.12.6.844; Gu ZY, 1999, DEVELOPMENT, V126, P2551; JOSSO N, 1993, RECENT PROG HORM RES, V48, P1; JOST A, 1953, RECENT PROG HORM RES, V8, P379; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Mishina Y, 1999, DEV BIOL, V213, P314, DOI 10.1006/dbio.1999.9378; Mishina Y, 2002, GENESIS, V32, P69, DOI 10.1002/gene.10038; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Mishina Y, 1996, GENE DEV, V10, P2577, DOI 10.1101/gad.10.20.2577; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Newfeld SJ, 1999, GENETICS, V152, P783; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Roberts LM, 1999, DEV BIOL, V208, P110, DOI 10.1006/dbio.1998.9190; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Teixeira J, 1996, ENDOCRINOLOGY, V137, P160, DOI 10.1210/en.137.1.160; Visser JA, 2001, MOL ENDOCRINOL, V15, P936, DOI 10.1210/me.15.6.936; Yi SE, 2000, DEVELOPMENT, V127, P621; Yi SE, 2001, P NATL ACAD SCI USA, V98, P7994, DOI 10.1073/pnas.141002798	30	297	309	1	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					408	410		10.1038/ng1003	http://dx.doi.org/10.1038/ng1003			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12368913				2022-12-17	WOS:000179034800017
J	Hacia, JG; Fan, JB; Ryder, O; Jin, L; Edgemon, K; Ghandour, G; Mayer, RA; Sun, B; Hsie, L; Robbins, CM; Brody, LC; Wang, D; Lander, ES; Lipshutz, R; Fodor, SPA; Collins, FS				Hacia, JG; Fan, JB; Ryder, O; Jin, L; Edgemon, K; Ghandour, G; Mayer, RA; Sun, B; Hsie, L; Robbins, CM; Brody, LC; Wang, D; Lander, ES; Lipshutz, R; Fodor, SPA; Collins, FS			Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays	NATURE GENETICS			English	Article							HUMAN-EVOLUTION; GENE; CHIMPANZEE; DIVERSITY; PRIMATES; SEQUENCES; LINKAGE; NUCLEAR; REGION; GENOME	Here we report the application of high-density oligonucleotide array (DNA chip)-based analysis to determine the distant history of single nucleotide polymorphisms (SNPs) in current human populations. We analysed orthologues for 397 human SNP sites (identified in CEPH:pedigrees from Amish, Venezuelan and Utah populations(1)) from 23 common chimpanzee, 19 pygmy chimpanzee and 11 gorilla genomic DNA samples. From this data we determined 214 proposed ancestral alleles (the sequence found in the last common ancestor of humans and chimpanzees). In a diverse human population set, we found that SNP alleles with higher frequencies were more likely to be ancestral than less frequently occurring alleles, There were, however, exceptions. We also found three shared human/pygmy chimpanzee polymorphisms, all involving CpG dinucleotides, and two shared human/gorilla polymorphisms, one involving a CpG dinucleotide. We demonstrate that mi;microarray-based assays allow rapid comparative sequence analysis of intra- and interspecies genetic variation.	Natl Human Genome Res Inst, Bethesda, MD 20892 USA; Affymetrix, Santa Clara, CA 95051 USA; Zool Soc San Diego, Ctr Reprod Endangered Species, San Diego, CA 92112 USA; Fudan Univ, Inst Genet, Shanghai 200433, Peoples R China; Univ Texas, Inst Human Genet, Houston, TX 77225 USA; Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Affymetrix; Zoological Society of San Diego; Fudan University; University of Texas System; Massachusetts Institute of Technology (MIT); Whitehead Institute	Collins, FS (corresponding author), Natl Human Genome Res Inst, Bldg 49-3A14, Bethesda, MD 20892 USA.		Jin, Li/C-1468-2009; Jin, Li/M-5063-2019	Jin, Li/0000-0002-4546-2415; Sun, Bryan/0000-0002-0740-0125	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000120, P01HG001323, ZIAHG000120] Funding Source: NIH RePORTER; NHGRI NIH HHS [5POLHGO1323-03] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		[Anonymous], 1984, AM NAT; Bergstrom TF, 1998, NAT GENET, V18, P237, DOI 10.1038/ng0398-237; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Clark AG, 1997, P NATL ACAD SCI USA, V94, P7730, DOI 10.1073/pnas.94.15.7730; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Cooper G, 1998, HUM MOL GENET, V7, P1425, DOI 10.1093/hmg/7.9.1425; CrouauRoy B, 1996, HUM MOL GENET, V5, P1131, DOI 10.1093/hmg/5.8.1131; DEEB SS, 1994, P NATL ACAD SCI USA, V91, P7262, DOI 10.1073/pnas.91.15.7262; Garner KJ, 1996, MOL PHYLOGENET EVOL, V6, P39, DOI 10.1006/mpev.1996.0056; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Hacia JG, 1998, NAT GENET, V18, P155, DOI 10.1038/ng0298-155; Hacia JG, 1996, NAT GENET, V14, P441, DOI 10.1038/ng1296-441; Jaeger EEM, 1998, IMMUNOGENETICS, V47, P115; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; Lai E, 1998, GENOMICS, V54, P31, DOI 10.1006/geno.1998.5581; MARTINKO JM, 1993, IMMUNOGENETICS, V37, P274; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; MOUNTAIN JL, 1994, P NATL ACAD SCI USA, V91, P6515, DOI 10.1073/pnas.91.14.6515; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Ruvolo M, 1996, MOL PHYLOGENET EVOL, V5, P202, DOI 10.1006/mpev.1996.0014; SAVATIER P, 1985, J MOL BIOL, V182, P21, DOI 10.1016/0022-2836(85)90024-5; SVED J, 1990, P NATL ACAD SCI USA, V87, P4692, DOI 10.1073/pnas.87.12.4692; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; WATKINS DI, 1995, CRIT REV IMMUNOL, V15, P1; WATTERSON GA, 1977, THEOR POPUL BIOL, V11, P141, DOI 10.1016/0040-5809(77)90023-5; Wise CA, 1997, MOL BIOL EVOL, V14, P707, DOI 10.1093/oxfordjournals.molbev.a025810; Yang AS, 1996, J MOL BIOL, V258, P240, DOI 10.1006/jmbi.1996.0246	28	297	371	1	26	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1999	22	2					164	167		10.1038/9674	http://dx.doi.org/10.1038/9674			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202YX	10369258				2022-12-17	WOS:000080680900021
J	Martens, UM; Zijlmans, JMJM; Poon, SSS; Dragowska, W; Yui, J; Chavez, EA; Ward, RK; Lansdorp, PM				Martens, UM; Zijlmans, JMJM; Poon, SSS; Dragowska, W; Yui, J; Chavez, EA; Ward, RK; Lansdorp, PM			Short telomeres on human chromosome 17p	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR; GENE; CARCINOMAS; (TTAGGG)N; MUTATIONS; SEQUENCE; 17P13.3; FUSION; CELLS; DNA	Human chromosomes terminate in a series of T(2)AG(3), repeats(1), which, together with associated proteins, are essential for chromosome stability(2,3). In somatic cells, these sequences are known to be gradually lost through successive cells divisions(4,5); however, information about changes on specific chromosomes is not available. Individual telomeres could mediate important biological effects as was shown in yeast, in which loss of a single telomere results in cell-cycle arrest and chromosome loss(6). We now demonstrate by quantitative fluorescence in situ hybridization (Q-FISH; ref. 7) that the number of T(2)AG(3) repeats on specific chromosome arms is very similar in different tissues from the same donor and varies only to some extent between donors. In all sixteen individuals studied, telomeres on chromosome 17p were shorter than the median telomere length-a finding confirmed by analysis of terminal restriction fragments from sorted chromosomes. These observations provide evidence of chromosome-specific factors regulating the number of T(2)AG(3) repeats in individual telomeres and raise the possibility that the relatively short telomeres on chromosome 17p contribute to the frequent loss of 17p alleles in human cancers.	British Columbia Canc Res Ctr, Terry Fox Lab Hematol Oncol, Vancouver, BC V5Z 1L3, Canada; Univ British Columbia, Dept Elect Engn, Ctr Integrated Comp Syst Res, Vancouver, BC, Canada; Univ British Columbia, Dept Med, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Lansdorp, PM (corresponding author), British Columbia Canc Res Ctr, Terry Fox Lab Hematol Oncol, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.			Lansdorp, Peter/0000-0001-7435-1071	NIAID NIH HHS [AI29524] Funding Source: Medline; NIGMS NIH HHS [GM56162] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029524, R21AI029524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056162] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Blackburn EH, 1995, TELOMERES; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; CORNELIS RS, 1994, CANCER RES, V54, P4200; DELANGE T, 1995, TELOMERES, P265; Deng GR, 1996, SCIENCE, V274, P2057, DOI 10.1126/science.274.5295.2057; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; HANISH JP, 1994, P NATL ACAD SCI USA, V91, P8861, DOI 10.1073/pnas.91.19.8861; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HASTIE ND, 1989, TRENDS GENET, V5, P326, DOI 10.1016/0168-9525(89)90137-6; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; IJDO JW, 1991, P NATL ACAD SCI USA, V88, P9051, DOI 10.1073/pnas.88.20.9051; Kirk KE, 1997, SCIENCE, V275, P1478, DOI 10.1126/science.275.5305.1478; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; LANSDORP PM, 1992, J EXP MED, V175, P1501, DOI 10.1084/jem.175.6.1501; MELTZER PS, 1993, NAT GENET, V4, P252, DOI 10.1038/ng0793-252; MONARD SP, 1995, HUMAN CHROMOSOMES PR, V2, P172; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; MURNANE JP, 1994, EMBO J, V13, P4953, DOI 10.1002/j.1460-2075.1994.tb06822.x; SALTMAN D, 1993, CHROMOSOMA, V102, P121, DOI 10.1007/BF00356029; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; SEIZINGER BR, 1991, CYTOGENET CELL GENET, V58, P1080, DOI 10.1159/000133722; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; White GRM, 1996, BRIT J CANCER, V74, P863, DOI 10.1038/bjc.1996.449; WILKIE AOM, 1990, NATURE, V346, P868, DOI 10.1038/346868a0; Zakian VA, 1996, ANNU REV GENET, V30, P141, DOI 10.1146/annurev.genet.30.1.141; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	30	297	305	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					76	80		10.1038/ng0198-018	http://dx.doi.org/10.1038/ng0198-018			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425906				2022-12-17	WOS:000071259600027
J	MCGRATH, JA; GATALICA, B; CHRISTIANO, AM; LI, KH; OWARIBE, K; MCMILLAN, JR; EADY, RAJ; UITTO, J				MCGRATH, JA; GATALICA, B; CHRISTIANO, AM; LI, KH; OWARIBE, K; MCMILLAN, JR; EADY, RAJ; UITTO, J			MUTATIONS IN THE 180-KD BULLOUS PEMPHIGOID ANTIGEN (BPAG2), A HEMIDESMOSOMAL TRANSMEMBRANE COLLAGEN (COL17A1), IN GENERALIZED ATROPHIC BENIGN EPIDERMOLYSIS-BULLOSA	NATURE GENETICS			English	Letter							GLYCOPROTEIN; MEMBRANE; ANTIBODY; CLONING; COMPLEX; DOMAIN; CELLS; GENE; SKIN; RNA		THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT DERMATOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON INST MOLEC MED,MOLEC DERMATOL SECT,PHILADELPHIA,PA 19107; SCH INFORMAT & SCI,NAGOYA,AICHI,JAPAN; ST THOMAS HOSP,JOHNS INST DERMATOL,DEPT CELL PATHOL,LONDON,ENGLAND	Jefferson University; Jefferson University; Jefferson University; Guy's & St Thomas' NHS Foundation Trust			McMillan, James R/C-6657-2009; McGrath, John/N-3529-2019; McGrath, John/D-6824-2012	McGrath, John/0000-0002-3708-9964	NIAMS NIH HHS [P01-AR38923] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038923] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABERDAM D, 1994, NAT GENET, V6, P299, DOI 10.1038/ng0394-299; BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8; CHENG J, 1990, Molecular and Cellular Biology, V10, P5215; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; GIUDICE GJ, 1992, J INVEST DERMATOL, V99, P243, DOI 10.1111/1523-1747.ep12616580; HINTNER H, 1982, ARCH DERMATOL, V118, P375, DOI 10.1001/archderm.118.6.375; ISHIKO A, 1993, J CLIN INVEST, V91, P1608, DOI 10.1172/JCI116368; JONKMAN MF, 1995, J CLIN INVEST, V95, P1345, DOI 10.1172/JCI117785; JONKMAN MF, 1992, J INVEST DERMATOL, V99, P489, DOI 10.1111/1523-1747.ep12616168; KEEN J, 1991, TRENDS GENET, V7, P5; KIVIRIKKO S, 1995, HUM MOL GENET, V4, P959, DOI 10.1093/hmg/4.5.959; LEIGH IM, 1987, EPITHELIA, V1, P17; LI K, 1991, J BIOL CHEM, V266, P24064; LI KH, 1993, J BIOL CHEM, V268, P8825; MCGRATH JA, 1995, J INVEST DERMATOL, V104, P467, DOI 10.1111/1523-1747.ep12605904; NISHIZAWA Y, 1993, J BIOCHEM-TOKYO, V113, P493, DOI 10.1093/oxfordjournals.jbchem.a124072; OWARIBE K, 1991, EXP CELL RES, V192, P622, DOI 10.1016/0014-4827(91)90084-8; PULKKINEN L, 1994, NAT GENET, V6, P293, DOI 10.1038/ng0394-293; PULKKINEN L, 1994, GENOMICS, V24, P357, DOI 10.1006/geno.1994.1627; PURKIS PE, 1990, J CELL SCI, V97, P39; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SONNENBERG A, 1987, J BIOL CHEM, V262, P10376; TIDMAN MJ, 1986, J INVEST DERMATOL, V86, P51, DOI 10.1111/1523-1747.ep12283807; UITTO J, 1992, J CLIN INVEST, V90, P687, DOI 10.1172/JCI115938; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; VAILLY J, 1995, J INVEST DERMATOL, V104, P462, DOI 10.1111/1523-1747.ep12605898; VERRANDO P, 1991, LAB INVEST, V64, P85; VIDAL F, 1995, NAT GENET, V10, P229, DOI 10.1038/ng0695-229	29	297	306	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1995	11	1					83	86		10.1038/ng0995-83	http://dx.doi.org/10.1038/ng0995-83			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	7550320				2022-12-17	WOS:A1995RR72800020
J	HECHT, JT; NELSON, LD; CROWDER, E; WANG, Y; ELDER, FFB; HARRISON, WR; FRANCOMANO, CA; PRANGE, CK; LENNON, GG; DEERE, M; LAWLER, J				HECHT, JT; NELSON, LD; CROWDER, E; WANG, Y; ELDER, FFB; HARRISON, WR; FRANCOMANO, CA; PRANGE, CK; LENNON, GG; DEERE, M; LAWLER, J			MUTATIONS IN EXON 17B OF CARTILAGE OLIGOMERIC MATRIX PROTEIN (COMP) CAUSE PSEUDOACHONDROPLASIA	NATURE GENETICS			English	Article							THROMBOSPONDIN; EXPRESSION; DYSPLASIA; DOMINANT; COLLAGEN; BINDING; GENE	Pseudoachondroplasia (PSACH) is a well characterized dwarfing condition mapping to chromosome 19p12-13.1. Cartilage oligomeric matrix protein (COMP), a cartilage specific protein, maps to the same location within a contig that spans the PSACH locus. Using single strand conformation polymorphism (SSCP) analysis and nucleotide sequencing we have identified COMP mutations in eight familiar and isolated PSACH cases. All mutations involve either a single base-pair change or a three base-pair deletion in exon 17B. Six mutations delete or change a well conserved aspartic acid residue within the calcium-binding type 3 repeats. These results demonstrate that mutations in the COMP gene cause pseudochondroplasia.	UNIV TEXAS,SCH MED,DEPT PATHOL,HOUSTON,TX 77225; NIH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892; LAWRENCE LIVERMORE NATL LAB,CTR HUMAN GENOME,LIVERMORE,CA 94551; HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT PATHOL,DIV VASC RES,BOSTON,MA 02115	University of Texas System; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Harvard University; Brigham & Women's Hospital; Harvard Medical School	HECHT, JT (corresponding author), UNIV TEXAS,SCH MED,DEPT PEDIAT,POB 20708,HOUSTON,TX 77225, USA.		Lennon, Greg/T-4717-2019; Lawler, Jack/AAJ-1379-2020		NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049081] Funding Source: NIH RePORTER; NCI NIH HHS [CA16672] Funding Source: Medline; NHLBI NIH HHS [HL49081] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS J, 1993, CURR BIOL, V3, P188, DOI 10.1016/0960-9822(93)90270-X; BORNSTEIN P, 1993, GENOMICS, V15, P607, DOI 10.1006/geno.1993.1114; BORNSTEIN P, 1992, FASEB J, V6, P3290, DOI 10.1096/fasebj.6.14.1426766; BRIGGS MD, 1993, GENOMICS, V18, P656, DOI 10.1016/S0888-7543(05)80369-6; COOPER RR, 1973, J BONE JOINT SURG AM, VA 55, P475, DOI 10.2106/00004623-197355030-00003; DICESAREPE, 1994, EUR J BIOCHEM, V223, P927; ELLARD JT, 1989, TEX SOC EL MICR; FINKELSTEIN JE, 1991, AM J HUM GENET, V48, P97; GELLIS SS, 1974, AM J DIS CHILD, V128, P833, DOI 10.1001/archpedi.1974.02110310081015; GUO NH, 1992, J BIOL CHEM, V267, P19349; HALL JG, 1987, AM J MED GENET, V28, P143, DOI 10.1002/ajmg.1320280121; HECHT JT, 1993, GENOMICS, V18, P661, DOI 10.1016/S0888-7543(05)80370-2; HECHT JT, 1992, AM J MED GENET, V44, P420, DOI 10.1002/ajmg.1320440406; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; Heinegard Dick, 1993, P189; JACENKO O, 1993, NATURE, V365, P56, DOI 10.1038/365056a0; Knowlton R. G., 1994, American Journal of Human Genetics, V55, pA190; KNOWLTON RG, 1994, AM J HUM GENET, V55, P1106; Kretsinger R H, 1980, Ann N Y Acad Sci, V356, P14, DOI 10.1111/j.1749-6632.1980.tb29594.x; LAWLER J, 1983, J BIOL CHEM, V258, P2098; LAWLER J, 1992, BIOCHEMISTRY-US, V31, P1173, DOI 10.1021/bi00119a029; LAWLER J, 1995, MOL BASIS THROMBOSIS; MAYNARD JA, 1972, LAB INVEST, V26, P40; MEWAR R, 1993, CYTOGENET CELL GENET, V64, P1, DOI 10.1159/000133547; MISENHEIMER TM, 1995, J BIOL CHEM, V270, P1729, DOI 10.1074/jbc.270.4.1729; MORGELIN M, 1992, J BIOL CHEM, V267, P6137; NEWTON G, 1994, GENOMICS, V24, P435, DOI 10.1006/geno.1994.1649; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; PEDRINIMILLE A, 1984, J BONE JOINT SURG AM, V66A, P1408, DOI 10.2106/00004623-198466090-00014; PROCKOP DJ, 1984, AM J HUM GENET, V36, P499; QABAR AN, 1994, J BIOL CHEM, V269, P1262; SAGE EH, 1991, J BIOL CHEM, V266, P14831; Sambrook J., 1989, MOL CLONING LAB MANU; SPRANGER J, 1974, BONE DYSPLASIA ATLAS; STANESCU R, 1993, AM J MED GENET, V45, P501, DOI 10.1002/ajmg.1320450420; STANESCU V, 1994, AM J MED GENET, V51, P22, DOI 10.1002/ajmg.1320510106; WYNNEDAVIES R, 1986, J MED GENET, V23, P425, DOI 10.1136/jmg.23.5.425	37	297	304	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1995	10	3					325	329		10.1038/ng0795-325	http://dx.doi.org/10.1038/ng0795-325			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG386	7670471				2022-12-17	WOS:A1995RG38600017
J	Sausen, M; Leary, RJ; Jones, S; Wu, J; Reynolds, CP; Liu, XY; Blackford, A; Parmigiani, G; Diaz, LA; Papadopoulos, N; Vogelstein, B; Kinzler, KW; Velculescu, VE; Hogarty, MD				Sausen, Mark; Leary, Rebecca J.; Jones, Sian; Wu, Jian; Reynolds, C. Patrick; Liu, Xueyuan; Blackford, Amanda; Parmigiani, Giovanni; Diaz, Luis A., Jr.; Papadopoulos, Nickolas; Vogelstein, Bert; Kinzler, Kenneth W.; Velculescu, Victor E.; Hogarty, Michael D.			Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma	NATURE GENETICS			English	Article							CHROMATIN REMODELING GENES; CELL CARCINOMA; INACTIVATING MUTATIONS; ACTIVATING MUTATIONS; RECURRENT MUTATIONS; THERAPEUTIC TARGET; FREQUENT MUTATIONS; LUNG-CANCER; ALK KINASE; DNA	Neuroblastomas are tumors of peripheral sympathetic neurons and are the most common solid tumor in children. To determine the genetic basis for neuroblastoma, we performed whole-genome sequencing (6 cases), exome sequencing (16 cases), genome-wide rearrangement analyses (32 cases) and targeted analyses of specific genomic loci (40 cases) using massively parallel sequencing. On average, each tumor had 19 somatic alterations in coding genes (range of 3-70). Among genes not previously known to be involved in neuroblastoma, chromosomal deletions and sequence alterations of the chromatin-remodeling genes ARID1A and ARID1B were identified in 8 of 71 tumors (11%) and were associated with early treatment failure and decreased survival. Using tumor-specific structural alterations, we developed an approach to identify rearranged DNA fragments in sera, providing personalized biomarkers for minimal residual disease detection and monitoring. These results highlight the dysregulation of chromatin remodeling in pediatric tumorigenesis and provide new approaches for the management of patients with neuroblastoma.	[Sausen, Mark; Leary, Rebecca J.; Jones, Sian; Wu, Jian; Diaz, Luis A., Jr.; Papadopoulos, Nickolas; Vogelstein, Bert; Kinzler, Kenneth W.; Velculescu, Victor E.] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD USA; [Reynolds, C. Patrick] Texas Tech Univ Hlth Sci Ctr, Ctr Canc, Lubbock, TX USA; [Liu, Xueyuan; Hogarty, Michael D.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Parmigiani, Giovanni] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Baltimore, MD USA; [Parmigiani, Giovanni] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Vogelstein, Bert] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Howard Hughes Med Inst, Baltimore, MD USA; [Hogarty, Michael D.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins Medicine; Texas Tech University System; Texas Tech University Health Science Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Harvard T.H. Chan School of Public Health; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; University of Pennsylvania; Pennsylvania Medicine	Velculescu, VE (corresponding author), Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD USA.	velculescu@jhmi.edu; hogartym@email.chop.edu	Velculescu, Victor/ABF-4846-2020	Velculescu, Victor/0000-0003-1195-438X; Sausen, Mark/0000-0002-2916-5269; Reynolds, C. Patrick/0000-0002-2827-8536; Diaz, Luis/0000-0002-7079-8914	US National Institutes of Health (NIH) [CA121113]; NATIONAL CANCER INSTITUTE [R01CA121113, R37CA057345, R37CA043460] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the families and children with neuroblastoma who contributed to this work. We thank J. Maris for valuable input to this work, J. Ptak, N. Silliman, L. Dobbyn, M. Whalen, J. Schaefer and T. Mosbruger for technical assistance with sequencing analyses, L. Kann and S. Angiuoli of Personal Genome Diagnostics for targeted sequence analyses, the Children's Oncology Group (COG), W. B. London and the COG Statistics and Data Center, J. Gastier-Foster and the Neuroblastoma Reference Laboratory, N. Ramirez and the Biopathology Center, C. Winter and the Children's Hospital of Philadelphia (CHOP) Nucleic Acids Bank, and T. Woodburn and the COG Cell Line Repository. This work was generously supported by the St. Baldrick's Foundation for childhood cancer research, the Virginia and D. K. Ludwig Fund for Cancer Research, Swim Across America, an American Association for Cancer Research (AACR) Stand Up To Cancer-Dream Team Translational Cancer Research Grant and US National Institutes of Health (NIH) grant CA121113.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bettegowda C, 2011, SCIENCE, V333, P1453, DOI 10.1126/science.1210557; BRODEUR GM, 1986, CANCER GENET CYTOGEN, V19, P101, DOI 10.1016/0165-4608(86)90377-8; Capasso M, 2010, CANCER TREAT RES, V155, P65, DOI 10.1007/978-1-4419-6033-7_4; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Cheung NKV, 2012, JAMA-J AM MED ASSOC, V307, P1062, DOI 10.1001/jama.2012.228; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Combaret V, 2002, CANCER RES, V62, P3646; Cotterman R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005799; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hogarty MD, 2008, CANCER RES, V68, P9735, DOI 10.1158/0008-5472.CAN-07-6866; Ichimura K, 2006, ONCOGENE, V25, P1261, DOI 10.1038/sj.onc.1209156; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KNUDSON AG, 1976, NEW ENGL J MED, V295, P1120, DOI 10.1056/NEJM197611112952007; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mueller S, 2009, CURR ONCOL REP, V11, P431, DOI 10.1007/s11912-009-0059-6; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Ries LAG, 1999, CANC INCIDENCE SURVI, V99-4649.; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang K, 2011, NATURE, V469, P216, DOI 10.1038/nature09609; Wang Q, 2006, CANCER RES, V66, P6050, DOI 10.1158/0008-5472.CAN-05-4618; Wang XM, 2004, BIOCHEM J, V383, P319, DOI 10.1042/BJ20040524; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123	53	296	332	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2013	45	1					12	U31		10.1038/ng.2493	http://dx.doi.org/10.1038/ng.2493			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	061HJ	23202128	Green Submitted, Green Accepted			2022-12-17	WOS:000312838800007
J	Stahl, EA; Wegmann, D; Trynka, G; Gutierrez-Achury, J; Do, R; Voight, BF; Kraft, P; Chen, R; Kallberg, HJ; Kurreeman, FAS; Kathiresan, S; Wijmenga, C; Gregersen, PK; Alfredsson, L; Siminovitch, KA; Worthington, J; de Bakker, PIW; Raychaudhuri, S; Plenge, RM				Stahl, Eli A.; Wegmann, Daniel; Trynka, Gosia; Gutierrez-Achury, Javier; Do, Ron; Voight, Benjamin F.; Kraft, Peter; Chen, Robert; Kallberg, Henrik J.; Kurreeman, Fina A. S.; Kathiresan, Sekar; Wijmenga, Cisca; Gregersen, Peter K.; Alfredsson, Lars; Siminovitch, Katherine A.; Worthington, Jane; de Bakker, Paul I. W.; Raychaudhuri, Soumya; Plenge, Robert M.		Diabet Genetics Replication Metaan; Myocardial Infarction Genetics Con	Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CELIAC-DISEASE; GENETIC SUSCEPTIBILITY; MISSING HERITABILITY; HEART-DISEASE; HUMAN HEIGHT; COMMON SNPS; RISK LOCI; VARIANTS	The genetic architectures of common, complex diseases are largely uncharacterized. We modeled the genetic architecture underlying genome-wide association study (GWAS) data for rheumatoid arthritis and developed a new method using polygenic risk-score analyses to infer the total liability-scale variance explained by associated GWAS SNPs. Using this method, we estimated that, together, thousands of SNPs from rheumatoid arthritis GWAS explain an additional 20% of disease risk (excluding known associated loci). We further tested this method on datasets for three additional diseases and obtained comparable estimates for celiac disease (43% excluding the major histocompatibility complex), myocardial infarction and coronary artery disease (48%) and type 2 diabetes (49%). Our results are consistent with simulated genetic models in which hundreds of associated loci harbor common causal variants and a smaller number of loci harbor multiple rare causal variants. These analyses suggest that GWAS will continue to be highly productive for the discovery of additional susceptibility loci for common diseases.	[Stahl, Eli A.; Chen, Robert; Kurreeman, Fina A. S.; Raychaudhuri, Soumya; Plenge, Robert M.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Stahl, Eli A.; Do, Ron; Chen, Robert; Kurreeman, Fina A. S.; Kathiresan, Sekar; de Bakker, Paul I. W.; Raychaudhuri, Soumya; Plenge, Robert M.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Stahl, Eli A.; Chen, Robert; Kurreeman, Fina A. S.; de Bakker, Paul I. W.; Raychaudhuri, Soumya; Plenge, Robert M.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Wegmann, Daniel] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Trynka, Gosia; Gutierrez-Achury, Javier; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Trynka, Gosia; Gutierrez-Achury, Javier; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Do, Ron; Kathiresan, Sekar] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA; [Do, Ron; Kathiresan, Sekar] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA USA; [Voight, Benjamin F.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Kallberg, Henrik J.; Alfredsson, Lars] Karolinska Inst Hosp Solna, Inst Environm Med, Stockholm, Sweden; [Gregersen, Peter K.] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Siminovitch, Katherine A.] Univ Toronto, Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Siminovitch, Katherine A.] Univ Hlth Network, Toronto, ON, Canada; [Worthington, Jane] Univ Manchester, Arthrit Res UK Epidemiol Unit, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Epidemiol, Utrecht, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; University of California System; University of California Los Angeles; University of Groningen; University of Groningen; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet; Northwell Health; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Manchester; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Stahl, EA (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	estahl@rics.bwh.harvard.edu; rplenge@partners.org	Wijmenga, Cisca/D-2173-2009; Boehm, Bernhard Otto/F-8750-2015; Duga, Stefano/F-8173-2014; de Bakker, Paul IW/B-8730-2009; Alfredsson, Lars/AAC-9007-2019; Walters, G. Bragi/L-4215-2013; Wijmenga, Cisca/AAE-7719-2019; Elliott, Amanda/G-5120-2012; Meitinger, Thomas/O-1318-2015; Roden, Michael/AAD-3843-2019; Hide, Winston/R-3815-2019; FROGUEL, Philippe/O-6799-2017; Hide, Winston A/V-2727-2017; Ramos, Rafel/D-9627-2016; Ramos, Rafel/P-2083-2019; Wegmann, Daniel/K-2199-2012; Rudan, Igor/I-1467-2012; Benediktsson, Rafn/R-2457-2018; Hide, Winston Hide/C-7217-2009; Worthington, Jane/M-9770-2014; Siminovitch, Katherine/K-1475-2013; Langenberg, Claudia/ABG-9067-2021; Aulchenko, Yurii/M-8270-2013	Duga, Stefano/0000-0003-3457-1410; de Bakker, Paul IW/0000-0001-7735-7858; Alfredsson, Lars/0000-0003-1688-6697; Walters, G. Bragi/0000-0002-5415-6487; Wijmenga, Cisca/0000-0002-5635-1614; Hide, Winston/0000-0002-8621-3271; FROGUEL, Philippe/0000-0003-2972-0784; Hide, Winston A/0000-0002-8621-3271; Ramos, Rafel/0000-0001-7970-5537; Ramos, Rafel/0000-0001-7970-5537; Wegmann, Daniel/0000-0003-2866-6739; Rudan, Igor/0000-0001-6993-6884; Benediktsson, Rafn/0000-0002-2954-9801; Hide, Winston Hide/0000-0002-8621-3271; Worthington, Jane/0000-0003-0544-042X; Langenberg, Claudia/0000-0002-5017-7344; Marrugat, Jaume/0000-0003-3320-554X; Aulchenko, Yurii/0000-0002-7899-1575; Van Duijn, Cornelia/0000-0002-2374-9204; Dina, Christian/0000-0002-7722-7348; Berzuini, Carlo/0000-0001-6056-0489; Raychaudhuri, Soumya/0000-0002-1901-8265; Meitinger, Thomas/0000-0002-8838-8403; Lindgren, Cecilia/0000-0002-4903-9374; Jorgensen, Torben/0000-0001-9453-2830; Gutierrez-Achury, Javier/0000-0002-4971-1474; Zeggini, Eleftheria/0000-0003-4238-659X; Voight, Benjamin/0000-0002-6205-9994; Weedon, Michael/0000-0002-6174-6135; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Hattersley, Andrew/0000-0001-5620-473X; Gloyn, Anna/0000-0003-1205-1844; Melander, Olle/0000-0002-2581-484X; Trynka, Gosia/0000-0002-6955-9529; Asselta, Rosanna/0000-0001-5351-0619	US National Institutes of Health (NIH) [R01-AR057108, R01-AR056768, U01-GM092691, R01-AR059648]; NIH [K08AR055688-01A1, NO1-AR-2-2263, RO1-AR44422]; Crescendo and Biogen-Idec; National Institute of Arthritis, Musculoskeletal and Skin Diseases of the NIH; Canada Research Chair; Canadian Institutes for Health Research [MOP79321, IIN-84042]; Ontario Research Fund [RE01061]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044422, R01AR059648, R01AR057108, K08AR055688, R01AR056768, N01AR022263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER; Medical Research Council [MC_U106179471] Funding Source: researchfish	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crescendo and Biogen-Idec; National Institute of Arthritis, Musculoskeletal and Skin Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	R.M.P. is supported by grants from the US National Institutes of Health (NIH) (R01-AR057108, R01-AR056768, U01-GM092691 and R01-AR059648) and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. S. R. is supported by an NIH Career Development Award (K08AR055688-01A1). The Brigham Rheumatoid Arthritis Sequential Study Registry is supported by a grant from Crescendo and Biogen-Idec. The North American Rheumatoid Arthritis Consortium is supported by the NIH (NO1-AR-2-2263 and RO1-AR44422). This research was also supported in part by the Intramural Research Program of the National Institute of Arthritis, Musculoskeletal and Skin Diseases of the NIH and by a Canada Research Chair and grants to K. A. S. from the Canadian Institutes for Health Research (MOP79321 and IIN-84042) and the Ontario Research Fund (RE01061). We acknowledge S. Purcell, A. Price and N. Zaitlen for help with the design and implementation of the study and analysis.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Almgren P, 2011, DIABETOLOGIA, V54, P2811, DOI 10.1007/s00125-011-2267-5; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Bush WS, 2010, AM J HUM GENET, V86, P621, DOI 10.1016/j.ajhg.2010.02.027; Chen R, 2011, GENES IMMUN, V12, P314, DOI 10.1038/gene.2011.8; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Eijgelsheim M, 2010, HUM MOL GENET, V19, P3885, DOI 10.1093/hmg/ddq303; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Falconer DS, 1996, INTRO QUANTITATIVE G; Fisher R. A., 1918, PHILOS T ROYAL SOC E, V52, DOI DOI 10.1017/S0080456800012163; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Freudenberg J, 2010, HUM MOL GENET, V19, P3863, DOI 10.1093/hmg/ddq304; Hu XL, 2011, AM J HUM GENET, V89, P496, DOI 10.1016/j.ajhg.2011.09.002; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Leuenberger C, 2010, GENETICS, V184, P243, DOI 10.1534/genetics.109.109058; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Myocardial Infarction Genetics Consortium, 2009, NAT GENET, V41, P762; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nistico L, 2006, GUT, V55, P803, DOI 10.1136/gut.2005.083964; NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503; NORTON B, 1976, NOTES REC ROY SOC, V31, P151, DOI 10.1098/rsnr.1976.0005; Orozco G, 2010, HUM MOL GENET, V19, pR137, DOI 10.1093/hmg/ddq368; Painter JN, 2011, NAT GENET, V43, P51, DOI 10.1038/ng.731; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Park L, 2010, GENETICA, V138, P1147, DOI 10.1007/s10709-010-9505-5; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Pritchard JK, 2010, NAT REV GENET, V11, P665, DOI 10.1038/nrg2880; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Raychaudhuri S, 2010, CURR OPIN RHEUMATOL, V22, P109, DOI 10.1097/BOR.0b013e328336474d; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spencer C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001337; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; van der Woude D, 2009, ARTHRITIS RHEUM-US, V60, P916, DOI 10.1002/art.24385; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang K, 2010, AM J HUM GENET, V86, P730, DOI 10.1016/j.ajhg.2010.04.003; Wegmann D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-116; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; Wheeler E, 2011, BRIEF FUNCT GENOMICS, V10, P52, DOI 10.1093/bfgp/elr008; Wray NR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000579; Xue W, 2011, NATURE, V473, P544, DOI 10.1038/nature09909; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	59	296	300	0	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2012	44	5					483	+		10.1038/ng.2232	http://dx.doi.org/10.1038/ng.2232			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	934BW	22446960	Green Accepted			2022-12-17	WOS:000303416300006
J	Pfeufer, A; Sanna, S; Arking, DE; Muller, M; Gateva, V; Fuchsberger, C; Ehret, GB; Orru, M; Pattaro, C; Kottgen, A; Perz, S; Usala, G; Barbalic, M; Li, M; Putz, B; Scuteri, A; Prineas, RJ; Sinner, MF; Gieger, C; Najjar, SS; Kao, WHL; Muhleisen, TW; Dei, M; Happle, C; Mohlenkamp, S; Crisponi, L; Erbel, R; Jockel, KH; Naitza, S; Steinbeck, G; Marroni, F; Hicks, AA; Lakatta, E; Muller-Myhsok, B; Pramstaller, PP; Wichmann, HE; Schlessinger, D; Boerwinkle, E; Meitinger, T; Uda, M; Coresh, J; Kaab, S; Abecasis, GR; Chakravarti, A				Pfeufer, Arne; Sanna, Serena; Arking, Dan E.; Mueller, Martina; Gateva, Vesela; Fuchsberger, Christian; Ehret, Georg B.; Orru, Marco; Pattaro, Cristian; Koettgen, Anna; Perz, Siegfried; Usala, Gianluca; Barbalic, Maja; Li, Man; Puetz, Benno; Scuteri, Angelo; Prineas, Ronald J.; Sinner, Moritz F.; Gieger, Christian; Najjar, Samer S.; Kao, W. H. Linda; Muehleisen, Thomas W.; Dei, Mariano; Happle, Christine; Moehlenkamp, Stefan; Crisponi, Laura; Erbel, Raimund; Joeckel, Karl-Heinz; Naitza, Silvia; Steinbeck, Gerhard; Marroni, Fabio; Hicks, Andrew A.; Lakatta, Edward; Mueller-Myhsok, Bertram; Pramstaller, Peter P.; Wichmann, H-Erich; Schlessinger, David; Boerwinkle, Eric; Meitinger, Thomas; Uda, Manuela; Coresh, Josef; Kaeaeb, Stefan; Abecasis, Goncalo R.; Chakravarti, Aravinda			Common variants at ten loci modulate the QT interval duration in the QTSCD Study	NATURE GENETICS			English	Article							NOS1 REGULATOR NOS1AP; CARDIAC REPOLARIZATION; GENETIC VARIANT; HEART-FAILURE; POPULATION; DISEASE; MUTATION; KCNH2; RISK; ASSOCIATION	The QT interval, a measure of cardiac repolarization, predisposes to ventricular arrhythmias and sudden cardiac death ( SCD) when prolonged or shortened. A common variant in NOS1AP is known to influence repolarization. We analyze genome-wide data from five population-based cohorts (ARIC, KORA, SardiNIA, GenNOVA and HNR) with a total of 15,842 individuals of European ancestry, to confirm the NOS1AP association and identify nine additional loci at P < 5 x 10(-8). Four loci map near the monogenic long-QT syndrome genes KCNQ1, KCNH2, SCN5A and KCNJ2. Two other loci include ATP1B1 and PLN, genes with established electrophysiological function, whereas three map to RNF207, near LITAF and within NDRG4-GINS3-SETD6-CNOT1, respectively, all of which have not previously been implicated in cardiac electrophysiology. These results, together with an accompanying paper from the QTGEN consortium, identify new candidate genes for ventricular arrhythmias and SCD.	[Arking, Dan E.; Ehret, Georg B.; Chakravarti, Aravinda] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA; [Pfeufer, Arne; Happle, Christine; Meitinger, Thomas] Helmholtz Ctr Munich, Inst Human Genet, Munich, Germany; [Pfeufer, Arne; Happle, Christine; Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-80804 Munich, Germany; [Sanna, Serena; Orru, Marco; Usala, Gianluca; Crisponi, Laura; Naitza, Silvia; Uda, Manuela] CNR, Ist Neurogenet & Neurofarmacol, Cagliari, Italy; [Mueller, Martina; Gieger, Christian; Wichmann, H-Erich] Helmholtz Ctr Munich, Inst Epidemiol, Munich, Germany; [Mueller, Martina; Wichmann, H-Erich] Univ Munich, Inst Informat Biometry & Epidemiol, Munich, Germany; [Mueller, Martina; Sinner, Moritz F.; Kaeaeb, Stefan] Univ Munich, Klinikum Grosshadern, Dept Med 1, D-80804 Munich, Germany; [Gateva, Vesela; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Fuchsberger, Christian; Pattaro, Cristian; Marroni, Fabio; Hicks, Andrew A.; Pramstaller, Peter P.] EURAC European Acad, Inst Med Genet, Bolzano, Italy; [Koettgen, Anna; Li, Man; Kao, W. H. Linda; Coresh, Josef] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Perz, Siegfried] Helmholtz Ctr Munich, Inst Med Informat, Munich, Germany; [Barbalic, Maja; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Genet Ctr, Houston, TX USA; [Puetz, Benno; Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Scuteri, Angelo] Ist Ricovero & Cura Anziani, Unita Operat Geriatria, Rome, Italy; [Prineas, Ronald J.] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; [Najjar, Samer S.; Lakatta, Edward] NIA, Cardiovasc Sci Lab, Gerontol Res Ctr, Baltimore, MD 21224 USA; [Muehleisen, Thomas W.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-5300 Bonn, Germany; [Muehleisen, Thomas W.] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; [Moehlenkamp, Stefan; Erbel, Raimund] Univ Duisburg Essen, Univ Hosp Essen, W German Heart Ctr, Clin Cardiol, Duisburg, Germany; [Joeckel, Karl-Heinz] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Duisburg, Germany; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, Bolzano, Italy; [Pramstaller, Peter P.] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; [Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA; [Coresh, Josef; Chakravarti, Aravinda] Johns Hopkins Univ, Dept Med, Baltimore, MD USA	Johns Hopkins University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Consiglio Nazionale delle Ricerche (CNR); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Michigan System; University of Michigan; European Academy of Bozen-Bolzano; Johns Hopkins University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Texas System; University of Texas Health Science Center Houston; Max Planck Society; Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Bonn; University of Bonn; University of Duisburg Essen; University of Duisburg Essen; Krankenhaus Bozen; University of Lubeck; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University	Chakravarti, A (corresponding author), Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA.	arne.pfeufer@helmholtz-muenchen.de; aravinda@jhmi.edu	Meitinger, Thomas/O-1318-2015; Uda, Manuela/AAC-2645-2019; Hicks, Andrew Anthony/E-9518-2017; Müller-Nurasyid, Martina/I-8735-2018; Wichmann, Heinz Erich/AAA-5695-2022; Crisponi, Laura/AAC-2642-2019; Barbalić, Maja/E-2161-2017; Pramstaller, Peter P/C-2357-2008; Kaab, Stefan/H-3915-2012; Pfeufer, Arne/B-6634-2013; sanna, serena/H-3009-2019; Pütz, Benno/P-2630-2016; Fuchsberger, Christian/C-9646-2010; Fuchsberger, Christian/ABD-7127-2021; Li, Man/AAX-3400-2020; Sinner, Moritz/AAW-5043-2020; EHRET, Georg B/A-9532-2009; Dei, Mariano/AAY-3870-2020; Kottgen, Anna/D-2920-2012; Naitza, Silvia/D-5620-2017; Möhlenkamp, Stefan/AGG-1320-2022; NAITZA, SILVIA/AAB-8775-2022; Abecasis, Goncalo R/B-7840-2010; Lakatta, Edward G/AAL-1447-2020; Marroni, Fabio/R-1819-2017; Müller-Myhsok, Bertram/A-3289-2013	Uda, Manuela/0000-0002-4890-6456; Hicks, Andrew Anthony/0000-0001-6320-0411; Müller-Nurasyid, Martina/0000-0003-3793-5910; Crisponi, Laura/0000-0001-9128-8537; Barbalić, Maja/0000-0001-8914-1691; sanna, serena/0000-0002-3768-1749; Pütz, Benno/0000-0002-2208-209X; Fuchsberger, Christian/0000-0002-5918-8947; Li, Man/0000-0002-3839-0281; EHRET, Georg B/0000-0002-5730-0675; NAITZA, SILVIA/0000-0002-0108-757X; Marroni, Fabio/0000-0002-1556-5907; Dei, Mariano/0000-0002-7404-508X; SCUTERI, ANGELO/0000-0003-4784-5441; Lakatta, Edward/0000-0002-4772-0035; Abecasis, Goncalo/0000-0003-1509-1825; Meitinger, Thomas/0000-0002-8838-8403; Gieger, Christian/0000-0001-6986-9554	National Heart, Lung, and Blood Institute [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367, R01HL086694]; National Human Genome Research Institute [U01HG004402]; National Institutes of Health [HHSN268200625226C, UL1RR025005]; NHLBI [HL86694, HL054512]; Donald W. Reynolds Cardiovascular Clinical Research Center at Johns Hopkins University; German Research Foundation Fellowship; German Federal Ministry of Education and Research (BMBF); German National Genome Research Network (NGFN); German National Competence network on atrial fibrillation (AFNET); Bioinformatics for the Functional Analysis of Mammalian Genomes [NGFN 01GS0499, 01GS0838, AF-Net01GI0204/N]; Fondation Leducq; State of Bavaria; National Institute on Aging [NO1-AG-1-2109]; National Institute on Aging to the University of Michigan [263-MA-410953]; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; Ministry of Health of the Autonomous Province of Bolzano; South Tyrolean Sparkasse Foundation; Heinz Nixdorf Foundation;  [NGFN 01GR0803];  [01EZ0874];  [NGFN 01GI0204];  [NGFN 01GR0103]; NATIONAL INSTITUTE ON AGING [ZIAAG000675, ZIAAG000799] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Donald W. Reynolds Cardiovascular Clinical Research Center at Johns Hopkins University(Johns Hopkins University); German Research Foundation Fellowship(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network (NGFN); German National Competence network on atrial fibrillation (AFNET); Bioinformatics for the Functional Analysis of Mammalian Genomes; Fondation Leducq(Leducq Foundation); State of Bavaria; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging to the University of Michigan(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ministry of Health of the Autonomous Province of Bolzano(Pronvincia Autonoma di Bolzano); South Tyrolean Sparkasse Foundation; Heinz Nixdorf Foundation; ; ; ; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We gratefully acknowledge all participants in the community-based studies of ARIC, KORA, SardiNIA, GenNOVA and Heinz Nixdorf Recall Study, and all the members of our laboratories for helpful discussion of this study. We thank G. Fischer for help with genotype imputation and data management for the KORA samples, Y. Li for her help on statistical analysis, K. Tarasov for in silico promotor analysis, A. Cao for his valuable advice and support in the SardiNIA project and all ARIC, KORA, SardiNIA, GenNOVA and Heinz Nixdorf Recall Study investigators for study design and continued operation. We also thank C. Egger and Y. D'Elia for the valuable support in data management and data administration; S. Melville and M. Facheris for the important work of drug classification in the GenNOVA project; and the primary care practitioners R. Stocker, S. Waldner, T. Pizzecco, J. Plangger, U. Marcadent and the personnel of the Hospital of Silandro (Department of Laboratory Medicine) for their participation and collaboration in the GenNOVA project. ARIC is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. In addition, we acknowledge support from NHLBI grants HL86694 and HL054512, and the Donald W. Reynolds Cardiovascular Clinical Research Center at Johns Hopkins University for genotyping and data analysis relevant to this study. A. K. is supported by a German Research Foundation Fellowship.; The KORA study was funded by grants by the German Federal Ministry of Education and Research (BMBF) in the context of the German National Genome Research Network (NGFN), the German National Competence network on atrial fibrillation (AFNET) and the Bioinformatics for the Functional Analysis of Mammalian Genomes program (BFAM) by grants to S. K. (NGFN 01GS0499, 01GS0838 and AF-Net01GI0204/N), A. P. (NGFN 01GR0803, 01EZ0874), H.-E. W. (NGFN 01GI0204) and to T. M. (NGFN 01GR0103). S. K. is also supported by a grant from the Fondation Leducq. The KORA platform is funded by the BMBF and by the State of Bavaria.; The SardiNIA team was supported by Contract NO1-AG-1-2109 from the National Institute on Aging and in part by the Intramural Research Program of the US National Institute on Aging, NIH. The efforts of G. R. A. were supported in part by contract 263-MA-410953 from the National Institute on Aging to the University of Michigan and by research grants from the National Human Genome Research Institute and the National Heart, Lung, and Blood Institute (to G. R. A.). The GenNOVA study was supported by the Ministry of Health of the Autonomous Province of Bolzano and the South Tyrolean Sparkasse Foundation. The Heinz Nixdorf Recall Study was funded by a grant of the Heinz Nixdorf Foundation (Chairman: G. Schmidt).	Aarnoudse AJLHJ, 2007, CIRCULATION, V116, P10, DOI 10.1161/CIRCULATIONAHA.106.676783; Akyol M, 2007, EUR HEART J, V28, P305, DOI 10.1093/eurheartj/ehl460; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Arking DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004333; Arking DE, 2004, CIRC RES, V94, P712, DOI 10.1161/01.RES.0000123861.16082.95; Bezzina CR, 2003, CARDIOVASC RES, V59, P27, DOI 10.1016/S0008-6363(03)00342-0; Chang YPC, 2007, AM J HUM GENET, V80, P253, DOI 10.1086/510918; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Friedlander Y, 2005, ANN HUM GENET, V69, P645, DOI 10.1046/j.1529-8817.2005.00182.x; Gouas L, 2005, EUR J HUM GENET, V13, P1213, DOI 10.1038/sj.ejhg.5201489; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Kao WHL, 2009, CIRCULATION, V119, P940, DOI 10.1161/CIRCULATIONAHA.108.791723; Liu Y, 2000, CYTOGENET CELL GENET, V90, P60, DOI 10.1159/000015662; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; MOSS AJ, 1991, CIRCULATION, V84, P1136, DOI 10.1161/01.CIR.84.3.1136; Newton-Cheh C, 2007, CIRCULATION, V116, P1128, DOI 10.1161/CIRCULATIONAHA.107.710780; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Pattaro C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-29; Pfeufer A, 2005, CIRC RES, V96, P693, DOI 10.1161/01.RES.0000161077.53751.e6; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Post W, 2007, HUM HERED, V64, P214, DOI 10.1159/000103630; Qu XH, 2008, DEV BIOL, V317, P486, DOI 10.1016/j.ydbio.2008.02.044; RAUTAHARJU PM, 1992, CAN J CARDIOL, V8, P690; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Scherf M, 2000, J MOL BIOL, V297, P599, DOI 10.1006/jmbi.2000.3589; Schmermund A, 2002, AM HEART J, V144, P212, DOI 10.1067/mhj.2002.123579; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; SCHOUTEN EG, 1991, CIRCULATION, V84, P1516, DOI 10.1161/01.CIR.84.4.1516; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Street VA, 2003, NEUROLOGY, V60, P22, DOI 10.1212/WNL.60.1.22; Tobin MD, 2008, INT J EPIDEMIOL, V37, P1132, DOI 10.1093/ije/dyn091; TOMASELLI GF, 1994, CIRCULATION, V90, P2534, DOI 10.1161/01.CIR.90.5.2534; Vrtovec B, 2003, CIRCULATION, V107, P1764, DOI 10.1161/01.CIR.0000057980.84624.95; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	41	296	305	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					407	414		10.1038/ng.362	http://dx.doi.org/10.1038/ng.362			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19305409	Green Accepted, Green Submitted			2022-12-17	WOS:000264659000013
J	GHOSH, S; PALMER, SM; RODRIGUES, NR; CORDELL, HJ; HEARNE, CM; CORNALL, RJ; PRINS, JB; MCSHANE, P; LATHROP, GM; PETERSON, LB; WICKER, LS; TODD, JA				GHOSH, S; PALMER, SM; RODRIGUES, NR; CORDELL, HJ; HEARNE, CM; CORNALL, RJ; PRINS, JB; MCSHANE, P; LATHROP, GM; PETERSON, LB; WICKER, LS; TODD, JA			POLYGENIC CONTROL OF AUTOIMMUNE DIABETES IN NONOBESE DIABETIC MICE	NATURE GENETICS			English	Article							MOUSE GENOME; MICROSATELLITE MARKERS; MURINE INTERLEUKIN-2; LINKAGE ANALYSIS; GENE; SUSCEPTIBILITY; RAT; MAP; CHROMOSOME-1; RESOLUTION	Partial exclusion mapping of the nonobese (NOD) diabetic mouse genome has shown linkage of diabetes to at least five different chromosomes. We have now excluded almost all of the genome for the presence of susceptibility genes with fully recessive effects and have obtained evidence of linkage of ten distinct loci to diabetes or the prediabetic lesion, insulitis, indicative of a polygenic mode of inheritance. The relative importance of these loci and their interactions have been assessed using a new application of multiple polychotomous regression methods. A candidate disease gene, interleukin-2 (Il-2), which is closely linked to insulitis and diabetes, is shown to have a different sequence in NOD, including an insertion and a deletion of tandem repeat sequences which encode amino acid repeats in the mature protein.	UNIV OXFORD, JOHN RADCLIFFE HOSP, NUFFIELD DEPT SURG, OXFORD OX3 9DU, ENGLAND; INSERM, F-75010 PARIS, FRANCE; MERCK RES LABS, DEPT CELLULAR & MOLEC PHARMACOL, RAHWAY, NJ 07065 USA; MERCK RES LABS, DEPT AUTOIMMUNE DIS RES, RAHWAY, NJ USA	University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); Merck & Company; Merck & Company			Wicker, Linda S/F-7384-2010; Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148; Cordell, Heather/0000-0002-1879-5572; Prins, Jan-Bas/0000-0002-1831-8522	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AITMAN TJ, 1991, MAMM GENOME, V1, P206, DOI 10.1007/BF00352326; BAIN SC, 1992, NAT GENET, V2, P212, DOI 10.1038/ng1192-212; CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243; CORNALL RJ, 1991, GENOMICS, V10, P874, DOI 10.1016/0888-7543(91)90175-E; CORNALL RJ, 1991, NATURE, V353, P262, DOI 10.1038/353262a0; CORNALL RJ, 1992, MAMM GENOME, V3, P620, DOI 10.1007/BF00352478; Crow J. F., 1986, BASIC CONCEPTS POPUL; DEGOUYON B, 1993, P NATL ACAD SCI USA, V90, P1877, DOI 10.1073/pnas.90.5.1877; DEGRAVE W, 1986, MOL BIOL REP, V11, P57, DOI 10.1007/BF00417597; DIETRICH W, 1992, GENETICS, V131, P423; DIETRICH W, 1993, GENETIC MAPS LOCUS M; Dixon W. J., 1990, BMDP STATISTICAL SOF; FLEMMING CL, 1993, EUR J IMMUNOL, V23, P917, DOI 10.1002/eji.1830230423; GARCHON HJ, 1991, NATURE, V353, P260, DOI 10.1038/353260a0; HEARNE CM, 1991, MAMM GENOME, V1, P273, DOI 10.1007/BF00352339; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; JACOB HJ, 1992, NAT GENET, V2, P56, DOI 10.1038/ng0992-56; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KASHIMA N, 1985, NATURE, V313, P402, DOI 10.1038/313402a0; KROEMER G, 1991, ADV IMMUNOL, V50, P147; LOVE JM, 1990, NUCLEIC ACIDS RES, V18, P4123, DOI 10.1093/nar/18.14.4123; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MATESANZ F, 1992, BIOCHIM BIOPHYS ACTA, V1132, P335, DOI 10.1016/0167-4781(92)90174-X; MATESANZ F, IN PRESS IMMUNOGENET; MCALEER MA, 1992, MAMM GENOME, V3, P457, DOI 10.1007/BF00356156; MORTON NE, 1991, ANN HUM GENET, V55, P301, DOI 10.1111/j.1469-1809.1991.tb00857.x; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; POUSTKA A, 1984, P NATL ACAD SCI-BIOL, V81, P4129, DOI 10.1073/pnas.81.13.4129; PRINS JB, 1993, SCIENCE, V260, P695, DOI 10.1126/science.8480181; RIGGINS GJ, 1992, NAT GENET, V2, P186, DOI 10.1038/ng1192-186; RISCH N, IN PRESS AM J HUM GE; RISE ML, 1991, SCIENCE, V253, P669, DOI 10.1126/science.1871601; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; WICKER LS, 1992, J EXP MED, V176, P67, DOI 10.1084/jem.176.1.67; ZURAWSKI SM, 1986, J IMMUNOL, V137, P3354	38	296	298	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1993	4	4					404	409		10.1038/ng0893-404	http://dx.doi.org/10.1038/ng0893-404			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LQ178	8401590				2022-12-17	WOS:A1993LQ17800020
J	Hughes, JR; Roberts, N; McGowan, S; Hay, D; Giannoulatou, E; Lynch, M; De Gobbi, M; Taylor, S; Gibbons, R; Higgs, DR				Hughes, Jim R.; Roberts, Nigel; McGowan, Simon; Hay, Deborah; Giannoulatou, Eleni; Lynch, Magnus; De Gobbi, Marco; Taylor, Stephen; Gibbons, Richard; Higgs, Douglas R.			Analysis of hundreds of cis-regulatory landscapes at high resolution in a single, high-throughput experiment	NATURE GENETICS			English	Article							PRIMARY ERYTHROID-CELLS; CHROMOSOME CONFORMATION; HUMAN GENOME; GENE-EXPRESSION; CHROMATIN INTERACTIONS; MOUSE GENOME; ENHANCER; CAPTURE; ERYTHROPOIESIS; IDENTIFICATION	Gene expression during development and differentiation is regulated in a cell-and stage-specific manner by complex networks of intergenic and intragenic cis-regulatory elements whose numbers and representation in the genome far exceed those of structural genes. Using chromosome conformation capture, it is now possible to analyze in detail the interaction between enhancers, silencers, boundary elements and promoters at individual loci, but these techniques are not readily scalable. Here we present a high-throughput approach (Capture-C) to analyze cis interactions, interrogating hundreds of specific interactions at high resolution in a single experiment. We show how this approach will facilitate detailed, genome-wide analysis to elucidate the general principles by which cis-acting sequences control gene expression. In addition, we show how Capture-C will expedite identification of the target genes and functional effects of SNPs that are associated with complex diseases, which most frequently lie in intergenic cis-acting regulatory elements.	[Hughes, Jim R.; Roberts, Nigel; Hay, Deborah; Lynch, Magnus; De Gobbi, Marco; Gibbons, Richard; Higgs, Douglas R.] Univ Oxford, MRC, Mol Haematol Unit, Weatherall Inst Mol Med, Oxford, England; [McGowan, Simon; Giannoulatou, Eleni; Taylor, Stephen] Univ Oxford, Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford, England	University of Oxford; University of Oxford	Higgs, DR (corresponding author), Univ Oxford, MRC, Mol Haematol Unit, Weatherall Inst Mol Med, Oxford, England.	jim.hughes@imm.ox.ac.uk; doug.higgs@imm.ox.ac.uk	De Gobbi, Marco/E-8136-2013; Gibbons, Richard/E-6937-2011	Gibbons, Richard/0000-0002-7680-9311; De Gobbi, Marco/0000-0003-4261-7642; Roberts, Nigel/0000-0002-5091-3604; Lynch, Magnus/0000-0001-7586-4338; McGowan, Simon/0000-0001-9720-1914; Giannoulatou, Eleni/0000-0002-7084-6736; Higgs, Douglas/0000-0003-3579-8705	Wellcome Trust [090532/Z/09/Z]; MRC Hub grant [G0900747 91070]; EpiGeneSys; MRC [MC_UU_12009/4, G1000801, MC_UU_12009/15, G0902418] Funding Source: UKRI; Medical Research Council [G0902418, MC_UU_12009/15, G1000801, G1000801b, MC_UU_12009/4] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC Hub grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EpiGeneSys; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Davies and P. Piazza for technical suggestions. We thank M. Suciu, B. Graham and T. Milne for suggestions and critically reading the manuscript. We thank Z.-P. Han and J. Telenius for computational support. We thank the HighThroughput Genomics Group at the Wellcome Trust Centre for Human Genetics (funded by Wellcome Trust grant reference 090532/Z/09/Z and MRC Hub grant G0900747 91070) for the generation of the sequencing data. This work was supported by the MRC (UK) and by the Blood theme within Oxford Biomedical Research Centre (which is part of the National Institute for Health Research Biomedical Research Centres scheme). We also thank EpiGeneSys for support.	Amigo JD, 2011, MOL CELL BIOL, V31, P1344, DOI 10.1128/MCB.01010-10; Bainbridge MN, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r62; Bau D, 2011, NAT STRUCT MOL BIOL, V18, P107, DOI 10.1038/nsmb.1936; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; De Gobbi M, 2007, BLOOD, V110, P4503, DOI 10.1182/blood-2007-06-097964; de Laat W, 2012, METHODS, V58, P189, DOI 10.1016/j.ymeth.2012.11.005; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ferreira R, 2013, MOL CELL BIOL, V33, P1254, DOI 10.1128/MCB.01525-12; Flygare J, 2011, BLOOD, V117, P3435, DOI 10.1182/blood-2010-07-295550; Gondor A, 2008, NAT PROTOC, V3, P303, DOI 10.1038/nprot.2007.540; Gottgens B, 2004, MOL CELL BIOL, V24, P1870, DOI 10.1128/MCB.24.5.1870-1883.2004; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Horakova AH, 2012, HUM MOL GENET, V21, P4367, DOI 10.1093/hmg/dds270; Hosseini M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003570; Hughes JR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0361; Hughes JR, 2005, P NATL ACAD SCI USA, V102, P9830, DOI 10.1073/pnas.0503401102; Kang JH, 2004, EUR J BIOCHEM, V271, P2452, DOI 10.1111/j.1432-1033.2004.04175.x; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kolovos P, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-1; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lower KM, 2009, P NATL ACAD SCI USA, V106, P21771, DOI 10.1073/pnas.0909331106; McGowan SJ, 2013, BIOINFORMATICS, V29, P2477, DOI 10.1093/bioinformatics/btt406; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Ogilvy S, 2007, MOL CELL BIOL, V27, P7206, DOI 10.1128/MCB.00931-07; Papadopoulos GL, 2013, NUCLEIC ACIDS RES, V41, P4938, DOI 10.1093/nar/gkt167; Pennacchio LA, 2013, NAT REV GENET, V14, P288, DOI 10.1038/nrg3458; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Sajan SA, 2012, ANNU REV GENOM HUM G, V13, P59, DOI 10.1146/annurev-genom-090711-163818; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; SPIVAK JL, 1973, BLOOD, V42, P257, DOI 10.1182/blood.V42.2.257.257; Stadhouders R, 2013, NAT PROTOC, V8, P509, DOI 10.1038/nprot.2013.018; Stein LD, 2013, BRIEF BIOINFORM, V14, P162, DOI 10.1093/bib/bbt001; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Tarailo-Graovac Maja, 2009, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s25; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; Vavouri T, 2006, TRENDS GENET, V22, P5, DOI 10.1016/j.tig.2005.10.005; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Vernimmen D, 2009, BLOOD, V114, P4253, DOI 10.1182/blood-2009-03-213439; Wallace HAC, 2007, CELL, V128, P197, DOI 10.1016/j.cell.2006.11.044; Zhou Z, 2010, J BIOL CHEM, V285, P15894, DOI 10.1074/jbc.M109.098376	52	295	303	0	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					205	+		10.1038/ng.2871	http://dx.doi.org/10.1038/ng.2871			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24413732	Green Submitted			2022-12-17	WOS:000331208300020
J	Jones, AV; Chase, A; Silver, RT; Oscier, D; Zoi, K; Wang, YL; Cario, H; Pahl, HL; Collins, A; Reiter, A; Grand, F; Cross, NCP				Jones, Amy V.; Chase, Andrew; Silver, Richard T.; Oscier, David; Zoi, Katerina; Wang, Y. Lynn; Cario, Holger; Pahl, Heike L.; Collins, Andrew; Reiter, Andreas; Grand, Francis; Cross, Nicholas C. P.			JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; SUSCEPTIBILITY LOCI; ESSENTIAL THROMBOCYTHEMIA; CANCER SUSCEPTIBILITY; ACTIVATING MUTATION; MYELOID METAPLASIA; DISORDERS; MYELOFIBROSIS	Chronic myeloproliferative neoplasms (MPNs) are a group of related conditions characterized by the overproduction of cells from one or more myeloid lineages. More than 95% of cases of polycythemia vera, and roughly half of essential thrombocythemia and primary myelofibrosis acquire a unique somatic 1849G> T JAK2 mutation (encoding V617F) that is believed to be a critical driver of excess proliferation(1-4). We report here that JAK2(V617F)-associated disease is strongly associated with a specific constitutional JAK2 haplotype, designated 46/1, in all three disease entities compared to healthy controls ( polycythemia vera, n = 192, P = 2.9 x 10(-16); essential thrombocythemia, n 78, P = 8.2 x 10(-9) and myelofibrosis, n = 41, P = 8.0 x 10(-5)). Furthermore, JAK2(V617F) specifically arises on the 46/1 allele in most cases. The 46/1 JAK2 haplotype thus predisposes to the development of JAK2(V617F)-associated MPNs (OR 3.7; 95% CI = 3.1-4.3) and provides a model whereby a constitutional genetic factor is associated with an increased risk of acquiring a specific somatic mutation.	[Jones, Amy V.; Chase, Andrew; Grand, Francis; Cross, Nicholas C. P.] Wessex Reg Genet Lab, Salisbury, Wilts, England; [Jones, Amy V.; Chase, Andrew; Collins, Andrew; Grand, Francis; Cross, Nicholas C. P.] Univ Southampton, Div Human Genet, Southampton SO9 5NH, Hants, England; [Silver, Richard T.; Wang, Y. Lynn] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Oscier, David] Royal Bournemouth Hosp, Dept Haematol, Bournemouth, Dorset, England; [Zoi, Katerina] Acad Athens, Biomed Res Fdn, Haematol Res Lab, Athens, Greece; [Cario, Holger] Univ Hosp Ulm, Dept Pediat & Adolescent Med, Ulm, Germany; [Pahl, Heike L.] Univ Hosp Freiburg, Dept Expt Anaesthesiol, Freiburg, Germany; [Reiter, Andreas] Univ Heidelberg, Fak Klin Med Mannheim, Med Univ Klin 3, D-6900 Heidelberg, Germany	University of Southampton; Cornell University; Academy of Athens; Ulm University; University of Freiburg; Ruprecht Karls University Heidelberg	Cross, NCP (corresponding author), Wessex Reg Genet Lab, Salisbury, Wilts, England.	ncpc@soton.ac.uk	Wang, Y. Lynn/GRF-6667-2022; Collins, Andrew/A-6595-2010; Silver MD, Richard T/GRE-5925-2022; Cario, Holger/AAH-6713-2019; Pahl, Heike/AGM-5260-2022; Collins, Andrew/S-2196-2019; Cross, Nicholas/B-4817-2009	Wang, Y. Lynn/0000-0003-0773-1212; Collins, Andrew/0000-0001-7108-0771; Collins, Andrew/0000-0001-7108-0771; Cross, Nicholas/0000-0001-5481-2555; Cario, Holger/0000-0002-6923-488X; Jones, Amy Victoria/0000-0003-3467-6765	Leukaemia Research (UK) Specialist Programme [0280]; Wellcome Trust [076113]; Deutsche Jose Carreras Leukarmie-Stiftung e. V. [DJCLS R06/02]; NATIONAL CANCER INSTITUTE [P01CA108671] Funding Source: NIH RePORTER	Leukaemia Research (UK) Specialist Programme; Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Jose Carreras Leukarmie-Stiftung e. V.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Leukaemia Research (UK) Specialist Programme Grant 0280 and makes use (in part) of data generated by the WTCCC. A full list of the investigators who contributed to the generation of the WTCCC data are available from www.wtccc.org.uk, funding for which was provided by the Wellcome Trust under award 076113. We are grateful to P. Strike (Salisbury Research and Development Support Unit) for statistical advice. A. R. was supported by the 'Deutsche Jose Carreras Leukarmie-Stiftung e. V. - DJCLS R06/02, Germany.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cario H, 2005, BRIT J HAEMATOL, V130, P800, DOI 10.1111/j.1365-2141.2005.05683.x; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jones AV, 2006, BLOOD, V107, P3339, DOI 10.1182/blood-2005-09-3917; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; KHOURY MJ, 1993, FUNDAMENTALS GENETIC, P264; Kralovics R, 2008, LEUKEMIA, V22, P1841, DOI 10.1038/leu.2008.233; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kralovics R, 2002, EXP HEMATOL, V30, P229, DOI 10.1016/S0301-472X(01)00789-5; Landgren O, 2008, BLOOD, V112, P2199, DOI 10.1182/blood-2008-03-143602; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Pardanani A, 2008, BLOOD, V111, P2785, DOI 10.1182/blood-2007-06-095703; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Rumi E, 2008, BLOOD, V112, P2587, DOI 10.1182/blood-2008-05-160739; Sandberg EM, 2004, CELL BIOCHEM BIOPHYS, V41, P207, DOI 10.1385/CBB:41:2:207; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378	21	295	304	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					446	449		10.1038/ng.334	http://dx.doi.org/10.1038/ng.334			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19287382	Green Accepted			2022-12-17	WOS:000264659000018
J	Frigola, J; Song, J; Stirzaker, C; Hinshelwood, RA; Peinado, MA; Clark, SJ				Frigola, J; Song, J; Stirzaker, C; Hinshelwood, RA; Peinado, MA; Clark, SJ			Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band	NATURE GENETICS			English	Article							ALTERED METHYLATION PATTERNS; DNA METHYLATION; CPG ISLANDS; EXPRESSION; HYPERMETHYLATION; INACTIVATION; P21(WAF1); RECEPTORS; MECHANISM; PROTEINS	We report a new mechanism in carcinogenesis involving coordinate long-range epigenetic gene silencing. Epigenetic silencing in cancer has always been envisaged as a local event silencing discrete genes. However, in this study of silencing in colorectal cancer, we found common repression of the entire 4-Mb band of chromosome 2q.14.2, associated with global methylation of histone H3 Lys9. DNA hypermethylation within the repressed genomic neighborhood was localized to three separate enriched CpG island `suburbs', with the largest hypermethylated suburb spanning 1 Mb. These data change our understanding of epigenetic gene silencing in cancer cells: namely, epigenetic silencing can span large regions of the chromosome, and both DNA-methylated and neighboring unmethylated genes can be coordinately suppressed by global changes in histone modification. We propose that loss of gene expression can occur through long-range epigenetic silencing, with similar implications as loss of heterozygosity in cancer.	St Vincents Hosp, Garvan Inst Med Res, Canc Program, Darlinghurst, NSW 2010, Australia; Hosp Duran & Reynals, Inst Recerca Oncol, Inst Invest Biomed Bellvitge IDIBELL, Barcelona 08907, Spain	Garvan Institute of Medical Research; St Vincents Hospital Sydney; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals	Clark, SJ (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Canc Program, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	s.clark@garvan.org.au	Frigola, Jordi/N-4602-2015; Clark, Susan J/U-7365-2019; Clark, Susan J/B-2272-2008; Peinado, Miguel A./A-5591-2008	Frigola, Jordi/0000-0002-7231-3853; Clark, Susan J/0000-0001-5925-5030; Clark, Susan J/0000-0001-5925-5030; Peinado, Miguel A./0000-0002-4090-793X; Stirzaker, Clare/0000-0001-5601-3140				Adamska M, 2004, DEV BIOL, V272, P134, DOI 10.1016/j.ydbio.2004.04.026; Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791; Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9; Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brockdorff N, 2002, TRENDS GENET, V18, P352, DOI 10.1016/S0168-9525(02)02717-8; Clark SJ, 2002, ONCOGENE, V21, P5380, DOI 10.1038/sj.onc.1205598; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Feltus FA, 2003, P NATL ACAD SCI USA, V100, P12253, DOI 10.1073/pnas.2037852100; Frigola J, 2005, HUM MOL GENET, V14, P319, DOI 10.1093/hmg/ddi028; Frigola J, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.7.e28; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gius D, 2004, CANCER CELL, V6, P361, DOI 10.1016/j.ccr.2004.08.029; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Huschtscha LI, 1998, CANCER RES, V58, P3508; Jaffrey RG, 2000, CANCER RES, V60, P4349; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kangas M, 1999, GENOMICS, V58, P82, DOI 10.1006/geno.1999.5811; Kondo Y, 2004, P NATL ACAD SCI USA, V101, P7398, DOI 10.1073/pnas.0306641101; Laird PW, 2005, HUM MOL GENET, V14, pR65, DOI 10.1093/hmg/ddi113; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Latham KE, 2005, TRENDS GENET, V21, P120, DOI 10.1016/j.tig.2004.12.003; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Lorincz MC, 2002, MOL CELL BIOL, V22, P7572, DOI 10.1128/MCB.22.21.7572-7580.2002; Melki JR, 1999, CANCER RES, V59, P3730; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Mylonas I, 2005, ONCOL REP, V13, P81; Nguyen C, 2001, J NATL CANCER I, V93, P1465, DOI 10.1093/jnci/93.19.1465; Nie Y, 2001, CARCINOGENESIS, V22, P1615, DOI 10.1093/carcin/22.10.1615; O'Neill MJ, 2005, HUM MOL GENET, V14, pR113, DOI 10.1093/hmg/ddi108; Palmisano WA, 2003, CANCER RES, V63, P4620; Pang RTK, 2004, MOL ENDOCRINOL, V18, P471, DOI 10.1210/me.2003-0245; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Reis FM, 2004, MOL CELL ENDOCRINOL, V225, P77, DOI 10.1016/j.mce.2004.02.016; Rush LJ, 2004, CANCER RES, V64, P2424, DOI 10.1158/0008-5472.CAN-03-2870; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Song JZ, 2002, ONCOGENE, V21, P1048, DOI 10.1038/sj.onc.1205153; Stirzaker C, 2004, CANCER RES, V64, P3871, DOI 10.1158/0008-5472.CAN-03-3690; Tang C, 1997, GUT, V40, P267, DOI 10.1136/gut.40.2.267; Tang CW, 1996, CARCINOGENESIS, V17, P2171, DOI 10.1093/carcin/17.10.2171; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; van Noesel MM, 2003, GENE CHROMOSOME CANC, V38, P226, DOI 10.1002/gcc.10278; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Zhu WG, 2004, J BIOL CHEM, V279, P15161, DOI 10.1074/jbc.M311703200	47	295	310	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2006	38	5					540	549		10.1038/ng1781	http://dx.doi.org/10.1038/ng1781			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	16642018				2022-12-17	WOS:000237147500015
J	van den Brink, GR; Bleuming, SA; Hardwick, JCH; Schepman, BL; Offerhaus, GJ; Keller, JJ; Nielsen, C; Gaffield, W; van Deventer, SJH; Roberts, DJ; Peppelenbosch, MP				van den Brink, GR; Bleuming, SA; Hardwick, JCH; Schepman, BL; Offerhaus, GJ; Keller, JJ; Nielsen, C; Gaffield, W; van Deventer, SJH; Roberts, DJ; Peppelenbosch, MP			Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation	NATURE GENETICS			English	Article							INTESTINAL TREFOIL FACTOR; COLORECTAL-CANCER; EXPRESSION; INHIBITION; CARCINOMA; BUTYRATE; COMPLEX; CULTURE; GROWTH; VILLIN	Wnt signaling defines the colonic epithelial progenitor cell phenotype(1), and mutations in the gene adenomatous polyposis coli (APC) that activate the Wnt pathway cause the familial adenomatous polyposis coli (FAP) syndrome and most sporadic colon cancers(2). The mechanisms that regulate the transition of epithelial precursor cells into their differentiated derivatives are poorly characterized. We report that Indian hedgehog (Ihh) is expressed by mature colonocytes and regulates their differentiation in vitro and in vivo. Hedgehog (Hh) signaling restricts the expression of Wnt targets to the base of the colonic crypt in vivo, and transfection of Ihh into colon cancer cells leads to a downregulation of both components of the nuclear TCF4-beta-catenin complex and abrogates endogenous Wnt signaling in vitro. In turn, expression of Ihh is downregulated in polyps of individuals with FAP and expression of doxycycline-inducible dominant negative TCF4 (dnTCF4) restores Ihh expression in APC mutant DLD-1 colon cancer cells. These data identify a new Wnt-Hh axis in colonic epithelial renewal.	Univ Amsterdam, Acad Med Ctr, Dept Expt Internal Med, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; ARS, Western Reg Res Ctr, USDA, Albany, CA USA; Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Harvard University; Massachusetts General Hospital; United States Department of Agriculture (USDA); University of Amsterdam; Academic Medical Center Amsterdam	van den Brink, GR (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Internal Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	g.r.vandenbrink@amc.uva.nl	Roberts, Drucilla/AAB-6379-2022; Hardwick, James/J-4862-2013	Peppelenbosch, Maikel/0000-0001-9112-6028; Hardwick, James/0000-0002-9575-5099				Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791; AUGERON C, 1984, CANCER RES, V44, P3961; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Boon EMJ, 2002, CANCER RES, V62, P5126; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Hao XP, 2001, CANCER RES, V61, P8085; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lengyel JA, 2002, DEV BIOL, V243, P1, DOI 10.1006/dbio.2002.0577; Pathi S, 2001, MECH DEVELOP, V106, P107, DOI 10.1016/S0925-4773(01)00427-0; PRINGAULT E, 1986, EMBO J, V5, P3119, DOI 10.1002/j.1460-2075.1986.tb04618.x; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; SUEMORI S, 1991, P NATL ACAD SCI USA, V88, P11017, DOI 10.1073/pnas.88.24.11017; Taupin D, 1996, LAB INVEST, V75, P25; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van den Brink GR, 2001, GASTROENTEROLOGY, V121, P317, DOI 10.1053/gast.2001.26261; van den Brink GR, 2002, GUT, V51, P628, DOI 10.1136/gut.51.5.628; WEST AB, 1988, GASTROENTEROLOGY, V94, P343, DOI 10.1016/0016-5085(88)90421-0	21	295	302	0	12	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2004	36	3					277	282		10.1038/ng1304	http://dx.doi.org/10.1038/ng1304			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	14770182	Bronze			2022-12-17	WOS:000189250400017
J	Kahle, KT; Wilson, FH; Leng, Q; Lalioti, MD; O'Connell, AD; Dong, K; Rapson, AK; MacGregor, GG; Giebisch, G; Hebert, SC; Lifton, RP				Kahle, KT; Wilson, FH; Leng, Q; Lalioti, MD; O'Connell, AD; Dong, K; Rapson, AK; MacGregor, GG; Giebisch, G; Hebert, SC; Lifton, RP			WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion	NATURE GENETICS			English	Article							INHERITED HYPERTENSION; FUNCTIONAL EXPRESSION; POTASSIUM CHANNEL; HYPERKALEMIA; MUTATIONS; COTRANSPORTER; ENDOCYTOSIS; CLATHRIN; PROTEIN; CL	A key question in systems biology is how diverse physiologic processes are integrated to produce global homeostasis(1). Genetic analysis can contribute by identifying genes that perturb this integration. One system orchestrates renal NaCl and K+ flux to achieve homeostasis of blood pressure and serum K+ concentration (refs. 2,3). Positional cloning implicated the serine-threonine kinase WNK4 in this process(4); clustered mutations in PRKWNK4, encoding WNK4, cause hypertension and hyperkalemia (pseudohypoaldosteronism type II, PHAII(5)) by altering renal NaCl and K+ handling. Wild-type WNK4 inhibits the renal Na-Cl cotransporter (NCCT); mutations that cause PHAII relieve this inhibition(6). This explains the hypertension of PHAII but does not account for the hyperkalemia. By expression in Xenopus laevis oocytes, we show that WNK4 also inhibits the renal K+ channel ROMK. This inhibition is independent of WNK4 kinase activity and is mediated by clathrin-dependent endocytosis of ROMK, mechanisms distinct from those that characterize WNK4 inhibition of NCCT. Most notably, the same mutations in PRKWNK4 that relieve NCCT inhibition markedly increase inhibition of ROMK. These findings establish WNK4 as a multifunctional regulator of diverse ion transporters; moreover, they explain the pathophysiology of PHAII. They also identify WNK4 as a molecular switch that can vary the balance between NaCl reabsorption and K+ secretion to maintain integrated homeostasis.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Yale University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 300 Cedar St,TAC S-341D, New Haven, CT 06510 USA.	richard.lifton@yale.edu	Leng, John/GRO-2256-2022; Leng, John/A-9359-2011	Wilson, Frederick/0000-0002-5019-0186				BOIM MA, 1995, AM J PHYSIOL-RENAL, V268, pF1132, DOI 10.1152/ajprenal.1995.268.6.F1132; Charette SJ, 2001, J BIOL CHEM, V276, P36071, DOI 10.1074/jbc.C100340200; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; Choate KA, 2003, P NATL ACAD SCI USA, V100, P663, DOI 10.1073/pnas.242728499; GAMBA G, 1993, P NATL ACAD SCI USA, V90, P2749, DOI 10.1073/pnas.90.7.2749; Giebisch G, 1998, AM J PHYSIOL-RENAL, V274, pF817, DOI 10.1152/ajprenal.1998.274.5.F817; GORDON RD, 1986, HYPERTENSION, V8, P93, DOI 10.1161/01.HYP.8.2.93; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Leipziger J, 2000, AM J PHYSIOL-RENAL, V279, pF919, DOI 10.1152/ajprenal.2000.279.5.F919; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Ortega B, 2000, J PHYSIOL-LONDON, V528, P5, DOI 10.1111/j.1469-7793.2000.00005.x; REEVES WB, 2000, KIDNEY PHYSL PATHOPH, P1333; Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Verrey F., 2000, KIDNEY PHYSL PATHOPH, P1441; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Zeng WZ, 2002, AM J PHYSIOL-RENAL, V283, pF630, DOI 10.1152/ajprenal.00378.2001	21	295	310	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2003	35	4					372	376		10.1038/ng1271	http://dx.doi.org/10.1038/ng1271			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	747DY	14608358				2022-12-17	WOS:000186791000020
J	Cowles, CR; Hirschhorn, JN; Altshuler, D; Lander, ES				Cowles, CR; Hirschhorn, JN; Altshuler, D; Lander, ES			Detection of regulatory variation in mouse genes	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GILBERTS-SYNDROME; CANDIDATE GENES; EXPRESSION; DNA; DIVERSITY; REGIONS; ASSAY	Functional polymorphism in genes can be classified as coding variation, altering the amino-acid sequence of the encoded protein, or regulatory variation, affecting the level or pattern of expression of the gene. Coding variation can be recognized directly from DNA sequence, and consequently its frequency and characteristics have been extensively described. By contrast, virtually nothing is known about the extent to which gene regulation varies in populations. Yet it is likely that regulatory variants are important in modulating gene function: alterations in gene regulation have been proposed to influence disease susceptibility and to have been the primary substrate for the evolution of species(1). Here, we report a systematic study to assess the extent of cis-acting regulatory variation in 69 genes across four inbred mouse strains. We find that at least four of these genes show allelic differences in expression level of 1.5-fold or greater, and that some of these differences are tissue specific. The results show that the impact of regulatory variants can be detected at a significant frequency in a genomic survey and suggest that such variation may have important consequences for organismal phenotype and evolution. The results indicate that larger-scale surveys in both mouse and human could identify a substantial number of genes with common regulatory variation.	Whitehead Inst, Cambridge, MA 02142 USA; MIT, Ctr Genome Res, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Lander, ES (corresponding author), Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lander@wi.mit.edu	Altshuler, David M/A-4476-2009	Altshuler, David M/0000-0002-7250-4107; Hirschhorn, Joel/0000-0002-1650-7901				BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Cambien F, 1999, AM J HUM GENET, V65, P183, DOI 10.1086/302448; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chen XN, 1997, P NATL ACAD SCI USA, V94, P10756, DOI 10.1073/pnas.94.20.10756; Dillon N, 1997, MOL CELL, V1, P131, DOI 10.1016/S1097-2765(00)80014-3; Grabe Niels, 2002, In Silico Biology, V2, pS1; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; KOBAYASHI M, 1995, MOL CELL PROBE, V9, P175, DOI 10.1006/mcpr.1995.0027; Landegren U, 1998, GENOME RES, V8, P769, DOI 10.1101/gr.8.8.769; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li QL, 1999, TRENDS GENET, V15, P403, DOI 10.1016/S0168-9525(99)01780-1; LI WH, 1991, GENETICS, V129, P513; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Monaghan G, 1996, LANCET, V347, P578, DOI 10.1016/S0140-6736(96)91273-8; Pastinen T, 1997, GENOME RES, V7, P606, DOI 10.1101/gr.7.6.606; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; RaveHarel N, 1997, AM J HUM GENET, V60, P87; SINGERSAM J, 1994, PCR METH APPL, V3, pS48; SYVANEN AC, 1990, GENOMICS, V8, P684, DOI 10.1016/0888-7543(90)90255-S; Szabo PE, 1995, GENE DEV, V9, P3097, DOI 10.1101/gad.9.24.3097	23	295	307	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2002	32	3					432	437		10.1038/ng992	http://dx.doi.org/10.1038/ng992			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12410233				2022-12-17	WOS:000179034800022
J	Ando, H; Furuta, T; Tsien, RY; Okamoto, H				Ando, H; Furuta, T; Tsien, RY; Okamoto, H			Photo-mediated gene activation using caged RNA/DNA in zebrafish embryos	NATURE GENETICS			English	Article							TRANSGENIC ZEBRAFISH; EXPRESSION; BOUNDARY; BRAIN	We report a new and simple technique for photo-mediated temporal and spatial control of gene activation in zebrafish embryos as an alternative to the gene 'knockdown' approach using antisense, morpholino-modified oligonucleotides (morpholinos). The synthetic compound 6-bromo-4-diazomethyl-7-hydroxycoumarin (Bhc-diazo) forms a covalent bond with the phosphate moiety of the sugar-phosphate backbone of RNA, a process known as caging. The 6-bromo-7-hydroxycoumarin-4-ylmethyl (Bhc) group binds to approximately 30 sites on the phosphate moieties per 1 kb of RNA sequence. Bhc-caged mRNA undergoes photolysis (uncaging) when exposed to long-wave ultraviolet light (350 to 365 nm). We show that Bhc-caged green fluorescent protein (Gfp) mRNA has severely reduced translational activity in vitro, whereas illumination of Bhc-caged mRNA with ultraviolet light leads to partial recovery of translational activity. Bhc-caged mRNA is highly stable in zebrafish embryos. in embryos injected with Bhc-caged Gfp mRNA at the one-cell stage, GFP protein expression and fluorescence is specifically induced by ultraviolet light. We also show that, consistent with results obtained using other methods, uncaging eng2a (which encodes the, transcription factor Engrailed2a) in the head region during early development causes a severe reduction in the size of the eye and enhanced development of the midbrain and the midbrain-hindbrain boundary at the expense of the forebrain.	RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Lab Dev Gene Regulat, Wako, Saitama 3510198, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Chuo Ku, Tokyo 1030027, Japan; Toho Univ, Dept Biomol Sci, Chiba 2748510, Japan; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	RIKEN; Japan Science & Technology Agency (JST); Toho University; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Okamoto, H (corresponding author), RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Lab Dev Gene Regulat, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hitoshi@brain.riken.go.jp	Furuta, Toshiaki/F-1363-2011; Okamoto, Hitoshi/P-9767-2015	Furuta, Toshiaki/0000-0001-8532-1775; Okamoto, Hitoshi/0000-0002-7512-8549	NINDS NIH HHS [NS27177] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027177, R01NS027177] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Araki I, 1999, DEVELOPMENT, V126, P5127; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Cambridge SB, 1997, SCIENCE, V277, P825, DOI 10.1126/science.277.5327.825; Chaulk SG, 1998, NUCLEIC ACIDS RES, V26, P3173, DOI 10.1093/nar/26.13.3173; Cruz FG, 2000, J AM CHEM SOC, V122, P8777, DOI 10.1021/ja001804h; Danielian PS, 1996, NATURE, V383, P332, DOI 10.1038/383332a0; DRIEVER W, 1994, TRENDS GENET, V10, P152, DOI 10.1016/0168-9525(94)90091-4; EKKER M, 1992, DEVELOPMENT, V116, P1001; FJOSE A, 1992, MECH DEVELOP, V39, P51, DOI 10.1016/0925-4773(92)90025-F; Furuta T, 1998, Methods Enzymol, V291, P50; Furuta T, 1999, P NATL ACAD SCI USA, V96, P1193, DOI 10.1073/pnas.96.4.1193; Furuta T., 2000, USA Patent, Patent No. [0031588, WO/00/31588]; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; ITO K, 1983, CHEM PHARM BULL, V31, P3014; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; Kikuchi Y, 1997, NEURON, V18, P369, DOI 10.1016/S0896-6273(00)81239-8; KIMMEL CB, 1993, ANNU REV NEUROSCI, V16, P707, DOI 10.1146/annurev.ne.16.030193.003423; KRAUSS S, 1991, EMBO J, V10, P3609, DOI 10.1002/j.1460-2075.1991.tb04927.x; KRAUSS S, 1991, NATURE, V353, P267, DOI 10.1038/353267a0; MARCH J, 1992, ADV ORG CHEM, P385; Miller JH, 1972, EXPT MOL GENETICS; Monroe WT, 1999, J BIOL CHEM, V274, P20895, DOI 10.1074/jbc.274.30.20895; MORI H, 1994, MOL BRAIN RES, V27, P221, DOI 10.1016/0169-328X(94)90004-3; MORITA T, 1995, NEUROSCI LETT, V198, P131, DOI 10.1016/0304-3940(95)11988-9; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Reifers F, 1998, DEVELOPMENT, V125, P2381; Ristoratore F, 1999, DEVELOPMENT, V126, P3769; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; SCHULTEMERKER S, 1995, ZEBRAFISH BOOK GUIDE; Segawa H, 2001, NEURON, V30, P423, DOI 10.1016/S0896-6273(01)00283-5; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; WALKER JW, 1989, METHOD ENZYMOL, V172, P288; Wilson Stephen W., 1992, Current Opinion in Neurobiology, V2, P9, DOI 10.1016/0959-4388(92)90154-D; Wulfman D.S., 1978, CHEM ISTRY DIAZONIUM, P821	39	295	308	1	85	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2001	28	4					317	325		10.1038/ng583	http://dx.doi.org/10.1038/ng583			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11479592				2022-12-17	WOS:000170174800011
J	Perez, GI; Robles, R; Knudson, CM; Flaws, JA; Korsmeyer, SJ; Tilly, JL				Perez, GI; Robles, R; Knudson, CM; Flaws, JA; Korsmeyer, SJ; Tilly, JL			Prolongation of ovarian lifespan into advanced chronological age by Bax-deficiency	NATURE GENETICS			English	Article							EXPRESSION; APOPTOSIS; BCL-2; MICE	Female mammals are endowed with a finite number of oocytes at birth, each enclosed by a single layer of somatic (granulosa) cells in a primordial follicle(1,2). The fate of most follicles is atretic degeneration(1,3), a process that culminates in near exhaustion of the oocyte reserve at approximately the fifth decade of life in women, leading to menopause(4,5). Apoptosis has a fundamental role in follicular atresia(6,7), and recent studies have shown that Bax, which is expressed in both granulosa cells(8,9) and oocytes(10), may be central to ovarian cell death(6-12). Here we show that young adult female Bax(-/-) mice possess threefold more primordial follicles in their ovarian reserve than their wild-type sisters, and this surfeit of follicles is maintained in advanced chronological age, such that 20-22-month-old female Bax(-/-) mice possess hundreds of follicles at ail developmental stages and exhibit ovarian steroid-driven uterine hypertrophy. These observations contrast with the ovarian and uterine atrophy seen in aged wild-type female mice. Aged female Bax(-/-) mice fail to become pregnant when housed with young adult males; however, metaphase II oocytes can be retrieved from, and corpora lutea form in, ovaries of aged Bax(-/-) females following superovulation with exogenous gonadotropins, and some oocytes are competent for in vitro fertilization and early embryogenesis. Therefore, ovarian lifespan can be extended by selectively disrupting Bax function, but other aspects of normal reproductive performance remain defective in aged Bax(-/-) female mice.	Massachusetts Gen Hosp, Vincent Ctr Reprod Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02114 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, Div Mol Oncol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University System of Maryland; University of Maryland Baltimore	Tilly, JL (corresponding author), Massachusetts Gen Hosp, Vincent Ctr Reprod Biol, Boston, MA 02114 USA.		Perez, Gloria I/GMX-1286-2022	Knudson, Charles Michael/0000-0003-3964-5466	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012279] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA49712] Funding Source: Medline; NIA NIH HHS [R01-AG12279] Funding Source: Medline; NICHD NIH HHS [R01-HD34226] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BAKER TG, 1963, PROC R SOC SER B-BIO, V158, P417, DOI 10.1098/rspb.1963.0055; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; GOSDEN RG, 1983, BIOL REPROD, V28, P255, DOI 10.1095/biolreprod28.2.255; Gougeon A, 1996, ENDOCR REV, V17, P121, DOI 10.1210/er.17.2.121; HAMMOND CB, 1996, OBSTET GYNECOL, V87, P25; Jurisicova A, 1998, MOL REPROD DEV, V51, P243, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;243::AID-MRD3&gt;3.0.CO;2-P; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kugu K, 1998, CELL DEATH DIFFER, V5, P67, DOI 10.1038/sj.cdd.4400316; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; RATTS VS, 1995, ENDOCRINOLOGY, V136, P3665, DOI 10.1210/en.136.8.3665; Tilly J L, 1996, Rev Reprod, V1, P162, DOI 10.1530/revreprod/1.3.162; Tilly J. L., 1996, CONTEMP OBSTET GYNEC, V41, P59; TILLY JL, 1995, ENDOCRINOLOGY, V136, P232, DOI 10.1210/en.136.1.232; TILLY JL, 1998, CELLS DIE COMPREHENS, P431; Wise PM, 1996, SCIENCE, V273, P67, DOI 10.1126/science.273.5271.67	15	295	320	1	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1999	21	2					200	203		10.1038/5985	http://dx.doi.org/10.1038/5985			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	163MH	9988273				2022-12-17	WOS:000078399500023
J	Mitsuyasu, H; Izuhara, K; Mao, XQ; Gao, PS; Arinobu, Y; Enomoto, T; Kawai, M; Sasaki, S; Dake, Y; Hamasaki, N; Shirakawa, T; Hopkin, JM				Mitsuyasu, H; Izuhara, K; Mao, XQ; Gao, PS; Arinobu, Y; Enomoto, T; Kawai, M; Sasaki, S; Dake, Y; Hamasaki, N; Shirakawa, T; Hopkin, JM			Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma	NATURE GENETICS			English	Letter							INTERLEUKIN-4; RECEPTOR; SIGNAL; STAT6		Churchill Hosp, Osler Chest Unit, Oxford OX3 7LJ, England; Kyushu Univ, Dept Clin Chem & Lab Med, Fac Med, Fukuoka 812, Japan; Wakayama Med Ctr, Dept Otolaryngol, Japanese Red Cross Soc, Wakayama, Japan; Kyoto Prevent Med Ctr, Kyoto, Japan; Osaka Med Coll, Dept Pediat, Takatsuki, Osaka 569, Japan	University of Oxford; Kyushu University; Osaka Medical College	Shirakawa, T (corresponding author), Churchill Hosp, Osler Chest Unit, Oxford OX3 7LJ, England.							Deichmann K, 1997, BIOCHEM BIOPH RES CO, V231, P696, DOI 10.1006/bbrc.1997.6115; Deichmann KA, 1998, CLIN EXP ALLERGY, V28, P151; GARIZZI JP, 1990, INT IMMUNOL, V2, P669; Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403; IDZERDA RL, 1990, J EXP MED, V171, P861, DOI 10.1084/jem.171.3.861; IZUHARA K, 1993, BIOCHEM BIOPH RES CO, V190, P992, DOI 10.1006/bbrc.1993.1147; Izuhara K, 1996, J BIOL CHEM, V271, P619, DOI 10.1074/jbc.271.2.619; Mao XQ, 1996, LANCET, V348, P581, DOI 10.1016/S0140-6736(95)10244-2; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; SCULTE T, 1997, J EXP MED, V186, P1419; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Takeda K, 1997, J MOL MED-JMM, V75, P317, DOI 10.1007/s001090050117; ZWARSI G, 1994, IMMUNOL TODAY, V15, P19	15	295	322	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1998	19	2					119	120		10.1038/472	http://dx.doi.org/10.1038/472			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620765				2022-12-17	WOS:000073865100016
J	Quaderi, NA; Schweiger, S; Gaudenz, K; Franco, B; Rugarli, EI; Berger, W; Feldman, GJ; Volta, M; Andolfi, G; Gilgenkrantz, S; Marion, RW; Hennekam, RCM; Opitz, JM; Muenke, M; Ropers, HH; Ballabio, A				Quaderi, NA; Schweiger, S; Gaudenz, K; Franco, B; Rugarli, EI; Berger, W; Feldman, GJ; Volta, M; Andolfi, G; Gilgenkrantz, S; Marion, RW; Hennekam, RCM; Opitz, JM; Muenke, M; Ropers, HH; Ballabio, A			Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22	NATURE GENETICS			English	Article							LINEAR SKIN DEFECTS; ACUTE PROMYELOCYTIC LEUKEMIA; XENOPUS NUCLEAR FACTOR-7; FAT GLOBULE-MEMBRANE; SONIC-HEDGEHOG; PROTEIN; MICROPHTHALMIA; ANOMALIES; DOMAIN; XNF7	Opitz syndrome (OS) is an inherited disorder characterized by midline defects including hypertelorism, hypospadias, lip-palate-laryngotracheal clefts and imperforate anus. We have identified a new gene on Xp22, MIDI (Midline 1), which is disrupted in an OS patient carrying an X-chromosome inversion and is also mutated in several OS families. MID 1 encodes a member of the B-box family of proteins, which contain protein-protein interaction domains, including a RING finger, and are implicated in fundamental processes such as body axis patterning and control of cell proliferation. The association of MIDI with OS suggests an important role for this gene in midline development.	TELETHON INST GENET & MED,I-20132 MILAN,ITALY; MAX PLANCK INST MOL GENET,D-14195 BERLIN,GERMANY; UNIV PENN,CHILDRENS HOSP PHILADELPHIA,SCH MED,DEPT PEDIAT,DIV HUMAN GENET & MOL BIOL,PHILADELPHIA,PA 19104; MONTEFIORE MED CTR,ALBERT EINSTEIN COLL MED,DEPT PEDIAT,BRONX,NY 10467; UNIV AMSTERDAM,INST HUMAN GENET,NL-1105 AZ AMSTERDAM,NETHERLANDS; UNIV UTAH,DEPT PEDIAT HUMAN GENET & OBSTET & GYNECOL,SALT LAKE CITY,UT 84132; CATHOLIC UNIV NIJMEGEN,DEPT HUMAN GENET,NL-6500 HB NIJMEGEN,NETHERLANDS; UNIV PENN,CHILDRENS HOSP PHILADELPHIA,SCH MED,DEPT GENET,PHILADELPHIA,PA 19104	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Max Planck Society; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Amsterdam; Utah System of Higher Education; University of Utah; Radboud University Nijmegen; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia			Quaderi, Nandita/V-8708-2019; BALLABIO, Andrea/AAL-2672-2020; Volta, Manuela/D-2147-2012; FRANCO, Brunella/S-2882-2018	BALLABIO, Andrea/0000-0003-1381-4604; Volta, Manuela/0000-0001-8468-0346; FRANCO, Brunella/0000-0001-5588-4569; Muenke, Maximilian/0000-0002-7719-6545; Rugarli, Elena/0000-0002-5782-1067	NICHD NIH HHS [R01HD29862, R29HD28732] Funding Source: Medline; Telethon [TGM06S01, TGM97000] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD028732, R01HD029862] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Telethon(Fondazione Telethon); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALGAZALI LI, 1990, J MED GENET, V27, P59, DOI 10.1136/jmg.27.1.59; Bailey T.L., 1994, P 2 INT C INT SYST M, V2, P28; Banfi S, 1996, NAT GENET, V13, P167, DOI 10.1038/ng0696-167; BELLINI M, 1993, EMBO J, V12, P107, DOI 10.1002/j.1460-2075.1993.tb05636.x; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; BERSHOF JF, 1992, J CRANIO MAXILL SURG, V20, P24, DOI 10.1016/S1010-5182(05)80192-1; BIRD LM, 1994, AM J MED GENET, V53, P141, DOI 10.1002/ajmg.1320530205; Borden KLB, 1996, P NATL ACAD SCI USA, V93, P1601, DOI 10.1073/pnas.93.4.1601; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; BORDEN KLB, 1993, FEBS LETT, V335, P255, DOI 10.1016/0014-5793(93)80741-C; CAPPA M, 1987, AM J MED GENET, V28, P303, DOI 10.1002/ajmg.1320280207; CHAN EKL, 1991, J CLIN INVEST, V87, P68, DOI 10.1172/JCI115003; CORDERO JF, 1978, AM J MED GENET, V2, P145, DOI 10.1002/ajmg.1320020205; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; FARNDON PA, 1983, CLIN GENET, V23, P446; FERRERO GB, 1995, HUM MOL GENET, V4, P1821, DOI 10.1093/hmg/4.10.1821; FRANCO B, 1995, CELL, V81, P15, DOI 10.1016/0092-8674(95)90367-4; FRYNS JP, 1992, CLIN GENET, V42, P314; GRIGNANI F, 1994, BLOOD, V83, P10; GUIONALMEIDA ML, 1992, AM J MED GENET, V43, P918, DOI 10.1002/ajmg.1320430603; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; HOWELL L, 1989, ANN OTO RHINOL LARYN, V98, P185, DOI 10.1177/000348948909800304; INOUE S, 1993, P NATL ACAD SCI USA, V90, P11117, DOI 10.1073/pnas.90.23.11117; Ishii T, 1995, BBA-GEN SUBJECTS, V1245, P285, DOI 10.1016/0304-4165(95)00102-6; JOHNSTON K, 1987, AM J MED GENET, V27, P603, DOI 10.1002/ajmg.1320270313; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LI XX, 1994, J CELL BIOL, V124, P7, DOI 10.1083/jcb.124.1.7; LI XX, 1993, J CELL SCI, V105, P389; LINDSAY EA, 1994, AM J MED GENET, V49, P229, DOI 10.1002/ajmg.1320490214; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MACDONALD MR, 1993, AM J MED GENET, V46, P706, DOI 10.1002/ajmg.1320460622; Maniatis T., 1982, MOL CLONING; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; MATHER IH, 1993, J DAIRY SCI, V76, P3832, DOI 10.3168/jds.S0022-0302(93)77726-7; May M, 1997, AM J MED GENET, V68, P244, DOI 10.1002/(SICI)1096-8628(19970120)68:2<244::AID-AJMG27>3.0.CO;2-T; MILLER M, 1991, DEVELOPMENT, V113, P569; Opitz, 1969, BIRTH DEFECTS OAS, VV, P95; Opitz J. M., 1969, BIRTH DEFECTS AOS, VV, P86; OPITZ JM, 1987, AM J MED GENET, V28, P275, DOI 10.1002/ajmg.1320280203; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PATARCA R, 1988, P NATL ACAD SCI USA, V85, P2733, DOI 10.1073/pnas.85.8.2733; REDDY BA, 1991, DEV BIOL, V148, P107, DOI 10.1016/0012-1606(91)90321-S; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Robin NH, 1996, AM J MED GENET, V62, P305, DOI 10.1002/(SICI)1096-8628(19960329)62:3<305::AID-AJMG20>3.0.CO;2-N; ROBIN NH, 1995, NAT GENET, V11, P459, DOI 10.1038/ng1295-459; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; SCHAEFER L, 1993, NAT GENET, V4, P272, DOI 10.1038/ng0793-272; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SEDANO HO, 1988, AM J MED GENET, V30, P847, DOI 10.1002/ajmg.1320300322; Shou WN, 1996, MOL CELL BIOL, V16, P990; STEVENS CA, 1988, J MED GENET, V25, P536, DOI 10.1136/jmg.25.8.536; TAKAHASHI M, 1988, MOL CELL BIOL, V8, P1853, DOI 10.1128/MCB.8.4.1853; TEMPLE IK, 1990, J MED GENET, V27, P56, DOI 10.1136/jmg.27.1.56; TOLMIE JL, 1987, J MED GENET, V24, P688, DOI 10.1136/jmg.24.11.688; VERLOES A, 1995, AM J MED GENET, V59, P123, DOI 10.1002/ajmg.1320590124; VERLOES A, 1989, AM J MED GENET, V34, P313, DOI 10.1002/ajmg.1320340303; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WAPENAAR MC, 1994, HUM MOL GENET, V3, P1155, DOI 10.1093/hmg/3.7.1155; WAPENAAR MC, 1993, HUM MOL GENET, V2, P947, DOI 10.1093/hmg/2.7.947	60	295	302	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					285	291		10.1038/ng1197-285	http://dx.doi.org/10.1038/ng1197-285			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354791	Green Submitted			2022-12-17	WOS:A1997YD66700021
J	VAN BROECKHOVEN, C; BACKHOVENS, H; CRUTS, M; DEWINTER, G; BRUYLAND, M; CRAS, P; MARTIN, JJ				VAN BROECKHOVEN, C; BACKHOVENS, H; CRUTS, M; DEWINTER, G; BRUYLAND, M; CRAS, P; MARTIN, JJ			MAPPING OF A GENE PREDISPOSING TO EARLY-ONSET ALZHEIMERS-DISEASE TO CHROMOSOME 14Q24.3	NATURE GENETICS			English	Article							PRECURSOR PROTEIN GENE; REPEAT POLYMORPHISM; LINKAGE; ALPHA-1-ANTICHYMOTRYPSIN; ALPHA-1-ANTITRYPSIN; MUTATION; MARKERS; LOCUS	Genetic linkage studies with chromosome 21 DNA markers and mutation analysis of the beta-amyloid protein precursor gene located in 21q21.3 have indicated that early-onset Alzheimer's disease (EOAD) is a heterogeneous disorder for which at least one other chromosomal locus exists. We examined two extended histopathologically confirmed EOAD pedigrees, AD/A and AD/B, with highly informative short tandem repeat (STR) polymorphisms and found complete linkage of the disease to a (CA)n dinucleotide repeat polymorphism at locus D14S43 in 14q24.3 (Z(max) = 13.25 at 0 = 0.0). Using additional chromosome 14 STR polymorphisms we were able to delineate the region containing the EOAD gene to an area of, at most, 8.9 centiMorgans between D14S42 and D14S53, flanking D14S43 on both sides.	INNOGENET INC, B-9052 GENT, BELGIUM; CITY HOSP RONSE, DEPT NEUROL, B-9600 RONSE, BELGIUM; UNIV BRUSSELS, DEPT NEUROL, B-1090 BRUSSELS, BELGIUM; UNIV ANTWERP, DEPT MED, BORN BUNGE FDN, NEUROBIOL LABS, B-2610 ANTWERP, BELGIUM; UNIV ANTWERP, DEPT MED, BORN BUNGE FDN, NEUROPATHOL LABS, B-2610 ANTWERP, BELGIUM	Innogenetics NV; University of Antwerp; University of Antwerp	VAN BROECKHOVEN, C (corresponding author), UNIV ANTWERP, BORN BUNGE FDN, DEPT BIOCHEM, NEUROGENET LAB, UNIV PLEIN 1, B-2610 ANTWERP, BELGIUM.		Cruts, Marc/J-6161-2013; Van Broeckhoven, Christine/G-8362-2017; Van Broeckhoven, Christine/M-7853-2019	Cruts, Marc/0000-0002-1338-992X; Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665				ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; COX DW, 1989, CYTOGENET CELL GENET, V51, P980; COX DW, 1982, NATURE, V297, P428, DOI 10.1038/297428a0; CRUTS M, 1992, NUCLEIC ACIDS RES, V20, P1159; FITCH N, 1988, ANN NEUROL, V23, P14, DOI 10.1002/ana.410230104; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HARDY J, 1992, NATURE, V359, P268, DOI 10.1038/359268a0; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MARTIN JJ, 1990, NEUROLOGY, V241, P62; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NAKAMURA Y, 1989, GENOMICS, V4, P76, DOI 10.1016/0888-7543(89)90317-0; OTT J, 1992, AM J HUM GENET, V51, P283; OTT J, 1985, ANAL HUMAN GENETIC L, P141; RABIN M, 1986, SOMAT CELL MOLEC GEN, V12, P209, DOI 10.1007/BF01560668; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; SALBAUM JM, 1988, EMBO J, V7, P2807, DOI 10.1002/j.1460-2075.1988.tb03136.x; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SCHELLENBERG GD, 1991, AM J HUM GENET, V48, P563; SEFTON L, 1990, GENOMICS, V7, P382, DOI 10.1016/0888-7543(90)90172-Q; SHARMA V, 1992, HUM MOL GENET, V1, P67, DOI 10.1093/hmg/1.1.67-a; SHARMA V, 1991, NUCLEIC ACIDS RES, V19, P1722, DOI 10.1093/nar/19.7.1722; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; STINISSEN P, 1991, NUCLEIC ACIDS RES, V19, P5089, DOI 10.1093/nar/19.18.5089; TANZI RE, 1987, NATURE, V329, P156, DOI 10.1038/329156a0; TANZI RE, 1992, AM J HUM GENET, V51, P273; VAN BROECKHOVEN C, 1987, NATURE, V329, P153; VANBROECKHOVEN C, 1988, GENETICS ALZHEIMERS, P124; WANG ZY, 1992, GENOMICS, V13, P532, DOI 10.1016/0888-7543(92)90121-8; WARREN AC, IN PRESS HUM GENET; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEITKAMP LR, 1983, AM J HUM GENET, V35, P443	37	295	303	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1992	2	4					335	339		10.1038/ng1292-335	http://dx.doi.org/10.1038/ng1292-335			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	1303290				2022-12-17	WOS:A1992KB49500021
J	Zou, J; Huss, M; Abid, A; Mohammadi, P; Torkamani, A; Telenti, A				Zou, James; Huss, Mikael; Abid, Abubakar; Mohammadi, Pejman; Torkamani, Ali; Telenti, Amalio			A primer on deep learning in genomics	NATURE GENETICS			English	Article							DNA	Deep learning methods are a class of machine learning techniques capable of identifying highly complex patterns in large datasets. Here, we provide a perspective and primer on deep learning applications for genome analysis. We discuss successful applications in the fields of regulatory genomics, variant calling and pathogenicity scores. We include general guidance for how to effectively use deep learning methods as well as a practical guide to tools and resources. This primer is accompanied by an interactive online tutorial.	[Zou, James] Stanford Univ, Dept Biomed Data Sci, Palo Alto, CA 94304 USA; [Zou, James] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Zou, James; Abid, Abubakar] Stanford Univ, Dept Elect Engn, Palo Alto, CA 94304 USA; [Huss, Mikael] Peltarion, Stockholm, Sweden; [Huss, Mikael] Karolinska Inst, Dept Learning Informat Management & Eth, Stockholm, Sweden; [Mohammadi, Pejman; Torkamani, Ali; Telenti, Amalio] Scripps Res Translat Inst, La Jolla, CA 92037 USA; [Mohammadi, Pejman; Torkamani, Ali; Telenti, Amalio] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	Stanford University; Stanford University; Karolinska Institutet; Scripps Research Institute	Zou, J (corresponding author), Stanford Univ, Dept Biomed Data Sci, Palo Alto, CA 94304 USA.; Zou, J (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; Zou, J (corresponding author), Stanford Univ, Dept Elect Engn, Palo Alto, CA 94304 USA.; Telenti, A (corresponding author), Scripps Res Translat Inst, La Jolla, CA 92037 USA.; Telenti, A (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	jamesz@stanford.edu; atelenti@scripps.edu	mohammadi, pejman/AAX-6002-2020; Telenti, Amalio/AAY-1674-2021	mohammadi, pejman/0000-0003-4457-8552; Torkamani, Ali/0000-0003-0232-8053; Huss, Mikael/0000-0003-0839-2451; telenti, amalio/0000-0001-6290-7677	Qualcomm Foundation; NIH Center for Translational Science Award (CTSA) [UL1TR002550]; Chan-Zuckerberg Biohub Investigator grant; National Science Foundation (NSF) grant [CRII 1657155];  [U54GM114833];  [U24TR002306]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002550] Funding Source: NIH RePORTER	Qualcomm Foundation; NIH Center for Translational Science Award (CTSA); Chan-Zuckerberg Biohub Investigator grant; National Science Foundation (NSF) grant(National Science Foundation (NSF)); ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank N. Wineinger, R. Dias, J. di Iulio and D. Evans for comments on the paper. The work of A. Telenti, A. Torkamani and P.M. is supported by the Qualcomm Foundation and the NIH Center for Translational Science Award (CTSA, grant UL1TR002550). Further support to A. Torkamani is from U54GM114833 and U24TR002306. J.Z. is supported by a Chan-Zuckerberg Biohub Investigator grant and National Science Foundation (NSF) grant CRII 1657155.	Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Angermueller C, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1189-z; Angermueller C, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156651; [Anonymous], FEEDBACK GAN FBGAN D; Avsec Z., 2018, KIPOI ACCELERATING C; Boza V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178751; Camacho DM, 2018, CELL, V173, P1581, DOI 10.1016/j.cell.2018.05.015; Chen LK, 2016, RICE, V9, P1, DOI 10.1186/s12284-016-0121-6; Chen YF, 2016, BIOINFORMATICS, V32, P1832, DOI 10.1093/bioinformatics/btw074; Ching T, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0387; Cui H., 2017, BOOSTING GENE EXPRES; Eser U., 2016, FIDDLE INTEGRATIVE D; Ghorbani A., 2017, INTERPRETATION NEURA; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Hill ST, 2018, NUCLEIC ACIDS RES, V46, P8105, DOI 10.1093/nar/gky567; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Jha A, 2017, BIOINFORMATICS, V33, pI274, DOI 10.1093/bioinformatics/btx268; Kelley DR, 2016, GENOME RES, V26, P990, DOI 10.1101/gr.200535.115; Khodabandelou G., 2018, GENOME FUNCTIONAL AN; Kleftogiannis D, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1058; Korvigo I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192829; Krizhevsky A., 2012, COMMUN ACM, P1097, DOI DOI 10.1145/3065386; Lanchantin J, 2017, BIOCOMPUT-PAC SYM, P254, DOI 10.1142/9789813207813_0025; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li YF, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2187-1; Libbrecht MW, 2015, NAT REV GENET, V16, P321, DOI 10.1038/nrg3920; Lin C, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx681; Liu F, 2016, SCI REP-UK, V6, DOI 10.1038/srep28517; Luo R., 2018, CLAIRVOYANTE MULTI T; Luo R., 2018, SKYHAWK ARTIFICIAL N; Ma W., 2017, DEEPGS PREDICTING PH; Min X, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1878-3; Park YJ, 2015, NAT BIOTECHNOL, V33, P825, DOI 10.1038/nbt.3313; Poplin R., 2017, CREATING UNIVERSAL S; Powers DMW., 2011, J MACH LEARN TECHNOL, V2, P37, DOI DOI 10.9735/2229-3981; Qi H, 2018, MVP PREDICTING PATHO; Quang D, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw226; Quang D, 2015, BIOINFORMATICS, V31, P761, DOI 10.1093/bioinformatics/btu703; Ribeiro Marco Tulio, 2016, KDD; Schreiber J., 2017, NUCLEOTIDE SEQUENCE; Shaham U, 2017, BIOINFORMATICS, V33, P2539, DOI 10.1093/bioinformatics/btx196; Shrikumar A, 2017, PMLR, V70, P3145, DOI DOI 10.1145/3292500.3330701; Shrikumar A., 2017, REVERSE COMPLEMENT P, DOI 10.1101/103663v1; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Stranger BE, 2017, NAT GENET, V49, P1664, DOI 10.1038/ng.3969; Sundaram L, 2018, NAT GENET, V50, P1161, DOI 10.1038/s41588-018-0167-z; Sundararajan M, 2017, PR MACH LEARN RES, V70; Tan J, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00025-15; Telenti A, 2018, HUM MOL GENET, V27, pR63, DOI 10.1093/hmg/ddy115; Teng H., 2017, CHIRON TRANSLATING N; Torracinta R, 2016, ADAPTIVE SOMATIC MUT; Tripathi R, 2016, NETW MODEL ANAL HLTH, V5, DOI 10.1007/s13721-016-0129-2; Wang H., 2018, DEEP LEARNING GENOMI; Wang YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19598; Webb S, 2018, NATURE, V554, P555, DOI 10.1038/d41586-018-02174-z; Xie R, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4226-0; Youssefian S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02288-w; Yu N, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1922-3; Yuan YC, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1334-9; Zeng HY, 2016, BIOINFORMATICS, V32, P121, DOI 10.1093/bioinformatics/btw255; Zeng WW, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4459-6; Zhou J., 2018, WHOLE GENOME DEEP LE; Zhou J, 2018, NAT GENET, V50, P1171, DOI 10.1038/s41588-018-0160-6; Zhou J, 2015, NAT METHODS, V12, P931, DOI [10.1038/NMETH.3547, 10.1038/nmeth.3547]	65	294	301	15	185	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2019	51	1					12	18		10.1038/s41588-018-0295-5	http://dx.doi.org/10.1038/s41588-018-0295-5			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HF3AV	30478442				2022-12-17	WOS:000454108800007
J	Giannakis, M; Hodis, E; Mu, XJ; Yamauchi, M; Rosenbluh, J; Cibulskis, K; Saksena, G; Lawrence, MS; Qian, ZR; Nishihara, R; Van Allen, EM; Hahn, WC; Gabriel, SB; Lander, ES; Getz, G; Ogino, S; Fuchs, CS; Garraway, LA				Giannakis, Marios; Hodis, Eran; Mu, Xinmeng Jasmine; Yamauchi, Mai; Rosenbluh, Joseph; Cibulskis, Kristian; Saksena, Gordon; Lawrence, Michael S.; Qian, Zhi Rong; Nishihara, Reiko; Van Allen, Eliezer M.; Hahn, William C.; Gabriel, Stacey B.; Lander, Eric S.; Getz, Gad; Ogino, Shuji; Fuchs, Charles S.; Garraway, Levi A.			RNF43 is frequently mutated in colorectal and endometrial cancers	NATURE GENETICS			English	Article							COMPREHENSIVE MOLECULAR CHARACTERIZATION; GASTRIC ADENOCARCINOMA; DRIVER MUTATIONS; CARCINOMA; LANDSCAPE; COLON	We report somatic mutations of RNF43 in over 18% of colorectal adenocarcinomas and endometrial carcinomas. RNF43 encodes an E3 ubiquitin ligase that negatively regulates Wnt signaling. Truncating mutations of RNF43 are more prevalent in microsatellite-unstable tumors and show mutual exclusivity with inactivating APC mutations in colorectal adenocarcinomas. These results indicate that RNF43 is one of the most commonly mutated genes in colorectal and endometrial cancers.	[Giannakis, Marios; Hodis, Eran; Mu, Xinmeng Jasmine; Yamauchi, Mai; Rosenbluh, Joseph; Qian, Zhi Rong; Nishihara, Reiko; Van Allen, Eliezer M.; Hahn, William C.; Ogino, Shuji; Fuchs, Charles S.; Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Van Allen, Eliezer M.; Hahn, William C.; Garraway, Levi A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Giannakis, Marios; Hodis, Eran; Mu, Xinmeng Jasmine; Rosenbluh, Joseph; Cibulskis, Kristian; Saksena, Gordon; Lawrence, Michael S.; Van Allen, Eliezer M.; Hahn, William C.; Gabriel, Stacey B.; Lander, Eric S.; Getz, Gad; Ogino, Shuji; Garraway, Levi A.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Hodis, Eran] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Hodis, Eran] Harvard Univ, Biophys Program, Cambridge, MA 02138 USA; [Nishihara, Reiko; Ogino, Shuji] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Nishihara, Reiko] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Nishihara, Reiko] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Getz, Gad] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Ogino, Shuji] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Fuchs, Charles S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Charming Div Network Med,Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Garraway, LA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	levi_garraway@dfci.harvard.edu	Mu, Xinmeng/P-2562-2016; Cibulskis, Kristian/AAC-7380-2019; Giannakis, Marios/Z-4908-2019; Lawrence, Michael/AAC-8202-2020	Mu, Xinmeng/0000-0002-8079-0828; Rosenbluh, Joseph/0000-0001-9815-8049; Cibulskis, Kristian/0000-0003-1343-1582; Ogino, Shuji/0000-0002-3909-2323	Dana-Farber Cancer Institute Leadership Council; Colon Cancer Alliance-American Association for Cancer Research Fellowship for Biomarker Research [14-40-40-GIAN]; Perry S. Levy Endowed Fellowship; National Institute of General Medical Sciences [T32GM007753]; Herchel Smith Fellowship; Agrusa Fund for Colorectal Cancer Research; National Human Genome Research Institute [U54HG003067]; National Cancer Institute [K07CA190673, P01CA87969, UM1CA167552, R01CA151993, R01CA118553, R01CA168141, P50CA127003]; NATIONAL CANCER INSTITUTE [P50CA127003, U01CA176058, R01CA118553, P01CA087969, UM1CA167552, K07CA190673, R01CA151993] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Dana-Farber Cancer Institute Leadership Council; Colon Cancer Alliance-American Association for Cancer Research Fellowship for Biomarker Research; Perry S. Levy Endowed Fellowship; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Herchel Smith Fellowship; Agrusa Fund for Colorectal Cancer Research; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Bahl, E. Nickerson and S. Chauvin for project management and A. Regev for help with computing resources, as well as A. Sivachenko, F. Huang and P. Tamayo for helpful discussions. This work was supported by the Dana-Farber Cancer Institute Leadership Council, the 2014 Colon Cancer Alliance-American Association for Cancer Research Fellowship for Biomarker Research, grant 14-40-40-GIAN, the Perry S. Levy Endowed Fellowship (M.G.), award T32GM007753 from the National Institute of General Medical Sciences, the Herchel Smith Fellowship (E.H.) and the Agrusa Fund for Colorectal Cancer Research (C.S.F.), as well as National Human Genome Research Institute grant U54HG003067 (E.S.L. and S.B.G.) and National Cancer Institute grants, K07CA190673 (R.N.), P01CA87969, UM1CA167552 and R01CA151993 (S.O.), R01CA118553 and R01CA168141 (C.S.F.) and P50CA127003 (M.G., W.C.H., L.A.G. and C.S.F.).	Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Jiang XM, 2013, P NATL ACAD SCI USA, V110, P12649, DOI 10.1073/pnas.1307218110; Jiao YC, 2014, J PATHOL, V232, P428, DOI 10.1002/path.4310; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246	16	294	303	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1264	1266		10.1038/ng.3127	http://dx.doi.org/10.1038/ng.3127			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU	25344691	Green Published, Green Accepted			2022-12-17	WOS:000345547300006
J	Franke, A; Balschun, T; Karlsen, TH; Hedderich, J; May, S; Lu, T; Schuldt, D; Nikolaus, S; Rosenstiel, P; Krawczak, M; Schreiber, S				Franke, Andre; Balschun, Tobias; Karlsen, Tom H.; Hedderich, Juergen; May, Sandra; Lu, Tim; Schuldt, Doerthe; Nikolaus, Susanna; Rosenstiel, Philip; Krawczak, Michael; Schreiber, Stefan			Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; GENE; AUTOPHAGY; MULTIPLE	Following up on recent genome-wide association studies (GWAS) of Crohn's disease, we investigated 50 previously reported susceptibility loci in a German sample of individuals with Crohn's disease (n = 1,850) or ulcerative colitis (n = 1,103) and healthy controls (n = 1,817). Among these loci, we identified variants in 3p21.31, NKX2-3 and CCNY as susceptibility factors for both diseases, whereas variants in PTPN2, HERC2 and STAT3 were associated only with ulcerative colitis in our sample collection.	[Franke, Andre; Balschun, Tobias; May, Sandra; Schuldt, Doerthe; Rosenstiel, Philip; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Karlsen, Tom H.] Univ Oslo, Rikshosp, Univ Hosp, Dept Med, N-0027 Oslo, Norway; [Hedderich, Juergen; Lu, Tim; Krawczak, Michael] Univ Kiel, Inst Med Informat & Stat, D-24105 Kiel, Germany; [Schuldt, Doerthe; Nikolaus, Susanna; Schreiber, Stefan] Univ Kiel, Dept Gen Internal Med, Univ Hosp Schleswig Holstein, D-24105 Kiel, Germany	University of Kiel; University of Oslo; National Hospital Norway; University of Kiel; University of Kiel; Schleswig Holstein University Hospital	Schreiber, S (corresponding author), Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany.	s.schreiber@mucosa.de	Franke, Andre/B-2151-2010; Rosenstiel, Philip/A-5137-2009; Balschun, Tobias/B-2356-2010; Krawczak, Michael/A-8964-2010	Franke, Andre/0000-0003-1530-5811; Rosenstiel, Philip/0000-0002-9692-8828; Krawczak, Michael/0000-0003-2603-1502				Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Franke A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000691; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379	10	294	303	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2008	40	6					713	715		10.1038/ng.148	http://dx.doi.org/10.1038/ng.148			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18438405				2022-12-17	WOS:000256212000011
J	Metherell, LA; Chapple, JP; Cooray, S; David, A; Becker, C; Ruschendorf, F; Naville, D; Begeot, M; Khoo, B; Nurnberg, P; Huebner, A; Cheetham, ME; Clark, AJL				Metherell, LA; Chapple, JP; Cooray, S; David, A; Becker, C; Ruschendorf, F; Naville, D; Begeot, M; Khoo, B; Nurnberg, P; Huebner, A; Cheetham, ME; Clark, AJL			Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2	NATURE GENETICS			English	Article							ADRENOCORTICOTROPIN RECEPTOR; ENDOPLASMIC-RETICULUM; CALCITONIN-RECEPTOR; LINKAGE ANALYSIS; GENE; IDENTIFICATION; ADIPOCYTES; EXPRESSION; PROTEINS; CELLS	Familial glucocorticoid deficiency (FGD), or hereditary unresponsiveness to adrenocorticotropin (ACTH; OMIM 202200), is an autosomal recessive disorder resulting from resistance to the action of ACTH on the adrenal cortex, which stimulates glucocorticoid production. Affected individuals are deficient in cortisol and, if untreated, are likely to succumb to hypoglycemia or overwhelming infection in infancy or childhood(1-3). Mutations of the ACTH receptor (melanocortin 2 receptor, MC2R) account for similar to25% of cases of FGD(4-7). FGD without mutations of MC2R is called FGD type 2. Using SNP array genotyping, we mapped a locus involved in FGD type 2 to chromosome 21q22.1. We identified mutations in a gene encoding a 19-kDa single-transmembrane domain protein(8), now known as melanocortin 2 receptor accessory protein (MRAP). We show that MRAP interacts with MC2R and may have a role in the trafficking of MC2R from the endoplasmic reticulum to the cell surface.	Barts & London Queen Mary Univ London, William Harvey Res Inst, Dept Endocrinol, London EC1A 7BE, England; UCL, Inst Ophthalmol, Div Pathol, London EC1V 9EL, England; Max Delbruck Ctr Mol Med, Mol Genet & Gene Mapping Ctr, Berlin, Germany; Hop Debrousse, INSERM, U418, F-69322 Lyon, France; Univ Med Berlin, Charite, Inst Med Genet, Berlin, Germany; Tech Univ Dresden, Childrens Hosp, D-8027 Dresden, Germany	University of London; Queen Mary University London; University of London; University College London; Helmholtz Association; Max Delbruck Center for Molecular Medicine; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technische Universitat Dresden	Clark, AJL (corresponding author), Barts & London Queen Mary Univ London, William Harvey Res Inst, Dept Endocrinol, London EC1A 7BE, England.	a.j.clark@qmul.ac.uk	Metherell, Louise A/E-8695-2012; Khoo, Bernard/B-1247-2009; Cheetham, Michael/B-4672-2011; Naville, Danielle/N-1200-2017	Metherell, Louise A/0000-0002-0530-3524; Khoo, Bernard/0000-0002-4223-9736; Naville, Danielle/0000-0003-2615-6161; Huebner, Angela/0000-0003-1338-5192; Cheetham, Michael/0000-0001-6429-654X; Chapple, Paul/0000-0003-1876-1505				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Boston BA, 1996, ENDOCRINOLOGY, V137, P2043, DOI 10.1210/en.137.5.2043; Chapple JP, 2003, J BIOL CHEM, V278, P19087, DOI 10.1074/jbc.M212349200; Clark AJL, 1998, ENDOCR REV, V19, P828, DOI 10.1210/er.19.6.828; CLARK AJL, 1993, LANCET, V341, P461, DOI 10.1016/0140-6736(93)90208-X; Elias LLK, 1999, J CLIN ENDOCR METAB, V84, P2766, DOI 10.1210/jc.84.8.2766; Genin E, 2002, HUM GENET, V111, P428, DOI 10.1007/s00439-002-0806-3; GOZANI O, 1994, EMBO J, V13, P3356, DOI 10.1002/j.1460-2075.1994.tb06638.x; GRUNFELD C, 1985, ENDOCRINOLOGY, V116, P113, DOI 10.1210/endo-116-1-113; Longshaw VM, 2004, J CELL SCI, V117, P701, DOI 10.1242/jcs.00905; Matsuzaki H, 2004, GENOME RES, V14, P414, DOI 10.1101/gr.2014904; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Metherell Louise A., 2001, American Journal of Human Genetics, V69, P641, DOI 10.1086/323266; MIGEON CJ, 1968, PEDIATR RES, V2, P501, DOI 10.1203/00006450-196811000-00008; Muff R, 1999, ENDOCRINOLOGY, V140, P2924, DOI 10.1210/en.140.6.2924; Naville D, 1996, J CLIN ENDOCR METAB, V81, P1442, DOI 10.1210/jc.81.4.1442; Noon LA, 2004, J BIOL CHEM, V279, P22803, DOI 10.1074/jbc.M401861200; Noon LA, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740017; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; SHEPARD TH, 1959, AMA J DIS CHILD, V97, P154, DOI 10.1001/archpedi.1959.02070010156002; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; TSIGOS C, 1993, J CLIN INVEST, V92, P2458, DOI 10.1172/JCI116853; WEBER A, 1995, J CLIN ENDOCR METAB, V80, P65, DOI 10.1210/jc.80.1.65; Xu AM, 2002, BIOCHEM BIOPH RES CO, V293, P1161, DOI 10.1016/S0006-291X(02)00354-6; Yang YK, 1997, MOL ENDOCRINOL, V11, P274, DOI 10.1210/me.11.3.274	26	294	306	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2005	37	2					166	170		10.1038/ng1501	http://dx.doi.org/10.1038/ng1501			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	893AB	15654338				2022-12-17	WOS:000226690100023
J	Edelmann, W; Cohen, PE; Kneitz, B; Winand, N; Lia, M; Heyer, J; Kolodner, R; Pollard, JW; Kucherlapati, R				Edelmann, W; Cohen, PE; Kneitz, B; Winand, N; Lia, M; Heyer, J; Kolodner, R; Pollard, JW; Kucherlapati, R			Mammalian MutS homologue 5 is required for chromosome pairing in meiosis	NATURE GENETICS			English	Article							DNA MISMATCH REPAIR; NONPOLYPOSIS COLORECTAL-CANCER; COLON-CANCER; CROSSING-OVER; GENE; MUTATION; MICE; MSH2; RECOMBINATION; ASSOCIATION	MSH5 (MutS homologue 5) is a member of a family of proteins known to be involved in DNA mismatch repair(1,2). Germline mutations in MSH2, MLH1 and GTBP (also known as MSH6) cause hereditary non-polyposis colon cancer (HNPCC) or Lynch syndrome(3-8). Inactivation of Msh2, Mlh1, Gtmbp (also known as Msh6) or Pms2 in mice leads to hereditary predisposition to intestinal and other cancers(9-14). Early studies in yeast revealed a role for some of these proteins, including Msh5, in meiosis(15-17). Gene targeting studies in mice confirmed roles for Mlh1 and Pms2 in mammalian meiosis(12-14,18). To assess the role of Msh5 in mammals, we generated and characterized mice with a null mutation in Msh5 Msh5(-/-) mice are viable but sterile. Meiosis in these mice is affected due to the disruption of chromosome pairing in prophase I. We found that this meiotic failure leads to a diminution in testicular size and a complete loss of ovarian structures, Our results show that normal Msh5 function is essential for meiotic progression and, in females, gonadal maintenance.	Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Dana-Farber Cancer Institute	Edelmann, W (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.		Kucherlapati, Raju/ABC-8807-2021		DIVISION OF CANCER PREVENTION AND CONTROL [N01CN065031] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA076329, R01CA067944] Funding Source: NIH RePORTER; NCI NIH HHS [CA 67944, CA 76329, N01-CN-65031] Funding Source: Medline	DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akiyama Y, 1997, CANCER RES, V57, P3920; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; COUNCE SJ, 1973, CHROMOSOMA, V44, P231, DOI 10.1007/BF00329119; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Edelmann W, 1997, CELL, V91, P467, DOI 10.1016/S0092-8674(00)80433-X; ENDERS GC, 1994, DEV BIOL, V163, P331, DOI 10.1006/dbio.1994.1152; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; IOFFE E, 1995, P NATL ACAD SCI USA, V92, P7357, DOI 10.1073/pnas.92.16.7357; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; MCDONOUGH PG, 1972, PEDIATR CLIN N AM, V19, P631; Miyaki M, 1997, NAT GENET, V17, P271, DOI 10.1038/ng1197-271; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Moens PB, 1998, CURR TOP DEV BIOL, V37, P241; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Plug AW, 1996, P NATL ACAD SCI USA, V93, P5920, DOI 10.1073/pnas.93.12.5920; Plug AW, 1998, J CELL SCI, V111, P413; PROLLA TA, 1994, MOL CELL BIOL, V14, P407, DOI 10.1128/MCB.14.1.407; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; SINGH RP, 1966, ANAT REC, V155, P369, DOI 10.1002/ar.1091550309; Spyropoulos B, 1994, Methods Mol Biol, V33, P131; WASSARMAN PM, 1988, ANNU REV BIOCHEM, V57, P415, DOI 10.1146/annurev.bi.57.070188.002215; Winand NJ, 1998, GENOMICS, V53, P69, DOI 10.1006/geno.1998.5447; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2	30	294	301	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1999	21	1					123	127		10.1038/5075	http://dx.doi.org/10.1038/5075			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	155RT	9916805				2022-12-17	WOS:000077960700023
J	Semina, EV; Ferrell, RE; Mintz-Hittner, HA; Bitoun, P; Alward, WLM; Reiter, RS; Funkhauser, C; Daack-Hirsch, S; Murray, JC				Semina, EV; Ferrell, RE; Mintz-Hittner, HA; Bitoun, P; Alward, WLM; Reiter, RS; Funkhauser, C; Daack-Hirsch, S; Murray, JC			A novel homeobox gene PITX3 is mutated in families with autosomal-dominant cataracts and ASMD	NATURE GENETICS			English	Article							SEGMENT MESENCHYMAL DYSGENESIS; PAX6 GENE; MUTATIONS; TRANSCRIPTION; HOMEODOMAIN; ANIRIDIA	We report here the identification of a new human homeobox gene, PITX3, and its involvement in anterior segment mesenchymal dysgenesis (ASMD) and congenital cataracts in humans. The PITX3 gene is the human homologue of the mouse Pitx3 gene and is a member of the RIEG/PITX homeobox gene family. The protein encoded by PITX3 shows 99% amino-acid identity to the mouse protein, with 100% identity in the homeodomain and approximately 70% overall identity to other members of this family. We mapped the human PITX3 gene to 10q25 using a radiation-hybrid panel. A collection of 80 DNA samples from individuals with various eye anomalies was screened for mutations in the PITX3 gene. We identified two mutations in independent patients. A 17-bp insertion in the 3'-end of the coding sequence, resulting in a frame shift, occured in a patient with ASMD and cataracts, and a G-->A substitution, changing a codon for serine into a codon for asparagine, in the 5'-end of the gene occured in a patient with congenital cataracts. Both mutations cosegregate with the disease phenotype in families, and neither were found in up to 300 control individuals studied, Further expression analysis of Pitx3 in the mouse supports a unique role in early ocular development, with later expression extending to the midbrain, tongue, incisors, sternum, vertebrae and limbs. These data strongly suggest a role for PITX3 in ASMD and cataracts and provide new evidence of the contribution of the RIEG/PITX gene family to the developmental program underpinning normal eye formation.	Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA; Univ Iowa, Dept Ophthalmol, Iowa City, IA 52242 USA; Univ Texas, Houston Med Sch, Dept Ophthalmol & Visual Sci, Houston, TX 77030 USA; Hop Jean Verdier, F-93143 Bondy, France; Univ Pittsburgh, Dept Human Genet, Sch Publ Hlth, Pittsburgh, PA 15261 USA	University of Iowa; University of Iowa; University of Iowa; University of Texas System; University of Texas Health Science Center Houston; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Murray, JC (corresponding author), Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.	jeff-murrat@uiowa.edu	Alward, Wallace/AAY-4149-2020	Bitoun, Pierre/0000-0001-6557-6826; Daack-Hirsch, Sandra/0000-0003-1192-7154; Alward, Wallace/0000-0001-6368-9018	NEI NIH HHS [EY08893] Funding Source: Medline; NIDCR NIH HHS [DE09170] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE009170] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BRAKENHOFF RH, 1994, HUM MOL GENET, V3, P279, DOI 10.1093/hmg/3.2.279; FERRELL RE, 1982, AM J HUM GENET, V34, P245; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; HANSON IM, 1994, NAT GENET, V6, P168, DOI 10.1038/ng0294-168; HEATHCOTE JG, 1991, CAN J OPHTHALMOL, V26, P35; HITTNER HM, 1982, AM J OPHTHALMOL, V93, P57, DOI 10.1016/0002-9394(82)90700-0; Jaffe L, 1997, GENE DEV, V11, P1327, DOI 10.1101/gad.11.10.1327; KUMAR J, 1997, GENE DEV, V11, P2033; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; Litt M, 1997, HUM MOL GENET, V6, P665, DOI 10.1093/hmg/6.5.665; MARNER E, 1989, ACTA OPHTHALMOL, V67, P151; MARTHA A, 1995, HUM MUTAT, V6, P44, DOI 10.1002/humu.1380060109; MCLEAN WHI, 1994, J INVEST DERMATOL, V102, P24, DOI 10.1111/1523-1747.ep12371726; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Prasad KSS, 1997, J BIOL CHEM, V272, P11457; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; ROESSLER BJ, 1993, J BIOL CHEM, V268, P26476; SARFARAZI M, 1997, HUM MOL GENET, V6, P16667; Semina EV, 1997, HUM MOL GENET, V6, P2109, DOI 10.1093/hmg/6.12.2109; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; Szeto DP, 1996, P NATL ACAD SCI USA, V93, P7706, DOI 10.1073/pnas.93.15.7706; TREISMAN J, 1992, BIOESSAYS, V14, P145, DOI 10.1002/bies.950140302	23	294	313	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1998	19	2					167	170		10.1038/527	http://dx.doi.org/10.1038/527			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620774				2022-12-17	WOS:000073865100025
J	HEMMINKI, A; PELTOMAKI, P; MECKLIN, JP; JARVINEN, H; SALOVAARA, R; NYSTROMLAHTI, M; DELACHAPELLE, A; AALTONEN, LA				HEMMINKI, A; PELTOMAKI, P; MECKLIN, JP; JARVINEN, H; SALOVAARA, R; NYSTROMLAHTI, M; DELACHAPELLE, A; AALTONEN, LA			LOSS OF THE WILD-TYPE MLH1 GENE IS A FEATURE OF HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER	NATURE GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; COLON-CANCER; DCC GENE; APC GENE; CARCINOMA; LOCUS; INSTABILITY; FAMILY; SUSCEPTIBILITY; MUTATIONS	The mechanism by which germline mutations of DNA mismatch repair genes cause susceptibility to tumour formation is not yet understood. Studies in vitro indicate that heterozygosity for these mutations, unlike homozygosity, does not affect mismatch repair. Surprisingly, no loss of heterozygosity at the predisposing loci has so far been described in hereditary nonpolyposis colorectal cancers. Here, we show that loss of heterozygosity (LOH) of markers within or adjacent to the MLH1 gene on chromosome 3p occurs nonrandomly in tumours from members of families in which the disease phenotype cosegregates with MLH1. In every informative case, the loss affects the wild type allele. These results suggest that DNA mismatch repair genes resemble tumour suppressor genes in that two hits are required to cause a phenotypic effect.	UNIV HELSINKI, DEPT MED GENET, SF-00014 HELSINKI, FINLAND; JYVASKYLA CENT HOSP, DEPT SURG, SF-40620 JYVASKYLA, FINLAND; UNIV HELSINKI, CENT HOSP, DEPT SURG, SF-00290 HELSINKI, FINLAND; UNIV HELSINKI, DEPT PATHOL, SF-00014 HELSINKI, FINLAND	University of Helsinki; Central Finland Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki			Aaltonen, Lauri/A-5375-2010; Mecklin, Jukka-Pekka/AAB-5378-2020; Mecklin, Jukka-Pekka/AAC-9650-2019	Aaltonen, Lauri/0000-0001-6839-4286; Mecklin, Jukka-Pekka/0000-0003-4895-2249; Peltomaki, Paivi/0000-0001-8819-2980; Nystrom, Minna/0000-0003-0827-0243				AALTONEN LA, 1994, CANCER RES, V54, P1645; AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; BODMER W, 1994, NAT GENET, V6, P217, DOI 10.1038/ng0394-217; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; GANLY PS, 1992, GENOMICS, V12, P221, DOI 10.1016/0888-7543(92)90369-4; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; ISOLA J, 1994, IN PRESS AM J PATHOL; JIRLCNY J, 1994, TRENDS GENET, V10, P164; JONES MH, 1992, GENE CHROMOSOME CANC, V5, P89, DOI 10.1002/gcc.2870050113; Jones Michael H., 1992, Human Molecular Genetics, V1, P131, DOI 10.1093/hmg/1.2.131; KNUDSON AG, 1993, NAT GENET, V5, P103, DOI 10.1038/ng1093-103; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KOURI M, 1990, CANCER, V65, P1825, DOI 10.1002/1097-0142(19900415)65:8<1825::AID-CNCR2820650827>3.0.CO;2-H; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LINDBLOM A, 1993, NAT GENET, V5, P279, DOI 10.1038/ng1193-279; LIU B, 1994, CANCER RES, V54, P4590; LOTHE RA, 1993, CANCER RES, V53, P5849; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; MECKLIN JP, 1987, GASTROENTEROLOGY, V93, P1021, DOI 10.1016/0016-5085(87)90565-8; MECKLIN JP, 1986, GASTROENTEROLOGY, V90, P328, DOI 10.1016/0016-5085(86)90928-5; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; NYSTROMLAHTI M, 1994, P NATL ACAD SCI USA, V91, P6054, DOI 10.1073/pnas.91.13.6054; NYSTROMLAHTI M, 1994, AM J HUM GENET, V55, P659; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; PELTOMAKI P, 1993, SCIENCE, V260, P810, DOI 10.1126/science.8484120; PELTOMAKI P, 1991, CANCER RES, V51, P4135; PELTOMAKI P, 1992, CANCER RES, V52, P4530; RISINGER JI, 1993, CANCER RES, V53, P5100; RISINGER JI, 1992, HUM MOL GENET, V1, P657, DOI 10.1093/hmg/1.8.657-a; Sambrook J., 1989, MOL CLONING LAB MANU; SPIRIO L, 1991, NUCLEIC ACIDS RES, V19, P6348, DOI 10.1093/nar/19.22.6348; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WU C, 1994, ONCOGENE, V9, P991	38	294	297	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1994	8	4					405	410		10.1038/ng1294-405	http://dx.doi.org/10.1038/ng1294-405			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	7894494				2022-12-17	WOS:A1994PV68200024
J	Andersson, AK; Ma, J; Wang, JM; Chen, X; Gedman, AL; Dang, JJ; Nakitandwe, J; Holmfeldt, L; Parker, M; Easton, J; Huether, R; Kriwacki, R; Rusch, M; Wu, G; Li, YJ; Mulder, H; Raimondi, S; Pounds, S; Kang, GL; Shi, L; Becksfort, J; Gupta, P; Payne-Turner, D; Vadodaria, B; Boggs, K; Yergeau, D; Manne, J; Song, GC; Edmonson, M; Nagahawatte, P; Wei, L; Cheng, C; Pei, DQ; Sutton, R; Venn, NC; Chetcuti, A; Rush, A; Catchpoole, D; Heldrup, J; Fioretos, T; Lu, C; Ding, L; Pui, CH; Shurtleff, S; Mullighan, CG; Mardis, ER; Wilson, RK; Gruber, TA; Zhang, JH; Downing, JR				Andersson, Anna K.; Ma, Jing; Wang, Jianmin; Chen, Xiang; Gedman, Amanda Larson; Dang, Jinjun; Nakitandwe, Joy; Holmfeldt, Linda; Parker, Matthew; Easton, John; Huether, Robert; Kriwacki, Richard; Rusch, Michael; Wu, Gang; Li, Yongjin; Mulder, Heather; Raimondi, Susana; Pounds, Stanley; Kang, Guolian; Shi, Lei; Becksfort, Jared; Gupta, Pankaj; Payne-Turner, Debbie; Vadodaria, Bhavin; Boggs, Kristy; Yergeau, Donald; Manne, Jayanthi; Song, Guangchun; Edmonson, Michael; Nagahawatte, Panduka; Wei, Lei; Cheng, Cheng; Pei, Deqing; Sutton, Rosemary; Venn, Nicola C.; Chetcuti, Albert; Rush, Amanda; Catchpoole, Daniel; Heldrup, Jesper; Fioretos, Thoas; Lu, Charles; Ding, Li; Pui, Ching-Hon; Shurtleff, Sheila; Mullighan, Charles G.; Mardis, Elaine R.; Wilson, Richard K.; Gruber, Tanja A.; Zhang, Jinghui; Downing, James R.		St Jude Children's Res Hosp-Washin	The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; K-RAS MUTATIONS; CHROMOSOMAL TRANSLOCATIONS; GENETIC ALTERATIONS; CANCER; IDENTIFICATION; RESISTANCE; T(4/11); FLT3; BREAKPOINT	Infant acute lymphoblastic leukemia (ALL) with MLL rearrangements (MLL-R) represents a distinct leukemia with a poor prognosis. To define its mutational landscape, we performed whole-genome, exome, RNA and targeted DNA sequencing on 65 infants (47 MLL-R and 18 non-MLL-R cases) and 20 older children (MLL-R cases) with leukemia. Our data show that infant MLL-R ALL has one of the lowest frequencies of somatic mutations of any sequenced cancer, with the predominant leukemic clone carrying a mean of 1.3 non-silent mutations. Despite this paucity of mutations, we detected activating mutations in kinase-PI3K-RAS signaling pathway components in 47% of cases. Surprisingly, these mutations were often subclonal and were frequently lost at relapse. In contrast to infant cases, MLL-R leukemia in older children had more somatic mutations (mean of 6.5 mutations/case versus 1.3 mutations/case, P = 7.15 x 10(-5)) and had frequent mutations (45%) in epigenetic regulators, a category of genes that, with the exception of MLL, was rarely mutated in infant MLL-R ALL.	[Andersson, Anna K.; Ma, Jing; Gedman, Amanda Larson; Dang, Jinjun; Nakitandwe, Joy; Holmfeldt, Linda; Raimondi, Susana; Payne-Turner, Debbie; Song, Guangchun; Pui, Ching-Hon; Shurtleff, Sheila; Mullighan, Charles G.; Gruber, Tanja A.; Downing, James R.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Andersson, Anna K.; Fioretos, Thoas] Lund Univ, Dept Clin Genet, Lund, Sweden; [Wang, Jianmin; Chen, Xiang; Parker, Matthew; Huether, Robert; Rusch, Michael; Wu, Gang; Li, Yongjin; Becksfort, Jared; Gupta, Pankaj; Edmonson, Michael; Nagahawatte, Panduka; Wei, Lei; Zhang, Jinghui] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Easton, John; Mulder, Heather; Vadodaria, Bhavin; Boggs, Kristy; Yergeau, Donald; Manne, Jayanthi] St Jude Childrens Res Hosp, Pediat Canc Genome Project Lab, Memphis, TN 38105 USA; [Kriwacki, Richard] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Pounds, Stanley; Kang, Guolian; Shi, Lei; Cheng, Cheng; Pei, Deqing] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Sutton, Rosemary; Venn, Nicola C.] Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia, Sydney, NSW, Australia; [Chetcuti, Albert; Rush, Amanda; Catchpoole, Daniel] Childrens Hosp Westmead, Tumor Bank, Childrens Canc Res Unit, Sydney, NSW, Australia; [Heldrup, Jesper] Skane Univ Hosp, Dept Pediat, Lund, Sweden; [Lu, Charles; Ding, Li; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med St Louis, Dept Genet, St Louis, MO USA; [Lu, Charles; Ding, Li; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med St Louis, Genome Inst, St Louis, MO USA; [Pui, Ching-Hon; Gruber, Tanja A.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; Lund University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Children's Cancer Institute; University of New South Wales Sydney; University of Sydney; Lund University; Skane University Hospital; Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); St Jude Children's Research Hospital	Andersson, AK (corresponding author), St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.	anna.andersson@med.lu.se; tanja.gruber@stjude.org; james.downing@stjude.org	Wilson, Richard K./AAF-4139-2019; Cheng, Cheng/N-8075-2018; Mullighan, Charles/H-3253-2011; Rush, Amanda/AFO-5668-2022; Wu, Gang/M-8012-2014; wang, jian/GVS-0711-2022; Raimondi, Susana C/N-8166-2018; Pui, Ching-Hon/N-8076-2018; Pounds, Stanley B/N-2480-2018; Downing, James R./N-8102-2018; Kriwacki, Richard/N-8154-2018; Sutton, Rosemary/J-3784-2014; Rush, Amanda/ABD-3077-2020; LI, YONGJIN/E-1688-2011; Heldrup, Jesper/AAW-6836-2020; Mardis, Elaine/W-2202-2019; Zhang, Jing/GWZ-7332-2022; Rush, Amanda/AAZ-5391-2020; Gruber, Tanja/AAH-1248-2021; Chen, Xiang/N-2524-2018; Rusch, Michael/AAG-1998-2019; Huether, Robert/E-9638-2012	Wilson, Richard K./0000-0002-1992-1358; Mullighan, Charles/0000-0002-1871-1850; Rush, Amanda/0000-0002-8714-8547; Wu, Gang/0000-0002-1678-5864; Pui, Ching-Hon/0000-0003-0303-5658; Pounds, Stanley B/0000-0002-9167-2114; Kriwacki, Richard/0000-0002-9798-6018; Sutton, Rosemary/0000-0002-0188-6005; Chen, Xiang/0000-0002-2499-8261; Rusch, Michael/0000-0002-5363-1848; Huether, Robert/0000-0001-7077-7470; Heldrup, Jesper/0000-0002-6211-1967; Parker, Matthew/0000-0003-2999-3870; Easton, John/0000-0003-4503-6608; Hagstrom-Andersson, Anna/0000-0002-2904-1311; Fioretos, Thoas/0000-0002-3235-6154; Holmfeldt, Linda/0000-0003-4140-3423	St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project; American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital; US National Institutes of Health [P30 CA021765]; Swedish Childhood Cancer Society; Swedish Research Council; Swedish Cancer Society; BioCARE; Gunnar Nilsson Cancer Foundation; NATIONAL CANCER INSTITUTE [P30CA021765, P30CA016056] Funding Source: NIH RePORTER	St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project; American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Childhood Cancer Society; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); BioCARE; Gunnar Nilsson Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all the patients and their parents from the St. Jude Children's Research Hospital (USA), the Department of Pediatrics at Lund University Hospital (Sweden) and the children's hospitals associated with the Australian and New Zealand Children's Haematology and Oncology Group. We thank B. Pappas and S. Malone for IT infrastructure. We thank the Tissue Resources Laboratory, the Flow Cytometry and Cell Sorting Core and the Clinical Applications of Core Technology Laboratories of the Hartwell Center for Bioinformatics and Biotechnology of St. Jude Children's Research Hospital. We thank E. Parganas and J. Ihle (St. Jude Children's Research Hospital) for the mouse BaF3 cells. This work was funded by the St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project and the American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital and was supported by a grant from the US National Institutes of Health (P30 CA021765). A.K.A. was supported by the Swedish Childhood Cancer Society, the Swedish Research Council, the Swedish Cancer Society, BioCARE and the Gunnar Nilsson Cancer Foundation. C.G.M. is a Pew Scholar in Biomedical Sciences and a St. Baldrick's Scholar.	Bardini M, 2015, LEUKEMIA, V29, P38, DOI 10.1038/leu.2014.154; Bardini M, 2011, LEUKEMIA, V25, P175, DOI 10.1038/leu.2010.232; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkt1030, 10.1093/nar/gkr1202, 10.1093/nar/gkq1079, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkn723, 10.1093/nar/gkx1094]; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Berman HM, 2008, ACTA CRYSTALLOGR A, V64, P88, DOI 10.1107/S0108767307035623; Biondi A, 2000, BLOOD, V96, P24, DOI 10.1182/blood.V96.1.24; Burke JE, 2012, P NATL ACAD SCI USA, V109, P15259, DOI 10.1073/pnas.1205508109; Chang VY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-55; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/nmeth.1363, 10.1038/NMETH.1363]; De Lorenzo P, 2014, LEUKEMIA, V28, P428, DOI 10.1038/leu.2013.280; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Dobbins SE, 2013, GENE CHROMOSOME CANC, V52, P954, DOI 10.1002/gcc.22090; Downing JR, 2012, NAT GENET, V44, P619, DOI 10.1038/ng.2287; DOWNING JR, 1994, BLOOD, V83, P330, DOI 10.1182/blood.V83.2.330.bloodjournal832330; Driessen EMC, 2013, HAEMATOLOGICA, V98, P937, DOI 10.3324/haematol.2012.067983; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; FORD AM, 1993, NATURE, V363, P358, DOI 10.1038/363358a0; Gale KB, 1997, P NATL ACAD SCI USA, V94, P13950, DOI 10.1073/pnas.94.25.13950; Gillert E, 1999, ONCOGENE, V18, P4663, DOI 10.1038/sj.onc.1202842; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Heerema NA, 2002, CANCER-AM CANCER SOC, V94, P1102, DOI 10.1002/cncr.10325; HEEREMA NA, 1994, BLOOD, V83, P2274, DOI 10.1182/blood.V83.8.2274.bloodjournal8382274; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Kalbfleisch JD, 1980, STAT ANAL FAILURE TI; Kim WI, 2009, BLOOD, V113, P1086, DOI 10.1182/blood-2008-01-132316; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Liang DC, 2006, CANCER, V106, P950, DOI 10.1002/cncr.21687; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Meyer C, 2013, LEUKEMIA, V27, P2165, DOI 10.1038/leu.2013.135; Mullighan CG, 2008, GENE DEV, V22, P1411, DOI 10.1101/gad.1673908; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Ono R, 2009, LEUKEMIA, V23, P2197, DOI 10.1038/leu.2009.177; Opatz S, 2013, BLOOD, V122, P1761, DOI 10.1182/blood-2013-01-476473; Pieters R, 2007, LANCET, V370, P240, DOI 10.1016/S0140-6736(07)61126-X; Pounds S, 2013, BIOINFORMATICS, V29, P2088, DOI 10.1093/bioinformatics/btt372; Prelle C, 2013, LEUKEMIA, V27, P1425, DOI 10.1038/leu.2012.365; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Reichel M, 1998, ONCOGENE, V17, P3035, DOI 10.1038/sj.onc.1202229; Rozen S, 2000, Methods Mol Biol, V132, P365; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Smith CC, 2013, BLOOD, V121, P3165, DOI 10.1182/blood-2012-07-442871; Smith G, 2010, BRIT J CANCER, V102, P693, DOI 10.1038/sj.bjc.6605534; Super HG, 1997, GENE CHROMOSOME CANC, V20, P185, DOI 10.1002/(SICI)1098-2264(199710)20:2<185::AID-GCC9>3.0.CO;2-#; Szczepanski T, 2010, LANCET ONCOL, V11, P880, DOI 10.1016/S1470-2045(09)70369-9; Tamai H, 2011, LEUKEMIA, V25, P888, DOI 10.1038/leu.2011.15; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tyner JW, 2009, BLOOD, V113, P1749, DOI 10.1182/blood-2008-04-152157; von Bubnoff N, 2009, CANCER RES, V69, P3032, DOI 10.1158/0008-5472.CAN-08-2923; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/NMETH.1628, 10.1038/nmeth.1628]; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Zhang JH, 2005, PLOS COMPUT BIOL, V1, P395, DOI 10.1371/journal.pcbi.0010053; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang YM, 2006, DNA REPAIR, V5, P1282, DOI 10.1016/j.dnarep.2006.05.020	67	293	301	1	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					330	U192		10.1038/ng.3230	http://dx.doi.org/10.1038/ng.3230			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25730765	Green Accepted			2022-12-17	WOS:000351922900007
J	Thorleifsson, G; Walters, GB; Hewitt, AW; Masson, G; Helgason, A; Dewan, A; Sigurdsson, A; Jonasdottir, A; Gudjonsson, SA; Magnusson, KP; Stefansson, H; Lam, DSC; Tam, POS; Gudmundsdottir, GJ; Southgate, L; Burdon, KP; Gottfredsdottir, MS; Aldred, MA; Mitchell, P; St Clair, D; Collier, DA; Tang, N; Sveinsson, O; Macgregor, S; Martin, NG; Cree, AJ; Gibson, J; MacLeod, A; Jacob, A; Ennis, S; Young, TL; Chan, JCN; Karwatowski, WSS; Hammond, CJ; Thordarson, K; Zhang, M; Wadelius, C; Lotery, AJ; Trembath, RC; Pang, CP; Hoh, J; Craig, JE; Kong, A; Mackey, DA; Jonasson, F; Thorsteinsdottir, U; Stefansson, K				Thorleifsson, Gudmar; Walters, G. Bragi; Hewitt, Alex W.; Masson, Gisli; Helgason, Agnar; DeWan, Andrew; Sigurdsson, Asgeir; Jonasdottir, Adalbjorg; Gudjonsson, Sigurjon A.; Magnusson, Kristinn P.; Stefansson, Hreinn; Lam, Dennis S. C.; Tam, Pancy O. S.; Gudmundsdottir, Gudrun J.; Southgate, Laura; Burdon, Kathryn P.; Gottfredsdottir, Maria Soffia; Aldred, Micheala A.; Mitchell, Paul; St Clair, David; Collier, David A.; Tang, Nelson; Sveinsson, Orn; Macgregor, Stuart; Martin, Nicholas G.; Cree, Angela J.; Gibson, Jane; MacLeod, Alex; Jacob, Aby; Ennis, Sarah; Young, Terri L.; Chan, Juliana C. N.; Karwatowski, Wojciech S. S.; Hammond, Christopher J.; Thordarson, Kristjan; Zhang, Mingzhi; Wadelius, Claes; Lotery, Andrew J.; Trembath, Richard C.; Pang, Chi Pui; Hoh, Josephine; Craig, Jamie E.; Kong, Augustine; Mackey, David A.; Jonasson, Fridbert; Thorsteinsdottir, Unnur; Stefansson, Kari			Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma	NATURE GENETICS			English	Article							NITRIC-OXIDE SYNTHASE; TRABECULAR MESHWORK; GENE-EXPRESSION; CAVEOLAE; IDENTIFICATION; BIOLOGY	We conducted a genome-wide association study for primary open-angle glaucoma (POAG) in 1,263 affected individuals (cases) and 34,877 controls from Iceland. We identified a common sequence variant at 7q31 (rs4236601[ A], odds ratio (OR) = 1.36, P = 5.0 x 10(-10)). We then replicated the association in sample sets of 2,175 POAG cases and 2,064 controls from Sweden, the UK and Australia (combined OR = 1.18, P = 0.0015) and in 299 POAG cases and 580 unaffected controls from Hong Kong and Shantou, China (combined OR = 5.42, P = 0.0021). The risk variant identified here is located close to CAV1 and CAV2, both of which are expressed in the trabecular meshwork and retinal ganglion cells that are involved in the pathogenesis of POAG.	[Thorleifsson, Gudmar; Walters, G. Bragi; Masson, Gisli; Sigurdsson, Asgeir; Jonasdottir, Adalbjorg; Gudjonsson, Sigurjon A.; Stefansson, Hreinn; Kong, Augustine; Stefansson, Kari] DeCODE genetics Inc, Reykjavik, Iceland; [Hewitt, Alex W.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Hewitt, Alex W.; Burdon, Kathryn P.; Craig, Jamie E.] Flinders Univ S Australia, Flinders Med Ctr, Dept Ophthalmol, Adelaide, SA, Australia; [Helgason, Agnar] Univ Iceland, Reykjavik, Iceland; [DeWan, Andrew; Hoh, Josephine] Yale Univ, Dept Epidemiol Publ Hlth, New Haven, CT USA; [Magnusson, Kristinn P.] Univ Akureyri, Dept Biotechnol, Akureyri, Iceland; [Tam, Pancy O. S.] Chinese Univ Hong Kong, Dept Optometry & Visual Sci, Hong Kong, Hong Kong, Peoples R China; [Gudmundsdottir, Gudrun J.] Eye Clin, Akranes, Iceland; [Gudmundsdottir, Gudrun J.] Eye Clin Hamrahlid, Reykjavik, Iceland; [Southgate, Laura] Guys Hosp, Sch Med, Dept Med & Mol Genet, Univ London Kings Coll, London SE1 9RT, England; [Gottfredsdottir, Maria Soffia; Jonasson, Fridbert] Natl Univ Hosp Reykjavik, Dept Ophthalmol, Reykjavik, Iceland; [Aldred, Micheala A.] Cleveland Clin, Genom Med Inst, Cleveland, OH 44106 USA; [Mitchell, Paul] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Westmead, NSW 2145, Australia; [Mitchell, Paul] Univ Sydney, Westmead Millennium Inst, Westmead, NSW 2145, Australia; [St Clair, David] Univ Aberdeen, Royal Cornhill Hosp, Dept Mental Hlth, Aberdeen, Scotland; [Collier, David A.] Kings Coll London, Inst Psychiat, Div Psychiat Med, London WC2R 2LS, England; [Collier, David A.] Sichuan Univ, W China Hosp, Dept Psychiat, Psychiatr Lab, Sichuan, Peoples R China; [Tang, Nelson] Chinese Univ Hong Kong, Lab Genet Dis Susceptibil, Li Ka Shing Inst Hlth Sci, Fac Med, Hong Kong, Peoples R China; [Sveinsson, Orn] Eye Clin, Reykjavik, Iceland; [Macgregor, Stuart; Martin, Nicholas G.] Queensland Inst Med Res, Genet & Populat Hlth, Brisbane, Qld 4006, Australia; [Cree, Angela J.] Univ Southampton, Sch Med, Clin Neurosci Div, Southampton, Hants, England; [Gibson, Jane; Ennis, Sarah] Univ Southampton, Sch Med, Div Human Genet, Genet Epidemiol & Bioinformat Grp, Southampton, Hants, England; [MacLeod, Alex; Jacob, Aby; Lotery, Andrew J.] Southampton Univ Hosp Trust, Southampton Eye Unit, Southampton, Hants, England; [Young, Terri L.] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC USA; [Chan, Juliana C. N.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Karwatowski, Wojciech S. S.] Univ Hosp Leicester, Dept Ophthalmol, Leicester, Leics, England; [Hammond, Christopher J.] Kings Coll London, Sch Med, Dept Twin Res & Genet Epidemiol, St Thomas Hosp, London WC2R 2LS, England; [Thordarson, Kristjan] Eye Clin, Reykjavik, Iceland; [Zhang, Mingzhi] Chinese Univ Hong Kong, Shantou, Peoples R China; [Zhang, Mingzhi] Shantou Univ, Joint Shantou Int Eye Ctr, Shantou, Peoples R China; [Wadelius, Claes] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden; [Mackey, David A.] Univ Western Australia, Lions Eye Inst, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia; [Mackey, David A.] Univ Tasmania, Royal Hobart Hosp, 31Discipline Med, Hobart, Tas, Australia; [Jonasson, Fridbert; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Flinders Medical Centre; Flinders University South Australia; University of Iceland; Yale University; University of Akureyri; Chinese University of Hong Kong; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Landspitali National University Hospital; Cleveland Clinic Foundation; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Aberdeen; University of London; King's College London; Sichuan University; Chinese University of Hong Kong; QIMR Berghofer Medical Research Institute; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Duke University; Chinese University of Hong Kong; Prince of Wales Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Shantou University; Uppsala University; Lions Eye Institute; University of Western Australia; Royal Hobart Hospital; University of Tasmania; University of Iceland	Thorleifsson, G (corresponding author), DeCODE genetics Inc, Reykjavik, Iceland.	gudmar.thorleifsson@decode.is; kstefans@decode.is	Magnusson, Kristinn/A-6479-2011; Jonasson, Fridbert/ABA-9889-2021; Burdon, Kathryn/AAD-2334-2022; Magnusson, Kristinn P Pétur/X-4907-2019; Stefansson, Kari/AAE-7187-2019; Helgason, Agnar/K-1522-2015; Macgregor, Stuart/C-6442-2009; Mitchell, Paul/P-1498-2014; Burdon, Kathryn/A-5026-2009; Mackey, David A/H-5340-2014; Pang, Chi P/I-5388-2014; St Clair, David/AAN-2412-2021; Southgate, Laura/H-7924-2019; Collier, David A/D-1649-2011; Hewitt, Alex W/D-1936-2013; Gibson, Jane/I-1630-2012; Lam, Dennis/AAL-1211-2020; Chan, Juliana/B-7918-2016; Walters, G. Bragi/L-4215-2013; Tang, Nelson L/P-5018-2017	Magnusson, Kristinn/0000-0003-4528-6826; Burdon, Kathryn/0000-0001-8217-1249; Magnusson, Kristinn P Pétur/0000-0003-4528-6826; Macgregor, Stuart/0000-0001-6731-8142; Burdon, Kathryn/0000-0001-8217-1249; Mackey, David A/0000-0001-7914-4709; Southgate, Laura/0000-0002-2090-1450; Collier, David A/0000-0003-4087-1559; Hewitt, Alex W/0000-0002-5123-5999; Gibson, Jane/0000-0002-0973-8285; Chan, Juliana/0000-0003-1325-1194; Walters, G. Bragi/0000-0002-5415-6487; Tang, Nelson L/0000-0002-3607-5819; Lotery, Andrew/0000-0001-5541-4305; Kong, Augustine/0000-0001-8193-5438; Helgason, Agnar/0000-0002-8545-3767; Trembath, Richard/0000-0003-0550-3400; Martin, Nicholas/0000-0003-4069-8020; Craig, Jamie/0000-0001-9955-9696; Cree, Angela/0000-0002-1987-8900; Gudjonsson, Sigurjon A./0000-0001-9314-7412; DeWan, Andrew/0000-0002-7679-8704; Stefansson, Hreinn/0000-0002-9331-6666; Hammond, Christopher/0000-0002-3227-2620; Jacob, Aby/0000-0002-7655-0469	Wellcome Trust [062346/Z/00/Z, 078751/Z/05/Z]; UK Department of Health via the National Institute for Health Research (NIHR); St. Thomas' NHS Foundation; NHS Foundation Trust; Clifford Craig Medical Research Trust; Ophthalmic Research Institute of Australia; Pfizer Australia; Glaucoma Australia; American Health Assistance Foundation; glaucoma research foundation; Australian National Health and Medical Research Council (NHMRC); International Glaucoma Association, UK; Eire Glaucoma Society; Swedish Research Council; US National Institutes of Health (NIH)/National Eye Institute [1RO1EY018246]; NIH Center for Inherited Diseases Research (CIDR); American Health Assistance Foundation (AHAF); Southampton Wellcome Trust Clinical Research Facility; Optegra UK Ltd; Verto Institute; Ellison Foundation for Aging Research; Australian NHMRC; NATIONAL EYE INSTITUTE [R01EY014685, R01EY018246] Funding Source: NIH RePORTER; Medical Research Council [G9817803B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10379, NF-SI-0507-10094] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK Department of Health via the National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); St. Thomas' NHS Foundation; NHS Foundation Trust; Clifford Craig Medical Research Trust; Ophthalmic Research Institute of Australia; Pfizer Australia(PfizerPfizer Australia); Glaucoma Australia; American Health Assistance Foundation; glaucoma research foundation; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); International Glaucoma Association, UK; Eire Glaucoma Society; Swedish Research Council(Swedish Research CouncilEuropean Commission); US National Institutes of Health (NIH)/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH Center for Inherited Diseases Research (CIDR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation (AHAF); Southampton Wellcome Trust Clinical Research Facility(Wellcome Trust); Optegra UK Ltd; Verto Institute; Ellison Foundation for Aging Research; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank all the participants whose contribution made this study possible, as well as their ophthalmologists. We also thank the personnel at deCODE recruitment center and core facilities for their hard work and enthusiasm. We would also like to acknowledge A. Hill (University Hospitals of Leicester National Health Service (NHS) Trust) for invaluable help with sample collection and the Wellcome Trust for funding (programme grant 062346/Z/00/Z and project grant 078751/Z/05/Z). The authors acknowledge financial support from the UK Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. We also thank the following organizations for their financial support: Clifford Craig Medical Research Trust; Ophthalmic Research Institute of Australia; Pfizer Australia; Glaucoma Australia; American Health Assistance Foundation; the glaucoma research foundation and the Australian National Health and Medical Research Council (NHMRC); the International Glaucoma Association, UK and the Eire Glaucoma Society and Optegra UK Ltd. J. E. C. is supported in part by an NHMRC Practitioner Fellowship, and D. A. M. is a Pfizer Australia Research Fellow. We would also like to thank O. Wallerman, M. Jansson, L.-I. Larsson and L. Tomic for their assistance and the Swedish Research Council for financial support. The authors acknowledge the funding and support of the following organizations: the US National Institutes of Health (NIH)/National Eye Institute grant 1RO1EY018246 and the NIH Center for Inherited Diseases Research (CIDR) (PI: T. Young); the Verto Institute, the American Health Assistance Foundation (AHAF) National Glaucoma Research and the Ellison Foundation for Aging Research; and the Southampton Wellcome Trust Clinical Research Facility. We thank D. R. Nyholt, G. Montgomery, S. Medland, S. Gordon, A. Henders, B. McEvoy, M. J. Wright, M. J. Campbell and A. Caracella for obtaining funding for and processing the Australian genotype data. S. M. is supported by an Australian NHMRC Career Development Award.	Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; Berta AI, 2007, MOL VIS, V13, P881; Borras T, 2003, PROG RETIN EYE RES, V22, P435, DOI 10.1016/S1350-9462(03)00018-1; Couet J, 2001, ADV DRUG DELIVER REV, V49, P223, DOI 10.1016/S0169-409X(01)00139-9; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fan BJ, 2006, CLIN BIOCHEM, V39, P249, DOI 10.1016/j.clinbiochem.2005.11.001; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fuchshofer R, 2009, EXP EYE RES, V88, P683, DOI 10.1016/j.exer.2009.01.005; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Gonzalez P, 2000, INVEST OPHTH VIS SCI, V41, P3678; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Hnasko Robert, 2003, Mol Interv, V3, P445, DOI 10.1124/mi.3.8.445; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Jasmin JF, 2009, CELL CYCLE, V8, P3978, DOI 10.4161/cc.8.23.10206; Jonasson F, 2003, EYE, V17, P747, DOI 10.1038/sj.eye.6700374; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Liu YT, 2008, INVEST OPHTH VIS SCI, V49, P3465, DOI 10.1167/iovs.08-1850; Mackey DA, 2009, TWIN RES HUM GENET, V12, P441, DOI 10.1375/twin.12.5.441; MANTEL N, 1959, J NATL CANCER I, V22, P719; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Nakano M, 2009, P NATL ACAD SCI USA, V106, P12838, DOI 10.1073/pnas.0906397106; Parat MO, 2009, INT REV CEL MOL BIO, V273, P117, DOI 10.1016/S1937-6448(08)01804-2; Pasutto F, 2009, AM J HUM GENET, V85, P447, DOI 10.1016/j.ajhg.2009.08.016; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Rao KN, 2009, P NATL ACAD SCI USA, V106, pE125, DOI 10.1073/pnas.0910416106; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Rice J. A., 1995, MATH STAT DATA ANAL; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Tamm ER, 2009, EXP EYE RES, V88, P648, DOI 10.1016/j.exer.2009.02.007; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Toda N, 2007, PROG RETIN EYE RES, V26, P205, DOI 10.1016/j.preteyeres.2007.01.004	35	293	309	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2010	42	10					906	+		10.1038/ng.661	http://dx.doi.org/10.1038/ng.661			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	655UO	20835238	Green Accepted			2022-12-17	WOS:000282276600024
J	Bei, JX; Li, Y; Jia, WH; Feng, BJ; Zhou, GQ; Chen, LZ; Feng, QS; Low, HQ; Zhang, HX; He, FC; Tai, ES; Kang, TB; Liu, ET; Liu, JJ; Zeng, YX				Bei, Jin-Xin; Li, Yi; Jia, Wei-Hua; Feng, Bing-Jian; Zhou, Gangqiao; Chen, Li-Zhen; Feng, Qi-Sheng; Low, Hui-Qi; Zhang, Hongxing; He, Fuchu; Tai, E. Shyong; Kang, Tiebang; Liu, Edison T.; Liu, Jianjun; Zeng, Yi-Xin			A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci	NATURE GENETICS			English	Article							EPSTEIN-BARR-VIRUS; 2ND PRIMARY CANCERS; N-TERMINAL KINASE; HAN CHINESE; LINKAGE; HLA; MEMBER; VARIANTS; SCAN; RISK	To identify genetic susceptibility loci for nasopharyngeal carcinoma (NPC), a genome-wide association study was performed using 464,328 autosomal SNPs in 1,583 NPC affected individuals (cases) and 1,894 controls of southern Chinese descent. The top 49 SNPs from the genome-wide association study were genotyped in 3,507 cases and 3,063 controls of southern Chinese descent from Guangdong and Guangxi. The seven supportive SNPs were further confirmed by transmission disequilibrium test analysis in 279 trios from Guangdong. We identified three new susceptibility loci, TNFRSF19 on 13q12 (rs9510787, P-combined = 1.53 x 10(-9), odds ratio (OR) = 1.20), MDS1-EVI1 on 3q26 (rs6774494, P-combined = 1.34 x 10(-8), OR = 0.84) and the CDKN2A-CDKN2B gene cluster on 9p21 (rs1412829, P-combined = 4.84 x 10(-7), OR = 0.78). Furthermore, we confirmed the role of HLA by revealing independent associations at rs2860580 (P-combined = 4.88 x 10(-67), OR = 0.58), rs2894207 (P-combined = 3.42 x 10(-33), OR = 0.61) and rs28421666 (P-combined = 2.49 x 10(-18), OR = 0.67). Our findings provide new insights into the pathogenesis of NPC by highlighting the involvement of pathways related to TNFRSF19 and MDS1-EVI1 in addition to HLA molecules.	[Bei, Jin-Xin; Jia, Wei-Hua; Feng, Bing-Jian; Chen, Li-Zhen; Feng, Qi-Sheng; Kang, Tiebang; Liu, Jianjun; Zeng, Yi-Xin] State Key Lab Oncol So China, Guangzhou, Guangdong, Peoples R China; [Bei, Jin-Xin; Jia, Wei-Hua; Feng, Bing-Jian; Chen, Li-Zhen; Feng, Qi-Sheng; Kang, Tiebang; Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yi; Low, Hui-Qi; Liu, Edison T.; Liu, Jianjun] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Feng, Bing-Jian] Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT USA; [Zhou, Gangqiao; Zhang, Hongxing; He, Fuchu] Beijing Proteome Res Ctr, Beijing Inst Radiat Med, State Key Lab Prote, Beijing, Peoples R China; [Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth, Singapore 117595, Singapore	Sun Yat Sen University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Utah System of Higher Education; University of Utah; Academy of Military Medical Sciences - China; National University of Singapore; National University of Singapore	Zeng, YX (corresponding author), State Key Lab Oncol So China, Guangzhou, Guangdong, Peoples R China.	liuj3@gis.a-star.edu.sg; zengyx@sysucc.org.cn	Liu, Jianjun/AAK-4989-2020; Tai, E Shyong/J-9831-2013; Bei, Jin-Xin/AAO-1259-2020; Liu, Edison/C-4141-2008	Liu, Jianjun/0000-0002-3255-3019; Zhou, Gangqiao/0000-0002-4895-5063; He, Fuchu/0000-0002-8571-2351; Tai, E Shyong/0000-0003-2929-8966				Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Chen MC, 2008, ANN ONCOL, V19, P1180, DOI 10.1093/annonc/mdn003; Chou J, 2008, HEAD NECK-J SCI SPEC, V30, P946, DOI 10.1002/hed.20833; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Eby MT, 2000, J BIOL CHEM, V275, P15336, DOI 10.1074/jbc.275.20.15336; Eliopoulos AG, 2001, SEMIN CANCER BIOL, V11, P435, DOI 10.1006/scbi.2001.0410; Feng BJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000606; Feng BJ, 2002, NAT GENET, V31, P395, DOI 10.1038/ng932; Hildesheim A, 2002, J NATL CANCER I, V94, P1780, DOI 10.1093/jnci/94.23.1780; Hu LF, 2008, EUR J HUM GENET, V16, P343, DOI 10.1038/sj.ejhg.5201951; Hu SM, 1999, GENOMICS, V62, P103, DOI 10.1006/geno.1999.5979; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Kurokawa M, 2000, EMBO J, V19, P2958, DOI 10.1093/emboj/19.12.2958; Li DJ, 2009, J MED VIROL, V81, P1253, DOI 10.1002/jmv.21503; Lo KW, 2002, SEMIN CANCER BIOL, V12, P451, DOI 10.1016/S1044579X02000883; Lu CC, 2005, INT J CANCER, V115, P742, DOI 10.1002/ijc.20946; LU SJ, 1990, NATURE, V346, P470, DOI 10.1038/346470a0; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McDermott AL, 2001, CLIN OTOLARYNGOL, V26, P82, DOI 10.1046/j.1365-2273.2001.00449.x; Mensah FK, 2007, GENET EPIDEMIOL, V31, P348, DOI 10.1002/gepi.20215; Metais JY, 2008, MOL THER, V16, P439, DOI 10.1038/sj.mt.6300372; Morikawa Y, 2008, ANN NY ACAD SCI, V1126, pA1, DOI 10.1196/annals.1366.036; Ng CC, 2009, J HUM GENET, V54, P392, DOI 10.1038/jhg.2009.49; Nitta E, 2005, ONCOGENE, V24, P6165, DOI 10.1038/sj.onc.1208754; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; Scelo G, 2007, CANCER CAUSE CONTROL, V18, P269, DOI 10.1007/s10552-006-0101-z; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Skibola CF, 2009, NAT GENET, V41, P873, DOI 10.1038/ng.419; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tse KP, 2009, AM J HUM GENET, V85, P194, DOI 10.1016/j.ajhg.2009.07.007; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Xiong W, 2004, CANCER RES, V64, P1972, DOI 10.1158/0008-5472.CAN-03-3253; Xu J, 1999, INT J CANCER, V84, P396, DOI 10.1002/(SICI)1097-0215(19990820)84:4&lt;396::AID-IJC11&gt;3.0.CO;2-#; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; Zeng YX, 2002, SEMIN CANCER BIOL, V12, P443, DOI 10.1016/S1044579X02000871	44	293	313	1	68	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2010	42	7					599	U173		10.1038/ng.601	http://dx.doi.org/10.1038/ng.601			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	616WO	20512145				2022-12-17	WOS:000279242400012
J	Sanna, S; Jackson, AU; Nagaraja, R; Willer, CJ; Chen, WM; Bonnycastle, LL; Shen, HQ; Timpson, N; Lettre, G; Usala, G; Chines, PS; Stringham, HM; Scott, LJ; Dei, M; Lai, S; Albai, G; Crisponi, L; Naitza, S; Doheny, KF; Pugh, EW; Ben-Shlomo, Y; Ebrahim, S; Lawlor, DA; Bergman, RN; Watanabe, RM; Uda, M; Tuomilehto, J; Coresh, J; Hirschhorn, JN; Shuldiner, AR; Schlessinger, D; Collins, FS; Smith, GD; Boerwinkle, E; Cao, A; Boehnke, M; Abecasis, GR; Mohlke, KL				Sanna, Serena; Jackson, Anne U.; Nagaraja, Ramaiah; Willer, Cristen J.; Chen, Wei-Min; Bonnycastle, Lori L.; Shen, Haiqing; Timpson, Nicholas; Lettre, Guillaume; Usala, Gianluca; Chines, Peter S.; Stringham, Heather M.; Scott, Laura J.; Dei, Mariano; Lai, Sandra; Albai, Giuseppe; Crisponi, Laura; Naitza, Silvia; Doheny, Kimberly F.; Pugh, Elizabeth W.; Ben-Shlomo, Yoav; Ebrahim, Shah; Lawlor, Debbie A.; Bergman, Richard N.; Watanabe, Richard M.; Uda, Manuela; Tuomilehto, Jaakko; Coresh, Josef; Hirschhorn, Joel N.; Shuldiner, Alan R.; Schlessinger, David; Collins, Francis S.; Smith, George Davey; Boerwinkle, Eric; Cao, Antonio; Boehnke, Michael; Abecasis, Goncalo R.; Mohlke, Karen L.			Common variants in the GDF5-UQCC region are associated with variation in human height	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; EXPRESSION; ADULT; OSTEOARTHRITIS; HERITABILITY; GENE; GDF5	Identifying genetic variants that influence human height will advance our understanding of skeletal growth and development. Several rare genetic variants have been convincingly and reproducibly associated with height in mendelian syndromes, and common variants in the transcription factor gene HMGA2 are associated with variation in height in the general population(1). Here we report genome-wide association analyses, using genotyped and imputed markers, of 6,669 individuals from Finland and Sardinia, and follow-up analyses in an additional 28,801 individuals. We show that common variants in the osteoarthritis-associated locus(2) GDF5-UQCC contribute to variation in height with an estimated additive effect of 0.44 cm (overall P < 10(-15)). Our results indicate that there may be a link between the genetic basis of height and osteoarthritis, potentially mediated through alterations in bone growth and development.	[Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Sanna, Serena; Jackson, Anne U.; Willer, Cristen J.; Chen, Wei-Min; Stringham, Heather M.; Scott, Laura J.; Boehnke, Michael; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Sanna, Serena; Usala, Gianluca; Dei, Mariano; Lai, Sandra; Albai, Giuseppe; Crisponi, Laura; Naitza, Silvia; Uda, Manuela; Cao, Antonio] Citta Univ Monserrato, CNR, INN, I-09042 Cagliari, Italy; [Nagaraja, Ramaiah; Schlessinger, David] NIA, Gerontol Res Ctr, Baltimore, MD 21224 USA; [Chen, Wei-Min] Univ Virginia, Sch Med, Dept Publ Hlth Sci, Div Biostat & Epidemiol, Charlottesville, VA 22908 USA; [Bonnycastle, Lori L.; Chines, Peter S.; Collins, Francis S.] NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Shen, Haiqing; Shuldiner, Alan R.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Timpson, Nicholas; Ben-Shlomo, Yoav; Lawlor, Debbie A.; Smith, George Davey] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; [Timpson, Nicholas; Lawlor, Debbie A.; Smith, George Davey] Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Bristol BS8 2PR, Avon, England; [Lettre, Guillaume; Hirschhorn, Joel N.] Harvard & MIT, Broad Inst, Program Med & Populat Genet, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Doheny, Kimberly F.; Pugh, Elizabeth W.] Johns Hopkins Univ, Sch Med, Inst Med Genet, CIDR, Baltimore, MD 21224 USA; [Ebrahim, Shah] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Bergman, Richard N.; Watanabe, Richard M.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Watanabe, Richard M.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; [Tuomilehto, Jaakko] Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, Diabet Unit, SF-00300 Helsinki, Finland; [Tuomilehto, Jaakko] Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; [Coresh, Josef] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Shuldiner, Alan R.] Vet Adm Med Ctr, Geriatr Res & Educ Ctr, Baltimore, MD 21201 USA; [Boerwinkle, Eric] Univ Texas Houston, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77225 USA; [Boerwinkle, Eric] Univ Texas Houston, Hlth Sci Ctr, Inst Mol Med, Houston, TX 77225 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; Consiglio Nazionale delle Ricerche (CNR); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Virginia; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University System of Maryland; University of Maryland Baltimore; University of Bristol; University of Bristol; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Johns Hopkins University; University of London; London School of Hygiene & Tropical Medicine; University of Southern California; University of Southern California; Finland National Institute for Health & Welfare; University of Helsinki; Johns Hopkins University; Johns Hopkins Medicine; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Mohlke, KL (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	goncalo@umich.edu; mohlke@med.unc.edu	sanna, serena/H-3009-2019; Abecasis, Goncalo R/B-7840-2010; Uda, Manuela/AAC-2645-2019; Timpson, Nicholas John/O-7548-2015; Dei, Mariano/AAY-3870-2020; Crisponi, Laura/AAC-2642-2019; Attrill, Lauren/V-1688-2018; Davey Smith, George/A-7407-2013; Ben-Shlomo, Yoav/ABD-2004-2021; NAITZA, SILVIA/AAB-8775-2022; Lai, Sandra/AAY-4176-2020; Naitza, Silvia/D-5620-2017; Chen, Wei-Min/A-8469-2009; Fox, Laura J/C-6249-2016	sanna, serena/0000-0002-3768-1749; Uda, Manuela/0000-0002-4890-6456; Timpson, Nicholas John/0000-0002-7141-9189; Crisponi, Laura/0000-0001-9128-8537; Davey Smith, George/0000-0002-1407-8314; Ben-Shlomo, Yoav/0000-0001-6648-3007; NAITZA, SILVIA/0000-0002-0108-757X; Willer, Cristen/0000-0001-5645-4966; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Abecasis, Goncalo/0000-0003-1509-1825; Dei, Mariano/0000-0002-7404-508X; Shuldiner, Alan/0000-0001-9921-4305; Lawlor, Debbie A/0000-0002-6793-2262	Intramural NIH HHS [Z01 HG000024] Funding Source: Medline; Medical Research Council [G0000934, G0600705] Funding Source: Medline; NCRR NIH HHS [M01 RR 16500, M01 RR016500] Funding Source: Medline; NHGRI NIH HHS [N01HG65403, R01 HG002651, R01 HG002651-05S2, HG002651] Funding Source: Medline; NHLBI NIH HHS [N01HC55015, HL72515, N01HC55019, N01-HC-55018, N01-HC-55016, N01HC55021, N01-HC-55022, N01HC55022, N01-HC-55021, HL084729, U01 HL084729, N01-HC-55020, N01HC55016, N01HC55020, U01 HL072515, N01HC55018, U01 HL084729-03, N01-HC-55015, N01-HC-55019] Funding Source: Medline; NIAMS NIH HHS [R01 AR046838, AR046838] Funding Source: Medline; NIA NIH HHS [AG18728, R01 AG018728] Funding Source: Medline; NIDDK NIH HHS [R56 DK062370, DK072193, U01 DK062370, DK062370, P30 DK072488, DK54361, R01 DK029867, R01 DK062370, R01 DK072193, R01 DK072193-04] Funding Source: Medline; Wellcome Trust [068545/Z/02] Funding Source: Medline; MRC [G0000934, G0600705] Funding Source: UKRI; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055016, N01HC055020, N01HC055022, N01HC055015, N01HC055021, N01HC055018, N01HC055019] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR016500] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072515, R42HL055018, R41HL055019, R41HL055018, U01HL084729] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403, Z01HG000024, ZIAHG000024, R01HG002651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK029867, R01DK062370, R01DK072193, P30DK072488, R56DK062370, U01DK062370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018728, ZIAAG000675] Funding Source: NIH RePORTER; Direct For Biological Sciences [0820619] Funding Source: National Science Foundation; Division Of Environmental Biology [1020271] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [0820940] Funding Source: National Science Foundation	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Burdick JT, 2006, NAT GENET, V38, P1002, DOI 10.1038/ng1863; CHANG SC, 1994, J BIOL CHEM, V269, P28227; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Chujo T, 2006, SPINE, V31, P2909, DOI 10.1097/01.brs.0000248428.22823.86; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; ELWOOD PC, 1984, J EPIDEMIOL COMMUN H, V38, P259, DOI 10.1136/jech.38.3.259; FEHILY AM, 1990, EUR J CLIN NUTR, V44, P107; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frere C, 2006, BLOOD, V108, P1562, DOI 10.1182/blood-2006-01-008094; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hsueh WC, 2000, DIABETES CARE, V23, P595, DOI 10.2337/diacare.23.5.595; Imabayashi H, 2003, EXP CELL RES, V288, P35, DOI 10.1016/S0014-4827(03)00130-7; Lawlor DA, 2003, J EPIDEMIOL COMMUN H, V57, P134, DOI 10.1136/jech.57.2.134; McKenzie CA, 2001, HUM MOL GENET, V10, P1077, DOI 10.1093/hmg/10.10.1077; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/136905203770326402; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Southam L, 2007, HUM MOL GENET, V16, P2226, DOI 10.1093/hmg/ddm174; Streeten EA, 2004, J BONE MINER RES, V19, P308, DOI 10.1359/JBMR.0301223; Valdes AM, 2007, ARTHRITIS RHEUM-US, V56, P137, DOI 10.1002/art.22301; Vetter K, 2001, MECH DEVELOP, V100, P123, DOI 10.1016/S0925-4773(00)00511-6; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	29	293	306	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					198	203		10.1038/ng.74	http://dx.doi.org/10.1038/ng.74			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18193045	Green Accepted, Green Submitted			2022-12-17	WOS:000252732900018
J	Hinds, DA; Kloek, AP; Jen, M; Chen, XY; Frazer, KA				Hinds, DA; Kloek, AP; Jen, M; Chen, XY; Frazer, KA			Common deletions and SNPs are in linkage disequilibrium in the human genome	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; SEGMENTAL DUPLICATIONS; CANDIDATE GENES; DISEASE; IDENTIFICATION; ARRANGEMENT; RESOLUTION; DISORDERS; PATTERNS	Humans show great variation in phenotypic traits such as height, eye color and susceptibility to disease. Genomic DNA sequence differences among individuals are responsible for the inherited components of these complex traits. Reports suggest that intermediate and large-scale DNA copy number and structural variations are prevalent enough to be an important source of genetic variation between individuals(1-8). Because association studies to identify genomic loci associated with particular phenotypic traits have focused primarily on genotyping SNPs, it is important to determine whether common structural polymorphisms are in linkage disequilibrium with common SNPs, and thus can be assessed indirectly in SNP-based studies. Here we examine 100 deletion polymorphisms ranging from 70 bp to 7 kb. We show that common deletions and SNPs ascertained with similar criteria have essentially the same distribution of linkage disequilibrium with surrounding SNPs, indicating that these polymorphisms may share evolutionary history and that most deletion polymorphisms are effectively assayed by proxy in SNP-based association studies.	Perlegen Sci Inc, Mountain View, CA 94043 USA		Frazer, KA (corresponding author), Perlegen Sci Inc, 2021 Stierlin Court, Mountain View, CA 94043 USA.	kelly_frazer@perlegen.com	Pillay, Nischalan/F-9536-2012; Jen, Min-Hua/AAP-4200-2021	Hinds, David/0000-0002-4911-803X; Frazer, Kelly/0000-0002-6060-8902				Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bhangale TR, 2005, HUM MOL GENET, V14, P59, DOI 10.1093/hmg/ddi006; BURN J, 1995, DEVELOPMENTAL MECHANISMS OF HEART DISEASE, P559; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; CONRAD DF, 2005, NAT GENET       1204; Dhami P, 2005, AM J HUM GENET, V76, P750, DOI 10.1086/429588; duMontcel ST, 1996, J MED GENET, V33, P719, DOI 10.1136/jmg.33.8.719; Frazer KA, 2003, GENOME RES, V13, P341, DOI 10.1101/gr.554603; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Goodship J, 1998, ARCH DIS CHILD, V79, P348, DOI 10.1136/adc.79.4.348; GREEN JE, 1990, AIDS RES HUM RETROV, V6, P85; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HIGGS DR, 1980, NATURE, V284, P632, DOI 10.1038/284632a0; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; LAUER J, 1980, CELL, V20, P119, DOI 10.1016/0092-8674(80)90240-8; Liling J, 1999, J MED GENET, V36, P794, DOI 10.1136/jmg.36.10.794; MCCARROLL SA, 2005, NAT GENET       1204; Nelis E, 1996, EUR J HUM GENET, V4, P25; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Weir B., 1996, GENETIC DATA ANAL	30	293	306	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					82	85		10.1038/ng1695	http://dx.doi.org/10.1038/ng1695			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16327809				2022-12-17	WOS:000234227200021
J	Hellemans, J; Preobrazhenska, O; Willaert, A; Debeer, P; Verdonk, PCM; Costa, T; Janssens, K; Menten, B; Van Roy, N; Vermeulen, SJT; Savarirayan, R; Van Hul, W; Vanhoenacker, F; Huylebroeck, D; De Paepe, A; Naeyaert, JM; Vandesompele, J; Speleman, F; Verschueren, K; Coucke, PJ; Mortier, GR				Hellemans, J; Preobrazhenska, O; Willaert, A; Debeer, P; Verdonk, PCM; Costa, T; Janssens, K; Menten, B; Van Roy, N; Vermeulen, SJT; Savarirayan, R; Van Hul, W; Vanhoenacker, F; Huylebroeck, D; De Paepe, A; Naeyaert, JM; Vandesompele, J; Speleman, F; Verschueren, K; Coucke, PJ; Mortier, GR			Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis	NATURE GENETICS			English	Article							AUTOSOMAL-DOMINANT OSTEOPOIKILOSIS; TYPE-2 SEGMENTAL MANIFESTATION; CAMURATI-ENGELMANN-DISEASE; NUCLEAR-MEMBRANE PROTEIN; FAMILY; GENE; SCLEROSTEOSIS; FIBROBLASTS; DENSITY; PRIMER	Osteopoikilosis, Buschke-Ollendorff syndrome (BOS) and melorheostosis are disorders characterized by increased bone density(1). The occurrence of one or more of these phenotypes in the same individual or family suggests that these entities might be allelic(2-4). We collected data from three families in which affected individuals had osteopoikilosis with or without manifestations of BOS or melorheostosis. A genome-wide linkage analysis in these families, followed by the identification of a microdeletion in an unrelated individual with these diseases, allowed us to map the gene that is mutated in osteopoikilosis. All the affected individuals that we investigated were heterozygous with respect to a loss-of-function mutation in LEMD3 (also called MAN1), which encodes an inner nuclear membrane protein. A somatic mutation in the second allele of LEMD3 could not be identified in fibroblasts from affected skin of an individual with BOS and an individual with melorheostosis. XMAN1, the Xenopus laevis ortholog, antagonizes BMP signaling during embryogenesis(5). In this study, LEMD3 interacted with BMP and activin-TGFP receptor-activated Smads and antagonized both signaling pathways in human cells.	Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; Univ Leuven VIB, Dept Dev Biol, Lab Mol Biol, Louvain, Belgium; Univ Leuven, Ctr Human Genet, Louvain, Belgium; Ghent Univ Hosp, Dept Orthoped Surg, Ghent, Belgium; Univ Montreal, Hop St Justine, Med Genet Serv, Montreal, PQ H3T 1C5, Canada; Univ Hosp, Dept Med Genet, Antwerp, Belgium; Univ Antwerp, Antwerp, Belgium; Murdoch Childrens Res Inst, Genet Hlth Serv Victoria, Melbourne, Vic, Australia; Univ Melbourne, Parkville, Vic 3052, Australia; Univ Hosp, Dept Radiol, Antwerp, Belgium; Ghent Univ Hosp, Dept Dermatol, Ghent, Belgium	Ghent University; Ghent University Hospital; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Ghent University; Ghent University Hospital; Universite de Montreal; University of Antwerp; Murdoch Children's Research Institute; University of Melbourne; Ghent University; Ghent University Hospital	Mortier, GR (corresponding author), Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium.	geert.mortier@ugent.be	Willaert, Andy/AAZ-9111-2020; Mortier, Geert/D-2542-2012; Coucke, Paul J/AAO-2954-2020; Vandesompele, Jo/W-3411-2018; Menten, Björn/B-3072-2013; speleman, frank/AAR-5184-2020	Mortier, Geert/0000-0001-9871-4578; Coucke, Paul J/0000-0001-7119-586X; Vandesompele, Jo/0000-0001-6274-0184; speleman, frank/0000-0002-6628-8559; Huylebroeck, Danny/0000-0003-4862-1079; Van Hul, Wim/0000-0002-5065-7858; Vermeulen, Stefan/0000-0003-3710-800X; verdonk, peter/0000-0001-6057-8590; Willaert, Andy/0000-0002-9543-1932				Asano Y, 2004, J CLIN INVEST, V113, P253, DOI 10.1172/JCI200416269; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; BERLIN R, 1967, ACTA MED SCAND, V181, P305; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Butkus CE, 1997, AM J MED GENET, V72, P43, DOI 10.1002/(SICI)1096-8628(19971003)72:1<43::AID-AJMG9>3.0.CO;2-W; CAMPBELL CJ, 1968, J BONE JOINT SURG AM, VA 50, P1281, DOI 10.2106/00004623-196850070-00001; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Debeer P, 2003, AM J MED GENET A, V119A, P188, DOI 10.1002/ajmg.a.20072; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Ehrig T, 2003, J AM ACAD DERMATOL, V49, P1163, DOI 10.1016/S0190-9622(03)00481-X; Freyschmidt J, 2001, EUR RADIOL, V11, P474, DOI 10.1007/s003300000562; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hall CM, 2002, AM J MED GENET, V113, P65, DOI 10.1002/ajmg.10828; Happle R, 2004, AM J MED GENET A, V125A, P221, DOI 10.1002/ajmg.a.20454; Janssens K, 2000, NAT GENET, V26, P273, DOI 10.1038/81563; Kinoshita A, 2000, NAT GENET, V26, P19, DOI 10.1038/79128; LAGIER R, 1984, SKELETAL RADIOL, V11, P161, DOI 10.1007/BF00349489; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lin F, 2000, J BIOL CHEM, V275, P4840, DOI 10.1074/jbc.275.7.4840; Matsuzaki H, 2004, GENOME RES, V14, P414, DOI 10.1101/gr.2014904; MELNICK JC, 1959, AMER J ROENTGENOL RA, V82, P229; Mori Y, 2003, ARTHRITIS RHEUM-US, V48, P1964, DOI 10.1002/art.11157; Nevin NC, 1999, AM J MED GENET, V82, P409, DOI 10.1002/(SICI)1096-8628(19990219)82:5<409::AID-AJMG10>3.0.CO;2-2; Osada SI, 2003, DEVELOPMENT, V130, P1783, DOI 10.1242/dev.00401; Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011; Rozencwaig R, 1997, Am J Orthop (Belle Mead NJ), V26, P83; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANROY N, 1994, GENE CHROMOSOME CANC, V10, P103, DOI 10.1002/gcc.2870100205; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489	29	293	318	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11					1213	1218		10.1038/ng1453	http://dx.doi.org/10.1038/ng1453			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	15489854	Bronze			2022-12-17	WOS:000224832800026
J	Graux, C; Cools, J; Melotte, C; Quentmeier, H; Ferrando, A; Levine, R; Vermeesch, JR; Stul, M; Dutta, B; Boeckx, N; Bosly, A; Heimann, P; Uyttebroeck, A; Mentens, N; Somers, R; MacLeod, RAF; Drexler, HG; Look, AT; Gilliland, DG; Michaux, L; Vandenberghe, P; Wlodarska, I; Marynen, P; Hagemeijer, A				Graux, C; Cools, J; Melotte, C; Quentmeier, H; Ferrando, A; Levine, R; Vermeesch, JR; Stul, M; Dutta, B; Boeckx, N; Bosly, A; Heimann, P; Uyttebroeck, A; Mentens, N; Somers, R; MacLeod, RAF; Drexler, HG; Look, AT; Gilliland, DG; Michaux, L; Vandenberghe, P; Wlodarska, I; Marynen, P; Hagemeijer, A			Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia	NATURE GENETICS			English	Article							DOUBLE-MINUTE CHROMOSOMES; TYROSINE KINASE; MYELOID LEUKEMIAS; GENES; PROTEIN; TRANSLOCATION; AMPLIFICATION; EXPRESSION; DELETIONS; IMATINIB	In T-cell acute lymphoblastic leukemia (T-ALL), transcription factors are known to be deregulated by chromosomal translocations, but mutations in protein tyrosine kinases have only rarely been identified(1-3). Here we describe the extrachromosomal (episomal)(4) amplification of ABL1 in 5 of 90 (5.6%) individuals with T-ALL, an aberration that is not detectable by conventional cytogenetics. Molecular analyses delineated the amplicon as a 500-kb region from chromosome band 9q34, containing the oncogenes ABL1 and NUP214 (refs.(5,6)). We identified a previously undescribed mechanism for activation of tyrosine kinases in cancer: the formation of episomes resulting in a fusion between NUP214 and ABL1. We detected the NUP214-ABL1 transcript in five individuals with the ABL1 amplification, in 5 of 85 (5.8%) additional individuals with T-ALL and in 3 of 22 T-ALL cell lines. The constitutively phosphorylated tyrosine kinase NUP214-ABL1 is sensitive to the tyrosine kinase inhibitor imatinib(7,8). The recurrent cryptic NUP214-ABL1 rearrangement is associated with increased HOX expression(1) and deletion of CDKN2A(9), consistent with a multistep pathogenesis of T-ALL. NUP214-ABL1 expression defines a new subgroup of individuals with T-ALL who could benefit from treatment with imatinib.	Univ Leuven, Dept Human Genet, Louvain, Belgium; Univ Leuven, Dept Hematol, Louvain, Belgium; Flanders Interuniv Inst Biotechnol, Dept Human Genet, Louvain, Belgium; German Collect Microorganisms & Cell Cultures, Braunschweig, Germany; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Flanders Interuniv Inst Biotechnol, Microarray Facil, Louvain, Belgium; Clin Univ UCL Mt Godinne, Dept Hematol, Brussels, Belgium; Free Univ Brussels, Erasme Hosp, Dept Med Genet, B-1050 Brussels, Belgium; Univ Leuven, Dept Pediat Hematooncol, Louvain, Belgium; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA USA; St Luc, Brussels, Belgium	KU Leuven; KU Leuven; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Universite Catholique Louvain; Universite Catholique Louvain Hospital; Universite Libre de Bruxelles; Vrije Universiteit Brussel; KU Leuven; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Marynen, P (corresponding author), Univ Leuven, Dept Human Genet, Louvain, Belgium.	peter.marynen@med.kuleuven.ac.be; anne.hagemeijer@med.kuleuven.ac.be	Melotte, Cindy/GXV-5465-2022	Vermeesch, Joris/0000-0002-3071-1191; Cools, Jan/0000-0001-6626-5843; Vandenberghe, Peter/0000-0003-4719-1935				Barber KE, 2004, LEUKEMIA, V18, P1153, DOI 10.1038/sj.leu.2403357; BENE MC, 1995, LEUKEMIA, V9, P1783; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; CARROLL SM, 1988, MOL CELL BIOL, V8, P1525, DOI 10.1128/MCB.8.4.1525; Cools J, 1999, BLOOD, V94, P1820, DOI 10.1182/blood.V94.5.1820.417k09_1820_1824; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; DEKLEIN A, 1986, BLOOD, V68, P1369; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; Dierlamm J, 1996, GENE CHROMOSOME CANC, V16, P261, DOI 10.1002/(SICI)1098-2264(199608)16:4<261::AID-GCC6>3.0.CO;2-W; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; FORNEROD M, 1995, ONCOGENE, V10, P1739; Golub TR, 1996, MOL CELL BIOL, V16, P4107; HAHN PJ, 1993, BIOESSAYS, V15, P477, DOI 10.1002/bies.950150707; HEBERT J, 1994, BLOOD, V84, P4038, DOI 10.1182/blood.V84.12.4038.bloodjournal84124038; Kelly LM, 2002, ANNU REV GENOM HUM G, V3, P179, DOI 10.1146/annurev.genom.3.032802.115046; KRAEMER D, 1994, P NATL ACAD SCI USA, V91, P1519, DOI 10.1073/pnas.91.4.1519; MAURER BJ, 1987, NATURE, V327, P434, DOI 10.1038/327434a0; MITELMAN F, 1995, INT SYSTEM HUMAN N S; Nagel S, 2003, CANCER RES, V63, P5329; Nieborowska-Skorska M, 2000, ONCOGENE, V19, P4117, DOI 10.1038/sj.onc.1203754; ODA T, 1994, J BIOL CHEM, V269, P22925; Paietta E, 2004, BLOOD, V104, P558, DOI 10.1182/blood-2004-01-0168; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Van Buggenhout G, 2004, J MED GENET, V41, P691, DOI 10.1136/jmg.2003.016865; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687	27	293	314	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2004	36	10					1084	1089		10.1038/ng1425	http://dx.doi.org/10.1038/ng1425			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	857YN	15361874	Green Published, Bronze			2022-12-17	WOS:000224156500017
J	Jacob, S; McClintock, MK; Zelano, B; Ober, C				Jacob, S; McClintock, MK; Zelano, B; Ober, C			Paternally inherited HLA alleles are associated with women's choice of male odor	NATURE GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MATING PREFERENCES; MICE; RECOGNITION; HUMANS; MOUSE; GENES; INFORMATION; MOLECULES; PATTERNS	The major histocompatibility complex (MHC) is a source of unique individual odors that influence individual recognition, mating preferences, nesting behavior and selective block of pregnancy in animals(1-10). Such phenomena have been difficult to study in humans, because the human leukocyte antigen (HLA, human MHC loci are the most polymorphic loci in the human genome(11), with the potential to generate millions of unique combinations of genotypes. In addition, high variability in background odors, encoded by the rest of the genome and influenced by cultural practices, contribute to a low signal-to-noise ratio that could mask HLA-based olfactory cues. Here we show that women can detect differences of one HLA allele among male odor donors with different MHC genotypes. Notably, the mechanism for a woman's ability to discriminate and choose odors is based on HLA alleles inherited from her father but not her mother. The parents' HLA alleles that she does not inherit show no relationship with odor choice, despite exposure to these HLA-encoded odors throughout her life. Our data indicate that paternally inherited HLA-associated odors influence odor preference and may serve as social cues.	Univ Chicago, Inst Mind & Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	McClintock, MK (corresponding author), Univ Chicago, Inst Mind & Biol, 5730 S Woodlawn Ave, Chicago, IL 60637 USA.	mkm1@midway.uchicago.edu	Jacob, Suma/J-7941-2013	Jacob, Suma/0000-0001-7434-7398	NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH082121] Funding Source: NIH RePORTER; NIMH NIH HHS [K23 MH082121] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amadou C, 1999, IMMUNOL REV, V167, P211, DOI 10.1111/j.1600-065X.1999.tb01394.x; Bateson P., 1983, P257; BEAUCHAMP GK, 1985, P NATL ACAD SCI USA, V82, P4186, DOI 10.1073/pnas.82.12.4186; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; BROWN RE, 1987, PHYSIOL BEHAV, V40, P65, DOI 10.1016/0031-9384(87)90186-7; Devos M., 1990, STANDARDIZED HUMAN O; EGID K, 1989, ANIM BEHAV, V38, P548, DOI 10.1016/S0003-3472(89)80051-X; EKLUND A, 1991, ANIM BEHAV, V42, P693, DOI 10.1016/S0003-3472(05)80254-4; Fan WF, 1996, IMMUNOGENETICS, V44, P97, DOI 10.1007/s002510050095; GILBERT AN, 1986, J COMP PSYCHOL, V100, P262, DOI 10.1037/0735-7036.100.3.262; GILDER PM, 1978, NATURE, V274, P364, DOI 10.1038/274364a0; HERRICK CJ, 1924, NEUROLOGICAL FDN BEH; Isles AR, 2001, NATURE, V409, P783, DOI 10.1038/35057323; MANNING CJ, 1992, NATURE, V360, P581, DOI 10.1038/360581a0; MCCARTY R, 1977, BEHAV BIOL, V19, P255, DOI 10.1016/S0091-6773(77)91542-5; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Ober C, 1997, AM J HUM GENET, V61, P497, DOI 10.1086/515511; OBER C, 1999, CHEM SIGNALS VERTEBR, V8, P189; Ochoa G, 1999, J THEOR BIOL, V199, P1, DOI 10.1006/jtbi.1999.0931; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Pause BM, 1996, BIOL PSYCHOL, V44, P31, DOI 10.1016/S0301-0511(96)05207-6; Pearse-Pratt R, 1998, GENETICA, V104, P223, DOI 10.1023/A:1026489524199; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; POTTS WK, 1991, NATURE, V352, P619, DOI 10.1038/352619a0; QUADAGNO DM, 1970, ANIM BEHAV, V18, P379, DOI 10.1016/S0003-3472(70)80051-3; SCHAAL B, 1991, ADV STUD BEHAV, V20, P135, DOI 10.1016/S0065-3454(08)60321-6; Schaefer ML, 2001, J NEUROSCI, V21, P2481, DOI 10.1523/JNEUROSCI.21-07-02481.2001; SMITH K, 2000, DEP PSYCHOL, P167; VINCENT C, 1979, TRANSPLANT P, V11, P1301; Wedekind C, 1997, P ROY SOC B-BIOL SCI, V264, P1471, DOI 10.1098/rspb.1997.0204; WEDEKIND C, 1995, P ROY SOC B-BIOL SCI, V260, P245, DOI 10.1098/rspb.1995.0087; Weitkamp LR, 1999, IMMUNOGENETICS, V49, P491, DOI 10.1007/s002510050525; YAMAGUCHI M, 1981, P NATL ACAD SCI-BIOL, V78, P5817, DOI 10.1073/pnas.78.9.5817; YAMAZAKI K, 1976, J EXP MED, V144, P1324, DOI 10.1084/jem.144.5.1324; YAMAZAKI K, 1979, J EXP MED, V150, P755, DOI 10.1084/jem.150.4.755; YAMAZAKI K, 1988, SCIENCE, V240, P1331, DOI 10.1126/science.3375818; YAMAZAKI K, 1983, SCIENCE, V221, P186, DOI 10.1126/science.6857281; YAMAZAKI K, 1999, CHEM SIGNALS VERTEBR, V8, P173	38	293	306	1	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2002	30	2					175	179		10.1038/ng830	http://dx.doi.org/10.1038/ng830			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11799397				2022-12-17	WOS:000173708700017
J	Chen, KS; Manian, P; Koeuth, T; Potocki, L; Zhao, Q; Chinault, AC; Lee, CC; Lupski, JR				Chen, KS; Manian, P; Koeuth, T; Potocki, L; Zhao, Q; Chinault, AC; Lee, CC; Lupski, JR			Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome	NATURE GENETICS			English	Article							SMITH-MAGENIS SYNDROME; YEAST ARTIFICIAL CHROMOSOMES; POLYMERASE CHAIN-REACTION; IN-SITU HYBRIDIZATION; SPINAL MUSCULAR-ATROPHY; PRADER-WILLI-SYNDROME; SOMATIC-CELL HYBRIDS; HUMAN X-CHROMOSOME; DISTAL SHORT ARM; HUMAN GENOME	Smith-Magenis syndrome (SMS), caused by del(17)p11.2, represents one of the most frequently observed human microdeletion syndromes. We have identified three copies of a low-copy-number repeat (SMS-REPs) located within and flanking the SMS common deletion region and show that SMS-REP represents a repeated gene cluster. We have isolated a corresponding cDNA clone that identifies a novel junction fragment from 29 unrelated SMS patients and a different-sized junction fragment from a patient with dup(17)p11.2. Our results suggest that homologous recombination of a flanking repeat gene cluster is a mechanism for this common microdeletion syndrome.	BAYLOR COLL MED,DEPT MOL & HUMAN GENET,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; TEXAS CHILDRENS HOSP,BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine			Chen, Ken-Shiung/A-2204-2011		NCRR NIH HHS [M01 RR-00188] Funding Source: Medline; NHGRI NIH HHS [HG00210] Funding Source: Medline; NICHD NIH HHS [HD24064] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BALLABIO A, 1990, GENOMICS, V8, P263, DOI 10.1016/0888-7543(90)90281-X; BELLANNECHANTELOT C, 1992, CELL, V70, P1059, DOI 10.1016/0092-8674(92)90254-A; BOTTO M, 1992, P NATL ACAD SCI USA, V89, P4957, DOI 10.1073/pnas.89.11.4957; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; Buetow K H, 1994, Science, V265, P2055, DOI 10.1126/science.8091228; Campbell HD, 1997, GENOMICS, V42, P46, DOI 10.1006/geno.1997.4709; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; Chen K-S, 1996, MENTAL RETARD DEV DI, V2, P122; CHEN KS, 1995, AM J HUM GENET, V56, P175; CHEVILLARD C, 1993, HUM MOL GENET, V2, P1235, DOI 10.1093/hmg/2.8.1235; CHRISTIAN SI, 1995, AM J HUM GENET, V57, P40; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; CHUMAKOV IM, 1992, NAT GENET, V1, P222, DOI 10.1038/ng0692-222; DEHOSTOS EL, 1993, CELL MOTIL CYTOSKEL, V26, P181, DOI 10.1002/cm.970260302; DeLaurenzi V, 1996, NAT GENET, V12, P52; ELDER FFB, 1985, AM J MED GENET, V20, P519, DOI 10.1002/ajmg.1320200312; ELSEA SH, 1995, AM J HUM GENET, V57, P1342; EVANS GA, 1989, GENE, V79, P9, DOI 10.1016/0378-1119(89)90088-7; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; Greenberg F, 1996, AM J MED GENET, V62, P247, DOI 10.1002/(SICI)1096-8628(19960329)62:3<247::AID-AJMG9>3.3.CO;2-9; GUZZETTA V, 1992, GENOMICS, V13, P551, DOI 10.1016/0888-7543(92)90124-B; GUZZETTA V, 1991, GENOMICS, V9, P31, DOI 10.1016/0888-7543(91)90217-3; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HALFORD S, 1993, HUM MOL GENET, V2, P191, DOI 10.1093/hmg/2.2.191; HERZ J, 1990, FEBS LETT, V276, P103, DOI 10.1016/0014-5793(90)80518-N; HIRAOKA LR, 1995, GENOMICS, V25, P323, DOI 10.1016/0888-7543(95)80150-K; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; JI Y, 1996, AM J HUM GENET, V59, pA158; JONES C, 1995, NATURE, V376, P145, DOI 10.1038/376145a0; Jurado LAP, 1996, AM J HUM GENET, V59, P781; JUYAL RC, 1995, AM J MED GENET, V58, P286, DOI 10.1002/ajmg.1320580317; JUYAL RC, 1995, AM J MED GENET, V59, P406, DOI 10.1002/ajmg.1320590332; Juyal RC, 1996, AM J HUM GENET, V58, P998; KALLIONIEMI OP, 1994, GENOMICS, V20, P125, DOI 10.1006/geno.1994.1138; Kimura T, 1997, AM J MED GENET, V69, P320; KMIEC EB, 1985, CELL, V40, P139, DOI 10.1016/0092-8674(85)90317-4; Koyama K, 1996, CYTOGENET CELL GENET, V72, P78, DOI 10.1159/000134167; KRAWCZAK M, 1991, HUM GENET, V86, P425; KWIATKOWSKI TJ, 1990, NUCLEIC ACIDS RES, V18, P7191, DOI 10.1093/nar/18.23.7191; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; LEDBETTER DH, 1995, METABOLIC MOL BASES, V1, P811; LEE CC, 1995, HUM MOL GENET, V4, P1373, DOI 10.1093/hmg/4.8.1373; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; LeGuern E, 1996, HUM MOL GENET, V5, P103, DOI 10.1093/hmg/5.1.103; LEHRMAN MA, 1987, J BIOL CHEM, V262, P3354; LI XM, 1992, NUCLEIC ACIDS RES, V20, P1117, DOI 10.1093/nar/20.5.1117; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; MANIATIS T, 1980, ANNU REV GENET, V14, P145, DOI 10.1146/annurev.ge.14.120180.001045; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; Matsuda Y, 1996, GENOMICS, V33, P325, DOI 10.1006/geno.1996.0203; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NAKAMURA T, 1992, ONCOGENE, V7, P733; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; OCHMAN H, 1988, GENETICS, V120, P621; PEETERS BPH, 1988, MOL GEN GENET, V212, P450, DOI 10.1007/BF00330849; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Reiter LT, 1997, HUM MOL GENET, V6, P1595, DOI 10.1093/hmg/6.9.1595; ROA BB, 1994, ADV HUM GENET, V22, P117; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; Roa BB, 1996, HUM GENET, V97, P642; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; Scheurlen WG, 1997, GENE CHROMOSOME CANC, V18, P50, DOI 10.1002/(SICI)1098-2264(199701)18:1<50::AID-GCC6>3.0.CO;2-0; Shaffer LG, 1997, AM J MED GENET, V69, P325, DOI 10.1002/(SICI)1096-8628(19970331)69:3<325::AID-AJMG20>3.0.CO;2-S; SILVERMAN GA, 1991, GENOMICS, V9, P219, DOI 10.1016/0888-7543(91)90245-A; SINGER BS, 1988, J MOL BIOL, V202, P233, DOI 10.1016/0022-2836(88)90454-8; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; STRATTON RF, 1986, AM J MED GENET, V24, P421, DOI 10.1002/ajmg.1320240305; TOWNSENDNICHOLSON A, 1995, GENOMICS, V25, P605, DOI 10.1016/0888-7543(95)80074-V; Trask BJ, 1996, HUM GENET, V98, P710, DOI 10.1007/s004390050291; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WHORISKEY SK, 1991, GENETICS, V127, P21; Wilgenbus KK, 1997, GENOMICS, V42, P1, DOI 10.1006/geno.1997.4707; WU CL, 1993, BIOCHIM BIOPHYS ACTA, V1174, P241, DOI 10.1016/0167-4781(93)90193-H; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q; ZHAO ZY, 1995, HUM MOL GENET, V4, P589, DOI 10.1093/hmg/4.4.589; ZORI RT, 1993, AM J MED GENET, V47, P504, DOI 10.1002/ajmg.1320470414	83	293	297	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					154	163		10.1038/ng1097-154	http://dx.doi.org/10.1038/ng1097-154			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326934				2022-12-17	WOS:A1997XZ55500020
J	HIROTSUNE, S; TAKAHARA, T; SASAKI, N; HIROSE, K; YOSHIKI, A; OHASHI, T; KUSAKABE, M; MURAKAMI, Y; MURAMATSU, M; WATANABE, S; NAKAO, K; KATSUKI, M; HAYASHIZAKI, Y				HIROTSUNE, S; TAKAHARA, T; SASAKI, N; HIROSE, K; YOSHIKI, A; OHASHI, T; KUSAKABE, M; MURAKAMI, Y; MURAMATSU, M; WATANABE, S; NAKAO, K; KATSUKI, M; HAYASHIZAKI, Y			THE REELER GENE ENCODES A PROTEIN WITH AN EGF-LIKE MOTIF EXPRESSED BY PIONEER NEURONS	NATURE GENETICS			English	Article							EPIDERMAL GROWTH-FACTOR; MOUSE CHROMOSOME-5; MUTANT MOUSE; LOCALIZATION; MUTATIONS; RESIDUES; DOMAINS; CELLS; MICE; LOCI	We have identified a strong candidate cDNA for the mouse reeler gene. This 5 kb transcript encodes a 99.4 kD protein consisting of 881 amino acids and possessing two EGF-like motifs. We assayed two independent mutant alleles - 'Jackson reeler', which has a deletion of the entire gene, and 'Orleans reeler' which exhibits a 220 bp deletion in the open reading frame, including the second EGF-like motif and resulting in a frame shift. In situ hybridization reveals that the transcript is detected exclusively in the pioneer neurons which guide neuronal cell migration along the radial array. Our findings offer an explanation for how the reeler mutant phenotype causes a disturbance of the complex architecture of the neuronal network.	INST PHYS & CHEM RES,TSUKUBA LIFE SCI CTR,GENOME SCI LAB,CELL BIOL LAB,TSUKUBA,IBARAKI 305,JAPAN; INST PHYS & CHEM RES,TSUKUBA LIFE SCI CTR,CELLULAR PHYSIOL LAB,TSUKUBA,IBARAKI 305,JAPAN; SHIONOGI & CO LTD,SHIONOGI INST MED SCI,SETTSU,OSAKA 566,JAPAN; KYUSHU UNIV,MED INST BIOREGULAT,HIGASHI KU,FUKUOKA 812,JAPAN	RIKEN; RIKEN; Shionogi & Company Limited; Kyushu University			Yoshiki, Atsushi/O-6162-2019; Sasaki, Nobuya/F-6579-2012	Yoshiki, Atsushi/0000-0002-9450-5151; 				BECKERS MC, 1994, GENOMICS, V23, P685, DOI 10.1006/geno.1994.1557; BIRNBOIM HC, 1988, NUCLEIC ACIDS RES, V16, P1487, DOI 10.1093/nar/16.4.1487; DERNONCOURT C, 1991, GENOMICS, V11, P1167, DOI 10.1016/0888-7543(91)90049-K; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; Dietz Harry C., 1992, Human Mutation, V1, P366, DOI 10.1002/humu.1380010504; DIETZ HC, 1992, J CLIN INVEST, V89, P1674, DOI 10.1172/JCI115766; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; GOFFINET AM, 1984, BRAIN RES REV, V7, P261, DOI 10.1016/0165-0173(84)90013-4; GOFFINET AM, 1991, MAMM GENOME, V1, P100, DOI 10.1007/BF02443785; GOFFINET AM, 1990, EXP BRAIN RES SER, V19, P135; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HANDFORD PA, 1990, EMBO J, V9, P475, DOI 10.1002/j.1460-2075.1990.tb08133.x; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; HAYASHIZAKI Y, 1994, GENETICS, V138, P1207; HIRAIWA N, 1993, J CELL SCI, V104, P289; HIROTSUNE S, 1993, BIOCHEM BIOPH RES CO, V194, P1406, DOI 10.1006/bbrc.1993.1981; KATARLINA K, 1994, NAT GENET, V6, P64; KELLEY MR, 1987, CELL, V51, P539, DOI 10.1016/0092-8674(87)90123-1; KOMORIYA A, 1984, P NATL ACAD SCI-BIOL, V81, P1351, DOI 10.1073/pnas.81.5.1351; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; MEYERS WA, 1970, BEHAV GENET, V1, P225; MIAO GG, 1994, P NATL ACAD SCI USA, V91, P11050, DOI 10.1073/pnas.91.23.11050; MONTGOMERY JC, 1994, MAMM GENOME, V5, P756, DOI 10.1007/BF00292008; OHSUMI T, 1995, ELECTROPHORESIS, V16, P203, DOI 10.1002/elps.1150160135; OKAZAKI Y, IN PRESS P NATN ACAD; PINTOLORD MC, 1982, DEV BRAIN RES, V4, P379, DOI 10.1016/0165-3806(82)90181-X; STEINDLER DA, 1977, NEUROSCI LETT, V6, P293, DOI 10.1016/0304-3940(77)90087-8; STEINDLER DA, 1976, BRAIN RES, V113, P386, DOI 10.1016/0006-8993(76)90949-5; TERASHIMA T, 1986, J COMP NEUROL, V252, P264, DOI 10.1002/cne.902520209; YOSHIKI A, 27TH P ANN M JAP SOC, V169; 1990, EMBO PRACTICAL COURS	31	293	298	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1995	10	1					77	83		10.1038/ng0595-77	http://dx.doi.org/10.1038/ng0595-77			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	7647795				2022-12-17	WOS:A1995QX57300019
J	RUSSELL, LJ; DIGIOVANNA, JJ; ROGERS, GR; STEINERT, PM; HASHEM, N; COMPTON, JG; BALE, SK				RUSSELL, LJ; DIGIOVANNA, JJ; ROGERS, GR; STEINERT, PM; HASHEM, N; COMPTON, JG; BALE, SK			MUTATIONS IN THE GENE FOR TRANSGLUTAMINASE-1 IN AUTOSOMAL RECESSIVE LAMELLAR ICHTHYOSIS	NATURE GENETICS			English	Article							FACTOR-XIII; SUBUNIT DEFICIENCY	We recently mapped the disease locus for severe autosomal recessive lamellar ichthyosis (LI) to chromosome 14q11 and showed complete linkage with TGM1, the gene encoding transglutaminase 1. We have now identified point mutations in TGM1 in two of the multiplex Li families used in the linkage study. Each nucleotide change causes a non-conservative amino acid substitution of histidine for one of two adjacent arginine residues in exon 3 of the gene (Arg141His, Arg142His). Within the transglutaminase family, these arginines are invariant within a conserved region, distant from the catalytic site of the enzyme. We hypothesize that these mutations adversely affect formation of crosslinks essential in production of cornified cell envelopes and a normal stratum corneum layer of the skin.	NIAMSD, GENET STUDIES SECT, SKIN BIOL LAB, BETHESDA, MD 20892 USA; NIAMSD, DERMATOL CLIN RES UNIT, BETHESDA, MD 20892 USA; AIN SHAMS UNIV, CTR GENET MED, CAIRO, EGYPT	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Egyptian Knowledge Bank (EKB); Ain Shams University				DiGiovanna, John J./0000-0002-2750-2313				BOARD P, 1992, BLOOD, V80, P937; BROCQ L, 1902, ANN DERMATOL SYPHIL, V3, P1; CHENG J, 1992, CELL, V70, P811, DOI 10.1016/0092-8674(92)90314-3; GENTILE V, 1994, GENOMICS, V20, P295, DOI 10.1006/geno.1994.1170; KAMURA T, 1992, J CLIN INVEST, V90, P315, DOI 10.1172/JCI115864; KIM IG, 1992, J BIOL CHEM, V267, P7710; KIM SY, 1994, J BIOL CHEM, V269, P27979; MIKKOLA H, 1994, BLOOD, V84, P517; PEDERSEN LC, 1994, PROTEIN SCI, V3, P1131, DOI 10.1002/pro.5560030720; Reichert Uwe, 1993, P107; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; RUSSELL LJ, 1994, AM J HUM GENET, V55, P1146; Sambrook J., 1989, MOL CLONING LAB MANU; STANDEN GR, 1993, BRIT J HAEMATOL, V85, P769, DOI 10.1111/j.1365-2141.1993.tb03221.x; Steinert P M, 1995, Cell Death Differ, V2, P33; TRAUPE H, 1989, ICHTHYOSES, P111; WANG M, 1994, GENOMICS, V23, P721, DOI 10.1006/geno.1994.1571; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296; 1987, ICHTHYOSIS OVERVIEW, P3	19	293	304	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1995	9	3					279	283		10.1038/ng0395-279	http://dx.doi.org/10.1038/ng0395-279			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	7773290				2022-12-17	WOS:A1995QL23200018
J	Girard, SL; Gauthier, J; Noreau, A; Xiong, L; Zhou, SR; Jouan, L; Dionne-Laporte, A; Spiegelman, D; Henrion, E; Diallo, O; Thibodeau, P; Bachand, I; Bao, JYJ; Tong, AHY; Lin, CH; Millet, B; Jaafari, N; Joober, R; Dion, PA; Lok, S; Krebs, MO; Rouleau, GA				Girard, Simon L.; Gauthier, Julie; Noreau, Anne; Xiong, Lan; Zhou, Sirui; Jouan, Loubna; Dionne-Laporte, Alexandre; Spiegelman, Dan; Henrion, Edouard; Diallo, Ousmane; Thibodeau, Pascale; Bachand, Isabelle; Bao, Jessie Y. J.; Tong, Amy Hin Yan; Lin, Chi-Ho; Millet, Bruno; Jaafari, Nematollah; Joober, Ridha; Dion, Patrick A.; Lok, Si; Krebs, Marie-Odile; Rouleau, Guy A.			Increased exonic de novo mutation rate in individuals with schizophrenia	NATURE GENETICS			English	Article							V(D)J RECOMBINATION; MENTAL-RETARDATION; COMMON VARIANTS; ASSOCIATION; SUBSTITUTIONS; DISEASE; GENE	Schizophrenia is a severe psychiatric disorder that profoundly affects cognitive, behavioral and emotional processes. The wide spectrum of symptoms and clinical variability in schizophrenia suggest a complex genetic etiology, which is consistent with the numerous loci thus far identified by linkage, copy number variation and association studies(1-4). Although schizophrenia heritability may be as high as similar to 80%, the genes responsible for much of this heritability remain to be identified(5). Here we sequenced the exomes of 14 schizophrenia probands and their parents. We identified 15 de novo mutations (DNMs) in eight probands, which is significantly more than expected considering the previously reported DNM rate(6-8). In addition, 4 of the 15 identified DNMs are nonsense mutations, which is more than what is expected by chance(9). Our study supports the notion that DNMs may account for some of the heritability reported for schizophrenia while providing a list of genes possibly involved in disease pathogenesis.	[Girard, Simon L.; Gauthier, Julie; Noreau, Anne; Xiong, Lan; Zhou, Sirui; Jouan, Loubna; Dionne-Laporte, Alexandre; Spiegelman, Dan; Henrion, Edouard; Diallo, Ousmane; Thibodeau, Pascale; Dion, Patrick A.; Rouleau, Guy A.] Univ Montreal, Ctr Excellence Neur, Ctr Hosp Univ Montreal Res Ctr, Montreal, PQ, Canada; [Bachand, Isabelle; Rouleau, Guy A.] Univ Montreal, Ctr Excellence Neur, Ctr Hosp Univ St Justine Res Ctr, Montreal, PQ, Canada; [Bao, Jessie Y. J.; Tong, Amy Hin Yan; Lin, Chi-Ho; Lok, Si] Univ Hong Kong, Li Ka Shing Fac Med, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Millet, Bruno; Jaafari, Nematollah; Krebs, Marie-Odile] Univ Paris 05, INSERM, Lab Physiopathol Malad Psychiat, Ctr Psychiat & Neurosci UMR 894, Paris, France; [Millet, Bruno] Univ Rennes 1, CH Guillaume Regnier Serv Hosp Univ Psychiat, Rennes, France; [Jaafari, Nematollah] Univ Poitiers, CHU, Ctr Hosp Henri Laborit, Unite Rech Clin Intersectorielle Psychiat,INSERM, Poitiers, France; [Joober, Ridha] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Dion, Patrick A.] Univ Montreal, Dept Pathol & Cellular Biol, Montreal, PQ, Canada; [Krebs, Marie-Odile] Univ Paris 05, Fac Med Paris Descartes, Serv Hosp Univ, Ctr Hosp St Anne, Paris, France; [Rouleau, Guy A.] Univ Montreal, Dept Med, Fac Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Hong Kong; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Rennes; Universite de Rennes 1; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; McGill University; Universite de Montreal; Assistance Publique Hopitaux Paris (APHP); GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal	Rouleau, GA (corresponding author), Univ Montreal, Ctr Excellence Neur, Ctr Hosp Univ Montreal Res Ctr, Montreal, PQ, Canada.	guy.rouleau@umontreal.ca	Krebs, Marie-Odile/O-2104-2017	Krebs, Marie-Odile/0000-0002-4715-9890; spiegelman, dan/0000-0003-4971-8868; Girard, Simon/0000-0002-4089-2280	Fondation Pierre Deniker; Genome Canada; Genome Quebec; Universite de Montreal; Canadian Foundation for Innovation, Brain & Behavior Research Foundation; Canadian Institutes of Health Research (CIHR) [RMF92086]	Fondation Pierre Deniker; Genome Canada(Genome Canada); Genome Quebec; Universite de Montreal; Canadian Foundation for Innovation, Brain & Behavior Research Foundation(Canada Foundation for Innovation); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Subjects were selected from the Psydev study, promoted by INSERM, through the Collaborative Network for Family Study in Psychiatry ('Reseau d'etude familiale en Psychiatry', REFAPSY), supported by the Fondation Pierre Deniker. We wish to thank S. Bannour, M.-J. Dos Santos, M. A. Gorsane, N. Benjemaa, M. Chayet, S. Leroy, F. Mouaffak, K. Ossian and F. Polides for participating in recruitment of subjects and for their technical help. This work was supported by Genome Canada and Genome Quebec and received co-funding from Universite de Montreal for the Synapse to Disease (S2D) project as well as funding from the Canadian Foundation for Innovation, Brain & Behavior Research Foundation. Bioinformatic analysis was supported by a Canadian Institutes of Health Research (CIHR) Team grant (RMF92086). G. A. R. is grateful for the support received through his positions as Canada Research Chair in Genetics of the Nervous System and Jeanne-et-J.-Louis-Levesque Chair for the Genetics of Brain Diseases. N. Jaafari was supported by an award, bourse chercheur invite, of the Region Poitou-Charente.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.0.CO;2-U; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hamdan FF, 2010, AM J HUM GENET, V87, P671, DOI 10.1016/j.ajhg.2010.09.017; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Hollenbach E, 1998, NEUROLOGY, V50, P1905, DOI 10.1212/WNL.50.6.1905; Jones JM, 2009, ARCH IMMUNOL THER EX, V57, P105, DOI 10.1007/s00005-009-0011-3; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LI WH, 1984, J MOL EVOL, V21, P58, DOI 10.1007/BF02100628; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Willerford DM, 1996, CURR OPIN GENET DEV, V6, P603, DOI 10.1016/S0959-437X(96)80090-6	29	292	298	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2011	43	9					860	U65		10.1038/ng.886	http://dx.doi.org/10.1038/ng.886			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	21743468				2022-12-17	WOS:000294325800011
J	Vermulst, M; Wanagat, J; Kujoth, GC; Bielas, JH; Rabinovitch, PS; Prolla, TA; Loeb, LA				Vermulst, Marc; Wanagat, Jonathan; Kujoth, Gregory C.; Bielas, Jason H.; Rabinovitch, Peter S.; Prolla, Tomas A.; Loeb, Lawrence A.			DNA deletions and clonal mutations drive premature aging in mitochondrial mutator mice	NATURE GENETICS			English	Article							SUBSTANTIA-NIGRA NEURONS; LIFE-SPAN; DIRECT REPEATS; RECOMBINATION	Mitochondrial DNA (mtDNA) mutations are thought to have a causal role in many age-related pathologies. Here we identify mtDNA deletions as a driving force behind the premature aging phenotype of mitochondrial mutator mice, and provide evidence for a homology-directed DNA repair mechanism in mitochondria that is directly linked to the formation of mtDNA deletions. In addition, our results demonstrate that the rate at which mtDNA mutations reach phenotypic expression differs markedly among tissues, which may be an important factor in determining the tolerance of a tissue to random mitochondrial mutagenesis.	[Vermulst, Marc; Bielas, Jason H.; Rabinovitch, Peter S.; Loeb, Lawrence A.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Wanagat, Jonathan] Univ Washington, Dept Gerontol & Geriat Med, Seattle, WA 98195 USA; [Kujoth, Gregory C.; Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Kujoth, Gregory C.; Prolla, Tomas A.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Loeb, LA (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	laloeb@u.washington.edu	Wanagat, Jonathan/B-2856-2009	Wanagat, Jonathan/0000-0002-8460-8616; Kujoth, Gregory/0000-0002-6636-2800	NATIONAL CANCER INSTITUTE [R01CA102029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES011045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021905, P01AG001751] Funding Source: NIH RePORTER; NCI NIH HHS [CA102029] Funding Source: Medline; NIA NIH HHS [AG01751, AG021905] Funding Source: Medline; NIEHS NIH HHS [ES11045] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103; Khaidakov M, 2006, MECH AGEING DEV, V127, P808, DOI 10.1016/j.mad.2006.07.008; Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082; TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988	15	292	298	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					392	394		10.1038/ng.95	http://dx.doi.org/10.1038/ng.95			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18311139				2022-12-17	WOS:000254388100008
J	McClelland, M; Sanderson, KE; Clifton, SW; Latreille, P; Porwollik, S; Sabo, A; Meyer, R; Bieri, T; Ozersky, P; McLellan, M; Harkins, CR; Wang, CY; Nguyen, C; Berghoff, A; Elliott, G; Kohlberg, S; Strong, C; Du, FY; Carter, J; Kremizki, C; Layman, D; Leonard, S; Sun, H; Fulton, L; Nash, W; Miner, T; Minx, P; Delehaunty, K; Fronick, C; Magrini, V; Nhan, M; Warren, W; Florea, L; Spieth, J; Wilson, RK				McClelland, M; Sanderson, KE; Clifton, SW; Latreille, P; Porwollik, S; Sabo, A; Meyer, R; Bieri, T; Ozersky, P; McLellan, M; Harkins, CR; Wang, CY; Nguyen, C; Berghoff, A; Elliott, G; Kohlberg, S; Strong, C; Du, FY; Carter, J; Kremizki, C; Layman, D; Leonard, S; Sun, H; Fulton, L; Nash, W; Miner, T; Minx, P; Delehaunty, K; Fronick, C; Magrini, V; Nhan, M; Warren, W; Florea, L; Spieth, J; Wilson, RK			Comparison of genome degradation in Paratyphi A and Typhi, human-restricted serovars of Salmonella enterica that cause typhoid	NATURE GENETICS			English	Article							SEROTYPE TYPHIMURIUM; ESCHERICHIA-COLI; CAUSATIVE AGENT; SEQUENCE; FEVER; EVOLUTION; STRAINS; GENES; IDENTIFICATION; CHEMOTAXIS	Salmonella enterica serovars often have a broad host range, and some cause both gastrointestinal and systemic disease. But the serovars Paratyphi A and Typhi are restricted to humans and cause only systemic disease. It has been estimated that Typhi arose in the last few thousand years. The sequence and microarray analysis of the Paratyphi A genome indicates that it is similar to the Typhi genome but suggests that it has a more recent evolutionary origin. Both genomes have independently accumulated many pseudogenes among their similar to4,400 protein coding sequences: 173 in Paratyphi A and similar to210 in Typhi. The recent convergence of these two similar genomes on a similar phenotype is subtly reflected in their genotypes: only 30 genes are degraded in both serovars. Nevertheless, these 30 genes include three known to be important in gastroenteritis, which does not occur in these serovars, and four for Salmonella-translocated effectors, which are normally secreted into host cells to subvert host functions. Loss of function also occurs by mutation in different genes in the same pathway (e.g., in chemotaxis and in the production of fimbriae).	Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA; Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Celera Appl Biosyst, Informat Res, Rockville, MD 20850 USA	University of Calgary; Washington University (WUSTL); Thermo Fisher Scientific; Applied Biosystems	McClelland, M (corresponding author), Sidney Kimmel Canc Ctr, 10835 Altman Row, San Diego, CA 92121 USA.	mmcclelland@skcc.org	McClelland, Michael/A-8583-2011; Wilson, Richard K./AAF-4139-2019; Magrini, Vincent/AAT-5830-2020	Wilson, Richard K./0000-0002-1992-1358; Magrini, Vincent/0000-0002-2019-4872; McClelland, Michael/0000-0003-1788-9347; Kremitzki, Colin/0000-0001-9175-3136; MCLELLAN, MICHAEL/0000-0002-2703-8784				Akinyemi KO, 2000, Z NATURFORSCH C, V55, P489; Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101; Andersson JO, 2001, MOL BIOL EVOL, V18, P829, DOI 10.1093/oxfordjournals.molbev.a003864; BOYD EF, 1993, J GEN MICROBIOL, V139, P1125, DOI 10.1099/00221287-139-6-1125; Boyd EF, 2003, J CLIN MICROBIOL, V41, P3823, DOI 10.1128/JCM.41.8.3823-3828.2003; Bren A, 2000, J BACTERIOL, V182, P6865, DOI 10.1128/JB.182.24.6865-6873.2000; Brumell JH, 2003, TRAFFIC, V4, P36, DOI 10.1034/j.1600-0854.2003.40106.x; BUCHWALD DS, 1984, REV INFECT DIS, V6, P345; Butler SM, 2004, P NATL ACAD SCI USA, V101, P5018, DOI 10.1073/pnas.0308052101; Chan K, 2003, J BACTERIOL, V185, P553, DOI 10.1128/JB.185.2.553-563.2003; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; EDELMAN R, 1986, REV INFECT DIS, V8, P329; Freeman JA, 2003, INFECT IMMUN, V71, P418, DOI 10.1128/IAI.71.1.418-427.2003; Hafiz Saleem, 1993, JPMA (Journal of the Pakistan Medical Association), V43, P178; HOFFMAN TA, 1975, AM J MED, V59, P481, DOI 10.1016/0002-9343(75)90255-7; Ivanoff B., 1995, SE ASIAN J TROP MED, V26, P1; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; JONES BD, 1992, INFECT IMMUN, V60, P2475, DOI 10.1128/IAI.60.6.2475-2480.1992; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Kingsley RA, 2003, INFECT IMMUN, V71, P629, DOI 10.1128/IAI.71.2.629-640.2003; Konadu EY, 2000, INFECT IMMUN, V68, P1529, DOI 10.1128/IAI.68.3.1529-1534.2000; LIU SL, 1995, J BACTERIOL, V177, P6585, DOI 10.1128/jb.177.22.6585-6592.1995; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Miao EA, 2003, MOL MICROBIOL, V48, P401, DOI 10.1046/j.1365-2958.2003.t01-1-03456.x; Mmolawa PT, 2003, J BACTERIOL, V185, P6481, DOI 10.1128/JB.185.21.6481-6485.2003; Naderer M, 2002, J BACTERIOL, V184, P2411, DOI 10.1128/JB.184.9.2411-2419.2002; Nair S, 2004, J BACTERIOL, V186, P3214, DOI 10.1128/JB.186.10.3214-3223.2004; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; PEARSON RD, 1995, PRINCIPLES PRACTICE, P998; Porwollik S, 2002, P NATL ACAD SCI USA, V99, P8956, DOI 10.1073/pnas.122153699; Porwollik S, 2004, J BACTERIOL, V186, P5883, DOI 10.1128/JB.186.17.5883-5898.2004; Porwollik S, 2003, NUCLEIC ACIDS RES, V31, P1869, DOI 10.1093/nar/gkg298; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; REEVES P, 1993, TRENDS GENET, V9, P17, DOI 10.1016/0168-9525(93)90067-R; SILVERMAN M, 1980, CELL, V19, P845, DOI 10.1016/0092-8674(80)90075-6; Smith J, 2004, B WORLD HEALTH ORGAN, V82, P24; Sood S, 1999, EMERG INFECT DIS, V5, P483, DOI 10.3201/eid0503.990329; Thomson N, 2004, J MOL BIOL, V339, P279, DOI 10.1016/j.jmb.2004.03.058; Threlfall EJ, 2003, INT J ANTIMICROB AG, V22, P487, DOI 10.1016/S0924-8579(03)00262-0; Tsolis RM, 1999, INFECT IMMUN, V67, P6385; Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wren BW, 2003, NAT REV MICROBIOL, V1, P55, DOI 10.1038/nrmicro730; Zhang SP, 2002, INFECT IMMUN, V70, P3843, DOI 10.1128/IAI.70.7.3843-3855.2002	49	292	1240	0	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2004	36	12					1268	1274		10.1038/ng1470	http://dx.doi.org/10.1038/ng1470			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	15531882				2022-12-17	WOS:000225354100013
J	Wuchty, S; Oltvai, ZN; Barabasi, AL				Wuchty, S; Oltvai, ZN; Barabasi, AL			Evolutionary conservation of motif constituents in the yeast protein interaction network	NATURE GENETICS			English	Article							GENE DISPENSABILITY; CELLULAR NETWORKS; ORGANIZATION; DATABASE	Understanding why some cellular components are conserved across species but others evolve rapidly is a key question of modern biology(1-3). Here we show that in Saccharomyces cerevisiae, proteins organized in cohesive patterns of interactions are conserved to a substantially higher degree than those that do not participate in such motifs. We find that the conservation of proteins in distinct topological motifs correlates with the interconnectedness and function of that motif and also depends on the structure of the overall interactome topology. These findings indicate that motifs may represent evolutionary conserved topological units of cellular networks molded in accordance with the specific biological function in which they participate.	Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA	University of Notre Dame; Northwestern University	Barabasi, AL (corresponding author), Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA.	zno008@northwestern.edu; alb@nd.edu	Barabasi, Albert-Laszlo/S-6474-2017	Barabasi, Albert/0000-0002-4028-3522				Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hirsh AE, 2003, NATURE, V421, P497, DOI 10.1038/421497a; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Hurst LD, 1999, CURR BIOL, V9, P747, DOI 10.1016/S0960-9822(99)80334-0; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Oltvai ZN, 2002, SCIENCE, V298, P763, DOI 10.1126/science.1078563; Pal C, 2003, NATURE, V421, P496, DOI 10.1038/421496b; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Snel B, 2002, P NATL ACAD SCI USA, V99, P5890, DOI 10.1073/pnas.092632599; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303	22	292	305	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2003	35	2					176	179		10.1038/ng1242	http://dx.doi.org/10.1038/ng1242			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726WV	12973352				2022-12-17	WOS:000185625300015
J	Nowak, KJ; Wattanasirichaigoon, D; Goebel, HH; Wilce, M; Pelin, K; Donner, K; Jacob, RL; Hubner, C; Oexle, K; Anderson, JR; Verity, CM; North, KN; Iannaccone, ST; Muller, CR; Nurnberg, P; Muntoni, F; Sewry, C; Hughes, I; Sutphen, R; Lacson, AG; Swoboda, KJ; Vigneron, J; Wallgren-Pettersson, C; Beggs, AH; Laing, NG				Nowak, KJ; Wattanasirichaigoon, D; Goebel, HH; Wilce, M; Pelin, K; Donner, K; Jacob, RL; Hubner, C; Oexle, K; Anderson, JR; Verity, CM; North, KN; Iannaccone, ST; Muller, CR; Nurnberg, P; Muntoni, F; Sewry, C; Hughes, I; Sutphen, R; Lacson, AG; Swoboda, KJ; Vigneron, J; Wallgren-Pettersson, C; Beggs, AH; Laing, NG			Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy	NATURE GENETICS			English	Article							MISSENSE MUTATIONS; DNASE-I; CARDIOMYOPATHY; SEQUENCE; COMPLEX	Muscle contraction results from the force generated between the thin filament protein actin and the thick filament protein myosin, which causes the thick and thin muscle filaments to slide past each other(1). There are skeletal muscle, cardiac muscle, smooth muscle and non-muscle isoforms of both actin and myosin(2). Inherited diseases in humans have been associated with defects in cardiac actin (dilated cardiomyopathy(3) and hypertrophic cardiomyopathy(4)), cardiac myosin (hypertrophic cardiomyopathy(5)) and non-muscle myosin (deafness(6)). Here we report that mutations in the human skeletal muscle cr-actin gene(2) (ACTA1) are associated with two different muscle diseases, 'congenital myopathy with excess of thin myofilaments' (actin myopathy(7)) and nemaline myopathy(8). Both diseases are characterized by structural abnormalities of the muscle fibres and variable degrees of muscle weakness. We have identified 15 different missense mutations resulting in 14 different amino acid changes. The missense mutations in ACTA1 are distributed throughout all six coding exons(2), and some involve known functional domains of actin(9). Approximately half of the patients died within their first year, but two female patients have survived into their thirties and have children. We identified dominant mutations in all but 1 of 14 families, with the missense mutations being single and heterozygous. The only family showing dominant inheritance comprised a 33-year-old affected mother and her two affected and two unaffected children. In another family, the clinically unaffected father is a somatic mosaic for the mutation seen in both of his affected children. We identified recessive mutations in one family in which the two affected siblings had heterozygous mutations in two different exons, one paternally and the other maternally inherited. We also identified de novo mutations in seven sporadic probands for which it was possible to analyse parental DNA.	Univ Western Australia, Queen Elizabeth II Med Ctr, Australian Neuromuscular Res Inst, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA 6009, Australia; Murdoch Univ, Dept Vet & Biomed Sci, Murdoch, WA 6150, Australia; Harvard Univ, Childrens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; Univ Mainz, Dept Neuropathol, D-6500 Mainz, Germany; Univ Western Australia, Crystallog Ctr, Perth, WA 6009, Australia; Univ Western Australia, Dept Pharmacol, Perth, WA 6009, Australia; Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland; Univ Helsinki, Dept Med Genet, Helsinki, Finland; Royal Perth Hosp, Dept Neuropathol, Perth, WA, Australia; Humboldt Univ, Dept Neuropaediat, Berlin, Germany; Addenbrookes Hosp, Dept Histopathol, Cambridge CB2 2QQ, England; Addenbrookes Hosp, Child Dev Ctr, Cambridge, England; Royal Alexandra Hosp Children, Neurogenet Res Unit, Sydney, NSW, Australia; Univ Texas, SW Med Ctr, Texas Scottish Rite Hosp Children, Dallas, TX USA; Univ Wurzburg, Dept Human Genet, D-8700 Wurzburg, Germany; Humboldt Univ, Inst Med Genet, Charite Med Sch, Berlin, Germany; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, Dept Paediat & Neonatal Med, London, England; Royal Manchester Childrens Hosp, Dept Paediat Neurol, Manchester M27 1HA, Lancs, England; Univ S Florida, Sch Med, All Childrens Hosp, Tampa, FL 33620 USA; Univ S Florida, Sch Med, Dept Pediat, Tampa, FL 33620 USA; Univ S Florida, Sch Med, Dept Pathol, Tampa, FL 33620 USA; Serv Matern Reg A Pinard, Nancy, France; Univ Helsinki, Folkhalsan Dept Med Genet, Helsinki, Finland	University of Western Australia; Murdoch University; Harvard University; Boston Children's Hospital; Harvard Medical School; Johannes Gutenberg University of Mainz; University of Western Australia; University of Western Australia; University of Helsinki; University of Helsinki; Royal Perth Hospital; University of Western Australia; Humboldt University of Berlin; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Wurzburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Imperial College London; Royal Manchester Children's Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of Helsinki	Laing, NG (corresponding author), Univ Western Australia, Queen Elizabeth II Med Ctr, Australian Neuromuscular Res Inst, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA 6009, Australia.		; North, Kathryn/K-6476-2012	Laing, Nigel/0000-0001-5111-3732; Pelin, Katarina/0000-0002-7040-7266; Swoboda, Kathryn/0000-0002-4593-6342; Donner, Kati/0000-0001-9190-4336; Beggs, Alan/0000-0001-8818-0568; North, Kathryn/0000-0003-0841-8009; Oexle, Konrad/0000-0001-7447-2252				AKKARI PA, 1994, CYTOGENET CELL GENET, V65, P265, DOI 10.1159/000133644; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Craig R, 1994, MYOLOGY, P134; DIETZEN CJ, 1993, MUSCLE NERVE, V16, P328; DRUMMOND DR, 1991, MOL GEN GENET, V226, P70, DOI 10.1007/BF00273589; DRUMMOND DR, 1992, EUR J BIOCHEM, V209, P171, DOI 10.1111/j.1432-1033.1992.tb17274.x; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; Goebel HH, 1997, NEUROMUSCULAR DISORD, V7, P160, DOI 10.1016/S0960-8966(97)00441-0; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; HEGYI G, 1974, EUR J BIOCHEM, V44, P7, DOI 10.1111/j.1432-1033.1974.tb03452.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; LAING NG, 1995, CURR OPIN NEUROL, V8, P391, DOI 10.1097/00019052-199510000-00012; LAING NG, 1995, NAT GENET, V9, P75, DOI 10.1038/ng0195-75; Lammens M, 1997, NEUROPEDIATRICS, V28, P116, DOI 10.1055/s-2007-973683; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Mendelson R, 1997, P NATL ACAD SCI USA, V94, P8533, DOI 10.1073/pnas.94.16.8533; Mogensen J, 1999, J CLIN INVEST, V103, pR39, DOI 10.1172/JCI6460; North KN, 1997, J MED GENET, V34, P705, DOI 10.1136/jmg.34.9.705; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Pelin K, 1999, P NATL ACAD SCI USA, V96, P2305, DOI 10.1073/pnas.96.5.2305; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; SAKAI Y, 1990, J BIOCHEM-TOKYO, V107, P499, DOI 10.1093/oxfordjournals.jbchem.a123074; SHETERLINE P, 1999, ACTIN, P1; TAN P, 1997, NEUROMUSCULAR DISORD, V7, P427; TAYLOR A, 1988, GENOMICS, V3, P323, DOI 10.1016/0888-7543(88)90123-1; WALLGRENPETTERS.C, 1998, INHERITED NEUROMUSCU, P247; WALLGRENPETTERSSON C, 1989, J NEUROL SCI, V89, P1, DOI 10.1016/0022-510X(89)90002-6; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; WERTMAN KF, 1992, GENETICS, V132, P337	30	292	299	0	26	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1999	23	2					208	212		10.1038/13837	http://dx.doi.org/10.1038/13837			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	240LM	10508519				2022-12-17	WOS:000082827500022
J	Li, H; Arber, S; Jessell, TM; Edlund, H				Li, H; Arber, S; Jessell, TM; Edlund, H			Selective agenesis of the dorsal pancreas in mice lacking homeobox gene Hlxb9	NATURE GENETICS			English	Article							HEDGEHOG; DIFFERENTIATION; MESENCHYME; NOTOCHORD	The initial stages of pancreatic development occur early during mammalian embryogenesis(1), but the genes governing this process remain largely unknown. The homeodomain protein Pdx1 is expressed in the developing pancreatic anlagen from the approximately 10-somite stage(2,3), and mutations in the gene Pdx1 prevent the development of the pancreas(3-5). The initial stages of pancreatic development, however, still occur in Pdx1-deficient mice(3). Hlxb9 (encoding Hb9; ref. 6) is a homeobox gene that in humans has been linked to dominant inherited sacral agenesis(7) and we show here that Hb9 is expressed at early stages of mouse pancreatic development and later in differentiated beta-cells. H1xb9 has an essential function in the initial stages of pancreatic development. In absence of Hlxb9 expression, the dorsal region of the gut epithelium fails to initiate a pancreatic differentiation program. In contrast, the ventral pancreatic endoderm develops but exhibits a later and more subtle perturbation in beta-cell differentiation and in islet cell organization, Thus, dorsally Hlxb9 is required for specifying the gut epithelium to a pancreatic fate and ventrally for ensuring proper endocrine cell differentiation.	Umea Univ, Dept Microbiol, S-90187 Umea, Sweden; Columbia Univ, Ctr Neurobiol & Behav, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Umea University; Columbia University; Howard Hughes Medical Institute	Edlund, H (corresponding author), Umea Univ, Dept Microbiol, S-90187 Umea, Sweden.	helena.edlund@micro.umu.se		Edlund, Helena/0000-0002-3553-7348; Arber, Silvia/0000-0002-6261-250X				Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; ARBER S, IN PRESS NEURON; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Edlund H, 1998, DIABETES, V47, P1817, DOI 10.2337/diabetes.47.12.1817; HARRISON KA, 1994, J BIOL CHEM, V269, P19968; Hebrok M, 1998, GENE DEV, V12, P1705, DOI 10.1101/gad.12.11.1705; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kim SK, 1997, DEVELOPMENT, V124, P4243; Offield MF, 1996, DEVELOPMENT, V122, P983; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Ross AJ, 1998, NAT GENET, V20, P358, DOI 10.1038/3828; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; WESSELLS NK, 1967, DEV BIOL, V15, P237, DOI 10.1016/0012-1606(67)90042-5	16	292	306	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1999	23	1					67	70						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	231XU	10471501				2022-12-17	WOS:000082337300018
J	Headon, DJ; Overbeek, PA				Headon, DJ; Overbeek, PA			Involvement of a novel Tnf receptor homologue in hair follicle induction	NATURE GENETICS			English	Article							FACTOR LIGAND SUPERFAMILY; ECTODERMAL DYSPLASIA; EDA GENE; MOUSE; TABBY; PROTEIN; DOMAIN; MICE; MUTATIONS; CLONING	Although inductive interactions are known to be essential for specification of cell fate in many vertebrate tissues, the signals and receptors responsible for transmitting this information remain largely unidentified. Mice with mutations in the downless (dl) gene have defects in hair follicle induction, lack sweat glands and have malformed teeth(1). These structures originate as ectodermal placodes, which invaginate into the underlying mesenchyme and differentiate to form specific organs(2-4). Positional cloning of the dl gene began with identification of the transgenic family OVE1. One branch of the family, dl(OVE1B), Carries an approximately 600-kb deletion at the dl locus caused by transgene integration. The mutated locus has been physically mapped in this family(5), and a 200-kb mouse YAC clone, YAC D9, has been identified and shown to rescue the dl phenotype in the spontaneous dl(Jackson) (dl(J), recessive) and Dl(sleek) (Dl(slk), dominant negative) mutants(6), Here we report the positional cloning of the dl gene, which encodes a novel member of the tumour necrosis factor (Tnf) receptor (Tnfr) family. The mutant phenotype and dl expression pattern suggests that this gene encodes a receptor that specifies hair follicle fate. Its ligand is likely to be the product of the tabby (Ta) gene, as Ta mutants have a phenotype identical to that of dl (ref. 1) mutants and Ta encodes a Tnf-like protein.	Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA	Baylor College of Medicine	Overbeek, PA (corresponding author), Baylor Coll Med, Dept Cell Biol, 1 Baylor Plaza, Houston, TX 77030 USA.			Overbeek, Paul/0000-0001-9784-2084	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL049953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045316] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL49953] Funding Source: Medline; NIAMS NIH HHS [AR45316] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Angerer L.M., 1992, IN SITU HYBRIDIZATIO, P15; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; BYRNE C, 1994, DEVELOPMENT, V120, P2369; FALCONER DS, 1953, Z INDUKT ABSTAMM VER, V85, P210, DOI 10.1007/BF00309836; FEINSTEIN E, 1995, TRENDS BIOCHEM SCI, V20, P342, DOI 10.1016/S0968-0004(00)89070-2; Ferguson BM, 1997, HUM MOL GENET, V6, P1589, DOI 10.1093/hmg/6.9.1589; GRUNEBERG H, 1971, J EMBRYOL EXP MORPH, V25, P1; GRUSS HJ, 1995, BLOOD, V85, P3378, DOI 10.1182/blood.V85.12.3378.bloodjournal85123378; Gruss HJ, 1996, INT J CLIN LAB RES, V26, P143, DOI 10.1007/BF02592977; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; HARDY MH, 1969, ADV BIOL SKIN, V9, P35; KAGHAD M, 1985, EMBO J, V4, P2911, DOI 10.1002/j.1460-2075.1985.tb04022.x; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LYON MF, 1996, GENETIC VARIANTS STR; Majumder K, 1998, MAMM GENOME, V9, P863, DOI 10.1007/s003359900884; MANN SJ, 1962, ANAT RECORD, V144, P135, DOI 10.1002/ar.1091440208; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; Montonen O, 1998, J HISTOCHEM CYTOCHEM, V46, P281, DOI 10.1177/002215549804600301; NAUNSMITH JH, 1998, TRENDS BIOL SCI, V23, P74; PENNYCUIK PR, 1984, GENET RES, V43, P51, DOI 10.1017/S0016672300025714; SEGRE JA, 1995, GENOMICS, V28, P549, DOI 10.1006/geno.1995.1187; Sengel P., 1976, MORPHOGENESIS SKIN; SHAWLOT W, 1989, MOL BIOL MED, V6, P299; SOAFER JA, 1974, GENET RES, V23, P219; Srivastava AK, 1997, P NATL ACAD SCI USA, V94, P13069, DOI 10.1073/pnas.94.24.13069; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Vielkind U, 1996, ACTA ANAT, V157, P183	29	292	308	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1999	22	4					370	374		10.1038/11943	http://dx.doi.org/10.1038/11943			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	222FH	10431242				2022-12-17	WOS:000081772500020
J	Firulli, AB; McFadden, DG; Lin, Q; Srivastava, D; Olson, EN				Firulli, AB; McFadden, DG; Lin, Q; Srivastava, D; Olson, EN			Heart and extra-embryonic mesodermal defects in mouse embryos lacking the bHLH transcription factor Hand1	NATURE GENETICS			English	Article							NEURAL CREST DERIVATIVES; GENE; EXPRESSION; PROTEINS	The basic helix-loop-helix (bHLH) transcription factors, Hand1 and Hand2 (refs 1,2), also called eHand/Hxt/Thing1 and dHand/Hed/Thing2 (refs 3,4), respectively, are expressed in the heart and certain neural-crest derivatives during embryogenesis. In addition, Hand1 is expressed in extraembryonic membranes, whereas Hand2 is expressed in the deciduum. Previous studies have demonstrated that Hand2 is required for formation of the right ventricle of the heart and the aortic arch arteries(5). We have generated a germline mutation in the mouse Hand1 gene by replacing the first coding exon with a beta-galactosidase reporter gene. Embryos homozygous for the Hand1 null allele died between embryonic days 8.5 and 9.5 and exhibited yolk sac abnormalities due to a deficiency in extraembryonic mesoderm, Heart development was also perturbed and did not progress beyond the cardiac-looping stage. Our results demonstrate important roles for Hand1 in extraembryonic mesodermal and heart development.	Univ Texas, SW Med Ctr, Dept Mol Biol & Oncol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol & Oncol, 6000 Harry Hines Blvd, Dallas, TX 75235 USA.			/0000-0001-6687-8949	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061677] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL061677-01A1, R01 HL061677] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTABA ARI, 1993, MECH DEVELOP, V44, P91, DOI 10.1016/0925-4773(93)90060-B; BARTH J, 1994, BIOTECHNIQUES, V17, P326; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; CHENG TC, 1993, SCIENCE, V261, P215, DOI 10.1126/science.8392225; CROSS JC, 1995, DEVELOPMENT, V121, P2513; CSERJESI P, 1995, DEV BIOL, V170, P664, DOI 10.1006/dbio.1995.1245; GREPIN C, 1994, MOL CELL BIOL, V14, P3115, DOI 10.1128/MCB.14.5.3115; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; LEDOUARIN NM, 1993, DEV BIOL, V159, P24, DOI 10.1006/dbio.1993.1219; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; NG YK, 1994, DEVELOPMENT, V120, P3257; OBRIEN TX, 1993, P NATL ACAD SCI USA, V90, P5157, DOI 10.1073/pnas.90.11.5157; Olson EN, 1996, SCIENCE, V272, P671, DOI 10.1126/science.272.5262.671; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154	16	292	301	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1998	18	3					266	270		10.1038/ng0398-266	http://dx.doi.org/10.1038/ng0398-266			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500550				2022-12-17	WOS:000072325000026
J	Seidner, G; Alvarez, MG; Yeh, JI; O'Driscoll, KR; Klepper, J; Stump, TS; Wang, D; Spinner, NB; Birnbaum, MJ; De Vivo, DC				Seidner, G; Alvarez, MG; Yeh, JI; O'Driscoll, KR; Klepper, J; Stump, TS; Wang, D; Spinner, NB; Birnbaum, MJ; De Vivo, DC			GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier	NATURE GENETICS			English	Article							GLUCOSE-TRANSPORTER GENE; EXPRESSION; ANTIBODIES; SEQUENCE; PROTEIN	The high metabolic requirements of the mammalian central nervous system require specialized structures for the facilitated transport of nutrients across the blood-brain barrier. Stereospecific high-capacity carriers, including those that recognize glucose, are key components of this barrier, which also protects the brain against noxious substances. Facilitated glucose transport in vertebrates is catalyzed by a family of carriers consisting of at least five functional isoforms with distinct tissue distributions, subcellular localizations and transport kinetics(1,2). Several of these transporters are expressed in the mammalian brain(3). GLUT-1, whose sequence was originally deduced from cDNAs cloned from human hepatoma and rat brain(4,5), is present at high levels in primate erythrocytes and brain endothelial cells. GLUT1 has been cloned and positionally mapped to the short arm of chromosome 1 (1p35-p31.3; refs 6-8). Despite substantial metabolic requirements of the central nervous system, no genetic disease caused by dysfunctional blood-brain barrier transport has been identified. Several years ago, we described two patients with infantile seizures, delayed development and acquired microcephaly who have normal circulating blood glucose, low-to-normal cerebrospinal fluid (CSF) lactate, but persistent hypoglycorrachia (low CSF glucose) and diminished transport of hexose into isolated red blood cells (RBC; ref. 9). These symptoms suggested the existence of a defect in glucose transport across the blood brain barrier. We now report two distinct classes of mutations as the molecular basis for the functional defect of glucose transport: hemizygosity of GLUT1 and nonsense mutations resulting in truncation of the GLUT-1 protein.	Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Cox Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Natl Taiwan Univ Hosp, Dept Family Med, Taipei, Taiwan; Columbia Presbyterian Med Ctr, Dept Neurol, New York, NY 10032 USA; Columbia Presbyterian Med Ctr, Dept Pediat, New York, NY 10032 USA; Columbia Presbyterian Med Ctr, Inst Neurol, Colleen Giblin Labs Pediat Neurol Res, New York, NY 10032 USA; Columbia Presbyterian Med Ctr, Babies & Childrens Hosp, New York, NY 10032 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; National Taiwan University; National Taiwan University Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital	Birnbaum, MJ (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, 415 Curie Blvd, Philadelphia, PA 19104 USA.			Birnbaum, Morris/0000-0001-9972-8680	NIDDK NIH HHS [DK 39615] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039615] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLARD WJ, 1985, J BIOL CHEM, V260, P8668; BIRNBAUM MJ, 1986, P NATL ACAD SCI USA, V83, P5784, DOI 10.1073/pnas.83.16.5784; DAVIES A, 1987, J BIOL CHEM, V262, P9347; De Vivo D. C., 1995, INT PEDIAT, V10, P51; DEHERREROS AG, 1989, J BIOL CHEM, V264, P19994; DEVIVO DC, 1991, NEW ENGL J MED, V325, P703, DOI 10.1056/NEJM199109053251006; FUKUMOTO H, 1988, DIABETES, V37, P657, DOI 10.2337/diabetes.37.5.657; HIRAKI Y, 1988, J BIOL CHEM, V263, P13655; JAMES DE, 1995, NEWS PHYSIOL SCI, V10, P67, DOI 10.1152/physiologyonline.1995.10.2.67; MAHER F, 1994, FASEB J, V8, P1003, DOI 10.1096/fasebj.8.13.7926364; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; OKA Y, 1990, NATURE, V345, P550, DOI 10.1038/345550a0; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; Santer R, 1997, NAT GENET, V17, P324, DOI 10.1038/ng1197-324; SHOWS TB, 1987, DIABETES, V36, P546, DOI 10.2337/diabetes.36.4.546; WILLIAMS SA, 1988, J BIOL CHEM, V263, P19513	17	292	300	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					188	191		10.1038/ng0298-188	http://dx.doi.org/10.1038/ng0298-188			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462754				2022-12-17	WOS:000071779500033
J	Pereira, L; Andrikopoulos, K; Tian, J; Lee, SY; Keene, DR; Ono, R; Reinhardt, DP; Sakai, LY; Biery, NJ; Bunton, T; Dietz, HC; Ramirez, F				Pereira, L; Andrikopoulos, K; Tian, J; Lee, SY; Keene, DR; Ono, R; Reinhardt, DP; Sakai, LY; Biery, NJ; Bunton, T; Dietz, HC; Ramirez, F			Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome	NATURE GENETICS			English	Article							DEVELOPING MOUSE AORTA; MICROFIBRILS; MUTATIONS; ORGANIZATION; COMPONENT; EXPRESSION; DELETION; REVEALS; MATRIX	Aortic aneurysm and dissection account for about 2% of all deaths in industrialized countries; they are also components of several genetic diseases, including Marfan syndrome (MFS)(1). The vascular phenotype of MFS results from mutations in fibrillin-1 (FBN1), the major constituent of extracellular microfibrils(2,3). Microfibrils, either associated with or devoid of elastin, give rise to a variety of extracellular networks in elastic and non-elastic tissues(3). It is believed that microfibrils regulate elastic fibre formation by guiding tropo-elastin deposition during embryogenesis and early post-natal life(4). Hence, vascular disease in MFS is thought to result when FBN1 mutations preclude elastic fibre maturation by disrupting microfibrillar assembly, Here we report a gene-targetting experiment in mice that indicates that fibrillin-1 microfibrils are predominantly engaged in tissue homeostasis rather than elastic matrix assembly. This finding, in turn, suggests that aortic dilation is due primarily to the failure by the microfibrillar array of the adventitia to sustain physiological haemodynamic stress, and that disruption of the elastic network of the media is a secondary event.	CUNY MT SINAI SCH MED,BROOKDALE CTR DEV & MOL BIOL,NEW YORK,NY 10029; UNIV SAO PAULO,INST BIOCIENCIAS,DEPT BIOL,BR-05508 SAO PAULO,BRAZIL; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,CUTANEOUS BIOL RES CTR,BOSTON,MA 02129; SHRINERS HOSP CHILDREN,PORTLAND,OR 97201; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MOL BIOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT GENET,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT COMPARAT MED & PATHOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Universidade de Sao Paulo; Harvard University; Harvard Medical School; Massachusetts General Hospital; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University			Pereira, Lygia V/C-1049-2012; Reinhardt, Dieter P/A-3102-2008	Pereira, Lygia V/0000-0002-0002-725X; Reinhardt, Dieter P/0000-0001-6535-9872	NIAMS NIH HHS [AR41135, AR42044] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042044] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ANDRIKOPOULOS K, 1995, NAT GENET, V9, P31, DOI 10.1038/ng0195-31; DAVIS EC, 1994, J CELL SCI, V107, P727; DAVIS EC, 1993, LAB INVEST, V68, P89; DIETZ HC, 1994, ADV HUM GENET, V22, P153; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; EWART AK, 1994, J CLIN INVEST, V93, P1071, DOI 10.1172/JCI117057; FIERING S, 1995, GENE DEV, V9, P2203, DOI 10.1101/gad.9.18.2203; GAUSE WC, 1989, PCR PRIMER LAB MANUA, P293; HOGAN B, 1994, MANIPULATING MOUSE E; HOLLISTER DW, 1990, NEW ENGL J MED, V323, P935; HURLE JM, 1994, J CELL SCI, V107, P2623; KAINULAINEN K, 1994, NAT GENET, V6, P64, DOI 10.1038/ng0194-64; KEENE DR, IN PRESS J HISTOCHEM; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Mecham R. P., 1994, EXTRACELLULAR MATRIX, P281; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; PUTNAM EA, 1995, NAT GENET, V11, P456, DOI 10.1038/ng1295-456; Ramirez F, 1996, CURR OPIN GENET DEV, V6, P309, DOI 10.1016/S0959-437X(96)80007-4; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; SAKAI LY, 1994, METHOD ENZYMOL, V245, P29; SAKAI LY, 1991, J BIOL CHEM, V266, P14763; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sambrook E., 1989, MOL CLONING LAB MANU; Tilson MD, 1990, CAUSE MANAGEMENT ANE, P97; ZHANG H, 1995, J CELL BIOL, V129, P1165, DOI 10.1083/jcb.129.4.1165; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855	27	292	304	0	22	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					218	222		10.1038/ng1097-218	http://dx.doi.org/10.1038/ng1097-218			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326947				2022-12-17	WOS:A1997XZ55500033
J	Marquet, S; Abel, L; Hillaire, D; Dessein, H; Kalil, J; Feingold, J; Weissenbach, J; Dessein, AJ				Marquet, S; Abel, L; Hillaire, D; Dessein, H; Kalil, J; Feingold, J; Weissenbach, J; Dessein, AJ			Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33	NATURE GENETICS			English	Letter							MULTILOCUS LINKAGE ANALYSIS; HUMAN RESISTANCE; MAJOR GENE; IMMUNE-RESPONSES; IGE LEVELS; REINFECTION; ASSOCIATION; SUSCEPTIBILITY; INTERLEUKIN-4; HAEMATOBIUM		FAC MED MARSEILLE,LAB PARASITOL MYCOL,INSERM,U399,F-13385 MARSEILLE 5,FRANCE; HOSP PITIE SALPETRIERE,INSERM,U436,PARIS,FRANCE; UNIV SAO PAULO,INST HEART,IMMUNOL LAB,BR-05508 SAO PAULO,BRAZIL; INSERM,U155,PARIS,FRANCE; GENETHON,EVRY,FRANCE; CNRS,URA 1922,EVRY,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universidade de Sao Paulo; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS)			KALIL, JORGE/C-8029-2012; MARQUET, Sandrine/I-6566-2016; MARQUET, Sandrine/B-2843-2008; Abel, Laurent/H-8888-2017	KALIL, JORGE/0000-0001-8415-4274; MARQUET, Sandrine/0000-0001-7011-6496; Abel, Laurent/0000-0001-7016-6493				ABEL L, 1991, AM J HUM GENET, V48, P959; BONNEY GE, 1984, AM J MED GENET, V18, P731, DOI 10.1002/ajmg.1320180420; BUTTERWORTH AE, 1985, T ROY SOC TROP MED H, V79, P393, DOI 10.1016/0035-9203(85)90391-8; CHANDRASEKHARAPPA SC, 1990, GENOMICS, V6, P94, DOI 10.1016/0888-7543(90)90452-Z; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; COULSSINIERPARI.P, 1995, EUR J IMMUNOL, V25, P2295; DEMENAIS F, 1994, GENET EPIDEMIOL, V11, P291; DEMEURE CE, 1993, J INFECT DIS, V168, P1000, DOI 10.1093/infdis/168.4.1000; DESSEIN AJ, 1992, IMMUNOL INVEST, V21, P423, DOI 10.3109/08820139209069383; DESSEIN AJ, 1988, J IMMUNOL, V140, P2727; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DUNNE DW, 1992, EUR J IMMUNOL, V22, P1483, DOI 10.1002/eji.1830220622; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAGAN P, 1991, NATURE, V349, P243, DOI 10.1038/349243a0; HAGAN P, 1987, T ROY SOC TROP MED H, V81, P938, DOI 10.1016/0035-9203(87)90359-2; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; MEYERS DA, 1994, GENOMICS, V23, P464, DOI 10.1006/geno.1994.1524; MOUT R, 1991, NUCLEIC ACIDS RES, V19, P3763, DOI 10.1093/nar/19.13.3763; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; POSTMA DS, 1995, NEW ENGL J MED, V333, P894, DOI 10.1056/NEJM199510053331402; RIHET P, 1991, EUR J IMMUNOL, V21, P2679, DOI 10.1002/eji.1830211106; ROBERTS M, 1993, INFECT IMMUN, V61, P4984, DOI 10.1128/IAI.61.12.4984-4993.1993; SALTMAN DL, 1993, GENOMICS, V16, P726, DOI 10.1006/geno.1993.1254; STANLEY ER, 1994, CYTOKINE HDB, P387; *UNDP WORLD BANK W, 1990, TROP DIS PROGR RES, P41; VANLIESHOUT L, 1995, J INFECT DIS, V172, P1336, DOI 10.1093/infdis/172.5.1336; VIGNAL A, 1993, METHODS MOL GENETICS, V1, P211; WILKINS HA, 1987, T ROY SOC TROP MED H, V81, P29, DOI 10.1016/0035-9203(87)90273-2	30	292	300	0	28	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1996	14	2					181	184		10.1038/ng1096-181	http://dx.doi.org/10.1038/ng1096-181			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL446	8841190				2022-12-17	WOS:A1996VL44600024
J	Oddoux, C; Struewing, JP; Clayton, CM; Neuhausen, S; Brody, LC; Kaback, M; Haas, B; Norton, L; Borgen, P; Jhanwar, S; Goldgar, D; Ostrer, H; Offit, K				Oddoux, C; Struewing, JP; Clayton, CM; Neuhausen, S; Brody, LC; Kaback, M; Haas, B; Norton, L; Borgen, P; Jhanwar, S; Goldgar, D; Ostrer, H; Offit, K			The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%	NATURE GENETICS			English	Letter							CANCER SUSCEPTIBILITY GENE; OVARIAN-CANCER; BREAST-CANCER; FAMILIES		NYU,MED CTR,DEPT PEDIAT,HUMAN GENET PROGRAM,NEW YORK,NY 10016; NCI,GENET EPIDEMIOL BRANCH,NIH,BETHESDA,MD 20892; UNIV UTAH,SCH MED,DEPT MED INFORMAT,GENET EPIDEMIOL GRP,SALT LAKE CITY,UT 84108; NIH,LAB GENE TRANSFER,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892; UNIV CALIF SAN DIEGO,DEPT PEDIAT & REPROD MED,SAN DIEGO,CA 92123; MEM SLOAN KETTERING CANC CTR,DEPT HUMAN GENET,NEW YORK,NY 10021; MEM SLOAN KETTERING CANC CTR,DEPT MED,BREAST CANC MED SERV,NEW YORK,NY 10021; MEM SLOAN KETTERING CANC CTR,DEPT SURG,BREAST SERV,NEW YORK,NY 10021; INT AGCY RES CANC,UNIT GENET EPIDEMIOL,LYON 08,FRANCE	New York University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California San Diego; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; World Health Organization; International Agency for Research on Cancer (IARC)			Struewing, Jeffery P/I-7502-2013; Struewing, Jeffery P/C-3221-2008	Struewing, Jeffery P/0000-0002-4848-3334; 	NCI NIH HHS [R01 CA 65673, P20 CA 58232, R01 CA 55914] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA065673, R01CA055914, P20CA058232] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berman DB, 1996, AM J HUM GENET, V58, P1166; EASTON DF, 1993, AM J HUM GENET, V52, P678; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; KRONN D, 1995, AM J HUM GENET, V57, P1250; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; ODDOUX C, 1995, PRENATAL DIAG, V15, P817, DOI 10.1002/pd.1970150905; Offit K, 1996, LANCET, V347, P1643, DOI 10.1016/S0140-6736(96)91484-1; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; TONIN P, 1995, AM J HUM GENET, V57, P189; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	16	292	296	1	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1996	14	2					188	190		10.1038/ng1096-188	http://dx.doi.org/10.1038/ng1096-188			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL446	8841192				2022-12-17	WOS:A1996VL44600026
J	SAUGIERVEBER, P; MUNNICH, A; BONNEAU, D; ROZET, JM; LEMERRER, M; GIL, R; BOESPFLUGTANGUY, O				SAUGIERVEBER, P; MUNNICH, A; BONNEAU, D; ROZET, JM; LEMERRER, M; GIL, R; BOESPFLUGTANGUY, O			X-LINKED SPASTIC PARAPLEGIA AND PELIZAEUS-MERZBACHER DISEASE ARE ALLELIC DISORDERS AT THE PROTEOLIPID PROTEIN LOCUS	NATURE GENETICS			English	Article							ANDROGEN RECEPTOR GENE; POINT MUTATION; LINKAGE MAP; CHROMOSOME; HETEROGENEITY; PLP; DELETION; FAMILY; REPEAT; MOUSE	Three forms of X-linked spastic paraplegia (SPG) have been defined. One locus (SPG 1) maps to Xq28 while two clinically distinct forms map to Xq22 (SPG2). A rare X-linked dysmyelinating disorder of the central nervous system, Pelizaeus-Merzbacher disease (PMD), has also been mapped to Xq21-q22, and is caused by mutations in the proteolipid protein gene (PLP) which encodes two myelin proteins, PLP and DM20. While narrowing the genetic interval containing SPG2 in a large pedigree, we found that PLP was the closest marker to the disease locus, implicating PLP as a possible candidate gene. We have found that a point mutation (His139Tyr) in exon 3B of an affected male produces a mutant PLP but a normal DM20,and segregates with the disease (Z(max)=6.63, theta=0.00). It appears, therefore, that SPG2 and PMD are allelic disorders.	INSERM,U393,UNITE RECH HANDICAPS GENET ENFANT,SERV GENET,F-75743 PARIS 15,FRANCE; HOP ENFANTS MALAD,INSERM,U383,UNITE RECH GENET CHROMOSOME & CANC,F-75743 PARIS 15,FRANCE; CHU POITIERS,F-86021 POITIERS,FRANCE; FAC MED CLERMONT FERRAND,INSERM,CJF 8806,BIOCHIM MED LAB,F-63001 CLERMONT FERRAND,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Poitiers; Universite de Poitiers; CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm)			ROZET, Jean-Michel/E-5737-2016; Bonneau, Dominique/K-6110-2015	ROZET, Jean-Michel/0000-0001-7951-7886; 				APAK S, 1989, AM J MED GENET, V34, P155, DOI 10.1002/ajmg.1320340203; BARKER DF, 1992, NUCLEIC ACIDS RES, V20, P929, DOI 10.1093/nar/20.4.929-a; BLUMEL J, 1957, J PEDIATR-US, V50, P454, DOI 10.1016/S0022-3476(57)80255-8; BOESPFLUGTANGUY O, 1991, ANN NEUROL, V30, P450; BOISON D, 1989, EMBO J, V8, P3295, DOI 10.1002/j.1460-2075.1989.tb08490.x; BONNEAU D, 1993, J MED GENET, V30, P381, DOI 10.1136/jmg.30.5.381; BOULLOCHE J, 1986, J CHILD NEUROL, V1, P233, DOI 10.1177/088307388600100310; BRIDGE PJ, 1991, AM J HUM GENET, V49, P183; BROWN TR, 1988, P NATL ACAD SCI USA, V85, P8151, DOI 10.1073/pnas.85.21.8151; DAUTIGNY A, 1986, NATURE, V321, P867, DOI 10.1038/321867a0; DAVIES KE, 1991, CYTOGENET CELL GENET, V58, P853, DOI 10.1159/000133183; DIEHL HJ, 1986, P NATL ACAD SCI USA, V83, P9807, DOI 10.1073/pnas.83.24.9807; DOLL R, 1992, AM J HUM GENET, V51, P161; FAIN PR, 1991, GENOMICS, V11, P1155, DOI 10.1016/0888-7543(91)90045-G; GENCIC S, 1990, J NEUROSCI, V10, P117; GENCIC S, 1989, AM J HUM GENET, V45, P435; GINTER DN, 1974, BIRTH DEFECTS ORIG A, V10, P334; GOLDBLATT J, 1989, CLIN GENET, V35, P116; HALLASSOS A, 1989, NUCLEIC ACIDS RES, V17, P3606; HARDING AE, 1983, LANCET, V1, P1151; HAZAN J, 1992, GENOMICS, V12, P183, DOI 10.1016/0888-7543(92)90364-X; HUANG THM, 1992, GENOMICS, V13, P375, DOI 10.1016/0888-7543(92)90256-R; HUDSON LD, 1989, P NATL ACAD SCI USA, V86, P8128, DOI 10.1073/pnas.86.20.8128; IWAKI A, 1993, HUM MOL GENET, V2, P19, DOI 10.1093/hmg/2.1.19; JOHNSTON AW, 1962, AM J HUM GENET, V14, P83; KENWRICK S, 1986, HUM GENET, V73, P264, DOI 10.1007/BF00401241; KEPPEN LD, 1987, AM J HUM GENET, V41, P933; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LUTY JA, 1990, AM J HUM GENET, V46, P776; MCCLATCHEY AI, 1992, AM J HUM GENET, V50, P896; McKusick V.A., 1992, MENDELIAN INHERITANC; Merzbacher L., 1910, Z F R GESAMTE NEUROL, V3, P1, DOI [10.1007/BF02893591, DOI 10.1007/BF02893591]; METTEY R, 1981, J GENET HUM, V29, P3227; NADON NL, 1990, DEVELOPMENT, V110, P529; NAVE KA, 1987, J NEUROCHEM, V49, P1873, DOI 10.1111/j.1471-4159.1987.tb02449.x; PHAMDINH D, 1993, HUM MOL GENET, V2, P465, DOI 10.1093/hmg/2.4.465; PHAMDINH D, 1991, P NATL ACAD SCI USA, V88, P7562, DOI 10.1073/pnas.88.17.7562; PRATT VM, 1991, AM J MED GENET, V38, P136, DOI 10.1002/ajmg.1320380129; PRATT VM, 1993, AM J HUM GENET, V52, P1053; RASKIND WH, 1991, AM J HUM GENET, V49, P1355; ROA BB, 1993, NAT GENET, V5, P269, DOI 10.1038/ng1193-269; ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881; SCHINDLER P, 1990, J NEUROCHEM, V55, P2079, DOI 10.1111/j.1471-4159.1990.tb05798.x; SCHNEIDER A, 1992, NATURE, V358, P758, DOI 10.1038/358758a0; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; STRAUTNIEKS S, 1992, AM J HUM GENET, V51, P871; SUTER U, 1993, TRENDS NEUROSCI, V16, P50, DOI 10.1016/0166-2236(93)90015-E; Thurmon T F, 1971, Birth Defects Orig Artic Ser, V7, P219; TIMSIT SG, 1992, J NEUROCHEM, V58, P1172, DOI 10.1111/j.1471-4159.1992.tb09378.x; TROFATTER JA, 1991, NUCLEIC ACIDS RES, V19, P6057, DOI 10.1093/nar/19.21.6057-a; TROFATTER JA, 1989, P NATL ACAD SCI USA, V86, P9427, DOI 10.1073/pnas.86.23.9427; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; WILLARD HF, 1985, SCIENCE, V230, P940, DOI 10.1126/science.3840606; ZATZ M, 1976, J MED GENET, V13, P217, DOI 10.1136/jmg.13.3.217; ZHANG YL, 1993, NAT GENET, V5, P46, DOI 10.1038/ng0993-46	57	292	294	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					257	262		10.1038/ng0394-257	http://dx.doi.org/10.1038/ng0394-257			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012387				2022-12-17	WOS:A1994MZ56200012
J	Yang, JH; Liu, DY; Wang, XW; Ji, CM; Cheng, F; Liu, BN; Hu, ZY; Chen, S; Pental, D; Ju, YH; Yao, P; Li, XM; Xie, K; Zhang, JH; Wang, JL; Liu, F; Ma, WW; Shopan, J; Zheng, HK; Mackenzie, SA; Zhang, MF				Yang, Jinghua; Liu, Dongyuan; Wang, Xiaowu; Ji, Changmian; Cheng, Feng; Liu, Baoning; Hu, Zhongyuan; Chen, Sheng; Pental, Deepak; Ju, Youhui; Yao, Pu; Li, Xuming; Xie, Kun; Zhang, Jianhui; Wang, Jianlin; Liu, Fan; Ma, Weiwei; Shopan, Jannat; Zheng, Hongkun; Mackenzie, Sally A.; Zhang, Mingfang			The genome sequence of allopolyploid Brassica juncea and analysis of differential homoeolog gene expression influencing selection	NATURE GENETICS			English	Article							EVOLUTION; REVEALS; POLYPLOIDY; DIVERSITY; OLERACEA; DATABASE; ORIGIN	The Brassica genus encompasses three diploid and three allopolyploid genomes, but a clear understanding of the evolution of agriculturally important traits via polyploidy is lacking. We assembled an allopolyploid Brassica juncea genome by shotgun and single-molecule reads integrated to genomic and genetic maps. We discovered that the A subgenomes of B. juncea and Brassica napus each had independent origins. Results suggested that A subgenomes of B. juncea were of monophyletic origin and evolved into vegetable-use and oil-use subvarieties. Homoeolog expression dominance occurs between subgenomes of allopolyploid B. juncea, in which differentially expressed genes display more selection potential than neutral genes. Homoeolog expression dominance in B. juncea has facilitated selection of glucosinolate and lipid metabolism genes in subvarieties used as vegetables and for oil production. These homoeolog expression dominance relationships among Brassicaceae genomes have contributed to selection response, predicting the directional effects of selection in a polyploid crop genome.	[Yang, Jinghua; Hu, Zhongyuan; Ma, Weiwei; Shopan, Jannat; Zhang, Mingfang] Zhejiang Univ, Inst Vegetable Sci, Lab Germplasm Innovat & Mol Breeding, Hangzhou, Zhejiang, Peoples R China; [Yang, Jinghua; Hu, Zhongyuan; Zhang, Mingfang] Minist Agr, Key Lab Hort Plant Growth Dev & Qual Improvement, Hangzhou, Peoples R China; [Yang, Jinghua; Hu, Zhongyuan; Zhang, Mingfang] Zhejiang Prov Key Lab Hort Plant Integrat Biol, Hangzhou, Zhejiang, Peoples R China; [Liu, Dongyuan; Ji, Changmian; Liu, Baoning; Ju, Youhui; Yao, Pu; Li, Xuming; Xie, Kun; Zhang, Jianhui; Zheng, Hongkun] Biomarker Technol Corp, Beijing, Peoples R China; [Wang, Xiaowu; Cheng, Feng] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing, Peoples R China; [Chen, Sheng] Univ Western Australia, Sch Plant Biol M084, Perth, WA, Australia; [Chen, Sheng] Univ Western Australia, UWA Inst Agr, Perth, WA, Australia; [Pental, Deepak] Univ Delhi South Campus, Ctr Genet Manipulat Crop Plants, New Delhi, India; [Wang, Jianlin] Tibet Univ, Agr & Anim Husb Coll, Coll Plant Sci & Technol, Linzhi, Peoples R China; [Liu, Fan] Beijing Acad Agr & Forestry Sci, Beijing Vegetable Res Ctr, Beijing, Peoples R China; [Yang, Jinghua; Liu, Dongyuan; Wang, Xiaowu; Ji, Changmian; Cheng, Feng; Mackenzie, Sally A.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA	Zhejiang University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; University of Western Australia; University of Western Australia; University of Delhi; Tibet University; Beijing Academy of Agriculture & Forestry; University of Nebraska System; University of Nebraska Lincoln	Zhang, MF (corresponding author), Zhejiang Univ, Inst Vegetable Sci, Lab Germplasm Innovat & Mol Breeding, Hangzhou, Zhejiang, Peoples R China.; Zhang, MF (corresponding author), Minist Agr, Key Lab Hort Plant Growth Dev & Qual Improvement, Hangzhou, Peoples R China.; Zhang, MF (corresponding author), Zhejiang Prov Key Lab Hort Plant Integrat Biol, Hangzhou, Zhejiang, Peoples R China.; Mackenzie, SA (corresponding author), Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA.	sally.mackenzie@unl.edu; mfzhang@zju.edu.cn	Chen, Sheng/B-1340-2011; Wang, Xiaowu/L-2579-2019; Zhang, Jianhui/ABD-5476-2020; Yang, Jinghua/G-9164-2016; Zhang, Jianhui/K-8793-2019; wang, jian/GVS-0711-2022	Chen, Sheng/0000-0002-5238-3432; Zhang, Jianhui/0000-0002-6362-4027; Zhang, Jianhui/0000-0002-6362-4027; Li, Xuming/0000-0002-5049-9706; Ji, Changmian/0000-0001-8781-4063	Science and Technology Program of Zhejiang Province [2015C32046]; Ear-marked Special Fund from Ministry of Agriculture [09162130135252]; National Natural Science Foundation of China [31372063]	Science and Technology Program of Zhejiang Province; Ear-marked Special Fund from Ministry of Agriculture; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank X.H. Qi for the construction of F<INF>2</INF> population for genetic mapping, and L.J. Fan for the flow cytometry analysis. This work was supported by grants from Science and Technology Program of Zhejiang Province (2015C32046), Ear-marked Special Fund from Ministry of Agriculture (09162130135252) and the National Natural Science Foundation of China (31372063).	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Bottley A, 2006, PLANT J, V47, P897, DOI 10.1111/j.1365-313X.2006.02841.x; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chang PL, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r125; Chen S, 2013, J HERED, V104, P416, DOI 10.1093/jhered/est015; Cheng F, 2013, PLANT CELL, V25, P1541, DOI 10.1105/tpc.113.110486; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Flagel L, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-16; Grover CE, 2012, NEW PHYTOL, V196, P966, DOI 10.1111/j.1469-8137.2012.04365.x; Institute of Archaeology of Chinese Academy of Science, 1963, SPEC ISS ARCH; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Li-Beisson Yonghua, 2013, Arabidopsis Book, V11, pe0161, DOI [10.1199/tab.0161, 10.1199/tab.0133]; Liu SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4930; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Michael TP, 2015, CURR OPIN PLANT BIOL, V24, P71, DOI 10.1016/j.pbi.2015.02.002; Mun JH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r111; Nagaharu U., 1935, JPN J BOT, V7, P389, DOI DOI 10.1038/35036519; Ostergaard L, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-10; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Prakash S., 1980, OPERA BOT, V55, P1, DOI DOI 10.1016/B978-1-891127-79-3.50001-9; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Verkerk R, 2009, MOL NUTR FOOD RES, V53, pS219, DOI 10.1002/mnfr.200800065; Wang JL, 2004, GENETICS, V167, P1961, DOI 10.1534/genetics.104.027896; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Warwick SI, 2006, PLANT SYST EVOL, V259, P237, DOI 10.1007/s00606-006-0421-1; Warwick SI, 2011, PLANT GENET GENOMICS, V9, P33, DOI 10.1007/978-1-4419-7118-0_2; Ye YN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-769; Zhang DW, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00957; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zou J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2343-1	35	291	320	14	214	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1225	1232		10.1038/ng.3657	http://dx.doi.org/10.1038/ng.3657			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27595476	hybrid			2022-12-17	WOS:000384391600018
J	Witkowski, L; Carrot-Zhang, J; Albrecht, S; Fahiminiya, S; Hamel, N; Tomiak, E; Grynspan, D; Saloustros, E; Nadaf', J; Rivera, B; Gilpin, C; Castellsague, E; Silva-Smith, R; Plourde, F; Wu, M; Saskin, A; Arseneault, M; Karabakhtsian, RG; Reilly, EA; Ueland, FR; Margiolaki, A; Pavlakis, K; Castellino, SM; Lamovec, J; Mackay, HJ; Roth, LM; Ulbright, TM; Bender, TA; Georgoulias, V; Longy, M; Berchuck, A; Tischkowitz, M; Nage, I; Siebert, R; Stewart, CJR; Arseneau, J; McCluggage, WG; Clarke, BA; Riazalhosseini', Y; Hasselblatt, M; Majewski, J; Foulkes, WD				Witkowski, Leora; Carrot-Zhang, Jian; Albrecht, Steffen; Fahiminiya, Somayyeh; Hamel, Nancy; Tomiak, Eva; Grynspan, David; Saloustros, Emmanouil; Nadaf', Javad; Rivera, Barbara; Gilpin, Catherine; Castellsague, Ester; Silva-Smith, Rachel; Plourde, Francois; Wu, Mona; Saskin, Avi; Arseneault, Madeleine; Karabakhtsian, Rouzan G.; Reilly, Elizabeth A.; Ueland, Frederick R.; Margiolaki, Anna; Pavlakis, Kitty; Castellino, Sharon M.; Lamovec, Janez; Mackay, Helen J.; Roth, Lawrence M.; Ulbright, Thomas M.; Bender, Tracey A.; Georgoulias, Vassilis; Longy, Michel; Berchuck, Andrew; Tischkowitz, Marc; Nage, Inga; Siebert, Reiner; Stewart, Colin J. R.; Arseneau, Jocelyne; McCluggage, W. Glenn; Clarke, Blaise A.; Riazalhosseini, Yasser; Hasselblatt, Martin; Majewski, Jacek; Foulkes, William D.			Germ line and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type	NATURE GENETICS			English	Article							BRG1; EXPRESSION; CANCERS; COMPLEXES; NEOPLASMS; GENOME; TUMORS; EXOME; GENE	Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is the most common undifferentiated ovarian malignancy in women under 40 years of age(1). We sequenced the exomes of six individuals from three families with SCCOHT. After discovering segregating deleterious germline mutations in SMARCA4 in all three families, we tested DNA from a fourth affected family, which also carried a segregating SMARCA4 germline mutation. All the familial tumors sequenced harbored either a somatic mutation or loss of the wild-type allele. Immunohistochemical analysis of these cases and additional familial and non-familial cases showed loss of SMARCA4 (BRG1) protein in 38 of 40 tumors overall. Sequencing of cases with available DNA identified at least one germline or somatic deleterious SMARCA4 mutation in 30 01 32 cases. Additionally, the SCCOHT cell line BIN-67 had biallelic deleterious mutations in SMARCA4. Our findings identify alterations in SMARCA4 as the major cause of SCCOHT, which could lead to improvements in genetic counseling and new treatment approaches.	[Witkowski, Leora; Hamel, Nancy; Gilpin, Catherine; Castellsague, Ester; Silva-Smith, Rachel; Plourde, Francois; Wu, Mona; Foulkes, William D.] McGill Univ, Dept Oncol & Human Genet, Program Canc Genet, Montreal, PQ, Canada; [Witkowski, Leora; Silva-Smith, Rachel; Plourde, Francois; Foulkes, William D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Dept Med Genet, Montreal, PQ, Canada; [Witkowski, Leora; Silva-Smith, Rachel; Plourde, Francois; Foulkes, William D.] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ, Canada; [Witkowski, Leora; Carrot-Zhang, Jian; Fahiminiya, Somayyeh; Rivera, Barbara; Castellsague, Ester; Wu, Mona; Saskin, Avi; Arseneault, Madeleine; Majewski, Jacek; Foulkes, William D.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Carrot-Zhang, Jian; Fahiminiya, Somayyeh; Nadaf', Javad; Arseneault, Madeleine; Riazalhosseini, Yasser; Majewski, Jacek] McGill Univ, Montreal, PQ, Canada; [Carrot-Zhang, Jian; Fahiminiya, Somayyeh; Nadaf', Javad; Arseneault, Madeleine; Riazalhosseini, Yasser; Majewski, Jacek] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Albrecht, Steffen] McGill Univ, Montreal Childrens Hosp, McGill Univ Hlth Ctr, Dept Pathol, Montreal, PQ H3H 1P3, Canada; [Hamel, Nancy; Foulkes, William D.] McGill Univ, Ctr Hlth, Res Inst, Dept Med Genet, Montreal, PQ H3H 1P3, Canada; [Tomiak, Eva; Gilpin, Catherine] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Genet, Ottawa, ON, Canada; [Grynspan, David] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pathol & Lab Med, Ottawa, ON, Canada; [Saloustros, Emmanouil; Margiolaki, Anna; Georgoulias, Vassilis] Univ Hosp Heraklion, Dept Med Oncol, Hereditary Canc Clin, Iraklion, Greece; [Karabakhtsian, Rouzan G.; Reilly, Elizabeth A.; Ueland, Frederick R.] Univ Kentucky, Markey Canc Ctr, Dept Pathol & Lab Med, Lexington, KY USA; [Pavlakis, Kitty] Univ Athens, Dept Pathol, Athens 11528, Greece; [Castellino, Sharon M.] Wake Forest Sch Med, Dept Pediat Hematol Oncol, Winston Salem, NC USA; [Lamovec, Janez] Inst Oncol, Dept Pathol, Ljubljana, Slovenia; [Mackay, Helen J.] Princess Margaret Canc Ctr, Dept Med Oncol, Toronto, ON, Canada; [Roth, Lawrence M.; Ulbright, Thomas M.; Bender, Tracey A.] Indiana Univ, Sch Med, Dept Pathol, Indianapolis, IN 46202 USA; [Longy, Michel] Inst Bergonie, Unite Oncogenet, Bordeaux, France; [Berchuck, Andrew] Duke Univ, Med Ctr, Div Gynecol Oncol, Durham, NC USA; [Tischkowitz, Marc] Univ Cambridge, Dept Med Genet, Cambridge, England; [Nage, Inga; Siebert, Reiner] Univ Kiel, Inst Human Genet, Kiel, Germany; [Nage, Inga; Siebert, Reiner] Univ Hosp Schleswig Holstein, Kiel, Germany; [Stewart, Colin J. R.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Arseneau, Jocelyne] McGill Univ, Royal Victoria Hosp, McGill Univ Hlth Ctr, Dept Pathol, Montreal, PQ H3A 1A1, Canada; [McCluggage, W. Glenn] Royal Grp Hosp Trust, Dept Pathol, Belfast, Antrim, North Ireland; [Clarke, Blaise A.] Univ Hlth Network, Dept Pathol Lab Med Program, Toronto, ON, Canada; [Hasselblatt, Martin] Univ Hosp Munster, Inst Neuropathol, Munster, Germany	McGill University; Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario; University Hospital of Heraklion; University of Kentucky; National & Kapodistrian University of Athens; Wake Forest University; Institute of Oncology - Slovenia; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Indiana University System; Indiana University-Purdue University Indianapolis; UNICANCER; Institut Bergonie; Duke University; University of Cambridge; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Western Australia; McGill University; Royal Victoria Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Munster	Foulkes, WD (corresponding author), McGill Univ, Dept Oncol & Human Genet, Program Canc Genet, Montreal, PQ, Canada.	william.foulkes@mcgill.ca	Tischkowitz, Marc/O-4452-2018; Foulkes, William D./AAR-9586-2021; Castellsagué, Ester/R-1676-2016; Carrot-Zhang, Jian/K-8618-2019; Siebert, Reiner/A-8049-2010; Hamel, Nancy/L-5122-2016; Saloustros, Emmanouil/AAC-8235-2020; Rivera, Barbara/AFM-6892-2022; Rivera, Barbara/AAI-8047-2020	Tischkowitz, Marc/0000-0002-7880-0628; Foulkes, William D./0000-0001-7427-4651; Castellsagué, Ester/0000-0003-1298-9971; Hamel, Nancy/0000-0001-8971-0428; Saloustros, Emmanouil/0000-0002-0485-0120; Rivera, Barbara/0000-0001-9434-6288; Rivera, Barbara/0000-0001-9434-6288; Clarke, Blaise/0000-0002-2585-8391; Hasselblatt, Martin/0000-0003-2707-8484	Jewish General Hospital Foundation; Jodi Taiger Lazarus Fund; Fonds de Recherche du Quebec-Sante; KinderKrebsInitiative Buchholz/Holm-Seppensen; Interdisziplinaren Zentrum fur Klinische Forschung (IZKF) Munster [Ha3/016/11]	Jewish General Hospital Foundation; Jodi Taiger Lazarus Fund; Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); KinderKrebsInitiative Buchholz/Holm-Seppensen; Interdisziplinaren Zentrum fur Klinische Forschung (IZKF) Munster	This work is dedicated to the memory of Georgia Enter and Latosha Durham. We thank K. Hill and the Small Cell Ovarian Cancer Foundation for help in recruitment to this study, B. Vanderhyden (University of Ottawa) for providing the BIN-67 cells, S. Croce and CS. Choong for aiding in the collection of pathological samples, P.-O. Fiset for help with immunohistochemistry and N. Benlimame, R. Zuhlke-Jenisch, C. Kemming, M. LeiBe, S. Peetz-Dienhart, L. Raestrup, K. Schmidt and C. Theile for technical assistance. N. Jabado, I. Bah and members of the Foulkes laboratory provided helpful discussions. We also thank the McGill University and Genome Quebec Innovation Centre for their cooperation, H. Pierce for her help with contacting family 1 and D. Samelak for her help with family 3. Equipment for immunohistochemistry analysis was made available through Sonderforschungsbereich Transregio (SFB TR) 128 (grant to T. Kuhlmann (Z1)). We received funding from the Jewish General Hospital Foundation and the Jodi Taiger Lazarus Fund (W.D.F.), the Fonds de Recherche du Quebec-Sante (LW), KinderKrebsInitiative Buchholz/Holm-Seppensen (R.S.) and Interdisziplinaren Zentrum fur Klinische Forschung (IZKF) Munster (Ha3/016/11) (M.H.).	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Brennan B, 2013, LANCET ONCOL, V14, pE329, DOI 10.1016/S1470-2045(13)70088-3; Clement PB, 2005, MODERN PATHOL, V18, pS113, DOI 10.1038/modpathol.3800313; Distelmaier F, 2006, CANCER, V107, P2298, DOI 10.1002/cncr.22213; EICHHORN JH, 1992, AM J SURG PATHOL, V16, P926, DOI 10.1097/00000478-199210000-00002; Estel R, 2011, ARCH GYNECOL OBSTET, V284, P1277, DOI 10.1007/s00404-011-1846-5; Gunduz E, 2005, INT J ONCOL, V26, P201; Hasselblatt M, 2011, AM J SURG PATHOL, V35, P933, DOI 10.1097/PAS.0b013e3182196a39; Holley T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050586; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kosho T, 2013, AM J MED GENET A, V161A, P1221, DOI 10.1002/ajmg.a.35933; Kupryjanczyk J, 2013, POL J PATHOL, V64, P238, DOI 10.5114/PJP.2013.39331; LAMOVEC J, 1995, ARCH PATHOL LAB MED, V119, P523; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Longy M, 1996, J MED GENET, V33, P333, DOI 10.1136/jmg.33.4.333; Martinez-Borges AR, 2009, PEDIATR BLOOD CANCER, V53, P1334, DOI 10.1002/pbc.22184; Matsubara D, 2013, CANCER SCI, V104, P266, DOI 10.1111/cas.12065; McCluggage WG, 2004, ADV ANAT PATHOL, V11, P288, DOI 10.1097/01.pap.0000138146.357376.1e; McCluggage WG, 2004, INT J GYNECOL PATHOL, V23, P330, DOI 10.1097/01.pgp.0000139644.38835.9d; McDonald JM, 2012, J PEDIATR SURG, V47, P588, DOI 10.1016/j.jpedsurg.2011.12.004; Oike T, 2013, CANCER RES, V73, P5508, DOI 10.1158/0008-5472.CAN-12-4593; PECCATORI F, 1993, GYNECOL ONCOL, V49, P95, DOI 10.1006/gyno.1993.1093; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Schneppenheim R, 2010, AM J HUM GENET, V86, P279, DOI 10.1016/j.ajhg.2010.01.013; SCULLY RE, 1987, ENVIRON HEALTH PERSP, V73, P15, DOI 10.2307/3430594; Scully RE, 1979, ATLAS TUMOR PATHOLOG; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Smith MJ, 2013, NAT GENET, V45, P295, DOI 10.1038/ng.2552; Smith MJ, 2012, NEUROGENETICS, V13, P141, DOI 10.1007/s10048-012-0319-8; Sun A, 2007, PROSTATE, V67, P203, DOI 10.1002/pros.20521; ULBRIGHT TM, 1987, HUM PATHOL, V18, P175, DOI 10.1016/S0046-8177(87)80336-2; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Wilson BG, 2014, MOL CELL BIOL, V34, P1136, DOI 10.1128/MCB.01372-13; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Witkowski L, 2013, J PATHOL, V231, P35, DOI 10.1002/path.4225; Wong AKC, 2000, CANCER RES, V60, P6171; YOUNG RH, 1994, AM J SURG PATHOL, V18, P1102, DOI 10.1097/00000478-199411000-00004	38	291	304	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					438	443		10.1038/ng.2931	http://dx.doi.org/10.1038/ng.2931			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24658002				2022-12-17	WOS:000335422900008
J	Lesca, G; Rudolf, G; Bruneau, N; Lozovaya, N; Labalme, A; Boutry-Kryza, N; Salmi, M; Tsintsadze, T; Addis, L; Motte, J; Wright, S; Tsintsadze, V; Michel, A; Doummar, D; Lascelles, K; Strug, L; Waters, P; de Bellescize, J; Vrielynck, P; de Saint Martin, A; Ville, D; Ryvlin, P; Arzimanoglou, A; Hirsch, E; Vincent, A; Pal, D; Burnashev, N; Sanlaville, D; Szepetowski, P				Lesca, Gaetan; Rudolf, Gabrielle; Bruneau, Nadine; Lozovaya, Natalia; Labalme, Audrey; Boutry-Kryza, Nadia; Salmi, Manal; Tsintsadze, Timur; Addis, Laura; Motte, Jacques; Wright, Sukhvir; Tsintsadze, Vera; Michel, Anne; Doummar, Diane; Lascelles, Karine; Strug, Lisa; Waters, Patrick; de Bellescize, Julitta; Vrielynck, Pascal; de Saint Martin, Anne; Ville, Dorothee; Ryvlin, Philippe; Arzimanoglou, Alexis; Hirsch, Edouard; Vincent, Angela; Pal, Deb; Burnashev, Nail; Sanlaville, Damien; Szepetowski, Pierre			GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction	NATURE GENETICS			English	Article							LANDAU-KLEFFNER-SYNDROME; LIGAND-BINDING DOMAIN; SPIKE-AND-WAVES; NMDA RECEPTORS; SLEEP; DISORDERS; DYSKINESIA; CHILDREN; SPECTRUM; LKS	Epileptic encephalopathies are severe brain disorders with the epileptic component contributing to the worsening of cognitive and behavioral manifestations(1). Acquired epileptic aphasia (Landau-Kleffner syndrome, LKS)(2) and continuous spike and waves during slow-wave sleep syndrome (CSWSS)(3) represent rare and closely related childhood focal epileptic encephalopathies of unknown etiology(4,5). They show electroclinical overlap with rolandic epilepsy (the most frequent childhood focal epilepsy) and can be viewed as different clinical expressions of a single pathological entity situated at the crossroads of epileptic, speech, language, cognitive and behavioral disorders(6-10). Here we demonstrate that about 20% of cases of LKS, CSWSS and electroclinically atypical rolandic epilepsy(11-13) often associated with speech impairment can have a genetic origin sustained by de novo or inherited mutations in the GRIN2A gene (encoding the N-methyl-d-aspartate (NMDA) glutamate receptor alpha 2 subunit, GluN2A). The identification of GRIN2A as a major gene for these epileptic encephalopathies provides crucial insights into the underlying pathophysiology.	[Lesca, Gaetan; Labalme, Audrey; Sanlaville, Damien] Univ Hosp Lyon, Dept Genet, Lyon, France; [Lesca, Gaetan; Sanlaville, Damien] Univ Lyon 1, F-69365 Lyon, France; [Lesca, Gaetan; Boutry-Kryza, Nadia; Ryvlin, Philippe; Arzimanoglou, Alexis; Sanlaville, Damien] CNRS, INSERM, U1028, UMR 5292,Ctr Rech Neurosci Lyon, Lyon, France; [Lesca, Gaetan; Rudolf, Gabrielle; Bruneau, Nadine; Labalme, Audrey; Boutry-Kryza, Nadia; Salmi, Manal; Tsintsadze, Timur; Motte, Jacques; de Bellescize, Julitta; de Saint Martin, Anne; Ville, Dorothee; Ryvlin, Philippe; Arzimanoglou, Alexis; Hirsch, Edouard; Burnashev, Nail; Sanlaville, Damien; Szepetowski, Pierre] French Epilepsy Language & Dev EPILAND Network, Marseille, France; [Rudolf, Gabrielle; Hirsch, Edouard] Strasbourg Univ Hosp, Dept Neurol, Strasbourg, France; [Rudolf, Gabrielle; Hirsch, Edouard] Strasbourg Univ, Strasbourg, France; [Bruneau, Nadine; Lozovaya, Natalia; Salmi, Manal; Tsintsadze, Timur; Tsintsadze, Vera; Burnashev, Nail; Szepetowski, Pierre] Aix Marseille Univ, Marseille, France; [Bruneau, Nadine; Lozovaya, Natalia; Salmi, Manal; Tsintsadze, Timur; Tsintsadze, Vera; Burnashev, Nail; Szepetowski, Pierre] INSERM, UMRS 901, F-13258 Marseille, France; [Bruneau, Nadine; Lozovaya, Natalia; Salmi, Manal; Tsintsadze, Timur; Tsintsadze, Vera; Burnashev, Nail; Szepetowski, Pierre] Mediterranean Inst Neurobiol INMED, Marseille, France; [Lozovaya, Natalia] Paris Descartes Univ, INSERM, UMRS 663, Paris, France; [Boutry-Kryza, Nadia] Univ Hosp Lyon, Med Genet Lab, Lyon, France; [Addis, Laura; Pal, Deb] Kings Coll London, Inst Psychiat, Dept Clin Neurosci, London, England; [Motte, Jacques] Amer Mem Hosp, Dept Pediat A, Reims, France; [Wright, Sukhvir; Vincent, Angela] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Michel, Anne] Univ Hosp Pontchaillou, Dept Neurol, Rennes, France; [Doummar, Diane] Armand Trousseau Hosp, Dept Neuropediat, Paris, France; [Lascelles, Karine] Evelina Childrens Hosp, Dept Paediat Neurol, London, England; [Strug, Lisa] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Strug, Lisa] Univ Toronto, Toronto, ON, Canada; [de Bellescize, Julitta; Ryvlin, Philippe; Arzimanoglou, Alexis] Univ Hosp Lyon, Epilepsy Sleep & Pediat Neurophysiol Dept, Lyon, France; [Vrielynck, Pascal] Catholic Univ Louvain, William Lennox Neurol Ctr, Ottignies, Belgium; [de Saint Martin, Anne] Strasbourg Univ Hosp, Dept Pediat 1, Strasbourg, France; [Ville, Dorothee] Univ Hosp Lyon, Dept Neuropediat, Lyon, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; University of London; King's College London; CHU de Reims; Universite de Reims Champagne-Ardenne; University of Oxford; CHU Rennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; CHU Lyon; Universite Catholique Louvain; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Lyon	Szepetowski, P (corresponding author), French Epilepsy Language & Dev EPILAND Network, Marseille, France.	pierre.szepetowski@inserm.fr	Burnashev, Nail/G-4056-2013; Addis, Laura/R-1385-2016; Bruneau, Nadine/O-2100-2016; Sanlaville, Damien/M-4716-2014; Vincent, Angela/AAE-7310-2019; Waters, Patrick/AAF-2658-2019; Lesca, Gaetan/C-6111-2019; Ryvlin, Philippe/K-7402-2019; Ryvlin, Philippe/O-5214-2016; Waters, Patrick/Y-3753-2019	Addis, Laura/0000-0001-8455-4278; Bruneau, Nadine/0000-0002-1523-3128; Sanlaville, Damien/0000-0001-9939-2849; Waters, Patrick/0000-0003-4142-2667; Ryvlin, Philippe/0000-0001-7775-6576; Ryvlin, Philippe/0000-0001-7775-6576; Waters, Patrick/0000-0003-4142-2667; Edouard, Hirsch/0000-0003-0833-8850; Salmi, Manal/0000-0003-0218-7342; Lesca, Gaetan/0000-0001-7691-9492; Strug, Lisa/0000-0003-0503-9740; Wright, Sukhvir/0000-0002-5464-3779; Arzimanoglou, Alexis/0000-0002-7233-2771; DE SAINT-MARTIN, ANNE/0000-0003-4666-5369; Rudolf, Gabrielle/0000-0002-2050-3911	Wellcome Trust; NIHR Oxford Biomedical Research Centre; ANR (Agence Nationale de la Recherche) [ANR-2010-BLAN-1405 01]; National PHRC (Projet Hospitalier de Recherche Clinique) [2010 03-08]; INSERM	Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); National PHRC (Projet Hospitalier de Recherche Clinique); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We thank all the subjects and families who participated in the study. Written informed consent was obtained from parents for their children and for themselves, according to the appropriate bioethics laws and ethical committees (no. 05/78, CPP Strasbourg, Alsace 1). We thank C. Boulay, M. Lim, E. Panagiotakaki, C. Seegmuller and M.-P. Valenti-Hirsch for their valuable participation in clinical analyses, R. Lamy for expert technical assistance, F. Michel at inMAGIC (INMED Imaging Centre) and all the administrative staff at INMED. Assistance from the Biological Resource Centre, Hospices Civils (Lyon, France) and from the Banque de Genome, Hopital de Brabois (Vandoeuvre-les-Nancy, France) was greatly appreciated. S. W. is supported by the Wellcome Trust. P. W. and A. V. are partly supported by the NIHR Oxford Biomedical Research Centre. This work was supported by ANR (Agence Nationale de la Recherche) grant EPILAND (ANR-2010-BLAN-1405 01) with EuroBiomed label, by National PHRC (Projet Hospitalier de Recherche Clinique) grant 2010 03-08 and by INSERM.	Arzimanoglou A, 2004, AICARDIS EPILEPSY CH, P176; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Boscolo S, 2005, J NEUROIMMUNOL, V160, P228, DOI 10.1016/j.jneuroim.2004.10.031; Carvill GL, 2013, NAT GENET, V45, P1073, DOI 10.1038/ng.2727; Cloarec R, 2012, NEUROLOGY, V79, P2097, DOI 10.1212/WNL.0b013e3182752c46; Connolly AM, 1999, J PEDIATR-US, V134, P607, DOI 10.1016/S0022-3476(99)70248-9; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Datta A, 2007, PEDIATR NEUROL, V36, P141, DOI 10.1016/j.pediatrneurol.2006.12.003; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Deonna T, 2006, EPILEPSIA, V47, P79, DOI 10.1111/j.1528-1167.2006.00697.x; Deonna T, 2010, BRAIN DEV-JPN, V32, P746, DOI 10.1016/j.braindev.2010.06.011; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Fejerman N, 2009, EPILEPSIA, V50, P9, DOI 10.1111/j.1528-1167.2009.02210.x; Irani SR, 2010, BRAIN, V133, P1655, DOI 10.1093/brain/awq113; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; LANDAU WM, 1957, NEUROLOGY, V7, P523, DOI 10.1212/WNL.7.8.523; Lee HY, 2012, CELL REP, V1, P2, DOI 10.1016/j.celrep.2011.11.001; Lesca G, 2012, EPILEPSIA, V53, P1526, DOI 10.1111/j.1528-1167.2012.03559.x; Massa R, 2001, NEUROLOGY, V57, P1071, DOI 10.1212/WNL.57.6.1071; Miyamoto H, 2003, NAT NEUROSCI, V6, P553, DOI 10.1038/nn1064; Nieuwenhuis L, 2006, SEIZURE-EUR J EPILEP, V15, P249, DOI 10.1016/j.seizure.2006.02.008; PATRY G, 1971, ARCH NEUROL-CHICAGO, V24, P242, DOI 10.1001/archneur.1971.00480330070006; Popescu G, 2003, NAT NEUROSCI, V6, P476, DOI 10.1038/nn1044; Reutlinger C, 2010, EPILEPSIA, V51, P1870, DOI 10.1111/j.1528-1167.2010.02555.x; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Roll P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013750; Rudolf G, 2009, EPILEPSIA, V50, P25, DOI 10.1111/j.1528-1167.2009.02214.x; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Stephani U, 2006, EPILEPSIA, V47, P67, DOI 10.1111/j.1528-1167.2006.00694.x; Talukder I, 2010, J NEUROSCI, V30, P11792, DOI 10.1523/JNEUROSCI.5382-09.2010; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tuchman R, 2009, EPILEPSIA, V50, P18, DOI 10.1111/j.1528-1167.2009.02212.x; Van Bogaert P, 2009, EPILEPSIA, V50, P1, DOI 10.1111/j.1528-1167.2009.02207.x; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wyllie DJA, 2006, J PHYSIOL-LONDON, V574, P477, DOI 10.1113/jphysiol.2006.112193; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009	36	291	307	2	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2013	45	9					1061	+		10.1038/ng.2726	http://dx.doi.org/10.1038/ng.2726			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	209ID	23933820				2022-12-17	WOS:000323748200017
J	Bielas, SL; Silhavy, JL; Brancati, F; Kisseleva, MV; Al-Gazali, L; Laszlo, S; Bayoumi, RA; Zaki, MS; Abdel-Aleem, A; Rosti, RO; Kayserili, H; Swistun, D; Scott, LC; Bertini, E; Boltshauser, E; Fazzi, E; Travaglini, L; Field, SJ; Gayral, S; Jacoby, M; Schurmans, S; Dallapiccola, B; Majerus, PW; Valente, EM; Gleeson, JG				Bielas, Stephanie L.; Silhavy, Jennifer L.; Brancati, Francesco; Kisseleva, Marina V.; Al-Gazali, Lihadh; Laszlo Sztriha; Bayoumi, Riad A.; Zaki, Maha S.; Abdel-Aleem, Alice; Rosti, Rasim Ozgur; Kayserili, Hulya; Swistun, Dominika; Scott, Lesley C.; Bertini, Enrico; Boltshauser, Eugen; Fazzi, Elisa; Travaglini, Lorena; Field, Seth J.; Gayral, Stephanie; Jacoby, Monique; Schurmans, Stephane; Dallapiccola, Bruno; Majerus, Philip W.; Valente, Enza Maria; Gleeson, Joseph G.			Mutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies	NATURE GENETICS			English	Article							JOUBERT-SYNDROME; POLYPHOSPHATE 5-PHOSPHATASE; MEMBRANE; PROTEIN; 3-PHOSPHATE; CEP290; FORMS; RAB8	Phosphotidylinositol (PtdIns) signaling is tightly regulated both spatially and temporally by subcellularly localized PtdIns kinases and phosphatases that dynamically alter downstream signaling events(1). Joubert syndrome is characterized by a specific midbrain-hindbrain malformation ('molar tooth sign'), variably associated retinal dystrophy, nephronophthisis, liver fibrosis and polydactyly(2) and is included in the newly emerging group of 'ciliopathies'. In individuals with Joubert disease genetically linked to JBTS1, we identified mutations in the INPP5E gene, encoding inositol polyphosphate-5- phosphatase E, which hydrolyzes the 5-phosphate of PtdIns(3,4,5) P3 and PtdIns(4,5) P2. Mutations clustered in the phosphatase domain and impaired 5-phosphatase activity, resulting in altered cellular PtdIns ratios. INPP5E localized to cilia in major organs affected by Joubert syndrome, and mutations promoted premature destabilization of cilia in response to stimulation. These data link PtdIns signaling to the primary cilium, a cellular structure that is becoming increasingly recognized for its role in mediating cell signals and neuronal function.	[Bielas, Stephanie L.; Silhavy, Jennifer L.; Swistun, Dominika; Scott, Lesley C.; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Neurogenet Lab, Dept Neurosci & Pediat, La Jolla, CA 92093 USA; [Brancati, Francesco; Travaglini, Lorena; Dallapiccola, Bruno; Valente, Enza Maria] Casa Sollievo Sofferenza Hosp, Casa Sollievo Sofferenza Mendel Inst, Rome, Italy; [Brancati, Francesco] G Annunzio Univ Fdn, Dept Biomed Sci, Ctr Studi Invecchiamento, Chieti, Italy; [Brancati, Francesco] G Annunzio Univ Fdn, Aging Res Ctr, Ctr Studi Invecchiamento, Chieti, Italy; [Kisseleva, Marina V.; Majerus, Philip W.] Washington Univ, Sch Med, Dept Internal Med, Div Hematol, St Louis, MO 63110 USA; [Al-Gazali, Lihadh] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates; [Al-Gazali, Lihadh] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pathol, Al Ain, U Arab Emirates; [Laszlo Sztriha] Univ Szeged, Dept Pediat, Szeged, Hungary; [Bayoumi, Riad A.] Sultan Qaboos Univ, Coll Med, Al Khoud, Oman; [Zaki, Maha S.] Natl Res Ctr, Dept Clin Genet, Cairo, Egypt; [Abdel-Aleem, Alice] Natl Res Ctr, Med Mol Genet Dept, Human Genet & Genome Res Div, Cairo, Egypt; [Rosti, Rasim Ozgur; Kayserili, Hulya] Istanbul Univ, Istanbul Fac Med, Istanbul, Turkey; [Bertini, Enrico] Bambino Gesu Childrens Res Hosp, Mol Med Unit, Dept Lab Med, Rome, Italy; [Boltshauser, Eugen] Univ Childrens Hosp Zurich, Dept Paediat Neurol, Zurich, Switzerland; [Fazzi, Elisa] Dept Child Neurol & Psychiat, Pavia, Italy; [Field, Seth J.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Gayral, Stephanie; Jacoby, Monique; Schurmans, Stephane] Univ Libre Bruxelles, IRIBHM, IBMM, Gosselies, Belgium; [Dallapiccola, Bruno] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Valente, Enza Maria] Univ Messina, Dept Med & Surg Paediat Sci, Messina, Italy	Howard Hughes Medical Institute; University of California System; University of California San Diego; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Washington University (WUSTL); United Arab Emirates University; United Arab Emirates University; Szeged University; Sultan Qaboos University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Istanbul University; IRCCS Bambino Gesu; University Children's Hospital Zurich; University of California System; University of California San Diego; Universite Libre de Bruxelles; Sapienza University Rome; University of Messina	Gleeson, JG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Neurogenet Lab, Dept Neurosci & Pediat, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu	Travaglini, Lorena/AAA-6245-2020; Valente, Enza Maria/G-2942-2017; Brancati, Francesco/AAC-3778-2022; Bertini, Enrico/ABG-1278-2020; Bertini, Enrico/A-2284-2014; Aleem, Alice Abdel/AAY-2598-2020; Bayoumi, Riad/ABH-2732-2020; Kayserili, Hülya/AAA-5593-2021; Fazzi, Elisa/J-6076-2016; Zaki, Maha S/B-9361-2013; Dallapiccola, Bruno/K-8692-2016	Valente, Enza Maria/0000-0002-0600-6820; Brancati, Francesco/0000-0003-3624-2354; Bertini, Enrico/0000-0001-9276-4590; Kayserili, Hülya/0000-0003-0376-499X; Fazzi, Elisa/0000-0003-4805-7906; Travaglini, Lorena/0000-0003-0142-6516; Zaki, Maha/0000-0001-7840-0002; Dallapiccola, Bruno/0000-0002-5031-1013; Bayoumi, Riad/0000-0001-8177-8129; Field, Seth/0000-0002-8893-4806; Abdel Aleem, Alice/0000-0001-5137-3382; Gayral, Stephanie/0000-0001-6276-3917; Bielas, Stephanie/0000-0003-0567-5632	Italian Ministry of Health [RC2008]; Telethon Foundation Italy [GGP08145]; National Institutes of Health [HL 16634 (]; American Heart Association [0730350N]; National Institute of Neurological Disorder and Stroke; Burroughs Welcome Fund; March of Dimes and the Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA138676, P30CA023100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016634, R37HL016634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R13NS053097, P30NS047101, R01NS048453, R01NS052455] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004265] Funding Source: NIH RePORTER	Italian Ministry of Health(Ministry of Health, Italy); Telethon Foundation Italy(Fondazione Telethon); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institute of Neurological Disorder and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Burroughs Welcome Fund(Burroughs Wellcome Fund); March of Dimes and the Howard Hughes Medical Institute(March of Dimes); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Marshfield Clinic Research Foundation, Center for Inherited Disease Research and University of California Los Angeles Microarray Core ( supported by the US National Heart, Lung, and Blood Institute and National Institutes of Health) for genotyping support. J. Meerloo at the University of California San Diego ( UCSD) Neuroscience Microscopy Imaging Core ( P30NS047101) provided imaging support. Ryan Anderson of the UCSD Material Sciences provided electron microscopy support. We thank members of the the Dixon lab ( UCSD) for suggestions and help with protein modeling, and members of the Mitchell lab ( Monash University) for reagents. This work was supported by the UCSD Neuroplasticity of Aging Training Grant ( to S. L. B.), the Italian Ministry of Health ( RC2008 to B. D., Ricerca Finalizzata 2006 to E. M. V.), the Telethon Foundation Italy ( GGP08145 to E. B. and E. M. V.), National Institutes of Health grant HL 16634 ( to P. W. M. and M. V. K.), American Heart Association grant 0730350N ( to M. V. K.), the National Institute of Neurological Disorder and Stroke, the Burroughs Welcome Fund, the March of Dimes and the Howard Hughes Medical Institute ( to J. G. G.).	Alieva I B, 1999, Membr Cell Biol, V12, P895; CALDWELL KK, 1991, J BIOL CHEM, V266, P18378; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; De Donatis A, 2008, J BIOL CHEM, V283, P19948, DOI 10.1074/jbc.M709428200; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Gleeson JG, 2000, ANN NEUROL, V47, P265, DOI 10.1002/1531-8249(200002)47:2<265::AID-ANA22>3.3.CO;2-E; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Kisseleva MV, 2000, J BIOL CHEM, V275, P20110, DOI 10.1074/jbc.M910119199; Kisseleva MV, 2002, J BIOL CHEM, V277, P6266, DOI 10.1074/jbc.M105969200; Kong AM, 2006, MOL CELL BIOL, V26, P6065, DOI 10.1128/MCB.00203-06; Murray SS, 2004, NAT METHODS, V1, P113, DOI 10.1038/NMETH712; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Rodriguez Luis G., 2004, V294, P23; Rohatgi R, 2008, SCIENCE, V320, P1726, DOI 10.1126/science.1160448; Saar K, 1999, AM J HUM GENET, V65, P1666, DOI 10.1086/302655; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Tsujishita Y, 2001, CELL, V105, P379, DOI 10.1016/S0092-8674(01)00326-9; TUCKER RW, 1979, CELL, V17, P527, DOI 10.1016/0092-8674(79)90261-7; Valente EM, 2005, ANN NEUROL, V57, P513, DOI 10.1002/ana.20422; Valente EM, 2006, ANN NEUROL, V59, P527, DOI 10.1002/ana.20749; Valente EM, 2008, EUR J MED GENET, V51, P1, DOI 10.1016/j.ejmg.2007.11.003; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Vandeput F, 2006, CELL SIGNAL, V18, P2193, DOI 10.1016/j.cellsig.2006.05.010; Vicinanza M, 2008, CELL MOL LIFE SCI, V65, P2833, DOI 10.1007/s00018-008-8353-2; Zhang XL, 1998, J BIOL CHEM, V273, P1574, DOI 10.1074/jbc.273.3.1574	33	291	297	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2009	41	9					1032	U108		10.1038/ng.423	http://dx.doi.org/10.1038/ng.423			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488WX	19668216	Green Accepted, Green Submitted			2022-12-17	WOS:000269382100018
J	Park, TJ; Haigo, SL; Wallingford, JB				Park, TJ; Haigo, SL; Wallingford, JB			Ciliogenesis defects in embryos lacking inturned or fuzzy function are associated with failure of planar cell polarity and Hedgehog signaling	NATURE GENETICS			English	Article							DROSOPHILA TISSUE POLARITY; INTRAFLAGELLAR TRANSPORT PROTEINS; NEURAL-TUBE CLOSURE; CONVERGENT EXTENSION; XENOPUS-LAEVIS; SONIC HEDGEHOG; QUAIL OVIDUCT; FLOOR PLATE; GENE; CILIA	The vertebrate planar cell polarity (PCP) pathway has previously been found to control polarized cell behaviors rather than cell fate. We report here that disruption of Xenopus laevis orthologs of the Drosophila melanogaster PCP effectors inturned (in) or fuzzy (fy) affected not only PCP-dependent convergent extension but also elicited embryonic phenotypes consistent with defective Hedgehog signaling. These defects in Hedgehog signaling resulted from a broad requirement for Inturned and Fuzzy in ciliogenesis. We show that these proteins govern apical actin assembly and thus control the orientation, but not assembly, of ciliary microtubules. Finally, accumulation of Dishevelled and Inturned near the basal apparatus of cilia suggests that these proteins function in a common pathway with core PCP components to regulate ciliogenesis. Together, these data highlight the interrelationships between cell polarity, cellular morphogenesis, signal transduction and cell fate specification.	Univ Texas, Dept Mol Cell & Dev Biol, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of California System; University of California Berkeley	Wallingford, JB (corresponding author), Univ Texas, Dept Mol Cell & Dev Biol, Austin, TX 78712 USA.	wallingford@mail.utexas.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074104] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM074104] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adler PN, 2004, CURR BIOL, V14, P2046, DOI 10.1016/j.cub.2004.11.007; Adler PN, 2001, CURR OPIN CELL BIOL, V13, P635, DOI 10.1016/S0955-0674(00)00263-5; ASSHETON R, 1896, Q J MICROSC SCI, V38, P465; BOISVIEUXULRICH E, 1990, CELL TISSUE RES, V259, P443, DOI 10.1007/BF01740770; BOISVIEUXULRICH E, 1991, BIOL CELL, V72, P3, DOI 10.1016/0248-4900(91)90072-U; CHAILLEY B, 1989, BIOL CELL, V67, P81, DOI 10.1111/j.1768-322X.1989.tb03012.x; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Collier S, 1997, DEVELOPMENT, V124, P4029; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Eaton S, 1996, J CELL BIOL, V135, P1277, DOI 10.1083/jcb.135.5.1277; EKKER SC, 1995, DEVELOPMENT, V121, P2337; Feiguin F, 2001, DEV CELL, V1, P93, DOI 10.1016/S1534-5807(01)00010-7; Hagiwara H, 2004, INT REV CYTOL, V234, P101, DOI 10.1016/S0074-7696(04)34003-9; Hallonet M, 1999, GENE DEV, V13, P3106, DOI 10.1101/gad.13.23.3106; Han YG, 2003, CURR BIOL, V13, P1679, DOI 10.1016/j.cub.2003.08.034; Hu D, 1999, DEVELOPMENT, V126, P4873; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Jenny A, 2005, NAT CELL BIOL, V7, P691, DOI 10.1038/ncb1271; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; KELLER R, 1992, DEV DYNAM, V193, P199, DOI 10.1002/aja.1001930302; Keller R, 2000, PHILOS T R SOC B, V355, P897, DOI 10.1098/rstb.2000.0626; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kimmel CB, 1998, DEV BIOL, V203, P245, DOI 10.1006/dbio.1998.9016; KONIG G, 1993, DEV BIOL, V160, P355, DOI 10.1006/dbio.1993.1312; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; Lee H, 2002, GENETICS, V160, P1535; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Lopez SL, 2003, DEVELOPMENT, V130, P2225, DOI 10.1242/dev.00443; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; NISHIKAWA S, 1992, HISTOCHEMISTRY, V98, P355, DOI 10.1007/BF00271070; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Park WJ, 1996, DEVELOPMENT, V122, P961; Pichon B, 2002, DEV GENES EVOL, V212, P491, DOI 10.1007/s00427-002-0270-z; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Take-uchi M, 2003, DEVELOPMENT, V130, P955, DOI 10.1242/dev.00305; TAMM S, 1988, J CELL SCI, V89, P67; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; TRUEB L, 1992, J MORPHOL, V214, P1, DOI 10.1002/jmor.1052140102; Wada N, 2005, DEVELOPMENT, V132, P3977, DOI 10.1242/dev.01943; Wallingford JB, 2005, AM J MED GENET C, V135C, P59, DOI 10.1002/ajmg.c.30054; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2001, DEVELOPMENT, V128, P2581; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407	50	291	301	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					303	311		10.1038/ng1753	http://dx.doi.org/10.1038/ng1753			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16493421				2022-12-17	WOS:000235589600011
J	Burley, SK; Almo, SC; Bonanno, JB; Capel, M; Chance, MR; Gaasterland, T; Lin, DW; Sali, A; Studier, FW; Swaminathan, S				Burley, SK; Almo, SC; Bonanno, JB; Capel, M; Chance, MR; Gaasterland, T; Lin, DW; Sali, A; Studier, FW; Swaminathan, S			Structural genomics: beyond the Human Genome Project	NATURE GENETICS			English	Article							MYCOPLASMA-GENITALIUM PROTEINS; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; PREDICTIONS; HEAD; FOLD	With access to whole genome sequences for various organisms and imminent completion of the Human Genome Project, the entire process of discovery in molecular and cellular biology is poised to change. Massively parallel measurement strategies promise to revolutionize how we study and ultimately understand the complex biochemical circuitry responsible for controlling normal development, physiologic homeostasis and disease processes. This information explosion is also providing the foundation for an important new initiative in structural biology. We are about to embark on a program of high-throughput X-ray crystallography aimed at developing a comprehensive mechanistic understanding of normal and abnormal human and microbial physiology at the molecular level. We present the rationale for creation of a structural genomics initiative, recount the efforts of ongoing structural genomics pilot studies, and detail the lofty goals, technical challenges and pitfalls facing structural biologists.	Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, New York, NY 10021 USA; Albert Einstein Coll Med, Bronx, NY 10461 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Howard Hughes Medical Institute; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; United States Department of Energy (DOE); Brookhaven National Laboratory	Burley, SK (corresponding author), Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.			Burley, Stephen K./0000-0002-2487-9713				Brenner SE, 1997, CURR OPIN STRUC BIOL, V7, P369, DOI 10.1016/S0959-440X(97)80054-1; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; COHEN SL, 1995, PROTEIN SCI, V4, P1088, DOI 10.1002/pro.5560040607; Cohen SL, 1996, STRUCTURE, V4, P1013, DOI 10.1016/S0969-2126(96)00108-6; DEO RC, IN PRESS CELL; Fetrow JS, 1998, J MOL BIOL, V282, P703, DOI 10.1006/jmbi.1998.2061; Fischer D, 1997, P NATL ACAD SCI USA, V94, P11929, DOI 10.1073/pnas.94.22.11929; Gaasterland T, 1998, TRENDS GENET, V14, P135, DOI 10.1016/S0168-9525(98)01430-9; Guenther BD, 1999, NAT STRUCT BIOL, V6, P359, DOI 10.1038/7594; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Huynen M, 1998, J MOL BIOL, V280, P323, DOI 10.1006/jmbi.1998.1884; LAI E, 1993, P NATL ACAD SCI USA, V90, P10421, DOI 10.1073/pnas.90.22.10421; Orengo CA, 1999, NUCLEIC ACIDS RES, V27, P275, DOI 10.1093/nar/27.1.275; Rychlewski L, 1998, FOLD DES, V3, P229, DOI 10.1016/S1359-0278(98)00034-0; Sali Andrej, 1998, Nature Structural Biology, V5, P1029, DOI 10.1038/4136; Sanchez R, 1999, J COMPUT PHYS, V151, P388, DOI 10.1006/jcph.1999.6200; Sanchez R, 1998, P NATL ACAD SCI USA, V95, P13597, DOI 10.1073/pnas.95.23.13597; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Wallace AC, 1997, PROTEIN SCI, V6, P2308; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0; Yang F, 1998, NAT STRUCT BIOL, V5, P763, DOI 10.1038/1796	21	291	301	0	21	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1999	23	2					151	157		10.1038/13783	http://dx.doi.org/10.1038/13783			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	240LM	10508510				2022-12-17	WOS:000082827500013
J	Mein, CA; Esposito, L; Dunn, MG; Johnson, GCL; Timms, AE; Goy, JV; Smith, AN; Sebag-Montefiore, L; Merriman, ME; Wilson, AJ; Pritchard, LE; Cucca, F; Barnett, AH; Bain, SC; Todd, JA				Mein, CA; Esposito, L; Dunn, MG; Johnson, GCL; Timms, AE; Goy, JV; Smith, AN; Sebag-Montefiore, L; Merriman, ME; Wilson, AJ; Pritchard, LE; Cucca, F; Barnett, AH; Bain, SC; Todd, JA			A search for type 1 diabetes susceptibility genes in families from the United Kingdom	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; MELLITUS IDDM; 15Q26 IDDM3; INSULIN; LOCUS; REGION	Genetic analysis of a mouse model of major histocompatability complex (MHC)-associated autoimmune type 1 (insulin-dependent) diabetes mellitus (IDDM) has shown that the disease is caused by a combination of a major effect at the MHC and at least ten other susceptibility loci elsewhere in the genome(1,2) A genome-wide scan of 93 affected sibpair families (ASP) from the UK (UK93) indicated a similar genetic basis for human type 1 diabetes, with the major genetic component at the MHC locus (IDDM1) explaining 34% of the familial clustering of the disease (lambda(s) = 2.5; refs 3,4). In the present report, we have analysed a further 263 multiplex families from the same population (UK263) to provide a total UK data set of 356 ASP families (UK356). Only four regions of the genome outside IDDM1/MHC, which was stilt the only major locus detected, were not excluded at lambda(s) = 3 and lod=-2, of which two showed evidence of linkage: chromosome 10p13-p11 (maximum lod score (MLS) = 4.7, P = 3 x 10(-6), lambda(s) = 1.56) and chromosome 16q22-16q24 (MLS = 3.4, P = 6.5 x 10(-5), lambda(s) = 1.6) These and other novel regions, including chromosome 14q12-q21 and chromosome 19p13-19q13, could potentially harbour disease loci but confirmation and fine mapping cannot be pursued effectively using conventional linkage analysis. instead, more powerful linkage disequilibrium-based(5-7) and haplotype mapping approaches(8) must be used; such data is already emerging for several type 1 diabetes loci detected initially by linkage(6,8-13).	Univ Oxford, Nuffield Dept Surg, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Birmingham, Birmingham Heartlands Hosp, Dept Med, Birmingham B9 5SS, W Midlands, England	University of Oxford; Wellcome Centre for Human Genetics; Heart of England NHS Foundation Trust; University of Birmingham	Todd, JA (corresponding author), Univ Oxford, Nuffield Dept Surg, Wellcome Trust Ctr Human Genet, Windmill Rd, Oxford OX3 7BN, England.		Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148; Wilson, Amanda/0000-0001-5681-9611; Mein, Charles/0000-0003-0811-9658; CUCCA, Francesco/0000-0002-7414-1995	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; COX NJ, 1988, AM J HUM GENET, V42, P167; CUCCA F, IN PRESS DIABETES; CUCCA F, IN PRESS NATURE GENE; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Delepine M, 1997, AM J HUM GENET, V60, P174; Donner H, 1997, J CLIN ENDOCR METAB, V82, P143, DOI 10.1210/jc.82.1.143; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; Field LL, 1996, GENOMICS, V33, P1, DOI 10.1006/geno.1996.0153; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; Kristiansen OP, 1998, DIABETES, V47, P281, DOI 10.2337/diab.47.2.281; Luo DF, 1996, HUM MOL GENET, V5, P693, DOI 10.1093/hmg/5.5.693; LYONS PA, INPRESS GENETICS AUT; Marron MP, 1997, HUM MOL GENET, V6, P1275, DOI 10.1093/hmg/6.8.1275; Merriman TR, 1998, HUM MOL GENET, V7, P517, DOI 10.1093/hmg/7.3.517; Morahan G, 1996, SCIENCE, V272, P1811, DOI 10.1126/science.272.5269.1811; NAKAGAWA Y, IN PRESS AM J HUM GE; Podolin PL, 1998, MAMM GENOME, V9, P283, DOI 10.1007/s003359900749; PRITCHARD LE, 1997, THESIS U OXFORD; Reed P, 1997, HUM MOL GENET, V6, P1011, DOI 10.1093/hmg/6.7.1011; RISCH N, 1993, AM J HUM GENET, V53, P702; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; THOMSON G, 1988, AM J HUM GENET, V43, P799; VANDEWALLE CL, 1993, DIABETOLOGIA, V36, P1155, DOI 10.1007/BF00401060; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Zamani M, 1996, HUM GENET, V98, P491, DOI 10.1007/s004390050245	30	291	299	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1998	19	3					297	300		10.1038/991	http://dx.doi.org/10.1038/991			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662409				2022-12-17	WOS:000074565900032
J	Yergeau, DA; Hetherington, CJ; Wang, Q; Zhang, P; Sharpe, AH; Binder, M; MarinPadilla, M; Tenen, DG; Speck, NA; Zhang, DE				Yergeau, DA; Hetherington, CJ; Wang, Q; Zhang, P; Sharpe, AH; Binder, M; MarinPadilla, M; Tenen, DG; Speck, NA; Zhang, DE			Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; TRANSCRIPTION FACTOR; MURINE MYELOPEROXIDASE; NUCLEAR FACTOR; IDENTIFICATION; ENHANCER; PROMOTER; CELLS; BINDS; DNA	Acute myeloid leukaemia (AML) is a major haematopoietic malignancy characterized by the proliferation of a malignant clone of myeloid progenitor cells(1,2). A reciprocal translocation, t(8;21)(q22;q22), observed in the leukaemic cells of approximately 40% of patients with the M2 subtype of AML disrupts both the AML1 (CBFA2) gene on chromosome 21 and the ETO (MTG8) gene on chromosome 8 (refs 3-5). A chimaeric protein is synthesized from one of the derivative chromosomes that contains the N terminus of the AML1 transcription factor, including its DNA-binding domain, fused to most of ETO, a protein of unknown function. We generated mice that mimic human t(8;21) with a 'knock-in' strategy. Mice heterozygous for an AML I-ETO allele (AML1-ETO/+) die in midgestation from haemorrhaging in the central nervous system and exhibit a severe block in fetal liver haematopoiesis. This phenotype is very similar to that resulting from homozygous disruption of the AML1 (Cbfa2) or Cbfb genes(6-8), indicating that AML1-ETO blocks normal AML1 function. However, yolk sac cells from AML1-ETO/+ mice differentiated into macrophages in haematopoietic colony forming unit (CFU) assays, unlike Cbfa2-/- or Cbfb-/- cells, which form no colonies in vitro(6-8). This indicates that AML1-ETO may have other functions besides blocking wild-type AML1, a property that may be important in leukaemogenesis.	HARVARD UNIV, INST MED, SCH MED, BOSTON, MA 02115 USA; BETH ISRAEL DEACONESS MED CTR, DIV HEMATOL ONCOL, BOSTON, MA USA; DARTMOUTH COLL SCH MED, DEPT BIOCHEM, HANOVER, NH 03755 USA; DARTMOUTH COLL SCH MED, DEPT ANAT, HANOVER, NH 03755 USA; DARTMOUTH COLL SCH MED, DEPT PATHOL, HANOVER, NH 03755 USA; BRIGHAM & WOMENS HOSP, DEPT PATHOL, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Dartmouth College; Dartmouth College; Dartmouth College; Harvard University; Brigham & Women's Hospital				Tenen, Daniel/0000-0002-6423-3888	NCI NIH HHS [CA41456] Funding Source: Medline; NIAMS NIH HHS [P030AR42689] Funding Source: Medline; NINDS NIH HHS [NS22897] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA041456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022897] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Armesilla AL, 1996, J BIOL CHEM, V271, P7781, DOI 10.1074/jbc.271.13.7781; BITTER MA, 1987, HUM PATHOL, V18, P211, DOI 10.1016/S0046-8177(87)80002-3; CAMERON S, 1994, BLOOD, V83, P2851, DOI 10.1182/blood.V83.10.2851.2851; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Castilla LH, 1996, CELL, V87, P687, DOI 10.1016/S0092-8674(00)81388-4; ERICKSON P, 1992, BLOOD, V80, P1825; Erickson PF, 1996, BLOOD, V88, P1813; Frank R, 1995, ONCOGENE, V11, P2667; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; GOTTSCHALK LR, 1990, MOL CELL BIOL, V10, P5486, DOI 10.1128/MCB.10.10.5486; HAAS JG, 1992, J IMMUNOL, V149, P237; HSIANG YHH, 1993, J IMMUNOL, V150, P3905; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LIU P, 1993, SCIENCE, V261, P1041, DOI 10.1126/science.8351518; Meyers S, 1996, ONCOGENE, V13, P303; MEYERS S, 1995, MOL CELL BIOL, V15, P1974; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; MIYOSHI H, 1993, EMBO J, V12, P2715, DOI 10.1002/j.1460-2075.1993.tb05933.x; NISSON PE, 1992, CANCER GENET CYTOGEN, V63, P81, DOI 10.1016/0165-4608(92)90384-K; NUCHPRAYOON I, 1994, MOL CELL BIOL, V14, P5558, DOI 10.1128/MCB.14.8.5558; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Rhoades KL, 1996, P NATL ACAD SCI USA, V93, P11895, DOI 10.1073/pnas.93.21.11895; ROWLEY JD, 1984, CANCER RES, V44, P3159; SUZOW J, 1993, MOL CELL BIOL, V13, P2141, DOI 10.1128/MCB.13.4.2141; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; WILLIAMS BO, 1994, EMBO J, V13, P4251, DOI 10.1002/j.1460-2075.1994.tb06745.x; WOTTON D, 1994, MOL CELL BIOL, V14, P840, DOI 10.1128/MCB.14.1.840; ZHANG DE, 1994, MOL CELL BIOL, V14, P8085, DOI 10.1128/MCB.14.12.8085	30	291	301	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					303	306		10.1038/ng0397-303	http://dx.doi.org/10.1038/ng0397-303			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054947				2022-12-17	WOS:A1997WK38600024
J	LoTenFoe, JR; Rooimans, MA; BosnoyanCollins, L; Alon, N; Wijker, M; Parker, L; Lightfoot, J; Carreau, M; Callen, DF; Savoia, A; Cheng, NC; vanBerkel, CGM; Strunk, MHP; Gille, JJP; Pals, G; Kruyt, FAE; Pronk, JC; Arwert, F; Buchwald, M; Joenje, H				LoTenFoe, JR; Rooimans, MA; BosnoyanCollins, L; Alon, N; Wijker, M; Parker, L; Lightfoot, J; Carreau, M; Callen, DF; Savoia, A; Cheng, NC; vanBerkel, CGM; Strunk, MHP; Gille, JJP; Pals, G; Kruyt, FAE; Pronk, JC; Arwert, F; Buchwald, M; Joenje, H			Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA	NATURE GENETICS			English	Article							COMPLEMENTATION GROUPS; ANEMIA-REGISTRY; PROTEIN; LOCALIZATION; DIAGNOSIS; CYTOPLASM; FACC		FREE UNIV AMSTERDAM, DEPT HUMAN GENET, NL-1081 BT AMSTERDAM, NETHERLANDS; HOSP SICK CHILDREN, DEPT GENET, TORONTO, ON M5G 1X8, CANADA; UNIV TORONTO, DEPT MOL & MED GENET, TORONTO, ON M5S 1A1, CANADA; WOMENS & CHILDRENS HOSP, DEPT CYTOGENET & MOL GENET, ADELAIDE, SA 5006, AUSTRALIA; IRCCS OSPED CSS, SERV GENET MED, I-71013 SAN GIOVANNI ROTONDO, ITALY	Vrije Universiteit Amsterdam; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Womens & Childrens Hospital Australia			Strunk, Mark HP/K-3597-2014; Savoia, Anna/B-6463-2014; Pals, Gerard/A-5198-2011; Savoia, Anna/AIC-4560-2022; Callen, David F/G-1975-2012; Strunk, Mark/I-2423-2017	Strunk, Mark HP/0000-0002-8619-3979; Savoia, Anna/0000-0002-2407-2696; Savoia, Anna/0000-0002-2407-2696; Strunk, Mark/0000-0002-8619-3979; Kruyt, Frank/0000-0002-2445-9380; Callen, David/0000-0002-6189-9991; Carreau, Madeleine/0000-0002-0582-6114; Pals, Gerard/0000-0003-4091-7115; Gille, Johan/0000-0003-4526-298X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL032987, R01HL032987, R01HL050131] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL50131, HL32987] Funding Source: Medline; Telethon [E.0364] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Telethon(Fondazione Telethon)		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AUERBACH AD, 1993, EXP HEMATOL, V21, P731; BAIROCH A, 1991, NUCLEIC ACIDS RES, V19, P2241, DOI 10.1093/nar/19.suppl.2241; BUCHWALD M, 1995, NAT GENET, V11, P228, DOI 10.1038/ng1195-228; BUCHWALD M, 1989, FANCONI ANEMIA CLIN, P226; BUTTURINI A, 1994, BLOOD, V84, P1650, DOI 10.1182/blood.V84.5.1650.bloodjournal8451650; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; DUCKWORTHRYSIECKI G, 1985, SOMAT CELL MOLEC GEN, V11, P35, DOI 10.1007/BF01534732; FANTES JA, 1992, AM J HUM GENET, V51, P1286; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES, P633; GIAMPIETRO PF, 1993, PEDIATRICS, V91, P1116; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; HURST HC, 1994, PROTEIN PROFILE, V1, P123; ISHIDA R, 1982, CANCER RES, V42, P4000; JOENJE H, 1995, BLOOD, V86, P2156, DOI 10.1182/blood.V86.6.2156.bloodjournal8662156; Joenje H, 1996, HUM GENET, V97, P280, DOI 10.1007/BF02185753; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; Kruyt FAE, 1996, BLOOD, V87, P938, DOI 10.1182/blood.V87.3.938.bloodjournal873938; LIU JM, 1994, BLOOD, V84, P3995, DOI 10.1182/blood.V84.12.3995.bloodjournal84123995; PRONK JC, 1995, NAT GENET, V11, P338, DOI 10.1038/ng1195-338; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; STRATHDEE CA, 1992, NATURE, V358, P434, DOI 10.1038/358434a0; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; WHITNEY M, 1995, NAT GENET, V11, P341, DOI 10.1038/ng1195-341; YAMASHITA T, 1994, P NATL ACAD SCI USA, V91, P6712, DOI 10.1073/pnas.91.14.6712; Young NS., 1994, APLASTIC ANEMIA ACQU, P275; YOUSSOUFIAN H, 1994, P NATL ACAD SCI USA, V91, P7975, DOI 10.1073/pnas.91.17.7975	27	291	294	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					320	323		10.1038/ng1196-320	http://dx.doi.org/10.1038/ng1196-320			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896563				2022-12-17	WOS:A1996VQ14600028
J	RICHARDS, RI; SUTHERLAND, GR				RICHARDS, RI; SUTHERLAND, GR			SIMPLE REPEAT DNA IS NOT REPLICATED SIMPLY	NATURE GENETICS			English	Editorial Material							MYOTONIC-DYSTROPHY; FRAGILE-X; MUTATIONS; DISEASE				RICHARDS, RI (corresponding author), WOMENS & CHILDRENS HOSP,CTR MED GENET,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA.		Richards, Robert/ABE-6423-2020; Sutherland, Grant Robert/D-2606-2012	Richards, Robert Ian/0000-0002-5978-6453				AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BROOK JD, 1993, NAT GENET, V3, P279; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; HARLEY HG, 1991, AM J HUM GENET, V49, P68; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; IONOV T, 1993, NATURE, V363, P558; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; KRONTIRIS TG, 1993, NEW ENGL J MED, V329, P517, DOI 10.1056/NEJM199308193290801; KUNKEL TA, 1993, NATURE, V365, P207, DOI 10.1038/365207a0; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LINDBLOM A, 1993, NAT GENET, V5, P279, DOI 10.1038/ng1193-279; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PALMER MS, 1993, HUM MUTAT, V2, P168, DOI 10.1002/humu.1380020303; PELTOMAKI P, 1993, SCIENCE, V260, P810, DOI 10.1126/science.8484120; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; THIBODEAU SN, 1993, SCIENCE, V260, P818; TSUJI S, 1994, NAT GENET, V6, P9; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WOOSTER R, 1994, NAT GENET, V6, P152, DOI 10.1038/ng0294-152; YAMADA M, 1994, NAT GENET, V6, P14; 1993, CELL, V72, P971	31	291	299	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					114	116		10.1038/ng0294-114	http://dx.doi.org/10.1038/ng0294-114			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	8162063				2022-12-17	WOS:A1994MU76300003
J	Morris, JA; Kemp, JP; Youlten, SE; Laurent, L; Logan, JG; Chai, RC; Vulpescu, NA; Forgetta, V; Kleinman, A; Mohanty, ST; Sergio, CM; Quinn, J; Nguyen-Yamamoto, L; Luco, AL; Vijay, J; Simon, MM; Pramatarova, A; Medina-Gomez, C; Trajanoska, K; Ghirardello, EJ; Butterfield, NC; Curry, KF; Leitch, VD; Sparkes, PC; Adoum, AT; Mannan, NS; Komla-Ebri, DSK; Pollard, AS; Dewhurst, HF; Hassall, TAD; Beltejar, MJG; Agee, M; Alipanahi, B; Auton, A; Bell, RK; Bryc, K; Elson, SL; Fontanillas, P; Furlotte, NA; McCreight, JC; Huber, KE; Litterman, NK; McIntyre, MH; Mountain, JL; Noblin, ES; Northover, CAM; Pitts, SJ; Sathirapongsasuti, JF; Sazonova, OV; Shelton, JF; Shringarpure, S; Tian, C; Tung, JY; Vacic, V; Wilson, CH; Adams, DJ; Vaillancourt, SM; Kaptoge, S; Baldock, P; Cooper, C; Reeve, J; Ntzani, EE; Evangelou, E; Ohlsson, C; Karasik, D; Rivadeneira, F; Kiel, DP; Tobias, JH; Gregson, CL; Harvey, NC; Grundberg, E; Goltzman, D; Adams, DJ; Lelliott, CJ; Hinds, DA; Ackert-Bicknell, CL; Hsu, YH; Maurano, MT; Croucher, PI; Williams, GR; Bassett, JHD; Evans, DM; Richards, JB				Morris, John A.; Kemp, John P.; Youlten, Scott E.; Laurent, Laetitia; Logan, John G.; Chai, Ryan C.; Vulpescu, Nicholas A.; Forgetta, Vincenzo; Kleinman, Aaron; Mohanty, Sindhu T.; Sergio, C. Marcelo; Quinn, Julian; Nguyen-Yamamoto, Loan; Luco, Aimee-Lee; Vijay, Jinchu; Simon, Marie-Michelle; Pramatarova, Albena; Medina-Gomez, Carolina; Trajanoska, Katerina; Ghirardello, Elena J.; Butterfield, Natalie C.; Curry, Katharine F.; Leitch, Victoria D.; Sparkes, Penny C.; Adoum, Anne-Tounsia; Mannan, Naila S.; Komla-Ebri, Davide S. K.; Pollard, Andrea S.; Dewhurst, Hannah F.; Hassall, Thomas A. D.; Beltejar, Michael-John G.; Agee, Michelle; Alipanahi, Babak; Auton, Adam; Bell, Robert K.; Bryc, Katarzyna; Elson, Sarah L.; Fontanillas, Pierre; Furlotte, Nicholas A.; McCreight, Jennifer C.; Huber, Karen E.; Litterman, Nadia K.; McIntyre, Matthew H.; Mountain, Joanna L.; Noblin, Elizabeth S.; Northover, Carrie A. M.; Pitts, Steven J.; Sathirapongsasuti, J. Fah; Sazonova, Olga V.; Shelton, Janie F.; Shringarpure, Suyash; Tian, Chao; Tung, Joyce Y.; Vacic, Vladimir; Wilson, Catherine H.; Adams, Douglas J.; Vaillancourt, Suzanne M.; Kaptoge, Stephen; Baldock, Paul; Cooper, Cyrus; Reeve, Jonathan; Ntzani, Evangelia E.; Evangelou, Evangelos; Ohlsson, Claes; Karasik, David; Rivadeneira, Fernando; Kiel, Douglas P.; Tobias, Jonathan H.; Gregson, Celia L.; Harvey, Nicholas C.; Grundberg, Elin; Goltzman, David; Adams, David J.; Lelliott, Christopher J.; Hinds, David A.; Ackert-Bicknell, Cheryl L.; Hsu, Yi-Hsiang; Maurano, Matthew T.; Croucher, Peter I.; Williams, Graham R.; Bassett, J. H. Duncan; Evans, David M.; Richards, J. Brent		23 Me Res Team	An atlas of genetic influences on osteoporosis in humans and mice	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BONE-MINERAL DENSITY; QUANTITATIVE ULTRASOUND; CHROMATIN; METAANALYSIS; HEEL; HIP; HERITABILITY; FRACTURES; CALCANEUS	Osteoporosis is a common aging-related disease diagnosed primarily using bone mineral density (BMD). We assessed genetic determinants of BMD as estimated by heel quantitative ultrasound in 426,824 individuals, identifying 518 genome-wide significant loci (301 novel), explaining 20% of its variance. We identified 13 bone fracture loci, all associated with estimated BMD (eBMD), in similar to 1.2 million individuals. We then identified target genes enriched for genes known to influence bone density and strength (maximum odds ratio (OR) = 58, P = 1 x 10(-75)) from cell-specific features, including chromatin conformation and accessible chromatin sites. We next performed rapid-throughput skeletal phenotyping of 126 knockout mice with disruptions in predicted target genes and found an increased abnormal skeletal phenotype frequency compared to 526 unselected lines (P < 0.0001). In-depth analysis of one gene, DAAM2, showed a disproportionate decrease in bone strength relative to mineralization. This genetic atlas provides evidence linking associated SNPs to causal genes, offers new insight into osteoporosis pathophysiology, and highlights opportunities for drug development.				d.evans1@uq.edu.au; brent.richards@mcgill.ca	Baldock, Paul/B-3840-2012; Rivadeneira, Fernando/O-5385-2015; Leitch, Victoria/AAV-6135-2020; Evangelou, Evangelos/C-3033-2013; Butterfield, Natalie/AAV-5483-2020; Komla-Ebri, Davide/ABE-6209-2021; Richards, J Brent/AAF-4225-2019; Reeve, Jonathan/C-7551-2012; Ohlsson, Claes/AGP-3544-2022; Gregson, Celia/AAE-1216-2021; tian, chao/GYD-3462-2022; Adams, David/GMW-8541-2022; Ackert-Bicknell, Cheryl/AAC-6833-2019; Kemp, John/R-3091-2018; Tobias, Jon/E-2832-2014; Evans, David/H-6325-2013	Rivadeneira, Fernando/0000-0001-9435-9441; Leitch, Victoria/0000-0001-5760-2887; Evangelou, Evangelos/0000-0002-5488-2999; Richards, J Brent/0000-0002-3746-9086; Reeve, Jonathan/0000-0002-4364-2682; Ohlsson, Claes/0000-0002-9633-2805; Gregson, Celia/0000-0001-6414-0529; Adams, David/0000-0001-9490-0306; Ackert-Bicknell, Cheryl/0000-0003-4253-4775; Hassall, Timothy/0000-0002-7883-3710; Medina-Gomez, Carolina/0000-0001-7999-5538; Trajanoska, Katerina/0000-0002-3792-4296; Komla-Ebri, Davide/0000-0002-8381-5381; Harvey, Nicholas/0000-0002-8194-2512; Ntzani, Evangelia/0000-0003-3712-4181; Kemp, John/0000-0002-9105-2249; Tobias, Jon/0000-0002-7475-3932; Vulpescu, Nicholas/0000-0003-1310-0257; Vijay, Jinchu/0000-0002-7311-475X; Logan, John/0000-0003-2801-700X; Butterfield, Natalie/0000-0002-5209-7508; Pollard, Andrea/0000-0001-7215-738X; Evans, David/0000-0003-0663-4621; Morris, John/0000-0003-2769-8202; Cooper, Cyrus/0000-0003-3510-0709; Croucher, Peter/0000-0002-7102-2413; Alipanahi, Babak/0000-0001-8216-7178	Canadian Institutes of Health Research; Canadian Foundation for Innovation; Fonds de Recherche Sante Quebec (FRSQ); FRQS Clinical Research Scholarship; Medical Research Council; European Union; National Institute for Health Research (NIHR); Biomedical Research Centre based at Guy's and St Thomas's NHS Foundation Trust; King's College London; National Health and Medical Research Council Senior Research Fellowship [APP1137714]; University of Queensland Development Fellowship [UQFEL1718945]; Arthritis Research UK [20000]; Wellcome Trust [101123, 094134]; Mrs. Janice Gibson and the Ernest Heine Family Foundation; Israel Science Foundation [1283/14]; US NIH NIAMS [1R01AR072199]; Netherlands Organization for Health Research and Development [ZonMw VIDI 016.136.361]; NIH/NIAMS [AR063702, AR060981]; National Institute of Arthritis Musculoskeletal and Skin Diseases [R01 AR041398, R01 AR072199]; Australian Government Research Training Program Scholarship; UK NIHR Biomedical Research Centre [201865 2008-12, 2007-12]; Swedish Research Council; Swedish Foundation for Strategic Research; European Calcified Tissue Society; Torsten and Ragnar Soderberg's Foundation; Novo Nordisk Foundation; Knut and Alice Wallenberg Foundation; NIH [R35 GM119703]; Wellcome Trust; Clinical Research Facility; Medical Research Council Programme [MC_UU_12013/4]; ALF/LUA research grant from the Sahlgrenska University Hospital; Lundberg Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR060981, R01AR063702, R01AR041398, R01AR070879, R01AR072199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119703] Funding Source: NIH RePORTER; EPSRC [EP/J008192/1] Funding Source: UKRI; MRC [MC_U147585827, G0400491, MC_UU_12013/4, MC_U147585819, MC_UP_A620_1015, MC_UU_12011/2] Funding Source: UKRI	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Fonds de Recherche Sante Quebec (FRSQ); FRQS Clinical Research Scholarship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Biomedical Research Centre based at Guy's and St Thomas's NHS Foundation Trust; King's College London(General Electric); National Health and Medical Research Council Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland Development Fellowship; Arthritis Research UK(Versus Arthritis); Wellcome Trust(Wellcome Trust); Mrs. Janice Gibson and the Ernest Heine Family Foundation; Israel Science Foundation(Israel Science Foundation); US NIH NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Arthritis Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); UK NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); European Calcified Tissue Society; Torsten and Ragnar Soderberg's Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); Clinical Research Facility; Medical Research Council Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ALF/LUA research grant from the Sahlgrenska University Hospital; Lundberg Foundation(European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research has been conducted using the UK Biobank Resource (accession IDs: 24268, 12703 and 4580). J.B.R. was supported by the Canadian Institutes of Health Research, the Canadian Foundation for Innovation and the Fonds de Recherche Sante Quebec (FRSQ), and a FRQS Clinical Research Scholarship. TwinsUK is funded by the Wellcome Trust, Medical Research Council, European Union, the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility, and Biomedical Research Centre based at Guy's and St Thomas's NHS Foundation Trust in partnership with King's College London. J.A.M. was funded by the Canadian Institutes of Health Research. D.M.E. was funded by a National Health and Medical Research Council Senior Research Fellowship (APP1137714) and funded by a Medical Research Council Programme Grant (MC_UU_12013/4). J.P.K. was funded by a University of Queensland Development Fellowship (UQFEL1718945). C.L.G. was funded by Arthritis Research UK (ref; 20000). G.R.W., J.H.D.B., and P.I.C. were funded by the Wellcome Trust (Strategic Award grant number 101123; project grant 094134), and P.I.C. was also funded by the Mrs. Janice Gibson and the Ernest Heine Family Foundation. D.K. was supported by Israel Science Foundation grant #1283/14. Y-H.H. was funded by US NIH NIAMS 1R01AR072199. F.R., C.M-G., and K.T. were funded by the Netherlands Organization for Health Research and Development (ZonMw VIDI 016.136.361 grant). C.L.A-B. was funded by NIH/NIAMS AR063702 AR060981. D. P.K. was funded by grants from the National Institute of Arthritis Musculoskeletal and Skin Diseases R01 AR041398, R01 AR072199. S.Y. was funded by the Australian Government Research Training Program Scholarship. J.R. and S.K. were funded by the Genetic Factors of Osteoporosis-GEFOS EU FP7 Integrated Project Grant Reference: 201865 2008-12 and 2007-12 UK NIHR Biomedical Research Centre Grant (Musculoskeletal theme) to Cambridge Clinical School. C.O. was supported by the Swedish Research Council, Swedish Foundation for Strategic Research, ALF/LUA research grant from the Sahlgrenska University Hospital, Lundberg Foundation, European Calcified Tissue Society, Torsten and Ragnar Soderberg's Foundation, Novo Nordisk Foundation, and Knut and Alice Wallenberg Foundation. M.T.M. was supported by NIH grant R35 GM119703. We thank M. Schull for assistance with high-performance computing at the University of Queensland Diamantina Institute and T. Winkler for invaluable technical support for the EasyStrata Software used in this study. We thank the Sanger Institute's Research Support Facility, Mouse Pipelines and Mouse Informatics Group who generated the mice and collected materials for this manuscript. We would like to thank the research participants and employees of 23andMe, Inc. for making this work possible.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 1991, Osteoporos Int, V1, P114; Arden NK, 1996, J BONE MINER RES, V11, P530; Bauer DC, 2007, OSTEOPOROSIS INT, V18, P771, DOI 10.1007/s00198-006-0317-5; Bauer DC, 1997, ARCH INTERN MED, V157, P629, DOI 10.1001/archinte.157.6.629; Belaghzal H, 2017, METHODS, V123, P56, DOI 10.1016/j.ymeth.2017.04.004; Benner C, 2016, BIOINFORMATICS, V32, P1493, DOI 10.1093/bioinformatics/btw018; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bone HG, 2017, LANCET DIABETES ENDO, V5, P513, DOI 10.1016/S2213-8587(17)30138-9; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Dallas SL, 2010, ANN NY ACAD SCI, V1192, P437, DOI 10.1111/j.1749-6632.2009.05246.x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Grundberg E, 2009, GENOME RES, V19, P1942, DOI 10.1101/gr.095224.109; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hart T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-778; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hunter DJ, 2001, OSTEOPOROSIS INT, V12, P406, DOI 10.1007/s001980170110; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Karasik D, 2002, OSTEOPOROSIS INT, V13, P796, DOI 10.1007/s001980200110; Kemp JP, 2017, NAT GENET, V49, P1468, DOI 10.1038/ng.3949; Kutmon M, 2016, NUCLEIC ACIDS RES, V44, pD488, DOI 10.1093/nar/gkv1024; Lawlor DA, 2016, INT J EPIDEMIOL, V45, P1866, DOI 10.1093/ije/dyw314; Lee HK, 2015, NEURON, V85, P1227, DOI 10.1016/j.neuron.2015.02.024; Lee HK, 2012, DEV CELL, V22, P183, DOI 10.1016/j.devcel.2011.10.025; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; McCloskey EV, 2015, OSTEOPOROSIS INT, V26, P1979, DOI 10.1007/s00198-015-3072-7; Medina-Gomez C, 2018, AM J HUM GENET, V102, P88, DOI 10.1016/j.ajhg.2017.12.005; Mifsud B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174744; Moayyeri A, 2012, OSTEOPOROSIS INT, V23, P143, DOI 10.1007/s00198-011-1817-5; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Richards JB, 2012, NAT REV GENET, V13, P576, DOI 10.1038/nrg3228; Rivadeneira F, 2016, TRENDS ENDOCRIN MET, V27, P262, DOI 10.1016/j.tem.2016.03.006; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Timpson NJ, 2018, NAT REV GENET, V19, P110, DOI 10.1038/nrg.2017.101; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Winkler TW, 2015, BIOINFORMATICS, V31, P259, DOI 10.1093/bioinformatics/btu621; Witte JS, 2014, NAT REV GENET, V15, P765, DOI 10.1038/nrg3786; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Youlten S, 2017, J BONE MINER RES, V32, pS55	58	290	296	9	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2019	51	2					258	+		10.1038/s41588-018-0302-x	http://dx.doi.org/10.1038/s41588-018-0302-x			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HJ6PM	30598549	Green Submitted, Green Accepted			2022-12-17	WOS:000457314300012
J	Ho, AS; Kannan, K; Roy, DM; Morris, LGT; Ganly, I; Katabi, N; Ramaswami, D; Walsh, LA; Eng, S; Huse, JT; Zhang, JN; Dolgalev, I; Huberman, K; Heguy, A; Viale, A; Drobnjak, M; Leversha, MA; Rice, CE; Singh, B; Iyer, NG; Leemans, CR; Bloemena, E; Ferris, RL; Seethala, RR; Gross, BE; Liang, YP; Sinha, R; Peng, LK; Raphael, BJ; Turcan, S; Gong, YX; Schultz, N; Kim, S; Chiosea, S; Shah, JP; Sander, C; Lee, W; Chan, TA				Ho, Allen S.; Kannan, Kasthuri; Roy, David M.; Morris, Luc G. T.; Ganly, Ian; Katabi, Nora; Ramaswami, Deepa; Walsh, Logan A.; Eng, Stephanie; Huse, Jason T.; Zhang, Jianan; Dolgalev, Igor; Huberman, Kety; Heguy, Adriana; Viale, Agnes; Drobnjak, Marija; Leversha, Margaret A.; Rice, Christine E.; Singh, Bhuvanesh; Iyer, N. Gopalakrishna; Leemans, C. Rene; Bloemena, Elisabeth; Ferris, Robert L.; Seethala, Raja R.; Gross, Benjamin E.; Liang, Yupu; Sinha, Rileen; Peng, Luke; Raphael, Benjamin J.; Turcan, Sevin; Gong, Yongxing; Schultz, Nikolaus; Kim, Seungwon; Chiosea, Simion; Shah, Jatin P.; Sander, Chris; Lee, William; Chan, Timothy A.			The mutational landscape of adenoid cystic carcinoma	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHROMATIN REMODELING GENES; SOMATIC POINT MUTATIONS; SQUAMOUS-CELL CARCINOMA; DNA-SEQUENCING DATA; BREAST-CANCER; TUMOR-GROWTH; INACTIVATING MUTATIONS; MISSENSE MUTATIONS; PROSTATE-CANCER	Adenoid cystic carcinomas (ACCs) are among the most enigmatic of human malignancies. These aggressive salivary gland cancers frequently recur and metastasize despite definitive treatment, with no known effective chemotherapy regimen. Here we determined the ACC mutational landscape and report the exome or whole-genome sequences of 60 ACC tumor-normal pairs. These analyses identified a low exonic somatic mutation rate (0.31 non-silent events per megabase) and wide mutational diversity. Notably, we found mutations in genes encoding chromatin-state regulators, such as SMARCA2, CREBBP and KDM6A, suggesting that there is aberrant epigenetic regulation in ACC oncogenesis. Mutations in genes central to the DNA damage response and protein kinase A signaling also implicate these processes. We observed MYB-NFIB translocations and somatic mutations in MYB-associated genes, solidifying the role of these aberrations as critical events in ACC. Lastly, we identified recurrent mutations in the FGF-IGF-PI3K pathway (30% of tumors) that might represent new avenues for therapy. Collectively, our observations establish a molecular foundation for understanding and exploring new treatments for ACC.	[Ho, Allen S.; Kannan, Kasthuri; Roy, David M.; Morris, Luc G. T.; Ganly, Ian; Ramaswami, Deepa; Walsh, Logan A.; Eng, Stephanie; Huse, Jason T.; Zhang, Jianan; Dolgalev, Igor; Huberman, Kety; Heguy, Adriana; Peng, Luke; Turcan, Sevin; Gong, Yongxing; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Ho, Allen S.; Morris, Luc G. T.; Ganly, Ian; Singh, Bhuvanesh; Shah, Jatin P.] Mem Sloan Kettering Canc Ctr, Dept Surg, Head & Neck Serv, New York, NY 10021 USA; [Katabi, Nora; Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core, New York, NY 10021 USA; [Drobnjak, Marija] Mem Sloan Kettering Canc Ctr, Pathol Core, New York, NY 10021 USA; [Leversha, Margaret A.; Rice, Christine E.] Mem Sloan Kettering Canc Ctr, Mol Cytogenet Core, New York, NY 10021 USA; [Iyer, N. Gopalakrishna] Natl Canc Ctr Singapore, Dept Surg Oncol, Singapore, Singapore; [Leemans, C. Rene] Vrije Univ Amsterdam, Med Ctr, Dept Otolaryngol Head & Neck Surg, Amsterdam, Netherlands; [Bloemena, Elisabeth] Vrije Univ Amsterdam, Med Ctr, Acad Ctr Dent, Dept Oral & Maxillofacial Surg & Oral Pathol, Amsterdam, Netherlands; [Ferris, Robert L.; Kim, Seungwon] Univ Pittsburgh, Med Ctr, Dept Otolaryngol Head & Neck Surg, Pittsburgh, PA USA; [Seethala, Raja R.; Chiosea, Simion] Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA USA; [Gross, Benjamin E.; Liang, Yupu; Sinha, Rileen; Sander, Chris; Lee, William] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Raphael, Benjamin J.] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [Schultz, Nikolaus; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; National Cancer Centre Singapore (NCCS); Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Memorial Sloan Kettering Cancer Center; Brown University; Memorial Sloan Kettering Cancer Center	Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	chant@mskcc.org	Bloemena, Elisabeth/V-1095-2018; Turcan, Sevin/AAF-1095-2019; Dolgalev, Igor/AAY-6406-2020; Heguy, Adriana/GPP-3907-2022; Schultz, Nikolaus/ABE-6347-2020; Bloemena, Elisabeth/AAZ-1247-2021; Chan, Timothy A/ABD-5850-2021	Bloemena, Elisabeth/0000-0002-0221-9538; Turcan, Sevin/0000-0002-0885-5607; Dolgalev, Igor/0000-0003-4451-126X; Shah, Jatin/0000-0002-6444-6592; Lee, William/0000-0001-9582-4413; Walsh, Logan/0000-0001-8771-2577; Kannan, Kasthuri/0000-0002-8479-0657; Sinha, Rileen/0000-0001-5497-5055; Ferris, Robert/0000-0001-6605-2071; Ganly, Ian/0000-0001-7636-5426; Leemans, C. Rene/0000-0001-7887-083X; Gong, Yongxing/0000-0003-1071-0375; Schultz, Nikolaus/0000-0002-0131-4904; Iyer, N. Gopalakrishna/0000-0002-8812-6219; Chiosea, Simion/0000-0002-5766-8779; Drobnjak, Marija/0000-0003-0676-4709	US National Institutes of Health (NIH) [RO1CA154767, R21DE023229, 5T32CA009685]; Geoffrey Beene Foundation; Starr Cancer Consortium; Louis Gerstner Foundation; American Head and Neck Society/American Academy of Otolaryngology-Head and Neck Surgery Foundation Young Investigator Combined Award; Howard Hughes Medical Institute Medical Research Fellows Program; NIH National Resource for Network Biology [GM103504]; Adenoid Cystic Carcinoma Research Foundation; NATIONAL CANCER INSTITUTE [R01CA154767, T32CA009685, T32CA160001, P30CA008748] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE023229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, P41GM103504] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geoffrey Beene Foundation; Starr Cancer Consortium; Louis Gerstner Foundation; American Head and Neck Society/American Academy of Otolaryngology-Head and Neck Surgery Foundation Young Investigator Combined Award; Howard Hughes Medical Institute Medical Research Fellows Program(Howard Hughes Medical Institute); NIH National Resource for Network Biology; Adenoid Cystic Carcinoma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Kayserian and S. Thomas for technical assistance. We are indebted to R.J. Wong (Memorial Sloan-Kettering Cancer Center), P. K. Brindle (St. Jude Children's Research Hospital) and O.J. Baker (State University of New York at Buffalo) for generously providing cell lines and constructs. We are additionally grateful to J.O. Boyle, S. G. Patel, A. R. Shaha, R.J. Wong, A. L. Ho, M. C. Mariano and L. Lopez for facilitating tissue procurement and contributing valuable input. This work was supported by the US National Institutes of Health (NIH) (RO1CA154767 (T. A. C.), R21DE023229 (T. A. C.), 5T32CA009685 (A. S. H.)), the Geoffrey Beene Foundation (T. A. C.), the Starr Cancer Consortium (T. A. C.) and the Louis Gerstner Foundation (T. A. C.). A. S. H. was supported by an American Head and Neck Society/American Academy of Otolaryngology-Head and Neck Surgery Foundation Young Investigator Combined Award. D. M. R. was supported by the Howard Hughes Medical Institute Medical Research Fellows Program. The cBio Portal was supported in part by the NIH National Resource for Network Biology (GM103504). T. A. C. would like to thank Jeff and Marnie Kaufman and the Adenoid Cystic Carcinoma Research Foundation for support of the work and inspiration to see it	Abdul M, 2008, PATHOL ONCOL RES, V14, P157, DOI 10.1007/s12253-008-9045-9; Adelstein DJ, 2012, SEMIN RADIAT ONCOL, V22, P245, DOI 10.1016/j.semradonc.2012.03.009; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Agulnik M, 2007, J CLIN ONCOL, V25, P3978, DOI 10.1200/JCO.2007.11.8612; Allen TD, 2011, CANCER RES, V71, P6010, DOI 10.1158/0008-5472.CAN-11-0595; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Binmadi NO, 2012, AM J PATHOL, V180, P1232, DOI 10.1016/j.ajpath.2011.12.009; Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; CHENG J, 1992, CANCER, V69, P2631, DOI 10.1002/1097-0142(19920601)69:11<2631::AID-CNCR2820691103>3.0.CO;2-P; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dey JH, 2010, CANCER RES, V70, P4151, DOI 10.1158/0008-5472.CAN-09-4479; Egloff AM, 2012, CLIN CANCER RES, V18, P5188, DOI 10.1158/1078-0432.CCR-11-2258; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gopalan A, 2009, CANCER RES, V69, P1400, DOI 10.1158/0008-5472.CAN-08-2467; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Holst VA, 1999, MODERN PATHOL, V12, P956; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Iyer NG, 2004, P NATL ACAD SCI USA, V101, P7386, DOI 10.1073/pnas.0401002101; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kimura S, 2000, VIRCHOWS ARCH, V437, P122, DOI 10.1007/s004280000209; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Laurie SA, 2011, LANCET ONCOL, V12, P815, DOI 10.1016/S1470-2045(10)70245-X; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Masse JE, 2002, J MOL BIOL, V323, P263, DOI 10.1016/S0022-2836(02)00938-5; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Munakata R, 1996, J ORAL PATHOL MED, V25, P441, DOI 10.1111/j.1600-0714.1996.tb00294.x; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Olsen EA, 2007, J CLIN ONCOL, V25, P3109, DOI 10.1200/JCO.2006.10.2434; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Persson M, 2012, GENE CHROMOSOME CANC, V51, P805, DOI 10.1002/gcc.21965; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Phuchareon J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006040; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodrigues S, 2007, ONCOGENE, V26, P5615, DOI 10.1038/sj.onc.1210347; Rozen S, 2000, Methods Mol Biol, V132, P365; Sarmento LM, 2011, EXPERT REV ANTICANC, V11, P1403, DOI [10.1586/ERA.11.73, 10.1586/era.11.73]; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Savore C, 2005, CLIN EXP METASTAS, V22, P377, DOI 10.1007/s10585-005-2339-3; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Spangle JM, 2010, J VIROL, V84, P9398, DOI 10.1128/JVI.00974-10; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan YM, 2008, CANCER LETT, V271, P1, DOI 10.1016/j.canlet.2008.04.036; Tien AL, 2011, BIOCHEM J, V435, P175, DOI 10.1042/BJ20100840; Tran PK, 2004, CIRC RES, V94, P550, DOI 10.1161/01.RES.0000117772.86853.34; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Van Houdt JKJ, 2012, NAT GENET, V44, P445, DOI 10.1038/ng.1105; Veekony H, 2007, CLIN CANCER RES, V13, P3133, DOI 10.1158/1078-0432.CCR-06-2555; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/NMETH.1628, 10.1038/nmeth.1628]; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wolffe AP, 2001, ONCOGENE, V20, P2988, DOI 10.1038/sj.onc.1204322; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang RB, 2003, J BIOL CHEM, V278, P33232, DOI 10.1074/jbc.M305022200; Yau C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r92; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang LN, 2011, P NATL ACAD SCI USA, V108, P13653, DOI 10.1073/pnas.1103360108; Zhou ZJ, 2004, CANCER RES, V64, P4699, DOI 10.1158/0008-5472.CAN-04-0810; 2012, ORAL ONCOL, V48, P95	97	290	303	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2013	45	7					791	+		10.1038/ng.2643	http://dx.doi.org/10.1038/ng.2643			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	172LQ	23685749	Green Accepted			2022-12-17	WOS:000321005200014
J	Hu, ZB; Wu, C; Shi, YY; Guo, H; Zhao, XY; Yin, ZH; Yang, L; Dai, JC; Hu, LM; Tan, W; Li, ZQ; Deng, QF; Wang, JC; Wu, W; Jin, GF; Jiang, Y; Yu, DK; Zhou, GQ; Chen, HY; Guan, P; Chen, YJ; Shu, YQ; Xu, L; Liu, XY; Liu, L; Xu, P; Han, BH; Bai, CX; Zhao, YX; Zhang, HB; Yan, Y; Ma, HX; Chen, JP; Chu, MJ; Lu, F; Zhang, ZD; Chen, F; Wang, XR; Jin, L; Lu, JC; Zhou, BS; Lu, DR; Wu, TC; Lin, DX; Shen, HB				Hu, Zhibin; Wu, Chen; Shi, Yongyong; Guo, Huan; Zhao, Xueying; Yin, Zhihua; Yang, Lei; Dai, Juncheng; Hu, Lingmin; Tan, Wen; Li, Zhiqiang; Deng, Qifei; Wang, Jiucun; Wu, Wei; Jin, Guangfu; Jiang, Yue; Yu, Dianke; Zhou, Guoquan; Chen, Hongyan; Guan, Peng; Chen, Yijiang; Shu, Yongqian; Xu, Lin; Liu, Xiangyang; Liu, Li; Xu, Ping; Han, Baohui; Bai, Chunxue; Zhao, Yuxia; Zhang, Haibo; Yan, Ying; Ma, Hongxia; Chen, Jiaping; Chu, Mingjie; Lu, Feng; Zhang, Zhengdong; Chen, Feng; Wang, Xinru; Jin, Li; Lu, Jiachun; Zhou, Baosen; Lu, Daru; Wu, Tangchun; Lin, Dongxin; Shen, Hongbing			A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese	NATURE GENETICS			English	Article							RISK; VARIANT; 15Q25; INFLAMMATION; POPULATIONS; 5P15.33; IMPACT; CELLS; STAT3; MAPS	Lung cancer is the leading cause of cancer-related deaths worldwide. To identify genetic factors that modify the risk of lung cancer in individuals of Chinese ancestry, we performed a genome-wide association scan in 5,408 subjects (2,331 individuals with lung cancer (cases) and 3,077 controls) followed by a two-stage validation among 12,722 subjects (6,313 cases and 6,409 controls). The combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 x 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 x 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 x 10(-20) and P = 1.0 x 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 x 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 x 10(-11) and P = 6.2 x 10(-13), respectively). Two of these loci (13q12.12 and 22q12.2) were newly identified in the Chinese population. These results suggest that genetic variants in 3q28, 5p15.33, 13q12.12 and 22q12.2 may contribute to the susceptibility of lung cancer in Han Chinese.	[Hu, Zhibin; Dai, Juncheng; Hu, Lingmin; Jin, Guangfu; Jiang, Yue; Ma, Hongxia; Chen, Jiaping; Chu, Mingjie; Lu, Feng; Zhang, Zhengdong; Chen, Feng; Wang, Xinru; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Minist Educ,Key Lab Modern Toxicol, Nanjing, Peoples R China; [Hu, Zhibin; Jin, Guangfu; Chen, Jiaping; Shen, Hongbing] Nanjing Med Univ, Clin Epidemiol Sect, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Peoples R China; [Hu, Zhibin; Wang, Xinru; Shen, Hongbing] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Peoples R China; [Wu, Chen; Tan, Wen; Yu, Dianke; Lin, Dongxin] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Wu, Chen; Tan, Wen; Yu, Dianke; Lin, Dongxin] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, Beijing 100730, Peoples R China; [Wu, Chen; Tan, Wen; Yu, Dianke; Liu, Xiangyang; Lin, Dongxin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Shi, Yongyong; Li, Zhiqiang; Zhou, Guoquan] Shanghai Jiao Tong Univ, Bio X Ctr, Shanghai 200030, Peoples R China; [Shi, Yongyong; Li, Zhiqiang; Zhou, Guoquan] Shanghai Jiao Tong Univ, Affiliated Changning Mental Hlth Ctr, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China; [Guo, Huan; Deng, Qifei; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Inst Occupat Med, Wuhan 430074, Peoples R China; [Guo, Huan; Deng, Qifei; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ,Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Zhao, Xueying; Wang, Jiucun; Chen, Hongyan; Jin, Li; Lu, Daru] Fudan Univ, State Key Lab Genet Engn, Ctr Fudan VARI Genet Epidemiol, Shanghai 200433, Peoples R China; [Zhao, Xueying; Wang, Jiucun; Chen, Hongyan; Jin, Li; Lu, Daru] Fudan Univ, MOE, Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Yin, Zhihua; Wu, Wei; Guan, Peng; Zhou, Baosen] China Med Univ, Dept Epidemiol, Sch Publ Hlth, Shenyang, Peoples R China; [Yang, Lei; Lu, Jiachun] Guangzhou Med Coll, State Key Lab Resp Dis, Inst Chem Carcinogenesis, Guangzhou, Guangdong, Peoples R China; [Chen, Yijiang; Shu, Yongqian] Nanjing Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Nanjing, Peoples R China; [Chen, Yijiang; Shu, Yongqian] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Peoples R China; [Xu, Lin] Nanjing Med Univ, Jiangsu Canc Hosp, Affiliated Canc Hosp, Dept Thorac Surg, Nanjing, Peoples R China; [Liu, Xiangyang] Chinese Acad Med Sci, Canc Hosp, Dept Thorac Surg, Beijing 100730, Peoples R China; [Liu, Li] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Ctr Canc, Wuhan 430074, Peoples R China; [Xu, Ping] Corp Staff Worker Hosp, Wuhan Iron & Steel Grp, Dept Oncol, Wuhan, Peoples R China; [Han, Baohui] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Resp Dis, Shanghai 200030, Peoples R China; [Bai, Chunxue] Fudan Univ, Zhongshan Hosp, Dept Resp Dis, Shanghai 200433, Peoples R China; [Zhao, Yuxia] China Med Univ, Affiliated Hosp 1, Dept Radiat Oncol, Shenyang, Peoples R China; [Zhang, Haibo; Yan, Ying] Shenyang No Hosp, Dept Radiotherapy, Shenyang, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Fudan University; Fudan University; China Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Huazhong University of Science & Technology; China Baowu Steel Group; Shanghai Jiao Tong University; Fudan University; China Medical University	Shen, HB (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Minist Educ,Key Lab Modern Toxicol, Nanjing, Peoples R China.	hbshen@njmu.edu.cn	Jin, Li/M-5063-2019; Wang, Jiucun/J-8744-2012; Li, Zhiqiang/AAI-4003-2021; Shi, Yongyong/GSO-1627-2022; Shu, Yongqian/ABD-5698-2021; Jin, Li/C-1468-2009; Wang, Xin/AAN-8435-2021; Guan, Peng/GWM-9170-2022; zhang, zheng/HCH-9684-2022	Wang, Jiucun/0000-0003-2765-0620; Li, Zhiqiang/0000-0002-0174-9254; Shi, Yongyong/0000-0003-1710-1505; Jin, Li/0000-0002-4546-2415; Wang, Xin/0000-0002-4457-7376; Wu, Chen/0000-0003-4954-1011; Shen, Hongbing/0000-0002-2581-5906; Jin, Guangfu/0000-0003-0249-5337; Lin, Dongxin/0000-0002-8723-8868	China National High-Tech Research and Development Program Grant [2009AA022705, 2009AA022701]; National Key Basic Research Program Grant [2011CB503805]; National Natural Science Foundation of China [30730080, 30972541, 30901233, 30872178]; Priority Academic Program Development of Jiangsu Higher Education Institutions	China National High-Tech Research and Development Program Grant; National Key Basic Research Program Grant(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work is funded by the China National High-Tech Research and Development Program Grant (2009AA022705, 2009AA022701) and partly funded by the National Key Basic Research Program Grant (2011CB503805), the National Natural Science Foundation of China (30730080, 30972541, 30901233 and 30872178) and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors wish to thank all the study participants, research staff and students who participated in this work. We thank C. Amos, J. Xu and Q. Wei for their manuscript editing.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680; Chen YL, 2010, CANCER RES, V70, P8917, DOI 10.1158/0008-5472.CAN-10-0518; Chew A, 2000, GENOMICS, V65, P104, DOI 10.1006/geno.2000.6162; Eby MT, 2000, J BIOL CHEM, V275, P15336, DOI 10.1074/jbc.275.20.15336; Guo H, 2010, J CLIN ONCOL, V28, P1928, DOI 10.1200/JCO.2009.24.4954; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Li MC, 2008, LUNG CANCER, V62, P145, DOI 10.1016/j.lungcan.2008.03.002; Liu B, 2010, CARCINOGENESIS, V31, P1405, DOI 10.1093/carcin/bgq126; Lu J, 2009, FASEB J, V23, P3459, DOI 10.1096/fj.09-136549; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Miki D, 2010, NAT GENET, V42, P893, DOI 10.1038/ng.667; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Truong T, 2010, JNCI-J NATL CANCER I, V102, P959, DOI 10.1093/jnci/djq178; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wu C, 2009, CANCER RES, V69, P5065, DOI 10.1158/0008-5472.CAN-09-0081; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang H, 2003, RESPIROLOGY, V8, P17, DOI 10.1046/j.1440-1843.2003.00433.x; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	28	290	309	2	208	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2011	43	8					792	U103		10.1038/ng.875	http://dx.doi.org/10.1038/ng.875			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	798CD	21725308				2022-12-17	WOS:000293178300016
J	Radstake, TRDJ; Gorlova, O; Rueda, B; Martin, JE; Alizadeh, BZ; Palomino-Morales, R; Coenen, MJ; Vonk, MC; Voskuyl, AE; Schuerwegh, AJ; Broen, JC; van Riel, PLCM; van't Slot, R; Italiaander, A; Ophoff, RA; Riemekasten, G; Hunzelmann, N; Simeon, CP; Ortego-Centeno, N; Gonzalez-Gay, MA; Gonzalez-Escribano, MF; Airo, P; van Laar, J; Herrick, A; Worthington, J; Hesselstrand, R; Smith, V; de Keyser, F; Houssiau, F; Chee, MM; Madhok, R; Shiels, P; Westhovens, R; Kreuter, A; Kiener, H; de Baere, E; Witte, T; Padykov, L; Klareskog, L; Beretta, L; Scorza, R; Lie, BA; Hoffmann-Vold, AM; Carreira, P; Varga, J; Hinchcliff, M; Gregersen, PK; Lee, AT; Ying, J; Han, Y; Weng, SF; Amos, CI; Wigley, FM; Hummers, L; Nelson, JL; Agarwal, SK; Assassi, S; Gourh, P; Tan, FK; Koeleman, BPC; Arnett, FC; Martin, J; Mayes, MD				Radstake, Timothy R. D. J.; Gorlova, Olga; Rueda, Blanca; Martin, Jose-Ezequiel; Alizadeh, Behrooz Z.; Palomino-Morales, Rogelio; Coenen, Marieke J.; Vonk, Madelon C.; Voskuyl, Alexandre E.; Schuerwegh, Annemie J.; Broen, Jasper C.; van Riel, Piet L. C. M.; van't Slot, Ruben; Italiaander, Annet; Ophoff, Roel A.; Riemekasten, Gabriela; Hunzelmann, Nico; Simeon, Carmen P.; Ortego-Centeno, Norberto; Gonzalez-Gay, Miguel A.; Gonzalez-Escribano, Maria F.; Airo, Paolo; van Laar, Jaap; Herrick, Ariane; Worthington, Jane; Hesselstrand, Roger; Smith, Vanessa; de Keyser, Filip; Houssiau, Fredric; Chee, Meng May; Madhok, Rajan; Shiels, Paul; Westhovens, Rene; Kreuter, Alexander; Kiener, Hans; de Baere, Elfride; Witte, Torsten; Padykov, Leonid; Klareskog, Lars; Beretta, Lorenzo; Scorza, Rafaella; Lie, Benedicte A.; Hoffmann-Vold, Anna-Maria; Carreira, Patricia; Varga, John; Hinchcliff, Monique; Gregersen, Peter K.; Lee, Annette T.; Ying, Jun; Han, Younghun; Weng, Shih-Feng; Amos, Christopher I.; Wigley, Fredrick M.; Hummers, Laura; Nelson, J. Lee; Agarwal, Sandeep K.; Assassi, Shervin; Gourh, Pravitt; Tan, Filemon K.; Koeleman, Bobby P. C.; Arnett, Frank C.; Martin, Javier; Mayes, Maureen D.		Spanish Scleroderma Grp	Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus	NATURE GENETICS			English	Article							CD4 T-CELLS; LUPUS-ERYTHEMATOSUS; FUNCTIONAL POLYMORPHISM; JAPANESE POPULATION; CD3-ZETA EXPRESSION; COMPLEX; RISK; SCLERODERMA; MECHANISMS; PHENOTYPE	Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis of the skin and internal organs that leads to profound disability and premature death. To identify new SSc susceptibility loci, we conducted the first genome-wide association study in a population of European ancestry including a total of 2,296 individuals with SSc and 5,171 controls. Analysis of 279,621 autosomal SNPs followed by replication testing in an independent case-control set of European ancestry (2,753 individuals with SSc (cases) and 4,569 controls) identified a new susceptibility locus for systemic sclerosis at CD247 (1q22-23, rs2056626, P = 2.09 x 10(-7) in the discovery samples, P = 3.39 x 10(-9) in the combined analysis). Additionally, we confirm and firmly establish the role of the MHC (P = 2.31 x 10(-18)), IRF5 (P = 1.86 x 10(-13)) and STAT4 (P = 3.37 x 10(-9)) gene regions as SSc genetic risk factors.	[Radstake, Timothy R. D. J.; Vonk, Madelon C.; Broen, Jasper C.; van Riel, Piet L. C. M.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands; [Gorlova, Olga; Ying, Jun; Han, Younghun; Weng, Shih-Feng; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Rueda, Blanca; Martin, Jose-Ezequiel; Palomino-Morales, Rogelio; Arnett, Frank C.; Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Alizadeh, Behrooz Z.; van't Slot, Ruben; Italiaander, Annet; Ophoff, Roel A.; Koeleman, Bobby P. C.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Coenen, Marieke J.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Voskuyl, Alexandre E.] Vrije Univ VU Med Ctr, Dept Rheumatol, Nijmegen, Netherlands; [Schuerwegh, Annemie J.] Leiden Univ, Dept Rheumatol, Nijmegen, Netherlands; [Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; [Riemekasten, Gabriela] Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany; [Hunzelmann, Nico] Univ Cologne, Dept Dermatol, D-5000 Cologne, Germany; [Simeon, Carmen P.] Hosp Valle de Hebron, Med Interna Serv, Barcelona, Spain; [Ortego-Centeno, Norberto] Hosp Clin Univ, Med Interna Serv, Granada, Spain; [Gonzalez-Gay, Miguel A.; Carreira, Patricia] Hosp Marques de Valdecilla, Serv Reumatol, Santander, Spain; [Gonzalez-Escribano, Maria F.] Hosp Virgen del Rocio, Serv Inmunol, Seville, Spain; [Airo, Paolo] Univ Brescia, Brescia, Italy; [van Laar, Jaap] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Herrick, Ariane; Worthington, Jane] Univ Manchester, Manchester Acad Hlth Sci Ctr, Dept Rheumatol & Epidemiol, Manchester, Lancs, England; [Hesselstrand, Roger] Lund Univ, Lund, Sweden; [Houssiau, Fredric] Katholieke Univ Leuven, Leuven, Belgium; [Chee, Meng May; Madhok, Rajan; Shiels, Paul] Univ Glasgow, Glasgow, Lanark, Scotland; [Westhovens, Rene] Univ Antwerp, B-2020 Antwerp, Belgium; [Kreuter, Alexander] Ruhr Univ Bochum, Bochum, Germany; [Kiener, Hans] Univ Vienna, Vienna, Austria; [de Baere, Elfride] Univ Ghent, Dept Genet, B-9000 Ghent, Belgium; [Witte, Torsten] Leibniz Univ Hannover, Hannover, Germany; [Padykov, Leonid; Klareskog, Lars] Karolinska Inst, Stockholm, Sweden; [Beretta, Lorenzo; Scorza, Rafaella] Univ Milan, Milan, Italy; [Lie, Benedicte A.] Oslo Univ Hosp, Rikshosp, Inst Immunol, Oslo, Norway; [Hoffmann-Vold, Anna-Maria] Oslo Univ Hosp, Rikshosp, Dept Rheumatol, Oslo, Norway; [Carreira, Patricia] Hosp 12 Octubre, E-28041 Madrid, Spain; [Varga, John; Hinchcliff, Monique] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Gregersen, Peter K.; Lee, Annette T.] Feinstein Inst Med Res, Manhasset, NY USA; [Hummers, Laura] Johns Hopkins Univ, Med Ctr, Baltimore, MD 21218 USA; [Nelson, J. Lee] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Agarwal, Sandeep K.; Assassi, Shervin; Gourh, Pravitt; Tan, Filemon K.; Mayes, Maureen D.] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA	Radboud University Nijmegen; University of Texas System; UTMD Anderson Cancer Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Leiden University; Leiden University - Excl LUMC; University of California System; University of California Los Angeles; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cologne; Hospital Universitari Vall d'Hebron; Hospital Universitario Marques de Valdecilla (HUMV); Virgen del Rocio University Hospital; University of Brescia; Newcastle University - UK; University of Manchester; Lund University; KU Leuven; University of Glasgow; University of Antwerp; Ruhr University Bochum; University of Vienna; Ghent University; Leibniz University Hannover; Karolinska Institutet; University of Milan; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; Hospital Universitario 12 de Octubre; Northwestern University; Feinberg School of Medicine; Northwell Health; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Fred Hutchinson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Radstake, TRDJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands.	tradstake73@gmail.com; maureen.d.mayes@uth.tmc.edu	Rueda-Medina, Blanca/F-3156-2019; Alizadeh, Behrooz Z Ziad/J-2921-2017; Centeno, Norberto Ortego/C-4793-2019; Coenen, Marieke/A-2159-2010; Riemekasten, Gabriela/B-5019-2017; Carreira, Patricia E/D-4429-2018; De Baere, Elfride/E-7405-2017; Palomino-Morales, Rogelio J/L-5720-2014; Vonk, M.C./L-4726-2015; Beretta, Lorenzo/AAB-8605-2019; González-Gay, Miguel A./B-2306-2008; González-Escribano, María Francisca/X-5554-2019; van Riel, P.L.C.M./H-8082-2014; Martín, María/HDL-9512-2022; Martin, Jose-Ezequiel/A-6136-2011; Worthington, Jane/M-9770-2014; Martín, Javier/AAV-5209-2021; Witte, Torsten/B-5783-2016; Martin, Javier/B-8141-2008; Varga, John/AAK-6472-2021; Gourh, Pravitt/L-9478-2017; Padyukov, Leonid/A-4890-2009; Martin, Jose Ezequiel/F-4869-2012	Rueda-Medina, Blanca/0000-0002-0263-7000; Alizadeh, Behrooz Z Ziad/0000-0002-1415-8007; Centeno, Norberto Ortego/0000-0003-2325-0937; Coenen, Marieke/0000-0001-8796-2031; Carreira, Patricia E/0000-0001-8279-3806; De Baere, Elfride/0000-0002-5609-6895; Palomino-Morales, Rogelio J/0000-0003-3507-343X; Vonk, M.C./0000-0002-2266-9907; Beretta, Lorenzo/0000-0002-6529-6258; González-Gay, Miguel A./0000-0002-7924-7406; Worthington, Jane/0000-0003-0544-042X; Martin, Javier/0000-0002-2202-0622; Hinchcliff, Monique/0000-0002-8652-9890; Gourh, Pravitt/0000-0002-6488-1850; Weng, Shih-Feng/0000-0001-8684-3487; Voskuyl, Alexandre/0000-0002-9699-1827; Klareskog, Lars/0000-0001-9601-6186; Herrick, Ariane/0000-0003-4941-7926; Padyukov, Leonid/0000-0003-2950-5670; Shiels, Paul/0000-0002-7577-9843; Martin, Jose Ezequiel/0000-0002-0051-8868; Hummers, Laura/0000-0002-4864-4011; Kreuter, Alexander/0000-0003-2275-499X	Dutch Association of Research (NWO); Dutch Arthritis Foundation (National Reumafonds); Spanish Society of Rheumatology; Spanish Ministry of Science [SAF2009-11110]; Junta de Andaluc a, Spain [CTS-4977]; Instituto de Salud Carlos III (ISCIII) [RD08/0075]; Netherlands Organization for Health Research and Development [016.096.121]; Dutch Diabetes Research Foundation [2008.40.001]; Dutch Arthritis Foundation [NR 09-1-408]; US National Insitutes of Mental Health [R01 MH078075]; German Research Foundation; US National Institutes of Health; National Institute of Arthritis and Musculoskeletal Diseases (NIH-NIAMS) [R01 AR055258,]; Two-Stage Genome Wide Association Study in Systemic Sclerosis; NIH-NIAMS Center of Research Translation (CORT) [SSc (P50AR054144)]; NIH-NIAMS SSc Family Registry; DNA Repository [N01-AR-0-2251]; University of Texas Health Science Center-Houston Center for Clinical and Translational Sciences [3UL1RR024148]; NIH-NIAMS K08 [K08AR054404]; SSc Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR054404, P50AR054144, R01AR055258, N01AR002251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078075] Funding Source: NIH RePORTER	Dutch Association of Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Arthritis Foundation (National Reumafonds); Spanish Society of Rheumatology; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andaluc a, Spain(Junta de Andalucia); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Dutch Diabetes Research Foundation; Dutch Arthritis Foundation; US National Insitutes of Mental Health; German Research Foundation(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal Diseases (NIH-NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Two-Stage Genome Wide Association Study in Systemic Sclerosis; NIH-NIAMS Center of Research Translation (CORT)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH-NIAMS SSc Family Registry(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); DNA Repository; University of Texas Health Science Center-Houston Center for Clinical and Translational Sciences; NIH-NIAMS K08(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); SSc Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the following grants: T.R.D.J.R. was funded by the VIDI laureate from the Dutch Association of Research (NWO) and Dutch Arthritis Foundation (National Reumafonds). J.M. was funded by GEN-FER from the Spanish Society of Rheumatology, SAF2009-11110 from the Spanish Ministry of Science, CTS-4977 from Junta de Andaluc a, Spain and in part by Redes Tematicas de Investigacion Cooperativa Sanitaria Program, RD08/0075 (RIER) from Instituto de Salud Carlos III (ISCIII), Spain (J.M.). R. B. is supported by the I3P Consejo Superior de Investigaciones Cientificas program funded by the 'Fondo Social Europeo'. B.Z.A. is supported by the Netherlands Organization for Health Research and Development (ZonMW grant 016.096.121). B. K. is supported by the Dutch Diabetes Research Foundation (grant 2008.40.001) and the Dutch Arthritis Foundation (Reumafonds, grant NR 09-1-408). Genotyping of the Dutch control samples was sponsored by US National Insitutes of Mental Health funding, R01 MH078075 (R.O.A.). The German controls were from the PopGen biobank (to B. K.). The PopGen project received infrastructure support through the German Research Foundation excellence cluster 'Inflammation at Interfaces'. The US analyses were supported by the US National Institutes of Health and National Institute of Arthritis and Musculoskeletal Diseases (NIH-NIAMS) R01 AR055258, Two-Stage Genome Wide Association Study in Systemic Sclerosis, (M. D. M.) and by the NIH-NIAMS Center of Research Translation (CORT) in SSc (P50AR054144) (F. C. A.), the NIH-NIAMS SSc Family Registry and DNA Repository (N01-AR-0-2251) (M. D. M.), University of Texas Health Science Center-Houston Center for Clinical and Translational Sciences (Houston Clinical and Translational Science Awards Program) (NIH-National Center for Research Resources 3UL1RR024148) (F. C. A.), NIH-NIAMS K08 Award (K08AR054404) (S. K. A.), SSc Foundation New Investigator Award (S. K. A.).	Agarwal SK, 2008, RHEUM DIS CLIN N AM, V34, P17, DOI 10.1016/j.rdc.2007.10.001; ARNETT FC, ANN RHEUM DIS; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Call ME, 2004, MOL IMMUNOL, V40, P1295, DOI 10.1016/j.molimm.2003.11.017; Dieude P, 2009, ARTHRITIS RHEUM-US, V60, P225, DOI 10.1002/art.24183; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Gorman CL, 2008, J IMMUNOL, V180, P1060, DOI 10.4049/jimmunol.180.2.1060; Gourh P, 2006, ARTHRITIS RHEUM-US, V54, P3945, DOI 10.1002/art.22196; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Ito I, 2009, ARTHRITIS RHEUM-US, V60, P1845, DOI 10.1002/art.24600; Jimenez SA, 2004, ANN INTERN MED, V140, P37, DOI 10.7326/0003-4819-140-1-200401060-00010; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Krishnan S, 2003, J IMMUNOL, V170, P4189, DOI 10.4049/jimmunol.170.8.4189; Krishnan S, 2005, J IMMUNOL, V175, P3417, DOI 10.4049/jimmunol.175.5.3417; Krishnan S, 2001, BLOOD, V97, P3851, DOI 10.1182/blood.V97.12.3851; Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, 1980, ARTHRITIS RHEUM, V23, P581; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rueda B, 2009, HUM MOL GENET, V18, P2071, DOI 10.1093/hmg/ddp119; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Tian C, 2009, MOL MED, V15, P371, DOI 10.2119/molmed.2009.00094; Tsuchiya N, 2009, ANN RHEUM DIS, V68, P1375, DOI 10.1136/ard.2009.111310; Warchol T, 2009, TISSUE ANTIGENS, V74, P68, DOI 10.1111/j.1399-0039.2009.01264.x; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	24	290	293	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2010	42	5					426	U71		10.1038/ng.565	http://dx.doi.org/10.1038/ng.565			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	589UK	20383147	Green Accepted			2022-12-17	WOS:000277179500014
J	Melzer, S; Lens, F; Gennen, J; Vanneste, S; Rohde, A; Beeckman, T				Melzer, Siegbert; Lens, Frederic; Gennen, Jerome; Vanneste, Steffen; Rohde, Antje; Beeckman, Tom			Flowering-time genes modulate meristem determinacy and growth form in Arabidopsis thaliana	NATURE GENETICS			English	Article							FLORAL INDUCTION; FT; ACTIVATION; TRANSITION; EXPRESSION; MORPHOLOGY; FRUITFULL; EVOLUTION; PATHWAYS; SIGNALS	Plants have evolved annual and perennial life forms as alternative strategies to adapt reproduction and survival to environmental constraints. In isolated situations, such as islands, woody perennials have evolved repeatedly from annual ancestors(1). Although the molecular basis of the rapid evolution of insular woodiness is unknown, the molecular difference between perennials and annuals might be rather small, and a change between these life strategies might not require major genetic innovations(2,3). Developmental regulators can strongly affect evolutionary variation(4) and genes involved in meristem transitions are good candidates for a switch in growth habit. We found that the MADS box proteins SUPPRESSOR OF OVEREXPRESSION OF CONSTANS 1 ( SOC1) and FRUITFULL (FUL) not only control flowering time, but also affect determinacy of all meristems. In addition, downregulation of both proteins established phenotypes common to the lifestyle of perennial plants, suggesting their involvement in the prevention of secondary growth and longevity in annual life forms.	[Melzer, Siegbert; Gennen, Jerome; Vanneste, Steffen; Rohde, Antje; Beeckman, Tom] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Melzer, Siegbert; Gennen, Jerome; Vanneste, Steffen; Rohde, Antje; Beeckman, Tom] Univ Ghent, Dept Mol Genet, B-9052 Ghent, Belgium; [Lens, Frederic] Katholieke Univ Leuven, Inst Bot & Microbiol, Lab Plant Syst, B-3001 Louvain, Belgium; [Lens, Frederic] Nat Herbarium Netherlands, Leiden Univ Branch, NL-2300 RA Leiden, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; KU Leuven; Leiden University; Leiden University - Excl LUMC	Melzer, S (corresponding author), Univ Ghent VIB, Dept Plant Syst Biol, Technol Pk 927, B-9052 Ghent, Belgium.	siegbert.melzer@psb.ugent.be	Rohde, Antje/AFO-6894-2022; Lens, Frederic/B-8482-2011; Vanneste, Steffen/K-8353-2013; Beeckman, Tom/ABA-1164-2020; Beeckman, Tom/ABI-1703-2020	Lens, Frederic/0000-0002-5001-0149; Vanneste, Steffen/0000-0002-9948-9672; Beeckman, Tom/0000-0001-8656-2060; Rohde, Antje/0000-0002-1574-1843; Melzer, Siegbert/0000-0003-4008-4782	Technology in Flanders; Research Foundation-Flanders (FWO)	Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation-Flanders (FWO)(FWO)	We appreciate the continuous support of K. Apel, D. Inze and E. Smets. We thank J. Chandler and M. De Cock for critical reading of the manuscript. S. V. is indebted to the Institute for the Promotion of Innovation through Science and Technology in Flanders for a predoctoral fellowship. F. L. and A. R. are postdoctoral fellows of the Research Foundation-Flanders (FWO). Seeds of 35S:FT plants were provided by P. Wigge (John Innes Centre), seeds of the soc1-1 allele were provided by G. Coupland (Max Planck Institute for Plant Breeding Research) and seeds of soc1-2 in Col and Ler backgrounds by I. Lee (University of Seoul).	Battey NH, 2002, CURR OPIN PLANT BIOL, V5, P62, DOI 10.1016/S1369-5266(01)00229-1; Bohle UR, 1996, P NATL ACAD SCI USA, V93, P11740, DOI 10.1073/pnas.93.21.11740; Borner R, 2000, PLANT J, V24, P591, DOI 10.1046/j.1365-313x.2000.00906.x; Carlquist S., 1974, ISLAND BIOL, DOI [10.5962/bhl.title.63768, DOI 10.5962/BHL.TITLE.63768]; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Cronk QCB, 2001, NAT REV GENET, V2, P607, DOI 10.1038/35084556; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Demura T, 2007, TRENDS PLANT SCI, V12, P64, DOI 10.1016/j.tplants.2006.12.006; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; Groover AT, 2005, TRENDS PLANT SCI, V10, P210, DOI 10.1016/j.tplants.2005.03.001; Hempel FD, 1997, DEVELOPMENT, V124, P3845; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kim SC, 1996, P NATL ACAD SCI USA, V93, P7743, DOI 10.1073/pnas.93.15.7743; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Long J, 2000, DEV BIOL, V218, P341, DOI 10.1006/dbio.1999.9572; Poduska B, 2003, GENETICS, V163, P1457; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Schonrock N, 2006, GENE DEV, V20, P1667, DOI 10.1101/gad.377206; Sibout R, 2008, CURR BIOL, V18, P458, DOI 10.1016/j.cub.2008.02.070; Teper-Bamnolker P, 2005, PLANT CELL, V17, P2661, DOI 10.1105/tpc.105.035766; Thomas H, 2000, J EXP BOT, V51, P1781, DOI 10.1093/jexbot/51.352.1781; Tooke F, 2005, J EXP BOT, V56, P2587, DOI 10.1093/jxb/eri254; Wang Q, 2007, CURR BIOL, V17, P1513, DOI 10.1016/j.cub.2007.07.059; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928	28	290	320	7	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2008	40	12					1489	1492		10.1038/ng.253	http://dx.doi.org/10.1038/ng.253			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18997783	Green Published, Green Submitted			2022-12-17	WOS:000261215900028
J	Hu, ZZ; Killion, PJ; Iyer, VR				Hu, Zhanzhi; Killion, Patrick J.; Iyer, Vishwanath R.			Genetic reconstruction of a functional transcriptional regulatory network	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; BINDING-SITES; EXPRESSION; GENOME; PHENOTYPES; CHROMATIN; PATHWAYS; DATABASE; TARGET	Although global analyses of transcription factor binding provide one view of potential transcriptional regulatory networks(1,2), regulation also occurs at levels distinct from transcription factor binding(3,4). Here, we use a genetic approach to identify targets of transcription factors in yeast and reconstruct a functional regulatory network. First, we profiled transcriptional responses in S. cerevisiae strains with individual deletions of 263 transcription factors. Then we used directed-weighted graph modeling and regulatory epistasis analysis to identify indirect regulatory relationships between these transcription factors, and from this we reconstructed a functional transcriptional regulatory network. The enrichment of promoter motifs and Gene Ontology annotations provide insight into the biological functions of the transcription factors.	Univ Texas, Ctr Syst & Synth Biol, Inst Mol & Cellular Biol, Sect Mol Genet & Microbiol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Iyer, VR (corresponding author), Univ Texas, Ctr Syst & Synth Biol, Inst Mol & Cellular Biol, Sect Mol Genet & Microbiol, 1 Univ Stn A4800, Austin, TX 78712 USA.	vishy@mail.utexas.edu		Hu, Zhanzhi/0000-0003-2171-0071				Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Chiang DY, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r43; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dilova I, 2004, J BIOL CHEM, V279, P46527, DOI 10.1074/jbc.M409012200; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hall DA, 2004, SCIENCE, V306, P482, DOI 10.1126/science.1096773; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hartemink A J, 2001, Pac Symp Biocomput, P422; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Killion PJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-32; Komeili A, 2000, J CELL BIOL, V151, P863, DOI 10.1083/jcb.151.4.863; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Rosenfeld N, 2003, J MOL BIOL, V329, P645, DOI 10.1016/S0022-2836(03)00506-0; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Van Driessche N, 2005, NAT GENET, V37, P471, DOI 10.1038/ng1545; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yeang CH, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r62; Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607	29	290	297	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					683	687		10.1038/ng2012	http://dx.doi.org/10.1038/ng2012			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17417638				2022-12-17	WOS:000245971300027
J	Chin, K; de Solorzano, CO; Knowles, D; Jones, A; Chou, W; Rodriguez, EG; Kuo, WL; Ljung, BM; Chew, K; Myambo, K; Miranda, M; Krig, S; Garbe, J; Stampfer, M; Yaswen, P; Gray, JW; Lockett, SJ				Chin, K; de Solorzano, CO; Knowles, D; Jones, A; Chou, W; Rodriguez, EG; Kuo, WL; Ljung, BM; Chew, K; Myambo, K; Miranda, M; Krig, S; Garbe, J; Stampfer, M; Yaswen, P; Gray, JW; Lockett, SJ			In situ analyses of genome instability in breast cancer	NATURE GENETICS			English	Article							MAMMARY EPITHELIAL-CELLS; TELOMERE DYSFUNCTION; HYBRIDIZATION; CARCINOMA; AMPLIFICATION; EXPRESSION; EVOLUTION; OCCURS; MICE	Transition through telomere crisis is thought to be a crucial event in the development of most breast carcinomas. Our goal in this study was to determine where this occurs in the context of histologically defined breast cancer progression. To this end, we assessed genome instability (using fluorescence in situ hybridization) and other features associated with telomere crisis in normal ductal epithelium, usual ductal hyperplasia, ductal carcinoma in situ and invasive cancer. We modeled this process in vitro by measuring these same features in human mammary epithelial cell cultures during ZNF217-mediated transition through telomere crisis and immortalization. Taken together, the data suggest that transition through telomere crisis and immortalization in breast cancer occurs during progression from usual ductal hyperplasia to ductal carcinoma in situ.	Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Engn, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Gray, JW (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	jwgray@lbl.gov	Gray, Joe/AAX-9549-2020; Ortiz-de-Solorzano, Carlos/G-3278-2010	Ortiz-de-Solorzano, Carlos/0000-0001-8720-0205	NATIONAL CANCER INSTITUTE [R01CA101359, R01CA090421] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA090421, R01 CA101359] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; de Solorzano CO, 1999, J MICROSC-OXFORD, V193, P212, DOI 10.1046/j.1365-2818.1999.00463.x; DUPONT WD, 1985, NEW ENGL J MED, V312, P146, DOI 10.1056/NEJM198501173120303; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herbert BS, 2001, BREAST CANCER RES, V3, P146, DOI 10.1186/bcr288; Holst CR, 2003, CANCER RES, V63, P1596; ISOLA JJ, 1995, AM J PATHOL, V147, P905; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; KALLIONIEMI OP, 1992, P NATL ACAD SCI USA, V89, P5321, DOI 10.1073/pnas.89.12.5321; Kelland LR, 2001, LANCET ONCOL, V2, P95, DOI 10.1016/S1470-2045(00)00226-6; Kim MM, 2001, P NATL ACAD SCI USA, V98, P7982, DOI 10.1073/pnas.131211098; Kuukasjarvi T, 1997, CANCER RES, V57, P1597; Kuukasjarvi T, 1997, AM J PATHOL, V150, P1465; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Meeker AK, 2004, AM J PATHOL, V164, P925, DOI 10.1016/S0002-9440(10)63180-X; Nishizaki T, 1997, GENE CHROMOSOME CANC, V19, P267, DOI 10.1002/(SICI)1098-2264(199708)19:4<267::AID-GCC9>3.0.CO;2-V; Nonet GH, 2001, CANCER RES, V61, P1250; O'Connell P, 1998, JNCI-J NATL CANCER I, V90, P697, DOI 10.1093/jnci/90.9.697; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Takimoto R, 2002, CANCER BIOL THER, V1, P47, DOI 10.4161/cbt.1.1.41; THOMPSON CT, 1994, AM J PATHOL, V144, P237; Waldman FM, 2000, JNCI-J NATL CANCER I, V92, P313, DOI 10.1093/jnci/92.4.313; Yashima K, 1998, CLIN CANCER RES, V4, P229	30	290	304	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					984	988		10.1038/ng1409	http://dx.doi.org/10.1038/ng1409			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15300252	Bronze			2022-12-17	WOS:000223658100025
J	Ausin, I; Alonso-Blanco, C; Jarillo, JA; Ruiz-Garcia, L; Martinez-Zapater, JM				Ausin, I; Alonso-Blanco, C; Jarillo, JA; Ruiz-Garcia, L; Martinez-Zapater, JM			Regulation of flowering time by FVE, a retinoblastoma-associated protein	NATURE GENETICS			English	Article							ARABIDOPSIS-THALIANA; REPRODUCTIVE DEVELOPMENT; REPEAT PROTEINS; GENE; VERNALIZATION; MUTATIONS; ENCODES; MUTANTS; FRIGIDA; LUMINIDEPENDENS	The initiation of flowering in plants is controlled by environmental and endogenous signals(1,2). Molecular analysis of this process in Arabidopsis thaliana indicates that environmental control is exerted through the photoperiod and vernalization pathways, whereas endogenous signals regulate the autonomous and gibberellin pathways. The vernalization and autonomous pathways converge on the negative regulation of FLC3,4, a gene encoding a MADS-box protein that inhibits flowering(3,4). We cloned FVE, a component of the autonomous pathway that encodes AtMSI4, a putative retinoblastoma-associated protein. FVE interacted with retinoblastoma protein in immunoprecipitation assays, and FLC chromatin was enriched in acetylated histones in fve mutants. We conclude that FVE participates in a protein complex repressing FLC transcription through a histone deacetylation mechanism. Our data provide genetic evidence of a new developmental function of these conserved proteins and identify a new genetic mechanism in the regulation of flowering.	Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, E-28049 Madrid, Spain; Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Biotecnol, Madrid 28040, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Martinez-Zapater, JM (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, Campus Univ, E-28049 Madrid, Spain.	zapater@cnb.uam.es	Martinez Zapater, Jose/I-4892-2012; Alonso-Blanco, Carlos/F-8864-2016; Ausin, Israel/A-7065-2011	Martinez Zapater, Jose/0000-0001-7217-4454; Alonso-Blanco, Carlos/0000-0002-4738-5556; Ausin, Israel/0000-0002-3707-1780; Ruiz-Garcia, Leonor/0000-0002-3182-4438; Jarillo, Jose Antonio/0000-0002-2963-7641				Ach RA, 1997, PLANT CELL, V9, P1595, DOI 10.1105/tpc.9.9.1595; Boniotti MB, 2001, PLANT J, V28, P341, DOI 10.1046/j.1365-313X.2001.01160.x; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Hennig L, 2003, DEVELOPMENT, V130, P2555, DOI 10.1242/dev.00470; Hicks GR, 1995, ANNU REV CELL DEV BI, V11, P155, DOI 10.1146/annurev.cb.11.110195.001103; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kaya H, 2001, CELL, V104, P131, DOI 10.1016/S0092-8674(01)00197-0; Kenzior AL, 1998, FEBS LETT, V440, P425, DOI 10.1016/S0014-5793(98)01500-2; Kohler C, 2003, EMBO J, V22, P4804, DOI 10.1093/emboj/cdg444; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Koornneef M, 1998, ANNU REV PLANT PHYS, V49, P345, DOI 10.1146/annurev.arplant.49.1.345; LEE I, 1994, PLANT CELL, V6, P75, DOI 10.1105/tpc.6.1.75; LEE I, 1994, PLANT J, V6, P903, DOI 10.1046/j.1365-313X.1994.6060903.x; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; MACKNIGHT R, 1997, CELL, V89, P1; MARTINEZZAPATER JM, 1990, PLANT PHYSIOL, V92, P770, DOI 10.1104/pp.92.3.770; MARTINEZZAPATER JM, 1995, PLANT J, V7, P543, DOI 10.1046/j.1365-313X.1995.7040543.x; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Rossi V, 2003, PLANT MOL BIOL, V51, P401, DOI 10.1023/A:1022090916446; Rossi V, 2001, MOL GENET GENOMICS, V265, P576, DOI 10.1007/s004380100461; Sanda SL, 1996, MOL GEN GENET, V251, P69; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Williams L, 2000, TRENDS PLANT SCI, V5, P239, DOI 10.1016/S1360-1385(00)01653-8	30	290	309	5	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2004	36	2					162	166		10.1038/ng1295	http://dx.doi.org/10.1038/ng1295			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	768KT	14745447	Bronze			2022-12-17	WOS:000188542700018
J	Kimura, A; Umehara, T; Horikoshi, M				Kimura, A; Umehara, T; Horikoshi, M			Chromosomal gradient of histone acetylation established by Sas2p and Sir2p functions as a shield against gene silencing	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE TELOMERES; YEAST HETEROCHROMATIN; LYSINE RESIDUES; CORE HISTONES; STRAND BREAKS; ACETYLTRANSFERASE; REPRESSION; H3; COMPLEX; PROTEIN	Genes located in chromosomal regions near telomeres are transcriptionally silent, whereas those located in regions away from telomeres are not. Here we show that there is a gradient of acetylation of histone H4 at lysine 16 (H4-Lys16) along a yeast chromosome; this gradient ranges from a hypoacetylated state in regions near the telomere to a hyperacetylated state in more distant regions. The hyperacetylation is regulated by Sas2p, a member of the MYST-type family of histone acetylases, whereas hypoacetylation is under the control of Sir2p, a histone deacetylase. Loss of hyperacetylation is accompanied by an increase in localization of the telomere protein Sir3p and the inactivation of gene expression in telomere-distal regions. Thus, the Sas2p and Sir2p function in concert to regulate transcription in yeast, by acetylating and deacetylating H4-Lys16 in a mechanism that may be common to all eukaryotes.	Japan Sci & Technol Corp, Horikoshi Gene Selector Project, Exploratoey Res Adv Technol, Tsukuba, Ibaraki 3002635, Japan; Univ Tokyo, Dev Biol Lab, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Japan Science & Technology Agency (JST); University of Tokyo	Horikoshi, M (corresponding author), Japan Sci & Technol Corp, Horikoshi Gene Selector Project, Exploratoey Res Adv Technol, 5-9-6 Tokodai, Tsukuba, Ibaraki 3002635, Japan.		Umehara, Takashi/N-5683-2015; Umehara, Takashi/AHB-1730-2022	Umehara, Takashi/0000-0003-3464-2960; Umehara, Takashi/0000-0003-3464-2960				APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Cockell M, 1999, CURR OPIN GENET DEV, V9, P199, DOI 10.1016/S0959-437X(99)80030-6; de Bruin D, 2000, MOL CELL BIOL, V20, P7991, DOI 10.1128/MCB.20.21.7991-8000.2000; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; EhrenhoferMurray AE, 1997, GENETICS, V145, P923; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Guarente L, 1999, NAT GENET, V23, P281, DOI 10.1038/15458; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; Kimura A, 1998, FEBS LETT, V431, P131, DOI 10.1016/S0014-5793(98)00752-2; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Loo S, 1995, ANNU REV CELL DEV BI, V11, P519, DOI 10.1146/annurev.cellbio.11.1.519; Louis EJ, 1995, YEAST, V11, P1553, DOI 10.1002/yea.320111604; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Meijsing SH, 2001, GENE DEV, V15, P3169, DOI 10.1101/gad.929001; Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Osada S, 2001, GENE DEV, V15, P3155, DOI 10.1101/gad.907201; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Smith ER, 1998, P NATL ACAD SCI USA, V95, P3561, DOI 10.1073/pnas.95.7.3561; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; SUKA N, 2002, NATURE GENET, V32; Takechi S, 1999, BIOCHEM BIOPH RES CO, V266, P405, DOI 10.1006/bbrc.1999.1836; THOMPSON JS, 1994, NATURE, V369, P245, DOI 10.1038/369245a0; TURNER BM, 1992, CELL, V69, P375, DOI 10.1016/0092-8674(92)90417-B; VegaPalas MA, 1997, NAT GENET, V15, P232, DOI 10.1038/ng0397-232; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; Yan Y, 2000, MOL CELL, V6, P1195, DOI 10.1016/S1097-2765(00)00116-7; Zakian VA, 1996, ANNU REV GENET, V30, P141, DOI 10.1146/annurev.genet.30.1.141	51	290	296	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					370	377		10.1038/ng993	http://dx.doi.org/10.1038/ng993			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12410229				2022-12-17	WOS:000179034800011
J	Monreal, AW; Ferguson, BM; Headon, DJ; Street, SL; Overbeek, PA; Zonana, J				Monreal, AW; Ferguson, BM; Headon, DJ; Street, SL; Overbeek, PA; Zonana, J			Mutations in the human homologue of mouse dl cause autosomal recessive and dominant hypohidrotic ectodermal dysplasia	NATURE GENETICS			English	Article							AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; ECTODYSPLASIN-A; EDA GENE; RECEPTOR; PROTEIN; IDENTIFICATION; ACTIVATION; APOPTOSIS; ENCODES; TABBY	X-linked hypohidrotic ectodermal dysplasia results in abnormal morphogenesis of teeth, hair and eccrine sweat glands(1). The gene (ED1) responsible for the disorder has been identified(2-4), as well as the analogous X-linked gene (Ta) in the mouse(5,6). Autosomal recessive disorders, phenotypically indistinguishable from the X-linked forms, exist in humans(7) and at two separate loci (crinkled, cr, and downless, dl) in mice(8). Dominant disorders, possibly allelic to the recessive loci, are seen in both species(9,10) (ED3, Dl(slk)). A candidate gene has recently been identified at the dl locus(11) that is mutated in both dl and Dl(slk) mutant alleles. We isolated and characterized its human DL homologue, and identified mutations in three families displaying recessive inheritance and two with dominant inheritance. The disorder does not map to the candidate gene locus in all autosomal recessive families, implying the existence of at least one additional human locus. The putative protein is predicted to have a single transmembrane domain, and shows similarity to two separate domains of the tumour necrosis factor receptor (TNFR) family(12,13).	Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Oregon Health & Science University; Baylor College of Medicine; Baylor College of Medicine	Ferguson, BM (corresponding author), Oregon Hlth Sci Univ, Dept Mol & Med Genet, 3181 SW San Jackson Pk Rd, Portland, OR 97201 USA.			Overbeek, Paul/0000-0001-9784-2084	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011311] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR45316] Funding Source: Medline; NIDCR NIH HHS [DE11311] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Arnold C, 1991, PCR Methods Appl, V1, P39; Baala L, 1999, AM J HUM GENET, V64, P651, DOI 10.1086/302239; Bayes M, 1998, HUM MOL GENET, V7, P1661, DOI 10.1093/hmg/7.11.1661; BELDJORD C, 1988, NUCLEIC ACIDS RES, V16, P4927, DOI 10.1093/nar/16.11.4927; Bettinardi A, 1997, BLOOD, V89, P902, DOI 10.1182/blood.V89.3.902; CLARKE A, 1987, J MED GENET, V24, P659, DOI 10.1136/jmg.24.11.659; Coolidge CJ, 1997, NUCLEIC ACIDS RES, V25, P888, DOI 10.1093/nar/25.4.888; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Ferguson BM, 1998, J MED GENET, V35, P112, DOI 10.1136/jmg.35.2.112; Ferguson BM, 1997, HUM MOL GENET, V6, P1589, DOI 10.1093/hmg/6.9.1589; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; Gyapay G, 1996, HUM MOL GENET, V5, P339, DOI 10.1093/hmg/5.3.339; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Ho LL, 1998, AM J HUM GENET, V62, P1102, DOI 10.1086/301839; Infante AJ, 1998, J PEDIATR-US, V133, P629, DOI 10.1016/S0022-3476(98)70102-7; JORGENSON RJ, 1987, J CRAN GENET DEV BIO, V7, P403; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kim UJ, 1996, GENOMICS, V34, P213, DOI 10.1006/geno.1996.0268; Konrad M, 1995, GENOMICS, V30, P514, DOI 10.1006/geno.1995.1272; Majumder K, 1998, MAMM GENOME, V9, P863, DOI 10.1007/s003359900884; Malek NP, 1998, RECENT RES CANCER, V147, P97; Monreal AW, 1998, AM J HUM GENET, V63, P380, DOI 10.1086/301984; Munoz F, 1997, AM J HUM GENET, V61, P94; Naismith JH, 1998, TRENDS BIOCHEM SCI, V23, P74, DOI 10.1016/S0968-0004(97)01164-X; Padanilam B. J., 1992, Human Molecular Genetics, V1, P407, DOI 10.1093/hmg/1.6.407; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Srivastava AK, 1997, P NATL ACAD SCI USA, V94, P13069, DOI 10.1073/pnas.94.24.13069; Sundberg, 1994, HDB MOUSE MUTATIONS; TARTAGLIA LA, 1992, J BIOL CHEM, V267, P4304; ZONANA J, 1992, AM J HUM GENET, V51, P1036	31	290	300	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1999	22	4					366	369		10.1038/11937	http://dx.doi.org/10.1038/11937			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	222FH	10431241				2022-12-17	WOS:000081772500019
J	Coin, F; Marinoni, JC; Rodolfo, C; Fribourg, S; Pedrini, AM; Egly, JM				Coin, F; Marinoni, JC; Rodolfo, C; Fribourg, S; Pedrini, AM; Egly, JM			Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH	NATURE GENETICS			English	Article							NUCLEOTIDE EXCISION-REPAIR; TRANSCRIPTION FACTOR TFIIH; RNA-POLYMERASE-II; DNA HELICASE; XERODERMA-PIGMENTOSUM; SACCHAROMYCES-CEREVISIAE; RAD3 PROTEIN; KINASE; ASSOCIATION; BTF2/TFIIH	In most cases, xeroderma pigmentosum group D (XP-D) and trichothiodystrophy (TTD) patients carry mutations in the carboxy-terminal domain of the evolutionarily conserved helicase XPD, which is one of the subunits of the transcription/repair factor TFIIH (ref 1, 2). In this study, we demonstrate that XPD interacts specifically with p44, another subunit of TFIIH, and that this interaction results in the stimulation of 5' --> 3' helicase activity. Mutations in the XPD C-terminal domain, as found in most patients, prevent the interaction with p44, thus explaining the decrease in XPD helicase activity and the nucleotide excision repair (NER) defect.	ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; CNR, Ist Genet Biochim & Evoluzionist, I-27100 Pavia, Italy	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Consiglio Nazionale delle Ricerche (CNR)	Egly, JM (corresponding author), ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, BP 163,CU Strasbourg, F-67404 Illkirch Graffenstaden, France.		Fribourg, Sebastien/M-7418-2014; Coin, Frédéric/F-5925-2013; Rodolfo, Carlo/H-8953-2019	Fribourg, Sebastien/0000-0003-4112-7510; Coin, Frédéric/0000-0002-5620-8519; Rodolfo, Carlo/0000-0001-7087-545X	Telethon [E.0550] Funding Source: Medline	Telethon(Fondazione Telethon)		BOOTSMA D, 1993, NATURE, V363, P114, DOI 10.1038/363114a0; Burglen L, 1997, AM J HUM GENET, V60, P72; Drapkin R, 1996, P NATL ACAD SCI USA, V93, P6488, DOI 10.1073/pnas.93.13.6488; Evans J, 1997, INTERNET WORLD, V8, P16; GERARD M, 1991, J BIOL CHEM, V266, P20940; GUZDER SN, 1994, NATURE, V369, P578, DOI 10.1038/369578a0; GUZDER SN, 1994, NATURE, V367, P91, DOI 10.1038/367091a0; Iyer N, 1996, BIOCHEMISTRY-US, V35, P2157, DOI 10.1021/bi9524124; JOHNSON RT, 1985, J CELL SCI, V76, P115; LEHMANN AR, 1995, TRENDS BIOCHEM SCI, V20, P402, DOI 10.1016/S0968-0004(00)89088-X; MA LB, 1994, NUCLEIC ACIDS RES, V22, P4095, DOI 10.1093/nar/22.20.4095; OREILLY DR, 1992, BACULOVIRUS EXPRESSI; Reardon JT, 1996, P NATL ACAD SCI USA, V93, P6482, DOI 10.1073/pnas.93.13.6482; Rossignol M, 1997, EMBO J, V16, P1628, DOI 10.1093/emboj/16.7.1628; ROY R, 1994, J BIOL CHEM, V269, P9826; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; SUNG P, 1987, P NATL ACAD SCI USA, V84, P8951, DOI 10.1073/pnas.84.24.8951; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; Taylor EM, 1997, P NATL ACAD SCI USA, V94, P8658, DOI 10.1073/pnas.94.16.8658; Winkler GS, 1998, J BIOL CHEM, V273, P1092, DOI 10.1074/jbc.273.2.1092; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; YOON H, 1992, GENE DEV, V6, P2463, DOI 10.1101/gad.6.12b.2463	27	290	302	1	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1998	20	2					184	188		10.1038/2491	http://dx.doi.org/10.1038/2491			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771713				2022-12-17	WOS:000076231300022
J	OTTMAN, R; RISCH, N; HAUSER, WA; PEDLEY, TA; LEE, JH; BARKERCUMMINGS, C; LUSTENBERGER, A; NAGLE, KJ; LEE, KS; SCHEUER, ML; NEYSTAT, M; SUSSER, M; WILHELMSEN, KC				OTTMAN, R; RISCH, N; HAUSER, WA; PEDLEY, TA; LEE, JH; BARKERCUMMINGS, C; LUSTENBERGER, A; NAGLE, KJ; LEE, KS; SCHEUER, ML; NEYSTAT, M; SUSSER, M; WILHELMSEN, KC			LOCALIZATION OF A GENE FOR PARTIAL EPILEPSY TO CHROMOSOME 10Q	NATURE GENETICS			English	Article							JUVENILE MYOCLONIC EPILEPSY; IDIOPATHIC GENERALIZED EPILEPSY; FAMILIAL NEONATAL CONVULSIONS; LINKAGE ANALYSIS; HLA REGION; LOCUS; COMPUTATIONS; MARKERS	There is strong evidence for a genetic contribution to epilepsy, but it is commonly assumed that this genetic contribution is limited to 'generalized' epilepsies, and that most forms of 'partial' epilepsy are nongenetic. In a linkage analysis of a single family containing 11 affected individuals, we obtained strong evidence for localization of a gene for partial epilepsy. This susceptibility gene maps to chromosome 10q, with a maximum two-point lod score for D10S192 of 3.99 at theta=0.0. All affected individuals share a single haplotype for seven tightly linked contiguous markers; the maximum rod score for this haplotype is 4.83 at theta=0.0. Key recombinants place the susceptibility locus within a 10 centimorgan interval.	COLUMBIA UNIV,SCH PUBL HLTH,DIV EPIDEMIOL,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT NEUROL,NEW YORK,NY 10032; NEW YORK STATE PSYCHIAT INST & HOSP,DEPT EPIDEMIOL BRAIN DISORDERS RES,NEW YORK,NY 10032; STANFORD UNIV,SCH MED,DEPT GENET,STANFORD,CA 94305	Columbia University; Columbia University; New York State Psychiatry Institute; Stanford University	OTTMAN, R (corresponding author), COLUMBIA UNIV,GH SERGIEVSKY CTR,NEW YORK,NY 10032, USA.		Ottman, Ruth/O-2371-2013; Hauser, W Allen/AAB-5277-2020; Lee, Joseph H/D-2441-2012; Renieri, Alessandra/K-5950-2016	Ottman, Ruth/0000-0001-7074-242X; Lee, Joseph H/0000-0002-2000-4821; Bergen, Arthur/0000-0002-6333-9576; Renieri, Alessandra/0000-0002-0846-9220	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020656] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS020656, R01 NS020656-13, 2RO1-NS20656] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], 1981, EPILEPSIA, V22, P489; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DURNER M, 1991, NEUROLOGY, V41, P1651, DOI 10.1212/WNL.41.10.1651; GREENBERG DA, 1988, AM J MED GENET, V31, P185, DOI 10.1002/ajmg.1320310125; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; HAUSER WA, 1991, EPILEPSIA, V31, P429; HEIJBEL J, 1975, EPILEPSIA, V16, P285, DOI 10.1111/j.1528-1157.1975.tb06059.x; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1988, AM J HUM GENET, V42, P498; LEHESJOKI AE, 1991, P NATL ACAD SCI USA, V88, P3696, DOI 10.1073/pnas.88.9.3696; LEPPERT M, 1989, NATURE, V337, P647, DOI 10.1038/337647a0; LEWIS TB, 1993, AM J HUM GENET, V53, P670; OTTMAN R, 1989, EPILEPSIA, V30, P107, DOI 10.1111/j.1528-1157.1989.tb05290.x; OTTMAN R, 1989, EPILEPSIA, V30, P157, DOI 10.1111/j.1528-1157.1989.tb05448.x; OTTMAN R, 1992, J CLIN EPIDEMIOL, V45, P721, DOI 10.1016/0895-4356(92)90049-S; OTTMAN R, IN PRESS AM J EPIDEM; OTTMAN R, 1990, EPILEPSIA, V31, P611; SCHEFFER IE, 1994, LANCET, V343, P515, DOI 10.1016/S0140-6736(94)91463-X; STEINLEIN O, 1994, GENOMICS, V22, P493, DOI 10.1006/geno.1994.1420; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEISSBECKER KA, 1991, AM J MED GENET, V38, P32, DOI 10.1002/ajmg.1320380109; WHITEHOUSE WP, 1993, AM J HUM GENET, V53, P652; 1989, EPILEPSIA, V30, P268	25	290	299	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1995	10	1					56	60		10.1038/ng0595-56	http://dx.doi.org/10.1038/ng0595-56			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	7647791	Green Accepted			2022-12-17	WOS:A1995QX57300016
J	Ford, CB; Shah, RR; Maeda, MK; Gagneux, S; Murray, MB; Cohen, T; Johnston, JC; Gardy, J; Lipsitch, M; Fortune, SM				Ford, Christopher B.; Shah, Rupal R.; Maeda, Midori Kato; Gagneux, Sebastien; Murray, Megan B.; Cohen, Ted; Johnston, James C.; Gardy, Jennifer; Lipsitch, Marc; Fortune, Sarah M.			Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis	NATURE GENETICS			English	Article							BEIJING-GENOTYPE; WESTERN CAPE; PROBABILITY-DISTRIBUTION; ANTIBIOTIC-RESISTANCE; SOUTH-AFRICA; STRAINS; MUTANTS; ACQUISITION; INFECTION; EVOLUTION	A key question in tuberculosis control is why some strains of M. tuberculosis are preferentially associated with resistance to multiple drugs. We demonstrate that M. tuberculosis strains from lineage 2 (East Asian lineage and Beijing sublineage) acquire drug resistances in vitro more rapidly than M. tuberculosis strains from lineage 4 (Euro-American lineage) and that this higher rate can be attributed to a higher mutation rate. Moreover, the in vitro mutation rate correlates well with the bacterial mutation rate in humans as determined by whole-genome sequencing of clinical isolates. Finally, using a stochastic mathematical model, we demonstrate that the observed differences in mutation rate predict a substantially higher probability that patients infected with a drug-susceptible lineage 2 strain will harbor multidrug-resistant bacteria at the time of diagnosis. These data suggest that interventions to prevent the emergence of drug-resistant tuberculosis should target bacterial as well as treatment-related risk factors.	[Ford, Christopher B.; Shah, Rupal R.; Lipsitch, Marc; Fortune, Sarah M.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Maeda, Midori Kato] Univ Calif San Francisco, Curry Int TB Ctr, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Gagneux, Sebastien] Univ Basel, Basel, Switzerland; [Murray, Megan B.; Cohen, Ted] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Cohen, Ted] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Cohen, Ted; Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Johnston, James C.; Gardy, Jennifer] British Columbia Ctr Dis Control, Communicable Dis Prevent & Control Serv, Vancouver, BC, Canada; [Gardy, Jennifer] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Fortune, Sarah M.] Ragon Inst MGH MIT & Harvard, Boston, MA USA; [Fortune, Sarah M.] Broad Inst MIT & Harvard, Cambridge, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of British Columbia; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Fortune, SM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	sfortune@hsph.harvard.edu	Gagneux, Sebastien/ABE-7909-2020	Gagneux, Sebastien/0000-0001-7783-9048; Cohen, Ted/0000-0002-8091-7198; Fortune, Sarah/0000-0001-7565-9975; Lipsitch, Marc/0000-0003-1504-9213	Director's Office of the US National Institutes of Health [DP2 0D001378]; National Institute of Allergy and Infectious Diseases [U19 AI076217]; US National Institutes of Health Models of Infectious Disease Agent Study program [1 U54 GM088558]; Howard Hughes Medical Institute Physician Scientist Early Career Award; Harvard University Graduate School of Arts and Sciences; Doris Duke Charitable Foundation Clinical Scientist Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007638, U19AI076217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001378] Funding Source: NIH RePORTER	Director's Office of the US National Institutes of Health; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health Models of Infectious Disease Agent Study program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Physician Scientist Early Career Award(Howard Hughes Medical Institute); Harvard University Graduate School of Arts and Sciences; Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a New Innovator's Award (DP2 0D001378) from the Director's Office of the US National Institutes of Health (S. M. F.), by a subcontract from the National Institute of Allergy and Infectious Diseases (U19 AI076217 to S. M. F. and M. B. M.), by the US National Institutes of Health Models of Infectious Disease Agent Study program, through cooperative agreement 1 U54 GM088558 (M. L.), by a Howard Hughes Medical Institute Physician Scientist Early Career Award (S. M. F.), by a Merit Fellowship from the Harvard University Graduate School of Arts and Sciences (C. B. F.) and by a Doris Duke Charitable Foundation Clinical Scientist Development Award (S. M. F.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases or the US National Institutes of Health.	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anh DD, 2000, EMERG INFECT DIS, V6, P302; Bergval IL, 2009, J ANTIMICROB CHEMOTH, V64, P515, DOI 10.1093/jac/dkp237; Blazquez J, 2003, CLIN INFECT DIS, V37, P1201, DOI 10.1086/378810; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Bradford WZ, 1996, LANCET, V348, P928, DOI 10.1016/S0140-6736(96)03027-9; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Colijn C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018327; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Coscolla Mireilla, 2010, Drug Discov Today Dis Mech, V7, pe43, DOI 10.1016/j.ddmec.2010.09.004; DAVID HL, 1970, APPL MICROBIOL, V20, P810, DOI 10.1128/AEM.20.5.810-814.1970; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; de Steenwinkel JEM, 2012, EMERG INFECT DIS, V18, P660, DOI 10.3201/eid1804.110912; Dowdy DW, 2013, AM J RESP CRIT CARE, V187, P543, DOI 10.1164/rccm.201207-1217OC; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Fallow A, 2010, J BACTERIOL, V192, P2228, DOI 10.1128/JB.01597-09; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Gelmanova IY, 2007, B WORLD HEALTH ORGAN, V85, P703, DOI 10.2471/BLT.06.038331; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; GOBLE M, 1993, NEW ENGL J MED, V328, P527, DOI 10.1056/NEJM199302253280802; Hall LMC, 2006, MICROBIOL-SGM, V152, P2505, DOI 10.1099/mic.0.29079-0; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Huang HY, 2010, J CLIN MICROBIOL, V48, P4474, DOI 10.1128/JCM.00930-10; Huet G, 2009, J BIOL CHEM, V284, P27101, DOI 10.1074/jbc.M109.041939; Ioerger TR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-670; Johnson R, 2010, INT J TUBERC LUNG D, V14, P119; Kato-Maeda M, 2012, CLIN VACCINE IMMUNOL, V19, P1227, DOI 10.1128/CVI.00250-12; Kimura M, 1971, Journal Molec Evol, V1, P1, DOI 10.1007/BF01659390; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; Lienhardt C, 2012, J INFECT DIS, V205, pS241, DOI 10.1093/infdis/jis034; Louw GE, 2011, AM J RESP CRIT CARE, V184, P269, DOI 10.1164/rccm.201011-1924OC; Luria SE, 1943, GENETICS, V28, P491; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Mestre O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016020; Migliori GB, 2007, EUROSURVEILLANCE, V12; Mizrahi V, 1998, MOL MICROBIOL, V29, P1331, DOI 10.1046/j.1365-2958.1998.01038.x; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; PablosMendez A, 1997, AM J MED, V102, P164, DOI 10.1016/S0002-9343(96)00402-0; Pang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032976; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Schmalstieg AM, 2012, ANTIMICROB AGENTS CH, V56, P4806, DOI 10.1128/AAC.05546-11; Seung KJ, 2004, CLIN INFECT DIS, V39, P1321, DOI 10.1086/425005; SHAW JB, 1954, AM REV TUBERC PULM, V69, P724; Springer B, 2004, MOL MICROBIOL, V53, P1601, DOI 10.1111/j.1365-2958.2004.04231.x; STEWART FM, 1994, GENETICS, V137, P1139; STEWART FM, 1990, GENETICS, V124, P175; Streicher EM, 2004, J CLIN MICROBIOL, V42, P891, DOI 10.1128/JCM.42.2.891-894.2004; Sun G, 2012, J INFECT DIS, V206, P1724, DOI 10.1093/infdis/jis601; Taype CA, 2012, INFECT GENET EVOL, V12, P577, DOI 10.1016/j.meegid.2012.02.002; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Vadwai V, 2012, TUBERCULOSIS, V92, P264, DOI 10.1016/j.tube.2012.01.002; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Werngren J, 2003, J CLIN MICROBIOL, V41, P1520, DOI 10.1128/JCM.41.4.1520-1524.2003; Weyer K, 1998, LAB SERVICES TUBER 2, VWHO/TB/98.258; Williams K, 2012, ANTIMICROB AGENTS CH, V56, P3114, DOI 10.1128/AAC.00384-12	72	289	296	0	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2013	45	7					784	+		10.1038/ng.2656	http://dx.doi.org/10.1038/ng.2656			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	172LQ	23749189	Green Accepted, Green Submitted			2022-12-17	WOS:000321005200013
J	Lindsay, ME; Schepers, D; Bolar, NA; Doyle, JJ; Gallo, E; Fert-Bober, J; Kempers, MJE; Fishman, EK; Chen, YC; Myers, L; Bjeda, D; Oswald, G; Elias, AF; Levy, HP; Anderlid, BM; Yang, MH; Bongers, EMHF; Timmermans, J; Braverman, AC; Canham, N; Mortier, GR; Brunner, HG; Byers, PH; Van Eyk, J; Van Laer, L; Dietz, HC; Loeys, BL				Lindsay, Mark E.; Schepers, Dorien; Bolar, Nikhita Ajit; Doyle, Jefferson J.; Gallo, Elena; Fert-Bober, Justyna; Kempers, Marlies J. E.; Fishman, Elliot K.; Chen, Yichun; Myers, Loretha; Bjeda, Djahita; Oswald, Gretchen; Elias, Abdallah F.; Levy, Howard P.; Anderlid, Britt-Marie; Yang, Margaret H.; Bongers, Ernie M. H. F.; Timmermans, Janneke; Braverman, Alan C.; Canham, Natalie; Mortier, Geert R.; Brunner, Han G.; Byers, Peter H.; Van Eyk, Jennifer; Van Laer, Lut; Dietz, Harry C.; Loeys, Bart L.			Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm	NATURE GENETICS			English	Article							GROWTH-FACTOR-BETA; MARFAN-SYNDROME; MOUSE MODEL; PATHOGENESIS; RECEPTOR; MICE; CONTRIBUTES; ACTIVATION; FIBRILLIN	Loeys-Dietz syndrome (LDS) associates with a tissue signature for high transforming growth factor (TGF)-beta signaling but is often caused by heterozygous mutations in genes encoding positive effectors of TGF-beta signaling, including either subunit of the TGF-beta receptor or SMAD3, thereby engendering controversy regarding the mechanism of disease. Here, we report heterozygous mutations or deletions in the gene encoding the TGF-beta 2 ligand for a phenotype within the LDS spectrum and show upregulation of TGF-beta signaling in aortic tissue from affected individuals. Furthermore, haploinsufficient Tgfb2(+/-) mice have aortic root aneurysm and biochemical evidence of increased canonical and noncanonical TGF-beta signaling. Mice that harbor both a mutant Marfan syndrome (MFS) allele (Fbn1(C1039G/+)) and Tgfb2 haploinsufficiency show increased TGF-beta signaling and phenotypic worsening in association with normalization of TGF-beta 2 expression and high expression of TGF-beta 1. Taken together, these data support the hypothesis that compensatory autocrine and/or paracrine events contribute to the pathogenesis of TGF-beta-mediated vasculopathies.	[Schepers, Dorien; Bolar, Nikhita Ajit; Mortier, Geert R.; Van Laer, Lut; Loeys, Bart L.] Univ Antwerp, Fac Med & Hlth Sci, Ctr Med Genet, B-2020 Antwerp, Belgium; [Lindsay, Mark E.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Dept Pediat, Helen B Taussig Childrens Heart Ctr, Baltimore, MD 21205 USA; [Lindsay, Mark E.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Lindsay, Mark E.; Doyle, Jefferson J.; Gallo, Elena; Chen, Yichun; Myers, Loretha; Bjeda, Djahita; Oswald, Gretchen; Elias, Abdallah F.; Levy, Howard P.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Schepers, Dorien; Bolar, Nikhita Ajit; Mortier, Geert R.; Van Laer, Lut; Loeys, Bart L.] Univ Antwerp Hosp, Antwerp, Belgium; [Fert-Bober, Justyna; Van Eyk, Jennifer] Johns Hopkins Univ, Dept Med, Div Cardiol, Bayview Prote Ctr, Baltimore, MD USA; [Kempers, Marlies J. E.; Bongers, Ernie M. H. F.; Brunner, Han G.; Loeys, Bart L.] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kempers, Marlies J. E.; Bongers, Ernie M. H. F.; Brunner, Han G.; Loeys, Bart L.] Radboud Univ Nijmegen, Inst Genet & Metab Disorders, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Fishman, Elliot K.] Johns Hopkins Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Anderlid, Britt-Marie] Karolinska Inst, Dept Clin Genet, Karolinska Univ Hosp, Stockholm, Sweden; [Yang, Margaret H.; Byers, Peter H.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Yang, Margaret H.; Byers, Peter H.] Univ Washington, Sch Med, Dept Genet, Seattle, WA USA; [Timmermans, Janneke] Radboud Univ Nijmegen, Dept Cardiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Braverman, Alan C.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Canham, Natalie] Northwick Pk Hosp & Clin Res Ctr, Dept Clin Genet, NW Thames Reg Genet Serv, Harrow HA1 3UJ, Middx, England; [Loeys, Bart L.] Univ Ghent, Dept Pediat & Genet, B-9000 Ghent, Belgium	University of Antwerp; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; University of Antwerp; Johns Hopkins University; Radboud University Nijmegen; Radboud University Nijmegen; Johns Hopkins University; Johns Hopkins Medicine; Karolinska Institutet; Karolinska University Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Radboud University Nijmegen; Washington University (WUSTL); Imperial College London; Ghent University	Loeys, BL (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Ctr Med Genet, B-2020 Antwerp, Belgium.	Bart.Loeys@ua.ac.be	Mortier, Geert/D-2542-2012; Elias, Abdallah F./R-7187-2019; Loeys, Bart/B-3236-2017; Timmermans, J./L-4693-2015; Bongers, M.H.F./L-4214-2015; Loeys, B.L./L-4493-2015; Elias, Abdallah Frederic/ABH-8521-2020; Brunner, Han/C-9928-2013; Chen, Yi-Chun/H-4468-2013; Doyle, Jefferson/C-3156-2013	Mortier, Geert/0000-0001-9871-4578; Loeys, Bart/0000-0003-3703-9518; Byers, Peter H./0000-0001-7786-7030; Schepers, Dorien/0000-0003-4225-6621; fishman, elliot/0000-0002-2567-1658	Fund for Scientific Research, Flanders (FWO; Belgium) [G.0458.09, G.0221.12]; European Grant Fighting Aneurysmal Disease [EC-FP7]; Special Research Fund of Ghent University [BOF10/GOA/005]; US National Institutes of Health [RO1-AR41135, PO1-AR049698, 5RC1HL100021-02]; Institutional Clinical and Translational Science Award [1U54RR023561-01A1]; National Marfan Foundation; Smilow Center for Marfan Syndrome Research; Howard Hughes Medical Institute; Freudmann Fund for Research in Ehlers Danlos Syndrome and Related Disorders; Baylor-Hopkins Center for Mendelian Genetics [1U54HG006542]; Scientific Research, Flanders (Belgium); Aneurysmal Pathology Foundation; Agency for Innovation by Science and Technology (IWT); Helen Hay Whitney Foundation; McKusick Fellowship of the National Marfan Foundation; NHLBI K08 Award [HL107738-01]; Fellow-to-Faculty Award from the National Marfan Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL107738, RC1HL100021] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698, R01AR041135] Funding Source: NIH RePORTER	Fund for Scientific Research, Flanders (FWO; Belgium)(FWO); European Grant Fighting Aneurysmal Disease; Special Research Fund of Ghent University(Ghent University); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Clinical and Translational Science Award; National Marfan Foundation; Smilow Center for Marfan Syndrome Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Freudmann Fund for Research in Ehlers Danlos Syndrome and Related Disorders; Baylor-Hopkins Center for Mendelian Genetics; Scientific Research, Flanders (Belgium)(FWO); Aneurysmal Pathology Foundation; Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Helen Hay Whitney Foundation; McKusick Fellowship of the National Marfan Foundation; NHLBI K08 Award; Fellow-to-Faculty Award from the National Marfan Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported in part by funding from the Fund for Scientific Research, Flanders (FWO; Belgium) (G.0458.09 and G.0221.12); a European Grant Fighting Aneurysmal Disease (EC-FP7); the Special Research Fund of Ghent University (BOF10/GOA/005); the US National Institutes of Health (RO1-AR41135 and PO1-AR049698 to H.C.D., 5RC1HL100021-02 to J.V.E. and H.C.D. and an Institutional Clinical and Translational Science Award 1U54RR023561-01A1 to J.V.E.); the National Marfan Foundation; the Smilow Center for Marfan Syndrome Research; the Howard Hughes Medical Institute; the Freudmann Fund for Research in Ehlers Danlos Syndrome and Related Disorders; and the Baylor-Hopkins Center for Mendelian Genetics (1U54HG006542). B.L.L. is senior clinical investigator of the Fund for Scientific Research, Flanders (Belgium); N.A.B. is supported by the Aneurysmal Pathology Foundation; D.S. is supported by a PhD grant from the Agency for Innovation by Science and Technology (IWT); E.G. is supported by a fellowship from the Helen Hay Whitney Foundation; J.J.D. is supported by the McKusick Fellowship of the National Marfan Foundation; and M.E.L. is supported by an NHLBI K08 Award (HL107738-01) and by a Fellow-to-Faculty Award from the National Marfan Foundation.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Bartram U, 2001, CIRCULATION, V103, P2745; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Choudhary B, 2009, GENESIS, V47, P115, DOI 10.1002/dvg.20466; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Gomez D, 2009, J PATHOL, V218, P131, DOI 10.1002/path.2516; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Iwata J, 2012, J CLIN INVEST, V122, P873, DOI 10.1172/JCI61498; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Langlois D, 2010, TRANSGENIC RES, V19, P1069, DOI 10.1007/s11248-010-9379-4; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Maleszewski JJ, 2009, AM J SURG PATHOL, V33, P194, DOI 10.1097/PAS.0b013e31817f3661; Matt P, 2009, CIRCULATION, V120, P526, DOI 10.1161/CIRCULATIONAHA.108.841981; MCKUSICK VA, 1955, CIRCULATION, V11, P321, DOI 10.1161/01.CIR.11.3.321; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Renard M, 2010, EUR J HUM GENET, V18, P895, DOI 10.1038/ejhg.2010.45; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744	31	289	305	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2012	44	8					922	+		10.1038/ng.2349	http://dx.doi.org/10.1038/ng.2349			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	22772368	Green Accepted			2022-12-17	WOS:000306854700019
J	Monot, M; Honore, N; Garnier, T; Zidane, N; Sherafi, D; Paniz-Mondolfi, A; Matsuoka, M; Taylor, GM; Donoghue, HD; Bouwman, A; Mays, S; Watson, C; Lockwood, D; Khamispour, A; Dowlati, Y; Shen, JP; Rea, TH; Vera-Cabrera, L; Stefani, MM; Banu, S; Macdonald, M; Sapkota, BR; Spencer, JS; Thomas, J; Harshman, K; Singh, P; Busso, P; Gattiker, A; Rougemont, J; Brennan, PJ; Cole, ST				Monot, Marc; Honore, Nadine; Garnier, Thierry; Zidane, Nora; Sherafi, Diana; Paniz-Mondolfi, Alberto; Matsuoka, Masanori; Taylor, G. Michael; Donoghue, Helen D.; Bouwman, Abi; Mays, Simon; Watson, Claire; Lockwood, Diana; Khamispour, Ali; Dowlati, Yahya; Shen Jianping; Rea, Thomas H.; Vera-Cabrera, Lucio; Stefani, Mariane M.; Banu, Sayera; Macdonald, Murdo; Sapkota, Bishwa Raj; Spencer, John S.; Thomas, Jerome; Harshman, Keith; Singh, Pushpendra; Busso, Philippe; Gattiker, Alexandre; Rougemont, Jacques; Brennan, Patrick J.; Cole, Stewart T.			Comparative genomic and phylogeographic analysis of Mycobacterium leprae	NATURE GENETICS			English	Article							NUMBER TANDEM REPEATS; HELICOBACTER-PYLORI; LEPROSY PATIENTS; YERSINIA-PESTIS; CAUSATIVE AGENT; BURULI ULCER; TUBERCULOSIS; SEQUENCE; EVOLUTION; POPULATIONS	Reductive evolution and massive pseudogene formation have shaped the 3.31-Mb genome of Mycobacterium leprae, an unculturable obligate pathogen that causes leprosy in humans. The complete genome sequence of M. leprae strain Br4923 from Brazil was obtained by conventional methods (6 x coverage), and Illumina resequencing technology was used to obtain the sequences of strains Thai53 (38 x coverage) and NHDP63 (46 x coverage) from Thailand and the United States, respectively. Whole-genome comparisons with the previously sequenced TN strain from India revealed that the four strains share 99.995% sequence identity and differ only in 215 polymorphic sites, mainly SNPs, and by 5 pseudogenes. Sixteen interrelated SNP subtypes were defined by genotyping both extant and extinct strains of M. leprae from around the world. The 16 SNP subtypes showed a strong geographical association that reflects the migration patterns of early humans and trade routes, with the Silk Road linking Europe to China having contributed to the spread of leprosy.	[Singh, Pushpendra; Busso, Philippe; Cole, Stewart T.] Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland; [Monot, Marc; Honore, Nadine; Garnier, Thierry; Zidane, Nora; Sherafi, Diana] Inst Pasteur, Paris, France; [Paniz-Mondolfi, Alberto] Inst Biomed, Caracas, Venezuela; [Matsuoka, Masanori] Natl Inst Infect Dis, Leprosy Res Ctr, Tokyo, Japan; [Taylor, G. Michael; Donoghue, Helen D.] UCL, Windeyer Inst, Ctr Infect Dis & Int Hlth, London, England; [Bouwman, Abi] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England; [Mays, Simon] English Heritage Ctr Archaeol, Ancient Monuments Lab, Portsmouth, Hants, England; [Watson, Claire; Lockwood, Diana] London Sch Hyg & Trop Med, London WC1, England; [Khamispour, Ali; Dowlati, Yahya] Univ Tehran Med Sci, Ctr Res & Training Skin Dis & Leprosy, Tehran, Iran; [Shen Jianping] China Ctr Dis Control & Prevent, Natl Ctr Leprosy Control, Nanjing, Peoples R China; [Rea, Thomas H.] Univ So Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA 90033 USA; [Vera-Cabrera, Lucio] Hosp Univ Jose E Gonzalez, Serv Dermatol, Monterrey, Nuevo Leon, Mexico; [Stefani, Mariane M.] Univ Fed Goias, Setor Univ, Trop Pathol & Publ Hlth Inst, Goiania, Go, Brazil; [Banu, Sayera] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Macdonald, Murdo; Sapkota, Bishwa Raj] Anandaban Hosp, Kathmandu, Nepal; [Spencer, John S.; Brennan, Patrick J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Thomas, Jerome; Harshman, Keith] Univ Lausanne, Ctr Integrat Genom, DNA Array Facil, Lausanne, Switzerland; [Gattiker, Alexandre; Rougemont, Jacques] Ecole Polytech Fed Lausanne, Bioinformat & Biostat Core Facil, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institute of Infectious Diseases (NIID); University of London; University College London; University of Manchester; English Heritage; University of London; London School of Hygiene & Tropical Medicine; Tehran University of Medical Sciences; Chinese Center for Disease Control & Prevention; University of Southern California; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidade Federal de Goias; International Centre for Diarrhoeal Disease Research (ICDDR); Colorado State University; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Cole, ST (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland.	stewart.cole@epfl.ch	Spencer, John S/G-6968-2017; Singh, Pushpendra/T-4248-2018; Monot, Marc/F-3058-2015; Sapkota, Bishwa/B-6403-2012; Singh, Pushpendra/J-6484-2015; Vera-Cabrera, Lucio/AAM-3641-2020; Donoghue, Helen D./D-6805-2013	Spencer, John S/0000-0002-8051-3038; Singh, Pushpendra/0000-0002-7277-115X; Monot, Marc/0000-0003-0738-7335; Singh, Pushpendra/0000-0001-9453-8669; Vera-Cabrera, Lucio/0000-0002-0890-9660; Donoghue, Helen D./0000-0003-3918-5252; Banu, Sayera/0000-0002-5121-1962	Fondation Raoul Follereau; Genopole programme; US National Institutes of Health; National Institute of Allergy and Infectious Diseases [RO1-AI47197-01A1, NO1-AI25469]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025469, R01AI047197] Funding Source: NIH RePORTER	Fondation Raoul Follereau; Genopole programme; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the study participants and staff from the various leprosy clinics for their invaluable participation and support; J. Molto, A. Marcsik, Y. Selim Erdal, E. Popescu, M. Slaus and J. Boldsen for their encouragement and help with a- DNA samples; and L. Frangeul, A. Kapopoulou and S. Uplekar for assistance with bioinformatics. This work received the financial support of the Fondation Raoul Follereau, the Genopole programme, and the US National Institutes of Health, National Institute of Allergy and Infectious Diseases (grant RO1-AI47197-01A1 and contract NO1-AI25469).	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Babu MM, 2003, TRENDS MICROBIOL, V11, P59, DOI 10.1016/S0966-842X(02)00031-8; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; BOUWMAN AS, 2002, ANCIENT BIOMOLECULES, V4, P173; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Browne SG., 1985, LEPROSY, P1; Canneva F, 2005, J BACTERIOL, V187, P5837, DOI 10.1128/JB.187.16.5837-5840.2005; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Cole ST, 2001, LEPROSY REV, V72, P449; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Erdal Y.S, 2004, ANADOLU ARASTIRMALAR, V22, P169; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gomez-Valero L, 2007, GENOME RES, V17, P1178, DOI 10.1101/gr.6360207; Groathouse NA, 2004, J CLIN MICROBIOL, V42, P1666, DOI 10.1128/JCM.42.4.1666-1672.2004; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Johnson PDR, 2007, EMERG INFECT DIS, V13, P1653, DOI 10.3201/eid1311.061369; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; Marsollier L, 2002, APPL ENVIRON MICROB, V68, P4623, DOI 10.1128/AEM.68.9.4623-4628.2002; Milano A, 2004, RES MICROBIOL, V155, P192, DOI 10.1016/j.resmic.2003.11.009; Mitchell A, 2005, J MOL EVOL, V61, P795, DOI 10.1007/s00239-004-0235-0; MOLNAR E, 2006, 16 EUR M PAL ASS PAL; Molto JE, 2002, PRESENT LEPROSY ARCH, P179; Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759; Monot M, 2008, J CLIN MICROBIOL, V46, P2291, DOI 10.1128/JCM.00239-08; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ortner DJ, 2003, IDENTIFICATION PATHO, P227; Palfi G., 2002, BAR INT SERIES, V1054, P205; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shin YC, 2000, J CLIN MICROBIOL, V38, P4535, DOI 10.1128/JCM.38.12.4535-4538.2000; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Stinear TP, 2007, GENOME RES, V17, P192, DOI 10.1101/gr.5942807; Strait DS, 1997, J HUM EVOL, V32, P17, DOI 10.1006/jhev.1996.0097; Taylor GM, 2006, J ARCHAEOL SCI, V33, P1569, DOI 10.1016/j.jas.2006.02.008; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Truman R, 2004, J CLIN MICROBIOL, V42, P2558, DOI 10.1128/JCM.42.6.2558-2565.2004; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Weng XM, 2007, J CLIN MICROBIOL, V45, P1728, DOI 10.1128/JCM.00018-07; *WHO, 2007, WKLY EPIDEMIOL REC, V82, P225; Wirth T, 2004, P NATL ACAD SCI USA, V101, P4746, DOI 10.1073/pnas.0306629101; WOODS SA, 1990, MOL MICROBIOL, V4, P1745, DOI 10.1111/j.1365-2958.1990.tb00552.x; WOODS SA, 1989, FEMS MICROBIOL LETT, V65, P305; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.0.CO;2-1; Young SK, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000214; Young SK, 2004, J CLIN MICROBIOL, V42, P4931, DOI 10.1128/JCM.42.11.4931-4936.2004; Zhang LF, 2005, J CLIN MICROBIOL, V43, P5221, DOI 10.1128/JCM.43.10.5221-5229.2005	65	289	537	2	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2009	41	12					1282	U39		10.1038/ng.477	http://dx.doi.org/10.1038/ng.477			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	524LN	19881526	Green Submitted, Bronze			2022-12-17	WOS:000272144900008
J	Tolhuis, B; Muijrers, I; de Wit, E; Teunissen, H; Talhout, W; van Steensel, B; van Lohuizen, M				Tolhuis, Bas; Muijrers, Inhua; de Wit, Elzo; Teunissen, Hans; Talhout, Wendy; van Steensel, Bas; van Lohuizen, Maarten			Genome-wide profiling of PRC1 and PRC2 polycomb chromatin binding in Drosophila melanogaster	NATURE GENETICS			English	Article							CELLULAR MEMORY; TRITHORAX GROUP; EXPRESSION; PROTEINS; GENE; IDENTIFICATION; TARGET; CANCER; CELLS; BMI1	Polycomb group (PcG) proteins maintain transcriptional repression of developmentally important genes(1) and have been implicated in cell proliferation and stem cell self-renewal2. We used a genome-wide approach(3) to map binding patterns of PcG proteins (Pc, esc and Sce) in Drosophila melanogaster Kc cells. We found that Pc associates with large genomic regions of up to similar to 150 kb in size, hereafter referred to as 'Pc domains'. Sce and esc accompany Pc in most of these domains. PcG-bound chromatin is trimethylated at histone H3 Lys27 and is generally transcriptionally silent. Furthermore, PcG proteins preferentially bind to developmental genes. Many of these encode transcriptional regulators and key components of signal transduction pathways, including Wingless, Hedgehog, Notch and Delta. We also identify several new putative functions of PcG proteins, such as in steroid hormone biosynthesis. These results highlight the extensive involvement of PcG proteins in the coordination of development through the formation of large repressive chromatin domains.	Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	van Lohuizen, M (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	m.v.lohuizen@nki.nl		de Wit, Elzo/0000-0003-2883-1415				Baehrecke EH, 2000, CELL DEATH DIFFER, V7, P1057, DOI 10.1038/sj.cdd.4400753; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breiling A, 2004, EMBO REP, V5, P976, DOI 10.1038/sj.embor.7400260; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dejardin J, 2005, NATURE, V434, P533, DOI 10.1038/nature03386; Ficz G, 2005, DEVELOPMENT, V132, P3963, DOI 10.1242/dev.01950; Greil F, 2003, GENE DEV, V17, P2825, DOI 10.1101/gad.281503; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Kirmizis A, 2003, MOL CANCER THER, V2, P113; Klebes A, 2005, DEVELOPMENT, V132, P3753, DOI 10.1242/dev.01927; Lascaris R, 2003, GENOME BIOL, V4; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Maurange C, 2002, GENE DEV, V16, P2672, DOI 10.1101/gad.242702; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Paul SM, 2003, DEVELOPMENT, V130, P4963, DOI 10.1242/dev.00691; Rietveld LEG, 2002, EMBO J, V21, P1389, DOI 10.1093/emboj/21.6.1389; Ringrose L, 2003, DEV CELL, V5, P759, DOI 10.1016/S1534-5807(03)00337-X; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schubeler D, 2002, NAT GENET, V32, P438, DOI 10.1038/ng1005; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Sun LV, 2003, P NATL ACAD SCI USA, V100, P9428, DOI 10.1073/pnas.1533393100; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; van Steensel B, 2003, P NATL ACAD SCI USA, V100, P2580, DOI 10.1073/pnas.0438000100; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799	30	289	301	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38	6					694	699		10.1038/ng1792	http://dx.doi.org/10.1038/ng1792			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16628213				2022-12-17	WOS:000237954800025
J	Xu, XL; Qiao, WH; Linke, SP; Cao, L; Li, WM; Furth, PA; Harris, CC; Deng, CX				Xu, XL; Qiao, WH; Linke, SP; Cao, L; Li, WM; Furth, PA; Harris, CC; Deng, CX			Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis	NATURE GENETICS			English	Letter							DAMAGE-INDUCED PHOSPHORYLATION; ATM-DEPENDENT PHOSPHORYLATION; DOUBLE-STRAND BREAKS; DNA-DAMAGE; GAMMA-IRRADIATION; MOUSE; MICE; PROTEIN; MDM2; MORPHOGENESIS	Breast cancer is a chief cause of cancer-related mortality that affects women worldwide. About 8% of cases are hereditary. and approximately half of these are associated with germline mutations of the breast tumor suppressor gene BRCA1 (refs. 1,2). We have previously reported a mouse model in which Brca1 exon 11 is eliminated in mammary epithelial cells through Cre-mediated excision(3). This mutation is often accompanied by alterations in transformation-related protein 53 (Trp53, encoding p53), which substantially accelerates mammary tumor formation. Here. we sought to elucidate the underlying mechanism(s) using mice deficient in the Brca1 exon 11 isoform (Brca1(Delta 11/Delta 11)). Brca1(Delta 11/Delta 11) embryos died late in gestation because of widespread apoptosis. Unexpectedly. elimination of one Trp53 allele completely rescues this embryonic lethality and restores normal mammary gland development. However, most female Brca1(Delta 11/Delta 11)Trp53(+/-) mice develop mammary tumors with loss of the remaining Trp53 allele within 6-12 months. Lymphoma and ovarian tumors also occurr at lower frequencies. Heterozygous mutation of Trp53 decreases p53 and results in attenuated apoptosis and G(1)-S checkpoint control, allowing Brca1(Delta 11/Delta 11) cells to proliferate. The p53 protein regulates Brca1 transcription both in vitro and in vivo, and Brca1 participates in p53 accumulation after gamma -irradiation through regulation of its phosphorylation and Mdm2 expression. These findings provide a mechanism for BRCA1-associated breast carcinogenesis.	NIDDKD, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA; Univ Maryland, Sch Med, Dept Med, Inst Human Virol, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore	Deng, CX (corresponding author), NIDDKD, Genet Dev & Dis Branch, NIH, 10-9N105, Bethesda, MD 20892 USA.		deng, chuxia/N-6713-2016	Linke, Steven/0000-0001-8584-4947	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056001, Z01DK056001] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andres JL, 1998, ONCOGENE, V16, P2229, DOI 10.1038/sj.onc.1201752; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Casey Graham, 1997, Current Opinion in Oncology, V9, P88; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Cressman VL, 1999, MOL CELL BIOL, V19, P7061; Deng CX, 2000, BIOESSAYS, V22, P728; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Hakem R, 1997, NAT GENET, V16, P298, DOI 10.1038/ng0797-298; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hill ADK, 1997, BRIT J SURG, V84, P1334; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Linke SP, 1997, CANCER RES, V57, P1171; Liu CY, 1996, GENE DEV, V10, P1835, DOI 10.1101/gad.10.14.1835; MacLachlan TK, 2000, J BIOL CHEM, V275, P31869, DOI 10.1074/jbc.M003338200; May P, 1999, ONCOGENE, V18, P7621, DOI 10.1038/sj.onc.1203285; Nakagawa K, 1999, MOL CELL BIOL, V19, P2828; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Schuyer M, 1999, MOL CELL ENDOCRINOL, V155, P143, DOI 10.1016/S0303-7207(99)00117-3; Shen SX, 1998, ONCOGENE, V17, P3115, DOI 10.1038/sj.onc.1202243; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 2000, GENE DEV, V14, P289; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Vaziri H, 1997, EMBO J, V16, P6018, DOI 10.1093/emboj/16.19.6018; WANG Y, 1992, P NATL ACAD SCI USA, V89, P4231, DOI 10.1073/pnas.89.10.4231; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743	30	289	297	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2001	28	3					266	271		10.1038/90108	http://dx.doi.org/10.1038/90108			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431698				2022-12-17	WOS:000169656400020
J	Lamb, NE; Freeman, SB; SavageAustin, A; Pettay, D; Taft, L; Hersey, J; Gu, YC; Shen, J; Saker, D; May, KM; Avramopoulos, D; Petersen, MB; Hallberg, A; Mikkelsen, M; Hassold, TJ; Sherman, SL				Lamb, NE; Freeman, SB; SavageAustin, A; Pettay, D; Taft, L; Hersey, J; Gu, YC; Shen, J; Saker, D; May, KM; Avramopoulos, D; Petersen, MB; Hallberg, A; Mikkelsen, M; Hassold, TJ; Sherman, SL			Susceptible chiasmate configurations of chromosome 21 predispose to non-disjunction in both maternal meiosis I and meiosis II	NATURE GENETICS			English	Article							REDUCED RECOMBINATION; DNA POLYMORPHISMS; ABERRANT RECOMBINATION; PARENTAL ORIGIN; MEIOTIC STAGE; NONDISJUNCTION; TRISOMY-21; AGE; MECHANISMS; ETIOLOGY	The cause of non-disjunction of chromosome 21 remains largely unknown. Advanced maternal age is associated with both maternal meiosis I (MI) and meiosis II (MII) non-disjunction events. While reduced genetic recombination has been demonstrated in maternal MI errors, the basis for MII errors remains uncertain. We studied 133 trisomy 21 cases with maternal MII errors to test the hypothesis that segregation at MII may also be influenced by genetic recombination. Our data support a highly significant association: MII non-disjunction involves increased recombination that is largely restricted to proximal 21q. Thus, while absence of a proximal recombination appears to predispose to nondisjunction in MI, the presence of a proximal exchange predisposes to non-disjunction in MII. These findings profoundly affect our understanding of trisomy 21 as they suggest that virtually all maternal non-disjunction results from events occurring in meioisis I.	EMORY UNIV,SCH MED,DEPT GENET & MOL MED,ATLANTA,GA 30322; CASE WESTERN RESERVE UNIV,SCH MED,DEPT GENET,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,CTR HUMAN GENET,CLEVELAND,OH 44106; EMORY UNIV,SCH MED,DEPT PEDIAT,DIV MED GENET,ATLANTA,GA; INST CHILD HLTH,DEPT GENET,ATHENS,GREECE; JF KENNEDY INST,DANISH CTR HUMAN GENOME RES,GLOSTRUP,DENMARK	Emory University; Case Western Reserve University; Case Western Reserve University; Emory University; Aarhus University			Avramopoulos, Dimitrios/J-4392-2012; Petersen, Michael Bjørn B/D-1483-2017; Shen, Joseph/AAY-5083-2020	Petersen, Michael Bjørn B/0000-0003-0316-8207; Shen, Joseph/0000-0002-5604-7639	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032111] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD32111] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABRUZZO MA, 1995, ENVIRON MOL MUTAGEN, V25, P38, DOI 10.1002/em.2850250608; ANTONARAKIS SE, 1993, NAT GENET, V3, P146, DOI 10.1038/ng0293-146; ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; ANTONARAKIS SE, 1992, AM J HUM GENET, V50, P544; Bridges CB, 1916, GENETICS, V1, P1; CHAKRAVARTI A, 1987, Genomics, V1, P35, DOI 10.1016/0888-7543(87)90102-9; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; FARNET C, 1989, MECH CONSEQUENCES DN; FISHER JM, 1995, AM J HUM GENET, V56, P669; HASSOLD T, 1990, HUM GENET, V85, P648; HASSOLD T, 1995, AM J HUM GENET, V57, P867; HASSOLD T, 1985, AM J HUM GENET, V37, P965; HASSOLD TJ, 1991, AM J HUM GENET, V49, P253; HAWLEY RS, 1993, ANNU REV GENET, V27, P281; HAWLEY RS, 1994, HUM MOL GENET, V3, P1521, DOI 10.1093/hmg/3.9.1521; HENDERSON SA, 1968, NATURE, V217, P22; JABS EW, 1991, GENOMICS, V9, P141, DOI 10.1016/0888-7543(91)90231-3; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LORBER BJ, 1992, AM J HUM GENET, V51, P1265; MACDONALD M, 1994, HUM MOL GENET, V3, P1365, DOI 10.1093/hmg/3.8.1365; MALONE RE, 1981, MOL CELL BIOL, V1, P891, DOI 10.1128/MCB.1.10.891; MASCARI MJ, 1993, AM J HUM GENET, V53, pA260; MIKKELSEN M, 1995, DEV BRAIN DYSFUNCT, V8, P4; MIYAZAKI WY, 1994, ANNU REV GENET, V28, P167, DOI 10.1146/annurev.ge.28.120194.001123; MORTON NE, 1989, ANN HUM GENET, V53, P263, DOI 10.1111/j.1469-1809.1989.tb01793.x; MORTON NE, 1984, GENET RES, V44, P99, DOI 10.1017/S0016672300026276; MORTON NE, 1994, ANN HUM GENET, V54, P39; PETERSEN MB, 1992, AM J HUM GENET, V51, P516; RAO DC, 1977, HUM HERED, V27, P99, DOI 10.1159/000152856; ROBINSON WP, 1993, AM J HUM GENET, V53, P740; ROEDER G, 1989, MOL CYTOGENETIC STUD, P303; SHERMAN SL, 1991, AM J HUM GENET, V49, P608; SHERMAN SL, 1994, HUM MOL GENET, V3, P1529, DOI 10.1093/hmg/3.9.1529; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; VANHUL W, 1993, GENOMICS, V15, P626, DOI 10.1006/geno.1993.1117; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519; Yoon PW, 1996, AM J HUM GENET, V58, P628	37	289	297	0	14	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					400	405		10.1038/ng1296-400	http://dx.doi.org/10.1038/ng1296-400			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944019				2022-12-17	WOS:A1996VV73000015
J	LIVAK, KJ; MARMARO, J; TODD, JA				LIVAK, KJ; MARMARO, J; TODD, JA			TOWARDS FULLY AUTOMATED GENOME-WIDE POLYMORPHISM SCREENING	NATURE GENETICS			English	Letter							5'->3' EXONUCLEASE ACTIVITY; AQUATICUS DNA-POLYMERASE; CHAIN-REACTION PRODUCT		UNIV OXFORD,WELLCOME TRUST CTR HUMAN GENET,NUFFIELD DEPT SURG,OXFORD OX3 7BN,ENGLAND	University of Oxford; Wellcome Centre for Human Genetics	LIVAK, KJ (corresponding author), PERKIN ELMER CORP,DIV APPL BIOSYST,850 LINCOLN CTR DR,FOSTER CITY,CA 94404, USA.		Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148				BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; COTTON RGH, 1993, MUTAT RES, V285, P125, DOI 10.1016/0027-5107(93)90060-S; HOLLAND PM, 1992, CLIN CHEM, V38, P462; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; LEE LG, 1993, NUCLEIC ACIDS RES, V21, P3761, DOI 10.1093/nar/21.16.3761; LIVAK KJ, IN PRESS PCR METH AP; LYAMICHEV V, 1993, SCIENCE, V260, P778, DOI 10.1126/science.7683443	7	289	328	0	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1995	9	4					341	342		10.1038/ng0495-341	http://dx.doi.org/10.1038/ng0495-341			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QQ753	7795635				2022-12-17	WOS:A1995QQ75300006
J	ENGELHARDT, JF; YANG, YP; STRATFORDPERRICAUDET, LD; ALLEN, ED; KOZARSKY, K; PERRICAUDET, M; YANKASKAS, JR; WILSON, JM				ENGELHARDT, JF; YANG, YP; STRATFORDPERRICAUDET, LD; ALLEN, ED; KOZARSKY, K; PERRICAUDET, M; YANKASKAS, JR; WILSON, JM			DIRECT GENE-TRANSFER OF HUMAN CFTR INTO HUMAN BRONCHIAL EPITHELIA OF XENOGRAFTS WITH E1-DELETED ADENOVIRUSES	NATURE GENETICS			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; EXPRESSION; CELLS; IDENTIFICATION; INVITRO; MONKEY; LUNG	We describe the use of a human bronchial xenograft model for studying the efficiency and biology of in vivo gene transfer into human bronchial epithelia with recombinant E1 deleted adenoviruses. All cell types in the surface epithelium except basal cells efficiently expressed the adenoviral transduced recombinant genes, lacZ and CFTR, for 3-5 weeks. Stable transgene expression was associated with high level expression of the early adenoviral gene, E2a, in a subset of transgene expressing cells and virtually undetectable expression of the late adenoviral genes encoding the structural proteins, hexon and fiber. These studies begin to address important issues that relate to safety and in vivo efficacy of recombinant adenoviruses for gene delivery into the human airway.	UNIV MICHIGAN,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT BIOL CHEM,ANN ARBOR,MI 48109; INST GUSTAVE ROUSSY,CNRS,UA 1301,F-94805 VILLEJUIF,FRANCE; UNIV N CAROLINA,DIV PULM DIS,CHAPEL HILL,NC 27599; WISTAR INST ANAT & BIOL,INST HUMAN GENE THERAPY,PHILADELPHIA,PA 19104	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; University of North Carolina; University of North Carolina Chapel Hill; The Wistar Institute			Wilson, James M/F-9220-2011	Wilson, James M/0000-0002-9630-3131; Engelhardt, John/0000-0003-2389-9277	NHLBI NIH HHS [HL34322] Funding Source: Medline; NIDDK NIH HHS [R01 DK047967] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047967] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AYERS MM, 1988, EUR RESPIR J, V1, P58; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; BLENKINSOPP WK, 1967, EXP CELL RES, V46, P144, DOI 10.1016/0014-4827(67)90416-8; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; BREEZE RG, 1977, AM REV RESPIR DIS, V116, P705, DOI 10.1164/arrd.1977.116.4.705; COTTON CU, 1987, J CLIN INVEST, V79, P80, DOI 10.1172/JCI112812; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; ENGELHARDT JF, 1991, P NATL ACAD SCI USA, V88, P11192, DOI 10.1073/pnas.88.24.11192; ENGELHARDT JF, 1992, J CLIN INVEST, V90, P2598, DOI 10.1172/JCI116155; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Graham F L, 1991, Methods Mol Biol, V7, P109, DOI 10.1385/0-89603-178-0:109; GREEN M, 1961, VIROLOGY, V13, P169, DOI 10.1016/0042-6822(61)90051-4; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; HAZINSKI TA, 1991, AM J RESP CELL MOL, V4, P206, DOI 10.1165/ajrcmb/4.3.206; HORWITZ MS, 1990, VIROLOGY, P01679; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; PLOPPER CG, 1989, AM J ANAT, V184, P31, DOI 10.1002/aja.1001840104; RANDELL SH, 1991, AM J RESP CELL MOL, V4, P544, DOI 10.1165/ajrcmb/4.6.544; REICHEL R, 1987, CELL, V48, P501, DOI 10.1016/0092-8674(87)90200-5; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; RUTTEN AAJJL, 1988, VIRCHOWS ARCH B CELL, V56, P117; SARKADI B, 1992, J BIOL CHEM, V267, P2087; STRATFORDPERRICAUDET LD, 1992, J CLIN INVEST, V90, P626, DOI 10.1172/JCI115902; TRAPNELL BC, 1991, P NATL ACAD SCI USA, V88, P6565, DOI 10.1073/pnas.88.15.6565; VERDUGO P, 1990, ANNU REV PHYSIOL, V52, P157, DOI 10.1146/annurev.ph.52.030190.001105; WELSH MJ, 1990, FASEB J, V4, P2718, DOI 10.1096/fasebj.4.10.1695593; WILSON DW, 1984, AM J ANAT, V171, P25, DOI 10.1002/aja.1001710104; YANKASKAS JR, 1985, LANCET, V1, P954; YOSHIMURA K, 1992, NUCLEIC ACIDS RES, V20, P3233, DOI 10.1093/nar/20.12.3233; ZEITLIN PL, 1992, P NATL ACAD SCI USA, V89, P344, DOI 10.1073/pnas.89.1.344	34	289	324	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1993	4	1					27	34		10.1038/ng0593-27	http://dx.doi.org/10.1038/ng0593-27			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA337	7685651				2022-12-17	WOS:A1993LA33700008
J	Moriyama, T; Nishii, R; Perez-Andreu, V; Yang, WJ; Klussmann, FA; Zhao, XJ; Lin, TN; Hoshitsuki, K; Nersting, J; Kihira, K; Hofmann, U; Komada, Y; Kato, M; McCorkle, R; Li, L; Koh, K; Najera, CR; Kham, SKY; Isobe, T; Chen, ZW; Chiew, EKH; Bhojwani, D; Jeffries, C; Lu, Y; Schwab, M; Inaba, H; Pui, CH; Relling, MV; Manabe, A; Hori, H; Schmiegelow, K; Yeoh, AEJ; Evans, WE; Yang, JJ				Moriyama, Takaya; Nishii, Rina; Perez-Andreu, Virginia; Yang, Wenjian; Klussmann, Federico Antillon; Zhao, Xujie; Lin, Ting-Nien; Hoshitsuki, Keito; Nersting, Jacob; Kihira, Kentaro; Hofmann, Ute; Komada, Yoshihiro; Kato, Motohiro; McCorkle, Robert; Li, Lie; Koh, Katsuyoshi; Najera, Cesar Rolando; Kham, Shirley Kow-Yin; Isobe, Tomoya; Chen, Zhiwei; Chiew, Edwynn Kean-Hui; Bhojwani, Deepa; Jeffries, Cynthia; Lu, Yan; Schwab, Matthias; Inaba, Hiroto; Pui, Ching-Hon; Relling, Mary V.; Manabe, Atsushi; Hori, Hiroki; Schmiegelow, Kjeld; Yeoh, Allen E. J.; Evans, William E.; Yang, Jun J.			NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; INFLAMMATORY-BOWEL-DISEASE; S-METHYLTRANSFERASE DEFICIENCY; DNA MISMATCH REPAIR; MAINTENANCE THERAPY; CROHNS-DISEASE; 6-THIOGUANINE NUCLEOTIDES; MERCAPTOPURINE METABOLISM; CATALYTIC-ACTIVITY; DOUBLE-BLIND	Widely used as anticancer and immunosuppressive agents, thiopurines have narrow therapeutic indices owing to frequent toxicities, partly explained by TPMT genetic polymorphisms. Recent studies identified germline NUDT15 variation as another critical determinant of thiopurine intolerance, but the underlying molecular mechanisms and the clinical implications of this pharmacogenetic association remain unknown. In 270 children enrolled in clinical trials for acute lymphoblastic leukemia in Guatemala, Singapore and Japan, we identified four NUDT15 coding variants (p.Arg139Cys, p.Arg139His, p.Val18Ile and p.Val18_Val19insGlyVal) that resulted in 74.4-100% loss of nucleotide diphosphatase activity. Loss-of-function NUDT15 diplotypes were consistently associated with thiopurine intolerance across the three cohorts (P = 0.021, 2.1 x 10(-5) and 0.0054, respectively; meta-analysis P = 4.45 x 10(-8), allelic effect size = -11.5). Mechanistically, NUDT15 inactivated thiopurine metabolites and decreased thiopurine cytotoxicity in vitro, and patients with defective NUDT15 alleles showed excessive levels of thiopurine active metabolites and toxicity. Taken together, these results indicate that a comprehensive pharmacogenetic model integrating NUDT15 variants may inform personalized thiopurine therapy.	[Moriyama, Takaya; Perez-Andreu, Virginia; Yang, Wenjian; Zhao, Xujie; Lin, Ting-Nien; Hoshitsuki, Keito; McCorkle, Robert; Li, Lie; Relling, Mary V.; Evans, William E.; Yang, Jun J.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA; [Moriyama, Takaya; Kihira, Kentaro; Komada, Yoshihiro; Hori, Hiroki] Mie Univ, Grad Sch Med, Dept Pediat, Tsu, Mie, Japan; [Nishii, Rina] Tokyo Med & Dent Univ, Grad Sch Med, Dept Pediat & Dev Biol, Tokyo, Japan; [Klussmann, Federico Antillon; Najera, Cesar Rolando] Unidad Nacl Oncol Pediat, Guatemala City, Guatemala; [Klussmann, Federico Antillon] Francisco Marroquin Med Sch, Guatemala City, Guatemala; [Hoshitsuki, Keito] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA USA; [Nersting, Jacob; Schmiegelow, Kjeld] Univ Copenhagen Hosp, Rigshosp, Dept Paediat & Adolescent Med, DK-2100 Copenhagen, Denmark; [Hofmann, Ute; Schwab, Matthias] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Hofmann, Ute; Schwab, Matthias] Univ Hosp Tubingen, Dept Clin Pharmacol, Tubingen, Germany; [Kato, Motohiro] Natl Ctr Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Tokyo, Japan; [Koh, Katsuyoshi] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan; [Kham, Shirley Kow-Yin; Chiew, Edwynn Kean-Hui; Yeoh, Allen E. J.] Natl Univ Hlth Syst, Natl Univ Canc Inst, Singapore, Singapore; [Isobe, Tomoya] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Isobe, Tomoya] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Bhojwani, Deepa] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA; [Jeffries, Cynthia; Lu, Yan] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA; [Schwab, Matthias] German Canc Res Ctr, German Canc Consortium, Heidelberg, Germany; [Schwab, Matthias] Univ Tubingen, Dept Biochem & Pharm, Tubingen, Germany; [Inaba, Hiroto; Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Manabe, Atsushi] St Lukes Int Hosp, Dept Pediat, Tokyo, Japan; [Schmiegelow, Kjeld] Univ Copenhagen, Inst Clin Med, Copenhagen, Denmark; [Yeoh, Allen E. J.] Natl Univ Singapore, Yong Loo Lin Sch Med, VIVA Univ Childrens Canc Ctr, Singapore 117595, Singapore	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Mie University; Tokyo Medical & Dental University (TMDU); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Rigshospitalet; University of Copenhagen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; National Center for Child Health & Development - Japan; Saitama Children's Medical Center; National University of Singapore; University of Tokyo; University of Tokyo; Children's Hospital Los Angeles; St Jude Children's Research Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; St Jude Children's Research Hospital; St. Luke's International Hospital; University of Copenhagen; National University of Singapore	Yang, JJ (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA.	jun.yang@stjude.org	Yeoh, Allen EJ/D-9663-2015; McCorkle, Rob/AAH-3759-2019; Schwab, Matthias/ABH-7449-2020; Evans, William E./C-2069-2012; Relling, Mary/N-5032-2018; Hoshitsuki, Keito/F-9429-2019; Pui, Ching-Hon/N-8076-2018; Inaba, Hiroto/N-3366-2018; Yang, Jun J./ABG-5646-2020; Nishii, Rina/AAC-4177-2022	Yeoh, Allen EJ/0000-0002-6454-976X; McCorkle, Rob/0000-0002-5028-8853; Evans, William E./0000-0002-9333-5322; Hoshitsuki, Keito/0000-0002-6723-0711; Pui, Ching-Hon/0000-0003-0303-5658; Inaba, Hiroto/0000-0003-0605-7342; Yang, Jun J./0000-0002-0770-9659; Loh, Mignon/0000-0003-4099-4700; Zhao, Xujie/0000-0001-7213-2270; Isobe, Tomoya/0000-0002-3487-3307; Moriyama, Takaya/0000-0001-8864-4174; Bhojwani, Deepa/0000-0002-7559-7927; Kato, Motohiro/0000-0001-5145-1774; Hofmann, Ute/0000-0003-0823-9027	US National Institutes of Health [CA021765, GM115279]; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; Order of St. Francis Foundation; V Foundation for Cancer Research; Danish Childhood Cancer Foundation; Japanese Ministry of Health; National Medical Research Council (Singapore); Children's Cancer Foundation; Viva Foundation for Children with Cancer; Mie Prefecture Study-Abroad Scholarship (Mie, Japan); Robert Bosch Foundation (Stuttgart, Germany); Pediatric Oncology Education Program [CA23944]; Alex's Lemonade Stand Foundation; NATIONAL CANCER INSTITUTE [P30CA021765, R25CA023944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM115279] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Order of St. Francis Foundation; V Foundation for Cancer Research; Danish Childhood Cancer Foundation; Japanese Ministry of Health; National Medical Research Council (Singapore)(National Medical Research Council, Singapore); Children's Cancer Foundation; Viva Foundation for Children with Cancer; Mie Prefecture Study-Abroad Scholarship (Mie, Japan); Robert Bosch Foundation (Stuttgart, Germany); Pediatric Oncology Education Program; Alex's Lemonade Stand Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the patients and parents who participated in the clinical trials included in this study, H. Toyoda at Mie University for his assistance in processing the Japanese Pediatric Leukemia/Lymphoma Study Group samples and C. Smith at St. Jude Children's Research Hospital for querying the 1000 Genomes Project data. This work was supported by the US National Institutes of Health (CA021765 and GM115279), the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital, the Order of St. Francis Foundation, the V Foundation for Cancer Research and the Danish Childhood Cancer Foundation. The Japanese Pediatric Leukemia/Lymphoma Study Group ALL B12 study is supported by the Japanese Ministry of Health, and the MaSpore ALL studies are supported by the National Medical Research Council (Singapore), Children's Cancer Foundation and the Viva Foundation for Children with Cancer. J.J.Y. is an American Society of Hematology Scholar. T.M. is supported by the Mie Prefecture Study-Abroad Scholarship (Mie, Japan). U.H. and M.S. are supported by the Robert Bosch Foundation (Stuttgart, Germany). K.H. is supported by the Pediatric Oncology Education Program grant (CA23944). T.I. is supported by Alex's Lemonade Stand Foundation's pediatric oncology student training (POST) program.	Antillon-Klussmann F, 2010, PEDIATR BLOOD CANCER, V55, P861; Arico M, 2005, Leukemia, V19, P1145, DOI 10.1038/sj.leu.2403783; CANDY S, 1995, GUT, V37, P674, DOI 10.1136/gut.37.5.674; Carter M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8871; CONNELL WR, 1993, GUT, V34, P1081, DOI 10.1136/gut.34.8.1081; de Boer NKH, 2007, NAT CLIN PRACT GASTR, V4, P686, DOI 10.1038/ncpgasthep1000; de Jong DJ, 2004, EUR J GASTROEN HEPAT, V16, P207, DOI 10.1097/00042737-200402000-00014; Diouf B, 2011, NAT MED, V17, P1298, DOI 10.1038/nm.2430; Ebbesen MS, 2013, J CLIN PHARMACOL, V53, P670, DOI 10.1002/jcph.81; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; Evans WE, 2001, J CLIN ONCOL, V19, P2293, DOI 10.1200/JCO.2001.19.8.2293; Fotoohi AK, 2010, BIOCHEM PHARMACOL, V79, P1211, DOI 10.1016/j.bcp.2010.01.006; Fraser AG, 2002, GUT, V50, P485, DOI 10.1136/gut.50.4.485; Gardiner SJ, 2008, CLIN GASTROENTEROL H, V6, P654, DOI 10.1016/j.cgh.2008.02.032; Goldberg R, 2015, EXPERT REV GASTROENT, V9, P891, DOI 10.1586/17474124.2015.1039987; Hanauer SB, 2004, GASTROENTEROLOGY, V127, P723, DOI 10.1053/j.gastro.2004.06.002; Hedeland RL, 2010, CANCER CHEMOTH PHARM, V66, P485, DOI 10.1007/s00280-009-1184-5; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Hindorf U, 2006, ALIMENT PHARM THER, V24, P331, DOI 10.1111/j.1365-2036.2006.02977.x; Hofmann U, 2012, ANAL CHEM, V84, P1294, DOI 10.1021/ac2031699; Holleman A, 2004, NEW ENGL J MED, V351, P533, DOI 10.1056/NEJMoa033513; Jacobsen JH, 2012, J CHROMATOGR B, V881-82, P115, DOI 10.1016/j.jchromb.2011.11.032; Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010; Kakuta Y, 2016, PHARMACOGENOMICS J, V16, P280, DOI 10.1038/tpj.2015.43; Karran P, 2008, NAT REV CANCER, V8, P24, DOI 10.1038/nrc2292; Kham SKY, 2008, EUR J CLIN PHARMACOL, V64, P373, DOI 10.1007/s00228-007-0426-x; KOREN G, 1990, NEW ENGL J MED, V323, P17, DOI 10.1056/NEJM199007053230104; Krynetskaia NF, 2003, MOL PHARMACOL, V64, P456, DOI 10.1124/mol.64.2.456; KRYNETSKI EY, 1995, P NATL ACAD SCI USA, V92, P949, DOI 10.1073/pnas.92.4.949; Krynetski EY, 2003, CANCER RES, V63, P100; LENNARD L, 1990, LANCET, V336, P225, DOI 10.1016/0140-6736(90)91745-V; LENNARD L, 1989, J CLIN ONCOL, V7, P1816, DOI 10.1200/JCO.1989.7.12.1816; LILLEYMAN JS, 1994, LANCET, V343, P1188, DOI 10.1016/S0140-6736(94)92400-7; Maltzman JS, 2003, J CLIN INVEST, V111, P1122, DOI 10.1172/JCI200318384; McLennan AG, 2000, ADV EXP MED BIOL, V486, P115; Meyer JA, 2013, NAT GENET, V45, P290, DOI 10.1038/ng.2558; POSTHUMA EFM, 1995, GUT, V36, P311, DOI 10.1136/gut.36.2.311; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; Regueiro M, 2002, J CLIN GASTROENTEROL, V35, P240, DOI 10.1097/00004836-200209000-00008; Reinisch W, 2010, GUT, V59, P752, DOI 10.1136/gut.2009.194159; Relling MV, 2011, CLIN PHARMACOL THER, V89, P387, DOI 10.1038/clpt.2010.320; Relling MV, 2010, LANCET ONCOL, V11, P507, DOI 10.1016/S1470-2045(10)70097-8; Relling MV, 2006, BLOOD, V107, P843, DOI 10.1182/blood-2005-08-3379; Relling MV, 1999, BLOOD, V93, P2817; Relling MV, 1999, JNCI-J NATL CANCER I, V91, P2001, DOI 10.1093/jnci/91.23.2001; Richards S, 1996, LANCET, V347, P1783; Schmiegelow K, 2009, LEUKEMIA, V23, P557, DOI 10.1038/leu.2008.316; Schmiegelow K, 2014, J PEDIAT HEMATOL ONC, V36, P503, DOI 10.1097/MPH.0000000000000206; Schwab M, 2002, PHARMACOGENETICS, V12, P429, DOI 10.1097/00008571-200208000-00003; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; Tai HL, 1996, AM J HUM GENET, V58, P694; Tai HL, 1997, P NATL ACAD SCI USA, V94, P6444, DOI 10.1073/pnas.94.12.6444; Takagi Y, 2012, J BIOL CHEM, V287, P21541, DOI 10.1074/jbc.M112.363010; Tanaka Y, 2015, BRIT J HAEMATOL, V171, P109, DOI 10.1111/bjh.13518; Teml A, 2007, CLIN PHARMACOKINET, V46, P187, DOI 10.2165/00003088-200746030-00001; TIDD DM, 1974, CANCER RES, V34, P733; Tzoneva G, 2013, NAT MED, V19, P368, DOI 10.1038/nm.3078; Vora A, 2013, LANCET ONCOL, V14, P199, DOI 10.1016/S1470-2045(12)70600-9; Xu H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8553; Yang JJ, 2015, J CLIN ONCOL, V33, P1235, DOI 10.1200/JCO.2014.59.4671; Yang Jun J, 2013, Methods Mol Biol, V999, P273, DOI 10.1007/978-1-62703-357-2_20; Yang SK, 2014, NAT GENET, V46, P1017, DOI 10.1038/ng.3060; Yates CR, 1997, ANN INTERN MED, V126, P608, DOI 10.7326/0003-4819-126-8-199704150-00003; Yeoh AEJ, 2012, J CLIN ONCOL, V30, P2384, DOI 10.1200/JCO.2011.40.5936	65	288	307	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2016	48	4					367	+		10.1038/ng.3508	http://dx.doi.org/10.1038/ng.3508			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DH6NZ	26878724	Green Accepted			2022-12-17	WOS:000372908800008
J	Liao, J; Karnik, R; Gu, HC; Ziller, MJ; Clement, K; Tsankov, AM; Akopian, V; Gifford, CA; Donaghey, J; Galonska, C; Pop, R; Reyon, D; Tsai, SQ; Mallard, W; Joung, JK; Rinn, JL; Gnirke, A; Meissner, A				Liao, Jing; Karnik, Rahul; Gu, Hongcang; Ziller, Michael J.; Clement, Kendell; Tsankov, Alexander M.; Akopian, Veronika; Gifford, Casey A.; Donaghey, Julie; Galonska, Christina; Pop, Ramona; Reyon, Deepak; Tsai, Shengdar Q.; Mallard, William; Joung, J. Keith; Rinn, John L.; Gnirke, Andreas; Meissner, Alexander			Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells	NATURE GENETICS			English	Article							DE-NOVO METHYLATION; DNA METHYLATION; SELF-RENEWAL; HUMAN ES; PLURIPOTENT; EXPRESSION; MAINTENANCE; MUTATIONS; INDUCTION; CPG	DNA methylation is a key epigenetic modification involved in regulating gene expression and maintaining genomic integrity. Here we inactivated all three catalytically active DNA methyltransferases (DNMTs) in human embryonic stem cells (ESCs) using CRISPR/Cas9 genome editing to further investigate the roles and genomic targets of these enzymes. Disruption of DNMT3A or DNMT3B individually as well as of both enzymes in tandem results in viable, pluripotent cell lines with distinct effects on the DNA methylation landscape, as assessed by whole-genome bisulfite sequencing. Surprisingly, in contrast to findings in mouse, deletion of DNMT1 resulted in rapid cell death in human ESCs. To overcome this immediate lethality, we generated a doxycycline-responsive tTA-DNMT1* rescue line and readily obtained homozygous DNMT1-mutant lines. However, doxycycline-mediated repression of exogenous DNMT1* initiates rapid, global loss of DNA methylation, followed by extensive cell death. Our data provide a comprehensive characterization of DNMT-mutant ESCs, including single-base genome-wide maps of the targets of these enzymes.	[Liao, Jing; Karnik, Rahul; Gu, Hongcang; Ziller, Michael J.; Clement, Kendell; Tsankov, Alexander M.; Akopian, Veronika; Gifford, Casey A.; Donaghey, Julie; Galonska, Christina; Pop, Ramona; Mallard, William; Rinn, John L.; Gnirke, Andreas; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Liao, Jing; Karnik, Rahul; Ziller, Michael J.; Clement, Kendell; Tsankov, Alexander M.; Akopian, Veronika; Gifford, Casey A.; Donaghey, Julie; Galonska, Christina; Pop, Ramona; Mallard, William; Rinn, John L.; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA USA; [Liao, Jing; Karnik, Rahul; Ziller, Michael J.; Clement, Kendell; Tsankov, Alexander M.; Akopian, Veronika; Gifford, Casey A.; Donaghey, Julie; Galonska, Christina; Pop, Ramona; Mallard, William; Rinn, John L.; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Reyon, Deepak; Tsai, Shengdar Q.; Joung, J. Keith] Massachusetts Gen Hosp, Dept Pathol, Mol Pathol Unit, Charlestown, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital	Meissner, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	alexander_meissner@harvard.edu	Tsai, Shengdar Q./G-4600-2012; Clement, Kendell/AAZ-6854-2021; Reyon, Deepak/HCH-3183-2022	Tsai, Shengdar Q./0000-0001-9161-3993; Galonska, Christina/0000-0002-6920-5608; Karnik, Rahul/0000-0002-0400-635X; Gu, Hongcang/0000-0002-1439-7606; Rinn, John/0000-0002-7231-7539; Gifford, Casey/0000-0002-7757-573X	Human Frontiers Science Program; US NIH Director's Pioneer Award [DP1 GM105378]; US NIH (National Institute of General Medical Sciences) [P01GM099117]; New York Stem Cell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117, DP1GM105378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036898] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); US NIH Director's Pioneer Award; US NIH (National Institute of General Medical Sciences); New York Stem Cell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank all members of the Meissner laboratory, in particular C. Sindhu for helpful discussion and Z.D. Smith for critical feedback on the manuscript. We thank K. Musunuru (Harvard University) for providing the CRIPSR/Cas9 plasmids and thank Q. Ding from the Musunuru laboratory for technical support. J.L. was supported by a postdoctoral fellowship from the Human Frontiers Science Program. J.K.J. is supported by US NIH Director's Pioneer Award DP1 GM105378. A.M. is a New York Stem Cell Foundation Robertson Investigator. The work was funded by a US NIH (National Institute of General Medical Sciences) grant (P01GM099117) and the New York Stem Cell Foundation.	Barra V, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-2; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Boyle P, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R92, 10.1186/gb-2012-13-10-r92]; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Chen TP, 2007, NAT GENET, V39, P391, DOI 10.1038/ng1982; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Clements EG, 2012, NUCLEIC ACIDS RES, V40, P4334, DOI 10.1093/nar/gks031; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Di Giaimo R, 2005, GENE, V351, P73, DOI 10.1016/j.gene.2005.02.015; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Dodge JE, 2002, GENE, V289, P41, DOI 10.1016/S0378-1119(02)00469-9; Egger G, 2006, P NATL ACAD SCI USA, V103, P14080, DOI 10.1073/pnas.0604602103; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Gordon CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069486; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Horii T, 2013, INT J MOL SCI, V14, P19774, DOI 10.3390/ijms141019774; Hsiao EC, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt52; Hutnick LK, 2010, J BIOL CHEM, V285, P21082, DOI 10.1074/jbc.M110.125674; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jin BL, 2008, HUM MOL GENET, V17, P690, DOI 10.1093/hmg/ddm341; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Klein CJ, 2011, NAT GENET, V43, P595, DOI 10.1038/ng.830; Landau DA, 2014, CANCER CELL, V26, P813, DOI 10.1016/j.ccell.2014.10.012; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; Li L, 2010, BIOPHYS J, V98, P2442, DOI 10.1016/j.bpj.2010.02.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martins-Taylor K, 2012, EPIGENETICS-US, V7, P71, DOI 10.4161/epi.7.1.18750; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Rao LJ, 2012, STEM CELL REV REP, V8, P1109, DOI 10.1007/s12015-012-9413-4; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Shah MY, 2011, NAT GENET, V43, P289, DOI 10.1038/ng0411-289; Shipony Z, 2014, NATURE, V513, P115, DOI 10.1038/nature13458; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Trowbridge JJ, 2009, CELL STEM CELL, V5, P442, DOI 10.1016/j.stem.2009.08.016; Tsankov AM, 2015, NATURE, V518, P344, DOI 10.1038/nature14233; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Winkelmann J, 2012, HUM MOL GENET, V21, P2205, DOI 10.1093/hmg/dds035; Woodfine K, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-1; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	66	288	303	2	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					469	U64		10.1038/ng.3258	http://dx.doi.org/10.1038/ng.3258			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE	25822089	Green Accepted, Green Submitted			2022-12-17	WOS:000353635800009
J	Lemke, JR; Lal, D; Reinthaler, EM; Steiner, I; Nothnagel, M; Alber, M; Geider, K; Laube, B; Schwake, M; Finsterwalder, K; Franke, A; Schilhabel, M; Jahn, JA; Muhle, H; Boor, R; Van Paesschen, W; Caraballo, R; Fejerman, N; Weckhuysen, S; De Jonghe, P; Larsen, J; Moller, RS; Hjalgrim, H; Addis, L; Tang, S; Hughes, E; Pal, DK; Veri, K; Vaher, U; Talvik, T; Dimova, P; Lopez, RG; Serratosa, JM; Linnankivi, T; Lehesjoki, AE; Ruf, S; Wolff, M; Buerki, S; Wohlrab, G; Kroell, J; Datta, AN; Fiedler, B; Kurlemann, G; Kluger, G; Hahn, A; Haberlandt, DE; Kutzer, C; Sperner, J; Becker, F; Weber, YG; Feucht, M; Steinbock, H; Neophythou, B; Ronen, GM; Gruber-Sedlmayr, U; Geldner, J; Harvey, RJ; Hoffmann, P; Herms, S; Altmuller, J; Toliat, MR; Thiele, H; Nurnberg, P; Wilhelm, C; Stephani, U; Helbig, I; Lerche, H; Zimprich, F; Neubauer, BA; Biskup, S; von Spiczak, S				Lemke, Johannes R.; Lal, Dennis; Reinthaler, Eva M.; Steiner, Isabelle; Nothnagel, Michael; Alber, Michael; Geider, Kirsten; Laube, Bodo; Schwake, Michael; Finsterwalder, Katrin; Franke, Andre; Schilhabel, Markus; Jaehn, Johanna A.; Muhle, Hiltrud; Boor, Rainer; Van Paesschen, Wim; Caraballo, Roberto; Fejerman, Natalio; Weckhuysen, Sarah; De Jonghe, Peter; Larsen, Jan; Moller, Rikke S.; Hjalgrim, Helle; Addis, Laura; Tang, Shan; Hughes, Elaine; Pal, Deb K.; Veri, Kadi; Vaher, Ulvi; Talvik, Tiina; Dimova, Petia; Lopez, Rosa Guerrero; Serratosa, Jose M.; Linnankivi, Tarja; Lehesjoki, Anna-Elina; Ruf, Susanne; Wolff, Markus; Buerki, Sarah; Wohlrab, Gabriele; Kroell, Judith; Datta, Alexandre N.; Fiedler, Barbara; Kurlemann, Gerhard; Kluger, Gerhard; Hahn, Andreas; Haberlandt, D. Edda; Kutzer, Christina; Sperner, Juergen; Becker, Felicitas; Weber, Yvonne G.; Feucht, Martha; Steinboeck, Hannelore; Neophythou, Birgit; Ronen, Gabriel M.; Gruber-Sedlmayr, Ursula; Geldner, Julia; Harvey, Robert J.; Hoffmann, Per; Herms, Stefan; Altmueller, Janine; Toliat, Mohammad R.; Thiele, Holger; Nuernberg, Peter; Wilhelm, Christian; Stephani, Ulrich; Helbig, Ingo; Lerche, Holger; Zimprich, Fritz; Neubauer, Bernd A.; Biskup, Saskia; von Spiczak, Sarah			Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes	NATURE GENETICS			English	Article							NMDA RECEPTOR; CENTROTEMPORAL SPIKES; SEIZURES; BENIGN; WAVES; CLASSIFICATION; TERMINOLOGY; CONTRIBUTE; COMPLEX; LINKAGE	Idiopathic focal epilepsy (IFE) with rolandic spikes is the most common childhood epilepsy, comprising a phenotypic spectrum from rolandic epilepsy (also benign epilepsy with centrotemporal spikes, BECTS) to atypical benign partial epilepsy (ABPE), Landau-Kleffner syndrome (LKS) and epileptic encephalopathy with continuous spike and waves during slow-wave sleep (CSWS)(1,2). The genetic basis is largely unknown. We detected new heterozygous mutations in GRIN2A in 27 of 359 affected individuals from 2 independent cohorts with IFE (7.5%; P = 4.83 x 10(-18), Fisher's exact test). Mutations occurred significantly more frequently in the more severe phenotypes, with mutation detection rates ranging from 12/245 (4.9%) in individuals with BECTS to 9/51 (17.6%) in individuals with CSWS (P = 0.009, Cochran-Armitage test for trend). In addition, exon-disrupting microdeletions were found in 3 of 286 individuals (1.0%; P = 0.004, Fisher's exact test). These results establish alterations of the gene encoding the NMDA receptor NR2A subunit as a major genetic risk factor for IFE.	[Lemke, Johannes R.] Univ Childrens Hosp Inselspital, Div Human Genet, Bern, Switzerland; [Lemke, Johannes R.; Lal, Dennis; Reinthaler, Eva M.; Jaehn, Johanna A.; Muhle, Hiltrud; Weckhuysen, Sarah; De Jonghe, Peter; Larsen, Jan; Moller, Rikke S.; Hjalgrim, Helle; Pal, Deb K.; Veri, Kadi; Vaher, Ulvi; Talvik, Tiina; Lopez, Rosa Guerrero; Serratosa, Jose M.; Linnankivi, Tarja; Lehesjoki, Anna-Elina; Datta, Alexandre N.; Hahn, Andreas; Becker, Felicitas; Weber, Yvonne G.; Altmueller, Janine; Thiele, Holger; Nuernberg, Peter; Stephani, Ulrich; Helbig, Ingo; Lerche, Holger; Zimprich, Fritz; Neubauer, Bernd A.; von Spiczak, Sarah] Univ Cologne, Partners EuroEPINOMICS, D-50931 Cologne, Germany; [Lal, Dennis; Altmueller, Janine; Toliat, Mohammad R.; Thiele, Holger; Nuernberg, Peter] Univ Cologne, CCG, D-50931 Cologne, Germany; [Lal, Dennis; Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Lal, Dennis; Hahn, Andreas; Neubauer, Bernd A.] Univ Med Ctr Giessen & Marburg, Dept Neuropediat, Giessen, Germany; [Reinthaler, Eva M.; Zimprich, Fritz] Med Univ Vienna, Dept Neurol, Vienna, Austria; [Steiner, Isabelle; Wilhelm, Christian; Biskup, Saskia] CeGaT, GmbH, Tubingen, Germany; [Alber, Michael; Ruf, Susanne; Wolff, Markus] Univ Tubingen, Dept Neuropediat, Tubingen, Germany; [Geider, Kirsten; Laube, Bodo] Tech Univ Darmstadt, Dept Neurophysiol & Neurosensory Syst, Darmstadt, Germany; [Schwake, Michael] Univ Bielefeld, Dept Chem Biochem 3, D-33615 Bielefeld, Germany; [Finsterwalder, Katrin; Jaehn, Johanna A.; Muhle, Hiltrud; Boor, Rainer; Stephani, Ulrich; Helbig, Ingo; von Spiczak, Sarah] Univ Med Ctr Schleswig Holstein, Dept Neuropediat, Kiel, Germany; [Finsterwalder, Katrin; Jaehn, Johanna A.; Muhle, Hiltrud; Boor, Rainer; Stephani, Ulrich; Helbig, Ingo; von Spiczak, Sarah] Christian Albrecht Univ Kiel, Kiel, Germany; [Franke, Andre; Schilhabel, Markus] Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Boor, Rainer; Stephani, Ulrich] No German Epilepsy Ctr Children & Adolescents, Schwentinental, Germany; [Van Paesschen, Wim] Univ Hosp, Dept Neurol, Louvain, Belgium; [Caraballo, Roberto; Fejerman, Natalio] Juan P Garrahan Pediat Hosp, Dept Neurol, Buenos Aires, DF, Argentina; [Weckhuysen, Sarah; De Jonghe, Peter] Univ Antwerp VIB, Dept Mol Genet, Neurogenet Grp, B-2610 Antwerp, Belgium; [Weckhuysen, Sarah; De Jonghe, Peter] Univ Antwerp, Inst Born Bunge, Neurogenet Lab, B-2020 Antwerp, Belgium; [Weckhuysen, Sarah] Epilepsy Ctr Kempenhaeghe, Hans Berger Clin, Oosterhout, Netherlands; [De Jonghe, Peter] Univ Antwerp Hosp, Dept Neurol, Antwerp, Belgium; [Larsen, Jan; Moller, Rikke S.; Hjalgrim, Helle] Danish Epilepsy Ctr, Dianalund, Denmark; [Addis, Laura; Tang, Shan; Pal, Deb K.] Kings Coll London, Kings Coll Hosp, Inst Psychiat, London, England; [Hughes, Elaine] Kings Coll London, Dept Paediat Neurosci, Neurol Clin, London, England; [Veri, Kadi; Vaher, Ulvi; Talvik, Tiina] Childrens Clin Tartu Univ Hosp, Dept Pediat, Tartu, Estonia; [Veri, Kadi; Vaher, Ulvi; Talvik, Tiina] Univ Tartu, EE-50090 Tartu, Estonia; [Dimova, Petia] St Naum Univ Hosp Neurol & Psychiat, Clin Child Neurol, Sofia, Bulgaria; [Lopez, Rosa Guerrero; Serratosa, Jose M.] Jimenez Diaz Univ Hosp, IIS Fdn, Dept Neurol, Madrid, Spain; [Lopez, Rosa Guerrero; Serratosa, Jose M.] CIBERER, Madrid, Spain; [Linnankivi, Tarja] Univ Helsinki, Cent Hosp, Dept Pediat Neurol, Helsinki, Finland; [Lehesjoki, Anna-Elina] Univ Helsinki, Folkhalsan Inst Genet, Neurosci Ctr, Helsinki, Finland; [Buerki, Sarah] Univ Childrens Hosp Inselspital, Dept Neuropediat, Bern, Switzerland; [Wohlrab, Gabriele] Univ Childrens Hosp, Neuropediat & Neurophysiol Dept, Zurich, Switzerland; [Kroell, Judith] Swiss Epilepsy Ctr, Zurich, Switzerland; [Datta, Alexandre N.] Univ Childrens Hosp, Dept Neuropediat, Basel, Switzerland; [Fiedler, Barbara; Kurlemann, Gerhard] Univ Childrens Hosp, Univ Med Ctr Munster, Dept Neuropediat, Munster, Germany; [Kluger, Gerhard] Schoen Clin Vogtareuth, Epilepsy Ctr Children & Adolescents, Dept Neuropediat & Neurorehabilitat, Vogtareuth, Germany; [Haberlandt, D. Edda] Univ Childrens Hosp, Dept Neuropediat, Innsbruck, Austria; [Kutzer, Christina] Kinderzentrum St Martin, Regensburg, Germany; [Sperner, Juergen] Neuropediat Med Practice, Lubeck, Germany; [Becker, Felicitas; Weber, Yvonne G.; Lerche, Holger] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Tubingen, Germany; [Feucht, Martha] Med Univ Vienna, Dept Pediat, Vienna, Austria; [Neophythou, Birgit] Med Univ Vienna, St Anna Childrens Hosp, Dept Pediat, Vienna, Austria; [Ronen, Gabriel M.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Gruber-Sedlmayr, Ursula] Med Univ Graz, Dept Pediat, Graz, Austria; [Geldner, Julia] Hosp Socio Med Ctr SMZ Sud Kaiser Franz Josef Spi, Dept Pediat, Vienna, Austria; [Harvey, Robert J.] UCL, Sch Pharm, Dept Pharm, London, England; [Hoffmann, Per; Herms, Stefan] Univ Bonn, Inst Human Genet, Bonn, Germany; [Hoffmann, Per; Herms, Stefan] Univ Basel, Div Med Genet, Basel, Switzerland; [Hoffmann, Per; Herms, Stefan] Univ Hosp, Dept Biomed, Basel, Switzerland; [Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Biskup, Saskia] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Biskup, Saskia] Univ Tubingen, German Ctr Neurodegenerat Dis, Tubingen, Germany	University of Bern; University Hospital of Bern; University of Cologne; University of Cologne; University of Cologne; University Hospital of Giessen & Marburg; Medical University of Vienna; CeGaT; Eberhard Karls University of Tubingen; Technical University of Darmstadt; University of Bielefeld; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; University of Kiel; Hospital de Pediatria Doctor Juan Garrahan; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; University of Antwerp; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of London; King's College London; University of Tartu; Medical University Sofia; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Bern; University Hospital of Bern; University Children's Hospital Zurich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Medical University of Vienna; Medical University of Vienna; Saint Anna Children's Hospital; McMaster University; Medical University of Graz; University of London; University College London; University of London School of Pharmacy; University of Bonn; University of Basel; University of Cologne; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Lerche, H (corresponding author), Univ Cologne, Partners EuroEPINOMICS, D-50931 Cologne, Germany.	holger.lerche@uni-tuebingen.de	Addis, Laura/R-1385-2016; Thiele, Holger/ABE-6792-2020; Weckhuysen, Sarah/HGB-9957-2022; Nothnagel, Michael/G-6545-2014; Neubauer, Bernd/AAZ-9391-2020; Buerki, Sarah E./ABA-5692-2020; Ronen, Gabriel M/AAS-3048-2021; Zimprich, Fritz/W-1738-2017; Helbig, Ingo/G-8467-2018; Harvey, Robert J/D-3994-2016; Ronen, Gabriel M/AAS-5028-2021; Muhle, Hiltrud/F-5715-2010; Hoffmann, Per/A-5149-2010; Herms, Stefan/J-1949-2014	Addis, Laura/0000-0001-8455-4278; Thiele, Holger/0000-0002-0169-998X; Weckhuysen, Sarah/0000-0003-2878-1147; Ronen, Gabriel M/0000-0002-7467-0627; Zimprich, Fritz/0000-0002-6998-5480; Helbig, Ingo/0000-0001-8486-0558; Harvey, Robert J/0000-0001-5956-6664; Ronen, Gabriel M/0000-0002-7467-0627; Hoffmann, Per/0000-0002-6573-983X; Guerrero, Rosa/0000-0002-4138-4667; Altmuller, Janine/0000-0003-4372-1521; Buerki, Sarah Elisabeth/0000-0003-3054-1791; Herms, Stefan/0000-0002-2786-8200; Wolff, Markus/0000-0001-5640-0888; Serratosa, Jose/0000-0003-2239-8948; Moller, Rikke S./0000-0002-9664-1448; Nothnagel, Michael/0000-0001-8305-7114; Linnankivi, Tarja/0000-0001-9190-2218; Schwake, Michael/0000-0002-4173-2166; Feucht, Martha/0000-0001-7691-8158	FWO/ESF-ECRP; EuroEPINOMICS-RES network; Academy of Finland [141549]; FWF [I643-B09]; EuroEPINOMICS-CoGIE network within the Eurocores framework of the European Science Foundation (ESF); German Federal Ministry for Education and Research (BMBF) [NGFNplus/EMINet 01GS08123, IonNeurONet 01GM1105A]; German Research Foundation (DFG) [SFB877]; Spanish Government [SAF2010-18586]; European Union Marie Curie International Reintegration Award of the Seventh Framework Programme [PIRG05-GA-2009-248866]; Waterloo Foundation; Ali Paris Fund for Landau-Kleffner Syndrome Research and Education; Charles Sykes Epilepsy Research Trust; National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Mental Health of South London; Maudsley National Health Service (NHS) Foundation Trust;  [32EP30_136042/1];  [G.A.136.11.N];  [SF0180035s08];  [EUI-EURC-2011-4325];  [HE5415/3-1];  [Nu50/8-1];  [Le1030/11-1];  [Ne416/5-1]; MRC [MR/J004049/1] Funding Source: UKRI; Austrian Science Fund (FWF) [I 643] Funding Source: researchfish; Medical Research Council [MR/J004049/1] Funding Source: researchfish	FWO/ESF-ECRP; EuroEPINOMICS-RES network; Academy of Finland(Academy of Finland); FWF(Austrian Science Fund (FWF)); EuroEPINOMICS-CoGIE network within the Eurocores framework of the European Science Foundation (ESF); German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Spanish Government(Spanish GovernmentEuropean Commission); European Union Marie Curie International Reintegration Award of the Seventh Framework Programme; Waterloo Foundation; Ali Paris Fund for Landau-Kleffner Syndrome Research and Education; Charles Sykes Epilepsy Research Trust; National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Mental Health of South London(National Institute for Health Research (NIHR)); Maudsley National Health Service (NHS) Foundation Trust; ; ; ; ; ; ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	S.v.S. received institutional support from Christian-Albrechts University Kiel and a scholarship from the German Epilepsy Society for research activities (Otfrid-Foerster-Stipendium). J.R.L. (32EP30_136042/1), P. D. J. (G.A.136.11.N and FWO/ESF-ECRP), T. T. (SF0180035s08), J. M. S. (EUI-EURC-2011-4325) and I. H. (HE5415/3-1) received financial support within the EuroEPINOMICS-RES network, and A.-E. L. (Academy of Finland, grant 141549), P.N. (Nu50/8-1), H. L. (Le1030/11-1), F.Z. (FWF I643-B09) and B.A.N. (Ne416/5-1) received financial support within the EuroEPINOMICS-CoGIE network within the Eurocores framework of the European Science Foundation (ESF). H. L. and S. Biskup received further support from the German Federal Ministry for Education and Research (BMBF; H. L.: NGFNplus/EMINet 01GS08123; H. L. and S. Biskup, IonNeurONet 01GM1105A). M. Schwake received financial support from the German Research Foundation (DFG; SFB877). J. M. S. received support from the Spanish Government (grant SAF2010-18586). D. K. P. and L. A. received support from a European Union Marie Curie International Reintegration Award of the Seventh Framework Programme (PIRG05-GA-2009-248866) and from the Waterloo Foundation, the Ali Paris Fund for Landau-Kleffner Syndrome Research and Education, the Charles Sykes Epilepsy Research Trust and the National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Mental Health of South London and Maudsley National Health Service (NHS) Foundation Trust.	Bali B, 2007, EPILEPSIA, V48, P2266; Balu DT, 2011, BRAIN RES, V1392, P1, DOI 10.1016/j.brainres.2011.03.051; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Claes LRF, 2009, HUM MUTAT, V30, pE904, DOI 10.1002/humu.21083; Di Maio R, 2013, NEUROBIOL DIS, V49, P87, DOI 10.1016/j.nbd.2012.07.013; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Frasca A, 2011, NEUROBIOL DIS, V43, P507, DOI 10.1016/j.nbd.2011.04.024; Ghasemi M, 2011, EPILEPSY BEHAV, V22, P617, DOI 10.1016/j.yebeh.2011.07.024; Gobbi G, 2006, EPILEPSIA, V47, P62, DOI 10.1111/j.1528-1167.2006.00693.x; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Henson MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042327; Hughes JR, 2011, EPILEPSY BEHAV, V20, P247, DOI 10.1016/j.yebeh.2010.10.015; Lacey CJ, 2012, J NEUROSCI, V32, P11067, DOI 10.1523/JNEUROSCI.5604-11.2012; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Lesca G, 2012, EPILEPSIA, V53, P1526, DOI 10.1111/j.1528-1167.2012.03559.x; Marini C, 2007, EPILEPSIA, V48, P1678, DOI 10.1111/j.1528-1167.2007.01122.x; Marini C, 2011, EPILEPSIA, V52, P24, DOI 10.1111/j.1528-1167.2011.02997.x; Neubauer BA, 1998, NEUROLOGY, V51, P1608, DOI 10.1212/WNL.51.6.1608; Niimura M, 2005, J NEUROCHEM, V92, P1377, DOI 10.1111/j.1471-4159.2005.02977.x; Pal DK, 2010, GENES BRAIN BEHAV, V9, P1004, DOI 10.1111/j.1601-183X.2010.00648.x; Paoletti P, 2011, EUR J NEUROSCI, V33, P1351, DOI 10.1111/j.1460-9568.2011.07628.x; Reutlinger C, 2010, EPILEPSIA, V51, P1870, DOI 10.1111/j.1528-1167.2010.02555.x; Fernandez IS, 2013, EPILEPSIA, V54, P741, DOI 10.1111/epi.12039; Schmermund A, 2002, AM HEART J, V144, P212, DOI 10.1067/mhj.2002.123579; Stephani U, 2000, EPILEPTIC DISORD, V2, pS3; Strug LJ, 2009, EUR J HUM GENET, V17, P1171, DOI 10.1038/ejhg.2008.267; Vadlamudi L, 2006, EPILEPSIA, V47, P550, DOI 10.1111/j.1528-1167.2006.00466.x; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005	32	288	305	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2013	45	9					1067	+		10.1038/ng.2728	http://dx.doi.org/10.1038/ng.2728			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	209ID	23933819				2022-12-17	WOS:000323748200018
J	Richter, J; Schlesner, M; Hoffmann, S; Kreuz, M; Leich, E; Burkhardt, B; Rosolowski, M; Ammerpohl, O; Wagener, R; Bernhart, SH; Lenze, D; Szczepanowski, M; Paulsen, M; Lipinski, S; Russell, RB; Adam-Klages, S; Apic, G; Claviez, A; Hasenclever, D; Hovestadt, V; Hornig, N; Korbel, JO; Kube, D; Langenberger, D; Lawerenz, C; Lisfeld, J; Meyer, K; Picelli, S; Pischimarov, J; Radlwimmer, B; Rausch, T; Rohde, M; Schilhabel, M; Scholtysik, R; Spang, R; Trautmann, H; Zenz, T; Borkhardt, A; Drexler, HG; Moller, P; MacLeod, RAF; Pott, C; Schreiber, S; Trumper, L; Loeffler, M; Stadler, PF; Lichter, P; Eils, R; Kuppers, R; Hummel, M; Klapper, W; Rosenstiel, P; Rosenwald, A; Brors, B; Siebert, R				Richter, Julia; Schlesner, Matthias; Hoffmann, Steve; Kreuz, Markus; Leich, Ellen; Burkhardt, Birgit; Rosolowski, Maciej; Ammerpohl, Ole; Wagener, Rabea; Bernhart, Stephan H.; Lenze, Dido; Szczepanowski, Monika; Paulsen, Maren; Lipinski, Simone; Russell, Robert B.; Adam-Klages, Sabine; Apic, Gordana; Claviez, Alexander; Hasenclever, Dirk; Hovestadt, Volker; Hornig, Nadine; Korbel, Jan O.; Kube, Dieter; Langenberger, David; Lawerenz, Chris; Lisfeld, Jasmin; Meyer, Katharina; Picelli, Simone; Pischimarov, Jordan; Radlwimmer, Bernhard; Rausch, Tobias; Rohde, Marius; Schilhabel, Markus; Scholtysik, Rene; Spang, Rainer; Trautmann, Heiko; Zenz, Thorsten; Borkhardt, Arndt; Drexler, Hans G.; Moeller, Peter; MacLeod, Roderick A. F.; Pott, Christiane; Schreiber, Stefan; Truemper, Lorenz; Loeffler, Markus; Stadler, Peter F.; Lichter, Peter; Eils, Roland; Kueppers, Ralf; Hummel, Michael; Klapper, Wolfram; Rosenstiel, Philip; Rosenwald, Andreas; Brors, Benedikt; Siebert, Reiner		ICGC MMML-Seq Project	Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing	NATURE GENETICS			English	Article							B-CELL LYMPHOMA; MYC; INACTIVATION; DIAGNOSIS; PROTEINS	Burkitt lymphoma is a mature aggressive B-cell lymphoma derived from germinal center B cells(1). Its cytogenetic hallmark is the Burkitt translocation t(8;14)(q24;q32) and its variants, which juxtapose the MYC oncogene with one of the three immunoglobulin loci(2). Consequently, MYC is deregulated, resulting in massive perturbation of gene expression(3). Nevertheless, MYC deregulation alone seems not to be sufficient to drive Burkitt lymphomagenesis. By whole-genome, whole-exome and transcriptome sequencing of four prototypical Burkitt lymphomas with immunoglobulin gene (IG)-MYC translocation, we identified seven recurrently mutated genes. One of these genes, ID3, mapped to a region of focal homozygous loss in Burkitt lymphoma(4). In an extended cohort, 36 of 53 molecularly defined Burkitt lymphomas (68%) carried potentially damaging mutations of ID3. These were strongly enriched at somatic hypermutation motifs. Only 6 of 47 other B-cell lymphomas with the IG-MYC translocation (13%) carried ID3 mutations. These findings suggest that cooperation between ID3 inactivation and IG-MYC translocation is a hallmark of Burkitt lymphomagenesis.	[Richter, Julia; Ammerpohl, Ole; Wagener, Rabea; Hornig, Nadine; Siebert, Reiner] Univ Kiel, Inst Human Genet, Kiel, Germany; [Schlesner, Matthias; Lawerenz, Chris; Eils, Roland; Brors, Benedikt] Deutsch Krebsforschungszentrum Heidelberg DKFZ, Div Theoret Bioinformat, Heidelberg, Germany; [Hoffmann, Steve; Bernhart, Stephan H.; Langenberger, David] Univ Leipzig, LIFE Res Ctr Civilizat Dis, Leipzig, Germany; [Kreuz, Markus; Rosolowski, Maciej; Hasenclever, Dirk; Loeffler, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Leich, Ellen; Pischimarov, Jordan; Rosenwald, Andreas] Univ Wurzburg, Inst Pathol, Wurzburg, Germany; [Burkhardt, Birgit] Univ Hosp Muenster, Munster, Germany; [Burkhardt, Birgit; Lisfeld, Jasmin; Rohde, Marius] Univ Hosp Giessen, Giessen, Germany; [Lenze, Dido; Hummel, Michael] Charite Univ Med Berlin, Inst Pathol, Berlin, Germany; [Szczepanowski, Monika; Klapper, Wolfram] Univ Kiel, Hematopathol Sect, Kiel, Germany; [Paulsen, Maren; Lipinski, Simone; Schilhabel, Markus; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Russell, Robert B.; Apic, Gordana] Heidelberg Univ, Cell Networks, Bioquant, Heidelberg, Germany; [Adam-Klages, Sabine] Univ Kiel, Inst Immunol, Kiel, Germany; [Claviez, Alexander] Univ Hosp Schleswig Holstein, Dept Pediat, Kiel, Germany; [Hovestadt, Volker; Picelli, Simone; Radlwimmer, Bernhard; Lichter, Peter] DKFZ, Div Mol Genet, Heidelberg, Germany; [Korbel, Jan O.; Rausch, Tobias] EMBL, Genome Biol Res Unit, Heidelberg, Germany; [Kube, Dieter; Truemper, Lorenz] Univ Gottingen, Dept Hematol & Oncol, Gottingen, Germany; [Meyer, Katharina; Spang, Rainer] Univ Regensburg, Inst Funct Genom, Regensburg, Germany; [Scholtysik, Rene; Kueppers, Ralf] Univ Duisburg Essen, Sch Med, Inst Cell Biol Canc Res, Essen, Germany; [Trautmann, Heiko; Pott, Christiane] Univ Med Ctr, Dept Internal Med Hematol & Oncol 2, Kiel, Germany; [Zenz, Thorsten] Heidelberg Univ, Dept Med 5, Heidelberg, Germany; [Zenz, Thorsten] Natl Ctr Tumor Dis NCT, Dept Translat Oncol, Heidelberg, Germany; [Zenz, Thorsten] Univ Ulm, Dept Med 3, Ulm, Germany; [Borkhardt, Arndt] Univ Dusseldorf, Dept Pediat Oncol Hematol & Clin Immunol, D-40225 Dusseldorf, Germany; [Drexler, Hans G.; MacLeod, Roderick A. F.] German Collect Microorganisms & Cell Cultures, Dept Human & Anim Cell Cultures, Braunschweig, Germany; [Moeller, Peter] Univ Ulm, Fac Med, Inst Pathol, Ulm, Germany; [Schreiber, Stefan] Univ Kiel, Dept Gen Internal Med, Kiel, Germany; [Stadler, Peter F.] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, Leipzig, Germany; [Stadler, Peter F.] Univ Leipzig, Interdisciplinary Ctr Bioinformat, Leipzig, Germany; [Eils, Roland] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Bioquant, Heidelberg, Germany	University of Kiel; Helmholtz Association; German Cancer Research Center (DKFZ); Leipzig University; Leipzig University; University of Wurzburg; University of Munster; University Hospital of Giessen & Marburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Kiel; University of Kiel; Ruprecht Karls University Heidelberg; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); University of Gottingen; University of Regensburg; University of Duisburg Essen; University of Kiel; Schleswig Holstein University Hospital; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ulm University; Heinrich Heine University Dusseldorf; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Ulm University; University of Kiel; Leipzig University; Leipzig University; Ruprecht Karls University Heidelberg	Siebert, R (corresponding author), Univ Kiel, Inst Human Genet, Kiel, Germany.	rsiebert@medgen.uni-kiel.de	Klapper, Wolfram/S-6314-2016; Rausch, Tobias/H-6511-2019; Paulsen, Maren D/K-4684-2013; Esser, Daniela/ABB-9383-2020; Schlesner, Matthias/I-4030-2013; Langenberger, David/D-4155-2013; Eils, Roland/B-6121-2009; Lipinski, Simone/L-9818-2017; Korbel, Jan O/G-6470-2012; Hoffmann, Steve/E-1438-2013; Ammerpohl, Ole/G-2691-2010; Hornig, Nadine/AAO-2648-2021; Stadler, Peter F. F/L-7857-2015; Rosenstiel, Philip/A-5137-2009; Russell, Rob/AAH-9145-2019; Brors, Benedikt/E-5620-2013; Hoell, Jessica/J-8136-2016; Russell, Robert/GWU-6389-2022; Radlwimmer, Bernhard F/I-3229-2013; Siebert, Reiner/A-8049-2010; Adam-Klages, Sabine/E-9761-2010; Langenberger, David/AAF-3313-2020; Burkhardt, Birgit/AAS-9678-2021	Rausch, Tobias/0000-0001-5773-5620; Paulsen, Maren D/0000-0003-4454-3632; Schlesner, Matthias/0000-0002-5896-4086; Langenberger, David/0000-0001-9424-9701; Eils, Roland/0000-0002-0034-4036; Lipinski, Simone/0000-0002-9322-7372; Korbel, Jan O/0000-0002-2798-3794; Stadler, Peter F. F/0000-0002-5016-5191; Rosenstiel, Philip/0000-0002-9692-8828; Russell, Rob/0000-0002-1905-4717; Brors, Benedikt/0000-0001-5940-3101; Hoell, Jessica/0000-0002-5532-9845; Russell, Robert/0000-0002-7213-1398; Radlwimmer, Bernhard F/0000-0002-4553-7800; Burkhardt, Birgit/0000-0002-1151-829X; Hummel, Michael/0000-0001-6717-605X; , Stephan/0000-0002-5928-9449; Claviez, Alexander/0000-0002-1561-5185; Kreuz, Markus/0000-0002-0520-8391; Spang, Rainer/0000-0002-1326-4297; Hovestadt, Volker/0000-0002-3480-6649; Kuppers, Ralf/0000-0002-6691-7191	Federal Ministry of Education and Research in Germany (BMBF) [01KU1002A, 01KU1002B, 01KU1002C, 01KU1002D, 01KU1002E, 01KU1002F, 01KU1002G, 01KU1002H, 01KU1002I, 01KU1002J]; Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft (DFG); KinderKrebsInitiative Buchholz/Holm-Seppensen	Federal Ministry of Education and Research in Germany (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); KinderKrebsInitiative Buchholz/Holm-Seppensen	This manuscript is dedicated to the memory of Karl Lennert, the founder of the Kiel classification of lymphoma, who died during the preparation of the manuscript. The authors thank O. Batic, C. Becher, C. Botz-von Drathen, A. Dietsch, J. Eils, M. Friskovec, K. Gobel, T. Grieb, S. Hengst, U. Jacobsen, T. Kaacksteen, H. Lammert, C. von der Lancken, H.-H. Muller, S. Radomski, J. Schieferstein, M. Schlapkohl, D. Schuster, S. Olmez and L. Valles for their excellent technical support. We are grateful to G. Richter for excellent work in the coordination of the ICGC MMML-Scq Consortium and to the members of the MMML Consortium for providing extensive data of the sample analyzed within that project. We are also very grateful to all individuals who participate in this study. The project was funded by the Federal Ministry of Education and Research in Germany (BMBF) within the Program for Medical Genuine Research (01KU1002A to 01KU1002J). The authors are responsible for the content of this publication. The MMML Consortium was funded by the Deutsche Krebshilfe from 2003 to 2011. Support of sequencing infrastructure by the Deutsche Forschungsgemeinschaft (DFG) and the KinderKrebsInitiative Buchholz/Holm-Seppensen is gratefully acknowledged. R.W. is the recipient of a Christoph-Schubert-Award from the KinderKrebsInitiative Buchholz/Holm-Seppensen.	Boerma EG, 2009, LEUKEMIA, V23, P225, DOI 10.1038/leu.2008.281; Casellas R, 2009, IMMUNOLOGY, V126, P316, DOI 10.1111/j.1365-2567.2008.03050.x; Choi YJ, 2012, J CELL BIOCHEM, V113, P985, DOI 10.1002/jcb.23428; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Dominguez-Sola D, 2012, CANCER CELL, V22, P141, DOI 10.1016/j.ccr.2012.07.018; Duan S, 2012, NATURE, V481, P90, DOI 10.1038/nature10688; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; JOHNSTON JM, 1992, LEUKEMIA LYMPHOMA, V8, P431, DOI 10.3109/10428199209051025; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Klapper W, 2008, BLOOD, V112, P1374, DOI 10.1182/blood-2008-01-136465; Klapper W, 2012, BLOOD, V119, P1882, DOI 10.1182/blood-2011-10-388470; Klapproth K, 2010, BRIT J HAEMATOL, V149, P484, DOI 10.1111/j.1365-2141.2010.08159.x; Li J, 2010, BLOOD, V116, P5615, DOI 10.1182/blood-2010-03-274506; Love C. L., 2011, BLOOD, V118, P433; Medina PP, 2008, EPIGENETICS-US, V3, P64, DOI 10.4161/epi.3.2.6153; Pan LH, 1999, MOL CELL BIOL, V19, P5969; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Salaverria I, 2011, J CLIN ONCOL, V29, P1835, DOI 10.1200/JCO.2010.32.8385; Sander S, 2012, CANCER CELL, V22, P167, DOI 10.1016/j.ccr.2012.06.012; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Schmitz R, 2011, BLOOD, V118, P200, DOI 10.1182/blood.V118.21.435.435; Scholtysik R, 2010, HAEMATOL-HEMATOL J, V95, P2047, DOI 10.3324/haematol.2010.026831; Seitz V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026837; Swerdlow SH, 2008, WHO CLASSIFICATION T, P179; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wilda M, 2004, LEUKEMIA, V18, P584, DOI 10.1038/sj.leu.2403254; Zenz T, 2008, BLOOD, V112, P3322, DOI 10.1182/blood-2008-04-154070	28	288	296	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1316	1320		10.1038/ng.2469	http://dx.doi.org/10.1038/ng.2469			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23143595	Green Published			2022-12-17	WOS:000311713200008
J	Kiezun, A; Garimella, K; Do, R; Stitziel, NO; Neale, BM; McLaren, PJ; Gupta, N; Sklar, P; Sullivan, PF; Moran, JL; Hultman, CM; Lichtenstein, P; Magnusson, P; Lehner, T; Shugart, YY; Price, AL; de Bakker, PIW; Purcell, SM; Sunyaev, SR				Kiezun, Adam; Garimella, Kiran; Do, Ron; Stitziel, Nathan O.; Neale, Benjamin M.; McLaren, Paul J.; Gupta, Namrata; Sklar, Pamela; Sullivan, Patrick F.; Moran, Jennifer L.; Hultman, Christina M.; Lichtenstein, Paul; Magnusson, Patrik; Lehner, Thomas; Shugart, Yin Yao; Price, Alkes L.; de Bakker, Paul I. W.; Purcell, Shaun M.; Sunyaev, Shamil R.			Exome sequencing and the genetic basis of complex traits	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; ALLELE FREQUENCY-SPECTRUM; RARE VARIANTS; POPULATION-STRUCTURE; PROTEIN FUNCTION; COMMON DISEASES; PLASMA-LEVELS; MUTATIONS; SELECTION		[Kiezun, Adam; McLaren, Paul J.; de Bakker, Paul I. W.; Sunyaev, Shamil R.] Harvard Univ, Sch Med, Dept Med, Div Genet,Brigham & Womens Hosp, Boston, MA 02114 USA; [Kiezun, Adam; Garimella, Kiran; Do, Ron; Stitziel, Nathan O.; Neale, Benjamin M.; McLaren, Paul J.; Gupta, Namrata; Moran, Jennifer L.; Price, Alkes L.; de Bakker, Paul I. W.; Sunyaev, Shamil R.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Do, Ron; Neale, Benjamin M.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Stitziel, Nathan O.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Neale, Benjamin M.; Purcell, Shaun M.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Sklar, Pamela] Mt Sinai Sch Med, Dept Psychiat, Friedman Brain Inst, New York, NY USA; [Sklar, Pamela] Mt Sinai Sch Med, Inst Genom & Multiscale Biol, New York, NY USA; [Sullivan, Patrick F.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC USA; [Hultman, Christina M.; Lichtenstein, Paul; Magnusson, Patrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Shugart, Yin Yao] NIMH, Div Neurosci & Basic Behav Sci, Bethesda, MD 20892 USA; [Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Sunyaev, SR (corresponding author), Harvard Univ, Sch Med, Dept Med, Div Genet,Brigham & Womens Hosp, Boston, MA 02114 USA.	ssunyaev@rics.bwh.harvard.edu	de Bakker, Paul IW/B-8730-2009; Magnusson, Patrik KE/C-4458-2017; Stitziel, Nathan/AAL-8413-2021	de Bakker, Paul IW/0000-0001-7735-7858; Magnusson, Patrik KE/0000-0002-7315-7899; Stitziel, Nathan/0000-0002-4963-8211; Garimella, Kiran/0000-0002-6212-5736; McLaren, Paul/0000-0001-6019-7018; Kiezun, Adam/0000-0002-6634-1073; YAO, YIN/0000-0003-3053-8429; Moran, Jennifer/0000-0002-5664-4716; lichtenstein, paul/0000-0003-3037-5287	US National Institutes of Health (NIH) [5R01 MH084676]; Collaboration for AIDS Vaccine Discovery of the Bill and Melinda Gates Foundation; NIH [AI069474, AI069428, AI69467, AI069415, Al32782, AI27661, AI25859, AI28568, AI30914, AI069495, AI069471, AI069532, AI069452, AI069450, AI069556]; Herman Foundation; Stanley Medical Research Institute; National Institute of Mental Health (NIMH) [1R01MH089208-01]; Canadian Institutes of Health Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445, KL2TR000446, TL1TR000447] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024977, UL1RR024975, TL1RR024978] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069415, U01AI069484, U01AI027661, UM1AI069501, U01AI069511, UM1AI069467, UM1AI069452, U01AI069477, U01AI068634, UM1AI069424, U01AI069502, R01AI030914, R37AI028568, U01AI069501, U01AI069471, U01AI025859, UM1AI068634, U01AI068636, UM1AI068636, U01AI069423, UM1AI069556, U01AI069432, R01AI028568, U01AI069474, U01AI069556, U01AI069465, U01AI046370, U01AI069532, U01AI069415, UM1AI069428, UM1AI069432, UM1AI069434, U01AI069452, UM1AI069511, UM1AI069484, U01AI034853, U01AI069419, R01AI077505, UM1AI069532, U01AI038844, U01AI069467, U01AI069434, UM1AI069495, U01AI069450, UM1AI069419, UM1AI069474, UM1AI069465, UM1AI069423, U01AI069513, UM1AI069450, UM1AI069471, U01AI032782, U01AI069472, UM1AI069477, U01AI034835, U01AI069424, U01AI069428, UM1AI069513, UM1AI069472, U01AI069495, UM1AI069502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084676, ZIAMH002929, R01MH095034, ZIAMH002930, RC2MH089905, R01MH089208] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collaboration for AIDS Vaccine Discovery of the Bill and Melinda Gates Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Herman Foundation; Stanley Medical Research Institute; National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors are grateful to S. Pollack for assistance with EIGENSOFT. This work was made possible, in part, by the US National Institutes of Health (NIH; grant 5R01 MH084676) and, in part, by the International HIV Controllers Study, supported by the Collaboration for AIDS Vaccine Discovery of the Bill and Melinda Gates Foundation (to P.I.W.d.B.), and the AIDS Clinical Trials Group, supported by the NIH (grants AI069513, AI34835, AI069432, AI069423, AI069477, AI069501, AI069474, AI069428, AI69467, AI069415, Al32782, AI27661, AI25859, AI28568, AI30914, AI069495, AI069471, AI069532, AI069452, AI069450, AI069556, AI069484, AI069472, AI34853, AI069465, AI069511, AI38844, AI069424, AI069434, AI46370, AI68634, AI069502, AI069419, AI068636, RR024975 and AI077505). Sequencing of the SCZ control individuals was funded by the NIH (grant RC2MH089905), the Herman Foundation and the Stanley Medical Research Institute. N.O.S. was supported, in part, by an NIH Training Grant (T32-HL07604-25; Division of Cardiovascular Medicine, Brigham and Women's Hospital). B.M.N. was supported by a National Institute of Mental Health (NIMH) grant (1R01MH089208-01). R. D. is supported by a Canadian Institutes of Health Research Banting Postdoctoral Fellowship. The views expressed in this paper do not necessarily represent the views of the NIMH, NIH, Department of Health and Human Services (HHS) or the US government.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; [Anonymous], 2008, NAT METHODS, V5, P15, DOI 10.1038/NMETH1155; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021097; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/NNANO.2009.12, 10.1038/nnano.2009.12]; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Eyre-Walker A, 2006, GENETICS, V173, P891, DOI 10.1534/genetics.106.057570; Fay JC, 2001, GENETICS, V158, P1227; Fuller CW, 2009, NAT BIOTECHNOL, V27, P1013, DOI 10.1038/nbt.1585; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hedges DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018595; Hellmann I, 2003, GENOME RES, V13, P831, DOI 10.1101/gr.944903; Hicks S, 2011, HUM MUTAT, V32, P661, DOI 10.1002/humu.21490; Hoffmann TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013584; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Jordan DM, 2010, CURR OPIN STRUC BIOL, V20, P342, DOI 10.1016/j.sbi.2010.03.006; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; KIMURA M, 1987, J MOL EVOL, V26, P24, DOI 10.1007/BF02111279; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lipman PJ, 2011, GENET EPIDEMIOL, V35, P303, DOI 10.1002/gepi.20578; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; MacArthur DG, 2010, HUM MOL GENET, V19, pR125, DOI 10.1093/hmg/ddq365; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Nachman MW, 2000, GENETICS, V156, P297; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pierce SB, 2010, AM J HUM GENET, V87, P282, DOI 10.1016/j.ajhg.2010.07.007; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Stitziel NO, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-227; Sul JH, 2011, LECT N BIOINFORMAT, V6577, P452, DOI 10.1007/978-3-642-20036-6_41; Sul JH, 2011, GENETICS, V188, P181, DOI 10.1534/genetics.110.125070; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tavtigian SV, 2009, AM J HUM GENET, V85, P427, DOI 10.1016/j.ajhg.2009.08.018; Teer JK, 2010, HUM MOL GENET, V19, pR145, DOI 10.1093/hmg/ddq333; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032; Yampolsky LY, 2005, HUM MOL GENET, V14, P3191, DOI 10.1093/hmg/ddi350; Zhao Q, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r114	97	288	292	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2012	44	6					623	630		10.1038/ng.2303	http://dx.doi.org/10.1038/ng.2303			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	22641211	Green Submitted, Green Accepted			2022-12-17	WOS:000304551100006
J	Benjamin, EJ; Rice, KM; Arking, DE; Pfeufer, A; van Noord, C; Smith, AV; Schnabel, RB; Bis, JC; Boerwinkle, E; Sinner, MF; Dehghan, A; Lubitz, SA; D'Agostino, RB; Lumley, T; Ehret, GB; Heeringa, J; Aspelund, T; Newton-Cheh, C; Larson, MG; Marciante, KD; Soliman, EZ; Rivadeneira, F; Wang, TJ; Eiriksdottir, G; Levy, D; Psaty, BM; Li, M; Chamberlain, AM; Hofman, A; Vasan, RS; Harris, TB; Rotter, JI; Kao, WHL; Agarwal, SK; Stricker, BHC; Wang, K; Launer, LJ; Smith, NL; Chakravarti, A; Uitterlinden, AG; Wolf, PA; Sotoodehnia, N; Kottgen, A; van Duijn, CM; Meitinger, T; Mueller, M; Perz, S; Steinbeck, G; Wichmann, HE; Lunetta, KL; Heckbert, SR; Gudnason, V; Alonso, A; Kaab, S; Ellinor, PT; Witteman, JCM				Benjamin, Emelia J.; Rice, Kenneth M.; Arking, Dan E.; Pfeufer, Arne; van Noord, Charlotte; Smith, Albert V.; Schnabel, Renate B.; Bis, Joshua C.; Boerwinkle, Eric; Sinner, Moritz F.; Dehghan, Abbas; Lubitz, Steven A.; D'Agostino, Ralph B., Sr.; Lumley, Thomas; Ehret, Georg B.; Heeringa, Jan; Aspelund, Thor; Newton-Cheh, Christopher; Larson, Martin G.; Marciante, Kristin D.; Soliman, Elsayed Z.; Rivadeneira, Fernando; Wang, Thomas J.; Eiriksdottir, Gudny; Levy, Daniel; Psaty, Bruce M.; Li, Man; Chamberlain, Alanna M.; Hofman, Albert; Vasan, Ramachandran S.; Harris, Tamara B.; Rotter, Jerome I.; Kao, W. H. Linda; Agarwal, Sunil K.; Stricker, Bruno H. Ch; Wang, Ke; Launer, Lenore J.; Smith, Nicholas L.; Chakravarti, Aravinda; Uitterlinden, Andre G.; Wolf, Philip A.; Sotoodehnia, Nona; Koettgen, Anna; van Duijn, Cornelia M.; Meitinger, Thomas; Mueller, Martina; Perz, Siegfried; Steinbeck, Gerhard; Wichmann, H-Erich; Lunetta, Kathryn L.; Heckbert, Susan R.; Gudnason, Vilmundur; Alonso, Alvaro; Kaeaeb, Stefan; Ellinor, Patrick T.; Witteman, Jacqueline C. M.			Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR ATBF1; LIFETIME RISK; DIFFERENTIATION; PREVALENCE	We conducted meta-analyses of genome-wide association studies for atrial fibrillation (AF) in participants from five community-based cohorts. Meta-analyses of 896 prevalent (15,768 referents) and 2,517 incident (21,337 referents) AF cases identified a new locus for AF (ZFHX3, rs2106261, risk ratio RR = 1.19; P = 2.3 x 10(-7)). We replicated this association in an independent cohort from the German AF Network (odds ratio = 1.44; P = 1.6 x 10(-11); combined RR = 1.25; combined P = 1.8 x 10(-15)).	[Benjamin, Emelia J.; Schnabel, Renate B.; D'Agostino, Ralph B., Sr.; Newton-Cheh, Christopher; Larson, Martin G.; Wang, Thomas J.; Levy, Daniel; Vasan, Ramachandran S.; Wolf, Philip A.; Lunetta, Kathryn L.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Benjamin, Emelia J.; Levy, Daniel; Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Med, Cardiol Sect, Boston, MA 02118 USA; [Benjamin, Emelia J.; Levy, Daniel; Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Med, Prevent Med Sect, Boston, MA 02118 USA; [Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Rice, Kenneth M.; Lumley, Thomas] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Arking, Dan E.; Ehret, Georg B.; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Pfeufer, Arne; Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Dept Human Genet, D-8000 Munich, Germany; [Pfeufer, Arne] German Natl Res Ctr Environm Hlth, Helmholtz Ctr Munich, Dept Human Genet, Munich, Germany; [van Noord, Charlotte; Dehghan, Abbas; Heeringa, Jan; Rivadeneira, Fernando; Hofman, Albert; Stricker, Bruno H. Ch; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Witteman, Jacqueline C. M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [van Noord, Charlotte] Dutch Med Evaluat Board, The Hague, Netherlands; [van Noord, Charlotte; Witteman, Jacqueline C. M.] Netherlands Consortium Healthy Aging, Leiden, Netherlands; [Smith, Albert V.; Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Schnabel, Renate B.] Johannes Gutenberg Univ Mainz, Gutenberg Heart Study, Med Clin Cardiol 2, Mainz, Germany; [Bis, Joshua C.; Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Div Epidemiol, Houston, TX USA; [Sinner, Moritz F.; Mueller, Martina; Steinbeck, Gerhard; Kaeaeb, Stefan] Univ Munich, Klinikum Grosshadern, Dept Med 1, D-8000 Munich, Germany; [Lubitz, Steven A.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Lubitz, Steven A.; Newton-Cheh, Christopher; Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [D'Agostino, Ralph B., Sr.; Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Newton-Cheh, Christopher] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Marciante, Kristin D.; Psaty, Bruce M.; Sotoodehnia, Nona] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Marciante, Kristin D.] Univ Washington, Dept Gen Internal Med, Seattle, WA 98195 USA; [Soliman, Elsayed Z.] Wake Forest Univ, Bowman Gray Sch Med, Dept Epidemiol & Prevent, Epidemiol Cardiol Res Ctr EPICARE, Winston Salem, NC USA; [Rivadeneira, Fernando; Stricker, Bruno H. Ch; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Wang, Thomas J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [Levy, Daniel] NHLBI, Ctr Populat Studies, Bethesda, MD 20892 USA; [Psaty, Bruce M.; Smith, Nicholas L.; Heckbert, Susan R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.; Heckbert, Susan R.] Ctr Hlth Studies, Grp Hlth, Washington, DC USA; [Li, Man; Kao, W. H. Linda; Koettgen, Anna] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Chamberlain, Alanna M.; Alonso, Alvaro] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Harris, Tamara B.; Launer, Lenore J.] NIA, Intramural Res Program, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Agarwal, Sunil K.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Stricker, Bruno H. Ch] Inspectorate Hlth Care, The Hague, Netherlands; [Wang, Ke; Lunetta, Kathryn L.] Boston Univ, Sch Med, Dept Biostat, Boston, MA 02118 USA; [Smith, Nicholas L.] Seattle Epidemiol Res & Informat Ctr, Dept Vet Affairs, Off Res & Dev, Seattle, WA USA; [Uitterlinden, Andre G.] Erasmus MC, Dept Clin Chem, Rotterdam, Netherlands; [Wolf, Philip A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Sotoodehnia, Nona] Univ Washington, Div Cardiol, Seattle, WA 98195 USA; [Mueller, Martina; Wichmann, H-Erich] Deutsch Forschungszentrum Gesundheit & Umwelt, Inst Epidemiol, Helmholtz Zentrum Munchen, Munich, Germany; [Perz, Siegfried] Deutsch Forschungszentrum Gesundheit & Umwelt Gmb, Inst Med Informat, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Ellinor, Patrick T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiac Arrhythmia Serv, Boston, MA USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Boston University; University of Washington; University of Washington Seattle; Johns Hopkins University; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Erasmus University Rotterdam; Erasmus MC; Icelandic Heart Association; Johannes Gutenberg University of Mainz; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Munich; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Boston University; University of Iceland; Harvard University; Massachusetts General Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Wake Forest University; Wake Forest Baptist Medical Center; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard Medical School; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Cedars Sinai Medical Center; University of North Carolina; University of North Carolina Chapel Hill; Boston University; Erasmus University Rotterdam; Erasmus MC; Boston University; University of Washington; University of Washington Seattle; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Harvard University; Harvard Medical School; Massachusetts General Hospital	Benjamin, EJ (corresponding author), NHLBI, Framingham Heart Study, Framingham, MA USA.	emelia@bu.edu; j.witteman@erasmusmc.nl	Gudnason, Vilmundur/AAE-7126-2019; Schnabel, Renate B/F-6527-2014; Levy, Daniel/ABB-2752-2021; Smith, Albert Vernon/K-5150-2015; Gudnason, Vilmundur/K-6885-2015; Müller-Nurasyid, Martina/I-8735-2018; Aspelund, Thor/C-5983-2008; Kottgen, Anna/D-2920-2012; Li, Man/AAX-3400-2020; Rotter, Jerome/AAY-6598-2021; Ramachandran, Vasan/Y-2527-2019; Soliman, Elsayed Z/AAD-7135-2020; Levy, Daniel/ABF-6873-2021; Alonso, Alvaro/A-4917-2010; Launer, Lenore J/A-8218-2010; Rivadeneira, Fernando/O-5385-2015; Soliman, Elsayed/D-8124-2011; Aspelund, Thor/K-7022-2019; Meitinger, Thomas/O-1318-2015; EHRET, Georg B/A-9532-2009; Aspelund, Thor/F-4826-2011; Rice, Kenneth M/A-4150-2013; Schnabel, Renate B/ABE-6668-2021; Kaab, Stefan/H-3915-2012; Wichmann, Heinz Erich/AAA-5695-2022; Sinner, Moritz/AAW-5043-2020; Dehghan, Abbas/ABE-7377-2020; Pfeufer, Arne/B-6634-2013; Dehghan, Abbas/B-9896-2008; Benjamin, Emelia/E-7103-2011	Gudnason, Vilmundur/0000-0001-5696-0084; Smith, Albert Vernon/0000-0003-1942-5845; Gudnason, Vilmundur/0000-0001-5696-0084; Müller-Nurasyid, Martina/0000-0003-3793-5910; Aspelund, Thor/0000-0002-7998-5433; Li, Man/0000-0002-3839-0281; Ramachandran, Vasan/0000-0001-7357-5970; Soliman, Elsayed Z/0000-0001-5632-8150; Levy, Daniel/0000-0003-1843-8724; Alonso, Alvaro/0000-0002-2225-8323; Rivadeneira, Fernando/0000-0001-9435-9441; Soliman, Elsayed/0000-0001-5632-8150; Aspelund, Thor/0000-0002-7998-5433; EHRET, Georg B/0000-0002-5730-0675; Rice, Kenneth M/0000-0001-5779-4495; Schnabel, Renate B/0000-0001-7170-9509; Meitinger, Thomas/0000-0002-8838-8403; Ballantyne, Christie/0000-0002-6432-1730; Chamberlain, Alanna/0000-0003-1888-9584; Lunetta, Kathryn/0000-0002-9268-810X; Ellinor, Patrick/0000-0002-2067-0533; Van Duijn, Cornelia/0000-0002-2374-9204; Dehghan, Abbas/0000-0001-6403-016X; Benjamin, Emelia/0000-0003-4076-2336; Wolf, Philip/0000-0002-3628-301X; Wang, Thomas/0000-0003-4063-6508; Larson, Martin/0000-0002-9631-1254	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006001, N01HC55021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG006000] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000069, M01 RR000425-30S1, UL1 RR025005] Funding Source: Medline; NHGRI NIH HHS [U01 HG004402-01, U01 HG004402] Funding Source: Medline; NHLBI NIH HHS [N01 HC055019, N01HC55020, R01 HL087652-01, N01 HC015103, N01 HC055016, N01 HC085083, R01 HL076784-01, N01HC55015, N01 HC055018, N01 HC045133, N01HC55019, N01HC55222, N01 HC025195, T32 HL007575, R01 HL086694, U01 HL080295-01, R01 HL080124-01, N01HC55021, N01 HC055020, N02 HL64278, R01 HL059367, N01 HC035129, R01 HL092577, N01 HC085081, N01 HC055222, R01 HL104156, N01HC85079, N01HC55022, R01 HL080124, N01 HC075150, N01 HC085079, N01 HC085085, N01 HC055021, U01 HL080295, N01HC55016, N01 HC055022, N01 HC085086, R01 HL059367-02, R01 HL088456, R01 HL086694-02, R01 HL087641, N01 HC055015, N01 HC085084, R01 HL086694-01A1, N01 HC085082, R01 HL088456-01, N01HC55018, N01 HC085080, N01HC85086, N01HC75150, R01 HL092577-01A1, R01 HL087652, N01HC25195, R01 HL076784, R01 HL093328, R01 HL087641-01, T32 HL007575-23, R01 HL093328-01] Funding Source: Medline; NIA NIH HHS [R01 AG028321-01, N01AG12100, R01 AG028321, N01 AG012100] Funding Source: Medline; NIDDK NIH HHS [P30 DK063491-039004, P30 DK063491-019004, P30 DK063491-029004, P30 DK063491-049004, R01 DK033651, P30 DK063491, P30 DK063491-06, P30 DK063491-05] Funding Source: Medline; NINDS NIH HHS [R01 NS017950, R01 NS017950-23] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Berry FB, 2001, J BIOL CHEM, V276, P25057, DOI 10.1074/jbc.M010378200; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Ellinor PT, 2005, HUM GENET, V118, P179, DOI 10.1007/s00439-005-0034-8; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300; Ido A, 1996, GENE, V168, P227, DOI 10.1016/0378-1119(95)00740-7; Jung CG, 2005, DEVELOPMENT, V132, P5137, DOI 10.1242/dev.02098; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Sun XD, 2005, NAT GENET, V37, P407, DOI 10.1038/ng1528	14	288	295	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2009	41	8					879	881		10.1038/ng.416	http://dx.doi.org/10.1038/ng.416			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19597492	Green Accepted, Green Submitted			2022-12-17	WOS:000268432900008
J	Sobacchi, C; Frattini, A; Guerrini, MM; Abinun, M; Pangrazio, A; Susani, L; Bredius, R; Mancini, G; Cant, A; Bishop, N; Grabowski, P; Del Fattore, A; Messina, C; Errigo, G; Coxon, FP; Scott, DI; Teti, A; Rogers, MJ; Vezzoni, P; Villa, A; Helfrich, MH				Sobacchi, Cristina; Frattini, Annalisa; Guerrini, Matteo M.; Abinun, Mario; Pangrazio, Alessandra; Susani, Lucia; Bredius, Robbert; Mancini, Grazia; Cant, Andrew; Bishop, Nick; Grabowski, Peter; Del Fattore, Andrea; Messina, Chiara; Errigo, Gabriella; Coxon, Fraser P.; Scott, Debbie I.; Teti, Anna; Rogers, Michael J.; Vezzoni, Paolo; Villa, Anna; Helfrich, Miep H.			Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL	NATURE GENETICS			English	Article							AUTOSOMAL RECESSIVE OSTEOPETROSIS; MICE; DEFICIENCY; REGULATOR; DEFECTS; RESCUE; MOUSE	Autosomal recessive osteopetrosis is usually associated with normal or elevated numbers of nonfunctional osteoclasts. Here we report mutations in the gene encoding RANKL ( receptor activator of nuclear factor - KB ligand) in six individuals with autosomal recessive osteopetrosis whose bone biopsy specimens lacked osteoclasts. These individuals did not show any obvious defects in immunological parameters and could not be cured by hematopoietic stem cell transplantation; however, exogenous RANKL induced formation of functional osteoclasts from their monocytes, suggesting that they could, theoretically, benefit from exogenous RANKL administration.	CNR, Inst Biomed Technol, I-20090 Segrate, Italy; Ist Clin Humanitas, I-20089 Rozzano, Italy; Newcastle Gen Hosp, Childrens Bone Marrow Transplant Unit, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Fac Med, Inst Cellular Med, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands; Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; Univ Sheffield, Acad Unit Child Hlth, Sheffield S1O 2TH, S Yorkshire, England; Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; Univ Padua, Pediat Hematol & Oncol Unit, I-35122 Padua, Italy; Univ Aberdeen, Bone & Musculoskeletal Programme, Aberdeen AB25 2ZD, Scotland; Univ Vita & Salute San Raffaele, Telethon Inst GeneTherapy, I-20090 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); IRCCS Humanitas Research Hospital; Newcastle General Hospital; Newcastle University - UK; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; University of Sheffield; University of L'Aquila; University of Padua; University of Aberdeen; Vita-Salute San Raffaele University	Frattini, A (corresponding author), CNR, Inst Biomed Technol, Via F Cervi 93, I-20090 Segrate, Italy.	annalisa.frattini@itb.cnr.it	SOBACCHI, CRISTINA/J-9345-2018; Frattini, Annalisa/B-7684-2015; Bredius, Robbert/AAF-2592-2019; Del Fattore, Andrea/H-4409-2015; Susani, Lucia/HHM-4185-2022; Vezzoni, Paolo/K-3197-2018; Vezzoni, Paolo/R-3416-2019; Grabowski, Peter S/G-2345-2010; Del Fattore, Andrea/AAP-2045-2020	SOBACCHI, CRISTINA/0000-0002-2684-7184; Frattini, Annalisa/0000-0002-1166-3091; Del Fattore, Andrea/0000-0003-3848-412X; Grabowski, Peter S/0000-0001-5924-1587; Del Fattore, Andrea/0000-0003-3848-412X; Bredius, Robbert/0000-0001-8151-1539; Vezzoni, Paolo/0000-0002-6382-3923; Susani, Lucia/0000-0003-3368-2135; Villa, Anna/0000-0003-4428-9013; Teti, Anna Maria/0000-0002-5887-4419; Wilkinson, Debbie/0000-0003-0237-3807; Rogers, Michael/0000-0002-1818-9249	Telethon [TGT06S01, TGT06A04] Funding Source: Medline; Chief Scientist Office [CZB/4/495] Funding Source: Medline	Telethon(Fondazione Telethon); Chief Scientist Office		Chalhoub N, 2003, NAT MED, V9, P399, DOI 10.1038/nm842; Chen W, 2007, HUM MOL GENET, V16, P410, DOI 10.1093/hmg/ddl474; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Frattini A, 2003, J BONE MINER RES, V18, P1740, DOI 10.1359/jbmr.2003.18.10.1740; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kostenuik PJ, 2005, CURR OPIN PHARMACOL, V5, P618, DOI 10.1016/j.coph.2005.06.005; Lam J, 2001, J CLIN INVEST, V108, P971, DOI 10.1172/JCI13890; Mizuno A, 2002, J BONE MINER METAB, V20, P337, DOI 10.1007/s007740200049; Nataf S, 2005, AM J PATHOL, V166, P275, DOI 10.1016/S0002-9440(10)62251-1; Pangrazio A, 2006, J BONE MINER RES, V21, P1098, DOI 10.1359/JBMR.060403; SLY WS, 1983, P NATL ACAD SCI-BIOL, V80, P2752, DOI 10.1073/pnas.80.9.2752; Sobacchi C, 2001, HUM MOL GENET, V10, P1767, DOI 10.1093/hmg/10.17.1767; Susani L, 2004, HUM MUTAT, V24, P225, DOI 10.1002/humu.20076	15	288	299	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					960	962		10.1038/ng2076	http://dx.doi.org/10.1038/ng2076			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17632511				2022-12-17	WOS:000248446900010
J	Hui, LJ; Bakiri, L; Mairhorfer, A; Schweifer, N; Haslinger, C; Kenner, L; Komnenovic, V; Scheuch, H; Beug, H; Wagner, EF				Hui, Lijian; Bakiri, Latifa; Mairhorfer, Andreas; Schweifer, Norbert; Haslinger, Christian; Kenner, Lukas; Komnenovic, Vukoslav; Scheuch, Harald; Beug, Hartmut; Wagner, Erwin F.			p38 alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway	NATURE GENETICS			English	Article							ACTIVATED PROTEIN-KINASE; P38 MAP KINASE; SIGNAL-REGULATED KINASE; CYCLIN D1 EXPRESSION; PHOSPHORYLATION; PROGRESSION; INDUCTION; DEATH; HPK1	yThe mitogen-activated protein kinase (MAPK) p38a controls inflammatory responses and cell proliferation. Using mice carrying conditional Mapk14 ( also known as p38a) alleles, we investigated its function in postnatal development and tumorigenesis. When we specifically deleted Mapk14 in the mouse embryo, fetuses developed to term but died shortly after birth, probably owing to lung dysfunction. Fetal hematopoietic cells and embryonic fibroblasts deficient in p38a showed increased proliferation resulting from sustained activation of the c-Jun N-terminal kinase (JNK)-c-Jun pathway. Notably, in chemical-induced liver cancer development, mice with liver-specific deletion of Mapk14 showed enhanced hepatocyte proliferation and tumor development that correlated with upregulation of the JNK-c-Jun pathway. Furthermore, inactivation of JNK or c-Jun suppressed the increased proliferation of Mapk14-deficient hepatocytes and tumor cells. These results demonstrate a new mechanism whereby p38a negatively regulates cell proliferation by antagonizing the JNK-c-Jun pathway in multiple cell types and in liver cancer development.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Boehringer Ingelheim KG, A-1121 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Boehringer Ingelheim	Wagner, EF (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	wagner@imp.ac.at	Bakiri, Latifa/AAP-1674-2020; Bakiri, Latifa/N-5780-2014	Kenner, Lukas/0000-0003-2184-1338; Wagner, Erwin F/0000-0001-7872-0196; bakiri, latifa/0000-0002-6300-2420	Austrian Science Fund (FWF) [F 2802] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Aguirre-Ghiso JA, 2004, CANCER RES, V64, P7336, DOI 10.1158/0008-5472.CAN-04-0113; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 2003, MOL CELL BIOL, V23, P3859, DOI 10.1128/MCB.23.11.3859-3871.2003; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Hochedlinger K, 2002, ONCOGENE, V21, P2441, DOI 10.1038/sj.onc.1205348; Ihle JN, 2000, CELL, V102, P131, DOI 10.1016/S0092-8674(00)00017-9; Iyoda K, 2003, CANCER-AM CANCER SOC, V97, P3017, DOI 10.1002/cncr.11425; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lizundia R, 2006, CANCER RES, V66, P6105, DOI 10.1158/0008-5472.CAN-05-3861; Ma WB, 2001, ONCOGENE, V20, P1703, DOI 10.1038/sj.onc.1204224; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Maekawa T, 1999, J BIOL CHEM, V274, P17813, DOI 10.1074/jbc.274.25.17813; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Puri PL, 2000, GENE DEV, V14, P574; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Stepniak E, 2006, GENE DEV, V20, P2306, DOI 10.1101/gad.390506; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; von Lindern M, 2001, ONCOGENE, V20, P3651, DOI 10.1038/sj.onc.1204494; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002	42	288	308	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					741	749		10.1038/ng2033	http://dx.doi.org/10.1038/ng2033			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17468757				2022-12-17	WOS:000246859100018
J	Levran, O; Attwooll, C; Henry, RT; Milton, KL; Neveling, K; Rio, P; Batish, SD; Kalb, R; Velleuer, E; Barral, S; Ott, J; Petrini, J; Schindler, D; Hanenberg, H; Auerbach, AD				Levran, O; Attwooll, C; Henry, RT; Milton, KL; Neveling, K; Rio, P; Batish, SD; Kalb, R; Velleuer, E; Barral, S; Ott, J; Petrini, J; Schindler, D; Hanenberg, H; Auerbach, AD			The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia	NATURE GENETICS			English	Article							BRCA1; PROTEIN; BACH1	Seven Fanconi anemia - associated proteins ( FANCA, FANCB, FANCC, FANCE, FANCF, FANCG and FANCL) form a nuclear Fanconi anemia core complex that activates the monoubiquitination of FANCD2, targeting FANCD2 to BRCA1-containing nuclear foci. Cells from individuals with Fanconi anemia of complementation groups D1 and J ( FA- D1 and FA- J) have normal FANCD2 ubiquitination. Using genetic mapping, mutation identification and western- blot data, we identify the defective protein in FA- J cells as BRIP1 ( also called BACH1), a DNA helicase that is a binding partner of the breast cancer tumor suppressor BRCA1.	Rockefeller Univ, Lab Human Genet & Hematol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Univ Wurzburg, Inst Human Genet, Wurzburg, Germany; Univ Dusseldorf, Dept Pediat Oncol Hematol & Immunol, Dusseldorf, Germany; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center; University of Wurzburg; Heinrich Heine University Dusseldorf; Rockefeller University	Auerbach, AD (corresponding author), Rockefeller Univ, Lab Human Genet & Hematol, 1230 York Ave, New York, NY 10021 USA.	auerbac@rockefeller.edu	高, 雨莉/HGU-8187-2022; Kalb, Reinhard/AAR-3249-2021; Rio, Paula/G-8681-2015; Levran, Orna/H-2772-2019; Velleuer, Eunike/U-6355-2019	Kalb, Reinhard/0000-0003-3906-6907; Rio, Paula/0000-0002-5424-5543; Velleuer, Eunike/0000-0003-4328-9556; Auerbach, Arleen/0000-0002-6911-8379; Petrini, John/0000-0001-5102-5679				Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chen JJ, 1999, CANCER RES, V59, p1752S; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gschwend M, 1996, AM J HUM GENET, V59, P377; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Levitus M, 2004, BLOOD, V103, P2498, DOI 10.1182/blood-2003-08-2915; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Meetei AR, 2004, NAT GENET, V36, P1219, DOI 10.1038/ng1458; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Rutter JL, 2003, HUM MUTAT, V22, P121, DOI 10.1002/humu.10238	13	288	293	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2005	37	9					931	933		10.1038/ng1624	http://dx.doi.org/10.1038/ng1624			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	16116424				2022-12-17	WOS:000231591900015
J	Piedrahita, JA; Oetama, B; Bennett, GD; van Waes, J; Kamen, BA; Richardson, J; Lacey, SW; Anderson, RGW; Finnell, RH				Piedrahita, JA; Oetama, B; Bennett, GD; van Waes, J; Kamen, BA; Richardson, J; Lacey, SW; Anderson, RGW; Finnell, RH			Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development	NATURE GENETICS			English	Article							NEURAL-TUBE DEFECTS; FOLATE-DEFICIENCY; IN-VIVO; HOMOCYSTEINE; EXPRESSION; RECEPTOR; RATS	Periconceptional folic acid supplementation reduces the occurrence of several human congenital malformations, including craniofacial, heart and neural tube defects(1-4). Although the underlying mechanism is unknown, there may be a maternal-to-fetal folate-transport defect or an inherent fetal biochemical disorder that is neutralized by supplementation. Previous experiments have identified a folate-binding protein(5-7) (Folbp1) that functions as a membrane receptor to mediate the high-affinity internalization and delivery of folate to the cytoplasm of the cell(8-10). In vitro, this receptor facilitates the accumulation of cellular folate a thousand-fold relative to the media, suggesting that it may be essential in cytoplasmic folate delivery in vivo. The importance of an adequate intracellular folate pool for normal embryogenesis has long been recognized in humans(11-16) and experimental animals(17-19). To determine whether Folbp1 is involved in maternal-to-fetal folate transport, we inactivated Folbp1 in mice. We also produced mice lacking Folbp2, another member of the folate receptor family that is GPI anchored but binds folate poorly(20). Folbp2(-/-) embryos developed normally, but Folbp 1(-/-) embryos had severe morphogenetic abnormalities and died in utero by embryonic day (E) 10. Supplementing pregnant Folbp1(+/-) dams with folinic acid reversed this phenotype in nullizygous pups. Our results suggest that Folbp1 has a critical role in folate homeostasis during development, and that functional defects in the human homologue (FOLR1) of Folbp1 may contribute to similar defects in humans.	Texas A&M Univ, Dept Vet Anat & Publ Hlth, College Stn, TX 77843 USA; Texas A&M Univ, Ctr Environm & Rural Hlth, College Stn, TX 77843 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Div Gastroenterol, Dallas, TX 75235 USA; Univ Nebraska, Med Ctr, Ctr Human Mol Genet, Omaha, NE 68198 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Nebraska System; University of Nebraska Medical Center	Finnell, RH (corresponding author), Texas A&M Univ, Dept Vet Anat & Publ Hlth, College Stn, TX 77843 USA.	rfinnell@unmc.edu	Finnell, Richard/D-8174-2018	Finnell, Richard/0000-0002-5962-8754	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009106] Funding Source: NIH RePORTER; NICHD NIH HHS [HD35396] Funding Source: Medline; NIEHS NIH HHS [ES07165, P30-ES09106] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; ANTONY AC, 1981, J BIOL CHEM, V256, P9684; BIRN H, 1993, AM J PHYSIOL, V264, pC302, DOI 10.1152/ajpcell.1993.264.2.C302; BOWER C, 1993, BRIT J NUTR, V69, P827, DOI 10.1079/BJN19930083; BRANDNER M, 1969, ANN RADIOL-RADIOL CL, V12, pR703; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; EMERSON DJ, 1962, AM J OBSTET GYNECOL, V84, P356, DOI 10.1016/0002-9378(62)90132-1; FORD JE, 1969, P NUTR SOC, V28, pA39; GOETSCH C, 1962, AM J OBSTET GYNECOL, V83, P1474, DOI 10.1016/S0002-9378(16)35992-0; GOLDEN JA, 1995, PEDIATRICS, V95, P506; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; HJELLE JT, 1991, AM J PHYSIOL, V260, pC338, DOI 10.1152/ajpcell.1991.260.2.C338; Ma GT, 1997, DEVELOPMENT, V124, P907; MILLER JW, 1994, AM J CLIN NUTR, V59, P1033, DOI 10.1093/ajcn/59.5.1033; MILLER JW, 1994, BIOCHEM J, V298, P415, DOI 10.1042/bj2980415; Mills JL, 1996, J NUTR, V126, pS756, DOI 10.1093/jn/126.suppl_3.756S; MILUNSKY A, 1968, J PEDIATR-US, V72, P790, DOI 10.1016/S0022-3476(68)80430-5; NELSON M M, 1949, J Nutr, V38, P11; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; REFSUM H, 1989, CLIN CHEM, V35, P1921; Rosenquist TH, 1996, P NATL ACAD SCI USA, V93, P15227, DOI 10.1073/pnas.93.26.15227; ROSS JF, 1994, CANCER-AM CANCER SOC, V73, P2432, DOI 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; SHAW EB, 1968, AM J DIS CHILD, V115, P477, DOI 10.1001/archpedi.1968.02100010479013; SHAW GM, 1994, TERATOLOGY, V49, P143, DOI 10.1002/tera.1420490210; SORIANO P, 1986, SCIENCE, V234, P1409, DOI 10.1126/science.3024318; STEEGERSTHEUNISSEN RPM, 1994, METABOLISM, V43, P1475, DOI 10.1016/0026-0495(94)90004-3; THIERSCH JB, 1952, AM J OBSTET GYNECOL, V63, P1298; WELTMAN S, 1994, VITAMIN RECEPTORS VI, P105; WERLER MM, 1993, JAMA-J AM MED ASSOC, V269, P2847	30	288	294	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1999	23	2					228	232		10.1038/13861	http://dx.doi.org/10.1038/13861			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	240LM	10508523				2022-12-17	WOS:000082827500026
J	Csankovszki, G; Panning, B; Bates, B; Pehrson, JR; Jaenisch, R				Csankovszki, G; Panning, B; Bates, B; Pehrson, JR; Jaenisch, R			Conditional deletion of Xist disrupts histone macroH2A localization but not maintenance of X inactivation	NATURE GENETICS			English	Letter							CHROMOSOME INACTIVATION; GENE-EXPRESSION; FEMALE MAMMALS; RNA		MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Univ Penn, Sch Vet Med, Dept Biol Anim, Philadelphia, PA 19104 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Pennsylvania	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.			Csankovszki, Gyorgyi/0000-0001-5918-034X	NATIONAL CANCER INSTITUTE [R35CA044339] Funding Source: NIH RePORTER; NCI NIH HHS [R35-CA44339] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANTON M, 1995, J VIROL, V69, P4600, DOI 10.1128/JVI.69.8.4600-4606.1995; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Hansen RS, 1998, P NATL ACAD SCI USA, V95, P5133, DOI 10.1073/pnas.95.9.5133; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; Marahrens Y, 1998, CELL, V92, P657, DOI 10.1016/S0092-8674(00)81133-2; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; PEHRSON JR, 1992, SCIENCE, V257, P1398; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; PRIEST JH, 1967, J CELL BIOL, V35, P483, DOI 10.1083/jcb.35.2.483; RACK KA, 1994, HUM MOL GENET, V3, P1053, DOI 10.1093/hmg/3.7.1053	15	288	294	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1999	22	4					323	324		10.1038/11887	http://dx.doi.org/10.1038/11887			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	222FH	10431231				2022-12-17	WOS:000081772500009
J	Jeon, JT; Carlborg, O; Tornsten, A; Giuffra, E; Amarger, V; Chardon, P; Andersson-Eklund, L; Andersson, K; Hansson, I; Lundstrom, K; Andersson, L				Jeon, JT; Carlborg, O; Tornsten, A; Giuffra, E; Amarger, V; Chardon, P; Andersson-Eklund, L; Andersson, K; Hansson, I; Lundstrom, K; Andersson, L			A paternally expressed QTL affecting skeletal and cardiac muscle mass in pigs maps to the IGF2 locus	NATURE GENETICS			English	Letter							GROWTH		Swedish Univ Agr Sci, Uppsala Biomed Ctr, Dept Anim Breeding & Genet, S-75124 Uppsala, Sweden; INRA, LMRA, CEA, F-78352 Jouy En Josas, France; Swedish Univ Agr Sci, Dept Food Sci, S-75007 Uppsala, Sweden	Swedish University of Agricultural Sciences; CEA; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Swedish University of Agricultural Sciences	Andersson, L (corresponding author), Swedish Univ Agr Sci, Uppsala Biomed Ctr, Dept Anim Breeding & Genet, Box 597, S-75124 Uppsala, Sweden.		Giuffra, Elisabetta/J-8080-2014; Giuffra, Elisabetta/I-3201-2013	Carlborg, Orjan/0000-0002-2722-5264; Giuffra, Elisabetta/0000-0001-9568-2056; Amarger, Valerie/0000-0001-9258-6675				Alexander LJ, 1996, MAMM GENOME, V7, P368, DOI 10.1007/s003359900106; ANDERSSON L, 1994, SCIENCE, V263, P1771, DOI 10.1126/science.8134840; Andersson-Eklund L, 1998, J ANIM SCI, V76, P694; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Dunger DB, 1998, NAT GENET, V19, P98, DOI 10.1038/ng0598-98; Edfors-Lilja I, 1998, J IMMUNOL, V161, P829; Falconer DS, 1996, INTRO QUANTITATIVE G; HILL WG, 1982, P NATL ACAD SCI-BIOL, V79, P142, DOI 10.1073/pnas.79.1.142; Kijas JMH, 1998, GENETICS, V150, P1177; Knott SA, 1998, GENETICS, V149, P1069; Marklund S, 1998, GENOME RES, V8, P826, DOI 10.1101/gr.8.8.826; Nezer C, 1999, NAT GENET, V21, P155, DOI 10.1038/5935; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797	14	288	323	1	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1999	21	2					157	158		10.1038/5938	http://dx.doi.org/10.1038/5938			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	163MH	9988263				2022-12-17	WOS:000078399500013
J	Knapik, EW; Goodman, A; Ekker, M; Chevrette, M; Delgado, J; Neuhauss, S; Shimoda, N; Driever, W; Fishman, MC; Jacob, HJ				Knapik, EW; Goodman, A; Ekker, M; Chevrette, M; Delgado, J; Neuhauss, S; Shimoda, N; Driever, W; Fishman, MC; Jacob, HJ			A microsatellite genetic linkage map for zebrafish (Danio rerio)	NATURE GENETICS			English	Article							HUMAN GENOME; MOUSE; EMBRYOS	We have constructed a zebrafish genetic linkage map consisting of 705 simple sequence-length polymorphism markers (SSLPs). The map covers 2350 centimorgans (cM) of the zebrafish genome with an average resolution of 3.3 cM. It is a complete map in genetic mapping terms (there is one linkage group for each of the 25 chromosomes), and it has been confirmed by somatic-cell hybrids and centromere-mapping using half-tetrad analysis. The markers are highly polymorphic in the zebrafish strains used for genetic crosses and provide a means to compare genetic segregation of developmental mutations between laboratories. These markers will provide an initial infrastructure for the positional cloning of the nearly 600 zebrafish genes identified as crucial to vertebrate development,and will become the anchor for the physical map of the zebrafish genome.	Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA; Univ Ottawa, Ottawa Civic Hosp, Loeb Inst Med Res, Ottawa, ON K1Y 4E9, Canada; McGill Univ, Dept Surg, Montreal, PQ H3G 1A4, Canada; Montreal Gen Hosp, Res Inst, Montreal, PQ H3G 1A4, Canada	Harvard University; Massachusetts General Hospital; University of Ottawa; Ottawa Hospital Research Institute; McGill University; McGill University	Knapik, EW (corresponding author), Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, D-85758 Neuherberg, Germany.	fishman@cvrc-taco.mgh.harvard.edu	Knapik, Ela W./J-6172-2014; Neuhauss, Stephan/AAX-9915-2020	Knapik, Ela W./0000-0002-2977-3619; Neuhauss, Stephan/0000-0002-9615-480X; Driever, Wolfgang/0000-0002-9551-9141	NCRR NIH HHS [RR08888] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR008888] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BISHOP MD, 1994, GENETICS, V136, P619; BREEN M, 1994, HUM MOL GENET, V3, P621, DOI 10.1093/hmg/3.4.621; CHIN AJ, 1997, DEV GENES EVOL, V207, P104; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; CRAWFORD AM, 1995, GENETICS, V140, P703; Daga RR, 1996, CHROMOSOME RES, V4, P29, DOI 10.1007/BF02254941; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; Driever W, 1996, J CLIN INVEST, V97, P1788, DOI 10.1172/JCI118608; Driever W, 1996, DEVELOPMENT, V123, P37; EKKER M, 1992, NEURON, V9, P27, DOI 10.1016/0896-6273(92)90217-2; Ekker M, 1996, GENOMICS, V33, P57, DOI 10.1006/geno.1996.0159; Fisher S, 1997, DEVELOPMENT, V124, P1301; GOFF DJ, 1992, GENOMICS, V14, P200, DOI 10.1016/S0888-7543(05)80309-X; Haffter P, 1996, DEVELOPMENT, V123, P1; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; JACOB HJ, 1995, NAT GENET, V9, P63, DOI 10.1038/ng0195-63; Johnson SL, 1996, GENETICS, V142, P1277; Knapik EW, 1996, DEVELOPMENT, V123, P451; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; MARTINEZBARBERA JP, 1997, GENE, V198, P653; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Phillips RB, 1996, CAN J ZOOL, V74, P323, DOI 10.1139/z96-040; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Rohrer GA, 1996, GENOME RES, V6, P371, DOI 10.1101/gr.6.5.371; Sambrooke J., 1989, MOL CLONING LAB MANU; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P843; SOLNICAKREZEL L, 1994, GENETICS, V136, P1401; STACHEL SE, 1993, DEVELOPMENT, V117, P1261	33	288	302	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1998	18	4					338	343		10.1038/ng0498-338	http://dx.doi.org/10.1038/ng0498-338			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	9537415				2022-12-17	WOS:000072755500015
J	Vermulst, M; Bielas, JH; Kujoth, GC; Ladiges, WC; Rabinovitch, PS; Prolla, TA; Loeb, LA				Vermulst, Marc; Bielas, Jason H.; Kujoth, Gregory C.; Ladiges, Warren C.; Rabinovitch, Peter S.; Prolla, Tomas A.; Loeb, Lawrence A.			Mitochondrial point mutations do not limit the natural lifespan of mice	NATURE GENETICS			English	Article							SUBSTANTIA-NIGRA NEURONS; DNA MUTATIONS; OXIDATIVE DAMAGE; DELETIONS; REPAIR; POLYMERASE; DISEASE; AGE	Whether mitochondrial mutations cause mammalian aging, or are merely correlated with it, is an area of intense debate(1). Here, we use a new, highly sensitive assay(2) to redefine the relationship between mitochondrial mutations and age. We measured the in vivo rate of change of the mitochondrial genome at a single-base pair level in mice, and we demonstrate that the mutation frequency in mouse mitochondria is more than ten times lower than previously reported. Although we observed an 11-fold increase in mitochondrial point mutations with age, we report that a mitochondrial mutator mouse(3) was able to sustain a 500-fold higher mutation burden than normal mice, without any obvious features of rapidly accelerated aging. Thus, our results strongly indicate that mitochondrial mutations do not limit the lifespan of wild-type mice.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Wisconsin, Dept Genet & Med Genet, Madison, WI 53706 USA; Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Madison; University of Washington; University of Washington Seattle	Loeb, LA (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	laloeb@u.washington.edu		Kujoth, Gregory/0000-0002-6636-2800	NATIONAL CANCER INSTITUTE [R01CA102029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES011045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG001751, R01AG021905] Funding Source: NIH RePORTER; NCI NIH HHS [CA102029] Funding Source: Medline; NIA NIH HHS [AG021905, AG001751] Funding Source: Medline; NIEHS NIH HHS [ES11045] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Bielas JH, 2005, NAT METHODS, V2, P285, DOI 10.1038/NMETH751; Copeland William C, 2002, Methods Mol Biol, V197, pv; Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798; Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Kreutzer DA, 1998, P NATL ACAD SCI USA, V95, P3578, DOI 10.1073/pnas.95.7.3578; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002; Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; PINZ KG, 1995, J BIOL CHEM, V270, P9202, DOI 10.1074/jbc.270.16.9202; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; TANAKA M, 1994, GENOMICS, V22, P327, DOI 10.1006/geno.1994.1391; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Trifunovic A, 2006, BBA-BIOENERGETICS, V1757, P611, DOI 10.1016/j.bbabio.2006.03.003; Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9; Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333	28	287	297	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					540	543		10.1038/ng1988	http://dx.doi.org/10.1038/ng1988			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17334366				2022-12-17	WOS:000245271200026
J	Kochi, Y; Yamada, R; Suzuki, A; Harley, JB; Shirasawa, S; Sawada, T; Bae, SC; Tokuhiro, S; Chang, XT; Sekine, A; Takahashi, A; Tsunoda, T; Ohnishi, Y; Kaufman, KM; Kang, CSP; Kang, CW; Otsubo, S; Yumura, W; Mimori, A; Koike, T; Nakamura, Y; Sasazuki, T; Yamamoto, K				Kochi, Y; Yamada, R; Suzuki, A; Harley, JB; Shirasawa, S; Sawada, T; Bae, SC; Tokuhiro, S; Chang, XT; Sekine, A; Takahashi, A; Tsunoda, T; Ohnishi, Y; Kaufman, KM; Kang, CSP; Kang, CW; Otsubo, S; Yumura, W; Mimori, A; Koike, T; Nakamura, Y; Sasazuki, T; Yamamoto, K			A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities	NATURE GENETICS			English	Article							REVISED CRITERIA; SUSCEPTIBILITY; GENE; POLYMORPHISMS; FAMILY; IDENTIFICATION; POPULATION; PSORIASIS; LOCI; CLASSIFICATION	Rheumatoid arthritis is a common autoimmune disease with a complex genetic etiology. Here we identify a SNP in the promoter region of FCRL3, a member of the Fc receptor-like family, that is associated with susceptibility to rheumatoid arthritis ( odds ratio = 2.15, P = 0.00000085). This polymorphism alters the binding affinity of nuclear factor-kappa B and regulates FCRL3 expression. We observed high FCRL3 expression on B cells and augmented autoantibody production in individuals with the disease-susceptible genotype. We also found associations between the SNP and susceptibility to autoimmune thyroid disease and systemic lupus erythematosus. FCRL3 may therefore have a pivotal role in autoimmunity.	RIKEN, SNP Res Ctr, Lab Rheumat Dis, Yokohama, Kanagawa 2300045, Japan; Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo 1130033, Japan; Univ Oklahoma, Oklahoma City, OK 73104 USA; US Dept Vet Affairs, Oklahoma City, OK 73104 USA; Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; Int Med Ctr Japan, Tokyo 1628655, Japan; Hanyang Univ, Hosp Rheumat Dis, Div Rheumatol, Dept Internal Med, Seoul 133792, South Korea; RIKEN, SNP Res Ctr, Lab SNP Anal, Yokohama, Kanagawa 2300045, Japan; RIKEN, SNP Res Ctr, Lab Genotyping, Yokohama, Kanagawa 2300045, Japan; RIKEN, SNP Res Ctr, Lab Med Informat, Yokohama, Kanagawa 2300045, Japan; Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo 1088639, Japan; Tokyo Womens Med Univ, Kidney Ctr, Dept Med, Tokyo 1628666, Japan; Hokkaido Univ, Sch Med, Dept Med 2, Sapporo, Hokkaido 0608638, Japan; RIKEN, SNP Res Ctr, Res Grp Personalized Med, Yokohama, Kanagawa 2300045, Japan	RIKEN; University of Tokyo; University of Oklahoma System; University of Oklahoma Health Sciences Center; US Department of Veterans Affairs; Oklahoma Medical Research Foundation; National Center for Global Health & Medicine - Japan; Hanyang University; RIKEN; RIKEN; RIKEN; Korea Advanced Institute of Science & Technology (KAIST); University of Tokyo; Tokyo Women's Medical University; Hokkaido University; RIKEN	Yamada, R (corresponding author), RIKEN, SNP Res Ctr, Lab Rheumat Dis, Yokohama, Kanagawa 2300045, Japan.	ryamada@src.riken.go.jp	Tsunoda, Tatsuhiko/K-2061-2014; Sawed, Tetsuji/GRX-6582-2022; Kang, Changwon/C-1938-2011; Kochi, Yuta/P-4487-2018; Yamamoto, Kazuhiko/N-5096-2015; Suzuki, Akari/N-5389-2015	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Kang, Changwon/0000-0002-0867-6385; Yamada, Ryo/0000-0002-1587-630X; Bae, Sang-Cheol/0000-0003-4658-1093	NCRR NIH HHS [P20 RR020143] Funding Source: Medline; NIAID NIH HHS [R01 AI024717] Funding Source: Medline; NIAMS NIH HHS [P01 AR049084, R01 AR042460] Funding Source: Medline; NIDCR NIH HHS [R01 DE015223] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042460, P01AR049084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015223] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Aikawa Y, 2002, INFLAMM RES, V51, P188, DOI 10.1007/PL00000291; ALARCON GS, 1990, ARTHRITIS RHEUM, V33, P1156; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barton A, 2004, ARTHRITIS RHEUM, V50, P1117, DOI 10.1002/art.20169; Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bowcock AM, 2004, HUM MOL GENET, V13, pR43, DOI 10.1093/hmg/ddh094; Capon F, 2001, J INVEST DERMATOL, V116, P728, DOI 10.1046/j.1523-1747.2001.01311.x; Capon F, 1999, AM J HUM GENET, V65, P1798, DOI 10.1086/302653; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Dai KZ, 2001, GENES IMMUN, V2, P263, DOI 10.1038/sj.gene.6363774; Davis RS, 2001, P NATL ACAD SCI USA, V98, P9772, DOI 10.1073/pnas.171308498; Davis RS, 2002, IMMUNOL REV, V190, P123, DOI 10.1034/j.1600-065X.2002.19009.x; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gray D, 1997, Semin Immunol, V9, P249, DOI 10.1006/smim.1997.0077; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Hatzivassiliou G, 2001, IMMUNITY, V14, P277, DOI 10.1016/S1074-7613(01)00109-1; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hoshinoso M, 1999, J BIOL CHEM, V274, P17837, DOI 10.1074/jbc.274.25.17837; Jirholt J, 1998, EUR J IMMUNOL, V28, P3321, DOI 10.1002/(SICI)1521-4141(199810)28:10<3321::AID-IMMU3321>3.0.CO;2-M; Jorgensen RA, 2004, PLANT CELL, V16, P787, DOI 10.1105/tpc.160490; Kaijzel EL, 2001, GENES IMMUN, V2, P135, DOI 10.1038/sj.gene.6363747; Kochi Y, 2004, ARTHRITIS RHEUM, V50, P63, DOI 10.1002/art.11366; Kyogoku C, 2002, ARTHRITIS RHEUM, V46, P1242, DOI 10.1002/art.10257; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935; Miller I, 2002, BLOOD, V99, P2662, DOI 10.1182/blood.V99.8.2662; Newton JL, 2004, GENES IMMUN, V5, P151, DOI 10.1038/sj.gene.6364045; Nieto A, 2000, ARTHRITIS RHEUM, V43, P735, DOI 10.1002/1529-0131(200004)43:4<735::AID-ANR3>3.0.CO;2-Q; Podolin PL, 1997, J IMMUNOL, V159, P1835; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2000, GENETICS, V155, P945; Radstake TRDJ, 2003, J RHEUMATOL, V30, P926; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Sebastiani P, 2003, P NATL ACAD SCI USA, V100, P9900, DOI 10.1073/pnas.1633613100; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; SUNDVALL M, 1995, NAT GENET, V10, P313, DOI 10.1038/ng0795-313; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Suzuki K, 2003, SCAND J RHEUMATOL, V32, P197, DOI 10.1080/03009740310003677; Takemura S, 2001, J IMMUNOL, V167, P1072, DOI 10.4049/jimmunol.167.2.1072; Teuscher C, 1997, J IMMUNOL, V159, P4930; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Tsao BP, 2003, TRENDS IMMUNOL, V24, P595, DOI 10.1016/j.it.2003.09.006; Tsunoda T, 2004, HUM MOL GENET, V13, P1623, DOI 10.1093/hmg/ddh177; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; van Eijk M, 2001, TRENDS IMMUNOL, V22, P677, DOI 10.1016/S1471-4906(01)02086-5; Weyand CM, 2003, ANN NY ACAD SCI, V987, P140, DOI 10.1111/j.1749-6632.2003.tb06042.x; Xu MJ, 2002, BIOCHEM BIOPH RES CO, V293, P1037, DOI 10.1016/S0006-291X(02)00332-7	50	287	314	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2005	37	5					478	485		10.1038/ng1540	http://dx.doi.org/10.1038/ng1540			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	15838509	Green Accepted			2022-12-17	WOS:000228862300016
J	Bishop, CE; Whitworth, DJ; Qin, YJ; Agoulnik, AI; Agoulnik, IU; Harrison, WR; Behringer, RR; Overbeek, PA				Bishop, CE; Whitworth, DJ; Qin, YJ; Agoulnik, AI; Agoulnik, IU; Harrison, WR; Behringer, RR; Overbeek, PA			A transgenic insertion upstream of Sox9 is associated with dominant XX sex reversal in the mouse	NATURE GENETICS			English	Article							Y-CHROMOSOME; CAMPOMELIC DYSPLASIA; DETERMINING REGION; SRY; GENE; EXPRESSION; TYROSINASE; MUTATIONS; SEQUENCES; SUGGESTS	In most mammals, male development is triggered by the transient expression of the Y-chromosome gene, Sry, which initiates a cascade of gene interactions ultimately leading to the formation of a testis from the indifferent fetal gonad(1-4). Several genes(5-8), in particular Sox9, have a crucial role in this pathway(9-14). Despite this, the direct downstream targets of Sry and the nature of the pathway itself remain to he clearly established(15,16). We report here a new dominant insertional mutation, Odsex (Ods), in which XX mice carrying a 150-kb deletion (approximately 1 Mb upstream of Sox9) develop as sterile XX males lacking Sry, During embryogenesis, wild-type XX fetal gonads downregulate Sox9 expression, whereas XY and XX Ods/+ fetal gonads upregulate and maintain its expression(13,14). We propose that Ods has removed a long-range, gonad-specific regulatory element that mediates the repression of Sox9 expression in XX fetal gonads. This repression would normally be antagonized by Sry protein in XY embryos. Our data ate consistent with Sox9 being a direct downstream target of Sry and provide genetic evidence to support a general repressor model of sex determination in mammals(17,18).	Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Dept Pathol & Lab Med, Houston, TX USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine	Bishop, CE (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.	bishop@bcm.tmc.edu	Agoulnik, Irina/AAD-4687-2020; Agoulnik, Alexander/AAK-3213-2020; Whitworth, Deanne/AAE-1019-2020	Agoulnik, Irina/0000-0003-4889-0324; Agoulnik, Alexander/0000-0001-6587-6845; Whitworth, Deanne/0000-0002-9097-0240; Overbeek, Paul/0000-0001-9784-2084; Qin, Jane Yangjun/0000-0003-0116-6988				BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bishop CE, 1998, MAMM GENOME, V8, pS378, DOI 10.1007/s003359900666; Burgoyne PS, 1998, BIOESSAYS, V20, P363, DOI 10.1002/(SICI)1521-1878(199805)20:5&lt;363::AID-BIES2&gt;3.0.CO;2-P; CAPEL B, 1993, NAT GENET, V5, P301, DOI 10.1038/ng1193-301; Capel B, 1998, ANNU REV PHYSIOL, V60, P497, DOI 10.1146/annurev.physiol.60.1.497; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; De Grandi A, 2000, MECH DEVELOP, V90, P323, DOI 10.1016/S0925-4773(99)00282-8; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; FOSTER JW, 1992, NATURE, V359, P531, DOI 10.1038/359531a0; Graves JAM, 1998, BIOESSAYS, V20, P264, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;264::AID-BIES10&gt;3.0.CO;2-1; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Hustert E, 1996, MAMM GENOME, V7, P881, DOI 10.1007/s003359900261; Kent J, 1996, DEVELOPMENT, V122, P2813; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; MANSOUR S, 1995, J MED GENET, V32, P415, DOI 10.1136/jmg.32.6.415; MCELREAVEY K, 1993, P NATL ACAD SCI USA, V90, P3368, DOI 10.1073/pnas.90.8.3368; Moniot B, 2000, MECH DEVELOP, V91, P323, DOI 10.1016/S0925-4773(99)00267-1; Pfeifer D, 1999, AM J HUM GENET, V65, P111, DOI 10.1086/302455; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SUTCLIFFE MJ, 1989, DEVELOPMENT, V107, P373; Swain A, 1999, GENE DEV, V13, P755, DOI 10.1101/gad.13.7.755; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; YOKOYAMA T, 1990, NUCLEIC ACIDS RES, V18, P7293, DOI 10.1093/nar/18.24.7293; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F; Zhao SL, 1999, DEV BIOL, V216, P154, DOI 10.1006/dbio.1999.9480	29	287	299	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2000	26	4					490	494		10.1038/82652	http://dx.doi.org/10.1038/82652			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101852				2022-12-17	WOS:000165671700027
J	Liu, D; Matzuk, MM; Sung, WK; Guo, QX; Wang, P; Wolgemuth, DJ				Liu, D; Matzuk, MM; Sung, WK; Guo, QX; Wang, P; Wolgemuth, DJ			Cyclin A1 is required for meiosis in the male mouse	NATURE GENETICS			English	Article							MALE GERM-CELL; DIFFERENTIAL EXPRESSION; PROMOTING FACTOR; MESSENGER-RNA; GENE; SPECIFICITY; ONCOGENESIS; COMPLEXES; DISTINCT; TESTIS	The mammalian A-type cyclin family consists of two members. cyclin Al (encoded by Ccna1) and cyclin AZ (encoded by Ccna2). Cyclin AZ promotes both G1/S and G2/M transitions(1,2), and targeted deletion of Ccna2 in mouse is embryonic lethal(3). Cyclin Al is expressed in mice exclusively in the germ cell lineage(4) and is expressed in humans at highest levels in the testis and certain myeloid leukaemia cells(5,6). To investigate the role of cyclin Al and possible redundancy among the cyclins in vivo, we generated mice bearing a null mutation of Ccna1. Ccna1(-/-) males were sterile due to a block of spermatogenesis before the first meiotic division, whereas females were normal. Meiosis arrest in Ccna1(-/-) males was associated with increased germ cell apoptosis, desynapsis abnormalities and reduction of Cdc2 kinase activation at the end of meiotic prophase. Cyclin Al is therefore essential for spermatocyte passage into the first meiotic division in mate mice, a function that cannot be complemented by the concurrently expressed B-type cyclins.	Columbia Univ Coll Phys & Surg, Ctr Reprod Sci, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Inst Human Nutr, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Irving Comprehens Canc Ctr, New York, NY 10032 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Wolgemuth, DJ (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Reprod Sci, 630 W 168th St, New York, NY 10032 USA.	djw3@columbia.edu		Wang, Pei/0000-0003-2373-7315				ANDERSEN B, 1993, P NATL ACAD SCI USA, V90, P11084, DOI 10.1073/pnas.90.23.11084; Brandeis M, 1998, P NATL ACAD SCI USA, V95, P4344, DOI 10.1073/pnas.95.8.4344; CHAPMAN DL, 1994, DEV BIOL, V165, P500, DOI 10.1006/dbio.1994.1270; Dix DJ, 1997, DEVELOPMENT, V124, P4595; DRESSER ME, 1979, EXP CELL RES, V121, P416, DOI 10.1016/0014-4827(79)90023-5; DUGGAL RN, 1987, ANN NY ACAD SCI, V513, P112, DOI 10.1111/j.1749-6632.1987.tb25002.x; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; GAUTIER J, 1990, CELL, V60, P487, DOI 10.1016/0092-8674(90)90599-A; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; GOETZ P, 1984, J CELL SCI, V65, P249; KLEENE KC, 1984, DEV BIOL, V105, P71, DOI 10.1016/0012-1606(84)90262-8; Kramer A, 1998, LEUKEMIA, V12, P893, DOI 10.1038/sj.leu.2401051; KREMER EJ, 1991, EXP CELL RES, V197, P330, DOI 10.1016/0014-4827(91)90442-W; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PEEPER DS, 1993, EMBO J, V12, P1947, DOI 10.1002/j.1460-2075.1993.tb05844.x; PINES J, 1993, TRENDS BIOCHEM SCI, V18, P195, DOI 10.1016/0968-0004(93)90185-P; Russell L. D., 1990, HISTOLOGICAL HISTOPA; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Sweeney C, 1996, DEVELOPMENT, V122, P53; WOLGEMUTH DJ, 1987, P NATL ACAD SCI USA, V84, P5813, DOI 10.1073/pnas.84.16.5813; WU S, 1995, DEV BIOL, V170, P195, DOI 10.1006/dbio.1995.1207; Yang R, 1997, CANCER RES, V57, P913	25	287	300	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1998	20	4					377	380		10.1038/3855	http://dx.doi.org/10.1038/3855			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	9843212				2022-12-17	WOS:000077199600027
J	Mendez, MJ; Green, LL; Corvalan, JRF; Jia, XC; MaynardCurrie, CE; Yang, XD; Gallo, ML; Louie, DM; Lee, DV; Erickson, KL; Luna, J; Roy, CMN; Abderrahim, H; Kirschenbaum, F; Noguchi, M; Smith, DH; Fukushima, A; Hales, JF; Finer, MH; Davis, CG; Zsebo, KM; Jakobovits, A				Mendez, MJ; Green, LL; Corvalan, JRF; Jia, XC; MaynardCurrie, CE; Yang, XD; Gallo, ML; Louie, DM; Lee, DV; Erickson, KL; Luna, J; Roy, CMN; Abderrahim, H; Kirschenbaum, F; Noguchi, M; Smith, DH; Fukushima, A; Hales, JF; Finer, MH; Davis, CG; Zsebo, KM; Jakobovits, A			Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice	NATURE GENETICS			English	Article							YEAST ARTIFICIAL CHROMOSOME; POLYMERASE CHAIN-REACTION; EPIDERMAL GROWTH-FACTOR; TRANSGENIC MICE; MONOCLONAL-ANTIBODIES; HEAVY; CELLS; RECOMBINATION; GENES; REPERTOIRE	We constructed two megabase-sized YACs containing large contiguous fragments of the human heavy and kappa (kappa) light chain immunoglobulin (Ig) loci in nearly germline configuration, including approximately 66 V-H and 32 V-kappa genes. We introduced these YACs into Ig-inactivated mice and observed human antibody production which closely resembled that seen in humans in all respects, including gene rearrangement, assembly, and repertoire. Diverse Ig gene usage together with somatic hypermutation enables the mice to generate high affinity fully human antibodies to multiple antigens, including human proteins. Our results underscore the importance of the large Ig fragments with multiple V genes for restoration of a normal humoral immune response. These mice are likely to be a valuable tool for the generation of therapeutic antibodies.	ABGENIX INC,FREMONT,CA 94555; CELL GENESYS INC,FOSTER CITY,CA 94404	Cell Genesys Inc			Pillay, Nischalan/F-9536-2012	Noguchi, Masato/0000-0002-3092-0946				ABERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256; ANAND R, 1989, NUCLEIC ACIDS RES, V17, P3425, DOI 10.1093/nar/17.9.3425; BERMAN JE, 1988, EMBO J, V7, P727, DOI 10.1002/j.1460-2075.1988.tb02869.x; BREZINSCHEK HP, 1995, J IMMUNOL, V155, P190; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; BRUGGEMANN M, 1991, EUR J IMMUNOL, V21, P1323, DOI 10.1002/eji.1830210535; Bruggemann M, 1996, IMMUNOL TODAY, V17, P391, DOI 10.1016/0167-5699(96)10025-6; Coligan JE., 1994, CURRENT PROTOCOLS IM; COOK GP, 1995, IMMUNOL TODAY, V16, P237, DOI 10.1016/0167-5699(95)80166-9; COX JPL, 1994, EUR J IMMUNOL, V24, P827, DOI 10.1002/eji.1830240409; DARIAVACH P, 1991, EUR J IMMUNOL, V21, P1499, DOI 10.1002/eji.1830210625; DENDUNNEN JT, 1992, HUM MOL GENET, V1, P19; FEENEY AJ, 1990, J EXP MED, V172, P137; Fishwild DM, 1996, NAT BIOTECHNOL, V14, P845, DOI 10.1038/nbt0796-845; FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0; Galfre G, 1981, Methods Enzymol, V73, P3; GEMMILL RM, 1991, ADV GENOME BIOL, V1, P217; GILL GN, 1984, J BIOL CHEM, V259, P7755; GREEN LL, 1994, NAT GENET, V7, P13, DOI 10.1038/ng0594-13; HERMANSON GG, 1991, NUCLEIC ACIDS RES, V19, P4943, DOI 10.1093/nar/19.18.4943; HUBER C, 1993, EUR J IMMUNOL, V23, P2860, DOI 10.1002/eji.1830231120; JAKOBOVITS A, 1994, CURR BIOL, V4, P761, DOI 10.1016/S0960-9822(00)00172-X; JAKOBOVITS A, 1993, P NATL ACAD SCI USA, V90, P2551, DOI 10.1073/pnas.90.6.2551; JAKOBOVITS A, 1993, NATURE, V362, P255, DOI 10.1038/362255a0; KAWAMOTO T, 1983, P NATL ACAD SCI-BIOL, V80, P1337, DOI 10.1073/pnas.80.5.1337; LONBERG N, 1994, NATURE, V368, P856, DOI 10.1038/368856a0; LUSTINARASIMHAN M, 1995, J BIOL CHEM, V270, P2716, DOI 10.1074/jbc.270.6.2716; MARKS JD, 1991, EUR J IMMUNOL, V21, P985, DOI 10.1002/eji.1830210419; MATSUDA F, 1993, ADV IMMUNOL, V62, P1; Max Edward E., 1993, P315; MENDEZ M, 1993, GENOME MAPPING SEQUE, V163; MENDEZ MJ, 1995, GENOMICS, V26, P294, DOI 10.1016/0888-7543(95)80214-7; RAY S, 1994, P NATL ACAD SCI USA, V91, P5548, DOI 10.1073/pnas.91.12.5548; Sato J D, 1983, Mol Biol Med, V1, P511; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Sherman F, 1986, LAB COURSE MANUAL ME; SILVERMAN GA, 1990, P NATL ACAD SCI USA, V87, P9913, DOI 10.1073/pnas.87.24.9913; TAYLOR LD, 1994, INT IMMUNOL, V6, P579, DOI 10.1093/intimm/6.4.579; TAYLOR LD, 1992, NUCLEIC ACIDS RES, V20, P6287, DOI 10.1093/nar/20.23.6287; TUAILLON N, 1993, P NATL ACAD SCI USA, V90, P3720, DOI 10.1073/pnas.90.8.3720; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; WAGNER SD, 1994, EUR J IMMUNOL, V24, P2672, DOI 10.1002/eji.1830241116; WEICHHOLD GM, 1993, GENOMICS, V16, P503, DOI 10.1006/geno.1993.1217; YAMADA M, 1991, J EXP MED, V173, P395, DOI 10.1084/jem.173.2.395	44	287	770	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					146	156		10.1038/ng0297-146	http://dx.doi.org/10.1038/ng0297-146			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020839				2022-12-17	WOS:A1997WF08700013
J	Singer, JB; Lewitzky, S; Leroy, E; Yang, F; Zhao, XJ; Klickstein, L; Wright, TM; Meyer, J; Paulding, CA				Singer, Jonathan B.; Lewitzky, Steve; Leroy, Elisabeth; Yang, Fan; Zhao, Xiaojun; Klickstein, Lloyd; Wright, Timothy M.; Meyer, Joanne; Paulding, Charles A.			A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury	NATURE GENETICS			English	Article							THERAPEUTIC ARTHRITIS RESEARCH; RANDOMIZED CONTROLLED-TRIAL; HYPERSENSITIVITY; HEPATOTOXICITY; ABACAVIR; EVENT; HLA-B-ASTERISK-5701; OSTEOARTHRITIS; PATHOGENESIS; IBUPROFEN	Lumiracoxib is a selective cyclooxygenase-2 inhibitor developed for the symptomatic treatment of osteoarthritis and acute pain(1). Concerns over hepatotoxicity have contributed to the withdrawal or non-approval of lumiracoxib in most major drug markets worldwide. We performed a case-control genome-wide association study on 41 lumiracoxib-treated patients with liver injury (cases) and 176 matched lumiracoxib-treated patients without liver injury (controls). Several SNPs from the MHC class II region showed strong evidence of association (the top SNP was rs9270986 with P = 2.8 x 10(-10)). These findings were replicated in an independent set of 98 lumiracoxib-treated cases and 405 matched lumiracoxib-treated controls (top SNP rs3129900, P = 4.4 x 10(-12)). Fine mapping identified a strong association to a common HLA haplotype (HLA-DRB1*1501-HLA-DQB1*0602-HLADRB5*0101-HLA-DQA1*0102, most significant allele P = 6.8 x 10(-25), allelic odds ratio = 5.0, 95% CI 3.6-7.0). These results offer the potential to improve the safety profile of lumiracoxib by identifying individuals at elevated risk for liver injury and excluding them from lumiracoxib treatment.	[Singer, Jonathan B.; Lewitzky, Steve; Leroy, Elisabeth; Yang, Fan; Zhao, Xiaojun; Klickstein, Lloyd; Wright, Timothy M.; Meyer, Joanne; Paulding, Charles A.] Novartis Inst BioMed Res, Cambridge, MA USA	Novartis	Paulding, CA (corresponding author), Novartis Inst BioMed Res, Cambridge, MA USA.	charles.paulding@novartis.com						Bannwarth B, 2007, EXPERT OPIN PHARMACO, V8, P1551, DOI 10.1517/14656566.8.10.1551; Center for Drug Evaluation and Research (CDER) in cooperation with the Center for Biologics Evaluation and Research (CBER) and the Center for Devices and Radiological Health (CDRH) at the Food and Drug Administration (FDA) Guidance for industry, 2009, PATIENT REPORTED OUT; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Farkouh ME, 2004, LANCET, V364, P675, DOI 10.1016/S0140-6736(04)16894-3; Hautekeete ML, 1999, GASTROENTEROLOGY, V117, P1181, DOI 10.1016/S0016-5085(99)70404-X; Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Kindmark A, 2008, PHARMACOGENOMICS J, V8, P186, DOI 10.1038/sj.tpj.6500458; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Matchaba P, 2005, CLIN THER, V27, P1196, DOI 10.1016/j.clinthera.2005.07.019; Navarro VJ, 2006, NEW ENGL J MED, V354, P731, DOI 10.1056/NEJMra052270; O'Donohue J, 2000, GUT, V47, P717, DOI 10.1136/gut.47.5.717; Oksenberg JR, 2008, NAT REV GENET, V9, P516, DOI 10.1038/nrg2395; Pichler Werner J, 2006, Allergol Int, V55, P17, DOI 10.2332/allergolint.55.17; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schnitzer TJ, 2004, LANCET, V364, P665, DOI 10.1016/S0140-6736(04)16893-1; Senior John R, 2007, Clin Liver Dis, V11, P507, DOI 10.1016/j.cld.2007.06.002; Temple R, 2006, PHARMACOEPIDEM DR S, V15, P241, DOI 10.1002/pds.1211; Uetrecht J, 2007, ANNU REV PHARMACOL, V47, P513, DOI 10.1146/annurev.pharmtox.47.120505.105150	21	286	303	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2010	42	8					711	U94		10.1038/ng.632	http://dx.doi.org/10.1038/ng.632			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	633RZ	20639878				2022-12-17	WOS:000280524000018
J	Brems, H; Chmara, M; Sahbatou, M; Denayer, E; Taniguchi, K; Kato, R; Somers, R; Messiaen, L; De Schepper, S; Fryns, JP; Cools, J; Marynen, P; Thomas, G; Yoshimura, A; Legius, E				Brems, Hilde; Chmara, Magdalena; Sahbatou, Mourad; Denayer, Ellen; Taniguchi, Koji; Kato, Reiko; Somers, Riet; Messiaen, Ludwine; De Schepper, Sofie; Fryns, Jean-Pierre; Cools, Jan; Marynen, Peter; Thomas, Gilles; Yoshimura, Akihiko; Legius, Eric			Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype	NATURE GENETICS			English	Article							SPROUTY DOMAIN; SUPPRESSOR; PTPN11; GENE; IDENTIFICATION; PATHWAY; PROTEIN; TYPE-1	We report germline loss- of- function mutations in SPRED1 in a newly identified autosomal dominant human disorder. SPRED1 is a member of the SPROUTY/ SPRED family(1) of proteins that act as negative regulators of RAS- RAF interaction and mitogen-activated protein kinase ( MAPK) signaling(2). The clinical features of the reported disorder resemble those of neurofibromatosis type 1 and consist of multiple cafe - au- lait spots, axillary freckling and macrocephaly. Melanocytes from a cafe - au- lait spot showed, in addition to the germline SPRED1 mutation, an acquired somatic mutation in the wild- type SPRED1 allele, indicating that complete SPRED1 inactivation is needed to generate a cafe - au- lait spot in this syndrome. This disorder is yet another member of the recently characterized group of phenotypically overlapping syndromes caused by mutations in the genes encoding key components of the RAS- MAPK pathway(3,4). To our knowledge, this is the first report of mutations in the SPRY ( SPROUTY)/ SPRED family of genes in human disease.	Catholic Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium; Med Univ Gdansk, Dept Biol & Genet, Gdansk, Poland; CEPH, Fdn Jean Dausset, F-75010 Paris, France; Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Fukuoka 8128582, Japan; VIB, Flanders Inst Biotechnol, Dept Mol & Dev Genet, Human Genome Lab, Louvain, Belgium; Univ Alabama Birmingham, Dept Genet, Med Genom Lab, Birmingham, AL USA; Ghent Univ Hosp, Dept Dermatol, Ghent, Belgium; NCI, Dept Canc Epidemiol & Genet, Bethesda, MD 20892 USA	Universite Catholique Louvain; Fahrenheit Universities; Medical University Gdansk; Foundation Jean Dausset-CEPH; Kyushu University; Flanders Institute for Biotechnology (VIB); University of Alabama System; University of Alabama Birmingham; Ghent University; Ghent University Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Legius, E (corresponding author), Catholic Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium.	Eric.Legius@uz.kuleuven.be	Yoshimura, Akihiko/K-5515-2013; Brems, Hilde/AAN-4075-2020; Legius, Eric/H-1735-2011	Cools, Jan/0000-0001-6626-5843; Chmara, Magdalena/0000-0003-1430-8367				[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; Bundschu K, 2006, J BIOL CHEM, V281, P36477, DOI 10.1074/jbc.R600023200; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; De Schepper S, 2006, ARCH DERMATOL RES, V297, P439, DOI 10.1007/s00403-006-0644-6; Digilio MC, 2002, AM J HUM GENET, V71, P389, DOI 10.1086/341528; Engelhardt CM, 2004, HISTOCHEM CELL BIOL, V122, P527, DOI 10.1007/s00418-004-0725-6; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Inoue H, 2005, J EXP MED, V201, P73, DOI 10.1084/jem.20040616; King JAJ, 2005, BIOCHEM J, V388, P445, DOI 10.1042/BJ20041284; Legius E, 2002, J MED GENET, V39, P571, DOI 10.1136/jmg.39.8.571; LEGIUS E, 1993, NAT GENET, V3, P122, DOI 10.1038/ng0293-122; Maertens O, 2007, AM J HUM GENET, V81, P243, DOI 10.1086/519562; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; Miyoshi K, 2004, ONCOGENE, V23, P5567, DOI 10.1038/sj.onc.1207759; NILHORI T, 2006, NAT GENET, V38, P294; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Shannon K, 2007, NAT GENET, V39, P8, DOI 10.1038/ng0107-8; Taniguchi K, 2007, MOL CELL BIOL, V27, P4541, DOI 10.1128/MCB.01600-06; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082	26	286	304	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1120	1126		10.1038/ng2113	http://dx.doi.org/10.1038/ng2113			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17704776				2022-12-17	WOS:000249122400022
J	Valente, EM; Silhavy, JL; Brancati, F; Barrano, G; Krishnaswami, SR; Castori, M; Lancaster, MA; Boltshauser, E; Boccone, L; Al-Gazali, L; Fazzi, E; Signorini, S; Louie, CM; Bellacchio, E; Bertini, E; Dallapiccola, B; Gleeson, JG				Valente, Enza Maria; Silhavy, Jennifer L.; Brancati, Francesco; Barrano, Giuseppe; Krishnaswami, Suguna Rani; Castori, Marco; Lancaster, Madeline A.; Boltshauser, Eugen; Boccone, Loredana; Al-Gazali, Lihadh; Fazzi, Elisa; Signorini, Sabrina; Louie, Carrie M.; Bellacchio, Emanuele; Bertini, Enrico; Dallapiccola, Bruno; Gleeson, Joseph G.		JSRD Study Grp	Mutations in CEP290, which encodes a centrosomal protein, cause pleiotropic forms of Joubert syndrome	NATURE GENETICS			English	Article							ABNORMAL EYE-MOVEMENTS; EPISODIC HYPERPNEA; CEREBELLAR VERMIS; RETARDATION; DISORDERS; DISEASE; ATAXIA	Joubert syndrome-related disorders (JSRD) are a group of syndromes sharing the neuroradiological features of cerebellar vermis hypoplasia and a peculiar brainstem malformation known as the 'molar tooth sign'. We identified mutations in the CEP290 gene in five families with variable neurological, retinal and renal manifestations. CEP290 expression was detected mostly in proliferating cerebellar granule neuron populations and showed centrosome and ciliary localization, linking JSRDs to other human ciliopathies.	Mendel Inst Med Genet & Twin Res, Ist Ricovero & Cura Carattere Sci, I-00198 Rome, Italy; Univ Calif San Diego, Dept Neurosci, Lab Neurogenet, La Jolla, CA 92093 USA; G Annunzio Univ, Dept Biomed Sci, I-66013 Chieti, Italy; G DAnnunzio Univ Fdn, Aging Res Ctr, I-66013 Chieti, Italy; Univ Roma La Sapienza, Dept Expt Med & Pathol, I-00187 Rome, Italy; Childrens Univ Hosp, Dept Neurol, CH-8032 Zurich, Switzerland; Osped Microcitemico, I-09120 Cagliari, Italy; United Emirates Univ, Fac Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates; Univ Pavia, IRCCS C Mondino Fdn, Dept Child Neurol & Psychiat, I-27100 Pavia, Italy; IRCCS, Bambino Gesu Hosp, Dept Lab Med, Mol Med Unit, I-00165 Rome, Italy	University of California System; University of California San Diego; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Sapienza University Rome; University Children's Hospital Zurich; United Arab Emirates University; IRCCS Fondazione Casimiro Mondino; University of Pavia; IRCCS Bambino Gesu	Valente, EM (corresponding author), Mendel Inst Med Genet & Twin Res, Ist Ricovero & Cura Carattere Sci, Viale Regina Margherita 261, I-00198 Rome, Italy.	e.valente@css-mendel.it; jogleeson@ucsd.edu	Bertini, Enrico/A-2284-2014; Fazzi, Elisa/J-6076-2016; Romano, Corrado/B-9695-2008; Valente, Enza Maria/G-2942-2017; Signorini, Sabrina Giovanna/AAA-8467-2019; Brancati, Francesco/AAC-3778-2022; Castori, Marco/K-1099-2016; Bertini, Enrico/ABG-1278-2020; Bellacchio, Emanuele/AAH-9255-2019; Dallapiccola, Bruno/K-8692-2016	Bertini, Enrico/0000-0001-9276-4590; Fazzi, Elisa/0000-0003-4805-7906; Romano, Corrado/0000-0003-1049-0683; Valente, Enza Maria/0000-0002-0600-6820; Brancati, Francesco/0000-0003-3624-2354; Castori, Marco/0000-0002-6069-0993; Lancaster, Madeline/0000-0003-2324-8853; Boccone, Loredana/0000-0002-0168-0322; Bellacchio, Emanuele/0000-0002-2757-849X; Dallapiccola, Bruno/0000-0002-5031-1013	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS048453] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; BOLTSHAUSER E, 1977, NEUROPADIATRIE, V8, P57, DOI 10.1055/s-0028-1091505; Chen DH, 2001, BIOCHEM BIOPH RES CO, V280, P99, DOI 10.1006/bbrc.2000.4087; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Gleeson JG, 2004, AM J MED GENET A, V125A, P125, DOI 10.1002/ajmg.a.20437; Hildebrandt F, 2005, NAT REV GENET, V6, P928, DOI 10.1038/nrg1727; JOUBERT M, 1969, NEUROLOGY, V19, P813, DOI 10.1212/WNL.19.9.813; Katsanis N, 2006, NAT GENET, V38, P135, DOI 10.1038/ng0206-135; Louie CM, 2005, HUM MOL GENET, V14, pR235, DOI 10.1093/hmg/ddi264; Maria BL, 1997, J CHILD NEUROL, V12, P423, DOI 10.1177/088307389701200703; Valente EM, 2005, ANN NEUROL, V57, P513, DOI 10.1002/ana.20422	14	286	298	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38	6					623	625		10.1038/ng1805	http://dx.doi.org/10.1038/ng1805			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16682970				2022-12-17	WOS:000237954800014
J	Ono, R; Nakamura, K; Inoue, K; Naruse, M; Usami, T; Wakisaka-Saito, N; Hino, T; Suzuki-Migishima, R; Ogonuki, N; Miki, H; Kohda, T; Ogura, A; Yokoyama, M; Kaneko-Ishino, T; Ishino, F				Ono, R; Nakamura, K; Inoue, K; Naruse, M; Usami, T; Wakisaka-Saito, N; Hino, T; Suzuki-Migishima, R; Ogonuki, N; Miki, H; Kohda, T; Ogura, A; Yokoyama, M; Kaneko-Ishino, T; Ishino, F			Deletion of Peg10, an imprinted gene acquired from a retrotransposon, causes early embryonic lethality	NATURE GENETICS			English	Article							TRANSPOSABLE ELEMENTS; MAMMALIAN GENOMES; RETROVIRAL GAG; IDENTIFICATION; EVOLUTION; ORIGIN; SYNCYTIN; FAMILY; GROWTH; MICE	By comparing mammalian genomes, we and others have identified actively transcribed Ty3/gypsy retrotransposon-derived genes with highly conserved DNA sequences and insertion sites(1-6). To elucidate the functions of evolutionarily conserved retrotransposon-derived genes in mammalian development, we produced mice that lack one of these genes, Peg10 ( paternally expressed 10)(1-3,7), which is a paternally expressed imprinted gene on mouse proximal chromosome 6. The Peg10 knockout mice showed early embryonic lethality owing to defects in the placenta. This indicates that Peg10 is critical for mouse parthenogenetic development and provides the first direct evidence of an essential role of an evolutionarily conserved retrotransposon-derived gene in mammalian development.	Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320011, Japan; Tokyo Med & Dent Univ, Med Res Inst, Dept Epigenet, Chiyoda Ku, Tokyo 1010062, Japan; Mitsubishi Kagaku Inst Life Sci, Tokyo 1948511, Japan; RIKEN, BioResouce Ctr, Tsukuba, Ibaraki 3050074, Japan; Tokyo Med & Dent Univ, Med Res Inst, Fac Recombinant Mice, Chiyoda Ku, Tokyo 1010062, Japan; Tokyo Inst Technol, Ctr Biol Resources & Informat, Div Gene Res, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Tokai Univ, Sch Hlth Sci, Kanagawa 2591193, Japan	Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); Mitsubishi Kagaku Institute of Life Sciences (MITILS); RIKEN; Tokyo Medical & Dental University (TMDU); Tokyo Institute of Technology; Tokai University	Kaneko-Ishino, T (corresponding author), Japan Sci & Technol Agcy, CREST, 4-1-8 Hon Machi, Kawaguchi, Saitama 3320011, Japan.	tkanekoi@is.icc.u-tokai.ac.jp; fishino.epgn@mri.tmd.ac.jp	Ogura, Atsuo/J-3916-2014; Ishino（Kaneko-Ishino）, Tomoko/AGY-0742-2022; Kohda, Takashi/C-2879-2014	Ogura, Atsuo/0000-0003-0447-1988; Kohda, Takashi/0000-0002-6856-5601				Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; BEECHEY C, 2003, MOUSE IMPRINTING DAT; Brandt J, 2005, GENE, V345, P101, DOI 10.1016/j.gene.2004.11.022; Butler M, 2001, J MOL EVOL, V52, P260, DOI 10.1007/s002390010154; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Dupressoir A, 2005, P NATL ACAD SCI USA, V102, P725, DOI 10.1073/pnas.0406509102; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Lux A, 2005, J BIOL CHEM, V280, P8482, DOI 10.1074/jbc.M409197200; Lynch C, 2003, CURR BIOL, V13, P1518, DOI 10.1016/S0960-9822(03)00618-3; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Nagasaki K, 1999, CANCER LETT, V140, P227, DOI 10.1016/S0304-3835(99)00087-7; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakamura TM, 1998, CELL, V92, P587, DOI 10.1016/S0092-8674(00)81123-X; Okabe H, 2003, CANCER RES, V63, P3043; Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803; Ono R, 2001, GENOMICS, V73, P232, DOI 10.1006/geno.2001.6494; Poulter R, 1998, GENE, V215, P241, DOI 10.1016/S0378-1119(98)00296-0; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Shigemoto K, 2001, NUCLEIC ACIDS RES, V29, P4079, DOI 10.1093/nar/29.19.4079; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; STURM KS, 1994, DEV DYNAM, V201, P11, DOI 10.1002/aja.1002010103; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; TOH H, 1985, NATURE, V318, P388, DOI 10.1038/318388a0; Tsou AP, 2003, J BIOMED SCI, V10, P625, DOI 10.1159/000073528; Volff JN, 2001, MOL BIOL EVOL, V18, P266, DOI 10.1093/oxfordjournals.molbev.a003801	30	286	304	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					101	106		10.1038/ng1699	http://dx.doi.org/10.1038/ng1699			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16341224				2022-12-17	WOS:000234227200024
J	Mukherjee, S; Berger, MF; Jona, G; Wang, XS; Muzzey, D; Snyder, M; Young, RA; Bulyk, ML				Mukherjee, S; Berger, MF; Jona, G; Wang, XS; Muzzey, D; Snyder, M; Young, RA; Bulyk, ML			Rapid analysis of the DNA-binding specificities of transcription factors with DNA microarrays	NATURE GENETICS			English	Article							PROTEIN-INTERACTION MAP; SACCHAROMYCES-CEREVISIAE; REGULATORY ELEMENTS; GENE-EXPRESSION; SNF1 KINASE; YEAST; GENOME; SITES; IDENTIFICATION; REPRESSION	We developed a new DNA microarray-based technology, called protein binding microarrays (PBMs), that allows rapid, high-throughput characterization of the in vitro DNA binding site sequence specificities of transcription factors in a single day. Using PBMs, we identified the DNA binding-site sequence specificities of the yeast transcription factors Abf1, Rap1 and Mig1. Comparison of these proteins' in vitro binding sites with their in vivo binding sites indicates that PBM-derived sequence specificities can accurately reflect in vivo DNA sequence specificities. In addition to previously identified targets, Abf1, Rap1 and Mig1 bound to 107, 90 and 75 putative new target intergenic regions, respectively, many of which were upstream of previously uncharacterized open reading frames. Comparative sequence analysis indicated that many of these newly identified sites are highly conserved across five sequenced sensu stricto yeast species and, therefore, are probably functional in vivo binding sites that may be used in a condition-specific manner. Similar PBM experiments should be useful in identifying new cis regulatory elements and transcriptional regulatory networks in various genomes.	Harvard Univ, Sch Med, Dept Med, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Grad Biophys Program, Boston, MA 02115 USA; Brigham & Womens Hosp, Harvard MIT Div Hlth Sci & Technol, Boston, MA 02115 USA; Yale Univ, Dept Mol Biol, New Haven, CT 06520 USA; Yale Univ, Dept Cellular Biol, New Haven, CT 06520 USA; Yale Univ, Dept Dev Biol, New Haven, CT 06520 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Yale University; Yale University; Yale University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Brigham & Women's Hospital	Bulyk, ML (corresponding author), Harvard Univ, Sch Med, Dept Med, Div Genet, Boston, MA 02115 USA.	mlbulyk@receptor.med.harvard.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Jona, Ghil/0000-0002-4526-6182	NHGRI NIH HHS [R01 HG003420-01, R01 HG003420, R01 HG002966-02, R01 HG002966] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002966, R01HG003420] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Bojunga N, 1999, MOL GEN GENET, V262, P869, DOI 10.1007/s004380051152; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Bulyk ML, 2001, P NATL ACAD SCI USA, V98, P7158, DOI 10.1073/pnas.111163698; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; DESJARLAIS JR, 1992, P NATL ACAD SCI USA, V89, P7345, DOI 10.1073/pnas.89.16.7345; Doi N, 2002, GENOME RES, V12, P487, DOI 10.1101/gr.218802; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Dudley AM, 2002, P NATL ACAD SCI USA, V99, P7554, DOI 10.1073/pnas.112683499; Grauslund M, 1999, NUCLEIC ACIDS RES, V27, P4391, DOI 10.1093/nar/27.22.4391; GRIGGS DW, 1991, P NATL ACAD SCI USA, V88, P8597, DOI 10.1073/pnas.88.19.8597; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hartemink Alexander J, 2002, Pac Symp Biocomput, P437; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jiang R, 1997, MOL CELL BIOL, V17, P2099, DOI 10.1128/MCB.17.4.2099; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Linnell J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh042; Liu X, 2001, Pac Symp Biocomput, P127; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Lutfiyya LL, 1998, GENETICS, V150, P1377; MacBeath G, 2000, SCIENCE, V289, P1760; Man TK, 2001, NUCLEIC ACIDS RES, V29, P2471, DOI 10.1093/nar/29.12.2471; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Palecek SP, 2002, MOL MICROBIOL, V45, P453, DOI 10.1046/j.1365-2958.2002.03024.x; PHILIPPAKIS A, IN PRES PAC S BIOCOM; Planta RJ, 1997, YEAST, V13, P1505, DOI 10.1002/(SICI)1097-0061(199712)13:16<1505::AID-YEA229>3.0.CO;2-I; Rae FK, 2004, ONCOGENE, V23, P3067, DOI 10.1038/sj.onc.1207360; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Robison K, 1998, J MOL BIOL, V284, P241, DOI 10.1006/jmbi.1998.2160; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sokal R. R., 1995, BIOMETRY PRINCIPLES; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tsujimoto Y, 2000, J BACTERIOL, V182, P5121, DOI 10.1128/JB.182.18.5121-5126.2000; Udalova IA, 2002, P NATL ACAD SCI USA, V99, P8167, DOI 10.1073/pnas.102674699; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Zaragoza O, 2001, BIOCHEM J, V359, P193, DOI 10.1042/0264-6021:3590193; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	49	286	295	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2004	36	12					1331	1339		10.1038/ng1473	http://dx.doi.org/10.1038/ng1473			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	15543148	Green Accepted			2022-12-17	WOS:000225354100023
J	Hemann, MT; Fridman, JS; Zilfou, JT; Hernando, E; Paddison, PJ; Cordon-Cardo, C; Hannon, GJ; Lowe, SW				Hemann, MT; Fridman, JS; Zilfou, JT; Hernando, E; Paddison, PJ; Cordon-Cardo, C; Hannon, GJ; Lowe, SW			An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo	NATURE GENETICS			English	Article							C-ELEGANS; INTERFERENCE; SUPPRESSION; CANCER; MOUSE; GENES; DICER	The application of RNA interference (RNAi) to mammalian systems has the potential to revolutionize genetics and produce novel therapies. Here we investigate whether RNAi applied to a well-characterized gene can stably suppress gene expression in hematopoietic stem cells and produce detectable phenotypes in mice. Deletion of the Trp53 tumor suppressor gene greatly accelerates Myc-induced lymphomagenesis, resulting in highly disseminated disease(1,2). To determine whether RNAi suppression of Trp53 could produce a similar phenotype, we introduced several Trp53 short hairpin RNAs (shRNAs) into hematopoietic stem cells derived from Emu-Myc transgenic mice, and monitored tumor onset and overall pathology in lethally irradiated recipients. Different Trp53 shRNAs produced distinct phenotypes in vivo, ranging from benign lymphoid hyperplasias to highly disseminated lymphomas that paralleled Trp53(-/-) lymphomagenesis in the Emu-Myc mouse. In all cases, the severity and type of disease correlated with the extent to which specific shRNAs inhibited p53 activity. Therefore, RNAi can stably suppress gene expression in stem cells and reconstituted organs derived from those cells. In addition, intrinsic differences between individual shRNA expression vectors targeting the same gene can be used to create an 'epi-allelic series' for dissecting gene function in vivo.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Cold Spring Harbor Laboratory; Memorial Sloan Kettering Cancer Center	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, POB 100, Cold Spring Harbor, NY 11724 USA.		Hannon, Gregory/AAB-3568-2019	Hernando, Eva/0000-0003-1023-0312	NCI NIH HHS [P30 CA008748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Attardi LD, 1999, CELL MOL LIFE SCI, V55, P48, DOI 10.1007/s000180050269; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; McCurrach ME, 2001, METHOD CELL BIOL, V66, P197; Paddison PJ, 2002, CANCER CELL, V2, P17, DOI 10.1016/S1535-6108(02)00092-2; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Zilfou JT, 2001, MOL CELL BIOL, V21, P3974, DOI 10.1128/MCB.21.12.3974-3985.2001	14	286	339	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2003	33	3					396	400		10.1038/ng1091	http://dx.doi.org/10.1038/ng1091			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12567186				2022-12-17	WOS:000181312700018
J	Kulkarni, RN; Holzenberger, M; Shih, DQ; Ozcan, U; Stoffel, M; Magnuson, MA; Kahn, CR				Kulkarni, RN; Holzenberger, M; Shih, DQ; Ozcan, U; Stoffel, M; Magnuson, MA; Kahn, CR			beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass	NATURE GENETICS			English	Article							GROWTH-FACTOR-I; INSULIN-RECEPTOR; GENE-EXPRESSION; MICE CAUSES; DIFFERENTIATION; TRANSCRIPTION; EXOCYTOSIS; SECRETION; KNOCKOUT; HORMONE	Regulation of glucose homeostasis by insulin depends on the maintenance of normal beta-cell mass and function. Insulin-like growth factor 1 (Igf1) has been implicated in islet development and differentiated function(1,2), but the factors controlling this process are poorly understood. Pancreatic islets produce Igf1 and Igf2, which bind to specific receptors on beta-cells(3-6). Igf1 has been shown to influence beta-cell apoptosis(7), and both Igf1 and Igf2 increase islet growth(8,9); Igf2 does so in a manner additive with fibroblast growth factor 2 (ref. 10). When mice deficient for the Igf1 receptor (Igf1r(+/-)) are bred with mice lacking insulin receptor substrate 2 (Irs2(-/-)), the resulting compound knockout mice show a reduction in mass of beta-cells(11) similar to that observed in pancreas of Igf1r(-/-) mice (ref. 11), suggesting a role for Igf1r in growth of beta-cells. It is possible, however, that the effects in these mice occur secondary to changes in vascular endothelium(12) or in the pancreatic ductal cells, or because of a decrease in the effects of other hormones implicated in islet growth. To directly define the role of Igf1, we have created a mouse with a beta-cell-specific knockout of Igf1r (Igf1r(-/-)). These mice show normal growth and development of beta-cells, but have reduced expression of Slc2a2 (also known as Glut2) and Gck (encoding glucokinase) in beta-cells, which results in defective glucose-stimulated insulin secretion and impaired glucose tolerance. Thus, Igf1r is not crucial for islet beta-cell development, but participates in control of differentiated function.	Harvard Univ, Sch Med, Dept Med, Joslin Diabet Ctr,Res Div, Boston, MA 02215 USA; Hop St Antoine, INSERM, U515, F-75571 Paris, France; Rockefeller Univ, Lab Metab Dis, New York, NY 10021 USA; Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Rockefeller University; Vanderbilt University	Kulkarni, RN (corresponding author), Harvard Univ, Sch Med, Dept Med, Joslin Diabet Ctr,Res Div, 1 Joslin Pl, Boston, MA 02215 USA.	rohit.kulkarni@joslin.harvard.edu	Kahn, Ronald/AAY-2435-2021; Magnuson, Mark A/B-1335-2009; Holzenberger, Martin/N-9732-2018; Magnuson, Mark/AAY-7172-2021	Kahn, Ronald/0000-0002-7583-9228; Magnuson, Mark A/0000-0002-8824-6499; Magnuson, Mark/0000-0002-8824-6499; Holzenberger, Martin/0000-0003-4869-725X; Stoffel, Markus/0000-0003-1304-5817				Arany E, 2000, PEDIATR RES, V48, P389, DOI 10.1203/00006450-200009000-00023; Argetsinger LS, 1996, J BIOL CHEM, V271, P29415, DOI 10.1074/jbc.271.46.29415; Aspinwall CA, 2000, J BIOL CHEM, V275, P22331, DOI 10.1074/jbc.M909647199; Blakesley VA, 1999, CONT ENDOCRINOL, V17, P143; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; BONNERWEIR S, 1994, TRENDS ENDOCRIN MET, V5, P60, DOI 10.1016/1043-2760(94)90003-5; DEMEYTS P, 1994, HORM RES, V42, P152, DOI 10.1159/000184188; Duncan SA, 1998, SCIENCE, V281, P692, DOI 10.1126/science.281.5377.692; Gannon M, 2000, GENESIS, V26, P139, DOI 10.1002/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7; Holzenberger M, 2000, ENDOCRINOLOGY, V141, P2557, DOI 10.1210/en.141.7.2557; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kulkarni RN, 1999, J CLIN INVEST, V104, pR69, DOI 10.1172/JCI8339; KULKARNI RN, 2001, MOL BASIS PANCREAS D, P299; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; LEAHY JL, 1990, ENDOCRINOLOGY, V126, P1593, DOI 10.1210/endo-126-3-1593; Leibiger B, 2001, MOL CELL, V7, P559, DOI 10.1016/S1097-2765(01)00203-9; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; Nguyen HQ, 1996, ONCOGENE, V12, P2109; OTONKOSKI T, 1988, DIABETES, V37, P1678, DOI 10.2337/diabetes.37.12.1678; RABINOVITCH A, 1982, DIABETES, V31, P160, DOI 10.2337/diabetes.31.2.160; Rhodes CJ, 2000, J MOL ENDOCRINOL, V24, P303, DOI 10.1677/jme.0.0240303; SANFORD LP, 2001, GENE KNOCKOUT PROTOC, P217; SMITH FE, 1991, P NATL ACAD SCI USA, V88, P6152, DOI 10.1073/pnas.88.14.6152; SWENNE I, 1992, DIABETOLOGIA, V35, P193, DOI 10.1007/BF00400917; VANSCHRAVENDIJK CFH, 1987, ENDOCRINOLOGY, V121, P1784, DOI 10.1210/endo-121-5-1784; WILSON PA, 1994, CURR BIOL, V4, P676, DOI 10.1016/S0960-9822(00)00152-4; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Xavier GD, 2000, J BIOL CHEM, V275, P36269, DOI 10.1074/jbc.M006597200; Zhang QM, 1997, P NATL ACAD SCI USA, V94, P6232, DOI 10.1073/pnas.94.12.6232	29	286	297	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2002	31	1					111	115		10.1038/ng872	http://dx.doi.org/10.1038/ng872			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11923875	Bronze			2022-12-17	WOS:000175362500025
J	Bomont, P; Cavalier, L; Blondeau, F; Hamida, CB; Belal, S; Tazir, M; Demir, E; Topaloglu, H; Korinthenberg, R; Tuysuz, B; Landrieu, P; Hentati, F; Koenig, M				Bomont, P; Cavalier, L; Blondeau, F; Hamida, CB; Belal, S; Tazir, M; Demir, E; Topaloglu, H; Korinthenberg, R; Tuysuz, B; Landrieu, P; Hentati, F; Koenig, M			The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy	NATURE GENETICS			English	Article							ACTIN-BINDING PROTEIN; INTERMEDIATE FILAMENTS; GENERALIZED DISORDER; DROSOPHILA; DOMAIN; KELCH; NEUROFILAMENTS; DISEASE; ENC-1; SOD1	Disorganization of the neurofilament network is a prominent feature of several neurodegenerative disorders including amyotrophic lateral sclerosis (ALS), infantile spinal muscular atrophy and axonal Charcot-Marie-Tooth disease(1-4). Giant axonal neuropathy (GAN, MIM 256850), a severe, autosomal recessive sensorimotor neuropathy affecting both the peripheral nerves and the central nervous system, is characterized by neurofilament accumulation, leading to segmental distension of the axons(5,6) GAN corresponds to a generalized disorganization of the cytoskeletal intermediate filaments (IFs), to which neurofilaments belong, as abnormal aggregation of multiple tissue-specific IFs has been reported: vimentin in endothelial cells, Schwann cells and cultured skin fibroblasts, and glial fibrillary acidic protein (GFAP) in astrocytes(7-11) Keratin Ifs also seem to be alterated, as most patients present characteristic curly or kinky hairs(12). We report here identification of the gene GAN, which encodes a novel, ubiquitously expressed protein we have named gigaxonin. We found one frameshift, four nonsense and nine missense mutations in GAN of GAN patients. Gigaxonin is composed of an amino-terminal BTB (for Broad-Complex, Tramtrack and Bric a brac) domain followed by a six kelch repeats, which are predicted to adopt a beta -propeller shape(13). Distantly related proteins sharing a similar domain organization have various functions associated with the cytoskeleton. predicting that gigaxonin is a novel and distinct cytoskeletal protein that may represent a general pathological target for other neurodegenerative disorders with alterations in the neurofilament network.	ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellularie, F-67404 Illkirch Graffenstaden, France; Inst Biol, Inst Genet Humaine, Lab Genet Mol & Chromosom, Montpellier, France; Inst Natl Neurol, Lab Neuropathol & Neurobiol Mol, Tunis, Tunisia; CHU Mustapha, Neurol Serv, Algiers, Algeria; Hacettepe Univ, Dept Pediat Neurol, Ankara, Turkey; Univ Freiburg, Kinderklin, Abt Neuropadiat & Muskelerkrankungen, D-7800 Freiburg, Germany; Istanbul Univ, Cerrahpasa Tip Fak, Div Genet, Dept Pediat, Istanbul, Turkey; Hop Univ Bicetre, Neurol Serv, Dept Pediat, Le Kremlin Bicetre, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Montpellier; Universite de Tunis-El-Manar; Institut National de Neurologie; Hacettepe University; University of Freiburg; Istanbul University; Istanbul University - Cerrahpasa; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP	Koenig, M (corresponding author), ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellularie, BP 163,CU Strasbourg, F-67404 Illkirch Graffenstaden, France.	mkoenig@igbmc.u-strasbg.fr	Korinthenberg, Rudolf/A-9796-2009; Demir, Ercan/CAA-1553-2022; Bomont, Pascale L/Y-5517-2018; TOPALOGLU, HALUK AYDIN/I-9318-2013; Bomont, Pascale/GLS-8721-2022; Tüysüz, Beyhan/AAN-4858-2020	Bomont, Pascale L/0000-0001-7216-3261; Bomont, Pascale/0000-0001-7216-3261; Tuysuz, Beyhan/0000-0002-9620-5021; Korinthenberg, Rudolf/0000-0002-4638-3460				Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; ASBURY AK, 1972, ACTA NEUROPATHOL, V20, P237, DOI 10.1007/BF00686905; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Ben Hamida C, 1997, NEUROGENETICS, V1, P129; BENHAMIDA M, 1990, NEUROLOGY, V40, P245; Bousquet O, 1996, CELL MOTIL CYTOSKEL, V33, P115, DOI 10.1002/(SICI)1097-0169(1996)33:2<115::AID-CM4>3.0.CO;2-B; BUISSONNIERE RF, 1989, REV NEUROL, V145, P355; Cavalier L, 2000, EUR J HUM GENET, V8, P527, DOI 10.1038/sj.ejhg.5200476; Couillard-Despres S, 1998, P NATL ACAD SCI USA, V95, P9626, DOI 10.1073/pnas.95.16.9626; Hernandez MC, 1998, EXP CELL RES, V242, P470, DOI 10.1006/excr.1998.4109; Hernandez MC, 1997, J NEUROSCI, V17, P3038; ITO N, 1994, J MOL BIOL, V238, P794, DOI 10.1006/jmbi.1994.1335; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Julien JP, 1998, BRAIN PATHOL, V8, P759, DOI 10.1111/j.1750-3639.1998.tb00199.x; KRETZSCHMAR HA, 1987, ACTA NEUROPATHOL, V73, P138, DOI 10.1007/BF00693779; Lupski JR, 2000, AM J HUM GENET, V67, P8, DOI 10.1086/302986; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; PENA SDJ, 1982, MUSCLE NERVE, V5, P166, DOI 10.1002/mus.880050215; PRINEAS JW, 1976, J NEUROPATH EXP NEUR, V35, P458, DOI 10.1097/00005072-197607000-00006; Robinson DN, 1997, J CELL BIOL, V138, P799, DOI 10.1083/jcb.138.4.799; Rouleau GA, 1996, ANN NEUROL, V39, P128, DOI 10.1002/ana.410390119; Soltysik-Espanola M, 1999, MOL BIOL CELL, V10, P2361, DOI 10.1091/mbc.10.7.2361; TREIBERHELD S, 1994, NEUROPEDIATRICS, V25, P89, DOI 10.1055/s-2008-1071592; Tu PH, 1997, LAB INVEST, V76, P441; VONBULOW M, 1995, EXP CELL RES, V219, P407, DOI 10.1006/excr.1995.1246; XU ZS, 1993, J CELL SCI, P101; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; ZEMMOURI R, IN PRESS NEUROMUSCUL; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	29	286	299	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2000	26	3					370	374		10.1038/81701	http://dx.doi.org/10.1038/81701			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062483				2022-12-17	WOS:000165176500032
J	Engert, JC; Berube, P; Mercier, J; Dore, C; Lepage, P; Ge, B; Bouchard, JP; Mathieu, J; Melancon, SB; Schalling, M; Lander, ES; Morgan, K; Hudson, TJ; Richter, A				Engert, JC; Berube, P; Mercier, J; Dore, C; Lepage, P; Ge, B; Bouchard, JP; Mathieu, J; Melancon, SB; Schalling, M; Lander, ES; Morgan, K; Hudson, TJ; Richter, A			ARSACS, a spastic ataxia common in northeastern Quebec, is caused by mutations in a new gene encoding an 11.5-kb ORF	NATURE GENETICS			English	Article							DISEQUILIBRIUM; LINKAGE; CHAPERONE; POPULATIONS; FREQUENCY; DISORDERS; SAGUENAY; FINLAND; ALLELE; BASE	Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS or SACS) is an early onset neurodegenerative disease with high prevalence (carrier frequency 1/22) in the Charlevoix-Saguenay-Lac-Saint-Jean (CSLSJ) region of Quebec. We previously mapped the gene responsible for ARSACS to chromosome 13q11 and identified two ancestral haplotypes. Here we report the cloning of this gene, SAGS, which encodes the protein sacsin. The ORF of SAGS is 11,487 bp and is encoded by a single gigantic exon spanning 12,794 bp. This exon is the largest to be identified in any vertebrate organism. The ORF is conserved in human and mouse. The putative protein contains three large segments with sequence similarity to each other and to the predicted protein of an Arabidopsis thaliana ORF. The presence of heat-shock domains suggests a function for sacsin in chaperone-mediated protein folding. SAGS is expressed in a variety of tissues, including the central nervous system. We identified two SAGS mutations in ARSACS families that lead to protein truncation, consistent with haplotype analysis.	Univ Montreal, Hop St Justine, Gen Med Serv, Dept Pediat, Montreal, PQ H3T 1C5, Canada; McGill Univ, Montreal Genome Ctr, Hlth Ctr Res Inst, Montreal, PQ, Canada; Hop Enfants Jesus, Serv Neurol, Quebec City, PQ G1J 1Z4, Canada; Hop Chicoutimi, Serv Neurol, Chicoutimi, PQ, Canada; Karolinska Inst, Neurogen Unit, Dept Mol Med, Stockholm, Sweden; MIT, Whitehead Inst Biomed Res, Cambridge, MA USA; McGill Univ, Dept Human Genet & Med, Montreal, PQ, Canada	Universite de Montreal; McGill University; Laval University; Karolinska Institutet; Massachusetts Institute of Technology (MIT); Whitehead Institute; McGill University	Richter, A (corresponding author), Univ Montreal, Hop St Justine, Gen Med Serv, Dept Pediat, Montreal, PQ H3T 1C5, Canada.	thudson@genome.wi.mit.edu; richtera@ere.umontreal.ca	Schalling, Martin/F-1518-2015	Schalling, Martin/0000-0001-5011-2922; Engert, James/0000-0001-8411-4790; Hudson, Thomas/0000-0002-1376-4849; Berube, Pierre/0000-0002-1008-192X				Austerlitz F, 1998, P NATL ACAD SCI USA, V95, P15140, DOI 10.1073/pnas.95.25.15140; Austerlitz F, 1999, GENET EPIDEMIOL, V16, P2, DOI 10.1002/(SICI)1098-2272(1999)16:1<2::AID-GEPI2>3.0.CO;2-9; Birren Bruce, 1999, P241; BOEHNKE M, 1994, AM J HUM GENET, V55, P379; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Bonfield JK, 1996, DNA SEQUENCE, V6, P109, DOI 10.3109/10425179609010197; Bouchard JP, 1998, NEUROMUSCULAR DISORD, V8, P474, DOI 10.1016/S0960-8966(98)00055-8; Bouchard JP., 1991, HDB CLIN NEUROLOGY H, V60, P451; Boysen C, 1997, BIOTECHNIQUES, V23, P978, DOI 10.2144/97236bm01; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Charbonneau H., 1987, HIST ATLAS CANADA, V1; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; DEBRAEKELEER M, 1995, ANN HUM BIOL, V22, P111, DOI 10.1080/03014469500003772; Desseyn JL, 1997, J BIOL CHEM, V272, P3168, DOI 10.1074/jbc.272.6.3168; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; DICKIE MM, 1965, MOUSE NEWS LETT, V32, P45; Dittmar KD, 1998, J BIOL CHEM, V273, P7358, DOI 10.1074/jbc.273.13.7358; Engert JC, 1999, GENOMICS, V62, P156, DOI 10.1006/geno.1999.6003; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Graham J, 1998, AM J HUM GENET, V63, P1517, DOI 10.1086/302102; GRAHAM J, 1998, THESIS U WASHINGTON; GUPTA RS, 1995, MOL BIOL EVOL, V12, P1063; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Heyer E, 1999, HUM BIOL, V71, P99; KIMURA Y, 1995, SCIENCE, V268, P1362, DOI 10.1126/science.7761857; KNOPPERS BM, 1991, CAN MED ASSOC J, V144, P128; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; McCarthy LC, 1997, GENOME RES, V7, P1153, DOI 10.1101/gr.7.12.1153; McNally EM, 1996, AM J HUM GENET, V59, P1040; Nagase T, 1998, DNA Res, V5, P277, DOI 10.1093/dnares/5.5.277; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Richter A, 1999, AM J HUM GENET, V64, P768, DOI 10.1086/302274; SCHALLING M, 1991, NEUROSCIENCE, V41, P753, DOI 10.1016/0306-4522(91)90365-U; Smith RF, 1996, GENOME RES, V6, P454, DOI 10.1101/gr.6.5.454; Thompson EA, 1997, AM J HUM GENET, V60, P197; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Etten WJ, 1999, NAT GENET, V22, P384, DOI 10.1038/11962; WEEKS DE, 1995, AM J HUM GENET, V56, P1506	42	286	298	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2000	24	2					120	125		10.1038/72769	http://dx.doi.org/10.1038/72769			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	280LQ	10655055				2022-12-17	WOS:000085104600010
J	Schwahn, U; Lenzner, S; Dong, J; Feil, S; Hinzmann, B; van Duijnhoven, G; Kirschner, R; Hemberger, M; Bergen, AAB; Rosenberg, T; Pinckers, AJLG; Fundele, R; Rosenthal, A; Cremers, FPM; Ropers, HH; Berger, W				Schwahn, U; Lenzner, S; Dong, J; Feil, S; Hinzmann, B; van Duijnhoven, G; Kirschner, R; Hemberger, M; Bergen, AAB; Rosenberg, T; Pinckers, AJLG; Fundele, R; Rosenthal, A; Cremers, FPM; Ropers, HH; Berger, W			Positional cloning of the gene for X-linked retinitis pigmentosa 2	NATURE GENETICS			English	Article							L1 SEQUENCE; YAC CONTIG; INSERTION; IDENTIFICATION; ELEMENT; TUBULIN; CELL; DNA; PHOTORECEPTORS; POLYMORPHISM	X-linked retinitis pigmentosa (XLRP) results from mutations in at least two different loci, designated RP2 and RP3, located at Xp11.3 and Xp21.1, respectively. The RP3 gene was recently isolated by positional cloning, whereas the RP2 locus was mapped genetically to a 5-cM interval. We have screened this region for genomic rearrangements by the YAC representation hybridization (YRH) technique and detected a LINE1 (L1) insertion in one XLRP patient. The L1 retrotransposition occurred in an intron of a novel gene that consisted of five exons and encoded a polypeptide of 350 amino acids. Subsequently, nonsense, missense and frameshift mutations, as well as two small deletions, were identified in six additional patients. The predicted gene product shows homology with human cofactor C, a protein involved in the ultimate step of beta-tubulin folding. Our data provide evidence that mutations in this gene, designated RP2, are responsible for progressive retinal degeneration.	Max Planck Inst Mol Genet, Berlin, Dahlem, Germany; Gesell Genomforsch MBH, MetaGen, Berlin, Germany; Univ Nijmegen Hosp, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Netherlands Ophthalm Res Inst, Dept Ophthalmogenet, NL-1100 AC Amsterdam, Netherlands; Natl Eye Clin Visually Impaired, Hellerup, Denmark; Univ Nijmegen Hosp, Dept Ophthalmol, NL-6500 HB Nijmegen, Netherlands	Max Planck Society; Radboud University Nijmegen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Radboud University Nijmegen	Berger, W (corresponding author), Max Planck Inst Mol Genet, Berlin, Dahlem, Germany.		Bergen, Arthur/J-3637-2013; Cremers, Frans/A-5625-2014	Cremers, Frans/0000-0002-4954-5592; Hemberger, Myriam/0000-0003-3332-6958; Bergen, Arthur/0000-0002-6333-9576; Kirschner-Schwabe, Renate/0000-0001-6335-3274				Adam GIR, 1996, DEVELOPMENT, V122, P839; BERGER W, 1992, NAT GENET, V1, P199, DOI 10.1038/ng0692-199; BHATTACHARYA SS, 1984, NATURE, V309, P253, DOI 10.1038/309253a0; BOCCACCIO C, 1990, GENE, V88, P181, DOI 10.1016/0378-1119(90)90030-U; Buraczynska M, 1997, AM J HUM GENET, V61, P1287, DOI 10.1086/301646; COLEMAN MP, 1994, GENOMICS, V21, P337, DOI 10.1006/geno.1994.1274; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; ECONOMOUPACHNIS A, 1985, P NATL ACAD SCI USA, V9, P2857; Frantz SA, 1996, MAMM GENOME, V7, P865, DOI 10.1007/s003359900256; HAGEMANN T, 1994, GENOMICS, V21, P262, DOI 10.1006/geno.1994.1255; ISHIHARA A, 1997, BIOTECHNIQUES, V23, P120; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; LEWIS GP, 1995, INVEST OPHTH VIS SCI, V36, P2404; MCCARTHY JEG, 1995, TRENDS BIOCHEM SCI, V20, P191, DOI 10.1016/S0968-0004(00)89006-4; MEINDL A, 1996, NAT GENET, V13, P36; MIKI Y, 1992, CANCER RES, V52, P643; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; MULHARDT C, 1994, NEURON, V13, P1003, DOI 10.1016/0896-6273(94)90265-8; MURESAN V, 1993, J CELL SCI, V104, P1229; NARITA N, 1993, J CLIN INVEST, V91, P1862, DOI 10.1172/JCI116402; OTT J, 1990, P NATL ACAD SCI USA, V87, P701, DOI 10.1073/pnas.87.2.701; Perou CM, 1996, NAT GENET, V13, P303, DOI 10.1038/ng0796-303; Roepman R, 1996, HUM MOL GENET, V5, P1035, DOI 10.1093/hmg/5.7.1035; Roepman R, 1996, HUM MOL GENET, V5, P827, DOI 10.1093/hmg/5.6.827; Ross J, 1996, TRENDS GENET, V12, P171, DOI 10.1016/0168-9525(96)10016-0; SALE WS, 1988, CELL MOTIL CYTOSKEL, V9, P243, DOI 10.1002/cm.970090306; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; SKOWRONSKI J, 1986, COLD SPRING HARB SYM, V51, P457, DOI 10.1101/SQB.1986.051.01.055; Takahara T, 1996, HUM MOL GENET, V5, P989, DOI 10.1093/hmg/5.7.989; TEAGUE PW, 1994, AM J HUM GENET, V55, P105; Thiselton DL, 1996, GENOME RES, V6, P1093, DOI 10.1101/gr.6.11.1093; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; WATANABE M, 1991, J NEUROBIOL, V22, P85, DOI 10.1002/neu.480220109; WIRTH B, 1988, Genomics, V2, P263, DOI 10.1016/0888-7543(88)90011-0; WOODFORD BJ, 1989, CELL TISSUE RES, V256, P495	36	286	301	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1998	19	4					327	332		10.1038/1214	http://dx.doi.org/10.1038/1214			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697692				2022-12-17	WOS:000075107600014
J	MCWHIR, J; SELFRIDGE, J; HARRISON, DJ; SQUIRES, S; MELTON, DW				MCWHIR, J; SELFRIDGE, J; HARRISON, DJ; SQUIRES, S; MELTON, DW			MICE WITH DNA-REPAIR GENE (ERCC-1) DEFICIENCY HAVE ELEVATED LEVELS OF P53, LIVER NUCLEAR ABNORMALITIES AND DIE BEFORE WEANING	NATURE GENETICS			English	Article							XERODERMA-PIGMENTOSUM; ESCHERICHIA-COLI; EXCISION; EXPRESSION; CELLS; MUTANTS; CLONING; INVITRO; PROTEIN	Defects in nucleotide excision repair are associated with the human condition xeroderma pigmentosum which predisposes to skin cancer. Mice with defective DNA repair were generated by targeting the excision repair cross complementing gene (ERCC-1) in the embryonic stem cell line, HM-1. Homozygous ERCC-1 mutants were runted at birth and died before weaning with liver failure. Examination of organs revealed polyploidy in perinatal liver, progressing to severe aneuploidy by 3 weeks of age. Elevated p53 levels were detected in liver, brain and kidney, supporting the hypothesised role for p53 as a monitor of DNA damage.	UNIV EDINBURGH,INST CELL & MOLEC BIOL,MAYFIELD RD,EDINBURGH EH9 3JR,MIDLOTHIAN,SCOTLAND; UNIV EDINBURGH,DEPT PATHOL,EDINBURGH EH8 9AG,MIDLOTHIAN,SCOTLAND; UNIV CAMBRIDGE,DEPT ZOOL,CANCER RES CAMPAIGN MAMMALIAN CELL DNA REPAIR RES GRP,CAMBRIDGE CB2 3EJ,ENGLAND	University of Edinburgh; University of Edinburgh; University of Cambridge				SELFRIDGE, JIM/0000-0003-2473-4386				[Anonymous], 1985, DNA REPAIR; BELT PBGM, 1991, NUCLEIC ACIDS RES, V19, P5633, DOI 10.1093/nar/19.20.5633; BIGGERSTAFF M, 1993, EMBO J, V12, P3685, DOI 10.1002/j.1460-2075.1993.tb06043.x; BIGGERSTAFF M, 1992, J BIOL CHEM, V267, P6879; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; BRUGAL G, 1992, CYTOMETRY, V13, P109, DOI 10.1002/cyto.990130202; BUSCH D, 1989, MUTAGENESIS, V4, P349, DOI 10.1093/mutage/4.5.349; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Cleaver J. E., 1989, METABOLIC BASIS INHE, V2, P2949; COLLINS AR, 1993, MUTAT RES, V293, P99, DOI 10.1016/0921-8777(93)90062-L; EPSTEIN CJ, 1967, NATURE, V214, P1050, DOI 10.1038/2141050a0; FLEJTER WL, 1992, P NATL ACAD SCI USA, V89, P261, DOI 10.1073/pnas.89.1.261; GULYAS KD, 1992, CELL, V69, P1031, DOI 10.1016/0092-8674(92)90621-I; HARRISON DJ, 1989, J CLIN PATHOL, V42, P624, DOI 10.1136/jcp.42.6.624; JENKINS JR, 1984, NUCLEIC ACIDS RES, V12, P5609, DOI 10.1093/nar/12.14.5609; KASTAN MB, 1991, CANCER RES, V51, P6304; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; MIDGLEY CA, 1992, J CELL SCI, V101, P183; MINTY AJ, 1981, J BIOL CHEM, V256, P1008; MITCHELL DL, 1990, BIOESSAYS, V12, P74, DOI 10.1002/bies.950120205; ODONOVAN A, 1993, NATURE, V363, P185, DOI 10.1038/363185a0; OLANOW CW, 1992, ANN NEUROL, V32, pS2, DOI 10.1002/ana.410320703; Ormerod M.G., 1990, FLOW CYTOMETRY PRACT, P69; PINKUS R, 1993, BIOCHEM J, V290, P637, DOI 10.1042/bj2900637; REGAN JD, 1990, MUTAT RES, V235, P157, DOI 10.1016/0921-8777(90)90069-H; SANCAR A, 1988, ANNU REV BIOCHEM, V57, P29, DOI 10.1146/annurev.bi.57.070188.000333; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHIESTL RH, 1990, MOL CELL BIOL, V10, P2485, DOI 10.1128/MCB.10.6.2485; SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; SQUIRES S, 1982, MUTAT RES, V95, P389, DOI 10.1016/0027-5107(82)90273-1; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; TOMKINSON AE, 1993, NATURE, V362, P860, DOI 10.1038/362860a0; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; VANDUIN M, 1987, NUCLEIC ACIDS RES, V15, P9195, DOI 10.1093/nar/15.22.9195; VANDUIN M, 1988, NUCLEIC ACIDS RES, V16, P5305, DOI 10.1093/nar/16.12.5305; VANDUIN M, 1989, MUTAT RES, V217, P83, DOI 10.1016/0921-8777(89)90059-1; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; VOIGT JM, 1989, J BIOL CHEM, V264, P5172; WEEDA G, 1993, BIOESSAYS, V15, P249, DOI 10.1002/bies.950150405; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U; WESTERVELD A, 1984, NATURE, V310, P425, DOI 10.1038/310425a0; YOKE WK, 1990, MUTAT RES, V235, P147	44	286	294	1	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1993	5	3					217	224		10.1038/ng1193-217	http://dx.doi.org/10.1038/ng1193-217			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	8275084				2022-12-17	WOS:A1993MF12200009
J	Qin, YJ; Yao, L; King, EE; Buddavarapu, K; Lenci, RE; Chocron, ES; Lechleiter, JD; Sass, M; Aronin, N; Schiavi, F; Boaretto, F; Opocher, G; Toledo, RA; Toledo, SPA; Stiles, C; Aguiar, RCT; Dahia, PLM				Qin, Yuejuan; Yao, Li; King, Elizabeth E.; Buddavarapu, Kalyan; Lenci, Romina E.; Chocron, E. Sandra; Lechleiter, James D.; Sass, Meghan; Aronin, Neil; Schiavi, Francesca; Boaretto, Francesca; Opocher, Giuseppe; Toledo, Rodrigo A.; Toledo, Sergio P. A.; Stiles, Charles; Aguiar, Ricardo C. T.; Dahia, Patricia L. M.			Germline mutations in TMEM127 confer susceptibility to pheochromocytoma	NATURE GENETICS			English	Article							MTOR; SIGNALS; RAPTOR; PHOSPHORYLATION; APOPTOSIS; INTERACTS; AKT/PKB; COMPLEX; BREAST; RICTOR	Pheochromocytomas, which are catecholamine-secreting tumors of neural crest origin, are frequently hereditary(1). However, the molecular basis of the majority of these tumors is unknown(2). We identified the transmembrane-encoding gene TMEM127 on chromosome 2q11 as a new pheochromocytoma susceptibility gene. In a cohort of 103 samples, we detected truncating germline TMEM127 mutations in approximately 30% of familial tumors and about 3% of sporadic-appearing pheochromocytomas without a known genetic cause. The wild-type allele was consistently deleted in tumor DNA, suggesting a classic mechanism of tumor suppressor gene inactivation. Pheochromocytomas with mutations in TMEM127 are transcriptionally related to tumors bearing NF1 mutations and, similarly, show hyperphosphorylation of mammalian target of rapamycin (mTOR) effector proteins. Accordingly, in vitro gain-of-function and loss-of-function analyses indicate that TMEM127 is a negative regulator of mTOR. TMEM127 dynamically associates with the endomembrane system and colocalizes with perinuclear (activated) mTOR, suggesting a subcompartmental-specific effect. Our studies identify TMEM127 as a tumor suppressor gene and validate the power of hereditary tumors to elucidate cancer pathogenesis.	[Qin, Yuejuan; Yao, Li; King, Elizabeth E.; Buddavarapu, Kalyan; Lenci, Romina E.; Aguiar, Ricardo C. T.; Dahia, Patricia L. M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Chocron, E. Sandra; Lechleiter, James D.; Dahia, Patricia L. M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Sass, Meghan] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Schiavi, Francesca; Boaretto, Francesca; Opocher, Giuseppe] Veneto Inst Oncol, Padua, Italy; [Toledo, Rodrigo A.; Toledo, Sergio P. A.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil; [Stiles, Charles] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Aguiar, Ricardo C. T.; Dahia, Patricia L. M.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; IRCCS Istituto Oncologico Veneto (IOV); Universidade de Sao Paulo; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Dahia, PLM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.	dahia@uthscsa.edu	Toledo, Rodrigo/GQQ-1711-2022; boaretto, francesca/K-9811-2016; Schiavi, Francesca/AAB-9908-2022; Qin, Yuejuan/F-6801-2010; Toledo, Rodrigo/ABH-5248-2020; Toledo, Rodrigo/N-4078-2013; Opocher, Giuseppe/F-3950-2014; Toledo, Sergio P. A./S-9291-2018	boaretto, francesca/0000-0003-2015-929X; Schiavi, Francesca/0000-0001-8529-4455; Toledo, Rodrigo/0000-0003-3070-6795; Toledo, Rodrigo/0000-0003-3070-6795; Opocher, Giuseppe/0000-0002-9845-9623; Lenci, Romina/0000-0002-0025-3134; Toledo, Sergio P. A./0000-0002-2590-3519	Voelcker Foundation Young Investigator Award; Cancer Therapy and Research Center (CTRC) at the University of Texas Health Science Center at San Antonio (UTHSCSA); NIH [P30 CA54174]; Voelcker Fund; US National Institutes of Health (NIH)National Cancer Institute [P30 CA54174]; NIH-National Institute on Aging (NIA) [P30 AG013319, P01AG19316]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000149] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019316, P30AG013319] Funding Source: NIH RePORTER	Voelcker Foundation Young Investigator Award; Cancer Therapy and Research Center (CTRC) at the University of Texas Health Science Center at San Antonio (UTHSCSA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Voelcker Fund; US National Institutes of Health (NIH)National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH-National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Jiang for technical assistance, V. Frohlich and J. Wewer for help with optical imaging, J. Blenis for kindly providing the 293E cell line, W. Kaelin Jr. for his comments and suggestions, and M. Jech, C. Colin, N. V. Nguyen, M. Pujana, M. Vidal, D. Hill, J. Bruder and the Familial Pheochromocytoma Consortium members for their contribution to earlier phases of this project. We also thank the subjects and families that participated in the study for their cooperation. P. L. M. D. is a Kimmel Foundation Scholar and a recipient of a Voelcker Foundation Young Investigator Award and is supported by the Cancer Therapy and Research Center (CTRC) at the University of Texas Health Science Center at San Antonio (UTHSCSA) (NIH-P30 CA54174). R. C. T. A. is supported by the Voelcker Fund. Immunofluorescence images were generated in the Core Optical Imaging Facility which is supported by UTHSCSA, US National Institutes of Health (NIH)National Cancer Institute P30 CA54174 (CTRC), NIH-National Institute on Aging (NIA) P30 AG013319 (Nathan Shock Center) and NIH-NIA P01AG19316.	Aguiar RCT, 1999, BLOOD, V94, P2403, DOI 10.1182/blood.V94.7.2403.419k39_2403_2413; Amar L, 2005, J CLIN ONCOL, V23, P8812, DOI 10.1200/JCO.2005.03.1484; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Dahia PLM, 2006, CURR OPIN ONCOL, V18, P1, DOI 10.1097/01.cco.0000198017.45982.06; Dahia PLM, 2005, PLOS GENET, V1, P72, DOI 10.1371/journal.pgen.0010008; Dahia PLM, 2005, CANCER RES, V65, P9651, DOI 10.1158/0008-5472.CAN-05-1427; Dahia PLM, 1999, HUM MOL GENET, V8, P185, DOI 10.1093/hmg/8.2.185; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Ferner RE, 2007, J MED GENET, V44, P81, DOI 10.1136/jmg.2006.045906; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Johannessen CM, 2008, CURR BIOL, V18, P56, DOI 10.1016/j.cub.2007.11.066; Jonsson G, 2007, GENE CHROMOSOME CANC, V46, P543, DOI 10.1002/gcc.20438; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schlisio S, 2008, GENE DEV, V22, P884, DOI 10.1101/gad.1648608; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Segouffin-Cariou C, 2000, J BIOL CHEM, V275, P3568, DOI 10.1074/jbc.275.5.3568; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smith PG, 2005, BLOOD, V105, P308, DOI 10.1182/blood-2004-01-0240; Snyder CM, 2006, MOL BIOL CELL, V17, P511, DOI 10.1091/mbc.E05-07-0682; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102	29	285	294	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2010	42	3					229	U31		10.1038/ng.533	http://dx.doi.org/10.1038/ng.533			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20154675	Green Accepted			2022-12-17	WOS:000274912400011
J	Zheng, P; Allen, WB; Roesler, K; Williams, ME; Zhang, S; Li, J; Glassman, K; Ranch, J; Nubel, D; Solawetz, W; Bhattramakki, D; Llaca, V; Deschamps, S; Zhong, GY; Tarczynski, MC; Shen, B				Zheng, Peizhong; Allen, William B.; Roesler, Keith; Williams, Mark E.; Zhang, Shirong; Li, Jiming; Glassman, Kimberly; Ranch, Jerry; Nubel, Douglas; Solawetz, William; Bhattramakki, Dinakar; Llaca, Victor; Deschamps, Stephane; Zhong, Gan-Yuan; Tarczynski, Mitchell C.; Shen, Bo			A phenylalanine in DGAT is a key determinant of oil content and composition in maize	NATURE GENETICS			English	Article							DIACYLGLYCEROL ACYLTRANSFERASE; EXPRESSION; SELECTION; PLANT	Plant oil is an important renewable resource for biodiesel production and for dietary consumption by humans and livestock. Through genetic mapping of the oil trait in plants, studies have reported multiple quantitative trait loci (QTLs) with small effects, but the molecular basis of oil QTLs remains largely unknown(1-5). Here we show that a high-oil QTL (qHO6) affecting maize seed oil and oleic-acid contents encodes an acyl-CoA: diacylglycerol acyltransferase (DGAT1-2), which catalyzes the final step of oil synthesis. We further show that a phenylalanine insertion in DGAT1-2 at position 469 (F469) is responsible for the increased oil and oleic-acid contents. The DGAT1-2 allele with F469 is ancestral, whereas the allele without F469 is a more recent mutant selected by domestication or breeding. Ectopic expression of the high-oil DGAT1-2 allele increases oil and oleic-acid contents by up to 41% and 107%, respectively. This work provides insights into the molecular basis of natural variation of oil and oleic-acid contents in plants and highlights DGAT as a promising target for increasing oil and oleic-acid contents in other crops.	[Zheng, Peizhong; Allen, William B.; Roesler, Keith; Zhang, Shirong; Li, Jiming; Glassman, Kimberly; Ranch, Jerry; Nubel, Douglas; Solawetz, William; Bhattramakki, Dinakar; Zhong, Gan-Yuan; Tarczynski, Mitchell C.; Shen, Bo] Pioneer HiBred Int Inc, Dupont Co, Johnston, IA 50131 USA; [Williams, Mark E.; Llaca, Victor; Deschamps, Stephane] Dupont Corp Genet Res, Expt Stn, Wilmington, DE 19880 USA	DuPont; DuPont	Shen, B (corresponding author), Pioneer HiBred Int Inc, Dupont Co, 7300 NW 62nd Ave,POB 1004, Johnston, IA 50131 USA.	Bo.Shen@pioneer.com	Deschamps, Stephane/R-3806-2019	Li, Jiming/0000-0003-4344-1896				ALREFAI R, 1995, GENOME, V38, P894, DOI 10.1139/g95-118; AN GH, 1989, PLANT CELL, V1, P115, DOI 10.1105/tpc.1.1.115; Belo A, 2008, MOL GENET GENOMICS, V279, P1, DOI 10.1007/s00438-007-0289-y; BERKE TG, 1995, CROP SCI, V35, P1542, DOI 10.2135/cropsci1995.0011183X003500060004x; CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; Clark D, 2006, CROP SCI, V46, P807, DOI 10.2135/cropsci2005.06-0153; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Ishida Y, 1996, NAT BIOTECHNOL, V14, P745, DOI 10.1038/nbt0696-745; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; Kinney AJ, 2002, BIOCHEM SOC T, V30, P1099, DOI 10.1042/BST0301099; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lambert R. J., 2004, Plant Breeding Reviews, V24, P153; Laurie CC, 2004, GENETICS, V168, P2141, DOI 10.1534/genetics.104.029686; Lung SC, 2006, LIPIDS, V41, P1073, DOI 10.1007/s11745-006-5057-y; Mangolin CA, 2004, EUPHYTICA, V137, P251, DOI 10.1023/B:EUPH.0000041588.95689.47; Milcamps A, 2005, J BIOL CHEM, V280, P5370, DOI 10.1074/jbc.M410276200; Moose SP, 2004, TRENDS PLANT SCI, V9, P358, DOI 10.1016/j.tplants.2004.05.005; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; PONELEIT CG, 1965, SCIENCE, V147, P1585, DOI 10.1126/science.147.3665.1585; Shen B, 2006, PLANT MOL BIOL, V60, P377, DOI 10.1007/s11103-005-4110-1; Song XF, 2004, MAYDICA, V49, P41; Voelker T, 2001, ANNU REV PLANT PHYS, V52, P335, DOI 10.1146/annurev.arplant.52.1.335; White P. J., 2003, Corn: chemistry and technology, P355; Zhao Zuo-yu, 2006, Methods Mol Biol, V318, P315	25	285	352	3	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2008	40	3					367	372		10.1038/ng.85	http://dx.doi.org/10.1038/ng.85			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18278045				2022-12-17	WOS:000253548400031
J	Lalioti, MD; Zhang, JH; Volkman, HM; Kahle, KT; Hoffmann, KE; Toka, HR; Nelson-Williams, C; Ellison, DH; Flavell, R; Booth, CJ; Lu, Y; Geller, DS; Lifton, RP				Lalioti, Maria D.; Zhang, Junhui; Volkman, Heather M.; Kahle, Kristopher T.; Hoffmann, Kristin E.; Toka, Hakan R.; Nelson-Williams, Carol; Ellison, David H.; Flavell, Richard; Booth, Carmen J.; Lu, Yin; Geller, David S.; Lifton, Richard P.			Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule	NATURE GENETICS			English	Article							NA-CL COTRANSPORTER; TRANSPORT PATHWAYS; CALCIUM-METABOLISM; HUMAN HYPERTENSION; MUTANT WNK4; HYPERKALEMIA; SODIUM; MICE; REABSORPTION; MUTATIONS	The mechanisms that govern homeostasis of complex systems have been elusive but can be illuminated by mutations that disrupt system behavior. Mutations in the gene encoding the kinase WNK4 cause pseudohypoaldosteronism type II (PHAII), a syndrome featuring hypertension and hyperkalemia. We show that physiology in mice transgenic for genomic segments harboring wild-type (TgWnk4(WT)) or PHAII mutant (TgWnk4(PHAII)) Wnk4 is changed in opposite directions: TgWnk4(PHAII) mice have higher blood pressure, hyperkalemia, hypercalciuria and marked hyperplasia of the distal convoluted tubule (DCT), whereas the opposite is true in TgWnk4(WT) mice. Genetic deficiency for the Na-Cl cotransporter of the DCT (NCC) reverses phenotypes seen in TgWnk4PHAII mice, demonstrating that the effects of the PHAII mutation are due to altered NCC activity. These findings establish that Wnk4 is a molecular switch that regulates the balance between NaCl reabsorption and K+ secretion by altering the mass and function of the DCT through its effect on NCC.	Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Med, Nephrol Sect, New Haven, CT 06520 USA; Oregon Hlth Sci Univ, Div Nephrol & Hypertens, Portland, OR 97239 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University; Oregon Health & Science University; Howard Hughes Medical Institute; Yale University; Yale University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06520 USA.	richard.lifton@yale.edu	, David/X-5730-2019; Toka, Hakan/AAQ-2162-2021	Ellison, David/0000-0003-2915-265X				Brooks HL, 2002, HYPERTENSION, V39, P470, DOI 10.1161/hy02t2.102959; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; Chrast R, 1999, TRANSGENIC RES, V8, P147, DOI 10.1023/A:1008858014473; GORDON RD, 1986, AUST NZ J MED, V16, P183, DOI 10.1111/j.1445-5994.1986.tb01145.x; Hansen PB, 2004, ACTA PHYSIOL SCAND, V181, P431, DOI 10.1111/j.1365-201X.2004.01315.x; Kahle KT, 2005, TRENDS ENDOCRIN MET, V16, P98, DOI 10.1016/j.tem.2005.02.012; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P14877, DOI 10.1073/pnas.0406172101; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P2064, DOI 10.1073/pnas.0308434100; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; KAISSLING B, 1985, AM J PHYSIOL, V248, P374; Kim GH, 1998, P NATL ACAD SCI USA, V95, P14552, DOI 10.1073/pnas.95.24.14552; Lalioti MD, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e14; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; LIND L, 1993, J HUM HYPERTENS, V7, P53; Loffing J, 2004, J AM SOC NEPHROL, V15, P2276, DOI 10.1097/01.ASN.0000138234.18569.63; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; Mayan H, 2004, J CLIN ENDOCR METAB, V89, P4025, DOI 10.1210/jc.2004-0037; MUJAIS SK, 1986, J CLIN INVEST, V77, P315, DOI 10.1172/JCI112293; Nijenhuis T, 2005, J CLIN INVEST, V115, P1651, DOI 10.1172/JCI24134; PAVER WK, 1964, MED J AUSTRALIA, V35, P305; Reilly RF, 2000, PHYSIOL REV, V80, P277, DOI 10.1152/physrev.2000.80.1.277; Rubera I, 2003, J CLIN INVEST, V112, P554, DOI 10.1172/JCI200316956; SCHAMBELAN M, 1981, KIDNEY INT, V19, P716, DOI 10.1038/ki.1981.72; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Wang T, 1996, AM J PHYSIOL-RENAL, V271, pF143, DOI 10.1152/ajprenal.1996.271.1.F143; Weinstein AM, 2005, AM J PHYSIOL-RENAL, V289, pF699, DOI 10.1152/ajprenal.00043.2005; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; YAMAKAWA H, 1992, HYPERTENSION, V19, P528, DOI 10.1161/01.HYP.19.6.528; Yamauchi K, 2004, P NATL ACAD SCI USA, V101, P4690, DOI 10.1073/pnas.0306924101; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443	33	285	289	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2006	38	10					1124	1132		10.1038/ng1877	http://dx.doi.org/10.1038/ng1877			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16964266				2022-12-17	WOS:000241251100011
J	Helgadottir, A; Manolescu, A; Helgason, A; Thorleifsson, G; Thorsteinsdottir, U; Gudbjartsson, DF; Gretarsdottir, S; Magnusson, KP; Gudmundsson, G; Hicks, A; Jonsson, T; Grant, SFA; Sainz, J; O'Brien, SJ; Sveinbjornsdottir, S; Valdimarsson, EM; Matthiasson, SE; Levey, AI; Abramson, JL; Reilly, MP; Vaccarino, V; Wolfe, ML; Gudnason, V; Quyyumi, AA; Topol, EJ; Rader, DJ; Thorgeirsson, G; Gulcher, JR; Hakonarson, H; Kong, A; Stefansson, K				Helgadottir, A; Manolescu, A; Helgason, A; Thorleifsson, G; Thorsteinsdottir, U; Gudbjartsson, DF; Gretarsdottir, S; Magnusson, KP; Gudmundsson, G; Hicks, A; Jonsson, T; Grant, SFA; Sainz, J; O'Brien, SJ; Sveinbjornsdottir, S; Valdimarsson, EM; Matthiasson, SE; Levey, AI; Abramson, JL; Reilly, MP; Vaccarino, V; Wolfe, ML; Gudnason, V; Quyyumi, AA; Topol, EJ; Rader, DJ; Thorgeirsson, G; Gulcher, JR; Hakonarson, H; Kong, A; Stefansson, K			A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction	NATURE GENETICS			English	Article							POPULATION-STRUCTURE; ADMIXTURE; 5-LIPOXYGENASE; MYELOPEROXIDASE; INFERENCE	Variants of the gene ALOX5AP ( also known as FLAP) encoding arachidonate 5-lipoxygenase activating protein are known to be associated with risk of myocardial infarction(1). Here we show that a haplotype (HapK) spanning the LTA4H gene encoding leukotriene A4 hydrolase, a protein in the same biochemical pathway as ALOX5AP, confers modest risk of myocardial infarction in an Icelandic cohort. Measurements of leukotriene B4 (LTB4) production suggest that this risk is mediated through upregulation of the leukotriene pathway. Three cohorts from the United States also show that HapK confers a modest relative risk (1.16) in European Americans, but it confers a threefold larger risk in African Americans. About 27% of the European American controls carried at least one copy of HapK, as compared with only 6% of African American controls. Our analyses indicate that HapK is very rare in Africa and that its occurrence in African Americans is due to European admixture. Interactions with other genetic or environmental risk factors that are more common in African Americans are likely to account for the greater relative risk conferred by HapK in this group.	deCODE Genet Inc, IS-101 Reykjavik, Iceland; NCI, Lab Genom Divers, Frederick, MD 21702 USA; Natl Univ Hosp Reykjavik, Reykjavik, Iceland; Emory Univ, Sch Med, Atlanta, GA USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Iceland Heart Assoc, Reykjavik, Iceland; Cleveland Clin Fdn, Cleveland, OH 44195 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Landspitali National University Hospital; Emory University; University of Pennsylvania; Icelandic Heart Association; Cleveland Clinic Foundation	Stefansson, K (corresponding author), deCODE Genet Inc, Sturlugata 8, IS-101 Reykjavik, Iceland.	kstefans@decode.is	Gudnason, Vilmundur/AAE-7126-2019; Stefansson, Kari/AAE-7187-2019; OBRIEN, STEPHEN/ABD-1346-2020; Gudnason, Vilmundur/K-6885-2015; Helgason, Agnar/K-1522-2015; Magnusson, Kristinn P Pétur/X-4907-2019; Hicks, Andrew Anthony/E-9518-2017; Magnusson, Kristinn/A-6479-2011; Manolescu, Andrei/G-4565-2014; Levey, Allan/F-2104-2011	Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Magnusson, Kristinn P Pétur/0000-0003-4528-6826; Hicks, Andrew Anthony/0000-0001-6320-0411; Magnusson, Kristinn/0000-0003-4528-6826; Manolescu, Andrei/0000-0002-0713-4664; Levey, Allan/0000-0002-3153-502X; Topol, Eric/0000-0002-1478-4729; OBRIEN, STEPHEN/0000-0001-7857-0757; Gudbjartsson, Daniel/0000-0002-5222-9857; Grant, Struan/0000-0003-2025-5302; Reilly, Muredach/0000-0002-3035-9386; Helgason, Agnar/0000-0002-8545-3767	NCRR NIH HHS [M01-RR00039] Funding Source: Medline; NHLBI NIH HHS [P50 HL077107-01] Funding Source: Medline; NIEHS NIH HHS [U54 ES012068] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES012068] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ADAMS J, 1973, SCIENCE, V180, P1137, DOI 10.1126/science.180.4091.1137; Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P443, DOI 10.1161/hq0302.105593; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; [Anonymous], 1979, Circulation, V59, P607; Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; Barnholtz-Sloan JS, 2005, CANCER EPIDEM BIOMAR, V14, P1545, DOI 10.1158/1055-9965.EPI-04-0832; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; CHAKRABORTY R, 1992, AM J HUM GENET, V50, P145; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Falush D, 2003, GENETICS, V164, P1567; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Jorde LB, 2004, NAT GENET, V36, pS28, DOI 10.1038/ng1435; LONG JC, 1991, GENETICS, V127, P417; MANTEL N, 1959, J NATL CANCER I, V22, P719; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Reiner AP, 2005, AM J HUM GENET, V76, P463, DOI 10.1086/428654; Royal CDM, 2004, NAT GENET, V36, pS5, DOI 10.1038/ng1454; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096	30	285	301	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					68	74		10.1038/ng1692	http://dx.doi.org/10.1038/ng1692			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16282974				2022-12-17	WOS:000234227200019
J	Leegwater, PAJ; Vermeulen, G; Konst, AAM; Naidu, S; Mulders, J; Visser, A; Kersbergen, P; Mobach, D; Fonds, D; van Berkel, CGM; Lemmers, RJLF; Frants, RR; Oudejans, CBM; Schutgens, RBH; Pronk, JC; van der Knaap, MS				Leegwater, PAJ; Vermeulen, G; Konst, AAM; Naidu, S; Mulders, J; Visser, A; Kersbergen, P; Mobach, D; Fonds, D; van Berkel, CGM; Lemmers, RJLF; Frants, RR; Oudejans, CBM; Schutgens, RBH; Pronk, JC; van der Knaap, MS			Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter	NATURE GENETICS			English	Article							GUANINE-NUCLEOTIDE-EXCHANGE; GLYCOGEN-SYNTHASE KINASE-3; SIGNAL-TRANSDUCTION; EPSILON-SUBUNIT; IDENTIFICATION; EIF2B-EPSILON; INACTIVATION; DOMAINS; INSULIN; YEAST	Leukoencephalopathy with vanishing white matter (VWM) is an inherited brain disease that occurs mainly in children. The course is chronic-progressive with additional episodes of rapid deterioration following febrile infection or minor head trauma. We have identified mutations in EIF2B5 and EIF2B2, encoding the epsilon- and beta -subunits of the translation initiation factor eIF2B and located on chromosomes 3q27 and 14q24, respectively, as causing VWM. We found 16 different mutations in EIF2B5 in 29 patients from 23 families. We also found two distantly related individuals who were homozygous with respect to a missense mutation in EIF2B2, affecting a conserved amino acid. Three other patients also had mutations in EIF2B2. As eIF2B has an essential role in the regulation of translation under different conditions, including stress, this may explain the rapid deterioration of people with VWM under stress. Mutant translation initiation factors have not previously been implicated in disease.	Free Univ Amsterdam, Med Ctr, Dept Human Genet, NL-1081 BT Amsterdam, Netherlands; Free Univ Amsterdam, Med Ctr, Dept Clin Chem, NL-1081 BT Amsterdam, Netherlands; Free Univ Amsterdam, Med Ctr, Dept Child Neurol, NL-1081 BT Amsterdam, Netherlands; Kennedy Krieger Inst, Dept Neurogenet, Baltimore, MD USA; Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Kennedy Krieger Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Pronk, JC (corresponding author), Free Univ Amsterdam, Med Ctr, Dept Human Genet, Van Der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.			Oudejans, Cees/0000-0003-0717-4946; Leegwater, Peter/0000-0002-4100-015X				Anthony TG, 2000, BBA-GENE STRUCT EXPR, V1492, P56, DOI 10.1016/S0167-4781(00)00062-2; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; BOEHNKE M, 1991, AM J HUM GENET, V49, P1174; Clemens MJ, 1996, TRANSLATIONAL CONTRO, P139; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Gomez E, 2000, MOL CELL BIOL, V20, P3965, DOI 10.1128/MCB.20.11.3965-3976.2000; HANEFELD F, 1993, NEUROPEDIATRICS, V24, P244, DOI 10.1055/s-2008-1071551; HINNEBUSCH AG, 1996, TRANSLATIONAL CONTRO, P194; Kleijn M, 1998, EUR J BIOCHEM, V253, P531, DOI 10.1046/j.1432-1327.1998.2530531.x; Leegwater PAJ, 1999, AM J HUM GENET, V65, P728, DOI 10.1086/302548; Pavitt GD, 1998, GENE DEV, V12, P514, DOI 10.1101/gad.12.4.514; Price NT, 1996, BIOCHEM J, V318, P637, DOI 10.1042/bj3180637; Quevedo C, 2000, J BIOL CHEM, V275, P19192, DOI 10.1074/jbc.M000238200; ROWLANDS AG, 1988, J BIOL CHEM, V263, P5526; Scheper GC, 1997, J BIOL CHEM, V272, P26850, DOI 10.1074/jbc.272.43.26850; Scheper GC, 1998, BIOCHEM J, V334, P463, DOI 10.1042/bj3340463; SCHIFFMANN R, 1994, ANN NEUROL, V35, P331, DOI 10.1002/ana.410350314; Singh LP, 1996, BIOCHEMISTRY-US, V35, P3206, DOI 10.1021/bi9522099; van der Knaap MS, 1998, NEUROLOGY, V51, P540, DOI 10.1212/WNL.51.2.540; vanderKnaap MS, 1997, NEUROLOGY, V48, P845, DOI 10.1212/WNL.48.4.845; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2	23	285	303	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					383	388		10.1038/ng764	http://dx.doi.org/10.1038/ng764			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11704758				2022-12-17	WOS:000172507500012
J	Manley, K; Shirley, TL; Flaherty, L; Messer, A				Manley, K; Shirley, TL; Flaherty, L; Messer, A			Msh2 deficiency prevents in vivo somatic instability of the CAG repeat in Huntington disease transgenic mice	NATURE GENETICS			English	Article							TRINUCLEOTIDE-REPEAT; SACCHAROMYCES-CEREVISIAE; (CAG)(N) REPEAT; GENE; DNA; PHENOTYPE; EXPANSION; SPERM; RECOMBINATION; INACTIVATION	Huntington disease (HD), an autosomal dominant, progressive neurodegenerative disorder, is caused by an expanded CAG repeat sequence leading to an increase in the number of glutamine residues in the encoded protein(1). The normal CAG repeat range is 5-36, whereas 38 or more repeats are found in the diseased state; the severity of disease is roughly proportional to the number of CAG repeats(1-5). HD shows anticipation, in which subsequent generations display earlier disease onsets due to intergenerational repeat expansion(1-6). For longer repeat lengths, somatic instability of the repeat size has been observed both in human cases at autopsy(7,8) and in transgenic mouse models containing either a genomic fragment of human HD exon 1 (ref. 9) or an expanded repeat inserted into the endogenous mouse gene Hdh (ref. 10). With increasing repeat number, the protein changes conformation and becomes increasingly prone to aggregation(11), suggesting important functional correlations between repeat length and pathology. Because dinucleotide repeat instability is known to increase when the mismatch repair enzyme MSH2 is missing(12-15), we examined instability of the HD CAC repeat by crossing transgenic mice carrying exon 1 of human HD (ref, 16) with Msh2(-/-) mice(15), Our results show that Msh2 is required for somatic instability of the CAC repeat.	New York State Dept Hlth, Wadsworth Ctr, David Axelrod Inst, Albany, NY USA; SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Messer, A (corresponding author), New York State Dept Hlth, Wadsworth Ctr, David Axelrod Inst, Albany, NY USA.	messer@wadsworth.org			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052822] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 52822] Funding Source: Medline; NINDS NIH HHS [NS37299] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Andrew SE, 1997, HUM MOL GENET, V6, P2005, DOI 10.1093/hmg/6.12.2005; Andrew SE, 1998, P NATL ACAD SCI USA, V95, P1126, DOI 10.1073/pnas.95.3.1126; Baross-Francis A, 1998, P NATL ACAD SCI USA, V95, P8739, DOI 10.1073/pnas.95.15.8739; DEROOIJ KE, 1995, HUM GENET, V95, P270, DOI 10.1007/BF00225192; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Giovannone B, 1997, HUM MUTAT, V10, P458, DOI 10.1002/(SICI)1098-1004(1997)10:6<458::AID-HUMU7>3.0.CO;2-9; Goellner GM, 1997, AM J HUM GENET, V60, P879; Kim SJ, 1997, BIOCHEM BIOPH RES CO, V240, P239, DOI 10.1006/bbrc.1997.7643; LEEFLANG EP, 1995, HUM MOL GENET, V4, P1519; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Manley K, 1999, BRAIN RES, V835, P74, DOI 10.1016/S0006-8993(99)01451-1; Morgan LJ, 1996, MAMM GENOME, V7, P553, DOI 10.1007/s003359900164; Pearson CE, 1997, HUM MOL GENET, V6, P1117, DOI 10.1093/hmg/6.7.1117; Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4; Reitmair AH, 1997, CANCER RES, V57, P3765; Saparbaev M, 1996, GENETICS, V142, P727; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; Sugawara N, 1997, P NATL ACAD SCI USA, V94, P9214, DOI 10.1073/pnas.94.17.9214; TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409; TROTTIER Y, 1994, J MED GENET, V31, P377, DOI 10.1136/jmg.31.5.377; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; ZUHLKE C, 1993, HUM MOL GENET, V2, P2063, DOI 10.1093/hmg/2.12.2063	27	285	290	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1999	23	4					471	473		10.1038/70598	http://dx.doi.org/10.1038/70598			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	261RZ	10581038				2022-12-17	WOS:000084023900027
J	Veldman, T; Vignon, C; Schrock, E; Rowley, JD; Ried, T				Veldman, T; Vignon, C; Schrock, E; Rowley, JD; Ried, T			Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping	NATURE GENETICS			English	Article							TRANSLOCATION; LEUKEMIA	Cytogenetic analysis provides critical information of diagnostic and prognostic importance for haematological malignancies(1,2). In fact, the identification of recurring chromosomal breakpoints in leukaemias and lymphomas has expedited the cloning of genes whose translocation-induced deregulation causes malignant transformation(3,4). The pillar of karyotype analysis rests on chromosome banding techniques that have the distinct advantage that the entire genome can be analysed in a single experiment. However, poorly spread or contracted metaphase chromosomes and highly rearranged karyotypes with numerous marker chromosomes, common in tumour cell preparations, are often difficult to interpret unambiguously and subtle chromosomal aberrations, in particular the exchange of telomeric chromatin or small insertions remain elusive, Fluorescence in situ hybridization (FISH) overcomes some of these limitations, but is mainly utilized to confirm the presence of previously characterized or suspected aberrations(5). We have developed a novel approach, termed spectral karyotyping or SKY6,7 based on the hybridization of 24 fluorescently labelled chromosome painting probes that allows the simultaneous and differential colour display of all human chromosomes. We have used SKY to complement conventional banding techniques in haematological malignancies by analysing 15 cases with unidentified chromosome aberrations. In all instances SKY provided additional cytogenetic information, including the identification of marker chromosomes, the detection of subtle chromosomal translocations and the clarification of complex chromosomal rearrangements. Thus, SKY in combination with standard chromosome banding allows the characterization of chromosomal aberrations in leukaemia with unprecedented accuracy.	NIH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892; UNIV CHICAGO,DEPT MED,HEMATOL ONCOL SECT,CHICAGO,IL 60637	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Chicago					NATIONAL CANCER INSTITUTE [R35CA042557] Funding Source: NIH RePORTER; NCI NIH HHS [CA42557] Funding Source: Medline; PHS HHS [9512-8] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Garini Y., 1996, Bioimaging, V4, P65, DOI 10.1002/1361-6374(199606)4:2<65::AID-BIO4>3.3.CO;2-4; Heim S, 1995, CANC CYTOGENETICS; LeBeau MM, 1996, BLOOD, V88, P1930; LEBEAU MM, 1993, BLOOD, V81, P1979; LEBEAU MM, 1991, ASS CYTOGENETICS TEC, P95; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; Malik Z, 1996, J MICROSC-OXFORD, V182, P133, DOI 10.1046/j.1365-2818.1996.131411.x; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; ROMANA SP, 1994, GENE CHROMOSOME CANC, V9, P186, DOI 10.1002/gcc.2870090307; ROWLEY JD, 1990, CANCER, V65, P2178, DOI 10.1002/1097-0142(19900515)65:10<2178::AID-CNCR2820651004>3.0.CO;2-#; SANDBERG AA, 1990, CHROMOSOMES HUMAN CA; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; TELENIUS H, 1992, GENE CHROMOSOME CANC, V4, P257, DOI 10.1002/gcc.2870040311	14	285	296	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1997	15	4					406	410		10.1038/ng0497-406	http://dx.doi.org/10.1038/ng0497-406			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WQ389	9090389				2022-12-17	WOS:A1997WQ38900022
J	Couch, FJ; Farid, LM; DeShano, ML; Tavtigian, SV; Calzone, K; Campeau, L; Peng, Y; Bogden, B; Chen, Q; Neuhausen, S; ShattuckEidens, D; Godwin, AK; Daly, M; Radford, DM; Sedlacek, S; Rommens, J; Simard, J; Garber, J; Merajver, S; Weber, BL				Couch, FJ; Farid, LM; DeShano, ML; Tavtigian, SV; Calzone, K; Campeau, L; Peng, Y; Bogden, B; Chen, Q; Neuhausen, S; ShattuckEidens, D; Godwin, AK; Daly, M; Radford, DM; Sedlacek, S; Rommens, J; Simard, J; Garber, J; Merajver, S; Weber, BL			BRCA2 germline mutations in male breast cancer cases and breast cancer families	NATURE GENETICS			English	Letter									UNIV PENN,DEPT MED,STELLAR CHANCE LABS 1010,PHILADELPHIA,PA 19104; UNIV PENN,DEPT PATHOL,PHILADELPHIA,PA 19104; MYRIAD GENET INC,SALT LAKE CITY,UT 84108; UNIV UTAH,DEPT GENET EPIDEMIOL,SALT LAKE CITY,UT 84108; FOX CHASE CANC CTR,DEPT MED ONCOL,PHILADELPHIA,PA 19111; WASHINGTON UNIV,SCH MED,DEPT SURG,ST LOUIS,MO 63110; UNIV COLORADO,DEPT MED,DENVER,CO 80220; HOSP SICK CHILDREN,DEPT GENET,TORONTO,ON M5G 1X8,CANADA; UNIV LAVAL,QUEBEC CITY,PQ G1V 4G2,CANADA; CHU LAVAL,RES CTR,DEPT MOLEC ENDOCRINOL,QUEBEC CITY,PQ G1V 4G2,CANADA; DANA FARBER CANC INST,DIV CANC EPIDEMIOL & CONTROL,BOSTON,MA 02115; UNIV MICHIGAN,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV PENN,DEPT GENET,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania; Myriad Genetics, Inc; Utah System of Higher Education; University of Utah; Fox Chase Cancer Center; Washington University (WUSTL); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Laval University; Laval University; Harvard University; Dana-Farber Cancer Institute; University of Michigan System; University of Michigan; University of Pennsylvania				Simard, Jacques/0000-0001-6906-3390; Calzone, Kathleen/0000-0002-2354-6810	NCI NIH HHS [CA09615, R01 CA57601, CA67403] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA067403, R01CA057601, T32CA009615] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		GANGULY A, 1989, P NATL ACAD SCI USA, V86, P2766; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	5	285	290	1	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1996	13	1					123	125		10.1038/ng0596-123	http://dx.doi.org/10.1038/ng0596-123			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH430	8673091				2022-12-17	WOS:A1996UH43000031
J	Curran, JE; Jowett, JBM; Elliott, KS; Gao, Y; Gluschenko, K; Wang, JM; Azim, DMA; Cai, GW; Mahaney, MC; Comuzzie, AG; Dyer, TD; Walder, KR; Zimmet, P; MacCluer, JW; Collier, GR; Kissebah, AH; Blangero, J				Curran, JE; Jowett, JBM; Elliott, KS; Gao, Y; Gluschenko, K; Wang, JM; Azim, DMA; Cai, GW; Mahaney, MC; Comuzzie, AG; Dyer, TD; Walder, KR; Zimmet, P; MacCluer, JW; Collier, GR; Kissebah, AH; Blangero, J			Genetic variation in selenoprotein S influences inflammatory response	NATURE GENETICS			English	Article							ENDOPLASMIC-RETICULUM STRESS; 15Q26 IDDM3; PROTEIN; POPULATION; COMPLEX; RISK; SUSCEPTIBILITY; POLYMORPHISM; METABOLISM; EXPRESSION	Chronic inflammation has a pathological role in many common diseases and is influenced by both genetic and environmental factors. Here we assess the role of genetic variation in selenoprotein S (SEPS1, also called SELS or SELENOS), a gene involved in stress response in the endoplasmic reticulum and inflammation control. After resequencing SEPS1, we genotyped 13 SNPs in 522 individuals from 92 families. As inflammation biomarkers, we measured plasma levels of IL-6, IL-1 beta and TNF-alpha. Bayesian quantitative trait nucleotide analysis identified associations between SEPS1 polymorphisms and all three proinflammatory cytokines. One promoter variant, -105G-->A, showed strong evidence for an association with each cytokine (multivariate P = 0.0000002). Functional analysis of this polymorphism showed that the A variant significantly impaired SEPS1 expression after exposure to endoplasmic reticulum stress agents (P = 0.00006). Furthermore, suppression of SEPS1 by short interfering RNA in macrophage cells increased the release of IL-6 and TNF-alpha. To investigate further the significance of the observed associations, we genotyped -105G-->A in 419 Mexican American individuals from 23 families for replication. This analysis confirmed a significant association with both TNF-alpha (P = 0.0049) and IL- 1 beta (P = 0.0101). These results provide a direct mechanistic link between SEPS1 and the production of inflammatory cytokines and suggest that SEPS1 has a role in mediating inflammation.	SW Fdn Biomed Res, San Antonio, TX 78227 USA; Int Diabet Inst, Caulfield, Vic, Australia; ChemGenex Pharmaceut, Geelong, Vic, Australia; Deakin Univ, Sch Hlth Sci, Metab Res Unit, Waurn Ponds, Vic, Australia	Texas Biomedical Research Institute; Deakin University	Blangero, J (corresponding author), SW Fdn Biomed Res, San Antonio, TX 78227 USA.	john@darwin.sfbr.org	Jowett, Jeremy/A-3809-2009; Zimmet, Paul/O-8486-2019; Blangero, John/ABA-7175-2021	Zimmet, Paul/0000-0003-0627-0776; Curran, Joanne/0000-0002-6898-155X				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Arthur JR, 2003, P NUTR SOC, V62, P393, DOI 10.1079/PNS2003254; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Blangero J, 2003, J THROMB HAEMOST, V1, P1391, DOI 10.1046/j.1538-7836.2003.00310.x; BLANGERO J, IN PRESS HUM BIOL; Buetow KH, 2001, P NATL ACAD SCI USA, V98, P581, DOI 10.1073/pnas.021506298; Caspersen C, 2000, J BIOL CHEM, V275, P22363, DOI 10.1074/jbc.M001569200; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; de Maat MPM, 2004, ARTERIOSCL THROM VAS, V24, P2168, DOI 10.1161/01.ATV.0000143856.01669.e7; Ferencik M, 2003, FOLIA MICROBIOL, V48, P417, DOI 10.1007/BF02931378; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; Gao Y, 2004, FEBS LETT, V563, P185, DOI 10.1016/S0014-5793(04)00296-0; Gao Y, 2003, DIABETES, V52, P929, DOI 10.2337/diabetes.52.4.929; Karlsson HKR, 2004, DIABETES, V53, P1424, DOI 10.2337/diabetes.53.6.1424; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Long AD, 1998, GENETICS, V149, P999; MacCluer JW, 1999, NUTR REV, V57, pS59, DOI 10.1111/j.1753-4887.1999.tb01790.x; Pahl HL, 1997, TRENDS BIOCHEM SCI, V22, P63, DOI 10.1016/S0968-0004(96)10073-6; Pantsulaia I, 2002, CYTOKINE, V19, P138, DOI 10.1006/cyto.2002.1959; Phillips PC, 1999, TRENDS GENET, V15, P6, DOI 10.1016/S0168-9525(98)01622-9; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Saadeddin Salam M, 2002, Med Sci Monit, V8, pRA5; Stengard JH, 2002, AM J HUM GENET, V71, P501, DOI 10.1086/342217; Susi M, 2001, SCAND J GASTROENTERO, V36, P372, DOI 10.1080/003655201300051153; Walder K, 2002, DIABETES, V51, P1859, DOI 10.2337/diabetes.51.6.1859; Williams-Blangero S, 2004, HUM BIOL, V76, P515, DOI 10.1353/hub.2004.0062; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zamani M, 1996, HUM GENET, V98, P491, DOI 10.1007/s004390050245	35	284	297	3	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1234	1241		10.1038/ng1655	http://dx.doi.org/10.1038/ng1655			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16227999				2022-12-17	WOS:000233045200023
J	Descargues, P; Deraison, C; Bonnart, C; Kreft, M; Kishibe, M; Ishida-Yamamoto, A; Elias, P; Barrandon, Y; Zambruno, G; Sonnenberg, A; Hovnanian, A				Descargues, P; Deraison, C; Bonnart, C; Kreft, M; Kishibe, M; Ishida-Yamamoto, A; Elias, P; Barrandon, Y; Zambruno, G; Sonnenberg, A; Hovnanian, A			Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity	NATURE GENETICS			English	Article							SERINE PROTEINASE-INHIBITOR; CORNEUM CHYMOTRYPTIC ENZYME; STRATUM-CORNEUM; BARRIER FUNCTION; PERMEABILITY BARRIER; SUBTILISIN-A; LEKTI; EXPRESSION; SKIN; DESQUAMATION	Mutations in SPINK5, encoding the serine protease inhibitor LEKTI, cause Netherton syndrome, a severe autosomal recessive genodermatosis. Spink5(-/-) mice faithfully replicate key features of Netherton syndrome, including altered desquamation, impaired keratinization, hair malformation and a skin barrier defect. LEKTI deficiency causes abnormal desmosome cleavage in the upper granular layer through degradation of desmoglein 1 due to stratum corneum tryptic enzyme and stratum corneum chymotryptic enzyme-like hyperactivity. This leads to defective stratum corneum adhesion and resultant loss of skin barrier function. Profilaggrin processing is increased and implicates LEKTI in the cornification process. This work identifies LEKTI as a key regulator of epidermal protease activity and degradation of desmoglein 1 as the primary pathogenic event in Netherton syndrome.	Univ Toulouse 3, INSERM, U563, F-31059 Toulouse 3, France; Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; Asahikawa Med Coll, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan; Univ Calif San Francisco, Vet Affairs Med Ctr, Dept Dermatol, San Francisco, CA 94121 USA; Swiss Fed Inst Technol, Sch Life Sci, Lab Stem Cell Dynam, CH-1015 Lausanne, Switzerland; IRCCS, Ist Dermopat Immacolata, Lab Mol & Cell Biol, I-00167 Rome, Italy; Hop Purpan, Dept Med Genet, F-31059 Toulouse 3, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Netherlands Cancer Institute; Asahikawa Medical College; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; IRCCS Istituto Dermopatico dell'Immacolata (IDI); CHU de Toulouse	Hovnanian, A (corresponding author), Univ Toulouse 3, INSERM, U563, Pl Dr Baylac, F-31059 Toulouse 3, France.	alain.hovnanian@toulouse.inserm.fr	Hovnanian, Alain/I-4711-2017; Zambruno, Giavanna/K-2933-2018; deraison, celine/P-6255-2016; BONNART, Chrystelle/A-1309-2011	Hovnanian, Alain/0000-0003-3412-7512; deraison, celine/0000-0002-9013-4592; Zambruno, Giovanna/0000-0002-1295-056X				Amagai M, 2000, NAT MED, V6, P1275, DOI 10.1038/81385; BARRANDON Y, 1988, J INVEST DERMATOL, V91, P315, DOI 10.1111/1523-1747.ep12475646; Bernard BA, 2003, J AM ACAD DERMATOL, V48, pS120, DOI 10.1067/mjd.2003.279; Bitoun E, 2003, HUM MOL GENET, V12, P2417, DOI 10.1093/hmg/ddg247; Bitoun E, 2002, J INVEST DERMATOL, V118, P352, DOI 10.1046/j.1523-1747.2002.01603.x; Brattsand M, 1999, J BIOL CHEM, V274, P30033, DOI 10.1074/jbc.274.42.30033; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; COMEL M, 1949, Dermatologica, V98, P133; deWolf K, 1996, DERMATOLOGY, V192, P400, DOI 10.1159/000246431; Ding X, 1999, J INVEST DERMATOL, V112, P739, DOI 10.1046/j.1523-1747.1999.00585.x; Ekholm IE, 2000, J INVEST DERMATOL, V114, P56, DOI 10.1046/j.1523-1747.2000.00820.x; ELIAS PM, 1991, ADV LIPID RES, V24, P1; ELIAS PM, 2004, J INVEST DERMATOL, V122, pR6; Fartasch M, 1999, ARCH DERMATOL, V135, P823, DOI 10.1001/archderm.135.7.823; Franzke CW, 1996, J BIOL CHEM, V271, P21886, DOI 10.1074/jbc.271.36.21886; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; HANSSON L, 1994, J BIOL CHEM, V269, P19420; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Hausser I, 1996, PEDIATR DERMATOL, V13, P183, DOI 10.1111/j.1442-200X.1996.tb02615.x; ISHIDAYAMAMOTO A, IN PRESS J INVEST DE; ITO M, 1984, J INVEST DERMATOL, V83, P1, DOI 10.1111/1523-1747.ep12261618; Jayakumar A, 2004, PROTEIN EXPRES PURIF, V35, P93, DOI 10.1016/j.pep.2003.12.004; JUDGE MR, 1994, BRIT J DERMATOL, V131, P615, DOI 10.1111/j.1365-2133.1994.tb04971.x; Kljuic A, 2003, EXP DERMATOL, V12, P20, DOI 10.1034/j.1600-0625.2003.120103.x; Komatsu N, 2002, J INVEST DERMATOL, V118, P436, DOI 10.1046/j.0022-202x.2001.01663.x; Kreutzmann P, 2004, J CHROMATOGR B, V803, P75, DOI 10.1016/j.jchromb.2003.07.016; Kuramoto N, 2002, J CLIN INVEST, V109, P243, DOI 10.1172/JCI13563; Levy-Nissenbaum E, 2003, NAT GENET, V34, P151, DOI 10.1038/ng1163; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; Magert HJ, 2002, INT J BIOCHEM CELL B, V34, P573, DOI 10.1016/S1357-2725(01)00179-0; Magert HJ, 2002, EUR J MED RES, V7, P49; Mitsudo K, 2003, BIOCHEMISTRY-US, V42, P3874, DOI 10.1021/bi027029v; NETHERTON EW, 1958, ARCH DERMATOL, V78, P483, DOI 10.1001/archderm.1958.01560100059009; Pulkkinen L, 2003, EXP DERMATOL, V12, P11, DOI 10.1034/j.1600-0625.2003.120102.x; Raghunath M, 2004, J INVEST DERMATOL, V123, P474, DOI 10.1111/j.0022-202X.2004.23220.x; RESING KA, 1984, J CELL BIOL, V99, P1372, DOI 10.1083/jcb.99.4.1372; Scheimberg I, 1996, PEDIATR PATHOL LAB M, V16, P359, DOI 10.1080/15513819609168677; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Simon M, 1997, J BIOL CHEM, V272, P31770, DOI 10.1074/jbc.272.50.31770; SMITH DL, 1995, BRIT J DERMATOL, V133, P153; Sprecher E, 2001, J INVEST DERMATOL, V117, P179, DOI 10.1046/j.1523-1747.2001.01389.x; STEVANOVIC DV, 1969, BRIT J DERMATOL, V81, P851, DOI 10.1111/j.1365-2133.1969.tb15956.x; SUZUKI Y, 1994, ARCH DERMATOL RES, V286, P249, DOI 10.1007/BF00387596; TRAUPE H, 1989, ICHTYOSIS GUIDE CLIN; Van Gysel D, 2001, DERMATOLOGY, V202, P99, DOI 10.1159/000051607; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; Yang T, 2004, GENE DEV, V18, P2354, DOI 10.1101/gad.1232104	50	284	293	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2005	37	1					56	65		10.1038/ng1493	http://dx.doi.org/10.1038/ng1493			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	15619623				2022-12-17	WOS:000225997500021
J	Khokha, MK; Hsu, D; Brunet, LJ; Dionne, MS; Harland, RM				Khokha, MK; Hsu, D; Brunet, LJ; Dionne, MS; Harland, RM			Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning	NATURE GENETICS			English	Article							APICAL ECTODERMAL RIDGE; SONIC-HEDGEHOG; VERTEBRATE LIMB; FEEDBACK LOOP; DEFORMITY GENE; GROWTH; OUTGROWTH; INDUCTION; PROTEINS; FAMILY	During limb outgrowth, signaling by bone morphogenetic proteins (BMPs) must be moderated to maintain the signaling loop between the zone of polarizing activity (ZPA) and the apical ectodermal ridge (AER). Gremlin, an extracellular BMP antagonist, has been proposed to fulfill this function and therefore be important in limb patterning. We tested this model directly by mutating the mouse gene encoding gremlin (Cktsf1b1, herein called gremlin). In the mutant limb, the feedback loop between the ZPA and the AER is interrupted, resulting in abnormal skeletal pattern. We also show that the gremlin mutation is allelic to the limb deformity mutation (ld). Although BMPs and their antagonists have multiple roles in limb development, these experiments show that gremlin is the principal BMP antagonist required for early limb outgrowth and patterning.	Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA; Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA	University of California System; University of California Berkeley; Stanford University	Harland, RM (corresponding author), Univ Calif Berkeley, Dept Cell & Mol Biol, 401 Barker Hall, Berkeley, CA 94720 USA.	harland@socrates.berkeley.edu	Dionne, Marc/J-2572-2013	Dionne, Marc/0000-0002-8283-1750				Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; CHAN DC, 1995, DEVELOPMENT, V121, P3151; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; Dionne MS, 2001, MOL CELL BIOL, V21, P636, DOI 10.1128/MCB.21.2.636-643.2001; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; Kuhlman J, 1997, DEVELOPMENT, V124, P133; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; MAAS RL, 1990, NATURE, V346, P853, DOI 10.1038/346853a0; Marigo V, 1996, DEVELOPMENT, V122, P1225; Merino R, 1999, DEVELOPMENT, V126, P2161; Merino R, 1999, DEVELOPMENT, V126, P5515; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; NISWANDER L, 1993, NATURE, V361, P68, DOI 10.1038/361068a0; Pearce JJH, 1999, DEV BIOL, V209, P98, DOI 10.1006/dbio.1999.9240; Pizette S, 1999, DEVELOPMENT, V126, P883; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Saunders J. W., 1968, EPITHELIAL MESENCHYM, P78; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; VOGT TF, 1992, MAMM GENOME, V3, P431, DOI 10.1007/BF00356152; Wang CC, 1997, GENOMICS, V39, P303, DOI 10.1006/geno.1996.4519; WOYCHIK RP, 1990, NATURE, V346, P850, DOI 10.1038/346850a0; ZELLER R, 1989, GENE DEV, V3, P1481, DOI 10.1101/gad.3.10.1481; Zhang DH, 2002, J BONE MINER RES, V17, P293, DOI 10.1359/jbmr.2002.17.2.293; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	30	284	298	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2003	34	3					303	307		10.1038/ng1178	http://dx.doi.org/10.1038/ng1178			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12808456				2022-12-17	WOS:000183815300018
J	Seitz, H; Youngson, N; Lin, SP; Dalbert, S; Paulsen, M; Bachellerie, JP; Ferguson-Smith, AC; Cavaille, J				Seitz, H; Youngson, N; Lin, SP; Dalbert, S; Paulsen, M; Bachellerie, JP; Ferguson-Smith, AC; Cavaille, J			Imprinted microRNA genes transcribed antisense to a reciprocally imprinted retrotransposon-like gene	NATURE GENETICS			English	Article							IDENTIFICATION; DOMAIN; RNA; METHYLATION; TARGETS; AIR	MicroRNAs (miRNAs) are an abundant class of RNAs that are similar to21-25 nucleotides (nt) long, interact with mRNAs and trigger either translation repression or RNA cleavage (RNA interference, RNAi) depending on the degree of complementarity with their targets. Here we show that the imprinted mouse distal chromosome 12 locus encodes two miRNA genes expressed from the maternally inherited chromosome and antisense to a retrotransposon-like gene (Rtl1) expressed only from the paternal allele.	Univ Toulouse 3, LBME, CNRS UMR 5099, IFR 109, F-31062 Toulouse, France; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Univ Saarland, FR Genet, Postfach 151150, D-66041 Saarbrucken, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Cambridge; Saarland University	Cavaille, J (corresponding author), Univ Toulouse 3, LBME, CNRS UMR 5099, IFR 109, 118 Route Narbonne, F-31062 Toulouse, France.		Ferguson-Smith, Anne C/G-7534-2011; cavaille, jerome/AAM-8047-2020; Paulsen, Martina/G-2262-2010; Seitz, Hervé/AAE-6487-2019; Youngson, Neil/AAB-7389-2019	Seitz, Hervé/0000-0001-8172-5393; Youngson, Neil/0000-0003-0690-4580; CAVAILLE, Jerome/0000-0003-2833-6836; Lin, Shau-Ping/0000-0003-3423-991X; Ferguson-Smith, Anne/0000-0002-7608-5894				Cavaille J, 2002, HUM MOL GENET, V11, P1527, DOI 10.1093/hmg/11.13.1527; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; NEUMANN B, 1995, NAT GENET, V9, P12, DOI 10.1038/ng0195-12; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rougeulle C, 2002, TRENDS GENET, V18, P434, DOI 10.1016/S0168-9525(02)02749-X; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	13	284	313	1	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2003	34	3					261	262		10.1038/ng1171	http://dx.doi.org/10.1038/ng1171			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12796779				2022-12-17	WOS:000183815300010
J	Reboul, J; Vaglio, P; Rual, JF; Lamesch, P; Martinez, M; Armstrong, CM; Li, SM; Jacotot, L; Bertin, N; Janky, R; Moore, T; Hudson, JR; Hartley, JL; Brasch, MA; Vandenhaute, J; Boulton, S; Endress, GA; Jenna, S; Chevet, E; Papasotiropoulos, V; Tolias, PP; Ptacek, J; Snyder, M; Huang, R; Chance, MR; Lee, HM; Doucette-Stamm, L; Hill, DE; Vidal, M				Reboul, J; Vaglio, P; Rual, JF; Lamesch, P; Martinez, M; Armstrong, CM; Li, SM; Jacotot, L; Bertin, N; Janky, R; Moore, T; Hudson, JR; Hartley, JL; Brasch, MA; Vandenhaute, J; Boulton, S; Endress, GA; Jenna, S; Chevet, E; Papasotiropoulos, V; Tolias, PP; Ptacek, J; Snyder, M; Huang, R; Chance, MR; Lee, HM; Doucette-Stamm, L; Hill, DE; Vidal, M			C-elegans ORFeome version 1.1: experimental verification of the genome annotation and resource for proteome-scale protein expression	NATURE GENETICS			English	Article							GENES; IDENTIFICATION; MICROARRAYS; CLONING	To verify the genome annotation and to create a resource to functionally characterize the proteome, we attempted to Gateway-clone all predicted protein-encoding open reading frames (ORFs), or the 'ORFeome,' of Caenorhabditis elegans. We successfully cloned approximately 12,000 ORFs (ORFeome 1.1), of which roughly 4,000 correspond to genes that are untouched by any cDNA or expressed-sequence tag (EST). More than 50% of predicted genes needed corrections in their intron-exon structures. Notably, approximately 11,000 C. elegans proteins can now be expressed under many conditions and characterized using various high-throughput strategies, including large-scale interactome mapping. We suggest that similar ORFeome projects will be valuable for other organisms, including humans.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Fac Univ Notre Dame Paix, Unite Rech Biol Mol, B-5000 Namur, Belgium; Res Genet Invitrogen, Huntsville, AL USA; Life Technol Invitrogen, Rockville, MD USA; Protedyne Crop, Windsor, CT 06095 USA; McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada; Publ Hlth Res Inst, Ctr Appl Genom, Newark, NJ 07103 USA; Yale Univ, New Haven, CT 06520 USA; Albert Einstein Coll Med, Ctr Synchrotron Biosci, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; Genome Therapeut, Waltham, MA 02453 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; University of Namur; Thermo Fisher Scientific; McGill University; Yale University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Vidal, M (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	marc_vidal@dfci.harvard.edu	Hill, David E/B-6617-2011; Bertin, Nicolas/O-9602-2019; Reboul, Jerome/P-9103-2016; chevet, eric/E-4992-2016; Bertin, Nicolas/C-3025-2008	Reboul, Jerome/0000-0002-5513-4546; chevet, eric/0000-0001-5855-4522; Bertin, Nicolas/0000-0002-9835-9606; Papasotiropoulos, Vasileios/0000-0002-0292-6793; Vaglio, Philippe/0000-0003-2900-5596; Janky, Rekin's/0000-0001-5135-2469; Rual, Jean-Francois/0000-0003-4465-8819; Huang, Raymond/0000-0001-7661-797X				Blandin G, 2000, FEBS LETT, V487, P31, DOI 10.1016/S0014-5793(00)02275-4; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Davy A, 2001, EMBO REP, V2, P821, DOI 10.1093/embo-reports/kve184; Gera JF, 2002, METHOD ENZYMOL, V350, P499, DOI 10.1016/S0076-6879(02)50981-2; Hammarstrom M, 2002, PROTEIN SCI, V11, P313, DOI 10.1110/ps.22102; Harrison PM, 2001, NUCLEIC ACIDS RES, V29, P818, DOI 10.1093/nar/29.3.818; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hazbun TR, 2001, P NATL ACAD SCI USA, V98, P4277, DOI 10.1073/pnas.091096398; Hillier L, 1991, PCR Methods Appl, V1, P124; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; KINOSHITA N, 1995, CELL, V83, P621, DOI 10.1016/0092-8674(95)90102-7; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MacBeath G, 2000, SCIENCE, V289, P1760; Mardis E, 2002, GENOME RES, V12, P669, DOI 10.1101/gr.032102; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Oshiro G, 2002, GENOME RES, V12, P1210, DOI 10.1101/gr.226802; Reboul J, 2001, NAT GENET, V27, P332, DOI 10.1038/85913; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Vaglio P, 2003, NUCLEIC ACIDS RES, V31, P237, DOI 10.1093/nar/gkg092; Vidal M, 2001, CELL, V104, P333, DOI 10.1016/S0092-8674(01)00221-5; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114	30	284	314	0	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2003	34	1					35	41		10.1038/ng1140	http://dx.doi.org/10.1038/ng1140			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12679813				2022-12-17	WOS:000182667900014
J	Clifton-Bligh, RJ; Wentworth, JM; Heinz, P; Crisp, MS; John, R; Lazarus, JH; Ludgate, M; Chatterjee, VK				Clifton-Bligh, RJ; Wentworth, JM; Heinz, P; Crisp, MS; John, R; Lazarus, JH; Ludgate, M; Chatterjee, VK			Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia	NATURE GENETICS			English	Article							ENHANCER-BINDING PROTEIN; CONGENITAL HYPOTHYROIDISM; IDENTIFICATION; PROMOTER; HORMONE; MOUSE; TRANSCRIPTION; HOMEODOMAIN; PITUITARY; RECEPTOR	Congenital hypothyroidism occurs in one of every three to four thousand newborns, owing to complete or partial failure of thyroid gland development(1). Although thyroid hypoplasia has recently been associated with mutations in the thyrotropin (TSH) receptor(2,3), the cause of thyroid agenesis is unknown. Proteins including thyroid transcription factors 1 (TTF-l; refs 4,5) and 2 (TTF-2; refs 6,7) and Pax8 (refs 8,9) are abundant in the developing mouse thyroid and are known to regulate genes expressed during its differentiation (for example, thyroid peroxidase and thyroglobulin genes). TTF-2 is a member of the forkhead/winged-helix domain transcription factor family, many of which are key regulators of embryogenesis(10). Here we report that the transcription factor FKHL15 (ref. 11) is the human homologue of mouse TTF-2 (encoded by the Titf2 gene) and that two siblings with thyroid agenesis, cleft palate and choanal atresia(12) are homozygous for a missense mutation (Ala65Val) within its forkhead domain. The mutant protein exhibits impaired DNA binding and loss of transcriptional function. Our observations represent the first description of a genetic cause for thyroid agenesis.	Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; Neath Gen Hosp, Dept Paediat, Neath SA11 2LQ, Wales; Univ Wales Hosp, Dept Pathol, Cardiff CF4 4XN, S Glam, Wales; Univ Wales Hosp, Dept Med, Cardiff CF4 4XN, S Glam, Wales; Univ Wales Hosp, Dept Med Biochem, Cardiff CF4 4XN, S Glam, Wales	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cardiff University; Cardiff University; Cardiff University	Chatterjee, VK (corresponding author), Addenbrookes Hosp, Dept Med, Level 5, Cambridge CB2 2QQ, England.	kkc1@mole.bio.cam.ac.uk	Lazarus, John H/H-5108-2017	Lazarus, John H/0000-0001-8852-704X; Chatterjee, Vengalil Krishna/0000-0002-2654-8854; Ludgate, Marian/0000-0002-7436-0821; Wentworth, John/0000-0002-5197-3529; Clifton-Bligh, Roderick/0000-0002-1545-0368	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abramowicz MJ, 1997, J CLIN INVEST, V99, P3018, DOI 10.1172/JCI119497; ADAMS M, 1994, J CLIN INVEST, V94, P506, DOI 10.1172/JCI117362; Ahlbom BE, 1997, HUM GENET, V99, P186, DOI 10.1007/s004390050335; AZABLANC P, 1993, MOL ENDOCRINOL, V7, P1297, DOI 10.1210/me.7.10.1297; BAMFORTH JS, 1989, J MED GENET, V26, P49, DOI 10.1136/jmg.26.1.49; Biebermann H, 1997, NEW ENGL J MED, V336, P1390, DOI 10.1056/NEJM199705083361914; Chadwick BP, 1997, GENOMICS, V41, P390, DOI 10.1006/geno.1997.4692; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DEFELICE M, 1998, NATURE GENET; Devriendt K, 1998, NEW ENGL J MED, V338, P1317, DOI 10.1056/NEJM199804303381817; FRANCISLANG H, 1992, MOL CELL BIOL, V12, P576, DOI 10.1128/MCB.12.2.576; GRANT DB, 1992, ARCH DIS CHILD, V67, P87, DOI 10.1136/adc.67.1.87; GRANT DB, 1988, BRIT MED J, V296, P1355, DOI 10.1136/bmj.296.6633.1355; GUAZZI S, 1990, EMBO J, V9, P3631, DOI 10.1002/j.1460-2075.1990.tb07574.x; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Lapi P, 1997, THYROID, V7, P383, DOI 10.1089/thy.1997.7.383; LAZARUS JH, 1988, LANCET, V2, P52; Macchia PE, 1998, NAT GENET, V19, P83, DOI 10.1038/ng0598-83; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; MIZUNO K, 1991, MOL CELL BIOL, V11, P4927, DOI 10.1128/MCB.11.10.4927; Perna MG, 1997, THYROID, V7, P377, DOI 10.1089/thy.1997.7.377; PLACHOV D, 1990, DEVELOPMENT, V110, P643; Roberts HE, 1997, AM J MED GENET, V71, P29, DOI 10.1002/(SICI)1096-8628(19970711)71:1<29::AID-AJMG5>3.0.CO;2-L; SAMUELS HH, 1974, J CLIN INVEST, V54, P853, DOI 10.1172/JCI107825; STEIN SA, 1994, MOL ENDOCRINOL, V8, P129, DOI 10.1210/me.8.2.129; WOOD WM, 1989, J BIOL CHEM, V264, P14840; Zannini M, 1997, EMBO J, V16, P3185, DOI 10.1093/emboj/16.11.3185; ZANNINI M, 1992, MOL CELL BIOL, V12, P4230, DOI 10.1128/MCB.12.9.4230	29	284	301	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1998	19	4					399	401		10.1038/1294	http://dx.doi.org/10.1038/1294			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697705				2022-12-17	WOS:000075107600027
J	Huang, LP; Gitschier, J				Huang, LP; Gitschier, J			A novel gene involved in zinc transport is deficient in the lethal milk mouse	NATURE GENETICS			English	Article							ACRODERMATITIS-ENTEROPATHICA; SACCHAROMYCES-CEREVISIAE; MUTATION; PROTEIN; RESISTANCE; EXPRESSION; METABOLISM; OTOLITH; DISEASE; SYSTEM	We have identified the gene responsible for the inherited zinc deficiency in the lethal milk (lm) mouse. The gene, here designated Znt4, encodes a 430-amino-acid protein that is homologous to two proteins, ZnT2 and ZnT3, responsible for sequestration of zinc into endosomal/lysosomal compartments and synaptic vesicles, respectively. We show that the Znt4 gene confers zinc resistance to a zinc-sensitive yeast strain and that it is abundantly expressed in the mammary epithelia and brain. The lethal milk mutant: has a nonsense mutation at arginine codon 297 in the Znt4 gene.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco								ACKLAND ML, 1992, J NUTR, V122, P1214, DOI 10.1093/jn/122.6.1214; CHAPLIN DD, 1994, CURRENT PROTOCOLS MO; CONKLIN DS, 1992, MOL CELL BIOL, V12, P3678, DOI 10.1128/MCB.12.9.3678; DICKIE MM, 1969, MOUSE NEWS LETT, V41, P30; ECKHERT CD, 1977, SCIENCE, V195, P789, DOI 10.1126/science.836589; ERWAY LC, 1984, J HERED, V75, P480, DOI 10.1093/oxfordjournals.jhered.a109990; Glover M T, 1988, Pediatr Dermatol, V5, P10, DOI 10.1111/j.1525-1470.1988.tb00877.x; GREEN MC, 1973, MOUSE NEWS LETT, V49, P32; Gwynn B., 1996, Molecular Biology of the Cell, V7, p550A; KAMIZONO A, 1989, MOL GEN GENET, V219, P161, DOI 10.1007/BF00261172; KURAMOTO Y, 1991, SEMIN DERMATOL, V10, P309; LEE DY, 1992, J NUTR, V122, P2233, DOI 10.1093/jn/122.11.2233; Lyon M., 1989, GENETIC VARIANTS STR; MOYNAHAN EJ, 1974, LANCET, V2, P399; NIES DH, 1989, P NATL ACAD SCI USA, V86, P7351, DOI 10.1073/pnas.86.19.7351; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; PALMITER RD, 1995, EMBO J, V14, P633; PILETZ JE, 1978, AM J CLIN NUTR, V31, P560, DOI 10.1093/ajcn/31.4.560; PILETZ JE, 1978, SCIENCE, V199, P181, DOI 10.1126/science.619449; PURICHIA N, 1972, DEV BIOL, V27, P395, DOI 10.1016/0012-1606(72)90178-9; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; Roberts E, 1931, SCIENCE, V74, P569, DOI 10.1126/science.74.1927.569; ROBINSON PJ, 1981, IMMUNOGENETICS, V14, P449, DOI 10.1007/BF00373326; Siracusa LD, 1996, MAMM GENOME, V6, pS51; Theophilos MB, 1996, HUM MOL GENET, V5, P1619, DOI 10.1093/hmg/5.10.1619; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; VANWOUWE JP, 1989, EUR J PEDIATR, V149, P2, DOI 10.1007/BF02024322; VONHEIJNE G, 1994, ANNU REV BIOPH BIOM, V23, P167; WHITE RA, 1992, NAT GENET, V2, P80, DOI 10.1038/ng0992-80; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454; ZHAO H, 1996, J BIOL CHEM, V271, P23202	32	284	301	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					292	297		10.1038/ng1197-292	http://dx.doi.org/10.1038/ng1197-292			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354792				2022-12-17	WOS:A1997YD66700022
J	QUANE, KA; HEALY, JMS; KEATING, KE; MANNING, BM; COUCH, FJ; PALMUCCI, LM; DORIGUZZI, C; FAGERLUND, TH; BERG, K; ORDING, H; BENDIXEN, D; MORTIER, W; LINZ, U; MULLER, CR; MCCARTHY, TV				QUANE, KA; HEALY, JMS; KEATING, KE; MANNING, BM; COUCH, FJ; PALMUCCI, LM; DORIGUZZI, C; FAGERLUND, TH; BERG, K; ORDING, H; BENDIXEN, D; MORTIER, W; LINZ, U; MULLER, CR; MCCARTHY, TV			MUTATIONS IN THE RYANODINE RECEPTOR GENE IN CENTRAL CORE DISEASE AND MALIGNANT HYPERTHERMIA	NATURE GENETICS			English	Article							MUSCLE SARCOPLASMIC-RETICULUM; POLYMERASE CHAIN-REACTION; RELEASE CHANNEL; MOLECULAR-CLONING; SUSCEPTIBILITY; CHROMOSOME-19; POLYMORPHISMS; LOCUS; DNA	Central core disease (CCD) of muscle is an inherited myopathy which is closely associated with malignant hyperthermia (MH) in humans. CCD has recently been shown to be tightly linked to the ryanodine receptor gene (RYR1) and mutations in this gene are known to be present in MH. Mutation screening of RYR1 has led to the identification of two previously undescribed mutations in different CCD pedigrees. One of these mutations was also detected in an unrelated MH pedigree whose members are asymptomatic of CCD. The data suggest a model to explain how a single mutation may result in two apparently distinct clinical phenotypes.	NATL UNIV IRELAND UNIV COLL CORK,DEPT BIOCHEM,CORK,IRELAND; ULLEVAL UNIV HOSP,DEPT ANAESTHESIA,N-0407 OSLO,NORWAY; UNIV COPENHAGEN,HERLEV HOSP,DK-2730 HERLEV,DENMARK; UNIV OSLO,ULLEVAL HOSP,INST MED GENET,DEPT MED GENET,OSLO 1,NORWAY; KLINIKEN STADT WUPPERTAL,KINDERKLIN,W-5600 WUPPERTAL,GERMANY; UNIV WURZBURG,BIOCTR,DEPT HUMAN GENET,W-8700 WURZBURG,GERMANY; UNIV TURIN,CTR MALATTIE NEUROMUSCOLARI PAOLO PETROLO,NEUROL CLIN 2,I-10126 TURIN,ITALY	University College Cork; University of Oslo; University of Copenhagen; Herlev & Gentofte Hospital; University of Oslo; University of Wurzburg; University of Turin			Healy, Sandra J/D-5256-2013					BRITT BA, 1987, MALIGNANT HYPERTHERM, P325; BYRNE E, 1982, J NEUROL SCI, V53, P77, DOI 10.1016/0022-510X(82)90081-8; CARPENTER S, 1984, PATHOLOGY SKELETAL M, P434; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DENBOROUGH MA, 1973, BMJ-BRIT MED J, V1, P272, DOI 10.1136/bmj.1.5848.272; DEUFEL T, 1992, AM J HUM GENET, V50, P1153; DUBOWITZ V, 1973, MAJOR PROBLEMS NEURO, P92; DUBOWITZ V, 1970, BRAIN, V93, P138; ELLIS FR, 1985, RECENT ADV ANAESTHES, V15, P173; ENG GD, 1978, ARCH NEUROL-CHICAGO, V35, P189, DOI 10.1001/archneur.1978.00500280007002; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; GILLARD EF, 1992, GENOMICS, V13, P1247, DOI 10.1016/0888-7543(92)90042-Q; GRONERT GA, 1986, MYOLOGY, V2, P1763; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HAAN EA, 1990, HUM GENET, V86, P187; HAKAMATA Y, 1992, FEBS LETT, V312, P229, DOI 10.1016/0014-5793(92)80941-9; HAYASHI K, 1989, MUSCLE NERVE, V12, P95, DOI 10.1002/mus.880120203; ISAACS H, 1975, J NEUROL NEUROSUR PS, V38, P1177, DOI 10.1136/jnnp.38.12.1177; KRIVOSICHORBER R, 1989, PRESSE MED, V18, P828; LEVITT RC, 1991, GENOMICS, V11, P543, DOI 10.1016/0888-7543(91)90061-I; LEVITT RC, 1992, GENOMICS, V14, P562, DOI 10.1016/S0888-7543(05)80152-1; MACKENZIE AE, 1990, AM J HUM GENET, V46, P1082; MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759; MORGANHUGHES JA, 1973, BRAIN, V96, P527, DOI 10.1093/brain/96.3.527; MULLEY JC, 1993, AM J HUM GENET, V52, P398; Old J. M, 1983, METHODS HAEMATOLOGY, P74; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OTSU K, 1990, J BIOL CHEM, V265, P13472; PALMUCCI L, 1978, J NEUROL, V218, P55, DOI 10.1007/BF00314719; SCHULMAN SR, 1993, ANESTHESIOLOGY, V78, P626, DOI 10.1097/00000542-199303000-00057; SHUAIB A, 1987, MEDICINE, V66, P389, DOI 10.1097/00005792-198709000-00004; SHY GM, 1956, BRAIN, V79, P610, DOI 10.1093/brain/79.4.610; ZHANG W, 1991, NUCLEIC ACIDS RES, V19, P6649, DOI 10.1093/nar/19.23.6649; ZORZATO F, 1990, J BIOL CHEM, V265, P2244; 1984, BRIT J ANAESTH, V56, P1267	36	284	291	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1993	5	1					51	55		10.1038/ng0993-51	http://dx.doi.org/10.1038/ng0993-51			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	8220423				2022-12-17	WOS:A1993LV56500015
J	OHLSSON, R; NYSTROM, A; PFEIFEROHLSSON, S; TOHONEN, V; HEDBORG, F; SCHOFIELD, P; FLAM, F; EKSTROM, TJ				OHLSSON, R; NYSTROM, A; PFEIFEROHLSSON, S; TOHONEN, V; HEDBORG, F; SCHOFIELD, P; FLAM, F; EKSTROM, TJ			IGF2 IS PARENTALLY IMPRINTED DURING HUMAN EMBRYOGENESIS AND IN THE BECKWITH-WIEDEMANN SYNDROME	NATURE GENETICS			English	Article							GROWTH FACTOR-II; GENE; EXPRESSION; RECEPTOR	The phenomenon of parental imprinting involves the preferential expression of one parental allele of a subset of chromosomal genes and has so far only been documented in the mouse. We show here, by exploiting sequence polymorphisms in exon nine of the human insulin-like growth factor 2 (IGF2) gene, that only the paternally-inherited allele is active in embryonic and extra-embryonic cells from first trimester pregnancies. In addition, only the paternal allele is expressed in tissues from a patient who suffered from Beckwith-Wiedemann syndrome. Thus the parental imprinting of IGF2 appears to be evolutionarily conserved from mouse to man and has implications for the generation of the Beckwith-Wiedemann syndrome.	UNIV CAMBRIDGE,DEPT ANAT,CAMBRIDGE CB2 3DY,ENGLAND; KAROLINSKA HOSP,DEPT OBSTET & GYNECOL,S-10401 STOCKHOLM 60,SWEDEN	University of Cambridge; Karolinska Institutet; Karolinska University Hospital	OHLSSON, R (corresponding author), KAROLINSKA HOSP,DEPT EXPTL DRUG RES,POB 60500,S-10401 STOCKHOLM 60,SWEDEN.		Schofield, Paul/AAA-9414-2020; Ekström, Tomas/B-7764-2013; Töhönen, Virpi/B-2013-2009	Schofield, Paul/0000-0002-5111-7263; 				BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BRICE AL, 1989, DEVELOPMENT, V106, P543; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; HAIG D, 1991, CELL, V64, P1045; HALL JG, 1990, AM J HUM GENET, V46, P103; JANSEN M, 1990, GROWTH FACTORS GENES, P25; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; Junien C, 1992, CURR OPIN GENET DEV, V2, P431, DOI 10.1016/S0959-437X(05)80154-6; LAWLER SD, 1993, PLACENTA, P82; LEFF SE, 1992, NATURE, V2, P265; LITTLE M, 1991, NATURE, V351, P609, DOI 10.1038/351609a0; OHLSSON R, 1989, EMBO J, V8, P1993, DOI 10.1002/j.1460-2075.1989.tb03606.x; OHLSSON R, 1989, DEVELOPMENT, V106, P555; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; RACHMILEWITZ J, 1992, FEBS LETT, V309, P25, DOI 10.1016/0014-5793(92)80731-U; REIK W, 1989, TRENDS GENET, V5, P331, DOI 10.1016/0168-9525(89)90138-8; SOLTER D, 1988, ANNU REV GENET, V22, P127; Surani MA, 1991, CURR OPIN GENET DEV, V1, P241, DOI 10.1016/S0959-437X(05)80077-2; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	21	284	289	0	18	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1993	4	1					94	97		10.1038/ng0593-94	http://dx.doi.org/10.1038/ng0593-94			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA337	8513333				2022-12-17	WOS:A1993LA33700021
J	STRATHDEE, CA; DUNCAN, AMV; BUCHWALD, M				STRATHDEE, CA; DUNCAN, AMV; BUCHWALD, M			EVIDENCE FOR AT LEAST 4 FANCONI ANEMIA GENES INCLUDING FACC ON CHROMOSOME-9	NATURE GENETICS			English	Article							INSITU HYBRIDIZATION; ANEMIA CELLS; COMPLEMENTATION; SUSCEPTIBILITY; LOCALIZATION; BREAKAGE; MARKERS; AGENTS	Fanconi anaemia (FA) is a DNA repair disorder characterized by cellular hypersensitivity to DNA cross-linking agents and extensive phenotypic heterogeneity. To determine the extent of genetic heterogeneity present in FA, a panel of somatic cell hybrids was constructed using polyethylene glycol-mediated cell fusion. Three new complementation groups were identified, designated FA(B), FA(C) and FA(D), and the gene defective in FA(C) which we have recently cloned was localized to chromosome 9q22.3 through in situ hybridization. These results suggest that mutations in at least four different genes lead to FA, a degree of genetic heterogeneity comparable to that of other DNA repair disorders.	HOSP SICK CHILDREN,RES INST,DEPT GENET,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA; QUEENS UNIV,DEPT PATHOL,KINGSTON K7L 2V7,ONTARIO,CANADA; KINGSTON GEN HOSP,CYTOGENET LAB,KINGSTON K7L 2V7,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Queens University - Canada; Queens University - Canada								AUERBACH AD, 1989, BLOOD, V73, P391; BUCHWALD M, 1989, FANCONI ANEMIA CLIN, P226; DUCKWORTHRYSIECKI G, 1985, SOMAT CELL MOLEC GEN, V11, P35, DOI 10.1007/BF01534732; FANCONI G., 1967, SEMINARS HAMATOL, V4, P233; GLANZ A, 1982, J MED GENET, V19, P412, DOI 10.1136/jmg.19.6.412; GORDONSMITH EC, 1991, SEMIN HEMATOL, V28, P104; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; ISHIDA R, 1982, CANCER RES, V42, P4000; JASPERS NGJ, 1988, CYTOGENET CELL GENET, V49, P259, DOI 10.1159/000132673; LEEDER JS, 1989, ANAL BIOCHEM, V177, P364, DOI 10.1016/0003-2697(89)90067-5; LIN CC, 1985, CYTOGENET CELL GENET, V39, P269, DOI 10.1159/000132156; MANN WR, 1991, GENOMICS, V9, P329, DOI 10.1016/0888-7543(91)90261-C; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; PAPADOPOULO D, 1990, P NATL ACAD SCI USA, V87, P8383, DOI 10.1073/pnas.87.21.8383; SANTERRE RF, 1984, GENE, V30, P147, DOI 10.1016/0378-1119(84)90115-X; SASAKI MS, 1973, CANCER RES, V33, P1829; SCHROEDER TM, 1976, HUM GENET, V32, P257, DOI 10.1007/BF00295817; SCHROEDER TM, 1964, HUM GENET, V1, P1694; SETLOW RB, 1978, NATURE, V271, P713, DOI 10.1038/271713a0; SOUTHERN PJ, 1982, J MOL APPL GENET, V1, P3027; STRATHDEE CA, IN PRESS NATURE; STRATHDEE CA, IN PRESS AM J PEDIAT; TANAKA K, 1990, NATURE, V348, P73, DOI 10.1038/348073a0; TSUI LC, 1991, GENES PHENOTYPES, P1; VERMEULEN W, 1991, MUTAT RES, V255, P201, DOI 10.1016/0921-8777(91)90054-S; WEKSBERG R, 1979, J CELL PHYSIOL, V101, P311, DOI 10.1002/jcp.1041010211; ZAKRZEWSKI S, 1982, HUM GENET, V62, P321, DOI 10.1007/BF00304547; ZAKRZEWSKI S, 1983, HUM GENET, V64, P55, DOI 10.1007/BF00289479	28	284	288	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1992	1	3					196	198		10.1038/ng0692-196	http://dx.doi.org/10.1038/ng0692-196			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	1303234				2022-12-17	WOS:A1992JC98200012
J	De Keersmaecker, K; Atak, ZK; Li, N; Vicente, C; Patchett, S; Girardi, T; Gianfelici, V; Geerdens, E; Clappier, E; Porcu, M; Lahortiga, I; Luca, R; Yan, JK; Hulselmans, G; Vranckx, H; Vandepoel, R; Sweron, B; Jacobs, K; Mentens, N; Wlodarska, I; Cauwelier, B; Cloos, J; Soulier, J; Uyttebroeck, A; Bagni, C; Hassan, BA; Vandenberghe, P; Johnson, AW; Aerts, S; Cools, J				De Keersmaecker, Kim; Atak, Zeynep Kalender; Li, Ning; Vicente, Carmen; Patchett, Stephanie; Girardi, Tiziana; Gianfelici, Valentina; Geerdens, Ellen; Clappier, Emmanuelle; Porcu, Michael; Lahortiga, Idoya; Luca, Rossella; Yan, Jiekun; Hulselmans, Gert; Vranckx, Hilde; Vandepoel, Roel; Sweron, Bram; Jacobs, Kris; Mentens, Nicole; Wlodarska, Iwona; Cauwelier, Barbara; Cloos, Jacqueline; Soulier, Jean; Uyttebroeck, Anne; Bagni, Claudia; Hassan, Bassem A.; Vandenberghe, Peter; Johnson, Arlen W.; Aerts, Stein; Cools, Jan			Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; SOMATIC MUTATIONS; UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; CODING GENOME; PROTEIN; NOTCH; PATHWAY; MLL; INACTIVATION	T-cell acute lymphoblastic leukemia (T-ALL) is caused by the cooperation of multiple oncogenic lesions(1,2). We used exome sequencing on 67 T-ALLs to gain insight into the mutational spectrum in these leukemias. We detected protein-altering mutations in 508 genes, with an average of 8.2 mutations in pediatric and 21.0 mutations in adult T-ALL. Using stringent filtering, we predict seven new oncogenic driver genes in T-ALL. We identify CNOT3 as a tumor suppressor mutated in 7 of 89 (7.9%) adult T-ALLs, and its knockdown causes tumors in a sensitized Drosophila melanogaster model(3). In addition, we identify mutations affecting the ribosomal proteins RPL5 and RPL10 in 12 of 122 (9.8%) pediatric T-ALLs, with recurrent alterations of Arg98 in RPL10. Yeast and lymphoid cells expressing the RPL10 Arg98Ser mutant showed a ribosome biogenesis defect. Our data provide insights into the mutational landscape of pediatric versus adult T-ALL and identify the ribosome as a potential oncogenic factor.	[De Keersmaecker, Kim; Atak, Zeynep Kalender; Vicente, Carmen; Girardi, Tiziana; Gianfelici, Valentina; Geerdens, Ellen; Porcu, Michael; Lahortiga, Idoya; Luca, Rossella; Yan, Jiekun; Hulselmans, Gert; Vranckx, Hilde; Vandepoel, Roel; Sweron, Bram; Jacobs, Kris; Mentens, Nicole; Wlodarska, Iwona; Bagni, Claudia; Hassan, Bassem A.; Vandenberghe, Peter; Aerts, Stein; Cools, Jan] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [De Keersmaecker, Kim; Vicente, Carmen; Girardi, Tiziana; Gianfelici, Valentina; Geerdens, Ellen; Porcu, Michael; Lahortiga, Idoya; Luca, Rossella; Yan, Jiekun; Vandepoel, Roel; Sweron, Bram; Jacobs, Kris; Mentens, Nicole; Bagni, Claudia; Hassan, Bassem A.; Cools, Jan] VIB, Ctr Biol Dis, Louvain, Belgium; [Li, Ning] BGI Europe, Copenhagen, Denmark; [Patchett, Stephanie; Johnson, Arlen W.] Univ Texas Austin, Sect Mol Genet & Microbiol, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Clappier, Emmanuelle; Soulier, Jean] Hop St Louis, Paris, France; [Cauwelier, Barbara] Acad Hosp St Jan, Brugge, Belgium; [Cloos, Jacqueline] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Uyttebroeck, Anne] Katholieke Univ Leuven Hosp, Louvain, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); University of Texas System; University of Texas Austin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven	Aerts, S (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium.	stein.aerts@med.kuleuven.be; jan.cools@cme.vib-kuleuven.be	Lucà, Rossella/J-5921-2018; De Keersmaecker, Kim/W-9702-2018; Clappier, Emmanuelle/V-2921-2017; Atak, Zeynep Kalender/AAW-1560-2020; Gianfelici, Valentina/AAA-8632-2020; Vicente, Carmen/AAA-7098-2021; Hassan, Bassem A/D-5221-2012; Aerts, Stein/A-1100-2009	Lucà, Rossella/0000-0003-2495-7803; De Keersmaecker, Kim/0000-0002-7420-9531; Atak, Zeynep Kalender/0000-0003-4761-8169; Vicente, Carmen/0000-0002-3363-3459; Hassan, Bassem A/0000-0001-9533-4908; Aerts, Stein/0000-0002-8006-0315; Bagni, Claudia/0000-0002-4419-210X; Gianfelici, Valentina/0000-0003-3326-091X; Porcu, Michael/0000-0002-9369-5547; Hulselmans, Gert/0000-0003-2205-1899; Girardi, Tiziana/0000-0002-1344-8459; Cools, Jan/0000-0001-6626-5843; Vandenberghe, Peter/0000-0003-4719-1935; Johnson, Arlen/0000-0002-4742-085X; Cloos, Jacqueline/0000-0001-9150-8026	KU Leuven [PF/10/016 SymBioSys]; FWO-Vlaanderen [G.0546.11, G.0704.11N]; Foundation against Cancer [SCIE2006-34, 2010-154]; European Research Council (ERC); Federal Office for Scientific, Technical and Cultural Affairs, Belgium; Ministry of Health, Cancer Plan; French program Carte d'Identite des Tumeurs (CIT, Ligue Contre le Cancer); Canceropole d'Ile de France; US National Institutes of Health (NIH) [GM53655]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053655] Funding Source: NIH RePORTER	KU Leuven(KU Leuven); FWO-Vlaanderen(FWO); Foundation against Cancer; European Research Council (ERC)(European Research Council (ERC)European Commission); Federal Office for Scientific, Technical and Cultural Affairs, Belgium; Ministry of Health, Cancer Plan; French program Carte d'Identite des Tumeurs (CIT, Ligue Contre le Cancer); Canceropole d'Ile de France(Region Ile-de-France); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from KU Leuven (concerted action grant to J. Cools and P.V. and PF/10/016 SymBioSys to J. Cools and S.A.), FWO-Vlaanderen (G.0546.11 to J. Cools, P.V., S.A. and A.U. and G.0704.11N to S.A.), the Foundation against Cancer (SCIE2006-34 to J. Cools and 2010-154 to S.A.), a European Research Council (ERC) starting grant (J. Cools), the Interuniversity Attraction Poles (IAP) granted by the Federal Office for Scientific, Technical and Cultural Affairs, Belgium (J. Cools and P.V.), a grant from the Ministry of Health, Cancer Plan (J. Cools, P.V. and S.A.), a grant from the French program Carte d'Identite des Tumeurs (CIT, Ligue Contre le Cancer) and from Canceropole d'Ile de France (J.S.), and a grant from the US National Institutes of Health (NIH; GM53655 to A.W.J. and SE). K.D.K. is a postdoctoral researcher, and P.V. is a senior clinical investigator of FWO-Vlaanderen.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Atak ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038463; Bossuyt W, 2009, PLOS BIOL, V7, P301, DOI 10.1371/journal.pbio.1000040; Burmeister T, 2009, BLOOD, V113, P4011, DOI 10.1182/blood-2008-10-183483; Chiocchetti A, 2011, AM J MED GENET A, V155A, P1472, DOI 10.1002/ajmg.a.33977; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; De Keersmaecker K, 2005, HAEMATOLOGICA, V90, P1116; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Hofer A, 2007, J BIOL CHEM, V282, P32630, DOI 10.1074/jbc.M705057200; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Jiao X, 2012, GENE CHROMOSOME CANC, V51, P480, DOI 10.1002/gcc.21935; King-Underwood L, 1998, BLOOD, V91, P2961, DOI 10.1182/blood.V91.8.2961.2961_2961_2968; Klauck SM, 2006, MOL PSYCHIATR, V11, P1073, DOI 10.1038/sj.mp.4001883; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Lederer D, 2012, AM J HUM GENET, V90, P119, DOI 10.1016/j.ajhg.2011.11.021; Lo KY, 2010, MOL CELL, V39, P196, DOI 10.1016/j.molcel.2010.06.018; Lorsbach RB, 2003, LEUKEMIA, V17, P637, DOI 10.1038/sj.leu.2402834; Lower KM, 2004, EUR J HUM GENET, V12, P787, DOI 10.1038/sj.ejhg.5201228; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Ono R, 2002, CANCER RES, V62, P4075; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rao SY, 2012, BLOOD, V120, P3764, DOI 10.1182/blood-2012-03-415349; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Tosello V, 2009, BLOOD, V114, P1038, DOI 10.1182/blood-2008-12-192039; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Van Vlierberghe P, 2012, J CLIN INVEST, V122, P3398, DOI 10.1172/JCI61269; Van Vlierberghe P, 2011, J EXP MED, V208, P2571, DOI 10.1084/jem.20112239; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	51	283	288	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					186	190		10.1038/ng.2508	http://dx.doi.org/10.1038/ng.2508			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	23263491	Green Accepted			2022-12-17	WOS:000314333000014
J	Cho, MH; Boutaoui, N; Klanderman, BJ; Sylvia, JS; Ziniti, JP; Hersh, CP; DeMeo, DL; Hunninghake, GM; Litonjua, AA; Sparrow, D; Lange, C; Won, S; Murphy, JR; Beaty, TH; Regan, EA; Make, BJ; Hokanson, JE; Crapo, JD; Kong, XY; Anderson, WH; Tal-Singer, R; Lomas, DA; Bakke, P; Gulsvik, A; Pillai, SG; Silverman, EK				Cho, Michael H.; Boutaoui, Nadia; Klanderman, Barbara J.; Sylvia, Jody S.; Ziniti, John P.; Hersh, Craig P.; DeMeo, Dawn L.; Hunninghake, Gary M.; Litonjua, Augusto A.; Sparrow, David; Lange, Christoph; Won, Sungho; Murphy, James R.; Beaty, Terri H.; Regan, Elizabeth A.; Make, Barry J.; Hokanson, John E.; Crapo, James D.; Kong, Xiangyang; Anderson, Wayne H.; Tal-Singer, Ruth; Lomas, David A.; Bakke, Per; Gulsvik, Amund; Pillai, Sreekumar G.; Silverman, Edwin K.			Variants in FAM13A are associated with chronic obstructive pulmonary disease	NATURE GENETICS			English	Article							GENE-EXPRESSION	We performed a genome-wide association study for chronic obstructive pulmonary disease (COPD) in three population cohorts, including 2,940 cases and 1,380 controls who were current or former smokers with normal lung function. We identified a new susceptibility locus at 4q22.1 in FAM13A and replicated this association in one case-control group (n = 1,006) and two family-based cohorts (n = 3,808) (rs7671167, combined P = 1.2 x 10(-11), combined odds ratio in case-control studies 0.76, 95% confidence interval 0.69-0.83).	[Cho, Michael H.; Boutaoui, Nadia; Klanderman, Barbara J.; Sylvia, Jody S.; Ziniti, John P.; Hersh, Craig P.; DeMeo, Dawn L.; Hunninghake, Gary M.; Litonjua, Augusto A.; Silverman, Edwin K.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Cho, Michael H.; Hersh, Craig P.; DeMeo, Dawn L.; Hunninghake, Gary M.; Litonjua, Augusto A.; Silverman, Edwin K.] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; [Sparrow, David] Vet Adm Boston Healthcare Syst, Boston, MA USA; [Sparrow, David] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Sparrow, David] Boston Univ, Sch Med, Boston, MA 02118 USA; [Lange, Christoph; Won, Sungho] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Murphy, James R.; Regan, Elizabeth A.; Make, Barry J.; Crapo, James D.] Natl Jewish Med & Res Ctr, Denver, CO USA; [Beaty, Terri H.] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA; [Hokanson, John E.] Univ Colorado Denver, Dept Epidemiol, Colorado Sch Publ Hlth, Aurora, CO USA; [Kong, Xiangyang; Tal-Singer, Ruth] GlaxoSmithKline Res & Dev Ltd, King Of Prussia, PA USA; [Anderson, Wayne H.; Pillai, Sreekumar G.] GlaxoSmithKline Res & Dev Ltd, Res Triangle Pk, NC USA; [Lomas, David A.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Bakke, Per; Gulsvik, Amund] Haukeland Hosp, N-5021 Bergen, Norway; [Bakke, Per; Gulsvik, Amund] Univ Bergen, Inst Med, Bergen, Norway	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; National Jewish Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; GlaxoSmithKline; GlaxoSmithKline; University of Cambridge; University of Bergen	Cho, MH (corresponding author), Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA.	remhc@channing.harvard.edu	Tal-Singer, Ruth/AAQ-2925-2021	Tal-Singer, Ruth/0000-0002-5275-8062; Kong, xiangyang/0000-0001-8184-2493; Litonjua, Augusto/0000-0003-0422-5875; Regan, Elizabeth/0000-0003-0624-9184	US National Institutes of Health (NIH) [R01 HL075478, R01 HL084323, P01 HL083069, U01 HL089856, K12HL089990, U01 HL089897]; National Heart, Lung, and Blood Institute; Centers for Medicare and Medicaid Services; Agency for Healthcare Research and Quality; US Department of Veterans Affairs; GlaxoSmithKline; MRC [G0500306] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL092222, R01HL084323, P01HL083069, K12HL089990, R01HL075478, U01HL089856, U01HL089897] Funding Source: NIH RePORTER; Medical Research Council [G0500306] Funding Source: researchfish	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Centers for Medicare and Medicaid Services; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); US Department of Veterans Affairs(US Department of Veterans Affairs); GlaxoSmithKline(GlaxoSmithKline); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by US National Institutes of Health (NIH) grants R01 HL075478, R01 HL084323, P01 HL083069, U01 HL089856 (E. K. S.), K12HL089990 (M. H. C) and U01 HL089897 (J.D.C.). The National Emphysema Treatment Trial was supported by the National Heart, Lung, and Blood Institute, the Centers for Medicare and Medicaid Services and the Agency for Healthcare Research and Quality. The Normative Aging Study is supported by the Cooperative Studies Program/ERIC of the US Department of Veterans Affairs and is a component of the Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC). The Norway cohort, the ECLIPSE study (Clinicaltrials.gov identifier NCT00292552; GSK Code SCO104960) and the ICGN study are funded by GlaxoSmithKline.	BELL B, 1972, AGING HUM DEVELOP, V3, P5, DOI 10.2190/GGVP-XLB5-PC3N-EF0G; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Cohen M, 2004, GENOMICS, V84, P374, DOI 10.1016/j.ygeno.2004.03.005; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Silverman Edwin K, 2006, Proc Am Thorac Soc, V3, P405, DOI 10.1513/pats.200603-092AW; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Wade KC, 2006, AM J RESP CELL MOL, V34, P727, DOI 10.1165/rcmb.2004-0389OC; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Wright JM, 2006, AM J RESP CELL MOL, V35, P327, DOI 10.1165/rcmb.2005-0359OC	15	283	292	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2010	42	3					200	202		10.1038/ng.535	http://dx.doi.org/10.1038/ng.535			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20173748	Green Accepted			2022-12-17	WOS:000274912400006
J	Veeriah, S; Taylor, BS; Meng, S; Fang, F; Yilmaz, E; Vivanco, I; Janakiraman, M; Schultz, N; Hanrahan, AJ; Pao, W; Ladanyi, M; Sander, C; Heguy, A; Holland, EC; Paty, PB; Mischel, PS; Liau, L; Cloughesy, TF; Mellinghoff, IK; Solit, DB; Chan, TA				Veeriah, Selvaraju; Taylor, Barry S.; Meng, Shasha; Fang Fang; Yilmaz, Emrullah; Vivanco, Igor; Janakiraman, Manickam; Schultz, Nikolaus; Hanrahan, Aphrothiti J.; Pao, William; Ladanyi, Marc; Sander, Chris; Heguy, Adriana; Holland, Eric C.; Paty, Philip B.; Mischel, Paul S.; Liau, Linda; Cloughesy, Timothy F.; Mellinghoff, Ingo K.; Solit, David B.; Chan, Timothy A.			Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies	NATURE GENETICS			English	Article							UBIQUITIN-PROTEIN LIGASE; TUMOR-SUPPRESSOR GENE; RECESSIVE JUVENILE PARKINSONISM; CYCLIN-E; FHIT GENE; CANCER; CARCINOMA; EXPRESSION; OVARIAN; SUBUNIT	Mutation of the gene PARK2, which encodes an E3 ubiquitin ligase, is the most common cause of early-onset Parkinson's disease(1-3). In a search for multisite tumor suppressors, we identified PARK2 as a frequently targeted gene on chromosome 6q25.2-q27 in cancer. Here we describe inactivating somatic mutations and frequent intragenic deletions of PARK2 in human malignancies. The PARK2 mutations in cancer occur in the same domains, and sometimes at the same residues, as the germline mutations causing familial Parkinson's disease. Cancer-specific mutations abrogate the growth-suppressive effects of the PARK2 protein. PARK2 mutations in cancer decrease PARK2's E3 ligase activity, compromising its ability to ubiquitinate cyclin E and resulting in mitotic instability. These data strongly point to PARK2 as a tumor suppressor on 6q25.2-q27. Thus, PARK2, a gene that causes neuronal dysfunction when mutated in the germline, may instead contribute to oncogenesis when altered in non-neuronal somatic cells.	[Veeriah, Selvaraju; Meng, Shasha; Fang Fang; Yilmaz, Emrullah; Vivanco, Igor; Janakiraman, Manickam; Hanrahan, Aphrothiti J.; Pao, William; Ladanyi, Marc; Heguy, Adriana; Mellinghoff, Ingo K.; Solit, David B.; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Taylor, Barry S.; Schultz, Nikolaus; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Pao, William; Solit, David B.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; [Paty, Philip B.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Mischel, Paul S.; Liau, Linda; Cloughesy, Timothy F.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Mellinghoff, Ingo K.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA; [Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Solit, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	solitd@mskcc.org; chant@mskcc.org	Sander, Chris/H-1452-2011; Ladanyi, Marc/AAG-8585-2019; Heguy, Adriana/GPP-3907-2022; Solit, David B./AAC-5309-2019; Schultz, Nikolaus/ABE-6347-2020; Cloughesy, Timothy Francis/AGV-1013-2022; Vivanco, Igor/AAN-8578-2021; Chan, Timothy A/ABD-5850-2021; Meng, Shasha/AAR-3936-2020; Yilmaz, Emrullah/AAR-6228-2021	Sander, Chris/0000-0001-6059-6270; Liau, Linda/0000-0002-4053-0052; Yilmaz, Emrullah/0000-0003-2308-713X; Vivanco, Igor/0000-0001-6347-9416; Janakiraman, Manickam/0000-0003-4423-6237; Schultz, Nikolaus/0000-0002-0131-4904	Brain Tumors Funders' Collaborative Fund; Cancer Genome Atlas Project; Flight Attendants Medical Research Institute; Louis Gerstner Foundation; Memorial Sloan-Kettering Society; Elsa U. Pardee Foundation; Doris Duke Charitable Foundation; NATIONAL CANCER INSTITUTE [R01CA121210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086875] Funding Source: NIH RePORTER	Brain Tumors Funders' Collaborative Fund; Cancer Genome Atlas Project; Flight Attendants Medical Research Institute; Louis Gerstner Foundation; Memorial Sloan-Kettering Society; Elsa U. Pardee Foundation; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Wongvipat, K. Huberman, I. Dolgalev and S. Thomas for exceptional technical expertise. We thank R. Levine for helpful discussions and comments. B. S. T. is the David H. Koch Fellow in cancer genomics. This work was supported in part by The Brain Tumors Funders' Collaborative Fund (I. K. M.), The Cancer Genome Atlas Project (N. S, C. S.), the Flight Attendants Medical Research Institute (T. A. C.), the Louis Gerstner Foundation (T. A. C.), the Memorial Sloan-Kettering Society (T. A. C.), the Elsa U. Pardee Foundation (T. A. C.) and the Doris Duke Charitable Foundation (T. A.C.)	Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; Betarbet R, 2005, EXP NEUROL, V191, pS17, DOI 10.1016/j.expneurol.2004.08.021; Cesari R, 2003, P NATL ACAD SCI USA, V100, P5956, DOI 10.1073/pnas.0931262100; Chen K, 2007, GENOME RES, V17, P659, DOI 10.1101/gr.6151507; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Corti O, 2005, CR BIOL, V328, P131, DOI 10.1016/j.crvi.2004.10.009; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Courjal F, 1996, INT J CANCER, V69, P247; Cox C, 2005, P NATL ACAD SCI USA, V102, P4542, DOI 10.1073/pnas.0408593102; Dachsel JC, 2005, FEBS LETT, V579, P3913, DOI 10.1016/j.febslet.2005.06.003; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Dohm CP, 2008, NEURODEGENER DIS, V5, P321, DOI 10.1159/000119459; Donnellan R, 1999, FASEB J, V13, P773, DOI 10.1096/fasebj.13.8.773; Ekholm-Reed Susanna, 2004, Cancer Research, V64, P2939; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Hasegawa T, 2008, J NEUROCHEM, V105, P1700, DOI 10.1111/j.1471-4159.2008.05277.x; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Keck JM, 2007, J CELL BIOL, V178, P371, DOI 10.1083/jcb.200703202; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitada T, 2000, MAMM GENOME, V11, P417, DOI 10.1007/s003350010080; Kitagawa K, 2009, CANCER SCI, V100, P1374, DOI 10.1111/j.1349-7006.2009.01196.x; Ledesma MD, 2002, J NEUROCHEM, V83, P1431, DOI 10.1046/j.1471-4159.2002.01253.x; Liu M, 2008, J BIOL CHEM, V283, P35783, DOI 10.1074/jbc.M806860200; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Major JE, 2007, BIOINFORMATICS, V23, P3091, DOI 10.1093/bioinformatics/btm339; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Martinez-Noel G, 2001, EUR J BIOCHEM, V268, P5912, DOI 10.1046/j.0014-2956.2001.02541.x; Mhawech-Fauceglia P, 2008, INT J GYNECOL PATHOL, V27, P539, DOI 10.1097/PGP.0b013e31816bcda4; MOLLER H, 1995, BRIT MED J, V310, P1500, DOI 10.1136/bmj.310.6993.1500; Moore DJ, 2008, J NEUROCHEM, V105, P1806, DOI 10.1111/j.1471-4159.2008.05261.x; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Ohta M, 1996, CELL, V84, P587, DOI 10.1016/S0092-8674(00)81034-X; Olsen JH, 2005, BRIT J CANCER, V92, P201, DOI 10.1038/sj.bjc.6602279; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Rankin CA, 2001, J BIOMED SCI, V8, P421; Reed SE, 2004, CANCER RES, V64, P795, DOI 10.1158/0008-5472.CAN-03-3417; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Sangfelt O, 2008, CELL CYCLE, V7, P1075, DOI 10.4161/cc.7.8.5648; Schlossmacher Michael G., 2005, V301, P351; Shiloh Y, 1996, J CLIN IMMUNOL, V16, P254, DOI 10.1007/BF01541389; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Sozzi G, 1996, CELL, V85, P17, DOI 10.1016/S0092-8674(00)81078-8; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Sriram SR, 2005, HUM MOL GENET, V14, P2571, DOI 10.1093/hmg/ddi292; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Toma MI, 2008, NEOPLASIA, V10, P634, DOI 10.1593/neo.08160; Um JW, 2009, MOL CELL NEUROSCI, V40, P421, DOI 10.1016/j.mcn.2008.12.010; Wang F, 2004, GENE CHROMOSOME CANC, V40, P85, DOI 10.1002/gcc.20020; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	62	283	291	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					77	U98		10.1038/ng.491	http://dx.doi.org/10.1038/ng.491			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA	19946270	Green Accepted, Bronze			2022-12-17	WOS:000273055100020
J	Pasqualucci, L; Bhagat, G; Jankovic, M; Compagno, M; Smith, P; Muramatsu, M; Honjo, T; Morse, HC; Nussenzweig, MC; Dalla-Favera, R				Pasqualucci, Laura; Bhagat, Govind; Jankovic, Mila; Compagno, Mara; Smith, Paula; Muramatsu, Masamichi; Honjo, Tasuku; Morse, Herbert C., III; Nussenzweig, Michel C.; Dalla-Favera, Riccardo			AID is required for germinal center-derived lymphomagenesis	NATURE GENETICS			English	Article							CYTIDINE DEAMINASE AID; CLASS SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; CENTER B-CELLS; ANTIBODY DIVERSIFICATION; SOMATIC HYPERMUTATION; EXPRESSION; TRANSLOCATIONS; PHENOTYPE; REGION	Most human B cell non-Hodgkin's lymphomas (B-NHLs) derive from germinal centers (GCs), the structure in which B cells undergo somatic hypermutation (SHM) and class switch recombination (CSR) before being selected for high-affinity antibody production(1). The pathogenesis of B-NHL is associated with distinct genetic lesions, including chromosomal translocations and aberrant SHM, which arise from mistakes occurring during CSR and SHM2-4. A direct link between these DNA remodeling events and GC lymphoma development, however, has not been demonstrated. Here we have crossed three mouse models of B cell lymphoma driven by oncogenes (Myc, Bcl6 and Myc/Bcl6; refs. 5,6) with mice lacking activation-induced cytidine deaminase (AID), the enzyme required for both CSR and SHM7,8. We show that AID deficiency prevents Bcl6-dependent, GC-derived B-NHL, but has no impact on Myc-driven, pre-GC lymphomas. Accordingly, abrogation of AID is associated with the disappearance of CSR- and SHM-mediated structural alterations. These results show that AID is required for GC-derived lymphomagenesis, supporting the notion that errors in AID-mediated antigen-receptor gene modification processes are principal contributors to the pathogenesis of human B-NHL.	[Pasqualucci, Laura; Bhagat, Govind; Compagno, Mara; Smith, Paula; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, Dept Pathol, New York, NY 10032 USA; [Pasqualucci, Laura; Bhagat, Govind; Compagno, Mara; Smith, Paula; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, Dept Genet & Dev, New York, NY 10032 USA; [Pasqualucci, Laura; Bhagat, Govind; Compagno, Mara; Smith, Paula; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Jankovic, Mila; Muramatsu, Masamichi] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; [Muramatsu, Masamichi] Kanazawa Univ, Grad Sch Med Sci, Dept Mol Genet, Kanazawa, Ishikawa 9208640, Japan; [Honjo, Tasuku] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto 6068501, Japan; [Morse, Herbert C., III] NIAID, NIH, Immunopathol Lab, Bethesda, MD 20892 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Columbia University; Columbia University; Columbia University; Rockefeller University; Kanazawa University; Kyoto University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Howard Hughes Medical Institute; Rockefeller University	Pasqualucci, L (corresponding author), Columbia Univ, Inst Canc Genet, Dept Pathol, New York, NY 10032 USA.	lp171@columbia.edu; rd10@columbia.edu	Nussenzweig, Michel/AAE-7292-2019; Honjo, Tasuku/N-4470-2016; Muramatsu, Masamichi/C-4339-2015; Bhagat, Govind/AAE-9493-2021	Muramatsu, Masamichi/0000-0002-0153-3533; Bhagat, Govind/0000-0001-6250-048X; Morse, Herbert/0000-0002-9331-3705	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000858, Z01AI000858] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; DALLAFAVERA R, 2004, NON HODGKINS LYMPHOM, P825; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Kotani A, 2007, P NATL ACAD SCI USA, V104, P1616, DOI 10.1073/pnas.0610732104; Kovalchuk AL, 2000, J EXP MED, V192, P1183, DOI 10.1084/jem.192.8.1183; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lenz G, 2007, J EXP MED, V204, P633, DOI 10.1084/jem.20062041; Mollejo M, 2005, HEMATOL ONCOL, V23, P108, DOI 10.1002/hon.762; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Pasqualucci L, 2004, BLOOD, V104, P3318, DOI 10.1182/blood-2004-04-1558; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Shaffer AL, 2002, NAT REV IMMUNOL, V2, P920, DOI 10.1038/nri953	30	283	293	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					108	112		10.1038/ng.2007.35	http://dx.doi.org/10.1038/ng.2007.35			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18066064				2022-12-17	WOS:000252118600026
J	Otto, EA; Loeys, B; Khanna, H; Hellemans, J; Sudbrak, R; Fan, SL; Muerb, U; O'Toole, JF; Helou, J; Attanasio, M; Utsch, B; Sayer, JA; Lillo, C; Jimeno, D; Coucke, P; De Paepe, A; Reinhardt, R; Klages, S; Tsuda, M; Kawakami, I; Kusakabe, T; Omran, H; Imm, A; Tippens, M; Raymond, PA; Hill, J; Beales, P; He, S; Kispert, A; Margolis, B; Williams, DS; Swaroop, A; Hildebrandt, F				Otto, EA; Loeys, B; Khanna, H; Hellemans, J; Sudbrak, R; Fan, SL; Muerb, U; O'Toole, JF; Helou, J; Attanasio, M; Utsch, B; Sayer, JA; Lillo, C; Jimeno, D; Coucke, P; De Paepe, A; Reinhardt, R; Klages, S; Tsuda, M; Kawakami, I; Kusakabe, T; Omran, H; Imm, A; Tippens, M; Raymond, PA; Hill, J; Beales, P; He, S; Kispert, A; Margolis, B; Williams, DS; Swaroop, A; Hildebrandt, F			Nephrocystin-5, a ciliary IQ domain protein, is mutated in Senior-Loken syndrome and interacts with RPGR and calmodulin	NATURE GENETICS			English	Article							LINKED RETINITIS-PIGMENTOSA; RENAL CYSTIC-DISEASE; JUVENILE NEPHRONOPHTHISIS; ROD PHOTORECEPTORS; GENE; ENCODES; EXPRESSION; MUTATIONS; INVERSIN	Nephronophthisis (NPHP) is the most frequent genetic cause of chronic renal failure in children(1-3). Identification of four genes mutated in NPHP subtypes 1- 4 (refs. 4- 9) has linked the pathogenesis of NPHP to ciliary functions(9). Ten percent of affected individuals have retinitis pigmentosa, constituting the renal-retinal Senior-Loken syndrome (SLSN). Here we identify, by positional cloning, mutations in an evolutionarily conserved gene, IQCB1 (also called NPHP5), as the most frequent cause of SLSN. IQCB1 encodes an IQ-domain protein, nephrocystin-5. All individuals with IQCB1 mutations have retinitis pigmentosa. Hence, we examined the interaction of nephrocystin-5 with RPGR (retinitis pigmentosa GTPase regulator), which is expressed in photoreceptor cilia and associated with 10-20% of retinitis pigmentosa. We show that nephrocystin-5, RPGR and calmodulin can be coimmunoprecipitated from retinal extracts, and that these proteins localize to connecting cilia of photoreceptors and to primary cilia of renal epithelial cells. Our studies emphasize the central role of ciliary dysfunction in the pathogenesis of SLSN.	Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Univ Michigan, Dept Ophthalmol, Ann Arbor, MI 48109 USA; Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; Max Planck Inst Mol Genet, Berlin, Germany; Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Hyogo 6781297, Japan; Univ Freiburg, Childrens Hosp, Freiburg, Germany; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; UCL, Inst Child Hlth, Mol Med Unit, London, England; Hannover Med Sch, Inst Mol Biol, D-30625 Hannover, Germany; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Johns Hopkins University; University of Michigan System; University of Michigan; Ghent University; Ghent University Hospital; Max Planck Society; University of Kiel; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Hyogo; University of Freiburg; University of Michigan System; University of Michigan; University of London; University College London; Hannover Medical School; University of Michigan System; University of Michigan	Hildebrandt, F (corresponding author), Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA.	fhilde@umich.edu	Kusakabe, Takehiro/H-7178-2012; Coucke, Paul J/AAO-2954-2020; Lillo, Concepcion/A-6321-2009; Loeys, Bart/B-3236-2017; Sayer, John A./AAN-2729-2020; Beales, Philip L/C-7367-2009; Jimeno, David/D-3096-2018	Kusakabe, Takehiro/0000-0002-8325-3665; Coucke, Paul J/0000-0001-7119-586X; Lillo, Concepcion/0000-0001-5814-9826; Loeys, Bart/0000-0003-3703-9518; Sayer, John A./0000-0003-1881-3782; Jimeno, David/0000-0001-7876-0083; Omran, Heymut/0000-0003-0282-6765; Attanasio, Massimo/0000-0002-1278-3650; Otto, Edgar/0000-0002-2387-9973; Utsch, Boris/0000-0003-4623-581X; Reinhardt, Richard/0000-0001-9376-2132; Swaroop, Anand/0000-0002-1975-1141; Raymond, Pamela/0000-0003-1083-5530	NATIONAL EYE INSTITUTE [R01EY007042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084725] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY007042] Funding Source: Medline; NIDDK NIH HHS [R01 DK084725] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BESHARSE JC, 1990, PHOTORECEPTOR CONNEC, P409; Breuer DK, 2002, AM J HUM GENET, V70, P1545, DOI 10.1086/340848; CHEN TY, 1994, P NATL ACAD SCI USA, V91, P11757, DOI 10.1073/pnas.91.24.11757; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Cuenca N, 2002, J NEUROCYTOL, V31, P649, DOI 10.1023/A:1025791512555; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; FANCONI G, 1951, Helv Paediatr Acta, V6, P1; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Gibbs D, 2004, J CELL SCI, V117, P6473, DOI 10.1242/jcs.01580; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hildebrandt F., 2004, PEDIATR NEPHROL, P665; Hong DH, 2002, INVEST OPHTH VIS SCI, V43, P3373; Hong DH, 2003, INVEST OPHTH VIS SCI, V44, P2413, DOI 10.1167/iovs.02-1206; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Morgan D, 2002, HUM GENET, V110, P377, DOI 10.1007/s00439-002-0696-4; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Otto E, 2002, AM J HUM GENET, V71, P1161, DOI 10.1086/344395; Otto E, 2000, J AM SOC NEPHROL, V11, P270, DOI 10.1681/ASN.V112270; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Roepman R, 2000, HUM MOL GENET, V9, P2095, DOI 10.1093/hmg/9.14.2095; Saunier S, 1997, HUM MOL GENET, V6, P2317, DOI 10.1093/hmg/6.13.2317; SMITH CH, 1945, AM J DIS CHILD, V69, P369; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75	25	283	296	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2005	37	3					282	288		10.1038/ng1520	http://dx.doi.org/10.1038/ng1520			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15723066				2022-12-17	WOS:000227297800019
J	Walley, AJ; Chavanas, S; Moffatt, ME; Esnouf, RM; Ubhi, B; Lawrence, R; Wong, K; Abecasis, GR; Jones, EY; Harper, JL; Hovnanian, A; Cookson, WOCM				Walley, AJ; Chavanas, S; Moffatt, ME; Esnouf, RM; Ubhi, B; Lawrence, R; Wong, K; Abecasis, GR; Jones, EY; Harper, JL; Hovnanian, A; Cookson, WOCM			Gene polymorphism in Netherton and common atopic disease	NATURE GENETICS			English	Article							PARTY DIAGNOSTIC-CRITERIA; GENOME-WIDE SEARCH; SERUM IGE LEVELS; UNDERLYING ASTHMA; LINKAGE; DERMATITIS; CHROMOSOME-11Q; ASSOCIATION; INHIBITOR; RECEPTOR	Atopic dermatitis (AD) and asthma are characterized by IgE-mediated atopic (allergic) responses to common proteins (allergens), many of which are proteinases. Loci influencing atopy have been localized to a number of chromosomal regions', including the chromosome 5q31 cytokine cluster(2-4). Netherton disease is a rare recessive skin disorder in which atopy is a universal accompaniment(5). The gene underlying Netherton disease (SPINK5)(6) encodes a 15-domain serine proteinase inhibitor (LEKTI) which is expressed in epithelial and mucosal surfaces and in the thymus(6,7). We have identified six coding polymorphisms in SPINK5 (Table 1) and found that a Glu420 --> Lys variant shows significant association with atopy and AD in two independent panels of families. Our results implicate a previously unrecognized pathway for the development of common allergic illnesses.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Great Ormond St Hosp Sick Children, Dept Paediat Dermatol, London WC1N 3JH, England	University of Oxford; Wellcome Centre for Human Genetics; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Cookson, WOCM (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	wocc@well.ox.ac.uk	Jones, Yvonne/N-8111-2019; Abecasis, Goncalo R/B-7840-2010; Cookson, William/HHC-1790-2022; Chavanas, stephane/K-1183-2014; Jones, Yvonne/J-2293-2016; Hovnanian, Alain/I-4711-2017; Walley, Andrew J/D-2573-2009	Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893; Hovnanian, Alain/0000-0003-3412-7512; Walley, Andrew J/0000-0001-7707-7549; chavanas, stephane/0000-0003-4323-2656; Abecasis, Goncalo/0000-0003-1509-1825				Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; Bennett ST, 1996, ANNU REV GENET, V30, P343, DOI 10.1146/annurev.genet.30.1.343; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Cookson W, 1999, NATURE, V402, pB5, DOI 10.1038/35037002; COOKSON WOCM, 1988, LANCET, V1, P86; COOKSON WOCM, 1992, LANCET, V340, P381, DOI 10.1016/0140-6736(92)91468-N; COOKSON WOCM, 1989, LANCET, V1, P1292; Cookson WOCM, 2001, NAT GENET, V27, P372, DOI 10.1038/86867; Cox HE, 1998, BRIT J DERMATOL, V138, P182; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; Deichmann KA, 1998, CLIN EXP ALLERGY, V28, P151; Graves PE, 2000, J ALLERGY CLIN IMMUN, V105, P506, DOI 10.1067/mai.2000.104940; HOLFORDSTREVENS V, 1984, J ALLERGY CLIN IMMUN, V73, P516, DOI 10.1016/0091-6749(84)90363-4; JUDGE MR, 1994, BRIT J DERMATOL, V131, P615, DOI 10.1111/j.1365-2133.1994.tb04971.x; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; Martinati LC, 1996, AM J RESP CRIT CARE, V153, P1682, DOI 10.1164/ajrccm.153.5.8630620; MEYERS DA, 1994, GENOMICS, V23, P464, DOI 10.1006/geno.1994.1524; Ober C, 1998, HUM MOL GENET, V7, P1393, DOI 10.1093/hmg/7.9.1393; RAJKA G, 1989, ACTA DERM-VENEREOL, P13; Rosenwasser LJ, 1997, INT ARCH ALLERGY IMM, V113, P61, DOI 10.1159/000237509; Schechter NM, 1998, J CELL PHYSIOL, V176, P365, DOI 10.1002/(SICI)1097-4652(199808)176:2<365::AID-JCP15>3.0.CO;2-2; SHIRAKAWA T, 1994, CLIN GENET, V46, P228; THOMAS WR, 1993, CLIN EXP ALLERGY, V23, P350, DOI 10.1111/j.1365-2222.1993.tb00338.x; Tobe VO, 1996, NUCLEIC ACIDS RES, V24, P3728, DOI 10.1093/nar/24.19.3728; Vorechovsky I, 1999, AM J HUM GENET, V64, P1096, DOI 10.1086/302326; Walley AJ, 2001, GENOMICS, V72, P15, DOI 10.1006/geno.2000.6435; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P406, DOI 10.1111/j.1365-2133.1994.tb08532.x; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x	31	283	298	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2001	29	2					175	178		10.1038/ng728	http://dx.doi.org/10.1038/ng728			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11544479				2022-12-17	WOS:000171374100023
J	Cookson, WOCM; Ubhi, B; Lawrence, R; Abecasis, GR; Walley, AJ; Cox, HE; Coleman, R; Leaves, NI; Trembath, RC; Moffatt, MF; Harper, JI				Cookson, WOCM; Ubhi, B; Lawrence, R; Abecasis, GR; Walley, AJ; Cox, HE; Coleman, R; Leaves, NI; Trembath, RC; Moffatt, MF; Harper, JI			Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci	NATURE GENETICS			English	Article							17Q; REGION; SCAN; 3Q21; MAPS; HLA; 4Q	We have carried out a genome screen for atopic dermatitis (AD) and have identified linkage to AD on chromosomes 1q21, 17q25 and 20p. These regions correspond closely with known psoriasis loci, as does a previously identified AD locus on chromosome 3q21. The results indicate that AD is influenced by genes with general effects on dermal inflammation and immunity.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; Inst Child Hlth, London, England; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Oxford; Wellcome Centre for Human Genetics; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of Leicester	Cookson, WOCM (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	william.cookson@ndm.ox.ac.uk	Abecasis, Goncalo R/B-7840-2010; Walley, Andrew J/D-2573-2009; Cookson, William/HHC-1790-2022	Walley, Andrew J/0000-0001-7707-7549; Trembath, Richard/0000-0003-0550-3400; Abecasis, Goncalo/0000-0003-1509-1825				Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; BOS J, 2000, IMMUNOLOGY ATOPIC DE, P178; Capon F, 1999, J INVEST DERMATOL, V112, P32, DOI 10.1046/j.1523-1747.1999.00471.x; Cookson W, 1999, NATURE, V402, pB5, DOI 10.1038/35037002; Enlund F, 1999, EUR J HUM GENET, V7, P783, DOI 10.1038/sj.ejhg.5200365; Enlund F, 1999, HUM HERED, V49, P2, DOI 10.1159/000022832; Hardas BD, 1996, J INVEST DERMATOL, V106, P753, DOI 10.1111/1523-1747.ep12345807; JUHLIN L, 1969, ARCH DERMATOL, V100, P12, DOI 10.1001/archderm.100.1.12; LARSEN FS, 1993, J AM ACAD DERMATOL, V28, P719, DOI 10.1016/0190-9622(93)70099-F; LARSEN FS, 1986, J AM ACAD DERMATOL, V15, P487; Lee YA, 2000, NAT GENET, V26, P470, DOI 10.1038/82625; Matthews D, 1996, NAT GENET, V14, P231, DOI 10.1038/ng1096-231; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; TOMFOHRDE J, 1994, SCIENCE, V264, P1141, DOI 10.1126/science.8178173; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813	15	283	295	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2001	27	4					372	373		10.1038/86867	http://dx.doi.org/10.1038/86867			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279517				2022-12-17	WOS:000167811200010
J	Zhao, Q; Feng, Q; Lu, HY; Li, Y; Wang, A; Tian, QL; Zhan, QL; Lu, YQ; Huang, T; Wang, YC; Fan, DL; Zhao, Y; Wang, ZQ; Zhou, CC; Chen, JY; Zhu, CR; Li, WJ; Weng, QJ; Xu, Q; Wang, ZX; Wei, XH; Han, B; Huang, XH				Zhao, Qiang; Feng, Qi; Lu, Hengyun; Li, Yan; Wang, Ahong; Tian, Qilin; Zhan, Qilin; Lu, Yiqi; Huang, Tao; Wang, Yongchun; Fan, Danlin; Zhao, Yan; Wang, Ziqun; Zhou, Congcong; Chen, Jiaying; Zhu, Chuanrang; Li, Wenjun; Weng, Qijun; Xu, Qun; Wang, Zi-Xuan; Wei, Xinghua; Han, Bin; Huang, Xuehui			Pan-genome analysis highlights the extent of genomic variation in cultivated and wild rice	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCUS; FULL-LENGTH CDNAS; WIDE ASSOCIATION; AGRONOMIC TRAITS; FLOWERING-TIME; ARABIDOPSIS-THALIANA; SEQUENCE DIVERGENCE; NATURAL VARIATION; OPEN SOFTWARE; ORYZA-SATIVA	The rich genetic diversity in Oryza sativa and Oryza rufipogon serves as the main sources in rice breeding. Large-scale resequencing has been undertaken to discover allelic variants in rice, but much of the information for genetic variation is often lost by direct mapping of short sequence reads onto the O. sativa japonica Nipponbare reference genome. Here we constructed a pan-genome dataset of the O. sativa-O. rufipogon species complex through deep sequencing and de novo assembly of 66 divergent accessions. Intergenomic comparisons identified 23 million sequence variants in the rice genome. This catalog of sequence variations includes many known quantitative trait nucleotides and will be helpful in pinpointing new causal variants that underlie complex traits. In particular, we systemically investigated the whole set of coding genes using this pan-genome data, which revealed extensive presence and absence of variation among rice accessions. This pan-genome resource will further promote evolutionary and functional studies in rice.	[Zhao, Qiang; Feng, Qi; Lu, Hengyun; Li, Yan; Wang, Ahong; Tian, Qilin; Zhan, Qilin; Lu, Yiqi; Huang, Tao; Wang, Yongchun; Fan, Danlin; Zhao, Yan; Wang, Ziqun; Zhou, Congcong; Chen, Jiaying; Zhu, Chuanrang; Li, Wenjun; Weng, Qijun; Wang, Zi-Xuan; Han, Bin; Huang, Xuehui] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS Ctr Excellence Mol Plant Sci, Natl Ctr Gene Res,Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Xu, Qun; Wei, Xinghua] Chinese Acad Agr Sci, China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Huang, Xuehui] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Shanghai Normal University	Huang, XH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, CAS Ctr Excellence Mol Plant Sci, Natl Ctr Gene Res,Inst Plant Physiol & Ecol, Shanghai, Peoples R China.; Huang, XH (corresponding author), Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai, Peoples R China.	xhhuang@shnu.edu.cn		Feng, Qi/0000-0001-5450-1343; Huang, Xuehui/0000-0003-0529-1532	National Bioresource Project, MEXT, Japan; National Natural Science Foundation of China [91535202, 91635302]; Ministry of Science and Technology of China [2016YFD0100902]; Chinese Academy of Sciences [XDA08020101, XDPB0401]	National Bioresource Project, MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank the China National Rice Research Institute for providing the cultivated rice germplasm and the Chinese wild rice accessions. The rest of the wild rice accessions were distributed from the National Institute of Genetics, which is supported by the National Bioresource Project, MEXT, Japan. We thank Z. Ning for assistance with genome assembly. This work was funded by the National Natural Science Foundation of China (91535202 and 91635302; to X.H.), the Ministry of Science and Technology of China (2016YFD0100902; to X.H.) and the Chinese Academy of Sciences (XDA08020101 and XDPB0401; to B.H.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Asano K, 2011, P NATL ACAD SCI USA, V108, P11034, DOI 10.1073/pnas.1019490108; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chen W, 2014, NAT GENET, V46, P714, DOI 10.1038/ng.3007; Cui JJ, 2007, J INTEGR PLANT BIOL, V49, P678, DOI 10.1111/j.1744-7909.2007.00467.x; Dong JQ, 2016, P NATL ACAD SCI USA, V113, P7949, DOI 10.1073/pnas.1608775113; Fujita D, 2013, P NATL ACAD SCI USA, V110, P20431, DOI 10.1073/pnas.1310790110; Gamuyao R, 2012, NATURE, V488, P535, DOI 10.1038/nature11346; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Goudet J., 2001, CLADISTICS; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; Hirsch CN, 2014, PLANT CELL, V26, P121, DOI 10.1105/tpc.113.119982; Huang XH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7258; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huang XQ, 2011, P NATL ACAD SCI USA, V108, P4488, DOI 10.1073/pnas.1100465108; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Komatsu M, 2001, DEV BIOL, V231, P364, DOI 10.1006/dbio.2000.9988; Kover PX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000551; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/NMETH.1311, 10.1038/nmeth.1311]; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2012, BIOINFORMATICS, V28, P1838, DOI 10.1093/bioinformatics/bts280; Li XM, 2015, NAT GENET, V47, P827, DOI 10.1038/ng.3305; Li YH, 2014, NAT BIOTECHNOL, V32, P1045, DOI 10.1038/nbt.2979; Liu XH, 2007, PLANT MOL BIOL, V65, P403, DOI 10.1007/s11103-007-9174-7; Lu TT, 2008, DNA RES, V15, P285, DOI 10.1093/dnares/dsn018; Luo JH, 2013, PLANT CELL, V25, P3360, DOI 10.1105/tpc.113.113589; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Ma Y, 2015, CELL, V160, P1209, DOI 10.1016/j.cell.2015.01.046; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marouli E, 2017, NATURE, V542, P186, DOI 10.1038/nature21039; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Navarro JAR, 2017, NAT GENET, V49, P476, DOI 10.1038/ng.3784; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Rellosa MC, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-7; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sakai H, 2014, DNA RES, V21, P397, DOI 10.1093/dnares/dsu006; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Schatz MC, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0506-z; Si LZ, 2016, NAT GENET, V48, P447, DOI 10.1038/ng.3518; Song XJ, 2015, P NATL ACAD SCI USA, V112, P76, DOI 10.1073/pnas.1421127112; Sui JM, 2012, PLANT MOL BIOL REP, V30, P187, DOI 10.1007/s11105-011-0321-6; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; WANG ZY, 1995, PLANT J, V7, P613, DOI 10.1046/j.1365-313X.1995.7040613.x; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yano K, 2016, NAT GENET, V48, P927, DOI 10.1038/ng.3596; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yu BS, 2007, PLANT J, V52, P891, DOI 10.1111/j.1365-313X.2007.03284.x; Zhang JW, 2016, P NATL ACAD SCI USA, V113, pE5163, DOI 10.1073/pnas.1611012113; Zhu BF, 2011, PLANT PHYSIOL, V155, P1301, DOI 10.1104/pp.110.168500	59	282	303	27	170	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2018	50	2					279	+		10.1038/s41588-018-0041-z	http://dx.doi.org/10.1038/s41588-018-0041-z			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FV4BT	29335547	hybrid			2022-12-17	WOS:000424519200019
J	Fontebasso, AM; Papillon-Cavanagh, S; Schwartzentruber, J; Nikbakht, H; Gerges, N; Fisett, PO; Bechet, D; Faury, D; De Jay, N; Ramkissoon, LA; Corcoran, A; Jones, DTW; Sturm, D; Johann, P; Tomita, T; Goldman, S; Nagib, M; Bendel, A; Goumnerova, L; Bowers, DC; Leonard, JR; Rubin, JB; Alden, T; Browd, S; Geyer, JR; Leary, S; Jallo, G; Cohen, K; Gupta, N; Prados, MD; Carret, AS; Ellezam, B; Crevier, L; Klekner, A; Bognar, L; Hauser, P; Garami, M; Myseros, J; Dong, ZF; Siege, PM; Malkin, HL; Ligon, AH; Albrecht, S; Pfister, SM; Ligon, KL; Majewski, J; Jabado, N; Kieran, MW				Fontebasso, Adam M.; Papillon-Cavanagh, Simon; Schwartzentruber, Jeremy; Nikbakht, Hamid; Gerges, Noha; Fisett, Pierre-Olivier; Bechet, Denise; Faury, Damien; De Jay, Nicolas; Ramkissoon, Lori A.; Corcoran, Aoife; Jones, David T. W.; Sturm, Dominik; Johann, Pascal; Tomita, Tadanori; Goldman, Stewart; Nagib, Mahmoud; Bendel, Anne; Goumnerova, Liliana; Bowers, Daniel C.; Leonard, Jeffrey R.; Rubin, Joshua B.; Alden, Tord; Browd, Samuel; Geyer, J. Russell; Leary, Sarah; Jallo, George; Cohen, Kenneth; Gupta, Nalin; Prados, Michael D.; Carret, Anne-Sophie; Ellezam, Benjamin; Crevier, Louis; Klekner, Almos; Bognar, Laszlo; Hauser, Peter; Garami, Miklos; Myseros, John; Dong, Zhifeng; Siege, Peter M.; Malkin, Hay Ley; Ligon, Azra H.; Albrecht, Steffen; Pfister, Stefan M.; Ligon, Keith L.; Majewski, Jacek; Jabado, Nada; Kieran, Mark W.			Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma	NATURE GENETICS			English	Article							FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; INTRINSIC PONTINE GLIOMAS; BMP RECEPTOR; HISTONE H3.3; I RECEPTOR; GLIOBLASTOMA; GENES; MOUSE; ALK2; SUBGROUPS	Pediatric midline high-grade astrocytomas (mHGAs) are incurable with few treatment targets identified. Most tumors harbor mutations encoding p.Lys27Met in histone H3 variants. In 40 treatment-naive mHGAs, 39 analyzed by whole-exome sequencing, we find additional somatic mutations specific to tumor location. Gain-of-function mutations in ACVR1 occur in tumors of the pons in conjunction with histone H3.1 p.Lys27Met substitution, whereas FGFR1 mutations or fusions occur in thalamic tumors associated with histone H3.3 p.Lys27Met substitution. Hyperactivation of the bone morphogenetic protein (BMP)-ACVR1 developmental pathway in mHGAs harboring ACVR1 mutations led to increased levels of phosphorylated SMAD1, SMAD5 and SMAD8 and upregulation of BMP downstream early-response genes in tumor cells. Global DNA methylation profiles were significantly associated with the p.Lys27Met alteration, regardless of the mutant histone H3 variant and irrespective of tumor location, supporting the role of this substitution in driving the epigenetic phenotype. This work considerably expands the number of potential treatment targets and further justifies pretreatment biopsy in pediatric mHGA as a means to orient therapeutic efforts in this disease.	[Fontebasso, Adam M.; Jabado, Nada] McGill Univ, Montreal Childrens Hosp, Div Expt Med, Montreal, PQ H3H 1P3, Canada; [Fontebasso, Adam M.; Jabado, Nada] McGill Univ, Ctr Hlth, Montreal, PQ H3H 1P3, Canada; [Papillon-Cavanagh, Simon; Nikbakht, Hamid; Gerges, Noha; Bechet, Denise; Faury, Damien; De Jay, Nicolas; Majewski, Jacek; Jabado, Nada] McGill Univ, Dept Human Genet, Montreal, PQ H3H 1P3, Canada; [Schwartzentruber, Jeremy] Wellcome Trust Sanger Inst, Hinxton, England; [Fisett, Pierre-Olivier; Albrecht, Steffen] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Dept Pathol, Montreal, PQ H3H 1P3, Canada; [Faury, Damien] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Ramkissoon, Lori A.; Corcoran, Aoife; Ligon, Azra H.; Ligon, Keith L.] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Dept Med Oncol, Boston, MA 02115 USA; [Jones, David T. W.; Sturm, Dominik; Johann, Pascal; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Tomita, Tadanori; Alden, Tord] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Dept Neurol Surg, Chicago, IL 60611 USA; [Goldman, Stewart] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat Hematol Oncol, Chicago, IL 60611 USA; [Nagib, Mahmoud] Boston Childrens Hosp, Dept Surg, Boston, MA USA; [Bendel, Anne] Childrens Hosp & Clin Minnesota, Dept Pediat Hematol Oncol, Minneapolis, MN USA; [Goumnerova, Liliana] Boston Childrens Hosp, Dept Neurosurg, Boston, MA USA; [Goumnerova, Liliana; Ligon, Azra H.; Ligon, Keith L.] Harvard Univ, Sch Med, Boston, MA USA; [Bowers, Daniel C.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Leonard, Jeffrey R.] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO USA; [Rubin, Joshua B.] Washington Univ, Sch Med, Dept Pediat Hematol Oncol, St Louis, MO USA; [Browd, Samuel] Seattle Childrens Hosp, Dept Neurosurg, Seattle, WA USA; [Geyer, J. Russell; Leary, Sarah] Seattle Childrens Hosp, Canc & Blood Disorders Ctr, Seattle, WA USA; [Jallo, George] Johns Hopkins Univ Hosp, Dept Neurol Surg, Baltimore, MD 21287 USA; [Cohen, Kenneth] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Dept Pediat Hematol Oncol, Baltimore, MD USA; [Prados, Michael D.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Carret, Anne-Sophie] Univ Montreal, CHU St Justine, Dept Hematol Oncol, Montreal, PQ, Canada; [Ellezam, Benjamin] Univ Montreal, CHU St Justine, Dept Pathol, Montreal, PQ, Canada; [Crevier, Louis] Univ Montreal, CHU St Justine, Dept Neurosurg, Montreal, PQ, Canada; [Klekner, Almos; Bognar, Laszlo] Univ Debrecen, Med & Hlth Sci Ctr, Dept Neurosurg, Debrecen, Hungary; [Hauser, Peter; Garami, Miklos] Semmelweis Univ, Dept Pediat 2, H-1085 Budapest, Hungary; [Myseros, John] Childrens Natl Med Ctr, Dept Neurosurg, Washington, DC 20010 USA; [Dong, Zhifeng; Siege, Peter M.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada; [Malkin, Hay Ley] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Ligon, Azra H.; Ligon, Keith L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ligon, Keith L.] Boston Childrens Hosp, Dept Pathol, Boston, MA USA; [Kieran, Mark W.] Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA USA	McGill University; McGill University; McGill University; Wellcome Trust Sanger Institute; McGill University; McGill University; Harvard University; Dana-Farber Cancer Institute; Helmholtz Association; German Cancer Research Center (DKFZ); Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Harvard University; Boston Children's Hospital; Children's Hospitals & Clinics of Minnesota; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL); Washington University (WUSTL); Seattle Children's Hospital; Seattle Children's Hospital; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California San Francisco; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Debrecen; Semmelweis University; Children's National Health System; McGill University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Ligon, KL (corresponding author), Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Dept Med Oncol, Boston, MA 02115 USA.	keith_ligon@dfci.harvard.edu; jacek.majewski@mcgill.ca; nada.jabado@mcgill.ca; mark_kieran@dfci.harvard.edu	Jones, David TW/G-9588-2013; Sturm, Dominik/AAL-3689-2020; Garami, Miklós/AAK-5680-2021; Jones, David T. W./Z-1963-2019; Jabado, Nada/AAN-4026-2020; Pfister, Stefan M/F-6860-2013; Prados, Michael/N-5220-2019; Johann, Pascal David/AAT-9368-2021; Papillon-Cavanagh, Simon/AAS-8749-2020	Jones, David TW/0000-0002-2036-5141; Sturm, Dominik/0000-0003-0250-1696; Pfister, Stefan M/0000-0002-5447-5322; Papillon-Cavanagh, Simon/0000-0002-0372-2266; Kieran, Mark/0000-0003-2184-7692; Bowers, Daniel/0000-0002-3947-2481; Leary, Sarah/0000-0003-0225-6184; Nikbakht, Hamid/0000-0003-0209-5667; Schwartzentruber, Jeremy/0000-0002-6183-2092	Genome Canada; McGill University; Montreal Children's Hospital Foundation; Hungarian Scientific Research Fund (OTKA) [T-04639]; National Research and Development Fund (NKFP) [1A/002/2004]; TAMOP [-4.2.2A-11/1/KONV-2012-0025]; NCI [P01CA142536]; Zach Carson DIPG Fund at Dana-Farber Cancer Institute (DFCI); Mikey Czech Foundation; Maria Foundation; CIHR; Cedars Cancer Institute; McGill Integrated Cancer Research Training Program; Genome Quebec; Institute for Cancer Research of the Canadian Institutes for Health Research (CIHR); Chercheur Clinicien Senior Award; Ellie Kavalieros Fund (DFCI); Caroline Fund (DFCI); Ryan Harvey DIPG Fund (DFCI); Stop&Shop Pediatric Brain Tumor Program (DFCI); Pediatric Brain Tumor Clinical and Research Fund (DFCI); CIHR Systems Biology Training Program at McGill University; T.D.Trust/Montreal Children's Hospital Foundation; NATIONAL CANCER INSTITUTE [P30CA060553, P01CA142536] Funding Source: NIH RePORTER	Genome Canada(Genome Canada); McGill University; Montreal Children's Hospital Foundation; Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Research and Development Fund (NKFP); TAMOP; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Zach Carson DIPG Fund at Dana-Farber Cancer Institute (DFCI); Mikey Czech Foundation; Maria Foundation; CIHR(Canadian Institutes of Health Research (CIHR)); Cedars Cancer Institute; McGill Integrated Cancer Research Training Program; Genome Quebec; Institute for Cancer Research of the Canadian Institutes for Health Research (CIHR); Chercheur Clinicien Senior Award; Ellie Kavalieros Fund (DFCI); Caroline Fund (DFCI); Ryan Harvey DIPG Fund (DFCI); Stop&Shop Pediatric Brain Tumor Program (DFCI); Pediatric Brain Tumor Clinical and Research Fund (DFCI); CIHR Systems Biology Training Program at McGill University; T.D.Trust/Montreal Children's Hospital Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to express their sincere gratitude toward all staff at the McGill University and Genome Quebec Innovation Centre for excellent technical expertise, library preparation and sequencing. The authors are very grateful to J.-J. Lebrun (McGill University) for primer sequences and materials for SMAD signaling studies. This work was performed within the context of the I-CHANGE (International Childhood Astrocytoma Integrated Genomics and Epigenomics) Consortium and was supported by funding from Genome Canada, Genome Quebec, the Institute for Cancer Research of the Canadian Institutes for Health Research (CIHR), McGill University and the Montreal Children's Hospital Foundation. This work was also supported by Hungarian Scientific Research Fund (OTKA) contract T-04639: National Research and Development Fund (NKFP) contract 1A/002/2004 (P.H.and M.G.) and TAMOP-4.2.2A-11/1/KONV-2012-0025 (A.K. and LB.). N.J.is a member of the Penny Cole laboratory and the recipient of a Chercheur Clinicien Senior Award. J.Majewski holds a Canada Research Chair (tier 2). L.G., K.L.L. and M.W.K. are supported by NCI P01CA142536. We acknowledge the support of the Zach Carson DIPG Fund at the Dana-Farber Cancer Institute (DFCI), the Ellie Kavalieros Fund (DFCI), the Mikey Czech Foundation, the Prayer From Maria Foundation, the Hope for Caroline Fund (DFCI), the Ryan Harvey DIPG Fund (DFCI), the Stop&Shop Pediatric Brain Tumor Program (DFCI) and the Pediatric Brain Tumor Clinical and Research Fund (DFCI). A.M.F.is supported by a studentship from CIHR, as well as by an award from the CIHR Systems Biology Training Program at McGill University. D.B. is supported by a studentship from the T.D. Trust/Montreal Children's Hospital Foundation, and N. Gerges is supported by a studentship from the Cedars Cancer Institute. N.D.J. is supported by an award from the McGill Integrated Cancer Research Training Program.	Chaikuad A, 2012, J BIOL CHEM, V287, P36990, DOI 10.1074/jbc.M112.365932; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Fukuda T, 2006, GENESIS, V44, P159, DOI 10.1002/dvg.20201; Fukuda T, 2008, BIOCHEM BIOPH RES CO, V377, P905, DOI 10.1016/j.bbrc.2008.10.093; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Kishigami S, 2004, DEV BIOL, V276, P185, DOI 10.1016/j.ydbio.2004.08.042; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lahti L, 2012, DEVELOPMENT, V139, P894, DOI 10.1242/dev.071936; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Mishina Y, 1999, DEV BIOL, V213, P314, DOI 10.1006/dbio.1999.9378; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Paugh BS, 2011, J CLIN ONCOL, V29, P3999, DOI 10.1200/JCO.2011.35.5677; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shen Q, 2009, J CLIN INVEST, V119, P3462, DOI 10.1172/JCI37412; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Zarghooni M, 2010, J CLIN ONCOL, V28, P1337, DOI 10.1200/JCO.2009.25.5463; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611	22	282	290	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					462	466		10.1038/ng.2950	http://dx.doi.org/10.1038/ng.2950			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24705250	Green Accepted			2022-12-17	WOS:000335422900012
J	Sartori, R; Schirwis, E; Blaauw, B; Bortolanza, S; Zhao, JH; Enzo, E; Stantzou, A; Mouisel, E; Toniolo, L; Ferry, A; Stricker, S; Goldberg, AL; Dupont, S; Piccolo, S; Amthor, H; Sandri, M				Sartori, Roberta; Schirwis, Elija; Blaauw, Bert; Bortolanza, Sergia; Zhao, Jinghui; Enzo, Elena; Stantzou, Amalia; Mouisel, Etienne; Toniolo, Luana; Ferry, Arnaud; Stricker, Sigmar; Goldberg, Alfred L.; Dupont, Sirio; Piccolo, Stefano; Amthor, Helge; Sandri, Marco			BMP signaling controls muscle mass	NATURE GENETICS			English	Article							TGF-BETA-SUPERFAMILY; SKELETAL-MUSCLE; UBIQUITIN LIGASES; ATROPHY; MICE; IDENTIFICATION; HYPERTROPHY; DENERVATION; RECEPTORS; PROMOTER	Cell size is determined by the balance between protein synthesis and degradation. This equilibrium is affected by hormones, nutrients, energy levels, mechanical stress and cytokines. Mutations that inactivate myostatin lead to excessive muscle growth in animals and humans, but the signals and pathways responsible for this hypertrophy remain largely unknown. Here we show that bone morphogenetic protein (BMP) signaling, acting through Smad1, Smad5 and Smad8 (Smad1/5/8), is the fundamental hypertrophic signal in mice. Inhibition of BMP signaling causes muscle atrophy, abolishes the hypertrophic phenotype of myostatin-deficient mice and strongly exacerbates the effects of denervation and fasting. BMP-Smad1/5/8 signaling negatively regulates a gene (Fbxo30) that encodes a ubiquitin ligase required for muscle loss, which we named muscle ubiquitin ligase of the SCF complex in atrophy-1 (MUSA1). Collectively, these data identify a critical role for the BMP pathway in adult muscle maintenance, growth and atrophy.	[Sartori, Roberta; Bortolanza, Sergia; Sandri, Marco] Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy; [Sartori, Roberta; Blaauw, Bert; Bortolanza, Sergia; Enzo, Elena; Toniolo, Luana; Dupont, Sirio; Piccolo, Stefano; Sandri, Marco] Univ Padua, Dept Biomed Sci, Padua, Italy; [Schirwis, Elija; Stantzou, Amalia; Mouisel, Etienne; Ferry, Arnaud; Amthor, Helge] Univ Paris 06, Inst Myol,UMR, Unite Mixte 76,Assoc Inst Myol, CNRS UMR 7215,INSERM U974, Paris, France; [Schirwis, Elija; Stantzou, Amalia; Amthor, Helge] Univ Versailles St Quentin En Yvelines, UFR Unite Format & Rech Sci Sante, Montigny Le Bretonneux, France; [Schirwis, Elija] Max Delbruck Ctr Mol Med, Berlin, Germany; [Zhao, Jinghui; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Stricker, Sigmar] Max Planck Inst Mol Genet, Dev & Dis Grp, D-14195 Berlin, Germany; [Amthor, Helge] Univ Paris 05, CHU Necker Enfants Malad, Serv Genet Med, Paris, France; [Sandri, Marco] CNR, Inst Neurosci, Padua, Italy; [Sandri, Marco] McGill Univ, Dept Med, Montreal, PQ, Canada	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; University of Padua; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Harvard University; Harvard Medical School; Max Planck Society; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Consiglio Nazionale delle Ricerche (CNR); McGill University	Sandri, M (corresponding author), Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy.	stefano.piccolo@unipd.it; helge.amthor@uvsq.fr; marco.sandri@unipd.it	ferry, arnaud/D-2816-2019; Dupont, Sirio/AAP-8133-2021; Sartori, Roberta/GRE-9950-2022; Toniolo, Luana/B-9647-2014; Stricker, Sigmar/B-9169-2009; blaauw, bert/A-7614-2014	ferry, arnaud/0000-0002-6050-4556; Toniolo, Luana/0000-0001-7160-5638; Stricker, Sigmar/0000-0002-7174-5363; blaauw, bert/0000-0002-3893-1463; PICCOLO, STEFANO/0000-0002-2037-0004; Enzo, Elena/0000-0001-9768-6368; Sartori, Roberta/0000-0002-2763-9838; Stantzou, Amalia/0000-0002-4903-6384; Mouisel, Etienne/0000-0002-4676-5709; BLAAUW, BERT/0000-0002-4167-5106; Dupont, Sirio/0000-0002-6869-1966	Telethon Italy [TCP04009]; European Research Council (ERC) [282310-MyoPHAGY]; European Union (MYOAGE) [223576]; Leducq Foundation; Italian Ministry of Education (MiUR); Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Telethon Italy(Fondazione Telethon); European Research Council (ERC)(European Research Council (ERC)European Commission); European Union (MYOAGE)(European Commission); Leducq Foundation(Leducq Foundation); Italian Ministry of Education (MiUR)(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	We gratefully acknowledge the critical reading of K. Dyar. We thank S.-J. Lee (Johns Hopkins University School of Medicine) for the kind gift of Mstn-/-mice and S. J. Burden (Skirball Institute, New York University Medical School) for the gift of MLC1f-Cre mice. HA-Skp1, Flag-Cul1 and Flag-Roc1 were kindly provided by S. H. Lecker. We acknowledge C. Beley and G. Precigout for AAV production. This work was supported by Telethon Italy (TCP04009), by the European Research Council (ERC; 282310-MyoPHAGY), by the European Union (MYOAGE, contract 223576 of Framework Programme 7), by the Leducq Foundation and by the Italian Ministry of Education (MiUR; PRIN 2010/2011) to M. S., by Associazione Italiana per la Ricerca sul Cancro (AIRC) Investigator grants to S. P. and S. D. and by a Comitato Promotore Telethon Grant, the AIRC Special Program Molecular Clinical Oncology" 5 per Mille," HSFP, Excellence-IIT and Epigenetics Flagship project CNR-MiUR grants to S. P., by the Association Francaise contre les Myopathies to H. A., E. S., A. S. and A. F., by the Agence Nationale de la Recherche to H. A. (ANR-12-BSV1-0038) and by the Deutsche Forschungsgemeinschaft and the Universite Franco-Allemand (as part of the MyoGrad International Graduate School for Myology GK 1631/1 and CDFA-06-11) to S. S., H. A., A. S. and E. S. E. E. is the recipient of a CARIPARO Foundation PhD fellowship.	Akiyama S, 1997, EXP CELL RES, V235, P362, DOI 10.1006/excr.1997.3680; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Blaauw B, 2008, HUM MOL GENET, V17, P3686, DOI 10.1093/hmg/ddn264; Blaauw B, 2009, FASEB J, V23, P3896, DOI 10.1096/fj.09-131870; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Gomes AV, 2012, FASEB J, V26, P2986, DOI 10.1096/fj.12-204495; Hirner S, 2008, J MOL BIOL, V379, P666, DOI 10.1016/j.jmb.2008.03.049; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Krause C, 2011, INT J BIOCHEM CELL B, V43, P478, DOI 10.1016/j.biocel.2011.01.007; Le Goff C, 2012, NAT GENET, V44, P85, DOI 10.1038/ng.1016; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Miyazono Kohei, 2002, Sci STKE, V2002, ppe40, DOI 10.1126/stke.2002.151.pe40; Mouisel E, 2010, MUSCLE NERVE, V41, P809, DOI 10.1002/mus.21624; Raffaello A, 2010, J CELL BIOL, V191, P101, DOI 10.1083/jcb.201001136; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sartorelli Vittorio, 2004, Sci STKE, V2004, pre11, DOI 10.1126/stke.2442004re11; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Winbanks CE, 2013, J CELL BIOL, V203, P345, DOI 10.1083/jcb.201211134; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	34	282	295	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2013	45	11					1309	+		10.1038/ng.2772	http://dx.doi.org/10.1038/ng.2772			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	244JL	24076600				2022-12-17	WOS:000326384100011
J	Maller, JB; McVean, G; Byrnes, J; Vukcevic, D; Palin, K; Su, Z; Howson, JMM; Auton, A; Myers, S; Morris, A; Pirinen, M; Brown, MA; Burton, PR; Caulfield, MJ; Compston, A; Farrall, M; Hall, AS; Hattersley, AT; Hill, AVS; Mathew, CG; Pembrey, M; Satsangi, J; Stratton, MR; Worthington, J; Craddock, N; Hurles, M; Ouwehand, W; Parkes, M; Rahman, N; Duncanson, A; Todd, JA; Kwiatkowski, DP; Samani, NJ; Gough, SCL; McCarthy, MI; Deloukas, P; Donnelly, P				Maller, Julian B.; McVean, Gilean; Byrnes, Jake; Vukcevic, Damjan; Palin, Kimmo; Su, Zhan; Howson, Joanna M. M.; Auton, Adam; Myers, Simon; Morris, Andrew; Pirinen, Matti; Brown, Matthew A.; Burton, Paul R.; Caulfield, Mark J.; Compston, Alastair; Farrall, Martin; Hall, Alistair S.; Hattersley, Andrew T.; Hill, Adrian V. S.; Mathew, Christopher G.; Pembrey, Marcus; Satsangi, Jack; Stratton, Michael R.; Worthington, Jane; Craddock, Nick; Hurles, Matthew; Ouwehand, Willem; Parkes, Miles; Rahman, Nazneen; Duncanson, Audrey; Todd, John A.; Kwiatkowski, Dominic P.; Samani, Nilesh J.; Gough, Stephen C. L.; McCarthy, Mark I.; Deloukas, Panagiotis; Donnelly, Peter		Wellcome Trust Case Control Consor	Bayesian refinement of association signals for 14 loci in 3 common diseases	NATURE GENETICS			English	Article								To further investigate susceptibility loci identified by genome-wide association studies, we genotyped 5,500 SNPs across 14 associated regions in 8,000 samples from a control group and 3 diseases: type 2 diabetes (T2D), coronary artery disease (CAD) and Graves' disease. We defined, using Bayes theorem, credible sets of SNPs that were 95% likely, based on posterior probability, to contain the causal disease-associated SNPs. In 3 of the 14 regions, TCF7L2 (T2D), CTLA4 (Graves' disease) and CDKN2A-CDKN2B (T2D), much of the posterior probability rested on a single SNP, and, in 4 other regions (CDKN2A-CDKN2B (CAD) and CDKAL1, FTO and HHEX (T2D)), the 95% sets were small, thereby excluding most SNPs as potentially causal. Very few SNPs in our credible sets had annotated functions, illustrating the limitations in understanding the mechanisms underlying susceptibility to common diseases. Our results also show the value of more detailed mapping to target sequences for functional studies.	[Maller, Julian B.; McVean, Gilean; Byrnes, Jake; Vukcevic, Damjan; Su, Zhan; Auton, Adam; Myers, Simon; Morris, Andrew; Pirinen, Matti; Farrall, Martin; Hill, Adrian V. S.; Kwiatkowski, Dominic P.; McCarthy, Mark I.; Donnelly, Peter] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Maller, Julian B.; McVean, Gilean; Myers, Simon; Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Palin, Kimmo; Stratton, Michael R.; Hurles, Matthew; Ouwehand, Willem; Kwiatkowski, Dominic P.; Deloukas, Panagiotis] Wellcome Trust Sanger Inst, Cambridge, England; [Howson, Joanna M. M.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Cambridge, England; [Howson, Joanna M. M.; Todd, John A.] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Juvenile Diabet Res Fdn,Wellcome Trust Diabet & I, Cambridge, England; [Brown, Matthew A.] Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld, Australia; [Burton, Paul R.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Burton, Paul R.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Caulfield, Mark J.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Clin Pharmacol & Barts & London Genome Ctr, London, England; [Compston, Alastair] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Hall, Alistair S.] Univ Leeds, LIGHT, MCRC, Leeds, W Yorkshire, England; [Hattersley, Andrew T.] Univ Exeter, Peninsula Coll Med & Dent, Exeter, Devon, England; [Mathew, Christopher G.] Kings Coll London, Sch Med, Guys Hosp, Dept Med & Mol Genet, London WC2R 2LS, England; [Pembrey, Marcus] UCL, Inst Child Hlth, Clin & Mol Genet Unit, London, England; [Satsangi, Jack] Univ Edinburgh, Western Gen Hosp, Sch Mol & Clin Med, Gastrointestinal Unit, Edinburgh, Midlothian, Scotland; [Stratton, Michael R.; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Worthington, Jane] Univ Manchester, Arthritis Res UK Epidemiol Unit, Manchester, Lancs, England; [Craddock, Nick] Cardiff Univ, Sch Med, Ctr Neuropsychiat Genet & Genom, MRC, Cardiff, S Glam, Wales; [Ouwehand, Willem] Univ Cambridge, Dept Haematol, Cambridge, England; [Ouwehand, Willem] Cambridge Ctr, Natl Hlth Serv Blood & Transplant, Cambridge, England; [Parkes, Miles] Addenbrookes Hosp, Inflammatory Bowel Dis Genet Res Grp, Cambridge, England; [Duncanson, Audrey] Wellcome Trust Res Labs, London, England; [Samani, Nilesh J.] Univ Leicester, Glenfield Gen Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Samani, Nilesh J.] Glenfield Gen Hosp, Leicester Natl Inst Hlth Res NIHR, Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England; [Gough, Stephen C. L.; McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Med, Oxford, England; [Gough, Stephen C. L.; McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; Nuffield Orthopaedic Centre; University of Oxford; University of Queensland; University of Leicester; University of Leicester; University of London; Queen Mary University London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Leeds; University of Exeter; University of Plymouth; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London; University of Edinburgh; University of London; Institute of Cancer Research - UK; University of Manchester; Cardiff University; University of Cambridge; NHS Blood & Transplant (NHSBT); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Oxford; University of Oxford	Donnelly, P (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	donnelly@well.ox.ac.uk	Worthington, Jane/M-9770-2014; Dominiczak, Anna F/P-9390-2017; Burton, Paul R/H-7527-2016; Hall, Alistair/K-1953-2019; Palin, Kimmo/ABG-5710-2020; Mathew, Christopher G/G-3434-2015; Deloukas, Panos/B-2922-2013; eyre, stephen/K-3776-2017; Brown, Matthew A/E-5749-2010; Myers, Simon R/A-6792-2015; Todd, John A/A-3542-2010; McCarthy, Mark/M-3763-2015; Rahman, Nazneen/D-2802-2013	Worthington, Jane/0000-0003-0544-042X; Dominiczak, Anna F/0000-0003-4913-3608; Palin, Kimmo/0000-0002-4621-6128; Mathew, Christopher G/0000-0003-4178-1838; Deloukas, Panos/0000-0001-9251-070X; eyre, stephen/0000-0002-1251-6974; Brown, Matthew A/0000-0003-0538-8211; Myers, Simon R/0000-0002-2585-9626; Todd, John A/0000-0003-2740-8148; Wallace, Chris/0000-0001-9755-1703; Munroe, Patricia/0000-0002-4176-2947; Zeggini, Eleftheria/0000-0003-4238-659X; Howson, Joanna/0000-0001-7618-0050; Hocking, Lynne J/0000-0002-2414-2826; Lindgren, Cecilia/0000-0002-4903-9374; Pirinen, Matti/0000-0002-1664-1350; McCarthy, Mark/0000-0002-4393-0510; McVean, Gil/0000-0002-5012-4162; Caulfield, Mark/0000-0001-9295-3594; Vukcevic, Damjan/0000-0001-7780-9586; Weedon, Michael/0000-0002-6174-6135; Burren, Oliver/0000-0002-3388-5760; Harrison, Pille/0000-0003-4117-6910; Newman, William/0000-0002-6382-4678; Massey, Dunecan/0000-0002-7144-4579; Maller, Julian/0000-0002-1565-9559; Donnelly, Peter/0000-0001-9495-3408; Mentzer, Alexander/0000-0002-4502-2209; Walker, Neil/0000-0001-9796-7688; Parkes, Miles/0000-0002-6467-0631; Lango Allen, Hana/0000-0002-7803-8688; Hattersley, Andrew/0000-0001-5620-473X; Wain, Louise/0000-0003-4951-1867; Rahman, Nazneen/0000-0003-4376-0440; Kwiatkowski, Dominic/0000-0002-5023-0176; Ouwehand, Willem/0000-0002-7744-1790; Hall, Alistair/0000-0003-0306-7887; bennett, amanda/0000-0003-2140-8710	Wellcome Trust; UK Medical Research Council; Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory; NIHR Biomedical Research Centers; MRC [G9521010, G19/9, G0800759, G0600329, G1100226, G0800675] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [G9521010, G0801418B, G0600329, G19/9, G0800759, G0800675, G1100226, G0600718B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10275, NF-SI-0508-10335, NF-SI-0611-10219] Funding Source: researchfish; Chief Scientist Office [ETM/75, ETM/137, CZB/4/540] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory; NIHR Biomedical Research Centers; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	We are grateful to D. Altshuler and colleagues at the Broad Institute for provision of SNP discovery information in some of our fine-mapping regions. We acknowledge the many physicians, research fellows and research nurses who contributed to the various case collections and the collection teams and senior management of the UK Blood Services responsible for the UK Blood Services Collection. The principal funder of the project was the Wellcome Trust. For the 1958 Birth Cohort, venous blood collection was funded by the UK Medical Research Council, and cell line production and DNA extraction and processing were funded by the Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory. Many of the authors of this paper received funding from the NIHR Biomedical Research Centers.	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Peden JF, 2011, HUM MOL GENET, V20, pR198, DOI 10.1093/hmg/ddr384; Steinman L, 2010, NAT IMMUNOL, V11, P41, DOI 10.1038/ni.1803; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639	7	282	285	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1294	1301		10.1038/ng.2435	http://dx.doi.org/10.1038/ng.2435			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23104008	Green Accepted, Green Published			2022-12-17	WOS:000311713200005
J	Kumar, V; Kato, N; Urabe, Y; Takahashi, A; Muroyama, R; Hosono, N; Otsuka, M; Tateishi, R; Omata, M; Nakagawa, H; Koike, K; Kamatani, N; Kubo, M; Nakamura, Y; Matsuda, K				Kumar, Vinod; Kato, Naoya; Urabe, Yuji; Takahashi, Atsushi; Muroyama, Ryosuke; Hosono, Naoya; Otsuka, Motoyuki; Tateishi, Ryosuke; Omata, Masao; Nakagawa, Hidewaki; Koike, Kazuhiko; Kamatani, Naoyuki; Kubo, Michiaki; Nakamura, Yusuke; Matsuda, Koichi			Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma	NATURE GENETICS			English	Article							HEPATITIS-C VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I; T-CELLS; GENETIC-VARIATION; HAPLOTYPE MAP; CHAIN-A; MICA; MHC; EXPRESSION	To identify the genetic susceptibility factor(s) for hepatitis C virus-induced hepatocellular carcinoma (HCV-induced HCC), we conducted a genome-wide association study using 432,703 autosomal SNPs in 721 individuals with HCV-induced HCC (cases) and 2,890 HCV-negative controls of Japanese origin. Eight SNPs that showed possible association (P < 1 x 10(-5)) in the genome-wide association study were further genotyped in 673 cases and 2,596 controls. We found a previously unidentified locus in the 5' flanking region of MICA on 6p21.33 (rs2596542, P-combined = 4.21 x 10(-13), odds ratio = 1.39) to be strongly associated with HCV-induced HCC. Subsequent analyses using individuals with chronic hepatitis C (CHC) indicated that this SNP is not associated with CHC susceptibility (P = 0.61) but is significantly associated with progression from CHC to HCC (P = 3.13 x 10(-8)). We also found that the risk allele of rs2596542 was associated with lower soluble MICA protein levels in individuals with HCV-induced HCC (P = 1.38 x 10(-13)).	[Kumar, Vinod; Urabe, Yuji; Nakamura, Yusuke; Matsuda, Koichi] Univ Tokyo, Lab Mol Med, Ctr Human Genome, Inst Med Sci, Tokyo, Japan; [Kumar, Vinod; Takahashi, Atsushi; Hosono, Naoya; Nakagawa, Hidewaki; Kamatani, Naoyuki; Kubo, Michiaki; Nakamura, Yusuke] Inst Phys & Chem Res RIKEN, Ctr Genom Med, Kanagawa, Japan; [Kato, Naoya; Muroyama, Ryosuke] Univ Tokyo, Unit Dis Control Genome Med, Inst Med Sci, Tokyo, Japan; [Otsuka, Motoyuki; Tateishi, Ryosuke; Omata, Masao; Koike, Kazuhiko] Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Tokyo, Japan	University of Tokyo; RIKEN; University of Tokyo; University of Tokyo	Matsuda, K (corresponding author), Univ Tokyo, Lab Mol Med, Ctr Human Genome, Inst Med Sci, Tokyo, Japan.	koichima@ims.u-tokyo.ac.jp	Tateishi, Ryosuke/G-7758-2014; Kubo, Michiaki/N-7947-2015; Otsuka, Motoyuki/H-9067-2019; Kumar, Vinod/ABC-4866-2020; Matsuda, Koichi/D-4597-2011	Tateishi, Ryosuke/0000-0003-3021-2517; Otsuka, Motoyuki/0000-0003-2869-2881; Kumar, Vinod/0000-0002-2775-6049; Matsuda, Koichi/0000-0001-7292-2686	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank all the subjects and the members of the Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan who donated their DNA for this work. We also thank the technical staff of the Laboratory for Genotyping Development, Center for Genomic Medicine, RIKEN, and the Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, the University of Tokyo. This work was conducted as a part of the BioBank Japan Project that was supported by the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government.	[Anonymous], 1999, NATURE, V401, P921; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Breslow N. E, 1987, IARC SCI PUBL, V1-406; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Doubrovina ES, 2003, J IMMUNOL, V171, P6891, DOI 10.4049/jimmunol.171.12.6891; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Hutin Y, 2004, J CLIN PHARMACOL, V44, P20, DOI 10.1177/0091270003258669; Jinushi M, 2005, J HEPATOL, V43, P1013, DOI 10.1016/j.jhep.2005.05.026; Jinushi M, 2003, INT J CANCER, V104, P354, DOI 10.1002/ijc.10966; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kohga K, 2008, CANCER SCI, V99, P1643, DOI 10.1111/j.1349-7006.2008.00859.x; Kuniholm MH, 2010, HEPATOLOGY, V51, P1514, DOI 10.1002/hep.23515; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Ota M, 1997, TISSUE ANTIGENS, V49, P448, DOI 10.1111/j.1399-0039.1997.tb02778.x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Schutte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SIMMONDS P, 1994, J GEN VIROL, V75, P1053, DOI 10.1099/0022-1317-75-5-1053; Singh R, 2007, WORLD J GASTROENTERO, V13, P1770, DOI 10.3748/wjg.v13.i12.1770; TANAKA T, 1994, HEPATOLOGY, V19, P1347, DOI 10.1016/0270-9139(94)90226-7; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; TSUKIYAMAKOHARA K, 1991, VIRUS GENES, V5, P243, DOI 10.1007/BF00568974; Umemura T, 2009, J GASTROENTEROL, V44, P102, DOI 10.1007/s00535-008-2251-0; Vong S, 2004, HEPATOLOGY, V39, P476, DOI 10.1002/hep.20049; Waldhauer I, 2008, CANCER RES, V68, P6368, DOI 10.1158/0008-5472.CAN-07-6768; Wang JH, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-46; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236	39	282	292	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2011	43	5					455	+		10.1038/ng.809	http://dx.doi.org/10.1038/ng.809			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	755XF	21499248				2022-12-17	WOS:000289972600016
J	Jin, J; Huang, W; Gao, JP; Yang, J; Shi, M; Zhu, MZ; Luo, D; Lin, HX				Jin, Jian; Huang, Wei; Gao, Ji-Ping; Yang, Jun; Shi, Min; Zhu, Mei-Zhen; Luo, Da; Lin, Hong-Xuan			Genetic control of rice plant architecture under domestication	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCUS; ZINC-FINGER PROTEINS; TOMATO FRUIT; EVOLUTION; ORIGIN; MAIZE; ARABIDOPSIS; ENCODES; SIZE; DNA	The closely related wild rice species Oryza rufipogon is considered the progenitor of cultivated rice (Oryza sativa)(1-5). The transition from the characteristic plant architecture of wild rice to that of cultivated rice was one of the most important events in rice domestication; however, the molecular basis of this key domestication transition has not been elucidated. Here we show that the PROG1 gene controls aspects of wild-rice plant architecture, including tiller angle and number of tillers. The gene encodes a newly identified zinc-finger nuclear transcription factor with transcriptional activity and is mapped on chromosome 7. PROG1 is predominantly expressed in the axillary meristems, the site of tiller bud formation. Rice transformation experiments demonstrate that artificial selection of an amino acid substitution in the PROG1 protein during domestication led to the transition from the plant architecture of wild rice to that of domesticated rice.	[Jin, Jian; Huang, Wei; Gao, Ji-Ping; Yang, Jun; Shi, Min; Zhu, Mei-Zhen; Luo, Da; Lin, Hong-Xuan] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Lin, HX (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, 300 Fenglin Rd, Shanghai 200032, Peoples R China.	hxlin@sibs.ac.cn		Gao, Ji-Ping/0000-0002-8968-4423	Ministry of Science and Technology of China; National Natural Science Foundation of China; Chinese Academy of Sciences; Shanghai Science and Technology Development Fund	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Science and Technology Development Fund	We thank Z.-Z. Piao and X.-M. Li for technical assistance. We thank S. Luan for critically reading the manuscript. This work was supported by grants from the Ministry of Science and Technology of China, the National Natural Science Foundation of China, the Chinese Academy of Sciences and the Shanghai Science and Technology Development Fund to H.-X.L.	CHANT S, 1995, GENDER PLACE CULT, V2, P147; Cheng CY, 2003, MOL BIOL EVOL, V20, P67, DOI 10.1093/molbev/msg004; COEN ES, 1990, CELL, V63, P1311, DOI 10.1016/0092-8674(90)90426-F; Cong B, 2008, NAT GENET, V40, P800, DOI 10.1038/ng.144; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Hao Wei, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P354; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Lin RC, 2007, SCIENCE, V318, P1302, DOI 10.1126/science.1146281; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Oka H. I., 1988, Origin of cultivated rice.; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Sharma SD, 2000, RICE BREEDING AND GENETICS, P349; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Vaughan DA, 2003, CURR OPIN PLANT BIOL, V6, P139, DOI 10.1016/S1369-5266(03)00009-8; Vitte C, 2004, MOL GENET GENOMICS, V272, P504, DOI 10.1007/s00438-004-1069-6; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Yu BS, 2007, PLANT J, V52, P891, DOI 10.1111/j.1365-313X.2007.03284.x	30	282	353	14	182	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1365	1369		10.1038/ng.247	http://dx.doi.org/10.1038/ng.247			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18820696				2022-12-17	WOS:000260501500032
J	Krishnan, KJ; Reeve, AK; Samuels, DC; Chinnery, PF; Blackwood, JK; Taylor, RW; Wanrooij, S; Spelbrink, JN; Lightowlers, RN; Turnbull, DM				Krishnan, Kim J.; Reeve, Amy K.; Samuels, David C.; Chinnery, Patrick F.; Blackwood, John K.; Taylor, Robert W.; Wanrooij, Sjoerd; Spelbrink, Johannes N.; Lightowlers, Robert N.; Turnbull, Doug M.			What causes mitochondrial DNA deletions in human cells?	NATURE GENETICS			English	Article							AICARDI-GOUTIERES-SYNDROME; SUBSTANTIA-NIGRA NEURONS; DOUBLE-STRAND BREAKS; EXTERNAL OPHTHALMOPLEGIA; ESCHERICHIA-COLI; COMMON DELETION; MTDNA DELETIONS; LAGGING-STRAND; MUSCLE-FIBERS; HUMAN-DISEASE	Mitochondrial DNA (mtDNA) deletions are a primary cause of mitochondrial disease and are likely to have a central role in the aging of postmitotic tissues. Understanding the mechanism of the formation and subsequent clonal expansion of these mtDNA deletions is an essential first step in trying to prevent their occurrence. We review the previous literature and recent results from our own laboratories, and conclude that mtDNA deletions are most likely to occur during repair of damaged mtDNA rather than during replication. This conclusion has important implications for prevention of mtDNA disease and, potentially, for our understanding of the aging process.	[Krishnan, Kim J.; Reeve, Amy K.; Chinnery, Patrick F.; Blackwood, John K.; Taylor, Robert W.; Lightowlers, Robert N.; Turnbull, Doug M.] Univ Newcastle Upon Tyne, Mitochondrial Res Grp, Sch Med, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Krishnan, Kim J.; Turnbull, Doug M.] Univ Newcastle Upon Tyne, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Samuels, David C.] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Wanrooij, Sjoerd; Spelbrink, Johannes N.] Inst Med Technol, Tampere 33014, Finland; [Wanrooij, Sjoerd; Spelbrink, Johannes N.] Tampere Univ Hosp, Tampere 33014, Finland; [Wanrooij, Sjoerd] Karolinska Inst, Dept Metab Dis, SE-14186 Huddinge, Sweden	Newcastle University - UK; Newcastle University - UK; Virginia Polytechnic Institute & State University; Tampere University; Tampere University Hospital; Karolinska Institutet	Krishnan, KJ (corresponding author), Univ Newcastle Upon Tyne, Mitochondrial Res Grp, Sch Med, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.	d.m.turnbull@ncl.ac.uk	Samuels, David C/A-5393-2008; Samuels, David/AHC-8381-2022; Spelbrink, Johannes N/L-4661-2015; Wanrooij, Sjoerd/J-1367-2019; Samuels, David/C-1365-2012	Samuels, David C/0000-0003-3529-7791; Samuels, David/0000-0003-3529-7791; Spelbrink, Johannes N/0000-0002-9756-2602; Reeve, Amy/0000-0002-4474-2204; Blackwood, John/0000-0003-1511-7562; Wanrooij, Sjoerd/0000-0001-6126-4382; Chinnery, Patrick/0000-0002-7065-6617	MRC [G0700718] Funding Source: UKRI; Medical Research Council [G0601943B] Funding Source: researchfish; Medical Research Council [G0700718] Funding Source: Medline; Wellcome Trust [074454] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Arai T, 2006, ACTA NEUROPATHOL, V112, P139, DOI 10.1007/s00401-006-0081-9; Barnerias C, 2006, DEV MED CHILD NEUROL, V48, P227, DOI 10.1017/S001216220600048X; Barritt JA, 1999, MOL HUM REPROD, V5, P927, DOI 10.1093/molehr/5.10.927; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345; Blakely EL, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011296; Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Chan CCW, 2005, MOL HUM REPROD, V11, P843, DOI 10.1093/molehr/gah243; CHEN X, 1995, AM J HUM GENET, V57, P239; Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211; Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Hanekamp T, 1999, CURR GENET, V34, P438, DOI 10.1007/s002940050418; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Horiguchi M, 2001, CANCER RES, V61, P3913; Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Krishnan KJ, 2004, J INVEST DERMATOL, V123, P1020, DOI 10.1111/j.0022-202X.2004.23457.x; Murphy JEJ, 2005, MUTAT RES-GEN TOX EN, V585, P127, DOI 10.1016/j.mrgentox.2005.04.011; Nguyen LH, 2000, J BIOL CHEM, V275, P25900, DOI 10.1074/jbc.M002672200; Prithivirajsingh S, 2004, FEBS LETT, V571, P227, DOI 10.1016/j.febslet.2004.06.078; Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018; ROBBERSO.DL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810; Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003; SARGENTINI NJ, 1992, MUTAT RES, V265, P83, DOI 10.1016/0027-5107(92)90041-Y; Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217; SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082; Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; THACKER J, 1992, NUCLEIC ACIDS RES, V20, P6183, DOI 10.1093/nar/20.23.6183; VanGoethem G, 1997, EUR J NEUROL, V4, P476; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; Wang GJ, 1997, BIOCHEM PHARMACOL, V54, P181, DOI 10.1016/S0006-2952(97)00158-5; Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634; Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392; YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164	48	282	294	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2008	40	3					275	279		10.1038/ng.f.94	http://dx.doi.org/10.1038/ng.f.94			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18305478				2022-12-17	WOS:000253548400015
J	Padiath, QS; Saigoh, K; Schiffmann, R; Asahara, H; Yamada, T; Koeppen, A; Hogan, K; Ptacek, LJ; Fu, YH				Padiath, Quasar S.; Saigoh, Kazumasa; Schiffmann, Raphael; Asahara, Hideaki; Yamada, Takeshi; Koeppen, Anulf; Hogan, Kirk; Ptacek, Louis J.; Fu, Ying-Hui			Lamin B1 duplications cause autosomal dominant leukodystrophy	NATURE GENETICS			English	Article							PROGRESSIVE MULTIPLE-SCLEROSIS; DREIFUSS MUSCULAR-DYSTROPHY; PELIZAEUS-MERZBACHER-DISEASE; NUCLEAR LAMINS; PARTIAL LIPODYSTROPHY; GENE-EXPRESSION; DNA-SEQUENCES; HUMAN TISSUES; DROSOPHILA; PROTEIN	Adult-onset autosomal dominant leukodystrophy (ADLD) is a slowly progressive neurological disorder characterized by symmetrical widespread myelin loss in the central nervous system, with a phenotype similar to chronic progressive multiple sclerosis. In this study, we identify a genomic duplication that causes ADLD. Affected individuals carry an extra copy of the gene for the nuclear laminar protein lamin B1, resulting in increased gene dosage in brain tissue from individuals with ADLD. Increased expression of lamin B1 in Drosophila melanogaster resulted in a degenerative phenotype. In addition, an abnormal nuclear morphology was apparent when cultured cells overexpressed this protein. This is the first human disease attributable to mutations in the gene encoding lamin B1. Antibodies to lamin B are found in individuals with autoimmune diseases, and it is also an antigen recognized by a monoclonal antibody raised against plaques from brains of individuals with multiple sclerosis. This raises the possibility that lamin B may be a link to the autoimmune attack that occurs in multiple sclerosis.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; NINDS, Dev & Metab Neurol Branch, NIH, Bethesda, MD 20892 USA; Kyushu Univ, Fac Med, Dept Neurol, Fukuoka 812, Japan; Iizuka Hosp, Dept Neurol, Iizuka, Fukuoka, Japan; Albany Med Coll, Vet Adm Med Ctr, Albany, NY 12208 USA; Albany Med Coll, Dept Neurol, Albany, NY 12208 USA; Univ Wisconsin, Dept Anesthesiol, Madison, WI 53792 USA; Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Kyushu University; Albany Medical College; US Department of Veterans Affairs; Veterans Health Administration (VHA); Albany Medical College; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute	Fu, YH (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.	yhf@neugenes.org	saigoh, Kazumasa/AFK-6417-2022; Saigoh, Kazumasa/AAG-2956-2020; saigoh, Kazumasa/AAG-4678-2022	Saigoh, Kazumasa/0000-0002-0905-5935; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041331, Z01NS002984] Funding Source: NIH RePORTER; NINDS NIH HHS [NS41331] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aarskog NK, 2000, HUM GENET, V107, P494, DOI 10.1007/s004390000399; Asahara H, 1996, Rinsho Shinkeigaku, V36, P968; Ausubel F., 1999, CURRENT PROTOCOLS MO; Bainton RJ, 2005, CELL, V123, P145, DOI 10.1016/j.cell.2005.07.029; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Boor PKI, 2005, J NEUROPATH EXP NEUR, V64, P412; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broers JLV, 1997, HISTOCHEM CELL BIOL, V107, P505, DOI 10.1007/s004180050138; Coffeen CM, 2000, HUM MOL GENET, V9, P787, DOI 10.1093/hmg/9.5.787; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; ELDRIDGE R, 1984, NEW ENGL J MED, V311, P948, DOI 10.1056/NEJM198410113111504; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Favreau C, 2003, EXP CELL RES, V282, P14, DOI 10.1006/excr.2002.5669; Garcia DM, 2003, BRAIN RES, V976, P9, DOI 10.1016/S0006-8993(03)02597-6; Gillert E, 1999, ONCOGENE, V18, P4663, DOI 10.1038/sj.onc.1202842; Glatt CE, 2001, NAT GENET, V27, P435, DOI 10.1038/86948; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Guillemin K, 2001, NAT CELL BIOL, V3, P848, DOI 10.1038/ncb0901-848; Haithcock E, 2005, P NATL ACAD SCI USA, V102, P16690, DOI [10.1073/pnas.0506955102, 10.1073/pnas.0506755102]; Hegele RA, 2006, AM J HUM GENET, V79, P383, DOI 10.1086/505885; Inoue K, 2002, AM J HUM GENET, V71, P838, DOI 10.1086/342728; Inoue K, 2005, NEUROGENETICS, V6, P1, DOI 10.1007/s10048-004-0207-y; Lin F, 1997, EXP CELL RES, V236, P378, DOI 10.1006/excr.1997.3735; LIN F, 1995, GENOMICS, V27, P230, DOI 10.1006/geno.1995.1036; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Mignot C, 2004, CELL MOL LIFE SCI, V61, P369, DOI 10.1007/s00018-003-3143-3; Moisan E, 2006, J LEUKOCYTE BIOL, V79, P489, DOI 10.1189/jlb.0405190; POLLARD KM, 1990, MOL CELL BIOL, V10, P2164, DOI 10.1128/MCB.10.5.2164; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Schiffmann R, 2004, CURR OPIN NEUROL, V17, P187, DOI 10.1097/00019052-200404000-00017; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; SCHWANKHAUS JD, 1994, ARCH NEUROL-CHICAGO, V51, P757, DOI 10.1001/archneur.1994.00540200033013; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; SEBOUN E, 1997, MOL GENETIC BASIS NE, P631; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Somech R, 2005, PEDIATR RES, V57, p8R, DOI 10.1203/01.PDR.0000159566.54287.6C; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Super HG, 1997, GENE CHROMOSOME CANC, V20, P185, DOI 10.1002/(SICI)1098-2264(199710)20:2<185::AID-GCC9>3.0.CO;2-#; TAN EM, 1988, ANN INTERN MED, V108, P897, DOI 10.7326/0003-4819-108-6-897; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1111/j.1574-6968.1999.tb13575.x; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; Woodward KJ, 2005, AM J HUM GENET, V77, P966, DOI 10.1086/498048; Worman HJ, 2005, INT REV CYTOL, V246, P231, DOI 10.1016/S0074-7696(05)46006-4; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981	50	282	295	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1114	1123		10.1038/ng1872	http://dx.doi.org/10.1038/ng1872			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16951681				2022-12-17	WOS:000241251100010
J	Clark, RM; Wagler, TN; Quijada, P; Doebley, J				Clark, RM; Wagler, TN; Quijada, P; Doebley, J			A distant upstream enhancer at the maize domestication gene tb1 has pleiotropic effects on plant and inflorescent architecture	NATURE GENETICS			English	Article							MORPHOLOGICAL DIFFERENCES; QUANTITATIVE TRAITS; GENOME EVOLUTION; FLOWERING PLANTS; FRUIT SIZE; TEOSINTE; ORIGIN; MECHANISMS; EXPRESSION; DOMINANCE	Although quantitative trait locus (QTL) mapping has been successful in describing the genetic architecture of complex traits(1-4), the molecular basis of quantitative variation is less well understood, especially in plants such as maize that have large genome sizes. Regulatory changes at the teosinte branched1 (tb1) gene have been proposed to underlie QTLs of large effect for morphological differences that distinguish maize (Zea mays ssp. mays) from its wild ancestors, the teosintes (Z. mays ssp. parviglumis and mexicana)(1,5-7). We used a fine mapping approach to show that intergenic sequences similar to 58-69 kb 5' to the tb1 cDNA confer pleiotropic effects on Z. mays morphology. Moreover, using an allele-specific expression assay, we found that sequences > 41 kb upstream of tb1 act in cis to alter tb1 transcription. Our findings show that the large stretches of noncoding DNA that comprise the majority of many plant genomes can be a source of variation affecting gene expression and quantitative phenotypes.	Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Doebley, J (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.	jdoebley@wisc.edu			NIGMS NIH HHS [GM-58816, F32 GM-65008] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058816, F32GM065008] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alonso-Blanco C, 2005, INT J DEV BIOL, V49, P717, DOI 10.1387/ijdb.051994ca; Bennetzen JL, 2005, ANN BOT-LONDON, V95, P127, DOI 10.1093/aob/mci008; Clark RM, 2004, P NATL ACAD SCI USA, V101, P700, DOI 10.1073/pnas.2237049100; DOEBLEY J, 1990, P NATL ACAD SCI USA, V87, P9888, DOI 10.1073/pnas.87.24.9888; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DOEBLEY J, 1993, GENETICS, V134, P559; DOEBLEY J, 1991, GENETICS, V129, P285; DOEBLEY J, 1995, GENETICS, V141, P333; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Lukens LN, 1999, GENET RES, V74, P291, DOI 10.1017/S0016672399004073; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; Meagher TR, 2005, NEW PHYTOL, V168, P71, DOI 10.1111/j.1469-8137.2005.01527.x; Rostoks N, 2002, FUNCT INTEGR GENOMIC, V2, P51, DOI 10.1007/s10142-002-0055-5; Salvi S, 2005, TRENDS PLANT SCI, V10, P297, DOI 10.1016/j.tplants.2005.04.008; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Sheehan MJ, 2004, GENETICS, V167, P1395, DOI 10.1534/genetics.103.026096; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Stam M, 2002, GENETICS, V162, P917; Tanksley SD, 2004, PLANT CELL, V16, pS181, DOI 10.1105/tpc.018119; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Wendel JF, 2002, GENETICA, V115, P37, DOI 10.1023/A:1016020030189; Wicker T, 2005, PLANT J, V41, P184, DOI 10.1111/j.1365-313X.2004.02285.x; Wicker T, 2001, PLANT J, V26, P307, DOI 10.1046/j.1365-313X.2001.01028.x	29	282	307	1	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2006	38	5					594	597		10.1038/ng1784	http://dx.doi.org/10.1038/ng1784			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	16642024				2022-12-17	WOS:000237147500024
J	Crabbe, JC; Phillips, TJ; Feller, DJ; Hen, R; Wenger, CD; Lessov, CN; Schafer, GL				Crabbe, JC; Phillips, TJ; Feller, DJ; Hen, R; Wenger, CD; Lessov, CN; Schafer, GL			Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors	NATURE GENETICS			English	Letter							ETHANOL; DEPENDENCE; TOLERANCE; ABUSE; LOCALIZATION; SENSITIVITY; AGGRESSION; DRUGS; WITHDRAWAL; BEHAVIOR		OREGON HLTH SCI UNIV,RES SERV 151W,PORTLAND,OR 97201; COLUMBIA UNIV,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032	Oregon Health & Science University; Columbia University	Crabbe, JC (corresponding author), DEPT VET AFFAIRS MED CTR,PORTLAND,OR 97201, USA.				NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA005828, P01AA008621, P60AA010760, P50AA010760] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA08621, P60 AA010760, AA05828, AA10760] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BELKNAP JK, 1993, PSYCHOPHARMACOLOGY, V112, P503, DOI 10.1007/BF02244901; BOSCHERT U, 1994, NEUROSCIENCE, V58, P167, DOI 10.1016/0306-4522(94)90164-3; BRUINVELS AT, 1994, NEUROPHARMACOLOGY, V33, P367, DOI 10.1016/0028-3908(94)90067-1; CRABBE JC, 1979, J PHARMACOL EXP THER, V208, P128; CRABBE JC, 1994, BEHAV NEUROSCI, V108, P186, DOI 10.1037/0735-7044.108.1.186; CRABBE JC, 1994, SCIENCE, V264, P1715, DOI 10.1126/science.8209252; CRABBE JC, 1991, J PHARMACOL EXP THER, V257, P663; CRABBE JC, 1983, PHARMACOL BIOCHEM BE, V18, P541, DOI 10.1016/0091-3057(83)90233-2; Goldman D, 1996, NAT GENET, V13, P137, DOI 10.1038/ng0696-137; KALANT H, 1971, PHARMACOL REV, V23, P135; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; LAGERSPE.KY, 1968, SCAND J PSYCHOL, V9, P157, DOI 10.1111/j.1467-9450.1968.tb00530.x; LE AD, 1980, PSYCHOPHARMACOLOGY, V67, P143, DOI 10.1007/BF00431969; LEMARQUAND D, 1994, BIOL PSYCHIAT, V36, P326, DOI 10.1016/0006-3223(94)90630-0; LEMARQUAND D, 1994, BIOL PSYCHIAT, V36, P395, DOI 10.1016/0006-3223(94)91215-7; LINNOILA M, 1983, LIFE SCI, V33, P2609, DOI 10.1016/0024-3205(83)90344-2; MAROTEAUX L, 1992, P NATL ACAD SCI USA, V89, P3020, DOI 10.1073/pnas.89.7.3020; MEHLMAN PT, 1994, AM J PSYCHIAT, V151, P1485; Melo JA, 1996, NAT GENET, V13, P147, DOI 10.1038/ng0696-147; MICZEK KA, 1995, PSYCHOPHARMACOLOGY, V121, P38, DOI 10.1007/BF02245590; Phillips TJ, 1996, J PHARMACOL EXP THER, V277, P613; PHILLIPS TJ, 1994, ALCOHOL CLIN EXP RES, V18, P931, DOI 10.1111/j.1530-0277.1994.tb00062.x; Pineyro G, 1995, NEUROREPORT, V7, P353; Ramboz Sylvie, 1995, Behavioural Brain Research, V73, P305, DOI 10.1016/0166-4328(96)00119-2; RATEY JJ, 1995, CNS DRUGS, V4, P256, DOI 10.2165/00023210-199504040-00003; RODRIGUEZ LA, 1995, ALCOHOL CLIN EXP RES, V19, P367, DOI 10.1111/j.1530-0277.1995.tb01517.x; SANMARINA A, 1989, PSYCHOPHARMACOLOGY, V99, P450, DOI 10.1007/BF00589891; SAUDOU F, 1994, NEUROCHEM INT, V25, P503, DOI 10.1016/0197-0186(94)90150-3; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; TERDAL ES, 1994, ALCOHOL CLIN EXP RES, V18, P542, DOI 10.1111/j.1530-0277.1994.tb00907.x	30	282	288	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1996	14	1					98	101		10.1038/ng0996-98	http://dx.doi.org/10.1038/ng0996-98			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VF611	8782828				2022-12-17	WOS:A1996VF61100029
J	Iorizzo, M; Ellison, S; Senalik, D; Zeng, P; Satapoomin, P; Huang, JY; Bowman, M; Iovene, M; Sanseverino, W; Cavagnaro, P; Yildiz, M; Macko-Podgorni, A; Moranska, E; Grzebelus, E; Grzebelus, D; Ashrafi, H; Zheng, ZJ; Cheng, SF; Spooner, D; Van Deynze, A; Simon, P				Iorizzo, Massimo; Ellison, Shelby; Senalik, Douglas; Zeng, Peng; Satapoomin, Pimchanok; Huang, Jiaying; Bowman, Megan; Iovene, Marina; Sanseverino, Walter; Cavagnaro, Pablo; Yildiz, Mehtap; Macko-Podgorni, Alicja; Moranska, Emilia; Grzebelus, Ewa; Grzebelus, Dariusz; Ashrafi, Hamid; Zheng, Zhijun; Cheng, Shifeng; Spooner, David; Van Deynze, Allen; Simon, Philipp			A high-quality carrot genome assembly provides new insights into carotenoid accumulation and asterid genome evolution	NATURE GENETICS			English	Article							DAUCUS-CAROTA; 1-DEOXY-D-XYLULOSE-5-PHOSPHATE SYNTHASE; FLOWERING TIME; GENE; SEQUENCE; BIOSYNTHESIS; ALIGNMENT; EXPRESSION; ROOT; PREDICTION	We report a high-quality chromosome-scale assembly and analysis of the carrot (Daucus carota) genome, the first sequenced genome to include a comparative evolutionary analysis among members of the euasterid II clade. We characterized two new polyploidization events, both occurring after the divergence of carrot from members of the Asterales order, clarifying the evolutionary scenario before and after radiation of the two main asterid clades. Large-and small-scale lineage-specific duplications have contributed to the expansion of gene families, including those with roles in flowering time, defense response, flavor, and pigment accumulation. We identified a candidate gene, DCAR_032551, that conditions carotenoid accumulation (Y) in carrot taproot and is coexpressed with several isoprenoid biosynthetic genes. The primary mechanism regulating carotenoid accumulation in carrot taproot is not at the biosynthetic level. We hypothesize that DCAR_032551 regulates upstream photosystem development and functional processes, including photomorphogenesis and root de-etiolation.	[Iorizzo, Massimo; Ellison, Shelby; Senalik, Douglas; Satapoomin, Pimchanok; Spooner, David; Simon, Philipp] Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA; [Senalik, Douglas; Spooner, David; Simon, Philipp] USDA ARS, Vegetable Crops Res Unit, Madison, WI USA; [Zeng, Peng; Huang, Jiaying; Zheng, Zhijun; Cheng, Shifeng] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China; [Bowman, Megan] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Iovene, Marina] CNR, Inst Biosci & Bioresources, Bari, Italy; [Sanseverino, Walter] Sequentia Biotech, Barcelona, Spain; [Cavagnaro, Pablo] Univ Nacl Cuyo, Fac Ciencias Agr, Natl Sci & Tech Res Council CONICET, Cuyo, Argentina; [Cavagnaro, Pablo] Inst Nacl Tecnol Agr, Estn Expt Agr Consulta, La Consulta, Argentina; [Yildiz, Mehtap] Yuzuncu Yil Univ, Fac Agr, Dept Agr Biotechnol, Van, Turkey; [Macko-Podgorni, Alicja; Moranska, Emilia; Grzebelus, Ewa; Grzebelus, Dariusz] Agr Univ Krakow, Inst Plant Biol & Biotechnol, Krakow, Poland; [Ashrafi, Hamid; Van Deynze, Allen] Univ Calif Davis, Seed Biotechnol Ctr, Davis, CA 95616 USA; [Iorizzo, Massimo; Ashrafi, Hamid] N Carolina State Univ, Dept Hort Sci, Plants Human Hlth Inst, Kannapolis, NC USA; [Ashrafi, Hamid] N Carolina State Univ, Dept Hort Sci, Raleigh, NC 27695 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); Beijing Genomics Institute (BGI); Michigan State University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Centro Nacional Patagonico (CENPAT); University Nacional Cuyo Mendoza; Instituto Nacional de Tecnologia Agropecuaria (INTA); Yuzuncu Yil University; Agricultural University Krakow; University of California System; University of California Davis; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Simon, P (corresponding author), Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA.; Simon, P (corresponding author), USDA ARS, Vegetable Crops Res Unit, Madison, WI USA.	philipp.simon@ars.usda.gov	Grzebelus, Dariusz/I-8832-2014; Grzebelus, E./AAE-8271-2019; Sanseverino, Walter/AAX-5254-2021; Yildiz, Mehtap/ABU-1488-2022; Iorizzo, Massimo/AAJ-3952-2020; Grzebelus, Ewa/AAX-5337-2021; Cavagnaro, Pablo/E-6091-2019; Iovene, Marina/J-5593-2015	Grzebelus, Dariusz/0000-0001-6999-913X; Grzebelus, E./0000-0003-2067-585X; Sanseverino, Walter/0000-0003-3324-5912; Cavagnaro, Pablo/0000-0001-5838-0876; Senalik, Douglas/0000-0001-8526-0554; Zeng, Peng/0000-0002-5460-2256; Iorizzo, Massimo/0000-0002-0032-8247; Ashrafi, Hamid/0000-0002-2094-2367; Simon, Philipp/0000-0001-6978-6062; Bowman, Megan/0000-0001-5742-1779; Iovene, Marina/0000-0002-5992-8677; Macko-Podgorni, Alicja/0000-0003-2416-2808	carrot industry; Bejo; Carosem; Monsanto; Nunhems; |Sumika; Takii; Vilmorin; National Science Foundation [1202666]; projects RGV-FAO [D.M.3824]; Polish National Science Center [2012/05/B/NZ9/03401]; Polish Ministry of Science and Higher Education to Faculty of Biotechnology and Horticulture, University of Agriculture in Krakow;  [PONa3_00025-BIOforIU]; ARS [ARS-0425034] Funding Source: Federal RePORTER	carrot industry; Bejo; Carosem; Monsanto; Nunhems; |Sumika; Takii; Vilmorin; National Science Foundation(National Science Foundation (NSF)); projects RGV-FAO; Polish National Science Center; Polish Ministry of Science and Higher Education to Faculty of Biotechnology and Horticulture, University of Agriculture in Krakow; ; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The authors appreciate the financial support of the carrot industry and the following vegetable seed companies-Bejo, Carosem, Monsanto, Nunhems, Rijk Zwaan (RZ), Sumika, Takii, and Vilmorin-with additional thanks to RZ for providing DH1, BAC libraries, and BES. S.E. was supported by the National Science Foundation under grant 1202666. M. Iovene thanks the projects RGV-FAO (D.M.3824) for partial financial support and PONa3_00025-BIOforIU for funding the acquisition of a fluorescence microscope. A.M.-P., E.M., E.G., and D.G. were supported by the Polish National Science Center, project 2012/05/B/NZ9/03401, and the statutory funds for science granted by the Polish Ministry of Science and Higher Education to the Faculty of Biotechnology and Horticulture, University of Agriculture in Krakow. The authors thank H. Ruess for assembly and annotation of the plastid genome and R. Kane for support in the development of plant materials.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arbizu C, 2014, AM J BOT, V101, P2005, DOI 10.3732/ajb.1400252; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Arscott SA, 2010, COMPR REV FOOD SCI F, V9, P223, DOI 10.1111/j.1541-4337.2009.00103.x; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [DOI 10.1007/BF02672069, 10.1007/BF02672069]; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Bowman M. J., 2012, THESIS U WISCONSIN M; Bowman MJ, 2014, J AM SOC HORTIC SCI, V139, P63, DOI 10.21273/JASHS.139.1.63; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bremer B., 2009, TIMETREE LIFE, P177; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; BUISHAND JG, 1979, EUPHYTICA, V28, P611, DOI 10.1007/BF00038928; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Campbell MA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-327; Cavagnaro PF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1118; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Clotault J, 2008, J EXP BOT, V59, P3563, DOI 10.1093/jxb/ern210; Cordoba E, 2011, J EXP BOT, V62, P2023, DOI 10.1093/jxb/erq393; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dai XB, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-321; Darzentas N, 2010, BIOINFORMATICS, V26, P2620, DOI 10.1093/bioinformatics/btq484; Dong F, 2000, THEOR APPL GENET, V101, P1001, DOI 10.1007/s001220051573; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Estevez JM, 2001, J BIOL CHEM, V276, P22901, DOI 10.1074/jbc.M100854200; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fuentes P, 2012, PLANT MOL BIOL, V79, P47, DOI 10.1007/s11103-012-9893-2; Gambin T, 2013, EVOL BIOINFORM, V9, P17, DOI 10.4137/EBO.S10619; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Goudet J., 2001, CLADISTICS; Grzebelus D, 2006, MOL GENET GENOMICS, V275, P450, DOI 10.1007/s00438-006-0102-3; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Huang SX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3640; Huang X, 2014, CURR OPIN PLANT BIOL, V21, P96, DOI 10.1016/j.pbi.2014.07.003; Ichikawa T, 2006, PLANT J, V48, P974, DOI 10.1111/j.1365-313X.2006.02924.x; Iorizzo M, 2013, AM J BOT, V100, P930, DOI 10.3732/ajb.1300055; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Iovene M, 2008, AM J BOT, V95, P793, DOI 10.3732/ajb.0700007; Iovene M, 2011, CHROMOSOME RES, V19, P493, DOI 10.1007/s10577-011-9202-y; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiao YN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r3; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Just BJ, 2007, THEOR APPL GENET, V114, P693, DOI 10.1007/s00122-006-0469-x; Just BJ, 2009, THEOR APPL GENET, V119, P1155, DOI 10.1007/s00122-009-1117-z; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim BR, 2005, BIOTECHNOL LETT, V27, P997, DOI 10.1007/s10529-005-7849-1; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim Seungill, 2014, Nat Genet, V46, P270, DOI 10.1038/ng.2877; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lang D, 2010, GENOME BIOL EVOL, V2, P488, DOI 10.1093/gbe/evq032; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau OS, 2012, TRENDS PLANT SCI, V17, P584, DOI 10.1016/j.tplants.2012.05.004; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lois LM, 2000, PLANT J, V22, P503, DOI 10.1046/j.1365-313x.2000.00764.x; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Macko-Podgorni A, 2013, GENETICA, V141, P255, DOI 10.1007/s10709-013-9725-6; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Miga KH, 2014, GENOME RES, V24, P697, DOI 10.1101/gr.159624.113; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nakamichi N, 2007, PLANT CELL PHYSIOL, V48, P822, DOI 10.1093/pcp/pcm056; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Noh B, 2004, PLANT CELL, V16, P2601, DOI 10.1105/tpc.104.025353; Novak P, 2013, BIOINFORMATICS, V29, P792, DOI 10.1093/bioinformatics/btt054; Novak P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-378; Palaisa K, 2004, P NATL ACAD SCI USA, V101, P9885, DOI 10.1073/pnas.0307839101; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Peng YH, 2014, PLANT PHYSIOL, V166, P1241, DOI 10.1104/pp.114.247668; Pritchard JK, 2000, GENETICS, V155, P945; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Rodriguez-Concepcion M, 2013, ARCH BIOCHEM BIOPHYS, V539, P110, DOI 10.1016/j.abb.2013.07.009; Rong J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-895; Rubatzky V.E., 1999, CARROTS RELATED VEGE; Ruiz-Sola M Aguila, 2012, Arabidopsis Book, V10, pe0158, DOI 10.1199/tab.0158; Saladie M, 2014, J EXP BOT, V65, P5077, DOI 10.1093/jxb/eru275; Salse J, 2009, P NATL ACAD SCI USA, V106, P14908, DOI 10.1073/pnas.0902350106; Sanseverino W, 2013, NUCLEIC ACIDS RES, V41, pD1167, DOI 10.1093/nar/gks1183; Santiago N, 2002, MOL BIOL EVOL, V19, P2285, DOI 10.1093/oxfordjournals.molbev.a004052; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Scaglione D, 2016, SCI REP-UK, V6, DOI 10.1038/srep19427; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Sherwin JC, 2012, T ROY SOC TROP MED H, V106, P205, DOI 10.1016/j.trstmh.2012.01.004; Simon P. W., 2000, Plant Breeding Reviews, V19, P157; Simon Philipp W., 2008, P327, DOI 10.1007/978-0-387-74110-9_8; SIMON PW, 1987, J AGR FOOD CHEM, V35, P1017, DOI 10.1021/jf00078a038; Simon PW, 2000, THEOR APPL GENET, V100, P735, DOI 10.1007/s001220051346; SIMON PW, 1989, HORTSCIENCE, V24, P174; Simon PW., 2009, PLANT BREED REV, V31, P325, DOI DOI 10.1002/9780470593783.CH7; Spalik K, 2010, J BIOGEOGR, V37, P1977, DOI 10.1111/j.1365-2699.2010.02334.x; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; STEWARD FC, 1958, AM J BOT, V45, P709, DOI 10.2307/2439729; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Truco MJ, 2013, G3-GENES GENOM GENET, V3, P617, DOI 10.1534/g3.112.004929; Van Ooijen J. W., 2006, JOINMAP 4 SOFTWARE C; Vanneste K, 2014, GENOME RES, V24, P1334, DOI 10.1101/gr.168997.113; Vogel G, 2005, SCIENCE, V309, P86, DOI 10.1126/science.309.5731.86; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Walter MH, 2002, PLANT J, V31, P243, DOI 10.1046/j.1365-313X.2002.01352.x; Wang HX, 2014, MOL BREEDING, V34, P143, DOI [10.1007/s11032-014-0163-7, 10.1007/s11032-014-0025-3]; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Wang YP, 2012, NUCLEIC ACIDS RES, V40, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; Wei N, 1996, PLANT PHYSIOL, V112, P871, DOI 10.1104/pp.112.3.871; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WELCH JE, 1947, SCIENCE, V106, P594, DOI 10.1126/science.106.2763.594; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zagorodskikh P., 1939, CR DOKLADY ACAD SCI, V25, P522; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195	128	281	292	8	114	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2016	48	6					657	+		10.1038/ng.3565	http://dx.doi.org/10.1038/ng.3565			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN0HE	27158781	Green Published, hybrid			2022-12-17	WOS:000376744200014
J	Borg, J; Papadopoulos, P; Georgitsi, M; Gutierrez, L; Grech, G; Fanis, P; Phylactides, M; Verkerk, AJMH; van der Spek, PJ; Scerri, CA; Cassar, W; Galdies, R; van IJcken, W; Ozgur, Z; Gillemans, N; Hou, J; Bugeja, M; Grosveld, FG; von Lindern, M; Felice, AE; Patrinos, GP; Philipsen, S				Borg, Joseph; Papadopoulos, Petros; Georgitsi, Marianthi; Gutierrez, Laura; Grech, Godfrey; Fanis, Pavlos; Phylactides, Marios; Verkerk, Annemieke J. M. H.; van der Spek, Peter J.; Scerri, Christian A.; Cassar, Wilhelmina; Galdies, Ruth; van IJcken, Wilfred; Ozgur, Zeliha; Gillemans, Nynke; Hou, Jun; Bugeja, Marisa; Grosveld, Frank G.; von Lindern, Marieke; Felice, Alex E.; Patrinos, George P.; Philipsen, Sjaak			Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin	NATURE GENETICS			English	Article							QUANTITATIVE-TRAIT LOCUS; EFFICIENT GENE DELIVERY; SICKLE-CELL-DISEASE; KRUPPEL-LIKE FACTOR; BETA-THALASSEMIA; LINKAGE ANALYSIS; CHROMOSOME 6Q23; GAMMA-GLOBIN; IN-VIVO; DNA	Hereditary persistence of fetal hemoglobin (HPFH) is characterized by persistent high levels of fetal hemoglobin (HbF) in adults. Several contributory factors, both genetic and environmental, have been identified(1) but others remain elusive. HPFH was found in 10 of 27 members from a Maltese family. We used a genome-wide SNP scan followed by linkage analysis to identify a candidate region on chromosome 19p13.12-13. Sequencing revealed a nonsense mutation in the KLF1 gene, p.K288X, which ablated the DNA-binding domain of this key erythroid transcriptional regulator(2). Only family members with HPFH were heterozygous carriers of this mutation. Expression profiling on primary erythroid progenitors showed that KLF1 target genes were downregulated in samples from individuals with HPFH. Functional assays suggested that, in addition to its established role in regulating adult globin expression, KLF1 is a key activator of the BCL11A gene, which encodes a suppressor of HbF expression(3). These observations provide a rationale for the effects of KLF1 haploinsufficiency on HbF levels.	[Borg, Joseph; Grech, Godfrey; Scerri, Christian A.; Cassar, Wilhelmina; Galdies, Ruth; Bugeja, Marisa; Felice, Alex E.] Univ Malta, Dept Physiol & Biochem, Mol Genet Lab, Msida, Malta; [Borg, Joseph; Grech, Godfrey; Scerri, Christian A.; Cassar, Wilhelmina; Galdies, Ruth; Felice, Alex E.] Mater Dei Hosp, Thalassaemia Clin, Sect Pathol, Msida, Malta; [Papadopoulos, Petros; Gutierrez, Laura; Fanis, Pavlos; Gillemans, Nynke; Hou, Jun; Grosveld, Frank G.; Philipsen, Sjaak] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands; [Georgitsi, Marianthi; Patrinos, George P.] Univ Patras, Dept Pharm, Patras, Greece; [Phylactides, Marios] Cyprus Inst Neurol & Genet, Nicosia, Cyprus; [Verkerk, Annemieke J. M. H.; van der Spek, Peter J.] Erasmus MC, Dept Bioinformat, Rotterdam, Netherlands; [van IJcken, Wilfred; Ozgur, Zeliha] Erasmus MC, Ctr Biom, Rotterdam, Netherlands; [Hou, Jun; Grosveld, Frank G.; Philipsen, Sjaak] Netherlands Consortium Syst Biol, Rotterdam, Netherlands; [Grosveld, Frank G.] Ctr Biomed Genet, Rotterdam, Netherlands; [von Lindern, Marieke] Erasmus MC, Dept Hematol, Rotterdam, Netherlands	University of Malta; Erasmus University Rotterdam; Erasmus MC; University of Patras; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Felice, AE (corresponding author), Univ Malta, Dept Physiol & Biochem, Mol Genet Lab, Msida, Malta.	alex.felice@um.edu.mt; gpatrinos@upatras.gr; j.philipsen@erasmusmc.nl	Scerri, Christian/D-3077-2012; Gutiérrez, Laura/B-3780-2016; Hou, Jun/AGJ-0692-2022; von Lindern, Marieke/AAH-2350-2020; Grech, Godfrey/A-4684-2013; van ijcken, willem/N-9805-2018; Grech, Godfrey/AAD-1303-2020; Gutiérrez, Laura/P-9367-2019; Papadopoulos, Petros/B-1913-2015	Scerri, Christian/0000-0002-6499-234X; Gutiérrez, Laura/0000-0001-8443-900X; Grech, Godfrey/0000-0003-4502-8237; van ijcken, willem/0000-0002-0421-8301; Grech, Godfrey/0000-0003-4502-8237; Papadopoulos, Petros/0000-0002-8342-329X; Borg, Joseph/0000-0002-2220-5651; Georgitsi, Marianthi/0000-0002-0354-0913; Verkerk, Annemieke JMH/0000-0002-7523-3656; Fanis, Pavlos/0000-0003-4590-4778; Felice, Alex/0000-0003-0015-3923	University of Malta; Mater Dei Hospital; Malta Government; European Molecular Biology Organization; Netherlands Scientific Organization [VENI 863.09.012, DN 82-294, 912-07-019]; Netherlands Genomics Initiative, Erasmus MC [296088]; Landsteiner Foundation for Blood Transfusion Research [0615]; Centre for Biomedical Genetics; European Commission, EuTRACC consortium [037445]; US National Institutes of Health (NIH) [R01-HL073455]; Research Promotion Foundation of Cyprus [PiDeltaE046_02]; European Commission [200754]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073455] Funding Source: NIH RePORTER	University of Malta; Mater Dei Hospital; Malta Government; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Netherlands Scientific Organization; Netherlands Genomics Initiative, Erasmus MC; Landsteiner Foundation for Blood Transfusion Research; Centre for Biomedical Genetics; European Commission, EuTRACC consortium(European CommissionEuropean Commission Joint Research Centre); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Promotion Foundation of Cyprus; European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the family members for their cooperation; T. van Gent for help with statistical analysis; T. van Dijk for expertise in lentiviral technology; N. Papazian for preparation of human fetal liver samples; and M. Pizzuto for administrative support. The population samples from Malta were obtained from the Malta BioBank (EuroBioBank). Recombinant human erythropoietin (Epo) was a kind gift from Ortho-Biotech, and recombinant human Stem Cell Factor (SCF) was a kind gift from Amgen. Supported by the University of Malta and Mater Dei Hospital (A. E. F.); the Malta Government (J.B.); the European Molecular Biology Organization (J.B., P. P.); the Netherlands Scientific Organization (VENI 863.09.012 to L. G. and DN 82-294 and 912-07-019 to S. P.); the Netherlands Genomics Initiative, Erasmus MC (MRace; 296088 to S. P.); the Landsteiner Foundation for Blood Transfusion Research (0615 to S. P.); the Centre for Biomedical Genetics (F. G. G.); the European Commission FP6 EuTRACC consortium (037445 to F. G. G.); the US National Institutes of Health (NIH) (R01-HL073455 to F. G. G.); the Research Promotion Foundation of Cyprus (Pi Delta E046_02 to G. P. P.); and the European Commission FP7 GEN2PHEN (200754 to G. P. P).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Antoniou M, 1991, Methods Mol Biol, V7, P421, DOI 10.1385/0-89603-178-0:421; Bieker JJ, 2005, MT SINAI J MED, V72, P333; Bottardi S, 2006, EMBO J, V25, P3586, DOI 10.1038/sj.emboj.7601232; Close J, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-33; Craig JE, 1996, NAT GENET, V12, P58, DOI 10.1038/ng0196-58; CRAIG JE, 1994, BLOOD, V83, P1673, DOI 10.1182/blood.V83.6.1673.1673; DONZE D, 1995, J BIOL CHEM, V270, P1955, DOI 10.1074/jbc.270.4.1955; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; FENG WC, 1994, J BIOL CHEM, V269, P1493; Follenzi A, 2002, HUM GENE THER, V13, P243, DOI 10.1089/10430340252769770; Follows GA, 2003, EMBO J, V22, P2798, DOI 10.1093/emboj/cdg250; Garner C, 1998, AM J HUM GENET, V62, P1468, DOI 10.1086/301859; GILMAN JG, 1985, BLOOD, V66, P783; Higgs DR, 2008, P NATL ACAD SCI USA, V105, P11595, DOI 10.1073/pnas.0806633105; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Leberbauer C, 2005, BLOOD, V105, P85, DOI 10.1182/blood-2004-03-1002; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Leykin I, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-7; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Muhlemann O, 2008, BBA-GENE REGUL MECH, V1779, P538, DOI 10.1016/j.bbagrm.2008.06.012; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pilon AM, 2008, MOL CELL BIOL, V28, P7394, DOI 10.1128/MCB.01087-08; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serjeant GR, 2001, DISORDERS HEMOGLOBIN, P895; Singleton BK, 2008, BLOOD, V112, P2081, DOI 10.1182/blood-2008-03-145672; Stamatoyannopoulos G., 2001, MOL BASIS BLOOD DIS, Vthird, P135; Thein SL, 2009, HUM MOL GENET, V18, pR216, DOI 10.1093/hmg/ddp401; TRIFILLIS P, 1991, BLOOD, V78, P3298; Wijgerde M, 1996, GENE DEV, V10, P2894, DOI 10.1101/gad.10.22.2894; Zhou DW, 2006, J BIOL CHEM, V281, P16052, DOI 10.1074/jbc.M601182200; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	38	281	291	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					801	U100		10.1038/ng.630	http://dx.doi.org/10.1038/ng.630			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20676099	Green Accepted, Green Published			2022-12-17	WOS:000281388400019
J	Brown, EJ; Schlondorff, JS; Becker, DJ; Tsukaguchi, H; Uscinski, AL; Higgs, HN; Henderson, JM; Pollak, MR				Brown, Elizabeth J.; Schloendorff, Johannes S.; Becker, Daniel J.; Tsukaguchi, Hiroyasu; Uscinski, Andrea L.; Higgs, Henry N.; Henderson, Joel M.; Pollak, Martin R.			Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; SLIT DIAPHRAGM; ACTIN; MDIA1; AUTOINHIBITION; INHERITANCE; NUCLEATION; PROTEIN; DOMAIN; TRPC6	Focal segmental glomerulosclerosis (FSGS) is a pattern of kidney injury observed either as an idiopathic finding or as a consequence of underlying systemic conditions. Several genes have been identified that, when mutated, lead to inherited FSGS and/or the related nephrotic syndrome. These findings have accelerated the understanding of glomerular podocyte function and disease, motivating our search for additional FSGS genes. Using linkage analysis, we identified a locus for autosomal-dominant FSGS susceptibility on a region of chromosome 14q. By sequencing multiple genes in this region, we detected nine independent nonconservative missense mutations in INF2, which encodes a member of the formin family of actin-regulating proteins. These mutations, all within the diaphanous inhibitory domain of INF2, segregate with FSGS in 11 unrelated families and alter highly conserved amino acid residues. The observation that alterations in this podocyte-expressed formin cause FSGS emphasizes the importance of fine regulation of actin polymerization in podocyte function.	[Brown, Elizabeth J.; Schloendorff, Johannes S.; Becker, Daniel J.; Pollak, Martin R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Brown, Elizabeth J.] Childrens Hosp, Div Renal, Boston, MA 02115 USA; [Schloendorff, Johannes S.; Becker, Daniel J.; Tsukaguchi, Hiroyasu; Uscinski, Andrea L.; Pollak, Martin R.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Higgs, Henry N.] Dartmouth Med Sch, Dept Biochem, Hanover, NH USA; [Henderson, Joel M.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Dartmouth College; Harvard University; Brigham & Women's Hospital	Pollak, MR (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	mpollak@rics.bwh.harvard.edu			US National Institutes of Health [DK54931, DK073091, DK080947, GM069818]; Pfizer Inc. and Merck and Co.; NephCure Foundation; Cole Pasqualucci Nephrotic Syndrome; FSGS; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK054931, R01DK088826, K08DK073091, K08DK080947, R01DK054931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069818] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Inc. and Merck and Co.; NephCure Foundation; Cole Pasqualucci Nephrotic Syndrome; FSGS; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the many individuals who participated in this study; S. DePalma for help with linkage analysis; and J. Jacobs, K. Tucker, J. Holt, A. Acharya, R. Wiggins, R. Weir, J. Levine and many others for help with family ascertainment. This work was support by grants from the US National Institutes of Health (DK54931 to M. R. P., DK073091 to J. M. H., DK080947 to J. S. S. and GM069818 to H. N. H.) and the Clinical Investigator Training Program: Beth Israel Deaconess Medical School in collaboration with Pfizer Inc. and Merck and Co., the NephCure Foundation, and the Cole Pasqualucci Nephrotic Syndrome and FSGS Research fund (to E. J. B.). M. R. P. is an Established Investigator of the American Heart Association.	Berger UV, 2001, J COMP NEUROL, V433, P101, DOI 10.1002/cne.1128; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Chhabra ES, 2009, J CELL SCI, V122, P1430, DOI 10.1242/jcs.040691; D'Agati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Markianos K, 2001, AM J HUM GENET, V68, P963, DOI 10.1086/319507; Nezami AG, 2006, STRUCTURE, V14, P257, DOI 10.1016/j.str.2005.12.003; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; Seth A, 2006, J CELL BIOL, V174, P701, DOI 10.1083/jcb.200605006; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215	22	281	292	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					72	U91		10.1038/ng.505	http://dx.doi.org/10.1038/ng.505			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA		Green Accepted, Bronze			2022-12-17	WOS:000273055100019
J	Ranish, JA; Yi, EC; Leslie, DM; Purvine, SO; Goodlett, DR; Eng, J; Aebersold, R				Ranish, JA; Yi, EC; Leslie, DM; Purvine, SO; Goodlett, DR; Eng, J; Aebersold, R			The study of macromolecular complexes by quantitative proteomics	NATURE GENETICS			English	Article							YEAST; TRANSCRIPTION; IDENTIFICATION; BINDING; TAGS; DNA	We describe a generic strategy for determining the specific composition, changes in the composition, and changes in the abundance of protein complexes. It is based on the use of isotope-coded affinity tag (ICAT) reagents(1) and mass spectrometry to compare the relative abundances of tryptic peptides derived from suitable pairs of purified or partially purified protein complexes. In a first application, the genuine protein components of a large RNA polymerase II (Pol II) preinitiation complex (PIC) were distinguished from a background of co-purifying proteins by comparing the relative abundances of peptides derived from a control sample and the specific complex that was purified from nuclear extracts by a single-step promoter DNA affinity procedure(2). In a second application, peptides derived from immunopurified STE12 protein complexes isolated from yeast cells in different states were used to detect quantitative changes in the abundance of the complexes, and to detect dynamic changes in the composition of the samples. The use of quantitative mass spectrometry to guide identification of specific complex components in partially purified samples, and to detect quantitative changes in the abundance and composition of protein complexes, provides the researcher with powerful new tools for the comprehensive analysis of macromolecular complexes.	Inst Syst Biol, Seattle, WA 98103 USA	Institute for Systems Biology (ISB)	Aebersold, R (corresponding author), Inst Syst Biol, 1441 N 34th St, Seattle, WA 98103 USA.	raebersold@systemsbiology.org	Eng, Jimmy K/I-4202-2012; Purvine, Samuel O/O-3358-2017	Eng, Jimmy K/0000-0001-6352-6737; Purvine, Samuel O/0000-0002-2257-2400; Leslie Pedrioli, Deena/0000-0003-2342-8010				AITCHISON JD, 1995, J CELL BIOL, V131, P1133, DOI 10.1083/jcb.131.5.1133; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Cagney G, 2002, NAT BIOTECHNOL, V20, P163, DOI 10.1038/nbt0202-163; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Griffin TJ, 2001, J AM SOC MASS SPECTR, V12, P1238, DOI 10.1016/S1044-0305(01)00316-6; Griffin TJ, 2001, ANAL CHEM, V73, P978, DOI 10.1021/ac001169y; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; KANG JJ, 1995, MOL CELL BIOL, V15, P1234; Kuras L, 2000, SCIENCE, V288, P1244, DOI 10.1126/science.288.5469.1244; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Li XY, 2000, SCIENCE, V288, P1242, DOI 10.1126/science.288.5469.1242; OLSON MV, 1991, MOL CELLULAR BIOL YE, V1, P1; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; REDDY P, 1991, CELL, V65, P349, DOI 10.1016/0092-8674(91)90168-X; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Shiio Y, 2002, EMBO J, V21, P5088, DOI 10.1093/emboj/cdf525; SPRAGUE GF, 1992, MOL CELLULAR BIOL YE, V2, P657; Tedford K, 1997, CURR BIOL, V7, P228, DOI 10.1016/S0960-9822(06)00118-7; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Yi EC, 2002, ELECTROPHORESIS, V23, P3205, DOI 10.1002/1522-2683(200209)23:18<3205::AID-ELPS3205>3.0.CO;2-Y; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; Zhang XL, 2002, RAPID COMMUN MASS SP, V16, P2325, DOI 10.1002/rcm.864; Zhou HL, 2002, NAT BIOTECHNOL, V20, P512, DOI 10.1038/nbt0502-512	30	281	294	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33	3					349	355		10.1038/ng1101	http://dx.doi.org/10.1038/ng1101			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12590263				2022-12-17	WOS:000181312700011
J	Concannon, P; Gogolin-Ewens, KJ; Hinds, DA; Wapelhorst, B; Morrison, VA; Stirling, B; Mitra, M; Farmer, J; Williams, SR; Cox, NJ; Bell, GI; Risch, N; Spielman, RS				Concannon, P; Gogolin-Ewens, KJ; Hinds, DA; Wapelhorst, B; Morrison, VA; Stirling, B; Mitra, M; Farmer, J; Williams, SR; Cox, NJ; Bell, GI; Risch, N; Spielman, RS			A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; COMPLEX TRAITS; GENE REGION; 15Q26 IDDM3; LOCUS; ASSOCIATION; MARKERS; DISEASE; PAIRS; HLA	During the past decade, the genetics of type 1 (insulin-dependent) diabetes mellitus (IDDM) has been studied extensively and the disorder has become a paradigm for genetically complex diseases. Previous genome screens(1,2) and studies focused on candidate genes(3-9) have provided evidence for genetic linkage between polymorphic DNA markers and 15 putative IDDM susceptibility loci, designated IDDM1-IDDM15. We have carried out a second-generation screen of the genome for linkage and analysed the data by multipoint linkage methods. An initial panel of 212 affected sibpairs (ASPs) was genotyped for 438 markers spanning all autosomes, and an additional 467 ASPs were used for follow-up genotyping. Other than the well-established linkage with the HLA region at chromosome 6p21.3, there was only one region, located on chromosome Iq and not previously reported, where the log likelihood ratio (lod) was greater than 3. Lods between 1.0 and 1.8 were found in six other regions, three of which have been reported in other studies. Another reported region(10), on chromosome 6q and loosely linked to HLA, also had an elevated led. Little or no support was found for most reported IDDM loci (lods were less than 1), despite larger sample sizes in the present study.	Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Virginia Mason Res Ctr, Seattle, WA 98101 USA; Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Pennsylvania; Virginia Mason Medical Center; University of Washington; University of Washington Seattle; Stanford University; Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago	Spielman, RS (corresponding author), Univ Penn, Sch Med, Dept Genet, 415 Curie Blvd, Philadelphia, PA 19104 USA.			Concannon, Patrick/0000-0002-5801-1859; Hinds, David/0000-0002-4911-803X; Martin, Beth/0000-0002-9661-014X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046627, R01DK046635, R01DK046618] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK046635, DK 46635, DK46627, DK46618] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAIN SC, 1990, AUTOIMMUNITY, V7, P83, DOI 10.3109/08916939008993380; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; COX NJ, 1988, AM J HUM GENET, V42, P167; CUDWORTH AG, 1975, BRIT MED J, V3, P133, DOI 10.1136/bmj.3.5976.133; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Davies JL, 1996, HUM MOL GENET, V5, P1071, DOI 10.1093/hmg/5.7.1071; Delepine M, 1997, AM J HUM GENET, V60, P174; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; Field LL, 1996, GENOMICS, V33, P1, DOI 10.1006/geno.1996.0153; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; Holmans P, 1997, AM J HUM GENET, V60, P657; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LaPorte R., 1995, DIABETES AM, V2nd ed, P37; LERNMARK A, 1990, AM J HUM GENET, V47, P1028; LUO DF, 1995, AM J HUM GENET, V57, P911; Luo DF, 1996, HUM MOL GENET, V5, P693, DOI 10.1093/hmg/5.5.693; Morahan G, 1996, SCIENCE, V272, P1811, DOI 10.1126/science.272.5269.1811; NERUP J, 1974, LANCET, V2, P864; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Owerbach D, 1997, DIABETES, V46, P1069, DOI 10.2337/diabetes.46.6.1069; OWERBACH D, 1995, DIABETES, V44, P132, DOI 10.2337/diabetes.44.1.132; RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1987, AM J HUM GENET, V40, P1; ROWE RE, 1995, NAT GENET, V10, P240, DOI 10.1038/ng0695-240; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; THOMSON G, 1980, ANN HUM GENET, V43, P383, DOI 10.1111/j.1469-1809.1980.tb01572.x; Zamani M, 1996, HUM GENET, V98, P491, DOI 10.1007/s004390050245	33	281	286	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1998	19	3					292	296		10.1038/985	http://dx.doi.org/10.1038/985			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662408				2022-12-17	WOS:000074565900031
J	McGrath, JA; McMillan, JR; Shemanko, CS; Runswick, SK; Leight, IM; Lane, EB; Garrod, DR; Eady, RAJ				McGrath, JA; McMillan, JR; Shemanko, CS; Runswick, SK; Leight, IM; Lane, EB; Garrod, DR; Eady, RAJ			Mutations in the plakophilin 1 gene result in ectodermal dysplasia skin fragility syndrome	NATURE GENETICS			English	Article							DESMOSOMAL PLAQUE PROTEIN; BETA-CATENIN; STRATIFIED EPITHELIA; MONOCLONAL-ANTIBODY; MULTIGENE FAMILY; BAND-6 PROTEIN; PLAKOGLOBIN; DIFFERENTIATION; DESMOPLAKIN; COMPONENTS	Members of the armadillo protein gene family, which includes plakoglobin and beta-catenin, have important functions in cytoskeleton/cell membrane interactions(1,2). These proteins may act as linker molecules at adherens junctions and desmosomes at the plasma membrane(3); in addition, they may have pivotal roles in signal transduction pathways and significant effects on cell behaviour during development(4-7). Here, we describe the first human mutations in one of these dual function proteins, plakophilin 1 (band-6 protein; refs 8-10). The affected individual has a complete absence of immunostaining for plakophilin 1 in the skin and is a compound heterozygote for autosomal-recessively inherited premature termination codons of translation on both alleles of the plakophilin 1 gene (PKP1). Clinically, there are features of both cutaneous fragility and congenital ectodermal dysplasia affecting skin, hair and nails. There is no evidence of significant abnormalities in other epithelia or tissues. Desmosomes in the skin are small and poorly formed with widening of keratinocyte intercellular spaces and perturbed desmosome/keratin intermediate filament interactions. The molecular findings and clinical observations in this patient attest to the dual importance of plakophilin 1 in both cutaneous cell-cell adhesion and epidermal morphogenesis.	UNIV DUNDEE,DEPT PHYSIOL & ANAT,CANC RES CAMPAIGN LABS,CELL STRUCT RES GRP,DUNDEE DD1 4HN,SCOTLAND; UNIV MANCHESTER,SCH BIOL SCI,MANCHESTER M13 9PT,LANCS,ENGLAND; UNIV LONDON QUEEN MARY & WESTFIELD COLL,ST BARTHOLOMEWS & ROYAL LONDON SCH MED & DENT,LONDON E1 2AT,ENGLAND	University of Dundee; University of Manchester; University of London; Queen Mary University London	McGrath, JA (corresponding author), UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,ST THOMAS HOSP,ST JOHNS INST DERMATOL,LONDON SE1 7EH,ENGLAND.		McMillan, James R/C-6657-2009; McGrath, John/N-3529-2019; McGrath, John/D-6824-2012	McGrath, John/0000-0002-3708-9964; Shemanko, Carrie/0000-0002-5260-6210	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bornslaeger EA, 1996, J CELL BIOL, V134, P985, DOI 10.1083/jcb.134.4.985; BUXTON RS, 1993, J CELL BIOL, V121, P481, DOI 10.1083/jcb.121.3.481; COLLINS JE, 1991, J CELL BIOL, V113, P381, DOI 10.1083/jcb.113.2.381; Corden L D, 1996, Exp Dermatol, V5, P297, DOI 10.1111/j.1600-0625.1996.tb00133.x; COWIN P, 1986, CELL, V46, P1063, DOI 10.1016/0092-8674(86)90706-3; Cowin P, 1996, CURR OPIN CELL BIOL, V8, P56, DOI 10.1016/S0955-0674(96)80049-4; FOISNER R, 1994, ACTA HISTOCHEM, V96, P421, DOI 10.1016/S0065-1281(11)80029-2; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; Garrod DR, 1993, CURR OPIN CELL BIOL, V5, P30, DOI 10.1016/S0955-0674(05)80005-5; Garrod DR, 1996, J ROY COLL PHYS LOND, V30, P366; Green KJ, 1996, FASEB J, V10, P871, DOI 10.1096/fasebj.10.8.8666164; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; HASHIMOTO T, 1993, J CELL SCI, V105, P275; HATZFELD M, 1994, J CELL SCI, V107, P2259; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; HEID HW, 1994, DIFFERENTIATION, V58, P113; KAPPRELL HP, 1988, J CELL BIOL, V106, P1679, DOI 10.1083/jcb.106.5.1679; KARNOVSKY A, 1995, P NATL ACAD SCI USA, V92, P4522, DOI 10.1073/pnas.92.10.4522; KOUKLIS PD, 1994, J CELL BIOL, V127, P1049, DOI 10.1083/jcb.127.4.1049; KOWALCZYK AP, 1994, BIOPHYS CHEM, V50, P97, DOI 10.1016/0301-4622(94)85023-2; McLean WHI, 1996, GENE DEV, V10, P1724, DOI 10.1101/gad.10.14.1724; Mertens C, 1996, J CELL BIOL, V135, P1009, DOI 10.1083/jcb.135.4.1009; Moll I, 1997, J INVEST DERMATOL, V108, P139, DOI 10.1111/1523-1747.ep12332388; NUBER UA, 1995, EUR J CELL BIOL, V66, P69; PARRISH EP, 1987, J PATHOL, V153, P265, DOI 10.1002/path.1711530311; PEIFER M, 1992, J CELL BIOL, V118, P681, DOI 10.1083/jcb.118.3.681; SCHMIDT A, 1994, EUR J CELL BIOL, V65, P229; STAPPENBECK TS, 1994, J BIOL CHEM, V269, P29351; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; VILELA MJ, 1987, J PATHOL, V153, P365, DOI 10.1002/path.1711530410	30	281	289	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					240	244		10.1038/ng1097-240	http://dx.doi.org/10.1038/ng1097-240			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326952				2022-12-17	WOS:A1997XZ55500038
J	Ebersole, TA; Chen, Q; Justice, MJ; Artzt, K				Ebersole, TA; Chen, Q; Justice, MJ; Artzt, K			The quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins	NATURE GENETICS			English	Article							MOLECULAR-CLONING; MESSENGER-RNA; NUCLEIC-ACID; MOUSE; BRAIN; GLYCOPROTEIN; MUTAGENESIS; MUTATIONS; FAMILY; LOCUS	The mouse quaking gene, essential for nervous system myelination and survival of the early embryo has been positionally cloned. Its sequence implies that the locus encodes a multifunctional gene used in a specific set of developing tissues to unite signal transduction with some aspect of RNA metabolism. The quaking(viable) (qk(v)) mutation has one class of messages truncated by a deletion. An independent ENU-induced mutation has a nonconservative amino acid change in one of two newly identified domains that are conserved from the C. elegans gld-1 tumour suppressor gene to the human Src-associated protein Sam68. The size and conservation of the quaking gene family implies that the pathway defined by this mutation may have broad relevance for rapid conveyance of extracellular information directly to primary gene transcripts.	UNIV TEXAS, DEPT ZOOL, AUSTIN, TX 78712 USA; KANSAS STATE UNIV, DIV BIOL, MANHATTAN, KS 66506 USA	University of Texas System; University of Texas Austin; Kansas State University					NICHD NIH HHS [HD10668, HD30658] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD010668, R01HD030658] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; BENNETT DOROTHEA, 1956, J MORPH, V98, P199, DOI 10.1002/jmor.1050980202; BENNETT WI, 1971, BIOL REPROD, V5, P30, DOI 10.1093/biolreprod/5.1.30; BODE VC, 1984, GENETICS, V108, P457; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CAMPAGNONI AT, 1993, J BIOL CHEM, V268, P4930; CRENSHAW EB, 1987, CELL, V49, P389, DOI 10.1016/0092-8674(87)90291-1; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DEWILLE JW, 1992, NEUROSCI LETT, V141, P195, DOI 10.1016/0304-3940(92)90893-C; EBERSOLE T, 1992, GENETICS, V131, P183; EHRICH E, 1987, GENE, V57, P229, DOI 10.1016/0378-1119(87)90126-0; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; FRIEDRIC.VL, 1974, BRAIN RES, V82, P168, DOI 10.1016/0006-8993(74)90902-0; FUJITA N, 1988, FEBS LETT, V232, P323, DOI 10.1016/0014-5793(88)80762-2; FUJITA N, 1990, J NEUROCHEM, V55, P1056, DOI 10.1111/j.1471-4159.1990.tb04596.x; FUMAGALLI S, 1994, NATURE, V368, P871, DOI 10.1038/368871a0; GIBSON TJ, 1993, FEBS LETT, V324, P361, DOI 10.1016/0014-5793(93)80152-K; HILL MA, 1994, J CELL BIOL, V126, P1221, DOI 10.1083/jcb.126.5.1221; HOBERT O, 1994, J BIOL CHEM, V269, P20225; IKENAKA K, 1992, J NEUROCHEM, V58, P2248, DOI 10.1111/j.1471-4159.1992.tb10970.x; JONES AR, 1995, GENE DEV, V9, P1491, DOI 10.1101/gad.9.12.1491; JUSTICE MJ, 1988, GENET RES, V51, P95, DOI 10.1017/S0016672300024101; JUSTICE MJ, 1986, GENET RES, V47, P187, DOI 10.1017/S0016672300023119; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; MAYEDA A, 1994, EMBO J, V13, P5483, DOI 10.1002/j.1460-2075.1994.tb06883.x; OGAWA W, 1994, J BIOL CHEM, V269, P29602; RICHARD S, 1995, MOL CELL BIOL, V15, P186, DOI 10.1128/MCB.15.1.186; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; ROSSI JM, 1992, P NATL ACAD SCI USA, V89, P2456, DOI 10.1073/pnas.89.6.2456; SHEDLOVSKY A, 1988, P NATL ACAD SCI USA, V85, P180, DOI 10.1073/pnas.85.1.180; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; STEWARD O, 1994, P NATL ACAD SCI USA, V91, P10766, DOI 10.1073/pnas.91.23.10766; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; TIMSIT S, 1995, J NEUROSCI, V15, P1012; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; WENG ZG, 1994, MOL CELL BIOL, V14, P4509, DOI 10.1128/MCB.14.7.4509; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; WONG G, 1992, CELL, V69, P551, DOI 10.1016/0092-8674(92)90455-L; YAN YM, 1993, NEURON, V11, P423, DOI 10.1016/0896-6273(93)90147-J; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	42	281	287	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1996	12	3					260	265		10.1038/ng0396-260	http://dx.doi.org/10.1038/ng0396-260			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589716				2022-12-17	WOS:A1996TY18300014
J	MORRAL, N; BERTRANPETIT, J; ESTIVILL, X; NUNES, V; CASALS, T; GIMENEZ, J; REIS, A; VARONMATEEVA, R; MACEK, M; KALAYDJIEVA, L; ANGELICHEVA, D; DANCHEVA, R; ROMEO, G; RUSSO, MP; GARNERONE, S; RESTAGNO, G; FERRARI, M; MAGNANI, C; CLAUSTRES, M; DESGEORGES, M; SCHWARTZ, M; SCHWARZ, M; DALLAPICCOLA, B; NOVELLI, G; FEREC, C; DEARCE, M; NEMETI, M; KERE, T; ANVRET, M; DAHL, N; KADASI, L				MORRAL, N; BERTRANPETIT, J; ESTIVILL, X; NUNES, V; CASALS, T; GIMENEZ, J; REIS, A; VARONMATEEVA, R; MACEK, M; KALAYDJIEVA, L; ANGELICHEVA, D; DANCHEVA, R; ROMEO, G; RUSSO, MP; GARNERONE, S; RESTAGNO, G; FERRARI, M; MAGNANI, C; CLAUSTRES, M; DESGEORGES, M; SCHWARTZ, M; SCHWARZ, M; DALLAPICCOLA, B; NOVELLI, G; FEREC, C; DEARCE, M; NEMETI, M; KERE, T; ANVRET, M; DAHL, N; KADASI, L			THE ORIGIN OF THE MAJOR CYSTIC-FIBROSIS MUTATION (DELTA-F508) IN EUROPEAN POPULATIONS	NATURE GENETICS			English	Article							REGULATOR CFTR GENE; MICROSATELLITE ALLELES; REPEAT POLYMORPHISM; MULTIPLEX PCR; IDENTIFICATION; HAPLOTYPES; INTRON-17B; LOCUS; DNA	Delta F508 is the most frequent cystic fibrosis (CF) mutation and accounts for approximately 70% of CF chromosomes worldwide. Three highly polymorphic microsatellite markers have been used to study the origin and evolution of Delta F508 chromosomes in Europe. Haplotype data demonstrate that Delta F508 occurred more than 52,000 years ago, in a population genetically distinct from any present European group, and spread throughout Europe in chronologically distinct expansions, which are responsible for the different frequencies of Delta F508 in Europe.	HOSP DURAN & REYNALS,INST RECERCA ONCOL,E-08907 BARCELONA,SPAIN; UNIV BARCELONA,BARCELONA,SPAIN; FREE UNIV BERLIN,W-1000 BERLIN,GERMANY; CHARLES UNIV,PRAGUE,CZECH REPUBLIC; UNIV SOFIA,HOSP OBSTET,BU-1126 SOFIA,BULGARIA; IST GIANNINA GASLINI,I-16148 GENOA,ITALY; UNIV TURIN,TURIN,ITALY; IST SCI HS RAFFAELE,MILAN,ITALY; INST BIOL,MONTPELLIER,FRANCE; RIGSHOSP,DK-2100 COPENHAGEN,DENMARK; ROYAL MANCHESTER CHILDRENS HOSP,MANCHESTER,LANCS,ENGLAND; UNIV ROME,ROME,ITALY; CTR BIOGENET,BREST,FRANCE; UNIV DUBLIN,DUBLIN,IRELAND; SEMMELWEIS UNIV MED,SCH MED,BUDAPEST,HUNGARY; CHILDRENS HOSP,OAKLAND,CA 94609; UNIV HELSINKI,HELSINKI,FINLAND; KAROLINSKA HOSP,S-10401 STOCKHOLM,SWEDEN; UNIV UPPSALA,UPPSALA,SWEDEN; UNIV BRATISLAVA,BRATISLAVA,SLOVAKIA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; University of Barcelona; Free University of Berlin; Charles University Prague; University of Sofia; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Turin; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Rigshospitalet; University of Copenhagen; Royal Manchester Children's Hospital; Sapienza University Rome; Semmelweis University; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of Helsinki; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Comenius University Bratislava			Novelli, Giuseppe/A-5195-2013; Novelli, Giuseppe/T-8822-2019; Novelli, Giuseppe/GQB-3329-2022; Kadasi, Ludevit/A-4677-2013; Ferec, Claude/ABG-9699-2020; Ferrari, Maurizio/D-9107-2013; Estivill, Xavier/A-3125-2013; Bertranpetit, Jaume/F-8550-2012; Nunes, Virginia/AAD-1014-2019; Morral, Nuria/AAC-7149-2020; Reis, André/D-2309-2009; Dallapiccola, Bruno/K-8692-2016	Novelli, Giuseppe/0000-0002-7781-602X; Novelli, Giuseppe/0000-0002-7781-602X; Ferec, Claude/0000-0002-2325-0710; Estivill, Xavier/0000-0002-0723-2256; Bertranpetit, Jaume/0000-0003-0100-0590; Nunes, Virginia/0000-0002-5747-9310; Reis, André/0000-0002-6301-6363; Morral, Nuria/0000-0002-8932-2887; Dallapiccola, Bruno/0000-0002-5031-1013				Ammerman A.J., 1984, NEOLITHIC TRANSITION; BANCHS I, IN PRESS HUMAN MUT; BERTRANPETIT J, 1991, ANN HUM GENET, V55, P51, DOI 10.1111/j.1469-1809.1991.tb00398.x; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; CASALS T, 1992, AM J HUM GENET, V50, P404; CHEHAB EF, 1991, AM J HUM GENET, V48, P223; Cystic Fibrosis Genetic Anal Consortium, 1990, AM J HUM GENET, V47, P354; DORK T, 1992, HUM GENET, V88, P417, DOI 10.1007/BF00215676; ESTIVILL X, 1989, LANCET, V2, P1404; ESTIVILL X, 1987, Genomics, V1, P257, DOI 10.1016/0888-7543(87)90052-8; ESTIVILL X, 1991, LANCET, V338, P458, DOI 10.1016/0140-6736(91)91092-9; GASPARINI P, 1991, HUM GENET, V86, P625; Gimbutas M., 1991, CIVILISATION GODDESS; Goudet J., 2001, CLADISTICS; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Laughlin W.S., 1968, MAN HUNTER, P304; MORRAL N, 1992, GENOMICS, V13, P1362, DOI 10.1016/0888-7543(92)90071-Y; MORRAL N, 1992, HUM GENET, V88, P356; MORRAL N, 1993, HUM MOL GENET, V2, P1015, DOI 10.1093/hmg/2.7.1015; MORRAL N, 1991, GENOMICS, V10, P692, DOI 10.1016/0888-7543(91)90454-M; NUNES V, 1990, NUCLEIC ACIDS RES, V18, P1318, DOI 10.1093/nar/18.5.1318-a; RAMSAY M, 1993, HUM MOL GENET, V2, P1007, DOI 10.1093/hmg/2.7.1007; REYNOLDS J, 1983, GENETICS, V105, P767; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMEO G, 1989, HUM GENET, V84, P1, DOI 10.1007/BF00210660; ROMMENS J, 1990, AM J HUM GENET, V46, P395; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SERRE JL, 1990, HUM GENET, V84, P449; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; STRINGER CB, 1990, SCI AM, V263, P98, DOI 10.1038/scientificamerican1290-98; Tsui Lap-Chee, 1992, Human Mutation, V1, P197, DOI 10.1002/humu.1380010304; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEBER JL, 1990, GENOME ANAL, V1, P159; ZIELENSKI J, 1991, AM J HUM GENET, V49, P1256; 1990, HUM GENET, V85, P436	36	281	291	1	48	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1994	7	2					169	175		10.1038/ng0694-169	http://dx.doi.org/10.1038/ng0694-169			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ037	7920636				2022-12-17	WOS:A1994NQ03700017
J	Wainberg, M; Sinnott-Armstrong, N; Mancuso, N; Barbeira, AN; Knowles, DA; Golan, D; Ermel, R; Ruusalepp, A; Quertermous, T; Hao, K; Bjorkegren, JLM; Im, HK; Pasaniuc, B; Rivas, MA; Kundaje, A				Wainberg, Michael; Sinnott-Armstrong, Nasa; Mancuso, Nicholas; Barbeira, Alvaro N.; Knowles, David A.; Golan, David; Ermel, Raili; Ruusalepp, Arno; Quertermous, Thomas; Hao, Ke; Bjorkegren, Johan L. M.; Im, Hae Kyung; Pasaniuc, Bogdan; Rivas, Manuel A.; Kundaje, Anshul			Opportunities and challenges for transcriptome-wide association studies	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENE-EXPRESSION; COMPLEX TRAITS; GWAS; TISSUES; RISK; EQTL; VARIANT; COLOCALIZATION; SCHIZOPHRENIA	Transcriptome-wide association studies (TWAS) integrate genome-wide association studies (GWAS) and gene expression datasets to identify gene-trait associations. In this Perspective, we explore properties of TWAS as a potential approach to prioritize causal genes at GWAS loci, by using simulations and case studies of literature-curated candidate causal genes for schizophrenia, low-density-lipoprotein cholesterol and Crohn's disease. We explore risk loci where TWAS accurately prioritizes the likely causal gene as well as loci where TWAS prioritizes multiple genes, some likely to be non-causal, owing to sharing of expression quantitative trait loci (eQTL). TWAS is especially prone to spurious prioritization with expression data from non-trait-related tissues or cell types, owing to substantial cross-cell-type variation in expression levels and eQTL strengths. Nonetheless, TWAS prioritizes candidate causal genes more accurately than simple baselines. We suggest best practices for causal-gene prioritization with TWAS and discuss future opportunities for improvement. Our results showcase the strengths and limitations of using eQTL datasets to determine causal genes at GWAS loci.	[Wainberg, Michael; Kundaje, Anshul] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Sinnott-Armstrong, Nasa; Golan, David; Kundaje, Anshul] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Mancuso, Nicholas; Pasaniuc, Bogdan] UCLA, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Barbeira, Alvaro N.; Im, Hae Kyung] Univ Chicago, Dept Med, Sect Genet Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Knowles, David A.] New York Genome Ctr, New York, NY USA; [Knowles, David A.] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Ermel, Raili; Ruusalepp, Arno] Tartu Univ Hosp, Dept Cardiac Surg, Tartu, Estonia; [Ruusalepp, Arno; Bjorkegren, Johan L. M.] Clin Gene Networks AB, Stockholm, Sweden; [Quertermous, Thomas] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA; [Hao, Ke; Bjorkegren, Johan L. M.] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY 10029 USA; [Bjorkegren, Johan L. M.] Univ Tartu, Inst Biomed & Translat Med, Dept Pathophysiol, Tartu, Estonia; [Bjorkegren, Johan L. M.] Karolinska Univ Sjukhuset, Integrated Cardio Metab Ctr, Karolinska Inst, Dept Med, Huddinge, Sweden; [Pasaniuc, Bogdan] UCLA, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Pasaniuc, Bogdan] UCLA, David Geffen Sch Med, Dept Computat Med, Los Angeles, CA 90095 USA; [Rivas, Manuel A.] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Chicago; Columbia University; Stanford University; Icahn School of Medicine at Mount Sinai; University of Tartu; Karolinska Institutet; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Stanford University	Kundaje, A (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.; Kundaje, A (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.; Pasaniuc, B (corresponding author), UCLA, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.; Im, HK (corresponding author), Univ Chicago, Dept Med, Sect Genet Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Bjorkegren, JLM (corresponding author), Clin Gene Networks AB, Stockholm, Sweden.; Bjorkegren, JLM (corresponding author), Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY 10029 USA.; Bjorkegren, JLM (corresponding author), Univ Tartu, Inst Biomed & Translat Med, Dept Pathophysiol, Tartu, Estonia.; Bjorkegren, JLM (corresponding author), Karolinska Univ Sjukhuset, Integrated Cardio Metab Ctr, Karolinska Inst, Dept Med, Huddinge, Sweden.; Pasaniuc, B (corresponding author), UCLA, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.; Pasaniuc, B (corresponding author), UCLA, David Geffen Sch Med, Dept Computat Med, Los Angeles, CA 90095 USA.; Rivas, MA (corresponding author), Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA.	johan.bjorkegren@mssm.edu; haky@uchicago.edu; pasaniuc@ucla.edu; mrivas@stanford.edu; akundaje@stanford.edu	Mancuso, Nicholas/GLQ-8627-2022; Kundaje, Anshul/Y-2598-2019; Rivas, Manuel/ABE-8173-2020; Kundaje, Anshul/Y-2739-2019	Kundaje, Anshul/0000-0003-3084-2287; Rivas, Manuel/0000-0003-1457-9925; Kundaje, Anshul/0000-0003-3084-2287; Barbeira, Alvaro/0000-0002-9153-6120; Hao, Ke/0000-0002-1815-9197; Mancuso, Nicholas/0000-0002-9352-5927; Quertermous, Thomas/0000-0002-7645-9067; Ruusalepp, Arno/0000-0001-5816-8613; Knowles, David/0000-0002-7408-146X	Natural Sciences and Engineering Research Council of Canada (NSERC) [PGSD3-476082-2015]; Stanford Bio-X Bowes fellowship; Stanford Graduate Fellowship; National Defense Science & Engineering Grant; NIH [1DP2OD022870, U01HG009431, 1U24HG008956, 5U01HG009080, R01HG009120, R01MH115676, R01MH107666, R01MH101820, P30DK20595, R01HL125863, R21TR001739]; NHGRI [R01HG010140]; Leducq Foundation [12CVD02]; American Heart Association [A14SFRN20840000]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009120, R01HG010140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM123485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH115676] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Stanford Bio-X Bowes fellowship; Stanford Graduate Fellowship(Stanford University); National Defense Science & Engineering Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Leducq Foundation(Leducq Foundation); American Heart Association(American Heart Association); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We gratefully acknowledge J. Pritchard, H. Tang and members of the laboratory of N. Zaitlen for helpful discussions. This work was funded in part by the Natural Sciences and Engineering Research Council of Canada (NSERC) (grant PGSD3-476082-2015 to M.W.); a Stanford Bio-X Bowes fellowship (to M.W.); a Stanford Graduate Fellowship (to N.S.-A.); a National Defense Science & Engineering Grant (to N.S.-A.); NIH grants 1DP2OD022870 and U01HG009431 (to A.K.), 1U24HG008956 and 5U01HG009080 (to M.A.R.), R01HG009120 and R01MH115676 (to B.P.), R01MH107666, R01MH101820 and P30DK20595 (to H.K.I.), and R01HL125863 and R21TR001739 (to J.L.M.B.); NHGRI grant R01HG010140 (to M.A.R.); Leducq Foundation grant 12CVD02 (to J.L.M.B.); and American Heart Association grant A14SFRN20840000 (to J.L.M.B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Barbeira AN, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007889; Barbeira AN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03621-1; Bhutani K, 2017, MODELING PREDICTION, DOI [10.1101/108316v1, DOI 10.1101/108316V1]; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; de Leeuw CA, 2016, NAT REV GENET, V17, P353, DOI 10.1038/nrg.2016.29; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4; Franzen O, 2016, SCIENCE, V353, P827, DOI 10.1126/science.aad6970; Gallagher MD, 2018, AM J HUM GENET, V102, P717, DOI 10.1016/j.ajhg.2018.04.002; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Gusev A, 2018, NAT GENET, V50, P538, DOI 10.1038/s41588-018-0092-1; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Hauberg ME, 2017, AM J HUM GENET, V100, P885, DOI 10.1016/j.ajhg.2017.04.016; He X, 2013, AM J HUM GENET, V92, P667, DOI 10.1016/j.ajhg.2013.03.022; Hormozdiari F, 2016, AM J HUM GENET, V99, P1245, DOI 10.1016/j.ajhg.2016.10.003; Hu YM, 2019, NAT GENET, V51, P568, DOI 10.1038/s41588-019-0345-7; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Liu SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aah7111; Luo Y, 2017, NAT GENET, V49, P186, DOI 10.1038/ng.3761; Mancuso N, 2019, NAT GENET, V51, P675, DOI 10.1038/s41588-019-0367-1; Mancuso N, 2017, AM J HUM GENET, V100, P473, DOI 10.1016/j.ajhg.2017.01.031; Mogil LS, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007586; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Ongen H, 2017, NAT GENET, V49, P1676, DOI 10.1038/ng.3981; Palazzo AF, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00002; Pavlides JMW, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0338-4; Plagnol V, 2009, BIOSTATISTICS, V10, P327, DOI 10.1093/biostatistics/kxn039; Regev A, 2017, ELIFE, V6, DOI 10.7554/eLife.27041; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Vosa U, 2018, UNRAVELING POLYGENIC, DOI [10.1101/447367v1, DOI 10.1101/447367V1]; Wallace C, 2012, HUM MOL GENET, V21, P2815, DOI 10.1093/hmg/dds098; Wheeler H. E, 2018, IMPUTED GENE ASS IDE, DOI [10.1101/471748v1, DOI 10.1101/471748V1]; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wen XQ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006646; Xu ZY, 2017, GENETICS, V207, P893, DOI 10.1534/genetics.117.300270; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	44	280	284	17	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2019	51	4					592	599		10.1038/s41588-019-0385-z	http://dx.doi.org/10.1038/s41588-019-0385-z			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HQ9SJ	30926968	Green Accepted, Green Submitted			2022-12-17	WOS:000462767500005
J	Polak, P; Kim, J; Braunstein, LZ; Karlic, R; Haradhavala, NJ; Tiao, G; Rosebrock, D; Livitz, D; Kubler, K; Mouw, KW; Kamburov, A; Maruvka, YE; Leshchiner, I; Lander, ES; Golub, TR; Zick, A; Orthwein, A; Lawrence, MS; Batra, RN; Caldas, C; Haber, DA; Laird, PW; Shen, H; Ellisen, LW; D'Andrea, AD; Chanock, SJ; Foulkes, WD; Getz, G				Polak, Paz; Kim, Jaegil; Braunstein, Lior Z.; Karlic, Rosa; Haradhavala, Nicholas J.; Tiao, Grace; Rosebrock, Daniel; Livitz, Dimitri; Kubler, Kirsten; Mouw, Kent W.; Kamburov, Atanas; Maruvka, Yosef E.; Leshchiner, Ignaty; Lander, Eric S.; Golub, Todd R.; Zick, Aviad; Orthwein, Alexandre; Lawrence, Michael S.; Batra, Rajbir N.; Caldas, Carlos; Haber, Daniel A.; Laird, Peter W.; Shen, Hui; Ellisen, Leif W.; D'Andrea, Alan D.; Chanock, Stephen J.; Foulkes, William D.; Getz, Gad			A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer	NATURE GENETICS			English	Article							COMPREHENSIVE MOLECULAR PORTRAITS; GERMLINE BRCA1 MUTATIONS; OVARIAN-CANCER; SEQUENCE VARIATION; PARP INHIBITORS; FAMILY-HISTORY; TUMORS; LANDSCAPE; VARIANTS; SUSCEPTIBILITY	Biallelic inactivation of BRCA1 or BRCA2 is associated with a pattern of genome-wide mutations known as signature 3. By analyzing similar to 1,000 breast cancer samples, we confirmed this association and established that germline nonsense and frameshift variants in PALB2, but not in ATM or CHEK2, can also give rise to the same signature. We were able to accurately classify missense BRCA1 or BRCA2 variants known to impair homologous recombination (HR) on the basis of this signature. Finally, we show that epigenetic silencing of RAD51C and BRCA1 by promoter methylation is strongly associated with signature 3 and, in our data set, was highly enriched in basal-like breast cancers in young individuals of African descent.	[Polak, Paz; Kim, Jaegil; Braunstein, Lior Z.; Haradhavala, Nicholas J.; Tiao, Grace; Rosebrock, Daniel; Livitz, Dimitri; Kubler, Kirsten; Kamburov, Atanas; Maruvka, Yosef E.; Leshchiner, Ignaty; Lander, Eric S.; Golub, Todd R.; Lawrence, Michael S.; Getz, Gad] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Polak, Paz; Haradhavala, Nicholas J.; Kubler, Kirsten; Kamburov, Atanas; Maruvka, Yosef E.; Lawrence, Michael S.; Haber, Daniel A.; Ellisen, Leif W.; Getz, Gad] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Polak, Paz; Kubler, Kirsten; Mouw, Kent W.; Kamburov, Atanas; Maruvka, Yosef E.; Golub, Todd R.; Haber, Daniel A.; Ellisen, Leif W.; Getz, Gad] Harvard Med Sch, Boston, MA 02115 USA; [Braunstein, Lior Z.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA; [Karlic, Rosa] Univ Zagreb, Div Mol Biol, Dept Biol, Bioinformat Grp,Fac Sci, Zagreb, Croatia; [Mouw, Kent W.] Brigham & Womens Hosp, Dept Radiat Oncol, 75 Francis St, Boston, MA 02115 USA; [Mouw, Kent W.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA USA; [Lander, Eric S.] Harvard Med Sch, Dept Syst Biol, Boston, MA USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pathol, Boston, MA 02115 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Zick, Aviad] Hadassah Hebrew Univ, Dept Oncol, Med Ctr, Jerusalem, Israel; [Orthwein, Alexandre; Foulkes, William D.] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Batra, Rajbir N.; Caldas, Carlos] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England; [Batra, Rajbir N.; Caldas, Carlos] Canc Res UK Cambridge Ctr, Cambridge, England; [Batra, Rajbir N.; Caldas, Carlos] Univ Cambridge, Dept Oncol, Hutchison MRC Res Ctr, Cambridge Biomed Campus, Cambridge, England; [Laird, Peter W.; Shen, Hui] Van Andel Res Inst, Grand Rapids, MI USA; [D'Andrea, Alan D.] Dana Farber Canc Inst, Ctr DNA Damage & Repair, Boston, MA 02115 USA; [D'Andrea, Alan D.] Harvard Med Sch, Ludwig Ctr, Harvard, Boston, MA USA; [Chanock, Stephen J.] US Natl Canc Inst, Div Canc Epidemiol & Genet, Bethesda, MD USA; [Foulkes, William D.] McGill Univ, Lady Davis Inst Med Res, Dept Human Genet, Montreal, PQ, Canada; [Foulkes, William D.] McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ, Canada; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center; University of Zagreb; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Hebrew University of Jerusalem; Hadassah University Medical Center; McGill University; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Van Andel Institute; Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Lady Davis Institute; McGill University; McGill University; Harvard University; Massachusetts General Hospital	Getz, G (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Getz, G (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA.; Getz, G (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Getz, G (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.	gadgetz@broadinstitute.org	Ellisen, Leif W/AAA-6572-2022; Foulkes, William D./AAR-9586-2021; Caldas, Carlos/U-7250-2019; Zick, Aviad/GZK-7645-2022; Laird, Peter W/G-8683-2012; Lawrence, Michael/AAC-8202-2020; Polak, Paz/AAH-9380-2020; Shen, Hui/AAO-4387-2020; Batra, Rajbir/I-2443-2014	Ellisen, Leif W/0000-0003-0444-7910; Foulkes, William D./0000-0001-7427-4651; Caldas, Carlos/0000-0003-3547-1489; Zick, Aviad/0000-0002-5077-9249; Laird, Peter W/0000-0001-9117-3641; Shen, Hui/0000-0001-9767-4084; Mouw, Kent/0000-0001-7939-7343; Rosebrock, Daniel/0000-0002-4818-4983; Kubler, Kirsten/0000-0002-0342-5579; Batra, Rajbir/0000-0001-7010-8189; Maruvka, Yosef/0000-0002-8918-9887; Karlic, Rosa/0000-0002-1291-2897; Kamburov, Atanas/0000-0002-0580-0619; Haradhvala, Nicholas/0000-0003-1113-3135; Livitz, Dimitri/0000-0003-2528-1446; Orthwein, Alexandre/0000-0002-7350-3413	Louis B. Mayer Foundation; Avon Breast Cancer Crusade; Breast Cancer Research Foundation (BCRF); NIH TCGA Genome Data Analysis Center [U24CA143845]; Massachusetts General Hospital; Ludwig Center at Harvard; Susan G. Komen; Cancer Research UK [16942] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10090, NF-SI-0611-10154] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIACP010227] Funding Source: NIH RePORTER	Louis B. Mayer Foundation; Avon Breast Cancer Crusade; Breast Cancer Research Foundation (BCRF); NIH TCGA Genome Data Analysis Center; Massachusetts General Hospital(General Electric); Ludwig Center at Harvard; Susan G. Komen(Susan G. Komen Breast Cancer Foundation); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	L.Z.B. was supported by the Louis B. Mayer Foundation. L.W.E. was supported by grants from the Avon Breast Cancer Crusade and the Breast Cancer Research Foundation (BCRF). G.G. and J.K. were partially funded by the NIH TCGA Genome Data Analysis Center (U24CA143845). P.P., N.J.H., Y.E.M., and A.K. were funded by the startup funds of G.G. at Massachusetts General Hospital. A.D.D. was supported by grants from the Ludwig Center at Harvard and the Breast Cancer Research Foundation (BCRF). W.D.F. was supported by Susan G. Komen. G. G. was partly funded by the Paul C. Zamecnick, MD, Chair in Oncology at Massachusetts General Hospital.	Abkevich V, 2012, BRIT J CANCER, V107, P1776, DOI 10.1038/bjc.2012.451; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Blanco A, 2014, BREAST CANCER RES TR, V147, P133, DOI 10.1007/s10549-014-3078-4; Burstein MD, 2015, CLIN CANCER RES, V21, P1688, DOI 10.1158/1078-0432.CCR-14-0432; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Ceccaldi R, 2015, NATURE, V518, P258, DOI 10.1038/nature14184; Chan SL, 2010, LANCET, V376, P211, DOI 10.1016/S0140-6736(10)61119-1; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Clamp A, 2015, LANCET ONCOL, V16, P10, DOI 10.1016/S1470-2045(14)71172-6; Connor AA, 2017, JAMA ONCOL, V3, P774, DOI 10.1001/jamaoncol.2016.3916; CORNELIS RS, 1995, GENE CHROMOSOME CANC, V13, P203, DOI 10.1002/gcc.2870130310; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Couch FJ, 2015, J CLIN ONCOL, V33, P304, DOI 10.1200/JCO.2014.57.1414; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dietze EC, 2015, NAT REV CANCER, V15, P248, DOI 10.1038/nrc3896; Easton DF, 2015, NEW ENGL J MED, V372, P2243, DOI 10.1056/NEJMsr1501341; Eccles DM, 2015, ANN ONCOL, V26, P2057, DOI 10.1093/annonc/mdv278; Ellis MJ, 2013, CANCER DISCOV, V3, P27, DOI 10.1158/2159-8290.CD-12-0462; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Evans T, 2017, THER ADV MED ONCOL, V9, P253, DOI 10.1177/1758834016687254; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gorski B, 2000, AM J HUM GENET, V66, P1963, DOI 10.1086/302922; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hyman DM, 2015, DRUG DISCOV TODAY, V20, P1422, DOI 10.1016/j.drudis.2015.08.005; Kasar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9866; Kaufman B, 2015, J CLIN ONCOL, V33, P244, DOI 10.1200/JCO.2014.56.2728; Kim J, 2016, NAT GENET, V48, P600, DOI 10.1038/ng.3557; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lindor NM, 2012, HUM MUTAT, V33, P8, DOI 10.1002/humu.21627; Livingston DM, 2009, SCIENCE, V324, P602, DOI 10.1126/science.1174839; Lord CJ, 2016, NAT REV CANCER, V16, P110, DOI 10.1038/nrc.2015.21; Loveday C, 2012, NAT GENET, V44, P475, DOI 10.1038/ng.2224; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meeks HD, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv315; Merajver SD, 1995, CLIN CANCER RES, V1, P539; Min A, 2013, MOL CANCER THER, V12, P865, DOI 10.1158/1535-7163.MCT-12-0950; Nielsen FC, 2016, NAT REV CANCER, V16, P599, DOI 10.1038/nrc.2016.72; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Pathania S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6496; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Popova T, 2012, CANCER RES, V72, P5454, DOI 10.1158/0008-5472.CAN-12-1470; Prakash R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016600; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Southey MC, 2016, J MED GENET, V53, P800, DOI 10.1136/jmedgenet-2016-103839; Spurdle AB, 2012, HUM MUTAT, V33, P2, DOI 10.1002/humu.21628; Thompson ER, 2016, J CLIN ONCOL, V34, P1455, DOI 10.1200/JCO.2015.63.7454; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Yeeles JTP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012815; YOUDEN WJ, 1950, CANCER-AM CANCER SOC, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	62	280	281	2	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2017	49	10					1476	+		10.1038/ng.3934	http://dx.doi.org/10.1038/ng.3934			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FI3JD	28825726	Green Accepted			2022-12-17	WOS:000411855800011
J	Griffith, M; Spies, NC; Krysiak, K; McMichael, JF; Coffman, AC; Danos, AM; Ainscough, BJ; Ramirez, CA; Rieke, DT; Kujan, L; Barnell, EK; Wagner, AH; Skidmore, ZL; Wollam, A; Liu, CJ; Jones, MR; Bilski, RL; Lesurf, R; Feng, YY; Shah, NM; Bonakdar, M; Trani, L; Matlock, M; Ramu, A; Campbell, KM; Spies, GC; Graubert, AP; Gangavarapu, K; Eldred, JM; Larson, DE; Walker, JR; Good, BM; Wu, CL; Su, AI; Dienstmann, R; Margolin, AA; Tamborero, D; Lopez-Bigas, N; Jones, SJM; Bose, R; Spencer, DH; Wartman, LD; Wilson, RK; Mardis, ER; Griffith, OL				Griffith, Malachi; Spies, Nicholas C.; Krysiak, Kilannin; McMichael, Joshua F.; Coffman, Adam C.; Danos, Arpad M.; Ainscough, Benjamin J.; Ramirez, Cody A.; Rieke, Damian T.; Kujan, Lynzey; Barnell, Erica K.; Wagner, Alex H.; Skidmore, Zachary L.; Wollam, Amber; Liu, Connor J.; Jones, Martin R.; Bilski, Rachel L.; Lesurf, Robert; Feng, Yan-Yang; Shah, Nakul M.; Bonakdar, Melika; Trani, Lee; Matlock, Matthew; Ramu, Avinash; Campbell, Katie M.; Spies, Gregory C.; Graubert, Aaron P.; Gangavarapu, Karthik; Eldred, James M.; Larson, David E.; Walker, Jason R.; Good, Benjamin M.; Wu, Chunlei; Su, Andrew I.; Dienstmann, Rodrigo; Margolin, Adam A.; Tamborero, David; Lopez-Bigas, Nuria; Jones, Steven J. M.; Bose, Ron; Spencer, David H.; Wartman, Lukas D.; Wilson, Richard K.; Mardis, Elaine R.; Griffith, Obi L.			CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer	NATURE GENETICS			English	Editorial Material							DATABASE; PERFORMANCE; GUIDELINES; MUTATIONS; ONTOLOGY; GENETICS; CATALOG	CIViC is an expert-crowdsourced knowledgebase for Clinical Interpretation of Variants in Cancer describing the therapeutic, prognostic, diagnostic and predisposing relevance of inherited and somatic variants of all types. CIViC is committed to open source code, open-access content, public application programming interfaces (APIs) and provenance of supporting evidence to allow for the transparent creation of current and accurate variant interpretations for use in cancer precision medicine.	[Griffith, Malachi; Spies, Nicholas C.; Krysiak, Kilannin; McMichael, Joshua F.; Coffman, Adam C.; Danos, Arpad M.; Ainscough, Benjamin J.; Ramirez, Cody A.; Kujan, Lynzey; Barnell, Erica K.; Wagner, Alex H.; Skidmore, Zachary L.; Wollam, Amber; Liu, Connor J.; Bilski, Rachel L.; Lesurf, Robert; Feng, Yan-Yang; Shah, Nakul M.; Trani, Lee; Matlock, Matthew; Ramu, Avinash; Campbell, Katie M.; Spies, Gregory C.; Graubert, Aaron P.; Eldred, James M.; Larson, David E.; Walker, Jason R.; Spencer, David H.; Wartman, Lukas D.; Wilson, Richard K.; Mardis, Elaine R.; Griffith, Obi L.] Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO 63130 USA; [Griffith, Malachi; Ainscough, Benjamin J.; Wagner, Alex H.; Wartman, Lukas D.; Wilson, Richard K.; Mardis, Elaine R.; Griffith, Obi L.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63130 USA; [Griffith, Malachi; Ainscough, Benjamin J.; Larson, David E.; Wilson, Richard K.; Mardis, Elaine R.; Griffith, Obi L.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Griffith, Malachi; Krysiak, Kilannin; Bose, Ron; Spencer, David H.; Wartman, Lukas D.; Wilson, Richard K.; Mardis, Elaine R.; Griffith, Obi L.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Rieke, Damian T.] Charite, Charite Comprehens Canc Ctr, Berlin, Germany; [Jones, Martin R.; Bonakdar, Melika; Jones, Steven J. M.] British Columbia Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Gangavarapu, Karthik; Good, Benjamin M.; Wu, Chunlei; Su, Andrew I.] Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Dienstmann, Rodrigo] Vall dHebron Inst Oncol, Oncol Data Sci Grp, Barcelona, Spain; [Margolin, Adam A.] Oregon Hlth & Sci Univ, Computat Biol, Portland, OR 97201 USA; [Tamborero, David; Lopez-Bigas, Nuria] Barcelona Inst Sci & Technol, Inst Res Biomed, Barcelona, Spain	Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; British Columbia Cancer Agency; Scripps Research Institute; Vall d'Hebron Institut d'Oncologia (VHIO); Oregon Health & Science University; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Griffith, M; Griffith, OL (corresponding author), Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO 63130 USA.; Griffith, M; Griffith, OL (corresponding author), Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63130 USA.; Griffith, M; Griffith, OL (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.; Griffith, M; Griffith, OL (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	mgriffit@wustl.edu; obigriffith@wustl.edu	Wilson, Richard K./AAF-4139-2019; Rieke, Damian/AAF-5262-2020; Mardis, Elaine/W-2202-2019; Lopez-Bigas, Nuria/F-6193-2011; Wu, Chunlei/ABF-4720-2020; Jones, Steven J/C-3621-2009; Griffith, Malachi/P-1285-2014; Rieke, Damian/AHE-8894-2022; Barnell, Erica/AAL-8917-2020; tamborero, david/M-5283-2015	Wilson, Richard K./0000-0002-1992-1358; Lopez-Bigas, Nuria/0000-0003-4925-8988; Wu, Chunlei/0000-0002-2629-6124; Jones, Steven J/0000-0003-3394-2208; Griffith, Malachi/0000-0002-6388-446X; Rieke, Damian/0000-0003-0027-7977; Barnell, Erica/0000-0003-1631-1201; Lesurf, Robert/0000-0001-7095-1491; Larson, David/0000-0001-7934-5906; Spies, Rachel/0000-0002-4505-3574; Ainscough, Benjamin/0000-0001-8340-514X; Shah, Nakul/0000-0003-1775-2279; Ramu, Avinash/0000-0003-3799-809X; tamborero, david/0000-0002-7218-2806; Campbell, Katie/0000-0001-6491-4432; Matlock, Matthew/0000-0003-3087-4027; Graubert, Aaron/0000-0001-5539-034X; Su, Andrew I./0000-0002-9859-4104; Skidmore, Zachary/0000-0003-1928-7139; Ramirez, Cody/0000-0001-5598-0876	National Cancer Institute (NCI) of National Institutes of Health (NIH) [U01CA209936]; National Human Genome Research Institute (NHGRI) of NIH [U54HG003079]; German Federal Ministry of Education and Research [031L0030E, 031L0023B]; Severo Ocho Centre of Excellence Award from MINECO (Government of Spain); CERCA (Generalitat de Catalunya); FEDER/UE [SAF2015-74072-JIN]; NHGRI [K99HG007940]; NCI [K22CA188163, K08CA166229]; Spanish Ministry of Economy and Competitiveness; NATIONAL CANCER INSTITUTE [K08CA166229, F32CA206247, K22CA188163, T32CA113275, U01CA209936] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, K99HG007940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM114833, R25GM103757, R01GM089820] Funding Source: NIH RePORTER	National Cancer Institute (NCI) of National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute (NHGRI) of NIH; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Severo Ocho Centre of Excellence Award from MINECO (Government of Spain); CERCA (Generalitat de Catalunya); FEDER/UE(European Commission); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Spanish Ministry of Economy and Competitiveness(Spanish Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	First and foremost, we are grateful to the community of curators, editors, domain experts and users who make CIViC possible. CIViC is supported by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) under award number U01CA209936 to O.L.G. (with M.G. and E.R.M. as co-principal investigators). This work was also supported by a grant to R.K.W. from the National Human Genome Research Institute (NHGRI) of the NIH under award number U54HG003079. D.T.R. was supported by the German Federal Ministry of Education and Research under award numbers 031L0030E and 031L0023B. The Institute for Research in Biomedicine is a recipient of a Severo Ocho Centre of Excellence Award from MINECO (Government of Spain) and is supported by CERCA (Generalitat de Catalunya). D.T. is funded by a grant from the Spanish Ministry of Economy and Competitiveness and FEDER/UE (SAF2015-74072-JIN). M.G. is supported by the NHGRI under award number K99HG007940. O.L.G. is supported by the NCI under award number K22CA188163. L.D.W. is supported by the NCI under award number K08CA166229. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Ainscough BJ, 2016, NAT METHODS, V13, P806, DOI 10.1038/nmeth.4000; Amendola LM, 2016, AM J HUM GENET, V98, P1067, DOI 10.1016/j.ajhg.2016.03.024; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Damodaran S, 2015, J MOL DIAGN, V17, P554, DOI 10.1016/j.jmoldx.2015.05.002; Dienstmann R, 2015, CANCER DISCOV, V5, P118, DOI 10.1158/2159-8290.CD-14-1118; Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Gagan J, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0203-x; Good BM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0438-7; Karczewski KJ, 2017, NUCLEIC ACIDS RES, V45, pD840, DOI 10.1093/nar/gkw971; Kibbe WA, 2015, NUCLEIC ACIDS RES, V43, pD1071, DOI 10.1093/nar/gku1011; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Laskin J, 2015, CSH MOL CASE STUD, V1, DOI 10.1101/mcs.a000570; Meric-Bernstam F, 2015, J CLIN ONCOL, V33, P2753, DOI 10.1200/JCO.2014.60.4165; Parnell LD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002216; Patterson SE, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0061-7; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ritter DI, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0367-z; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Thorn Caroline F, 2013, Methods Mol Biol, V1015, P311, DOI 10.1007/978-1-62703-435-7_20; Xin JW, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0953-9; Yeh P, 2013, CLIN CANCER RES, V19, P1894, DOI 10.1158/1078-0432.CCR-12-1894	23	280	282	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2017	49	2					170	174		10.1038/ng.3774	http://dx.doi.org/10.1038/ng.3774			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ3YM	28138153	Green Accepted, Green Published, Green Submitted			2022-12-17	WOS:000393148600002
J	Cooper, CS; Eeles, R; Wedge, DC; Van Loo, P; Gundem, G; Alexandrov, LB; Kremeyer, B; Butler, A; Lynch, AG; Camacho, N; Massie, CE; Kay, J; Luxton, HJ; Edwards, S; Kote-Jarai, Z; Dennis, N; Merson, S; Leongamornlert, D; Zamora, J; Corbishley, C; Thomas, S; Nik-Zainal, S; O'Meara, S; Matthews, L; Clark, J; Hurst, R; Mithen, R; Bristow, RG; Boutros, PC; Fraser, M; Cooke, S; Raine, K; Jones, D; Menzies, A; Stebbings, L; Hinton, J; Teague, J; McLaren, S; Mudie, L; Hardy, C; Anderson, E; Joseph, O; Goody, V; Robinson, B; Maddison, M; Gamble, S; Greenman, C; Berney, D; Hazell, S; Livni, N; Fisher, C; Ogden, C; Kumar, P; Thompson, A; Woodhouse, C; Nicol, D; Mayer, E; Dudderidge, T; Shah, NC; Gnanapragasam, V; Voet, T; Campbell, P; Futreal, A; Easton, D; Warren, AY; Foster, CS; Stratton, MR; Whitaker, HC; McDermott, U; Brewer, DS; Neal, DE				Cooper, Colin S.; Eeles, Rosalind; Wedge, David C.; Van Loo, Peter; Gundem, Gunes; Alexandrov, Ludmil B.; Kremeyer, Barbara; Butler, Adam; Lynch, Andrew G.; Camacho, Niedzica; Massie, Charlie E.; Kay, Jonathan; Luxton, Hayley J.; Edwards, Sandra; Kote-Jarai, Zsofia; Dennis, Nening; Merson, Sue; Leongamornlert, Daniel; Zamora, Jorge; Corbishley, Cathy; Thomas, Sarah; Nik-Zainal, Serena; O'Meara, Sarah; Matthews, Lucy; Clark, Jeremy; Hurst, Rachel; Mithen, Richard; Bristow, Robert G.; Boutros, Paul C.; Fraser, Michael; Cooke, Susanna; Raine, Keiran; Jones, David; Menzies, Andrew; Stebbings, Lucy; Hinton, Jon; Teague, Jon; McLaren, Stuart; Mudie, Laura; Hardy, Claire; Anderson, Elizabeth; Joseph, Olivia; Goody, Victoria; Robinson, Ben; Maddison, Mark; Gamble, Stephen; Greenman, Christopher; Berney, Dan; Hazell, Steven; Livni, Naomi; Fisher, Cyril; Ogden, Christopher; Kumar, Pardeep; Thompson, Alan; Woodhouse, Christopher; Nicol, David; Mayer, Erik; Dudderidge, Tim; Shah, Nimish C.; Gnanapragasam, Vincent; Voet, Thierry; Campbell, Peter; Futreal, Andrew; Easton, Douglas; Warren, Anne Y.; Foster, Christopher S.; Stratton, Michael R.; Whitaker, Hayley C.; McDermott, Ultan; Brewer, Daniel S.; Neal, David E.		ICGC Prostate Grp	Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue	NATURE GENETICS			English	Article							COPY-NUMBER ANALYSIS; 21 BREAST CANCERS; MUTATIONAL PROCESSES; RADICAL PROSTATECTOMY; LANDSCAPE; GENOMES; HETEROGENEITY; ALGORITHMS; SIGNATURES; EVOLUTION	Genome-wide DNA sequencing was used to decrypt the phylogeny of multiple samples from distinct areas of cancer and morphologically normal tissue taken from the prostates of three men. Mutations were present at high levels in morphologically normal tissue distant from the cancer, reflecting clonal expansions, and the underlying mutational processes at work in morphologically normal tissue were also at work in cancer. Our observations demonstrate the existence of ongoing abnormal mutational processes, consistent with field effects, underlying carcinogenesis. This mechanism gives rise to extensive branching evolution and cancer clone mixing, as exemplified by the coexistence of multiple cancer lineages harboring distinct ERG fusions within a single cancer nodule. Subsets of mutations were shared either by morphologically normal and malignant tissues or between different ERG lineages, indicating earlier or separate clonal cell expansions. Our observations inform on the origin of multifocal disease and have implications for prostate cancer therapy in individual cases.	[Cooper, Colin S.; Eeles, Rosalind; Camacho, Niedzica; Edwards, Sandra; Kote-Jarai, Zsofia; Merson, Sue; Leongamornlert, Daniel; Matthews, Lucy; Brewer, Daniel S.] Inst Canc Res, Div Genet & Epidemiol, London SW3 6JB, England; [Cooper, Colin S.] Univ E Anglia, Dept Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Cooper, Colin S.; Clark, Jeremy; Hurst, Rachel; Brewer, Daniel S.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Eeles, Rosalind; Dennis, Nening; Thomas, Sarah; Hazell, Steven; Livni, Naomi; Fisher, Cyril; Ogden, Christopher; Kumar, Pardeep; Thompson, Alan; Woodhouse, Christopher; Nicol, David; Mayer, Erik; Dudderidge, Tim] Royal Marsden NHS Fdn Trust, London, England; [Eeles, Rosalind; Dennis, Nening; Thomas, Sarah; Hazell, Steven; Livni, Naomi; Fisher, Cyril; Ogden, Christopher; Kumar, Pardeep; Thompson, Alan; Woodhouse, Christopher; Nicol, David; Mayer, Erik; Dudderidge, Tim] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England; [Wedge, David C.; Van Loo, Peter; Gundem, Gunes; Alexandrov, Ludmil B.; Kremeyer, Barbara; Butler, Adam; Zamora, Jorge; Nik-Zainal, Serena; O'Meara, Sarah; Cooke, Susanna; Raine, Keiran; Jones, David; Menzies, Andrew; Stebbings, Lucy; Hinton, Jon; Teague, Jon; McLaren, Stuart; Mudie, Laura; Hardy, Claire; Anderson, Elizabeth; Joseph, Olivia; Goody, Victoria; Robinson, Ben; Maddison, Mark; Gamble, Stephen; Campbell, Peter; Futreal, Andrew; Stratton, Michael R.; McDermott, Ultan] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, Cambs, England; [Van Loo, Peter] VIB, Dept Human Genet, Human Genome Lab, Leuven, Belgium; [Van Loo, Peter] Katholieke Univ Leuven, Leuven, Belgium; [Van Loo, Peter] Canc Res UK London Res Inst, London WC2A 3PX, England; [Lynch, Andrew G.] Canc Res UK Cambridge Res Inst, Stat & Computat Biol Lab, Cambridge, England; [Massie, Charlie E.; Kay, Jonathan; Luxton, Hayley J.; Shah, Nimish C.; Gnanapragasam, Vincent; Whitaker, Hayley C.; Neal, David E.] Canc Res UK Cambridge Res Inst, Urol Res Lab, Cambridge, England; [Corbishley, Cathy] St George Hosp, Dept Histopathol, London, England; [Mithen, Richard] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Bristow, Robert G.; Fraser, Michael] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Bristow, Robert G.; Fraser, Michael] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Bristow, Robert G.; Fraser, Michael] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Boutros, Paul C.] Ontario Inst Canc Res, Informat & Biocomp, Toronto, ON, Canada; [Boutros, Paul C.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Greenman, Christopher] Univ E Anglia, Sch Comp Sci, Norwich NR4 7TJ, Norfolk, England; [Berney, Dan] Barts & London Queen Marys Sch Med & Dent, Barts Canc Ctr, Dept Mol Oncol, London, England; [Voet, Thierry] Katholieke Univ Leuven, Dept Human Genet, Lab Reprod Genom, Leuven, Belgium; [Easton, Douglas] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Warren, Anne Y.] Cambridge Univ Hosp NHS Fdn Trust, Dept Histopathol, Cambridge, England; [Foster, Christopher S.] Univ Liverpool, Dept Histopathol, Liverpool L69 3BX, Merseyside, England; [Foster, Christopher S.] HCA Pathol Labs, London, England; [Brewer, Daniel S.] Genome Anal Ctr, Norwich, Norfolk, England; [Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Surg Oncol, Cambridge CB2 2QQ, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of East Anglia; University of East Anglia; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Wellcome Trust Sanger Institute; Flanders Institute for Biotechnology (VIB); KU Leuven; Cancer Research UK; Cancer Research UK; CRUK Cambridge Institute; Cancer Research UK; CRUK Cambridge Institute; St Georges University London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of East Anglia; University of London; Queen Mary University London; KU Leuven; University of Cambridge; University of Cambridge; University of Liverpool; The Genome Analysis Centre (TGAC); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Cooper, CS (corresponding author), Inst Canc Res, Div Genet & Epidemiol, London SW3 6JB, England.	colin.cooper@icr.ac.uk; ros.eeles@icr.ac.uk; den22@medschl.cam.ac.uk	Alexandrov, Ludmil/AAS-1454-2021; Voet, Thierry/E-8877-2017; Luxton, Hayley/AAT-2450-2020; Wedge, David/AAC-4977-2021; Nik-Zainal, Serena/ABD-4437-2020; Kay, Jonathan/HGE-1248-2022; Mayer, Erik K/A-6207-2013; Nicol, David L/M-6809-2016; Brewer, Daniel S/D-6201-2018; Dudderidge, Tim/AAO-1430-2020; Gamble, Stephen/D-1417-2011	Alexandrov, Ludmil/0000-0003-3596-4515; Voet, Thierry/0000-0003-1204-9963; Luxton, Hayley/0000-0003-1431-3844; Mayer, Erik K/0000-0002-5509-4580; Nicol, David L/0000-0002-5623-7467; Brewer, Daniel S/0000-0003-4753-9794; Lynch, Andy/0000-0002-7876-7338; Nik-Zainal, Serena/0000-0001-5054-1727; Nicol, David/0000-0003-0107-6990; Gamble, Stephen/0000-0002-0867-3723; Massie, Charlie/0000-0003-2314-4843; Eeles, Rosalind/0000-0002-3698-6241; Wedge, David/0000-0002-7572-3196; McDermott, Ultan/0000-0001-9032-4700; Bova, George/0000-0003-1639-3104; Bristow, Robert/0000-0002-8553-9544; Hurst, Rachel/0000-0001-8066-324X; Berney, Daniel/0000-0001-5474-8696; Boutros, Paul/0000-0003-0553-7520; Raine, Keiran/0000-0002-5634-1539; Dudderidge, Tim/0000-0001-6373-3613; Van Loo, Peter/0000-0003-0292-1949; Leongamornlert, Daniel/0000-0002-3486-3168; Mithen, Richard/0000-0001-7307-4324	Cancer Research UK [C5047/A14835]; Dallaglio Foundation; Wellcome Trust; Bob Champion Cancer Trust; Orchid Cancer Appeal; RoseTrees Trust; North West Cancer Research Fund; Big C; King family; Grand Charity of Freemasons; Research Foundation Flanders (FWO); Biomedical Research Centre at the Institute of Cancer Research - National Institute for Health Research; Royal Marsden NHS Foundation Trust - National Institute for Health Research; National Cancer Research Prostate Cancer: Mechanisms of Progression and Treatment (PROMPT) [G0500966/75466]; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044431, BBS/E/T/000PR6193, BBS/E/T/000PR5885, BBS/E/F/00042686] Funding Source: researchfish; Cancer Research UK [15007, 14835, 17528] Funding Source: researchfish; Versus Arthritis [20406] Funding Source: researchfish; The Francis Crick Institute [10202] Funding Source: researchfish; BBSRC [BBS/E/F/00042686, BBS/E/F/00044431, BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Dallaglio Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Bob Champion Cancer Trust; Orchid Cancer Appeal; RoseTrees Trust(Rosetrees Trust); North West Cancer Research Fund; Big C; King family; Grand Charity of Freemasons; Research Foundation Flanders (FWO)(FWO); Biomedical Research Centre at the Institute of Cancer Research - National Institute for Health Research; Royal Marsden NHS Foundation Trust - National Institute for Health Research; National Cancer Research Prostate Cancer: Mechanisms of Progression and Treatment (PROMPT); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Versus Arthritis(Versus Arthritis); The Francis Crick Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Cancer Research UK (grant C5047/A14835), the Dallaglio Foundation and the Wellcome Trust. We also acknowledge support from the Bob Champion Cancer Trust, the Orchid Cancer Appeal, the RoseTrees Trust, the North West Cancer Research Fund, Big C, the King family, the Grand Charity of Freemasons, and the Research Foundation Flanders (FWO). We thank D. Holland from the Infrastructure Management Team and P. Clapham from the Informatics Systems Group at the Wellcome Trust Sanger Institute. We acknowledge the Biomedical Research Centre at the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, supported by the National Institute for Health Research. We acknowledge support from the National Cancer Research Prostate Cancer: Mechanisms of Progression and Treatment (PROMPT) collaborative (grant G0500966/75466). We thank the National Institute for Health Research, Hutchison Whampoa Limited and the Human Research Tissue Bank (Addenbrooke's Hospital), the Cancer Research UK Cambridge Research Institute Histopathology, the In-situ Hybridisation Core Facility, the Genomics Core Facility Cambridge and the Cambridge University Hospitals Media Studio.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Andreoiu M, 2010, HUM PATHOL, V41, P781, DOI 10.1016/j.humpath.2010.02.011; Attard G, 2008, ONCOGENE, V27, P253, DOI 10.1038/sj.onc.1210640; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Boyd LK, 2012, GENE CHROMOSOME CANC, V51, P579, DOI 10.1002/gcc.21944; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Cheng L, 1998, J NATL CANCER I, V90, P233, DOI 10.1093/jnci/90.3.233; Clark J, 2008, ONCOGENE, V27, P1993, DOI 10.1038/sj.onc.1210843; Dworkin AM, 2009, SEMIN CANCER BIOL, V19, P165, DOI 10.1016/j.semcancer.2009.02.007; Gaisa NT, 2011, J PATHOL, V225, P172, DOI 10.1002/path.2959; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Holstege H, 2014, GENOME RES, V24, P733, DOI 10.1101/gr.162131.113; Karavitakis M, 2011, NAT REV CLIN ONCOL, V8, P48, DOI 10.1038/nrclinonc.2010.190; Kobayashi M, 2008, PROSTATE, V68, P1715, DOI 10.1002/pros.20832; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindberg J, 2013, EUR UROL, V63, P347, DOI 10.1016/j.eururo.2012.03.050; Mucci NR, 2000, J NATL CANCER I, V92, P1941, DOI 10.1093/jnci/92.23.1941; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Svensson MA, 2011, LAB INVEST, V91, P404, DOI 10.1038/labinvest.2010.179; Tareen Basir, 2009, Rev Urol, V11, P203; Tsai MF, 2007, NUCLEIC ACIDS RES, V35, pW63, DOI 10.1093/nar/gkm383; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Warren AY, 2013, PROSTATE, V73, P194, DOI 10.1002/pros.22556; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	38	280	282	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					367	U118		10.1038/ng.3221	http://dx.doi.org/10.1038/ng.3221			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25730763	Green Accepted, Green Submitted			2022-12-17	WOS:000351922900012
J	Pierron, G; Tirode, F; Lucchesi, C; Reynaud, S; Ballet, S; Cohen-Gogo, S; Perrin, V; Coindre, JM; Delattre, O				Pierron, Gaelle; Tirode, Franck; Lucchesi, Carlo; Reynaud, Stephanie; Ballet, Stelly; Cohen-Gogo, Sarah; Perrin, Virginie; Coindre, Jean-Michel; Delattre, Olivier			A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion	NATURE GENETICS			English	Article							EWING SARCOMA; EXPRESSION; BCOR; TRANSLOCATION; FAMILY; MUTATIONS; CYCLIN; TUMORS	The identification of subtype-specific translocations has revolutionized the diagnostics of sarcoma and has provided new insight into oncogenesis. We used RNA-seq to investigate samples from individuals diagnosed with small round cell tumors of bone, possibly Ewing sarcoma, but which lacked the canonical EWSR1-ETS translocation. A new fusion was observed between BCOR (encoding the BCL6 co-repressor) and CCNB3 (encoding the testis-specific cyclin B3) on the X chromosome. RNA-seq results were confirmed by RT-PCR and through cloning of the tumor-specific genomic translocation breakpoints. In total, 24 BCOR-CCNB3-positive tumors were identified among a series of 594 sarcoma cases. Gene profiling experiments indicated that BCOR-CCNB3-positive cases are biologically distinct from other sarcomas, particularly Ewing sarcoma. Finally, we show that CCNB3 immunohistochemistry is a powerful diagnostic marker for this subgroup of sarcoma and that overexpression of BCOR-CCNB3 or of truncated CCNB3 activates S phase in NIH3T3 cells. Thus, the intrachromosomal X-chromosome fusion described here represents a new subtype of bone sarcoma caused by a newly identified gene fusion mechanism.	[Pierron, Gaelle; Reynaud, Stephanie; Ballet, Stelly; Delattre, Olivier] Ctr Hosp, Inst Curie, Unite Genet Somat, Paris, France; [Tirode, Franck; Lucchesi, Carlo; Cohen-Gogo, Sarah; Perrin, Virginie; Delattre, Olivier] Ctr Rech, Inst Curie, INSERM, U830, Paris, France; [Coindre, Jean-Michel] Inst Bergonie, Bordeaux, France	Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UNICANCER; Institut Bergonie	Delattre, O (corresponding author), Ctr Hosp, Inst Curie, Unite Genet Somat, Paris, France.	olivier.delattre@curie.fr	Cohen-Gogo, Sarah/AAM-4700-2021; Tirode, Franck/B-4586-2009	Cohen-Gogo, Sarah/0000-0002-8852-1104; Tirode, Franck/0000-0003-4731-7817; Lucchesi, Carlo/0000-0001-6657-2341; delattre, olivier/0000-0002-8730-2276	Ligue Nationale Contre le Cancer; Region Ile de France; Institut National du Cancer (INCa) [2008-044, 0627, ZP09-027-EPI]; European Union (European Embryonal Tumors pipeline); Courir pour Mathieu; Dans les Pas du Geant; Olivier Chape; Les Bagouzamanon; Les Amis de Claire	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Region Ile de France(Region Ile-de-France); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); European Union (European Embryonal Tumors pipeline); Courir pour Mathieu; Dans les Pas du Geant; Olivier Chape; Les Bagouzamanon; Les Amis de Claire	We thank S. Chanock for fruitful discussions and critical reading of the manuscript. We are indebted to V. Raynal, P. Legoix-Ne, A. Nicolas, D. Gentien, S. Lair, A. Lermine and E. Barillot for critical technical help. We thank the following individuals for contributing cases and paraffin blocks or for supplying clinical information: J. Champigneulle, A. Croue, P. Dechelotte, J.M. Guinebretiere, C. Jeanne-Pasquier, A. Moreau, J.M. Picquenot, D. Ranchere-Vince, X. Sastre-Garau, P. Terrier, M.C. Vacher-Lavenue, V. Verkaere and L. Guillou. We thank E. Louis, S. Thoraval and T. Scarcez from the Life Science Company for help in applying SOLiD technology. We also thank N. Bretschneider, C. Gugenmus, M. Scherf and M. Seifert from the Genomatix company for the analysis of data. This work was supported by grants from the Ligue Nationale Contre le Cancer (Equipe Labellisee and Carte d'Identite des Tumeurs program), the Region Ile de France, the Institut National du Cancer (INCa; 2008-044, 0627 and ZP09-027-EPI), the European Union (European Embryonal Tumors pipeline) and the following associations: Courir pour Mathieu, Dans les Pas du Geant, Olivier Chape, Les Bagouzamanon and Les Amis de Claire.	Armengol G, 1997, BRIT J CANCER, V75, P1403, DOI 10.1038/bjc.1997.242; Broadhead Matthew L., 2011, Sarcoma, V2011, P959248, DOI 10.1155/2011/959248; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Dauphinot L, 2001, ONCOGENE, V20, P3258, DOI 10.1038/sj.onc.1204437; DELATTRE O, 1994, NEW ENGL J MED, V331, P294, DOI 10.1056/NEJM199408043310503; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Fan ZP, 2009, NAT CELL BIOL, V11, P1002, DOI 10.1038/ncb1913; GALLANT P, 1994, EMBO J, V13, P595, DOI 10.1002/j.1460-2075.1994.tb06297.x; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Grossmann V, 2011, BLOOD, V118, P6153, DOI 10.1182/blood-2011-07-365320; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huynh KD, 2000, GENE DEV, V14, P1810; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ng D, 2004, NAT GENET, V36, P411, DOI 10.1038/ng1321; Ng TL, 2007, J MOL DIAGN, V9, P459, DOI 10.2353/jmoldx.2007.070009; Nguyen TB, 2002, J BIOL CHEM, V277, P41960, DOI 10.1074/jbc.M203951200; Peter M, 2001, LAB INVEST, V81, P905, DOI 10.1038/labinvest.3780299; Sboner A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r104; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szuhai K, 2009, CLIN CANCER RES, V15, P2259, DOI 10.1158/1078-0432.CCR-08-2184; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venables W.N., 2005, R LANGUAGE ENV STAT; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Yamamoto Y, 2010, BLOOD, V116, P4274, DOI 10.1182/blood-2010-01-264432	27	280	298	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2012	44	4					461	U151		10.1038/ng.1107	http://dx.doi.org/10.1038/ng.1107			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22387997	Green Submitted			2022-12-17	WOS:000302130600024
J	Wang, C; Li, YL; Shi, L; Ren, J; Patti, M; Wang, T; de Oliveira, JRM; Sobrido, MJ; Quintans, B; Baquero, M; Cui, XN; Zhang, XY; Wang, LQ; Xu, HB; Wang, JH; Yao, J; Dai, XH; Liu, J; Zhang, L; Ma, HY; Gao, Y; Ma, XX; Feng, SL; Liu, MG; Wang, QK; Forster, IC; Zhang, X; Liu, JY				Wang, Cheng; Li, Yulei; Shi, Lei; Ren, Jie; Patti, Monica; Wang, Tao; de Oliveira, Joao R. M.; Sobrido, Maria-Jesus; Quintans, Beatriz; Baquero, Miguel; Cui, Xiaoniu; Zhang, Xiang-Yang; Wang, Lianqing; Xu, Haibo; Wang, Junhan; Yao, Jing; Dai, Xiaohua; Liu, Juan; Zhang, Lu; Ma, Hongying; Gao, Yong; Ma, Xixiang; Feng, Shenglei; Liu, Mugen; Wang, Qing K.; Forster, Ian C.; Zhang, Xue; Liu, Jing-Yu			Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis	NATURE GENETICS			English	Article							TRANSPORT; DISEASE; IDENTIFICATION; BRAIN	Familial idiopathic basal ganglia calcification (IBGC) is a genetic condition with a wide spectrum of neuropsychiatric symptoms, including parkinsonism and dementia. Here, we identified mutations in SLC20A2, encoding the type III sodium-dependent phosphate transporter 2 (PiT2), in IBGC-affected families of varied ancestry, and we observed significantly impaired phosphate transport activity for all assayed PiT2 mutants in Xenopus laevis oocytes. Our results implicate altered phosphate homeostasis in the etiology of IBGC.	[Wang, Cheng; Li, Yulei; Ren, Jie; Cui, Xiaoniu; Zhang, Xiang-Yang; Yao, Jing; Dai, Xiaohua; Liu, Juan; Zhang, Lu; Ma, Hongying; Gao, Yong; Ma, Xixiang; Feng, Shenglei; Liu, Mugen; Wang, Qing K.; Liu, Jing-Yu] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Peoples R China; [Wang, Cheng; Li, Yulei; Ren, Jie; Cui, Xiaoniu; Zhang, Xiang-Yang; Yao, Jing; Dai, Xiaohua; Liu, Juan; Zhang, Lu; Ma, Hongying; Gao, Yong; Ma, Xixiang; Feng, Shenglei; Liu, Mugen; Wang, Qing K.; Liu, Jing-Yu] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Peoples R China; [Shi, Lei; Wang, Lianqing; Zhang, Xue] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, McKusick Zhang Ctr Genet Med, Beijing 100730, Peoples R China; [Shi, Lei; Wang, Lianqing; Zhang, Xue] Peking Union Med Coll, Beijing 100021, Peoples R China; [Patti, Monica; Forster, Ian C.] Univ Zurich, Inst Physiol, Zurich Ctr Integrated Human Physiol, Zurich, Switzerland; [de Oliveira, Joao R. M.] Univ Fed Pernambuco, Keizo Asami Lab, Dept Neuropsychiat, Recife, PE, Brazil; [Wang, Tao] Union Hosp HUST, Dept Neurol, Wuhan, Peoples R China; [Sobrido, Maria-Jesus; Quintans, Beatriz] Clin Hosp Santiago de Compostela, Fdn Publ Galega Med Xenom, Serv Galego Saude SERGAS, Santiago De Compostela, Spain; [Sobrido, Maria-Jesus; Quintans, Beatriz] Inst Hlth Carlos III, Ctr Network Res Rare Dis CIBERER, Barcelona, Spain; [Baquero, Miguel] Univ Valencia, Hosp Univ & Politecn La Fe, Serv Neurol, Dept Med, Valencia, Spain; [Xu, Haibo] Union Hosp HUST, Dept Radiol, Wuhan, Peoples R China; [Wang, Junhan] Hosp HUST, Dept Clin Lab, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Universidade Federal de Pernambuco; Huazhong University of Science & Technology; Complexo Hospitalario Universitario de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitari i Politecnic La Fe; University of Valencia; Huazhong University of Science & Technology	Liu, JY (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Peoples R China.	xuezhang@pumc.edu.cn; liujy@mail.hust.edu.cn	Wang, Lianqing/AAX-5278-2020; Oliveira, João/GXN-3304-2022; de Oliveira, João/GWV-0126-2022	Wang, Lianqing/0000-0002-7161-4718; Wang, Cheng/0000-0002-7822-259X; Yao, Jing/0000-0003-1844-3988; Forster, Ian/0000-0003-3087-9952	National Natural Science Foundation of China [30670736, 30972655, 30730097, 31021091, 30871386]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT1006]; Swiss National Science Foundation; John Simon Guggenheim Memorial Foundation; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Institute of Health Carlos III; FEDER funds	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); John Simon Guggenheim Memorial Foundation; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Institute of Health Carlos III(Instituto de Salud Carlos III); FEDER funds(European Commission)	We would like to thank all the family members for their enthusiastic participation in the study. X. Z. would like to thank K. Hong, Q. Liu, Z. Wu, W. Xia, C. Zhang and L. Zou for clinical support. J. R. M. d. O. would like to thank R. Lemos and D. Oliveira for technical support. This study was mainly supported by the National Natural Science Foundation of China (30670736 and 30972655 to J.-Y. L. and 30730097 and 31021091 to X. Z.) and by the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT; IRT1006 to X. Z.). I. C. F. is supported by the Swiss National Science Foundation. M. L. is supported by the National Natural Science Foundation of China (30871386). J. R. M. d. O. is supported by the John Simon Guggenheim Memorial Foundation and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico M.-J. S. and B. Q. are supported by research contracts from the Institute of Health Carlos III and by FEDER funds. The study was approved by the ethics committees of HUST and Peking Union Medical College. Written informed consent was obtained from all participants or their legal guardians.	Bottger P, 2002, J BIOL CHEM, V277, P42741, DOI 10.1074/jbc.M207096200; Dai XH, 2010, AM J MED GENET B, V153B, P1305, DOI 10.1002/ajmg.b.31102; Giachelli CM, 2009, KIDNEY INT, V75, P890, DOI 10.1038/ki.2008.644; Kavanaugh MP, 1996, KIDNEY INT, V49, P959, DOI 10.1038/ki.1996.135; Kendrick J, 2011, ADV CHRONIC KIDNEY D, V18, P113, DOI 10.1053/j.ackd.2010.12.003; Lagrue E, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-91; Manyam BV, 2005, PARKINSONISM RELAT D, V11, P73, DOI 10.1016/j.parkreldis.2004.12.001; Miklossy J, 2005, ACTA NEUROPATHOL, V109, P643, DOI 10.1007/s00401-005-1007-7; Oliveira JRM, 2004, NEUROLOGY, V63, P2165, DOI 10.1212/01.WNL.0000145601.88274.88; Prie D, 2010, NEW ENGL J MED, V362, P2399, DOI 10.1056/NEJMra0904186; Ravera S, 2007, AM J PHYSIOL-CELL PH, V293, pC606, DOI 10.1152/ajpcell.00064.2007; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]; Villa-Bellosta R, 2009, AM J PHYSIOL-RENAL, V296, pF691, DOI 10.1152/ajprenal.90623.2008; Wider C, 2009, J NEUROL, V256, P839, DOI 10.1007/s00415-009-5025-6	15	280	296	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2012	44	3					254	256		10.1038/ng.1077	http://dx.doi.org/10.1038/ng.1077			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22327515				2022-12-17	WOS:000300843600008
J	Ganesh, SK; Zakai, NA; van Rooij, FJA; Soranzo, N; Smith, AV; Nalls, MA; Chen, MH; Kottgen, A; Glazer, NL; Dehghan, A; Kuhnel, B; Aspelund, T; Yang, Q; Tanaka, T; Jaffe, A; Bis, JCM; Verwoert, GC; Teumer, A; Fox, CS; Guralnik, JM; Ehret, GB; Rice, K; Felix, JF; Rendon, A; Eiriksdottir, G; Levy, D; Patel, KV; Boerwinkle, E; Rotter, JI; Hofman, A; Sambrook, JG; Hernandez, DG; Zheng, G; Bandinelli, S; Singleton, AB; Coresh, J; Lumley, T; Uitterlinden, AG; vanGils, JM; Launer, LJ; Cupples, LA; Oostra, BA; Zwaginga, JJ; Ouwehand, WH; Thein, SL; Meisinger, C; Deloukas, P; Nauck, M; Spector, TD; Gieger, C; Gudnason, V; van Duijn, CM; Psaty, BM; Ferrucci, L; Chakravarti, A; Greinacher, A; O'Donnell, CJ; Witteman, JCM; Furth, S; Cushman, M; Harris, TB; Lin, JP				Ganesh, Santhi K.; Zakai, Neil A.; van Rooij, Frank J. A.; Soranzo, Nicole; Smith, Albert V.; Nalls, Michael A.; Chen, Ming-Huei; Kottgen, Anna; Glazer, Nicole L.; Dehghan, Abbas; Kuhnel, Brigitte; Aspelund, Thor; Yang, Qiong; Tanaka, Toshiko; Jaffe, Andrew; Bis, Joshua C. M.; Verwoert, Germaine C.; Teumer, Alexander; Fox, Caroline S.; Guralnik, Jack M.; Ehret, Georg B.; Rice, Kenneth; Felix, Janine F.; Rendon, Augusto; Eiriksdottir, Gudny; Levy, Daniel; Patel, Kushang V.; Boerwinkle, Eric; Rotter, Jerome I.; Hofman, Albert; Sambrook, Jennifer G.; Hernandez, Dena G.; Zheng, Gang; Bandinelli, Stefania; Singleton, Andrew B.; Coresh, Josef; Lumley, Thomas; Uitterlinden, Andre G.; vanGils, Janine M.; Launer, Lenore J.; Cupples, L. Adrienne; Oostra, Ben A.; Zwaginga, Jaap-Jan; Ouwehand, Willem H.; Thein, Swee-Lay; Meisinger, Christa; Deloukas, Panos; Nauck, Matthias; Spector, Tim D.; Gieger, Christian; Gudnason, Vilmundur; van Duijn, Cornelia M.; Psaty, Bruce M.; Ferrucci, Luigi; Chakravarti, Aravinda; Greinacher, Andreas; O'Donnell, Christopher J.; Witteman, Jacqueline C. M.; Furth, Susan; Cushman, Mary; Harris, Tamara B.; Lin, Jing-Ping			Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BLOOD-PRESSURE; HEMOGLOBIN CONCENTRATION; HEMOCHROMATOSIS GENE; HEREDITARY HEMOCHROMATOSIS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; FETAL-HEMOGLOBIN; CELIAC-DISEASE; C-MYB	Measurements of erythrocytes within the blood are important clinical traits and can indicate various hematological disorders. We report here genome-wide association studies (GWAS) for six erythrocyte traits, including hemoglobin concentration (Hb), hematocrit (Hct), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC) and red blood cell count (RBC). We performed an initial GWAS in cohorts of the CHARGE Consortium totaling 24,167 individuals of European ancestry and replication in additional independent cohorts of the HaemGen Consortium totaling 9,456 individuals. We identified 23 loci significantly associated with these traits in a meta-analysis of the discovery and replication cohorts (combined P values ranging from 5 x 10(-8) to 7 x 10(-86)). Our findings include loci previously associated with these traits (HBS1L-MYB, HFE, TMPRSS6, TFR2, SPTA1) as well as new associations (EPO, TFRC, SH2B3 and 15 other loci). This study has identified new determinants of erythrocyte traits, offering insight into common variants underlying variation in erythrocyte measures.	[Ganesh, Santhi K.] NHGRI, Div Intramural Res, Bethesda, MD 20892 USA; [Ganesh, Santhi K.; Fox, Caroline S.; Levy, Daniel] NHLBI, Div Intramural Res, Bethesda, MD 20892 USA; [Ganesh, Santhi K.; Ehret, Georg B.; Chakravarti, Aravinda] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Zakai, Neil A.; Cushman, Mary] Univ Vermont, Dept Med, Burlington, VT USA; [Zakai, Neil A.; Cushman, Mary] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [van Rooij, Frank J. A.; Dehghan, Abbas; Verwoert, Germaine C.; Felix, Janine F.; Hofman, Albert; Uitterlinden, Andre G.; Oostra, Ben A.; van Duijn, Cornelia M.; Witteman, Jacqueline C. M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [van Rooij, Frank J. A.; Dehghan, Abbas; Verwoert, Germaine C.; Felix, Janine F.; Hofman, Albert; Uitterlinden, Andre G.; Oostra, Ben A.; van Duijn, Cornelia M.; Witteman, Jacqueline C. M.] NCHA, NGI, Leiden, Netherlands; [Soranzo, Nicole; Ouwehand, Willem H.; Deloukas, Panos] Wellcome Trust Sanger Inst, Hinxton, England; [Soranzo, Nicole; Cupples, L. Adrienne; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Smith, Albert V.; Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Hernandez, Dena G.] NIA, Intramural Res Program, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Chen, Ming-Huei; Yang, Qiong; Fox, Caroline S.; Levy, Daniel; Cupples, L. Adrienne; O'Donnell, Christopher J.] NHLBIs Framingham Heart Study, Framingham, MA USA; [Chen, Ming-Huei] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Kottgen, Anna; Jaffe, Andrew; Coresh, Josef] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Glazer, Nicole L.; Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Glazer, Nicole L.; Bis, Joshua C. M.; Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Kuhnel, Brigitte; Meisinger, Christa; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Yang, Qiong] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Tanaka, Toshiko; Ferrucci, Luigi] NIA, Longitudinal Studies Sect, Clin Res Branch, NIH, Baltimore, MD 21224 USA; [Tanaka, Toshiko] MedStar Res Inst, Hyattsville, MD USA; [Verwoert, Germaine C.; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Teumer, Alexander] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Guralnik, Jack M.; Patel, Kushang V.; Launer, Lenore J.; Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD 20892 USA; [Ehret, Georg B.] Univ Hosp Geneva, Ctr Cardiol, Geneva, Switzerland; [Rice, Kenneth; Lumley, Thomas] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Rendon, Augusto; Sambrook, Jennifer G.; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge, England; [Rendon, Augusto; Sambrook, Jennifer G.; Ouwehand, Willem H.] Natl Hlth Serv Blood & Transplant, Cambridge, England; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Zheng, Gang; Lin, Jing-Ping] NHLBI, Off Biostat Res, Div Cardiovasc Sci, NIH, Bethesda, MD 20892 USA; [Bandinelli, Stefania] Geriatr Unit ASF, Florence, Italy; [Uitterlinden, Andre G.] Erasmus MC, Dept Clin Chem, Rotterdam, Netherlands; [Zwaginga, Jaap-Jan] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Oostra, Ben A.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Zwaginga, Jaap-Jan] Sanquin Res, Dept Expt Immunohematol, Amsterdam, Netherlands; [Thein, Swee-Lay] Kings Coll London, Dept Haematol, London WC2R 2LS, England; [Nauck, Matthias] Ernst Moritz Arndt Univ Greifswald, Inst Klin Chem & Lab Med, Greifswald, Germany; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth, Grp Hlth Res Inst, Seattle, WA USA; [Greinacher, Andreas] Ernst Moritz Arndt Univ Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany; [O'Donnell, Christopher J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [Furth, Susan] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; University of Vermont; University of Vermont; Erasmus University Rotterdam; Erasmus MC; Wellcome Trust Sanger Institute; University of London; King's College London; Icelandic Heart Association; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Framingham Heart Study; Boston University; Johns Hopkins University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Iceland; Boston University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Erasmus University Rotterdam; Erasmus MC; Ernst Moritz Arndt Universitat Greifswald; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Geneva; University of Washington; University of Washington Seattle; University of Cambridge; NHS Blood & Transplant (NHSBT); University of Texas System; University of Texas Health Science Center Houston; Cedars Sinai Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; University of London; King's College London; Ernst Moritz Arndt Universitat Greifswald; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Ernst Moritz Arndt Universitat Greifswald; Harvard University; Harvard Medical School; Massachusetts General Hospital; Johns Hopkins University; Johns Hopkins Medicine	Ganesh, SK (corresponding author), NHGRI, Div Intramural Res, Bethesda, MD 20892 USA.	ganeshs@mail.nih.gov; odonnellc@mail.nih.gov	Rice, Kenneth M/A-4150-2013; Deloukas, Panos/B-2922-2013; Yang, Qiong/G-5438-2014; Launer, Lenore J/A-8218-2010; Levy, Daniel/ABF-6873-2021; Singleton, Andrew B/C-3010-2009; Teumer, Alexander/S-7438-2019; van Rooij, Frank/AAI-3997-2020; Levy, Daniel/ABB-2752-2021; bandinelli, stefania/AAL-4570-2020; Dehghan, Abbas/ABE-7377-2020; EHRET, Georg B/A-9532-2009; Spector, Tim D/F-6533-2012; Aspelund, Thor/K-7022-2019; Smith, Albert Vernon/K-5150-2015; Kottgen, Anna/D-2920-2012; Gudnason, Vilmundur/AAE-7126-2019; Aspelund, Thor/C-5983-2008; Gudnason, Vilmundur/K-6885-2015; Aspelund, Thor/F-4826-2011; Meisinger, Christine/B-5358-2014; Jaffe, Andrew/GPF-5693-2022; Rotter, Jerome/AAY-6598-2021; Dehghan, Abbas/B-9896-2008	Rice, Kenneth M/0000-0001-5779-4495; Deloukas, Panos/0000-0001-9251-070X; Levy, Daniel/0000-0003-1843-8724; Teumer, Alexander/0000-0002-8309-094X; van Rooij, Frank/0000-0002-8600-9852; EHRET, Georg B/0000-0002-5730-0675; Aspelund, Thor/0000-0002-7998-5433; Smith, Albert Vernon/0000-0003-1942-5845; Gudnason, Vilmundur/0000-0001-5696-0084; Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; Jaffe, Andrew/0000-0001-6886-1454; Glazer, Nicole/0000-0002-6397-609X; Rendon, Augusto/0000-0001-8994-0039; Gieger, Christian/0000-0001-6986-9554; Dehghan, Abbas/0000-0001-6403-016X; Chen, Ming-Huei/0000-0003-3551-8726; Soranzo, Nicole/0000-0003-1095-3852; Felix, Janine/0000-0002-9801-5774; Van Duijn, Cornelia/0000-0002-2374-9204; van Gils, Janine/0000-0003-2429-7462; Cupples, L. Adrienne/0000-0003-0273-7965; Meisinger, Christa/0000-0002-9026-6544	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086694, ZIAHL006001, ZIAHL006094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK066174, K24DK078737, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG001050, ZIAAG006000] Funding Source: NIH RePORTER; MRC [G0000111] Funding Source: UKRI; Medical Research Council [G0000111] Funding Source: Medline; NHLBI NIH HHS [R01 HL086694-02, R01 HL086694-03, R01 HL086694, R01 HL086694-01A1] Funding Source: Medline; NIDDK NIH HHS [K24 DK078737, P30 DK063491-039004, P30 DK063491-019004, U01 DK066174, P30 DK063491, P30 DK063491-029004, P30 DK063491-05, P30 DK063491-049004] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGRE P, 1985, NATURE, V314, P380, DOI 10.1038/314380a0; Bea S, 2005, BLOOD, V106, P3183, DOI 10.1182/blood-2005-04-1399; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; de Simone G, 2005, HYPERTENSION, V45, P625, DOI 10.1161/01.HYP.0000157526.07977.ec; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; ELWOOD PC, 1974, LANCET, V1, P891; Emambokus N, 2003, EMBO J, V22, P4478, DOI 10.1093/emboj/cdg434; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; GAGNON DR, 1994, AM HEART J, V127, P674, DOI 10.1016/0002-8703(94)90679-3; Gollob MH, 2001, CIRCULATION, V104, P3030, DOI 10.1161/hc5001.102111; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; HAMOSH A, ONLINE MENDELIAN INH; HAVLIK RJ, 1980, CIRCULATION, V61, P710, DOI 10.1161/01.CIR.61.4.710; Higgs DR, 2008, P NATL ACAD SCI USA, V105, P11595, DOI 10.1073/pnas.0806633105; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Iliadou A, 2007, J MED GENET, V44, P24, DOI 10.1136/jmg.2006.043521; Jongmans M, 2005, AM J MED GENET A, V134A, P165, DOI 10.1002/ajmg.a.30598; Kalidas K, 2005, J HUM GENET, V50, P21, DOI 10.1007/s10038-004-0212-x; Kerenyi MA, 2008, BLOOD, V112, P3878, DOI 10.1182/blood-2008-02-138339; LETCHER RL, 1983, HYPERTENSION, V5, P757, DOI 10.1161/01.HYP.5.5.757; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lin JP, 2007, AM J HEMATOL, V82, P605, DOI 10.1002/ajh.20868; Lin JP, 2005, J MED GENET, V42, P75, DOI 10.1136/jmg.2004.021097; MARCHESI SL, 1987, J CLIN INVEST, V80, P191, DOI 10.1172/JCI113047; Martins PD, 2007, ARTERIOSCL THROM VAS, V27, P1023, DOI 10.1161/ATVBAHA.107.140442; McLaren CE, 2007, AM J HEMATOL, V82, P898, DOI 10.1002/ajh.20937; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Menzel S, 2007, BLOOD, V110, P3624, DOI 10.1182/blood-2007-05-093419; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; OTT EO, 1974, STROKE, V5, P330, DOI 10.1161/01.STR.5.3.330; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Roest M, 1999, CIRCULATION, V100, P1268, DOI 10.1161/01.CIR.100.12.1268; Roetto A, 2002, BLOOD CELL MOL DIS, V29, P465, DOI 10.1006/bcmd.2002.0585; Roy CN, 2007, BLOOD, V109, P4038, DOI 10.1182/blood-2006-10-051755; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Sarnak MJ, 2002, J AM COLL CARDIOL, V40, P27, DOI 10.1016/S0735-1097(02)01938-1; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Sharp DS, 1996, CIRCULATION, V93, P1677, DOI 10.1161/01.CIR.93.9.1677; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Swinkels DW, 2008, NEPHROL DIAL TRANSPL, V23, P250, DOI 10.1093/ndt/gfn267; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; TELL GS, 1994, HYPERTENSION, V23, P59, DOI 10.1161/01.HYP.23.1.59; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tong ZZ, 2008, P NATL ACAD SCI USA, V105, P6998, DOI 10.1073/pnas.0800454105; Tuomainen TP, 1999, CIRCULATION, V100, P1274, DOI 10.1161/01.CIR.100.12.1274; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883; WANNAMETHEE G, 1994, THROMB HAEMOSTASIS, V72, P58; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; WELLS RE, 1962, J CLIN INVEST, V41, P1591, DOI 10.1172/JCI104617; WHITFIELD J B, 1985, Genetic Epidemiology, V2, P133, DOI 10.1002/gepi.1370020204; Yang XL, 2007, J TURBUL, V8, P1, DOI 10.1080/14685240701194107; Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214; Zeng S M, 2001, J Gend Specif Med, V4, P35; Zeng She Min, 2003, J Gend Specif Med, V6, P36	65	280	287	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2009	41	11					1191	U48		10.1038/ng.466	http://dx.doi.org/10.1038/ng.466			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	512KM	19862010	Green Submitted, Green Accepted			2022-12-17	WOS:000271247600011
J	Shaw-Smith, C; Pittman, AM; Willatt, L; Martin, H; Rickman, L; Gribble, S; Curley, R; Cumming, S; Dunn, C; Kalaitzopoulos, D; Porter, K; Prigmore, E; Krepischi-Santos, ACV; Varela, MC; Koiffmann, CP; Lees, AJ; Rosenberg, C; Firth, HV; de Silva, R; Carter, NP				Shaw-Smith, Charles; Pittman, Alan M.; Willatt, Lionel; Martin, Howard; Rickman, Lisa; Gribble, Susan; Curley, Rebecca; Cumming, Sally; Dunn, Carolyn; Kalaitzopoulos, Dimitrios; Porter, Keith; Prigmore, Elena; Krepischi-Santos, Ana C. V.; Varela, Monica C.; Koiffmann, Celia P.; Lees, Andrew J.; Rosenberg, Carla; Firth, Helen V.; de Silva, Rohan; Carter, Nigel P.			Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; LOW-COPY REPEATS; TAU GENE; FRONTOTEMPORAL DEMENTIA; SOTOS-SYNDROME; HAPLOTYPE; REARRANGEMENTS; ARCHITECTURE; MICROARRAY; MUTATIONS	Recently, the application of array-based comparative genomic hybridization ( array CGH) has improved rates of detection of chromosomal imbalances in individuals with mental retardation and dysmorphic features(1-4). Here, we describe three individuals with learning disability and a heterozygous deletion at chromosome 17q21.3, detected in each case by array CGH. FISH analysis demonstrated that the deletions occurred as de novo events in each individual and were between 500 kb and 650 kb in size. A recently described 900- kb inversion that suppresses recombination between ancestral H1 and H2 haplotypes(5) encompasses the deletion. We show that, in each trio, the parent of origin of the deleted chromosome 17 carries at least one H2 chromosome. This region of 17q21.3 shows complex genomic architecture with well-described low-copy repeats (LCRs)(5,6). The orientation of LCRs flanking the deleted segment in inversion heterozygotes is likely to facilitate the generation of this microdeletion by means of non-allelic homologous recombination.	Univ Cambridge, Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 2QQ, England; UCL, Reta Lila Weston Inst Neurol Studies, London WC1N 1PJ, England; Addenbrookes Hosp, Reg Cytogenet Lab, Cambridge CB2 2QQ, England; Addenbrookes Hosp, Reg Mol Genet Lab, Cambridge CB2 2QQ, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Sao Paulo, Dept Genet & Evolutionary Biol, BR-05422970 Sao Paulo, Brazil; Univ Sao Paulo, Human Genome Res Ctr, BR-05508900 Sao Paulo, Brazil	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; Universidade de Sao Paulo; Universidade de Sao Paulo	Shaw-Smith, C (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 2QQ, England.	css@sanger.ac.uk	KOIFFMANN, CELIA/F-9828-2012; Pittman, Alan/AAP-2534-2020; Pittman, Alan M/D-6231-2012; Krepischi, Ana C V/E-4976-2012; Lees, Andrew J/A-6605-2009; rosenberg, carla/N-4148-2015	Pittman, Alan/0000-0002-8112-2987; Pittman, Alan M/0000-0002-8112-2987; Krepischi, Ana C V/0000-0003-2931-8605; Lees, Andrew J/0000-0002-2476-4385; rosenberg, carla/0000-0003-3253-4448	MRC [G0501560] Funding Source: UKRI; Medical Research Council [G0501560(76517), G0501560] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Bishop GA, 1999, EXP NEUROL, V160, P489, DOI 10.1006/exnr.1999.7227; Cassidy S. B., 2005, MANAGEMENT GENETIC S; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; Cruts M, 2005, HUM MOL GENET, V14, P1753, DOI 10.1093/hmg/ddi182; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; Evans W, 2004, NEUROSCI LETT, V369, P183, DOI 10.1016/j.neulet.2004.05.119; FLINT J, 1995, NAT GENET, V9, P132, DOI 10.1038/ng0295-132; Gimelli G, 2003, HUM MOL GENET, V12, P849, DOI 10.1093/hmg/ddg101; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Hardy J, 2005, BIOCHEM SOC T, V33, P582, DOI 10.1042/BST0330582; Hurles M E, 2001, BMC Genomics, V2, P11, DOI 10.1186/1471-2164-2-11; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ikegami S, 2000, NEUROSCI LETT, V279, P129, DOI 10.1016/S0304-3940(99)00964-7; KHALIFA MM, 1993, CLIN GENET, V44, P258; Knight SJL, 1999, LANCET, V354, P1676, DOI 10.1016/S0140-6736(99)03070-6; Kurotaki N, 2003, HUM MUTAT, V22, P378, DOI 10.1002/humu.10270; Lopes J, 1999, HUM MOL GENET, V8, P2285, DOI 10.1093/hmg/8.12.2285; Myers AJ, 2005, HUM MOL GENET, V14, P2399, DOI 10.1093/hmg/ddi241; Phelan MC, 2001, AM J MED GENET, V101, P91, DOI 10.1002/1096-8628(20010615)101:2<91::AID-AJMG1340>3.0.CO;2-C; Pittman AM, 2005, J MED GENET, V42, P837, DOI 10.1136/jmg.2005.031377; Pittman AM, 2004, HUM MOL GENET, V13, P1267, DOI 10.1093/hmg/ddh138; Rosenberg C, 2006, J MED GENET, V43, P180, DOI 10.1136/jmg.2005.032268; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Varela MC, 2006, CYTOGENET GENOME RES, V114, P89, DOI 10.1159/000091934; Visser R, 2005, AM J HUM GENET, V76, P52, DOI 10.1086/426950; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977	29	280	283	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2006	38	9					1032	1037		10.1038/ng1858	http://dx.doi.org/10.1038/ng1858			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16906163				2022-12-17	WOS:000240112100020
J	Dumitrescu, AM; Liao, XH; Abdullah, MSY; Lado-Abeal, J; Majed, FA; Moeller, LC; Boran, G; Schomburg, L; Weiss, RE; Refetoff, S				Dumitrescu, AM; Liao, XH; Abdullah, MSY; Lado-Abeal, J; Majed, FA; Moeller, LC; Boran, G; Schomburg, L; Weiss, RE; Refetoff, S			Mutations in SECISBP2 result in abnormal thyroid hormone metabolism	NATURE GENETICS			English	Article							SELENOCYSTEINE TRANSFER-RNA; 5'-DEIODINASE ACTIVITY; TARGETED DISRUPTION; SELENOPROTEIN-P; GENE TRSP; SELENIUM; EXPRESSION; MICE; TRANSPORTER; THYROXINE	Incorporation of selenocysteine (Sec), through recoding of the UGA stop codon, creates a unique class of proteins. Mice lacking tRNA(Sec) die in utero(1), but the in vivo role of other components involved in selenoprotein synthesis is unknown, and Sec incorporation defects have not been described in humans. Deiodinases (DIOs) are selenoproteins involved in thyroid hormone metabolism. We identified three of seven siblings with clinical evidence of abnormal thyroid hormone metabolism. Their fibroblasts showed decreased DIO2 enzymatic activity not linked to the DIO2 locus. Systematic linkage analysis of genes involved in DIO2 synthesis and degradation led to the identification of an inherited Sec incorporation defect, caused by a homozygous missense mutation in SECISBP2 (also called SBP2). An unrelated child with a similar phenotype was compound heterozygous with respect to mutations in SECISBP2. Because SBP2 is epistatic to selenoprotein synthesis, these defects had a generalized effect on selenoproteins. Incomplete loss of SBP2 function probably causes the mild phenotype.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Secur Forces Hosp, Dept Pediat Endocrinol, Riyadh, Saudi Arabia; Prince Abdullah Hosp, Bisha, Saudi Arabia; Adelaide & Meath Hosp, Dept Pathol, Dublin, Ireland; Charite Univ Med Berlin, Inst Expt Endocrinol, Berlin, Germany; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago; Security Forces Hospital - Saudi Arabia; Trinity College Dublin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Chicago; University of Chicago	Refetoff, S (corresponding author), Univ Chicago, Dept Med, MC 3090,5841 S Maryland Ave, Chicago, IL 60637 USA.	refetoff@uchicago.edu	Refetoff, Samuel/ABB-1263-2021; Schomburg, Lutz/D-8096-2013	Refetoff, Samuel/0000-0003-0164-8231; Schomburg, Lutz/0000-0001-9445-1555; lado-abeal, joaquin/0000-0002-3970-9696; Moeller, Lars/0000-0002-9330-9036				BALZANO S, 1990, ENDOCRINOLOGY, V127, P882, DOI 10.1210/endo-127-2-882; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Botero D, 2002, MOL ENDOCRINOL, V16, P1999, DOI 10.1210/me.2002-0135; Carlson BA, 2005, J BIOL CHEM, V280, P5542, DOI 10.1074/jbc.M411725200; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; Chu FF, 2004, CANCER RES, V64, P962, DOI 10.1158/0008-5472.CAN-03-2272; Copeland PR, 2003, GENE, V312, P17, DOI 10.1016/S0378-1119(03)00588-2; Curcio-Morelli C, 2003, J CLIN INVEST, V112, P189, DOI 10.1172/JCI200318348; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Dumitrescu A, 2004, THYROID, V14, P761; Dumitrescu AM, 2004, AM J HUM GENET, V74, P168, DOI 10.1086/380999; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kumaraswamy E, 2003, MOL CELL BIOL, V23, P1477, DOI 10.1128/MCB.23.5.1477-1488.2003; LEONARD JL, 1988, BIOCHEM BIOPH RES CO, V151, P1164, DOI 10.1016/S0006-291X(88)80488-1; Lescure A, 2002, GENE, V291, P279, DOI 10.1016/S0378-1119(02)00629-7; Moustafa ME, 2003, J NUTR, V133, p2494S, DOI 10.1093/jn/133.7.2494S; Olson GE, 2005, BIOL REPROD, V73, P201, DOI 10.1095/biolreprod.105.040360; Sachdev SW, 2001, BIOCHEM J, V357, P851; Schneider MJ, 2001, MOL ENDOCRINOL, V15, P2137, DOI 10.1210/me.15.12.2137; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Schomburg L, 2004, CELL MOL LIFE SCI, V61, P1988, DOI 10.1007/s00018-004-4114-z; Schussler GC, 2000, THYROID, V10, P141, DOI 10.1089/thy.2000.10.141; SCHUSSLER GC, 1967, J CLIN ENDOCR METAB, V27, P242, DOI 10.1210/jcem-27-2-242; Schweizer U, 2004, J NUTR, V134, P707, DOI 10.1093/jn/134.4.707	27	280	295	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1247	1252		10.1038/ng1654	http://dx.doi.org/10.1038/ng1654			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16228000				2022-12-17	WOS:000233045200025
J	Ewart-Toland, A; Briassouli, P; de Koning, JP; Mao, JH; Yuan, JW; Chan, F; MacCarthy-Morrogh, L; Ponder, BAJ; Nagase, H; Burn, J; Ball, S; Almeida, M; Linardopoulos, S; Balmain, A				Ewart-Toland, A; Briassouli, P; de Koning, JP; Mao, JH; Yuan, JW; Chan, F; MacCarthy-Morrogh, L; Ponder, BAJ; Nagase, H; Burn, J; Ball, S; Almeida, M; Linardopoulos, S; Balmain, A			Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER; CENTROSOME AMPLIFICATION; COLORECTAL CANCERS; BREAST-CANCER; SKIN TUMORS; KINASE; LOCUS; ASSOCIATION; MICE	Linkage analysis and haplotype mapping in interspecific mouse crosses (Mus musculus x Mus spretus) identified the gene encoding Aurora2 (Stk6 in mouse and STK15 in human) as a candidate skin tumor susceptibility gene. The Stk6 allele inherited from the susceptible M. musculus parent was overexpressed in normal cells and preferentially amplified in tumor cells from F 1 hybrid mice. We identified a common genetic variant in STK15 ( resulting in the amino acid substitution F31I) that is preferentially amplified and associated with the degree of aneuploidy in human colon tumors. The Ile31 variant transforms rat1 cells more potently than the more common Phe31 variant. The E2 ubiquitin-conjugating enzyme UBE2N was a preferential binding partner of the weak STK15 Phe31 variant form in yeast two-hybrid screens and in human cells. This interaction results in colocalization of UBE2N with STK15 at the centrosomes during mitosis. These results are consistent with an important role for the Ile31 variant of STK15 in human cancer susceptibility.	Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94115 USA; Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; Inst Canc Res, Haddows Labs, Ctr Canc Therapeut, Canc Res UK, Sutton SM2 5NG, Surrey, England; Strangeways Res Labs, Univ Dept Oncol, Human Canc Genet Grp, Canc Res UK, Cambridge CB1 8RN, England; Roswell Pk Canc Inst, Buffalo, NY 14263 USA; Inst Human Genet, Newcastle Upon Tyne NE1 3B2, Tyne & Wear, England; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; University of London; Institute of Cancer Research - UK; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Roswell Park Cancer Institute; University of California System; University of California San Francisco	Linardopoulos, S (corresponding author), Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94115 USA.	spiros@icr.ac.uk; abalmain@cc.ucsf.edu	Toland, Amanda Ewart/E-4202-2011; Mao, Jian-Hua/EIZ-8595-2022; Almeida, Maria Rosário/C-4385-2018	Mao, Jian-Hua/0000-0001-9320-6021; Almeida, Maria Rosário/0000-0002-1889-5469; Linardopoulos, Spiros/0000-0002-6600-400X; Toland, Amanda/0000-0002-0271-1792; Burn, John/0000-0002-9823-2322				Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; ALDAZ CM, 1989, MOL CARCINOGEN, V2, P22, DOI 10.1002/mc.2940020104; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Balmain A, 1998, TRENDS GENET, V14, P139, DOI 10.1016/S0168-9525(98)01422-X; Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; Cormier RT, 2000, ONCOGENE, V19, P3182, DOI 10.1038/sj.onc.1203646; Dahlman I, 2002, NAT GENET, V30, P149, DOI 10.1038/ng825; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Fijneman RJA, 1996, NAT GENET, V14, P465, DOI 10.1038/ng1296-465; Giet R, 1999, J CELL SCI, V112, P3591; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; IWABUCHI H, 1995, CANCER RES, V55, P6172; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; KEMP CJ, 1993, CANCER RES, V53, P6022; Korn WM, 1999, GENE CHROMOSOME CANC, V25, P82, DOI 10.1002/(SICI)1098-2264(199906)25:2<82::AID-GCC2>3.0.CO;2-6; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; McKenna S, 2001, J BIOL CHEM, V276, P40120, DOI 10.1074/jbc.M102858200; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Miyoshi Y, 2001, INT J CANCER, V92, P370, DOI 10.1002/ijc.1200; NAGASE H, 1995, NAT GENET, V10, P424, DOI 10.1038/ng0895-424; Nagase H, 1999, P NATL ACAD SCI USA, V96, P15032, DOI 10.1073/pnas.96.26.15032; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Ponder BAJ, 2001, NATURE, V411, P336, DOI 10.1038/35077207; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; SEGRAVES R, 2002, DNA ARRAYS LAB MANUA, P380; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	39	280	295	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2003	34	4					403	412		10.1038/ng1220	http://dx.doi.org/10.1038/ng1220			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	12881723				2022-12-17	WOS:000184470500018
J	Xu, X; Peng, M; Fang, Z; Xu, XP				Xu, X; Peng, M; Fang, Z; Xu, XP			The direction of microsatellite mutations is dependent upon allele length	NATURE GENETICS			English	Article							REPEAT LOCI; INSTABILITY; FREQUENCIES; EVOLUTION; MODEL; YEAST; SIZE	Microsatellites, comprising tandemly repeated short nucleotide sequences, are ubiquitous in eukaryotic: genomes. Mutations within microsatellites are frequent, altering their overall length by insertion or deletion of a small number of repeat units, with a rate as high as 10(-3) in humans(1). Despite their high mutability, stable allele frequency distributions are typically observed for microsatellites in humans as well as other primates(2,3), although the mechanism maintaining these stable distributions remains unclear. Previous studies have suggested that microsatellite mutations occur more frequently in longer alleles and favour expansion(4-8). Generalizing these results has been hindered because the sample sizes were small, only a small subset of alleles for any marker was studied and the direction of mutation (expansion or contraction) was not rigorously determined. Here we examine 236 mutations at 122 tetranucleotide repeat markers and find that the rate of contraction mutations increases exponentially with allele size. whereas the rate of expansion mutations is constant across the entire allele distribution. The overall rate of expansion mutations does not differ from that of contractions. Our findings offer an explanation for the stationary allele distribution of microsatellites.	Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA; Anhui Med Univ, Inst Biomed, Hefei, Anhui, Peoples R China	Harvard University; Harvard T.H. Chan School of Public Health; Anhui Medical University	Xu, X (corresponding author), Harvard Univ, Sch Publ Hlth, Program Populat Genet, 665 Huntington Ave, Boston, MA 02115 USA.		Xu, Xin/A-1687-2016	Xu, Xin/0000-0002-6324-5211				Amos W, 1996, NAT GENET, V13, P390, DOI 10.1038/ng0896-390; Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; GARZA JC, 1995, MOL BIOL EVOL, V12, P594; Goldstein DB, 1997, J HERED, V88, P335, DOI 10.1093/oxfordjournals.jhered.a023114; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; Kimmel M, 1996, THEOR POPUL BIOL, V50, P345, DOI 10.1006/tpbi.1996.0035; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Primmer CR, 1996, NAT GENET, V13, P391, DOI 10.1038/ng0896-391; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; Twerdi CD, 1999, P NATL ACAD SCI USA, V96, P2875, DOI 10.1073/pnas.96.6.2875; VALDES AM, 1993, GENETICS, V133, P737; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Wierdl M, 1997, GENETICS, V146, P769; Xu XP, 1999, AM J HUM GENET, V64, P1694, DOI 10.1086/302405; ZHIVOTOVSKY LA, 1995, P NATL ACAD SCI USA, V92, P11549, DOI 10.1073/pnas.92.25.11549	17	280	304	1	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2000	24	4					396	399		10.1038/74238	http://dx.doi.org/10.1038/74238			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	299HK	10742105				2022-12-17	WOS:000086192800020
J	Bassett, DE; Eisen, MB; Boguski, MS				Bassett, DE; Eisen, MB; Boguski, MS			Gene expression informatics - it's all in your mine	NATURE GENETICS			English	Review							DATABASE; HYBRIDIZATION; ARRAYS	Technologies for whole-genome RNA expression studies are becoming increasingly reliable and accessible. However, universal standards to make the data more suitable for comparative analysis and for inter-operability with other information resources have yet to emerge. Improved access to large electronic data sets, reliable and consistent annotation and effective tools for 'data mining' are critical. Analysis methods that exploit large data warehouses of gene expression experiments will be necessary to realize the full potential of this technology.	Rosetta Inpharmat, Kirkland, WA 98034, Australia; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA	Stanford University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Bassett, DE (corresponding author), Rosetta Inpharmat, Kirkland, WA 98034, Australia.	boguski@ncbi.nlm.nih.gov		Eisen, Michael/0000-0002-7528-738X; Bassett, Douglas/0000-0002-1619-4618				Baxevanis A, 1998, BIOINFORMATICS PRACT; Benson DA, 1998, NUCLEIC ACIDS RES, V26, P1, DOI 10.1093/nar/26.1.1; Berry M., 1997, DATA MINING TECHNIQU; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Brownstein MJ, 1998, TRENDS BIOTECHNOL, P27, DOI 10.1016/S0167-7799(98)00134-6; Carr D.B., 1997, STAT COMPUTING GRAPH, V8, P20; Chen Y., 1997, BIOMED OPTICS, V2, P364; Cheung VG, 1999, NAT GENET, V21, P15, DOI 10.1038/4439; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; CHUANG SE, 1993, J BACTERIOL, V175, P2026, DOI 10.1128/JB.175.7.2026-2036.1993; Cole KA, 1999, NAT GENET, V21, P38, DOI 10.1038/4466; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; EISEN MB, IN PRESS P NATL ACAD; Ermolaeva O, 1998, NAT GENET, V20, P19, DOI 10.1038/1670; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; GRESS TM, 1992, MAMM GENOME, V3, P609, DOI 10.1007/BF00352477; IYER VR, IN PRESS SCIENCE; Kanehisa M, 1998, TRENDS BIOTECHNOL, P24, DOI 10.1016/S0167-7799(98)00133-4; Kaufman L, 2009, FINDING GROUPS DATA; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; McEntyre J, 1998, TRENDS GENET, V14, P39, DOI 10.1016/S0168-9525(97)01325-5; Michaels G S, 1998, Pac Symp Biocomput, P42; Ouellette BFF, 1997, GENOME RES, V7, P952, DOI 10.1101/gr.7.10.952; RINGWALD M, 1994, SCIENCE, V265, P2033, DOI 10.1126/science.8091224; Ringwald M, 1997, SEMIN CELL DEV BIOL, V8, P489, DOI 10.1006/scdb.1997.0177; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schuler GD, 1996, METHOD ENZYMOL, V266, P141; SPELLMAN PT, IN PRESS MOL BIOL CE; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Wen XL, 1998, P NATL ACAD SCI USA, V95, P334, DOI 10.1073/pnas.95.1.334	37	280	313	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1999	21			S			51	55		10.1038/4478	http://dx.doi.org/10.1038/4478			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	156NU	9915502				2022-12-17	WOS:000078008200013
J	Li, XC; Everett, LA; Lalwani, AK; Desmukh, D; Friedman, TB; Green, ED; Wilcox, ER				Li, XC; Everett, LA; Lalwani, AK; Desmukh, D; Friedman, TB; Green, ED; Wilcox, ER			A mutation in PDS causes non-syndromic recessive deafness	NATURE GENETICS			English	Letter							POPULATION		Natl Inst Deafness & Other Commun Disorders, Genet Mol Lab, NIH, Rockville, MD 20850 USA; Natl Human Genome Res Inst, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; Univ Calif San Francisco, Sch Med, Div Otol Neurotol & Skullbase Surg, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA; Ichalkaranji Tilawani, Rotary Deaf Sch, Kolhapur 416115, Maharashtra, India	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California San Francisco	Wilcox, ER (corresponding author), Natl Inst Deafness & Other Commun Disorders, Genet Mol Lab, NIH, Rockville, MD 20850 USA.				NIDCD NIH HHS [Z01DC00026] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000026] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ARCAND P, 1991, J OTOLARYNGOL, V20, P247; BALDWIN CT, 1995, HUM MOL GENET, V4, P1637, DOI 10.1093/hmg/4.9.1637; BATSAKIS JG, 1962, ARCHIV OTOLARYNGOL, V76, P401; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Gausden E, 1997, J MED GENET, V34, P126, DOI 10.1136/jmg.34.2.126; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; HJELSTUEN OK, 1995, ANALYST, V120, P863, DOI 10.1039/an9952000863; JOHNSEN T, 1987, J LARYNGOL OTOL, V101, P1187, DOI 10.1017/S0022215100103470; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Reardon W, 1996, J MED GENET, V33, P1037, DOI 10.1136/jmg.33.12.1037; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R	13	280	300	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1998	18	3					215	217		10.1038/ng0398-215	http://dx.doi.org/10.1038/ng0398-215			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500541	Green Published			2022-12-17	WOS:000072325000017
J	HOGERVORST, FBL; CORNELIS, RS; BOUT, M; VANVLIET, M; OOSTERWIJK, JC; OLMER, R; BAKKER, B; KLIJN, JGM; VASEN, HFA; MEIJERSHEIJBOER, H; MENKO, FH; CORNELISSE, CJ; DENDUNNEN, JT; DEVILEE, P; VANOMMEN, GJB				HOGERVORST, FBL; CORNELIS, RS; BOUT, M; VANVLIET, M; OOSTERWIJK, JC; OLMER, R; BAKKER, B; KLIJN, JGM; VASEN, HFA; MEIJERSHEIJBOER, H; MENKO, FH; CORNELISSE, CJ; DENDUNNEN, JT; DEVILEE, P; VANOMMEN, GJB			RAPID DETECTION OF BRCA1 MUTATIONS BY THE PROTEIN TRUNCATION TEST	NATURE GENETICS			English	Article							FAMILIAL BREAST; LINKAGE; CANCER	More than 75% of the reported mutations in the hereditary breast and ovarian cancer gene, BRCA1, result in truncated proteins, We have used the protein truncation test (PTT) to screen for mutations in exon 11, which encodes 61% of BRCA1. In 45 patients from breast and/or ovarian cancer families we found six novel mutations: two single nucleotide insertions, three small deletions (1-5 bp) and a nonsense mutation identified two unrelated families, Furthermore, we were able to amplify the remaining coding region by RT-PCR using lymphocyte RNA. Combined with PTT, we detected aberrantly spliced products affecting exons 5 and 6 in one of two BRCA1-linked families examined. The protein truncation test promises to become a valuable technique in detecting BRCA1 mutations.	LEIDEN UNIV,DEPT PATHOL,2333 AL LEIDEN,NETHERLANDS; UNIV LEIDEN HOSP,DEPT CLIN GENET,2333 AA LEIDEN,NETHERLANDS; FDN DETECT HEREDITARY TUMOURS,2333 AA LEIDEN,NETHERLANDS; DANIEL DEN HOED HOSP,3075 EA ROTTERDAM,NETHERLANDS; ERASMUS UNIV ROTTERDAM,DEPT CLIN GENET,3015 GE ROTTERDAM,NETHERLANDS; FREE UNIV AMSTERDAM HOSP,DEPT CLIN GENET,1081 HV AMSTERDAM,NETHERLANDS	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	HOGERVORST, FBL (corresponding author), LEIDEN UNIV,DEPT HUMAN GENET,MGC,WASSENAARSEWEG 72,2333 AL LEIDEN,NETHERLANDS.		Bakker, Egbert/D-3525-2009; DEVILEE, PETER/ABR-2140-2022; Oosterwijk, Jan C./G-5770-2011; dunnen, johan den/ABH-4228-2020	Bakker, Egbert/0000-0002-2843-7357; dunnen, johan den/0000-0002-6304-1710; Vasen, Hans/0000-0003-2682-2603				CASTILLA, 1994, NAT GENET, V8, P387; CORNELIS RS, IN PRESS HUM GENET, V119; EASTON DF, 1993, AM J HUM GENET, V52, P678; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; LYNCH HT, 1989, GENETIC EPIDEMIOLOGY, P289; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NAROD SA, 1995, AM J HUM GENET, V56, P254; NOWAK R, 1994, SCIENCE, V266, P1470, DOI 10.1126/science.7985008; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; ROBERTS RG, 1991, AM J HUM GENET, V49, P298; ROEST PAM, 1993, HUM MOL GENET, V2, P1719, DOI 10.1093/hmg/2.10.1719; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; VANDERLUIJT R, 1994, GENOMICS, V20, P1, DOI 10.1006/geno.1994.1119; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	19	280	302	1	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1995	10	2					208	212		10.1038/ng0695-208	http://dx.doi.org/10.1038/ng0695-208			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	7663517	Green Published			2022-12-17	WOS:A1995RA85700019
J	Nielsen, JB; Thorolfsdottir, RB; Fritsche, LG; Zhou, W; Skov, MW; Graham, SE; Herron, TJ; McCarthy, S; Schmidt, EM; Sveinbjornsson, G; Surakka, I; Mathis, MR; Yamazaki, M; Crawford, RD; Gabrielsen, ME; Skogholt, AH; Holmen, OL; Lin, MX; Wolford, BN; Dey, R; Dalen, H; Sulem, P; Chung, JH; Backman, JD; Arnar, DO; Thorsteinsdottir, U; Baras, A; O'Dushlaine, C; Holst, AG; Wen, XQ; Hornsby, W; Dewey, FE; Boehnke, M; Kheterpal, S; Mukherjee, B; Lee, S; Kang, HM; Holm, H; Kitzman, J; Shavit, JA; Jalife, J; Brummett, CM; Teslovich, TM; Carey, DJ; Gudbjartsson, DF; Stefansson, K; Abecasis, GR; Hveem, K; Willer, CJ				Nielsen, Jonas B.; Thorolfsdottir, Rosa B.; Fritsche, Lars G.; Zhou, Wei; Skov, Morten W.; Graham, Sarah E.; Herron, Todd J.; McCarthy, Shane; Schmidt, Ellen M.; Sveinbjornsson, Gardar; Surakka, Ida; Mathis, Michael R.; Yamazaki, Masatoshi; Crawford, Ryan D.; Gabrielsen, Maiken E.; Skogholt, Anne Heidi; Holmen, Oddgeir L.; Lin, Maoxuan; Wolford, Brooke N.; Dey, Rounak; Dalen, Havard; Sulem, Patrick; Chung, Jonathan H.; Backman, Joshua D.; Arnar, David O.; Thorsteinsdottir, Unnur; Baras, Aris; O'Dushlaine, Colm; Holst, Anders G.; Wen, Xiaoquan; Hornsby, Whitney; Dewey, Frederick E.; Boehnke, Michael; Kheterpal, Sachin; Mukherjee, Bhramar; Lee, Seunggeun; Kang, Hyun M.; Holm, Hilma; Kitzman, Jacob; Shavit, Jordan A.; Jalife, Jose; Brummett, Chad M.; Teslovich, Tanya M.; Carey, David J.; Gudbjartsson, Daniel F.; Stefansson, Kari; Abecasis, Goncalo R.; Hveem, Kristian; Willer, Cristen J.			Biobank-driven genomic discovery yields new insight into atrial fibrillation biology	NATURE GENETICS			English	Article							WIDE ASSOCIATION; RISK; MYOSIN; VARIANTS; METAANALYSIS; MUTATIONS; HEAVY; EXPRESSION; DURATION; MYOCYTES	To identify genetic variation underlying atrial fibrillation, the most common cardiac arrhythmia, we performed a genome-wide association study of >1,000,000 people, including 60,620 atrial fibrillation cases and 970,216 controls. We identified 142 independent risk variants at 111 loci and prioritized 151 functional candidate genes likely to be involved in atrial fibrillation. Many of the identified risk variants fall near genes where more deleterious mutations have been reported to cause serious heart defects in humans (GATA4, MYH6, NKX2-5, PITX2, TBX5)(1), or near genes important for striated muscle function and integrity (for example, CFL2, MYH7, PKP2, RBM20, SGCG, SSPN). Pathway and functional enrichment analyses also suggested that many of the putative atrial fibrillation genes act via cardiac structural remodeling, potentially in the form of an 'atrial cardiomyopathy'(2), either during fetal heart development or as a response to stress in the adult heart.	[Nielsen, Jonas B.; Fritsche, Lars G.; Zhou, Wei; Graham, Sarah E.; Surakka, Ida; Lin, Maoxuan; Wolford, Brooke N.; Hornsby, Whitney; Jalife, Jose; Willer, Cristen J.] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Nielsen, Jonas B.; Graham, Sarah E.; Surakka, Ida; Lin, Maoxuan; Kitzman, Jacob; Willer, Cristen J.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Thorolfsdottir, Rosa B.; Sveinbjornsson, Gardar; Sulem, Patrick; Arnar, David O.; Thorsteinsdottir, Unnur; Holm, Hilma; Stefansson, Kari] Amgen Inc, deCODE Genet, Reykjavik, Iceland; [Thorolfsdottir, Rosa B.; Arnar, David O.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Fritsche, Lars G.; Gabrielsen, Maiken E.; Skogholt, Anne Heidi; Holmen, Oddgeir L.; Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, HUNT Res Ctr, Levanger, Norway; [Fritsche, Lars G.; Gabrielsen, Maiken E.; Skogholt, Anne Heidi; Holmen, Oddgeir L.; Abecasis, Goncalo R.; Hveem, Kristian; Willer, Cristen J.] Norwegian Univ Sci & Technol, Dept Publ Hlth, KG Jebsen Ctr Genet Epidemiol, Trondheim, Norway; [Fritsche, Lars G.; Zhou, Wei; Crawford, Ryan D.; Wolford, Brooke N.; Willer, Cristen J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Skov, Morten W.; Holst, Anders G.] Copenhagen Univ Hosp, Rigshosp, Heart Ctr, Lab Mol Cardiol,Dept Cardiol, Copenhagen, Denmark; [Herron, Todd J.; Jalife, Jose] Univ Michigan, Dept Internal Med, Ctr Arrhythmia Res, Ann Arbor, MI 48109 USA; [McCarthy, Shane; Chung, Jonathan H.; Backman, Joshua D.; Baras, Aris; O'Dushlaine, Colm; Dewey, Frederick E.; Teslovich, Tanya M.] Regeneron Genet Ctr, Tarrytown, NY USA; [Schmidt, Ellen M.; Dey, Rounak; Wen, Xiaoquan; Boehnke, Michael; Mukherjee, Bhramar; Lee, Seunggeun; Kang, Hyun M.; Abecasis, Goncalo R.] Univ Michigan, Ctr Stat Genet, Dept Biostat, Ann Arbor, MI 48109 USA; [Mathis, Michael R.; Kheterpal, Sachin; Brummett, Chad M.] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Yamazaki, Masatoshi] Univ Tokyo, Med Device Dev & Regulat Res Ctr, Tokyo, Japan; [Holmen, Oddgeir L.] St Olavs Univ Hosp, Dept Cardiol, Trondheim, Norway; [Dalen, Havard; Hveem, Kristian] Nord Trondelag Hosp Trust, Levanger Hosp, Dept Med, Levanger, Norway; [Dalen, Havard] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway; [Dalen, Havard] Trondheim Reg & Univ Hosp, St Olavs Univ Hosp, Dept Cardiol, Trondheim, Norway; [Arnar, David O.] Landspitali Natl Univ Hosp, Dept Med, Reykjavik, Iceland; [Shavit, Jordan A.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Jalife, Jose] Fdn Ctr Nacl InvestCardiovasc CNIC, Madrid, Spain; [Carey, David J.] Geisinger Hlth Syst, Danville, PA USA; [Gudbjartsson, Daniel F.] Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Iceland; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Michigan System; University of Michigan; Rigshospitalet; University of Copenhagen; University of Michigan System; University of Michigan; Regeneron; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Tokyo; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Landspitali National University Hospital; University of Michigan System; University of Michigan; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Geisinger Health System; University of Iceland	Willer, CJ (corresponding author), Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA.; Willer, CJ (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.; Hveem, K (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, HUNT Res Ctr, Levanger, Norway.; Abecasis, GR; Hveem, K (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth, KG Jebsen Ctr Genet Epidemiol, Trondheim, Norway.; Abecasis, GR (corresponding author), Univ Michigan, Ctr Stat Genet, Dept Biostat, Ann Arbor, MI 48109 USA.	goncalo@umich.edu; kristian.hveem@ntnu.no; cristen@umich.edu	Jalife, Jose/AAJ-9156-2021; Dalen, Havard/A-8087-2018; Jalife, Jose/L-4833-2015; Wolford, Brooke/GQZ-2025-2022; Jalife, Jose/A-8781-2019; Hveem, Kristian/AFV-4683-2022; Dey, Rounak/AAQ-9662-2021; Fritsche, Lars G/AAF-9387-2019; Wolford, Brooke/Y-3162-2019; Stefansson, Kari/AAE-7187-2019	Jalife, Jose/0000-0003-0080-3500; Dalen, Havard/0000-0003-1192-3663; Jalife, Jose/0000-0003-0080-3500; Jalife, Jose/0000-0003-0080-3500; Dey, Rounak/0000-0002-6540-8280; Fritsche, Lars G/0000-0002-2110-1690; Wolford, Brooke/0000-0003-3153-1552; Kitzman, Jacob/0000-0002-6145-882X; Brummett, Chad/0000-0003-0974-7242; Surakka, Ida/0000-0002-6669-5541; Lin, Maoxuan/0000-0001-5191-1857; Nielsen, Jonas Bille/0000-0002-6654-2852; Schmidt, Ellen/0000-0003-1198-7536; Sveinbjornsson, Gardar/0000-0003-2429-9468; Mathis, Michael/0000-0002-9697-2212	Stiftelsen Kristian Gerhard Jebsen; Faculty of Medicine and Health Sciences Norwegian University of Science and Technology (NTNU); Central Norway Regional Health Authority; Danish Heart Foundation [16-R107-A6779]; Lundbeck Foundation [R220-2016-1434]; American Heart Association Scientist Development Grant [0735464Z]; National Institutes of Health [R01-HL124232, R35-HL135824, R01-HL127564, R01-HL117626-02-S1, R01-HL130705]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117626, R01HL109946, R01HL130705, R35HL135824, R01HL124232, R01HL127564] Funding Source: NIH RePORTER	Stiftelsen Kristian Gerhard Jebsen; Faculty of Medicine and Health Sciences Norwegian University of Science and Technology (NTNU); Central Norway Regional Health Authority; Danish Heart Foundation; Lundbeck Foundation(Lundbeckfonden); American Heart Association Scientist Development Grant(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Nord-Trondelag Health Study (the HUNT Study) is a collaboration between the HUNT Research Centre (Faculty of Medicine, Norwegian University of Science and Technology (NTNU)), Nord-Trondelag County Council, the Central Norway Health Authority, and the Norwegian Institute of Public Health. The K.G. Jebesen Center for Genetic Epidemiology is financed by Stiftelsen Kristian Gerhard Jebsen, the Faculty of Medicine and Health Sciences Norwegian University of Science and Technology (NTNU), and the Central Norway Regional Health Authority. This research has been conducted using the UK Biobank Resource under application number 24460. J.B.N. was supported by grants from the Danish Heart Foundation (16-R107-A6779) and the Lundbeck Foundation (R220-2016-1434). T.J.H. was supported by an American Heart Association Scientist Development Grant (0735464Z). J.A.S. was supported by National Institutes of Health grant R01-HL124232. C.J.W. was supported by National Institutes of Health grants R35-HL135824, R01-HL127564, R01-HL117626-02-S1, and R01-HL130705. To the best of our knowledge, this manuscript complies with all relevant ethical regulations.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Benonisdottir S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13490; Bjornsson T., 2017, BIORXIV, DOI [10.1101/180794, DOI 10.1101/180794]; Brauch KM, 2009, J AM COLL CARDIOL, V54, P930, DOI 10.1016/j.jacc.2009.05.038; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Bult CJ, 2000, IEEE INTERNATIONAL SYMPOSIUM ON BIO-INFORMATICS AND BIOMEDICAL ENGINEERING, PROCEEDINGS, P29, DOI 10.1109/BIBE.2000.889586; Bycroft C., 2017, BIORXIV, DOI [DOI 10.1101/16629824, DOI 10.1101/166298]; Canon S, 2016, J MOL CELL CARDIOL, V99, P162, DOI 10.1016/j.yjmcc.2016.08.012; Carey DJ, 2016, GENET MED, V18, P906, DOI 10.1038/gim.2015.187; Christophersen IE, 2017, NAT GENET, V49, P946, DOI 10.1038/ng.3843; Cook JP, 2017, EUR J HUM GENET, V25, P240, DOI 10.1038/ejhg.2016.150; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; England J, 2013, CELL MOL LIFE SCI, V70, P1221, DOI 10.1007/s00018-012-1131-1; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Fritsche LG, 2018, AM J HUM GENET, V102, P1048, DOI 10.1016/j.ajhg.2018.04.001; Ge T, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006711; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Goette A, 2016, EUROPACE, V18, P1455, DOI 10.1093/europace/euw161; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Herron TJ, 2001, AM J PHYSIOL-HEART C, V281, pH1217, DOI 10.1152/ajpheart.2001.281.3.H1217; Herron TJ, 2010, FASEB J, V24, P415, DOI 10.1096/fj.09-140566; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Jin SC, 2017, NAT GENET, V49, P1593, DOI 10.1038/ng.3970; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lindauer James, 2005, Journal of Electrocardiology, V38, P90, DOI 10.1016/j.jelectrocard.2005.06.062; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Lubitz SA, 2010, JAMA-J AM MED ASSOC, V304, P2263, DOI 10.1001/jama.2010.1690; Ma C, 2013, GENET EPIDEMIOL, V37, P539, DOI 10.1002/gepi.21742; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Nielsen JB, 2018, AM J HUM GENET, V102, P103, DOI 10.1016/j.ajhg.2017.12.003; Nielsen JB, 2015, HEART RHYTHM, V12, P1887, DOI 10.1016/j.hrthm.2015.04.026; Nielsen JB, 2013, HEART RHYTHM, V10, P1249, DOI 10.1016/j.hrthm.2013.04.012; Nielsen JB, 2013, J AM COLL CARDIOL, V61, P2557, DOI 10.1016/j.jacc.2013.03.032; NOGUCHI S, 1995, SCIENCE, V270, P819, DOI 10.1126/science.270.5237.819; Orr N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11303; Oyen N, 2012, J AM COLL CARDIOL, V60, P917, DOI 10.1016/j.jacc.2012.03.046; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Roselli C, 2018, NAT GENET, V50, P1225, DOI 10.1038/s41588-018-0133-9; Schmidt EM, 2015, BIOINFORMATICS, V31, P2601, DOI 10.1093/bioinformatics/btv201; Skov MW, 2016, AM J CARDIOL, V118, P708, DOI 10.1016/j.amjcard.2016.06.013; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Teerlink JR, 2011, LANCET, V378, P667, DOI 10.1016/S0140-6736(11)61219-1; Thorolfsdottir RB, 2017, J AM COLL CARDIOL, V70, P2157, DOI 10.1016/j.jacc.2017.09.005; Veerman CC, 2017, CIRC RES, V121, P537, DOI 10.1161/CIRCRESAHA.117.310959; Wagner AH, 2016, NUCLEIC ACIDS RES, V44, pD1036, DOI 10.1093/nar/gkv1165; Wells A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1262; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wu Y, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1216-0; Wen XQ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006646; Yamazaki M, 2012, PROG BIOPHYS MOL BIO, V110, P269, DOI 10.1016/j.pbiomolbio.2012.08.004; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zhou SH, 2009, ANN NONINVAS ELECTRO, V14, pS3, DOI 10.1111/j.1542-474X.2008.00258.x; Zhou W, 2017, BIORXIV, DOI [10.1101/212357, DOI 10.1101/212357]	66	279	281	3	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2018	50	9					1234	+		10.1038/s41588-018-0171-3	http://dx.doi.org/10.1038/s41588-018-0171-3			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GS0CH	30061737	Green Submitted, Green Accepted			2022-12-17	WOS:000443151300013
J	Holm, H; Gudbjartsson, DF; Arnar, DO; Thorleifsson, G; Thorgeirsson, G; Stefansdottir, H; Gudjonsson, SA; Jonasdottir, A; Mathiesen, EB; Njolstad, I; Nyrnes, A; Wilsgaard, T; Hald, EM; Hveem, K; Stoltenberg, C; Lochen, ML; Kong, A; Thorsteinsdottir, U; Stefansson, K				Holm, Hilma; Gudbjartsson, Daniel F.; Arnar, David O.; Thorleifsson, Gudmar; Thorgeirsson, Gudmundur; Stefansdottir, Hrafnhildur; Gudjonsson, Sigurjon A.; Jonasdottir, Aslaug; Mathiesen, Ellisiv B.; Njolstad, Inger; Nyrnes, Audhild; Wilsgaard, Tom; Hald, Erin M.; Hveem, Kristian; Stoltenberg, Camilla; Lochen, Maja-Lisa; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari			Several common variants modulate heart rate, PR interval and QRS duration	NATURE GENETICS			English	Article							MYOSIN HEAVY-CHAIN; GENOME-WIDE ASSOCIATION; HOLT-ORAM-SYNDROME; SODIUM-CHANNEL; ALPHA-MYOSIN; ATRIAL-FIBRILLATION; ISCHEMIC-STROKE; GENETIC-FACTORS; EXPRESSION; DISEASE	Electrocardiographic measures are indicative of the function of the cardiac conduction system. To search for sequence variants that modulate heart rate, PR interval and QRS duration in individuals of European descent, we performed a genome-wide association study in similar to 10,000 individuals and followed up the top signals in an additional similar to 10,000 individuals. We identified several genome-wide significant associations (with P < 1.6 x 10(-7)). We identified one locus for heart rate (MYH6), four for PR interval (TBX5, SCN10A, CAV1 and ARHGAP24) and four for QRS duration (TBX5, SCN10A, 6p21 and 10q21). We tested for association between these loci and subjects with selected arrhythmias in Icelandic and Norwegian case-control sample sets. We observed correlations between TBX5 and CAV1 and atrial fibrillation (P = 4.0 x 10(-5) and P = 0.00032, respectively), between TBX5 and advanced atrioventricular block (P = 0.0067), and between SCN10A and pacemaker implantation (P = 0.0029). We also replicated previously described associations with the QT interval.	[Holm, Hilma; Gudbjartsson, Daniel F.; Thorleifsson, Gudmar; Gudjonsson, Sigurjon A.; Jonasdottir, Aslaug; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE genet, Reykjavik, Iceland; Landspitali Univ Hosp, Dept Med, Reykjavik, Iceland; [Arnar, David O.; Thorgeirsson, Gudmundur; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Mathiesen, Ellisiv B.] Univ Tromso, Inst Clin Med, Tromso, Norway; [Mathiesen, Ellisiv B.] Univ Hosp N Norway, Dept Neurol, Tromso, Norway; [Njolstad, Inger; Nyrnes, Audhild; Wilsgaard, Tom; Lochen, Maja-Lisa] Univ Tromso, Inst Community Med, Tromso, Norway; [Nyrnes, Audhild] Univ Hosp N Norway, Dept Geriatr, Tromso, Norway; [Hald, Erin M.; Lochen, Maja-Lisa] Univ Hosp N Norway, Dept Cardiol, Tromso, Norway; [Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Stoltenberg, Camilla] Norwegian Inst Publ Hlth, Oslo, Norway	Landspitali National University Hospital; University of Iceland; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; Norwegian University of Science & Technology (NTNU); Norwegian Institute of Public Health (NIPH)	Holm, H (corresponding author), deCODE genet, Reykjavik, Iceland.	hilma.holm@decode.is; kstefans@decode.is	Stefansson, Kari/AAE-7187-2019; Njolstad, Inger/X-3784-2019; Stoltenberg, Camilla/G-5090-2017; Hveem, Kristian/AFV-4683-2022	Gudjonsson, Sigurjon A./0000-0001-9314-7412; Gudbjartsson, Daniel/0000-0002-5222-9857; Kong, Augustine/0000-0001-8193-5438; Lochen, Maja-Lisa/0000-0002-8532-6573				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; BASSON CT, 1994, NEW ENGL J MED, V330, P885, DOI 10.1056/NEJM199403313301302; Basson CT, 1997, NAT GENET, V15, P411, DOI 10.1038/ng0497-411c; BJORNSSON S, 1993, LAEKNABLADID, V79, P21; BRODSKY M, 1977, ARCH INTERN MED, V137, P165, DOI 10.1001/archinte.137.2.165; Carniel E, 2005, CIRCULATION, V112, P54, DOI 10.1161/CIRCULATIONAHA.104.507699; Cheng S, 2009, JAMA-J AM MED ASSOC, V301, P2571, DOI 10.1001/jama.2009.888; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Desai AD, 2006, AM J MED, V119, P600, DOI 10.1016/j.amjmed.2005.08.028; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Engelman JA, 1998, AM J HUM GENET, V63, P1578, DOI 10.1086/302172; Franco D, 1998, CARDIOVASC RES, V38, P25, DOI 10.1016/S0008-6363(97)00321-0; Ghosh TK, 2009, MOL CELL BIOL, V29, P2205, DOI 10.1128/MCB.01923-08; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gudbjartsson DF, 2009, NAT GENET, V41, P876, DOI 10.1038/ng.417; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; HANSON B, 1989, AM J CARDIOL, V63, P606, DOI 10.1016/0002-9149(89)90907-7; HAVLIK RJ, 1980, J ELECTROCARDIOL, V13, P45, DOI 10.1016/S0022-0736(80)80008-2; Herron TJ, 2002, CIRC RES, V90, P1150, DOI 10.1161/01.RES.0000022879.57270.11; Hesse B, 2001, AM J MED, V110, P253, DOI 10.1016/S0002-9343(00)00713-0; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Kao WHL, 2009, CIRCULATION, V119, P940, DOI 10.1161/CIRCULATIONAHA.108.791723; Katoh M, 2004, INT J MOL MED, V14, P333; KURABAYASHI M, 1988, J CLIN INVEST, V82, P524, DOI 10.1172/JCI113627; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li JP, 2009, ANN NONINVAS ELECTRO, V14, P147, DOI 10.1111/j.1542-474X.2009.00289.x; Li QY, 1997, NAT GENET, V15, P21; Lindauer James, 2005, Journal of Electrocardiology, V38, P90, DOI 10.1016/j.jelectrocard.2005.06.062; LOMPRE AM, 1984, J BIOL CHEM, V259, P6437; LOWN B, 1952, CIRCULATION, V5, P693, DOI 10.1161/01.CIR.5.5.693; MAHDAVI V, 1984, P NATL ACAD SCI-BIOL, V81, P2626, DOI 10.1073/pnas.81.9.2626; Maier SKG, 2004, CIRCULATION, V109, P1421, DOI 10.1161/01.CIR.0000121421.61896.24; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Moskowitz IPG, 2004, DEVELOPMENT, V131, P4107, DOI 10.1242/dev.01265; Mutikainen S, 2009, ANN NONINVAS ELECTRO, V14, P57, DOI 10.1111/j.1542-474X.2008.00273.x; Newton-Cheh C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S7; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Palatini P, 2004, CLIN EXP HYPERTENS, V26, P637, DOI 10.1081/CEH-200031959; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Postma AV, 2008, CIRC RES, V102, P1433, DOI 10.1161/CIRCRESAHA.107.168294; Rabert DK, 1998, PAIN, V78, P107, DOI 10.1016/S0304-3959(98)00120-1; Ruan YF, 2009, NAT REV CARDIOL, V6, P337, DOI 10.1038/nrcardio.2009.44; Russell MW, 1997, J ELECTROCARDIOL, V30, P64, DOI 10.1016/S0022-0736(98)80034-4; SAKSENA S, 2004, ELECTROPHYSIOLOGICAL; Sangameswaran L, 1996, J BIOL CHEM, V271, P5953, DOI 10.1074/jbc.271.11.5953; Smith JG, 2009, HEART RHYTHM, V6, P634, DOI 10.1016/j.hrthm.2009.02.022; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; ZAKUT R, 1995, ONCOGENE, V11, P393; Zhou SH, 2009, ANN NONINVAS ELECTRO, V14, pS3, DOI 10.1111/j.1542-474X.2008.00258.x	56	279	284	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2010	42	2					117	U40		10.1038/ng.511	http://dx.doi.org/10.1038/ng.511			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549WG	20062063				2022-12-17	WOS:000274084400006
J	Cordeddu, V; Di Schiavi, E; Pennacchio, LA; Ma'ayan, A; Sarkozy, A; Fodale, V; Cecchetti, S; Cardinale, A; Martin, J; Schackwitz, W; Lipzen, A; Zampino, G; Mazzanti, L; Digilio, MC; Martinelli, S; Flex, E; Lepri, F; Bartholdi, D; Kutsche, K; Ferrero, GB; Anichini, C; Selicorni, A; Rossi, C; Tenconi, R; Zenker, M; Merlo, D; Dallapiccola, B; Iyengar, R; Bazzicalupo, P; Gelb, BD; Tartaglia, M				Cordeddu, Viviana; Di Schiavi, Elia; Pennacchio, Len A.; Ma'ayan, Avi; Sarkozy, Anna; Fodale, Valentina; Cecchetti, Serena; Cardinale, Alessio; Martin, Joel; Schackwitz, Wendy; Lipzen, Anna; Zampino, Giuseppe; Mazzanti, Laura; Digilio, Maria C.; Martinelli, Simone; Flex, Elisabetta; Lepri, Francesca; Bartholdi, Deborah; Kutsche, Kerstin; Ferrero, Giovanni B.; Anichini, Cecilia; Selicorni, Angelo; Rossi, Cesare; Tenconi, Romano; Zenker, Martin; Merlo, Daniela; Dallapiccola, Bruno; Iyengar, Ravi; Bazzicalupo, Paolo; Gelb, Bruce D.; Tartaglia, Marco			Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair	NATURE GENETICS			English	Article							INTERACTION DATABASE; C-ELEGANS; RAS; PTPN11; PHOSPHATASE; NETWORK; SUR-8	N-myristoylation is a common form of co-translational protein fatty acylation resulting from the attachment of myristate to a required N-terminal glycine residue(1,2). We show that aberrantly acquired N-myristoylation of SHOC2, a leucine-rich repeat-containing protein that positively modulates RAS-MAPK signal flow(3-6), underlies a clinically distinctive condition of the neuro-cardio-facial-cutaneous disorders family. Twenty-five subjects with a relatively consistent phenotype previously termed Noonan-like syndrome with loose anagen hair (MIM607721)(7) shared the 4A>G missense change in SHOC2 (producing an S2G amino acid substitution) that introduces an N-myristoylation site, resulting in aberrant targeting of SHOC2 to the plasma membrane and impaired translocation to the nucleus upon growth factor stimulation. Expression of SHOC2(S2G) in vitro enhanced MAPK activation in a cell typespecific fashion. Induction of SHOC2(S2G) in Caenorhabditis elegans engendered protruding vulva, a neomorphic phenotype previously associated with aberrant signaling. These results document the first example of an acquired N-terminal lipid modification of a protein causing human disease.	[Cordeddu, Viviana; Fodale, Valentina; Martinelli, Simone; Flex, Elisabetta; Tartaglia, Marco] Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, I-00161 Rome, Italy; [Di Schiavi, Elia; Bazzicalupo, Paolo] CNR, Ist Genet & Biofis A Buzzati Traverso, Naples, Italy; [Pennacchio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; [Pennacchio, Len A.; Martin, Joel; Schackwitz, Wendy; Lipzen, Anna] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Ma'ayan, Avi; Iyengar, Ravi] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, SBCNY, New York, NY USA; [Sarkozy, Anna; Lepri, Francesca; Dallapiccola, Bruno] San Giovanni Rotondo & Ist Mendel, Ist Ricovero & Cura Carattere Sci Casa Sollievo S, Rome, Italy; [Fodale, Valentina; Dallapiccola, Bruno] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy; [Cecchetti, Serena; Merlo, Daniela] Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, I-00161 Rome, Italy; [Cardinale, Alessio; Merlo, Daniela] IRCCS San Raffaele Pisana, Rome, Italy; [Zampino, Giuseppe] Univ Cattolica Sacro Cuore, Ist Clin Pediat, Rome, Italy; [Mazzanti, Laura] Univ Bologna, Dipartimento Pediat, Bologna, Italy; [Digilio, Maria C.] Bambino Gesu Pediat Hosp, Sez Genet Med, Rome, Italy; [Bartholdi, Deborah] Univ Zurich, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland; [Kutsche, Kerstin] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, Hamburg, Germany; [Ferrero, Giovanni B.] Univ Turin, Dipartimento Pediat, Turin, Italy; [Anichini, Cecilia] Univ Siena, Dipartimento Pediat Ostetr & Med Riproduz, I-53100 Siena, Italy; [Selicorni, Angelo] Fdn Policlin Milano, IRCCS, Clin Pediat 1, Milan, Italy; [Rossi, Cesare] St Orsola Marcello Malpighi Hosp, Unita Operat Genet Med, Bologna, Italy; [Tenconi, Romano] Univ Padua, Dipartimento Pediat, I-35128 Padua, Italy; [Zenker, Martin] Univ Erlangen Nurnberg, Inst Human Genet, Univ Hosp Erlangen, D-8520 Erlangen, Germany; [Gelb, Bruce D.] Mt Sinai Sch Med, Ctr Mol Cardiol, New York, NY USA; [Gelb, Bruce D.] Mt Sinai Sch Med, Dept Pediat, New York, NY USA; [Gelb, Bruce D.] Mt Sinai Sch Med, Dept Genet, New York, NY USA; [Gelb, Bruce D.] Mt Sinai Sch Med, Dept Genom Sci, New York, NY USA	Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Icahn School of Medicine at Mount Sinai; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Sapienza University Rome; Istituto Superiore di Sanita (ISS); IRCCS San Raffaele Pisana; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Bologna; IRCCS Bambino Gesu; University of Zurich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Turin; University of Siena; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Padua; University of Erlangen Nuremberg; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Tartaglia, M (corresponding author), Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, Viale Regina Elena 299, I-00161 Rome, Italy.	bruce.gelb@mssm.edu; mtartaglia@iss.it	Cecchetti, Serena/N-1061-2015; Ferrero, Giovanni Battista/K-5265-2018; Tartaglia, Marco/K-2955-2018; Rossi, Cesare/AAC-2083-2022; Merlo, Daniela/K-7986-2016; Flex, Elisabetta/A-5958-2017; Digilio, Maria Cristina/AAI-2434-2019; cordeddu, viviana/A-5612-2016; Lepri, Francesca Romana/AAA-6115-2020; cordeddu, viviana/J-2272-2014; Zampino, Giuseppe/AAC-2152-2019; Ma'ayan, Avi/AAG-3131-2019; Schackwitz, Wendy/GXH-9536-2022; Martinelli, Simone/J-9432-2018; Di Schiavi, Elia/B-8046-2015; Dallapiccola, Bruno/K-8692-2016	Cecchetti, Serena/0000-0002-3601-176X; Ferrero, Giovanni Battista/0000-0002-3793-5788; Tartaglia, Marco/0000-0001-7736-9672; Rossi, Cesare/0000-0003-1826-615X; Merlo, Daniela/0000-0003-4240-5762; Flex, Elisabetta/0000-0002-6802-1356; cordeddu, viviana/0000-0001-7159-7383; Ma'ayan, Avi/0000-0002-6904-1017; Martinelli, Simone/0000-0002-5843-419X; Di Schiavi, Elia/0000-0002-8179-6666; mazzanti, laura/0000-0002-7670-6494; Lepri, Francesca Romana/0000-0001-5331-0473; Martin, Joel/0000-0001-9511-6441; Pennacchio, Len/0000-0002-8748-3732; Schackwitz, Wendy/0000-0002-3013-9180; Lipzen, Anna/0000-0003-2293-9329; Dallapiccola, Bruno/0000-0002-5031-1013	TelethonItaly [GGP07115]; Convenzione Italia- USA; NIH [HL71207, HD01294, HL074728]; SBCNY [P50GM071558]; German Research Foundation ( DFG) [ZE 524/ 4- 1]; IRCCS- CSS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001294] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL074728, R01HL071207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558, R01GM054508] Funding Source: NIH RePORTER	TelethonItaly(Fondazione Telethon); Convenzione Italia- USA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SBCNY; German Research Foundation ( DFG)(German Research Foundation (DFG)); IRCCS- CSS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to the affected individuals and families who participated in the study, the physicians who referred the subjects, A. Fire ( Stanford University School of Medicine, Stanford, California) and J. D. McGhee ( University of Calgary, Calgary, Canada) for plasmids, and C. Ramoni, S. Venanzi and T. Squatriti ( Istituto Superiore di Sanita`, Rome, Italy) and the Open Laboratory ( IGB- CNR, Naples, Italy) for experimental support. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center ( University of Minnesota, Minneapolis, Minnesota), funded by the US National Institutes of Health ( NIH) National Center for Research Resources. We also thank M. C. Silengo ( Universita` di Torino, Turin, Italy), S. Spranger ( Praxis fuer Humangenetik, Bremen, Germany), I. M. Gaspar ( Egas Moniz Hospital, Lisbon, Portugal) and D. R. Bertola ( HC/ FMUSP, Sa ~ o Paulo, Brazil) for their contribution in DNA sampling and valuable clinical assistance. This research was funded by grants from TelethonItaly ( GGP07115) and ` Convenzione Italia- USA- malattie rare' to M. T., the NIH ( HL71207, HD01294 and HL074728) to B. D. G., SBCNY ( P50GM071558) to A. M. and R. I. the German Research Foundation ( DFG) ( ZE 524/ 4- 1) to M. Z. and IRCCS- CSS ( Ricerca Corrente 2009) to F. L.	ALLANSON JE, 1987, J MED GENET, V24, P9, DOI 10.1136/jmg.24.1.9; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Berger SI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-372; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Dijkstra EW., 1959, NUMER MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Duerr Janet S, 2006, WormBook, P1; Eisenmann DM, 2000, GENETICS, V156, P1097; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kishore RS, 2002, DEV BIOL, V241, P339, DOI 10.1006/dbio.2001.0513; Li WQ, 2000, GENE DEV, V14, P895; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Mazzanti L, 2003, AM J MED GENET A, V118A, P279, DOI 10.1002/ajmg.a.10923; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Roberts A, 2006, J MED GENET, V43, P833, DOI 10.1136/jmg.2006.042796; Rodriguez-Viciana P, 2006, MOL CELL, V22, P217, DOI 10.1016/j.molcel.2006.03.027; Sarkozy A., 2009, V17, P55; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Selfors LM, 1998, P NATL ACAD SCI USA, V95, P6903, DOI 10.1073/pnas.95.12.6903; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; Sulston J.E., 1988, NEMATODE CAENORHABDI, P587; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tartaglia M., 2009, V17, P20; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; TOSTI A, 1991, DERMATOLOGICA, V182, P247; Utsumi T, 2001, J BIOL CHEM, V276, P10505, DOI 10.1074/jbc.M006134200; VACHON L, 1987, MOL PHARMACOL, V31, P159; VANDERBURGT I, 1994, AM J MED GENET, V53, P187, DOI 10.1002/ajmg.1320530213; VORON DA, 1976, AM J MED, V60, P447, DOI 10.1016/0002-9343(76)90764-6; Xenarios I, 2001, NUCLEIC ACIDS RES, V29, P239, DOI 10.1093/nar/29.1.239	36	279	293	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2009	41	9					1022	U95		10.1038/ng.425	http://dx.doi.org/10.1038/ng.425			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488WX	19684605	Green Accepted, Green Published			2022-12-17	WOS:000269382100016
J	Richards, A; van den Maagdenberg, AMJM; Jen, JC; Kavanagh, D; Bertram, P; Spitzer, D; Liszewski, MK; Barilla-LaBarca, ML; Terwindt, GM; Kasai, Y; McLellan, M; Grand, MG; Vanmolkot, KRJ; de Vries, B; Wan, J; Kane, MJ; Mamsa, H; Schafer, R; Stam, AH; Haan, J; Paulus, TVMDJ; Storimans, CW; van Schooneveld, MJ; Oosterhuis, JA; Gschwendter, A; Dichgans, M; Kotschet, KE; Hodgkinson, S; Hardy, TA; Delatycki, MB; Hajj-Ali, RA; Kothari, PH; Nelson, SF; Frants, RR; Baloh, RW; Ferrari, MD; Atkinson, JP				Richards, Anna; van den Maagdenberg, Arn M. J. M.; Jen, Joanna C.; Kavanagh, David; Bertram, Paula; Spitzer, Dirk; Liszewski, M. Kathryn; Barilla-LaBarca, Maria-Louise; Terwindt, Gisela M.; Kasai, Yumi; McLellan, Mike; Grand, Mark Gilbert; Vanmolkot, Kaate R. J.; de Vries, Boukje; Wan, Jijun; Kane, Michael J.; Mamsa, Hafsa; Schaefer, Ruth; Stam, Anine H.; Haan, Joost; Paulus, T. V. M. de Jong; Storimans, Caroline W.; van Schooneveld, Mary J.; Oosterhuis, Jendo A.; Gschwendter, Andreas; Dichgans, Martin; Kotschet, Katya E.; Hodgkinson, Suzanne; Hardy, Todd A.; Delatycki, Martin B.; Hajj-Ali, Rula A.; Kothari, Parul H.; Nelson, Stanley F.; Frants, Rune R.; Baloh, Robert W.; Ferrari, Michel D.; Atkinson, John P.			C-terminal truncations in human 3 '-5 ' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy	NATURE GENETICS			English	Article							CEREBRORETINAL VASCULOPATHY; HEREDITARY ENDOTHELIOPATHY; VASCULAR RETINOPATHY; NEPHROPATHY	Autosomal dominant retinal vasculopathy with cerebral leukodystrophy is a microvascular endotheliopathy with middle- age onset. In nine families, we identified heterozygous C- terminal frameshift mutations in TREX1, which encodes a 3'-5' exonuclease. These truncated proteins retain exonuclease activity but lose normal perinuclear localization. These data have implications for the maintenance of vascular integrity in the degenerative cerebral microangiopathies leading to stroke and dementias.	Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Neurol, NL-2300 RC Leiden, Netherlands; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; N Shore Long Isl Jewish Hlth Syst, Dept Med, Div Rheumatol, Manhasset, NY 11030 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Ophthalmol, St Louis, MO 63110 USA; Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Ophthalmogenet, NL-1000 GC Amsterdam, Netherlands; Acad Med Ctr, Dept Ophthalmol, NL-1100 DD Amsterdam, Netherlands; Erasmus MC, Dept Epidemiol & Biostat, NL-3000 CA Rotterdam, Netherlands; Meander Med Ctr, NL-3800 BM Amersfoort, Netherlands; Univ Med Ctr, Dept Ophthalmol, NL-3508 GA Utrecht, Netherlands; Leiden Univ, Med Ctr, Dept Ophthalmol, NL-2300 RC Leiden, Netherlands; Univ Munich, Klinikum Grosshadern, Dept Neurol, D-81377 Munich, Germany; Monash Med Ctr, Dept Neurol, Clayton, Vic 3168, Australia; Liverpool Hosp, Dept Neurol, Liverpool, NSW 2170, Australia; Concord Repatriat Gen Hosp, Dept Neurol, Concord, NSW 2139, Australia; Bruce Lefroy Ctr Genet Hlth Res, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia; Cleveland Clin Fdn, Dept Rheumat & Immunol Dis, Cleveland, OH 44195 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA	Washington University (WUSTL); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California Los Angeles; Northwell Health; Washington University (WUSTL); Washington University (WUSTL); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Meander Medisch Centrum; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Munich; Monash University; Liverpool Hospital; Concord Repatriation General Hospital; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Cleveland Clinic Foundation; University of California System; University of California Los Angeles	Atkinson, JP (corresponding author), Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA.	jatkinso@im.wustl.edu	Kavanagh, David/E-8498-2011; Barillla-LaBarca, Maria Louise/AAR-9207-2021; Ferrari, Michel D./ABE-3758-2021; van den Maagdenberg, Arn M.J.M./AAE-9052-2019; Nelson, Stanley F/D-4771-2009; Dichgans, Martin/HCH-3247-2022; Delatycki, Martin B/A-5409-2013; Richards, Anna/E-8337-2013	Kavanagh, David/0000-0003-4718-0072; Ferrari, Michel D./0000-0001-9691-9449; Nelson, Stanley F/0000-0002-2082-3114; Dichgans, Martin/0000-0002-0654-387X; MCLELLAN, MICHAEL/0000-0002-2703-8784; Atkinson, John/0000-0002-2514-3441; Hardy, Todd/0000-0003-4145-3172; Schafer, Ruth Christine/0000-0002-4324-1854; Hodgkinson, Suzanne/0000-0002-9029-6663	NEI NIH HHS [R01 EY15311] Funding Source: Medline; NIDCD NIH HHS [P50 DC02952] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY015311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC002952] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Cohn AC, 2005, CLIN EXP OPHTHALMOL, V33, P181, DOI 10.1111/j.1442-9071.2005.00976.x; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Goutieres F, 2005, BRAIN DEV-JPN, V27, P201, DOI 10.1016/j.braindev.2003.12.011; GRAND MG, 1988, OPHTHALMOLOGY, V95, P649, DOI 10.1016/s0161-6420(88)33131-3; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Jen J, 1997, NEUROLOGY, V49, P1322, DOI 10.1212/WNL.49.5.1322; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Ophoff RA, 2001, AM J HUM GENET, V69, P447, DOI 10.1086/321975; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Storimans C W, 1991, Eur J Ophthalmol, V1, P73; Terwindt GM, 1998, BRAIN, V121, P303, DOI 10.1093/brain/121.2.303; Weil S, 1999, NEUROLOGY, V53, P629, DOI 10.1212/WNL.53.3.629	15	279	296	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1068	1070		10.1038/ng2082	http://dx.doi.org/10.1038/ng2082			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17660820				2022-12-17	WOS:000249122400014
J	Hong, YK; Foreman, K; Shin, JW; Hirakawa, S; Curry, CL; Sage, DR; Libermann, T; Dezube, BJ; Fingeroth, JD; Detmar, M				Hong, YK; Foreman, K; Shin, JW; Hirakawa, S; Curry, CL; Sage, DR; Libermann, T; Dezube, BJ; Fingeroth, JD; Detmar, M			Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus	NATURE GENETICS			English	Article							GROWTH-FACTOR RECEPTOR-3; GENE-EXPRESSION; CELLS; IDENTIFICATION; ORIGIN; PROX1; KSHV	Kaposi sarcoma is considered a neoplasm of lymphatic endothelium infected with Kaposi sarcoma-associated herpesvirus. It is characterized by the expression of lymphatic lineage-specific genes by Kaposi sarcoma tumor cells. Here we show that infection of differentiated blood vascular endothelial cells with Kaposi sarcoma-associated herpesvirus leads to their lymphatic reprogramming; induction of similar to70% of the main lymphatic lineage-specific genes, including PROX1, a master regulator of lymphatic development; and downregulation of blood vascular genes.	Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Loyola Univ, Med Ctr, Maywood, IL 60153 USA; Beth Israel Deaconess Med Ctr, Dept Med, BIDMC Genom Ctr, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Loyola University Chicago; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Detmar, M (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Bldg 149,13th St, Charlestown, MA 02129 USA.	michael.detmar@cbrc2.mgh.harvard.edu		Libermann, Towia/0000-0002-4006-8179; Curry, Christine L/0000-0003-4783-9623				Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; BECKSTEAD JH, 1985, AM J PATHOL, V119, P294; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Hong YK, 2002, DEV DYNAM, V225, P351, DOI 10.1002/dvdy.10163; Jussila L, 1998, CANCER RES, V58, P1599; Moses AV, 2002, J VIROL, V76, P8383, DOI 10.1128/JVI.76.16.8383-8399.2002; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Poole LJ, 2002, J VIROL, V76, P3395, DOI 10.1128/JVI.76.7.3395-3420.2002; SCHALLING M, 1995, NAT MED, V1, P707, DOI 10.1038/nm0795-707; Skobe M, 1999, J INVEST DERMATOL, V113, P1047, DOI 10.1046/j.1523-1747.1999.00798.x; Tang J, 2003, J VIROL, V77, P5975, DOI 10.1128/JVI.77.10.5975-5984.2003; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Weninger W, 1999, LAB INVEST, V79, P243; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505	15	279	287	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					683	685		10.1038/ng1383	http://dx.doi.org/10.1038/ng1383			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15220917	Bronze			2022-12-17	WOS:000222354100016
J	Freimer, N; Sabatti, C				Freimer, N; Sabatti, C			The Human Phenome Project	NATURE GENETICS			English	Article							HUMAN GENOME; PHENOTYPES; DISCOVERY; GENETICS; CANCER	A principal goal of genetic research is to identify specific genotypes that are associated with human phenotypes. it will soon be possible to conduct genome-wide genotyping on a massive scale. Our current approaches for defining and assaying phenotypes may be inadequate for making optimal use of such genotypic data. We propose an international effort to create phenomic databases, that is, comprehensive assemblages of systematically collected phenotypic information, and to develop new approaches for analyzing such phenotypic data. We term this effort the Human Phenome Project and suggest a scientific and organizational scope for the project.	Ctr Neurobehav Genet, Inst Neuropsychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Freimer, N (corresponding author), Ctr Neurobehav Genet, Inst Neuropsychiat, Gonda Bldg Room 3506,695 Charles E Young Dr S, Los Angeles, CA 90095 USA.							Almasy L, 1997, GENET EPIDEMIOL, V14, P953, DOI 10.1002/(SICI)1098-2272(1997)14:6<953::AID-GEPI65>3.0.CO;2-K; Barron A, 1998, IEEE T INFORM THEORY, V44, P2743, DOI 10.1109/18.720554; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Breiman, 1999, 567 U CAL DEP STAT, P29; Breiman L., 1984, CLASSIFICATION REGRE, DOI DOI 10.1201/9781315139470; Cardno AG, 2002, AM J PSYCHIAT, V159, P539, DOI 10.1176/appi.ajp.159.4.539; Couzin J, 2002, SCIENCE, V298, P941, DOI 10.1126/science.298.5595.941a; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Feijen M, 2000, BRIT MED BULL, V56, P894, DOI 10.1258/0007142001903580; Goldschmidt R, 2001, FOCUS BIOTECHNOL, V1, P15; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Jarvelin MR, 1997, PAEDIATR PERINAT EP, V11, P298, DOI 10.1111/j.1365-3016.1997.tb00007.x; Kaufman L, 2009, FINDING GROUPS DATA; KELSEY JF, 2000, COMPREHENSIVE TXB PS, P2432; Mahner M, 1997, J THEOR BIOL, V186, P55, DOI 10.1006/jtbi.1996.0335; Mardia KV, 1979, MULTIVARIATE ANAL; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Mitchell P, 2002, NAT BIOTECHNOL, V20, P529, DOI 10.1038/nbt0602-529; Paigen K, 2000, MAMM GENOME, V11, P715, DOI 10.1007/s003350010152; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Peters LL, 2002, PHYSIOL GENOMICS, V11, P185, DOI 10.1152/physiolgenomics.00077.2002; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; RANTAKALLIO P, 1969, ACTA PAEDIAT SC S193, V0193; SILVERMAN BW, 1986, DENT ESTIMATION STAT; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; Vapnik V, 2013, NATURE STAT LEARNING; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490	30	279	298	1	21	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2003	34	1					15	21		10.1038/ng0503-15	http://dx.doi.org/10.1038/ng0503-15			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12721547				2022-12-17	WOS:000182667900006
J	North, KN; Yang, N; Wattanasirichaigoon, D; Mills, M; Easteal, S; Beggs, AH				North, KN; Yang, N; Wattanasirichaigoon, D; Mills, M; Easteal, S; Beggs, AH			A common nonsense mutation results in alpha-actinin-3 deficiency in the general population	NATURE GENETICS			English	Letter							ALPHA-ACTININ; MUSCULAR-DYSTROPHY; RATES		Royal Alexandra Hosp Children, Neurogenet Res Unit, Sydney, NSW, Australia; Univ Sydney, Dept Paediat & Child Hlth, Sydney, NSW 2006, Australia; Harvard Univ, Childrens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; Australian Natl Univ, John Curtin Sch Med Res, Human Genet Grp, Canberra, ACT 2601, Australia	University of Sydney; Harvard University; Boston Children's Hospital; Harvard Medical School; Australian National University; John Curtin School of Medical Research	North, KN (corresponding author), Royal Alexandra Hosp Children, Neurogenet Res Unit, Sydney, NSW, Australia.		North, Kathryn N/K-6476-2012	North, Kathryn N/0000-0003-0841-8009; Easteal, Simon/0000-0002-0462-502X; Beggs, Alan/0000-0001-8818-0568	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K02AR002026, R01AR044345] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR44345, K02 AR02026] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BEGGS AH, 1992, J BIOL CHEM, V267, P9281; BLANCHARD A, 1989, J MUSCLE RES CELL M, V10, P280, DOI 10.1007/BF01758424; Chan YM, 1998, BIOCHEM BIOPH RES CO, V248, P134, DOI 10.1006/bbrc.1998.8920; Cooke J, 1997, TRENDS GENET, V13, P360, DOI 10.1016/S0168-9525(97)01233-X; Flood G, 1997, EUR BIOPHYS J BIOPHY, V25, P431, DOI 10.1007/s002490050057; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; MINETTI C, 1991, NEUROLOGY, V41, P1977, DOI 10.1212/WNL.41.12.1977; North KN, 1996, NEUROMUSCULAR DISORD, V6, P229, DOI 10.1016/0960-8966(96)00361-6; Simoneau JA, 1998, PEDIATRIC ANAEROBIC PERFORMANCE, P5; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; Vainzof M, 1997, NEUROPEDIATRICS, V28, P223, DOI 10.1055/s-2007-973704	12	279	293	0	34	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1999	21	4					353	354		10.1038/7675	http://dx.doi.org/10.1038/7675			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	181KC	10192379				2022-12-17	WOS:000079439700010
J	Wen, WQ; Cho, YS; Zheng, W; Dorajoo, R; Kato, N; Qi, L; Chen, CH; Delahanty, RJ; Okada, Y; Tabara, Y; Gu, DF; Zhu, DL; Haiman, CA; Mo, ZN; Gao, YT; Saw, SM; Go, MJ; Takeuchi, F; Chang, LC; Kokubo, Y; Liang, J; Hao, M; Le Marchand, L; Zhang, Y; Hu, YL; Wong, TY; Long, JR; Han, BG; Kubo, M; Yamamoto, K; Su, MH; Miki, T; Henderson, BE; Song, HD; Tan, AH; He, J; Ng, DPK; Cai, QY; Tsunoda, T; Tsai, FJ; Iwai, N; Chen, GK; Shi, JJ; Xu, JF; Sim, XL; Xiang, YB; Maeda, S; Ong, RTH; Li, C; Nakamura, Y; Aung, T; Kamatani, N; Liu, JJ; Lu, W; Yokota, M; Seielstad, M; Fann, CSJ; Wu, JY; Lee, JY; Hu, FB; Tanaka, T; Tai, ES; Shu, XO				Wen, Wanqing; Cho, Yoon-Shin; Zheng, Wei; Dorajoo, Rajkumar; Kato, Norihiro; Qi, Lu; Chen, Chien-Hsiun; Delahanty, Ryan J.; Okada, Yukinori; Tabara, Yasuharu; Gu, Dongfeng; Zhu, Dingliang; Haiman, Christopher A.; Mo, Zengnan; Gao, Yu-Tang; Saw, Seang-Mei; Go, Min-Jin; Takeuchi, Fumihiko; Chang, Li-Ching; Kokubo, Yoshihiro; Liang, Jun; Hao, Mei; Le Marchand, Loic; Zhang, Yi; Hu, Yanling; Wong, Tien-Yin; Long, Jirong; Han, Bok-Ghee; Kubo, Michiaki; Yamamoto, Ken; Su, Mei-Hsin; Miki, Tetsuro; Henderson, Brian E.; Song, Huaidong; Tan, Aihua; He, Jiang; Ng, Daniel P-K; Cai, Qiuyin; Tsunoda, Tatsuhiko; Tsai, Fuu-Jen; Iwai, Naoharu; Chen, Gary K.; Shi, Jiajun; Xu, Jianfeng; Sim, Xueling; Xiang, Yong-Bing; Maeda, Shiro; Ong, Rick T. H.; Li, Chun; Nakamura, Yusuke; Aung, Tin; Kamatani, Naoyuki; Liu, Jian-Jun; Lu, Wei; Yokota, Mitsuhiro; Seielstad, Mark; Fann, Cathy S. J.; Wu, Jer-Yuarn; Lee, Jong-Young; Hu, Frank B.; Tanaka, Toshihiro; Tai, E. Shyong; Shu, Xiao-Ou		Genetic Invest ANthropometric Tria	Meta-analysis identifies common variants associated with body mass index in east Asians	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; ADULT OBESITY; RISK LOCI; FTO GENE; POPULATIONS; SNP; DATABASE; TRAITS; CDKAL1; MC4R	Multiple genetic loci associated with obesity or body mass index (BMI) have been identified through genome-wide association studies conducted predominantly in populations of European ancestry. We performed a meta-analysis of associations between BMI and approximately 2.4 million SNPs in 27,715 east Asians, which was followed by in silico and de novo replication studies in 37,691 and 17,642 additional east Asians, respectively. We identified ten BMI-associated loci at genome-wide significance (P < 5.0 x 10(-8)), including seven previously identified loci (FTO, SEC16B, MC4R, GIPR-QPCTL, ADCY3-DNAJC27, BDNF and MAP2K5) and three novel loci in or near the CDKAL1, PCSK1 and GP2 genes. Three additional loci nearly reached the genome-wide significance threshold, including two previously identified loci in the GNPDA2 and TFAP2B genes and a newly identified signal near PAX6, all of which were associated with BMI with P < 5.0 x 10(-7). Findings from this study may shed light on new pathways involved in obesity and demonstrate the value of conducting genetic studies in non-European populations.	[Wen, Wanqing; Zheng, Wei; Delahanty, Ryan J.; Long, Jirong; Cai, Qiuyin; Shi, Jiajun; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Dept Med, Div Epidemiol, Nashville, TN 37212 USA; [Wen, Wanqing; Zheng, Wei; Delahanty, Ryan J.; Long, Jirong; Cai, Qiuyin; Shi, Jiajun; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Wen, Wanqing; Zheng, Wei; Delahanty, Ryan J.; Long, Jirong; Cai, Qiuyin; Shi, Jiajun; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Cho, Yoon-Shin; Go, Min-Jin; Han, Bok-Ghee; Lee, Jong-Young] Natl Inst Hlth, Ctr Genome Sci, Cheongwon Gun, South Korea; [Cho, Yoon-Shin] Hallym Univ, Dept Biomed Sci, Chunchon, South Korea; [Dorajoo, Rajkumar; Ong, Rick T. H.; Liu, Jian-Jun; Seielstad, Mark] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Dorajoo, Rajkumar] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, Hammersmith Hosp, London, England; [Kato, Norihiro; Takeuchi, Fumihiko] Natl Ctr Global Hlth & Med, Res Inst, Dept Gene Diagnost & Therapeut, Tokyo, Japan; [Qi, Lu; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Chen, Chien-Hsiun; Chang, Li-Ching; Su, Mei-Hsin; Fann, Cathy S. J.; Wu, Jer-Yuarn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chen, Chien-Hsiun; Tsai, Fuu-Jen; Wu, Jer-Yuarn] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Okada, Yukinori; Kamatani, Naoyuki] RIKEN, Lab Stat Anal, CGM, Yokohama, Kanagawa, Japan; [Okada, Yukinori] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Tabara, Yasuharu] Ehime Univ, Grad Sch Med, Dept Basic Med Res & Educ, Toon, Japan; [Gu, Dongfeng] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100730, Peoples R China; [Gu, Dongfeng] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100730, Peoples R China; [Gu, Dongfeng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhu, Dingliang; Zhang, Yi] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Zhu, Dingliang] Shanghai Jiao Tong Univ, Shanghai Inst Hypertens, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Zhu, Dingliang; Zhang, Yi] Sino French Res Ctr Life Sci & Genom, Shanghai, Peoples R China; [Zhu, Dingliang] Shanghai Key Lab Vasc Biol, Shanghai, Peoples R China; [Haiman, Christopher A.; Henderson, Brian E.; Chen, Gary K.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Peoples R China; [Gao, Yu-Tang; Xiang, Yong-Bing] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Saw, Seang-Mei; Ng, Daniel P-K; Tai, E. Shyong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Kokubo, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka, Japan; [Liang, Jun] Southeast Univ, Affiliated Hosp, Cent Hosp Xuzhou, Dept Endocrinol, Xuzhou, Peoples R China; [Hao, Mei; He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Le Marchand, Loic] Univ Hawaii, Canc Res Ctr, Epidemiol Program, Honolulu, HI 96813 USA; [Hu, Yanling] Guangxi Med Univ, Med Sci Res Ctr, Nanning, Peoples R China; [Wong, Tien-Yin; Aung, Tin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Wong, Tien-Yin; Aung, Tin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Wong, Tien-Yin] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Kubo, Michiaki] RIKEN, CGM, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Yamamoto, Ken] Kyushu Univ, Med Inst Bioregulat, Div Genome Anal, Fukuoka 812, Japan; [Miki, Tetsuro] Ehime Univ, Grad Sch Med, Dept Geriatr Med, Toon, Japan; [Song, Huaidong] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Mol Med Ctr, Shanghai Inst Endocrinol,Ruijin Hosp, Shanghai 200030, Peoples R China; [Tan, Aihua] Guangxi Med Univ, Affiliated Hosp 1, Ctr Metab Dis & Diabet, Nanning, Peoples R China; [Tsunoda, Tatsuhiko] RIKEN, CGM, Lab Med Informat, Yokohama, Kanagawa, Japan; [Iwai, Naoharu] Natl Cerebral & Cardiovasc Ctr, Dept Genom Med, Suita, Osaka, Japan; [Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC USA; [Sim, Xueling] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore; [Maeda, Shiro] RIKEN, CGM, Lab Endocrinol & Metab, Yokohama, Kanagawa, Japan; [Ong, Rick T. H.] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Li, Chun] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med, Tokyo, Japan; [Lu, Wei] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Yokota, Mitsuhiro] Aichi Gakuin Univ, Sch Dent, Dept Genome Sci, Nagoya, Aichi 464, Japan; [Seielstad, Mark] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Tanaka, Toshihiro] RIKEN, CGM, Lab Cardiovasc Dis, Yokohama, Kanagawa, Japan; [Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Tai, E. Shyong] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore	Vanderbilt University; Vanderbilt University; Vanderbilt University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Hallym University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Imperial College London; National Center for Global Health & Medicine - Japan; Harvard University; Harvard T.H. Chan School of Public Health; Academia Sinica - Taiwan; China Medical University Taiwan; RIKEN; University of Tokyo; Ehime University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Southern California; Guangxi Medical University; Shanghai Jiao Tong University; National University of Singapore; National Cerebral & Cardiovascular Center - Japan; Southeast University - China; Tulane University; Cancer Research Center of Hawaii; University of Hawaii System; Guangxi Medical University; National University of Singapore; Singapore National Eye Center; National University of Singapore; Centre for Eye Research Australia; University of Melbourne; RIKEN; Kyushu University; Ehime University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Guangxi Medical University; RIKEN; National Cerebral & Cardiovascular Center - Japan; Wake Forest University; Wake Forest Baptist Medical Center; National University of Singapore; RIKEN; National University of Singapore; Vanderbilt University; University of Tokyo; Shanghai Center for Disease Control & Prevention; Aichi Gakuin University; University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; RIKEN; National University of Singapore; National University of Singapore	Shu, XO (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Epidemiol, Nashville, TN 37212 USA.	xiao-ou.shu@vanderbilt.edu	Gao, Y./GWZ-3665-2022; Kubo, Michiaki/N-7947-2015; He, Jiang/AAF-5303-2020; Liu, Jianjun/AAK-4989-2020; Tsunoda, Tatsuhiko/K-2061-2014; Lee, Jong-Young/M-6319-2013; Lu, Wei/AAE-2921-2022; Chen, Chien Hsiun/Q-3826-2018; Fann, Cathy SJ/F-9410-2010; Seielstad, Mark/T-7841-2019; Tanaka, Toshihiro/J-9310-2014; Zheng, Wei/O-3351-2013; Li, Chun/B-8388-2012; Tsai, Fuu-Jen/J-4140-2015; Tai, E Shyong/J-9831-2013; Wu, Jer-Yuarn/S-7010-2018; zhang, weihua/GXV-1334-2022; gao, yi/HCI-8298-2022; Wong, Tien Yin/AAC-9724-2020; Li, Chun/R-1095-2019; Sim, Xueling/AAZ-6652-2020; Gao, Yu/HGE-1937-2022	He, Jiang/0000-0002-8286-9652; Liu, Jianjun/0000-0002-3255-3019; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Lee, Jong-Young/0000-0002-0092-9958; Lu, Wei/0000-0002-4150-8674; Fann, Cathy SJ/0000-0001-9025-2276; Tanaka, Toshihiro/0000-0001-6201-9784; Zheng, Wei/0000-0003-1226-070X; Wong, Tien Yin/0000-0002-8448-1264; Li, Chun/0000-0002-8819-2443; Sim, Xueling/0000-0002-1233-7642; Seielstad, Mark/0000-0001-5783-1401; SHI, JIAJUN/0000-0001-5194-0009; Tai, E Shyong/0000-0003-2929-8966; Long, Jirong/0000-0002-7433-9766; Dorajoo, Rajkumar/0000-0001-6608-2051; mo, zengnan/0000-0002-3047-3138	US National Institutes of Health (NIH) [R01 CA064277, R37 CA070867, R01 CA090899, R01 CA118229, R01 CA092585, R01 CA122756]; Ingram professorship funds; Allen Foundation; Vanderbilt Clinical and Translational Science Award (CTSA) [1 UL1 RR024975]; National Center for Research Resources (NCRR) at NIH; NIH [R01 CA064277, R01 CA118229, R01 CA092585, HL071981]; Korea Centers for Disease Control and Prevention [4845-301, 4851-302, 4851-307]; Biomedical Research Council of Singapore (BMRC) [05/1/36/19/413, 03/1/27/18/216]; National Medical Research Council of Singapore (NMRC) [NMRC/1174/2008]; NMRC [NMRC/CSA/008/2009, NMRC/0796/2003, NMRC/STaR/0003/2008, NMRC/0975/2005]; Japan Science Technology Agency; Program for Promotion of Fundamental Studies in Health Sciences; National Institute of Biomedical Innovation Organization (NIBIO); National Center for Global Health and Medicine (NCGM); American Heart Association; Boston Obesity Nutrition Research Center [DK46200]; National Heart, Lung, and Blood Institute at NIH [HL072507, HL087263, HL090682]; BMRC [06/1/21/19/466, 09/1/35/19/616, 08/1/35/19/550]; Centre for Molecular Epidemiology at National University of Singapore; Chinese National Key Program for Basic Research [973:2004CB518603]; Chinese National High Tech Program [863:2009AA022703]; National Cancer Institute (NCI) [CA063464, CA054281, CA132839]; NIH Genes, Environment and Health Initiative (GEI) [HG004726]; GEI [HG04424]; NATIONAL CANCER INSTITUTE [R01CA122756, R37CA054281, R01CA092585, R01CA090899, R01CA118229, R37CA070867, R01CA054281, R01CA148667, P30CA071789, U01CA063464, R01CA063464, R01CA124558, R01CA064277, R01CA132839] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024977, UL1RR024975, TL1RR024978] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087263, R01HL071981, R01HL090682, U01HL072507] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004726, U01HG004446, U01HG004424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21390209] Funding Source: KAKEN	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ingram professorship funds; Allen Foundation; Vanderbilt Clinical and Translational Science Award (CTSA); National Center for Research Resources (NCRR) at NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Centers for Disease Control and Prevention; Biomedical Research Council of Singapore (BMRC)(Agency for Science Technology & Research (A*STAR)); National Medical Research Council of Singapore (NMRC)(National Medical Research Council, Singapore); NMRC(National Medical Research Council, Singapore); Japan Science Technology Agency(Japan Science & Technology Agency (JST)); Program for Promotion of Fundamental Studies in Health Sciences; National Institute of Biomedical Innovation Organization (NIBIO)(National Institute of Biomedical Innovation); National Center for Global Health and Medicine (NCGM); American Heart Association(American Heart Association); Boston Obesity Nutrition Research Center; National Heart, Lung, and Blood Institute at NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); BMRC(Agency for Science Technology & Research (A*STAR)); Centre for Molecular Epidemiology at National University of Singapore(National University of Singapore); Chinese National Key Program for Basic Research; Chinese National High Tech Program(National High Technology Research and Development Program of China); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Genes, Environment and Health Initiative (GEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GEI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Shanghai Genome Wide Associations Studies (SGWAS) would like to thank the dedicated investigators and staff members from the research teams at Vanderbilt University, the Shanghai Cancer Institute and the Shanghai Institute of Preventive Medicine and, most of all, the study participants for their contributions to this work. Genotyping assays and statistical analyses for the SGWAS were primarily supported by grants from the US National Institutes of Health (NIH; R01 CA064277, R37 CA070867, R01 CA090899, R01 CA118229, R01 CA092585 and R01 CA122756), as well as by Ingram professorship funds, Allen Foundation funds and a Vanderbilt Clinical and Translational Science Award (CTSA; 1 UL1 RR024975) from the National Center for Research Resources (NCRR) at the NIH. NIH grants provided support for the participating studies, including the Shanghai Breast Cancer Study (R01 CA064277), the Shanghai Breast Cancer Survival Study (R01 CA118229) and the Shanghai Endometrial Cancer Study (R01 CA092585). The KARE project was supported by grants from the Korea Centers for Disease Control and Prevention (4845-301, 4851-302 and 4851-307). The Singapore Prospective Study Program (SP2) was funded through grants from the Biomedical Research Council of Singapore (BMRC; 05/1/36/19/413 and 03/1/27/18/216) and the National Medical Research Council of Singapore (NMRC; NMRC/1174/2008). E. S. T. also received support from the NMRC through a clinician scientist award (NMRC/CSA/008/2009). The Singapore Malay Eye Study (SiMES) was funded by the NMRC (NMRC/0796/2003 and NMRC/STaR/0003/2008) and the BMRC (09/1/35/19/616). The CAGE Network Studies were supported by grants for the Core Research for Evolutional Science and Technology (CREST) from the Japan Science Technology Agency, the Program for Promotion of Fundamental Studies in Health Sciences, the National Institute of Biomedical Innovation Organization (NIBIO) and the National Center for Global Health and Medicine (NCGM). L. Q. is supported by a grant from the NIH (HL071981), an American Heart Association Scientist Development Award and the Boston Obesity Nutrition Research Center (DK46200). The Genetic Epidemiology Network of Salt Sensitivity (GenSalt) is supported by research grants from the National Heart, Lung, and Blood Institute at the NIH (HL072507, HL087263 and HL090682). SINDI was funded by grants from the BMRC (09/1/35/19/616 and 08/1/35/19/550) and the NMRC (NMRC/STaR/0003/2008). SCORM was funded by the NMRC (NMRC/0975/2005), the BMRC (06/1/21/19/466) and the Centre for Molecular Epidemiology at the National University of Singapore. The SIH was supported by the Chinese National Key Program for Basic Research (973:2004CB518603) and the Chinese National High Tech Program (863:2009AA022703). The MEC was supported by grants from the National Cancer Institute (NCI; CA063464, CA054281 and CA132839) and from the NIH Genes, Environment and Health Initiative (GEI; HG004726). Assistance with genotype cleaning for the MEC Japanese prostate cancer study was provided by the Gene Environment Association Studies (GENEVA) Coordinating Center (HG004446). Assistance with data cleaning was provided by the National Center for Biotechnology Information. Funding support for genotyping, which was performed at the Broad Institute of MIT and Harvard University, was provided by the GEI (HG04424).	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Dandona P, 2004, J CLIN ENDOCR METAB, V89, P5043, DOI 10.1210/jc.2004-0436; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Okada Y., 2012, NAT GENET       0212, DOI 10.1038ng.1086; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Winkler C, 2010, DIABETES, V59, P2063, DOI 10.2337/db10-0099; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Zeggini E, 2009, PHARMACOGENOMICS, V10, P191, DOI 10.2217/14622416.10.2.191; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	35	278	294	1	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2012	44	3					307	U112		10.1038/ng.1087	http://dx.doi.org/10.1038/ng.1087			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22344219	Green Accepted			2022-12-17	WOS:000300843600017
J	Chasman, DI; Schurks, M; Anttila, V; de Vries, B; Schminke, U; Launer, LJ; Terwindt, GM; van den Maagdenberg, AMJM; Fendrich, K; Volzke, H; Ernst, F; Griffiths, LR; Buring, JE; Kallela, M; Freilinger, T; Kubisch, C; Ridker, PM; Palotie, A; Ferrari, MD; Hoffmann, W; Zee, RYL; Kurth, T				Chasman, Daniel I.; Schuerks, Markus; Anttila, Verneri; de Vries, Boukje; Schminke, Ulf; Launer, Lenore J.; Terwindt, Gisela M.; van den Maagdenberg, Arn M. J. M.; Fendrich, Konstanze; Voelzke, Henry; Ernst, Florian; Griffiths, Lyn R.; Buring, Julie E.; Kallela, Mikko; Freilinger, Tobias; Kubisch, Christian; Ridker, Paul M.; Palotie, Aarno; Ferrari, Michel D.; Hoffmann, Wolfgang; Zee, Robert Y. L.; Kurth, Tobias		IHGC	Genome-wide association study reveals three susceptibility loci for common migraine in the general population	NATURE GENETICS			English	Article							RECEPTOR; COHORT; HEALTH; TOOL	Migraine is a common, heterogeneous and heritable neurological disorder. Its pathophysiology is incompletely understood, and its genetic influences at the population level are unknown. In a population-based genome-wide analysis including 5,122 migraineurs and 18,108 non-migraineurs, rs2651899 (1p36.32, PRDM16), rs10166942 (2q37.1, TRPM8) and rs11172113 (12q13.3, LRP1) were among the top seven associations (P < 5 x 10(-6)) with migraine. These SNPs were significant in a meta-analysis among three replication cohorts and met genome-wide significance in a meta-analysis combining the discovery and replication cohorts (rs2651899, odds ratio (OR) = 1.11, P = 3.8 x 10(-9); rs10166942, OR = 0.85, P = 5.5 x 10(-12); and rs11172113, OR = 0.90, P = 4.3 x 10(-9)). The associations at rs2651899 and rs10166942 were specific for migraine compared with non-migraine headache. None of the three SNP associations was preferential for migraine with aura or without aura, nor were any associations specific for migraine features. TRPM8 has been the focus of neuropathic pain models, whereas LRP1 modulates neuronal glutamate signaling, plausibly linking both genes to migraine pathophysiology.	[Chasman, Daniel I.; Schuerks, Markus; Buring, Julie E.; Ridker, Paul M.; Zee, Robert Y. L.; Kurth, Tobias] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med,Dept Med, Boston, MA 02115 USA; [Chasman, Daniel I.; Ridker, Paul M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Donald W Reynolds Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; [Schuerks, Markus] Univ Hosp Essen, Dept Neurol, Essen, Germany; [Anttila, Verneri; Palotie, Aarno] Wellcome Trust Sanger Inst, Cambridge, England; [Anttila, Verneri; Palotie, Aarno] Univ Helsinki, FIMM, Helsinki, Finland; [de Vries, Boukje; van den Maagdenberg, Arn M. J. M.] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Schminke, Ulf] Ernst Moritz Arndt Univ Greifswald, Dept Neurol, Greifswald, Germany; [Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Terwindt, Gisela M.; van den Maagdenberg, Arn M. J. M.; Ferrari, Michel D.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Fendrich, Konstanze; Hoffmann, Wolfgang] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Sect Epidemiol Hlth Care & Community Hlth, Greifswald, Germany; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Sect Clin Epidemiol Res, Greifswald, Germany; [Ernst, Florian] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Griffiths, Lyn R.] Griffith Univ, Griffith Hlth Inst, Genom Res Ctr, Gold Coast, Qld, Australia; [Kallela, Mikko] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; [Freilinger, Tobias] Univ Munich, Klinikum Grosshadern, Dept Neurol, Munich, Germany; [Freilinger, Tobias] Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Kubisch, Christian] Univ Ulm, Inst Human Genet, Ulm, Germany; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Palotie, Aarno] Univ Helsinki, Cent Hosp, Dept Med Genet, Helsinki, Finland; [Palotie, Aarno] Broad Inst MIT & Harvard, Boston, MA USA; [Kurth, Tobias] INSERM, Neuroepidemiol U708, Paris, France; [Kurth, Tobias] Univ Paris 06, F-75005 Paris, France	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Duisburg Essen; Wellcome Trust Sanger Institute; University of Helsinki; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Ernst Moritz Arndt Universitat Greifswald; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Griffith University; Menzies Health Institute Queensland; University of Helsinki; Helsinki University Central Hospital; University of Munich; University of Munich; Ulm University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Schurks, M (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med,Dept Med, Boston, MA 02115 USA.	markus.schuerks@post.harvard.edu; tobias.kurth@inserm.fr	Hoffmann, Wolfgang/E-6001-2013; Kurth, Tobias/A-9243-2012; Kubisch, Christian/F-1893-2011; Ferrari, Michel D./ABE-3758-2021; van den Maagdenberg, Arn M.J.M./AAE-9052-2019	Kurth, Tobias/0000-0001-7169-2620; Kubisch, Christian/0000-0003-4220-0978; Ferrari, Michel D./0000-0001-9691-9449; Palotie, Aarno/0000-0002-2527-5874; Griffiths, Lyn/0000-0002-6774-5475; Anttila, Verneri/0000-0002-0073-4675; Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Institute of Neurological Disorders and Stroke [NS-061836]; National Heart, Lung, and Blood Institute [HL-043851, HL-080467, HL-099355]; National Cancer Institute [CA-47988]; Donald W. Reynolds Foundation; Leducq Foundation; Netherlands Organisation for Scientific Research (NWO) [918.56.602]; Spinoza grants; Center for Medical Systems Biology (CMSB) [050-060-409]; Ministry of Health, Welfare and Sport; National Institute of Public Health and the Environment, The Netherlands; Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403, 03ZIK012]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg-West Pomerania; Academy of Finland [200923]; Wellcome Trust [089062]; European Community [FP7/2007-2013]; European Community (through the SYNSYS Consortium) [242167]; European Community (through the ENGAGE Consortium) [201413]; Helsinki University Central Hospital; Finnish Culture Foundation; German Federal Ministry of Education and Research (BMBF) within the National Genome Research Network [EMINet-01GS08120, 01GS08121]; Deutsche Forschungsgemeinschaft; Center for Molecular Medicine Cologne; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080467, RC1HL099355, R01HL043851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG007260, ZIAAG007270] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Donald W. Reynolds Foundation; Leducq Foundation(Leducq Foundation); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Spinoza grants; Center for Medical Systems Biology (CMSB); Ministry of Health, Welfare and Sport; National Institute of Public Health and the Environment, The Netherlands(Netherlands Government); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Siemens Healthcare, Erlangen, Germany(Siemens AG); Federal State of Mecklenburg-West Pomerania; Academy of Finland(Academy of Finland); Wellcome Trust(Wellcome Trust); European Community(European Commission); European Community (through the SYNSYS Consortium)(European Commission); European Community (through the ENGAGE Consortium)(European Commission); Helsinki University Central Hospital; Finnish Culture Foundation(Finnish Cultural Foundation); German Federal Ministry of Education and Research (BMBF) within the National Genome Research Network(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Molecular Medicine Cologne; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study is supported by a grant from the National Institute of Neurological Disorders and Stroke (NS-061836). The Women's Health Study and the Women's Genome Health Study are supported by grants from the National Heart, Lung, and Blood Institute (HL-043851, HL-080467 and HL-099355) and the National Cancer Institute (CA-47988). Part of the research for this work was supported by grants from the Donald W. Reynolds Foundation and the Leducq Foundation. Genome-wide genotyping and collaborative scientific support was provided by Amgen.; Genotyping in the Genetic Epidemiology of Migraine Study was supported by the Netherlands Organisation for Scientific Research (NWO) VICI (918.56.602) and Spinoza (2009) grants and the Center for Medical Systems Biology (CMSB) established by the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NGI/NWO), project no. 050-060-409. The GEM study was supported by the Ministry of Health, Welfare and Sport and the National Institute of Public Health and the Environment, The Netherlands.; SHIP is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103 and 01ZZ0403), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. Genome-wide data have been supported by the Federal Ministry of Education and Research (grant no. 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany and the Federal State of Mecklenburg-West Pomerania. The SHIP authors are grateful to the contribution of A. Teumer, A. Hoffmann and A. Petersmann in generating the SNP data. The University of Greifswald is a member of the 'Center of Knowledge Interchange' program of Siemens AG.; The IHGC study was supported, among others, by the Academy of Finland (200923 to A.P.), the Wellcome Trust (grant number 089062), the European Community's Seventh Framework Programme (FP7/2007-2013) (through the SYNSYS Consortium (grant agreement no. 242167) and the ENGAGE Consortium (grant agreement no. 201413)), the Helsinki University Central Hospital (to M.K.) and the Finnish Culture Foundation (to V.A.). Funding by the German Federal Ministry of Education and Research (BMBF) within the National Genome Research Network (NGFNplus, EMINet-01GS08120 for C.K., 01GS08121 to M. Dichgans), the Deutsche Forschungsgemeinschaft (to C.K.) and the Center for Molecular Medicine Cologne (to C.K.). For a full list of acknowledgements, please see reference 5.	Andreou AP, 2009, EXPERT OPIN INV DRUG, V18, P789, DOI [10.1517/13543780902913792, 10.1517/13543780902913792 ]; Anttila V, 2010, NAT GENET, V42, P869, DOI 10.1038/ng.652; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Biondi David M, 2006, Curr Pain Headache Rep, V10, P167, DOI 10.1007/s11916-006-0042-y; de Vries B, 2009, HUM GENET, V126, P115, DOI 10.1007/s00439-009-0684-z; Dray A, 2008, BRIT J ANAESTH, V101, P48, DOI 10.1093/bja/aen107; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Haut SR, 2006, LANCET NEUROL, V5, P148, DOI 10.1016/S1474-4422(06)70348-9; Hindorff LA, CATALOG PUBLISHED GE; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Mulder EJ, 2003, TWIN RES, V6, P422, DOI 10.1375/twin.6.5.422; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; SECKERWALKER LM, 1995, BRIT J HAEMATOL, V91, P490, DOI 10.1111/j.1365-2141.1995.tb05329.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394	26	278	285	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2011	43	7					695	U116		10.1038/ng.856	http://dx.doi.org/10.1038/ng.856			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	784UV	21666692	Green Accepted			2022-12-17	WOS:000292184600016
J	Herring, CD; Raghunathan, A; Honisch, C; Patel, T; Applebee, MK; Joyce, AR; Albert, TJ; Blattner, FR; van den Boom, D; Cantor, CR; Palsson, BO				Herring, Christopher D.; Raghunathan, Anu; Honisch, Christiane; Patel, Trina; Applebee, M. Kenyon; Joyce, Andrew R.; Albert, Thomas J.; Blattner, Frederick R.; van den Boom, Dirk; Cantor, Charles R.; Palsson, Bernhard O.			Comparative genome sequencing of Escherichia coli allows observation of bacterial evolution on a laboratory timescale	NATURE GENETICS			English	Article							ADAPTIVE EVOLUTION; GLYCEROL KINASE; GROWTH PHENOTYPES; ADAPTATION; MUTATIONS; PROTEIN; DISSIMILATION; POPULATION; VIRUS	We applied whole-genome resequencing of Escherichia coli to monitor the acquisition and fixation of mutations that conveyed a selective growth advantage during adaptation to a glycerol-based growth medium. We identified 13 different de novo mutations in five different E. coli strains and monitored their fixation over a 44-d period of adaptation. We obtained proof that the observed spontaneous mutations were responsible for improved fitness by creating single, double and triple site-directed mutants that had growth rates matching those of the evolved strains. The success of this new genome-scale approach indicates that real-time evolution studies will now be practical in a wide variety of contexts.	Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; Univ Calif San Diego, Bioinformat Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Nimblegan Syst Inc, Madison, WI 53711 USA; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; CUNY Mt Sinai Sch Med, Div Infect Dis, New York, NY 10029 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Palsson, BO (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	bpalsson@bioeng.ucsd.edu		Palsson, Bernhard/0000-0003-2357-6785; Herring, Christopher/0000-0003-1621-5906	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062791, F32GM074590] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62791, 1F32GM074590-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Bansal A, 2002, P NATL ACAD SCI USA, V99, P16871, DOI 10.1073/pnas.262671399; Barker CS, 2004, J BACTERIOL, V186, P7529, DOI 10.1128/JB.186.22.7529-7537.2004; Dobrindt U, 2002, CURR TOP MICROBIOL, V264, P157; Dominique SA, 2004, RES MICROBIOL, V155, P319, DOI 10.1016/j.resmic.2003.12.008; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Eppler T, 2002, J BACTERIOL, V184, P3044, DOI 10.1128/JB.184.11.3044-3052.2002; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Fong SS, 2005, BIOTECHNOL BIOENG, V91, P643, DOI 10.1002/bit.20542; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Herring CD, 2003, GENE, V311, P153, DOI 10.1016/S0378-1119(03)00585-7; Holtman CK, 2001, J BACTERIOL, V183, P3336, DOI 10.1128/JB.183.11.3336-3344.2001; Honisch C, 2004, GENOME RES, V14, P2495, DOI 10.1101/gr.2977704; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; JANSON CA, 1974, J BIOL CHEM, V249, P2562; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; King T, 2004, J BACTERIOL, V186, P5614, DOI 10.1128/JB.186.17.5614-5620.2004; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; LIN ECC, 1976, ANNU REV MICROBIOL, V30, P535, DOI 10.1146/annurev.mi.30.100176.002535; LIU WZ, 1994, BIOCHEMISTRY-US, V33, P10120, DOI 10.1021/bi00199a040; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Miller BG, 2004, BIOCHEMISTRY-US, V43, P6387, DOI 10.1021/bi049424m; Pelosi L, 2006, GENETICS, V173, P1851, DOI 10.1534/genetics.105.049619; Rokyta DR, 2005, NAT GENET, V37, P441, DOI 10.1038/ng1535; Ross P, 2000, BIOTECHNIQUES, V29, P620, DOI 10.2144/00293rr05; ROTH JR, 1996, ESCHERICHIA COLI SAL, P2256; Saier MH, 1996, ESCHERICHIA COLI SAL, V1, P1325; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Zeyl C, 2005, GENETICS, V169, P1825, DOI 10.1534/genetics.104.027102; ZWAIG N, 1970, J BACTERIOL, V102, P753, DOI 10.1128/JB.102.3.753-759.1970	35	278	292	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2006	38	12					1406	1412		10.1038/ng1906	http://dx.doi.org/10.1038/ng1906			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17086184	Bronze			2022-12-17	WOS:000242404200017
J	Tishkoff, SA; Kidd, KK				Tishkoff, SA; Kidd, KK			Implications of biogeography of human populations for 'race' and medicine	NATURE GENETICS			English	Article							RECENT POSITIVE SELECTION; LOW NUCLEOTIDE DIVERSITY; HUMAN GENETIC DIVERSITY; LINKAGE DISEQUILIBRIUM; SEQUENCE VARIATION; HUMAN GENOME; EVOLUTIONARY HISTORY; BALANCING SELECTION; HAPLOTYPE VARIATION; NATURAL-SELECTION	In this review, we focus on the biogeographical distribution of genetic variation and address whether or not populations cluster according to the popular concept of 'race'. We show that racial classifications are inadequate descriptors of the distribution of genetic variation in our species. Although populations do cluster by broad geographic regions, which generally correspond to socially recognized races, the distribution of genetic variation is quasicontinuous in clinal patterns related to geography. The broad global pattern reflects the accumulation of genetic drift associated with a recent African origin of modern humans, followed by expansion out of Africa and across the rest of the globe. Because disease genes may be geographically restricted due to mutation, genetic drift, migration and natural selection, knowledge of individual ancestry will be important for biomedical studies. Identifiers based on race will often be insufficient.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	University System of Maryland; University of Maryland College Park; Yale University	Kidd, KK (corresponding author), Univ Maryland, Dept Biol, Bldg 144, College Pk, MD 20742 USA.	tishkoff@umd.edu; kenneth.kidd@yale.edu						Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Bamshad MJ, 2002, P NATL ACAD SCI USA, V99, P10539, DOI 10.1073/pnas.162046399; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Britten RJ, 2002, P NATL ACAD SCI USA, V99, P13633, DOI 10.1073/pnas.172510699; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Calafell F, 1998, EUR J HUM GENET, V6, P38, DOI 10.1038/sj.ejhg.5200151; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Chakravarti A, 2001, NATURE, V409, P822, DOI 10.1038/35057281; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Fischer A, 2004, MOL BIOL EVOL, V21, P799, DOI 10.1093/molbev/msh083; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gould SJ., 1981, MISMEASURE MAN; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; Kang AM, 1999, BIOL PSYCHIAT, V46, P151, DOI 10.1016/S0006-3223(99)00101-8; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; KIDD K, 2001, NEW DIMENSIONS BIOET, P11; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; Kidd KK, 2004, J HERED, V95, P406, DOI 10.1093/jhered/esh060; Kittles RA, 2003, ANNU REV GENOM HUM G, V4, P33, DOI 10.1146/annurev.genom.4.070802.110356; LI WH, 1991, GENETICS, V129, P513; Long JC, 2003, HUM BIOL, V75, P449, DOI 10.1353/hub.2003.0058; Marks J., 1995, HUMAN BIODIVERSITY G; NEEL JV, 1962, AM J HUM GENET, V14, P353; Ohashi J, 2004, AM J HUM GENET, V74, P1198, DOI 10.1086/421330; Oota H, 2004, ANN HUM GENET, V68, P93, DOI 10.1046/j.1529-8817.2003.00060.x; Osier MV, 2002, AM J PHYS ANTHROPOL, V119, P77, DOI 10.1002/ajpa.10094; Osier MV, 2002, AM J HUM GENET, V71, P84, DOI 10.1086/341290; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Pritchard JK, 2000, GENETICS, V155, P945; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Risch N, 2003, AM J HUM GENET, V72, P812, DOI 10.1086/373882; RISCH N, 2002, GENOME BIOL, V12, P602; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Saunders MA, 2002, GENETICS, V162, P1849; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Tishkoff SA, 2000, AM J HUM GENET, V67, P901, DOI 10.1086/303068; Tishkoff SA, 2003, CURR OPIN GENET DEV, V13, P569, DOI 10.1016/j.gde.2003.10.010; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Verrelli BC, 2004, AM J HUM GENET, V75, P363, DOI 10.1086/423287; Verrelli BC, 2002, AM J HUM GENET, V71, P1112, DOI 10.1086/344345; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Wolpoff MH, 1996, SCIENCE, V274, P704; Wooding SP, 2002, AM J HUM GENET, V71, P528, DOI 10.1086/342260; Wright S., 1969, THEORY GENE FREQUENC, V2, P520; Yu N, 2003, GENETICS, V164, P1511; Zhao H, 1999, ANN HUM GENET, V63, P167, DOI 10.1046/j.1469-1809.1999.6320167.x	70	278	296	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11		S			S21	S27		10.1038/ng1438	http://dx.doi.org/10.1038/ng1438			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867PH	15507999	Bronze			2022-12-17	WOS:000224854000007
J	Nakai, H; Montini, E; Fuess, S; Storm, TA; Grompe, M; Kay, MA				Nakai, H; Montini, E; Fuess, S; Storm, TA; Grompe, M; Kay, MA			AAV serotype 2 vectors preferentially integrate into active genes in mice	NATURE GENETICS			English	Article							IN-VIVO; RETROVIRAL INTEGRATION; HUMAN GENOME; LEUKEMIA; EXPRESSION; THERAPY; SITES; LIVER; NUCLEOSOMES; JUNCTIONS	Recombinant adeno-associated virus serotype 2 (rAAV2) is a promising vector for gene therapy because it can achieve long-term stable transgene expression in animals and human subjects after direct administration of vectors into various target tissues(1). In the liver, although stable transgene expression primarily results from extrachromosomal vector genomes(2), a series of experiments has shown that vector genomes integrate into host chromosomes in hepatocytes(3-5) at a low frequency(2). Despite the low integration efficiency, recent reports of retroviral insertional mutagenesis in mice(6) and two human subjects(7,8) have raised concerns about the potential for rAAV2-mediated insertional mutagenesis. Here we characterize rAAV2-targeted chromosomal integration sites isolated from selected or non-selected hepatocytes in vector-injected mouse livers. We document frequent chromosomal deletions of up to 2 kb at integration sites (14 of 14 integrations, 100%; most of the deletions were <0.3 kb) and preferred integration into genes (21 of 29 integrations, 72%). In addition, all of the targeted genes analyzed (20 of 20 targeted genes, 100%) were expressed in the liver. This is the first report to our knowledge on host chromosomal effects of rAAV2 integration in animals, and it provides insights into the nature of rAAV2 vector integration into chromosomes in quiescent somatic cells in animals and human subjects.	Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA	Stanford University; Stanford University; Oregon Health & Science University; Oregon Health & Science University	Kay, MA (corresponding author), Stanford Univ, Dept Pediat, Sch Med, 300 Pasteur Dr,Rm G305A, Stanford, CA 94305 USA.	markay@stanford.edu	Montini, Eugenio/L-1152-2016	Montini, Eugenio/0000-0003-1771-6067; Kay, Mark/0000-0002-2799-2615; Grompe, Markus/0000-0002-6616-4345				CHALKER DL, 1992, GENE DEV, V6, P117, DOI 10.1101/gad.6.1.117; Chen SJ, 2000, MOL THER, V1, P414, DOI 10.1006/mthe.2000.0065; Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leclercq I, 2000, J VIROL, V74, P2305, DOI 10.1128/JVI.74.5.2305-2312.2000; Li ZX, 2002, SCIENCE, V296, P497, DOI 10.1126/science.1068893; Marshall E, 2003, SCIENCE, V299, P320, DOI 10.1126/science.299.5605.320; Marshall E, 2002, SCIENCE, V298, P34, DOI 10.1126/science.298.5591.34; Miao CH, 1998, NAT GENET, V19, P13, DOI 10.1038/ng0598-13; Miki R, 2001, P NATL ACAD SCI USA, V98, P2199, DOI 10.1073/pnas.041605498; Miller DG, 2002, NAT GENET, V30, P147, DOI 10.1038/ng824; MULLER HP, 1994, EMBO J, V13, P4704, DOI 10.1002/j.1460-2075.1994.tb06794.x; Nakai H, 2003, MOL THER, V7, P101, DOI 10.1016/S1525-0016(02)00023-0; Nakai H, 2001, J VIROL, V75, P6969, DOI 10.1128/JVI.75.15.6969-6976.2001; Nakai H, 1999, J VIROL, V73, P5438, DOI 10.1128/JVI.73.7.5438-5447.1999; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; Rutledge EA, 1997, J VIROL, V71, P8429, DOI 10.1128/JVI.71.11.8429-8436.1997; SANDMEYER SB, 1990, ANNU REV GENET, V24, P491; SCHERDIN U, 1990, J VIROL, V64, P907, DOI 10.1128/JVI.64.2.907-912.1990; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VIJAYA S, 1986, J VIROL, V60, P683, DOI 10.1128/JVI.60.2.683-692.1986; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yang CC, 1997, J VIROL, V71, P9231, DOI 10.1128/JVI.71.12.9231-9247.1997	29	278	297	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2003	34	3					297	302		10.1038/ng1179	http://dx.doi.org/10.1038/ng1179			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12778174				2022-12-17	WOS:000183815300017
J	Ramoz, N; Rueda, LA; Bouadjar, B; Montoya, LS; Orth, G; Favre, M				Ramoz, N; Rueda, LA; Bouadjar, B; Montoya, LS; Orth, G; Favre, M			Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis	NATURE GENETICS			English	Article							PAPILLOMAVIRUSES; LESIONS; MODEL	Epidermodysplasia verruciformis (OMIM 226400) is a rare autosomal recessive genodermatosis associated with a high risk of skin carcinoma that results from an abnormal susceptibility to infection by specific human papillomaviruses (HPVs). We recently mapped a susceptibility locus for epidermodysplasia verruciformis (EV1) to chromosome 17q25. Here we report the identification of nonsense mutations in two adjacent novel genes, EVER1 and EVER2, that are associated with the disease. The gene products EVER1 and EVER2 have features of integral membrane proteins and are localized in the endoplasmic reticulum.	Inst Pasteur, Unite Papillomavirus, F-75724 Paris 15, France; Unidad Dermatol LA Rueda, Bogota, Colombia; Ctr Hosp Univ Bab el Oued, Algiers, Algeria; Univ Ind Santander, Bucaramanga, Colombia	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidad Industrial de Santander	Orth, G (corresponding author), Inst Pasteur, Unite Papillomavirus, 25 Rue Dr Roux, F-75724 Paris 15, France.	gorth@pasteur.fr	ramoz, nicolas/K-3316-2015; ORTH, Gérard C/C-2518-2009	ramoz, nicolas/0000-0002-8070-9938; 				Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Boxman ILA, 1997, J INVEST DERMATOL, V108, P712, DOI 10.1111/1523-1747.ep12292090; Howley P. M., 2001, FIELDS VIROLOGY, V2, P2197; JABLONSKA S, 1972, CANCER RES, V32, P583; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Majewski S, 1997, CLIN DERMATOL, V15, P321, DOI 10.1016/S0738-081X(96)00169-1; ORTH G, 1979, CANCER RES, V39, P1074; ORTH G, 1978, P NATL ACAD SCI USA, V75, P1537, DOI 10.1073/pnas.75.3.1537; ORTH G, 1987, PAPOVAVIRIDAE, V2, P199; Ramoz N, 2000, J INVEST DERMATOL, V114, P1148, DOI 10.1046/j.1523-1747.2000.00996.x; Ramoz N, 1999, J INVEST DERMATOL, V112, P259, DOI 10.1046/j.1523-1747.1999.00536.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	14	278	290	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2002	32	4					579	581		10.1038/ng1044	http://dx.doi.org/10.1038/ng1044			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12426567				2022-12-17	WOS:000179593000008
J	Alexander, CM; Reichsman, F; Hinkes, MT; Lincecum, J; Becker, KA; Cumberledge, S; Bernfield, M				Alexander, CM; Reichsman, F; Hinkes, MT; Lincecum, J; Becker, KA; Cumberledge, S; Bernfield, M			Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice	NATURE GENETICS			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; CELL-SURFACE PROTEOGLYCAN; TRANSGENIC MICE; EPITHELIAL-CELLS; DROSOPHILA; FAMILY; GENE; TRANSFORMATION; RECEPTOR; WNT-1	Syndecan-1 is a cell-surface, heparan-sulphate proteoglycan (HSPG) predominantly expressed by epithelial cells. It binds specifically to many proteins, including oncoproteins. For example, it induces the assembly of a signalling complex between FCF ligands and their cognate receptors(1). But so far there has been no direct evidence that this proteoglycan contributes to tumorigenesis. Here we have examined the role of syndecan-1 (encoded by Sdc1) during mammary tumour formation in response to the ectopic expression of the proto-oncogene Wnt1. We crossed syndecan-1-deficient mice with transgenic mice that express Wnt1 in mammary gland (TgN(Wnt-1)1Hev; ref. 2). Ectopic Wnt-1 expression induces generalized mammary hyperplasia, followed by the development of solitary tumours (median time 22 weeks(3)). We show that in Sdc1(-/-) mice, Wnt-1-induced hyperplasia in virgin mammary gland was reduced by 70%, indicating that the Wnt-1 signalling pathway was inhibited. Of the 39 tumours that developed in a test cohort of mice, only 1 evolved in the Sdc1(-/-) background. In addition, we show that soluble syndecan-1 ectodomain purified from mouse mammary epithelial cells stimulates the activity of a Wnt-1 homologue in a tissue culture assay. Our results provide both genetic and biochemical evidence that syndecan-1 can modulate Wnt signalling, and is critical for Wnt-1-induced tumorigenesis of the mouse mammary gland.	Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	Harvard University; Boston Children's Hospital; University of Massachusetts System; University of Massachusetts Amherst	Alexander, CM (corresponding author), Childrens Hosp, Div Newborn Med, Enders 950, Boston, MA 02115 USA.							Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Binari RC, 1997, DEVELOPMENT, V124, P2623; BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x; BROWN AMC, 1986, CELL, V46, P1001, DOI 10.1016/0092-8674(86)90699-9; BURRUS LW, 1995, EXP CELL RES, V220, P363, DOI 10.1006/excr.1995.1327; Cardiff RD, 1999, J MAMMARY GLAND BIOL, V4, P105, DOI 10.1023/A:1018712905244; Conrad H. E., 1998, HEPARIN BINDING PROT; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Hacker U, 1997, DEVELOPMENT, V124, P3565; Haerry TE, 1997, DEVELOPMENT, V124, P3055; Jackson D, 1997, J MAMMARY GLAND BIOL, V2, P385, DOI 10.1023/A:1026351414004; Jackson SM, 1997, DEVELOPMENT, V124, P4113; JALKANEN M, 1987, J CELL BIOL, V105, P3087, DOI 10.1083/jcb.105.6.3087; JUE SF, 1992, MOL CELL BIOL, V12, P321, DOI 10.1128/MCB.12.1.321; KATO M, 1995, MOL BIOL CELL, V6, P559, DOI 10.1091/mbc.6.5.559; LEE FS, 1995, P NATL ACAD SCI USA, V92, P2268, DOI 10.1073/pnas.92.6.2268; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lin XH, 1999, DEVELOPMENT, V126, P3715; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; RAMAKRISHNA NR, 1993, DEVELOPMENT S, V119, P95; RAPRAEGER AC, 1995, CHEM BIOL, V2, P645, DOI 10.1016/1074-5521(95)90025-X; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; SHACKLEFORD GM, 1993, P NATL ACAD SCI USA, V90, P740, DOI 10.1073/pnas.90.2.740; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Ugolini F, 1999, ONCOGENE, V18, P1903, DOI 10.1038/sj.onc.1202739; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374	32	278	285	1	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2000	25	3					329	332		10.1038/77108	http://dx.doi.org/10.1038/77108			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	329RD	10888884				2022-12-17	WOS:000087920900024
J	Garkavtsev, I; Kazarov, A; Gudkov, A; Riabowol, K				Garkavtsev, I; Kazarov, A; Gudkov, A; Riabowol, K			Suppression of the novel growth inhibitor p33(ING1) promotes neoplastic transformation	NATURE GENETICS			English	Article							CLONING; EXPRESSION; GENE; CELLS	Using a new strategy for tumour suppressor gene isolation based on subtractive hybridization and the subsequent selection of transforming 'genetic suppressor elements', we have cloned a novel gene called ING1 encoding a 33-kD protein (p33(ING1)) that displays characteristics of a tumour suppressor. Acute expression of transfected constructs encoding this gene inhibited cell growth while chronic expression of ING1 antisense constructs promoted cell transformation. Limited analyses of tumour cell lines show that mutation of the ING1 gene occurs in neuroblastoma cells and reduced expression was seen in some breast cancer cell lines. These results demonstrate that ING1 can act as a potent growth regulator in normal and in established cells and provide evidence for a role as a candidate tumour suppressor gene whose inactivation may contribute to the development of cancers.	UNIV CALGARY,DEPT MED BIOCHEM,CALGARY,AB T2N 4N1,CANADA; UNIV CALGARY,SO ALBERTA CANC RES,CALGARY,AB T2N 4N1,CANADA; UNIV ILLINOIS,DEPT GENET,CHICAGO,IL 60607	University of Calgary; University of Calgary; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital				Gudkov, Andrei/0000-0003-2548-0154	NATIONAL CANCER INSTITUTE [R01CA060730, R21CA062045] Funding Source: NIH RePORTER; NCI NIH HHS [CA60730, CA62045] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ATADJA P, 1995, P NATL ACAD SCI USA, V92, P8348, DOI 10.1073/pnas.92.18.8348; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; GUDKOV AV, 1994, P NATL ACAD SCI USA, V91, P3744, DOI 10.1073/pnas.91.9.3744; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; LEVINE AJ, 1993, ANNU REV BIOCHEM, V62, P623, DOI 10.1146/annurev.bi.62.070193.003203; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; OSSOVSKAYA V, IN PRESS P NATL ACAD; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; RIABOWOL K, 1989, CELL, V57, P393, DOI 10.1016/0092-8674(89)90914-8; Sambrook J, 1989, MOL CLONING LAB MANU; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; YASWEN P, 1990, P NATL ACAD SCI USA, V87, P7360, DOI 10.1073/pnas.87.19.7360	16	278	348	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					415	420		10.1038/ng1296-415	http://dx.doi.org/10.1038/ng1296-415			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944021				2022-12-17	WOS:A1996VV73000017
J	Metcalfe, JA; Parkhill, J; Campbell, L; Stacey, M; Biggs, P; Byrd, PJ; Taylor, AMR				Metcalfe, JA; Parkhill, J; Campbell, L; Stacey, M; Biggs, P; Byrd, PJ; Taylor, AMR			Accelerated telomere shortening in ataxia telangiectasia	NATURE GENETICS			English	Letter							HUMAN FIBROBLASTS; ASSOCIATION; LYMPHOCYTES; CHROMOSOMES; CARCINOMA; LEUKEMIA; PATIENT; FUSION; CELLS		UNIV BIRMINGHAM,SCH MED,CRC INST CANC STUDIES,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND	University of Birmingham			Parkhill, Julian/G-4703-2011	Parkhill, Julian/0000-0002-7069-5958; Stacey, Michael/0000-0002-3807-6233				ALEDO R, 1989, CANCER GENET CYTOGEN, V40, P95, DOI 10.1016/0165-4608(89)90150-7; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; BACCHETTI S, 1995, INT J ONCOL, V7, P423; BENN PA, 1976, AM J HUM GENET, V28, P465; BLACKBURN EH, 1984, ANNU REV BIOCHEM, V53, P163, DOI 10.1146/annurev.bi.53.070184.001115; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; FITZGERALD PH, 1984, HUM GENET, V67, P385, DOI 10.1007/BF00291396; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HASTIE ND, 1989, TRENDS GENET, V5, P326, DOI 10.1016/0168-9525(89)90137-6; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HAYASHI K, 1975, HUMANGENETIK, V30, P135, DOI 10.1007/BF00291946; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; KOJIS TL, 1989, HUM GENET, V83, P347, DOI 10.1007/BF00291379; MANDAHL N, 1985, HUM GENET, V71, P321, DOI 10.1007/BF00388457; MORGAN R, 1986, HUM GENET, V73, P260, DOI 10.1007/BF00401240; PANDITA TK, 1995, CYTOGENET CELL GENET, V71, P86, DOI 10.1159/000134069; PATHAK S, 1988, CYTOGENET CELL GENET, V47, P227, DOI 10.1159/000132555; SALTMAN D, 1993, CHROMOSOMA, V102, P121, DOI 10.1007/BF00356029; SALTMAN D, 1989, CYTOGENET CELL GENET, V50, P230, DOI 10.1159/000132766; Sambrook J, 1989, MOL CLONING LAB MANU; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Sedgwick R, 1991, HDB CLIN NEUROLOGY, P347; Taylor A. M. R., 1996, P138; TAYLOR AMR, 1987, J MED GENET, V24, P669, DOI 10.1136/jmg.24.11.669; TAYLOR AMR, 1981, INT J CANCER, V27, P311, DOI 10.1002/ijc.2910270309; Taylor AMR, 1996, BLOOD, V87, P423, DOI 10.1182/blood.V87.2.423.bloodjournal872423; THICK J, 1994, LEUKEMIA, V8, P564; VAZIRI H, 1993, AM J HUM GENET, V52, P661; ZAKIAN VA, 1989, ANNU REV GENET, V23, P579, DOI 10.1146/annurev.genet.23.1.579	30	278	287	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1996	13	3					350	353		10.1038/ng0796-350	http://dx.doi.org/10.1038/ng0796-350			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673136				2022-12-17	WOS:A1996UU28300025
J	APPLE, RJ; ERLICH, HA; KLITZ, W; MANOS, MM; BECKER, TM; WHEELER, CM				APPLE, RJ; ERLICH, HA; KLITZ, W; MANOS, MM; BECKER, TM; WHEELER, CM			HLA DR-DQ ASSOCIATIONS WITH CERVICAL-CARCINOMA SHOW PAPILLOMAVIRUS-TYPE SPECIFICITY	NATURE GENETICS			English	Article							OLIGONUCLEOTIDE PROBES; SEVERE MALARIA; INFECTION; RISK; DNA; ANTIGENS; LINKAGE; CANCER; WOMEN	Cervical carcinoma is now known to be associated with human papillomaviruses (HPV), but the evidence for a link with specific HLA loci is controversial. The role of genetic variation at the HLA class II loci and among HPV types in cervical carcinoma was investigated by PCR DNA amplification and oligonucleotide probe typing of paraffin-embedded invasive cervical cancer tissue from Hispanic patients and of cervical swabs from Hispanic controls. Certain HLA class II haplotypes (such as DRB1(*)1501-DQB1(*)0602) were associated significantly, while DR13 haplotypes were negatively associated with cervical carcinoma. These associations are HPV16-type specific. These results suggest that specific HLA class II haplotypes may influence the immune response to specific HPV-encoded epitopes and affect the risk of cervical neoplasia.	ROCHE MOLEC SYST,DEPT HUMAN GENET,ALAMEDA,CA 94501; UNIV CALIF BERKELEY,DEPT INTEGRAT BIOL,BERKELEY,CA 94720; JOHNS HOPKINS SCH PUBL HLTH,DEPT IMMUNOL & INFECT DIS,BALTIMORE,MD; UNM,CTR CANC,NEW MEXICO TUMOR REGISTRY,ALBUQUERQUE,NM	Roche Holding; University of California System; University of California Berkeley; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of New Mexico			apple, raymond J/I-4506-2012	apple, raymond J/0000-0002-8007-0345				Amiel J.L, 1967, HISTOCOMPAT TEST, V1967, P79; APPLE RJ, 1992, TISSUE ANTIGENS, V40, P69, DOI 10.1111/j.1399-0039.1992.tb01962.x; BAUER H, 1992, DIAGNOSTIC MOL PATHO, P313; BAUER HM, 1991, JAMA-J AM MED ASSOC, V265, P472; BECKER TM, 1992, WESTERN J MED, V156, P376; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; BRINTON LA, 1992, EPIDEMIOLOGY CERVICA, P3; BUGAWAN TL, 1991, IMMUNOGENETICS, V33, P163, DOI 10.1007/BF01719235; CARMICHAEL JA, 1990, AM J OBSTET GYNECOL, V162, P645; CHAN SY, 1992, J VIROL, V66, P5714, DOI 10.1128/JVI.66.10.5714-5725.1992; CHEN LP, 1991, P NATL ACAD SCI USA, V88, P110, DOI 10.1073/pnas.88.1.110; DANOS O, 1984, J INVEST DERMATOL, V83, P73; DAVID ALM, 1992, LANCET, V340, P52, DOI 10.1016/0140-6736(92)92464-Q; DEVILLIERS EM, 1989, J VIROL, V63, P4898, DOI 10.1128/JVI.63.11.4898-4903.1989; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; ERLICH HA, 1993, NAT GENET, V3, P358, DOI 10.1038/ng0493-358; GLEW SS, 1992, NATURE, V356, P22, DOI 10.1038/356022a0; GLEW SS, 1993, HUM IMMUNOL, V37, P157, DOI 10.1016/0198-8859(93)90181-Y; HAN R, 1992, NATURE, V356, P66, DOI 10.1038/356066a0; HELLAND A, 1992, NATURE, V356, P23, DOI 10.1038/356023a0; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; KIVIAT NB, 1989, J INFECT DIS, V159, P293, DOI 10.1093/infdis/159.2.293; KLITZ W, IN PRESS AM J HUM GE; KOUTSKY LA, 1992, NEW ENGL J MED, V327, P1272, DOI 10.1056/NEJM199210293271804; LORINCZ AT, 1992, OBSTET GYNECOL, V79, P328, DOI 10.1097/00006250-199203000-00002; LORINCZ AT, 1990, AM J OBSTET GYNECOL, V162, P645, DOI 10.1016/0002-9378(90)90974-C; LU SJ, 1990, NATURE, V346, P470, DOI 10.1038/346470a0; MANOS MM, 1989, CANCER CEL, V7, P209; MUNOZ N, 1992, EPIDEMIOLOGY CERVICA; NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493; PETERS RK, 1986, JNCI-J NATL CANCER I, V77, P1063; REEVES WC, 1985, INT J CANCER, V36, P55, DOI 10.1002/ijc.2910360110; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SCHARF SJ, 1991, HUM IMMUNOL, V30, P190, DOI 10.1016/0198-8859(91)90034-7; SCHIFFMAN MH, 1993, JNCI-J NATL CANCER I, V85, P958, DOI 10.1093/jnci/85.12.958; SCHIFFMAN MH, 1992, EPIDEMIOLOGY HUMAN P, P169; Sokal R.R., 1981, BIOL RES; STRANG G, 1990, J GEN VIROL, V71, P423, DOI 10.1099/0022-1317-71-2-423; VANDENVELDE C, 1993, LANCET, V341, P442, DOI 10.1016/0140-6736(93)93044-2; WANK R, 1992, NATURE, V356, P22, DOI 10.1038/356022b0; WANK R, 1991, NATURE, V352, P723, DOI 10.1038/352723a0; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; WHEELER CM, 1993, J SEX TRANS DIS, V120, P286	44	278	288	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					157	162		10.1038/ng0294-157	http://dx.doi.org/10.1038/ng0294-157			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	8162070				2022-12-17	WOS:A1994MU76300010
J	Nakanishi, Y; Seno, H; Fukuoka, A; Ueo, T; Yamaga, Y; Maruno, T; Nakanishi, N; Kanda, K; Komekado, H; Kawada, M; Isomura, A; Kawada, K; Sakai, Y; Yanagita, M; Kageyama, R; Kawaguchi, Y; Taketo, MM; Yonehara, S; Chiba, T				Nakanishi, Yuki; Seno, Hiroshi; Fukuoka, Ayumi; Ueo, Taro; Yamaga, Yuichi; Maruno, Takahisa; Nakanishi, Naoko; Kanda, Keitaro; Komekado, Hideyuki; Kawada, Mayumi; Isomura, Akihiro; Kawada, Kenji; Sakai, Yoshiharu; Yanagita, Motoko; Kageyama, Ryoichiro; Kawaguchi, Yoshiya; Taketo, Makoto M.; Yonehara, Shin; Chiba, Tsutomu			Dclk1 distinguishes between tumor and normal stem cells in the intestine	NATURE GENETICS			English	Article							DOUBLECORTIN-LIKE; MYELOID-LEUKEMIA; CANCER; IDENTIFICATION; COLON; MICE; POLYPOSIS; ABLATION; ORIGIN; MARKER	There is great interest in tumor stem cells (TSCs) as potential therapeutic targets; however, cancer therapies targeting TSCs are limited. A drawback is that TSC markers are often shared by normal stem cells (NSCs)(1-4); thus, therapies that target these markers may cause severe injury to normal tissues. To identify a potential TSC-specific marker, we focused on doublecortin-like kinase 1 (Dclk1). Dclk1 was reported as a candidate NSC marker in the gut(5,6), but recent reports have implicated it as a marker of differentiated cells (for example, Tuft cells)(7,8). Using lineage-tracing experiments, we show here that Dclk1 does not mark NSCs in the intestine but instead marks TSCs that continuously produce tumor progeny in the polyps of Apc(Min/+) mice. Specific ablation of Dclk1-positive TSCs resulted in a marked regression of polyps without apparent damage to the normal intestine. Our data suggest the potential for developing a therapy for colorectal cancer based on targeting Dclk1-positive TSCs.	[Nakanishi, Yuki; Seno, Hiroshi; Ueo, Taro; Yamaga, Yuichi; Maruno, Takahisa; Nakanishi, Naoko; Kanda, Keitaro; Komekado, Hideyuki; Kawada, Mayumi; Chiba, Tsutomu] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Fukuoka, Ayumi; Yonehara, Shin] Kyoto Univ, Grad Sch Biostudies, Lab Mol & Cellular Biol, Kyoto, Japan; [Isomura, Akihiro; Kageyama, Ryoichiro] Kyoto Univ, Inst Virus Res, Kyoto 606, Japan; [Kawada, Kenji; Sakai, Yoshiharu] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan; [Yanagita, Motoko] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Japan; [Kawaguchi, Yoshiya] Kyoto Univ, Dept Clin Applicat, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University	Seno, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan.	seno@kuhp.kyoto-u.ac.jp	Yanagita, Motoko/AAJ-7731-2021	Seno, Hiroshi/0000-0002-8509-8128; Fukuoka, Ayumi/0000-0002-6752-7814; Yanagita, Motoko/0000-0002-0339-9008; Nakanishi, Naoko/0000-0003-0092-2593	Japan Society for the Promotion of Science (JSPS) KAKENHI [10J02434, 21229009, 23590937, 24229005, 24659363, 24590914, 24590916]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Culture, Science, Sports and Technology of Japan [LS075]; Princess Takamatsu Cancer Research Fund [10-24212]; Grants-in-Aid for Scientific Research [23590937, 13J02261] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Princess Takamatsu Cancer Research Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Kohno (Nara Institute of Science and Technology) for kindly providing diphtheria toxin. We also thank Y. Kimura, S. Ishizu, M. Nakatsuji, R. Akitake-Kawano, K. Furuyama and T. S. Stappenbeck for technical assistance and helpful suggestions. This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI 10J02434, 21229009, 23590937, 24229005, 24659363, 24590914 and 24590916; the Research Program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Health and Labour Sciences Research Grants for Research on Intractable Diseases, Hepatitis, and Innovative Development and Practical Application of New Drugs for Hepatitis B from the Ministry of Health, Labour and Welfare, Japan; the Funding Program for Next-Generation World-leading Researchers (LS075) and Grants-in Aid from the Ministry of Education, Culture, Science, Sports and Technology of Japan; and the Princess Takamatsu Cancer Research Fund 10-24212.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Cocciadiferro L, 2009, ANN NY ACAD SCI, V1155, P257, DOI 10.1111/j.1749-6632.2009.03696.x; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Davies EJ, 2011, MOL CARCINOGEN, V50, P254, DOI 10.1002/mc.20631; Gerbe F, 2011, J CELL BIOL, V192, P767, DOI 10.1083/jcb.201010127; Gerbe F, 2009, GASTROENTEROLOGY, V137, P2179, DOI 10.1053/j.gastro.2009.06.072; Giannakis M, 2006, J BIOL CHEM, V281, P11292, DOI 10.1074/jbc.M512118200; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; May R, 2008, STEM CELLS, V26, P630, DOI 10.1634/stemcells.2007-0621; May R, 2009, STEM CELLS, V27, P2571, DOI 10.1002/stem.193; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Saqui-Salces M, 2011, HISTOCHEM CELL BIOL, V136, P191, DOI 10.1007/s00418-011-0831-1; SAUER B, 1990, New Biologist, V2, P441; Singh SK, 2003, CANCER RES, V63, P5821; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Verissimo CS, 2010, ENDOCR-RELAT CANCER, V17, P399, DOI 10.1677/ERC-09-0301; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	32	277	288	1	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2013	45	1					98	U143		10.1038/ng.2481	http://dx.doi.org/10.1038/ng.2481			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	061HJ	23202126	Green Published, Green Submitted			2022-12-17	WOS:000312838800020
J	Lin, ZW; Li, XR; Shannon, LM; Yeh, CT; Wang, ML; Bai, GH; Peng, Z; Li, JR; Trick, HN; Clemente, TE; Doebley, J; Schnable, PS; Tuinstra, MR; Tesso, TT; White, F; Yu, JM				Lin, Zhongwei; Li, Xianran; Shannon, Laura M.; Yeh, Cheng-Ting; Wang, Ming L.; Bai, Guihua; Peng, Zhao; Li, Jiarui; Trick, Harold N.; Clemente, Thomas E.; Doebley, John; Schnable, Patrick S.; Tuinstra, Mitchell R.; Tesso, Tesfaye T.; White, Frank; Yu, Jianming			Parallel domestication of the Shattering1 genes in cereals	NATURE GENETICS			English	Article							RICE ORYZA-SATIVA; SORGHUM-BICOLOR; WILD-RICE; GENOME; ASSOCIATION; DIVERSITY; EVOLUTION; MARKERS; ORIGIN; MAIZE	A key step during crop domestication is the loss of seed shattering. Here, we show that seed shattering in sorghum is controlled by a single gene, Shattering1 (Sh1), which encodes a YABBY transcription factor. Domesticated sorghums harbor three different mutations at the Sh1 locus. Variants at regulatory sites in the promoter and intronic regions lead to a low level of expression, a 2.2-kb deletion causes a truncated transcript that lacks exons 2 and 3, and a GT-to-GG splice-site variant in the intron 4 results in removal of the exon 4. The distributions of these non-shattering haplotypes among sorghum landraces suggest three independent origins. The function of the rice ortholog (OsSh1) was subsequently validated with a shattering-resistant mutant, and two maize orthologs (ZmSh1-1 and ZmSh1-5.1+ZmSh1-5.2) were verified with a large mapping population. Our results indicate that Sh1 genes for seed shattering were under parallel selection during sorghum, rice and maize domestication.	[Lin, Zhongwei; Li, Xianran; Bai, Guihua; Tesso, Tesfaye T.; Yu, Jianming] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Shannon, Laura M.; Doebley, John] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Yeh, Cheng-Ting; Schnable, Patrick S.] Iowa State Univ, Ctr Plant Genom, Ames, IA USA; [Yeh, Cheng-Ting; Schnable, Patrick S.] Iowa State Univ, Dept Agron, Ames, IA USA; [Wang, Ming L.] ARS, USDA, Griffin, GA USA; [Bai, Guihua] ARS, USDA, Manhattan, KS USA; [Peng, Zhao; Li, Jiarui; Trick, Harold N.; White, Frank] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Clemente, Thomas E.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE USA; [Tuinstra, Mitchell R.] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA	Kansas State University; University of Wisconsin System; University of Wisconsin Madison; Iowa State University; Iowa State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Kansas State University; University of Nebraska System; University of Nebraska Lincoln; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Yu, JM (corresponding author), Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA.	jyu@ksu.edu	Li, Xianran/I-5651-2012; Lin, Zhongwei/ABD-9297-2021; Peng, Zhao/B-2386-2018; bai, guihua/L-6374-2019; Li, Xianran/AAH-1070-2019; Yu, Jianming/Q-6722-2019	Li, Xianran/0000-0002-4252-6911; bai, guihua/0000-0002-1194-319X; Yu, Jianming/0000-0001-5326-3099; Yeh, Cheng-Ting/0000-0002-1392-2018; Trick, Harold/0000-0001-5255-5575; Schnable, Patrick/0000-0001-9169-5204	Agriculture and Food Research Initiative from US Department of Agriculture (USDA) National Institute of Food and Agriculture [2011-03587]; National Science Foundation [DBI-0820610, DBI-0820619, DBI-1027527]; US Department of Energy [DE-SC0002259]; USDA-ARS; Kansas State University; Kansas State University Center for Sorghum Improvement; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007133] Funding Source: NIH RePORTER; Direct For Biological Sciences [0820619] Funding Source: National Science Foundation	Agriculture and Food Research Initiative from US Department of Agriculture (USDA) National Institute of Food and Agriculture; National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Kansas State University; Kansas State University Center for Sorghum Improvement; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by an Agriculture and Food Research Initiative Competitive Grant (2011-03587 to J.Y. and T. T. T.) from the US Department of Agriculture (USDA) National Institute of Food and Agriculture, the Plant Genome Research Program of the National Science Foundation (DBI-0820610 to J.Y., DBI-0820619 to J.D. and DBI-1027527 to P. S. S.), the Plant Feedstock Genomics Program of the US Department of Energy (DE-SC0002259 to J.Y.), the USDA-ARS (M. L. W. and G. B.), the Targeted Excellence Program of Kansas State University and the Kansas State University Center for Sorghum Improvement.	Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Casa AM, 2008, CROP SCI, V48, P30, DOI 10.2135/cropsci2007.02.0080; Cong B, 2008, NAT GENET, V40, P800, DOI 10.1038/ng.144; CUI YX, 1995, THEOR APPL GENET, V90, P787, DOI 10.1007/BF00222013; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; DEWET JMJ, 1967, EVOLUTION, V21, P787, DOI [10.2307/2406774, 10.1111/j.1558-5646.1967.tb03434.x]; DOEBLEY J, 1991, GENETICS, V129, P285; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Fukuta Y, 1998, BREEDING SCI, V48, P345; Gu XY, 2005, THEOR APPL GENET, V110, P1108, DOI 10.1007/s00122-005-1939-2; HARLAN JR, 1973, EVOLUTION, V27, P311, DOI [10.1111/j.1558-5646.1973.tb00676.x, 10.2307/2406971]; HARLAN JR, 1992, CROP MAN; He ZW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002100; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li CB, 2006, NEW PHYTOL, V170, P185, DOI 10.1111/j.1469-8137.2005.01647.x; Lin ZW, 2007, PLANTA, V226, P11, DOI 10.1007/s00425-006-0460-4; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Matsui K, 2004, GENOME, V47, P469, DOI [10.1139/g04-007, 10.1139/G04-007]; Murray SC, 2009, PLANT GENOME-US, V2, P48, DOI 10.3835/plantgenome2008.10.0011; Nalam VJ, 2006, THEOR APPL GENET, V112, P373, DOI 10.1007/s00122-005-0140-y; Onishi K, 2007, GENOME, V50, P757, DOI 10.1139/G07-051; Onishi K, 2007, BREEDING SCI, V57, P7, DOI 10.1270/jsbbs.57.7; PATERSON AH, 1995, SCIENCE, V269, P1714, DOI 10.1126/science.269.5231.1714; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050	30	277	304	5	156	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2012	44	6					720	U154		10.1038/ng.2281	http://dx.doi.org/10.1038/ng.2281			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	22581231	Green Accepted, Green Submitted			2022-12-17	WOS:000304551100023
J	Melo, SA; Ropero, S; Moutinho, C; Aaltonen, LA; Yamamoto, H; Calin, GA; Rossi, S; Fernandez, AF; Carneiro, F; Oliveira, C; Ferreira, B; Liu, CG; Villanueva, A; Capella, G; Schwartz, S; Shiekhattar, R; Esteller, M				Melo, Sonia A.; Ropero, Santiago; Moutinho, Catia; Aaltonen, Lauri A.; Yamamoto, Hiroyuki; Calin, George A.; Rossi, Simona; Fernandez, Agustin F.; Carneiro, Fatima; Oliveira, Carla; Ferreira, Bibiana; Liu, Chang-Gong; Villanueva, Alberto; Capella, Gabriel; Schwartz, Simo, Jr.; Shiekhattar, Ramin; Esteller, Manel			RETRACTED: A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function (Retracted article. See vol. 48, pg. 221, 2016)	NATURE GENETICS			English	Article; Retracted Publication							MICROSATELLITE INSTABILITY; EXPRESSION; GENE; CELLS; HYPERMETHYLATION; TUMORIGENESIS; REPRESSION; REGULATOR; PROMOTER; TRBP	microRNAs (miRNAs) are small noncoding RNAs that regulate gene expression by targeting messenger RNA (mRNA) transcripts. Recently, a miRNA expression profile of human tumors has been characterized by an overall miRNA downregulation(1-3). Explanations for this observation include a failure of miRNA post-transcriptional regulation(4), transcriptional silencing associated with hypermethylation of CpG island promoters(5-7) and miRNA transcriptional repression by oncogenic factors(8). Another possibility is that the enzymes and cofactors involved in miRNA processing pathways may themselves be targets of genetic disruption, further enhancing cellular transformation(9). However, no loss-of-function genetic alterations in the genes encoding these proteins have been reported. Here we have identified truncating mutations in TARBP2 (TAR RNA-binding protein 2), encoding an integral component of a DICER1-containing complex(10,11), in sporadic and hereditary carcinomas with microsatellite instability(12-14). The presence of TARBP2 frameshift mutations causes diminished TRBP protein expression and a defect in the processing of miRNAs. The reintroduction of TRBP in the deficient cells restores the efficient production of miRNAs and inhibits tumor growth. Most important, the TRBP impairment is associated with a destabilization of the DICER1 protein. These results provide, for a subset of human tumors, an explanation for the observed defects in the expression of mature miRNAs.	[Melo, Sonia A.; Ropero, Santiago; Moutinho, Catia; Fernandez, Agustin F.; Ferreira, Bibiana; Esteller, Manel] Spanish Natl Canc Res Ctr CNIO, Canc Epigenet Lab, Madrid 28029, Spain; [Aaltonen, Lauri A.] Acad Finland, Tumor Genom Grp, F-00014 Helsinki, Finland; [Aaltonen, Lauri A.] Univ Helsinki, Genome Scale Biol Res Program, Biomedicum, Dept Med Genet, F-00014 Helsinki, Finland; [Yamamoto, Hiroyuki] Sapporo Med Univ, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Calin, George A.; Rossi, Simona; Liu, Chang-Gong] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Carneiro, Fatima; Oliveira, Carla] Univ Porto, Fac Med, P-4200465 Oporto, Portugal; [Carneiro, Fatima; Oliveira, Carla] Hosp Sao Joao, P-4200465 Oporto, Portugal; [Carneiro, Fatima; Oliveira, Carla] Inst Mol Pathol & Immunol IPATIMUP, P-4200465 Oporto, Portugal; [Villanueva, Alberto; Capella, Gabriel] IDIBELL Inst Catala Oncol, Translat Res Lab, Barcelona 08907, Spain; [Schwartz, Simo, Jr.] Vall Hebron Univ Hosp, CIBBIM Nanomed, Mol Biol & Biochem Res Ctr Nanomed, Barcelona 08035, Catalonia, Spain; [Shiekhattar, Ramin] Ctr Genom Regulat, Barcelona 08003, Catalonia, Spain; [Shiekhattar, Ramin; Esteller, Manel] ICREA, Barcelona 08010, Catalonia, Spain; [Esteller, Manel] IDIBELL, ICO, PEBC, Barcelona 08907, Catalonia, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Academy of Finland; University of Helsinki; Sapporo Medical University; University of Texas System; UTMD Anderson Cancer Center; Universidade do Porto; Sao Joao Hospital; Universidade do Porto; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Universitari Vall d'Hebron; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Esteller, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Canc Epigenet Lab, Madrid 28029, Spain.	mesteller@iconcologia.net	Carneiro, Fatima/AAV-8677-2021; Fernandez, Agustin F./N-7302-2014; Carneiro, Fatima/J-6432-2013; Esteller, Manel/L-5956-2014; Aaltonen, Lauri/A-5375-2010; MELO, SONIA/H-8972-2013; Schwartz, Simo/H-7776-2012; Calin, George/E-9390-2011; Oliveira, Carla/F-8188-2011; Capella, Gabriel/I-1879-2015	Carneiro, Fatima/0000-0002-1964-1006; Fernandez, Agustin F./0000-0002-3792-4085; Carneiro, Fatima/0000-0002-1964-1006; Esteller, Manel/0000-0003-4490-6093; Aaltonen, Lauri/0000-0001-6839-4286; MELO, SONIA/0000-0002-2291-4263; Oliveira, Carla/0000-0001-8340-2264; Schwartz, Simo/0000-0001-8297-7971; Calin, George/0000-0001-6704-5615; Capella, Gabriel/0000-0002-4669-7320	FCT-Foundation Science and Technology Portugal [SFRH/BD/15900/2005, GABBA 2005]; ICREA;  [SAF2007-00027-65134];  [FIS PI08-0517];  [Consolider CSD2006-49];  [CANCERDIP FP7-200620]; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079091] Funding Source: NIH RePORTER	FCT-Foundation Science and Technology Portugal; ICREA(ICREA); ; ; ; ; ICREA(ICREA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grants SAF2007-00027-65134, FIS PI08-0517, Consolider CSD2006-49 and CANCERDIP FP7-200620. S. A. M. is a research fellow of the FCT-Foundation Science and Technology Portugal SFRH/BD/15900/2005 GABBA 2005 PhD program. M. E. is an ICREA Research Professor.	Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Fleisher AS, 1999, CANCER RES, V59, P1090; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hammond SM, 2007, NAT GENET, V39, P582, DOI 10.1038/ng0507-582; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406	26	277	296	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2009	41	3					365	370		10.1038/ng.317	http://dx.doi.org/10.1038/ng.317			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19219043	Green Accepted			2022-12-17	WOS:000263640200020
J	Jordanova, A; Irobi, J; Thomas, FP; Van Dijck, P; Meerschaert, K; Dewil, M; Dierick, I; Jacobs, A; De Vriendt, E; Guergueltcheva, V; Rao, CV; Tournev, I; Gondim, FAA; D'Hooghe, M; Van Gerwen, V; Callaerts, P; Van den Bosch, L; Timmermans, JPR; Robberecht, W; Gettemans, J; Thevelein, JM; De Jonghe, P; Kremensky, I; Timmerman, V				Jordanova, A; Irobi, J; Thomas, FP; Van Dijck, P; Meerschaert, K; Dewil, M; Dierick, I; Jacobs, A; De Vriendt, E; Guergueltcheva, V; Rao, CV; Tournev, I; Gondim, FAA; D'Hooghe, M; Van Gerwen, V; Callaerts, P; Van den Bosch, L; Timmermans, JPR; Robberecht, W; Gettemans, J; Thevelein, JM; De Jonghe, P; Kremensky, I; Timmerman, V			Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy	NATURE GENETICS			English	Article							PROTEIN-PROTEIN INTERACTIONS; SITE-DIRECTED MUTAGENESIS; AMINO-ACID; ENZYME STRUCTURE; CYTOKINE; DISEASE; LOCALIZATION; TRANSLATION; MUTATIONS; HOMOLOGY	Charcot-Marie-Tooth (CMT) neuropathies are common disorders of the peripheral nervous system caused by demyelination or axonal degeneration, or a combination of both features. We previously assigned the locus for autosomal dominant intermediate CMT neuropathy type C (DI-CMTC) to chromosome 1p34-p35. Here we identify two heterozygous missense mutations (G41R and E196K) and one de novo deletion ( 153 - 156delVKQV) in tyrosyl-tRNA synthetase (YARS) in three unrelated families affected with DI-CMTC. Biochemical experiments and genetic complementation in yeast show partial loss of aminoacylation activity of the mutant proteins, and mutations in YARS, or in its yeast ortholog TYS1, reduce yeast growth. YARS localizes to axonal termini in differentiating primary motor neuron and neuroblastoma cultures. This specific distribution is significantly reduced in cells expressing mutant YARS proteins. YARS is the second aminoacyl-tRNA synthetase found to be involved in CMT, thereby linking protein-synthesizing complexes with neurodegeneration.	Univ Antwerp Flanders Interuniv Inst Biotechnol, Dept Mol Genet, B-2610 Antwerp, Belgium; Med Univ Sofia, Lab Mol Pathol, Sofia 1431, Bulgaria; St Louis Univ, Dept Neurol, St Louis, MO 63110 USA; St Louis Univ, St Louis Vet Affairs Med Ctr, Spinal cord Injury Serv, Inst Mol Virol,Dept Mol Microbiol & Immunol, St Louis, MO 63110 USA; Univ Leuven Flanders Interuniv Inst Biotechnol, Mol Cell Biol Lab, Dept Mol Microbiol, B-3001 Louvain, Belgium; Univ Ghent Flanders Interuniv Inst Biotechnol, Dept Med Prot Res, B-9000 Ghent, Belgium; Univ Leuven, Dept Expt Neurol, Neurobiol Lab, B-3000 Louvain, Belgium; Med Univ Sofia, Dept Neurol, Sofia 1431, Bulgaria; St Jan Hosp, Dept Neurol, B-8000 Brugge, Belgium; Univ Leuven Flanders Interuniv Inst Biotechnol, Dept Human Genet, Lab Dev Genet, B-3000 Louvain, Belgium; Univ Leuven Flanders Interuniv Inst Biotechnol, Dept Biol, Lab Dev Genet, B-3000 Louvain, Belgium; Univ Antwerp, Cell Biol & Histol Lab, B-2020 Antwerp, Belgium; Univ Antwerp Hosp, Div Neurol, B-2650 Antwerp, Belgium	Medical University Sofia; Saint Louis University; Saint Louis University; KU Leuven; Ghent University; KU Leuven; Medical University Sofia; KU Leuven; KU Leuven; University of Antwerp; University of Antwerp	Timmerman, V (corresponding author), Univ Antwerp Flanders Interuniv Inst Biotechnol, Dept Mol Genet, Univ Pl 1, B-2610 Antwerp, Belgium.	vincent.timmerman@ua.ac.be	Thomas, Florian P/AAL-3813-2020; Thevelein, Johan M./A-7897-2013; Timmerman, Vincent/O-7283-2019; de Assis Gondim, Francisco/J-1463-2014; Callaerts, Patrick/I-8118-2013; Jordanova, Albena/H-8323-2015; Thevelein, Johan M./AAK-4203-2021; Van Den Bosch, Ludo/B-7258-2012	Thevelein, Johan M./0000-0002-2626-0180; Timmerman, Vincent/0000-0002-2162-0933; de Assis Gondim, Francisco/0000-0002-8957-5796; Jordanova, Albena/0000-0002-3833-3754; Van Den Bosch, Ludo/0000-0003-0104-4067; Callaerts, Patrick/0000-0003-4530-4561; Thomas, Florian P/0000-0002-6103-4138; Timmermans, Jean-Pierre/0000-0003-2506-6252				Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; BARBARESE E, 1995, J CELL SCI, V108, P2781; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; De Corte V, 2004, J CELL SCI, V117, P5283, DOI 10.1242/jcs.01410; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; Gaete J, 1998, NEUROSCI LETT, V251, P197, DOI 10.1016/S0304-3940(98)00538-2; Giuditta A, 2002, TRENDS NEUROSCI, V25, P400, DOI 10.1016/S0166-2236(02)02188-4; Jordanova A, 2003, AM J HUM GENET, V73, P1423, DOI 10.1086/379792; Kennerson ML, 2001, AM J HUM GENET, V69, P883, DOI 10.1086/323743; Kiga D, 2002, P NATL ACAD SCI USA, V99, P9715, DOI 10.1073/pnas.142220099; Kleeman TA, 1997, J BIOL CHEM, V272, P14420, DOI 10.1074/jbc.272.22.14420; Nair S, 1997, J MOL BIOL, V269, P1, DOI 10.1006/jmbi.1997.1025; Ohno S, 2001, J BIOCHEM-TOKYO, V130, P417, DOI 10.1093/oxfordjournals.jbchem.a003001; OlinkCoux M, 1996, J NEUROSCI, V16, P1346; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Tanghe A, 2002, APPL ENVIRON MICROB, V68, P5981, DOI 10.1128/AEM.68.12.5981-5989.2002; Van Damme P, 2003, J NEUROSCI, V23, P4942; Verhoeven K, 2001, AM J HUM GENET, V69, P889, DOI 10.1086/323742; Wakasugi K, 1998, EMBO J, V17, P297, DOI 10.1093/emboj/17.1.297; Wakasugi K, 1999, J BIOL CHEM, V274, P23155, DOI 10.1074/jbc.274.33.23155; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007; WINTER G, 1982, NATURE, V299, P756, DOI 10.1038/299756a0; Yang XL, 2004, TRENDS BIOCHEM SCI, V29, P250, DOI 10.1016/j.tibs.2004.03.002; Yang XL, 2002, P NATL ACAD SCI USA, V99, P15369, DOI 10.1073/pnas.242611799; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	30	277	294	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2006	38	2					197	202		10.1038/ng1727	http://dx.doi.org/10.1038/ng1727			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16429158	Green Published			2022-12-17	WOS:000234953200014
J	Wang, JB; Mager, J; Chen, YJ; Schneider, E; Cross, JC; Nagy, A; Magnuson, T				Wang, JB; Mager, J; Chen, YJ; Schneider, E; Cross, JC; Nagy, A; Magnuson, T			Imprinted X inactivation maintained by a mouse Polycomb group gene	NATURE GENETICS			English	Article							CHROMOSOME INACTIVATION; HISTONE DEACETYLASE; TRANSCRIPTIONAL REPRESSION; DROSOPHILA; EMBRYOS; COMPLEX; EED; DIFFERENTIATION; MAINTENANCE; ACETYLATION	In mammals, dosage compensation of X-linked genes is achieved by the transcriptional silencing of one X chromosome in the female (reviewed in ref. 1). This process, called X inactivation, is usually random in the embryo proper. In marsupials and the extra-embryonic region of the mouse, however, X inactivation is imprinted: the paternal X chromosome is preferentially inactivated whereas the maternal X is always active. Having more than one active X chromosome is deleterious to extra-embryonic development in the mouse(2). Here we show that the gene eed (embryonic ectoderm development)(3,4), a member of the mouse Polycomb group (Pc-G) of genes, is required for primary and secondary trophoblast giant cell development in female embryos. Results from mice carrying a paternally inherited X-linked green fluorescent protein (GFP) transgene implicate eed in the stable maintenance of imprinted X inactivation in extra-embryonic tissues. Based on the recent finding that the Eed protein interacts with histone deacetylases, we suggest that this maintenance activity involves hypoacetylation of the inactivated paternal X chromosome in the extra-embryonic tissues.	Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; Univ Calgary, Dept Biochem & Mol Biol, Genes & Dev Res Grp, Calgary, AB, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of Calgary; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Magnuson, T (corresponding author), Univ N Carolina, Dept Genet, CB 7264,102 Mason Farm Rd, Chapel Hill, NC 27599 USA.		Nagy, Andras/G-6465-2013; Cross, James/F-4814-2011; Cross, James/AAU-2973-2020	Nagy, Andras/0000-0003-4311-0413; Cross, James/0000-0003-0956-9378; Cross, James/0000-0003-0956-9378				BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; Faust C, 1998, DEVELOPMENT, V125, P4495; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Gilbert SL, 1999, P NATL ACAD SCI USA, V96, P13825, DOI 10.1073/pnas.96.24.13825; Hadjantonakis AK, 1998, NAT GENET, V19, P220, DOI 10.1038/896; Hansen RS, 1996, HUM MOL GENET, V5, P1345, DOI 10.1093/hmg/5.9.1345; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Keohane AM, 1998, DEV GENET, V22, P65, DOI 10.1002/(SICI)1520-6408(1998)22:1&lt;65::AID-DVG7&gt;3.0.CO;2-5; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; MIGEON BR, 1988, NATURE, V335, P93, DOI 10.1038/335093a0; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng J, 2000, MOL CELL BIOL, V20, P3069, DOI 10.1128/MCB.20.9.3069-3078.2000; O'Neill LP, 1999, EMBO J, V18, P2897, DOI 10.1093/emboj/18.10.2897; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; RINCHIK EM, 1993, MAMM GENOME, V4, P349, DOI 10.1007/BF00360583; Sado T, 2000, DEV BIOL, V225, P294, DOI 10.1006/dbio.2000.9823; Schumacher A, 1996, NATURE, V384, P648, DOI 10.1038/384648a0; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; Sewalt RGAB, 1998, MOL CELL BIOL, V18, P3586, DOI 10.1128/MCB.18.6.3586; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; STRUHL G, 1985, EMBO J, V4, P3259, DOI 10.1002/j.1460-2075.1985.tb04075.x; Tanaka M, 1999, MECH DEVELOP, V87, P129, DOI 10.1016/S0925-4773(99)00158-6; Tie F, 1998, DEVELOPMENT, V125, P3483; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	28	277	283	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2001	28	4					371	375		10.1038/ng574	http://dx.doi.org/10.1038/ng574			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11479595				2022-12-17	WOS:000170174800019
J	Lancaster, JM; Wooster, R; Mangion, J; Phelan, CM; Cochran, C; Gumbs, C; Seal, S; Barfoot, R; Collins, N; Bignell, G; Patel, S; Hamoudi, R; Larsson, C; Wiseman, RW; Berchuck, A; Iglehart, JD; Marks, JR; Ashworth, A; Stratton, MR; Futreal, PA				Lancaster, JM; Wooster, R; Mangion, J; Phelan, CM; Cochran, C; Gumbs, C; Seal, S; Barfoot, R; Collins, N; Bignell, G; Patel, S; Hamoudi, R; Larsson, C; Wiseman, RW; Berchuck, A; Iglehart, JD; Marks, JR; Ashworth, A; Stratton, MR; Futreal, PA			BRCA2 mutations in primary breast and ovarian cancers	NATURE GENETICS			English	Letter									DUKE UNIV, MED CTR, DEPT SURG, DURHAM, NC 27710 USA; NIEHS, MOLEC CARCINOGENESIS LAB, NIH, RES TRIANGLE PK, NC 27709 USA; INST CANC RES, HADDOW LABS, SECT MOL CARCINOGENESIS, SURREY, ENGLAND; INST CANC RES, CHESTER BEATTY LABS, LONDON SW3 6JB, ENGLAND; KAROLINSKA HOSP, DEPT MOLEC MED, ENDOCRINE TUMOR UNIT, S-10401 STOCKHOLM, SWEDEN; MCGILL UNIV, MONTREAL GEN HOSP, DEPT HUMAN GENET & MED, MONTREAL, PQ H3G 1A4, CANADA; INST CANC RES, HADDOW LABS, CRC, CTR BIOL MOLEC, SURREY, ENGLAND; DUKE UNIV, MED CTR, DEPT OBSTET & GYNECOL, DIV GYNECOL ONCOL, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DEPT GENET, DURHAM, NC USA	Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Karolinska Institutet; Karolinska University Hospital; McGill University; University of London; Institute of Cancer Research - UK; Duke University; Duke University				Hamoudi, Rifat/0000-0002-1402-0868	NCI NIH HHS [1R21-CA66228, P50-CA68438, R21-CA68348] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA068438, R21CA066228] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CHEN YM, 1995, SCIENCE, V270, P789, DOI 10.1126/science.270.5237.789; CLETONJANSEN AM, 1995, BRIT J CANCER, V72, P1241, DOI 10.1038/bjc.1995.493; COLLINS N, 1995, ONCOGENE, V10, P1673; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; HOSKING L, 1995, NAT GENET, V9, P343, DOI 10.1038/ng0495-343; KERANGUEVEN F, 1995, GENE CHROMOSOME CANC, V13, P291, DOI 10.1002/gcc.2870130410; KIM TM, 1994, CANCER RES, V54, P605; LUNDBERG C, 1987, P NATL ACAD SCI USA, V84, P2372, DOI 10.1073/pnas.84.8.2372; MERAJVER SD, 1995, NAT GENET, V9, P439, DOI 10.1038/ng0495-439; Phelan CM, 1996, NAT GENET, V13, P120, DOI 10.1038/ng0596-120; TAKAHASHI H, 1995, CANCER RES, V55, P2998; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	13	277	281	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1996	13	2					238	240		10.1038/ng0696-238	http://dx.doi.org/10.1038/ng0696-238			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640235				2022-12-17	WOS:A1996UN39500028
J	CHURCH, DM; STOTLER, CJ; RUTTER, JL; MURRELL, JR; TROFATTER, JA; BUCKLER, AJ				CHURCH, DM; STOTLER, CJ; RUTTER, JL; MURRELL, JR; TROFATTER, JA; BUCKLER, AJ			ISOLATION OF GENES FROM COMPLEX SOURCES OF MAMMALIAN GENOMIC DNA USING EXON AMPLIFICATION	NATURE GENETICS			English	Article							SOMATIC-CELL HYBRIDS; SYNDROME TYPE-VII; MESSENGER-RNA; TRANSCRIBED SEQUENCES; EXPRESSION; CDNAS; MUTATION; CLONING; REGION; LOCUS	Modifications to exon amplification have been instituted that increase its speed, efficiency and reliability. Exons were isolated from target human or mouse genomic DNA sources ranging from 30 kilobases (kb) to 3 megabases (Mb) in complexity. The efficiency was dependent upon the amount of input DNA, and ranged from isolation of an exon for every 20 kb to an exon for every 80 kb of target genomic DNA. In these studies, several novel genes and a smaller number of genes isolated previously that reside on human chromosome 9 have been identified. These results indicate that exon amplification is presently adaptable to large scale isolation of exons from complex sources of genomic DNA.	MASSACHUSETTS GEN HOSP, MOLEC NEUROGENET, BOSTON, MA 02114 USA; HARVARD UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School				Rutter, Joni/0000-0002-6502-2361				ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ADELMAN JP, 1987, SCIENCE, V235, P1514, DOI 10.1126/science.3547652; AKLI S, 1990, J BIOL CHEM, V265, P7324; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambrose Christine, 1992, Human Molecular Genetics, V1, P697, DOI 10.1093/hmg/1.9.697; AUCH D, 1990, NUCLEIC ACIDS RES, V18, P6743, DOI 10.1093/nar/18.22.6743; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; BELLEFROID EJ, 1989, DNA-J MOLEC CELL BIO, V8, P377, DOI 10.1089/dna.1.1989.8.377; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CHURCH DM, 1993, HUM MOL GENET, V2, P1915, DOI 10.1093/hmg/2.11.1915; COOPER TA, 1989, NUCLEIC ACIDS RES, V17, P7905, DOI 10.1093/nar/17.19.7905; CORBO L, 1990, SCIENCE, V249, P652, DOI 10.1126/science.2382140; CRAIG SP, 1988, CYTOGENET CELL GENET, V48, P48, DOI 10.1159/000132584; DUYAO MP, 1993, HUM MOL GENET, V2, P673, DOI 10.1093/hmg/2.6.673; DUYK GM, 1990, P NATL ACAD SCI USA, V87, P8995, DOI 10.1073/pnas.87.22.8995; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; HEMPEL WM, 1991, J IMMUNOL, V146, P3713; HENIKOFF S, 1986, CELL, V44, P33, DOI 10.1016/0092-8674(86)90482-4; HODGES PE, 1989, P NATL ACAD SCI USA, V86, P4142, DOI 10.1073/pnas.86.11.4142; INNIS MA, 1988, P NATL ACAD SCI USA, V85, P9436, DOI 10.1073/pnas.85.24.9436; JONES KW, 1992, NAT GENET, V1, P278, DOI 10.1038/ng0792-278; KHAN AS, 1992, NAT GENET, V2, P180, DOI 10.1038/ng1192-180; KWIATKOWSKI DJ, 1993, CYTOGENET CELL GENET, V64, P94; LIDBERG U, 1992, GENOMICS, V13, P630, DOI 10.1016/0888-7543(92)90134-E; LIU P, 1989, SCIENCE, V246, P813, DOI 10.1126/science.2479099; LOVETT M, 1991, P NATL ACAD SCI USA, V88, P9628, DOI 10.1073/pnas.88.21.9628; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MARDON HJ, 1987, NUCLEIC ACIDS RES, V15, P7725, DOI 10.1093/nar/15.19.7725; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; OBAR RA, 1990, NATURE, V347, P256, DOI 10.1038/347256a0; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; PARIMOO S, 1991, P NATL ACAD SCI USA, V88, P9623, DOI 10.1073/pnas.88.21.9623; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SPENCER CA, 1986, NATURE, V322, P279, DOI 10.1038/322279a0; STAPLETON P, 1993, NAT GENET, V3, P292, DOI 10.1038/ng0493-292; TAKENAGA K, 1988, MOL CELL BIOL, V8, P5561, DOI 10.1128/MCB.8.12.5561; TAYLOR SAM, 1992, NAT GENET, V1, P697; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; VANDUIN M, 1989, MOL CELL BIOL, V9, P1794, DOI 10.1128/MCB.9.4.1794; VASAN NS, 1991, AM J HUM GENET, V48, P305; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; WARBURTON D, 1990, GENOMICS, V6, P358, DOI 10.1016/0888-7543(90)90577-H; WEIL D, 1989, EMBO J, V8, P1705, DOI 10.1002/j.1460-2075.1989.tb03562.x; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WILLIAMS T, 1986, NATURE, V322, P275, DOI 10.1038/322275a0	52	277	301	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1994	6	1					98	105		10.1038/ng0194-98	http://dx.doi.org/10.1038/ng0194-98			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ177	8136842				2022-12-17	WOS:A1994MQ17700021
J	Klarin, D; Damrauer, SM; Cho, K; Sun, YV; Teslovich, TM; Honerlaw, J; Gagnon, DR; Du Vall, SL; Li, J; Peloso, GM; Chaffin, M; Small, AM; Huang, J; Tang, H; Lynch, JA; Ho, YL; Liu, D; Emdin, CA; Li, AH; Huffman, JE; Lee, JS; Natarajan, P; Chowdhury, R; Saleheen, D; Vujkovic, MR; Baras, A; Pyarajan, S; Di Angelantonio, E; Neale, BM; Naheed, AI; Khera, AV; Danesh, J; Chan, KM; Abecasis, G; Willer, C; Dewey, FE; Carey, DJ; Concato, J; Gaziano, JM; O'Donnell, C; Tsao, PS; Kathiresan, S; Rader, DJ; Wilson, PWF; Assimes, TL				Klarin, Derek; Damrauer, Scott M.; Cho, Kelly; Sun, Yan, V; Teslovich, Tanya M.; Honerlaw, Jacqueline; Gagnon, David R.; Du Vall, Scott L.; Li, Jin; Peloso, Gina M.; Chaffin, Mark; Small, Aeron M.; Huang, Jie; Tang, Hua; Lynch, Julie A.; Ho, Yuk-Lam; Liu, Dajiangj; Emdin, Connor A.; Li, Alexander H.; Huffman, Jennifer E.; Lee, Jennifer S.; Natarajan, Pradeep; Chowdhury, Rajiv; Saleheen, Danish; Vujkovic, Ma Rijana; Baras, Aris; Pyarajan, Saiju; Di Angelantonio, Emanuele; Neale, Benjamin M.; Naheed, Al Iya; Khera, Amit, V; Danesh, John; Chan, Kyong-Mi; Abecasis, Goncalo; Willer, Cristen; Dewey, Frederick E.; Carey, David J.; Concato, John; Gaziano, J. Michael; O'Donnell, Christopherj; Tsao, Philip S.; Kathiresan, Sekar; Rader, Daniel J.; Wilson, Peter W. F.; Assimes, Themistocles L.		Global Lipids Genetics Consortium; Myocardial Infarction Genetics MIG; Geisinger-Regeneron DiscovEHR Coll; VA Million Vet Program	Genetics of blood lipids among similar to 300,000 multi-ethnic participants of the Million Veteran Program	NATURE GENETICS			English	Article							CORONARY-ARTERY-DISEASE; GENOME-WIDE ASSOCIATION; CODING VARIANTS; HEART-DISEASE; LOW-FREQUENCY; LOCI; RISK; METAANALYSIS; MUTATIONS; BIOBANK	The Million Veteran Program (MVP) was established in 2011 as a national research initiative to determine how genetic variation influences the health of US military veterans. Here we genotyped 312,571 MVP participants using a custom biobank array and linked the genetic data to laboratory and clinical phenotypes extracted from electronic health records covering a median of 10.0 years of follow-up. Among 297,626 veterans with at least one blood lipid measurement, including 57,332 black and 24,743 Hispanic participants, we tested up to around 32 million variants for association with lipid levels and identified 118 novel genome-wide significant loci after meta-analysis with data from the Global Lipids Genetics Consortium (total n > 600,000). Through a focus on mutations predicted to result in a loss of gene function and a phenome-wide association study, we propose novel indications for pharmaceutical inhibitors targeting PCSK9 (abdominal aortic aneurysm), ANGPTL4 (type 2 diabetes) and PDE3B (triglycerides and coronary disease).	[Klarin, Derek; Emdin, Connor A.; Natarajan, Pradeep; Khera, Amit, V; Kathiresan, Sekar] Harvard Med Sch, Ctr Genom Med, Massachusetts Gen Hosp, Boston, MA USA; [Klarin, Derek; Chaffin, Mark; Emdin, Connor A.; Natarajan, Pradeep; Neale, Benjamin M.; Khera, Amit, V; Kathiresan, Sekar] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Klarin, Derek] Boston VA Healthcare Syst, Boston, MA USA; [Damrauer, Scott M.; Small, Aeron M.; Saleheen, Danish; Vujkovic, Ma Rijana; Chan, Kyong-Mi] Corporal Michael Crescenz VA Med Ctr, Philadelphia, PA USA; [Damrauer, Scott M.] Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Cho, Kelly; Honerlaw, Jacqueline; Gagnon, David R.; Huang, Jie; Ho, Yuk-Lam; Huffman, Jennifer E.; Pyarajan, Saiju; Gaziano, J. Michael; O'Donnell, Christopherj] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr MA, Boston, MA USA; [Sun, Yan, V] Emory Univ, Sch Med, Dept Epidemiol, Rollins Sch Publ Hlth,Dept Biomed Informat, Atlanta, GA USA; [Teslovich, Tanya M.; Li, Alexander H.; Baras, Aris; Dewey, Frederick E.] Regeneron Genet Ctr, Tarrytown, NY USA; [Gagnon, David R.; Peloso, Gina M.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Du Vall, Scott L.; Lynch, Julie A.] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Du Vall, Scott L.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT USA; [Li, Jin; Lee, Jennifer S.; Tsao, Philip S.; Assimes, Themistocles L.] Stanford Univ, Dept Med, Perelman Sch Med, Stanford, CA 94305 USA; [Li, Jin; Lee, Jennifer S.; Tsao, Philip S.; Assimes, Themistocles L.] Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Small, Aeron M.; Concato, John] Yale Sch Med, Dept Med, New Haven, CT USA; [Tang, Hua] Stanford Univ, Dept Genet, Sch Med, Stanford, CA USA; [Lynch, Julie A.] Univ Massachusetts, Coll Nursing & Hlth Sci, Boston, MA 02125 USA; [Liu, Dajiangj] Penn State Coll Med, Inst Personalized Med, Dept Publ Hlth Sci, Hershey, PA USA; [Natarajan, Pradeep] Harvard Med Sch, Cardiovasc Res Ctr, Massachusetts Gen Hosp, Boston, MA USA; [Chowdhury, Rajiv; Di Angelantonio, Emanuele; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Cambridge, England; [Saleheen, Danish; Vujkovic, Ma Rijana] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA USA; [Pyarajan, Saiju; Gaziano, J. Michael] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA USA; [Neale, Benjamin M.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Neale, Benjamin M.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Naheed, Al Iya] Int Ctr Diarrheal Dis Res, Hlth Syst & Populat Studies Div, Initiat Noncommunicable Dis, Dhaka, Bangladesh; [Chan, Kyong-Mi; Rader, Daniel J.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Abecasis, Goncalo] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Willer, Cristen] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Willer, Cristen] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Willer, Cristen] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Carey, David J.] Geisinger Hlth Syst, Danville, PA USA; [Concato, John] VA Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, West Haven, CT USA; [Gaziano, J. Michael; O'Donnell, Christopherj; Rader, Daniel J.] Harvard Med Sch, Dept Med, Boston, MA USA; [Rader, Daniel J.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA USA; [Rader, Daniel J.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Rader, Daniel J.] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA USA; [Wilson, Peter W. F.] Atlanta VA Med Ctr, Decatur, GA USA; [Klarin, Derek; Damrauer, Scott M.; Wilson, Peter W. F.] Emory Clin Cardiovasc Res Inst, Atlanta, GA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Emory University; Rollins School Public Health; Regeneron; Boston University; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Yale University; Stanford University; University of Massachusetts System; University of Massachusetts Boston; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Cambridge; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; International Centre for Diarrhoeal Disease Research (ICDDR); University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Geisinger Health System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center	Assimes, TL (corresponding author), Stanford Univ, Dept Med, Perelman Sch Med, Stanford, CA 94305 USA.; Assimes, TL (corresponding author), Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA.	tassimes@stanford.edu	Chowdhury, Rajiv/AHB-1253-2022; Assimes, Themistocles Leonard/D-9696-2015; DiAngelantonio, Emanuele/ABE-6852-2020; Natarajan, Pradeep/H-9764-2019; A, Naheed/AHB-2940-2022; A, Naheed/AHB-2941-2022; Vujković, Marijana/S-9414-2019	Assimes, Themistocles Leonard/0000-0003-2349-0009; Natarajan, Pradeep/0000-0001-8402-7435; A, Naheed/0000-0002-6016-5603; A, Naheed/0000-0002-6016-5603; Vujković, Marijana/0000-0003-4924-5714; DuVall, Scott/0000-0002-4898-3865; Di Angelantonio, Emanuele/0000-0001-8776-6719; Gagnon, David/0000-0002-6367-3179; Damrauer, Scott/0000-0001-8009-1632; Klarin, Derek/0000-0002-4636-5780; Liu, Dajiang/0000-0001-6553-858X	Department of Veterans Affairs Cooperative Studies Program [G002]; Department of Veterans Affairs [1I0101BX003340, 1I01BX003362, 1I01CX001025]; NIH [T32 HL007734, K01HL125751, R01HL127564]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL125751, R33HL120781, K08HL140203, T32HL007734, R01HL142711, R01HL127564] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003362, I01BX003340, I01BX002641, I01CX001025] Funding Source: NIH RePORTER; MRC [MR/L003120/1] Funding Source: UKRI	Department of Veterans Affairs Cooperative Studies Program(US Department of Veterans Affairs); Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Data on patients with coronary artery disease and myocardial infarctions have been contributed by the CARDIoGRAMplusC4D investigators and the Myocardial Infarction Genetics and CARDIoGRAM Exome investigators. Both datasets were obtained online (see URLs). This research is based on data from the MVP, Office of Research and Development, Veterans Health Administration, and was supported by the Department of Veterans Affairs Cooperative Studies Program award G002. This research was also supported by three additional Department of Veterans Affairs awards (1I0101BX003340, 1I01BX003362, and 1I01CX001025) and the NIH (T32 HL007734, K01HL125751, R01HL127564). The content of this manuscript does not represent the views of the Department of Veterans Affairs or the United States Government.	Abul-Husn NS, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7000; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Ahmad F, 2016, SCI REP-UK, V6, DOI 10.1038/srep28056; Albrechtsen A, 2013, DIABETOLOGIA, V56, P298, DOI 10.1007/s00125-012-2756-1; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Asselbergs FW, 2012, AM J HUM GENET, V91, P823, DOI 10.1016/j.ajhg.2012.08.032; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bedenis R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003748.pub4; Below JE, 2016, SCI REP-UK, V6, DOI 10.1038/srep19429; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Chung YW, 2015, P NATL ACAD SCI USA, V112, pE2253, DOI 10.1073/pnas.1416230112; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Dewey FE, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6814; Dewey FF, 2016, NEW ENGL J MED, V374, P1123, DOI 10.1056/NEJMoa1510926; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Diogo D., 2017, PREPRINT; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Gandotra S, 2011, NEW ENGL J MED, V364, P740, DOI 10.1056/NEJMoa1007487; Gaziano JM, 2016, J CLIN EPIDEMIOL, V70, P214, DOI 10.1016/j.jclinepi.2015.09.016; Graham MJ, 2017, NEW ENGL J MED, V377, P222, DOI 10.1056/NEJMoa1701329; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Harrison SC, 2018, JAMA CARDIOL, V3, P26, DOI 10.1001/jamacardio.2017.4293; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Hyde CL, 2016, NAT GENET, V48, P1031, DOI 10.1038/ng.3623; Khera AV, 2017, JAMA-J AM MED ASSOC, V317, P937, DOI 10.1001/jama.2017.0972; Klarin D, 2017, NAT GENET, V49, P1392, DOI 10.1038/ng.3914; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liu DJ, 2017, NAT GENET, V49, P1758, DOI 10.1038/ng.3977; Loh PR, 2016, NAT GENET, V48, P811, DOI 10.1038/ng.3571; Lu H, 2016, ARTERIOSCL THROM VAS, V36, P1753, DOI 10.1161/ATVBAHA.116.307613; Lu XF, 2017, NAT GENET, V49, P1722, DOI 10.1038/ng.3978; Maass PG, 2015, NAT GENET, V47, P647, DOI 10.1038/ng.3302; Mahajan A, 2018, NAT GENET, V50, P559, DOI 10.1038/s41588-018-0084-1; Mancuso N, 2017, AM J HUM GENET, V100, P473, DOI 10.1016/j.ajhg.2017.01.031; Marouli E, 2017, NATURE, V542, P186, DOI 10.1038/nature21039; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Nelson CP, 2017, NAT GENET, V49, P1385, DOI 10.1038/ng.3913; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Rani J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07238-0; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Shinohara Y, 2010, LANCET NEUROL, V9, P959, DOI 10.1016/S1474-4422(10)70198-8; Sidore C, 2015, NAT GENET, V47, P1272, DOI 10.1038/ng.3368; Stitziel NO., 2016, NEW ENGL J MED, V374, P1134; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Tsuchikane E, 1999, CIRCULATION, V100, P21, DOI 10.1161/01.CIR.100.1.21; Vandeput F, 2013, P NATL ACAD SCI USA, V110, P19778, DOI 10.1073/pnas.1305427110; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Zhang W, 2007, BLOOD, V110, P1475, DOI 10.1182/blood-2006-10-052522; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264	60	276	277	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2018	50	11					1514	+		10.1038/s41588-018-0222-9	http://dx.doi.org/10.1038/s41588-018-0222-9			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GY2UB	30275531	Green Accepted, Green Submitted			2022-12-17	WOS:000448398000007
J	Du, XM; Huang, G; He, SP; Yang, ZE; Sun, GF; Ma, XF; Li, N; Zhang, XY; Sun, JL; Liu, M; Jia, YH; Pan, ZE; Gong, WF; Liu, ZH; Zhu, HQ; Ma, L; Liu, FY; Yang, DG; Wang, F; Fan, W; Gong, Q; Peng, Z; Wang, LR; Wang, XY; Xu, SJ; Shang, HH; Lu, CR; Zheng, HK; Huang, SW; Lin, T; Zhu, YX; Li, FG				Du, Xiongming; Huang, Gai; He, Shoupu; Yang, Zhaoen; Sun, Gaofei; Ma, Xiongfeng; Li, Nan; Zhang, Xueyan; Sun, Junling; Liu, Min; Jia, Yinhua; Pan, Zhaoe; Gong, Wenfang; Liu, Zhaohui; Zhu, Heqin; Ma, Lei; Liu, Fuyan; Yang, Daigang; Wang, Fan; Fan, Wei; Gong, Qian; Peng, Zhen; Wang, Liru; Wang, Xiaoyang; Xu, Shuangjiao; Shang, Haihong; Lu, Cairui; Zheng, Hongkun; Huang, Sanwen; Lin, Tao; Zhu, Yuxian; Li, Fuguang			Resequencing of 243 diploid cotton accessions based on an updated A genome identifies the genetic basis of key agronomic traits	NATURE GENETICS			English	Article							GOSSYPIUM-ARBOREUM L.; PROVIDES INSIGHTS; WIDE ASSOCIATION; DOMESTICATION; SEQUENCE; PREDICTION; DIVERSITY; LOCI; RICE; MAP	The ancestors of Gossypium arboreum and Gossypium herbaceum provided the A subgenome for the modern cultivated allotetraploid cotton. Here, we upgraded the G. arboreum genome assembly by integrating different technologies. We resequenced 243 G. arboreum and G. herbaceum accessions to generate a map of genome variations and found that they are equally diverged from Gossypium raimondii. Independent analysis suggested that Chinese G. arboreum originated in South China and was subsequently introduced to the Yangtze and Yellow River regions. Most accessions with domestication-related traits experienced geographic isolation. Genome-wide association study (GWAS) identified 98 significant peak associations for 11 agronomically important traits in G. arboreum. A nonsynonymous substitution (cysteine-to-arginine substitution) of GaKASIII seems to confer substantial fatty acid composition (C16:0 and C16:1) changes in cotton seeds. Resistance to fusarium wilt disease is associated with activation of GaGSTF9 expression. Our work represents a major step toward understanding the evolution of the A genome of cotton.	[Du, Xiongming; Sun, Gaofei; Li, Fuguang] Anyang Inst Technol, State Key Lab Cotton Biol, Res Base, Anyang, Peoples R China; [Du, Xiongming; He, Shoupu; Yang, Zhaoen; Ma, Xiongfeng; Zhang, Xueyan; Sun, Junling; Jia, Yinhua; Pan, Zhaoe; Gong, Wenfang; Zhu, Heqin; Ma, Lei; Yang, Daigang; Gong, Qian; Peng, Zhen; Wang, Liru; Wang, Xiaoyang; Xu, Shuangjiao; Shang, Haihong; Lu, Cairui; Li, Fuguang] Chinese Acad Agr Sci, Inst Cotton Res, Anyang, Peoples R China; [Huang, Gai; Liu, Zhaohui; Zhu, Yuxian] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing, Peoples R China; [Huang, Gai; Zhu, Yuxian] Wuhan Univ, Inst Adv Studies, Wuhan, Hubei, Peoples R China; [Huang, Gai; Zhu, Yuxian] Wuhan Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China; [Li, Nan; Fan, Wei; Huang, Sanwen; Lin, Tao] Chinese Acad Agr Sci, Genome Anal Lab, Minist Agr, Agr Genom Inst Shenzhen, Shenzhen, Peoples R China; [Liu, Min; Liu, Fuyan; Wang, Fan; Zheng, Hongkun] Biomarker Technol Corp, Beijing, Peoples R China	Anyang Institute of Technology; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Peking University; Wuhan University; Wuhan University; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Ministry of Agriculture & Rural Affairs	Li, FG (corresponding author), Anyang Inst Technol, State Key Lab Cotton Biol, Res Base, Anyang, Peoples R China.; Li, FG (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, Anyang, Peoples R China.; Zhu, YX (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing, Peoples R China.; Zhu, YX (corresponding author), Wuhan Univ, Inst Adv Studies, Wuhan, Hubei, Peoples R China.; Zhu, YX (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China.; Lin, T (corresponding author), Chinese Acad Agr Sci, Genome Anal Lab, Minist Agr, Agr Genom Inst Shenzhen, Shenzhen, Peoples R China.	lintao_solab@126.com; zhuyx@whu.edu.cn; aylifug@163.com	Huang, Sanwen/ABE-9053-2020; liu, zhao/GXV-6141-2022; Shoupu, He/AAR-5173-2021; Du, Xiongming/AAI-9999-2020	Huang, Sanwen/0000-0002-8547-5309; Shoupu, He/0000-0001-8434-5484; Du, Xiongming/0000-0003-1704-2568; Qian, Gong/0000-0003-1724-4653; Zhu, Yuxian/0000-0003-2371-5933; Nan, Li/0000-0003-1271-6017; Huang, Gai/0000-0003-0426-9691	National Natural Science Foundation of China [31621005, 90717009]; National Key Technology RD Program; Ministry of Science and Technology [2016YFD0100203, 2016YFD0100306]; National Science and Technology Support Program; Ministry of Agriculture [2013BAD01B03]; Agricultural Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAAS-ASTIP-IVFCAAS); Guangdong Province Program [00201515]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science and Technology Support Program; Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Agricultural Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAAS-ASTIP-IVFCAAS); Guangdong Province Program	This work was supported by funding from the National Natural Science Foundation of China (grants 31621005 to F. Li and 90717009 to Y.Z.), the National Key Technology R&D Program, the Ministry of Science and Technology (2016YFD0100203 to X.D. and 2016YFD0100306 to S. He), the National Science and Technology Support Program, the Ministry of Agriculture (2013BAD01B03 to X.D.), the Agricultural Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAAS-ASTIP-IVFCAAS to S. Huang), and the leading talents of Guangdong Province Program (00201515 to S. Huang).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Barrett J. C., 2001, BIOINFORMATICS, V21, P847; Chen Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128981; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Desai A, 2006, GENOME, V49, P336, DOI 10.1139/G05-116; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Dowd MK, 2010, J COTTON SCI, V14, P64; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; Falush D, 2003, GENETICS, V164, P1567; Fang L, 2017, NAT GENET, V49, P1089, DOI 10.1038/ng.3887; Goudet J., 2001, CLADISTICS; Guo WZ, 2006, J INTEGR PLANT BIOL, V48, P1008, DOI 10.1111/j.1744-7909.2006.00316.x; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Haegi A, 2013, PHYTOPATHOLOGY, V103, P802, DOI 10.1094/PHYTO-11-12-0293-R; Han YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq862; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Institute of Cotton Research CAAS & Institute of Industrial Crops JAAS, 1989, CHIN AS COTT; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Keilwagen J, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw092; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Kulkarni Venkatesh N., 2009, V3, P69, DOI 10.1007/978-0-387-70810-2_4; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li MX, 2012, HUM GENET, V131, P747, DOI 10.1007/s00439-011-1118-2; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Liu Q, 2002, PLANT PHYSIOL, V129, P1732, DOI 10.1104/pp.001933; Liu X, 2015, SCI REP-UK, V5, DOI [10.1038/srep14139, 10.1038/srep10007]; Ma XX, 2008, J INTEGR PLANT BIOL, V50, P491, DOI 10.1111/j.1744-7909.2008.00636.x; Marchler-Bauer A., 1999, NUCLEIC ACIDS RES, V39, P1544; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Olsen KM, 2013, ANNU REV PLANT BIOL, V64, P47, DOI 10.1146/annurev-arplant-050312-120048; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Qi JJ, 2013, NAT GENET, V45, P1510, DOI 10.1038/ng.2801; Roppolo D, 2014, PLANT PHYSIOL, V165, P1709, DOI 10.1104/pp.114.239137; Roppolo D, 2011, NATURE, V473, P380, DOI 10.1038/nature10070; Schnittger A, 2002, CURR BIOL, V12, P415, DOI 10.1016/S0960-9822(02)00693-0; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; STANTON MA, 1994, CROP SCI, V34, P519, DOI 10.2135/cropsci1994.0011183X003400020039x; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Turley RB, 2010, PHYSIOLOGY OF COTTON, P332, DOI 10.1007/978-90-481-3195-2_29; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang MJ, 2017, NAT GENET, V49, P579, DOI 10.1038/ng.3807; Watt G., 1907, WILD CULTIVATED COTT; Wendel J.F., 2012, POLYPLOIDY GENOME EV, P181, DOI DOI 10.1007/978-3-642-31442-1_10; WENDEL JF, 1989, AM J BOT, V76, P1795, DOI 10.2307/2444478; Wendel JF, 2010, PHYSIOLOGY OF COTTON, P1, DOI 10.1007/978-90-481-3195-2_1; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang CX, 2011, P NATL ACAD SCI USA, V108, P11836, DOI 10.1073/pnas.1100532108; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yu N, 2015, BIOL PLANTARUM, V59, P773, DOI 10.1007/s10535-015-0555-5; Yuan DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17662; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhou ZK, 2015, NAT BIOTECHNOL, V33, P408, DOI 10.1038/nbt.3096	71	276	295	25	267	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2018	50	6					796	+		10.1038/s41588-018-0116-x	http://dx.doi.org/10.1038/s41588-018-0116-x			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GH7KD	29736014				2022-12-17	WOS:000433621000007
J	Stuart, BD; Choi, JM; Zaidi, S; Xing, C; Holohan, B; Chen, R; Choi, MW; Dharwadkar, P; Torres, F; Girod, CE; Weissler, J; Fitzgerald, J; Kershaw, C; Klesney-Tait, J; Mageto, Y; Shay, JW; Ji, WZ; Bilguvar, K; Mane, S; Lifton, RP; Garcia, CK				Stuart, Bridget D.; Choi, Jungmin; Zaidi, Samir; Xing, Chao; Holohan, Brody; Chen, Rui; Choi, Mihwa; Dharwadkar, Pooja; Torres, Fernando; Girod, Carlos E.; Weissler, Jonathan; Fitzgerald, John; Kershaw, Corey; Klesney-Tait, Julia; Mageto, Yolanda; Shay, Jerry W.; Ji, Weizhen; Bilguvar, Kaya; Mane, Shrikant; Lifton, Richard P.; Garcia, Christine Kim			Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening	NATURE GENETICS			English	Article							DE-NOVO MUTATIONS; DYSKERATOSIS-CONGENITA; INTERSTITIAL PNEUMONIA; AUTISTIC SPECTRUM; GENE; MATURATION; DISEASE	Idiopathic pulmonary fibrosis (IPF) is an age-related disease featuring progressive lung scarring. To elucidate the molecular basis of IPF, we performed exome sequencing of familial kindreds with pulmonary fibrosis. Gene burden analysis comparing 78 European cases and 2,816 controls implicated PARN, an exoribonuclease with no previous connection to telomere biology or disease, with five new heterozygous damaging mutations in unrelated cases and none in controls (P = 1.3 x 10(-8)); mutations were shared by all affected relatives (odds in favor of linkage = 4,096: 1). RTEL1, an established locus for dyskeratosis congenita, harbored significantly more new damaging and missense variants at conserved residues in cases than in controls (P = 1.6 x 10(-6)). PARN and RTEL1 mutation carriers had shortened leukocyte telomere lengths, and we observed epigenetic inheritance of short telomeres in family members. Together, these genes explain similar to 7% of familial pulmonary fibrosis and strengthen the link between lung fibrosis and telomere dysfunction.	[Stuart, Bridget D.; Xing, Chao; Choi, Mihwa; Garcia, Christine Kim] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Stuart, Bridget D.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Choi, Jungmin; Zaidi, Samir; Ji, Weizhen; Bilguvar, Kaya; Mane, Shrikant; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Choi, Jungmin; Zaidi, Samir; Ji, Weizhen; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Holohan, Brody; Shay, Jerry W.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Chen, Rui; Dharwadkar, Pooja; Torres, Fernando; Girod, Carlos E.; Weissler, Jonathan; Fitzgerald, John; Kershaw, Corey; Garcia, Christine Kim] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Klesney-Tait, Julia] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Mageto, Yolanda] Univ Vermont, Coll Med, Dept Internal Med, Burlington, VT USA; [Bilguvar, Kaya; Mane, Shrikant; Lifton, Richard P.] Yale Univ, Sch Med, Yale Ctr Genome Anal, New Haven, CT USA; [Lifton, Richard P.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University; Howard Hughes Medical Institute; Yale University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Iowa; University of Vermont; Yale University; Yale University	Garcia, CK (corresponding author), Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.	christine.garcia@utsouthwestern.edu	Kershaw, Corey/AAZ-2094-2021; Wang, Guilin/G-8794-2018	Kershaw, Corey/0000-0002-9696-1994; Dharwadkar, Pooja/0000-0003-0373-298X	US National Institutes of Health (NIH) National Center for Advancing Translational Sciences grant [UL1TR001105]; US NIH grant [U54HG006504, K12HD068369, R01HL093096]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068369] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093096] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) National Center for Advancing Translational Sciences grant; US NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the probands and their families for their participation, to A. Young for technical excellence, to S. Nolasco, K. Stephens and G. Wools for their help with blood sample collections, to the Yale Center for Genome Analysis for the generation of exome sequence data, and to the Yale Center for Genome Analysis and the McDermott Center Bioinformatics Core for sequence analysis. The authors acknowledge funding support from the following sources: US National Institutes of Health (NIH) National Center for Advancing Translational Sciences grant UL1TR001105; US NIH grant U54HG006504 (to the Yale Center for Mendelian Genomics); the Howard Hughes Medical Institute (R.P.L.); US NIH grant K12HD068369 (B.D.S.); and US NIH grant R01HL093096 (C.K.G.).	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Ballew BJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003695; Ballew BJ, 2013, HUM GENET, V132, P473, DOI 10.1007/s00439-013-1265-8; Berndt H, 2012, RNA, V18, P958, DOI 10.1261/rna.032292.112; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Cogan JD, 2015, AM J RESP CRIT CARE, V191, P646, DOI 10.1164/rccm.201408-1510OC; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; de Leon AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010680; Dehlin E, 2000, EMBO J, V19, P1079, DOI 10.1093/emboj/19.5.1079; Deng Z, 2013, P NATL ACAD SCI USA, V110, pE3408, DOI 10.1073/pnas.1300600110; Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Herbert B., 2003, CURRENT PROTOCOLS CE; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; Kropski JA, 2014, CHEST, V146, pE1, DOI 10.1378/chest.13-2224; Le Guen T, 2013, HUM MOL GENET, V22, P3239, DOI 10.1093/hmg/ddt178; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Marshall RP, 2000, THORAX, V55, P143, DOI 10.1136/thorax.55.2.143; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; Olson JM, 1999, AM J HUM GENET, V65, P1760, DOI 10.1086/302662; Parry EM, 2011, J MED GENET, V48, P327, DOI 10.1136/jmg.2010.085100; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Steele MP, 2005, AM J RESP CRIT CARE, V172, P1146, DOI 10.1164/rccm.200408-1104OC; Stuart BD, 2014, LANCET RESP MED, V2, P557, DOI 10.1016/S2213-2600(14)70124-9; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Vannier JB, 2012, CELL, V149, P795, DOI 10.1016/j.cell.2012.03.030; Vulliamy T, 2008, P NATL ACAD SCI USA, V105, P8073, DOI 10.1073/pnas.0800042105; Walne AJ, 2007, HUM MOL GENET, V16, P1619, DOI 10.1093/hmg/ddm111; Walne AJ, 2013, AM J HUM GENET, V92, P448, DOI 10.1016/j.ajhg.2013.02.001; Wang Y, 2009, AM J HUM GENET, V84, P52, DOI 10.1016/j.ajhg.2008.11.010; Yoda M, 2013, CELL REP, V5, P715, DOI 10.1016/j.celrep.2013.09.029; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141	39	276	283	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					512	U114		10.1038/ng.3278	http://dx.doi.org/10.1038/ng.3278			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE		Green Accepted			2022-12-17	WOS:000353635800014
J	Hay, A; Tsiantis, M				Hay, Angela; Tsiantis, Miltos			The genetic basis for differences in leaf form between Arabidopsis thaliana and its wild relative Cardamine hirsuta	NATURE GENETICS			English	Article							ROUGH-SHEATH2 GENE; LATERAL ORGANS; HOMEOBOX GENE; EXPRESSION; LEAVES; ASYMMETRIC-LEAVES1; EFFICIENT; IDENTITY; PROTEIN; SYSTEM	A key question in biology is how differences in gene function or regulation produce new morphologies during evolution. Here we investigate the genetic basis for differences in leaf form between two closely related plant species, Arabidopsis thaliana and Cardamine hirsuta. We report that in C. hirsuta, class I KNOTTED1-like homeobox (KNOX) proteins are required in the leaf to delay cellular differentiation and produce a dissected leaf form, in contrast to A. thaliana, in which KNOX exclusion from leaves results in a simple leaf form. These differences in KNOX expression arise through changes in the activity of upstream gene regulatory sequences. The function of ASYMMETRIC LEAVES1/ROUGHSHEATH2/PHANTASTICA (ARP) proteins to repress KNOX expression is conserved between the two species, but in C. hirsuta the ARP-KNOX regulatory module controls new developmental processes in the leaf. Thus, evolutionary tinkering with KNOX regulation, constrained by ARP function, may have produced diverse leaf forms by modulating growth and differentiation patterns in developing leaf primordia.	Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	University of Oxford	Tsiantis, M (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	miltos.tsiantis@plants.ox.ac.uk						Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chen JJ, 1997, PLANT CELL, V9, P1289, DOI 10.1105/tpc.9.8.1289; Chuck G, 1996, PLANT CELL, V8, P1277, DOI 10.1105/tpc.8.8.1277; Craft J, 2005, PLANT J, V41, P899, DOI 10.1111/j.1365-313X.2005.02342.x; Dinneny JR, 2004, DEVELOPMENT, V131, P1101, DOI 10.1242/dev.00949; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Hareven D, 1996, CELL, V84, P735, DOI 10.1016/S0092-8674(00)81051-X; Hay A, 2003, PLANT PHYSIOL, V131, P1671, DOI 10.1104/pp.102.017434; Kim JY, 2003, DEVELOPMENT, V130, P4351, DOI 10.1242/dev.00618; Kim M, 2003, NATURE, V424, P438, DOI 10.1038/nature01820; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Lenhard M, 2002, DEVELOPMENT, V129, P3195; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Ori N, 2000, DEVELOPMENT, V127, P5523; Scanlon MJ, 1996, DEVELOPMENT, V122, P1683; Schneeberger R, 1998, DEVELOPMENT, V125, P2857; SMITH LG, 1992, DEVELOPMENT, V116, P21; Theodoris G, 2003, P NATL ACAD SCI USA, V100, P6837, DOI 10.1073/pnas.1132113100; Timmermans MCP, 1999, SCIENCE, V284, P151, DOI 10.1126/science.284.5411.151; Tsiantis M, 1999, SCIENCE, V284, P154, DOI 10.1126/science.284.5411.154; Waites R, 1998, CELL, V93, P779, DOI 10.1016/S0092-8674(00)81439-7; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Xu L, 2003, DEVELOPMENT, V130, P4097, DOI 10.1242/dev.00622	26	276	297	5	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2006	38	8					942	947		10.1038/ng1835	http://dx.doi.org/10.1038/ng1835			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	16823378				2022-12-17	WOS:000239325700026
J	Rifkin, SA; Kim, J; White, KP				Rifkin, SA; Kim, J; White, KP			Evolution of gene expression in the Drosophila melanogaster subgroup	NATURE GENETICS			English	Article							SALIVARY-GLAND CHROMOSOMES; PHENOTYPIC EVOLUTION; PUFFING ACTIVITY; PATTERNS; CONSERVATION; SELECTION; VARIANCE; HOMOLOGY	Little is known about broad patterns of variation and evolution of gene expression during any developmental process. Here we investigate variation in genome-wide gene expression among Drosophila simulans, Drosophila yakuba and four strains of Drosophila melanogaster during a major developmental transition-the start of metamorphosis. Differences in gene activity between these lineages follow a phylogenetic pattern, and 27% of all of the genes in these genomes differ in their developmental gene expression between at least two strains or species. We identify, on a gene-by-gene basis, the evolutionary forces that shape this variation and show that, both within the transcriptional network that controls metamorphosis and across the whole genome, the expression changes of transcription factor genes are relatively stable, whereas those of their downstream targets are more likely to have evolved. Our results demonstrate extensive evolution of developmental gene expression among closely related species.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	Yale University; Yale University	White, KP (corresponding author), Yale Univ, Sch Med, Dept Genet, POB 208005, New Haven, CT 06520 USA.	kevin.white@yale.edu	TATSUTA, HARUKI/F-2997-2010	Rifkin, Scott/0000-0001-8476-3256				Alonso CR, 2001, CURR BIOL, V11, P1473, DOI 10.1016/S0960-9822(01)00425-0; ANDRES AJ, 1994, METHOD CELL BIOL, V44, P565, DOI 10.1016/S0091-679X(08)60932-2; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; ASHBURNER M, 1969, CHROMOSOMA, V27, P156, DOI 10.1007/BF00326142; ASHBURNER M, 1972, CHROMOSOMA, V38, P283, DOI 10.1007/BF00290926; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Cavalieri D, 2000, P NATL ACAD SCI USA, V97, P12369, DOI 10.1073/pnas.210395297; DAMERVAL C, 1994, GENETICS, V137, P289; Davidson EH, 2001, GENOMIC REGULATORY S; DICKINSON WJ, 1988, BIOESSAYS, V8, P204, DOI 10.1002/bies.950080608; DICKINSON WJ, 1993, EVOLUTION, V47, P1396, DOI [10.2307/2410155, 10.1111/j.1558-5646.1993.tb02162.x]; Diehl F, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e38; Hansen TF, 1996, EVOLUTION, V50, P1404, DOI 10.1111/j.1558-5646.1996.tb03914.x; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Johnson NA, 2001, GENETICA, V112, P45, DOI 10.1023/A:1013371201773; Kerr MK, 2002, STAT SINICA, V12, P203; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; LACHAISE D, 1988, EVOL BIOL, V22, P159; LANDE R, 1976, EVOLUTION, V30, P314, DOI 10.1111/j.1558-5646.1976.tb00911.x; Lewontin R., 1983, SCIENTIA, V118, P63; Li YJ, 1999, GENES GENET SYST, V74, P117, DOI 10.1266/ggs.74.117; LYNCH M, 1986, EVOLUTION, V40, P915, DOI 10.1111/j.1558-5646.1986.tb00561.x; MARONI G, 1983, DROS INFORM SERV, V59, P142; MARTINS EP, 1994, AM NAT, V144, P193, DOI 10.1086/285670; MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2; Moriyama EN, 1996, MOL BIOL EVOL, V13, P261, DOI 10.1093/oxfordjournals.molbev.a025563; Palopoli MF, 1996, GENETICS, V144, P1321; Powell J.R., 1997, PROGR PROSPECTS EVOL; Reinke V, 2002, ANNU REV GENOM HUM G, V3, P153, DOI 10.1146/annurev.genom.3.031302.100922; Riddiford L., 1993, DEV DROSOPHILA MELAN, V2, P899; Robertson CW, 1936, J MORPHOL, V59, P351, DOI 10.1002/jmor.1050590207; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Sokal R. R., 1995, BIOMETRY; Stowers RS, 1999, DEV BIOL, V213, P116, DOI 10.1006/dbio.1999.9358; Swofford DL, 1996, PAUP PHYLOGENETIC AN; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; TURELLI M, 1988, EVOLUTION, V42, P1085, DOI [10.2307/2408923, 10.1111/j.1558-5646.1988.tb02526.x]; Wagner GP, 1996, AM ZOOL, V36, P36; WAGNER GP, 1993, J EVOLUTION BIOL, V6, P449, DOI 10.1046/j.1420-9101.1993.6030449.x; Wagner GP, 1999, P NATL ACAD SCI USA, V96, P5111, DOI 10.1073/pnas.96.9.5111; WENSINK PC, 1974, CELL, V3, P315, DOI 10.1016/0092-8674(74)90045-2; White KP, 2001, NAT REV GENET, V2, P528, DOI 10.1038/35080565; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Wilkins A.S, 2001, EVOLUTION DEV PATHWA; Wimmer EA, 2000, SCIENCE, V287, P2476, DOI 10.1126/science.287.5462.2476; Yang YH, 2002, J COMPUT GRAPH STAT, V11, P108, DOI 10.1198/106186002317375640; Yang YH, 2001, PROC SPIE, V4266, P141, DOI 10.1117/12.427982	50	276	278	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2003	33	2					138	144		10.1038/ng1086	http://dx.doi.org/10.1038/ng1086			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12548287				2022-12-17	WOS:000180773700010
J	Baxter, RV; Ben Othmane, K; Rochelle, JM; Stajich, JE; Hulette, C; Dew-Knight, S; Hentati, F; Ben Hamida, M; Bel, S; Stenger, JE; Gilbert, JR; Pericak-Vance, MA; Vance, JM				Baxter, RV; Ben Othmane, K; Rochelle, JM; Stajich, JE; Hulette, C; Dew-Knight, S; Hentati, F; Ben Hamida, M; Bel, S; Stenger, JE; Gilbert, JR; Pericak-Vance, MA; Vance, JM			Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21	NATURE GENETICS			English	Article								We previously localized and fine-mapped Charcot Marie Tooth 4A (CMT4A), the autosoma[ recessive, demyelinating peripheral neuropathy, to chromosome 8. Through additional positional cloning, we have identified a good candidate gene, encoding ganglioside-induced differentiation-associated protein-1 (GDAP1). We found three different mutations in four different Tunisian families-two nonsense and one missense mutation. How mutations in GDAP1 lead to CMT4A remains to be understood.	Duke Univ, Med Ctr, Inst Genom Sci & Policy, Ctr Human Genet, Durham, NC 27710 USA; Inst Natl Neurol, Tunis 1007, Tunisia	Duke University; Universite de Tunis-El-Manar; Institut National de Neurologie	Vance, JM (corresponding author), Duke Univ, Med Ctr, Inst Genom Sci & Policy, Ctr Human Genet, Res Pk Bldg 11 Room 105,Box 2903, Durham, NC 27710 USA.	jeff@chg.mc.duke.edu	Stajich, Jason Eric/C-7297-2008	Stajich, Jason Eric/0000-0002-7591-0020; Vance, Jeffery/0000-0003-3815-8199				Barhoumi C, 2001, NEUROMUSCULAR DISORD, V11, P27, DOI 10.1016/S0960-8966(00)00162-0; Ben Othmane K, 1998, NEUROGENETICS, V2, P18, DOI 10.1007/s100480050047; Cuesta A, 2002, NAT GENET, V30, P22, DOI 10.1038/ng798; De Jonghe P, 1997, J Peripher Nerv Syst, V2, P370; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P619, DOI 10.1001/archneur.1968.00470360041003; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P603, DOI 10.1001/archneur.1968.00470360025002; Martinotti Alessia, 1992, Human Molecular Genetics, V1, P331, DOI 10.1093/hmg/1.5.331; OTHMANE KB, 1993, HUM MOL GENET, V2, P1625, DOI 10.1093/hmg/2.10.1625; Vance JM, 2000, ARCH NEUROL-CHICAGO, V57, P638, DOI 10.1001/archneur.57.5.638	9	276	285	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2002	30	1					21	22		10.1038/ng796	http://dx.doi.org/10.1038/ng796			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11743579				2022-12-17	WOS:000173105600006
J	Zierer, J; Jackson, MA; Kastenmuller, G; Mangino, M; Long, T; Telenti, A; Mohney, RP; Small, KS; Bell, JT; Steves, CJ; Valdes, AM; Spector, TD; Menni, C				Zierer, Jonas; Jackson, Matthew A.; Kastenmueller, Gabi; Mangino, Massimo; Long, Tao; Telenti, Amalio; Mohney, Robert P.; Small, Kerrin S.; Bell, Jordana T.; Steves, Claire J.; Valdes, Ana M.; Spector, Tim D.; Menni, Cristina			The fecal metabolome as a functional readout of the gut microbiome	NATURE GENETICS			English	Article							GENE-EXPRESSION; VISCERAL FAT; MASS; QUANTIFICATION; SEQUENCES; CAFFEINE; IMPACT; URINE; DIET	The human gut microbiome plays a key role in human health1, but 16S characterization lacks quantitative functional annotation(2). The fecal metabolome provides a functional readout of microbial activity and can be used as an intermediate phenotype mediating host-microbiome interactions(3). In this comprehensive description of the fecal metabolome, examining 1,116 metabolites from 786 individuals from a population-based twin study (TwinsUK), the fecal metabolome was found to be only modestly influenced by host genetics (heritability (H-2) = 17.9%). One replicated locus at the NAT2 gene was associated with fecal metabolic traits. The fecal metabolome largely reflects gut microbial composition, explaining on average 67.7% (+/- 18.8%) of its variance. It is strongly associated with visceral-fat mass, thereby illustrating potential mechanisms underlying the wellestablished microbial influence on abdominal obesity. Fecal metabolic profiling thus is a novel tool to explore links among microbiome composition, host phenotypes, and heritable complex traits.	[Zierer, Jonas; Jackson, Matthew A.; Mangino, Massimo; Small, Kerrin S.; Bell, Jordana T.; Steves, Claire J.; Valdes, Ana M.; Spector, Tim D.; Menni, Cristina] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Zierer, Jonas; Kastenmueller, Gabi] Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, German Res Ctr Environm Hlth, Neuherberg, Germany; [Mangino, Massimo] Guys & St Thomas Fdn Trust, NIHR Biomed Res Ctr, London, England; [Long, Tao; Telenti, Amalio] Human Longev Inc, San Diego, CA USA; [Mohney, Robert P.] Metabolon Inc, Durham, NC USA; [Valdes, Ana M.] NIHR Nottingham Biomed Res Ctr, Nottingham, England; [Valdes, Ana M.] Univ Nottingham, Sch Med, Nottingham, England; [Zierer, Jonas] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY USA; [Long, Tao] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA	University of London; King's College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Guy's & St Thomas' NHS Foundation Trust; Metabolon; University of Nottingham; Cornell University; Sanford Burnham Prebys Medical Discovery Institute	Spector, TD; Menni, C (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England.	tim.spector@kcl.ac.uk; cristina.menni@kcl.ac.uk	Bell, Jordana/AAH-7312-2019; Kastenmüller, Gabi/ABF-5987-2020; Mangino, Massimo/F-5134-2011; Telenti, Amalio/AAY-1674-2021; Jackson, Matthew/N-1019-2016	Mangino, Massimo/0000-0002-2167-7470; Small, Kerrin/0000-0003-4566-0005; Valdes, Ana M./0000-0003-1141-4471; Zierer, Jonas/0000-0002-9693-1859; Jackson, Matthew/0000-0002-7891-6217; Long, Tao/0000-0002-7052-9546; Kastenmuller, Gabi/0000-0002-2368-7322; Bell, Jordana/0000-0002-3858-5986; Steves, Claire/0000-0002-4910-0489	Wellcome Trust; European Community's Seventh Framework Programme (FP7); National Institute for Health Research (NIHR); Chronic Disease Research Foundation; Denise Coates Foundation; MRC AIM HY project grant [MR/M016560/1]; MRC [MR/N01183X/1, MR/N030125/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); European Community's Seventh Framework Programme (FP7)(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Chronic Disease Research Foundation; Denise Coates Foundation; MRC AIM HY project grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Wellcome Trust, European Community's Seventh Framework Programme (FP7/2007-2013). The study also received support from the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and the Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London, by the Chronic Disease Research Foundation and by the Denise Coates Foundation. HLI, Inc., collaborated with King's College London to produce the metabolomics data from Metabolon, Inc. C.M. was funded by the MRC AIM HY (MR/M016560/1) project grant. We thank J. Goodrich and R. Ley for support in sequencing the fecal samples.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Arora T, 2016, J INTERN MED, V280, P339, DOI 10.1111/joim.12508; Bastian F, 2008, LECT N BIOINFORMAT, V5109, P124, DOI 10.1007/978-3-540-69828-9_12; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beaumont M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1052-7; Cangelosi GA, 2014, APPL ENVIRON MICROB, V80, P5884, DOI 10.1128/AEM.01763-14; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Clarke G, 2014, MOL ENDOCRINOL, V28, P1221, DOI 10.1210/me.2014-1108; Csardi G., 2006, INTERJOURNAL COMPLEX; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Dejean S., 2013, MIXOMICS OMICS DATA; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Evans A, 2014, METABOLOMICS, V4, pS24; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Goodrich JK, 2016, CELL HOST MICROBE, V19, P731, DOI 10.1016/j.chom.2016.04.017; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Jackson MA, 2016, PEERJ, V4, DOI 10.7717/peerj.2341; Kaul S, 2012, OBESITY, V20, P1313, DOI 10.1038/oby.2011.393; Keegan KP, 2016, METHODS MOL BIOL, V1399, P207, DOI 10.1007/978-1-4939-3369-3_13; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Long T, 2017, NAT GENET, V49, P568, DOI 10.1038/ng.3809; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marcobal A, 2013, ISME J, V7, P1933, DOI 10.1038/ismej.2013.89; McDonagh EM, 2014, PHARMACOGENET GENOM, V24, P409, DOI 10.1097/FPC.0000000000000062; Meinl W, 2009, DRUG METAB DISPOS, V37, P1179, DOI 10.1124/dmd.108.025916; Menni C, 2016, OBESITY, V24, P1380, DOI 10.1002/oby.21488; Moayyeri A, 2013, INT J EPIDEMIOL, V42, P76, DOI 10.1093/ije/dyr207; Neale M., 1994, METHODOLOGY GENETIC; Nyeki A, 2003, BRIT J CLIN PHARMACO, V55, P62, DOI 10.1046/j.1365-2125.2003.01730.x; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; O'Toole PW, 2010, INT DAIRY J, V20, P281, DOI 10.1016/j.idairyj.2009.11.010; Pallister T, 2017, INT J OBESITY, V41, P1106, DOI 10.1038/ijo.2017.70; Parseus A, 2017, GUT, V66, P429, DOI 10.1136/gutjnl-2015-310283; Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646; Petersen AK, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-120; Raffler J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005487; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Schaefer J., 2014, GENENET MODELING INF; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Shoaie S, 2015, CELL METAB, V22, P320, DOI 10.1016/j.cmet.2015.07.001; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Telenti A, 2016, P NATL ACAD SCI USA, V113, P11901, DOI 10.1073/pnas.1613365113; Tigchelaar EF, 2016, GUT, V65, P540, DOI 10.1136/gutjnl-2015-310328; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vandeputte D, 2016, GUT, V65, P57, DOI 10.1136/gutjnl-2015-309618; Varemo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111; Weimann A, 2005, J MASS SPECTROM, V40, P307, DOI 10.1002/jms.785; Westcott SL, 2015, PEERJ, V3, DOI 10.7717/peerj.1487; Wolak ME, 2012, METHODS ECOL EVOL, V3, P129, DOI 10.1111/j.2041-210X.2011.00125.x; Yang Jian, 2011, Am J Hum Genet, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhao JH, 2007, J STAT SOFTW, V23; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	57	275	281	22	157	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2018	50	6					790	+		10.1038/s41588-018-0135-7	http://dx.doi.org/10.1038/s41588-018-0135-7			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GH7KD	29808030	Green Accepted, Green Submitted			2022-12-17	WOS:000433621000006
J	Heinzen, EL; Swoboda, KJ; Hitomi, Y; Gurrieri, F; Nicole, S; de Vries, B; Tiziano, FD; Fontaine, B; Walley, NM; Heavin, S; Panagiotakaki, E; Fiori, S; Abiusi, E; Di Pietro, L; Sweney, MT; Newcomb, TM; Viollet, L; Huff, C; Jorde, LB; Reyna, SP; Murphy, KJ; Shianna, KV; Gumbs, CE; Little, L; Silver, K; Ptacek, LJ; Haan, J; Ferrari, MD; Bye, AM; Herkes, GK; Whitelaw, CM; Webb, D; Lynch, BJ; Uldall, P; King, MD; Scheffer, IE; Neri, G; Arzimanoglou, A; van den Maagdenberg, AMJM; Sisodiya, SM; Mikati, MA; Goldstein, DB				Heinzen, Erin L.; Swoboda, Kathryn J.; Hitomi, Yuki; Gurrieri, Fiorella; Nicole, Sophie; de Vries, Boukje; Tiziano, F. Danilo; Fontaine, Bertrand; Walley, Nicole M.; Heavin, Sinead; Panagiotakaki, Eleni; Fiori, Stefania; Abiusi, Emanuela; Di Pietro, Lorena; Sweney, Matthew T.; Newcomb, Tara M.; Viollet, Louis; Huff, Chad; Jorde, Lynn B.; Reyna, Sandra P.; Murphy, Kelley J.; Shianna, Kevin V.; Gumbs, Curtis E.; Little, Latasha; Silver, Kenneth; Ptacek, Louis J.; Haan, Joost; Ferrari, Michel D.; Bye, Ann M.; Herkes, Geoffrey K.; Whitelaw, Charlotte M.; Webb, David; Lynch, Bryan J.; Uldall, Peter; King, Mary D.; Scheffer, Ingrid E.; Neri, Giovanni; Arzimanoglou, Alexis; van den Maagdenberg, Arn M. J. M.; Sisodiya, Sanjay M.; Mikati, Mohamad A.; Goldstein, David B.		European Alternating Hemiplegia; Biobanca Registro Clinico; European Network Res Alternating	De novo mutations in ATP1A3 cause alternating hemiplegia of childhood	NATURE GENETICS			English	Article							ONSET DYSTONIA-PARKINSONISM; GENE MUTATION; MIGRAINE; PUMP; PATHOPHYSIOLOGY; GENOMES	Alternating hemiplegia of childhood (AHC) is a rare, severe neurodevelopmental syndrome characterized by recurrent hemiplegic episodes and distinct neurological manifestations. AHC is usually a sporadic disorder and has unknown etiology. We used exome sequencing of seven patients with AHC and their unaffected parents to identify de novo nonsynonymous mutations in ATP1A3 in all seven individuals. In a subsequent sequence analysis of ATP1A3 in 98 other patients with AHC, we found that ATP1A3 mutations were likely to be responsible for at least 74% of the cases; we also identified one inherited mutation in a case of familial AHC. Notably, most AHC cases are caused by one of seven recurrent ATP1A3 mutations, one of which was observed in 36 patients. Unlike ATP1A3 mutations that cause rapid-onset dystonia-parkinsonism, AHC-causing mutations in this gene caused consistent reductions in ATPase activity without affecting the level of protein expression. This work identifies de novo ATP1A3 mutations as the primary cause of AHC and offers insight into disease pathophysiology by expanding the spectrum of phenotypes associated with mutations in ATP1A3.	[Heinzen, Erin L.; Hitomi, Yuki; Walley, Nicole M.; Shianna, Kevin V.; Gumbs, Curtis E.; Little, Latasha; Goldstein, David B.] Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27708 USA; [Heinzen, Erin L.; Shianna, Kevin V.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Swoboda, Kathryn J.; Sweney, Matthew T.; Newcomb, Tara M.] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Swoboda, Kathryn J.; Viollet, Louis; Reyna, Sandra P.; Murphy, Kelley J.] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [Gurrieri, Fiorella; Tiziano, F. Danilo; Fiori, Stefania; Abiusi, Emanuela; Di Pietro, Lorena; Neri, Giovanni] Univ Cattolica Sacro Cuore, Inst Med Genet, Policlin A Gemelli, Rome, Italy; [Nicole, Sophie; Fontaine, Bertrand] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France; [Nicole, Sophie; Fontaine, Bertrand] INSERM, U975, Paris, France; [Nicole, Sophie; Fontaine, Bertrand] CNRS, UMR7225, Paris, France; [de Vries, Boukje; van den Maagdenberg, Arn M. J. M.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Fontaine, Bertrand] Grp Hosp Pitie Salpetriere, AP HP, Dept Neurol, F-75634 Paris, France; [Fontaine, Bertrand] Grp Hosp Pitie Salpetriere, AP HP, Ctr Reference Canalopathies Musculaires, F-75634 Paris, France; [Heavin, Sinead; Scheffer, Ingrid E.] Univ Melbourne, Austin Hlth, Dept Med, Melbourne, Vic, Australia; [Panagiotakaki, Eleni; Arzimanoglou, Alexis] Univ Hosp Lyon HCL, Woman Mother Child Hosp, Epilepsy Sleep & Pediat Neurophysiol Dept, Lyon, France; [Huff, Chad; Jorde, Lynn B.] Univ Utah, Eccles Inst Human Genet, Dept Human Genet, Salt Lake City, UT USA; [Silver, Kenneth] Univ Chicago, Dept Neurol, Comer Childrens Hosp, Chicago, IL 60637 USA; [Silver, Kenneth] Univ Chicago, Dept Pediat, Comer Childrens Hosp, Chicago, IL 60637 USA; [Ptacek, Louis J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Ptacek, Louis J.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Haan, Joost] Rijnland Hosp, Dept Neurol, Leiderdorp, Netherlands; [Haan, Joost; Ferrari, Michel D.; van den Maagdenberg, Arn M. J. M.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Bye, Ann M.] Sydney Childrens Hosp, Dept Paediat Neurol, Randwick, NSW, Australia; [Herkes, Geoffrey K.; Whitelaw, Charlotte M.] Univ Sydney, Royal N Shore Hosp, Sydney, NSW 2006, Australia; [Whitelaw, Charlotte M.] Univ Sydney, No Clin Sch, Sydney, NSW 2006, Australia; [Webb, David] Our Ladys Childrens Hosp, Dublin, Ireland; [Lynch, Bryan J.; King, Mary D.] Childrens Univ Hosp, Dublin, Ireland; [Uldall, Peter] Univ Copenhagen, Rigshosp, Dept Paediat & Adolescent Med, DK-2100 Copenhagen, Denmark; [Scheffer, Ingrid E.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic, Australia; [Scheffer, Ingrid E.] Florey Neurosci Inst, Melbourne, Vic, Australia; [Arzimanoglou, Alexis] CNRS, INSERM, U1028, Lyon, France; [Arzimanoglou, Alexis] CNRS, UMR 5292, Lyon, France; [Sisodiya, Sanjay M.] UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London, England; [Mikati, Mohamad A.] Duke Univ, Med Ctr, Div Pediat Neurol, Durham, NC USA; [Mikati, Mohamad A.] Duke Univ, Dept Neurobiol, Durham, NC USA; [Goldstein, David B.] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC USA	Duke University; Duke University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; CHU Lyon; Utah System of Higher Education; University of Utah; University of Chicago; University of Chicago; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Rijnland Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Royal North Shore Hospital; University of Sydney; University of Sydney; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Childrens University Hospital - Temple Street; Rigshospitalet; University of Copenhagen; Royal Children's Hospital Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; University of London; University College London; Duke University; Duke University; Duke University	Goldstein, DB (corresponding author), Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27708 USA.	mohamad.mikati@dm.duke.edu; d.goldstein@dm.duke.edu	Tiziano, Francesco Danilo/A-7260-2010; Granata, Tiziana/J-9012-2016; Di Pietro, Lorena/Z-3179-2019; Scheffer, Ingrid E/G-1668-2013; Nardocci, Nardo/AAB-9903-2019; Hitomi, Yuki/V-8236-2019; Panagiotakaki, Eleni/AAN-1067-2020; Nevšímalová, Soňa/H-3533-2017; Abiusi, Emanuela/H-6743-2018; van den Maagdenberg, Arn M.J.M./AAE-9052-2019; Ferrari, Michel D./ABE-3758-2021; Casari, Giorgio/J-3070-2018; Gurrieri, Fiorella/K-3214-2016; Stagnaro, Michela/AAZ-6525-2020; Bassi, Maria Teresa T/A-3517-2014; Goldstein, David/AAY-8125-2020; Herkes, Geoffrey/ABC-7464-2020; Kemlink, David/F-9567-2017; NICOLE, Sophie/N-4348-2018; Vigevano, Federico/K-9466-2016	Tiziano, Francesco Danilo/0000-0002-5545-6158; Granata, Tiziana/0000-0002-0170-6836; Di Pietro, Lorena/0000-0001-5723-2169; Scheffer, Ingrid E/0000-0002-2311-2174; Nardocci, Nardo/0000-0001-5863-5592; Nevšímalová, Soňa/0000-0003-0083-3742; Ferrari, Michel D./0000-0001-9691-9449; Casari, Giorgio/0000-0002-0115-8980; Gurrieri, Fiorella/0000-0002-6775-5972; Bassi, Maria Teresa T/0000-0002-8236-1197; Herkes, Geoffrey/0000-0002-4491-8441; Kemlink, David/0000-0003-1398-5796; Arzimanoglou, Alexis/0000-0002-7233-2771; NICOLE, Sophie/0000-0001-8793-7928; Vigevano, Federico/0000-0001-7513-0051; DE GRANDIS, ELISA/0000-0002-9733-9216; Swoboda, Kathryn/0000-0002-4593-6342; Abiusi, Emanuela/0000-0001-9028-012X; Crawley, Francis P./0000-0002-6893-5916; Mikati, Mohamad/0000-0003-0363-8715; martinelli boneschi, filippo/0000-0002-9955-1368; Panagiotakaki, Eleni/0000-0003-2611-0227; Zucca, Claudio/0000-0001-7621-2542; Webb, David/0000-0002-0762-8277	Italian Patient Association for Alternating Hemiplegia (AISEA Onlus); Center for Human Genome Variation; Center for HIV/AIDS Vaccine Immunology; Joseph and Kathleen Bryan Alzheimer's Disease Research Center from the National Institutes of Health (NIH), including the National Institute of Allergy and Infectious Disease [UO1AIO67854]; National Institute on Aging [P30 AG028377]; National Institute of Neurological Disorders and Stroke [RC2NS070344, 1RC2NS070342-01]; National Institute of Mental Health [RC2MH089915]; AHCF; ENRAH for SMEs Consortium under the European Commission Sixth Framework Programme; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; University Pierre and Marie Curie; Association Francaise Contre les Myopathies; Association Francaise de l'Hemiplegie Alternante; AISEA Onlus; Wellcome Trust [084730]; National Center for Research Resources [UL1RR025764]; NIH [1T32HL105321-01]; University of Luxembourg Institute for Systems Biology Program; Center for Medical Systems Biology established in The Netherlands Genomics Initiative and The Netherlands Organisation for Scientific Research [050-060-409]; Contrat d'Interface from Assistance Publique-Hopitaux de Paris; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025764] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS070344, RC2NS070342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028377] Funding Source: NIH RePORTER	Italian Patient Association for Alternating Hemiplegia (AISEA Onlus); Center for Human Genome Variation; Center for HIV/AIDS Vaccine Immunology; Joseph and Kathleen Bryan Alzheimer's Disease Research Center from the National Institutes of Health (NIH), including the National Institute of Allergy and Infectious Disease; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); AHCF; ENRAH for SMEs Consortium under the European Commission Sixth Framework Programme; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University Pierre and Marie Curie; Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); Association Francaise de l'Hemiplegie Alternante; AISEA Onlus; Wellcome Trust(Wellcome TrustEuropean Commission); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Luxembourg Institute for Systems Biology Program; Center for Medical Systems Biology established in The Netherlands Genomics Initiative and The Netherlands Organisation for Scientific Research; Contrat d'Interface from Assistance Publique-Hopitaux de Paris; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Italian Patient Association for Alternating Hemiplegia (AISEA Onlus) for coordinating and funding the project I.B.AHC Biobank and Clinical Registry for Alternating Hemiplegia. Specifically, we thank M.T. Bassi and E. Tenderini for preparing all of the samples from AHC-affected individuals for analysis. Many thanks also to the Scientific Institute E. Medea, which hosts the I.B.AHC Biobank according to the I.B.AHC protocol.; The following individuals contributed next-generation sequenced control samples to this study: D. Attix, E. Behr, R. Brown, J. Burke, D. Daskalakis, V. Dixon, Z. Farfel, R. Gbadegesin, A. Holden, E. Holtzman, J. Hoover-Fong, C. Hulette, S. Kerns, D. Lancet, D. Levy, N. Liang, W. Lowe, P. Lugar, D. Marchuk, J. McEvoy, J. Milner, H. Oster, R. Ottman, S. Palmer, E. Pras, V. Shashi, N. Sobriera, D. Valle, K. Welsh-Bohmer and M. Winn, as well as the MURDOCK study community registry. Funding for the collection and sequencing of control samples was provided by the Center for Human Genome Variation, the Center for HIV/AIDS Vaccine Immunology and the Joseph and Kathleen Bryan Alzheimer's Disease Research Center under grants from the National Institutes of Health (NIH), including the National Institute of Allergy and Infectious Disease (UO1AIO67854); the National Institute on Aging (P30 AG028377); the National Institute of Neurological Disorders and Stroke (RC2NS070344 and 1RC2NS070342-01) and the National Institute of Mental Health (RC2MH089915).; This study was funded in part by grants from the AHCF (to K.J.S., S.P.R. and T.M.N.); the ENRAH for SMEs Consortium under the European Commission Sixth Framework Programme; the Institut National de la Sante et de la Recherche Medicale (to S.N. and B.F.); the Centre National de la Recherche Scientifique (to S.N. and B.F.); the University Pierre and Marie Curie (to S.N. and B.F.); the Association Francaise Contre les Myopathies (to S.N. and B.F.); the Association Francaise de l'Hemiplegie Alternante (to S.N., A.M.J.M.v.d.M. and B.d.V.); AISEA Onlus (to F.G. and G.N.); the Center for Human Genome Variation; the Wellcome Trust (084730 to S.M.S.); the National Center for Research Resources (UL1RR025764 to the University of Utah Center for Clinical and Translational Sciences; K.J.S.); the NIH (1T32HL105321-01 to C.H.); the University of Luxembourg Institute for Systems Biology Program (to C.H.) and the Center for Medical Systems Biology established in The Netherlands Genomics Initiative and The Netherlands Organisation for Scientific Research (project 050-060-409 to A.M.J.M.v.d.M. and M.D.F.). S.N. is a recipient of a Contrat d'Interface from Assistance Publique-Hopitaux de Paris.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Anselm IA, 2009, NEUROLOGY, V73, P400, DOI 10.1212/WNL.0b013e3181b04acd; Bassi MT, 2004, J MED GENET, V41, P621, DOI 10.1136/jmg.2003.017863; BELLUS GA, 1995, AM J HUM GENET, V56, P368; Blanco-Arias P, 2009, HUM MOL GENET, V18, P2370, DOI 10.1093/hmg/ddp170; BOURGEOIS M, 1993, J PEDIATR-US, V122, P673, DOI 10.1016/S0022-3476(06)80003-X; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Ge DL, 2011, BIOINFORMATICS, V27, P1998, DOI 10.1093/bioinformatics/btr317; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Kamm C, 2008, NEUROLOGY, V70, P1501, DOI 10.1212/01.wnl.0000310431.41036.e0; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MIKATI MA, 1992, NEUROLOGY, V42, P2251, DOI 10.1212/WNL.42.12.2251; Mikati MA, 2000, PEDIATR NEUROL, V23, P134, DOI 10.1016/S0887-8994(00)00157-0; Neville BGR, 2007, DEV MED CHILD NEUROL, V49, P777, DOI 10.1111/j.1469-8749.2007.00777.x; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Panagiotakaki E, 2010, BRAIN, V133, P3598, DOI 10.1093/brain/awq295; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Rho JM, 1998, J CHILD NEUROL, V13, P39, DOI 10.1177/088307389801300107; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Svetel M, 2010, J NEUROL, V257, P472, DOI 10.1007/s00415-009-5385-y; Sweney MT, 2009, PEDIATRICS, V123, pe534, DOI 10.1542/peds.2008-2027; Swoboda KJ, 2004, ANN NEUROL, V55, P884, DOI 10.1002/ana.20134; Vanmolkot KRJ, 2003, ANN NEUROL, V54, P360, DOI 10.1002/ana.10674; VERRETT S, 1971, PEDIATRICS, V47, P675; Zhu M., AM J HUM GE IN PRESS	29	275	297	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2012	44	9					1030	+		10.1038/ng.2358	http://dx.doi.org/10.1038/ng.2358			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	001WP	22842232	Green Submitted, Green Accepted			2022-12-17	WOS:000308491200015
J	Jallow, M; Teo, YY; Small, KS; Rockett, KA; Deloukas, P; Clark, TG; Kivinen, K; Bojang, KA; Conway, DJ; Pinder, M; Sirugo, G; Sisay-Joof, F; Usen, S; Auburn, S; Bumpstead, SJ; Campino, S; Coffey, A; Dunham, A; Fry, AE; Green, A; Gwilliam, R; Hunt, SE; Inouye, M; Jeffreys, AE; Mendy, A; Palotie, A; Potter, S; Ragoussis, J; Rogers, J; Rowlands, K; Somaskantharajah, E; Whittaker, P; Widden, C; Donnelly, P; Howie, B; Marchini, J; Morris, A; SanJoaquin, M; Achidi, EA; Agbenyega, T; Allen, A; Amodu, O; Corran, P; Djimde, A; Dolo, A; Doumbo, OK; Drakeley, C; Dunstan, S; Evans, J; Farrar, J; Fernando, D; Hien, TT; Horstmann, RD; Ibrahim, M; Karunaweera, N; Kokwaro, G; Koram, KA; Lemnge, M; Makani, J; Marsh, K; Michon, P; Modiano, D; Molyneux, ME; Mueller, I; Parker, M; Peshu, N; Plowe, CV; Puijalon, O; Reeder, J; Reyburn, H; Riley, EM; Sakuntabhai, A; Singhasivanon, P; Sirima, S; Tall, A; Taylor, TE; Thera, M; Troye-Blomberg, M; Williams, TN; Wilson, M; Kwiatkowski, DP				Jallow, Muminatou; Teo, Yik Ying; Small, Kerrin S.; Rockett, Kirk A.; Deloukas, Panos; Clark, Taane G.; Kivinen, Katja; Bojang, Kalifa A.; Conway, David J.; Pinder, Margaret; Sirugo, Giorgio; Sisay-Joof, Fatou; Usen, Stanley; Auburn, Sarah; Bumpstead, Suzannah J.; Campino, Susana; Coffey, Alison; Dunham, Andrew; Fry, Andrew E.; Green, Angela; Gwilliam, Rhian; Hunt, Sarah E.; Inouye, Michael; Jeffreys, Anna E.; Mendy, Alieu; Palotie, Aarno; Potter, Simon; Ragoussis, Jiannis; Rogers, Jane; Rowlands, Kate; Somaskantharajah, Elilan; Whittaker, Pamela; Widden, Claire; Donnelly, Peter; Howie, Bryan; Marchini, Jonathan; Morris, Andrew; SanJoaquin, Miguel; Achidi, Eric Akum; Agbenyega, Tsiri; Allen, Angela; Amodu, Olukemi; Corran, Patrick; Djimde, Abdoulaye; Dolo, Amagana; Doumbo, Ogobara K.; Drakeley, Chris; Dunstan, Sarah; Evans, Jennifer; Farrar, Jeremy; Fernando, Deepika; Hien, Tran Tinh; Horstmann, Rolf D.; Ibrahim, Muntaser; Karunaweera, Nadira; Kokwaro, Gilbert; Koram, Kwadwo A.; Lemnge, Martha; Makani, Julie; Marsh, Kevin; Michon, Pascal; Modiano, David; Molyneux, Malcolm E.; Mueller, Ivo; Parker, Michael; Peshu, Norbert; Plowe, Christopher V.; Puijalon, Odile; Reeder, John; Reyburn, Hugh; Riley, Eleanor M.; Sakuntabhai, Anavaj; Singhasivanon, Pratap; Sirima, Sodiomon; Tall, Adama; Taylor, Terrie E.; Thera, Mahamadou; Troye-Blomberg, Marita; Williams, Thomas N.; Wilson, Michael; Kwiatkowski, Dominic P.		Wellcome Trust Case Control Consor; Malaria Genomic Epidemiology Netwo	Genome-wide and fine-resolution association analysis of malaria in West Africa	NATURE GENETICS			English	Article							BETA-GLOBIN GENE; LINKAGE DISEQUILIBRIUM; NATURAL-SELECTION; HEMOGLOBIN-C; POPULATION; CHILDREN; POWER; INDICATORS; COVERAGE; ORIGIN	We report a genome-wide association (GWA) study of severe malaria in The Gambia. The initial GWA scan included 2,500 children genotyped on the Affymetrix 500K GeneChip, and a replication study included 3,400 children. We used this to examine the performance of GWA methods in Africa. We found considerable population stratification, and also that signals of association at known malaria resistance loci were greatly attenuated owing to weak linkage disequilibrium (LD). To investigate possible solutions to the problem of low LD, we focused on the HbS locus, sequencing this region of the genome in 62 Gambian individuals and then using these data to conduct multipoint imputation in the GWA samples. This increased the signal of association, from P = 4 x 10(-7) to P = 4 x 10(-14), with the peak of the signal located precisely at the HbS causal variant. Our findings provide proof of principle that fine-resolution multipoint imputation, based on population-specific sequencing data, can substantially boost authentic GWA signals and enable fine mapping of causal variants in African populations.	[Teo, Yik Ying; Small, Kerrin S.; Rockett, Kirk A.; Clark, Taane G.; Auburn, Sarah; Campino, Susana; Fry, Andrew E.; Green, Angela; Jeffreys, Anna E.; Mendy, Alieu; Ragoussis, Jiannis; Rogers, Jane; Rowlands, Kate; Donnelly, Peter; Marchini, Jonathan; Morris, Andrew; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Jallow, Muminatou; Bojang, Kalifa A.; Conway, David J.; Pinder, Margaret; Sirugo, Giorgio; Sisay-Joof, Fatou; Usen, Stanley] MRC Labs, Banjul, Gambia; [Rockett, Kirk A.; Deloukas, Panos; Clark, Taane G.; Kivinen, Katja; Auburn, Sarah; Bumpstead, Suzannah J.; Campino, Susana; Coffey, Alison; Dunham, Andrew; Gwilliam, Rhian; Hunt, Sarah E.; Inouye, Michael; Palotie, Aarno; Potter, Simon; Somaskantharajah, Elilan; Whittaker, Pamela; Widden, Claire; SanJoaquin, Miguel; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Cambridge, England; [Donnelly, Peter; Howie, Bryan; Marchini, Jonathan] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [SanJoaquin, Miguel; Molyneux, Malcolm E.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Achidi, Eric Akum] Univ Buea, Buea, South West Prov, Cameroon; [Agbenyega, Tsiri; Evans, Jennifer] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Allen, Angela; Michon, Pascal; Mueller, Ivo; Reeder, John] Papua New Guinea Inst Med Res, Madang, Papua N Guinea; [Allen, Angela] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Amodu, Olukemi] Univ Ibadan, Coll Med, Inst Child Hlth, Ibadan, Nigeria; [Corran, Patrick] Natl Inst Biol Stand & Controls, Potters Bar, Herts, England; [Djimde, Abdoulaye; Dolo, Amagana; Doumbo, Ogobara K.; Thera, Mahamadou] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali; [Drakeley, Chris; Reyburn, Hugh; Riley, Eleanor M.] London Sch Hyg & Trop Med, London WC1, England; [Drakeley, Chris; Reyburn, Hugh; Riley, Eleanor M.] Kilimanjaro Christian Med Ctr, Joint Malaria Programme, Moshi, Tanzania; [Dunstan, Sarah; Farrar, Jeremy; Hien, Tran Tinh] Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam; [Evans, Jennifer; Horstmann, Rolf D.] Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany; [Fernando, Deepika; Karunaweera, Nadira] Univ Colombo, Fac Med, Colombo, Sri Lanka; [Ibrahim, Muntaser] Univ Khartoum, Inst Endem Dis, Khartoum, Sudan; [Kokwaro, Gilbert; Marsh, Kevin; Peshu, Norbert; Williams, Thomas N.] Kenyan Med Res Inst KEMRI, Wellcome Trust Programme, Kilifi, Kenya; [Koram, Kwadwo A.; Wilson, Michael] Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana; [Lemnge, Martha] Natl Inst Med Res, Dar Es Salaam, Tanzania; [Makani, Julie] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Modiano, David] Univ Roma La Sapienza, Rome, Italy; [Parker, Michael] Univ Oxford, Dept Publ Hlth & Primary Hlth Care, Ethox Ctr, Oxford, England; [Plowe, Christopher V.; Taylor, Terrie E.] Blantyre Malaria Project, Blantyre 3, Malawi; [Plowe, Christopher V.] Univ Maryland, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21201 USA; [Puijalon, Odile; Sakuntabhai, Anavaj] Inst Pasteur, Unite Immunol Mol Parasites, Paris, France; [Singhasivanon, Pratap] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Sirima, Sodiomon] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Tall, Adama] Inst Pasteur, Dakar, Senegal; [Taylor, Terrie E.] Michigan State Univ, Coll Osteopath Med, Dept Internal Med, E Lansing, MI 48824 USA; [Troye-Blomberg, Marita] Stockholm Univ, Wenner Gren Inst, S-10691 Stockholm, Sweden	University of Oxford; Wellcome Centre for Human Genetics; MRC Laboratory Molecular Biology; Wellcome Trust Sanger Institute; University of Oxford; University of Malawi; Kwame Nkrumah University Science & Technology; PNG Institute Of Medical Research; University of Oxford; University of Ibadan; National Institute for Biological Standards & Control; University of Bamako; University of London; London School of Hygiene & Tropical Medicine; Kilimanjaro Christian Medical Centre; University of Oxford; Bernhard Nocht Institut fur Tropenmedizin; University of Colombo; University of Khartoum; Kenya Medical Research Institute; University of Ghana; National Institute of Medical Research; Muhimbili University of Health & Allied Sciences; Sapienza University Rome; University of Oxford; Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Mahidol University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Michigan State University; Michigan State University College of Osteopathic Medicine; Stockholm University	Kwiatkowski, DP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	dominic@sanger.ac.uk	Sirugo, Giorgio/N-9056-2019; Mueller, Ivo/C-7251-2013; Fry, Andrew/AAN-2730-2020; Fry, Andrew/AFK-7448-2022; Breen, Gerome D/A-5540-2010; Riley, Eleanor/AAL-1382-2020; Campino, Susana/AAM-2577-2020; Dominiczak, Anna F/P-9390-2017; Clark, Taane G./AAM-2570-2020; Makani, Julie/E-8525-2017; Dunstan, Sarah/AAO-9597-2020; Mead, Daniel/AAE-6629-2019; mangano, valentina/I-2456-2012; eyre, stephen/K-3776-2017; Breen, Gerome/Y-2706-2019; Farrar, Jeremy J./HGA-7610-2022; Ragoussis, Ioannis/AAD-9790-2022; Marchini, Jonathan/ABE-9024-2020; Makani, Julie/N-9370-2013; Troye-Blomberg, Marita/B-9210-2016; Deloukas, Panos/B-2922-2013; Sirugo, Giorgio/L-1628-2016; Riley, Eleanor M/C-8960-2013; Yuldasheva, Nadira Yusupovna/GXM-9013-2022; Auburn, Sarah/N-2266-2013	Mueller, Ivo/0000-0001-6554-6889; Fry, Andrew/0000-0001-9778-6924; Fry, Andrew/0000-0001-9778-6924; Breen, Gerome D/0000-0003-2053-1792; Riley, Eleanor/0000-0003-3447-3570; Campino, Susana/0000-0003-1403-6138; Dominiczak, Anna F/0000-0003-4913-3608; Clark, Taane G./0000-0001-8985-9265; Makani, Julie/0000-0002-4801-6250; Mead, Daniel/0000-0001-7717-4330; eyre, stephen/0000-0002-1251-6974; Breen, Gerome/0000-0003-2053-1792; Marchini, Jonathan/0000-0003-0610-8322; Makani, Julie/0000-0002-4801-6250; Troye-Blomberg, Marita/0000-0002-2804-0325; Deloukas, Panos/0000-0001-9251-070X; Riley, Eleanor M/0000-0003-3447-3570; Munroe, Patricia/0000-0002-4176-2947; Thera, Mahamadou A/0000-0002-2679-035X; Mangano, Valentina D/0000-0002-2021-6162; Ragoussis, Ioannis/0000-0002-8515-0934; Hattersley, Andrew/0000-0001-5620-473X; Conway, David/0000-0002-8711-3037; Yuldasheva, Nadira Yusupovna/0000-0001-6213-6358; Oluoch, Tom/0000-0001-9621-5900; Apinjoh, Tobias/0000-0001-9889-7271; Karunaweera, Nadira/0000-0003-3985-1817; Hart, Lee/0000-0002-6473-0964; Auburn, Sarah/0000-0002-4638-536X; Lees, Charlie/0000-0002-0732-8215; Dunstan, Sarah/0000-0001-7873-933X; Reeder, John/0000-0003-1395-1289; Maslen, Gareth/0000-0001-7318-3678; Walton, Robert/0000-0001-7700-1907; Palotie, Aarno/0000-0002-2527-5874; Ishengoma, Deus/0000-0003-2040-3416; Moyes, Catherine/0000-0002-8028-4079; Zeggini, Eleftheria/0000-0003-4238-659X; Dunger, Professor David/0000-0002-2566-9304; Donnelly, Peter/0000-0001-9495-3408; SIRIMA, Sodiomon Bienvenu/0000-0002-0972-4211; Farrar, Jeremy/0000-0002-2700-623X; Singhasivanon, Pratap/0000-0002-9759-1702; Small, Kerrin/0000-0003-4566-0005; Manske, Magnus/0000-0001-5916-0947; Bojang, Kalifa/0000-0001-7506-0938; Weedon, Michael/0000-0002-6174-6135; Hunt, Sarah/0000-0002-8350-1235; Kwiatkowski, Dominic/0000-0002-5023-0176; Newport, Melanie/0000-0002-8946-7525; Lango Allen, Hana/0000-0002-7803-8688; Kivinen, Katja/0000-0002-1135-7625; Amodu, Olukemi/0000-0003-1477-4229; Inouye, Michael/0000-0001-9413-6520	Wellcome Trust [077383/Z/05/Z]; Bill & Melinda Gates Foundation; Foundation for the National Institutes of Health [566]; Medical Research Council [G0600230]; MRC [G0600718, G0600329, MC_U190081993, MC_U190081977, G19/9, G0800675, G9828345, G0800759, G0600230] Funding Source: UKRI; Medical Research Council [G0600329, G19/9, MC_U190081993, G9828345, G0600718, MC_U190081977, G0800675, G0800759] Funding Source: researchfish; Chief Scientist Office [CZB/4/540] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI065683] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Gambian children and their parents and guardians who made this study possible; and the doctors, nurses and fieldworkers at the Royal Victoria Hospital, Banjul and other health clinics who assisted with this work. MalariaGEN's primary funding is from the Wellcome Trust (grant number 077383/Z/05/Z) and from the Bill & Melinda Gates Foundation, through the Foundation for the National Institutes of Health (grant number 566) as part of the Grand Challenges in Global Health initiative. The Wellcome Trust (Sanger Institute core funding) and the Medical Research Council (grant number G0600230) provide additional support for genotyping, bioinformatics and analysis. The MalariaGEN Resource Centre is part of the European Union Network of Excellence on the Biology and Pathology of Malaria Parasites.	Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bhangale TR, 2008, NAT GENET, V40, P841, DOI 10.1038/ng.180; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHEBLOUNE Y, 1988, P NATL ACAD SCI USA, V85, P4431, DOI 10.1073/pnas.85.12.4431; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Hanchard N, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-52; Kwiatkowski D, 2008, NATURE, V456, P732, DOI 10.1038/nature07632; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Mockenhaupt FP, 2004, BLOOD, V104, P2003, DOI 10.1182/blood-2003-11-4090; Modiano D, 2008, HUM MOL GENET, V17, P789, DOI 10.1093/hmg/ddm350; MOLYNEUX ME, 1989, Q J MED, V71, P441; PAGNIER J, 1984, P NATL ACAD SCI-BIOL, V81, P1771, DOI 10.1073/pnas.81.6.1771; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Romans P, 1999, AM J TROP MED HYG, V60, P22, DOI 10.4269/ajtmh.1999.60.22; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Taylor T, 2006, T ROY SOC TROP MED H, V100, P615, DOI 10.1016/j.trstmh.2005.09.021; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Williams TN, 2005, BLOOD, V106, P368, DOI 10.1182/blood-2005-01-0313	38	275	277	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					657	665		10.1038/ng.388	http://dx.doi.org/10.1038/ng.388			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19465909	Green Accepted, Green Published			2022-12-17	WOS:000266411700014
J	Yu, XW; Ng, CP; Habacher, H; Roy, S				Yu, Xianwen; Ng, Chee Peng; Habacher, Hermann; Roy, Sudipto			Foxj1 transcription factors are master regulators of the motile ciliogenic program	NATURE GENETICS			English	Article							LEFT-RIGHT ASYMMETRY; AIRWAY EPITHELIAL-CELLS; PROTEIN-KINASE-A; ZEBRAFISH EMBRYO; HEDGEHOG ACTIVITY; KUPFFERS VESICLE; SONIC-HEDGEHOG; FACTOR HFH-4; NEURAL-TUBE; FACTOR RFX3	Motile cilia induce fluid movement through their rhythmic beating activity. In mammals, the transcription factor Foxj1 has been implicated in motile cilia formation. Here we show that a zebrafish Foxj1 homolog, foxj1a, is a target of Hedgehog signaling in the floor plate. Loss of Foxj1a compromises the assembly of motile cilia that decorate floor plate cells. Besides the floor plate, foxj1a is expressed in Kupffer's vesicle and pronephric ducts, where it also promotes ciliary differentiation. We show that Foxj1a activates a constellation of genes essential for motile cilia formation and function, and that its activity is sufficient for ectopic development of cilia that resemble motile cilia. We also document that a paralogous gene, foxj1b, is expressed in the otic vesicle and seems to regulate motile cilia formation in this tissue. Our findings identify a dedicated master regulatory role for Foxj1 in the transcriptional program that controls the production of motile cilia.	[Yu, Xianwen; Ng, Chee Peng; Habacher, Hermann; Roy, Sudipto] Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, Singapore 138673, Singapore; [Roy, Sudipto] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Roy, S (corresponding author), Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, 61 Biopolis Dr, Singapore 138673, Singapore.	sudipto@imcb.a-star.edu.sg	Yu, Xianwen/Q-2646-2019		Institute of Molecular and Cell Biology; Agency for Science, Technology and Research of Singapore	Institute of Molecular and Cell Biology; Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR))	We wish to thank J. Briscoe for discussion, M. Ma for the plasmid containing zebrafish cetn2 cDNA, C. X. Goh for technical assistance, S. Choksi for advice on ChIP and S. Choksi and other members of our laboratory for their comments on the manuscript. This work was funded by the Institute of Molecular and Cell Biology and the Agency for Science, Technology and Research of Singapore. S. R. is an adjunct faculty member in the Department of Biological Sciences, National University of Singapore.	Ait-Lounis A, 2007, DIABETES, V56, P950, DOI 10.2337/db06-1187; Alexander J, 1999, CURR BIOL, V9, P1147, DOI 10.1016/S0960-9822(00)80016-0; AMOS WB, 1985, CELL MOTIL CYTOSKEL, V5, P239, DOI 10.1002/cm.970050306; Beisson J, 2003, CURR OPIN CELL BIOL, V15, P96, DOI 10.1016/S0955-0674(02)00017-0; Blatt EN, 1999, AM J RESP CELL MOL, V21, P168, DOI 10.1165/ajrcmb.21.2.3691; Bonnafe E, 2004, MOL CELL BIOL, V24, P4417, DOI 10.1128/MCB.24.10.4417-4427.2004; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Chen WB, 2001, DEVELOPMENT, V128, P2385; Choi VM, 2006, GENE EXPR PATTERNS, V6, P443, DOI 10.1016/j.modgep.2005.11.007; Concordet JP, 1996, DEVELOPMENT, V122, P2835; Dubruille R, 2002, DEVELOPMENT, V129, P5487, DOI 10.1242/dev.00148; DUTCHER SK, 1995, TRENDS GENET, V11, P398, DOI 10.1016/S0168-9525(00)89123-4; Ertzer R, 2007, DEV BIOL, V301, P578, DOI 10.1016/j.ydbio.2006.11.004; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Gomperts BN, 2004, J CELL SCI, V117, P1329, DOI 10.1242/jcs.00978; HACKETT BP, 1995, P NATL ACAD SCI USA, V92, P4249, DOI 10.1073/pnas.92.10.4249; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Huang T, 2003, J CELL SCI, V116, P4935, DOI 10.1242/jcs.00830; Ikeda T, 2005, FEBS LETT, V579, P819, DOI 10.1016/j.febslet.2004.12.070; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lim L, 1997, P NATL ACAD SCI USA, V94, P3094, DOI 10.1073/pnas.94.7.3094; Liu Y, 2007, DEVELOPMENT, V134, P1111, DOI 10.1242/dev.02806; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Ma M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030018; Majumdar A, 2000, DEVELOPMENT, V127, P2089; Odenthal J, 2000, DEV BIOL, V219, P350, DOI 10.1006/dbio.1999.9589; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Pelletier GJ, 1998, AM J PHYSIOL-LUNG C, V274, pL351, DOI 10.1152/ajplung.1998.274.3.L351; Riley BB, 1997, DEV BIOL, V191, P191, DOI 10.1006/dbio.1997.8736; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Xu J, 2006, GENETICS, V174, P735, DOI 10.1534/genetics.106.061523; You YJ, 2004, AM J PHYSIOL-LUNG C, V286, pL650, DOI 10.1152/ajplung.00170.2003; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301	44	275	282	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1445	1453		10.1038/ng.263	http://dx.doi.org/10.1038/ng.263			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	19011630				2022-12-17	WOS:000261215900021
J	Chuck, G; Meeley, R; Irish, E; Sakai, H; Hake, S				Chuck, George; Meeley, Robert; Irish, Erin; Sakai, Hajime; Hake, Sarah			The maize tasselseed4 microRNA controls sex determination and meristem cell fate by targeting Tasselseed6/indeterminate spikelet1	NATURE GENETICS			English	Article							FLORAL ORGAN IDENTITY; GENES; EXPRESSION; MUTANTS; PROTEIN; BOUNDARY; APETALA2; ENCODES; DOMAIN	In maize ( Zea mays), sex determination occurs through abortion of female carpels in the tassel and arrest of male stamens in the ear. The Tasselseed6 ( Ts6) and tasselseed4 ( ts4) mutations permit carpel development in the tassel while increasing meristem branching, showing that sex determination and acquisition of meristem fate share a common pathway. We show that ts4 encodes a mir172 microRNA that targets APETALA2 floral homeotic transcription factors. Three lines of evidence suggest that indeterminate spikelet1 ( ids1), an APETALA2 gene required for spikelet meristem determinacy, is a key target of ts4. First, loss of ids1 suppresses the ts4 sex determination and branching defects. Second, Ts6 mutants phenocopy ts4 and possess mutations in the microRNA binding site of ids1. Finally, IDS1 protein is expressed more broadly in ts4 mutants compared to wild type. Our results demonstrate that sexual identity in maize is acquired by limiting floral growth through negative regulation of the floral homeotic pathway.	Univ Calif Albany, USDA Agr Res Serv, Plant Gene Express Ctr, Albany, CA 94710 USA; Pioneer A DuPont Co, Johnston, IA 50131 USA; Univ Iowa, Dept Sci Biol, Iowa City, IA 52242 USA; Dupont Crop Genet, Wilmington, DE 19880 USA	United States Department of Agriculture (USDA); DuPont; University of Iowa; DuPont	Chuck, G (corresponding author), Univ Calif Albany, USDA Agr Res Serv, Plant Gene Express Ctr, Albany, CA 94710 USA.	gchuck@nature.berkeley.edu	Irish, Erin/C-7331-2016	Irish, Erin/0000-0003-4244-7938				Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; Bortiri E, 2006, PLANT CELL, V18, P574, DOI 10.1105/tpc.105.039032; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; CHENG PC, 1983, AM J BOT, V70, P450, DOI 10.2307/2443252; Chuck G, 1998, GENE DEV, V12, P1145, DOI 10.1101/gad.12.8.1145; DELONG A, 1993, CELL, V74, P757, DOI 10.1016/0092-8674(93)90522-R; Irish EE, 1997, AM J BOT, V84, P1502, DOI 10.2307/2446611; IRISH EE, 1994, DEV GENET, V15, P155, DOI 10.1002/dvg.1020150206; JACKSON D, 1994, DEVELOPMENT, V120, P405; Jackson D., 1991, MOL PLANT PATHOLOGY, P163; Kaplinsky NJ, 2003, DEVELOPMENT, V130, P1149, DOI 10.1242/dev.00336; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; NICKERSON NORTON H., 1959, ANN MISSOURI BOT GARD, V46, P19, DOI 10.2307/2394566; Okamuro JK, 1997, PLANT CELL, V9, P37, DOI 10.1105/tpc.9.1.37; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Phipps IF, 1928, J HERED, V19, P399, DOI 10.1093/oxfordjournals.jhered.a103030; POSTLETHEWAIT SN, 1964, AM J BOT, V51, P238, DOI 10.2307/2440292; Reeves R, 1996, BIOCHEMISTRY-US, V35, P5063, DOI 10.1021/bi952424p; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; VEIT B, 1993, PLANT CELL, V5, P1205, DOI 10.1105/tpc.5.10.1205; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Zhao L, 2007, PLANT J, V51, P840, DOI 10.1111/j.1365-313X.2007.03181.x	26	275	305	4	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1517	1521		10.1038/ng.2007.20	http://dx.doi.org/10.1038/ng.2007.20			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	18026103				2022-12-17	WOS:000251267400022
J	van Overveld, PGM; Lemmers, RJFL; Sandkuijl, LA; Enthoven, L; Winokur, ST; Bakels, F; Padberg, GW; van Ommen, GJB; Frants, RR; van der Maarel, SM				van Overveld, PGM; Lemmers, RJFL; Sandkuijl, LA; Enthoven, L; Winokur, ST; Bakels, F; Padberg, GW; van Ommen, GJB; Frants, RR; van der Maarel, SM			Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy	NATURE GENETICS			English	Article							DNA REARRANGEMENTS; METHYLATION; MUTATIONS; FSHD	The autosomal dominant myopathy facioscapulohumeral muscular dystrophy (FSHD1, OMIM 158900) is caused by contraction of the D4Z4 repeat array on 4qter. We show that this contraction causes marked hypomethylation of the contracted D4Z4 allele in individuals with FSHD1. Individuals with phenotypic FSHD1, who are clinically identical to FSHD1 but have an unaltered D4Z4, also have hypomethylation of D4Z4. These results strongly suggest that hypomethylation of D4Z4 is a key event in the cascade of epigenetic events causing FSHD1.	Leiden Univ, Med Ctr, Dept Human Genet, Ctr Human & Clin Genet, NL-2300 RA Leiden, Netherlands; Leiden Univ, Med Ctr, Leiden Amsterdam Ctr Drug Res, Div Med Pharmacol, NL-2300 RA Leiden, Netherlands; Univ Calif Irvine, Coll Med, Dept Biol Chem, Irvine, CA 92717 USA; Radboud Univ Nijmegen Med Ctr, Dept Neurol, Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California Irvine; Radboud University Nijmegen	van der Maarel, SM (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Ctr Human & Clin Genet, POB 9502, NL-2300 RA Leiden, Netherlands.	maarel@lumc.nl	Padberg, G.W.A.M./H-8079-2014; van der Maarel, Silvere/X-3631-2018	van der Maarel, Silvere/0000-0001-8103-711X; van Overveld, Petra GM/0000-0003-0216-5004				Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; Kondo T, 2000, HUM MOL GENET, V9, P597, DOI 10.1093/hmg/9.4.597; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; Lunt P W, 1998, Neuromuscul Disord, V8, P126, DOI 10.1016/S0960-8966(98)00012-1; Padberg GW, 1982, FACIOSCAPULOHUMERAL; Rand E, 2003, J CELL BIOCHEM, V88, P400, DOI 10.1002/jcb.10352; Randolph-Anderson BL, 2002, AM J HUM GENET, V71, P530; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P1997, DOI 10.1093/hmg/5.12.1997; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052	15	275	288	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2003	35	4					315	317		10.1038/ng1262	http://dx.doi.org/10.1038/ng1262			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	747DY	14634647				2022-12-17	WOS:000186791000011
J	Harrison, KA; Thaler, J; Pfaff, SL; Gu, H; Kehrl, JH				Harrison, KA; Thaler, J; Pfaff, SL; Gu, H; Kehrl, JH			Pancreas dorsal lobe agenesis and abnormal islets of Langerhans in Hlxb9-deficient mice	NATURE GENETICS			English	Article							HOMEODOMAIN TRANSCRIPTION FACTOR; HOMEOBOX GENE; BETA-CELLS; DIFFERENTIATION; REVEALS; REQUIREMENT; MESENCHYME; INTESTINE; NOTOCHORD; PDX-1	In most mammals the pancreas develops from the foregut endoderm as ventral and dorsal buds. These buds fuse and develop into a complex organ composed of endocrine, exocrine and ductal components(1,2). This developmental process depends upon an integrated network of transcription factors. Gene targeting experiments have revealed critical roles for Pdx1, lsl1, Pax4, Pax6 and Nkx2-2 (refs 3-10). The homeobox gene HLXB9 (encoding HB9) is prominently expressed in adult human pancreas(11), although its role in pancreas development and function is unknown. To facilitate its study, we isolated the mouse HLXB9 orthologue, Hlxb9. During mouse development, the dorsal and ventral pancreatic buds and mature beta-cells in the islets of Langerhans express Hlxb9. In mice homologous for a null mutation of Hlxb9, the dorsal lobe of the pancreas fails to develop. The remnant Hlxb9(-/-) pancreas has small islets of Langerhans with reduced numbers of insulin-producing p-cells. Hlxb9(-/-) beta-cells express low levels of the glucose transporter Glut2 and homeodomain factor Nkx 6-1. Thus, Hlxb9 is key to normal pancreas development and function.	NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Salk Institute	Kehrl, JH (corresponding author), NIAID, Immunoregulat Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	jkehrl@niaid.nih.gov	Kehrl, John/AAE-6292-2019	Kehrl, John/0000-0002-6526-159X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000737, Z01AI000719] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; BAUBONIS W, 1993, NUCLEIC ACIDS RES, V21, P2025, DOI 10.1093/nar/21.9.2025; Githens Sherwood, 1993, P21; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; HARRISON KA, 1994, J BIOL CHEM, V269, P19968; Hebrok M, 1998, GENE DEV, V12, P1705, DOI 10.1101/gad.12.11.1705; Jensen J, 1996, J BIOL CHEM, V271, P18749, DOI 10.1074/jbc.271.31.18749; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kim SK, 1997, DEVELOPMENT, V124, P4243; Offield MF, 1996, DEVELOPMENT, V122, P983; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Ross AJ, 1998, NAT GENET, V20, P358, DOI 10.1038/3828; RUDNICK A, 1994, P NATL ACAD SCI USA, V91, P12203, DOI 10.1073/pnas.91.25.12203; Sander M, 1997, J MOL MED, V75, P327, DOI 10.1007/s001090050118; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Sussel L, 1998, DEVELOPMENT, V125, P2213; THALER J, IN PRESS NEURON; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002	26	275	294	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1999	23	1					71	75		10.1038/12674	http://dx.doi.org/10.1038/12674			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	231XU	10471502				2022-12-17	WOS:000082337300019
J	Hayashi, YK; Chou, FL; Engvall, E; Ogawa, M; Matsuda, C; Hirabayashi, S; Yokochi, K; Ziober, BL; Kramer, RH; Kaufman, SJ; Ozawa, E; Goto, Y; Nonaka, I; Tsukahara, T; Wang, JZ; Hoffman, EP; Arahata, K				Hayashi, YK; Chou, FL; Engvall, E; Ogawa, M; Matsuda, C; Hirabayashi, S; Yokochi, K; Ziober, BL; Kramer, RH; Kaufman, SJ; Ozawa, E; Goto, Y; Nonaka, I; Tsukahara, T; Wang, JZ; Hoffman, EP; Arahata, K			Mutations in the integrin alpha 7 gene cause congenital myopathy	NATURE GENETICS			English	Article							JUNCTIONAL EPIDERMOLYSIS-BULLOSA; DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; CYTOPLASMIC DOMAINS; NERVOUS-SYSTEM; CHAIN GENE; EXPRESSION; LAMININ; MEROSIN; DEFICIENCY	The basal lamina of muscle fibers plays a crucial role in the of development and function of skeletal muscle. An important laminin receptor in muscle is integrin alpha 7 beta 1D. Integrin beta 1 is expressed throughout the body, while integrin alpha 7 is more muscle-specific(1-5). To address the role of integrin alpha 7 in human muscle disease, we determined alpha 7 protein expression in muscle biopsies from 117 patients with unclassified congenital myopathy and congenital muscular dystrophy by immunocytochemistry. We found three unrelated patients with integrin alpha 7 deficiency and normal laminin alpha 2 chain expression. To determine nine if any of these three patients had mutations of the integrin alpha 7 gene, ITGA7, we cloned and sequenced the full-length human ITGA7 cDNA, and screened the patients for mutations. One patient had splice mutations on both alleles; one causing a 21-bp insertion in the conserved cysteine-rich region, and the other causing a 98-bp deletion, A second patient was a compound heterozygote for the same 98-bp deletion, and had a l-bp frame-shift deletion on the other allele. A third showed marked deficiency of ITGA7 mRNA, Clinically, these patients showed congenital myopathy with delayed motor milestones, Our results demonstrate that mutations in ITGA7 are involved in a form of congenital myopathy.	Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 187, Japan; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Cell Biol, Kodaira, Tokyo 187, Japan; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Kodaira, Tokyo 187, Japan; Univ Pittsburgh, Sch Med, Dept Human Genet, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA; La Jolla Canc Res Ctr, Burnham Inst, La Jolla, CA 92037 USA; Agcy Ind Sci & Technol, Natl Inst Biosci & Human Technol, Dept Biomol Engn, Oho, Ibaraki 305, Japan; Nagano Childrens Hosp, Dept Pediat, Nagano 399, Japan; Seirei Mikatabara Hosp, Dept Neuropediat, Shizuoka 433, Japan; Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA; Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Sanford Burnham Prebys Medical Discovery Institute; National Institute of Advanced Industrial Science & Technology (AIST); University of California System; University of California San Francisco; University of Illinois System; University of Illinois Urbana-Champaign	Arahata, K (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 187, Japan.	arahata@ncnaxp.ncnp.go.jp		Hoffman, Eric/0000-0001-6470-5139	NIA NIH HHS [AG 14632] Funding Source: Medline; PHS HHS [R01 29525] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG014632] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ARAHATA K, 1989, P NATL ACAD SCI USA, V86, P7154, DOI 10.1073/pnas.86.18.7154; ARAHATA K, 1991, J NEUROL SCI, V101, P148, DOI 10.1016/0022-510X(91)90039-A; BANKER BQ, 1994, MYOLOGY, P1275; COLLO G, 1993, J BIOL CHEM, V268, P19019; DUBOWITZ V, 1989, COLOR ATLAS MUSCLE D, P52; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; Guicheney P, 1997, NEUROMUSCULAR DISORD, V7, P180, DOI 10.1016/S0960-8966(97)00460-4; HAYASHI YK, 1993, J NEUROL SCI, V119, P53, DOI 10.1016/0022-510X(93)90191-Z; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Hodges BL, 1997, J CELL SCI, V110, P2873; Kil SH, 1996, INT J DEV NEUROSCI, V14, P181, DOI 10.1016/0736-5748(96)00006-8; KIVIRIKKO S, 1995, HUM MOL GENET, V4, P959, DOI 10.1093/hmg/4.5.959; Martin PT, 1996, DEV BIOL, V174, P125, DOI 10.1006/dbio.1996.0057; Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318; MIZUNO Y, 1994, MUSCLE NERVE, V17, P206, DOI 10.1002/mus.880170212; Nagano A, 1996, NAT GENET, V12, P254, DOI 10.1038/ng0396-254; PHILPOT J, 1995, NEUROMUSCULAR DISORD, V5, P301, DOI 10.1016/0960-8966(94)00069-L; Pulkkinen L, 1997, HUM MOL GENET, V6, P669, DOI 10.1093/hmg/6.5.669; Ruzzi L, 1997, J CLIN INVEST, V99, P2826, DOI 10.1172/JCI119474; SONG WK, 1993, J CELL SCI, V106, P1139; SONG WK, 1992, J CELL BIOL, V117, P643, DOI 10.1083/jcb.117.3.643; TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351; VACHON P, 1997, J CLIN INVEST, V100, P170; Velling T, 1996, DEV DYNAM, V207, P355, DOI 10.1002/(SICI)1097-0177(199612)207:4<355::AID-AJA1>3.0.CO;2-G; VIDAL F, 1995, GENOMICS, V30, P273, DOI 10.1006/geno.1995.9877; VONDERMARK H, 1991, J BIOL CHEM, V266, P23593; WANG W, 1995, GENOMICS, V26, P56; YOSHIDA M, 1993, J BIOCHEM-TOKYO, V114, P634, DOI 10.1093/oxfordjournals.jbchem.a124229; ZIOBER BL, 1993, J BIOL CHEM, V268, P26773; [No title captured]	30	275	282	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1998	19	1					94	97		10.1038/ng0598-94	http://dx.doi.org/10.1038/ng0598-94			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590299				2022-12-17	WOS:000073346700027
J	Nakamura, T; Largaespada, DA; Shaughnessy, JD; Jenkins, NA; Copeland, NG				Nakamura, T; Largaespada, DA; Shaughnessy, JD; Jenkins, NA; Copeland, NG			Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias	NATURE GENETICS			English	Article							LEUKEMIA-VIRUS DNA; T-CELL LEUKEMIA; HOMEOBOX GENE; CHROMOSOMAL TRANSLOCATION; LINKAGE MAP; PRE-B; MICE; TRANSCRIPTION; PROTEIN; MOUSE	Retroviruses induce myeloid leukaemia in BXH-2 mice by the insertional mutation of cellular proto-oncogenes or tumour suppressor genes. Disease genes can thus be identified by proviral tagging through the identification of common viral integration sites in BXH-2 leukaemia. Here, we describe a new approach for proviral tagging that greatly facilitates the identification of BXH-2 leukaemia genes. Using this approach, we identify three genes whose expression is activated by proviral integration in BXH-2 leukaemias; Hoxa7, Hoxa9, and a Pbx1-related homeobox gene, Meis1. Proviral activation of Hoxa7 or Hoxa9 is strongly correlated with proviral activation of Meis1 implying that Hoxa7 and Hoxa9 cooperate with Meis1 in leukaemia formation. These studies provide the first genetic evidence that Pbx1-related genes cooperate with Hox genes in leukaemia formation and identify a number of new murine myeloid leukaemia genes.	NCI,FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,MAMMALIAN GENET LAB,FREDERICK,MD 21702	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick			Largaespada, David/C-9832-2014					BADER JL, 1978, J PEDIATR-US, V92, P925, DOI 10.1016/S0022-3476(78)80362-X; Bickmore W., 1992, Techniques for the analysis of complex genomes., P19; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BUCHBERG AM, 1990, MOL CELL BIOL, V10, P4658, DOI 10.1128/MCB.10.9.4658; CAWTHON RM, 1991, GENOMICS, V9, P446, DOI 10.1016/0888-7543(91)90410-G; CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; CHATTOPADHYAY SK, 1980, P NATL ACAD SCI-BIOL, V77, P5774, DOI 10.1073/pnas.77.10.5774; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; DEDERA DA, 1993, CELL, V74, P833, DOI 10.1016/0092-8674(93)90463-Z; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DUBE ID, 1991, BLOOD, V78, P2996; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; HATANO M, 1991, SCIENCE, V253, P79, DOI 10.1126/science.1676542; HENTHORN P, 1990, SCIENCE, V247, P467, DOI 10.1126/science.2105528; HERR W, 1983, J VIROL, V46, P70, DOI 10.1128/JVI.46.1.70-82.1983; HUNGER SP, 1991, BLOOD, V77, P687; ICHIKAWA Y, 1969, J CELL PHYSIOL, V74, P223, DOI 10.1002/jcp.1040740303; JENKINS NA, 1982, J VIROL, V42, P379, DOI 10.1128/JVI.42.2.379-388.1982; KAMPS MP, 1993, MOL CELL BIOL, V13, P351, DOI 10.1128/MCB.13.1.351; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; KAMPS MP, 1994, ONCOGENE, V9, P3159; KENNEDY MA, 1991, P NATL ACAD SCI USA, V88, P8900, DOI 10.1073/pnas.88.20.8900; KONGSUWAN K, 1989, NUCLEIC ACIDS RES, V17, P1881, DOI 10.1093/nar/17.5.1881; LARGAESPADA DA, 1995, J VIROL, V69, P5095, DOI 10.1128/JVI.69.8.5095-5102.1995; Largaespada DA, 1996, NAT GENET, V12, P137, DOI 10.1038/ng0296-137; LU M, 1991, EMBO J, V10, P2905, DOI 10.1002/j.1460-2075.1991.tb07840.x; LU QA, 1995, MOL CELL BIOL, V15, P3786; MONICA K, 1991, MOL CELL BIOL, V11, P6149, DOI 10.1128/MCB.11.12.6149; MOSCOW JJ, 1995, MOL CELL BIOL, V15, P5434; MOUNTZ JD, 1984, SCIENCE, V226, P1087, DOI 10.1126/science.6494925; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; PHELAN ML, 1995, MOL CELL BIOL, V15, P3989; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; PRIVITERA E, 1992, BLOOD, V79, P1781; RAUSKOLB C, 1994, EMBO J, V13, P3561, DOI 10.1002/j.1460-2075.1994.tb06663.x; Sambrook J., 1989, MOL CLONING LAB MANU; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; VANDIJK MA, 1994, CELL, V78, P617, DOI 10.1016/0092-8674(94)90526-6; VANLOHUIZEN M, 1990, BIOCHIM BIOPHYS ACTA, V1032, P213, DOI 10.1016/0304-419X(90)90005-L	42	275	281	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1996	12	2					149	153		10.1038/ng0296-149	http://dx.doi.org/10.1038/ng0296-149			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563752				2022-12-17	WOS:A1996TU07900014
J	Wong, VK; Baker, S; Pickard, DJ; Parkhill, J; Page, AJ; Feasey, NA; Kingsley, RA; Thomson, NR; Keanel, JA; Weill, FX; Edwards, DJ; Hawkey, J; Harris, SR; Mather, AE; Cain, AK; Hadfield, J; Hart, PJ; Thieu, NTV; Klemm, EJ; Glinos, DA; Breiman, RF; Watson, CH; Kariuki, S; Gordon, MA; Heyderman, RS; Okoro, C; Jacobs, J; Lunguya, O; Edmunds, WJ; Msefula, C; Chabalgoity, JA; Kama, M; Jenkins, K; Dutta, S; Marks, F; Campos, J; Thompson, C; Obaro, S; MacLennan, CA; Dolecek, C; Keddy, KH; Smith, AM; Parry, CM; Karkey, A; Mulholland, EK; Campbell, JI; Dongol, S; Basnyat, B; Dufour, M; Bandaranayake, D; Naseri, TT; Singh, SP; Hatta, M; Newton, P; Onsare, RS; Isaia, L; Dance, D; Davong, V; Thwaites, G; Wijedoru, L; Crump, JA; De Pinna, E; Nair, S; Nilles, EJ; Thanh, DP; Turner, P; Soeng, S; Valcanis, M; Powling, J; Dimovski, K; Hogg, G; Farrar, J; Holt, KE; Dougan, G				Wong, Vanessa K.; Baker, Stephen; Pickard, Derek J.; Parkhill, Julian; Page, Andrew J.; Feasey, Nicholas A.; Kingsley, Robert A.; Thomson, Nicholas R.; Keanel, Jacqueline A.; Weill, Francois-Xavier; Edwards, David J.; Hawkey, Jane; Harris, Simon R.; Mather, Alison E.; Cain, Amy K.; Hadfield, James; Hart, Peter J.; Nga Tran Vu Thieu; Klemm, Elizabeth J.; Glinos, Dafni A.; Breiman, Robert F.; Watson, Conall H.; Kariuki, Samuel; Gordon, Melita A.; Heyderman, Robert S.; Okoro, Chinyere; Jacobs, Jan; Lunguya, Octavie; Edmunds, W. John; Msefula, Chisorno; Chabalgoity, Jose A.; Kama, Mike; Jenkins, Kylie; Dutta, Shanta; Marks, Florian; Campos, Josefina; Thompson, Corinne; Obaro, Stephen; MacLennan, Calman A.; Dolecek, Christiane; Keddy, Karen H.; Smith, Anthony M.; Parry, Christopher M.; Karkey, Abhilasha; Mulholland, E. Kim; Campbell, James I.; Dongol, Sabina; Basnyat, Buddha; Dufour, Muriel; Bandaranayake, Don; Naseri, Take Toleafoa; Singh, Shalini Pravin; Hatta, Mochammad; Newton, Paul; Onsare, Robert S.; Isaia, Lupeoletalalei; Dance, David; Davong, Viengmon; Thwaites, Guy; Wijedoru, Lalith; Crump, John A.; De Pinna, Elizabeth; Nair, Satheesh; Nilles, Eric J.; Duy Pham Thanh; Turner, Paul; Soeng, Sona; Valcanis, Mary; Powling, Joan; Dimovski, Karolina; Hogg, Geoff; Farrar, Jeremy; Holt, Kathryn E.; Dougan, Gordon			Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events	NATURE GENETICS			English	Article							ENTERICA SEROVAR TYPHI; ANTIBIOTIC-RESISTANCE; INTERACTIVE TREE; INCHI1 PLASMIDS; FEVER; MUTATIONS; EVOLUTION; ANNOTATION; POPULATION; PARATYPHI	The emergence of multidrug-resistant (MDR) typhoid is a major global health threat affecting many countries where the disease is endemic. Here whole-genome sequence analysis of 1,832 Salmonella enterica serovar Typhi (S. Typhi) identifies a single dominant MDR lineage, H58, that has emerged and spread throughout Asia and Africa over the last 30 years. Our analysis identifies numerous transmissions of H58, including multiple transfers from Asia to Africa and an ongoing, unrecognized MDR epidemic within Africa itself. Notably, our analysis indicates that H58 lineages are displacing antibiotic-sensitive isolates, transforming the global population structure of this pathogen. H58 isolates can harbor a complex MDR element residing either on transmissible IncHI1 plasmids or within multiple chromosomal integration sites. We also identify new mutations that define the H58 lineage. This phylogeographical analysis provides a framework to facilitate global management of MDR typhoid and is applicable to similar MDR lineages emerging in other bacterial species.	[Wong, Vanessa K.; Pickard, Derek J.; Page, Andrew J.; Kingsley, Robert A.; Keanel, Jacqueline A.; Mather, Alison E.; Cain, Amy K.; Hadfield, James; Klemm, Elizabeth J.; Glinos, Dafni A.; Okoro, Chinyere; MacLennan, Calman A.; Dougan, Gordon] Wellcome Trust Sanger Inst, Hinxton, England; [Wong, Vanessa K.] Univ Cambridge, Hosp Natl Hlth Serv NHS Fdn Trust, Addenbrookes Hosp, Dept Microbiol, Cambridge, England; [Baker, Stephen; Nga Tran Vu Thieu; Thompson, Corinne; Thwaites, Guy] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Baker, Stephen; Thompson, Corinne; Dolecek, Christiane; Newton, Paul; Dance, David; Thwaites, Guy; Turner, Paul; Farrar, Jeremy] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Baker, Stephen; Thomson, Nicholas R.; Mulholland, E. Kim] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Feasey, Nicholas A.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Kingsley, Robert A.] Inst Food Res, Norwich, Norfolk, England; [Weill, Francois-Xavier] Inst Pasteur, Unite Bacteries Pathogenes Enter, Paris, France; [Edwards, David J.; Hawkey, Jane] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Hawkey, Jane] Univ Melbourne, Fac Vet & Agr Sci, Melbourne, Vic, Australia; [MacLennan, Calman A.] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Inst Biomed Res, Birmingham, W Midlands, England; [Breiman, Robert F.; Kariuki, Samuel] Kenya Med Res Inst KEMRI, Nairobi, Kenya; [Breiman, Robert F.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Breiman, Robert F.] Emory Global Hlth Inst, Atlanta, GA USA; [Watson, Conall H.; Edmunds, W. John] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Ctr Math Modelling Infect Dis, London WC1, England; [Gordon, Melita A.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Program, Blantyre, Malawi; [Jacobs, Jan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Jacobs, Jan] Univ Leuven, Katholieke Univ KU Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Lunguya, Octavie] Natl Inst Biomed Res, Kinshasa, DEM REP CONGO; [Lunguya, Octavie] Univ Hosp Kinshasa, Kinshasa, DEM REP CONGO; [Msefula, Chisorno] Univ Malawi, Coll Med, Dept Microbiol, Blantyre, Malawi; [Chabalgoity, Jose A.] Inst Higiene, Facultad Medicina, Dept Desarrollo Biotecnol, Montevideo, Uruguay; [Kama, Mike] Minist Hlth, Suva, Fiji; [Jenkins, Kylie] Fiji Hlth Sector Support Program, Suva, Fiji; [Dutta, Shanta] Natl Inst Cholera & Enter Dis, Kolkata, India; [Marks, Florian] Int Vaccine Inst, Dept Epidemiol, Seoul, South Korea; [Campos, Josefina] Carlos G Malbran Inst, ANLIS, Enteropathogen Div, Buenos Aires, DF, Argentina; [Obaro, Stephen] Univ Nebraska, Med Ctr, Div Pediat Infect Dis, Omaha, NE 68182 USA; [Obaro, Stephen] Univ Abuja, Teaching Hosp, Abuja, Nigeria; [Obaro, Stephen] Bingham Univ, Karu, Nigeria; [MacLennan, Calman A.] Novartis Vaccines Inst Global Hlth, Siena, Italy; [Keddy, Karen H.; Smith, Anthony M.] Univ Witwatersrand, Ctr Enter Dis, Natl Inst Communicable Dis, Div Natl Hlth Lab Serv, Johannesburg, South Africa; [Parry, Christopher M.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Parry, Christopher M.] Nagasaki Univ, Grad Sch Trop Med & Global Hlth, Nagasaki 852, Japan; [Dongol, Sabina; Basnyat, Buddha] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Patan Acad Hlth Sci, Kathmandu, Nepal; [Mulholland, E. Kim] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Dufour, Muriel] Inst Environm Sci & Res Ltd ESR, Enter & Leptospira Reference Lab, Porirua, New Zealand; [Bandaranayake, Don] Inst Environm Sci & Res, Natl Ctr Biosecur & Infect Dis, Porirua, New Zealand; [Singh, Shalini Pravin] WHO, Ctr Communicable Dis Control, Natl Influenza Ctr, Suva, Fiji; [Hatta, Mochammad] Hasanuddin Univ, Dept Microbiol, Makassar, Indonesia; [Newton, Paul; Dance, David; Davong, Viengmon] Mahosot Hosp, Microbiol Lab, Lao Oxford Mahosot Wellcome Trust Res Unit, Viangchan, Laos; [Wijedoru, Lalith; Turner, Paul] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Wijedoru, Lalith] Chelsea & Westminster Hosp, Paediat Emergency Med, London, England; [Crump, John A.] Univ Otago, Ctr Int Hlth & Otago Int Hlth Res Network, Dunedin Sch Med, Dunedin, New Zealand; [De Pinna, Elizabeth; Nair, Satheesh] Publ Hlth England, Salmonella Reference Serv, London, England; [Nilles, Eric J.] WHO, Div Pacific Tech Support, Emerging Dis Surveillance & Response, Suva, Fiji; [Turner, Paul; Soeng, Sona] Angkor Hosp Children, Cambodia Oxford Med Res Unit, Siem Reap, Cambodia; [Valcanis, Mary; Powling, Joan; Dimovski, Karolina; Hogg, Geoff] Univ Melbourne, Microbiol Diagnost Unit, Dept Microbiol & Immunol, Doherty Inst Infect & Immun,Publ Hlth Lab, Melbourne, Vic, Australia	Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; Liverpool School of Tropical Medicine; University of Liverpool; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Melbourne; University of Melbourne; University of Birmingham; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; University of London; London School of Hygiene & Tropical Medicine; University of Liverpool; University of Malawi; Institute of Tropical Medicine (ITM); KU Leuven; Institute Nacional de Recherche Biomedical; University of Malawi; Universidad de la Republica, Uruguay; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); International Vaccine Institute; University of Nebraska System; University of Nebraska Medical Center; Novartis; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of London; London School of Hygiene & Tropical Medicine; Nagasaki University; University of Oxford; Murdoch Children's Research Institute; Institute of Environmental Science & Research (ESR) - New Zealand; Institute of Environmental Science & Research (ESR) - New Zealand; World Health Organization; Universitas Hasanuddin; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Imperial College London; University of Otago; Public Health England; World Health Organization; University of Melbourne	Wong, VK (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.	vw1@sanger.ac.uk	Farrar, Jeremy J./HGA-7610-2022; Thomson, Nicholas R/P-5988-2014; Hawkey, Jane/AAE-3443-2021; Crump, John A./AAZ-6289-2020; Msefula, Chisomo/AAY-9107-2020; Thwaites, Guy E/R-4993-2019; Nilles, Eric/ABA-4757-2021; Jacobs, Jan/GRX-7316-2022; Crump, John A./AAZ-6412-2020; Keddy, Karen Helena/AAZ-2189-2020; Pham, Thanh Duy/AAX-3845-2020; MacLennan, Calman A/L-9343-2014; HATTA, MOCHAMMAD/D-3742-2019; Parkhill, Julian/G-4703-2011; Holt, Kathryn E/A-8108-2012; Gordon, Melita/F-5563-2012	Thomson, Nicholas R/0000-0002-4432-8505; Hawkey, Jane/0000-0001-9661-5293; Crump, John A./0000-0002-4529-102X; Thwaites, Guy E/0000-0002-2858-2087; Nilles, Eric/0000-0001-7044-5257; Crump, John A./0000-0002-4529-102X; Keddy, Karen Helena/0000-0001-8640-2235; Pham, Thanh Duy/0000-0001-7029-9210; MacLennan, Calman A/0000-0001-9694-0846; HATTA, MOCHAMMAD/0000-0002-8456-4203; Parkhill, Julian/0000-0002-7069-5958; Holt, Kathryn E/0000-0003-3949-2471; Feasey, Nicholas/0000-0003-4041-1405; Gordon, Melita/0000-0002-0629-0884; Dufour, Muriel/0000-0003-3638-4918; Nair, Satheesh/0000-0002-7297-1485; Msefula, Chisomo/0000-0003-2304-886X; Glinos, Dafni/0000-0001-5556-0222; Kingsley, Robert/0000-0002-0194-6485; Page, Andrew/0000-0001-6919-6062; Turner, Paul/0000-0002-1013-7815; Campos, Josefina/0000-0003-1409-0441; Watson, Conall/0000-0002-2469-791X; Cain, Amy/0000-0002-4230-6572; Newton, Paul/0000-0002-4608-6431; Okoro, Chinyere/0000-0002-2466-304X; Dance, David/0000-0001-9189-7244; Weill, Francois-Xavier/0000-0001-9941-5799; Baker, Stephen/0000-0003-1308-5755; Farrar, Jeremy/0000-0002-2700-623X; Marks, Florian/0000-0002-6043-7170; Heyderman, Robert/0000-0003-4573-449X; Keane, Jacqueline A./0000-0003-0739-6848	Wellcome Trust; Wellcome Trust award [098051]; Wellcome Trust research fellowship [WT092152MA]; Wellcome Trust for the Malawi-Liverpool Wellcome Trust Clinical Research Programme [101113/Z/13/Z]; Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme; Wellcome Trust (Major Overseas Programmes-Thailand Unit Core Grant); European Society for Paediatric Infectious Diseases; University of Oxford-Li Ka Shing Global Health Foundation; Wellcome Trust [089275/H/091Z]; National Health and Medical Research Council of Australia [1061409]; Victorian Life Sciences Computation Initiative (VLSCI) [VR0082]; Clinical Research Fellowship from GlaxoSmithKline; UK Medical Research Council PhD studentship; Institut Pasteur; Institut de Veille Sanitaire; French government 'Investissement d'Avenir' program (Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence) [ANR-10-LABX-62-IBEID]; UK Medical Research Council [MR/J003999/1, G1100100/1]; Society in Science; Branco Weiss Fellowship; antibiotic resistance surveillance project in the Democratic Republic of the Congo; Belgian Directorate General of Development Cooperation [2.01]; Institute of Tropical Medicine (Antwerp, Belgium) [2.01]; Bill and Melinda Gates Foundation; US National Institutes of Health-National Science Foundation Ecology and Evolution of Infectious Disease program [R01 TW009237]; UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J010367/1]; UK BBSRC Zoonoses in Emerging Livestock Systems awards [BB/L017679, BB/L018926, BB/L018845]; US National Institutes of Health grant [R01 AI099525-02]; Royal Society [100087/Z/12/Z]; National Institute of Allergy and Infectious Diseases of the US National Institutes of Health [R01 AI097493]; FOGARTY INTERNATIONAL CENTER [R01TW009237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI062563, R01AI097493, R01AI099525] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/J010367/1, BB/L018926/1, BB/L018845/1] Funding Source: researchfish; Medical Research Council [G9818340, 1263989, G1100100] Funding Source: researchfish; Div Of Molecular and Cellular Bioscience [1330800] Funding Source: National Science Foundation; BBSRC [BB/J010367/1, BB/L018926/1, BB/L018845/1] Funding Source: UKRI; MRC [G9818340] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Wellcome Trust award(Wellcome Trust); Wellcome Trust research fellowship(Wellcome Trust); Wellcome Trust for the Malawi-Liverpool Wellcome Trust Clinical Research Programme; Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme(Wellcome Trust); Wellcome Trust (Major Overseas Programmes-Thailand Unit Core Grant)(Wellcome Trust); European Society for Paediatric Infectious Diseases; University of Oxford-Li Ka Shing Global Health Foundation; Wellcome Trust(Wellcome Trust); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Life Sciences Computation Initiative (VLSCI); Clinical Research Fellowship from GlaxoSmithKline; UK Medical Research Council PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institut Pasteur(European Commission); Institut de Veille Sanitaire; French government 'Investissement d'Avenir' program (Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence)(French National Research Agency (ANR)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Society in Science; Branco Weiss Fellowship; antibiotic resistance surveillance project in the Democratic Republic of the Congo; Belgian Directorate General of Development Cooperation; Institute of Tropical Medicine (Antwerp, Belgium); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); US National Institutes of Health-National Science Foundation Ecology and Evolution of Infectious Disease program; UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK BBSRC Zoonoses in Emerging Livestock Systems awards(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust. We would like to thank the members of the Pathogen Informatics Team and the core sequencing teams at the Wellcome Trust Sanger Institute (Cambridge, UK). We are grateful to D. Harris for his superb work in managing the sequence data. We also thank L. Fabre for her excellent technical assistance.; This work was supported by a number of organizations. The authors affiliated with the Wellcome Trust Sanger Institute were funded by Wellcome Trust award 098051; N.A.F. was supported by Wellcome Trust research fellowship WT092152MA. N.A.F., R.S.H. and this work were supported by a strategic award from the Wellcome Trust for the Malawi-Liverpool Wellcome Trust Clinical Research Programme (101113/Z/13/Z). C.M.P. was funded by the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme, supported by the Wellcome Trust (Major Overseas Programmes-Thailand Unit Core Grant), the European Society for Paediatric Infectious Diseases and the University of Oxford-Li Ka Shing Global Health Foundation. D.D., P.N. and V.D. were supported by the Wellcome Trust (core grant 089275/H/091Z). K.E.H. was supported by the National Health and Medical Research Council of Australia (fellowship 1061409) and the Victorian Life Sciences Computation Initiative (VLSCI; grant VR0082). C.A.M. was supported by a Clinical Research Fellowship from GlaxoSmithKline, and P.J.H. was supported by a UK Medical Research Council PhD studentship. This work forms part of a European Union Framework Programme 7 Marie Curie Actions Industry Academia Partnerships and Pathways (LAPP) Consortium Programme, entitled GENDRIVAX (Genome-Driven Vaccine Development for Bacterial Infections), involving the Wellcome Trust Sanger Institute, KEMRI Nairobi and the Novartis Vaccines Institute for Global Health. The authors affiliated with the Institut Pasteur were funded by the Institut Pasteur, the Institut de Veille Sanitaire and the French government 'Investissement d'Avenir' program (Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence, grant ANR-10-LABX-62-IBEID). C.H.W. was supported by the UK Medical Research Council (MR/J003999/1). CO. was supported by Society in Science and the Branco Weiss Fellowship, administered by ETH Zurich. A.K.C. was supported by the UK Medical Research Council (G1100100/1). J.J. was supported by the antibiotic resistance surveillance project in the Democratic Republic of the Congo, funded by project 2.01 of the Third Framework Agreement between the Belgian Directorate General of Development Cooperation and the Institute of Tropical Medicine (Antwerp, Belgium). F.M. was supported by a research grant from the Bill and Melinda Gates Foundation. The findings and conclusions contained within this publication are those of the authors and do not necessarily reflect positions or policies of the Bill and Melinda Gates Foundation. J.A. Crump was supported by the joint US National Institutes of Health-National Science Foundation Ecology and Evolution of Infectious Disease program (R01 TW009237), the UK Biotechnology and Biological Sciences Research Council (BBSRC; BB/J010367/1) and UK BBSRC Zoonoses in Emerging Livestock Systems awards BB/L017679, BB/L018926 and BB/L018845. S.K. was supported by US National Institutes of Health grant R01 AI099525-02. S.B. is a Sir Henry Dale Fellow, jointly funded by the Wellcome Trust and the Royal Society (100087/Z/12/Z). S.O. was supported by the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health (R01 AI097493). The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. C.D.; was supported by the University of Oxford-Li Ka Shing Global Health Foundation.	ANDERSON ES, 1975, J HYG-CAMBRIDGE, V74, P289, DOI 10.1017/S0022172400024360; Ashton PM, 2015, NAT BIOTECHNOL, V33, P296, DOI 10.1038/nbt.3103; Baker S, 2008, J CLIN MICROBIOL, V46, P1741, DOI 10.1128/JCM.02249-07; Baker S, 2013, ELIFE, V2, DOI 10.7554/eLife.01229; Baker S, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110008; Baucheron S, 2005, ANTIMICROB AGENTS CH, V49, P862, DOI 10.1128/AAC.49.2.862-863.2005; Bhutta ZA, 2006, BMJ-BRIT MED J, V333, P78, DOI 10.1136/bmj.333.7558.78; BODHIDATTA L, 1987, REV INFECT DIS, V9, P841; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119; Bwakura-Dangarembizi M, 2014, NEW ENGL J MED, V370, P41, DOI 10.1056/NEJMoa1214901; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Chau TT, 2007, ANTIMICROB AGENTS CH, V51, P4315, DOI 10.1128/AAC.00294-07; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Chiou CS, 2014, ANTIMICROB AGENTS CH, V58, P6501, DOI 10.1128/AAC.03608-14; Connor BA, 2005, LANCET INFECT DIS, V5, P623, DOI 10.1016/S1473-3099(05)70239-5; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eaves DJ, 2004, ANTIMICROB AGENTS CH, V48, P4012, DOI 10.1128/AAC.48.10.4012-4015.2004; Fraser A, 2007, VACCINE, V25, P7848, DOI 10.1016/j.vaccine.2007.08.027; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Gomes C, 2013, MICROB DRUG RESIST, V19, P88, DOI 10.1089/mdr.2012.0036; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Haanpera M, 2005, ANTIMICROB AGENTS CH, V49, P457, DOI 10.1128/AAC.49.1.457-460.2005; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hendriksen RS, 2015, J CLIN MICROBIOL, V53, P262, DOI 10.1128/JCM.02026-14; Hensel M, 1997, MOL MICROBIOL, V24, P155, DOI 10.1046/j.1365-2958.1997.3271699.x; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Holt KE, 2007, J BACTERIOL, V189, P4257, DOI 10.1128/JB.00232-07; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Holt KE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001490; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001245; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000929; Holt KE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-144; Holt KE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-36; Hooper D C, 1993, Drugs, V45 Suppl 3, P8; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Kariuki S, 2010, J CLIN MICROBIOL, V48, P2171, DOI 10.1128/JCM.01983-09; Keddy KH, 2010, EMERG INFECT DIS, V16, P879, DOI 10.3201/eid1605.091917; Khan MI, 2010, EXPERT REV VACCINES, V9, P485, DOI [10.1586/erv.10.43, 10.1586/ERV.10.43]; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lawhon SD, 2003, MOL MICROBIOL, V48, P1633, DOI 10.1046/j.1365-2958.2003.03535.x; Le Hello S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00395; Le TAH, 2007, J CLIN MICROBIOL, V45, P3485, DOI 10.1128/JCM.00948-07; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lutterloh E, 2012, CLIN INFECT DIS, V54, P1100, DOI 10.1093/cid/cis012; Marvig RL, 2012, ANTIMICROB AGENTS CH, V56, P4519, DOI 10.1128/AAC.00630-12; Menezes GA, 2012, CLIN MICROBIOL INFEC, V18, P239, DOI 10.1111/j.1469-0691.2011.03546.x; Mirza SH, 1996, J MED MICROBIOL, V44, P317, DOI 10.1099/00222615-44-5-317; Mogasale V, 2014, LANCET GLOB HEALTH, V2, pE570, DOI 10.1016/S2214-109X(14)70301-8; OLARTE J, 1973, ANTIMICROB AGENTS CH, V4, P597, DOI 10.1128/AAC.4.6.597; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Phan MD, 2009, ANTIMICROB AGENTS CH, V53, P716, DOI 10.1128/AAC.00645-08; Phoba MF, 2012, EMERG INFECT DIS, V18, P1692, DOI 10.3201/eid1810.120525; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Song YJ, 2010, J ANTIMICROB CHEMOTH, V65, P1631, DOI 10.1093/jac/dkq175; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Teplitski M, 2003, J BACTERIOL, V185, P7257, DOI 10.1128/JB.185.24.7257-7265.2003; Thomson N, 2004, J MOL BIOL, V339, P279, DOI 10.1016/j.jmb.2004.03.058; Wain J, 1997, CLIN INFECT DIS, V25, P1404, DOI 10.1086/516128; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	73	274	279	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					632	639		10.1038/ng.3281	http://dx.doi.org/10.1038/ng.3281			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25961941	Green Submitted, Green Accepted, Bronze			2022-12-17	WOS:000355386500014
J	Cowper-Sal-lari, R; Zhang, XY; Wright, JB; Bailey, SD; Cole, MD; Eeckhoute, J; Moore, JH; Lupien, M				Cowper-Sal-lari, Richard; Zhang, Xiaoyang; Wright, Jason B.; Bailey, Swneke D.; Cole, Michael D.; Eeckhoute, Jerome; Moore, Jason H.; Lupien, Mathieu			Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; EPIGENETIC SIGNATURES; SUSCEPTIBILITY; ENHANCERS; DISTINCT; DEFINES; PROMOTERS; RS6983267; PROTEINS; DYNAMICS	Genome-wide association studies (GWAS) have identified thousands of SNPs that are associated with human traits and diseases. But, because the vast majority of these SNPs are located in non-coding regions of the genome, the mechanisms by which they promote disease risk have remained elusive. Employing a new methodology that combines cistromics, epigenomics and genotype imputation, we annotate the non-coding regions of the genome in breast cancer cells and systematically identify the functional nature of SNPs associated with breast cancer risk. Our results show that breast cancer risk-associated SNPs are enriched in the cistromes of FOXA1 and ESR1 and the epigenome of histone H3 lysine 4 monomethylation (H3K4me1) in a cancer- and cell type-specific manner. Furthermore, the majority of the risk-associated SNPs modulate the affinity of chromatin for FOXA1 at distal regulatory elements, thereby resulting in allele-specific gene expression, which is exemplified by the effect of the rs4784227 SNP on the TOX3 gene within the 16q12.1 risk locus.	[Bailey, Swneke D.; Lupien, Mathieu] Princess Margaret Hosp, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [Cowper-Sal-lari, Richard; Zhang, Xiaoyang; Wright, Jason B.; Cole, Michael D.; Moore, Jason H.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Genet, Lebanon, NH USA; [Cowper-Sal-lari, Richard; Zhang, Xiaoyang; Moore, Jason H.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Inst Quantitat Biomed Sci, Lebanon, NH USA; [Bailey, Swneke D.; Lupien, Mathieu] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Eeckhoute, Jerome] Univ Lille Nord France, UMR 1011, INSERM, Lille, France; [Eeckhoute, Jerome] Inst Pasteur, F-59019 Lille, France	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Norris Cotton Cancer Center; University of Toronto; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	Lupien, M (corresponding author), Princess Margaret Hosp, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M4X 1K9, Canada.	jason.h.moore@dartmouth.edu; mlupien@uhnres.utoronto.ca	Eeckhoute, Jerome/AAN-8219-2021; Moore, Jason H./AAV-9645-2021	Eeckhoute, Jerome/0000-0002-7222-9264; Moore, Jason H./0000-0002-5015-1099; Lupien, Mathieu/0000-0003-0929-9478	US National Cancer Institute (NCI) [2P30CA023108-32]; American Cancer Society (ACS) [1RG-82-003-27]; US National Institutes of Health (NIH) [R01LM009012, R01CA155004]; Princess Margaret Hospital Foundation; NATIONAL CANCER INSTITUTE [R01CA155004, R01CA080320, P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK096822] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009012] Funding Source: NIH RePORTER; Direct For Biological Sciences [0923008] Funding Source: National Science Foundation	US National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society (ACS)(American Cancer Society); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Princess Margaret Hospital Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank M. Brown, M.L. Freedman and M. Lemaire for discussions, as well as B.G. Neel and R. Marcotte for technical assistance. We acknowledge support from the US National Cancer Institute (NCI; 2P30CA023108-32), the American Cancer Society (ACS; 1RG-82-003-27 to M.L.), the US National Institutes of Health (NIH; R01LM009012 to J.H.M. and R01CA155004 to M.L.) and the Princess Margaret Hospital Foundation (M.L.).	Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Antoniou AC, 2008, AM J HUM GENET, V82, P937, DOI 10.1016/j.ajhg.2008.02.008; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; Dittmer S, 2011, J CELL SCI, V124, P252, DOI 10.1242/jcs.068759; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Grant SFA, 2008, CLIN CHEM, V54, P1116, DOI 10.1373/clinchem.2008.105395; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Hutter CM, 2011, CANCER EPIDEM BIOMAR, V20, P1950, DOI 10.1158/1055-9965.EPI-11-0524; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Krum SA, 2008, MOL ENDOCRINOL, V22, P2393, DOI 10.1210/me.2008-0100; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Long JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001002; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Lupien M, 2009, ENDOCR-RELAT CANCER, V16, P381, DOI 10.1677/ERC-09-0038; Magnani L, 2011, TRENDS GENET, V27, P465, DOI 10.1016/j.tig.2011.07.002; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; O'Flaherty E, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-13; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Riaz M, 2012, BREAST CANCER RES TR, V133, P843, DOI 10.1007/s10549-011-1663-3; Ruiz-Narvaez EA, 2010, CANCER EPIDEM BIOMAR, V19, P1320, DOI 10.1158/1055-9965.EPI-09-1250; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Sekiya T, 2007, MOL CELL, V28, P291, DOI 10.1016/j.molcel.2007.10.002; Smid M, 2006, J CLIN ONCOL, V24, P2261, DOI 10.1200/JCO.2005.03.8802; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Udler MS, 2010, HUM MOL GENET, V19, P2507, DOI 10.1093/hmg/ddq122; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang XY, 2012, GENOME RES, V22, P1437, DOI 10.1101/gr.135665.111	47	274	277	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1191	1198		10.1038/ng.2416	http://dx.doi.org/10.1038/ng.2416			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23001124	Green Accepted			2022-12-17	WOS:000310495800009
J	Lienert, F; Wirbelauer, C; Som, I; Dean, A; Mohn, F; Schubeler, D				Lienert, Florian; Wirbelauer, Christiane; Som, Indrani; Dean, Ann; Mohn, Fabio; Schuebeler, Dirk			Identification of genetic elements that autonomously determine DNA methylation states	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; CPG ISLANDS; CHROMATIN-STRUCTURE; HISTONE; METHYLTRANSFERASE; NANOG; TRANSCRIPTION; PLURIPOTENT; METHYLOME; PROMOTER	Cytosine methylation is a repressive, epigenetically propagated DNA modification. Although patterns of DNA methylation seem tightly regulated in mammals, it is unclear how these are specified and to what extent this process entails genetic or epigenetic regulation. To dissect the role of the underlying DNA sequence, we sequentially inserted over 50 different DNA elements into the same genomic locus in mouse stem cells. Promoter sequences of approximately 1,000 bp autonomously recapitulated correct DNA methylation in pluripotent cells. Moreover, they supported proper de novo methylation during differentiation. Truncation analysis revealed that this regulatory potential is contained within small methylation-determining regions (MDRs). MDRs can mediate both hypomethylation and de novo methylation in cis, and their activity depends on developmental state, motifs for DNA-binding factors and a critical CpG density. These results demonstrate that proximal sequence elements are both necessary and sufficient for regulating DNA methylation and reveal basic constraints of this regulation.	[Lienert, Florian; Wirbelauer, Christiane; Mohn, Fabio; Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Lienert, Florian; Schuebeler, Dirk] Univ Basel, Fac Sci, Basel, Switzerland; [Som, Indrani; Dean, Ann] NIDDKD, Cellular & Dev Biol Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA	Friedrich Miescher Institute for Biomedical Research; University of Basel; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Schubeler, D (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	dirk@fmi.ch		Mohn, Fabio/0000-0001-9889-5225	Boehringer Ingelheim; National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health; Novartis Research Foundation; European Union [FP7-HEALTH-2010-257082, LSHG-CT-2006-037415]; European Research Council [ERC-204264]; Swiss initiative in Systems Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075033, ZIADK015508] Funding Source: NIH RePORTER	Boehringer Ingelheim(Boehringer Ingelheim); National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Novartis Research Foundation; European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Swiss initiative in Systems Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to M. Pietrzak for sequencing. We thank M. Lorincz of the University of British Columbia-Vancouver for providing plasmids for RMCE and S. Fiering for advice. We would also like to thank members of the Schubeler group and S. Gasser for critical comments on the manuscript. F.L. is supported by a PhD fellowship of the Boehringer Ingelheim Fonds. Research in the laboratory of A.D. is supported by the Intramural Program of National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health. Research in the laboratory of D.S. is supported by the Novartis Research Foundation, by the European Union (NoE "EpiGeneSys" FP7-HEALTH-2010-257082, LSHG-CT-2006-037415), the European Research Council (ERC-204264) and by the RTD "Cellplasticity" of the Swiss initiative in Systems Biology (SystemsX.ch).	Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cohen NM, 2011, CELL, V145, P773, DOI 10.1016/j.cell.2011.04.024; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Dickson J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000804; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Feng YQ, 1999, J MOL BIOL, V292, P779, DOI 10.1006/jmbi.1999.3113; Fromm G, 2009, BIOCHEM CELL BIOL, V87, P781, DOI 10.1139/O09-048; Gebhard C, 2010, CANCER RES, V70, P1398, DOI 10.1158/0008-5472.CAN-09-3406; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Horvath GC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-63; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Kim M, 2006, J BIOL CHEM, V281, P34288, DOI 10.1074/jbc.M607168200; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lorincz MC, 2002, MOL CELL BIOL, V22, P7572, DOI 10.1128/MCB.22.21.7572-7580.2002; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sato N, 2006, BIOCHEM BIOPH RES CO, V344, P845, DOI 10.1016/j.bbrc.2006.04.007; Schilling E, 2007, GENOMICS, V90, P314, DOI 10.1016/j.ygeno.2007.04.011; Schubeler D, 2000, MOL CELL BIOL, V20, P9103, DOI 10.1128/MCB.20.24.9103-9112.2000; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Suzuki M, 2006, ONCOGENE, V25, P2477, DOI 10.1038/sj.onc.1209272; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Velasco G, 2010, P NATL ACAD SCI USA, V107, P9281, DOI 10.1073/pnas.1000473107; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	51	274	275	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2011	43	11					1091	U78		10.1038/ng.946	http://dx.doi.org/10.1038/ng.946			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	21964573				2022-12-17	WOS:000296584000012
J	Di Bernardo, MC; Crowther-Swanepoel, D; Broderick, P; Webb, E; Sellick, G; Wild, R; Sullivan, K; Vijayakrishnan, J; Wang, YF; Pittman, AM; Sunter, NJ; Hall, AG; Dyer, MJS; Matutes, E; Dearden, C; Mainou-Fowler, T; Jackson, GH; Summerfield, G; Harris, RJ; Pettitt, AR; Hillmen, P; Allsup, DJ; Bailey, JR; Pratt, G; Pepper, C; Fegan, C; Allan, JM; Catovsky, D; Houlston, RS				Di Bernardo, Maria Chiara; Crowther-Swanepoel, Dalemari; Broderick, Peter; Webb, Emily; Sellick, Gabrielle; Wild, Ruth; Sullivan, Kate; Vijayakrishnan, Jayaram; Wang, Yufei; Pittman, Alan M.; Sunter, Nicola J.; Hall, Andrew G.; Dyer, Martin J. S.; Matutes, Estella; Dearden, Claire; Mainou-Fowler, Tryfonia; Jackson, Graham H.; Summerfield, Geoffrey; Harris, Robert J.; Pettitt, Andrew R.; Hillmen, Peter; Allsup, David J.; Bailey, James R.; Pratt, Guy; Pepper, Chris; Fegan, Chris; Allan, James M.; Catovsky, Daniel; Houlston, Richard S.			A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia	NATURE GENETICS			English	Article							CELL DEVELOPMENT; NUCLEAR-BODY; EXPRESSION; FAMILIES; RISK	We conducted a genome-wide association study of 299,983 tagging SNPs for chronic lymphocytic leukemia (CLL) and performed validation in two additional series totaling 1,529 cases and 3,115 controls. We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)). These data provide the first evidence for the existence of common, low-penetrance susceptibility to a hematological malignancy and new insights into disease causation in CLL.	[Di Bernardo, Maria Chiara; Crowther-Swanepoel, Dalemari; Broderick, Peter; Webb, Emily; Sellick, Gabrielle; Wild, Ruth; Sullivan, Kate; Vijayakrishnan, Jayaram; Wang, Yufei; Pittman, Alan M.; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; [Sunter, Nicola J.; Hall, Andrew G.; Allan, James M.] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Dyer, Martin J. S.] Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Matutes, Estella; Dearden, Claire; Catovsky, Daniel] Inst Canc Res, Sect Haematooncol, Sutton SM2 5NG, Surrey, England; [Mainou-Fowler, Tryfonia] Newcastle Univ, Sch Med, Newcastle Upon Tyne, Tyne & Wear, England; [Jackson, Graham H.] Royal Victoria Infirm, Dept Haematol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Summerfield, Geoffrey] Queen Elizabeth Hosp, Dept Haematol, Newcastle Upon Tyne NE9 6SX, Tyne & Wear, England; [Harris, Robert J.; Pettitt, Andrew R.] Univ Liverpool, Sch Canc Studies, Div Haematol, Liverpool L69 3BX, Merseyside, England; [Hillmen, Peter] Gen Infirm, Dept Haematol, Leeds LS1 3EX, W Yorkshire, England; [Allsup, David J.] Hull Royal Infirm, Dept Haematol, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Bailey, James R.] Hull York Med Sch, Kingston Upon Hull HU16 5JQ, N Humberside, England; [Bailey, James R.] Univ Hull, Kingston Upon Hull HU16 5JQ, N Humberside, England; [Pratt, Guy] Birmingham Heartlands Hosp, Dept Haematol, Birmingham B9, W Midlands, England; [Pepper, Chris] Cardiff Univ, Sch Med, Dept Haematol, Cardiff, S Glam, Wales; [Fegan, Chris] Cardiff & Vale NHS Trust, Cardiff CF14 4XW, S Glam, Wales	University of London; Institute of Cancer Research - UK; Newcastle University - UK; University of Leicester; University of London; Institute of Cancer Research - UK; Newcastle University - UK; Newcastle University - UK; University of Liverpool; Leeds General Infirmary; University of Hull; University of Hull; University of York - UK; University of Hull; Heart of England NHS Foundation Trust; Cardiff University; Cardiff University	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England.	richard.houlston@icr.ac.uk	Pittman, Alan M/D-6231-2012; Allan, James/B-4448-2009; Jackson, Graham/GMW-7638-2022; Hall, Andy/AAD-8622-2020; Allsup, David/H-2195-2017; Hall, Andrew G/B-3485-2009; Pepper, Chris/B-4357-2009; Pittman, Alan/AAP-2534-2020; Dyer, Martin/F-2691-2014	Pittman, Alan M/0000-0002-8112-2987; Jackson, Graham/0000-0003-0756-969X; Allsup, David/0000-0001-6159-6109; Pittman, Alan/0000-0002-8112-2987; Pepper, Chris/0000-0003-3603-8839; Broderick, Peter/0000-0002-8348-5829; Houlston, Richard/0000-0002-5268-0242; Dyer, Martin/0000-0002-5033-2236; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Webb, Emily/0000-0002-4019-7456; Allan, James/0000-0002-7580-5087	Leukaemia Research Fund (LRF) [LRF05001 and 06002]; CLL Global Research Foundation, Cancer Research UK; Bobby Moore Fund [C1298/A8362]; European Union [CPRB LSHC-CT-2004-503465]; Medical Research Council [G0000934, MC_U132670597] Funding Source: researchfish; MRC [MC_U132670597, G0000934] Funding Source: UKRI	Leukaemia Research Fund (LRF); CLL Global Research Foundation, Cancer Research UK(Cancer Research UK); Bobby Moore Fund; European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Leukaemia Research Fund (LRF) provided principal funding for the study (LRF05001 and 06002). Additional funding was provided by CLL Global Research Foundation, Cancer Research UK (C1298/A8362 supported by the Bobby Moore Fund), the Arbib fund and the European Union (CPRB LSHC-CT-2004-503465). D. C.-S. was in receipt of a PhD studentship from the Institute of Cancer Research. We are grateful to M. Yuille for input into our early work on familial CLL. This study made use of genotyping data on the 1958 Birth Cohort. Genotyping data on controls was generated and generously supplied to us by P. Deloukas of the Wellcome Trust Sanger Institute. A full list of the investigators who contributed to the generation of the data are available from http:// www. wtccc. org. uk. We are grateful to all investigators who contributed to the study of acute leukemia, from which phase 3 controls were drawn, to members of the ICLLLC (Supplementary Note online) and to investigators who contributed to NSCCG and GELCAPS, from which phase 1 and 2 controls were drawn. Finally, we are grateful to all the study subjects for their participation.	Allan JM, 2001, P NATL ACAD SCI USA, V98, P11592, DOI 10.1073/pnas.191211198; Bloch DB, 1996, J BIOL CHEM, V271, P29198, DOI 10.1074/jbc.271.46.29198; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Catovsky D, 2007, LANCET, V370, P230, DOI 10.1016/S0140-6736(07)61125-8; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Dent AL, 1996, BLOOD, V88, P1423, DOI 10.1182/blood.V88.4.1423.bloodjournal8841423; Goldin LR, 2004, BLOOD, V104, P1850, DOI 10.1182/blood-2004-01-0341; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kovalevska L. M., 2006, Experimental Oncology, V28, P225; Ling PD, 2005, EMBO J, V24, P3565, DOI 10.1038/sj.emboj.7600820; Madani N, 2002, J VIROL, V76, P11133, DOI 10.1128/JVI.76.21.11133-11138.2002; Oliver PM, 2004, J EXP MED, V200, P1179, DOI 10.1084/jem.20041129; Petitti D, 1994, METAANALYSIS DECISIO; Pfeifer D, 2007, BLOOD, V109, P1202, DOI 10.1182/blood-2006-07-034256; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Sayala HA, 2006, BLOOD, V108, p14A, DOI 10.1182/blood.V108.11.34.34; Sellick GS, 2007, BLOOD, V110, P3326, DOI 10.1182/blood-2007-05-091561; Sellick GS, 2006, SEMIN ONCOL, V33, P195, DOI 10.1053/j.seminoncol.2006.01.013; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; van Krieken JHJM, 2007, LEUKEMIA, V21, P201, DOI 10.1038/sj.leu.2404467; Weiss N S, 1979, Natl Cancer Inst Monogr, P139	28	274	281	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2008	40	10					1204	1210		10.1038/ng.219	http://dx.doi.org/10.1038/ng.219			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18758461				2022-12-17	WOS:000259651000020
J	Holst, F; Stahl, PR; Ruiz, C; Hellwinkel, O; Jehan, Z; Wendland, M; Lebeau, A; Terracciano, L; Al-Kuraya, K; Janicke, F; Sauter, G; Simon, R				Holst, Frederik; Stahl, Phillip R.; Ruiz, Christian; Hellwinkel, Olaf; Jehan, Zeenath; Wendland, Marc; Lebeau, Annette; Terracciano, Luigi; Al-Kuraya, Khawla; Jaenicke, Fritz; Sauter, Guido; Simon, Ronald			Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer	NATURE GENETICS			English	Article							URINARY-BLADDER CANCER; IN-SITU HYBRIDIZATION; CLINICAL-TRIALS; TISSUE; OVEREXPRESSION; PROLIFERATION; HETEROGENEITY; EXPRESSION; TAMOXIFEN; THERAPY	Using an Affymetrix 10K SNP array to screen for gene copy number changes in breast cancer, we detected a single-gene amplification of the ESR1 gene, which encodes estrogen receptor alpha, at 6q25. A subsequent tissue microarray analysis of more than 2,000 clinical breast cancer samples showed ESR1 amplification in 20.6% of breast cancers. Ninety-nine percent of tumors with ESR1 amplification showed estrogen receptor protein overexpression, compared with 66.6% cancers without ESR1 amplification ( P < 0.0001). In 175 women who had received adjuvant tamoxifen monotherapy, survival was significantly longer for women with cancer with ESR1 amplification than for women with estrogen receptor - expressing cancers without ESR1 amplification ( P = 0.023). Notably, we also found ESR1 amplification in benign and precancerous breast diseases, suggesting that ESR1 amplification may be a common mechanism in proliferative breast disease and a very early genetic alteration in a large subset of breast cancers.	Univ Med Ctr Hamburg Eppendorf, Dept Pathol, D-20246 Hamburg, Germany; Univ Basel Hosp, Dept Pathol, CH-4031 Basel, Switzerland; Univ Med Ctr Hamburg Eppendorf, Dept Urol, D-20246 Hamburg, Germany; Univ Med Ctr Hamburg Eppendorf, Dept Gynecol, D-20246 Hamburg, Germany; King Faisal Specialist Hosp & Res Ctr, Riyadh 21211, Saudi Arabia	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Basel; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; King Faisal Specialist Hospital & Research Center	Simon, R (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Pathol, D-20246 Hamburg, Germany.	r.simon@uke.uni-hamburg.de	Terracciano, Luigi M./AAB-5335-2022; Holst, Frederik/H-3149-2019	Terracciano, Luigi M./0000-0002-9393-9660; Holst, Frederik/0000-0002-5928-2175; Simon, Ronald/0000-0003-0158-4258				Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; ANDERSEN J, 1989, CANCER, V64, P1901, DOI 10.1002/1097-0142(19891101)64:9<1901::AID-CNCR2820640924>3.0.CO;2-W; Courjal F, 1996, INT J CANCER, V69, P247; Dybdal N, 2005, BREAST CANCER RES TR, V93, P3, DOI 10.1007/s10549-004-6275-8; FERLAY J, 2000, GLOBOCAN 2000 CANC I; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; IP M, 1979, SCIENCE, V203, P361, DOI 10.1126/science.760195; KATZENELLENBOGEN BS, 1987, CANCER RES, V47, P4355; Khan SA, 1998, J NATL CANCER I, V90, P37, DOI 10.1093/jnci/90.1.37; Koivisto P, 1997, CANCER RES, V57, P314; Nessling M, 2005, CANCER RES, V65, P439; Pauletti G, 1996, ONCOGENE, V13, P63; Pegram MD, 1998, J CLIN ONCOL, V16, P2659, DOI 10.1200/JCO.1998.16.8.2659; Press MF, 2005, CLIN CANCER RES, V11, P6598, DOI 10.1158/1078-0432.CCR-05-0636; Rose C, 1980, Recent Results Cancer Res, V71, P134; Ruiz C, 2006, INT J CANCER, V118, P2190, DOI 10.1002/ijc.21581; SAUTER G, 1993, CANCER RES, V53, P2199; SAUTER G, 1995, CYTOMETRY, V21, P40, DOI 10.1002/cyto.990210109; Shoker BS, 1999, J PATHOL, V188, P237; Simon R, 2002, ONCOGENE, V21, P2476, DOI 10.1038/sj.onc.1205304; Simon R, 2001, J NATL CANCER I, V93, P1141, DOI 10.1093/jnci/93.15.1141; STIERER M, 1993, ANN SURG, V218, P13, DOI 10.1097/00000658-199307000-00004; SUNDERLAND MC, 1991, J CLIN ONCOL, V9, P1283, DOI 10.1200/JCO.1991.9.7.1283; Wagner U, 1997, AM J PATHOL, V151, P753; Wolmark N, 2001, ANN NY ACAD SCI, V949, P99	25	274	284	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2007	39	5					655	660		10.1038/ng2006	http://dx.doi.org/10.1038/ng2006			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17417639				2022-12-17	WOS:000245971300022
J	Benetti, R; Garcia-Cao, M; Blasco, MA				Benetti, Roberta; Garcia-Cao, Marta; Blasco, Maria A.			Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres	NATURE GENETICS			English	Article							CONSTITUTIVE HETEROCHROMATIN; HISTONE METHYLTRANSFERASES; CHROMOSOMAL INSTABILITY; DNA-DAMAGE; CELLS; MICE; STABILITY/; PROTEINS; COMPLEX; FAMILY	Mammalian telomeres have epigenetic marks of constitutive heterochromatin. Here, we study the impact of telomere length on the maintenance of heterochromatin domains at telomeres. Telomerase-deficient Terc(-/-) mice with short telomeres show decreased trimethylation of histone 3 at Lys9 ( H3K9) and histone 4 at Lys20 ( H4K20) in telomeric and subtelomeric chromatin as well as decreased CBX3 binding accompanied by increased H3 and H4 acetylation at these regions. Subtelomeric DNA methylation is also decreased in conjunction with telomere shortening in Terc(-/-) mice. In contrast, telomere repeat factors 1 and 2 show normal binding to telomeres independent of telomere length. These results indicate that loss of telomeric repeats leads to a change in the architecture of telomeric and subtelomeric chromatin consisting of loss of heterochromatic features leading to a more 'open' chromatin state. These observations highlight the importance of telomere repeats in the establishment of constitutive heterochromatin at mammalian telomeres and subtelomeres and point to histone modifications as important in counting telomere repeats.	Spanish Natl Canc Ctr, Mol Oncol Program, Telomeres & Telomerase Grp, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Blasco, MA (corresponding author), Spanish Natl Canc Ctr, Mol Oncol Program, Telomeres & Telomerase Grp, Madrid 28029, Spain.	mblasco@cnio.es	Blasco, Maria A./M-1694-2014	Blasco, Maria A./0000-0002-4211-233X; BENETTI, Roberta/0000-0001-8863-0821				Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chan SWL, 2002, ONCOGENE, V21, P553, DOI 10.1038/sj.onc.1205082; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; CHIEN CT, 1993, CELL, V75, P531, DOI 10.1016/0092-8674(93)90387-6; COCKELL M, 1995, J CELL BIOL, V129, P909, DOI 10.1083/jcb.129.4.909; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Espejel S, 2002, EMBO J, V21, P2207, DOI 10.1093/emboj/21.9.2207; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Garcia-Cao M, 2002, NAT GENET, V32, P415, DOI 10.1038/ng1011; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Koering CE, 2002, EMBO REP, V3, P1055, DOI 10.1093/embo-reports/kvf215; Kourmouli N, 2004, J CELL SCI, V117, P2491, DOI 10.1242/jcs.01238; Lustig AJ, 1998, CURR OPIN GENET DEV, V8, P233, DOI 10.1016/S0959-437X(98)80146-9; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Muntoni A, 2005, HUM MOL GENET, V14, pR191, DOI 10.1093/hmg/ddi266; Niida H, 2000, MOL CELL BIOL, V20, P4115, DOI 10.1128/MCB.20.11.4115-4127.2000; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Samper E, 2001, EMBO REP, V2, P800, DOI 10.1093/embo-reports/kve174; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Steinert S, 2004, MOL CELL BIOL, V24, P4571, DOI 10.1128/MCB.24.10.4571-4580.2004; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4	29	274	288	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2007	39	2					243	250		10.1038/ng1952	http://dx.doi.org/10.1038/ng1952			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17237781				2022-12-17	WOS:000244063900024
J	Sato, TK; Yamada, RG; Ukai, H; Baggs, JE; Miraglia, LJ; Kobayashi, TJ; Welsh, DK; Kay, SA; Ueda, HR; Hogenesch, JB				Sato, TK; Yamada, RG; Ukai, H; Baggs, JE; Miraglia, LJ; Kobayashi, TJ; Welsh, DK; Kay, SA; Ueda, HR; Hogenesch, JB			Feedback repression is required for mammalian circadian clock function	NATURE GENETICS			English	Article							KAIC PHOSPHORYLATION; GENE-EXPRESSION; TRANSCRIPTION; MPER1; LOOP; CRYPTOCHROMES; MECHANISM; RHYTHMS; PROTEIN; PERIOD	Direct evidence for the requirement of transcriptional feedback repression in circadian clock function has been elusive. Here, we developed a molecular genetic screen in mammalian cells to identify mutants of the circadian transcriptional activators CLOCK and BMAL1, which were uncoupled from CRYPTOCHROME (CRY)- mediated transcriptional repression. Notably, mutations in the PER-ARNT-SIM domain of CLOCK and the C terminus of BMAL1 resulted in synergistic insensitivity through reduced physical interactions with CRY. Coexpression of these mutant proteins in cultured fibroblasts caused arrhythmic phenotypes in population and single-cell assays. These data demonstrate that CRY-mediated repression of the CLOCK/BMAL1 complex activity is required for maintenance of circadian rhythmicity and provide formal proof that transcriptional feedback is required for mammalian clock function.	Genom Inst, San Diego, CA 92121 USA; Novartis Res Fdn, San Diego, CA 92121 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Genome Technol, Jupiter, FL 33458 USA; RIKEN, Ctr Dev Biol, Lab Syst Biol, Kobe, Hyogo 6500047, Japan; Scripps Res Inst, Dept Biochem, Jupiter, FL 33458 USA; Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92037 USA; Vet Adm San Diego Healthcare Syst, La Jolla, CA 92161 USA; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA	Novartis; Scripps Research Institute; Scripps Research Institute; RIKEN; Scripps Research Institute; University of California System; University of California San Diego; Scripps Research Institute	Ueda, HR (corresponding author), Genom Inst, 10675 John J Hopkins Dr, San Diego, CA 92121 USA.	uedah-tky@umin.ac.jp; hogenesch@scripps.edu	Welsh, David K/G-2277-2011; Kay, Steve A/F-6025-2011; Ueda, Hiroki R/C-5037-2014	Kay, Steve A/0000-0002-0402-2878; Ueda, Hiroki R/0000-0001-8342-9176	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074924] Funding Source: NIH RePORTER; NIMH NIH HHS [P50 MH074924-01, P50 MH074924] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Cook E. R., 1981, Tree-Ring Bulletin, V41, P45; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Yildiz O, 2005, MOL CELL, V17, P69, DOI 10.1016/j.molcel.2004.11.022; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	33	274	279	3	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					312	319		10.1038/ng1745	http://dx.doi.org/10.1038/ng1745			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16474406	Green Accepted			2022-12-17	WOS:000235589600012
J	Date, H; Onodera, O; Tanaka, H; Iwabuchi, K; Uekawa, K; Igarashi, S; Koike, R; Hiroi, T; Yuasa, T; Awaya, Y; Sakai, T; Takahashi, T; Nagatomo, H; Sekijima, Y; Kawachi, I; Takiyama, Y; Nishizawa, M; Fukuhara, N; Saito, K; Sugano, S; Tsuji, S				Date, H; Onodera, O; Tanaka, H; Iwabuchi, K; Uekawa, K; Igarashi, S; Koike, R; Hiroi, T; Yuasa, T; Awaya, Y; Sakai, T; Takahashi, T; Nagatomo, H; Sekijima, Y; Kawachi, I; Takiyama, Y; Nishizawa, M; Fukuhara, N; Saito, K; Sugano, S; Tsuji, S			Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene	NATURE GENETICS			English	Article							CEREBELLAR ATROPHY HMSNCA; HEREDITARY MOTOR; LINKAGE ANALYSIS; PROTEINS; FEATURES; FAMILY	Friedreich ataxia (FRDA), the most common autosomal recessive neurodegenerative disease among Europeans and people of European descent, is characterized by an early onset (usually before the age of 25), progressive ataxia, sensory loss, absence of tendon reflexes and pyramidal weakness of the legs(1-4). We have recently identified a unique group of patients whose clinical presentations are characterized by autosomal recessive inheritance, early age of onset, FRDA-like clinical presentations and hypoalbuminemia. Linkage to the FRDA locus, however, was excluded. Given the similarities of the clinical presentations to those of the recently described ataxia with oculomotor apraxia (AOA) linked to chromosome 9p13, we confirmed that the disorder of our patients is also linked to the same locus(5). We narrowed the candidate region and have identified a new gene encoding a member of the histidine triad (HIT) superfamily as the 'causative' gene. We have called its product aprataxin; the gene symbol is APTX. Although many HIT proteins have been identified, aprataxin is the first to be linked to a distinct phenotype.	Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan; Kanagawa Rehabil Ctr, Dept Neurol & Psychiat, Kanagawa, Japan; Natl Kumamoto Minami Hosp, Dept Neurol, Kumamoto, Japan; Hosoki Hosp, Kouchi, Japan; Kohnodai Hosp, Natl Ctr Neurol & Psychiat, Dept Neurol, Tokyo, Japan; Seibo Hosp, Dept Pediat, Tokyo, Japan; Natl Chikugo Hosp, Fukuoka, Japan; Yokohama City Univ, Med Ctr, Dept Psychiat, Kanagawa, Japan; Shinshu Univ, Sch Med, Dept Med 3, Nagano, Japan; Jichi Med Sch, Dept Neurol, Minami Kawachi, Tochigi 32904, Japan; Natl Saigata Hosp, Dept Neurol, Niigata, Japan; Tokyo Womens Med Univ, Sch Med, Dept Pediat, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Dept Virol, Tokyo, Japan	Niigata University; National Center for Neurology & Psychiatry - Japan; Yokohama City University; Shinshu University; Jichi Medical University; Tokyo Women's Medical University; University of Tokyo	Tsuji, S (corresponding author), Niigata Univ, Brain Res Inst, Dept Neurol, 1 Asahimachi, Niigata 951, Japan.		Kawachi, Izumi/AFE-8189-2022; Onodera, Osamu/K-7327-2013	Onodera, Osamu/0000-0003-3354-5472; Saito, Kayoko/0000-0003-2632-0873				AICARDI J, 1988, ANN NEUROL, V24, P497, DOI 10.1002/ana.410240404; ARAIE M, 1977, JPN J OPHTHALMOL, V21, P355; Barbot C, 2001, ARCH NEUROL-CHICAGO, V58, P201, DOI 10.1001/archneur.58.2.201; Brenner C, 1999, J CELL PHYSIOL, V181, P179, DOI 10.1002/(SICI)1097-4652(199911)181:2<179::AID-JCP1>3.0.CO;2-8; COGAN DG, 1953, AM J OPHTHALMOL, V36, P433, DOI 10.1016/0002-9394(53)90553-4; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Friedreich N., 1876, VIRCHOWS ARCH PATHOL, V68, P145, DOI 10.1007/BF01879049; Friedreich N., 1877, VIRCHOWS ARCH PATHOL, V70, P140, DOI 10.1007/BF01936635; FUKUHARA N, 1995, J NEUROL SCI, V133, P140, DOI 10.1016/0022-510X(95)00176-3; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; INOUE N, 1971, CLIN NEUROL TOKYO, V11, P855; KAWASAKI S, 1982, CLIN NEUROL, V22, P15; KOIKE R, 1998, NEUROL MED, V48, P237; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kubota Hiroshi, 1995, Brain and Nerve (Tokyo), V47, P289; KURITATAKAHASHI S, NEUROOPHTHALMOL, V12, P41; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Lima CD, 1996, P NATL ACAD SCI USA, V93, P5357, DOI 10.1073/pnas.93.11.5357; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Moreira MD, 2001, AM J HUM GENET, V68, P501, DOI 10.1086/318191; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAMBROOK J, 2001, MOL CLONING LAB MANU, V1; Sekijima Y, 1998, J NEUROL SCI, V158, P30, DOI 10.1016/S0022-510X(98)00103-8; Seraphin B., 1992, DNA Sequence, V3, P177, DOI 10.3109/10425179209034013; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UEKAWA K, 1992, CLIN NEUROL, V32, P1067	28	274	286	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					184	188		10.1038/ng1001-184	http://dx.doi.org/10.1038/ng1001-184			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11586299				2022-12-17	WOS:000171374100025
J	Bargal, R; Avidan, N; Ben-Asher, E; Olender, Z; Zeigler, M; Frumkin, A; Raas-Rothschild, A; Glusman, G; Lancet, D; Bach, G				Bargal, R; Avidan, N; Ben-Asher, E; Olender, Z; Zeigler, M; Frumkin, A; Raas-Rothschild, A; Glusman, G; Lancet, D; Bach, G			Identification of the gene causing mucolipidosis type IV	NATURE GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; NATURAL-HISTORY; PROTEIN; PREDICTION; DATABASE; DNA	Mucolipidosis type IV (MLIV) is an autosomal recessive, neurodegenerative, lysosomal storage disorder(1) characterized by psychomotor retardation and ophthalmological abnormalities including corneal opacities, retinal degeneration and strabismus. Most patients reach a maximal developmental level of 12-15 months(2). The disease was classified as a mucolipidosis following observations by electron microscopy indicating the lysosomal storage of lipids together with water-soluble, granulated substances(1,3-6). Over 80% of the MLIV patients diagnosed are Ashkenazi Jews, including severely affected and mildly affected patients(3,4). The gene causing MLIV was previously mapped to human chromosome 19p13.2-13.3 in a region of approximately 1 cM (ref. 7). Haplotype analysis in the MLIV gene region of over 70 MLIV Ashkenazi chromosomes indicated the existence of two founder chromosomes among 95% of the Ashkenazi MLIV families: a major haplotype in 72% and a minor haplotype in 23% of the MLIV chromosomes (ref. 7, and G.B., unpublished data). The remaining 5% are distinct haplotypes found only in single patients. The basic metabolic defect causing the lysosomal storage in MLIV has not yet been identified. Thus. positional cloning was an alternative to identify the MLIV gene. We report here the identification of a new gene in this human chromosomal region in which MLIV-specific mutations were identified.	Hadassah Hebrew Univ Hosp, Dept Human Genet, Jerusalem, Israel; Weizmann Inst Sci, Dept Mol Genet, Crown Human Genome Ctr, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Weizmann Institute of Science	Bach, G (corresponding author), Hadassah Hebrew Univ Hosp, Dept Human Genet, Jerusalem, Israel.							Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMIR N, 1987, PEDIATRICS, V79, P953; BACH G, 1992, GENETIC DIVERSITY AMONG JEWS, P301; BERMAN ER, 1974, J PEDIATR-US, V84, P519, DOI 10.1016/S0022-3476(74)80671-2; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; CHITAYAT D, 1991, AM J MED GENET, V41, P313, DOI 10.1002/ajmg.1320410310; Glusman G, 2000, BIOINFORMATICS, V16, P482, DOI 10.1093/bioinformatics/16.5.482; GOEBEL HH, 1982, CLIN NEUROPATHOL, V1, P73; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; Harris PC, 1999, HUM MOL GENET, V8, P1861, DOI 10.1093/hmg/8.10.1861; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hofmann K, 1999, NUCLEIC ACIDS RES, V27, P215, DOI 10.1093/nar/27.1.215; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MERIN S, 1975, INVEST OPHTH VISUAL, V14, P437; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; REIS S, 1993, AM J MED GENET, V47, P392; ROST B, 1993, P NATL ACAD SCI USA, V90, P7558, DOI 10.1073/pnas.90.16.7558; Sessa A, 1997, J NEPHROL, V10, P295; Slaugenhaupt SA, 1999, AM J HUM GENET, V65, P773, DOI 10.1086/302549; SOLOVYEV V, 1997, ISMB, V5, P294	21	274	282	1	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					118	121		10.1038/79095	http://dx.doi.org/10.1038/79095			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	10973263				2022-12-17	WOS:000089078000032
J	Matthijs, G; Schollen, E; Pardon, E; VeigaDaCunha, M; Jaeken, J; Cassiman, JJ; VanSchaftingen, E				Matthijs, G; Schollen, E; Pardon, E; VeigaDaCunha, M; Jaeken, J; Cassiman, JJ; VanSchaftingen, E			Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome)	NATURE GENETICS			English	Article							SERUM TRANSFERRIN	Carbohydrate-deficient glycoprotein syndrome type 1 (CDG1 or Jaeken syndrome) is the prototype of a class of genetic multisystem disorders characterized by defective glycosylation of glycoconjugates(1-4). It is mostly a severe disorder which presents neonatally. There is a severe encephalopathy with axial hypotonia, abnormal eye movements and pronounced psychomotor retardation, as well as a peripheral neuropathy, cerebellar hypoplasia and retinitis pigmentosa. The patients show a peculiar distribution of subcutaneous fat, nipple retraction and hypogonadism. There is a 20% lethality in the first years of life due to severe infections, liver insufficiency or cardiomyopathy(2,3,5). CDG1 shows an autosomal recessive mode of inheritance and has been mapped to chromosome 16p(6,7). Most patients show a deficiency of phosphomannomutase (PMM)(8), an enzyme necessary for the synthesis of GDP-mannose. We have cloned the PMM1 gene, which is on chromosome 22q13 (ref, 9), We now report the identification of a second human PMM gene, PMM2, which is located on 16p13 and which encodes a protein with 66% identity to PMM1. We found eleven different missense mutations in PMM2 in 16 CDG1 patients from different geographical origins and with a documented phosphomannomutase deficiency. Our results give conclusive support to the biochemical finding that the phosphomannomutase deficiency is the basis for CDG1.	INT INST CELLULAR & MOL PATHOL, PHYSIOL CHEM LAB, B-1200 BRUSSELS, BELGIUM; UNIV CATHOLIQUE LOUVAIN, B-1200 BRUSSELS, BELGIUM; KATHOLIEKE UNIV LEUVEN HOSP, DEPT PEDIAT, B-3000 LOUVAIN, BELGIUM	Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven	Matthijs, G (corresponding author), CATHOLIC UNIV LEUVEN, CTR HUMAN GENET, CAMPUS GASTHUISBERG, B-3000 LOUVAIN, BELGIUM.		Van+Schaftingen, Emile/AAF-5532-2020	Matthijs, Gert/0000-0001-6710-1912; Van Schaftingen, Emile/0000-0002-6199-7647				CHEN ISY, 1983, NATURE, V305, P502, DOI 10.1038/305502a0; DOGGETT NA, 1995, NATURE, V377, P335; JAEKEN J, 1984, CLIN CHIM ACTA, V144, P245, DOI 10.1016/0009-8981(84)90059-7; JAEKEN J, 1980, PEDIATR RES, V14, P179, DOI 10.1203/00006450-198002000-00117; JAEKEN J, 1993, J INHERIT METAB DIS, V16, P813, DOI 10.1007/BF00714272; Jaeken J, 1997, J MED GENET, V34, P73, DOI 10.1136/jmg.34.1.73; JAEKEN J, IN PRESS J INHER MET; JAEKEN J, IN PRESS EUR J PEDIA; KEPES F, 1988, J BIOL CHEM, V263, P9155; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LONGMIRE JL, 1993, GENET ANAL-BIOMOL E, V10, P69, DOI 10.1016/1050-3862(93)90037-J; MARTINSSON T, 1994, HUM MOL GENET, V3, P2037; Matthijs G, 1996, GENOMICS, V35, P597, DOI 10.1006/geno.1996.0404; Matthijs G, 1997, GENOMICS, V40, P41, DOI 10.1006/geno.1996.4536; Sambrook J, 1989, MOL CLONING LAB MANU; STIBLER H, 1994, J NEUROL NEUROSUR PS, V57, P552, DOI 10.1136/jnnp.57.5.552; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1; WADA Y, 1992, BIOCHEM BIOPH RES CO, V189, P832, DOI 10.1016/0006-291X(92)92278-6; YAMASHITA K, 1993, J BIOL CHEM, V268, P5783	19	274	278	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1997	16	1					88	92		10.1038/ng0597-88	http://dx.doi.org/10.1038/ng0597-88			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	9140401				2022-12-17	WOS:A1997WX02400028
J	Frankel, WN; Schork, NJ				Frankel, WN; Schork, NJ			Who's afraid of epistasis?	NATURE GENETICS			English	Editorial Material							QUANTITATIVE TRAITS; GENETIC DISSECTION; CONGENIC STRAINS; LINKAGE ANALYSIS; COMPLEX TRAITS; LOCUS; MICE; EPILEPSY		CASE WESTERN RESERVE UNIV,DEPT EPIDEMIOL & BIOSTAT,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,DEPT GENET,CLEVELAND,OH 44106; HARVARD UNIV,SCH PUBL HLTH,DEPT BIOSTAT,BOSTON,MA 02115; HARVARD UNIV,SCH PUBL HLTH,PROGRAM & POPULAT GENET,BOSTON,MA 02115	Case Western Reserve University; Case Western Reserve University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Frankel, WN (corresponding author), JACKSON LAB,600 MAIN ST,BAR HARBOR,ME 04609, USA.			Schork, Nicholas/0000-0003-0920-5013				Bateson W, 1907, PROGR REI BOTANICAE, V1, P368; CHEVERUD JM, 1995, GENETICS, V139, P1455; DESANCTIS GT, 1995, NAT GENET, V11, P150, DOI 10.1038/ng1095-150; Falconer D. S., 1989, Introduction to quantitative genetics.; FRANKEL WN, 1995, TRENDS GENET, V11, P471, DOI 10.1016/S0168-9525(00)89155-6; FRANKEL WN, 1995, MAMM GENOME, V6, P839, DOI 10.1007/BF00292432; FRANKEL WN, 1995, MAMM GENOME, V6, P830, DOI 10.1007/BF00292431; FUJNEMAN RJA, 1996, NAT GENET, V14, P465; GROOT PC, 1992, FASEB J, V6, P2826, DOI 10.1096/fasebj.6.10.1634045; HARTL DL, 1968, J THEOR BIOL, V20, P129, DOI 10.1016/0022-5193(68)90186-0; JANSEN RC, 1994, GENETICS, V136, P1447; JOHNSON KR, 1995, GENOMICS, V29, P457, DOI 10.1006/geno.1995.9981; JORDE LB, 1995, AM J HUM GENET, V56, P11; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1989, GENETICS, V121, P185; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LETTS VA, 1995, GENOMICS, V29, P719, DOI 10.1006/geno.1995.9946; Morel L, 1996, MAMM GENOME, V7, P335, DOI 10.1007/s003359900098; RAPP JP, 1994, J HYPERTENS, V12, P349; Rieseberg LH, 1996, SCIENCE, V272, P741, DOI 10.1126/science.272.5262.741; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; SCHORK NJ, 1990, GENET EPIDEMIOL, V7, P427, DOI 10.1002/gepi.1370070605; SCHORK NJ, IN PRESS HYPERTENSIO; TIENARI PJ, 1994, GENOMICS, V19, P320, DOI 10.1006/geno.1994.1064; vanWezel T, 1996, NAT GENET, V14, P468, DOI 10.1038/ng1296-468; WRIGHT S, 1982, ANNU REV GENET, V16, P1, DOI 10.1146/annurev.ge.16.120182.000245; Wright S, 1931, GENETICS, V16, P0097; WRIGHT S, 1978, J ANIM SCI, V46, P1192, DOI 10.2527/jas1978.4651192x	29	274	276	1	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					371	373		10.1038/ng1296-371	http://dx.doi.org/10.1038/ng1296-371			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944011				2022-12-17	WOS:A1996VV73000002
J	Blasco, MA; Rizen, M; Greider, CW; Hanahan, D				Blasco, MA; Rizen, M; Greider, CW; Hanahan, D			Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis	NATURE GENETICS			English	Letter									COLD SPRING HARBOR LAB,NEW YORK,NY 11724; UNIV CALIF SAN FRANCISCO,HORMONE RES INST,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	Cold Spring Harbor Laboratory; University of California System; University of California San Francisco			Blasco, Maria A./M-1694-2014	Blasco, Maria A./0000-0002-4211-233X; Greider, Carol/0000-0002-5494-8126	NATIONAL INSTITUTE ON AGING [R37AG009383, R01AG009383] Funding Source: NIH RePORTER; NIA NIH HHS [AG09383] Funding Source: Medline; NIGMS NIH HHS [GMO7618] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARBEIT JM, 1994, J VIROL, V68, P4358, DOI 10.1128/JVI.68.7.4358-4368.1994; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; AVILION AA, IN PRESS CANCER RES; BACCHETTI S, 1995, INT J ONCOL, V7, P423; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BLASCO MA, 1995, SCIENCE, V269, P1267, DOI 10.1126/science.7544492; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; CHADENEAU C, 1995, ONCOGENE, V11, P893; CHRISTOFORI G, 1994, NATURE, V369, P414, DOI 10.1038/369414a0; COLLINS K, 1995, CELL, V81, P677, DOI 10.1016/0092-8674(95)90529-4; COUNTER CM, 1995, BLOOD, V85, P2315, DOI 10.1182/blood.V85.9.2315.bloodjournal8592315; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; COUNTER CM, 1994, J VIROL, V68, P3410, DOI 10.1128/JVI.68.5.3410-3414.1994; COUNTER GM, 1994, P NATL ACAD SCI USA, V91, P2900; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1995, CURR OPIN GENET DEV, V5, P249, DOI 10.1016/0959-437X(95)80016-6; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HIYAMA K, IN PRESS J IMMUN; HURLIN PJ, IN PRESS ONCOGENE; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; SHAW JW, IN PRESS CURR OPIN O	28	274	290	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1996	12	2					200	204		10.1038/ng0296-200	http://dx.doi.org/10.1038/ng0296-200			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563761				2022-12-17	WOS:A1996TU07900023
J	ANDERSEN, PM; NILSSON, P; ALAHURULA, V; KERANEN, ML; TARVAINEN, I; HALTIA, T; NILSSON, L; BINZER, M; FORSGREN, L; MARKLUND, SL				ANDERSEN, PM; NILSSON, P; ALAHURULA, V; KERANEN, ML; TARVAINEN, I; HALTIA, T; NILSSON, L; BINZER, M; FORSGREN, L; MARKLUND, SL			AMYOTROPHIC-LATERAL-SCLEROSIS ASSOCIATED WITH HOMOZYGOSITY FOR AN ASP90ALA MUTATION IN CUZN-SUPEROXIDE DISMUTASE	NATURE GENETICS			English	Article							NORTHERN SWEDEN; COPPER; POPULATION; ALS; SOD	Recent reports have shown heterozygosity for some twenty different mutations in the CuZn-superoxide dismutase (CuZn-SOD) gene in familial amyotrophic lateral sclerosis (FALS), and analysed samples from patients have shown decreased enzymic activity. Here we report homozygosity for an exon 4 mutation, Asp90Ala in fourteen patients among four unrelated ALS families and four apparently sporadic ALS patients from Sweden and Finland. The erythrocyte CuZn-SOD activity is essentially normal. Our findings suggest that this CuZn-SOD mutation causes ALS by a gain of function rather than by loss, and that the Asp90Ala mutation is less detrimental than previously reported mutations.	UMEA UNIV HOSP, DEPT CLIN CHEM, S-90185 UMEA, SWEDEN; UMEA UNIV HOSP, DEPT NEUROL, S-90185 UMEA, SWEDEN; CENT LASARETTET KEMI, DEPT NEUROL, SF-94100 KEMI, FINLAND; LAPIN KESKUSSAIRAALA, DEPT NEUROL, SF-96101 ROVANIEMI, FINLAND; MIKKELIN KESKUSSAIRAALA, DEPT NEUROL, SF-50100 MIKKELI, FINLAND; KAUNIALA SJUKHUS KRIGSINVALIDER, SF-02700 KAUNIAINEN, FINLAND	Umea University; Umea University								BECKMAN G, 1973, HEREDITAS, V73, P305; BECKMAN G, 1973, HUM HERED, V23, P346, DOI 10.1159/000152595; BECKMAN G, 1975, HEREDITAS, V79, P43; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; BORDO D, 1994, J MOL BIOL, V238, P366, DOI 10.1006/jmbi.1994.1298; BOWLING AC, 1993, J NEUROCHEM, V61, P2322, DOI 10.1111/j.1471-4159.1993.tb07478.x; CHIO A, 1987, ACTA NEUROL SCAND, V75, P277, DOI 10.1111/j.1600-0404.1987.tb07933.x; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; DUMON J, 1971, J MED GENET, V8, P113, DOI 10.1136/jmg.8.1.113; ERIKSSON AW, 1973, ISRAEL J MED SCI, V9, P1156; FORSGREN L, 1983, ACTA NEUROL SCAND, V68, P20, DOI 10.1111/j.1600-0404.1983.tb04810.x; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HENTATI A, 1994, NAT GENET, V7, P425, DOI 10.1038/ng0794-425; ILSHAFEY A, 1994, HUM MOL GENET, V3, P363; JONES CT, 1994, HUM MOL GENET, V3, P649, DOI 10.1093/hmg/3.4.649; KURLAND LT, 1955, NEUROLOGY, V5, P182, DOI 10.1212/WNL.5.3.182; KURLAND LT, 1955, NEUROLOGY, V5, P249, DOI 10.1212/WNL.5.4.249; LEVANON D, 1985, EMBO J, V4, P77, DOI 10.1002/j.1460-2075.1985.tb02320.x; MARKLUND S, 1976, J BIOL CHEM, V251, P7504; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; MARKLUND SL, 1985, CRC HDB METHODS OXYG, P249; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MIETTINEN OS, 1974, AM J EPIDEMIOL, V100, P515; MYLLYLA VV, 1979, ACTA NEUROL SCAND, V60, P170; NAKANO R, 1994, BIOCHEM BIOPH RES CO, V200, P695, DOI 10.1006/bbrc.1994.1506; OGASAWARA M, 1993, NAT GENET, V5, P323, DOI 10.1038/ng1293-323; OHMAN M, 1986, CLIN SCI, V70, P365; PRAMATAROVA A, 1995, AM J HUM GENET, V56, P592; RAINERO I, 1994, NEUROLOGY, V44, P347, DOI 10.1212/WNL.44.2.347; ROBBERECHT W, 1994, J NEUROCHEM, V62, P384; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SIDDIQUE T, 1994, AM J HUM GENET, V55, pA1419; SJALANDER A, IN PRESS HUM MOL GEN; SWASH M, 1992, NEUROMUSCULAR DISORD, V2, P7, DOI 10.1016/0960-8966(92)90020-7; TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7; TANDAN R, 1985, ANN NEUROL, V18, P271, DOI 10.1002/ana.410180302; TSUDA T, 1994, NEURON, V13, P727, DOI 10.1016/0896-6273(94)90039-6; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; YIM MB, 1993, J BIOL CHEM, V268, P4099	40	274	279	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1995	10	1					61	66		10.1038/ng0595-61	http://dx.doi.org/10.1038/ng0595-61			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	7647793				2022-12-17	WOS:A1995QX57300017
J	AALTONEN, J; BJORSES, P; SANDKUIJL, L; PERHEENTUPA, J; PELTONEN, L				AALTONEN, J; BJORSES, P; SANDKUIJL, L; PERHEENTUPA, J; PELTONEN, L			AN AUTOSOMAL LOCUS CAUSING AUTOIMMUNE-DISEASE - AUTOIMMUNE POLYGLANDULAR DISEASE TYPE-I ASSIGNED TO CHROMOSOME-21	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; LOCALIZATION; GENE	Autoimmune polyglandular disease type I (APECED) is an autosomal recessive autoimmune disease characterized by a variable combination of the failure of the endocrine glands. The pathogenesis of this unique autoimmune disease is unknown; unlike many other autoimmune diseases, APECED does not show association to specific HLA haplotypes. Unravelling the APECED locus will identify a novel gene outside the HLA loci influencing the outcome of autoimmune diseases. We have assigned the disease locus to chromosome 21q22.3 by linkage analyses in 14 Finnish families. Linkage disequilibrium studies have significantly increased the informativeness of the analyses and helped to locate the critical DNA region for the APECED locus to just 500 kilobases, a much more precise definition than linkage analyses alone could achieve.	NATL PUBL HLTH INST,DEPT HUMAN MOLEC GENET,SF-00300 HELSINKI,FINLAND; CHILDRENS HOSP,SF-00290 HELSINKI,FINLAND; ERASMUS UNIV ROTTERDAM,INST CLIN GENET,3000 DR ROTTERDAM,NETHERLANDS; SYLVIUS LABS,DEPT HUMAN GENET,2333 AL LEIDEN,NETHERLANDS	Finland National Institute for Health & Welfare; Erasmus University Rotterdam								Aaltonen J., 1993, European Journal of Human Genetics, V1, P164; AHONEN P, 1985, CLIN GENET, V27, P535, DOI 10.1111/j.1399-0004.1985.tb02037.x; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; AHONEN P, 1988, J CLIN ENDOCR METAB, V66, P1152, DOI 10.1210/jcem-66-6-1152; ANTONARAKIS SE, 1993, TRENDS GENET, V9, P142, DOI 10.1016/0168-9525(93)90210-9; ARNAOUT MA, 1990, J CLIN INVEST, V85, P977, DOI 10.1172/JCI114529; CARSON DA, 1992, FASEB J, V6, P2800, DOI 10.1096/fasebj.6.10.1634042; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; GU Z, 1991, AM J HUM GENET, V49, pA406; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HAWKINS JW, 1987, HUM GENET, V76, P375, DOI 10.1007/BF00272448; HELLSTEN E, 1993, GENOMICS, V16, P720, DOI 10.1006/geno.1993.1253; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LAWRENCE S, 1993, P NATL ACAD SCI USA, V90, P7210, DOI 10.1073/pnas.90.15.7210; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; LEVANON D, 1986, BIOCHEM BIOPH RES CO, V141, P374, DOI 10.1016/S0006-291X(86)80379-5; Luria SE, 1943, GENETICS, V28, P491; McKusick V.A., 1992, MENDELIAN INHERITANC; MULLIS KB, 1987, METHOD ENZYMOL, V155, P355; Norio R., 1981, BIOCULTURAL ASPECTS, P359; SYVANEN AC, 1991, GENOMICS, V12, P1; TODD JA, 1992, CURR OPIN IMMUNOL, V4, P699, DOI 10.1016/0952-7915(92)90048-J; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164; YETMAN N, 1992, IMMUNOL TODAY, V13, P239; ZLOTOGORA J, 1992, J MED GENET, V29, P824, DOI 10.1136/jmg.29.11.824	25	274	281	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1994	8	1					83	87		10.1038/ng0994-83	http://dx.doi.org/10.1038/ng0994-83			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	7987397	Green Published			2022-12-17	WOS:A1994PE15700020
J	ZHANG, YL; CHEN, HS; KHANNA, VK; DELEON, S; PHILLIPS, MS; SCHAPPERT, K; BRITT, BA; BROWNELL, AKW; MACLENNAN, DH				ZHANG, YL; CHEN, HS; KHANNA, VK; DELEON, S; PHILLIPS, MS; SCHAPPERT, K; BRITT, BA; BROWNELL, AKW; MACLENNAN, DH			A MUTATION IN THE HUMAN RYANODINE RECEPTOR GENE ASSOCIATED WITH CENTRAL CORE DISEASE	NATURE GENETICS			English	Article							MALIGNANT HYPERTHERMIA SUSCEPTIBILITY; MUSCLE SARCOPLASMIC-RETICULUM; PROBABLE CAUSAL MUTATION; MOLECULAR-CLONING; CHROMOSOME-19; PORCINE; LINKAGE; DNA; HETEROGENEITY; SUBSTITUTION	Central core disease (CCD) is a morphologically distinct, autosomal dominant myopathy with variable clinical features. A close association with malignant hypertheria (MH) has been identified. Since MH and CCD genes have been linked to the skeletal muscle ryanodine receptor (RYR1) gene, cDNA sequence analysis was used to search for a causal RYR1 mutation in a CCD individual. The only amino acid substitution found was an Arg2434His mutation, resulting from the substitution of A for G7301. This mutation was linked to CCD with a lod score of 4.8 at a recombinant fraction of 0.0 in 16 informative meioses in a 130 member family, suggesting a causal relationship to CCD.	UNIV TORONTO,CHARLES H BEST INST,BANTING & BEST DEPT MED RES,112 COLL ST,TORONTO M5G 1L6,ONTARIO,CANADA; HOSP SICK CHILDREN,CANADIAN GENET DIS NETWORK CORE SEQUENCING FACIL,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT ANESTHESIA,TORONTO M5G 2C4,ON,CANADA; UNIV CALGARY,DEPT CLIN NEUROSCI,CALGARY T2N 1N4,ALBERTA,CANADA; FOOTHILLS PROV GEN HOSP,CALGARY T2N 2T9,AB,CANADA	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Calgary; University of Calgary								BANKER BQ, 1986, MYOLOGY, P1528; BRITT BA, 1989, MALIGNANT HYPERTHERM, P53; BROWNELL AKW, 1988, BRIT J ANAESTH, V60, P303, DOI 10.1093/bja/60.3.303; CALDWELL JH, 1992, NAT GENET, V2, P87, DOI 10.1038/ng1092-87; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.biochem.56.1.395; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DENBOROUGH MA, 1973, BMJ-BRIT MED J, V1, P272, DOI 10.1136/bmj.1.5848.272; DEUFEL T, 1992, AM J HUM GENET, V50, P1151; DUBOWITZ V, 1965, J NEUROL NEUROSUR PS, V28, P432, DOI 10.1136/jnnp.28.5.432; ENG GD, 1978, ARCH NEUROL-CHICAGO, V35, P189, DOI 10.1001/archneur.1978.00500280007002; FRANK JP, 1980, ANN NEUROL, V7, P11, DOI 10.1002/ana.410070105; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; GILLARD EF, 1992, GENOMICS, V13, P1247, DOI 10.1016/0888-7543(92)90042-Q; HAAN EA, 1990, HUM GENET, V86, P187; HOGAN K, 1992, ANESTH ANALG, V75, P441; KAUSCH K, 1991, GENOMICS, V10, P765, DOI 10.1016/0888-7543(91)90461-M; LEVITT RC, 1991, GENOMICS, V11, P543, DOI 10.1016/0888-7543(91)90061-I; MACKENZIE AE, 1990, AM J HUM GENET, V46, P1082; MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759; MACLENNAN DH, 1990, NATURE, V343, P559, DOI 10.1038/343559a0; MCCARTHY TV, 1990, NATURE, V343, P562, DOI 10.1038/343562a0; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MULLEY JC, 1993, AM J HUM GENET, V52, P398; OTSU K, 1991, GENOMICS, V11, P744, DOI 10.1016/0888-7543(91)90083-Q; OTSU K, 1990, J BIOL CHEM, V265, P13472; OTSU K, 1992, GENOMICS, V13, P835, DOI 10.1016/0888-7543(92)90163-M; OTT J, 1976, AM J HUM GENET, V28, P528; PATTERSON VH, 1979, BRAIN, V102, P581, DOI 10.1093/brain/102.3.581; RAMSEY PL, 1975, J BONE JOINT SURG AM, V57, P648, DOI 10.2106/00004623-197557050-00011; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHUAIB A, 1987, MEDICINE, V66, P389, DOI 10.1097/00005792-198709000-00004; SHY GM, 1956, BRAIN, V79, P610, DOI 10.1093/brain/79.4.610; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; WALSH MP, 1986, ANESTHESIOLOGY, V64, P473, DOI 10.1097/00000542-198604000-00010; WANG AM, 1989, P NATL ACAD SCI USA, V89, P9719; WROGEMANN K, 1976, LANCET, V1, P672; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	38	274	281	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1993	5	1					46	50		10.1038/ng0993-46	http://dx.doi.org/10.1038/ng0993-46			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	8220422				2022-12-17	WOS:A1993LV56500014
J	Li, ML; Zhang, Z; Li, XG; Ye, JY; Wu, XS; Tan, ZJ; Liu, C; Shen, BY; Wang, XA; Wu, WG; Zhou, DZ; Zhang, D; Wang, T; Liu, BY; Qu, K; Ding, QC; Weng, H; Ding, Q; Mu, JS; Shu, YJ; Bao, RF; Cao, Y; Chen, PZ; Liu, TY; Jiang, L; Hu, YP; Dong, P; Gu, J; Lu, W; Shi, WB; Lu, JH; Gong, W; Tang, ZH; Zhang, Y; Wang, XF; Chin, YE; Weng, XL; Zhang, H; Tang, W; Zheng, YL; He, L; Wang, H; Liu, Y; Liu, YB				Li, Maolan; Zhang, Zhou; Li, Xiaoguang; Ye, Junyi; Wu, Xiangsong; Tan, Zhujun; Liu, Chang; Shen, Baiyong; Wang, Xu-An; Wu, Wenguang; Zhou, Daizhan; Zhang, Di; Wang, Ting; Liu, Bingya; Qu, Kai; Ding, Qichen; Weng, Hao; Ding, Qian; Mu, Jiasheng; Shu, Yijun; Bao, Runfa; Cao, Yang; Chen, Peizhan; Liu, Tianyu; Jiang, Lin; Hu, Yunping; Dong, Ping; Gu, Jun; Lu, Wei; Shi, Weibin; Lu, Jianhua; Gong, Wei; Tang, Zhaohui; Zhang, Yong; Wang, Xuefeng; Chin, Y. Eugene; Weng, Xiaoling; Zhang, Hong; Tang, Wei; Zheng, Yonglan; He, Lin; Wang, Hui; Liu, Yun; Liu, Yingbin			Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway	NATURE GENETICS			English	Article							BILIARY-TRACT; CANCER; MUTAGENESIS; GENOME	Individuals with gallbladder carcinoma (GBC), the most aggressive malignancy of the biliary tract, have a poor prognosis. Here we report the identification of somatic mutations for GBC in 57 tumor-normal pairs through a combination of exome sequencing and ultra-deep sequencing of cancer-related genes. The mutation pattern is defined by a dominant prevalence of C>T mutations at TCN sites. Genes with a significant frequency (false discovery rate (FDR) <0.05) of non-silent mutations include TP53 (47.1%), KRAS (7.8%) and ERBB3 (11.8%). Moreover, ErbB signaling (including EGFR, ERBB2, ERBB3, ERBB4 and their downstream genes) is the most extensively mutated pathway, affecting 36.8% (21/57) of the GBC samples. Multivariate analyses further show that cases with ErbB pathway mutations have a worse outcome (P = 0.001). These findings provide insight into the somatic mutational landscape in GBC and highlight the key role of the ErbB signaling pathway in GBC pathogenesis.	[Li, Maolan; Zhang, Zhou; Wu, Xiangsong; Tan, Zhujun; Wang, Xu-An; Wu, Wenguang; Ding, Qichen; Weng, Hao; Ding, Qian; Mu, Jiasheng; Shu, Yijun; Bao, Runfa; Cao, Yang; Liu, Tianyu; Jiang, Lin; Hu, Yunping; Dong, Ping; Gu, Jun; Lu, Wei; Shi, Weibin; Lu, Jianhua; Gong, Wei; Tang, Zhaohui; Zhang, Yong; Wang, Xuefeng; Liu, Yingbin] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Gen Surg, Shanghai, Peoples R China; [Li, Maolan; Zhang, Zhou; Wu, Xiangsong; Tan, Zhujun; Wang, Xu-An; Wu, Wenguang; Ding, Qichen; Weng, Hao; Ding, Qian; Mu, Jiasheng; Shu, Yijun; Bao, Runfa; Cao, Yang; Liu, Tianyu; Jiang, Lin; Hu, Yunping; Dong, Ping; Gu, Jun; Lu, Wei; Shi, Weibin; Lu, Jianhua; Gong, Wei; Tang, Zhaohui; Zhang, Yong; Wang, Xuefeng; Liu, Yingbin] Shanghai Jiao Tong Univ, Sch Med, Inst Biliary Tract Dis, Shanghai, Peoples R China; [Zhang, Zhou; Zhou, Daizhan; Zhang, Di; Wang, Ting; He, Lin] Shanghai Jiao Tong Univ, BioX Ctr, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai, Peoples R China; [Li, Xiaoguang; Chen, Peizhan; Wang, Hui] Chinese Acad Sci, Univ Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci,Key Lab Food Safety Res, Shanghai, Peoples R China; [Ye, Junyi; Weng, Xiaoling; Zhang, Hong; He, Lin; Liu, Yun] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Liu, Chang; Qu, Kai] Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Hepatobiliary Surg, Xian, Peoples R China; [Shen, Baiyong; Liu, Bingya] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Gen Surg, Shanghai, Peoples R China; [Chin, Y. Eugene] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Tang, Wei] NCI, Lab Human Carcinogenesis, Ctr Canc Res, US NIH, Bethesda, MD 20892 USA; [Zheng, Yonglan] Univ Chicago, Dept Med, Chicago, IL USA; [He, Lin] Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Hui] Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Fudan University; Xi'an Jiaotong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Chicago; Zhejiang University	Liu, YB (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Gen Surg, Shanghai, Peoples R China.	huiwang@sibs.ac.cn; superliuyun@fudan.edu.cn; liuybphd@126.com	Liu, Yingbin/AAI-1919-2020; LIU, YING/GZL-7252-2022; wang, xuan/GXF-3679-2022; Zheng, Yonglan/O-4112-2019; Liu, Bingya/GMW-5655-2022	Liu, Yingbin/0000-0001-6110-0185; Zheng, Yonglan/0000-0001-6597-7072; Gong, Wei/0000-0002-9949-6207; Liu, Bingya/0000-0002-4406-3762; zhou, daizhan/0000-0001-9104-2801	National Natural Science Foundation of China [81172026, 81272402, 81301816, 81172029, 81370728, 81125020, 81328022, 81302507]; National High-Technology Research and Development Program (863 Program) [2012AA022606, 2012BAK01B00]; Foundation for Interdisciplinary Research of Shanghai Jiao Tong University [YG2011ZD07]; Shanghai Science and Technology Commission Intergovernmental International Cooperation Project [12410705900]; Shanghai Science and Technology Commission Medical-Guiding Project [12401905800]; China Postdoctoral Science Foundation [2013M541513]; Program for Changjiang Scholars; Leading Talent program of Shanghai	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); Foundation for Interdisciplinary Research of Shanghai Jiao Tong University; Shanghai Science and Technology Commission Intergovernmental International Cooperation Project; Shanghai Science and Technology Commission Medical-Guiding Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Program for Changjiang Scholars(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Leading Talent program of Shanghai	This study was supported by the National Natural Science Foundation of China (81172026, 81272402, 81301816, 81172029, 81370728, 81125020, 81328022 and 81302507), the National High-Technology Research and Development Program (863 Program, 2012AA022606; 2012BAK01B00), the Foundation for Interdisciplinary Research of Shanghai Jiao Tong University (YG2011ZD07), the Shanghai Science and Technology Commission Intergovernmental International Cooperation Project (12410705900), the Shanghai Science and Technology Commission Medical-Guiding Project (12401905800), the China Postdoctoral Science Foundation (2013M541513), the Program for Changjiang Scholars and the Leading Talent program of Shanghai.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Boutros C, 2012, SURG ONCOL, V21, pE183, DOI 10.1016/j.suronc.2012.08.002; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Desai MD, 2013, EXPERT OPIN INV DRUG, V22, P341, DOI 10.1517/13543784.2013.761972; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Goldin RD, 2009, HISTOPATHOLOGY, V55, P218, DOI 10.1111/j.1365-2559.2008.03192.x; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Jiao YC, 2013, NAT GENET, V45, P1470, DOI 10.1038/ng.2813; Kiguchi K, 2001, CANCER RES, V61, P6971; Kuong KJ, 2013, NAT GENET, V45, P964, DOI 10.1038/ng.2736; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li M., 2013, CHIN J PRACT SURG, V33, P414; Macdonald-Obermann JL, 2013, J BIOL CHEM, V288, P30773, DOI 10.1074/jbc.M113.489534; Maurya SK, 2012, SURG ONCOL, V21, P37, DOI 10.1016/j.suronc.2010.09.003; Nakazawa K, 2005, J PATHOL, V206, P356, DOI 10.1002/path.1779; Pignochino Y, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-631; Randi G, 2006, INT J CANCER, V118, P1591, DOI 10.1002/ijc.21683; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Sliwkowski MX, 2003, NAT STRUCT BIOL, V10, P158, DOI 10.1038/nsb0303-158; Srivastava K, 2011, MUTAT RES-REV MUTAT, V728, P67, DOI 10.1016/j.mrrev.2011.06.002; Wistuba II, 2004, NAT REV CANCER, V4, P695, DOI 10.1038/nrc1429; Wolpin BM, 2010, NEW ENGL J MED, V362, P1335, DOI 10.1056/NEJMe1001183; Wong KM, 2011, ANNU REV GENOM HUM G, V12, P407, DOI 10.1146/annurev-genom-082509-141532	26	273	307	2	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					872	876		10.1038/ng.3030	http://dx.doi.org/10.1038/ng.3030			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	24997986				2022-12-17	WOS:000339704400016
J	Albers, CA; Paul, DS; Schulze, H; Freson, K; Stephens, JC; Smethurst, PA; Jolley, JD; Cvejic, A; Kostadima, M; Bertone, P; Breuning, MH; Debili, N; Deloukas, P; Favier, R; Fiedler, J; Hobbs, CM; Huang, N; Hurles, ME; Kiddle, G; Krapels, I; Nurden, P; Ruivenkamp, CAL; Sambrook, JG; Smith, K; Stemple, DL; Strauss, G; Thys, C; van Geet, C; Newbury-Ecob, R; Ouwehand, WH; Ghevaert, C				Albers, Cornelis A.; Paul, Dirk S.; Schulze, Harald; Freson, Kathleen; Stephens, Jonathan C.; Smethurst, Peter A.; Jolley, Jennifer D.; Cvejic, Ana; Kostadima, Myrto; Bertone, Paul; Breuning, Martijn H.; Debili, Najet; Deloukas, Panos; Favier, Remi; Fiedler, Janine; Hobbs, Catherine M.; Huang, Ni; Hurles, Matthew E.; Kiddle, Graham; Krapels, Ingrid; Nurden, Paquita; Ruivenkamp, Claudia A. L.; Sambrook, Jennifer G.; Smith, Kenneth; Stemple, Derek L.; Strauss, Gabriele; Thys, Chantal; van Geet, Chris; Newbury-Ecob, Ruth; Ouwehand, Willem H.; Ghevaert, Cedric			Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome	NATURE GENETICS			English	Article							DEVELOPMENTAL DISORDER; THROMBOCYTOPENIA; BINDING; COMPONENT; GENE; EXPRESSION	The exon-junction complex (EJC) performs essential RNA processing tasks(1-5). Here, we describe the first human disorder, thrombocytopenia with absent radii (TAR)(6), caused by deficiency in one of the four EJC subunits. Compound inheritance of a rare null allele and one of two low-frequency SNPs in the regulatory regions of RBM8A, encoding the Y14 subunit of EJC, causes TAR. We found that this inheritance mechanism explained 53 of 55 cases (P < 5 x 10(-228)) of the rare congenital malformation syndrome. Of the 53 cases with this inheritance pattern, 51 carried a submicroscopic deletion of 1q21.1 that has previously been associated with TAR(7), and two carried a truncation or frameshift null mutation in RBM8A. We show that the two regulatory SNPs result in diminished RBM8A transcription in vitro and that Y14 expression is reduced in platelets from individuals with TAR. Our data implicate Y14 insufficiency and, presumably, an EJC defect as the cause of TAR syndrome.	[Albers, Cornelis A.; Stephens, Jonathan C.; Smethurst, Peter A.; Jolley, Jennifer D.; Cvejic, Ana; Hobbs, Catherine M.; Kiddle, Graham; Sambrook, Jennifer G.; Ouwehand, Willem H.; Ghevaert, Cedric] Univ Cambridge, Dept Haematol, Cambridge, England; [Albers, Cornelis A.; Stephens, Jonathan C.; Smethurst, Peter A.; Jolley, Jennifer D.; Cvejic, Ana; Hobbs, Catherine M.; Kiddle, Graham; Sambrook, Jennifer G.; Ouwehand, Willem H.; Ghevaert, Cedric] Natl Hlth Serv NHS Blood & Transplant, Cambridge, England; [Albers, Cornelis A.; Paul, Dirk S.; Cvejic, Ana; Deloukas, Panos; Huang, Ni; Hurles, Matthew E.; Stemple, Derek L.; Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Cambridge, England; [Schulze, Harald] Charite, Inst Transfus Med, D-13353 Berlin, Germany; [Schulze, Harald; Fiedler, Janine] Charite, Lab Pediat Mol Biol, D-13353 Berlin, Germany; [Freson, Kathleen; Thys, Chantal; van Geet, Chris] Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium; [Kostadima, Myrto; Bertone, Paul] EBI, EMBL, Cambridge, England; [Breuning, Martijn H.; Ruivenkamp, Claudia A. L.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Debili, Najet; Favier, Remi] INSERM, U790, Villejuif, France; [Fiedler, Janine] Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany; [Krapels, Ingrid] Maastricht Univ, Med Ctr, Dept Clin Genet, Maastricht, Netherlands; [Nurden, Paquita] Hop Xavier Arnozan, Ctr Reference Pathol Plaquettaires, Hematol Lab, Pessac, France; [Smith, Kenneth; Newbury-Ecob, Ruth] Univ Bristol, Div Child Hlth, Bristol, Avon, England; [Smith, Kenneth; Newbury-Ecob, Ruth] St Michaels Hosp, Dept Clin Genet, Bristol, Avon, England; [Strauss, Gabriele] Charite, Dept Pediat Oncol & Hematol, D-13353 Berlin, Germany; [van Geet, Chris] Univ Ziekenhuis Leuven, Dept Pediat, Louvain, Belgium	University of Cambridge; Wellcome Trust Sanger Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; KU Leuven; European Molecular Biology Laboratory (EMBL); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Institut National de la Sante et de la Recherche Medicale (Inserm); Free University of Berlin; Maastricht University; CHU Bordeaux; University of Bristol; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; KU Leuven; University Hospital Leuven	Albers, CA (corresponding author), Univ Cambridge, Dept Haematol, Cambridge, England.	caa@sanger.ac.uk; cg348@cam.ac.uk	Paul, Dirk S./H-3469-2019; Bertone, Paul/A-6600-2013; Albers, Kees/A-4170-2015; Deloukas, Panos/B-2922-2013; Bertone, Paul/Z-3734-2019	Paul, Dirk S./0000-0002-8230-0116; Bertone, Paul/0000-0001-5059-4829; Albers, Kees/0000-0003-4115-3727; Deloukas, Panos/0000-0001-9251-070X; Bertone, Paul/0000-0001-5059-4829; Stephens, Jonathan/0000-0003-2020-9330; Cvejic, Ana/0000-0003-3204-9311; Kostadima, Myrto Areti/0000-0002-1818-4050; freson, kathleen/0000-0002-4381-2442; Ouwehand, Willem/0000-0002-7744-1790; Ghevaert, Cedric/0000-0002-9251-0934	National Institutes for Health Research (NIHR) [RP-PG-0310-1002, RBAG096]; British Heart Foundation [FS/09/039, RG/09/12/28096]; Wellcome Trust [WT-082597/Z/07/Z, WT-084183/2/07/2, WT091310]; Deutsche Forschungsgemeinschaft [SCHU1421/3-1]; Sanitatsrat Dr. Emil Alexander Hubner-und-Gemahlin-Stiftung [T114/17644/2008/sm]; Excellentie Financiering KULeuven [EF/05/013]; Fonds Wetenschappelijk Onderzoek-Vlaanderen [G.0490.10N, G.0743.09]; Research Council of the University of Leuven (Onderzoeksraad-K.U. Leuven) [GOA/2009/13]; Marie-Curie NetSim Initial Training Network [EC-215820]; Gis-Maladies Rares, Diagnostic Differentiel des Purpuras Thrombopeniques Idiopathiques Chroniques et des Thrombopenies Congenitales (DIATROC); INSERM [ANR-08-GENO-028-03]; British Heart Foundation [FS/09/039/27788, RG/09/012/28096, RG/08/014/24067] Funding Source: researchfish; National Institute for Health Research [RP-PG-0310-1002] Funding Source: researchfish	National Institutes for Health Research (NIHR); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sanitatsrat Dr. Emil Alexander Hubner-und-Gemahlin-Stiftung; Excellentie Financiering KULeuven(KU Leuven); Fonds Wetenschappelijk Onderzoek-Vlaanderen(FWO); Research Council of the University of Leuven (Onderzoeksraad-K.U. Leuven); Marie-Curie NetSim Initial Training Network; Gis-Maladies Rares, Diagnostic Differentiel des Purpuras Thrombopeniques Idiopathiques Chroniques et des Thrombopenies Congenitales (DIATROC); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank C. Langford and P. Ellis for performing the enrichment for the exome sequencing, S. Balasubramaniam for assistance with data processing and the Wellcome Trust Sanger Institute sequencing core for sequencing. We thank V. Mooser from GlaxoSmithKline, G. Waeber and P. Vollenweider from CoLaus and J. Durham, C. Scott and colleagues at the Sanger Institute for providing access to their collection of whole-exome sequencing data for the CoLaus cohort<SUP>12</SUP>. We thank R. Durbin, B. Gottgens and I. Palacios for comments on the manuscript. This study makes use of data generated by the UK10K Consortium, which were derived from samples from the TwinsUK cohort. A full list of the investigators who contributed to the generation of the data is available from their website (see URLs). The study was supported by grants from the National Institutes for Health Research (NIHR; RP-PG-0310-1002 to C.G., G.K., P.A.S. and W.H.O.), the British Heart Foundation (FS/09/039 to C.G. and RG/09/12/28096 to C.A.A.), project grants from the Wellcome Trust (WT-082597/Z/07/Z to A.C. and WT-084183/2/07/2 to J.C.S.), grants by the Deutsche Forschungsgemeinschaft (SCHU1421/3-1 to H.S.) and the Sanitatsrat Dr. Emil Alexander Hubner-und-Gemahlin-Stiftung (T114/17644/2008/sm to H.S.), by the Excellentie Financiering KULeuven (EF/05/013), by research grants from the Fonds Wetenschappelijk Onderzoek-Vlaanderen (G.0490.10N and G.0743.09) and by a grant from the Research Council of the University of Leuven (Onderzoeksraad-K.U. Leuven; GOA/2009/13 to C.T., K.F. and C.v.G.). The project made use of NHS Blood and Transplant donors from the Cambridge BioResource (see URLs). This local resource for genotype-phenotype association studies is supported by a grant from the NIHR to the Cambridge Biomedical Research Centre (RBAG096 to J.C.S. and J.D.J.). D.S.P. and M.K. were supported by a Marie-Curie NetSim Initial Training Network grant (EC-215820). The French cases were collected with support from the Gis-Maladies Rares, Diagnostic Differentiel des Purpuras Thrombopeniques Idiopathiques Chroniques et des Thrombopenies Congenitales (DIATROC) program and INSERM (ANR-08-GENO-028-03). Funding for UK10K was provided by the Wellcome Trust (WT091310).	Albers CA, 2011, NAT GENET, V43, P735, DOI 10.1038/ng.885; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Coffey AJ, 2011, EUR J HUM GENET, V19, P827, DOI 10.1038/ejhg.2011.28; Edery P, 2011, SCIENCE, V332, P240, DOI 10.1126/science.1202205; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Freson K, 2001, BLOOD, V98, P85, DOI 10.1182/blood.V98.1.85; Freson K, 2007, J HYPERTENS, V25, P117, DOI 10.1097/HJH.0b013e3280109c6c; Geddis AE, 2006, SEMIN HEMATOL, V43, P196, DOI 10.1053/j.seminhematol.2006.04.003; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797; Greenhalgh KL, 2002, J MED GENET, V39, P876, DOI 10.1136/jmg.39.12.876; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; HALL JG, 1969, MEDICINE, V48, P411, DOI 10.1097/00005792-196948060-00001; Haremaki T, 2010, DEV DYNAM, V239, P1977, DOI 10.1002/dvdy.22330; He HL, 2011, SCIENCE, V332, P238, DOI 10.1126/science.1200587; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Klopocki E, 2007, AM J HUM GENET, V80, P232, DOI 10.1086/510919; Lawrence M, 2009, BIOINFORMATICS, V25, P1841, DOI 10.1093/bioinformatics/btp328; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Paul DS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002139; PERKINS AS, 1991, DEVELOPMENT, V111, P479; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Salicioni AM, 2000, GENOMICS, V69, P54, DOI 10.1006/geno.2000.6315; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Tarpey PS, 2007, NAT GENET, V39, P1127, DOI 10.1038/ng2100; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	36	273	278	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2012	44	4					435	U248		10.1038/ng.1083	http://dx.doi.org/10.1038/ng.1083			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22366785	Green Accepted			2022-12-17	WOS:000302130600019
J	Soler Artigas, M; Loth, DW; Wain, LV; Gharib, SA; Obeidat, M; Tang, WB; Zhai, GJ; Zhao, JH; Smith, AV; Huffman, JE; Albrecht, E; Jackson, CM; Evans, DM; Cadby, G; Fornage, M; Manichaikul, A; Lopez, LM; Johnson, T; Aldrich, MC; Aspelund, T; Barroso, I; Campbell, H; Cassano, PA; Couper, DJ; Eiriksdottir, G; Franceschini, N; Garcia, M; Gieger, C; Gislason, GK; Grkovic, I; Hammond, CJ; Hancock, DB; Harris, TB; Ramasamy, A; Heckbert, SR; Heliovaara, M; Homuth, G; Hysi, PG; Alan, L; Jankovic, S; Joubert, BR; Karrasch, S; Klopp, N; Koch, B; Kritchevsky, SB; Launer, LJ; Liu, YM; Loehr, LR; Lohman, K; Loos, RJF; Lumley, T; Al Balushi, KA; Ang, WQ; Barr, RG; Beilby, J; Blakey, JD; Boban, M; Boraska, V; Brisman, J; Britton, JR; Brusselle, GG; Cooper, C; Curjuric, I; Dahgam, S; Deary, IJ; Ebrahim, S; Eijgelsheim, M; Francks, C; Gaysina, D; Granell, R; Gu, XJ; Hankinson, JL; Hardy, R; Harris, SE; Henderson, J; Henry, A; Hingorani, AD; Hofman, A; Holt, PG; Hui, JN; Hunter, ML; Imboden, M; Jameson, KA; Kerr, SM; Kolcic, I; Kronenberg, F; Liu, JZ; Marchini, J; McKeever, T; Morris, AD; Olin, AC; Porteous, DJ; Postma, DS; Rich, SS; Ring, SM; Rivadeneira, F; Rochat, T; Sayer, AA; Sayers, I; Sly, PD; Smith, GD; Sood, A; Starr, JM; Uitterlinden, AG; Vonk, JM; Wannamethee, SG; Whincup, PH; Wijmenga, C; Williams, OD; Wong, A; Mangino, M; Marciante, KD; McArdle, WL; Meibohm, B; Morrison, AC; North, KE; Omenaas, E; Palmer, LJ; Pietilainen, KH; Pin, I; Polasek, O; Pouta, A; Psaty, BM; Hartikainen, AL; Rantanen, T; Ripatti, S; Rotter, JI; Rudan, I; Rudnicka, AR; Schulz, H; Shin, SY; Spector, TD; Surakka, I; Vitart, V; Volzke, H; Wareham, NJ; Warrington, NM; Wichmann, HE; Wild, SH; Wilk, JB; Wjst, M; Wright, AF; Zgaga, L; Zemunik, T; Pennell, CE; Nyberg, F; Kuh, D; Holloway, JW; Boezen, HM; Lawlor, DA; Morris, RW; Probst-Hensch, N; Kaprio, J; Wilson, JF; Hayward, C; Kahonen, M; Heinrich, J; Musk, AW; Jarvis, DL; Glaser, S; Jarvelin, MR; Stricker, BHC; Elliott, P; O'Connor, GT; Strachan, DP; London, SJ; Hall, IP; Gudnason, V; Tobin, MD				Soler Artigas, Maria; Loth, Daan W.; Wain, Louise V.; Gharib, Sina A.; Obeidat, Ma'en; Tang, Wenbo; Zhai, Guangju; Zhao, Jing Hua; Smith, Albert Vernon; Huffman, Jennifer E.; Albrecht, Eva; Jackson, Catherine M.; Evans, David M.; Cadby, Gemma; Fornage, Myriam; Manichaikul, Ani; Lopez, Lorna M.; Johnson, Toby; Aldrich, Melinda C.; Aspelund, Thor; Barroso, Ines; Campbell, Harry; Cassano, Patricia A.; Couper, David J.; Eiriksdottir, Gudny; Franceschini, Nora; Garcia, Melissa; Gieger, Christian; Gislason, Gauti Kjartan; Grkovic, Ivica; Hammond, Christopher J.; Hancock, Dana B.; Harris, Tamara B.; Ramasamy, Adaikalavan; Heckbert, Susan R.; Heliovaara, Markku; Homuth, Georg; Hysi, Pirro G.; James, Alan L.; Jankovic, Stipan; Joubert, Bonnie R.; Karrasch, Stefan; Klopp, Norman; Koch, Beate; Kritchevsky, Stephen B.; Launer, Lenore J.; Liu, Yongmei; Loehr, Laura R.; Lohman, Kurt; Loos, Ruth J. F.; Lumley, Thomas; Al Balushi, Khalid A.; Ang, Wei Q.; Barr, R. Graham; Beilby, John; Blakey, John D.; Boban, Mladen; Boraska, Vesna; Brisman, Jonas; Britton, John R.; Brusselle, Guy G.; Cooper, Cyrus; Curjuric, Ivan; Dahgam, Santosh; Deary, Ian J.; Ebrahim, Shah; Eijgelsheim, Mark; Francks, Clyde; Gaysina, Darya; Granell, Raquel; Gu, Xiangjun; Hankinson, John L.; Hardy, Rebecca; Harris, Sarah E.; Henderson, John; Henry, Amanda; Hingorani, Aroon D.; Hofman, Albert; Holt, Patrick G.; Hui, Jennie; Hunter, Michael L.; Imboden, Medea; Jameson, Karen A.; Kerr, Shona M.; Kolcic, Ivana; Kronenberg, Florian; Liu, Jason Z.; Marchini, Jonathan; McKeever, Tricia; Morris, Andrew D.; Olin, Anna-Carin; Porteous, David J.; Postma, Dirkje S.; Rich, Stephen S.; Ring, Susan M.; Rivadeneira, Fernando; Rochat, Thierry; Sayer, Avan Aihie; Sayers, Ian; Sly, Peter D.; Smith, George Davey; Sood, Akshay; Starr, John M.; Uitterlinden, Andre G.; Vonk, Judith M.; Wannamethee, S. Goya; Whincup, Peter H.; Wijmenga, Cisca; Williams, O. Dale; Wong, Andrew; Mangino, Massimo; Marciante, Kristin D.; McArdle, Wendy L.; Meibohm, Bernd; Morrison, Alanna C.; North, Kari E.; Omenaas, Ernst; Palmer, Lyle J.; Pietilainen, Kirsi H.; Pin, Isabelle; Polasek, Ozren; Pouta, Anneli; Psaty, Bruce M.; Hartikainen, Anna-Liisa; Rantanen, Taina; Ripatti, Samuli; Rotter, Jerome I.; Rudan, Igor; Rudnicka, Alicja R.; Schulz, Holger; Shin, So-Youn; Spector, Tim D.; Surakka, Ida; Vitart, Veronique; Voelzke, Henry; Wareham, Nicholas J.; Warrington, Nicole M.; Wichmann, H-Erich; Wild, Sarah H.; Wilk, Jemma B.; Wjst, Matthias; Wright, Alan F.; Zgaga, Lina; Zemunik, Tatijana; Pennell, Craig E.; Nyberg, Fredrik; Kuh, Diana; Holloway, John W.; Boezen, H. Marike; Lawlor, Debbie A.; Morris, Richard W.; Probst-Hensch, Nicole; Kaprio, Jaakko; Wilson, James F.; Hayward, Caroline; Kahonen, Mika; Heinrich, Joachim; Musk, Arthur W.; Jarvis, Deborah L.; Glaeser, Sven; Jarvelin, Marjo-Riitta; Stricker, Bruno H. Ch; Elliott, Paul; O'Connor, George T.; Strachan, David P.; London, Stephanie J.; Hall, Ian P.; Gudnason, Vilmundur; Tobin, Martin D.		Int Lung Canc Consortium; GIANT Consortium	Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function	NATURE GENETICS			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GENETIC-VARIATION; METAANALYSIS; VARIANTS; RISK; PROTEIN; POLYMORPHISMS; IMPUTATION; MORTALITY; WOMEN	Pulmonary function measures reflect respiratory health and are used in the diagnosis of chronic obstructive pulmonary disease. We tested genome-wide association with forced expiratory volume in 1 second and the ratio of forced expiratory volume in 1 second to forced vital capacity in 48,201 individuals of European ancestry with follow up of the top associations in up to an additional 46,411 individuals. We identified new regions showing association (combined P < 5 x 10(-8)) with pulmonary function in or near MFAP2, TGFB2, HDAC4, RARB, MECOM (also known as EVI1), SPATA9, ARMC2, NCR3, ZKSCAN3, CDC123, C10orf11, LRP1, CCDC38, MMP15, CFDP1 and KCNE2. Identification of these 16 new loci may provide insight into the molecular mechanisms regulating pulmonary function and into molecular targets for future therapy to alleviate reduced lung function.	[Soler Artigas, Maria; Wain, Louise V.; Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Soler Artigas, Maria; Wain, Louise V.; Tobin, Martin D.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Loth, Daan W.; Eijgelsheim, Mark; Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.; Stricker, Bruno H. Ch] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Loth, Daan W.; Stricker, Bruno H. Ch] Inspectorate Healthcare, The Hague, Netherlands; [Gharib, Sina A.] Univ Washington, Ctr Lung Biol, Seattle, WA 98195 USA; [Gharib, Sina A.; Marciante, Kristin D.; Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Obeidat, Ma'en; Launer, Lenore J.; Al Balushi, Khalid A.; Blakey, John D.; Henry, Amanda; Sayers, Ian; Hall, Ian P.] Univ Nottingham Hosp, Nottingham Resp Biomed Res Unit, Div Therapeut & Mol Med, London, England; [Tang, Wenbo; Cassano, Patricia A.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Zhai, Guangju; Hammond, Christopher J.; Hysi, Pirro G.; Mangino, Massimo; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Zhai, Guangju] Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada; [Zhao, Jing Hua; Loos, Ruth J. F.; Wareham, Nicholas J.] Addenbrookes Hosp, Inst Metab Sci, Epidemiol Unit, MRC, Cambridge, England; [Smith, Albert Vernon; Aspelund, Thor; Eiriksdottir, Gudny; Gislason, Gauti Kjartan; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert Vernon; Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Huffman, Jennifer E.; Vitart, Veronique; Wright, Alan F.; Hayward, Caroline] Western Gen Hosp, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Albrecht, Eva; Gieger, Christian] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, Neuherberg, Germany; [Jackson, Catherine M.] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Evans, David M.; Smith, George Davey; Lawlor, Debbie A.] Univ Bristol, Sch Social & Community Med, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Cadby, Gemma; Palmer, Lyle J.] Ontario Inst Canc Res, Toronto, ON, Canada; [Cadby, Gemma; Palmer, Lyle J.; Warrington, Nicole M.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada; [Fornage, Myriam; Gu, Xiangjun] Univ Texas Houston, Brown Fdn Inst Mol Med, Houston, TX USA; [Fornage, Myriam; Morrison, Alanna C.] Univ Texas Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX USA; [Manichaikul, Ani; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Manichaikul, Ani] Univ Virginia, Div Biostat & Epidemiol, Dept Publ Hlth Sci, Charlottesville, VA USA; [Lopez, Lorna M.; Deary, Ian J.; Harris, Sarah E.; Starr, John M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Lopez, Lorna M.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Johnson, Toby] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Clin Pharmacol & Genome Ctr, London, England; [Aldrich, Melinda C.] Vanderbilt Univ, Dept Thorac Surg, Nashville, TN USA; [Aldrich, Melinda C.] Vanderbilt Univ, Div Epidemiol, Nashville, TN USA; [Barroso, Ines; Shin, So-Youn] Wellcome Trust Sanger Inst, Cambridge, England; [Barroso, Ines] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 2QQ, England; [Campbell, Harry; Rudan, Igor; Wild, Sarah H.; Zgaga, Lina; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Couper, David J.] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Franceschini, Nora; Loehr, Laura R.; North, Kari E.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Garcia, Melissa; Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD 20892 USA; [Grkovic, Ivica; Jankovic, Stipan; Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia; [Hancock, Dana B.; Joubert, Bonnie R.; London, Stephanie J.] NIEHS, Epidemiol Branch, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Hancock, Dana B.] Res Triangle Inst Int, Behav Hlth Epidemiol Program, Res Triangle Pk, NC USA; [Ramasamy, Adaikalavan; Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Ramasamy, Adaikalavan] Kings Coll London, Guys Hosp, Dept Med & Mol Genet, London WC2R 2LS, England; [Heckbert, Susan R.; Marciante, Kristin D.; Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Heckbert, Susan R.; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Heckbert, Susan R.; Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Heliovaara, Markku; Kaprio, Jaakko] Natl Inst Hlth & Welf, Helsinki, Finland; [Homuth, Georg] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [James, Alan L.] Sir Charles Gairdner Hosp, Dept Pulm Physiol & Sleep Med, W Australian Sleep Disorders Res Inst, Nedlands, WA 6009, Australia; [James, Alan L.; Musk, Arthur W.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [James, Alan L.; Hui, Jennie; Hunter, Michael L.; Musk, Arthur W.] Sir Charles Gairdner Hosp, Dept Resp Med, Busselton Populat Med Res Fdn, Nedlands, WA 6009, Australia; [Karrasch, Stefan] Univ Munich, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Klopp, Norman] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Unit Mol Epidemiol, Neuherberg, Germany; [Koch, Beate] Univ Hosp Greifswald, Dept Internal Med B, Greifswald, Germany; [Kritchevsky, Stephen B.] Wake Forest Sch Med, Sticht Ctr Aging, Winston Salem, NC USA; [Lohman, Kurt] Wake Forest Univ, Bowman Gray Sch Med, Div Publ Hlth Sci, Dept Biostat Sci, Winston Salem, NC USA; [Liu, Yongmei; Ang, Wei Q.; Warrington, Nicole M.; Pennell, Craig E.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Lumley, Thomas] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [Barr, R. Graham] Columbia Univ, Med Ctr, Dept Med, New York, NY USA; [Beilby, John] Univ Western Australia, Dept Surg & Pathol, Nedlands, WA 6009, Australia; [Beilby, John; Hui, Jennie] Queen Elizabeth II Med Ctr, PathW Lab Med Western Australia, Nedlands, WA, Australia; [Boban, Mladen; Boraska, Vesna; Kolcic, Ivana; Polasek, Ozren; Zemunik, Tatijana] Univ Split, Fac Med, Split, Croatia; [Brisman, Jonas; Dahgam, Santosh; Olin, Anna-Carin; Nyberg, Fredrik] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Publ Hlth & Community Med, Gothenburg, Sweden; [Britton, John R.; McKeever, Tricia] Univ Nottingham, Sch Community Hlth Sci, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Britton, John R.; McKeever, Tricia] Univ Nottingham, Nottingham Resp Biomed Res Unit, Nottingham NG7 2RD, England; [Cooper, Cyrus; Jameson, Karen A.; Sayer, Avan Aihie] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Curjuric, Ivan; Imboden, Medea; Probst-Hensch, Nicole] Swiss Trop & Publ Hlth TPH Inst, Basel, Switzerland; [Brusselle, Guy G.] Ghent Univ Hosp, Dept Resp Med, B-9000 Ghent, Belgium; [Curjuric, Ivan; Imboden, Medea; Probst-Hensch, Nicole] Univ Basel, CH-4003 Basel, Switzerland; [Ebrahim, Shah] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Noncommun Dis Epidemiol Unit, London WC1, England; [Ebrahim, Shah] S Asia Ctr Chron Dis, New Delhi, India; [Francks, Clyde] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Gaysina, Darya; Hardy, Rebecca; Wong, Andrew; Kuh, Diana] MRC Unit Lifelong Hlth & Ageing, London, England; [Granell, Raquel; Henderson, John; Ring, Susan M.; McArdle, Wendy L.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Hankinson, John L.] Hankinson Consulting Inc, Athens, GA USA; [Harris, Sarah E.] Univ Edinburgh, Med Genet Sect, Edinburgh, Midlothian, Scotland; [Hingorani, Aroon D.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Holt, Patrick G.; Sly, Peter D.] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Holt, Patrick G.; Sly, Peter D.] Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Hui, Jennie] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Hui, Jennie; Hunter, Michael L.; Musk, Arthur W.] Univ Western Australia, Sch Populat Hlth, Nedlands, WA 6009, Australia; [Kerr, Shona M.; Porteous, David J.] Univ Edinburgh, Inst Genet & Mol Med, Mol Med Ctr, Edinburgh, Midlothian, Scotland; [Kronenberg, Florian] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, Innsbruck, Austria; [Liu, Jason Z.; Marchini, Jonathan] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Morris, Andrew D.] Univ Dundee, Inst Med Res, Dundee, Scotland; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Rivadeneira, Fernando; Uitterlinden, Andre G.; Stricker, Bruno H. Ch] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Rochat, Thierry] Univ Hosp Geneva, Div Pulm Med, Geneva, Switzerland; [Sood, Akshay] Univ New Mexico, Dept Med, Albuquerque, NM 87131 USA; [Starr, John M.] Univ Edinburgh, Geriatr Med Unit, Edinburgh, Midlothian, Scotland; [Vonk, Judith M.; Boezen, H. Marike] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Wannamethee, S. Goya; Morris, Richard W.] UCL, Dept Primary Care & Populat Hlth, London, England; [Whincup, Peter H.; Rudnicka, Alicja R.; Strachan, David P.] St Georges Univ London, Div Populat Hlth Sci & Educ, London, England; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Williams, O. Dale] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; [Meibohm, Bernd] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Memphis, TN 38163 USA; [Omenaas, Ernst] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway; [Pietilainen, Kirsi H.] Univ Helsinki, Cent Hosp, Obes Res Unit, Dept Med,Div Internal Med, Helsinki, Finland; [Pietilainen, Kirsi H.; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Pietilainen, Kirsi H.; Ripatti, Samuli; Surakka, Ida; Kaprio, Jaakko] Univ Helsinki, Inst Mol Med, Helsinki, Finland; [Pin, Isabelle] CHU Grenoble, F-38043 Grenoble, France; [Pin, Isabelle] Ctr Rech Albert Bonniot, INSERM, U823, Grenoble, France; [Pin, Isabelle] Univ Grenoble 1, Grenoble, France; [Polasek, Ozren; Rudan, Igor] Gen Info Ltd, Zagreb, Croatia; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Children Young People & Families, Oulu, Finland; [Hartikainen, Anna-Liisa] Univ Oulu, Inst Clin Med, Oulu, Finland; [Rantanen, Taina] Univ Jyvaskyla, Dept Hlth Sci, Ctr Gerontol Res, Jyvaskyla, Finland; [Ripatti, Samuli; Surakka, Ida] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Publ Hlth Genom Unit, Helsinki, Finland; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Schulz, Holger; Wichmann, H-Erich; Heinrich, Joachim] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Neuherberg, Germany; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Study Hlth Pomerania SHIP Clin Epidemiol Res, Greifswald, Germany; [Wichmann, H-Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Wilk, Jemma B.] Brigham & Womens Hosp, Dept Med, Div Aging, Boston, MA 02115 USA; [Wilk, Jemma B.] Harvard Univ, Sch Med, Boston, MA USA; [Wjst, Matthias] Helmholtz Zentrum Munchen, Comprehens Pneumol Ctr, Inst Lung Biol & Dis, Neuherberg, Germany; [Wjst, Matthias] Tech Univ Munich, IMSE, Munich, Germany; [Zgaga, Lina] Univ Zagreb, Fac Med, Andrija Stampar Sch Publ Hlth, Zagreb 41000, Croatia; [Nyberg, Fredrik] AstraZeneca Res & Dev, Molndal, Sweden; [Holloway, John W.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, FIN-33101 Tampere, Finland; [Kahonen, Mika] Tampere Univ Hosp, Tampere, Finland; [Musk, Arthur W.] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA 6009, Australia; [Jarvis, Deborah L.; Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, MRC Hlth Protect Agcy HPA Ctr Environm & Hlth, London, England; [Glaeser, Sven] Univ Hosp Greifswald, Dept Internal Med B, Greifswald, Germany; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Stricker, Bruno H. Ch] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [O'Connor, George T.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [O'Connor, George T.] NHLBI, Framingham Heart Study, Framingham, MA USA	University of Leicester; University of Leicester; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cornell University; University of London; King's College London; Memorial University Newfoundland; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Icelandic Heart Association; University of Iceland; University of Edinburgh; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of St Andrews; University of Bristol; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Virginia; University of Virginia; University of Edinburgh; University of Edinburgh; University of London; Queen Mary University London; Vanderbilt University; Vanderbilt University; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Edinburgh; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Split; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Research Triangle Institute; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Finland National Institute for Health & Welfare; Ernst Moritz Arndt Universitat Greifswald; University of Western Australia; University of Western Australia; University of Western Australia; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Wake Forest University; Wake Forest University; Wake Forest Baptist Medical Center; University of Western Australia; University of Auckland; Columbia University; University of Western Australia; University of Western Australia; University of Split; University of Gothenburg; University of Nottingham; University of Nottingham; University of Southampton; University of Basel; Swiss Tropical & Public Health Institute; Ghent University; Ghent University Hospital; University of Basel; University of London; London School of Hygiene & Tropical Medicine; Max Planck Society; University of Bristol; University of Edinburgh; University of London; University College London; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Edinburgh; Medical University of Innsbruck; University of Oxford; University of Dundee; University of Groningen; Erasmus University Rotterdam; Erasmus MC; University of Geneva; University of New Mexico; University of Edinburgh; University of Groningen; University of London; University College London; St Georges University London; University of Groningen; University of Alabama System; University of Alabama Birmingham; University of Tennessee System; University of Tennessee Health Science Center; University of Bergen; Haukeland University Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Finland National Institute for Health & Welfare; University of Oulu; University of Jyvaskyla; Finland National Institute for Health & Welfare; Cedars Sinai Medical Center; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ernst Moritz Arndt Universitat Greifswald; University of Munich; University of Munich; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Zagreb; AstraZeneca; University of Southampton; Tampere University; Tampere University; Tampere University Hospital; University of Western Australia; Imperial College London; University of Oulu; University of Oulu; Erasmus University Rotterdam; Erasmus MC; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Tobin, MD (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester, Leics, England.	london2@niehs.nih.gov; mt47@leicester.ac.uk	Zemunik, Tatijana/D-8584-2017; Grković, Ivica/D-8728-2017; Vonk, Judith M/ABA-3009-2020; Rantanen, Taina/O-6579-2016; Artigas, María Soler/L-6529-2013; Hui, Jennie/A-9543-2013; Davey Smith, George/A-7407-2013; Wilson, James F/A-5704-2009; Perica, Vesna Boraska/D-8230-2017; Holloway, John W/B-5424-2009; Study, Raine/K-4517-2013; Ramasamy, Adaikalavan/G-2632-2010; Porteous, David/AAA-3446-2021; Palmer, Lyle John/N-1948-2019; Boban, Mladen/E-2777-2017; Cadby, Gemma/AAE-3849-2022; Granell, Raquel/AAB-5256-2022; Wijmenga, Cisca/AAE-7719-2019; Wijmenga, Cisca/D-2173-2009; Rivadeneira, Fernando/O-5385-2015; Gaysina, Darya/J-5720-2013; Wong, Andrew/M-8899-2016; Rudan, Igor/I-1467-2012; Smith, Albert Vernon/K-5150-2015; Marchini, Jonathan/ABE-9024-2020; Granell, Raquel/AAY-4846-2020; Polasek, Ozren/B-6002-2011; Wong, Andrew/AAE-6995-2019; London, Stephanie/C-3734-2019; Kolcic, Ivana/E-2713-2017; Kuh, Diana/L-6019-2014; Campbell, Harry/E-2959-2010; Loos, Ruth J F/Q-2862-2016; Hunter, Michael L/B-3213-2013; Gudnason, Vilmundur/K-6885-2015; Aspelund, Thor/K-7022-2019; Lopez, Lorna/AAR-4912-2020; Ripatti, Samuli/H-9446-2014; Zgaga, Lina/Q-9415-2018; jackson, cathy/H-4869-2013; Hancock, Dana/D-8577-2012; PIN, Isabelle/N-3020-2013; Schulz, Holger/J-5643-2015; Hayward, Caroline/M-8818-2016; Olin, Anna-Carin/ABH-2627-2021; Lopez, Lorna M/F-7265-2010; Deary, Ian J/C-6297-2009; Francks, Clyde/AGU-8875-2022; Kaprio, Jaakko/A-1820-2008; Warrington, Nicole/P-4868-2014; Palmer, Lyle John/K-3196-2014; Francks, Clyde/E-1384-2012; Heinrich, Joachim/N-1720-2013; Vonk, Judith/K-8477-2019; Aldrich, Melinda/C-7783-2013; Kronenberg, Florian/B-1736-2008; Loos, Ruth/GON-5877-2022; Janković, Stipan/E-3315-2017; Wichmann, Heinz Erich/AAA-5695-2022; Evans, David M/H-6325-2013; Hardy, Rebecca/AFR-1989-2022; Mangino, Massimo/F-5134-2011; Porteous, David J/C-7289-2013; Gudnason, Vilmundur/AAE-7126-2019; Rotter, Jerome/AAY-6598-2021; Sayer, Avan Aihie/A-4359-2012; Karrasch, Stefan/GQI-2691-2022; Aspelund, Thor/C-5983-2008; Sly, Peter D/F-1486-2010; Pennell, Craig/ABD-6902-2020; Holt, Patrick/H-1548-2011	Zemunik, Tatijana/0000-0001-8120-2891; Grković, Ivica/0000-0001-9010-2091; Vonk, Judith M/0000-0001-7531-4547; Rantanen, Taina/0000-0002-1604-1945; Artigas, María Soler/0000-0002-3213-1107; Hui, Jennie/0000-0002-1653-2496; Davey Smith, George/0000-0002-1407-8314; Wilson, James F/0000-0001-5751-9178; Perica, Vesna Boraska/0000-0003-3999-1529; Holloway, John W/0000-0001-9998-0464; Ramasamy, Adaikalavan/0000-0002-7598-2892; Porteous, David/0000-0003-1249-6106; Palmer, Lyle John/0000-0002-1628-3055; Boban, Mladen/0000-0003-1570-9621; Granell, Raquel/0000-0002-4890-4012; Wijmenga, Cisca/0000-0002-5635-1614; Rivadeneira, Fernando/0000-0001-9435-9441; Wong, Andrew/0000-0003-2079-4779; Rudan, Igor/0000-0001-6993-6884; Smith, Albert Vernon/0000-0003-1942-5845; Marchini, Jonathan/0000-0003-0610-8322; Polasek, Ozren/0000-0002-5765-1862; Wong, Andrew/0000-0003-2079-4779; London, Stephanie/0000-0003-4911-5290; Kolcic, Ivana/0000-0001-7918-6052; Kuh, Diana/0000-0001-7386-2857; Campbell, Harry/0000-0002-6169-6262; Loos, Ruth J F/0000-0002-8532-5087; Hunter, Michael L/0000-0001-6704-4815; Gudnason, Vilmundur/0000-0001-5696-0084; Aspelund, Thor/0000-0002-7998-5433; Lopez, Lorna/0000-0002-0241-9783; Ripatti, Samuli/0000-0002-0504-1202; Zgaga, Lina/0000-0003-4089-9703; Schulz, Holger/0000-0002-1157-200X; Hayward, Caroline/0000-0002-9405-9550; Deary, Ian J/0000-0002-1733-263X; Kaprio, Jaakko/0000-0002-3716-2455; Warrington, Nicole/0000-0003-4195-775X; Palmer, Lyle John/0000-0002-1628-3055; Francks, Clyde/0000-0002-9098-890X; Heinrich, Joachim/0000-0002-9620-1629; Vonk, Judith/0000-0001-7531-4547; Kronenberg, Florian/0000-0003-2229-1120; Evans, David M/0000-0003-0663-4621; Mangino, Massimo/0000-0002-2167-7470; Porteous, David J/0000-0003-1249-6106; Gudnason, Vilmundur/0000-0001-5696-0084; Aspelund, Thor/0000-0002-7998-5433; Sly, Peter D/0000-0001-6305-2201; Pennell, Craig/0000-0002-0937-6165; Cooper, Cyrus/0000-0003-3510-0709; Lawlor, Debbie A/0000-0002-6793-2262; Joubert, Bonnie/0000-0001-7952-1180; Kerr, Shona/0000-0002-4137-1495; Cassano, Patricia A./0000-0003-4827-5073; Morris, Richard/0000-0001-7240-4563; s, hema/0000-0002-3440-9475; Morrison, Alanna/0000-0001-6381-4296; Rich, Stephen/0000-0003-3872-7793; Kahonen, Mika/0000-0002-4510-7341; Hall, Ian/0000-0001-9933-3216; Brisman, Jonas/0000-0003-2333-3273; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Hancock, Dana/0000-0003-2240-3604; Hingorani, Aroon/0000-0001-8365-0081; Meibohm, Bernd/0000-0003-3923-3648; Couper, David/0000-0002-4313-9235; Jarvis, Deborah/0000-0002-1753-3896; Tobin, Martin/0000-0002-3596-7874; Elliott, Paul/0000-0002-7511-5684; Wain, Louise/0000-0003-4951-1867; Rudnicka, Alicja R/0000-0003-0369-8574; Brusselle, Guy/0000-0001-7021-8505; GHARIB, SINA A./0000-0002-2480-4367; Loth, Daan/0000-0003-1260-9326; Hammond, Christopher/0000-0002-3227-2620; Hysi, Pirro/0000-0001-5752-2510; Loehr, Laura/0000-0002-9054-1825; Surakka, Ida/0000-0002-6669-5541; Hardy, Rebecca/0000-0001-9949-0799; Al Balushi, Khalid/0000-0003-4638-8787; Wannamethee, Sasiwarang/0000-0001-9484-9977; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Nyberg, Fredrik/0000-0003-0892-5668; Kritchevsky, Stephen/0000-0003-3336-6781; Barroso, Ines/0000-0001-5800-4520; Aihie Sayer, Avan/0000-0003-1283-6457; Henry, Amanda/0000-0001-6299-7676; Gieger, Christian/0000-0001-6986-9554; Whincup, Peter/0000-0002-5589-4107; Gaysina, Darya/0000-0002-9283-5667; McKeever, Tricia/0000-0003-0914-0416; O'Connor, George/0000-0002-6476-3926; Holt, Patrick/0000-0003-1193-0935; Pietilainen, Kirsi/0000-0002-8522-1288; Beilby, John/0000-0002-4915-2254; Johnson, Toby/0000-0002-5998-3270; Sayers, Ian/0000-0001-5601-5410	Academy of Finland [104781, 120315, 129269, 1114194]; Center of Excellence in Complex Disease Genetics [213506, 129680]; SALVE; Althingi (Icelandic Parliament); Arthritis Research Campaign; Asthma UK; AstraZeneca; AXA; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F019394/1, G20234]; British Heart Foundation [PG/97012, PG/06/154/22043, FS05/125]; British Lung Foundation; Research United Kingdom; Chief Scientist Office, Scottish Government Health Directorate [CZD/16/6]; Croatian Institute for Public Health; UK Department of Health; Dutch Kidney Foundation; Erasmus Medical Center and Erasmus University, Rotterdam; Estonian Genome Center, University of Tartu, Estonia [SF0180142s08]; EU [018996, QLK4-CT-1999-01237]; European Commission [QLG1-CT-2000-01643, LSHB-CT-2006-018996, LSHG-CT2006- 01894, QLG2-CT-2002-01254, HEALTH-F2-2008-201865, HEALTH-F2-2008-35627, HEALTH-F4-2007-201413]; Finnish Foundation for Cardiovascular Research; Flight Attendant Medical Research Institute (FAMRI); German Asthma and COPD Network (COSYCONET: BMBF) [01GI0883]; German Bundesministerium fuer Forschung und Technology [01 AK 803 A-H, 01 IG 07015 G]; German Federal Ministry of Education and Research (BMBF); German National Genome Research Network; German Ministry of Cultural Affairs; GlaxoSmithKline; Gyllenberg Foundations; Healthway, Western Australia; Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany; East Midlands Development Agency; European Regional Development Fund; Higher Education Funding Council for England (HEFCE); Hjartavernd (Icelandic Heart Association); Innsbruck Medical University; Institute for Anthropological Research in Zagreb; International Osteoporosis Foundation; NIH, National Institute on Aging and National Institute of Environmental Health Sciences; Jalmari and Rauha Ahokas Foundation; Juvenile Diabetes Research Foundation International (JDRF); Lifelong Health and Wellbeing Initiative [G0700704/84698]; Medical Research Council UK [G1000861, G0501942, G0902313, G0000934, G0800582, G0500539, G0600705, G9901462]; Tampere University Hospital; Ministry of Science, Education and Sport of the Republic of Croatia [108-1080315-0302]; Medical Research Council Human Genetics Unit; Medisearch-The Leicester Medical Research Foundation; Munich Center of Health Sciences (MC Health) as part of LMUinnovativ; National Health and Medical Research Council of Australia [ID 403981, ID 003209]; National Human Genome Research Institute (NHGRI) [U01-HG-004729, U01-HG-004402]; National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centres (Guy's & St. Thomas' NHS Foundation Trust; King's College London and Cambridge University Hospitals NHS Foundation Trust; University of Cambridge; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) [050-060-810]; Netherlands Organization for the Health Research and Development (ZonMw); Netherlands Organization of Scientific Research NOW [1750102007006, 175.010.2005.011, 911-03-012]; Northern Netherlands Collaboration of Provinces (SNN); Norwegian University of Science and Technology; Novo Nordisk; Ontario Institute of Cancer Research and Canadian Cancer Society Research Institute [CCSRI 020214]; Republic of Croatia Ministry of Science, Education and Sports [108-1080315-0302]; Research Institute for Diseases in the Elderly (RIDE) [014-93-015]; Research Into Ageing [251]; Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg-West Pomerania; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Structure Enhancing Fund (FES) of the Dutch government; Swedish Heart and Lung Foundation [20050561]; Swedish Research Council for Worklife and Social research (FAS) [2001-0263, 2003-0139]; Swiss National Science Foundation [4026-28099, 3347CO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 32-65896.01, 32-59302.99, 32-52720.97, 32-4253.94]; Asthma, Allergy and Inflammation Research Trust; Great Wine Estates of the Margaret River region of Western Australia; Netherlands' Ministry of Economic Affairs, Ministry of Education, Culture and Science and Ministry for Health, Welfare and Sports; Royal Society; University of Split and Zagreb Medical Schools; Tromso University [U01 DK062418]; UBS Wealth Foundation [BA29s8Q7-DZZ]; University Hospital Oulu, Biocenter, University of Oulu, Finland [75617]; University Medical Center Groningen; University of Bristol; University of Leicester; University of Nottingham; US National Institutes of Health (NIH) [1P50 CA70907, RO1 CA121197, U19 CA148127, CA55769, CA127219, R01HL071051, R01HL071205, R01HL071250, R01HL071251, R01HL071252, R01HL071258, R01HL071259, UL1RR025005, HHSN268200625226C, HHSN268200782096C, R01-HL084099]; US NIH National Cancer Institute [RO1CA111703]; US NIH National Center for Research Resources [M01-RR00425, 5M01 RR00997]; US NIH National Eye Institute (NEI); US NIH National Heart, Lung and Blood Institute [N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222]; US NIH National Institute of Allergy and Infectious Diseases (NIAID); US NIH National Institute of Child Health and Human Development (NICHD); US NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK063491]; US NIH National Institute of Environmental Health Sciences (NIEHS) [ZO1 ES49019, ES015794]; US NIH National Institute of Mental Health (NIMH) [5R01MH63706: 02]; US NIH National Institute of Neurological Disorders and Stroke (NINDD); US NIH National Institute on Aging (NIA) [R01 AG032098, RC1 AG035835, N01AG12100, N01AG62101, N01AG62103, N01AG62106, 1R01AG032098-01A1, AG-023269, AG-15928, AG-20098, AG-027058]; Wellcome Trust [077016/Z/05/Z, GR069224, 068545/Z/02, 076113/B/04/Z, 079895]; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [G0000934, G0401540, G0902125, G0501942, MC_UP_A620_1015, MC_U127561128, MC_PC_U127561128, MC_U123092720, G1000861, G0701863, G0800582, G0801056, MC_U106188470, G0902313, MC_U123092721, G0600705] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: researchfish; British Heart Foundation [RG/08/013/25942] Funding Source: researchfish; Medical Research Council [MC_PC_U127561128, MC_U106188470, G0501942, G0801056, MC_U123092720, G0902125, G0801056B, MC_UP_A620_1014, MC_UP_A620_1015, G0800582, G0701863, G0902313, MC_U123092721, G0600705, G1000861, U1475000001, MC_U127561128, G0700704B, U1475000002, G0000934, G9815508, G0401540] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish; Chief Scientist Office [CZB/4/710, CZD/16/6/2] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC015103, N01HC095162, N01HC085081, N01HC085083, N01HC095164, N01HC055222, N01HC075150, N01HC095167, N01HC085085, N01HC095169, N01HC085082, N01HC095163, N01HC045134, N01HC048048, N01HC095095, N01HC085080, N01HC035129, N01HC025195, N01HC048049, N01HC048047, N01HC048050, N01HC095165, N01HC095168, N01HC045133, N01HC085084, N01HC095160, N01HC095161, N01HC005187, N01HC095159, N01HC085086, N01HC095166, N01HC085079] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P50CA070907, R01CA111703, U19CA148127, R01CA121197, R01CA055769, R01CA127219] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156, M01RR000425, UL1RR025005, M01RR000997] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL048048, R01HL071250, R01HL071051, R01HL071251, R01HL071205, R01HL071022, R43HL095169, R01HL075476, R01HL048049, R01HL048050, R01HL064278, R01HL087641, R01HL074104, R01HL059367, RC1HL100543, R01HL087652, K23HL094531, R01HL071252, R01HL077612, R01HL071258, R01HL087679, R01HL080295, U01HL080295, R01HL105756, R01HL084099, R01HL071259, R01HL048048, R44HL095169, R01HL086694, R01HL088133] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402, U01HG004729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, U01DK062418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES049019, R01ES015794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063706, RL1MH083268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG012100, N01AG062101, R01AG032098, RC1AG035835, R56AG020098, N01AG062106, ZIAAG007380, R01AG020098, N01AG062103, R01AG027058, R01AG015928] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Center of Excellence in Complex Disease Genetics(Academy of Finland); SALVE; Althingi (Icelandic Parliament); Arthritis Research Campaign(Versus Arthritis); Asthma UK; AstraZeneca(AstraZeneca); AXA; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); British Lung Foundation; Research United Kingdom; Chief Scientist Office, Scottish Government Health Directorate; Croatian Institute for Public Health; UK Department of Health; Dutch Kidney Foundation; Erasmus Medical Center and Erasmus University, Rotterdam; Estonian Genome Center, University of Tartu, Estonia; EU(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Finnish Foundation for Cardiovascular Research; Flight Attendant Medical Research Institute (FAMRI); German Asthma and COPD Network (COSYCONET: BMBF)(Federal Ministry of Education & Research (BMBF)); German Bundesministerium fuer Forschung und Technology; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network; German Ministry of Cultural Affairs; GlaxoSmithKline; Gyllenberg Foundations(GlaxoSmithKline); Healthway, Western Australia; Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany(Helmholtz Association); East Midlands Development Agency; European Regional Development Fund(European Commission); Higher Education Funding Council for England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Hjartavernd (Icelandic Heart Association); Innsbruck Medical University; Institute for Anthropological Research in Zagreb; International Osteoporosis Foundation; NIH, National Institute on Aging and National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jalmari and Rauha Ahokas Foundation; Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); Lifelong Health and Wellbeing Initiative; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Tampere University Hospital; Ministry of Science, Education and Sport of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Medical Research Council Human Genetics Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medisearch-The Leicester Medical Research Foundation; Munich Center of Health Sciences (MC Health) as part of LMUinnovativ; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centres (Guy's & St. Thomas' NHS Foundation Trust(National Institute for Health Research (NIHR)); King's College London and Cambridge University Hospitals NHS Foundation Trust; University of Cambridge(University of Cambridge); Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)Netherlands Government); Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Netherlands Organization of Scientific Research NOW(Netherlands Organization for Scientific Research (NWO)); Northern Netherlands Collaboration of Provinces (SNN); Norwegian University of Science and Technology; Novo Nordisk(Novo Nordisk); Ontario Institute of Cancer Research and Canadian Cancer Society Research Institute; Republic of Croatia Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia); Research Institute for Diseases in the Elderly (RIDE); Research Into Ageing; Siemens Healthcare, Erlangen, Germany(Siemens AG); Federal State of Mecklenburg-West Pomerania; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Structure Enhancing Fund (FES) of the Dutch government; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council for Worklife and Social research (FAS); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Asthma, Allergy and Inflammation Research Trust; Great Wine Estates of the Margaret River region of Western Australia; Netherlands' Ministry of Economic Affairs, Ministry of Education, Culture and Science and Ministry for Health, Welfare and Sports; Royal Society(Royal Society of London); University of Split and Zagreb Medical Schools; Tromso University; UBS Wealth Foundation; University Hospital Oulu, Biocenter, University of Oulu, Finland; University Medical Center Groningen; University of Bristol; University of Leicester; University of Nottingham; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US NIH National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US NIH National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US NIH National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US NIH National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); US NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US NIH National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); US NIH National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US NIH National Institute of Neurological Disorders and Stroke (NINDD); US NIH National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the many colleagues who contributed to collection and phenotypic characterization of the clinical sampling, genotyping and analysis of the data. We especially thank those who kindly agreed to participate in the studies. Major funding for this work is from the following sources (alphabetical): Academy of Finland (project grants 104781, 120315, 129269, 1114194, Center of Excellence in Complex Disease Genetics (213506 and 129680) and SALVE); Althingi (Icelandic Parliament); Arthritis Research Campaign; Asthma UK; AstraZeneca; AXA Research Fund; Biotechnology and Biological Sciences Research Council (BBSRC) (BB/F019394/1, G20234); British Heart Foundation (PG/97012, PG/06/154/22043, FS05/125); British Lung Foundation; Canadian Institutes of Health Research (Grant ID MOP-82893); Cancer Research United Kingdom; Chief Scientist Office, Scottish Government Health Directorate (CZD/16/6); Croatian Institute for Public Health; UK Department of Health; Dutch Kidney Foundation; Erasmus Medical Center and Erasmus University, Rotterdam; Estonian Genome Center, University of Tartu, Estonia (SF0180142s08); EU funding (GABRIEL GRANT Number: 018996, ECRHS II Coordination Number: QLK4-CT-1999-01237); European Commission (DG XII, EURO-BLCS, FP-5 QLG1-CT-2000-01643, FP-6 LSHB-CT-2006-018996 (GABRIEL), FP-6 LSHG-CT2006- 018947 (EUROSPAN), FP-6 GenomEUtwin project QLG2-CT-2002-01254, FP7/2007-2013: HEALTH-F2-2008-201865, GEFOS, HEALTH-F2-2008-35627, TREAT-OA, HEALTH-F4-2007-201413 (ENGAGE)); Finnish Foundation for Cardiovascular Research; Flight Attendant Medical Research Institute (FAMRI); German Asthma and COPD Network (COSYCONET: BMBF grant 01GI0883); German Bundesministerium fuer Forschung und Technology (01 AK 803 A-H, 01 IG 07015 G); German Federal Ministry of Education and Research (BMBF) (03ZIK012, 01ZZ9603, 01ZZ0103 and 01ZZ0403): German National Genome Research Network (NGFN-2 and NGFN-plus); German Ministry of Cultural Affairs; GlaxoSmithKline; Gyllenberg Foundations; Healthway, Western Australia; Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany; Healthcare and Bioscience iNet (funded by the East Midlands Development Agency, partially financed by the European Regional Development Fund, delivered by Medilink East Midlands); Higher Education Funding Council for England (HEFCE); Hjartavernd (Icelandic Heart Association); Innsbruck Medical University; Institute for Anthropological Research in Zagreb; International Osteoporosis Foundation; Intramural Research Program of the NIH, National Institute on Aging and National Institute of Environmental Health Sciences; Jalmari and Rauha Ahokas Foundation; Juvenile Diabetes Research Foundation International (JDRF); Lifelong Health and Wellbeing Initiative (G0700704/84698); Medical Research Council UK (G1000861, G0501942, G0902313, G0000934, G0800582, G0500539, G0600705, PrevMetSyn/SALVE, G9901462); Medical Research Fund of the Tampere University Hospital; Ministry of Science, Education and Sport of the Republic of Croatia (108-1080315-0302); Medical Research Council Human Genetics Unit; Medisearch-The Leicester Medical Research Foundation; Munich Center of Health Sciences (MC Health) as part of LMUinnovativ; National Health and Medical Research Council of Australia (Grant ID 403981 and ID 003209); National Human Genome Research Institute (NHGRI) (U01-HG-004729, U01-HG-004402); National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centres (Guy's & St.; Thomas' NHS Foundation Trust in partnership with King's College London and Cambrdge University Hospitals NHS Foundation Trust in partnership with the University of Cambridge); Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) (050-060-810); Netherlands Organization for the Health Research and Development (ZonMw); Netherlands Organization of Scientific Research NOW (1750102007006, 175.010.2005.011, 911-03-012); Northern Netherlands Collaboration of Provinces (SNN); Norwegian University of Science and Technology; Novo Nordisk; Ontario Institute of Cancer Research and Canadian Cancer Society Research Institute (CCSRI 020214); Republic of Croatia Ministry of Science, Education and Sports research grants (108-1080315-0302); Research Institute for Diseases in the Elderly (RIDE) (014-93-015: RIDE2); Research Into Ageing (251); Siemens Healthcare, Erlangen, Germany and the Federal State of Mecklenburg-West Pomerania; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Structure Enhancing Fund (FES) of the Dutch government; Swedish Heart and Lung Foundation grant 20050561; Swedish Research Council for Worklife and Social research (FAS), grants 2001-0263, 2003-0139; Swiss National Science Foundation (grants no. 4026-28099,3347CO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 32-65896.01,32-59302.99, 32-52720.97, 32-4253.; 94); The Asthma, Allergy and Inflammation Research Trust; The Great Wine Estates of the Margaret River region of Western Australia; The Netherlands' Ministry of Economic Affairs, Ministry of Education, Culture and Science and Ministry for Health, Welfare and Sports; The Royal Society; The University of Split and Zagreb Medical Schools; Tromso University; U01 DK062418; UBS Wealth Foundation Grant BA29s8Q7-DZZ; UK Department of Health Policy Research Programme; University Hospital Oulu, Biocenter, University of Oulu, Finland (75617); University Medical Center Groningen; University of Bristol; University of Leicester HEFCE CIF award; University of Nottingham; US National Institutes of Health (NIH) (1P50 CA70907, RO1 CA121197, U19 CA148127, CA55769, CA127219, R01HL071051, R01HL071205, R01HL071250, R01HL071251, R01HL071252, R01HL071258, R01HL071259, UL1RR025005, contracts HHSN268200625226C, HHSN268200782096C, R01-HL084099); US NIH National Cancer Institute (RO1CA111703); US NIH National Center for Research Resources (grants M01-RR00425 and 5M01 RR00997); US NIH National Eye Institute (NEI); US NIH National Heart, Lung and Blood Institute (contracts N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, N01-HC-95095, N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-45134, N01-HC-05187, N01-HC-45205, N01-HC-45204, N01 HC-25195, N01-HC-95159 through N01-HC-95169, RR-024156, N02-HL-6-4278, R01 HL-071022, R01 HL-077612, R01 HL-074104, RC1 HL100543, HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C and HHSN268201100012C, grants HL080295, HL087652, HL105756, R01-HL-084099, R01HL087641, R01HL59367, R01HL086694, HL088133, HL075336 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01), 1K23HL094531-01); US NIH National Institute of Allergy and Infectious Diseases (NIAID); US NIH National Institute of Child Health and Human Development (NICHD); US NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (DK063491); US NIH National Institute of Environmental Health Sciences (NIEHS) (ZO1 ES49019, ES015794); US IH National Institute of Mental Health (NIMH) (5R01MH63706: 02); US NIH National Institute of Neurological Disorders and Stroke (NINDD); US NIH National Institute on Aging (NIA) (R01 AG032098, RC1 AG035835, N01AG12100, N01AG62101, N01AG62103, N01AG62106, 1R01AG032098-01A1, AG-023269, AG-15928, AG-20098, AG-027058); Wellcome Trust (077016/Z/05/Z, GR069224, 068545/Z/02, 076113/B/04/Z, 079895).	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bieganowski P, 2004, J BIOL CHEM, V279, P44656, DOI 10.1074/jbc.M406151200; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Chu HW, 2004, AM J PATHOL, V165, P1097, DOI 10.1016/S0002-9440(10)63371-8; Clancy RM, 2010, ARTHRITIS RHEUM-US, V62, P3415, DOI 10.1002/art.27658; Cowley EA, 2002, J PHYSIOL-LONDON, V538, P747, DOI 10.1113/jphysiol.2001.013300; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; GIBSON MA, 1986, J BIOL CHEM, V261, P1429; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hole DJ, 1996, BRIT MED J, V313, P711; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Lillis AP, 2005, J THROMB HAEMOST, V3, P1884, DOI 10.1111/j.1538-7836.2005.01371.x; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Maran C, 2009, CURR GENOMICS, V10, P361, DOI 10.2174/138920209788920976; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Massaro GD, 2000, PHYSIOL GENOMICS, V4, P51, DOI 10.1152/physiolgenomics.2000.4.1.51; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Pillai SG, 2010, AM J RESP CRIT CARE, V182, P1498, DOI 10.1164/rccm.201002-0151OC; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Ruse CE, 2007, RESP MED, V101, P340, DOI 10.1016/j.rmed.2006.05.017; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; STRACHAN DP, 1992, J EPIDEMIOL COMMUN H, V46, P66, DOI 10.1136/jech.46.1.66; Talmud PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4838; Tewari R, 2010, TRENDS CELL BIOL, V20, P470, DOI 10.1016/j.tcb.2010.05.003; Thompson HGR, 2006, AM J PHYSIOL-LUNG C, V291, pL1277, DOI 10.1152/ajplung.00057.2006; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; Wilk JB, 2000, GENET EPIDEMIOL, V19, P81, DOI 10.1002/1098-2272(200007)19:1<81::AID-GEPI6>3.0.CO;2-8; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Wu H, 2007, ENVIRON HEALTH PERSP, V115, P616, DOI 10.1289/ehp.9740; Yang J, 2002, J CELL BIOL, V159, P431, DOI 10.1083/jcb.200207153; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Young RP, 2007, EUR RESPIR J, V30, P616, DOI 10.1183/09031936.00021707; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	54	273	274	3	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2011	43	11					1082	1090		10.1038/ng.941	http://dx.doi.org/10.1038/ng.941			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	21946350	Green Accepted, Green Submitted, Green Published			2022-12-17	WOS:000296584000011
J	Huffmeier, U; Uebe, S; Ekici, AB; Bowes, J; Giardina, E; Korendowych, E; Juneblad, K; Apel, M; McManus, R; Ho, P; Bruce, IN; Ryan, AW; Behrens, F; Lascorz, J; Bohm, B; Traupe, H; Lohmann, J; Gieger, C; Wichmann, HE; Herold, C; Steffens, M; Klareskog, L; Wienker, TF; FitzGerald, O; Alenius, GM; McHugh, NJ; Novelli, G; Burkhardt, H; Barton, A; Reis, A				Hueffmeier, Ulrike; Uebe, Steffen; Ekici, Arif B.; Bowes, John; Giardina, Emiliano; Korendowych, Eleanor; Juneblad, Kristina; Apel, Maria; McManus, Ross; Ho, Pauline; Bruce, Ian N.; Ryan, Anthony W.; Behrens, Frank; Lascorz, Jesus; Boehm, Beate; Traupe, Heiko; Lohmann, Joerg; Gieger, Christian; Wichmann, Heinz-Erich; Herold, Christine; Steffens, Michael; Klareskog, Lars; Wienker, Thomas F.; FitzGerald, Oliver; Alenius, Gerd-Marie; McHugh, Neil J.; Novelli, Giuseppe; Burkhardt, Harald; Barton, Anne; Reis, Andre			Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis	NATURE GENETICS			English	Article							GENES; IL23R; IL12B; ACT1	Psoriatic arthritis (PsA) is an inflammatory joint disease that is distinct from other chronic arthritides and which is frequently accompanied by psoriasis vulgaris (PsV) and seronegativity for rheumatoid factor. We conducted a genome-wide association study in 609 German individuals with PsA (cases) and 990 controls with replication in 6 European cohorts including a total of 5,488 individuals. We replicated PsA associations at HLA-C and IL12B and identified a new association at TRAF3IP2 (rs13190932, P = 8.56 x 10(-17)). TRAF3IP2 was also associated with PsV in a German cohort including 2,040 individuals (rs13190932, P = 1.95 x 10(-3)). Sequencing of the exons of TRAF3IP2 identified a coding variant (p.Asp10Asn, rs33980500) as the most significantly associated SNP (P = 1.13 x 10(-20), odds ratio = 1.95). Functional assays showed reduced binding of this TRAF3IP2 variant to TRAF6, suggesting altered modulation of immunoregulatory signals through altered TRAF interactions as a new and shared pathway for PsA and PsV.	[Hueffmeier, Ulrike; Uebe, Steffen; Ekici, Arif B.; Lascorz, Jesus; Reis, Andre] Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany; [Bowes, John; Ho, Pauline; Bruce, Ian N.; Barton, Anne] Univ Manchester, Arthritis Res UK Epidemiol Unit, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Giardina, Emiliano; Novelli, Giuseppe] Univ Roma Tor Vergata, Dept Biopathol, Ctr Excellence Genom Risk Assessment Multifactori, Sch Med, Rome, Italy; [Giardina, Emiliano; Novelli, Giuseppe] Fdn PTV Policlin Tor Vergata, Rome, Italy; [Korendowych, Eleanor; McHugh, Neil J.] Royal Natl Hosp Rheumat Dis, Bath BA1 1RL, Avon, England; [Juneblad, Kristina; Alenius, Gerd-Marie] Univ Hosp, Dept Publ Hlth & Clin Med, Umea, Sweden; [McManus, Ross; Ryan, Anthony W.] Trinity Coll Dublin, Inst Mol Med, Dept Clin Med, Dublin, Ireland; [Behrens, Frank; Boehm, Beate; Burkhardt, Harald] Goethe Univ Frankfurt, Div Rheumatol, Dept Internal Med 2, Frankfurt, Germany; [Traupe, Heiko] Univ Munster, Dept Dermatol, D-4400 Munster, Germany; [Lohmann, Joerg] Psoriasis Rehabil Hosp, Bad Bentheim, Germany; [Gieger, Christian; Wichmann, Heinz-Erich] Helmholtz Ctr Munich, Inst Epidemiol, Munich, Germany; [Wichmann, Heinz-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Epidemiol, Munich, Germany; [Wichmann, Heinz-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Herold, Christine; Steffens, Michael; Wienker, Thomas F.] Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-5300 Bonn, Germany; [Klareskog, Lars] Karolinska Inst, Stockholm, Sweden; [FitzGerald, Oliver] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [FitzGerald, Oliver] Univ Coll Dublin, Sch Med & Med Sci, St Vincents Univ Hosp, Dept Rheumatol, Dublin 2, Ireland; [McHugh, Neil J.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England	University of Erlangen Nuremberg; University of Manchester; University of Rome Tor Vergata; Royal National Hospital for Rheumatic Diseases (RNHRD); Umea University; Trinity College Dublin; Goethe University Frankfurt; University of Munster; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Bonn; Karolinska Institutet; University College Dublin; University College Dublin; Saint Vincent's University Hospital; University of Bath	Reis, A (corresponding author), Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany.	andre.reis@uk-erlangen.de	Novelli, Giuseppe/GQB-3329-2022; Reis, André/D-2309-2009; Novelli, Giuseppe/A-5195-2013; Ekici, Arif B/C-3971-2013; Bowes, John/B-3472-2015; Giardina, Emiliano/J-1965-2012; Ryan, Anthony W/A-1336-2010; McManus, Ross/AAE-9236-2020; Behrens, Frank/AAI-8910-2021; Wichmann, Heinz Erich/AAA-5695-2022; Huffmeier, Ulrike/D-2806-2013; Barton, Anne/N-2053-2014; Novelli, Giuseppe/T-8822-2019	Novelli, Giuseppe/0000-0002-7781-602X; Reis, André/0000-0002-6301-6363; Novelli, Giuseppe/0000-0002-7781-602X; Ekici, Arif B/0000-0001-6099-7066; Bowes, John/0000-0003-4659-031X; Behrens, Frank/0000-0001-8750-7186; Huffmeier, Ulrike/0000-0001-6448-4671; Barton, Anne/0000-0003-3316-2527; Ryan, Anthony/0000-0001-5005-3344; Steffens, Michael/0000-0002-6445-8593; McManus, Ross/0000-0002-0529-9617; Klareskog, Lars/0000-0001-9601-6186; FitzGerald, Oliver/0000-0002-6607-6070; Bruce, Ian/0000-0003-3047-500X; giardina, emiliano/0000-0002-2741-5009; Gieger, Christian/0000-0001-6986-9554	Interdisciplinary Centre for Clinical Research of the University of Erlangen-Nuremberg [IZKF B32/A8]; Helmholtz Center Munich; German Federal Ministry of Education and Research (BMBF); German National Genome Research Network [NGFN-2, NGFNPlus: 01GS0823]; Munich Center of Health Sciences (MC Health); National Institute for Health Research; Manchester Biomedical Research Centre; Science Foundation Ireland; Arthritis Research; Wyeth Pharma GmbH, Germany; ADIPSO (Association for the Defense of Psoriasis Patients); Wellcome Trust [076113]	Interdisciplinary Centre for Clinical Research of the University of Erlangen-Nuremberg; Helmholtz Center Munich(Helmholtz Association); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network; Munich Center of Health Sciences (MC Health); National Institute for Health Research(National Institute for Health Research (NIHR)); Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Arthritis Research(Versus Arthritis); Wyeth Pharma GmbH, Germany; ADIPSO (Association for the Defense of Psoriasis Patients); Wellcome Trust(Wellcome TrustEuropean Commission)	We are grateful to all subjects and control probands for participation in this study. We thank P. Rothe, M. Kirsch, P. Badorf, P. Gilbert and K. Krause for excellent technical assistance. We thank D. Fried for helping with the cloning of constructs. The work was supported in part by a grant from the Interdisciplinary Centre for Clinical Research (IZKF B32/A8) of the University of Erlangen-Nuremberg and a grant from the ELAN fund (Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung) of the University of Erlangen-Nuremberg. The KORA (Cooperative Health Research in the Region of Augsburg) research platform was initiated and financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Part of this work was financed by the German National Genome Research Network (NGFN-2 and NGFNPlus: 01GS0823). Our research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. We acknowledge the National Institute for Health Research, Manchester Biomedical Research Centre and Science Foundation Ireland for support. A. B., I.N. B. and J.B. are funded by Arthritis Research. H. B. and F. B. were supported by a research grant of Wyeth Pharma GmbH, Germany (Forschungsforderungspreis Rheumatologie 2008). E.G. and G.N. are funded by the ADIPSO (Association for the Defense of Psoriasis Patients).; The Irish control DNA was provided by the Irish Blood Transfusion Service and Trinity College Dublin population DNA Biobank. This study makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of the investigators who contributed to the generation of the data is available from http://www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under award 076113. U.H., E.G., E.K., M.A., P.H., I.N.B., F.B., O.F., G.-M.A., N.J.M., G.N., H.B., A.B. and A.R. are members of the Psoriatic Arthritis Genetics in Europe (PAGE) Consortium.	Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; ELDER JT, 1994, ARCH DERMATOL, V130, P216, DOI 10.1001/archderm.130.2.216; Feng BJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000606; Filer C, 2008, ARTHRITIS RHEUM-US, V58, P3705, DOI 10.1002/art.24128; Ho PYPC, 2008, ANN RHEUM DIS, V67, P677, DOI 10.1136/ard.2007.071399; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Huffmeier U, 2009, J MED GENET, V46, P736, DOI 10.1136/jmg.2008.065029; Huffmeier U, 2010, ANN RHEUM DIS, V69, P876, DOI 10.1136/ard.2009.108951; Huffmeier U, 2009, J INVEST DERMATOL, V129, P355, DOI 10.1038/jid.2008.233; Hunter CA, 2007, NAT IMMUNOL, V8, P232, DOI 10.1038/ni0307-232; Ibrahim G, 2009, ARTHRIT CARE RES, V61, P1373, DOI 10.1002/art.24608; Kanamori M, 2002, FEBS LETT, V532, P241, DOI 10.1016/S0014-5793(02)03688-8; Karason A, 2009, RHEUMATOLOGY, V48, P1424, DOI 10.1093/rheumatology/kep243; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Uebe S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-472	29	273	288	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					996	U118		10.1038/ng.688	http://dx.doi.org/10.1038/ng.688			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20953186	Green Accepted			2022-12-17	WOS:000283540500018
J	Saal, LH; Gruvberger-Saal, SK; Persson, C; Loevgren, K; Jumppanen, M; Staaf, J; Jonsson, G; Pires, MM; Maurer, M; Holm, K; Koujak, S; Subramaniyam, S; Vallon-Christersson, J; Olsson, H; Su, T; Memeo, L; Ludwig, T; Ethier, SP; Krogh, M; Szabolcs, M; Murty, VV; Isola, J; Hibshoosh, H; Parsons, R; Borg, A				Saal, Lao H.; Gruvberger-Saal, Sofia K.; Persson, Camilla; Loevgren, Kristina; Jumppanen, Mervi; Staaf, Johan; Jonsson, Goeran; Pires, Maira M.; Maurer, Matthew; Holm, Karolina; Koujak, Susan; Subramaniyam, Shivakumar; Vallon-Christersson, Johan; Olsson, Hakan; Su, Tao; Memeo, Lorenzo; Ludwig, Thomas; Ethier, Stephen P.; Krogh, Morten; Szabolcs, Matthias; Murty, Vundavalli V. V. S.; Isola, Jorma; Hibshoosh, Hanina; Parsons, Ramon; Borg, Ake			Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair	NATURE GENETICS			English	Article							CELL-LINES; PROSTATE-CANCER; BRCA1; INSTABILITY; PHENOTYPE; CARCINOMA; PATTERNS; SUBTYPES; MICE	Basal-like breast cancer (BBC) is a subtype of breast cancer with poor prognosis(1 - 3). Inherited mutations of BRCA1, a cancer susceptibility gene involved in double-strand DNA break (DSB) repair, lead to breast cancers that are nearly always of the BBC subtype(3 - 5); however, the precise molecular lesions and oncogenic consequences of BRCA1 dysfunction are poorly understood. Here we show that heterozygous inactivation of the tumor suppressor gene Pten leads to the formation of basal-like mammary tumors in mice, and that loss of PTEN expression is significantly associated with the BBC subtype in human sporadic and BRCA1-associated hereditary breast cancers. In addition, we identify frequent gross PTEN mutations, involving intragenic chromosome breaks, inversions, deletions and micro copy number aberrations, specifically in BRCA1-deficient tumors. These data provide an example of a specific and recurrent oncogenic consequence of BRCA1-dependent dysfunction in DNA repair and provide insight into the pathogenesis of BBC with therapeutic implications. These findings also argue that obtaining an accurate census of genes mutated in cancer will require a systematic examination for gross gene rearrangements, particularly in tumors with deficient DSB repair.	[Saal, Lao H.] Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA; [Persson, Camilla; Loevgren, Kristina; Staaf, Johan; Jonsson, Goeran; Holm, Karolina; Vallon-Christersson, Johan; Olsson, Hakan; Borg, Ake] Lund Univ, Dept Clin Sci, Div Oncol, S-22185 Lund, Sweden; [Jumppanen, Mervi] Seinajoki Cent Hosp, Dept Pathol, Seinajoki 60220, Finland; [Jumppanen, Mervi; Isola, Jorma] Tampere Univ, Inst Med Technol, Tampere 33014, Finland; [Pires, Maira M.] Columbia Univ, Dept Biochem, New York, NY 10032 USA; [Maurer, Matthew; Parsons, Ramon] Columbia Univ, Dept Med, New York, NY 10032 USA; [Subramaniyam, Shivakumar; Ludwig, Thomas; Szabolcs, Matthias; Murty, Vundavalli V. V. S.; Hibshoosh, Hanina; Parsons, Ramon] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Su, Tao; Hibshoosh, Hanina; Parsons, Ramon] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Memeo, Lorenzo] Mediterranean Inst Oncol, Pathol Unit, I-95029 Catania, Italy; [Ethier, Stephen P.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA; [Krogh, Morten] Lund Univ, Dept Theoret, S-22362 Lund, Sweden; [Borg, Ake] Lund Univ, Lund Strateg Ctr Stem Cell Biol & Cell Therapy, S-22185 Lund, Sweden; [Saal, Lao H.; Gruvberger-Saal, Sofia K.; Maurer, Matthew; Koujak, Susan; Murty, Vundavalli V. V. S.; Parsons, Ramon] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA	Columbia University; Lund University; Seinajoki Central Hospital; Tampere University; Columbia University; Columbia University; Columbia University; Columbia University; Mediterranean Institute of Oncology; Barbara Ann Karmanos Cancer Institute; Wayne State University; Lund University; Lund University; Columbia University	Parsons, R (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.	rep15@columbia.edu	SUBRAMANIYAM, SHIVAKUMAR/HCI-4231-2022; Califano, Andrea/F-7239-2012; Su, Tao/T-4411-2019; Saal, Lao H/A-2919-2011; Ludwig, Thomas/Q-6484-2016; Jönsson, Göran/D-1212-2014	Su, Tao/0000-0002-9148-6127; Saal, Lao H/0000-0002-0815-1896; Ludwig, Thomas/0000-0003-3461-2585; Vallon-Christersson, Johan/0000-0002-2195-0385; Memeo, Lorenzo/0000-0003-4251-7203; Parsons, Ramon/0000-0002-6656-3514; Olsson, Hakan/0000-0002-8794-9635	NATIONAL CANCER INSTITUTE [R01CA082783, P01CA097403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA082783-08, R01 CA082783-06, P01 CA097403, R01 CA082783-07, R01 CA082783, CA097403, CA082783] Funding Source: Medline; NIGMS NIH HHS [5T32 GM07367-29, T32 GM007367] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Evers B, 2006, ONCOGENE, V25, P5885, DOI 10.1038/sj.onc.1209871; GIOVANELLA BC, 1974, JNCI-J NATL CANCER I, V52, P921, DOI 10.1093/jnci/52.3.921; Greenblatt MS, 2001, CANCER RES, V61, P4092; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Janzen V, 2006, NATURE, V441, P418, DOI 10.1038/441418b; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; Jonsson G, 2007, GENE CHROMOSOME CANC, V46, P543, DOI 10.1002/gcc.20438; Laakso M, 2005, MODERN PATHOL, V18, P1321, DOI 10.1038/modpathol.3800456; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Loman N, 2001, JNCI-J NATL CANCER I, V93, P1215, DOI 10.1093/jnci/93.16.1215; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Saal LH, 2002, GENOME BIOL, V3; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; SILVA LD, 2007, J CLIN PATHOL   0511; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; STAAF J, IN PRESS HUM MUTAT; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlinson GE, 1998, CANCER RES, V58, P3237; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096	30	273	283	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					102	107		10.1038/ng.2007.39	http://dx.doi.org/10.1038/ng.2007.39			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18066063	Green Accepted, Green Published			2022-12-17	WOS:000252118600025
J	Stephens, P; Edkins, S; Davies, H; Greenman, C; Cox, C; Hunter, C; Bignell, G; Teague, J; Smith, R; Stevens, C; O'Meara, S; Parker, A; Tarpey, P; Avis, T; Barthorpe, A; Brackenbury, L; Buck, G; Butler, A; Clements, J; Cole, J; Dicks, E; Edwards, K; Forbes, S; Gorton, M; Gray, K; Halliday, K; Harrison, R; Hills, K; Hinton, J; Jones, D; Kosmidou, V; Laman, R; Lugg, R; Menzies, A; Perry, J; Petty, R; Raine, K; Shepherd, R; Small, A; Solomon, H; Stephens, Y; Tofts, C; Varian, J; Webb, A; West, S; Widaa, S; Yates, A; Brasseur, F; Cooper, CS; Flanagan, AM; Green, A; Knowles, M; Leung, SY; Looijenga, LHJ; Malkowicz, B; Pierotti, MA; Teh, B; Yuen, ST; Nicholson, AG; Lakhani, S; Easton, DF; Weber, BL; Stratton, MR; Futreal, PA; Wooster, R				Stephens, P; Edkins, S; Davies, H; Greenman, C; Cox, C; Hunter, C; Bignell, G; Teague, J; Smith, R; Stevens, C; O'Meara, S; Parker, A; Tarpey, P; Avis, T; Barthorpe, A; Brackenbury, L; Buck, G; Butler, A; Clements, J; Cole, J; Dicks, E; Edwards, K; Forbes, S; Gorton, M; Gray, K; Halliday, K; Harrison, R; Hills, K; Hinton, J; Jones, D; Kosmidou, V; Laman, R; Lugg, R; Menzies, A; Perry, J; Petty, R; Raine, K; Shepherd, R; Small, A; Solomon, H; Stephens, Y; Tofts, C; Varian, J; Webb, A; West, S; Widaa, S; Yates, A; Brasseur, F; Cooper, CS; Flanagan, AM; Green, A; Knowles, M; Leung, SY; Looijenga, LHJ; Malkowicz, B; Pierotti, MA; Teh, B; Yuen, ST; Nicholson, AG; Lakhani, S; Easton, DF; Weber, BL; Stratton, MR; Futreal, PA; Wooster, R			A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; GENOME	We examined the coding sequence of 518 protein kinases, similar to 1.3 Mb of DNA per sample, in 25 breast cancers. In many tumors, we detected no somatic mutations. But a few had numerous somatic mutations with distinctive patterns indicative of either a mutator phenotype or a past exposure.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Ludwig Inst Canc Res, B-1200 Brussels, Belgium; Inst Canc Res, Sutton SM2 5NG, Surrey, England; UCL, Inst Orthopaed, Stanmore, Middx, England; Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2XY, England; St James Univ Hosp, Canc Res UK Clin Ctr, Leeds LS9 7TF, W Yorkshire, England; Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; Erasmus Univ, Josephine Nefkens Inst, NL-3015 GE Rotterdam, Netherlands; Univ Penn, Div Urol, Philadelphia, PA 19104 USA; Nazl Tumori & FIRC Inst Mol Oncol, Milan, Italy; Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI 49503 USA; Royal Brompton Hosp, London SW3 6NP, England; Inst Canc Res, Chester Beatty Labs, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; Strangeways Res Labs, Canc Res UK Genet Epidemiol Grp, Cambridge CB1 4RN, England; Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA	Wellcome Trust Sanger Institute; Ludwig Institute for Cancer Research; University of London; Institute of Cancer Research - UK; University of London; University College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cancer Research UK; Saint James's University Hospital; University of Leeds; University of Hong Kong; Erasmus University Rotterdam; Erasmus MC; University of Pennsylvania; Fondazione IRCCS Istituto Nazionale Tumori Milan; Van Andel Institute; Royal Brompton Hospital; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; University of Pennsylvania	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	mrs@sanger.ac.uk	Lakhani, Sunil R/I-1970-2018; Yuen, Siu/K-6311-2014; Looijenga, Leendert/B-8145-2019; Leung, Suet Yi/C-4340-2009; Pierotti, Marco Alessandro/AAC-4728-2022; Leung, Suet Yi/T-9620-2019	Lakhani, Sunil R/0000-0003-4067-2760; Looijenga, Leendert/0000-0002-8146-1911; Pierotti, Marco Alessandro/0000-0002-7431-8332; Flanagan, Adrienne/0000-0002-2832-1303; Green, Anthony/0000-0002-9795-0218; Raine, Keiran/0000-0002-5634-1539; Laman, Ross/0000-0003-0545-0521; Leung, Suet Yi/0000-0001-8614-4619; Avis, Tim/0000-0001-6120-5729; Buck, Gemma/0000-0001-5289-1050; Hunter, Christopher/0000-0002-1335-0881; Gray, Kristian/0000-0002-7035-7107; Teh, Bin Tean/0000-0003-1514-1124; Yates, Andrew/0000-0002-8886-4772; Edkins, Sarah/0000-0003-0717-1972; Knowles, Margaret/0000-0002-9363-8657				Huang ME, 2003, P NATL ACAD SCI USA, V100, P11529, DOI 10.1073/pnas.2035018100; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Persons DL, 1997, MODERN PATHOL, V10, P720; Wagner E, 2002, J CELL SCI, V115, P3033; Wang TL, 2002, P NATL ACAD SCI USA, V99, P3076, DOI 10.1073/pnas.261714699; Xiao W, 1999, MUTAT RES-FUND MOL M, V431, P155, DOI 10.1016/S0027-5107(99)00203-1	7	273	299	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2005	37	6					590	592		10.1038/ng1571	http://dx.doi.org/10.1038/ng1571			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15908952				2022-12-17	WOS:000229495300011
J	Lipkin, SM; Moens, PB; Wang, V; Lenzi, M; Shanmugarajah, D; Gilgeous, A; Thomas, J; Cheng, J; Touchman, JW; Green, ED; Schwartzberg, P; Collins, FS; Cohen, PE				Lipkin, SM; Moens, PB; Wang, V; Lenzi, M; Shanmugarajah, D; Gilgeous, A; Thomas, J; Cheng, J; Touchman, JW; Green, ED; Schwartzberg, P; Collins, FS; Cohen, PE			Meiotic arrest and aneuploidy in MLH3-deficient mice	NATURE GENETICS			English	Article							DNA MISMATCH REPAIR; CROSSING-OVER; MUTS HOMOLOG; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SYNAPSIS; MEIOSIS; GENE; RECOMBINATION; MLH1; MSH5	MutL homolog 3 (Mlh3) is a member of a family of proteins conserved during evolution and having dual roles in DNA mismatch repair and meiosis(1,2). The pathway in eukaryotes consists of the DNA-binding components, which are the homologs of the bacterial MutS protein (MSH 2-6), and the MutL homologs, which bind to the MutS homologs and are essential for the repair process. Three of the six homologs of MutS that function in these processes, Msh2, Msh3 and Msh6, are involved in the mismatch repair of mutations, frameshifts and replication errors(2,3), and two others, Msh4 and Msh5, have specific roles in meiosis(4-10). Of the four MutL homologs, Mlh1, Mlh3, Pms1 and Pms2, three are involved in mismatch repair and at least two, Pms2 and Mlh1, are essential for meiotic progression in both yeast and mice(2,3,11-14). To assess the role of Mlh3 in mammalian meiosis, we have generated and characterized Mlh3(-/-) mice 15. Here we show that Mlh3(-/-) mice are viable but sterile. Mlh3 is required for Mlh1 binding to meiotic chromosomes and localizes to meiotic chromosomes from the mid pachynema stage of prophase I. Mlh3(-/-) spermatocytes reach metaphase before succumbing to apoptosis, but oocytes fail to complete meiosis I after fertilization. Our results show that Mlh3 has an essential and distinct role in mammalian meiosis.	Univ Calif Irvine, Dept Med, Div Hematol Oncol, Irvine, CA 92697 USA; NHGRI, Genet & Mol Biol Branch, Bethesda, MD 20892 USA; York Univ, Dept Biol, N York, ON M3J 1P3, Canada; Albert Einstein Coll Med, Coll Med, Dept Mol Genet, Bronx, NY 10467 USA; NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; NHGRI, Transgen & Knockout Core Facil, Bethesda, MD 20892 USA	University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); York University - Canada; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Cohen, PE (corresponding author), Univ Calif Irvine, Dept Med, Div Hematol Oncol, Irvine, CA 92697 USA.		wang, vicky/AAO-6474-2020		NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123, Z01HG000123] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Anderson LK, 1999, GENETICS, V151, P1569; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; Cohen PE, 2001, BIOESSAYS, V23, P996, DOI 10.1002/bies.1145; de Vries SS, 1999, GENE DEV, V13, P523, DOI 10.1101/gad.13.5.523; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Edelmann W, 2000, CANCER RES, V60, P803; Ellsworth RE, 2000, P NATL ACAD SCI USA, V97, P1172, DOI 10.1073/pnas.97.3.1172; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Green ED, 2001, NAT REV GENET, V2, P573, DOI 10.1038/35084503; Guarne A, 2001, EMBO J, V20, P5521, DOI 10.1093/emboj/20.19.5521; Her CT, 1999, MAMM GENOME, V10, P1054, DOI 10.1007/s003359901161; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Hunter N, 1997, GENE DEV, V11, P1573, DOI 10.1101/gad.11.12.1573; Kneitz B, 2000, GENE DEV, V14, P1085; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Lipkin SM, 2000, NAT GENET, V24, P27, DOI 10.1038/71643; Marra G, 1998, P NATL ACAD SCI USA, V95, P8568, DOI 10.1073/pnas.95.15.8568; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Moens PB, 2002, J CELL SCI, V115, P1611; Osoegawa K, 2000, GENOME RES, V10, P116; PaquisFlucklinger V, 1997, GENOMICS, V44, P188, DOI 10.1006/geno.1997.4857; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Touchman JW, 2000, GENOME RES, V10, P165, DOI 10.1101/gr.10.2.165; Wang DH, 1996, CANCER LETT, V100, P31, DOI 10.1016/0304-3835(95)04068-4; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395	29	273	287	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2002	31	4					385	390		10.1038/ng931	http://dx.doi.org/10.1038/ng931			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12091911				2022-12-17	WOS:000177147100013
J	Whitelaw, E; Martin, DIK				Whitelaw, E; Martin, DIK			Retrotransposons as epigenetic mediators of phenotypic variation in mammals	NATURE GENETICS			English	Editorial Material							DNA METHYLATION; TRANSPOSABLE ELEMENTS; TRANSCRIPTIONAL INTERFERENCE; DROSOPHILA-MELANOGASTER; RNA INTERFERENCE; MOUSE EMBRYO; C-ELEGANS; GENE; INHERITANCE; EXPRESSION	Phenotypic variation in mammals is frequently attributed to the action of quantitative trait loci (QTL) or the environment, but may also be epigenetic in origin. Here we consider a mechanism for phenotypic variation based on interference of transcription by somatically active retrotransposons. Transcriptionally competent retrotransposons may number in the tens of thousands in mammalian genomes. We propose that silencing of retrotransposons occurs by cosuppression during early embryogenesis, but that this process is imperfect and produces a mosaic pattern of retrotransposon expression in somatic cells. Transcriptional interference by active retrotransposons perturbs expression of neighboring genes in somatic cells, in a mosaic pattern corresponding to activity of each retrotransposon. The epigenotype of retrotransposon activity is reset in each generation, but incomplete resetting can lead to heritable epigenetic effects. The stochastic nature of retrotransposon activity, and the very large number of genes that may be affected, produce subtle phenotypic variations even between genetically identical individuals, which may affect disease risk and be heritable in a non-mendelian fashion.	Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; Univ Sydney, Dept Biochem, Sydney, NSW 2006, Australia	Victor Chang Cardiac Research Institute; University of Sydney	Martin, DIK (corresponding author), Victor Chang Cardiac Res Inst, Sydney, NSW, Australia.	d.martin@victorchang.unsw.edu.au						Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; BOUCHARD TJ, 1990, SCIENCE, V250, P223, DOI 10.1126/science.2218526; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Chaboissier MC, 1998, P NATL ACAD SCI USA, V95, P11781, DOI 10.1073/pnas.95.20.11781; CORBIN V, 1989, NATURE, V337, P279, DOI 10.1038/337279a0; EMERMAN M, 1984, CELL, V39, P459, DOI 10.1016/0092-8674(84)90453-7; ESSIEN FB, 1990, TERATOLOGY, V42, P183, DOI 10.1002/tera.1420420209; Falconer, 1989, INTRO QUANTITATIVE G, P438; FERRANTE F, 1994, CLIN EXP HYPERTENS, V16, P1, DOI 10.3109/10641969409068580; FIERING S, 1995, GENE DEV, V9, P2203, DOI 10.1101/gad.9.18.2203; FINCHAM JRS, 1974, ANNU REV GENET, V8, P15, DOI 10.1146/annurev.ge.08.120174.000311; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347; GARTNER K, 1981, NATURE, V292, P646, DOI 10.1038/292646a0; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; GRUNEBERG H, 1970, NATURE, V225, P39, DOI 10.1038/225039a0; Hollick JB, 1997, TRENDS GENET, V13, P302, DOI 10.1016/S0168-9525(97)01184-0; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; HUMMEL KP, 1958, J EXP ZOOL, V137, P389, DOI 10.1002/jez.1401370303; JABLONKA E, 1995, EPIGENETIC INHERITAN, P46; Jensen S, 1999, NAT GENET, V21, P209, DOI 10.1038/5997; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Kazazian HH, 1998, CURR OPIN GENET DEV, V8, P343, DOI 10.1016/S0959-437X(98)80092-0; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Kidwell MG, 1997, P NATL ACAD SCI USA, V94, P7704, DOI 10.1073/pnas.94.15.7704; KRIEG AM, 1992, FASEB J, V6, P2537, DOI 10.1096/fasebj.6.8.1592206; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; Machin GA, 1996, AM J MED GENET, V61, P216, DOI 10.1002/(SICI)1096-8628(19960122)61:3<216::AID-AJMG5>3.0.CO;2-S; MARTIENSSEN R, 1994, GENETICS, V136, P1157; MARTIENSSEN RA, 1995, CURR OPIN GENET DEV, V5, P234, DOI 10.1016/0959-437X(95)80014-X; Martin N, 1997, NAT GENET, V17, P387, DOI 10.1038/ng1297-387; McClintock B, 1968, CARNEGIE I WASHINGTO, V66, P20; MICHAUD EJ, 1994, GENE DEV, V8, P1463, DOI 10.1101/gad.8.12.1463; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; MONK M, 1987, DEVELOPMENT, V99, P371; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; PACKER AI, 1993, DEV BIOL, V157, P281, DOI 10.1006/dbio.1993.1133; PARKHURST SM, 1986, MOL CELL BIOL, V6, P47, DOI 10.1128/MCB.6.1.47; PIKO L, 1984, P NATL ACAD SCI-BIOL, V81, P488, DOI 10.1073/pnas.81.2.488; PROUDFOOT NJ, 1986, NATURE, V322, P562, DOI 10.1038/322562a0; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Roemer I, 1997, CURR BIOL, V7, P277, DOI 10.1016/S0960-9822(06)00124-2; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Vasicek TJ, 1997, GENETICS, V147, P777; WLKINSON DA, 1994, RETROVIRIDAE, P465; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	52	273	284	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2001	27	4					361	365		10.1038/86850	http://dx.doi.org/10.1038/86850			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279513				2022-12-17	WOS:000167811200006
J	Siegfried, Z; Eden, S; Mendelsohn, M; Feng, X; Tsuberi, BZ; Cedar, H				Siegfried, Z; Eden, S; Mendelsohn, M; Feng, X; Tsuberi, BZ; Cedar, H			DNA methylation represses transcription in vivo	NATURE GENETICS			English	Article							CELL-SPECIFIC DEMETHYLATION; GLOBIN GENE-EXPRESSION; CYTOSINE METHYLATION; CPG ISLAND; ACTIVATION; BINDING; SITES	DNA in somatic tissue is characterized by a bimodal pattern of methylation, which is established in the animal through a series of developmental events'. In the mouse blastula, most DNA is unmethylated, but after implantation a wave of de novo methylation modifies most of the genome, excluding the majority of Cpt islands, which are mainly associated with housekeeping genes. This genomic methylation pattern is broadly maintained during the life of the organism by maintenance methylation, and generally correlates with gene expression. Experiments both in vitro(3-5) and in vivo(6-9) indicate that methylation inhibits transcription, It has not yet been possible, however, to determine the role of DNA methylation on specific. sequences during normal development Cis-acting regulatory elements and trans-acting factors appear to be involved in both stage- and tissue-specific demethylation processes(10,11). Spl-like elements have a key role in protecting the CpG island of Aprt (encoding adenine phosphoribosyl transferase) from de novo methylation, and when these elements are specifically mutated, the Aprf CpG island becomes methylated genome, in transgenic mice(12,13) . We have now characterized an embryo-specific element,ment from the CpG island sequence upstream of Aprt that can protect itself from de novo methylation in transgenic mice as well as reduce methylation of flanking sequences. We placed this element on a removable cassette adjacent to a human HBB (encoding P-globin) reporter and generated a transgene whose methylation pattern can be switched in vivo. Analysis of globin transcription in this system showed that methylation in cis inhibits gt,ne expression in a variety of tissues, indicating that DNA modification may serve as a global genomic repressor.	Hebrew Univ Jerusalem, Sch Med, Dept Cellular Biochem, IL-91120 Jerusalem, Israel; Columbia Univ, Sch Med, Ctr Neurobiol & Behav, New York, NY 10032 USA	Hebrew University of Jerusalem; Columbia University	Cedar, H (corresponding author), Hebrew Univ Jerusalem, Sch Med, Dept Cellular Biochem, IL-91120 Jerusalem, Israel.	cedar@md2.huji.ac.il						BEARD C, 1995, GENE DEV, V9, P2325, DOI 10.1101/gad.9.19.2325; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; BUSSLINGER M, 1983, CELL, V34, P197, DOI 10.1016/0092-8674(83)90150-2; CALZONE FJ, 1987, METHOD ENZYMOL, V152, P611; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; GRUENBAUM Y, 1982, NATURE, V295, P620, DOI 10.1038/295620a0; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; HOGAN B, 1986, MANIPULATING MOUSE E, P92; HORNSTRA IK, 1994, MOL CELL BIOL, V14, P1419, DOI 10.1128/MCB.14.2.1419; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; KLAGES S, 1992, NUCLEIC ACIDS RES, V20, P1925, DOI 10.1093/nar/20.8.1925; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; LICHTENSTEIN M, 1994, CELL, V76, P913, DOI 10.1016/0092-8674(94)90365-4; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nickel J, 1995, NUCLEIC ACIDS RES, V23, P4785, DOI 10.1093/nar/23.23.4785; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; RAZIN A, 1995, HUM MOL GENET, V4, P1751, DOI 10.1093/hmg/4.suppl_1.1751; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Weiss A, 1996, CELL, V86, P709, DOI 10.1016/S0092-8674(00)80146-4; YISRAELI J, 1986, CELL, V46, P409, DOI 10.1016/0092-8674(86)90661-6; YISRAELI J, 1988, P NATL ACAD SCI USA, V85, P4638, DOI 10.1073/pnas.85.13.4638; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	28	273	280	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1999	22	2					203	206		10.1038/9727	http://dx.doi.org/10.1038/9727			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202YX	10369268				2022-12-17	WOS:000080680900031
J	Forrest, D; Erway, LC; Ng, L; Altschuler, R; Curran, T				Forrest, D; Erway, LC; Ng, L; Altschuler, R; Curran, T			Thyroid hormone receptor beta is essential for development of auditory function	NATURE GENETICS			English	Letter							PROTEIN; RESISTANCE; GENE; RATS		UNIV CINCINNATI, DEPT BIOL SCI, CINCINNATI, OH 45221 USA; UNIV MICHIGAN, KRESGE HEARING RES INST, ANN ARBOR, MI 48109 USA; ST JUDE CHILDRENS RES HOSP, DEPT DEV NEUROBIOL, MEMPHIS, TN 38105 USA	University System of Ohio; University of Cincinnati; University of Michigan System; University of Michigan; St Jude Children's Research Hospital	Forrest, D (corresponding author), MT SINAI SCH MED, DEPT HUMAN GENET, 5TH AVE 100TH ST, NEW YORK, NY 10029 USA.		Curran, Tom/C-1164-2008; Curran, Tom/D-7515-2011; Curran, Thomas/AAE-7631-2019; Curran, Tom/F-5234-2018	Curran, Tom/0000-0003-1444-7551; Curran, Thomas/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551	NCI NIH HHS [P30 CA21765] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANAND VT, 1989, ACTA OTO-LARYNGOL, V108, P83, DOI 10.3109/00016488909107396; BRADLEY DJ, 1994, P NATL ACAD SCI USA, V91, P439, DOI 10.1073/pnas.91.2.439; BRUCKERDAVIS F, 1995, ANN INTERN MED, V123, P572, DOI 10.7326/0003-4819-123-8-199510150-00002; BURROW GN, 1994, NEW ENGL J MED, V331, P1072; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; COREY DP, 1994, P NATL ACAD SCI USA, V91, P433, DOI 10.1073/pnas.91.2.433; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DEESCOBAR GM, 1991, ADV EXP MED BIOL, V299, P133; Delong G. Robeert, 1993, American Journal of Clinical Nutrition, V57, p286S, DOI 10.1093/ajcn/57.2.286S; DEOL MS, 1976, ACTA OTO-LARYNGOL, V81, P429; DEOL MS, 1973, J MED GENET, V10, P235, DOI 10.1136/jmg.10.3.235; ERWAY LC, 1993, HEARING RES, V65, P125, DOI 10.1016/0378-5955(93)90207-H; FORREST D, 1994, SEMIN CANCER BIOL, V5, P167; FORREST D, 1990, EMBO J, V9, P1519, DOI 10.1002/j.1460-2075.1990.tb08270.x; FORREST D, IN PRESS EMBO J; FREEMAN S, 1993, HEARING RES, V69, P229, DOI 10.1016/0378-5955(93)90112-E; HEBERT R, 1986, PEDIATR RES, V20, P570, DOI 10.1203/00006450-198606000-00020; HEBERT R, 1995, DEV BRAIN RES, V23, P161; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; McCarrison R, 1908, LANCET, V2, P1275; MEYERHOFF WL, 1979, LARYNGOSCOPE, V89, P1; OMALLEY BW, 1995, HEARING RES, V88, P181, DOI 10.1016/0378-5955(95)00111-G; Pendred V, 1896, LANCET, V148, P532, DOI [DOI 10.1016/S0140-6736(01)74403-0, 10.1016/S0140-6736(01)74403-0]; REFETOFF S, 1993, ENDOCR REV, V14, P348, DOI 10.1210/er.14.3.348; REFETOFF S, 1967, J CLIN ENDOCR METAB, V27, P279, DOI 10.1210/jcem-27-2-279; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SJOBERG M, 1995, MOL CELL BIOL, V15, P4718; STANBURY JB, 1984, J ENDOCRINOL INVEST, V7, P409, DOI 10.1007/BF03351027; STEEL KP, 1994, TRENDS GENET, V10, P428, DOI 10.1016/0168-9525(94)90113-9; STRAIT KA, 1990, J BIOL CHEM, V265, P10514; TAKEDA K, 1992, J CLIN ENDOCR METAB, V74, P49, DOI 10.1210/jc.74.1.49; UZIEL A, 1986, ACTA OTO-LARYNGOL, P23; UZIEL A, 1981, ACTA OTO-LARYNGOL, V92, P469, DOI 10.3109/00016488109133286; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0	34	273	280	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1996	13	3					354	357		10.1038/ng0796-354	http://dx.doi.org/10.1038/ng0796-354			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673137				2022-12-17	WOS:A1996UU28300026
J	ZEMEL, S; BARTOLOMEI, MS; TILGHMAN, SM				ZEMEL, S; BARTOLOMEI, MS; TILGHMAN, SM			PHYSICAL LINKAGE OF 2 MAMMALIAN IMPRINTED GENES, H19 AND INSULIN-LIKE GROWTH FACTOR-II	NATURE GENETICS			English	Article							WIEDEMANN-BECKWITH SYNDROME; EARLY MOUSE EMBRYOGENESIS; FACTOR-II GENE; DOMINANT INHERITANCE; BETA-GLOBIN; EXPRESSION; YEAST; MICE; CHROMOSOME-11; GENOME	Parental imprinting is a phenomenon in mammals whereby the maternal and paternal alleles of a gene are differentially expressed. Three murine genes have been shown to display this type of allele-specific expression. Two of them, insulin-like growth factor-2 (Igf-2) and H19, map to the distal end of mouse chromosome 7, but are imprinted in opposite directions. Pulsed-field gel electrophoresis and large-fragment DNA cloning were utilized to establish a physical map that includes H19 and Igf-2. Igf-2 lies approximately 90 kilobases of DNA 5' to H19, in the same transcriptional orientation. This physical proximity is conserved in humans, based on pulsed-field gel analysis. We conclude that H19 and Igf-2 constitute an imprinted domain.	PRINCETON UNIV,HOWARD HUGHES MED INST,PRINCETON,NJ 08544; PRINCETON UNIV,DEPT MOLEC BIOL,PRINCETON,NJ 08544	Howard Hughes Medical Institute; Princeton University; Princeton University								ALECK KA, 1989, AM J MED GENET, V33, P155, DOI 10.1002/ajmg.1320330202; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; Bartolomei M.S., 1992, SEMIN DEV BIOL, V3, P107; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; BELL GI, 1985, P NATL ACAD SCI USA, V82, P6450, DOI 10.1073/pnas.82.19.6450; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BRUNKOW ME, 1991, GENE DEV, V5, P1092, DOI 10.1101/gad.5.6.1092; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CARLE GF, 1985, P NATL ACAD SCI USA, V82, P3756, DOI 10.1073/pnas.82.11.3756; CATTANACH BM, 1986, J EMBRYOL EXP MORPH, V97, P137; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CATTANACH BM, 1982, MOUSE NEWS LETT, V66, P62; CHOI ORB, 1988, CELL, V55, P17, DOI 10.1016/0092-8674(88)90005-0; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DECHIARA TM, 1991, CELL, V64; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; GLASER T, 1989, SOMAT CELL MOLEC GEN, V15, P477, DOI 10.1007/BF01534910; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; KOUFOS A, 1989, AM J HUM GENET, V44, P711; LEE JE, 1990, DEVELOPMENT, V110, P151; LUBINSKY M, 1974, LANCET, V1, P983; MCGRATH J, 1984, SCIENCE, V226, P1317, DOI 10.1126/science.6542249; NICKOL JM, 1988, P NATL ACAD SCI USA, V85, P2548, DOI 10.1073/pnas.85.8.2548; NIIKAWA N, 1986, AM J MED GENET, V24, P41, DOI 10.1002/ajmg.1320240107; OMALLEY KL, 1988, NUCLEIC ACIDS RES, V16, P4437; PACHNIS V, 1988, EMBO J, V7, P673, DOI 10.1002/j.1460-2075.1988.tb02862.x; PING AJ, 1989, AM J HUM GENET, V44, P720; POIRIER F, 1991, DEVELOPMENT, V113, P1105; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; ROSSI JM, 1992, P NATL ACAD SCI USA, V89, P2456, DOI 10.1073/pnas.89.6.2456; ROTWEIN P, 1990, DNA CELL BIOL, V9, P725, DOI 10.1089/dna.1990.9.725; SEARLE AG, 1990, GENET RES, V56, P237, DOI 10.1017/S0016672300035333; SOARES MB, 1986, J MOL BIOL, V192, P737, DOI 10.1016/0022-2836(86)90025-2; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; TURLEAU C, 1984, HUM GENET, V67, P219, DOI 10.1007/BF00273006; WAZIRI M, 1983, J PEDIATR-US, V102, P873, DOI 10.1016/S0022-3476(83)80014-6; WENTWORTH BM, 1986, J MOL EVOL, V23, P305, DOI 10.1007/BF02100639; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	41	273	277	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					61	65		10.1038/ng0992-61	http://dx.doi.org/10.1038/ng0992-61			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	1303252				2022-12-17	WOS:A1992JM64600018
J	Hu, Z; Zhu, D; Wang, W; Li, WY; Jia, WL; Zeng, X; Ding, WC; Yu, L; Wang, XL; Wang, LM; Shen, H; Zhang, CL; Liu, HJ; Liu, X; Zhao, Y; Fang, XD; Li, SC; Chen, W; Tang, T; Fu, AS; Wang, Z; Chen, G; Gao, QL; Li, S; Xi, L; Wang, CY; Liao, SJ; Ma, XY; Wu, P; Li, K; Wang, SX; Zhou, JF; Wang, J; Xu, X; Wang, H; Ma, D				Hu, Zheng; Zhu, Da; Wang, Wei; Li, Weiyang; Jia, Wenlong; Zeng, Xi; Ding, Wencheng; Yu, Lan; Wang, Xiaoli; Wang, Liming; Shen, Hui; Zhang, Changlin; Liu, Hongjie; Liu, Xiao; Zhao, Yi; Fang, Xiaodong; Li, Shuaicheng; Chen, Wei; Tang, Tang; Fu, Aisi; Wang, Zou; Chen, Gang; Gao, Qinglei; Li, Shuang; Xi, Ling; Wang, Changyu; Liao, Shujie; Ma, Xiangyi; Wu, Peng; Li, Kezhen; Wang, Shixuan; Zhou, Jianfeng; Wang, Jun; Xu, Xun; Wang, Hui; Ma, Ding			Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism	NATURE GENETICS			English	Article							HUMAN-PAPILLOMAVIRUS; INTRAEPITHELIAL NEOPLASIA; PHYSICAL STATE; MYC LOCUS; DNA; REARRANGEMENTS; SEQUENCES; SITES	Human papillomavirus (HPV) integration is a key genetic event in cervical carcinogenesis(1). By conducting whole-genome sequencing and high-throughput viral integration detection, we identified 3,667 HPV integration breakpoints in 26 cervical intraepithelial neoplasias, 104 cervical carcinomas and five cell lines. Beyond recalculating frequencies for the previously reported frequent integration sites POU5F1B (9.7%), FHIT (8.7%), KLF12 (7.8%), KLF5 (6.8%), LRP1B (5.8%) and LEPREL1 (4.9%), we discovered new hot spots HMGA2 (7.8%), DLG2 (4.9%) and SEMA3D (4.9%). Protein expression from FHIT and LRP1B was downregulated when HPV integrated in their introns. Protein expression from MYC and HMGA2 was elevated when HPV integrated into flanking regions. Moreover, microhomologous sequence between the human and HPV genomes was significantly enriched near integration breakpoints, indicating that fusion between viral and human DNA may have occurred by microhomology-mediated DNA repair pathways(2). Our data provide insights into HPV integration-driven cervical carcinogenesis.	[Hu, Zheng; Zhu, Da; Ding, Wencheng; Yu, Lan; Wang, Xiaoli; Wang, Liming; Shen, Hui; Zhang, Changlin; Chen, Gang; Gao, Qinglei; Li, Shuang; Xi, Ling; Wang, Changyu; Liao, Shujie; Ma, Xiangyi; Wu, Peng; Li, Kezhen; Wang, Shixuan; Wang, Hui; Ma, Ding] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan 430074, Hubei, Peoples R China; [Wang, Wei] Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China; [Li, Weiyang; Jia, Wenlong; Zeng, Xi; Liu, Hongjie; Liu, Xiao; Zhao, Yi; Fang, Xiaodong; Chen, Wei] BGI, Shenzhen, Peoples R China; [Li, Weiyang; Wang, Jun] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510641, Guangdong, Peoples R China; [Jia, Wenlong; Li, Shuaicheng] City Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China; [Tang, Tang] WuHan Frasergen Bioinformat Co Ltd, Wuhan, Peoples R China; [Fu, Aisi; Wang, Zou] Wuhan Inst Biotechnol, Wuhan, Peoples R China; [Zhou, Jianfeng] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Hematol, Wuhan, Hubei, Peoples R China; [Wang, Jun] King Abdulaziz Univ, Princess Jawhara Ctr Excellence Res Hereditary Di, Jeddah 21413, Saudi Arabia; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Wang, Jun] Aarhus Univ, Ctr ISequencing, Aarhus, Denmark	Huazhong University of Science & Technology; Southern Medical University - China; Beijing Genomics Institute (BGI); South China University of Technology; City University of Hong Kong; Huazhong University of Science & Technology; King Abdulaziz University; Novo Nordisk Foundation; University of Copenhagen; Aarhus University	Ma, D (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan 430074, Hubei, Peoples R China.	xuxun@genomics.cn; huit71@sohu.com; dingma424@yahoo.com	Fang, Xiaodong/K-6743-2018; Gao, Qinglei/B-1141-2019; Liu, Xiao/P-2732-2015; Li, Weiyang/GRO-0563-2022; Xu, Xun/AAI-6763-2020; wu, peng/M-1812-2019; Zhang, Changlin/ABI-4611-2020; Jia, Justin/AAV-4349-2021; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Fang, Xiaodong/0000-0001-7061-3337; Liu, Xiao/0000-0002-8073-0534; Xu, Xun/0000-0002-5338-5173; wu, peng/0000-0002-4016-6641; Jia, Justin/0000-0002-7136-9919; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; Wu, Peng/0000-0003-4498-7663; Hu, Zheng/0000-0001-9306-9442; Wang, Wei/0000-0002-3422-0402; LI, Shuaicheng/0000-0001-6246-6349; gao, qinglei/0000-0002-9448-3423	National Development Program (973) for the Key Basic Research of China [2015CB553903, 2013CB911304]; National Natural Science Funding of China [81230038, 81372805, 81172466, 81272859, 81372801, 81372804, 81402158, 81372806, 81370469, 81172468, 81101964, 81230052, 81302266]; Chinese 863 Program [2012AA02A507, 2012AA02A201]; Guangdong Enterprise Key Laboratory of Human Disease Genomics; ShenZhen Engineering Laboratory for Clinical Molecular Diagnostic; China National GeneBank-Shenzhen	National Development Program (973) for the Key Basic Research of China; National Natural Science Funding of China(National Natural Science Foundation of China (NSFC)); Chinese 863 Program(National High Technology Research and Development Program of China); Guangdong Enterprise Key Laboratory of Human Disease Genomics; ShenZhen Engineering Laboratory for Clinical Molecular Diagnostic; China National GeneBank-Shenzhen	This work was supported by funds from the National Development Program (973) for the Key Basic Research of China (2015CB553903 and 2013CB911304) and the National Natural Science Funding of China (81230038, 81372805, 81172466, 81272859, 81372801, 81372804, 81402158, 81370469, 81372806, 81370469, 81172468, 81101964, 81230052 and 81302266). The study is also sponsored by the Chinese 863 Program (2012AA02A507, 2012AA02A201), Guangdong Enterprise Key Laboratory of Human Disease Genomics, ShenZhen Engineering Laboratory for Clinical Molecular Diagnostic and China National GeneBank-Shenzhen. We thank all participants recruited for this study. We thank our colleagues from BGI, H. Huang, L. Huang, X. Zhuang, L. Lin, H. Cao, X. Fang, X. Zhang, Y. Shuang and H. Yang for sequencing and analysis.	Adey A, 2013, NATURE, V500, P207, DOI 10.1038/nature12064; Arias-Pulido H, 2006, J CLIN MICROBIOL, V44, P1755, DOI 10.1128/JCM.44.5.1755-1762.2006; Boulet GAV, 2009, CANCER EPIDEM BIOMAR, V18, P2992, DOI 10.1158/1055-9965.EPI-09-0025; Campitelli M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043393; Crosbie EJ, 2013, LANCET, V382, P889, DOI 10.1016/S0140-6736(13)60022-7; Dall KL, 2008, CANCER RES, V68, P8249, DOI 10.1158/0008-5472.CAN-08-1741; Das P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041012; ELAWADY MK, 1987, VIROLOGY, V159, P389, DOI 10.1016/0042-6822(87)90478-8; Ferber MJ, 2003, ONCOGENE, V22, P7233, DOI 10.1038/sj.onc.1207006; Oliveira AG, 2013, CLIN MICROBIOL INFEC, V19, pE447, DOI 10.1111/1469-0691.12233; Hudelist G, 2004, GYNECOL ONCOL, V92, P873, DOI 10.1016/j.ygyno.2003.11.035; Kalantari M, 2001, DIAGN MOL PATHOL, V10, P46, DOI 10.1097/00019606-200103000-00008; Klaes R, 1999, CANCER RES, V59, P6132; Lawson ARJ, 2011, GENOME RES, V21, P505, DOI 10.1101/gr.115782.110; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Li WY, 2013, GENOMICS, V102, P338, DOI 10.1016/j.ygeno.2013.07.002; Luft F, 2001, INT J CANCER, V92, P9, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1144>3.0.CO;2-L; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Peter M, 2006, ONCOGENE, V25, P5985, DOI 10.1038/sj.onc.1209625; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; Schmitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039632; Schmitz M, 2012, INT J CANCER, V131, pE593, DOI 10.1002/ijc.27433; Shi YY, 2013, NAT GENET, V45, P918, DOI 10.1038/ng.2687; Stanley MA, 2007, BIOCHEM SOC T, V35, P1456, DOI 10.1042/BST0351456; Thorland EC, 2000, CANCER RES, V60, P5916; Verdin H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003358; Wentzensen N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009; Xu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066693; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	30	272	294	7	144	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2015	47	2					158	163		10.1038/ng.3178	http://dx.doi.org/10.1038/ng.3178			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA1TQ	25581428				2022-12-17	WOS:000348694700011
J	Olcaydu, D; Harutyunyan, A; Jager, R; Berg, T; Gisslinger, B; Pabinger, I; Gisslinger, H; Kralovics, R				Olcaydu, Damla; Harutyunyan, Ashot; Jaeger, Roland; Berg, Tiina; Gisslinger, Bettina; Pabinger, Ingrid; Gisslinger, Heinz; Kralovics, Robert			A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms	NATURE GENETICS			English	Article							TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; ACTIVATING MUTATION; MYELOID METAPLASIA; GENETIC-VARIATION; DISORDERS; MYELOFIBROSIS; HETEROGENEITY; CANCER; TUMORS	Genome-wide association studies have identified a number of new disease susceptibility loci that represent haplotypes defined by numerous SNPs. SNPs within a disease-associated haplotype are thought to influence either the expression of genes or the sequence of the proteins they encode. In a series of investigations of the JAK2 gene in myeloproliferative neoplasms, we uncovered a new property of haplotypes that can explain their disease association. We observed a nonrandom distribution of the somatic JAK2(V617F) oncogenic mutation between two parental alleles of the JAK2 gene. We identified a haplotype that preferentially acquires JAK2(V617F) and confers susceptibility to myeloproliferative neoplasms. One interpretation of our results is that a certain combination of SNPs may render haplotypes differentially susceptible to somatic mutagenesis. Thus, disease susceptibility loci may harbor somatic mutations that have a role in disease pathogenesis.	[Olcaydu, Damla; Harutyunyan, Ashot; Jaeger, Roland; Berg, Tiina; Kralovics, Robert] Austrian Acad Sci, Ctr Mol Med, A-1010 Vienna, Austria; [Gisslinger, Bettina; Pabinger, Ingrid; Gisslinger, Heinz; Kralovics, Robert] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Blood Coagulat, Vienna, Austria	Austrian Academy of Sciences; Medical University of Vienna	Kralovics, R (corresponding author), Austrian Acad Sci, Ctr Mol Med, A-1010 Vienna, Austria.	robert.kralovics@cemm.oeaw.ac.at	Harutyunyan, Ashot S/M-3528-2014	Harutyunyan, Ashot S/0000-0002-9050-9315; Kralovics, Robert/0000-0002-6997-8539; Jager, Roland/0000-0003-4530-1344	Austrian Academy of Sciences; Austrian Science Fund [P20033-B11]; Medical University of Vienna	Austrian Academy of Sciences; Austrian Science Fund(Austrian Science Fund (FWF)); Medical University of Vienna	The study was supported by funding from the Austrian Academy of Sciences, Austrian Science Fund (FWF, P20033-B11) and the Initiative for Cancer Research of the Medical University of Vienna. We thank C. Ay and N. Bachhofner for help with sample collection and T. Burkard for advice on statistical analysis. We thank H. Pickersgill for help with the manuscript.	Agaiwy A, 2008, AM J SURG PATHOL, V32, P1553, DOI 10.1097/PAS.0b013e31817587ea; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kralovics R, 2008, LEUKEMIA, V22, P1841, DOI 10.1038/leu.2008.233; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kralovics R, 2006, BLOOD, V108, P1377, DOI 10.1182/blood-2005-11-009605; Laghi L, 2001, BRIT J CANCER, V84, P196, DOI 10.1054/bjoc.2000.1560; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; LEVI S, 1991, CANCER RES, V51, P3497; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Li S, 2008, BLOOD, V111, P3863, DOI 10.1182/blood-2007-09-111971; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Mechanic LE, 2007, CANCER EPIDEM BIOMAR, V16, P214, DOI 10.1158/1055-9965.EPI-06-0790; Moskaluk CA, 1997, CANCER RES, V57, P2140; Pardanani A, 2008, BLOOD, V111, P2785, DOI 10.1182/blood-2007-06-095703; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Plo I, 2008, BLOOD, V112, P1402, DOI 10.1182/blood-2008-01-134114; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; SOZZI G, 1995, CANCER RES, V55, P135	22	272	280	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					450	454		10.1038/ng.341	http://dx.doi.org/10.1038/ng.341			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19287385				2022-12-17	WOS:000264659000019
J	Cong, B; Barrero, LS; Tanksley, SD				Cong, Bin; Barrero, Luz S.; Tanksley, Steven D.			Regulatory change in YABBY-like transcription factor led to evolution of extreme fruit size during tomato domestication	NATURE GENETICS			English	Article							FLOWER DEVELOPMENT; LYCOPERSICON; EXPRESSION; PLANTS; CROSS; RICE; GENE	Plant domestication represents an accelerated form of evolution, resulting in exaggerated changes in the tissues and organs of greatest interest to humans ( for example, seeds, roots and tubers). One of the most extreme cases has been the evolution of tomato fruit. Cultivated tomato plants produce fruit as much as 1,000 times larger than those of their wild progenitors. Quantitative trait mapping studies have shown that a relatively small number of genes were involved in this dramatic transition, and these genes control two processes: cell cycle and organ number determination(1). The key gene in the first process has been isolated and corresponds to fw2.2, a negative regulator of cell division(2,3). However, until now, nothing was known about the molecular basis of the second process. Here, we show that the second major step in the evolution of extreme fruit size was the result of a regulatory change of a YABBY-like transcription factor (fasciated) that controls carpel number during flower and/or fruit development.	[Cong, Bin; Barrero, Luz S.; Tanksley, Steven D.] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA; [Cong, Bin; Barrero, Luz S.; Tanksley, Steven D.] Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Tanksley, SD (corresponding author), Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA.	sdt4@cornell.edu						Barrero LS, 2004, THEOR APPL GENET, V109, P669, DOI 10.1007/s00122-004-1676-y; COEN ES, 1990, CELL, V63, P1311, DOI 10.1016/0092-8674(90)90426-F; Cong B, 2002, P NATL ACAD SCI USA, V99, P13606, DOI 10.1073/pnas.172520999; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; ESHED Y, 1995, GENETICS, V141, P1147; Fourquin C, 2005, P NATL ACAD SCI USA, V102, P4649, DOI 10.1073/pnas.0409577102; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Jang S, 2004, PLANT MOL BIOL, V56, P133, DOI 10.1007/s11103-004-2648-y; Jones Jonathan D. G., 1992, Transgenic Research, V1, P285, DOI 10.1007/BF02525170; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lippman Z, 2001, GENETICS, V158, P413; Nesbitt TC, 2002, GENETICS, V162, P365; ROE JL, 1993, CELL, V75, P939, DOI 10.1016/0092-8674(93)90537-Z; Tanksley SD, 2004, PLANT CELL, V16, pS181, DOI 10.1105/tpc.018119	17	272	302	9	170	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2008	40	6					800	804		10.1038/ng.144	http://dx.doi.org/10.1038/ng.144			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18469814				2022-12-17	WOS:000256212000024
J	Sandhu, MS; Weedon, MN; Fawcett, KA; Wasson, J; Debenham, SL; Daly, A; Lango, H; Frayling, TM; Neumann, RJ; Sherva, R; Blech, I; Pharoah, PD; Palmer, CNA; Kimber, C; Tavendale, R; Morris, AD; McCarthy, MI; Walker, M; Hitman, G; Glaser, B; Permutt, MA; Hattersley, AT; Wareham, NJ; Barroso, I				Sandhu, Manjinder S.; Weedon, Michael N.; Fawcett, Katherine A.; Wasson, Jon; Debenham, Sally L.; Daly, Allan; Lango, Hana; Frayling, Timothy M.; Neumann, Rosalind J.; Sherva, Richard; Blech, Ilana; Pharoah, Paul D.; Palmer, Colin N. A.; Kimber, Charlotte; Tavendale, Roger; Morris, Andrew D.; McCarthy, Mark I.; Walker, Mark; Hitman, Graham; Glaser, Benjamin; Permutt, M. Alan; Hattersley, Andrew T.; Wareham, Nicholas J.; Barroso, Ines			Common variants in WFS1 confer risk of type 2 diabetes	NATURE GENETICS			English	Article							ENDOPLASMIC-RETICULUM STRESS; NUCLEAR FACTOR-4-ALPHA GENE; BETA-CELL LOSS; TRANSMEMBRANE PROTEIN; OPTIC ATROPHY; E23K VARIANT; POLYMORPHISM; ASSOCIATION; MELLITUS	We studied genes involved in pancreatic beta cell function and survival, identifying associations between SNPs in WFS1 and diabetes risk in UK populations that we replicated in an Ashkenazi population and in additional UK studies. In a pooled analysis comprising 9,533 cases and 11,389 controls, SNPs in WFS1 were strongly associated with diabetes risk. Rare mutations in WFS1 cause Wolfram syndrome; using a gene-centric approach, we show that variation in WFS1 also predisposes to common type 2 diabetes.	UK Med Res Council, Epidemiol Unit, Strangeways Res Lab, Cambridge CB1 8RN, England; Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England; Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX1 2LU, Devon, England; Wellcome Trust Sanger Inst, Metab Dis Grp, Cambridge CB10 1SA, England; Washington Univ, Sch Med, St Louis, MO 63110 USA; Hadassah Hebrew Univ, Med Ctr, Endocrine & Metab Serv, IL-91120 Jerusalem, Israel; Univ Cambridge, Strangeways Res Lab, Dept Oncol, Canc Res UK, Cambridge CB1 8RN, England; Univ Dundee, Ninewells Hosp & Med Sch, Div Med & Therapeut, Diabet Res Grp, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Populat Pharmacogenet Grp, Biomed Res Ctr, Dundee DD1 9SY, Scotland; Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Newcastle, Sch Clin Med Sci, Diabet Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ London, Queen Marys Sch Med & Dent, Ctr Diabet & Metab Med, London E1 1BB, England	University of Cambridge; University of Cambridge; University of Exeter; Wellcome Trust Sanger Institute; Washington University (WUSTL); Hebrew University of Jerusalem; Hadassah University Medical Center; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Dundee; University of Dundee; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Newcastle University - UK; University of London; Queen Mary University London	Sandhu, MS (corresponding author), UK Med Res Council, Epidemiol Unit, Strangeways Res Lab, Cambridge CB1 8RN, England.	manj.sandhu@srl.cam.ac.uk; ib1@sanger.ac.uk	Study, GoDARTS/K-9448-2016; Pharoah, Paul/V-6658-2019; Glaser, Benjamin/F-8411-2017; Allen, Hana Lango/G-9026-2012; Palmer, Colin NA/C-7053-2008; Morris, Andrew D/C-2837-2009; McCarthy, Mark/M-3763-2015	Pharoah, Paul/0000-0001-8494-732X; Glaser, Benjamin/0000-0003-4711-5000; Allen, Hana Lango/0000-0002-7803-8688; Palmer, Colin NA/0000-0002-6415-6560; Hattersley, Andrew/0000-0001-5620-473X; Weedon, Michael/0000-0002-6174-6135; Fawcett, Katherine/0000-0002-6675-2112; Barroso, Ines/0000-0001-5800-4520; Ricketts, Sally/0000-0002-5644-7958; Sherva, Richard/0000-0003-2133-1493; McCarthy, Mark/0000-0002-4393-0510	MRC [G0500070] Funding Source: UKRI; Medical Research Council [MC_U106179471, G0500070] Funding Source: Medline; Wellcome Trust [077016, 068545/z/02] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Ishihara H, 2004, HUM MOL GENET, V13, P1159, DOI 10.1093/hmg/ddh125; KARASIK A, 1989, DIABETES CARE, V12, P135, DOI 10.2337/diacare.12.2.135; Love-Gregory LD, 2004, DIABETES, V53, P1134, DOI 10.2337/diabetes.53.4.1134; Minton JAL, 2002, DIABETES, V51, P1287, DOI 10.2337/diabetes.51.4.1287; Nielsen EMD, 2003, DIABETES, V52, P573, DOI 10.2337/diabetes.52.2.573; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Riggs AC, 2005, DIABETOLOGIA, V48, P2313, DOI 10.1007/s00125-005-1947-4; Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141; Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081	14	272	281	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2007	39	8					951	953		10.1038/ng2067	http://dx.doi.org/10.1038/ng2067			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17603484	Green Accepted			2022-12-17	WOS:000248446900007
J	Windpassinger, C; Auer-Grumbach, M; Irobi, J; Patel, H; Petek, E; Horl, G; Malli, R; Reed, JA; Dierick, I; Verpoorten, N; Warner, TT; Proukakis, C; Van den Bergh, P; Verellen, C; Van Maldergem, L; Merlini, L; De Jonghe, P; Timmerman, V; Crosby, AH; Wagner, K				Windpassinger, C; Auer-Grumbach, M; Irobi, J; Patel, H; Petek, E; Horl, G; Malli, R; Reed, JA; Dierick, I; Verpoorten, N; Warner, TT; Proukakis, C; Van den Bergh, P; Verellen, C; Van Maldergem, L; Merlini, L; De Jonghe, P; Timmerman, V; Crosby, AH; Wagner, K			Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome	NATURE GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; CHROMOSOME 11Q12-Q14; AGGRESOME FORMATION; SPASTIC PARAPLEGIA; HETEROGENEITY	Distal hereditary motor neuropathy (dHMN) or distal spinal muscular atrophy (OMIM #182960) is a heterogeneous group of disorders characterized by an almost exclusive degeneration of motor nerve fibers, predominantly in the distal part of the limbs(1). Silver syndrome (OMIM #270685) is a rare form of hereditary spastic paraparesis mapped to chromosome 11q12q14 (SPG17) in which spasticity of the legs is accompanied by amyotrophy of the hands and occasionally also the lower limbs(2,3). Silver syndrome and most forms of dHMN are autosomal dominantly inherited with incomplete penetrance and a broad variability in clinical expression. A genome-wide scan in an Austrian family with dHMN-V (ref. 4) showed linkage to the locus SPG17, which was confirmed in 16 additional families with a phenotype characteristic of dHMN or Silver syndrome. After refining the critical region to 1 Mb, we sequenced the gene Berardinelli-Seip congenital lipodystrophy (BSCL2) and identified two heterozygous missense mutations resulting in the amino acid substitutions N88S and S90L. Null mutations in BSCL2, which encodes the protein seipin, were previously shown to be associated with autosomal recessive Berardinelli-Seip congenital lipodystrophy 5 (OMIM #269700). We show that seipin is an integral membrane protein of the endoplasmic reticulum (ER). The amino acid substitutions N88S and S90L affect glycosylation of seipin and result in aggregate formation leading to neurodegeneration.	Med Univ Graz, Inst Med Biol & Human Genet, A-8010 Graz, Austria; Univ Antwerp VIB, Dept Mol Genet, B-2020 Antwerp, Belgium; Univ London St Georges Hosp, Sch Med, Div Med Genet, London SW17 0RE, England; Med Univ Graz, Dept Med Biochem & Med Mol Biol, A-8010 Graz, Austria; UCL Royal Free & Univ Coll Med Sch, Dept Clin Neurosci, London NW3 2PF, England; Univ Louvain, St Luc Univ Hosp, Dept Neurol, Brussels, Belgium; Univ Louvain, St Luc Univ Hosp, Med Genet Unit, Brussels, Belgium; Ctr Human Genet, Inst Pathol & Genet, Loverval, Belgium; Ist Ortoped Rizzoli, Neuromuscular Lab, Bologna, Italy	Medical University of Graz; Flanders Institute for Biotechnology (VIB); University of Antwerp; St Georges University London; Medical University of Graz; University of London; University College London; UCL Medical School; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; IRCCS Istituto Ortopedico Rizzoli	Wagner, K (corresponding author), Med Univ Graz, Inst Med Biol & Human Genet, Harrachgasse 21-8, A-8010 Graz, Austria.	klaus.wagner@meduni-graz.at	Van Maldergem, Lionel/O-3242-2019; Timmerman, Vincent/O-7283-2019; Crosby, Andrew H/E-2218-2015; Van Maldergem, Lionel/G-9849-2017; Proukakis, Christos/G-4548-2013; Malli, Roland/B-7369-2008; Warner, Thomas T/A-1454-2013; proukakis, christos/ABE-3447-2020; Merlini, Luciano/N-6478-2019	Van Maldergem, Lionel/0000-0001-8880-5214; Timmerman, Vincent/0000-0002-2162-0933; Crosby, Andrew H/0000-0003-3667-9054; Van Maldergem, Lionel/0000-0001-8880-5214; Warner, Thomas T/0000-0001-6195-6995; proukakis, christos/0000-0001-6423-6539; Merlini, Luciano/0000-0002-1108-1198; Malli, Roland/0000-0001-6327-8729; Hoerl, Gerd/0000-0002-0884-0851				Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Auer-Grumbach M, 2000, BRAIN, V123, P1612, DOI 10.1093/brain/123.8.1612; CHRISTODOULOU K, 1995, HUM MOL GENET, V4, P1629, DOI 10.1093/hmg/4.9.1629; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; HARDING AE, 1993, SEMIN NEUROL, V13, P333, DOI 10.1055/s-2008-1041143; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lee MJ, 2003, HUM MOL GENET, V12, P1917, DOI 10.1093/hmg/ddg198; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Patel H, 2001, AM J HUM GENET, V69, P209, DOI 10.1086/321267; Ryan MC, 2002, NEUROBIOL DIS, V10, P109, DOI 10.1006/nbdi.2002.0500; Saliba RS, 2002, J CELL SCI, V115, P2907; SILVER JR, 1966, J NEUROL NEUROSUR PS, V29, P135, DOI 10.1136/jnnp.29.2.135; Van Maldergem L, 2002, J MED GENET, V39, P722, DOI 10.1136/jmg.39.10.722; Windpassinger C, 2003, HUM GENET, V114, P99, DOI 10.1007/s00439-003-1021-6	17	272	295	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2004	36	3					271	276		10.1038/ng1313	http://dx.doi.org/10.1038/ng1313			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	14981520	Bronze			2022-12-17	WOS:000189250400016
J	Miao, D; Margolis, CA; Vokes, NI; Liu, D; Taylor-Weiner, A; Wankowicz, SM; Adeegbe, D; Keliher, D; Schilling, B; Tracy, A; Manos, M; Chau, NG; Hanna, GJ; Polak, P; Rodig, SJ; Signoretti, S; Sholl, LM; Engelman, JA; Getz, G; Janne, PA; Haddad, RI; Choueiri, TK; Barbie, DA; Haq, R; Awad, MM; Schadendorf, D; Hodi, FS; Bellmunt, J; Wong, KK; Hammerman, P; Van Allen, EM				Miao, Diana; Margolis, Claire A.; Vokes, Natalie I.; Liu, David; Taylor-Weiner, Amaro; Wankowicz, Stephanie M.; Adeegbe, Dennis; Keliher, Daniel; Schilling, Bastian; Tracy, Adam; Manos, Michael; Chau, Nicole G.; Hanna, Glenn J.; Polak, Paz; Rodig, Scott J.; Signoretti, Sabina; Sholl, Lynette M.; Engelman, Jeffrey A.; Getz, Gad; Janne, Pasi A.; Haddad, Robert I.; Choueiri, Toni K.; Barbie, David A.; Haq, Rizwan; Awad, Mark M.; Schadendorf, Dirk; Hodi, F. Stephen; Bellmunt, Joaquim; Wong, Kwok-Kin; Hammerman, Peter; Van Allen, Eliezer M.			Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors	NATURE GENETICS			English	Article							CELL LUNG-CANCER; PD-1 BLOCKADE; METASTATIC MELANOMA; SOMATIC MUTATIONS; CTLA-4 BLOCKADE; SEQUENCING DATA; RESISTANCE; THERAPY; IMMUNOTHERAPY; EVOLUTION	Tumor mutational burden correlates with response to immune checkpoint blockade in multiple solid tumors, although in microsatellite-stable tumors this association is of uncertain clinical utility. Here we uniformly analyzed whole-exome sequencing (WES) of 249 tumors and matched normal tissue from patients with clinically annotated outcomes to immune checkpoint therapy, including radiographic response, across multiple cancer types to examine additional tumor genomic features that contribute to selective response. Our analyses identified genomic correlates of response beyond mutational burden, including somatic events in individual driver genes, certain global mutational signatures, and specific HLA-restricted neoantigens. However, these features were often interrelated, highlighting the complexity of identifying genetic driver events that generate an immunoresponsive tumor environment. This study lays a path forward in analyzing large clinical cohorts in an integrated and multifaceted manner to enhance the ability to discover clinically meaningful predictive features of response to immune checkpoint blockade.	[Miao, Diana; Margolis, Claire A.; Vokes, Natalie I.; Liu, David; Taylor-Weiner, Amaro; Wankowicz, Stephanie M.; Keliher, Daniel; Manos, Michael; Chau, Nicole G.; Hanna, Glenn J.; Rodig, Scott J.; Signoretti, Sabina; Sholl, Lynette M.; Janne, Pasi A.; Haddad, Robert I.; Choueiri, Toni K.; Barbie, David A.; Haq, Rizwan; Awad, Mark M.; Schadendorf, Dirk; Hodi, F. Stephen; Bellmunt, Joaquim; Wong, Kwok-Kin; Hammerman, Peter; Van Allen, Eliezer M.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Miao, Diana; Margolis, Claire A.; Vokes, Natalie I.; Liu, David; Taylor-Weiner, Amaro; Wankowicz, Stephanie M.; Keliher, Daniel; Tracy, Adam; Polak, Paz; Getz, Gad; Haq, Rizwan; Van Allen, Eliezer M.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Adeegbe, Dennis; Wong, Kwok-Kin] NYU, Langone Med Ctr, Perlmutter Canc Ctr, New York, NY USA; [Schilling, Bastian] Univ Hosp Wurzburg, Dept Dermatol Venereol & Allergol, Wurzburg, Germany; [Rodig, Scott J.; Signoretti, Sabina; Sholl, Lynette M.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Engelman, Jeffrey A.; Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Getz, Gad] Harvard Med Sch, Boston, MA USA; [Schadendorf, Dirk] Univ Duisburg Essen, Univ Hosp, Dept Dermatol, Essen, Germany	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; New York University; NYU Langone Medical Center; University of Wurzburg; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Duisburg Essen	Van Allen, EM (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Van Allen, EM (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	eliezerm_vanallen@dfci.harvard.edu	Bellmunt, Joaquim/B-8151-2019; Nadeem, Sohail/I-5248-2013; Polak, Paz/AAH-9380-2020; Choueiri, Toni/K-5238-2019; Schilling, Bastian/AAY-8646-2020; Rodig, Scott/Y-3889-2019; Liu, David/ABF-1275-2020; Schadendorf, Dirk/AAE-8206-2019	Bellmunt, Joaquim/0000-0003-2328-3421; Nadeem, Sohail/0000-0002-1052-011X; Choueiri, Toni/0000-0002-9201-3217; Schilling, Bastian/0000-0001-8859-4103; Liu, David/0000-0003-0346-5033; Miao, Diana/0000-0003-1754-2319; wong, kwok kin/0000-0001-6323-235X; Wankowicz, Stephanie/0000-0002-4225-7459; Margolis, Claire/0000-0002-1019-2419; Haddad, Robert/0000-0003-1413-0079; Schadendorf, Dirk/0000-0003-3524-7858; Keliher, Daniel/0000-0001-5144-7898	BroadIgnite; BroadNext10; NIH [R01CA227388, K08CA188615]; Howard Hughes Medical Institute Medical Research Fellows Program; Center for Immuno-Oncology at the Dana-Farber Cancer Institute; Stand Up To Cancer-American Cancer Society Lung Cancer Dream Team Translational Research Grant [SU2C- AACR DT17 15SU2C- AACR DT17 15]; American Association for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA166480, K08CA188615, T32CA009172, R01CA140594] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER	BroadIgnite; BroadNext10; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Medical Research Fellows Program(Howard Hughes Medical Institute); Center for Immuno-Oncology at the Dana-Farber Cancer Institute; Stand Up To Cancer-American Cancer Society Lung Cancer Dream Team Translational Research Grant; American Association for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by BroadIgnite (E.M.V.A.), BroadNext10 (E.M.V.A., D.M.), NIH R01CA227388 (E.M.V.A.) and NIH K08CA188615 (E.M.V.A.). D.M. was supported by the Howard Hughes Medical Institute Medical Research Fellows Program. This research was also supported by the Center for Immuno-Oncology at the Dana-Farber Cancer Institute and a Stand Up To Cancer-American Cancer Society Lung Cancer Dream Team Translational Research Grant (SU2C- AACR DT17 15). Stand Up To Cancer (SU2C) is a program of the Entertainment Industry Foundation. Research grants are administered by the American Association for Cancer Research, the scientific partner of SU2C.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Carbognin L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130142; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; Colli LM, 2016, CANCER RES, V76, P3767, DOI 10.1158/0008-5472.CAN-16-0170; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Gao JJ, 2017, GENOME MED, V9, DOI 10.1186/s13073-016-0393-x; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Garofalo A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0333-9; George S, 2017, IMMUNITY, V46, P197, DOI 10.1016/j.immuni.2017.02.001; Gettinger S, 2016, J CLIN ONCOL, V34, P2980, DOI 10.1200/JCO.2016.66.9929; Goel S, 2017, NATURE, V548, P471, DOI 10.1038/nature23465; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Henderson S, 2014, CELL REP, V7, P1833, DOI 10.1016/j.celrep.2014.05.012; Hodges C, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026930; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Johnson DB, 2015, CANCER IMMUNOL RES, V3, P288, DOI 10.1158/2326-6066.CIR-14-0207; Kato S, 2017, CLIN CANCER RES, V23, P4242, DOI 10.1158/1078-0432.CCR-16-3133; Kim J, 2016, NAT GENET, V48, P600, DOI 10.1038/ng.3557; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Miao D, 2018, SCIENCE, V359, P801, DOI 10.1126/science.aan5951; Mouw KW, 2017, CLIN CANCER RES, V23, P3214, DOI 10.1158/1078-0432.CCR-16-2017; Mullane SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep27702; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Nielsen M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0288-x; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Pan D, 2018, SCIENCE, V359, P770, DOI 10.1126/science.aao1710; Peng WY, 2016, CANCER DISCOV, V6, P202, DOI 10.1158/2159-8290.CD-15-0283; Riaz N, 2016, NAT GENET, V48, P1327, DOI 10.1038/ng.3677; Rizvi H, 2018, J CLIN ONCOL, V36, P633, DOI 10.1200/JCO.2017.75.3384; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Roh W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3560; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Sade-Feldman M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01062-w; Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Sharma P, 2016, CANCER J, V22, P68, DOI 10.1097/PPO.0000000000000185; Shukla SA, 2015, NAT BIOTECHNOL, V33, P1152, DOI 10.1038/nbt.3344; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Sucker A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15440; Taylor-Weiner A, 2018, NAT METHODS, V15, P531, DOI 10.1038/s41592-018-0036-9; Topalian SL, 2016, NAT REV CANCER, V16, P275, DOI 10.1038/nrc.2016.36; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Van Allen EM, 2015, CANCER IMMUNOL RES, V3, P855, DOI 10.1158/2326-6066.CIR-15-0024; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	62	271	275	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2018	50	9					1271	+		10.1038/s41588-018-0200-2	http://dx.doi.org/10.1038/s41588-018-0200-2			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GS0CH	30150660	Green Accepted			2022-12-17	WOS:000443151300018
J	So, LH; Ghosh, A; Zong, CH; Sepulveda, LA; Segev, R; Golding, I				So, Lok-Hang; Ghosh, Anandamohan; Zong, Chenghang; Sepulveda, Leonardo A.; Segev, Ronen; Golding, Ido			General properties of transcriptional time series in Escherichia coli	NATURE GENETICS			English	Article							PROTEIN EXPRESSION; SINGLE-CELL; NOISE; MOLECULE; DYNAMICS; REVEALS; STOCHASTICITY; NETWORK; ELONGATION; INITIATION	Gene activity is described by the time series of discrete, stochastic mRNA production events. This transcriptional time series shows intermittent, bursty behavior. One consequence of this temporal intricacy is that gene expression can be tuned by varying different features of the time series. Here we quantify copy-number statistics of mRNA from 20 Escherichia coli promoters using single-molecule fluorescence in situ hybridization in order to characterize the general properties of these transcriptional time series. We find that the degree of burstiness is correlated with gene expression level but is largely independent of other parameters of gene regulation. The observed behavior can be explained by the underlying variation in the duration of bursting events. Using Shannon's mutual information function, we estimate the mutual information transmitted between an outside stimulus, such as the extracellular concentration of inducer molecules, and intracellular levels of mRNA. This suggests that the outside stimulus transmits information reflected in the properties of transcriptional time series.	[So, Lok-Hang; Sepulveda, Leonardo A.; Golding, Ido] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [So, Lok-Hang; Zong, Chenghang; Golding, Ido] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Ghosh, Anandamohan; Segev, Ronen] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Ghosh, Anandamohan; Segev, Ronen] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Sepulveda, Leonardo A.; Golding, Ido] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Golding, Ido] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA	Baylor College of Medicine; University of Illinois System; University of Illinois Urbana-Champaign; Ben Gurion University; Ben Gurion University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Golding, I (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	igolding@illinois.edu	Sepúlveda, Leonardo A./AAL-3981-2020; SEGEV, RONEN/F-1550-2012; Zong, Chenghang/F-3243-2013	Sepúlveda, Leonardo A./0000-0003-3602-1009; Segev, Ronen/0000-0002-8109-1076; Zong, Chenghang/0000-0002-8337-8038	US National Institutes of Health [R01GM082837]; National Science Foundation [082265]; Human Frontier Science Program [RGY 70/2008]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082837] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to S. Adhya, W. Boos, M. Cashel, V. Chakravartty, L. Chubiz, D. Court, J. Cronan, M. Dreyfus, M. Elowitz, Y. Feng, H. Garcia, T. Hwa, J. Imlay, S. Jang, T. Kuhlman, J. Little, A. van Oudenaarden, A. Raj, C. Rao, R. Milo, V. Shahrezaei, A. Sokac and P. Swain for advice and for providing reagents. We thank members of the Golding laboratory for providing help with experiments. We thank H. Garcia, J. Kondev, R. Phillips, A. Raj, A. Sanchez, S. Sawai and G. Tkacik for commenting on earlier versions of the manuscript. Work in the Golding laboratory was supported by grants from US National Institutes of Health (R01GM082837) and the National Science Foundation (082265, PFC: Center for the Physics of Living Cells). Work in the Segev and Golding laboratories was supported by a joint grant from the Human Frontier Science Program (RGY 70/2008).	Abdel-Hamid AM, 2007, J BACTERIOL, V189, P369, DOI 10.1128/JB.01373-06; Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; Alon U., 2020, An introduction to systems biology: design principles of biological circuits ed., V2nd edn, P249; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; BARKER DF, 1980, J BACTERIOL, V143, P789, DOI 10.1128/JB.143.2.789-800.1980; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Chubb JR, 2010, CURR OPIN GENET DEV, V20, P478, DOI 10.1016/j.gde.2010.06.009; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Cox CD, 2008, P NATL ACAD SCI USA, V105, P10809, DOI 10.1073/pnas.0804829105; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Dobrzynski M, 2009, P NATL ACAD SCI USA, V106, P2583, DOI 10.1073/pnas.0803507106; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fang FC, 2005, P NATL ACAD SCI USA, V102, P4933, DOI 10.1073/pnas.0501417102; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Garcia HG, 2010, TRENDS CELL BIOL, V20, P723, DOI 10.1016/j.tcb.2010.07.002; Geva-Zatorsky N, 2010, CELL, V140, P643, DOI 10.1016/j.cell.2010.02.011; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goh KI, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48002; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Golding I, 2006, CURR BIOL, V16, pR371, DOI 10.1016/j.cub.2006.04.014; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; HERNANDEZ VJ, 1990, J BIOL CHEM, V265, P11605; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kaufmann BB, 2007, PLOS BIOL, V5, P1973, DOI 10.1371/journal.pbio.0050239; KENNELL D, 1977, J MOL BIOL, V114, P1, DOI 10.1016/0022-2836(77)90279-0; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kittisopikul M, 2010, P NATL ACAD SCI USA, V107, P13300, DOI 10.1073/pnas.1003975107; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Liang ST, 1999, J MOL BIOL, V292, P19, DOI 10.1006/jmbi.1999.3056; LIM WA, 1989, NATURE, V339, P31, DOI 10.1038/339031a0; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mao CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.83; Michalowski CB, 2005, J BACTERIOL, V187, P6430, DOI 10.1128/JB.187.18.6430-6442.2005; Mitarai N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000109; Mooney RA, 2009, MOL CELL, V33, P97, DOI 10.1016/j.molcel.2008.12.021; Neidhardt F., 1987, ESCHERICHIA COLI SAL; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Pare A, 2009, CURR BIOL, V19, P2037, DOI 10.1016/j.cub.2009.10.028; Paulsson J, 2000, PHYS REV LETT, V84, P5447, DOI 10.1103/PhysRevLett.84.5447; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Potrykus K, 2006, J BIOL CHEM, V281, P15238, DOI 10.1074/jbc.M601531200; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Sauer R T, 1990, Adv Protein Chem, V40, P1, DOI 10.1016/S0065-3233(08)60286-7; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Simpson ML, 2004, J THEOR BIOL, V229, P383, DOI 10.1016/j.jtbi.2004.04.017; Singh A, 2010, BIOPHYS J, V98, pL32, DOI 10.1016/j.bpj.2010.03.001; Singh D, 2009, P NATL ACAD SCI USA, V106, P864, DOI 10.1073/pnas.0810205106; Tan RZ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.14; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Tkacik G, 2008, P NATL ACAD SCI USA, V105, P12265, DOI 10.1073/pnas.0806077105; Tkacik G, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031920; TOKESON JPE, 1991, J BACTERIOL, V173, P2319, DOI 10.1128/JB.173.7.2319-2327.1991; van Zon JS, 2006, BIOPHYS J, V91, P4350, DOI 10.1529/biophysj.106.086157; WEICKERT MJ, 1993, MOL MICROBIOL, V10, P245, DOI 10.1111/j.1365-2958.1993.tb01950.x; Whitelaw NC, 2010, DEV CELL, V19, P649, DOI 10.1016/j.devcel.2010.11.001; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Yunger S, 2010, NAT METHODS, V7, P631, DOI [10.1038/NMETH.1482, 10.1038/nmeth.1482]; Zeng LY, 2010, CELL, V141, P682, DOI 10.1016/j.cell.2010.03.034; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zong CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.96	75	271	273	0	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2011	43	6					554	U84		10.1038/ng.821	http://dx.doi.org/10.1038/ng.821			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21532574	Green Accepted			2022-12-17	WOS:000291017000012
J	Calvo, SE; Tucker, EJ; Compton, AG; Kirby, DM; Crawford, G; Burtt, NP; Rivas, M; Guiducci, C; Bruno, DL; Goldberger, OA; Redman, MC; Wiltshire, E; Wilson, CJ; Altshuler, D; Gabriel, SB; Daly, MJ; Thorburn, DR; Mootha, VK				Calvo, Sarah E.; Tucker, Elena J.; Compton, Alison G.; Kirby, Denise M.; Crawford, Gabriel; Burtt, Noel P.; Rivas, Manuel; Guiducci, Candace; Bruno, Damien L.; Goldberger, Olga A.; Redman, Michelle C.; Wiltshire, Esko; Wilson, Callum J.; Altshuler, David; Gabriel, Stacey B.; Daly, Mark J.; Thorburn, David R.; Mootha, Vamsi K.			High-throughput, pooled sequencing identifies mutations in NUBPL and FOXRED1 in human complex I deficiency	NATURE GENETICS			English	Article							RESPIRATORY-CHAIN DISORDERS; NONSENSE MUTATION; MITOCHONDRIAL-DNA; NDUFS4 GENE; DATABASE; CRITERIA; CAPTURE; PATIENT	Discovering the molecular basis of mitochondrial respiratory chain disease is challenging given the large number of both mitochondrial and nuclear genes that are involved. We report a strategy of focused candidate gene prediction, high-throughput sequencing and experimental validation to uncover the molecular basis of mitochondrial complex I disorders. We created seven pools of DNA from a cohort of 103 cases and 42 healthy controls and then performed deep sequencing of 103 candidate genes to identify 151 rare variants that were predicted to affect protein function. We established genetic diagnoses in 13 of 60 previously unsolved cases using confirmatory experiments, including cDNA complementation to show that mutations in NUBPL and FOXRED1 can cause complex I deficiency. Our study illustrates how large-scale sequencing, coupled with functional prediction and experimental validation, can be used to identify causal mutations in individual cases.	[Calvo, Sarah E.; Rivas, Manuel; Goldberger, Olga A.; Altshuler, David; Daly, Mark J.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Calvo, Sarah E.; Goldberger, Olga A.; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Calvo, Sarah E.; Crawford, Gabriel; Burtt, Noel P.; Rivas, Manuel; Guiducci, Candace; Redman, Michelle C.; Altshuler, David; Gabriel, Stacey B.; Daly, Mark J.; Mootha, Vamsi K.] Harvard & MIT, Broad Inst, Cambridge, MA USA; [Tucker, Elena J.; Compton, Alison G.; Kirby, Denise M.; Bruno, Damien L.; Thorburn, David R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Tucker, Elena J.; Compton, Alison G.; Kirby, Denise M.; Bruno, Damien L.; Thorburn, David R.] Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic, Australia; [Tucker, Elena J.; Thorburn, David R.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Wiltshire, Esko] Univ Otago Wellington, Dept Paediat & Child Hlth, Wellington, New Zealand; [Wiltshire, Esko] Capital & Coast Dist Hlth Board, Cent Reg Genet Serv, Wellington, New Zealand; [Wilson, Callum J.] Starship Childrens Hosp, Natl Metab Serv, Auckland, New Zealand; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; University of Otago; Starship Children's Hospital; Harvard University; Harvard Medical School	Mootha, VK (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	david.thorburn@mcri.edu.au; vamsi@hms.harvard.edu	Tucker, Elena J/B-3487-2012; Daly, Mark J/B-2453-2017; Bruno, Damien L/C-3665-2013; Altshuler, David M/A-4476-2009; Thorburn, David R/G-6266-2013; Rivas, Manuel/ABE-8173-2020	Daly, Mark J/0000-0002-0949-8752; Altshuler, David M/0000-0002-7250-4107; Rivas, Manuel/0000-0003-1457-9925; Compton, Alison/0000-0002-2725-7055; Tucker, Elena/0000-0002-6380-5100; thorburn, david/0000-0002-7725-9470; Wiltshire, Esko/0000-0002-8962-2708	Australian National Health & Medical Research Council [436901]; Australian Postgraduate Award; US National Institutes of Health [GM077465]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077465] Funding Source: NIH RePORTER	Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Tregoning, A. Laskowski and S. Smith for assistance with enzyme assays and DNA preparation, M. McKenzie and M. Ryan for the NDUFAF2 antibody, J. Boehm for the lentiviral expression vector, S. Flynn for assistance with human subjects protocols, R. Onofrio for designing PCR primers, K. Ardlie and S. Mahan for assistance in DNA sample preparation, J. Wilkinson and L. Ambrogio for Illumina sequence project management, T. Fennel for sequence alignment, L. Ziaugra for genotyping assistance, M. Cabili for tool evaluation, J. Flannick for assistance with pooled sequence analysis, I. Adzhubei and S. Sunyaev for PolyPhen-2.0 predictions, M. DePristo, E. Banks and A. Sivachenko for advice on sequence data analysis, M. Garber for assistance with evolutionary conservation analyses, J. Pirruccello, R. Do and S. Kathiresan for data and analysis of control data, and the many physicians who referred subjects and assisted with these studies. This work was supported by a grant (436901) and Principal Research Fellowship from the Australian National Health & Medical Research Council awarded to D. R. T., an Australian Postgraduate Award to E. J. T. and a grant from the US National Institutes of Health (GM077465) to V. K. M. The authors wish to dedicate this article to the memory of our co-author Denise Kirby, an outstanding scientist and dear colleague who died during the preparation of this manuscript.	ANDERSON SL, 2009, J INHERIT METAB DIS, V32, P121; Benit P, 2003, HUM GENET, V112, P563, DOI 10.1007/s00439-002-0884-2; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00; Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257; Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006; Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002; Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368; Dimmic Matthew W, 2005, Pac Symp Biocomput, P382; Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Karolchik Donna, 2009, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0104s28; Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255; Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683; Lamande SR, 1998, HUM MOL GENET, V7, P981, DOI 10.1093/hmg/7.6.981; Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015; Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896; Leshinsky-Silver E, 2009, MOL GENET METAB, V97, P185, DOI 10.1016/j.ymgme.2009.03.002; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Petruzzella V, 2001, HUM MOL GENET, V10, P529, DOI 10.1093/hmg/10.5.529; Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020; Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Smeitink J, 2001, J BIOENERG BIOMEMBR, V33, P259, DOI 10.1023/A:1010743321800; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001; van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716	51	271	302	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2010	42	10					851	+		10.1038/ng.659	http://dx.doi.org/10.1038/ng.659			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	655UO	20818383	Green Accepted			2022-12-17	WOS:000282276600014
J	Raychaudhuri, S; Thomson, BP; Remmers, EF; Eyre, S; Hinks, A; Guiducci, C; Catanese, JJ; Xie, G; Stahl, EA; Chen, R; Alfredsson, L; Amos, CI; Ardlie, KG; Barton, A; Bowes, J; Burtt, NP; Chang, M; Coblyn, J; Costenbader, KH; Criswell, LA; Crusius, JBA; Cui, J; De Jager, PL; Ding, B; Emery, P; Flynn, E; Harrison, P; Hocking, LJ; Huizinga, TWJ; Kastner, DL; Ke, XY; Kurreeman, FAS; Lee, AT; Liu, XD; Li, YH; Martin, P; Morgan, AW; Padyukov, L; Reid, DM; Seielstad, M; Seldin, MF; Shadick, NA; Steer, S; Tak, PP; Thomson, W; van der Helm-van Mil, AHM; van der Horst-Bruinsma, IE; Weinblatt, ME; Wilson, AG; Wolbink, GJ; Wordsworth, P; Altshuler, D; Karlson, EW; Toes, REM; de Vries, N; Begovich, AB; Siminovitch, KA; Worthington, J; Klareskog, L; Gregersen, PK; Daly, MJ; Plenge, RM				Raychaudhuri, Soumya; Thomson, Brian P.; Remmers, Elaine F.; Eyre, Stephen; Hinks, Anne; Guiducci, Candace; Catanese, Joseph J.; Xie, Gang; Stahl, Eli A.; Chen, Robert; Alfredsson, Lars; Amos, Christopher I.; Ardlie, Kristin G.; Barton, Anne; Bowes, John; Burtt, Noel P.; Chang, Monica; Coblyn, Jonathan; Costenbader, Karen H.; Criswell, Lindsey A.; Crusius, J. Bart A.; Cui, Jing; De Jager, Phillip L.; Ding, Bo; Emery, Paul; Flynn, Edward; Harrison, Pille; Hocking, Lynne J.; Huizinga, Tom W. J.; Kastner, Daniel L.; Ke, Xiayi; Kurreeman, Fina A. S.; Lee, Annette T.; Liu, Xiangdong; Li, Yonghong; Martin, Paul; Morgan, Ann W.; Padyukov, Leonid; Reid, David M.; Seielstad, Mark; Seldin, Michael F.; Shadick, Nancy A.; Steer, Sophia; Tak, Paul P.; Thomson, Wendy; van der Helm-van Mil, Annette H. M.; van der Horst-Bruinsma, Irene E.; Weinblatt, Michael E.; Wilson, Anthony G.; Wolbink, Gert Jan; Wordsworth, Paul; Altshuler, David; Karlson, Elizabeth W.; Toes, Rene E. M.; de Vries, Niek; Begovich, Ann B.; Siminovitch, Katherine A.; Worthington, Jane; Klareskog, Lars; Gregersen, Peter K.; Daly, Mark J.; Plenge, Robert M.		BIRAC Consortium; Consortium, Y	Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISM; MULTIPLE-SCLEROSIS; SUSCEPTIBILITY LOCI; CELIAC-DISEASE; PTPN22; REPLICATION; PTPRC; CD45; MUTATION	To discover new rheumatoid arthritis (RA) risk loci, we systematically examined 370 SNPs from 179 independent loci with P < 0.001 in a published meta-analysis of RA genome-wide association studies (GWAS) of 3,393 cases and 12,462 controls(1). We used Gene Relationships Across Implicated Loci (GRAIL)(2), a computational method that applies statistical text mining to PubMed abstracts, to score these 179 loci for functional relationships to genes in 16 established RA disease loci(1,3-11). We identified 22 loci with a significant degree of functional connectivity. We genotyped 22 representative SNPs in an independent set of 7,957 cases and 11,958 matched controls. Three were convincingly validated: CD2-CD58 (rs11586238, P = 1 x 10(-6) replication, P = 1 x 10(-9) overall), CD28 (rs1980422, P = 5 x 10(-6) replication, P = 1 x 10(-9) overall) and PRDM1 (rs548234, P = 1 x 10(-5) replication, P = 2 x 10(-8) overall). An additional four were replicated (P < 0.0023): TAGAP (rs394581, P = 0.0002 replication, P = 4 x 10(-7) overall), PTPRC (rs10919563, P = 0.0003 replication, P = 7 x 10(-7) overall), TRAF6-RAG1 (rs540386, P = 0.0008 replication, P = 4 x 10(-6) overall) and FCGR2A (rs12746613, P = 0.0022 replication, P = 2 x 10(-5) overall). Many of these loci are also associated to other immunologic diseases.	[Raychaudhuri, Soumya; Stahl, Eli A.; Chen, Robert; Coblyn, Jonathan; Costenbader, Karen H.; Cui, Jing; Kurreeman, Fina A. S.; Shadick, Nancy A.; Weinblatt, Michael E.; Karlson, Elizabeth W.; Plenge, Robert M.] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Raychaudhuri, Soumya; Thomson, Brian P.; Guiducci, Candace; Ardlie, Kristin G.; Burtt, Noel P.; De Jager, Phillip L.; Altshuler, David; Daly, Mark J.; Plenge, Robert M.] Broad Inst, Cambridge, MA USA; [Raychaudhuri, Soumya; Altshuler, David; Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Remmers, Elaine F.; Kastner, Daniel L.] NIAMSD, Genet & Genom Branch, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Eyre, Stephen; Hinks, Anne; Barton, Anne; Bowes, John; Flynn, Edward; Ke, Xiayi; Martin, Paul; Thomson, Wendy; Worthington, Jane] Univ Manchester, Arthrit Res Campaign Epidemiol Unit, Manchester, Lancs, England; [Catanese, Joseph J.; Chang, Monica; Li, Yonghong; Begovich, Ann B.] Celera, Alameda, CA USA; [Xie, Gang; Liu, Xiangdong; Siminovitch, Katherine A.] Univ Toronto, Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Xie, Gang; Liu, Xiangdong; Siminovitch, Katherine A.] Univ Hlth Network, Toronto, ON, Canada; [Alfredsson, Lars; Ding, Bo] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Houston, TX USA; [Criswell, Lindsey A.] Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA USA; [Crusius, J. Bart A.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Immunogenet Lab, Amsterdam, Netherlands; [De Jager, Phillip L.] Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Boston, MA 02115 USA; [Emery, Paul; Morgan, Ann W.] Univ Leeds, Leeds Inst Mol Med, Natl Inst Hlth Res, Leeds Musculoskeletal Biomed Res Unit, Leeds LS2 9JT, W Yorkshire, England; [Harrison, Pille; Wordsworth, Paul] Univ Oxford, Inst Musculoskeletal Sci, Botnar Res Ctr, Oxford, England; [Hocking, Lynne J.; Reid, David M.] Univ Aberdeen, Div Appl Med, Musculoskeletal & Genet Sect, Aberdeen AB9 1FX, Scotland; [Huizinga, Tom W. J.; Kurreeman, Fina A. S.; van der Helm-van Mil, Annette H. M.; Toes, Rene E. M.] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Lee, Annette T.; Gregersen, Peter K.] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Padyukov, Leonid; Klareskog, Lars] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Seielstad, Mark] Genome Inst Singapore, Singapore, Singapore; [Seldin, Michael F.] Univ Calif Davis, Rowe Program Genet, Davis, CA 95616 USA; [Steer, Sophia] Kings Coll Hosp London, Natl Hlth Serv Fdn Trust, London, England; [Tak, Paul P.; de Vries, Niek] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [van der Horst-Bruinsma, Irene E.] Vrije Univ Amsterdam, Med Ctr, Dept Rheumatol, Amsterdam, Netherlands; [Wilson, Anthony G.] Univ Sheffield, Sch Med & Biomed Sci, Sheffield, S Yorkshire, England; [Wolbink, Gert Jan] Jan van Breemen Inst, Amsterdam, Netherlands; [Wolbink, Gert Jan] Univ Amsterdam, Acad Med Ctr, Sanquin Res Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Begovich, Ann B.] Roche Diagnost, Pleasanton, CA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Manchester; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Karolinska Institutet; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; Vrije Universiteit Amsterdam; Harvard University; Brigham & Women's Hospital; University of Leeds; University of Oxford; University of Aberdeen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Northwell Health; Karolinska Institutet; Karolinska University Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of California System; University of California Davis; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Sheffield; University of Amsterdam; Academic Medical Center Amsterdam; Roche Holding	Raychaudhuri, S (corresponding author), Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, 75 Francis St, Boston, MA 02115 USA.	soumya@broad.mit.edu; rplenge@partners.org	Worthington, Jane/M-9770-2014; Siminovitch, Katherine/K-1475-2013; de Vries, Niek/J-9348-2013; Bowes, John/B-3472-2015; Hinks, Anne/E-1853-2015; Seielstad, Mark/T-7841-2019; Alfredsson, Lars/AAC-9007-2019; Daly, Mark J/B-2453-2017; van der Horst-Bruinsma, Irene/AAC-7744-2022; emery, paul/B-3560-2013; eyre, stephen/K-3776-2017; Ke, Xiayi/C-7674-2009; Altshuler, David M/A-4476-2009; Barton, Anne/N-2053-2014; Crusius, Jakob Bart/AAE-9051-2019; Padyukov, Leonid/A-4890-2009; Ng, Wan-Fai/R-8083-2016	Worthington, Jane/0000-0003-0544-042X; de Vries, Niek/0000-0002-6257-8604; Bowes, John/0000-0003-4659-031X; Hinks, Anne/0000-0001-8843-3967; Alfredsson, Lars/0000-0003-1688-6697; Daly, Mark J/0000-0002-0949-8752; van der Horst-Bruinsma, Irene/0000-0002-8086-9915; eyre, stephen/0000-0002-1251-6974; Altshuler, David M/0000-0002-7250-4107; Barton, Anne/0000-0003-3316-2527; Crusius, Jakob Bart/0000-0001-9046-0155; Seielstad, Mark/0000-0001-5783-1401; Hocking, Lynne J/0000-0002-2414-2826; Wolbink, Gerrit Jan/0000-0003-1924-7460; Raychaudhuri, Soumya/0000-0002-1901-8265; Thomson, Wendy/0000-0002-9022-5179; McInnes, Iain/0000-0002-6462-4280; Padyukov, Leonid/0000-0003-2950-5670; Harrison, Pille/0000-0003-4117-6910; Remmers, Elaine F/0000-0002-9522-1249; Morgan, Ann/0000-0003-1109-624X; Wilson, Anthony Gerard/0000-0003-4855-3926; Klareskog, Lars/0000-0001-9601-6186; Ng, Wan-Fai/0000-0002-5539-388X; Hyrich, Kimme/0000-0001-8242-9262; Martin, Paul/0000-0002-1016-6851; Li, Yonghong/0000-0001-7326-0717; Packham, Jon/0000-0001-5531-1680; Young-Min, Steven/0000-0001-8270-6207; van der Helm - van Mil, Annette/0000-0001-8572-1437; Hensor, Elizabeth/0000-0002-5245-4755; Toes, Rene/0000-0002-9618-6414; Conaghan, Philip/0000-0002-3478-5665	US National Institutes of Health (NIH) Career Development Award [1K08AR055688-01A1]; American College of Rheumatology Bridge Grant; NIH [AI55314-3, U01 HG004171, DK62432, R01 DK083756-1, DK64869, NO1-AR-2-2263, RO1 AR44422]; Fox Trot Fund; William Randolph Hearst Fund of Harvard University; Burroughs Wellcome Fund; National Center for Research Resources [U54 RR020278]; Millennium Pharmaceuticals; Intramural Research Program of the National Institute of Arthritis; Musculoskeletal and Skin Diseases of the NIH; Canadian Institutes for Health Research [MOP79321, IIN-84042]; Ontario Research Fund [RE01061]; Canada Research Chair; Biogen-Idec; National Heart, Lung, and Blood Institute's (STAMPEED);  [R01HL087676]; National Institute for Health Research [NF-SI-0508-10299] Funding Source: researchfish; Versus Arthritis [18475] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087676] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI055314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055688, N01AR022263, R01AR044422, R01AR056768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064869, U01DK062432, R01DK083756] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Rheumatology Bridge Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fox Trot Fund; William Randolph Hearst Fund of Harvard University; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Intramural Research Program of the National Institute of Arthritis; Musculoskeletal and Skin Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Biogen-Idec(Biogen); National Heart, Lung, and Blood Institute's (STAMPEED); ; National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	S. R. is supported by a US National Institutes of Health (NIH) Career Development Award (1K08AR055688-01A1) and an American College of Rheumatology Bridge Grant. R. M. P. is supported by a K08 grant from the NIH (AI55314-3), a private donation from the Fox Trot Fund, the William Randolph Hearst Fund of Harvard University, the American College of Rheumatology 'Within Our Reach' campaign and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. M. J. D. is supported by NIH grants through the U01 (HG004171, DK62432) and R01 (DK083756-1, DK64869) mechanisms. The Broad Institute Center for Genotyping and Analysis is supported by grant U54 RR020278 from the National Center for Research Resources. The Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study (BRASS) Registry is supported by a grant from Millennium Pharmaceuticals and Biogen-Idec. The North American Rheumatoid Arthritis Consortium (NARAC) is supported by the NIH (NO1-AR-2-2263 and RO1 AR44422). This research was also supported in part by the Intramural Research Program of the National Institute of Arthritis, Musculoskeletal and Skin Diseases of the NIH. This research was also supported in part by grants to KAS from the Canadian Institutes for Health Research (MOP79321 and IIN-84042) and the Ontario Research Fund (RE01061) and by a Canada Research Chair. We acknowledge the help of C. E. van der Schoot for healthy control samples for the Genetics Network Rheumatology Amsterdam (GENRA) and the help of B. A. C. Dijkmans, D. van Schaardenburg, A. S. Pe a, P. L. Klarenbeek, Z. Zhang, M. T. Nurmohammed, W. F. Lems, R. R. J. van de Stadt, W. H. Bos, J. Ursum, M. G. M. Bartelds, D. M. Gerlag, M. G. H. van der Sande, C. A. Wijbrandts and M. M. J. Herenius in gathering GENRA patient samples and data. We thank the Myocardial Infarction Genetics Consortium (MIGen) study for the use of genotype data from their healthy controls in our study. The MIGen study was funded by the US NIH and National Heart, Lung, and Blood Institute's SNP Typing for Association with Multiple Phenotypes from Existing Epidemiologic Data (STAMPEED) genomics research program R01HL087676 and a grant from the National Center for Research Resources. We thank the Johanna Seddon Progression of AMD Study, AMD Registry Study, Family Study of AMD, The US Twin Study of AMD and the Age-Related Eye Disease Study (AREDS) for use of genotype data from their healthy controls in our study. We thank D. Hafler and the Multiple Sclerosis collaborative for use of genotype data from their healthy controls recruited at Brigham and Women's Hospital.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barcellos LF, 2001, NAT GENET, V29, P23, DOI 10.1038/ng722; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Calame K, 2008, CURR OPIN IMMUNOL, V20, P259, DOI 10.1016/j.coi.2008.04.010; Costenbader KH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2421; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; De Jager PL, 2009, P NATL ACAD SCI USA, V106, P5264, DOI 10.1073/pnas.0813310106; Duits AJ, 1995, ARTHRITIS RHEUM, V38, P1832, DOI 10.1002/art.1780381217; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Jacobsen M, 2000, NAT GENET, V26, P495, DOI 10.1038/82659; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; KURITZ SJ, 1988, ANNU REV PUBL HEALTH, V9, P123, DOI 10.1146/annurev.pu.09.050188.001011; Kurreeman FAS, 2007, PLOS MED, V4, P1515, DOI 10.1371/journal.pmed.0040278; Maddison PJ, 2004, OXFORD TXB RHEUMATOL, P1185; Nielen MMJ, 2005, ANN RHEUM DIS, V64, P1199, DOI 10.1136/ard.2004.029389; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Raychaudhuri S., 2006, COMPUTATIONAL TEXT A; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rubio JP, 2008, GENES IMMUN, V9, P624, DOI 10.1038/gene.2008.59; Sato M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1921; SCHRAVEN B, 1990, NATURE, V345, P71, DOI 10.1038/345071a0; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Suzuki A, 2008, NAT GENET, V40, P1224, DOI 10.1038/ng.205; Tchilian EZ, 2001, J IMMUNOL, V166, P6144, DOI 10.4049/jimmunol.166.10.6144; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Vorechovsky I, 2001, NAT GENET, V29, P22, DOI 10.1038/ng723; Wesoly J, 2005, ARTHRITIS RHEUM-US, V52, P2948, DOI 10.1002/art.21294; WIJBRANDTS CA, 2007, ANN RHEUM DIS; Zhernakova A, 2007, AM J HUM GENET, V81, P1284, DOI 10.1086/522037	43	271	278	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2009	41	12					1313	U76		10.1038/ng.479	http://dx.doi.org/10.1038/ng.479			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	524LN	19898481	Green Accepted			2022-12-17	WOS:000272144900013
J	Benko, S; Fantes, JA; Amiel, J; Kleinjan, DJ; Thomas, S; Ramsay, J; Jamshidi, N; Essafi, A; Heaney, S; Gordon, CT; McBride, D; Golzio, C; Fisher, M; Perry, P; Abadie, V; Ayuso, C; Holder-Espinasse, M; Kilpatrick, N; Lees, MM; Picard, A; Temple, IK; Thomas, P; Vazquez, MP; Vekemans, M; Roest Crollius, H; Hastie, ND; Munnich, A; Etchevers, HC; Pelet, A; Farlie, PG; FitzPatrick, DR; Lyonnet, S				Benko, Sabina; Fantes, Judy A.; Amiel, Jeanne; Kleinjan, Dirk-Jan; Thomas, Sophie; Ramsay, Jacqueline; Jamshidi, Negar; Essafi, Abdelkader; Heaney, Simon; Gordon, Christopher T.; McBride, David; Golzio, Christelle; Fisher, Malcolm; Perry, Paul; Abadie, Veronique; Ayuso, Carmen; Holder-Espinasse, Muriel; Kilpatrick, Nicky; Lees, Melissa M.; Picard, Arnaud; Temple, I. Karen; Thomas, Paul; Vazquez, Marie-Paule; Vekemans, Michel; Roest Crollius, Hugues; Hastie, Nicholas D.; Munnich, Arnold; Etchevers, Heather C.; Pelet, Anna; Farlie, Peter G.; FitzPatrick, David R.; Lyonnet, Stanislas			Highly conserved non-coding elements on either side of SOX9 associated with Pierre Robin sequence	NATURE GENETICS			English	Article							GENE-EXPRESSION; UPSTREAM; DOWNSTREAM; MECHANISMS; DISTINCT	Pierre Robin sequence (PRS) is an important subgroup of cleft palate. We report several lines of evidence for the existence of a 17q24 locus underlying PRS, including linkage analysis results, a clustering of translocation breakpoints 1.06-1.23 Mb upstream of SOX9, and microdeletions both similar to 1.5 Mb centromeric and similar to 1.5 Mb telomeric of SOX9. We have also identified a heterozygous point mutation in an evolutionarily conserved region of DNA with in vitro and in vivo features of a developmental enhancer. This enhancer is centromeric to the breakpoint cluster and maps within one of the microdeletion regions. The mutation abrogates the in vitro enhancer function and alters binding of the transcription factor MSX1 as compared to the wild-type sequence. In the developing mouse mandible, the 3-Mb region bounded by the microdeletions shows a regionally specific chromatin decompaction in cells expressing Sox9. Some cases of PRS may thus result from developmental misexpression of SOX9 due to disruption of very-long-range cis-regulatory elements.	[Fantes, Judy A.; Kleinjan, Dirk-Jan; Ramsay, Jacqueline; Essafi, Abdelkader; Heaney, Simon; McBride, David; Fisher, Malcolm; Perry, Paul; Hastie, Nicholas D.; FitzPatrick, David R.] MRC HGU, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Benko, Sabina; Amiel, Jeanne; Thomas, Sophie; Golzio, Christelle; Vekemans, Michel; Munnich, Arnold; Etchevers, Heather C.; Pelet, Anna; Lyonnet, Stanislas] Hop Necker Enfants Malad, INSERM, U 781, Paris, France; [Amiel, Jeanne; Vekemans, Michel; Munnich, Arnold; Lyonnet, Stanislas] Hop Necker Enfants Malad, AP HP, Dept Genet, Paris, France; [Jamshidi, Negar; Gordon, Christopher T.; Kilpatrick, Nicky; Thomas, Paul; Farlie, Peter G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Abadie, Veronique; Vekemans, Michel; Munnich, Arnold; Lyonnet, Stanislas] Univ Paris 05, Fac Med, Paris, France; [Abadie, Veronique] Hop Necker Enfants Malad, AP HP, Serv Pediat, Paris, France; [Ayuso, Carmen] Fdn Jimenez Diaz, Ciberer Madrid, Spain; [Holder-Espinasse, Muriel] CHRU Lille, Hop Jeanne Flandre, Lille, France; [Lees, Melissa M.] Great Ormond St Hosp Sick Children, N Thames Reg Genet Serv, London, England; [Picard, Arnaud; Vazquez, Marie-Paule] Hop Enfants Armand Trousseau, AP HP, Serv Chirurg Maxillofacial & Chirurg Plast, Paris, France; [Picard, Arnaud; Vazquez, Marie-Paule] Univ Paris 06, UFR Med Pierre & Marie Curie, Paris, France; [Temple, I. Karen] Univ Southampton, Div Human Genet, Wessex Clin Genet Acad Grp, Southampton, Hants, England; [Roest Crollius, Hugues] Ecole Normale Super, CNRS, Dept Biol, UMR 8541, Paris, France	University of Edinburgh; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Southampton; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite	FitzPatrick, DR (corresponding author), MRC HGU, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland.	david.fitzpatrick@hgu.mrc.ac.uk; stanislas.lyonnet@inserm.fr	Lyonnet, Stanislas/H-5483-2017; amiel, jeanne/AGX-1124-2022; amiel, jeanne/H-3501-2017; temple, isabel K/K-2391-2015; Essafi, Abdelkader/A-6602-2009; FitzPatrick, David R/C-7301-2013; thomas, sophie/GVS-1279-2022; Thomas, Paul Q/K-4497-2012; Jamshidi, Negar/J-6136-2019; Fisher, Malcolm Edgar/GQH-8954-2022; Gordon, Chris/F-1267-2017; THOMAS, Sophie/F-4492-2017; Etchevers, Heather C./B-5813-2012	Lyonnet, Stanislas/0000-0001-5426-9417; amiel, jeanne/0000-0001-5973-4728; Fisher, Malcolm Edgar/0000-0003-1074-8103; Gordon, Chris/0000-0002-9300-8399; THOMAS, Sophie/0000-0002-8569-3277; Etchevers, Heather C./0000-0003-0201-3799; Golzio, Christelle/0000-0002-4420-3921; ROEST CROLLIUS, Hugues/0000-0002-8209-173X; FitzPatrick, David R./0000-0003-4861-969X; Benko, Sabina/0000-0001-6130-7944; Ayuso, Carmen/0000-0002-9242-7065; Temple, Isabel Karen/0000-0002-6045-1781; PELET, Anastella/0000-0002-8353-1725	Agence Nationale de la Recherche; Fondation pour la Recherche Medicale (FRM); MRC (UK); National Health and Medical Research Council (Australia); US National Institutes of Health [NS039818]; FRM; Medical Research Council [MC_U127527180, MC_U127561093] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039818] Funding Source: NIH RePORTER; MRC [MC_U127561093, MC_U127527180] Funding Source: UKRI	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FRM(Fondation pour la Recherche Medicale); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the affected individuals and their families who participated in this study, to the Associations Francaises du Syndrome de Robin, to the Centres de References Anomalies Cranio-Faciales Rares (AP-HP, Necker and Trousseau hospitals), and to C. Ozilou, G. Staub and G. Guedu-Molina for assistance. We thank T. Attie-Bitach, G. Couly and L. Legeai-Mallet (Necker) and V. van Heyningen and R. Hill (MRC HGU) for useful discussion. This study was underwritten by grants from the Agence Nationale de la Recherche (ERARE grant CraniRare), EUROCRAN FP5, the Fondation pour la Recherche Medicale (FRM), the MRC (UK) and the National Health and Medical Research Council (Australia). S. T. was supported in part by grant NS039818 from the US National Institutes of Health and S. B. by the FRM.	Ahituv N, 2005, HUM MOL GENET, V14, P3057, DOI 10.1093/hmg/ddi338; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Andelfinger G, 2002, AM J HUM GENET, V71, P663, DOI 10.1086/342360; Bagheri-Fam S, 2001, GENOMICS, V78, P73, DOI 10.1006/geno.2001.6648; Bagheri-Fam S, 2006, DEV BIOL, V291, P382, DOI 10.1016/j.ydbio.2005.11.013; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bien-Willner GA, 2007, HUM MOL GENET, V16, P1143, DOI 10.1093/hmg/ddm061; Cai JL, 2005, HUM MOL GENET, V14, P903, DOI 10.1093/hmg/ddi083; Cirulli ET, 2007, HUM MOL GENET, V16, P1931, DOI 10.1093/hmg/ddm140; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Etchevers HC, 2006, ADV EXP MED BIOL, V589, P213; Holder-Espinasse M, 2001, J PEDIATR-US, V139, P588, DOI 10.1067/mpd.2001.117784; Hong CS, 2005, SEMIN CELL DEV BIOL, V16, P694, DOI 10.1016/j.semcdb.2005.06.005; Jakobsen LP, 2007, J MED GENET, V44, P381, DOI 10.1136/jmg.2006.046177; Jamshidi N, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.010157; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; McCauley DW, 2006, NATURE, V441, P750, DOI 10.1038/nature04691; Morey C, 2007, DEVELOPMENT, V134, P909, DOI 10.1242/dev.02779; Mori-Akiyama Y, 2003, P NATL ACAD SCI USA, V100, P9360, DOI 10.1073/pnas.1631288100; Pheasant M, 2007, GENOME RES, V17, P1245, DOI 10.1101/gr.6406307; Robin P, 1994, Plast Reconstr Surg, V93, P1301; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Suzuki T, 2006, DEV GROWTH DIFFER, V48, P477, DOI 10.1111/j.1440-169x.2006.00886.x; Velagaleti GVN, 2005, AM J HUM GENET, V76, P652, DOI 10.1086/429252; VINTINER GM, 1991, AM J MED GENET, V41, P44, DOI 10.1002/ajmg.1320410113; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007	30	271	281	3	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2009	41	3					359	364		10.1038/ng.329	http://dx.doi.org/10.1038/ng.329			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19234473				2022-12-17	WOS:000263640200019
J	Vega, H; Waisfisz, Q; Gordillo, M; Sakai, N; Yanagihara, I; Yamada, M; van Gosliga, D; Kayserili, H; Xu, CZ; Ozono, K; Jabs, EW; Inui, K; Joenje, H				Vega, H; Waisfisz, Q; Gordillo, M; Sakai, N; Yanagihara, I; Yamada, M; van Gosliga, D; Kayserili, H; Xu, CZ; Ozono, K; Jabs, EW; Inui, K; Joenje, H			Roberts syndrome is caused by mutations in ESCO2, a human homolog of yeast ECO1 that is essential for the establishment of sister chromatid cohesion	NATURE GENETICS			English	Article							SYNDROME FIBROBLASTS; DNA-REPLICATION; ACETYLTRANSFERASE; ABNORMALITIES	Roberts syndrome is an autosomal recessive disorder characterized by craniofacial anomalies, tetraphocomelia and loss of cohesion at heterochromatic regions of centromeres and the Y chromosome. We identified mutations in a new human gene, ESCO2, associated with Roberts syndrome in 15 kindreds. The ESCO2 protein product is a member of a conserved protein family that is required for the establishment of sister chromatid cohesion during S phase and has putative acetyltransferase activity.	Univ Nacl Colombia, Inst Genet, Bogota, Colombia; Osaka Univ, Grad Sch Med, Dept Dev Med Pediat D5, Suita, Osaka 5650871, Japan; Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, NL-1081 BT Amsterdam, Netherlands; Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Osaka Med Ctr Maternal & Child Hlth, Dept Dev Infect Dis, Res Inst, Osaka 5941101, Japan; Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34390 Istanbul, Turkey	Universidad Nacional de Colombia; Osaka University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Johns Hopkins University; Istanbul University	Vega, H (corresponding author), Univ Nacl Colombia, Inst Genet, Ciudad Univ, Bogota, Colombia.	hhvegaf@unal.edu.co; ejabs1@jhem.jhmi.edu		Jabs, Ethylin/0000-0001-8983-5466; Waisfisz, Quinten/0000-0002-7384-9182	Telethon [GTF04002] Funding Source: Medline	Telethon(Fondazione Telethon)		Bellows AM, 2003, NUCLEIC ACIDS RES, V31, P6334, DOI 10.1093/nar/gkg811; BURNS MA, 1989, MUTAT RES, V216, P243, DOI 10.1016/0165-1161(89)90049-6; GERMAN J, 1979, CLIN GENET, V16, P441; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; Hoque MT, 2002, J BIOL CHEM, V277, P42306, DOI 10.1074/jbc.M206836200; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; JABS EW, 1991, CHROMOSOMA, V100, P251, DOI 10.1007/BF00344159; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Tanaka K, 2000, MOL CELL BIOL, V20, P3459, DOI 10.1128/MCB.20.10.3459-3469.2000; TOMKINS D, 1979, AM J MED GENET, V4, P17, DOI 10.1002/ajmg.1320040104; TOMKINS DJ, 1984, AM J HUM GENET, V36, P1332; Toth A, 1999, GENE DEV, V13, P320, DOI 10.1101/gad.13.3.320; VANDENBERG DJ, 1993, AM J MED GENET, V47, P1104, DOI 10.1002/ajmg.1320470735; Williams BC, 2003, CURR BIOL, V13, P2025, DOI 10.1016/j.cub.2003.11.018	15	271	285	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2005	37	5					468	470		10.1038/ng1548	http://dx.doi.org/10.1038/ng1548			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	15821733				2022-12-17	WOS:000228862300014
J	Wu, GQ; Markowitz, GS; Li, L; D'Agati, VD; Factor, SM; Geng, L; Tibara, S; Tuchman, J; Cai, YQ; Park, JH; van Adelsberg, J; Hou, H; Kucherlapati, R; Edelmann, W; Somlo, S				Wu, GQ; Markowitz, GS; Li, L; D'Agati, VD; Factor, SM; Geng, L; Tibara, S; Tuchman, J; Cai, YQ; Park, JH; van Adelsberg, J; Hou, H; Kucherlapati, R; Edelmann, W; Somlo, S			Cardiac defects and renal failure in mice with targeted mutations in Pkd2	NATURE GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; HEART; GENE; ENCODES; PROTEIN; MOUSE	PKD2, mutations in which cause autosomal dominant polycystic kidney disease(1) (ADPKD), encodes an integral membrane glycoprotein(2) with similarity to calcium channel subunits(1,3). We induced two mutations in the mouse homologue Pkd2 (ref. 4): an unstable allele (WS25; hereafter denoted pkd2(WS25)) that can undergo homologous-recombination-based somatic rearrangement to form a null allele; and a true null mutation (WS183; hereafter denoted Pkd2(-)). We examined these mutations to understand the function of polycystin-2, the protein product of Pkd2, and to provide evidence that kidney and liver cyst formation associated with Pkd2 deficiency occurs by a two-hit mechanism(4-9). Pkd2(-/-) mice die in utero between embryonic day (E) 13.5 and parturition. They have structural defects in cardiac septation and cyst formation in maturing nephrons and pancreatic ducts. Pancreatic ductal cysts also occur in adult pkd2(WS25/-) mice, suggesting that this clinical manifestation of ADPKD also occurs by a two-hit mechanism. As in human ADPKD, formation of kidney cysts in adult pkd2(WS25/-) mice is associated with renal failure and early death (median survival, 65 weeks versus 94 weeks for controls). Adult Pkd2(+/-) mice have intermediate survival in the absence of cystic disease or renal failure, providing the first indication of a deleterious effect of haploinsufficiency at Pkd2 on long-term survival. Our studies advance our understanding of the function of polycystin-2 in development and our mouse models recapitulate the complex human ADPKD phenotype.	Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Columbia University; Columbia University; Yale University	Somlo, S (corresponding author), Yale Univ, Sch Med, Nephrol Sect, Boyer Ctr Mol Med, 333 Cedar St, New Haven, CT 06510 USA.	stefan.somlo@yale.edu	Kucherlapati, Raju/ABC-8807-2021		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051041, R01DK054053] Funding Source: NIH RePORTER; NIDDK NIH HHS [1RO1 DK54053, R01 DK051041] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bardaji A, 1998, AM J KIDNEY DIS, V32, P970, DOI 10.1016/S0272-6386(98)70071-X; Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Chen XZ, 1999, NATURE, V401, P383, DOI 10.1038/43907; Clark TG, 1999, DEVELOPMENT, V126, P2631; Conway SJ, 1997, CARDIOVASC RES, V36, P163, DOI 10.1016/S0008-6363(97)00172-7; Emmons SW, 1999, NATURE, V401, P339, DOI 10.1038/43810; Fishman MC, 1997, DEVELOPMENT, V124, P2099; Gittes GK, 1996, DEVELOPMENT, V122, P439; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Hateboer N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; HUSTON J, 1993, J AM SOC NEPHROL, V3, P1871; Koptides M, 1999, HUM MOL GENET, V8, P509, DOI 10.1093/hmg/8.3.509; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Markowitz GS, 1999, AM J PHYSIOL-RENAL, V277, pF17, DOI 10.1152/ajprenal.1999.277.1.F17; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Olson EN, 1996, SCIENCE, V272, P671, DOI 10.1126/science.272.5262.671; Pei Y, 1999, J AM SOC NEPHROL, V10, P1524; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rossant J, 1996, CIRC RES, V78, P349, DOI 10.1161/01.RES.78.3.349; Stockelman MG, 1998, AM J PHYSIOL-RENAL, V275, pF154, DOI 10.1152/ajprenal.1998.275.1.F154; Torra R, 1999, AM J HUM GENET, V65, P345, DOI 10.1086/302501; Torra R, 1997, CLIN NEPHROL, V47, P19; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6	28	271	280	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2000	24	1					75	78		10.1038/71724	http://dx.doi.org/10.1038/71724			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	271TH	10615132				2022-12-17	WOS:000084609200020
J	Samadashwily, GM; Raca, G; Mirkin, SM				Samadashwily, GM; Raca, G; Mirkin, SM			Trinucleotide repeats affect DNA replication in vivo	NATURE GENETICS			English	Article							FRAGILE-X-SYNDROME; AGAROSE-GEL ELECTROPHORESIS; HUMAN HEREDITARY-DISEASES; CGG TRIPLET REPEATS; SYNTHESIS IN-VITRO; ESCHERICHIA-COLI; DELAYED REPLICATION; MISMATCH REPAIR; SWITCH REGION; CTG	(CCG)(n).(CCG)(n) and (CTG)(n).(CAG)(n) repeats of varying length were cloned into a bacterial plasmid, and the progression of the replication fork through these repeats was followed using electrophoretic analysis of replication intermediates. We observed stalling of the replication fork within repeated DNAs and found that this effect depends on repeat length, repeat orientation relative to the replication origin and the status of protein synthesis in a cell. Interruptions within repeated DNAs, similar to those observed in human genes, abolished the replication blockage. Our results suggest that the formation of unusual DNA structures by trinucleotide repeats in the lagging-strand template may account for the observed replication blockage and have relevance to repeat expansion in humans.	UNIV ILLINOIS, DEPT MOL GENET, CHICAGO, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital			Mirkin, Sergei/A-7310-2010; Mirkin, Sergei/AAR-7226-2020	Mirkin, Sergei/0000-0003-4576-7582				AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; Bacolla A, 1997, J BIOL CHEM, V272, P16783, DOI 10.1074/jbc.272.27.16783; BALBAS P, 1986, GENE, V50, P3, DOI 10.1016/0378-1119(86)90307-0; BATES G, 1994, BIOESSAYS, V16, P277, DOI 10.1002/bies.950160411; Bowater RP, 1996, J MOL BIOL, V264, P82, DOI 10.1006/jmbi.1996.0625; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; CHEN XA, 1995, P NATL ACAD SCI USA, V92, P5199, DOI 10.1073/pnas.92.11.5199; CLEWELL DB, 1972, J BACTERIOL, V110, P667, DOI 10.1128/JB.110.2.667-676.1972; Cox R, 1997, P NATL ACAD SCI USA, V94, P5237, DOI 10.1073/pnas.94.10.5237; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; FRY M, 1994, P NATL ACAD SCI USA, V91, P4950, DOI 10.1073/pnas.91.11.4950; GACY AM, 1995, CELL, V81, P533; Gordenin DA, 1997, NAT GENET, V16, P116, DOI 10.1038/ng0697-116; HACKER KJ, 1994, J BIOL CHEM, V269, P24221; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; JAWORSKI A, 1995, P NATL ACAD SCI USA, V92, P11019, DOI 10.1073/pnas.92.24.11019; JODICE C, 1994, AM J HUM GENET, V54, P959; Kang S, 1996, J MOL BIOL, V258, P543, DOI 10.1006/jmbi.1996.0266; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; KANG SM, 1995, J BIOL CHEM, V270, P27014, DOI 10.1074/jbc.270.45.27014; KETTANI A, 1995, J MOL BIOL, V254, P638, DOI 10.1006/jmbi.1995.0644; KOHWI Y, 1993, NUCLEIC ACIDS RES, V21, P5651; Kornberg A., 1992, DNA REPLICATION; Krasilnikov AS, 1997, NUCLEIC ACIDS RES, V25, P1339, DOI 10.1093/nar/25.7.1339; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; KURYAVYI VV, 1995, NAT GENET, V9, P339, DOI 10.1038/ng0495-339; MARTINPARRAS L, 1991, J MOL BIOL, V220, P843, DOI 10.1016/0022-2836(91)90357-C; MCMURRAY CT, 1995, CHROMOSOMA, V104, P2; MITCHELL JE, 1995, NUCLEIC ACIDS RES, V23, P1876, DOI 10.1093/nar/23.11.1876; Ohshima K, 1996, J BIOL CHEM, V271, P1853, DOI 10.1074/jbc.271.4.1853; Ohshima K, 1997, J BIOL CHEM, V272, P16798, DOI 10.1074/jbc.272.27.16798; Petruska J, 1996, NUCLEIC ACIDS RES, V24, P1992, DOI 10.1093/nar/24.11.1992; REABAN ME, 1994, J BIOL CHEM, V269, P21850; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; REISS AL, 1994, HUM MOL GENET, V3, P393, DOI 10.1093/hmg/3.3.393; SAMADASHWILY GM, 1993, EMBO J, V12, P4975, DOI 10.1002/j.1460-2075.1993.tb06191.x; Shimizu M, 1996, J MOL BIOL, V258, P614, DOI 10.1006/jmbi.1996.0273; SNOW K, 1994, HUM MOL GENET, V3, P1543, DOI 10.1093/hmg/3.9.1543; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; Subramanian PS, 1996, AM J HUM GENET, V59, P407; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; TRINH TQ, 1991, NATURE, V352, P544, DOI 10.1038/352544a0; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; WEBB T, 1992, AM J MED GENET, V43, P1057, DOI 10.1002/ajmg.1320430633; Wells RD, 1996, J BIOL CHEM, V271, P2875, DOI 10.1074/jbc.271.6.2875; Yu A, 1997, BIOCHEMISTRY-US, V36, P3687, DOI 10.1021/bi9625410; YU AD, 1995, NUCLEIC ACIDS RES, V23, P2706, DOI 10.1093/nar/23.14.2706; Zheng MX, 1996, J MOL BIOL, V264, P323, DOI 10.1006/jmbi.1996.0643	50	271	275	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					298	304		10.1038/ng1197-298	http://dx.doi.org/10.1038/ng1197-298			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354793				2022-12-17	WOS:A1997YD66700023
J	FitzGerald, MG; Bean, JM; Hegde, SR; Unsal, H; MacDonald, DJ; Harkin, DP; Finkelstein, DM; Isselbacher, KJ; Haber, DA				FitzGerald, MG; Bean, JM; Hegde, SR; Unsal, H; MacDonald, DJ; Harkin, DP; Finkelstein, DM; Isselbacher, KJ; Haber, DA			Heterozygous ATM mutations do not contribute to early onset of breast cancer	NATURE GENETICS			English	Article							ATAXIA-TELANGIECTASIA GENE; SACCHAROMYCES-CEREVISIAE; IONIZING-RADIATION; NORMAL DONORS; RADIOSENSITIVITY; FAMILIES; LYMPHOCYTES; PRODUCT; PROTEIN; HOMOLOG	Ataxia telangiectasia (AT) is a recessive syndrome, including cerebellar degeneration, immunologic defects and cancer predisposition(1,2), attributed to mutations in the recently isolated ATM (ataxia telangiectasia, mutated) gene(3). AT is diagnosed in 1/40,000 to 1/100,000 live births, with carriers calculated to comprise similar to 1% of the population. Studies of AT families have suggested that female relatives presumed to be carriers have a 5 to 8-fold increased risk for developing breast cancer(4,5), raising the possibility that germline ATM mutations may account for similar to 5% of all breast cancer cases. The increased risk for breast cancer reported for AT family members has been most evident among younger women, leading to an age-specific relative risk model predicting that 8% of breast cancer in women under age 40 arises in AT carriers, compared with 2% of cases between 40-59 years(6). To test this hypothesis, we undertook a germ-line mutational analysis of the ATM gene in a population of women with early onset of breast cancer, using a protein truncation (PTT) assay to detect chain-terminating mutations, which account for 90% of mutations identified in children with AT(7-11). We detected a heterozygous ATM mutation in 2/202 (1%) controls, consistent with the frequency of AT carriers predicted from epidemiologic studies. ATM mutations were present in only 2/401 (0.5%) women with early onset of breast cancer (P = 0.6). We conclude that heterozygous ATM mutations do not confer genetic predisposition to early onset of breast cancer.	MASSACHUSETTS GEN HOSP, CTR CANC, CTR CANC RISK ANAL, CHARLESTOWN, MA 02129 USA; MASSACHUSETTS GEN HOSP, CTR CANC, DEPT BIOSTAT, CHARLESTOWN, MA 02129 USA; HARVARD UNIV, SCH MED, CHARLESTOWN, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University				Bean, James/0000-0001-6733-5794				Athma P, 1996, CANCER GENET CYTOGEN, V92, P130, DOI 10.1016/S0165-4608(96)00328-7; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Baumer A, 1996, HUM GENET, V98, P246, DOI 10.1007/s004390050202; BEAMISH H, 1994, INT J RADIAT BIOL, V65, P175, DOI 10.1080/09553009414550211; BORRESEN AL, 1990, GENE CHROMOSOME CANC, V2, P339, DOI 10.1002/gcc.2870020412; Byrd PJ, 1996, HUM MOL GENET, V5, P145, DOI 10.1093/hmg/5.1.145; COLE J, 1988, INT J RADIAT BIOL, V54, P929, DOI 10.1080/09553008814552331; CUNLIFFE PN, 1975, BRIT J RADIOL, V48, P374, DOI 10.1259/0007-1285-48-569-374; EASTON DF, 1994, INT J RADIAT BIOL, V66, pS177, DOI 10.1080/09553009414552011; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; Gilad S, 1996, HUM MOL GENET, V5, P433, DOI 10.1093/hmg/5.4.433; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; HARI KL, 1995, CELL, V82, P815, DOI 10.1016/0092-8674(95)90478-6; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; HOULDSWORTH J, 1980, NUCLEIC ACIDS RES, V8, P3709, DOI 10.1093/nar/8.16.3709; Jorgensen TJ, 1996, INT J RADIAT BIOL, V69, P527, DOI 10.1080/095530096145535; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KHANNA KK, 1993, ONCOGENE, V8, P3307; MORRELL D, 1986, J NATL CANCER I, V77, P89; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; PIPPARD EC, 1988, CANCER RES, V48, P2929; Ramsay J, 1996, LANCET, V347, P1627, DOI 10.1016/S0140-6736(96)91114-9; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; SHILOH Y, 1995, EUR J HUM GENET, V3, P116; STINE GJ, 1989, NEW HUMAN GENETICS, P393; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; Telatar M, 1996, AM J HUM GENET, V59, P40; Thacker J, 1994, INT J RADIAT BIOL, V66, P587; Vorechovsky I, 1996, CANCER RES, V56, P4130; Vorechovsky I, 1996, CANCER RES, V56, P2726; WEST CML, 1995, INT J RADIAT BIOL, V68, P197, DOI 10.1080/09553009514551101; WOOSTER R, 1993, HUM GENET, V92, P91, DOI 10.1007/BF00216153; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; ZAKIAN VA, 1995, CELL, V82, P685, DOI 10.1016/0092-8674(95)90463-8	39	271	276	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					307	310		10.1038/ng0397-307	http://dx.doi.org/10.1038/ng0397-307			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054948				2022-12-17	WOS:A1997WK38600025
J	HOUWEN, RHJ; BAHARLOO, S; BLANKENSHIP, K; RAEYMAEKERS, P; JUYN, J; SANDKUIJL, LA; FREIMER, NB				HOUWEN, RHJ; BAHARLOO, S; BLANKENSHIP, K; RAEYMAEKERS, P; JUYN, J; SANDKUIJL, LA; FREIMER, NB			GENOME SCREENING BY SEARCHING FOR SHARED SEGMENTS - MAPPING A GENE FOR BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	NATURE GENETICS			English	Article							LINKAGE MAP; DISEQUILIBRIUM; PEDIGREE; TRAITS	It is now feasible to map disease genes by screening the genome for linkage disequilibrium between the disease and marker alleles. This report presents the first application of this approach for a previously unmapped locus. A gene for benign recurrent intrahepatic cholestasis (BRIC) was mapped to chromosome 18 by searching for chromosome segments shared by only three distantly related patients. The screening results were confirmed by identyifying an extended haplotype conserved between the patients. Probability calculations indicate that such segment sharing is unlikely to arise by chance. Searching the genome for segments shared by patients is a powerful empirical method for mapping disease genes. Computer simulations suggest that, in appropriate populations, the approach may be used to localize genes for common diseases.	UNIV CALIF SAN FRANCISCO,NEUROGENET LAB,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,CTR NEUROBIOL & PSYCHIAT,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143; WILHELMINA CHILDRENS HOSP,UTRECHT,NETHERLANDS; CATHOLIC UNIV LEUVEN,CTR HUMAN GENET,B-3000 LOUVAIN,BELGIUM; LEIDEN UNIV,DEPT HUMAN GENET,2300 RA LEIDEN,NETHERLANDS; ERASMUS UNIV ROTTERDAM,INST CLIN GENET,ROTTERDAM,NETHERLANDS	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Wilhelmina Kinderziekenhuis; KU Leuven; Leiden University; Leiden University - Excl LUMC; Erasmus University Rotterdam					NIMH NIH HHS [MH49499, MH47563, MH00916] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049499, K21MH000916] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BENHAMIDA C, 1993, NAT GENET, V5, P195; BODMER W, 1994, NAT GENET, V6, P217, DOI 10.1038/ng0394-217; BRENARD R, 1989, J CLIN GASTROENTEROL, V11, P546, DOI 10.1097/00004836-198910000-00011; BUETOW K, 1993, AM J HUM GENET, V53, pA176; COOK JTE, 1993, DIABETES, V42, P1536, DOI 10.2337/diabetes.42.10.1536; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; DONNELLY KP, 1983, THEOR POPUL BIOL, V23, P34, DOI 10.1016/0040-5809(83)90004-7; ELSTON RC, 1984, GENET EPIDEMIOL, V1, P315; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HEUTINK P, 1992, HUM MOL GENET, V1, P7, DOI 10.1093/hmg/1.1.7; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; LEWONTIN RC, 1988, GENETICS, V120, P849; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; NYSTROMLAHTI M, 1994, P NATL ACAD SCI USA, V91, P6054, DOI 10.1073/pnas.91.13.6054; Ott J., 1991, ANAL HUMAN GENETIC L; PLOMIN R, 1994, SCIENCE, V264, P1733, DOI 10.1126/science.8209254; POLLAK MR, 1993, NAT GENET, V5, P201, DOI 10.1038/ng1093-201; SANDKUYL L, 1989, HUM GENET, V82, P159, DOI 10.1007/BF00284050; SHAPIRO RH, 1963, NEW ENGL J MED, V268, P708; SUMMERSKILL WHJ, 1959, LANCET, V2, P686; VANSOEST S, 1994, GENOMICS, V22, P499, DOI 10.1006/geno.1994.1422; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	27	271	277	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1994	8	4					380	386		10.1038/ng1294-380	http://dx.doi.org/10.1038/ng1294-380			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	7894490	Green Published			2022-12-17	WOS:A1994PV68200020
J	Jansen, PR; Watanabe, K; Stringer, S; Skene, N; Bryois, J; Hammerschlag, AR; de Leeuw, CA; Benjamins, JS; Munoz-Manchado, AB; Nagel, M; Savage, JE; Tiemeier, H; White, T; Tung, JY; Hinds, DA; Vacic, V; Wang, X; Sullivan, PF; van der Sluis, S; Polderman, TJC; Smit, AB; Hjerling-Leffler, J; Van Someren, EJW; Posthuma, D; Agee, M; Alipanahi, B; Auton, A; Bell, RK; Bryc, K; Elson, SL; Fontanillas, P; Furlotte, NA; Huber, KE; Kleinman, A; Litterman, NK; McCreight, JC; McIntyre, MH; Mountain, JL; Noblin, ES; Northover, CAM; Pitts, SJ; Sathirapongsasuti, JF; Sazonova, OV; Shelton, JF; Shringarpure, S; Tian, C; Wilson, CH				Jansen, Philip R.; Watanabe, Kyoko; Stringer, Sven; Skene, Nathan; Bryois, Julien; Hammerschlag, Anke R.; de Leeuw, Christiaan A.; Benjamins, Jeroen S.; Munoz-Manchado, Ana B.; Nagel, Mats; Savage, Jeanne E.; Tiemeier, Henning; White, Tonya; Tung, Joyce Y.; Hinds, David A.; Vacic, Vladimir; Wang, Xin; Sullivan, Patrick F.; van der Sluis, Sophie; Polderman, Tinca J. C.; Smit, August B.; Hjerling-Leffler, Jens; Van Someren, Eus J. W.; Posthuma, Danielle; Agee, Michelle; Alipanahi, Babak; Auton, Adam; Bell, Robert K.; Bryc, Katarzyna; Elson, Sarah L.; Fontanillas, Pierre; Furlotte, Nicholas A.; Huber, Karen E.; Kleinman, Aaron; Litterman, Nadia K.; McCreight, Jennifer C.; McIntyre, Matthew H.; Mountain, Joanna L.; Noblin, Elizabeth S.; Northover, Carrie A. M.; Pitts, Steven J.; Sathirapongsasuti, J. Fah; Sazonova, Olga, V; Shelton, Janie F.; Shringarpure, Suyash; Tian, Chao; Wilson, Catherine H.		23andMe Res Team	Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways	NATURE GENETICS			English	Article							GENETIC-VARIANTS; MOTOR RESTLESSNESS; SLEEP; ASSOCIATION; SIGNATURES; DATABASE; EPIDEMIOLOGY; METAANALYSIS; COMPLAINTS; BEHAVIOR	Insomnia is the second most prevalent mental disorder, with no sufficient treatment available. Despite substantial heritability, insight into the associated genes and neurobiological pathways remains limited. Here, we use a large genetic association sample (n = 1,331,010) to detect novel loci and gain insight into the pathways, tissue and cell types involved in insomnia complaints. We identify 202 loci implicating 956 genes through positional, expression quantitative trait loci, and chromatin mapping. The meta-analysis explained 2.6% of the variance. We show gene set enrichments for the axonal part of neurons, cortical and subcortical tissues, and specific cell types, including striatal, hypothalamic, and claustrum neurons. We found considerable genetic correlations with psychiatric traits and sleep duration, and modest correlations with other sleep-related traits. Mendelian randomization identified the causal effects of insomnia on depression, diabetes, and cardiovascular disease, and the protective effects of educational attainment and intracranial volume. Our findings highlight key brain areas and cell types implicated in insomnia, and provide new treatment targets.	[Jansen, Philip R.; Watanabe, Kyoko; Stringer, Sven; Hammerschlag, Anke R.; de Leeuw, Christiaan A.; Nagel, Mats; Savage, Jeanne E.; van der Sluis, Sophie; Polderman, Tinca J. C.; Posthuma, Danielle] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Amsterdam Neurosci, Dept Complex Trait Genet, Amsterdam, Netherlands; [Jansen, Philip R.; Tiemeier, Henning; White, Tonya] Erasmus Univ, Dept Child & Adolescent Psychiat, Med Ctr, Rotterdam, Netherlands; [Skene, Nathan; Munoz-Manchado, Ana B.; Hjerling-Leffler, Jens] Karolinska Inst, Dept Med Biochem & Biophys, Lab Mol Neurobiol, Stockholm, Sweden; [Skene, Nathan; Sullivan, Patrick F.] UCL Inst Neurol, Queen Sq, London, England; [Bryois, Julien] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Benjamins, Jeroen S.] Univ Utrecht, Dept Social Hlth & Org Psychol, Utrecht, Netherlands; [Benjamins, Jeroen S.] Univ Utrecht, Helmholtz Inst, Dept Expt Psychol, Utrecht, Netherlands; [Nagel, Mats; van der Sluis, Sophie; Posthuma, Danielle] Vrije Univ Amsterdam Med Ctr, Amsterdam Neurosci, Dept Clin Genet, Sect Complex Trait Genet, Amsterdam, Netherlands; [Tiemeier, Henning] Erasmus Univ, Dept Psychiat, Med Ctr, Rotterdam, Netherlands; [Tung, Joyce Y.; Hinds, David A.; Vacic, Vladimir; Wang, Xin; Agee, Michelle; Alipanahi, Babak; Auton, Adam; Bell, Robert K.; Bryc, Katarzyna; Elson, Sarah L.; Fontanillas, Pierre; Furlotte, Nicholas A.; Huber, Karen E.; Kleinman, Aaron; Litterman, Nadia K.; McCreight, Jennifer C.; McIntyre, Matthew H.; Mountain, Joanna L.; Noblin, Elizabeth S.; Northover, Carrie A. M.; Pitts, Steven J.; Sathirapongsasuti, J. Fah; Sazonova, Olga, V; Shelton, Janie F.; Shringarpure, Suyash; Tian, Chao; Wilson, Catherine H.] 23andMe Inc, Mountain View, CA USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27515 USA; [Smit, August B.] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Mol & Cellular Neurobiol, Amsterdam Neurosci, Amsterdam, Netherlands; [Van Someren, Eus J. W.] Netherlands Inst Neurosci, Dept Sleep & Cognit, Amsterdam, Netherlands; [Van Someren, Eus J. W.] Univ Amsterdam, VU Univ, Ctr Neurogen & Cognit Res, Amsterdam Neurosci,Med Ctr,Dept Psychiat, Amsterdam, Netherlands; [Van Someren, Eus J. W.] Univ Amsterdam, VU Univ, Ctr Neurogen & Cognit Res, Amsterdam Neurosci,Med Ctr,Dept Integrat Neurophy, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Karolinska Institutet; University of London; University College London; Karolinska Institutet; Utrecht University; Utrecht University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Erasmus University Rotterdam; Erasmus MC; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Vrije Universiteit Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	Posthuma, D (corresponding author), Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Amsterdam Neurosci, Dept Complex Trait Genet, Amsterdam, Netherlands.; Posthuma, D (corresponding author), Vrije Univ Amsterdam Med Ctr, Amsterdam Neurosci, Dept Clin Genet, Sect Complex Trait Genet, Amsterdam, Netherlands.	d.posthuma@vu.nl	Tiemeier, Henning/H-6534-2019; Manchado, Ana Munoz/AAB-6399-2019; tian, chao/GYD-3462-2022; Van Someren, Eus/AAA-6789-2020; White, Tonya/AAU-2226-2021; Benjamins, Jeroen/H-2106-2011	Tiemeier, Henning/0000-0002-4395-1397; White, Tonya/0000-0003-0271-1896; Jansen, Philip/0000-0003-1550-2444; Watanabe, Kyoko/0000-0002-3303-8860; Posthuma, Danielle/0000-0001-7582-2365; Polderman, Tinca/0000-0001-5564-301X; Munoz Manchado, Ana/0000-0002-1121-6072; de Leeuw, Christiaan/0000-0003-1076-9828; Alipanahi, Babak/0000-0001-8216-7178; Benjamins, Jeroen/0000-0003-4341-7167; van der Sluis, Sophie/0000-0001-9958-7216; Skene, Nathan/0000-0002-6807-3180	Netherlands Organization for Scientific Research (NWO Brain and Cognition) [433-09-228]; Netherlands Organization for Scientific Research (NWO MagW VIDI) [452-12-014]; Netherlands Organization for Scientific Research (NWO VICI) [435-13-005, 453-07-001]; Netherlands Organization for Scientific Research [NWO 645-000-003]; Sophia Foundation for Scientific Research [S14-27]; European Research Council [ERC-ADG-2014-671084 INSOMNIA]; Swiss National Science Foundation [P2GEP3_165049]; Wellcome Trust [108726/Z/15/Z]; Swedish Research Council (Vetenskapsradet) [2014-3863]; Swedish Brain Foundation (Hjarnfonden); NWO [480-05-003]; VU University, Amsterdam; Dutch Brain Foundation	Netherlands Organization for Scientific Research (NWO Brain and Cognition)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (NWO MagW VIDI)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (NWO VICI)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Sophia Foundation for Scientific Research; European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Brain Foundation (Hjarnfonden); NWO(Netherlands Organization for Scientific Research (NWO)); VU University, Amsterdam; Dutch Brain Foundation	This work was funded by The Netherlands Organization for Scientific Research (NWO Brain and Cognition 433-09-228, NWO MagW VIDI 452-12-014, NWO VICI 435-13-005 and 453-07-001, and NWO 645-000-003). P.R.J. was funded by the Sophia Foundation for Scientific Research (S14-27), E.J.W.V.S. was funded by the European Research Council (grant no. ERC-ADG-2014-671084 INSOMNIA), and J.B. was funded by the Swiss National Science Foundation (grant no. P2GEP3_165049). N.G.S. was supported by the Wellcome Trust (grant no. 108726/Z/15/Z). J.H.L. was funded by the Swedish Research Council (Vetenskapsradet, award no. 2014-3863), the Swedish Brain Foundation (Hjarnfonden) and the Wellcome Trust (grant no. 108726/Z/15/Z). Analyses were carried out on the Genetic Cluster Computer, which is financed by the NWO (480-05-003), by the VU University, Amsterdam, and by the Dutch Brain Foundation, and is hosted by the Dutch National Computing and Networking Services SurfSARA. This research has been conducted using the UK Biobank Resource (application no. 16406). We thank the UK Biobank and 23andMe research participants and employees for making this work possible.	Altena E, 2008, SLEEP, V31, P1271; [Anonymous], 2013, DIAGNOSTIC STAT MANU; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Benjamins JS, 2017, SLEEP MED REV, V36, P71, DOI 10.1016/j.smrv.2016.10.005; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Butler MG, 2015, INT J MOL SCI, V16, P6464, DOI 10.3390/ijms16036464; Cho YW, 2009, J CLIN NEUROL, V5, P20, DOI 10.3988/jcn.2009.5.1.20; Colombo MA, 2016, SLEEP, V39, P1015, DOI 10.5665/sleep.5744; Dai XJ, 2014, NEUROPSYCH DIS TREAT, V10, P2163, DOI 10.2147/NDT.S69681; de Leeuw CA, 2016, NAT REV GENET, V17, P353, DOI 10.1038/nrg.2016.29; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; DeAndrade MP, 2012, HUM MOL GENET, V21, P3984, DOI 10.1093/hmg/dds221; DeAndrade MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035518; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Feige B, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy032; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Freeman A, 2012, CURR BIOL, V22, P1142, DOI 10.1016/j.cub.2012.04.027; Hammerschlag AR, 2017, NAT GENET, V49, P1584, DOI 10.1038/ng.3888; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hawrylycz M, 2015, NAT NEUROSCI, V18, P1832, DOI 10.1038/nn.4171; Hu YN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10448; Janik P, 2014, ACTA NEUROBIOL EXP, V74, P218; Johann AF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180339; Jones SE, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006125; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kripke DF, 2015, SLEEP MED, V16, P217, DOI 10.1016/j.sleep.2014.11.003; Krystal AD, 2002, SLEEP, V25, P630; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lane JM, 2017, NAT GENET, V49, P274, DOI 10.1038/ng.3749; Lane JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10889; Laramie JM, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-46; Lazarus M, 2012, TRENDS NEUROSCI, V35, P723, DOI 10.1016/j.tins.2012.07.001; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lind MJ, 2015, SLEEP, V38, P1423, DOI 10.5665/sleep.4982; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Mathur BN, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00048; McDowell KA, 2014, J PARKINSON DIS, V4, P531, DOI 10.3233/JPD-140374; Morin CM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.26; Morphy H, 2007, SLEEP, V30, P274; Nagel M, 2018, NAT GENET, V50, P920, DOI 10.1038/s41588-018-0151-7; Paparrigopoulos T, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-531; Qiu MH, 2010, EUR J NEUROSCI, V31, P499, DOI 10.1111/j.1460-9568.2009.07062.x; Renouard L, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400177; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Schormair B, 2017, LANCET NEUROL, V16, P898, DOI 10.1016/S1474-4422(17)30327-7; Skene NG, 2018, NAT GENET, V50, P825, DOI 10.1038/s41588-018-0129-5; Sniekers S, 2017, NAT GENET, V49, P1107, DOI 10.1038/ng.3869; Stefansson H, 2007, NEW ENGL J MED, V357, P639, DOI 10.1056/NEJMoa072743; Stoffers D, 2014, BRAIN, V137, P610, DOI 10.1093/brain/awt329; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Suzuki A, 2013, P NATL ACAD SCI USA, V110, P10288, DOI 10.1073/pnas.1308295110; Swardfager W, 2016, NEUROSCI BIOBEHAV R, V64, P148, DOI 10.1016/j.neubiorev.2016.02.017; Toffoli M, 2017, NEUROL SCI, V38, P1233, DOI 10.1007/s10072-017-2945-2; Tung JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023473; Vetrivelan R, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00145; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wassing R, 2016, P NATL ACAD SCI USA, V113, P2538, DOI 10.1073/pnas.1522520113; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; Wei Y, 2016, SLEEP, V39, P2113, DOI 10.5665/sleep.6308; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; WILSON CJ, 1981, BRAIN RES, V220, P67, DOI 10.1016/0006-8993(81)90211-0; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Zhang B, 2006, SLEEP, V29, P85, DOI 10.1093/sleep/29.1.85; Zhernakova DV, 2017, NAT GENET, V49, P139, DOI 10.1038/ng.3737; Zhu ZH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02317-2	72	270	273	8	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2019	51	3					394	+		10.1038/s41588-018-0333-3	http://dx.doi.org/10.1038/s41588-018-0333-3			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HN1KZ	30804565	Green Submitted			2022-12-17	WOS:000459947200009
J	Cai, J; Liu, X; Vanneste, K; Proost, S; Tsai, WC; Liu, KW; Chen, LJ; He, Y; Xu, Q; Bian, C; Zheng, ZJ; Sun, FM; Liu, WQ; Hsiao, YY; Pan, ZJ; Hsu, CC; Yang, YP; Hsu, YC; Chuang, YC; Dievart, A; Dufayard, JF; Xu, X; Wang, JY; Wang, J; Xiao, XJ; Zhao, XM; Du, R; Zhang, GQ; Wang, MN; Su, YY; Xie, GC; Liu, GH; Li, LQ; Huang, LQ; Luo, YB; Chen, HH; Van de Peer, Y; Liu, ZJ				Cai, Jing; Liu, Xin; Vanneste, Kevin; Proost, Sebastian; Tsai, Wen-Chieh; Liu, Ke-Wei; Chen, Li-Jun; He, Ying; Xu, Qing; Bian, Chao; Zheng, Zhijun; Sun, Fengming; Liu, Weiqing; Hsiao, Yu-Yun; Pan, Zhao-Jun; Hsu, Chia-Chi; Yang, Ya-Ping; Hsu, Yi-Chin; Chuang, Yu-Chen; Dievart, Anne; Dufayard, Jean-Francois; Xu, Xun; Wang, Jun-Yi; Wang, Jun; Xiao, Xin-Ju; Zhao, Xue-Min; Du, Rong; Zhang, Guo-Qiang; Wang, Meina; Su, Yong-Yu; Xie, Gao-Chang; Liu, Guo-Hui; Li, Li-Qiang; Huang, Lai-Qiang; Luo, Yi-Bo; Chen, Hong-Hwa; Van de Peer, Yves; Liu, Zhong-Jian			The genome sequence of the orchid Phalaenopsis equestris	NATURE GENETICS			English	Article							CRASSULACEAN ACID METABOLISM; MADS-BOX GENE; MOLECULAR PHYLOGENETICS; PLANT; IDENTIFICATION; DUPLICATIONS; POLYPLOIDY; EPIPHYTISM; EVOLUTION; PROGRAM	Orchidaceae, renowned for its spectacular flowers and other reproductive and ecological adaptations, is one of the most diverse plant families. Here we present the genome sequence of the tropical epiphytic orchid Phalaenopsis equestris, a frequently used parent species for orchid breeding. P. equestris is the first plant with crassulacean acid metabolism (CAM) for which the genome has been sequenced. Our assembled genome contains 29,431 predicted protein-coding genes. We find that contigs likely to be underassembled, owing to heterozygosity, are enriched for genes that might be involved in self-incompatibility pathways. We find evidence for an orchid-specific paleopolyploidy event that preceded the radiation of most orchid clades, and our results suggest that gene duplication might have contributed to the evolution of CAM photosynthesis in P. equestris. Finally, we find expanded and diversified families of MADS-box C/D-class, B-class AP3 and AGL6-class genes, which might contribute to the highly specialized morphology of orchid flowers.	[Cai, Jing; Liu, Ke-Wei; Chen, Li-Jun; Xiao, Xin-Ju; Zhang, Guo-Qiang; Wang, Meina; Xie, Gao-Chang; Liu, Guo-Hui; Li, Li-Qiang; Huang, Lai-Qiang; Liu, Zhong-Jian] Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China; [Cai, Jing; Liu, Ke-Wei; Chen, Li-Jun; Xiao, Xin-Ju; Zhang, Guo-Qiang; Wang, Meina; Xie, Gao-Chang; Liu, Guo-Hui; Li, Li-Qiang; Huang, Lai-Qiang; Liu, Zhong-Jian] Orchid Conservat & Res Ctr Shenzhen, Shenzhen, Peoples R China; [Cai, Jing; Liu, Ke-Wei; Huang, Lai-Qiang; Liu, Zhong-Jian] Tsinghua Univ, Grad Sch Shenzhen, State Key Lab Hlth Sci & Technol, Ctr Biotechnol & BioMed,Shenzhen Key Lab Gene & A, Shenzhen 518057, Peoples R China; [Cai, Jing; Liu, Ke-Wei; Huang, Lai-Qiang; Liu, Zhong-Jian] Tsinghua Univ, Grad Sch Shenzhen, Div Life & Hlth Sci, Shenzhen 518057, Peoples R China; [Cai, Jing; Liu, Ke-Wei; Huang, Lai-Qiang] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Liu, Xin; Bian, Chao; Zheng, Zhijun; Sun, Fengming; Liu, Weiqing; Xu, Xun; Wang, Jun-Yi; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [He, Ying; Van de Peer, Yves] VIB, Dept Plant Syst Biol, Ghent, Belgium; [Vanneste, Kevin; Proost, Sebastian; He, Ying; Van de Peer, Yves] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [Tsai, Wen-Chieh] Natl Cheng Kung Univ, Inst Trop Plant Sci, Tainan 70101, Taiwan; [Xu, Qing; Luo, Yi-Bo] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Hsiao, Yu-Yun; Pan, Zhao-Jun; Hsu, Chia-Chi; Yang, Ya-Ping; Hsu, Yi-Chin; Chuang, Yu-Chen; Chen, Hong-Hwa] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan; [Dievart, Anne; Dufayard, Jean-Francois] Ctr Cooprat Int Rech Agronom Dev CIRAD, UMR Ameliorat Genet & Adaptat Plantes Mediterrane, Montpellier, France; [Zhao, Xue-Min; Du, Rong] State Forestry Adm, Beijing, Peoples R China; [Su, Yong-Yu; Huang, Lai-Qiang; Liu, Zhong-Jian] South China Agr Univ, Coll Forestry, Guangzhou, Guangdong, Peoples R China; [Chen, Hong-Hwa] Natl Cheng Kung Univ, Orchid Res Ctr, Tainan 70101, Taiwan; [Van de Peer, Yves] Genom Res Inst, Dept Genet, Pretoria, South Africa	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Tsinghua University; Beijing Genomics Institute (BGI); Flanders Institute for Biotechnology (VIB); Ghent University; National Cheng Kung University; Chinese Academy of Sciences; Institute of Botany, CAS; National Cheng Kung University; CIRAD; South China Agricultural University; National Cheng Kung University	Huang, LQ (corresponding author), Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China.	huanglq@mail.tsinghua.edu.cn; luoyb@ibcas.ac.cn; hhchen@mail.ncku.edu.tw; yves.vandepeer@psb.vib-ugent.be; liuzj@sinicaorchid.org	wang, junyi/GYA-3213-2022; Dufayard, Jean-François/AAC-7013-2020; Xu, Xun/AAI-6763-2020; Van de Peer, Yves/AAE-7666-2019; Proost, Sebastian/AAB-9845-2022; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Xu, Xun/0000-0002-5338-5173; Van de Peer, Yves/0000-0003-4327-3730; Proost, Sebastian/0000-0002-6792-9442; Dievart, Anne/0000-0001-9460-4638; Luo, Yi-bo/0000-0002-2824-8011; Liu, Xin/0000-0003-3256-2940; Cai, Jing/0000-0002-2496-4731; Zhang, Guo-Qiang/0000-0001-6439-019X; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931	948 Program of the State Forestry Administration (China) [2011-4-53]; Shenzhen Municipal Science AMP; Technology Programs for Building State and Shenzhen Key Laboratories [2006464, 200712, CXB201005260070A]; Youth Talent Fund of the Shenzhen municipal government [JC201005310690A]; Ghent University; European Union [322739-DOUBLE-UP]; Hercules Foundation; Flemish Government Department of Economy, Science and Innovation	948 Program of the State Forestry Administration (China); Shenzhen Municipal Science AMP; Technology Programs for Building State and Shenzhen Key Laboratories; Youth Talent Fund of the Shenzhen municipal government; Ghent University(Ghent University); European Union(European Commission); Hercules Foundation; Flemish Government Department of Economy, Science and Innovation	We thank J.C. Pires for helpful discussions. The authors acknowledge support from the 948 Program of the State Forestry Administration (China) (2011-4-53) to Z.-J.L. and X.-M.Z., the Shenzhen Municipal Science & Technology Programs for Building State and Shenzhen Key Laboratories (no. 2006464, 200712 and CXB201005260070A) to L.-Q.H., the Youth Talent Fund of the Shenzhen municipal government (JC201005310690A) to J.C. and the Ghent University Multidisciplinary Research Partnership 'Bioinformatics: From Nucleotides to Networks' to Y.V.d.P.Y.V.d.P. also acknowledges support from the European Union Seventh Framework Programme (FP7/2007-2013) under European Research Council Advanced Grant Agreement 322739-DOUBLE-UP. Part of this work was carried out using the Stevin Supercomputer Infrastructure at Ghent University, funded by Ghent University, the Hercules Foundation and the Flemish Government Department of Economy, Science and Innovation.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BENZING DH, 1987, ANN MO BOT GARD, V74, P183, DOI 10.2307/2399394; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bosch M, 2008, MOL PLANT, V1, P879, DOI 10.1093/mp/ssn053; CAMPBELL CS, 1999, PLANT SYSTEMATICS PH; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Chen Nansheng, 2004, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s05; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cozzolino S, 2005, TRENDS ECOL EVOL, V20, P487, DOI 10.1016/j.tree.2005.06.004; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; Darwin C, 2011, VARIOUS CONTRIVANCES; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; Dixit R, 2001, PLANT PHYSIOL, V125, P105, DOI 10.1104/pp.125.1.105; Douzery EJP, 1999, AM J BOT, V86, P887, DOI 10.2307/2656709; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Favaro R, 2002, MOL GENET GENOMICS, V268, P152, DOI 10.1007/s00438-002-0746-6; Fu CH, 2011, PLANT CELL PHYSIOL, V52, P238, DOI 10.1093/pcp/pcq201; Gravendeel B, 2004, PHILOS T ROY SOC B, V359, P1523, DOI 10.1098/rstb.2004.1529; Holtum JAM, 2007, AM J BOT, V94, P1670, DOI 10.3732/ajb.94.10.1670; Hsiao YY, 2013, GENE, V518, P91, DOI 10.1016/j.gene.2012.11.069; Hsu CC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-3; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiao YN, 2014, PLANT CELL, V26, P2792, DOI 10.1105/tpc.114.127597; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim C, 2014, PLANT CELL, V26, P2420, DOI 10.1105/tpc.114.125583; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Leitch IJ, 2009, ANN BOT-LONDON, V104, P469, DOI 10.1093/aob/mcp003; Leseberg CH, 2006, GENE, V378, P84, DOI 10.1016/j.gene.2006.05.022; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lin S, 2001, J AM SOC HORTIC SCI, V126, P195, DOI 10.21273/JASHS.126.2.195; Luttge U, 2004, ANN BOT-LONDON, V93, P629, DOI 10.1093/aob/mch087; Luttge U., 1989, VASCULAR PLANTS EPIP, VVolume 76; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Masiero S, 2011, PLANT CELL, V23, P865, DOI 10.1105/tpc.110.081737; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; O'Donoghue EM, 2002, J EXP BOT, V53, P513, DOI 10.1093/jexbot/53.368.513; Pan ZJ, 2014, NEW PHYTOL, V202, P1024, DOI 10.1111/nph.12723; Pan ZJ, 2011, PLANT CELL PHYSIOL, V52, P1515, DOI 10.1093/pcp/pcr092; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pospisilova J., 1991, BIOL PLANTARUM, V33, P500; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Proost S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr955; Proost S, 2011, PLANT J, V66, P58, DOI 10.1111/j.1365-313X.2011.04521.x; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; Ramirez SR, 2007, NATURE, V448, P1042, DOI 10.1038/nature06039; Ruelens P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3280; Schiestl FP, 2003, SCIENCE, V302, P437, DOI 10.1126/science.1087835; Schnable JC, 2011, P NATL ACAD SCI USA, V108, P4069, DOI 10.1073/pnas.1101368108; Seok HY, 2010, BIOCHEM BIOPH RES CO, V401, P598, DOI 10.1016/j.bbrc.2010.09.108; Silvera K, 2010, FUNCT PLANT BIOL, V37, P995, DOI 10.1071/FP10084; Silvera K, 2009, PLANT PHYSIOL, V149, P1838, DOI 10.1104/pp.108.132555; Soltis DE, 2014, AM J BOT, V101, P1057, DOI 10.3732/ajb.1400178; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tapia-Lopez R, 2008, PLANT PHYSIOL, V146, P1182, DOI 10.1104/pp.107.108647; Thompson J.D., 2003, CURR PROTOC BIOINFOR, V1, P2, DOI [10.1002/0471250953.bi0203s00, DOI 10.1002/0471250953.BI0203S00]; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai WC, 2004, PLANT CELL PHYSIOL, V45, P831, DOI 10.1093/pcp/pch095; Tsai WC, 2008, PLANT CELL PHYSIOL, V49, P814, DOI 10.1093/pcp/pcn059; Tsai WC, 2013, PLANT CELL PHYSIOL, V54, pE7, DOI 10.1093/pcp/pcs187; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Vanneste K, 2014, GENOME RES, V24, P1334, DOI 10.1101/gr.168997.113; Vanneste K, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0353; Vanneste K, 2013, MOL BIOL EVOL, V30, P177, DOI 10.1093/molbev/mss214; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Whitten WM, 2007, AM J BOT, V94, P1860, DOI 10.3732/ajb.94.11.1860; Whitten WM, 2000, AM J BOT, V87, P1842, DOI 10.2307/2656837; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195	86	270	303	18	181	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2015	47	1					65	+		10.1038/ng.3149	http://dx.doi.org/10.1038/ng.3149			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX5TM	25420146	Green Published, hybrid			2022-12-17	WOS:000346990400013
J	Brastianos, PK; Taylor-Weiner, A; Manley, PE; Jones, RT; Dias-Santagata, D; Thorner, AR; Lawrence, MS; Rodriguez, FJ; Bernardo, LA; Schubert, L; Sunkavalli, A; Shillingford, N; Calicchio, ML; Lidov, HGW; Taha, H; Martinez-Lage, M; Santi, M; Storm, PB; Lee, JYK; Palmer, JN; Adappa, ND; Scott, RM; Dunn, IF; Laws, ER; Stewart, C; Ligon, KL; Hoang, MP; Van Hummelen, P; Hahn, WC; Louis, DN; Resnick, AC; Kieran, MW; Getz, G; Santagata, S				Brastianos, Priscilla K.; Taylor-Weiner, Amaro; Manley, Peter E.; Jones, Robert T.; Dias-Santagata, Dora; Thorner, Aaron R.; Lawrence, Michael S.; Rodriguez, Fausto J.; Bernardo, Lindsay A.; Schubert, Laura; Sunkavalli, Ashwini; Shillingford, Nick; Calicchio, Monica L.; Lidov, Hart G. W.; Taha, Hala; Martinez-Lage, Maria; Santi, Mariarita; Storm, Phillip B.; Lee, John Y. K.; Palmer, James N.; Adappa, Nithin D.; Scott, R. Michael; Dunn, Ian F.; Laws, Edward R., Jr.; Stewart, Chip; Ligon, Keith L.; Hoang, Mai P.; Van Hummelen, Paul; Hahn, William C.; Louis, David N.; Resnick, Adam C.; Kieran, Mark W.; Getz, Gad; Santagata, Sandro			Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas	NATURE GENETICS			English	Article							ADAMANTINOMATOUS CRANIOPHARYNGIOMAS; BETA-CATENIN; CANCER; TUMORS; INHIBITION; RESISTANCE; DISCOVERY; FRAMEWORK; MELANOMA; SURVIVAL	Craniopharyngiomas are epithelial tumors that typically arise in the suprasellar region of the brain(1). Patients experience substantial clinical sequelae from both extension of the tumors and therapeutic interventions that damage the optic chiasm, the pituitary stalk and the hypothalamic area(2-4). Using whole-exome sequencing, we identified mutations in CTNNB1 (beta-catenin) in nearly all adamantinomatous craniopharyngiomas examined (11/12, 92%) and recurrent mutations in BRAF (resulting in p. Val600Glu) in all papillary craniopharyngiomas (3/3, 100%). Targeted genotyping revealed BRAF p. Val600Glu in 95% of papillary craniopharyngiomas (36 of 39 tumors) and mutation of CTNNB1 in 96% of adamantinomatous craniopharyngiomas (51 of 53 tumors). The CTNNB1 and BRAF mutations were clonal in each tumor subtype, and we detected no other recurrent mutations or genomic aberrations in either subtype. Adamantinomatous and papillary craniopharyngiomas harbor mutations that are mutually exclusive and clonal. These findings have important implications for the diagnosis and treatment of these neoplasms.	[Brastianos, Priscilla K.] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA; [Brastianos, Priscilla K.] Massachusetts Gen Hosp, Div Neurooncol, Boston, MA 02114 USA; [Brastianos, Priscilla K.; Dias-Santagata, Dora; Lidov, Hart G. W.; Scott, R. Michael; Dunn, Ian F.; Laws, Edward R., Jr.; Ligon, Keith L.; Hoang, Mai P.; Hahn, William C.; Louis, David N.; Kieran, Mark W.; Getz, Gad; Santagata, Sandro] Harvard Univ, Sch Med, Boston, MA USA; [Brastianos, Priscilla K.; Jones, Robert T.; Thorner, Aaron R.; Ligon, Keith L.; Van Hummelen, Paul] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Brastianos, Priscilla K.; Taylor-Weiner, Amaro; Lawrence, Michael S.; Stewart, Chip; Hahn, William C.; Getz, Gad] Broad Inst MIT & Harvard, Boston, MA USA; [Manley, Peter E.; Kieran, Mark W.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Jones, Robert T.; Thorner, Aaron R.; Schubert, Laura; Sunkavalli, Ashwini; Van Hummelen, Paul; Hahn, William C.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Dias-Santagata, Dora; Bernardo, Lindsay A.; Hoang, Mai P.; Louis, David N.; Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Rodriguez, Fausto J.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Shillingford, Nick; Calicchio, Monica L.; Lidov, Hart G. W.; Ligon, Keith L.; Santagata, Sandro] Boston Childrens Hosp, Dept Pathol, Boston, MA USA; [Lidov, Hart G. W.; Ligon, Keith L.; Santagata, Sandro] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Taha, Hala] Childrens Canc Hosp Egypt, Cairo, Egypt; [Martinez-Lage, Maria] Hosp Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Santi, Mariarita] Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA; [Storm, Phillip B.; Lee, John Y. K.; Palmer, James N.; Resnick, Adam C.] Hosp Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Storm, Phillip B.; Resnick, Adam C.] Childrens Hosp Philadelphia, Div Neurosurg, Philadelphia, PA 19104 USA; [Palmer, James N.; Adappa, Nithin D.] Hosp Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Scott, R. Michael] Boston Childrens Hosp, Dept Neurosurg, Boston, MA USA; [Dunn, Ian F.; Laws, Edward R., Jr.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Kieran, Mark W.] Boston Childrens Hosp, Dept Pediat, Boston, MA USA; [Santagata, Sandro] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Johns Hopkins University; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Children's Cancer Hospital 57357; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute	Brastianos, PK (corresponding author), Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA.	pbrast@broadinstitute.org; gadgetz@broadinstitute.org; ssantagata@partners.org	Martinez-Lage, Maria/S-6665-2019; Lawrence, Michael/AAC-8202-2020	Kieran, Mark/0000-0003-2184-7692; Hoang, Mai/0000-0002-1406-7981; Jones, Robert/0000-0001-8007-4023; Brastianos, Priscilla/0000-0003-4470-8425; van hummelen, paul/0000-0002-4801-8600; Sunkavalli, Ashwini/0000-0002-5561-3694; Shillingford, Nick/0000-0001-9636-9977; Santagata, Sandro/0000-0002-7528-9668; Martinez-Lage, Maria/0000-0002-5859-7562	Brain Science Foundation [K12 CA090354-11, K08 NS064168]; Terri Brodeur Breast Cancer Foundation; Conquer Cancer Foundation; American Brain Tumor Association; NATIONAL CANCER INSTITUTE [P01CA142536, K12CA090354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS064168] Funding Source: NIH RePORTER	Brain Science Foundation; Terri Brodeur Breast Cancer Foundation; Conquer Cancer Foundation; American Brain Tumor Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Ducar for his assistance with genomic analyses; S. Chauvin for project management; L. Brown and H. Malkin for assisting with sample collection; T. Woo, B. Rich, R. Machaidze and D. Feldman for technical assistance; N. Stransky for the design of Figure 2a; and H. Taylor-Weiner and C. H. Brastianos for critical review of the manuscript. This work was supported by the Jared Branfman Sunflowers for Life Fund for Pediatric Brain and Spinal Cancer Research, the Pediatric Low-Grade Astrocytoma (PLGA) Program (S. S., W. C. H. and Charles D. Stiles), Pedals for Pediatrics and the Clark Family (P. E. M. and M. W. K.), the Stahl Family Charitable Foundation (P. E. M.), the Stop & Shop Pediatric Brain Tumor Program (P. E. M. and M. W. K.), the Pediatric Brain Tumor Clinical and Research Fund (P. E. M. and M. W. K.), the Children's Brain Tumor Foundation and the V Foundation (S. S.). S. S. is supported by grant K08 NS064168, and P. K. B. is supported by grant K12 CA090354-11, the Brain Science Foundation, Susan G. Komen for the Cure, the Terri Brodeur Breast Cancer Foundation, the Conquer Cancer Foundation and the American Brain Tumor Association.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Ascierto PA, 2013, J CLIN ONCOL, V31, P3205, DOI 10.1200/JCO.2013.49.8691; Barkhoudarian G, 2013, PITUITARY, V16, P1, DOI 10.1007/s11102-012-0402-z; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Brastianos PK, 2013, NAT GENET, V45, P285, DOI 10.1038/ng.2526; Buslei R, 2005, ACTA NEUROPATHOL, V109, P589, DOI 10.1007/s00401-005-1004-x; Capper D, 2011, ACTA NEUROPATHOL, V122, P11, DOI 10.1007/s00401-011-0841-z; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chamberlain MC, 2013, J NEURO-ONCOL, V114, P237, DOI 10.1007/s11060-013-1176-5; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Corcoran RB, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001148; CROTTY TB, 1995, J NEUROSURG, V83, P206, DOI 10.3171/jns.1995.83.2.0206; Cushing H., 1932, JAMA-J AM MED ASSOC, V100, P284; Demichelis F, 2008, NUCLEIC ACIDS RES, V36, P2446, DOI 10.1093/nar/gkn089; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dias-Santagata D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017948; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Dietrich S, 2012, NEW ENGL J MED, V366, P2038, DOI 10.1056/NEJMc1202124; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Duff JM, 2000, NEUROSURGERY, V46, P291, DOI 10.1097/00006123-200002000-00007; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Jones DTW, 2009, ONCOGENE, V28, P2119, DOI 10.1038/onc.2009.73; Kato K, 2004, J PATHOL, V203, P814, DOI 10.1002/path.1562; Laczmanska I, 2011, ACTA BIOCHIM POL, V58, P467; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liubinas SV, 2011, J CLIN NEUROSCI, V18, P451, DOI 10.1016/j.jocn.2010.10.004; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Louis DN, 2007, WHO CLASSIFICATION T, P238; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Manley PE, 2012, J NEURO-ONCOL, V108, P543, DOI 10.1007/s11060-012-0859-7; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ribas A, 2011, NAT REV CLIN ONCOL, V8, P426, DOI 10.1038/nrclinonc.2011.69; Rickert CH, 2003, J NEUROL NEUROSUR PS, V74, P260, DOI 10.1136/jnnp.74.2.260; Rush S, 2013, J CLIN ONCOL, V31, pE159, DOI 10.1200/JCO.2012.44.1568; Schindler G, 2011, ACTA NEUROPATHOL, V121, P397, DOI 10.1007/s00401-011-0802-6; Sekine S, 2002, AM J PATHOL, V161, P1997, DOI 10.1016/S0002-9440(10)64477-X; Sievert AJ, 2013, P NATL ACAD SCI USA, V110, P5957, DOI 10.1073/pnas.1219232110; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Stanley FKT, 2013, MUTAT RES-FUND MOL M, V750, P31, DOI 10.1016/j.mrfmmm.2013.07.008; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tian YJ, 2011, J MOL DIAGN, V13, P669, DOI 10.1016/j.jmoldx.2011.07.002; WEINER HL, 1994, NEUROSURGERY, V35, P1001, DOI 10.1227/00006123-199412000-00001; Yoshimoto M, 2004, J NEUROSURG, V101, P85, DOI 10.3171/ped.2004.101.2.0085	50	270	291	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					161	U100		10.1038/ng.2868	http://dx.doi.org/10.1038/ng.2868			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24413733	Green Accepted, Green Submitted			2022-12-17	WOS:000331208300012
J	Zhang, HX; Zhai, Y; Hu, ZB; Wu, C; Qian, J; Jia, WH; Ma, FC; Huang, WF; Yu, LX; Yue, W; Wang, ZF; Li, PY; Zhang, Y; Liang, RX; Wei, ZL; Cui, Y; Xie, WM; Cai, M; Yu, XS; Yuan, YF; Xia, X; Zhang, XM; Yang, H; Qiu, W; Yang, JM; Gong, F; Chen, MS; Shen, HB; Lin, DX; Zeng, YX; He, FC; Zhou, GQ				Zhang, Hongxing; Zhai, Yun; Hu, Zhibin; Wu, Chen; Qian, Ji; Jia, Weihua; Ma, Fuchao; Huang, Wenfeng; Yu, Lixia; Yue, Wei; Wang, Zhifu; Li, Peiyao; Zhang, Yang; Liang, Renxiang; Wei, Zhongliang; Cui, Ying; Xie, Weimin; Cai, Mi; Yu, Xinsen; Yuan, Yunfei; Xia, Xia; Zhang, Xiumei; Yang, Hao; Qiu, Wei; Yang, Jingmin; Gong, Feng; Chen, Minshan; Shen, Hongbing; Lin, Dongxin; Zeng, Yi-Xin; He, Fuchu; Zhou, Gangqiao			Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR; CHROMOSOME 1P; GENE; UBIQUITIN; CANCER; KIF1B; HEPATOCARCINOGENESIS; NEUROBLASTOMA; MUTATION; RISK	To identify susceptibility variants for hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), we conducted a genome-wide association study by genotyping 440,794 SNPs in 355 chronic HBV carriers with HCC and 360 chronic HBV carriers without HCC, all of Chinese ancestry. We identified one intronic SNP (rs17401966) in KIF1B on chromosome 1p36.22 that was highly associated with HBV-related HCC and confirmed this association in five additional independent samples, consisting of 1,962 individuals with HCC, 1,430 control subjects and 159 family trios. Across the six studies, the association with rs17401966 was highly statistically significant (joint odds ratio = 0.61, P = 1.7 x 10(-18)). In addition to KIF1B, the association region tagged two other plausible causative genes, UBE4B and PGD. Our findings provide evidence that the 1p36.22 locus confers susceptibility to HBV-related HCC, and suggest that KIF1B-, UBE4B- or PGD-related pathways might be involved in the pathogenesis of this malignancy.	[Zhang, Hongxing; Zhai, Yun; Yu, Lixia; Yue, Wei; Wang, Zhifu; Li, Peiyao; Zhang, Yang; Cai, Mi; Xia, Xia; Zhang, Xiumei; Yang, Hao; Qiu, Wei; Gong, Feng; He, Fuchu; Zhou, Gangqiao] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China; [Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Wu, Chen; Lin, Dongxin] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, Beijing 100037, Peoples R China; [Qian, Ji; Yang, Jingmin] Fudan Univ, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Qian, Ji; Yang, Jingmin] Fudan Univ, Ctr Evolutionary Biol, Sch Life Sci, Shanghai 200433, Peoples R China; [Qian, Ji; Yang, Jingmin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Jia, Weihua; Yuan, Yunfei; Zeng, Yi-Xin] State Key Lab Oncol So China, Guangzhou, Guangdong, Peoples R China; [Jia, Weihua; Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Ma, Fuchao; Huang, Wenfeng; Cui, Ying; Xie, Weimin] Canc Inst Guangxi, Nanning, Guangxi, Peoples R China; [Liang, Renxiang; Wei, Zhongliang] Liver Canc Inst Fusui Cty, Guangxi, Peoples R China; [Chen, Minshan] Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Oncol, Guangzhou 510275, Guangdong, Peoples R China; [He, Fuchu] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Academy of Military Medical Sciences - China; Nanjing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Fudan University; Fudan University; Fudan University; Sun Yat Sen University; Sun Yat Sen University; Fudan University	Zhou, GQ (corresponding author), Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China.	hefc@nic.bmi.ac.cn; zhougq114@gmail.com		Shen, Hongbing/0000-0002-2581-5906; Lin, Dongxin/0000-0002-8723-8868; Wu, Chen/0000-0003-4954-1011; He, Fuchu/0000-0002-8571-2351; Zhou, Gangqiao/0000-0002-4895-5063; Huang, Wenfeng/0000-0002-3194-4368; Yuan, Yunfei/0000-0003-2467-3683	Chinese National High-tech Program [2006AA02A412]; Chinese Key Project for Infectious Diseases [2008ZX10002-016]; Chinese National Science Fund for Creative Research Groups Program [30621063]; Beijing Science and Technology NOVA program [2006A54]	Chinese National High-tech Program; Chinese Key Project for Infectious Diseases; Chinese National Science Fund for Creative Research Groups Program(Science Fund for Creative Research Groups); Beijing Science and Technology NOVA program	We thank the subjects and their families for participating in this study, and the clinicians, nurses and study coordinators for their contributions. This study was supported in part by grants from Chinese National High-tech Program 2006AA02A412 (G.Z.), Chinese Key Project for Infectious Diseases 2008ZX10002-016 (G.Z.), Chinese National Science Fund for Creative Research Groups Program 30621063 (F. H.) and Beijing Science and Technology NOVA program 2006A54 (G.Z.).	Aulchenko YS, 2008, NAT GENET, V40, P1402, DOI 10.1038/ng.251; Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Benn DE, 2000, CANCER RES, V60, P7048; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chatterjee A, 2008, CELL CYCLE, V7, P1231, DOI 10.4161/cc.7.9.5795; Chen CJ, 1997, J GASTROEN HEPATOL, V12, pS294, DOI 10.1111/j.1440-1746.1997.tb00513.x; Chen CJ, 2002, HEPATOLOGY, V36, P1046, DOI 10.1053/jhep.2002.37084; Dawson SP, 2008, BBA-MOL BASIS DIS, V1782, P775, DOI 10.1016/j.bbadis.2008.08.003; Giusti L, 2008, J PROTEOME RES, V7, P4079, DOI 10.1021/pr8000404; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Houlston RS, 1996, QJM-INT J MED, V89, P737, DOI 10.1093/qjmed/89.10.737; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Kim YJ, 2005, INTERVIROLOGY, V48, P10, DOI 10.1159/000082089; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Krona C, 2003, ONCOGENE, V22, P2343, DOI 10.1038/sj.onc.1206324; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; Li SP, 2001, J HEPATOL, V34, P840, DOI 10.1016/S0168-8278(01)00047-2; McGlynn KA, 2005, BEST PRACT RES CL GA, V19, P3, DOI 10.1016/j.bpg.2004.10.004; Menashe I, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-36; Midorikawa Y, 2009, HEPATOLOGY, V49, P513, DOI 10.1002/hep.22698; Munirajan AK, 2008, J BIOL CHEM, V283, P24426, DOI 10.1074/jbc.M802316200; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Nicodemus KK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-130; NOVELLO F, 1968, BIOCHEM J, V107, P775, DOI 10.1042/bj1070775; Schlisio S, 2008, GENE DEV, V22, P884, DOI 10.1101/gad.1648608; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Stacey SN, 2008, NAT GENET, V40, P1313, DOI 10.1038/ng.234; Turyn J, 2003, HORM METAB RES, V35, P565, DOI 10.1055/s-2003-43500; Yang HW, 2001, ONCOGENE, V20, P5075, DOI 10.1038/sj.onc.1204456; Yeh IT, 2008, HUM GENET, V124, P279, DOI 10.1007/s00439-008-0553-1; Yu MW, 1997, AM J EPIDEMIOL, V145, P1039, DOI 10.1093/oxfordjournals.aje.a009060; Yu MW, 2000, J NATL CANCER I, V92, P1159, DOI 10.1093/jnci/92.14.1159; Zhai Y, 2006, GASTROENTEROLOGY, V130, P2001, DOI 10.1053/j.gastro.2006.02.030	34	270	290	1	184	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					755	U39		10.1038/ng.638	http://dx.doi.org/10.1038/ng.638			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20676096				2022-12-17	WOS:000281388400009
J	Styrkarsdottir, U; Halldorsson, BV; Gretarsdottir, S; Gudbjartsson, DF; Walters, GB; Ingvarsson, T; Jonsdottir, T; Saemundsdottir, J; Snorradottir, S; Center, JR; Nguyen, TV; Alexandersen, P; Gulcher, JR; Eisman, JA; Christiansen, C; Sigurdsson, G; Kong, A; Thorsteinsdottir, U; Stefansson, K				Styrkarsdottir, Unnur; Halldorsson, Bjarni V.; Gretarsdottir, Solveig; Gudbjartsson, Daniel F.; Walters, G. Bragi; Ingvarsson, Thorvaldur; Jonsdottir, Thorbjorg; Saemundsdottir, Jona; Snorradottir, Steinunn; Center, Jacqueline R.; Nguyen, Tuan V.; Alexandersen, Peter; Gulcher, Jeffrey R.; Eisman, John A.; Christiansen, Claus; Sigurdsson, Gunnar; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari			New sequence variants associated with bone mineral density	NATURE GENETICS			English	Article							OSTEOPOROTIC FRACTURES; BUCHEM-DISEASE; SOST GENE; BMD; SCLEROSTEOSIS; PROTEIN; LRP5; HIP	In an extended genome-wide association study of bone mineral density among 6,865 Icelanders and a follow-up in 8,510 subjects of European descent, we identified four new genome-wide significant loci. These are near the SOST gene at 17q21, the MARK3 gene at 14q32, the SP7 gene at 12q13 and the TNFRSF11A (RANK) gene at 18q21. Furthermore, nonsynonymous SNPs in the C17orf53, LRP4, ADAM19 and IBSP genes were suggestively associated with bone density.	[Styrkarsdottir, Unnur; Halldorsson, Bjarni V.; Gretarsdottir, Solveig; Gudbjartsson, Daniel F.; Walters, G. Bragi; Jonsdottir, Thorbjorg; Saemundsdottir, Jona; Snorradottir, Steinunn; Gulcher, Jeffrey R.; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Styrkarsdottir, Unnur] Reykjavik Univ, IS-103 Reykjavik, Iceland; [Ingvarsson, Thorvaldur] Univ Akureyri, Inst Hlth Sci, FSA Univ Hosp, IS-600 Akureyri, Iceland; [Center, Jacqueline R.; Nguyen, Tuan V.; Eisman, John A.] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Center, Jacqueline R.; Nguyen, Tuan V.; Eisman, John A.] St Vincents Hosp, Sydney, NSW 2010, Australia; [Center, Jacqueline R.; Nguyen, Tuan V.; Eisman, John A.] Univ New S Wales, Sydney, NSW 2010, Australia; [Alexandersen, Peter] Ctr Clin & Basic Res AS, DK-2750 Ballerup, Denmark; [Christiansen, Claus] Nordic Biosci AS, DK-2730 Herlev, Denmark; [Sigurdsson, Gunnar] Univ Iceland, Landspitali Univ Hosp, Div Endocrinol & Metab, IS-108 Reykjavik, Iceland	Reykjavik University; University of Akureyri; Garvan Institute of Medical Research; St Vincents Hospital Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney; Center Clinical & Basic Research; Landspitali National University Hospital; University of Iceland	Stefansson, K (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	unnur.styrkarsdottir@decode.is; kari.stefansson@decode.is	Nguyen, Tuan V/B-6147-2008; Center, Jacqueline/AAY-8712-2021; Stefansson, Kari/AAE-7187-2019; Walters, G. Bragi/L-4215-2013; Nguyen, Tuan V./AAD-9503-2020; Eisman, John A/C-2886-2014	Nguyen, Tuan V/0000-0002-3246-6281; Center, Jacqueline/0000-0002-5278-4527; Walters, G. Bragi/0000-0002-5415-6487; Nguyen, Tuan V./0000-0002-3246-6281; Kong, Augustine/0000-0001-8193-5438; Halldorsson, Bjarni/0000-0003-0756-0767; Gudbjartsson, Daniel/0000-0002-5222-9857; Styrkarsdottir, Unnur/0000-0001-8146-8278				Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kanis JA, 2008, BONE, V42, P467, DOI 10.1016/j.bone.2007.11.001; Mizuguchi T, 2004, J HUM GENET, V49, P80, DOI 10.1007/s10038-003-0111-6; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Sigurdsson G, 2008, J BONE MINER RES, V23, P1584, DOI 10.1359/JBMR.080507; Sims AM, 2008, J BONE MINER RES, V23, P499, DOI 10.1359/JBMR.071113; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Uitterlinden AG, 2004, AM J HUM GENET, V75, P1032, DOI 10.1086/426458; van Meurs JBJ, 2008, JAMA-J AM MED ASSOC, V299, P1277, DOI 10.1001/jama.299.11.1277	15	270	291	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					15	17		10.1038/ng.284	http://dx.doi.org/10.1038/ng.284			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19079262				2022-12-17	WOS:000262085300011
J	Owusu-Ansah, E; Yavari, A; Mandal, S; Banerjee, U				Owusu-Ansah, Edward; Yavari, Amir; Mandal, Sudip; Banerjee, Utpal			Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpoint	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR FOXO3A; DROSOPHILA EYE; OXIDATIVE STRESS; PROLIFERATION; APOPTOSIS; OXYGEN; JNK; SUPEROXIDE; ACTIVATION; EXPRESSION	During electron transport, the mitochondrion generates ATP and reactive oxygen species (ROS), a group of partially reduced and highly reactive metabolites of oxygen(1). In this in vivo genetic analysis in Drosophila melanogaster, we establish that disruption of complex I of the mitochondrial electron transport chain specifically retards the cell cycle during the G1-S transition. The mechanism involves a specific signaling cascade initiated by ROS and transduced by ASK-1, JNK, FOXO and the Drosophila p27 homolog, Dacapo. On the basis of our data combined with previous analyses of the system(2), we conclude that mitochondrial dysfunction activates at least two retrograde signals to specifically enforce a G1-S cell cycle checkpoint. One such signal involves an increase in AMP production and downregulation of cyclin E protein; another independent pathway involves increased ROS and upregulation of Dacapo. Thus, our results indicate that the mitochondrion can use AMP and ROS at sublethal concentrations as independent signaling molecules to modulate cell cycle progression.	[Owusu-Ansah, Edward; Yavari, Amir; Mandal, Sudip; Banerjee, Utpal] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Banerjee, U (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	banerjee@mbi.ucla.edu		Mandal, Sudip/0000-0002-2211-483X	NEI NIH HHS [R01 EY008152, R01-EY00852] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008152] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Baker NE, 2001, SEMIN CELL DEV BIOL, V12, P499, DOI 10.1006/scdb.2001.0274; Baonza A, 2005, DEV CELL, V8, P529, DOI 10.1016/j.devcel.2005.01.019; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; DENOOIJ JC, 1995, SCIENCE, V270, P983, DOI 10.1126/science.270.5238.983; Edgar BA, 1996, SCIENCE, V274, P1646, DOI 10.1126/science.274.5293.1646; EDWARD EOA, 2008, NAT PROTOC; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; Jasper H, 2002, DEV CELL, V3, P511, DOI 10.1016/S1534-5807(02)00297-6; Karim FD, 1998, DEVELOPMENT, V125, P1; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Kuzin B, 1996, CELL, V87, P639, DOI 10.1016/S0092-8674(00)81384-7; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Newsome TP, 2000, DEVELOPMENT, V127, P851; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8; WOLFF T, 1991, DEVELOPMENT, V113, P841; Xu WM, 2004, NAT CELL BIOL, V6, P1129, DOI 10.1038/ncb1188	28	270	275	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2008	40	3					356	361		10.1038/ng.2007.50	http://dx.doi.org/10.1038/ng.2007.50			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18246068				2022-12-17	WOS:000253548400029
J	O'Sullivan, JM; Tan-Wong, SM; Morillon, A; Lee, B; Coles, J; Mellor, J; Proudfoot, NJ				O'Sullivan, JM; Tan-Wong, SM; Morillon, A; Lee, B; Coles, J; Mellor, J; Proudfoot, NJ			Gene loops juxtapose promoters and terminators in yeast	NATURE GENETICS			English	Article							RNA-POLYMERASE-II; 3 END; TRANSCRIPTION; SSU72; POLYADENYLATION; ARCHITECTURE; ELONGATION; COMPLEXES	Mechanistic analysis of transcriptional initiation and termination by RNA polymerase II (PolII) indicates that some factors are common to both processes(1,2). Here we show that two long genes of Saccharomyces cerevisiae, FMP27 and SEN1, exist in a looped conformation, effectively bringing together their promoter and terminator regions. We also show that PolII is located at both ends of FMP27 when this gene is transcribed from a GAL1 promoter under induced and noninduced conditions. Under these conditions, the C-terminal domain of the large subunit of PolII is phosphorylated at Ser5. Notably, inactivation of Kin28p causes a loss of both Ser5 phosphorylation and the loop conformation. These data suggest that gene loops are involved in the early stages of transcriptional activation. They also predict a previously unknown structural dimension to gene regulation, in which both ends of the transcription unit are defined before and during the transcription cycle.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Oxford, Dept Biochem, Oxford OX1 3RE, England	University of Oxford; University of Oxford	Proudfoot, NJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	nicholas.proudfoot@path.ox.ac.uk	O'Sullivan, Justin/HDO-1639-2022; Morillon, Antonin/M-4751-2017	O'Sullivan, Justin/0000-0003-2927-450X; Morillon, Antonin/0000-0002-0575-5264; Proudfoot, Nicholas/0000-0001-8646-3222				Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bhat PJ, 2001, MOL MICROBIOL, V40, P1059, DOI 10.1046/j.1365-2958.2001.02421.x; Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Calvo O, 2001, MOL CELL, V7, P1013, DOI 10.1016/S1097-2765(01)00236-2; Calvo O, 2003, GENE DEV, V17, P1321, DOI 10.1101/gad.1093603; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; Dieci G, 2003, TRENDS BIOCHEM SCI, V28, P202, DOI 10.1016/S0968-0004(03)00054-9; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756; Ganem C, 2003, EMBO J, V22, P1588, DOI 10.1093/emboj/cdg141; He XY, 2003, GENE DEV, V17, P1030, DOI 10.1101/gad.1075203; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1	27	270	276	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					1014	1018		10.1038/ng1411	http://dx.doi.org/10.1038/ng1411			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15314641	Bronze			2022-12-17	WOS:000223658100031
J	Sosa-Pineda, B; Wigle, JT; Oliver, G				Sosa-Pineda, B; Wigle, JT; Oliver, G			Hepatocyte migration during liver development requires Prox1	NATURE GENETICS			English	Article							MOUSE DEVELOPMENT; ENDODERM; GENE; GUT		St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Oliver, G (corresponding author), St Jude Childrens Res Hosp, Dept Genet, 332 N Lauderdale St, Memphis, TN 38105 USA.		Wigle, J.t./G-2005-2014	Wigle, J.t./0000-0002-4985-7684	NATIONAL EYE INSTITUTE [R01EY012162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058462] Funding Source: NIH RePORTER; NEI NIH HHS [EY12162] Funding Source: Medline; NIGMS NIH HHS [GM58462] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Hentsch B, 1996, GENE DEV, V10, P70, DOI 10.1101/gad.10.1.70; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; LEDOUARIN NM, 1975, MED BIOL, V53, P427; OLIVER G, 1993, MECH DEVELOP, V44, P3, DOI 10.1016/0925-4773(93)90012-M; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Zaret KS, 1996, ANNU REV PHYSIOL, V58, P231, DOI 10.1146/annurev.physiol.58.1.231; ZARET KS, 1988, CURR OPIN GENE DEV, V8, P526	12	270	278	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2000	25	3					254	255		10.1038/76996	http://dx.doi.org/10.1038/76996			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	329RD	10888866				2022-12-17	WOS:000087920900007
J	KOBAYASHI, T; HIRAYAMA, Y; KOBAYASHI, E; KUBO, Y; HINO, O				KOBAYASHI, T; HIRAYAMA, Y; KOBAYASHI, E; KUBO, Y; HINO, O			A GERMLINE INSERTION IN THE TUBEROUS SCLEROSIS (TSC2) GENE GIVES RISE TO THE EKER RAT MODEL OF DOMINANTLY INHERITED CANCER	NATURE GENETICS			English	Article								The Eker rat hereditary renal carcinoma (RC) is an excellent example of a mendelian dominant predisposition to a specific cancer in an experimental animal. We have previously established a new conserved linkage group on rat chromosome 10q and human chromosome 16p13.3, and shown that the Eker mutation is tightly linked to the tuberous sclerosis (Tsc2) gene. We now describe a germline mutation in the gene encoding Tsc2 caused by the insertion of an approximately 5 kilobase DNA fragment in the Eker rat, resulting in aberrant RNA expression from the mutant allele. The phenotype of tuberous sclerosis in humans differs from that of the Eker rat, except for the occurence of renal tumours. The Eker rat may therefore provide insights into species-specific differences in tumourigenesis and/or phenotype-specific mutations.	JAPANESE FDN CANC RES, INST CANC, DEPT EXPTL PATHOL, TOKYO 170, JAPAN	Japanese Foundation for Cancer Research								EKER R, 1961, NATURE, V189, P858, DOI 10.1038/189858b0; EVERITT JI, 1992, J UROLOGY, V148, P1932, DOI 10.1016/S0022-5347(17)37087-8; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; HINO O, 1993, P NATL ACAD SCI USA, V90, P327, DOI 10.1073/pnas.90.1.327; HINO O, 1993, JPN J CANCER RES, V84, P1106, DOI 10.1111/j.1349-7006.1993.tb02808.x; HINO O, 1994, BIOCHEM BIOPH RES CO, V203, P1302, DOI 10.1006/bbrc.1994.2324; HINO O, 1993, P NATL ACAD SCI USA, V90, P730, DOI 10.1073/pnas.90.2.730; HINO O, 1985, INT J CANCER, V35, P5, DOI 10.1002/ijc.2910350103; HINO O, 1993, CANCER RES, V53, P5856; HINO O, 1994, CANCER LETT, V83, P117, DOI 10.1016/0304-3835(94)90307-7; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; KUBO Y, 1994, CANCER RES, V54, P2633; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; NELLIST M, 1993, CELL, V75, P1305; WARD CJ, 1994, CELL, V77, P881; WU JS, 1994, NAT GENET, V7, P541, DOI 10.1038/ng0894-541; YEUNG RS, 1993, P NATL ACAD SCI USA, V90, P8038, DOI 10.1073/pnas.90.17.8038	19	270	273	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1995	9	1					70	74		10.1038/ng0195-70	http://dx.doi.org/10.1038/ng0195-70			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PZ913	7704028				2022-12-17	WOS:A1995PZ91300017
J	Poirier, K; Lebrun, N; Broix, L; Tian, G; Saillour, Y; Boscheron, C; Parrini, E; Valence, S; Saint Pierre, B; Oger, M; Lacombe, D; Genevieve, D; Fontana, E; Darra, F; Cances, C; Barth, M; Bonneau, D; Dalla Bernadina, B; N'Guyen, S; Gitiaux, C; Parent, P; Portes, VD; Pedespan, JM; Legrez, V; Castelnau-Ptakine, L; Nitschke, P; Hieu, T; Masson, C; Zelenika, D; Andrieux, A; Francis, F; Guerrini, R; Cowan, NJ; Bahi-Buisson, N; Chelly, J				Poirier, Karine; Lebrun, Nicolas; Broix, Loic; Tian, Guoling; Saillour, Yoann; Boscheron, Cecile; Parrini, Elena; Valence, Stephanie; Saint Pierre, Benjamin; Oger, Madison; Lacombe, Didier; Genevieve, David; Fontana, Elena; Darra, Franscesca; Cances, Claude; Barth, Magalie; Bonneau, Dominique; Dalla Bernadina, Bernardo; N'Guyen, Sylvie; Gitiaux, Cyril; Parent, Philippe; Portes, Vincent des; Pedespan, Jean Michel; Legrez, Victoire; Castelnau-Ptakine, Laetitia; Nitschke, Patrick; Hieu, Thierry; Masson, Cecile; Zelenika, Diana; Andrieux, Annie; Francis, Fiona; Guerrini, Renzo; Cowan, Nicholas J.; Bahi-Buisson, Nadia; Chelly, Jamel			Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly	NATURE GENETICS			English	Article							NEURONAL MIGRATION DEFECTS; SEVERE INTELLECTUAL DISABILITY; MICROTUBULE-BINDING DOMAIN; DNA-SEQUENCING DATA; GAMMA-TUBULIN; CYTOPLASMIC DYNEIN; KINESIN; PROTEIN; GENE; CHAPERONIN	The genetic causes of malformations of cortical development (MCD) remain largely unknown. Here we report the discovery of multiple pathogenic missense mutations in TUBG1, DYNC1H1 and KIF2A, as well as a single germline mosaic mutation in KIF5C, in subjects with MCD. We found a frequent recurrence of mutations in DYNC1H1, implying that this gene is a major locus for unexplained MCD. We further show that the mutations in KIF5C, KIF2A and DYNC1H1 affect ATP hydrolysis, productive protein folding and microtubule binding, respectively. In addition, we show that suppression of mouse Tubg1 expression in vivo interferes with proper neuronal migration, whereas expression of altered gamma-tubulin proteins in Saccharomyces cerevisiae disrupts normal microtubule behavior. Our data reinforce the importance of centrosomal and microtubule-related proteins in cortical development and strongly suggest that microtubule-dependent mitotic and postmitotic processes are major contributors to the pathogenesis of MCD.	[Poirier, Karine; Lebrun, Nicolas; Broix, Loic; Saillour, Yoann; Valence, Stephanie; Saint Pierre, Benjamin; Oger, Madison; Castelnau-Ptakine, Laetitia; Bahi-Buisson, Nadia; Chelly, Jamel] Univ Paris 05, CNRS, Inst Cochin, UMR 8104, Paris, France; [Poirier, Karine; Lebrun, Nicolas; Broix, Loic; Saillour, Yoann; Valence, Stephanie; Saint Pierre, Benjamin; Oger, Madison; Castelnau-Ptakine, Laetitia; Bahi-Buisson, Nadia; Chelly, Jamel] INSERM, U1016, Paris, France; [Tian, Guoling; Cowan, Nicholas J.] NYU, Med Ctr, Dept Mol Pharmacol & Biochem, New York, NY 10016 USA; [Boscheron, Cecile; Andrieux, Annie] Univ Grenoble 1, INSERM, Inst Neurosci, U836, Grenoble, France; [Parrini, Elena; Guerrini, Renzo] Univ Florence, A Meyer Childrens Hosp, Pediat Neurol Unit & Labs, Florence, Italy; [Parrini, Elena; Guerrini, Renzo] Stella Maris Fdn, IRCCS, Pisa, Italy; [Lacombe, Didier] CHU Pellegrin, Dept Med Genet, Bordeaux, France; [Genevieve, David] Univ Montpellier I, INSERM, Dept Med Genet, U844, Montpellier, France; [Fontana, Elena; Darra, Franscesca; Dalla Bernadina, Bernardo] Azienda Osped Univ Verona, UOC Neuropsichiatria Infantile, Verona, Italy; [Cances, Claude] CHU Toulouse, Dept Pediat, Toulouse, France; [Barth, Magalie; Bonneau, Dominique] Univ Angers, INSERM, U694, CHU 4, Angers, France; [Barth, Magalie; Bonneau, Dominique; Gitiaux, Cyril] CHU Angers, Serv Genet, Angers, France; [N'Guyen, Sylvie] CHU Nantes, Clin Med Pediat, F-44035 Nantes 01, France; [Gitiaux, Cyril; Bahi-Buisson, Nadia] Univ Paris 05, Hop Necker Enfants Malad, Unite Neurol Pediat, Paris, France; [Parent, Philippe] Serv Pediat & Genet Med, Brest, France; [Portes, Vincent des] Univ Lyon 1, CHU Lyon, Ctr Reference Deficiences Intellectuelles Causes, CNRS,L2C2, Bron, France; [Pedespan, Jean Michel] CHU Pellegrin, Serv Pediat, Bordeaux, France; [Legrez, Victoire] CHU Bicetre, Serv Neuropediat, Le Kremlin Bicetre, France; [Nitschke, Patrick; Hieu, Thierry; Masson, Cecile] Univ Paris 05, Paris, France; [Zelenika, Diana] CNG, Evry, France; [Francis, Fiona] INSERM, Inst Fer Moulin, Paris, France; [Francis, Fiona] Univ Paris 06, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; New York University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; IRCCS Fondazione Stella Maris; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Chelly, J (corresponding author), Univ Paris 05, CNRS, Inst Cochin, UMR 8104, Paris, France.	nicholas.cowan@nyumc.org; jamel.chelly@inserm.fr	ANDRIEUX, ANNIE/B-2134-2017; POIRIER, Karine/N-3009-2018; Bonneau, Dominique/K-6110-2015; Francis, Fiona/B-5854-2016; Chelly, Jamel/J-7528-2015; lacombe, didier/K-7967-2014; Gitiaux, Cyril/AAB-9102-2020; DARRA, Francesca/J-7297-2018; Parrini, Elena/K-5283-2016; Bahi-Buisson, Nadia/H-5207-2017	ANDRIEUX, ANNIE/0000-0002-4022-6405; POIRIER, Karine/0000-0002-7928-2906; Chelly, Jamel/0000-0002-0939-8719; Bonneau, Dominique/0000-0002-6886-0969; Broix, Loic/0000-0002-8231-370X; Fontana, Elena/0000-0002-4553-2452; Guerrini, Renzo/0000-0002-7272-7079; DARRA, Francesca/0000-0002-1062-8438; Parrini, Elena/0000-0001-8933-7694; Saillour, Yoann/0000-0002-5110-9239; Francis, Fiona/0000-0001-8542-7537; Gitiaux, Cyril/0000-0002-2190-6843; Bahi-Buisson, Nadia/0000-0002-5352-0929; Lacombe, Didier/0000-0002-8956-2207	INSERM; Fondation pour la Recherche Medicale; Fondation JED; Fondation Maladies Rares; Agence National de Recherche [ANR Blanc 1103 01, R11039KK, ANR E-Rare-012-01, E10107KP]; EU-FP7 project GENECODYS [241995]; US National Institutes of Health [GM097376]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097376] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation JED; Fondation Maladies Rares; Agence National de Recherche(French National Research Agency (ANR)); EU-FP7 project GENECODYS; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the patients and their families for their participation. We thank F.J. Fourniol, N. Levy and members of the Chelly lab for their thoughtful comments and help. We thank I. Gibbons and A. Carter (Medical Research Council Laboratory of Molecular Biology) for providing the seryl-tRNA synthetase dynein heavy chain fusion constructs used in the experiments described in this paper. A full-length cDNA encoding human KIF5C was generously provided by F.A. Stephenson (School of Pharmacy, University College London). A full-length cDNA encoding human gamma-tubulin was generously provided by B.R. Oakley (Department of Molecular Biosciences, University of Kansas). We also thank members of the Cochin Hospital Cell Bank, the Centre National de Genotypage, Genoscope, the Paris Descartes Bioinformatics platforms and the Cochin Institute genomic platform for their technical and bioinformatic assistance. This work was supported by funding from INSERM, the Fondation pour la Recherche Medicale (FRM funding within the frame of the programme Equipe FRM; J.C.), the Fondation JED, the Fondation Maladies Rares, the Agence National de Recherche (ANR Blanc 1103 01, project R11039KK; ANR E-Rare-012-01, project E10107KP) and the EU-FP7 project GENECODYS, grant number 241995. This work was also supported by a grant (GM097376 to N.J.C.) from the US National Institutes of Health.	Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Bernal C, 2005, ANAL BIOCHEM, V337, P55, DOI 10.1016/j.ab.2004.10.011; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Breuss M, 2012, CELL REP, V2, P1554, DOI 10.1016/j.celrep.2012.11.017; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobyns WB, 1999, NEUROLOGY, V53, P270, DOI 10.1212/WNL.53.2.270; Dunn S, 2008, J CELL SCI, V121, P1085, DOI 10.1242/jcs.026492; Erickson RP, 2010, MUTAT RES-REV MUTAT, V705, P96, DOI 10.1016/j.mrrev.2010.04.002; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Francis F, 2006, EUR J NEUROSCI, V23, P877, DOI 10.1111/j.1460-9568.2006.04649.x; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; Guerrini R, 2008, TRENDS NEUROSCI, V31, P154, DOI 10.1016/j.tins.2007.12.004; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; Harms MB, 2012, NEUROLOGY, V78, P1714, DOI 10.1212/WNL.0b013e3182556c05; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Jaglin XH, 2009, TRENDS GENET, V25, P555, DOI 10.1016/j.tig.2009.10.003; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Kousar R, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-119; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Manzini MC, 2011, CURR OPIN GENET DEV, V21, P333, DOI 10.1016/j.gde.2011.01.006; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MELKI R, 1993, J CELL BIOL, V122, P1301, DOI 10.1083/jcb.122.6.1301; NAKATA T, 1995, J CELL BIOL, V131, P1039, DOI 10.1083/jcb.131.4.1039; Ori-McKenney KM, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-26; Ostergaard P, 2012, AM J HUM GENET, V90, P356, DOI 10.1016/j.ajhg.2011.12.018; Poirier K, 2007, HUM MUTAT, V28, P1055, DOI 10.1002/humu.20572; Poirier K, 2013, EUR J HUM GENET, V21, P381, DOI 10.1038/ejhg.2012.195; Poirier K, 2010, HUM MOL GENET, V19, P4462, DOI 10.1093/hmg/ddq377; RAKIC P, 1995, NEURON, V14, P1101, DOI 10.1016/0896-6273(95)90258-9; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TIAN GL, 1995, NATURE, V375, P250, DOI 10.1038/375250a0; Tischfield MA, 2011, CURR OPIN GENET DEV, V21, P286, DOI 10.1016/j.gde.2011.01.003; Tsurusaki Y, 2012, NEUROGENETICS, V13, P327, DOI 10.1007/s10048-012-0337-6; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Weedon MN, 2011, AM J HUM GENET, V89, P308, DOI 10.1016/j.ajhg.2011.07.002; Willemsen MH, 2012, J MED GENET, V49, P179, DOI 10.1136/jmedgenet-2011-100542; Wise DO, 2000, GENOMICS, V67, P164, DOI 10.1006/geno.2000.6247; Wynshaw-Boris A, 2010, SEMIN CELL DEV BIOL, V21, P823, DOI 10.1016/j.semcdb.2010.07.008	55	269	283	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2013	45	6					639	+		10.1038/ng.2613	http://dx.doi.org/10.1038/ng.2613			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	152XA	23603762	Green Submitted, Green Accepted			2022-12-17	WOS:000319563900011
J	Goode, LL; Chenevix-Trench, G; Song, H; Ramus, SJ; Notaridou, M; Lawrenson, K; Widschwendter, M; Vierkant, RA; Larson, MC; Kjaer, SK; Birrer, MJ; Berchuck, A; Schildkraut, J; Tomlinson, I; Kiemeney, LA; Cook, LS; Gronwald, J; Garcia-Closas, M; Gore, ME; Campbell, I; Whittemore, AS; Sutphen, R; Phelan, C; Anton-Culver, H; Pearce, CL; Lambrechts, D; Rossing, MA; Chang-Claude, J; Moysich, KB; Goodman, MT; Dork, T; Nevanlinna, H; Ness, RB; Rafnar, T; Hogdall, C; Hogdall, E; Fridley, BL; Cunningham, JM; Sieh, W; McGuire, V; Godwin, AK; Cramer, DW; Hernandez, D; Levine, D; Lu, K; Iversen, ES; Palmieri, RT; Houlston, R; van Altena, AM; Aben, KKH; Massuger, LFAG; Brooks-Wilson, A; Kelemen, LE; Le, ND; Jakubowska, A; Lubinski, J; Medrek, K; Stafford, A; Easton, DF; Tyrer, J; Bolton, KL; Harrington, P; Eccles, D; Chen, A; Molina, AN; Davila, BN; Arango, H; Tsai, Y; Chen, ZH; Risch, HA; McLaughlin, J; Narod, SA; Ziogas, A; Brewster, W; Gentry-Maharaj, A; Menon, U; Wu, AH; Stram, DO; Pike, MC; Beesley, J; Webb, PM; Chen, XQ; Ekici, AB; Thiel, FC; Beckmann, MW; Yang, H; Wentzensen, N; Lissowska, J; Fasching, PA; Despierre, E; Amant, F; Vergote, I; Doherty, J; Hein, R; Wang-Gohrke, S; Lurie, G; Carney, ME; Thompson, PJ; Runnebaum, I; Hillemanns, P; Durst, M; Antonenkova, N; Bogdanova, N; Leminen, A; Butzow, R; Heikkinen, T; Stefansson, K; Sulem, P; Besenbacher, S; Sellers, TA; Gayther, SA; Pharoah, PDP				Goode, Llen L.; Chenevix-Trench, Georgia; Song, Honglin; Ramus, Susan J.; Notaridou, Maria; Lawrenson, Kate; Widschwendter, Martin; Vierkant, Robert A.; Larson, Melissa C.; Kjaer, Susanne K.; Birrer, Michael J.; Berchuck, Andrew; Schildkraut, Joellen; Tomlinson, Ian; Kiemeney, Lambertus A.; Cook, Linda S.; Gronwald, Jacek; Garcia-Closas, Montserrat; Gore, Martin E.; Campbell, Ian; Whittemore, Alice S.; Sutphen, Rebecca; Phelan, Catherine; Anton-Culver, Hoda; Pearce, Celeste Leigh; Lambrechts, Diether; Rossing, Mary Anne; Chang-Claude, Jenny; Moysich, Kirsten B.; Goodman, Marc T.; Doerk, Thilo; Nevanlinna, Heli; Ness, Roberta B.; Rafnar, Thorunn; Hogdall, Claus; Hogdall, Estrid; Fridley, Brooke L.; Cunningham, Julie M.; Sieh, Weiva; McGuire, Valerie; Godwin, Andrew K.; Cramer, Daniel W.; Hernandez, Dena; Levine, Douglas; Lu, Karen; Iversen, Edwin S.; Palmieri, Rachel T.; Houlston, Richard; van Altena, Anne M.; Aben, Katja K. H.; Massuger, Leon F. A. G.; Brooks-Wilson, Angela; Kelemen, Linda E.; Le, Nhu D.; Jakubowska, Anna; Lubinski, Jan; Medrek, Krzysztof; Stafford, Anne; Easton, Douglas F.; Tyrer, Jonathan; Bolton, Kelly L.; Harrington, Patricia; Eccles, Diana; Chen, Ann; Molina, Ashley N.; Davila, Barbara N.; Arango, Hector; Tsai, Yu; Chen, Zhihua; Risch, Harvey A.; McLaughlin, John; Narod, Steven A.; Ziogas, Argyrios; Brewster, Wendy; Gentry-Maharaj, Aleksandra; Menon, Usha; Wu, Anna H.; Stram, Daniel O.; Pike, Malcolm C.; Beesley, Jonathan; Webb, Penelope M.; Chen, Xiaoqing; Ekici, Arif B.; Thiel, Falk C.; Beckmann, Matthias W.; Yang, Hannah; Wentzensen, Nicolas; Lissowska, Jolanta; Fasching, Peter A.; Despierre, Evelyn; Amant, Frederic; Vergote, Ignace; Doherty, Jennifer; Hein, Rebecca; Wang-Gohrke, Shan; Lurie, Galina; Carney, Michael E.; Thompson, Pamela J.; Runnebaum, Ingo; Hillemanns, Peter; Duerst, Matthias; Antonenkova, Natalia; Bogdanova, Natalia; Leminen, Arto; Butzow, Ralf; Heikkinen, Tuomas; Stefansson, Kari; Sulem, Patrick; Besenbacher, Soeren; Sellers, Thomas A.; Gayther, Simon A.; Pharoah, Paul D. P.		Wellcome Trust Case-Control Conso; Australian Canc Study Ovarian Canc; Australian Ovarian Canc Study Grp; OCAC	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24	NATURE GENETICS			English	Article							POLY(ADP-RIBOSE) POLYMERASE; MULTIPLE LOCI; CELLS; GENE; VARIANTS	Ovarian cancer accounts for more deaths than all other gynecological cancers combined. To identify common low-penetrance ovarian cancer susceptibility genes, we conducted a genome-wide association study of 507,094 SNPs in 1,768 individuals with ovarian cancer (cases) and 2,354 controls, with follow up of 21,955 SNPs in 4,162 cases and 4,810 controls, leading to the identification of a confirmed susceptibility locus at 9p22 (in BNC2)(1). Here, we report on nine additional candidate loci (defined as having P <= 10(-4)) identified after stratifying cases by histology, which we genotyped in an additional 4,353 cases and 6,021 controls. We confirmed two new susceptibility loci with P <= 5 x 10(-8) (8q24, P = 8.0 x 10(-15) and 2q31, P = 3.8 x 10(-14)) and identified two additional loci that approached genome-wide significance (3q25, P = 7.1 x 10(-8) and 17q21, P = 1.4 x 10(-7)). The associations of these loci with serous ovarian cancer were generally stronger than with other cancer subtypes. Analysis of HOXD1, MYC, TIPARP and SKAP1 at these loci and of BNC2 at 9p22 supports a functional role for these genes in ovarian cancer development.	[Goode, Llen L.; Vierkant, Robert A.; Larson, Melissa C.; Fridley, Brooke L.] Mayo Clin Coll Med, Dept Hlth Sci Res, Rochester, MN USA; [Chenevix-Trench, Georgia; Beesley, Jonathan; Webb, Penelope M.; Chen, Xiaoqing; Australian Canc Study Ovarian Canc] Post Off Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld, Australia; [Song, Honglin; Stafford, Anne; Tyrer, Jonathan; Harrington, Patricia] Univ Cambridge, Strangeways Res Lab, Dept Oncol, Cancer Res United Kingdom, Cambridge, England; [Notaridou, Maria; Lawrenson, Kate; Widschwendter, Martin; Menon, Usha; Gayther, Simon A.] UCL, Dept Gynecol Oncol, Elizabeth Garrett Anderson EGA Inst Womens Hlt, London, England; [Kjaer, Susanne K.; Runnebaum, Ingo] Juliane Marie Ctr, Dept Gynecol & Obstet, Copenhagen, Denmark; [Kjaer, Susanne K.; Runnebaum, Ingo] Inst Canc Epidemiol, Dept Virus, Hormones & Canc, Danish Canc Soc, Copenhagen, Denmark; [Birrer, Michael J.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Berchuck, Andrew; Schildkraut, Joellen] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC USA; [Tomlinson, Ian] London Sch Med & Dent, Inst Canc, Ctr Mol Oncol & Imaging, London, England; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol, Biostatist & Hlth Technol Assessment HTA, NL-6525 ED Nijmegen, Netherlands; [Lubinski, Jan] Univ New Mexico, Div Epidemiol & Biostatist, Albuquerque, NM 87131 USA; [Cook, Linda S.] Alberta Hlth Services Canc Care, Calgary, AB, Canada; [Gronwald, Jacek; Medrek, Krzysztof] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland; [Garcia-Closas, Montserrat; Wentzensen, Nicolas] Natl Canc Inst, Natl Inst Hlth, Div Canc Epidemiol & Genet, Rockville, MD USA; [Gore, Martin E.] Royal Marsden Hosp, Gynecol Oncol Unit, London, England; [Campbell, Ian] Peter MacCallum Canc Inst, Ctr Canc Genom & Predict Med, Melbourne, Australia; [Campbell, Ian] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Whittemore, Alice S.; Molina, Ashley N.; Davila, Barbara N.] Stanford Univ, Sch Med, Div Epidemiol & Biostatist, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Sutphen, Rebecca; Sieh, Weiva; McGuire, Valerie] Univ S Florida, Coll Med, Pediat Epidemiol Ctr, Tampa, FL USA; [Phelan, Catherine] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Anton-Culver, Hoda] Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA; [Pearce, Celeste Leigh; Wu, Anna H.; Stram, Daniel O.; Pike, Malcolm C.] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA; [Lambrechts, Diether] VIB, Vesalius Res Ctr, Brussels, Belgium; [Lambrechts, Diether] LU Leuven, Louvain, Belgium; [Rossing, Mary Anne] Fred Hutchinson Canc Res Ctr, Program Epidemiol, Seattle, WA 98104 USA; [Chang-Claude, Jenny; Hein, Rebecca] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Moysich, Kirsten B.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Goodman, Marc T.; Carney, Michael E.; Thompson, Pamela J.] Univ Hawaii, Canc Res Ctr, Honolulu, HI 96813 USA; [Doerk, Thilo] Hannover Med Sch, Clin Obstet & Gynaecol, Hannover, Germany; [Nevanlinna, Heli; Leminen, Arto; Heikkinen, Tuomas] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, Helsinki, Finland; [Ness, Roberta B.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Rafnar, Thorunn; Stefansson, Kari; Sulem, Patrick; Besenbacher, Soeren] DeCODE Genet, Reykjavik, Iceland; [Hogdall, Claus] Juliane Marie Ctr, Dept Gynecol & Obstet, Copenhagen, Denmark; [Hogdall, Estrid] Hormones & Canc Inst Canc Epidemiol, Danish Canc Soc, Dept Virus, Copenhagen, Denmark; [Cunningham, Julie M.] Mayo Clin Coll Med, Dept Lab Med & Pathol, Rochester, MN USA; [Godwin, Andrew K.] Fox Chase Canc Ctr, Dept Med Oncol, Womens Canc Program, Philadelphia, PA 19111 USA; [Cramer, Daniel W.] Brigham & Womens Hosp, Obstetr & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; [Hernandez, Dena] Natl Inst Hlth, NIA, Bethesda, MD USA; [Levine, Douglas] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Lu, Karen] MD Anderson Canc Ctr, Houston, TX USA; [Iversen, Edwin S.] Duke Univ, Dept Stat, Durham, NC USA; [Palmieri, Rachel T.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Houlston, Richard] Inst Canc Res, Royal Canc Hosp, Mol & Populat Genet Team, London, England; [van Altena, Anne M.; Massuger, Leon F. A. G.] Radboud Univ Nijmegen, Med Ctr, Dept Gynaecol, NL-6525 ED Nijmegen, Netherlands; [Aben, Katja K. H.] Comprehens Canc Ctr E, Nijmegen, Netherlands; [Brooks-Wilson, Angela] Genome Sci Ctr, British Columbia Canc Agcy, Vancouver, BC, Canada; [Brooks-Wilson, Angela] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada; [Kelemen, Linda E.] Alberta Hlth Serv Canc Care, Calgary, AB, Canada; [Le, Nhu D.] British Columbia Canc Agcy, Cancer Control Res, Vancouver, BC V5Z 4E6, Canada; [Easton, Douglas F.] Univ Cambridge, Strangeways Res Lab, Canc Res United Kingdom Genet Epidemiol Unit, Cambridge, England; [Bolton, Kelly L.] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge, England; [Eccles, Diana] Univ Southampton, Sch Med, Wessex Clin Genet Serv Princess Anne Hosp, Southampton, Hants, England; [Arango, Hector] W Coast Gynecol Oncol, Clearwater, FL USA; [Risch, Harvey A.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT USA; [McLaughlin, John] Canc Care Ontario, Toronto, ON, Canada; [Narod, Steven A.] Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada; [Brewster, Wendy] Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Chapel Hill, NC USA; [Australian Ovarian Canc Study Grp] Peter MacCallum Canc Inst, Melbourne, Australia; [Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany; [Thiel, Falk C.] Univ Breast Ctr Franconia, Univ Hosp Erlangen, Dept Gynecol & Obstet, Erlangen, Germany; [Beckmann, Matthias W.; Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Beckmann, Matthias W.; Lissowska, Jolanta] M Sklodowska Curie Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Fasching, Peter A.] Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Despierre, Evelyn; Amant, Frederic; Vergote, Ignace] Univ Hosp Leuven, Dept Gynecol Oncol, Leuven, Belgium; [Wang-Gohrke, Shan] Univ Ulm, Dept Obstet & Gynaecol, Ulm, Germany; [Duerst, Matthias] Friedrich Schiller Univ, Clin Obstet & Gynaecol, Jena, Germany; [Antonenkova, Natalia] Byelorussian Inst Oncol & Med Radiol Aleksandro N, Minsk, BELARUS; [Bogdanova, Natalia] Byelorussian Inst Oncol & Med Radiol Aleksandro N, Minsk, BELARUS; [Bogdanova, Natalia] Hannover Med Sch, Clin Obstet & Gynaecol, D-3000 Hannover, Germany; [Butzow, Ralf] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, Helsinki, Finland; [Butzow, Ralf] Univ Helsinki, Cent Hosp, Dept Pathol, Helsinki, Finland; [Pharoah, Paul D. P.] Univ Cambridge, Strangeways Res Lab, Canc Res United Kingdom Dept Oncol, Cambridge, England; [Pharoah, Paul D. P.] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge, England	Mayo Clinic; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; CRUK Cambridge Institute; University of Cambridge; University of London; University College London; Danish Cancer Society; Harvard University; Massachusetts General Hospital; Duke University; University of London; Queen Mary University London; Radboud University Nijmegen; University of New Mexico; Alberta Health Services (AHS); Pomeranian Medical University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Royal Marsden NHS Foundation Trust; Peter Maccallum Cancer Center; University of Melbourne; Stanford University; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; University of California System; University of California Irvine; University of Southern California; Flanders Institute for Biotechnology (VIB); KU Leuven; Fred Hutchinson Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); Roswell Park Cancer Institute; Cancer Research Center of Hawaii; University of Hawaii System; Hannover Medical School; University of Helsinki; Helsinki University Central Hospital; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Danish Cancer Society; Mayo Clinic; Fox Chase Cancer Center; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Radboud University Nijmegen; British Columbia Cancer Agency; Simon Fraser University; Alberta Health Services (AHS); University of Calgary; British Columbia Cancer Agency; University of Cambridge; University of Cambridge; University of Southampton; Yale University; Cancer Care Ontario; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Peter Maccallum Cancer Center; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; KU Leuven; University Hospital Leuven; Ulm University; Friedrich Schiller University of Jena; Hannover Medical School; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Cambridge; University of Cambridge	Gayther, SA (corresponding author), Mayo Clin Coll Med, Dept Hlth Sci Res, Rochester, MN USA.	gayther@usc.edu	Fasching, Peter A/ABH-9912-2020; Verdrengh, Evelien/H-4571-2012; Dörk, Thilo/J-8620-2012; Pharoah, Paul/V-6658-2019; Brooks-Wilson, Angela/E-9399-2012; Aben, Katja KH/G-9686-2016; Chenevix-Trench, Georgia/AAV-2014-2020; Bogdanova, Natalia V./Y-2205-2019; Bowtell, David/H-1007-2016; Amant, Frédéric/W-7436-2019; Ekici, Arif B/C-3971-2013; Ramus, Susan/AAG-8352-2019; Garcia-Closas, Montserrat/AAZ-6930-2021; Narod, Steven A/AAA-6112-2022; Garcia-Closas, Montserrat/F-3871-2015; Vierkant, Robert/AAP-4927-2020; Massuger, Leon F.A.G./H-8072-2014; Wentzensen, Nicolas/AAG-8522-2019; Fridley, Brooke L/D-8315-2015; Jakubowska, Anna/O-8050-2014; Menon, Usha/C-4716-2008; Kiemeney, Lambertus A./D-3357-2009; Lissowska, Jolanta/AAH-3252-2020; Lambrechts, Diether/AAJ-3167-2020; Gronwald, Jacek/A-4576-2017; Eccles, Diana/K-6327-2019; van Altena, Anne M/B-9824-2016; McLaughlin, John R/E-4577-2013; Stefansson, Kari/AAE-7187-2019; campbell, Ian G/F-6006-2011; Webb, Penelope/D-5736-2013	Fasching, Peter A/0000-0003-4885-8471; Dörk, Thilo/0000-0002-9458-0282; Pharoah, Paul/0000-0001-8494-732X; Brooks-Wilson, Angela/0000-0003-1009-6408; Aben, Katja KH/0000-0002-0214-2147; Chenevix-Trench, Georgia/0000-0002-1878-2587; Bowtell, David/0000-0001-9089-7525; Amant, Frédéric/0000-0002-5452-4905; Ekici, Arif B/0000-0001-6099-7066; Ramus, Susan/0000-0003-0005-7798; Garcia-Closas, Montserrat/0000-0003-1033-2650; Garcia-Closas, Montserrat/0000-0003-1033-2650; Vierkant, Robert/0000-0001-6242-5221; Fridley, Brooke L/0000-0001-7739-7956; Jakubowska, Anna/0000-0002-5650-0501; Menon, Usha/0000-0003-3708-1732; Kiemeney, Lambertus A./0000-0002-2368-1326; Lissowska, Jolanta/0000-0003-2695-5799; Lambrechts, Diether/0000-0002-3429-302X; Gronwald, Jacek/0000-0002-3643-2871; Eccles, Diana/0000-0002-9935-3169; Webb, Penelope/0000-0003-0733-5930; Levine, Douglas/0000-0003-1038-8232; Hogdall, Estrid/0000-0003-4689-5658; Bolton, Kelly/0000-0001-6584-3357; Hogdall, Claus/0000-0002-5959-8874; Nevanlinna, Heli/0000-0002-0916-2976; Houlston, Richard/0000-0002-5268-0242; Widschwendter, Martin/0000-0002-7778-8380; Besenbacher, Soren/0000-0003-1455-1738; Beesley, Jonathan/0000-0003-1942-325X; Kjaer, Susanne/0000-0002-8347-1398; Weber, Rachel/0000-0001-7119-7734; Lawrenson, Kate/0000-0002-6469-2515; Lubinski, Jan/0000-0003-2931-3003; Campbell, Ian/0000-0002-7773-4155; Heikkinen, Tuomas/0000-0003-1154-6204; Roth, Rebecca/0000-0002-2841-4921; Goodman, Marc/0000-0002-4839-3021	Ovarian Cancer Research Fund; Mermaid 1; Danish Cancer Society; National Cancer Institute, Bethesda, Maryland, USA [R01-CA61107]; US National Institutes of Health; National Cancer Institute [R01CA- 122443, CA-58860, CA-92044, R01-CA58598, N01-CN-55424, N01-PC-67001, N01-PC-35137]; Mayo Foundation; US National Cancer Institute; Department of Health and Human Services; Ovarian Cancer Specialized Program of Research Excellence (SPORE) [P50 CA083638]; Cancer Research UK; Eastern Cancer Registration and Information Centre for subject recruitment; US National Institutes of Health [R01-CA106414, R01-CA-63682, R01CA- 63678, R01-CA112523, R01-CA-87538]; American Cancer Society [CRTG-00-196-01-CCE]; Advanced Cancer Detection Center; Department of Defense [DAMD17-98-1-8659]; Canadian Institutes for Health Research; Canadian Cancer Society; University of California, Irvine [R01-CA-114343]; Lon V Smith Foundation [LVS-39420]; OAK Foundation; National Health and Medical Research Council of Australia [199600]; US Army Medical Research and Materiel Command [DAMD17-01-1-0729, W81XWH-06-1-0220]; Cancer Council Tasmania; Cancer Foundation of Western Australia; ELAN Foundation; Erlangen University Hospital; German Federal Ministry of Education and Research of Germany; Programme of Clinical Biomedical Research [01 GB 9401]; University of Ulm; German Cancer Research Center; California Cancer Research Program [00-01389V-20170, 2110200]; Helsinki University Central Hospital; Academy of Finland; Finnish Cancer Society; DIVISION OF CANCER CONTROL &POPULATION SCIENCE [N01PC067010] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA114343, R01CA106414, R01CA076016, R01CA063678, P01CA017054, R01CA063464, R01CA140323, P50CA136393, P50CA083638, R01CA122443, K07CA143047, K07CA092044, R01CA112523, R01CA087538, R01CA058598, U01CA058860, R01CA058860, R03CA113148, R01CA063682, U01CA063464, R01CA061132, P30CA014089] Funding Source: NIH RePORTER; Cancer Research UK [10118, 11022] Funding Source: researchfish; Medical Research Council [G0801875] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; MRC [G0801875] Funding Source: UKRI	Ovarian Cancer Research Fund; Mermaid 1; Danish Cancer Society(Danish Cancer Society); National Cancer Institute, Bethesda, Maryland, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mayo Foundation; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Health and Human Services; Ovarian Cancer Specialized Program of Research Excellence (SPORE); Cancer Research UK(Cancer Research UK); Eastern Cancer Registration and Information Centre for subject recruitment; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Advanced Cancer Detection Center; Department of Defense(United States Department of Defense); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); University of California, Irvine(University of California System); Lon V Smith Foundation; OAK Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); US Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Cancer Council Tasmania(Cancer Council Tasmania); Cancer Foundation of Western Australia(Cancer Council Western Australia); ELAN Foundation; Erlangen University Hospital; German Federal Ministry of Education and Research of Germany; Programme of Clinical Biomedical Research; University of Ulm; German Cancer Research Center; California Cancer Research Program; Helsinki University Central Hospital; Academy of Finland(Academy of Finland); Finnish Cancer Society; DIVISION OF CANCER CONTROL &POPULATION SCIENCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study made use of data generated by the Wellcome Trust Case Control consortium. A full list of the investigators who contributed to the generation of the data is available from http://www. wtccc. org. uk/.Funding for the project was provided by the Wellcome Trust under award 076113. The Ovarian Cancer Association Consortium is supported by a grant from the Ovarian Cancer Research Fund thanks to donations by the family and friends of Kathryn Sladek Smith.; The MAL study is supported by grants from Mermaid 1, the Danish Cancer Society and the National Cancer Institute, Bethesda, Maryland, USA (R01-CA61107). The MAY study and the phase 3 and combined analyses were supported by the US National Institutes of Health, National Cancer Institute grants R01CA- 122443 and funding from the Mayo Foundation. The PBCS was funded by Intramural Research Funds of the US National Cancer Institute, Department of Health and Human Services. The Fox Chase Cancer Center ovarian cancer study, part of the National Cancer Institute collaboration, is supported by an Ovarian Cancer Specialized Program of Research Excellence (SPORE) (P50 CA083638). The NCO study is supported by the US National Institutes of Health, National Cancer Institute grant R01-CA-76016. The SEA study is funded by a programme grant from Cancer Research UK. We thank the SEARCH team and the Eastern Cancer Registration and Information Centre for subject recruitment. The TBO study was supported by the US National Institutes of Health (R01-CA106414); the American Cancer Society (CRTG-00-196-01-CCE); and the Advanced Cancer Detection Center Grant, Department of Defense (DAMD17-98-1-8659). The TOR study was supported by grants from the Canadian Institutes for Health Research, the National Cancer Institute of Canada with funds provided by the Canadian Cancer Society and the US National Institutes of Health (R01-CA-63682 and R01CA- 63678). Additional support for the TOR, NCO, MAY, TBO and NCI studies was provided by the University of California, Irvine grant R01-CA-114343. The UCI study is supported by the US National Institutes of Health, National Cancer Institute grants CA-58860, CA-92044 and the Lon V Smith Foundation grant LVS-39420. The UKO study is supported by funding from Cancer Research UK, the Eve Appeal and the OAK Foundation. Some of this work was undertaken at University College London Hospital/University College London, who received a proportion of funding from the Department of Health's National Institutes for Health Research Biomedical Research Centre funding scheme. We particularly thank I. Jacobs, E. Wozniak, A. Ryan, J. Ford and N. Balogun for their contribution to the study. The AUS study is supported by the National Health and Medical Research Council of Australia (199600), US Army Medical Research and Materiel Command under DAMD17-01-1-0729 (award no. W81XWH-06-1-0220) and the Cancer Council Tasmania and Cancer Foundation of Western Australia. G. C.-M. T. and P. M. W. are Research Fellows of the National Health and Medical Research Council. The Australian Ovarian Cancer Study (AOCS) Management Group (D. Bowtell, A. deFazio, G. C.-T., D. G., A. K. G. and P. M. W.) gratefully acknowledges the contribution of all the clinical and scientific collaborators (see http://www. aocstudy. org/). The Australian Cancer Study (ACS) Management Group comprises P. D. P. P., P. M. W., A. Green, N. Hayward and D. Whiteman. The BAV study is supported by the ELAN Foundation and Erlangen University Hospital. The BEL study is supported by the National Cancer Plan-Action 29 for the support of Translational Research. The DOV study (Seattle Diseases of the Ovary) was supported by the US National Institutes of Health grants R01-CA112523 and R01-CA-87538. The GER study was supported by the German Federal Ministry of Education and Research of Germany, the Programme of Clinical Biomedical Research (01 GB 9401), and the genotyping was supported in part by the state of Baden-Wrttemberg through the Medical Faculty, University of Ulm (P. 685).; Data management wassupported by the German Cancer Research Center. The HAW study was supported by the US Public Health Service grant R01-CA58598 and contracts N01-CN-55424, N01-PC-67001 and N01-PC-35137 from the National Cancer Institute, US National Institutes of Health, Department of Health and Human Services. Funding for the USC study was received from the California Cancer Research Program grants 00-01389V-20170 and 2110200, US Public Health Service grants CA14089, CA17054, CA61132, CA63464, N01-PC-67010 and R03CA113148 and the California Department of Health Services sub-contract 050E8709 as part of its statewide cancer reporting program (University of Southern California). The HJO study gratefully acknowledges the contribution of F. Kramer and W. Zheng to the recruitment of subjects at Hannover Medical School. The HMO study gratefully acknowledges the help of L. Gacucova in sample preparation. The HOC study was financially supported by the Helsinki University Central Hospital Research Fund, Academy of Finland and the Finnish Cancer Society.	Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Buzzai M, 2008, CURR OPIN HEMATOL, V15, P82, DOI 10.1097/MOH.0b013e3282f3ded0; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Fang L, 2009, CELL CYCLE, V8, P2819, DOI 10.4161/cc.8.17.9514; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jacinto FV, 2007, CANCER RES, V67, P11481, DOI 10.1158/0008-5472.CAN-07-2687; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Katoh M, 2003, INT J ONCOL, V23, P541; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kosco KA, 2008, MOL IMMUNOL, V45, P510, DOI 10.1016/j.molimm.2007.05.024; Lakhani SR, 2004, CLIN CANCER RES, V10, P2473, DOI 10.1158/1078-0432.CCR-1029-3; Lawrenson K, 2009, CELL PROLIFERAT, V42, P385, DOI 10.1111/j.1365-2184.2009.00604.x; Lawrenson K, 2010, NEOPLASIA, V12, P317, DOI 10.1593/neo.91948; Li NFF, 2004, LAB INVEST, V84, P923, DOI 10.1038/labinvest.3700093; Ma Q, 2001, BIOCHEM BIOPH RES CO, V289, P499, DOI 10.1006/bbrc.2001.5987; Okubo Y, 2002, CLIN EXP METASTAS, V19, P503, DOI 10.1023/A:1020346211686; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Sankararaman S, 2008, AM J HUM GENET, V82, P290, DOI 10.1016/j.ajhg.2007.09.022; Shiraishi M, 2002, ONCOGENE, V21, P3659, DOI 10.1038/sj.onc.1205453; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Udler MS, 2009, HUM MOL GENET, V18, P1692, DOI 10.1093/hmg/ddp078; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444	30	269	279	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2010	42	10					874	+		10.1038/ng.668	http://dx.doi.org/10.1038/ng.668			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	655UO	20852632	Green Submitted, Green Accepted			2022-12-17	WOS:000282276600018
J	Gregersen, PK; Amos, CI; Lee, AT; Lu, Y; Remmers, EF; Kastner, DL; Seldin, MF; Criswell, LA; Plenge, RM; Holers, VM; Mikuls, TR; Sokka, T; Moreland, LW; Bridges, SL; Xie, G; Begovich, AB; Siminovitch, KA				Gregersen, Peter K.; Amos, Chistopher I.; Lee, Annette T.; Lu, Yue; Remmers, Elaine F.; Kastner, Daniel L.; Seldin, Michael F.; Criswell, Lindsey A.; Plenge, Robert M.; Holers, V. Michael; Mikuls, Ted R.; Sokka, Tuulikki; Moreland, Larry W.; Bridges, S. Louis, Jr.; Xie, Gang; Begovich, Ann B.; Siminovitch, Katherine A.			REL, encoding a member of the NF-kappa B family of transcription factors, is a newly defined risk locus for rheumatoid arthritis	NATURE GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; C-REL; INCEPTION COHORT; CELLS; ASSOCIATION; EXPRESSION; VARIANTS; ITGAM	We conducted a genome-wide association study of rheumatoid arthritis in 2,418 cases and 4,504 controls from North America and identified an association at the REL locus, encoding c-Rel, on chromosome 2p13 (rs13031237, P = 6.01 x 10(-10)). Replication in independent case-control datasets comprising 2,604 cases and 2,882 controls confirmed this association, yielding an allelic OR 1.25 (P = 3.08 x 10(-14)) for marker rs13031237 and an allelic OR 1.21 (P = 2.60 x 10(-11)) for marker rs13017599 in the combined dataset. The combined dataset also provides definitive support for associations at both CTLA4 (rs231735; OR = 0.85; P = 6.25 x 10(-9)) and BLK (rs2736340; OR = 1.19; P = 5.69 x 10(-9)). c-Rel is an NF-kappa B family member with distinct functional properties in hematopoietic cells, and its association with rheumatoid arthritis suggests disease pathways that involve other recently identified rheumatoid arthritis susceptibility genes including CD40, TRAF1, TNFAIP3 and PRKCQ(1,2).	[Gregersen, Peter K.; Lee, Annette T.] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Amos, Chistopher I.; Lu, Yue] Univ Texas MD Anderson Canc Ctr, Houston, TX USA; [Remmers, Elaine F.; Kastner, Daniel L.] NIAMSD, Genet & Genom Branch, NIH, Bethesda, MD 20892 USA; [Seldin, Michael F.] Univ Calif Davis, Rowe Program Genet, Davis, CA 95616 USA; [Criswell, Lindsey A.] Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; [Plenge, Robert M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Holers, V. Michael] Univ Colorado, Denver Sch Med, Denver, CO 80202 USA; [Sokka, Tuulikki] Univ Nebraska, Med Ctr, Omaha, NE USA; [Sokka, Tuulikki] Jyvaskyla Cent Hosp, Jyvaskyla, Finland; [Moreland, Larry W.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Bridges, S. Louis, Jr.] Univ Alabama Birmingham, Birmingham, AL USA; [Xie, Gang; Siminovitch, Katherine A.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Xie, Gang; Siminovitch, Katherine A.] Univ Hlth Network, Toronto, ON M5G 1X5, Canada; [Begovich, Ann B.] Celera, Alameda, CA USA	Northwell Health; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of California System; University of California Davis; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Nebraska System; University of Nebraska Medical Center; Central Finland Central Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alabama System; University of Alabama Birmingham; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Gregersen, PK (corresponding author), N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA.	peterg@nshs.edu; ksimin@mshri.on.ca	Siminovitch, Katherine/K-1475-2013	Remmers, Elaine F/0000-0002-9522-1249; Moreland, Larry/0000-0003-4483-0359	US National Institutes of Health [NO1-AR-2-2263, RO1 AR44422]; Eileen Ludwig Greenland Center for Rheumatoid Arthritis and the Muriel Fusfeld Foundation; Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Institutes for Health Research [MOP79321]; Ontario Research Fund [RE01061]; Canada Research Chair; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041139, R01AR044422, N01AR022263] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eileen Ludwig Greenland Center for Rheumatoid Arthritis and the Muriel Fusfeld Foundation; Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the US National Institutes of Health NO1-AR-2-2263 (P. K. G.), RO1 AR44422 (P. K. G.) and by the Eileen Ludwig Greenland Center for Rheumatoid Arthritis and the Muriel Fusfeld Foundation. The work was also supported in part by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases and by grants from the Canadian Institutes for Health Research (MOP79321) and Ontario Research Fund (RE01061) and a Canada Research Chair to K. A. S.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; Boumpas DT, 2003, ARTHRITIS RHEUM-US, V48, P719, DOI 10.1002/art.10856; Bunting K, 2007, J IMMUNOL, V178, P7097, DOI 10.4049/jimmunol.178.11.7097; Coenen MJH, 2009, GENES IMMUN, V10, P101, DOI 10.1038/gene.2008.77; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; Ding B, 2009, ARTHRITIS RHEUM, V60, P30, DOI 10.1002/art.24135; Fries JF, 2002, ARTHRITIS RHEUM, V46, P2320, DOI 10.1002/art.10485; Grumont R, 2001, J EXP MED, V194, P1021, DOI 10.1084/jem.194.8.1021; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Lee HS, 2009, ARTHRITIS RHEUM-US, V60, P364, DOI 10.1002/art.24245; Lu KT, 2006, BLOOD, V108, P3769, DOI 10.1182/blood-2006-03-008839; Mason NJ, 2004, J IMMUNOL, V172, P3704, DOI 10.4049/jimmunol.172.6.3704; Mise-Omata S, 2007, J IMMUNOL, V179, P6596, DOI 10.4049/jimmunol.179.10.6596; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Owyang AM, 2001, J IMMUNOL, V167, P4948, DOI 10.4049/jimmunol.167.9.4948; Pennisi E, 2008, SCIENCE, V322, P842, DOI 10.1126/science.322.5903.842; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Sokka T, 2005, CLIN EXP RHEUMATOL, V23, pS178; Toubi E, 2004, AUTOIMMUNITY, V37, P457, DOI 10.1080/08916930400002386; TRYNKA G, 2009, GUT             0224, DOI DOI 10.1136/GUT.2008.169052; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Weisman MH, 2003, ARTHRITIS RHEUM, V48, pS119; Wolfe F, 2003, ARTHRITIS RHEUM, V48, P1530, DOI 10.1002/art.11024; Zhou HJ, 2007, BLOOD, V110, P2121, DOI 10.1182/blood-2007-02-073080	30	269	276	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					820	U77		10.1038/ng.395	http://dx.doi.org/10.1038/ng.395			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	19503088	Green Accepted			2022-12-17	WOS:000267786200013
J	Stamatoyannopoulos, JA; Adzhubei, I; Thurman, RE; Kryukov, GV; Mirkin, SM; Sunyaev, SR				Stamatoyannopoulos, John A.; Adzhubei, Ivan; Thurman, Robert E.; Kryukov, Gregory V.; Mirkin, Sergei M.; Sunyaev, Shamil R.			Human mutation rate associated with DNA replication timing	NATURE GENETICS			English	Article							HUMAN-CHROMOSOMES; GENOME; DISEASE; REGIONS	Eukaryotic DNA replication is highly stratified, with different genomic regions shown to replicate at characteristic times during S phase. Here we observe that mutation rate, as reflected in recent evolutionary divergence and human nucleotide diversity, is markedly increased in later-replicating regions of the human genome. All classes of substitutions are affected, suggesting a generalized mechanism involving replication time-dependent DNA damage. This correlation between mutation rate and regionally stratified replication timing may have substantial evolutionary implications.	[Stamatoyannopoulos, John A.; Thurman, Robert E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.; Thurman, Robert E.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Adzhubei, Ivan; Kryukov, Gregory V.; Sunyaev, Shamil R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [Mirkin, Sergei M.] Tufts Univ, Dept Biol, Medford, MA 02155 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Tufts University	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jstam@u.washington.edu; ssunyaev@rics.bwh.harvard.edu	Kryukov, Gregory V/A-9592-2008; Mirkin, Sergei/AAR-7226-2020; Mirkin, Sergei/A-7310-2010	Mirkin, Sergei/0000-0003-4576-7582; Kryukov, Gregory/0000-0002-6131-9483; Adzhubey, Ivan/0000-0002-1483-9259	US National Institutes of Health [U54HG003042, R01GM071852];  [R01GM078598];  [R01MH084676];  [U54LM008748];  [R01GM60987]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592, R01HG003042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078598, R01GM060987, R01GM071923, R01GM071852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084676] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank A. Kondrashov, M. Przeworski and J. Cameron for helpful discussions. This work was supported by US National Institutes of Health grants U54HG003042 and R01GM071852 to J.A.S.; R01GM078598, R01MH084676 and U54LM008748 to S. R. S. and R01GM60987 to S. M. M.	Chuang JH, 2004, PLOS BIOL, V2, P253, DOI 10.1371/journal.pbio.0020029; Day N, 2007, BIOINFORMATICS, V23, P1424, DOI 10.1093/bioinformatics/btm096; HANAWALT PC, 1994, SCIENCE, V266, P1957, DOI 10.1126/science.7801121; Hellmann I, 2005, GENOME RES, V15, P1222, DOI 10.1101/gr.3461105; Jeon Y, 2005, P NATL ACAD SCI USA, V102, P6419, DOI 10.1073/pnas.0405088102; Karnani N, 2007, GENOME RES, V17, P865, DOI 10.1101/gr.5427007; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Tyekucheva S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r76; Watanabe Y, 2002, HUM MOL GENET, V11, P13, DOI 10.1093/hmg/11.1.13; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Yang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000264	15	269	274	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					393	395		10.1038/ng.363	http://dx.doi.org/10.1038/ng.363			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19287383	Green Accepted			2022-12-17	WOS:000264659000010
J	McGowan, KA; Li, JZ; Park, CY; Beaudry, V; Tabor, HK; Sabnis, AJ; Zhang, W; Fuchs, H; de Angelis, MH; Myers, RM; Attardi, LD; Barsh, GS				McGowan, Kelly A.; Li, Jun Z.; Park, Christopher Y.; Beaudry, Veronica; Tabor, Holly K.; Sabnis, Amit J.; Zhang, Weibin; Fuchs, Helmut; de Angelis, Martin Hrabe; Myers, Richard M.; Attardi, Laura D.; Barsh, Gregory S.			Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects	NATURE GENETICS			English	Article							DIAMOND-BLACKFAN ANEMIA; PROTEIN S19; P53-DEPENDENT CHECKPOINT; DROSOPHILA-MELANOGASTER; CRE RECOMBINASE; MOUSE; MICE; GENE; PROLIFERATION; P53	Mutations in genes encoding ribosomal proteins cause the Minute phenotype in Drosophila and mice, and Diamond-Blackfan syndrome in humans. Here we report two mouse dark skin (Dsk) loci caused by mutations in Rps19 (ribosomal protein S19) and Rps20 (ribosomal protein S20). We identify a common pathophysiologic program in which p53 stabilization stimulates Kit ligand expression, and, consequently, epidermal melanocytosis via a paracrine mechanism. Accumulation of p53 also causes reduced body size and erythrocyte count. These results provide a mechanistic explanation for the diverse collection of phenotypes that accompany reduced dosage of genes encoding ribosomal proteins, and have implications for understanding normal human variation and human disease.	[McGowan, Kelly A.; Li, Jun Z.; Tabor, Holly K.; Sabnis, Amit J.; Zhang, Weibin; Myers, Richard M.; Attardi, Laura D.; Barsh, Gregory S.] Stanford Univ, Div Radiat & Canc Biol, Dept Genet, Stanford, CA 94305 USA; [Li, Jun Z.; Tabor, Holly K.; Myers, Richard M.] Stanford Univ, Stanford Human Genome Ctr, Div Radiat & Canc Biol, Stanford, CA 94305 USA; [Park, Christopher Y.] Stanford Univ, Dept Pathol, Div Radiat & Canc Biol, Stanford, CA 94305 USA; [Beaudry, Veronica; Attardi, Laura D.] Stanford Univ, Dept Radiat Oncol, Div Radiat & Canc Biol, Stanford, CA 94305 USA; [Fuchs, Helmut; de Angelis, Martin Hrabe] Helmholtz Zentrum Muenchen, German Res Ctr Environm Hlth, Inst Expt Genet, D-85764 Neuherberg, Germany; [Barsh, Gregory S.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Stanford University	Barsh, GS (corresponding author), Stanford Univ, Div Radiat & Canc Biol, Dept Genet, Stanford, CA 94305 USA.	gbarsh@stanford.edu	Fuchs, Helmut/M-7347-2014; de Angelis, Martin Hrabe/F-5531-2012	Fuchs, Helmut/0000-0002-5143-2677; de Angelis, Martin Hrabe/0000-0002-7898-2353; Sabnis, Amit/0000-0002-2061-5139; Li, Jun/0000-0001-6727-0812	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068882] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM068882] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alizadeh A, 2008, PIGM CELL MELANOMA R, V21, P63, DOI 10.1111/j.1755-148X.2007.00425.x; Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Angelini M, 2007, HUM MOL GENET, V16, P1720, DOI 10.1093/hmg/ddm120; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CABLE J, 1995, MECH DEVELOP, V50, P139, DOI 10.1016/0925-4773(94)00331-G; Chan EL, 2007, MOL CARCINOGEN, V46, P49, DOI 10.1002/mc.20192; Cmejla R, 2007, HUM MUTAT, V28, P1178, DOI 10.1002/humu.20608; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Ellis SR, 2008, CURR TOP DEV BIOL, V82, P217, DOI 10.1016/S0070-2153(07)00008-7; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Fitch KR, 2003, GENE DEV, V17, P214, DOI 10.1101/gad.1023703; Flygare J, 2007, BLOOD, V109, P3152, DOI 10.1182/blood-2006-09-001222; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Gazda HT, 2006, BRIT J HAEMATOL, V135, P149, DOI 10.1111/j.1365-2141.2006.06268.x; Hirobe T, 2005, PIGM CELL RES, V18, P2, DOI 10.1111/j.1600-0749.2004.00198.x; HIROBE T, 1984, ANAT REC, V208, P589, DOI 10.1002/ar.1092080414; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kunisada T, 1998, DEVELOPMENT, V125, P2915; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Leger-Silvestre I, 2005, J BIOL CHEM, V280, P38177, DOI 10.1074/jbc.M506916200; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; Matsson H, 2006, BLOOD CELL MOL DIS, V36, P259, DOI 10.1016/j.bcmd.2005.12.002; Matsson H, 2004, MOL CELL BIOL, V24, P4032, DOI 10.1128/MCB.24.9.4032-4037.2004; MAYER TC, 1973, DEV BIOL, V34, P39, DOI 10.1016/0012-1606(73)90337-0; MCCULLOC.EA, 1965, BLOOD-J HEMATOL, V26, P399, DOI 10.1182/blood.V26.4.399.399; Miyake K, 2008, STEM CELLS, V26, P323, DOI 10.1634/stemcells.2007-0569; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Panic L, 2006, MOL CELL BIOL, V26, P8880, DOI 10.1128/MCB.00751-06; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Schultz J, 1929, GENETICS, V14, P366; SJALANDER A, 1995, HUM HERED, V45, P144, DOI 10.1159/000154275; Slominski A, 2005, ENDOCRINOLOGY, V146, P1245, DOI 10.1210/en.2004-0733; STEEL KP, 1992, DEVELOPMENT, V115, P1111; Strehlow ANT, 2007, HUM MOL GENET, V16, P391, DOI 10.1093/hmg/ddl467; Sulic S, 2005, GENE DEV, V19, P3070, DOI 10.1101/gad.359305; Van Raamsdonk CD, 2004, NAT GENET, V36, P961, DOI 10.1038/ng1412; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147	50	269	275	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					963	970		10.1038/ng.188	http://dx.doi.org/10.1038/ng.188			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18641651	Green Accepted			2022-12-17	WOS:000258026900012
J	Oh, SW; Mukhopadhyay, A; Dixit, BL; Raha, T; Green, MR; Tissenbaum, HA				Oh, SW; Mukhopadhyay, A; Dixit, BL; Raha, T; Green, MR; Tissenbaum, HA			Identification of direct DAF-16 targets controlling longevity, metabolism and diapause by chromatin immunoprecipitation	NATURE GENETICS			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; REGULATES LIFE-SPAN; C-ELEGANS; SIGNALING PATHWAY; OXIDATIVE STRESS; PROTEIN DAF-16; GENES; MUTANTS; SCREEN; FAMILY	DAF-16, a forkhead transcription factor, is a key regulator of longevity, metabolism and dauer diapause in Caenorhabditis elegans. The precise mechanism by which DAF-16 regulates multiple functions, however, is poorly understood. Here, we used chromatin immunoprecipitation (ChIP) to identify direct targets of DAF-16. We cloned 103 target sequences containing consensus DAF-16 binding sites and selected 33 targets for further analysis. Expression of most of these genes is regulated in a DAF-16-dependent manner, and inactivation of more than half of these genes significantly altered DAF-16-dependent functions, including life span, fat storage and dauer formation. Our results show that the ChIP-based cloning strategy leads to greater enrichment for DAF-16 target genes than previous screening strategies. We also demonstrate that DAF-16 is recruited to multiple promoters to coordinate regulation of its downstream targets. The large number of target genes discovered provides insight into how DAF-16 controls diverse biological functions.	Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Tissenbaum, HA (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	heidi.tissenbaum@umassmed.edu	Mukhopadhyay, Arnab/N-6005-2016	Mukhopadhyay, Arnab/0000-0002-5266-7849; OH, SEUNG WOOK/0000-0001-7632-6822				Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; CONTE D, 2003, CURRENT PROTOCOLS MO; de Belle I, 2003, J BIOL CHEM, V278, P14306, DOI 10.1074/jbc.M210502200; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; GOTTLIEB S, 1994, GENETICS, V137, P107; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; HOSONO R, 1982, EXP GERONTOL, V17, P163, DOI 10.1016/0531-5565(82)90052-3; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; MALONE EA, 1994, GENETICS, V136, P879; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Mukhopadhyay A, 2005, CELL METAB, V2, P35, DOI 10.1016/j.cmet.2005.06.004; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Oka T, 1998, J BIOL CHEM, V273, P22570, DOI 10.1074/jbc.273.35.22570; Raha T, 2005, PLOS BIOL, V3, P221, DOI 10.1371/journal.pbio.0030044; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Weinmann AS, 2004, NAT REV IMMUNOL, V4, P381, DOI 10.1038/nri1353; Yanase S, 2002, MECH AGEING DEV, V123, P1579, DOI 10.1016/S0047-6374(02)00093-3	30	269	303	3	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2006	38	2					251	257		10.1038/ng1723	http://dx.doi.org/10.1038/ng1723			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16380712				2022-12-17	WOS:000234953200024
J	Person, RE; Li, FQ; Duan, ZJ; Benson, KF; Wechsler, J; Papadaki, HA; Eliopoulos, G; Kaufman, C; Bertolone, SJ; Nakamoto, B; Papayannopoulou, T; Grimes, HL; Horwitz, M				Person, RE; Li, FQ; Duan, ZJ; Benson, KF; Wechsler, J; Papadaki, HA; Eliopoulos, G; Kaufman, C; Bertolone, SJ; Nakamoto, B; Papayannopoulou, T; Grimes, HL; Horwitz, M			Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2	NATURE GENETICS			English	Article							SEVERE CONGENITAL NEUTROPENIA; HERMANSKY-PUDLAK-SYNDROME; ELASTASE; GENE; DIFFERENTIATION	Mice lacking the transcriptional repressor oncoprotein Gfi1 are unexpectedly neutropenic(1,2). We therefore screened GFI1 as a candidate for association with neutropenia in affected individuals without mutations in ELA2 (encoding neutrophil elastase), the most common cause of severe congenital neutropenia (SCN; ref. 3). We found dominant negative zinc finger mutations that disable transcriptional repressor activity. The phenotype also includes immunodeficient lymphocytes and production of a circulating population of myeloid cells that appear immature. We show by chromatin immunoprecipitation, gel shift, reporter assays and elevated expression of ELA2 in vivo in neutropenic individuals that GFI1 represses ELA2, linking these two genes in a common pathway involved in myeloid differentiation.	Univ Washington, Div Med Genet, Dept Med, Sch Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; Univ Crete, Dept Hematol, Sch Med, Univ Hosp Heraklion, Iraklion, Greece; Univ Louisville, Inst Cellular Therapeut, Sch Med, Louisville, KY 40202 USA; Univ Louisville, Dept Surg, Sch Med, Louisville, KY 40202 USA; Univ Louisville, Div Hematol Oncol, Sch Med, Dept Pediat, Louisville, KY 40202 USA; Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University Hospital of Heraklion; University of Crete; University of Louisville; University of Louisville; University of Louisville; University of Washington; University of Washington Seattle	Horwitz, M (corresponding author), Univ Washington, Div Med Genet, Dept Med, Sch Med, Box 357720, Seattle, WA 98195 USA.			Grimes, H. Leighton/0000-0001-8162-6758; Horwitz, Marshall/0000-0002-1683-1680	NATIONAL CANCER INSTITUTE [R01CA105152] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA105152-02, R01 CA105152] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anikster Y, 2001, NAT GENET, V28, P376, DOI 10.1038/ng576; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Devriendt K, 2001, NAT GENET, V27, P313, DOI 10.1038/85886; Duan ZJ, 2003, P NATL ACAD SCI USA, V100, P5932, DOI 10.1073/pnas.1031694100; Duan ZJ, 2001, MOL CELL BIOL, V21, P3083, DOI 10.1128/MCB.21.9.3083-3095.2001; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; Gorlin RJ, 2000, AM J MED GENET, V91, P368, DOI 10.1002/(SICI)1096-8628(20000424)91:5<368::AID-AJMG10>3.0.CO;2-9; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Horwitz M, 2003, CURR OPIN HEMATOL, V10, P49, DOI 10.1097/00062752-200301000-00008; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Li FQ, 2001, J BIOL CHEM, V276, P14230, DOI 10.1074/jbc.M010279200; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Papadaki HA, 2002, ANN HEMATOL, V81, P50, DOI 10.1007/s00277-001-0401-z; Papayannopoulou T, 2001, BLOOD, V98, P2403, DOI 10.1182/blood.V98.8.2403; Wallis D, 2003, DEVELOPMENT, V130, P221, DOI 10.1242/dev.00190; ZWEIDLERMCKAY PA, 1996, MOL CELL BIOL, V16, P40242	19	269	281	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2003	34	3					308	312		10.1038/ng1170	http://dx.doi.org/10.1038/ng1170			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12778173	Green Accepted			2022-12-17	WOS:000183815300019
J	O'Sullivan, JN; Bronner, MP; Brentnall, TA; Finley, JC; Shen, WT; Emerson, S; Emond, MJ; Gollahon, KA; Moskovitz, AH; Crispin, DA; Potter, JD; Rabinovitch, PS				O'Sullivan, JN; Bronner, MP; Brentnall, TA; Finley, JC; Shen, WT; Emerson, S; Emond, MJ; Gollahon, KA; Moskovitz, AH; Crispin, DA; Potter, JD; Rabinovitch, PS			Chromosomal instability in ulcerative colitis is related to telomere shortening	NATURE GENETICS			English	Article							LENGTH DYNAMICS; DYSFUNCTION; CANCER; MICE; EVOLUTION; DYSPLASIA; SEQUENCE; TUMORS; CELLS; P53	Ulcerative colitis, a chronic inflammatory disease of the colon, is associated with a high risk of colorectal carcinoma(1) that is thought to develop through genomic instability(2). We considered that the rapid cell turnover and oxidative injury observed in ulcerative colitis might accelerate telomere shortening(3), thereby increasing the potential of chromosomal ends to fuse(4), resulting in cycles of chromatin bridge breakage and fusion(5,6) and chromosomal instability associated with tumor cell progression(7,8). Here we have used quantitative fluorescence in situ hybridization to compare chromosomal aberrations and telomere shortening in non-dysplastic mucosa taken from individuals affected by ulcerative colitis, either with (UC progressors) or without (UC non-progressors) dysplasia or cancer. Losses, but not gains, of chromosomal arms and centromeres are highly correlated with telomere shortening. Chromosomal losses are greater and telomeres are shorter in biopsy samples from UC progressors than in those from UC non-progressors or control individuals without ulcerative colitis. A mechanistic link between telomere shortening and chromosomal instability is supported by a higher frequency of anaphase bridges-an intermediate in the breakage and fusion of chromatin bridges(9)-in UC progressors than in UC non-progressors or control individuals. Our study shows that telomere length is correlated with chromosomal instability in a precursor of human cancer.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Surg, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Rabinovitch, PS (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	petersr@u.washington.edu		Potter, John/0000-0001-5439-1500; O'Sullivan, Jacintha/0000-0001-8622-9858				Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BRENTNALL TA, 1994, GASTROENTEROLOGY, V107, P369, DOI 10.1016/0016-5085(94)90161-9; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Day JP, 1998, CARCINOGENESIS, V19, P259, DOI 10.1093/carcin/19.2.259; DELANGE T, 1995, TELOMERES, P265; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Fouladi B, 2000, NEOPLASIA, V2, P540, DOI 10.1038/sj.neo.7900107; Gisselsson D, 2001, AM J PATHOL, V158, P199, DOI 10.1016/S0002-9440(10)63958-2; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Kilburn AE, 2001, MOL CELL BIOL, V21, P126, DOI 10.1128/MCB.21.1.126-135.2001; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Loeb KR, 1999, AM J PATHOL, V154, P1621, DOI 10.1016/S0002-9440(10)65415-6; Martens UM, 1998, NAT GENET, V18, P76, DOI 10.1038/ng0198-018; McClintock B, 1941, GENETICS, V26, P234; MEYNE J, 1990, CHROMOSOMA, V99, P3, DOI 10.1007/BF01737283; Oexle K, 1998, J THEOR BIOL, V190, P369, DOI 10.1006/jtbi.1997.0559; Rabinovitch PS, 1999, CANCER RES, V59, P5148; RIDDELL RH, 1983, HUM PATHOL, V14, P931, DOI 10.1016/S0046-8177(83)80175-0; RUBIN CE, 1992, GASTROENTEROLOGY, V103, P1611, DOI 10.1016/0016-5085(92)91185-7; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Rufer N, 1998, NAT BIOTECHNOL, V16, P743, DOI 10.1038/nbt0898-743; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tlsty TD, 1997, CURR TOP MICROBIOL, V221, P37; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; Whitehead CM, 1999, J CELL BIOCHEM, P192; Wright WE, 2000, NAT MED, V6, P849, DOI 10.1038/78592	29	269	279	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2002	32	2					280	284		10.1038/ng989	http://dx.doi.org/10.1038/ng989			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12355086				2022-12-17	WOS:000178311100017
J	Gonzalez-Suarez, E; Samper, E; Flores, JM; Blasco, MA				Gonzalez-Suarez, E; Samper, E; Flores, JM; Blasco, MA			Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis	NATURE GENETICS			English	Article							IMMORTAL HUMAN-CELLS; HUMAN TUMOR-CELLS; MOUSE TELOMERASE; CANCER; RAS; CARCINOGENESIS; PAPILLOMAS; INHIBITION; EXPRESSION; SUBUNIT	Inhibition of telomerase is proposed to limit the growth of cancer cells by triggering telomere shortening and cell death(1-9). Telomere maintenance by telomerase is sufficient, in some cell types, to allow immortal growth(1-5). Telomerase has been shown to cooperate with oncogenes in transforming cultured primary human cells into neoplastic cells, suggesting that telomerase activation contributes to malignant transformation(6). Moreover. telomerase inhibition in human tumour cell lines using dominant-negative versions of TERT leads to telomere shortening and cell death(7,8). These findings have led to the proposition that telomerase inhibition may result in cessation of tumour growth(9). The absence of telomerase from most normal cells supports the potential efficacy of anti-telomerase drugs for tumour therapy, as its inhibition is unlikely to have toxic effects. Mice deficient for Terc RNA (encoding telomerase) lack telomerase activity, and constitute a model for evaluating the role of telomerase and telomeres in tumourigenesis(10). Late-generation Terc(-/-) mice show defects in proliferative tissues(10-15) and a moderate increase in the incidence of spontaneous tumours in highly proliferative cell types (lymphomas, teratocarcinomas(12)). The appearance of these tumours is thought to be a consequence of chromosomal instability in these mice(10,12,16,17). These observations have challenged the expected effectiveness of anti-telomerase-based cancer therapies(18). Different cell types may nonetheless vary in their sensitivity to the chromosomal instability produced by telomere lost; or to the activation of telomere-rescue mechanisms. Here we show that late-generation Terc(-/-) mice, which have short telomeres and are telomerase-deficient(10), are resistant to tumour development in multi-stage skin carcinogenesis. Our results predict that an anti-telomerase-based tumour therapy may be effective in epithelial tumours.	Natl Biotechnol Ctr, Dept Immunol & Oncol, Madrid, Spain; Univ Complutense Madrid, Fac Vet, Dept Anim Pathol 2, Madrid, Spain	Complutense University of Madrid	Blasco, MA (corresponding author), Natl Biotechnol Ctr, Dept Immunol & Oncol, Madrid, Spain.	mblasco@cnb.uam.es	Gonzalez-Suarez, Eva/L-6298-2014; Blasco, Maria A./M-1694-2014	Gonzalez-Suarez, Eva/0000-0003-0858-8171; Blasco, Maria A./0000-0002-4211-233X				BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0; BALMAIN A, 1992, PRINCESS TAKAMATSU S, V22, P97; Bednarek AK, 1997, MOL CARCINOGEN, V20, P329, DOI 10.1002/(SICI)1098-2744(199712)20:4<329::AID-MC1>3.0.CO;2-E; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bryan TM, 1997, HUM MOL GENET, V6, P921, DOI 10.1093/hmg/6.6.921; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; de Lange T, 1999, CELL, V98, P273, DOI 10.1016/S0092-8674(00)81955-8; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HECKNER E, 1982, CARCINOGENESIS COMPR; HENNINGS H, 1994, KERATINOCYTE METHODS, P21; Herrera E, 2000, EMBO J, V19, P472, DOI 10.1093/emboj/19.3.472; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Herrera E, 1999, EMBO J, V18, P1172, DOI 10.1093/emboj/18.5.1172; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Martin-Rivera L, 1998, P NATL ACAD SCI USA, V95, P10471, DOI 10.1073/pnas.95.18.10471; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rufer N, 1998, NAT BIOTECHNOL, V16, P743, DOI 10.1038/nbt0898-743; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423; Zumstein LA, 1999, NAT MED, V5, P1129, DOI 10.1038/13451	30	269	286	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					114	117		10.1038/79089	http://dx.doi.org/10.1038/79089			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	10973262				2022-12-17	WOS:000089078000031
J	Cormier, RT; Hong, KH; Halberg, RB; Hawkins, TL; Richardson, P; Mulherkar, R; Dove, WF; Lander, ES				Cormier, RT; Hong, KH; Halberg, RB; Hawkins, TL; Richardson, P; Mulherkar, R; Dove, WF; Lander, ES			Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis	NATURE GENETICS			English	Letter							MOUSE SMALL-INTESTINES; ENHANCING FACTOR; ADENOMATOUS POLYPOSIS; MAJOR MODIFIER; NEOPLASIA; MUTATION; LOCUS; GENE; LOCALIZATION; PROTEIN	Individuals inheriting the same mutation predisposing to cancer may show very different outcomes, ranging from early aggressive cancer to disease-free survival. Experimental mouse models can provide a powerful tool to identify factors in the environment and genetic background that account for such modifications. The Min mouse strain(1), in which the Apc(Min) mutation disrupts the mouse homologue of the human familial polyposis gene(2), develops intestinal neoplasms whose multiplicity is strongly affected by genetic background(3). We previously mapped(4,5) a strong modifier locus, Mom1 (modifier of Min-1), to a 4-cM region on mouse chromosome 4 containing a candidate gene Pla2g2a encoding a secretory phospholipase(6). Here, we report that a cosmid transgene overexpressing Pla2g2a caused a reduction in tumour multiplicity and size, comparable to that conferred by a single copy of the resistance allele of Mom1. These results offer strong evidence that this secretory phospholipase can provide active tumour resistance, The association of Pla2g2a with Mom1 thus withstands a strong functional test and is likely to represent the successful identification of a polymorphic quantitative trait locus in mammals.	UNIV WISCONSIN,MCARDLE LAB CANC RES,MADISON,WI 53706; UNIV WISCONSIN,GENET LAB,MADISON,WI 53706; WHITEHEAD INST BIOMED RES,CAMBRIDGE CTR 9,CAMBRIDGE,MA 02142; MIT,DEPT BIOL,CAMBRIDGE,MA 02139; CANC RES INST,LAB GENET ENGN,MUMBAI,INDIA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)					NATIONAL CANCER INSTITUTE [R01CA063677, R37CA063677] Funding Source: NIH RePORTER; NCI NIH HHS [CA50585, CA63677, CA07075] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL SF, 1996, J BIOL, V215, P403; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; DOVE WF, 1987, GENETICS, V116, P5; Dove WF, 1997, CANCER RES, V57, P812; Dudley ME, 1996, INT J CANCER, V65, P249, DOI 10.1002/(SICI)1097-0215(19960117)65:2<249::AID-IJC20>3.0.CO;2-7; Gould KA, 1997, P NATL ACAD SCI USA, V94, P5848, DOI 10.1073/pnas.94.11.5848; Gould KA, 1996, GENETICS, V144, P1769; Gould KA, 1996, GENETICS, V144, P1777; Gould KA, 1996, CELL GROWTH DIFFER, V7, P1361; HALBERG R, 1992, J MOL BIOL, V228, P840, DOI 10.1016/0022-2836(92)90868-K; Hamilton BA, 1997, NEURON, V18, P711, DOI 10.1016/S0896-6273(00)80312-8; HARWIG SSL, 1995, J CLIN INVEST, V95, P603, DOI 10.1172/JCI117704; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; LANDER ES, 1989, GENETICS, V121, P185; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; MULHERKAR R, 1991, HISTOCHEMISTRY, V96, P367, DOI 10.1007/BF00271358; MULHERKAR R, 1993, FEBS LETT, V317, P263, DOI 10.1016/0014-5793(93)81289-C; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; PEETERS T, 1975, GUT, V16, P553, DOI 10.1136/gut.16.7.553; Reddy ST, 1997, J BIOL CHEM, V272, P3231, DOI 10.1074/jbc.272.6.3231; Rhodin J.A., 1974, HISTOLOGY TEXT ATLAS; Sambrook J, 1989, MOL CLONING LAB MANU; Shoemaker AR, 1997, BBA-REV CANCER, V1332, pF25, DOI 10.1016/S0304-419X(96)00041-8; Spirio LN, 1996, CANCER RES, V56, P955; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tischfield JA, 1996, GENOMICS, V32, P328, DOI 10.1006/geno.1996.0126; Tomlinson IPM, 1996, ANN HUM GENET, V60, P369, DOI 10.1111/j.1469-1809.1996.tb00434.x; WAGLE A, 1989, CELL BIOL INT REP, V13, P309, DOI 10.1016/0309-1651(89)90154-9	29	269	278	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1997	17	1					88	91		10.1038/ng0997-88	http://dx.doi.org/10.1038/ng0997-88			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288104				2022-12-17	WOS:A1997XU72400024
J	KANDT, RS; HAINES, JL; SMITH, M; NORTHRUP, H; GARDNER, RJM; SHORT, MP; DUMARS, K; ROACH, ES; STEINGOLD, S; WALL, S; BLANTON, SH; FLODMAN, P; KWIATKOWSKI, DJ; JEWELL, A; WEBER, JL; ROSES, AD; PERICAKVANCE, MA				KANDT, RS; HAINES, JL; SMITH, M; NORTHRUP, H; GARDNER, RJM; SHORT, MP; DUMARS, K; ROACH, ES; STEINGOLD, S; WALL, S; BLANTON, SH; FLODMAN, P; KWIATKOWSKI, DJ; JEWELL, A; WEBER, JL; ROSES, AD; PERICAKVANCE, MA			LINKAGE OF AN IMPORTANT GENE LOCUS FOR TUBEROUS SCLEROSIS TO A CHROMOSOME 16 MARKER FOR POLYCYSTIC KIDNEY-DISEASE	NATURE GENETICS			English	Article							HYDROXYLASE PAH LOCUS; ABO BLOOD-GROUP; PCR DETECTION; V-ABL; HETEROGENEITY; RECOMBINATION; POLYMORPHISM; RFLP	Tuberous sclerosis complex (TSC) is an autosomal dominant disorder of unknown aetiology that affects numerous body systems including skin, brain and kidneys. Some TSC has been linked to chromosome 9, additional TSC genes on chromosomes 11 and 12 have been proposed, but the majority of TSC families remain unlinked. Using TSC families in which data had excluded linkage to chromosome 9, we failed to detect linkage with loci on chromosomes 11, 12 and others. One marker examined was D16S283, the closest locus on the proximal side of the polycystic kidney disease type 1 (PKD1) gene. Linkage between TSC and D16S283 demonstrated a lod score of 9.50 at THETA = 0.02 with one family independently presenting a lod score of 4.44 at THETA = 0.05. These data reveal an important TSC locus near the region of PKD1 on chromosome 16p13.	MASSACHUSETTS GEN HOSP,MOLEC NEUROGENET LAB,CHARLESTON,MA 02129; UNIV CALIF IRVINE,DEPT PEDIAT,IRVINE,CA 92717; UNIV TEXAS,SCH MED,DEPT PEDIAT,DIV MED GENET,HOUSTON,TX 77030; UNIV OTAGO,DEPT PEDIAT & CHILD HLTH,DUNEDIN,NEW ZEALAND; UNIV TEXAS,HLTH SCI CTR,SW MED SCH,DIV PEDIAT NEUROL,DALLAS,TX 75235; UNIV VIRGINIA,DEPT PEDIAT,CHARLOTTESVILLE,VA 22908; BRIGHAM & WOMENS HOSP,DIV EXPTL MED & HEMATOL ONCOL,BOSTON,MA 02115; MARSHFIELD MED RES FDN,MARSHFIELD,WI 54449	Harvard University; Massachusetts General Hospital; University of California System; University of California Irvine; University of Texas System; University of Otago; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Virginia; Harvard University; Brigham & Women's Hospital	KANDT, RS (corresponding author), UNIV N CAROLINA,MED CTR,DEPT PEDIAT,DIV NEUROL,DURHAM,NC 27710, USA.		Roach, Ewell/E-3958-2011; Haines, Jonathan/C-3374-2012; Blanton, Susan Halloran/ABF-1323-2021	Haines, Jonathan/0000-0002-4351-4728; 				ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BERNSTEIN J, 1974, Birth Defects Original Article Series, V10, P35; BURLEY MW, IN PRESS ANN HUM GEN; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; CONNOR JM, 1987, J MED GENET, V24, P544, DOI 10.1136/jmg.24.9.544; DWORNICZAK B, 1991, NUCLEIC ACIDS RES, V19, P1958; FAHSOLD R, 1991, HUM GENET, V88, P85, DOI 10.1007/BF00204934; FRYER AE, 1987, LANCET, V1, P659; GERMINO GG, 1992, GENOMICS, V13, P144, DOI 10.1016/0888-7543(92)90214-D; GLEBEL LB, 1990, NUCLEIC ACIDS RES, V18, P3103; Gomez MR, 1988, TUBEROUS SCLEROSIS; HAINES JL, 1991, ANN NY ACAD SCI, V615, P256; HAINES JL, 1991, CYTOGENET CELL GENET, V58, P1939; HAINES JL, 1991, AM J HUM GENET, V49, P764; HAINES JL, IN PRESS ANN HUM GEN; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HARRIS PC, 1991, LANCET, V338, P1484, DOI 10.1016/0140-6736(91)92300-Q; JANSSEN LAJ, 1990, GENOMICS, V8, P237, DOI 10.1016/0888-7543(90)90277-2; JANSSEN LAJ, 1991, ANN NY ACAD SCI, V615, P306; KANDT RS, 1989, EXP NEUROL, V104, P223, DOI 10.1016/0014-4886(89)90033-2; KANDT RS, 1991, ANN NY ACAD SCI, V615, P284; KANDT RS, IN PRESS ANN HUM GEN; KWIATKOWSKI DJ, 1991, AM J HUM GENET, V48, P121; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LITT M, 1990, NUCLEIC ACIDS RES, V18, P5921, DOI 10.1093/nar/18.19.5921-a; NORTHRUP H, 1987, LANCET, V2, P804; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; POVEY S, 1988, LANCET, V2, P279; POVEY S, 1991, ANN NY ACAD SCI, V615, P298; POVEY S, 1992, IN PRESS ANN HUM GEN; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; SAMPSON JR, 1989, J MED GENET, V26, P511, DOI 10.1136/jmg.26.8.511; SANTOS C C, 1990, Current Opinion in Pediatrics, V2, P1075, DOI 10.1097/00008480-199012000-00006; SHEPHERD CW, 1991, MAYO CLIN PROC, V66, P792, DOI 10.1016/S0025-6196(12)61196-3; SMITH M, 1990, GENOMICS, V6, P105, DOI 10.1016/0888-7543(90)90454-3; STAPLETON FB, 1980, J PEDIATR-US, V97, P574, DOI 10.1016/S0022-3476(80)80011-4; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEDEMEYER N, 1991, NUCLEIC ACIDS RES, V19, P1959, DOI 10.1093/nar/19.8.1959; WIEDERHOLT WC, 1985, NEUROLOGY, V35, P600, DOI 10.1212/WNL.35.4.600	43	269	278	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					37	41		10.1038/ng0992-37	http://dx.doi.org/10.1038/ng0992-37			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	1303246	Green Published			2022-12-17	WOS:A1992JM64600013
J	Li, M; Atmaca-Sonmez, P; Othman, M; Branham, KEH; Khanna, R; Wade, MS; Li, Y; Liang, LM; Zareparsi, S; Swaroop, A; Abecasis, GR				Li, Mingyao; Atmaca-Sonmez, Pelin; Othman, Mohammad; Branham, Kari E. H.; Khanna, Ritu; Wade, Michael S.; Li, Yun; Liang, Liming; Zareparsi, Sepideh; Swaroop, Anand; Abecasis, Goncalo R.			CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration	NATURE GENETICS			English	Article							COMPLEMENT FACTOR-H; LINKAGE DISEQUILIBRIUM; RISK-FACTORS; GENOME SCAN; MACULOPATHY; POLYMORPHISM; DISEASE; LOC387715; SMOKING; TRAITS	In developed countries, age-related macular degeneration is a common cause of blindness in the elderly. A common polymorphism, encoding the sequence variation Y402H in complement factor H (CFH), has been strongly associated with disease susceptibility. Here, we examined 84 polymorphisms in and around CFH in 726 affected individuals (including 544 unrelated individuals) and 268 unrelated controls. In this sample, 20 of these polymorphisms showed stronger association with disease susceptibility than the Y402H variant. Further, no single polymorphism could account for the contribution of the CFH locus to disease susceptibility. Instead, multiple polymorphisms defined a set of four common haplotypes (of which two were associated with disease susceptibility and two seemed to be protective) and multiple rare haplotypes (associated with increased susceptibility in aggregate). Our results suggest that there are multiple disease susceptibility alleles in the region and that noncoding CFH variants play a role in disease susceptibility.	Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Pennsylvania; University of Michigan System; University of Michigan	Abecasis, GR (corresponding author), Univ Michigan, Dept Biostat, 1420 Washington Hts, Ann Arbor, MI 48109 USA.	swaroop@umich.edu; goncalo@umich.edu	Abecasis, Goncalo R/B-7840-2010; Branham, Kari/AAA-8336-2022	Swaroop, Anand/0000-0002-1975-1141; Branham, Kari/0000-0002-2492-254X; Abecasis, Goncalo/0000-0003-1509-1825	NATIONAL EYE INSTITUTE [R01EY016862] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY016862-01A1] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Abecasis GR, 2001, AM J HUM GENET, V69, P198; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fisher SA, 2005, HUM MOL GENET, V14, P2257, DOI 10.1093/hmg/ddi230; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hirvela H, 1996, OPHTHALMOLOGY, V103, P871, DOI 10.1016/S0161-6420(96)30593-9; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Klein R, 2002, AM J EPIDEMIOL, V156, P589, DOI 10.1093/aje/kwf092; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li MY, 2006, AM J HUM GENET, V78, P778, DOI 10.1086/503711; Li MY, 2005, AM J HUM GENET, V76, P934, DOI 10.1086/430277; Li N, 2003, GENETICS, V165, P2213; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; RISCH N, 1990, AM J HUM GENET, V46, P222; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Valdes AM, 1997, AM J HUM GENET, V60, P703; Weeks DE, 2001, AM J OPHTHALMOL, V132, P682, DOI 10.1016/S0002-9394(01)01214-4; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986	30	268	284	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2006	38	9					1049	1054		10.1038/ng1871	http://dx.doi.org/10.1038/ng1871			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16936733	Green Accepted, Green Submitted			2022-12-17	WOS:000240112100023
J	Perry, WL; Hustad, CM; Swing, DA; O'Sullivan, TN; Jenkins, NA; Copeland, NG				Perry, WL; Hustad, CM; Swing, DA; O'Sullivan, TN; Jenkins, NA; Copeland, NG			The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a(18H) mice	NATURE GENETICS			English	Article							MOTH-EATEN; RECEPTOR; MOUSE; GENE; POLYUBIQUITINATION; DEGRADATION; PATHOLOGY; MUTATIONS; PATHWAY; DOMAIN	Non-agouti-lethal 18H (a(18H)) mice are dark agouti with black pinna hairs. What makes these mice unique is that they develop a spectrum of immunological diseases not seen in other agouti mutant mice(1). On the JU/Ct background, a(18H) mice develop an inflammatory disease of the large intestine, On the C57BL/6J background, they develop a fatal disease characterized by pulmonary chronic interstitial inflammation and alveolar proteinosis, inflammation of the glandular stomach and skin resulting in scarring due to constant itching, and hyperplasia of lymphoid cells, haematopoietic cells and the forestomach epithelium. Previous studies suggested that the a(18H) mutation results from a paracentric inversion that affects two loci: agouti and another, as yet unidentified locus designated itchy (the provisional gene symbol is Itch), that is responsible for the immunological phenotype of a(18H) mice(1). Here we confirm that a(18H) results from an inversion and show that Itch encodes a novel E3 ubiquitin protein ligase, a protein involved in ubiquitin-mediated protein degradation. Our results indicate that ubiquitin-dependent proteolysis is an important mediator of the immune response in vivo and provide evidence for itch's role in inflammation and the regulation of epithelial and haematopoietic cell growth.	NCI, Frederick Canc Res & Dev Ctr, ABL Basic Res Program, Mammalian Genet Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Copeland, NG (corresponding author), NCI, Frederick Canc Res & Dev Ctr, ABL Basic Res Program, Mammalian Genet Lab, Frederick, MD 21702 USA.	copeland@ncifcrf.gov						CATTANACH BM, 1987, MOUSE NEWS LETT, V77, P123; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; DAVID M, 1995, MOL CELL BIOL, V15, P7050; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; FERRY WL, 1995, GENETICS, V140, P267; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; HUSTAD CM, 1995, GENETICS, V140, P255; Jiao HY, 1997, EXP HEMATOL, V25, P592; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; LOS M, 1995, NATURE, V375, P81, DOI 10.1038/375081a0; MIYAZAWA K, 1994, BLOOD, V83, P137; MORI S, 1995, BIOCHEM BIOPH RES CO, V213, P32, DOI 10.1006/bbrc.1995.2094; MORI S, 1995, J BIOL CHEM, V270, P29447, DOI 10.1074/jbc.270.49.29447; MORI S, 1993, J BIOL CHEM, V268, P577; Piao XH, 1996, P NATL ACAD SCI USA, V93, P14665, DOI 10.1073/pnas.93.25.14665; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; SIDMAN CL, 1978, J IMMUNOL, V121, P2392; Sudol M, 1996, TRENDS BIOCHEM SCI, V21, P161, DOI 10.1016/0968-0004(96)30018-2; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; VRIELING HD, 1994, P NATL ACAD SCI USA, V91, P170; WARD JM, 1978, VET PATHOL, V15, P170, DOI 10.1177/030098587801500203	25	268	278	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1998	18	2					143	146		10.1038/ng0298-143	http://dx.doi.org/10.1038/ng0298-143			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462742				2022-12-17	WOS:000071779500021
J	Nagano, A; Koga, R; Ogawa, M; Kurano, Y; Kawada, J; Okada, R; Hayashi, YK; Tsukahara, T; Arahata, K				Nagano, A; Koga, R; Ogawa, M; Kurano, Y; Kawada, J; Okada, R; Hayashi, YK; Tsukahara, T; Arahata, K			Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy	NATURE GENETICS			English	Article							X-CHROMOSOME; FACTOR-VIII; LINKAGE; GENE; LOCALIZATION; SKELETAL; PROTEIN; MUSCLE	Mutations in the STA gene at the Xq28 locus have been found in patients with X-linked Emery-Dreifuss muscular dystrophy (EDMD). This gene encodes a hitherto unknown protein named 'emerin'. To elucidate the subcellular localization of emerin, we raised two antisera against synthetic peptide fragments predicted from emerin cDNA. Using both antisera, we found positive nuclear membrane staining in skeletal, cardiac and smooth muscles in the normal controls and in patients with neuromuscular diseases other than EDMD. In contrast, a deficiency in immunofluorescent staining of skeletal and cardiac muscle from EDMD patients was observed. A 34 kD protein is immunoreactive with the antisera - the protein is equivalent to that predicted for emerin. Together, our findings suggest the specific deficiency of emerin in the nuclear membrane of muscle cells in patients with EDMD.	NCNP,DEPT NEUROMUSCULAR RES,NATL INST NEUROSCI,KODAIRA,TOKYO 187,JAPAN; TOKYO MED COLL,DEPT INTERNAL MED 3,SHINJUKU KU,TOKYO 160,JAPAN; FUJIREBIO CENT RES INST,HACHIOJI,TOKYO 192,JAPAN; KANAZAWA MED UNIV,DEPT NEUROL,UCHINADA,ISHIKAWA 92002,JAPAN; JUNTENDO UNIV,SCH MED,RES LAB CARDIOVASC PATHOL,BUNKYO KU,TOKYO 113,JAPAN	National Center for Neurology & Psychiatry - Japan; Tokyo Medical University; H.U. Group Holdings Inc; Kanazawa Medical University; Juntendo University								ARAHATA K, 1989, P NATL ACAD SCI USA, V86, P7154, DOI 10.1073/pnas.86.18.7154; ARAHATA K, 1991, J NEUROL SCI, V101, P148, DOI 10.1016/0022-510X(91)90039-A; ARAHATA K, 1988, NATURE, V333, P861, DOI 10.1038/333861a0; ARIKAWAHIRASAWA E, 1995, NEUROMUSCULAR DISORD, V5, P429, DOI 10.1016/0960-8966(94)00087-P; BIONE S, 1993, P NATL ACAD SCI USA, V90, P10977, DOI 10.1073/pnas.90.23.10977; BIONE S, 1995, HUM MOL GENET, V4, P1859; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; COLE CG, 1992, NEUROMUSCULAR DISORD, V2, P51, DOI 10.1016/0960-8966(92)90027-4; DEDUVE C, 1981, J CELL BIOL, V91, pS293, DOI 10.1083/jcb.91.3.293s; DUBOWITZ V, 1989, COLOR ATLAS MUSCLE D; EMERY AEH, 1966, J NEUROL NEUROSUR PS, V29, P338, DOI 10.1136/jnnp.29.4.338; EMERY AEH, 1989, BRIT MED BULL, V45, P772, DOI 10.1093/oxfordjournals.bmb.a072357; HODGSON S, 1986, HUM GENET, V74, P409, DOI 10.1007/BF00280495; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; KLAUCK SM, 1995, HUM MOL GENET, V4, P1853, DOI 10.1093/hmg/4.10.1853; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOGA R, 1994, BIOCHEM BIOPH RES CO, V202, P577, DOI 10.1006/bbrc.1994.1967; KRESS W, 1992, NEUROMUSCULAR DISORD, V2, P111, DOI 10.1016/0960-8966(92)90042-5; NIGRO V, 1995, HUM MOL GENET, V4, P2003, DOI 10.1093/hmg/4.10.2003; ROMEO G, 1988, HUM GENET, V80, P59, DOI 10.1007/BF00451457; THOMAS NST, 1986, J MED GENET, V23, P596, DOI 10.1136/jmg.23.6.596; YATES JRW, 1986, J MED GENET, V23, P587, DOI 10.1136/jmg.23.6.587	22	268	269	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1996	12	3					254	259		10.1038/ng0396-254	http://dx.doi.org/10.1038/ng0396-254			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589715				2022-12-17	WOS:A1996TY18300013
J	MARTINI, R; ZIELASEK, J; TOYKA, KV; GIESE, KP; SCHACHNER, M				MARTINI, R; ZIELASEK, J; TOYKA, KV; GIESE, KP; SCHACHNER, M			PROTEIN ZERO (P0)-DEFICIENT MICE SHOW MYELIN DEGENERATION IN PERIPHERAL-NERVES CHARACTERISTIC OF INHERITED HUMAN NEUROPATHIES	NATURE GENETICS			English	Article							PO GENE; SENSORY NEUROPATHY; HEREDITARY MOTOR; EXPRESSION; MUTATION; TYPE-1B; HYPOMYELINATION; TENASCIN	Mutations in the human gene for the myelin recognition molecule protein zero (P0) give rise to severe and progressive forms of dominantly inherited peripheral neuropathies. We have previously reported that mice homozygous for a null mutation in P0 have severely hypomyelinated nerves ten weeks after birth. Here we show hypomyelination already exists at day four with subsequent demyelination and impaired nerve conduction. Furthermore, heterozygous mutants show normal myelination, but develop progressive demyelination after four months of age. Thus, the pathology of homo- and heterozygous P0 mutants resembles that of the severely affected Dejerine-Sottas and the more mildly affected Charcot-Marie-Tooth type 1B patients, respectively.	UNIV WURZBURG,NEUROL KLIN,D-97080 WURZBURG,GERMANY	University of Wurzburg	MARTINI, R (corresponding author), SWISS FED INST TECHNOL,DEPT NEUROBIOL,CH-8093 ZURICH,SWITZERLAND.		Giese, Karl P/A-3112-2011	Giese, Karl P/0000-0003-4503-7344; Martini, Rudolf/0000-0002-5463-5592				ADIKOFER K, 1995, NAT GENET, V11, P274; Dyck P.J, 1993, PNP, P1094; FRUTTIGER M, 1995, J NEUROCYTOL, V24, P1, DOI 10.1007/BF01370156; FRUTTIGER M, 1995, EUR J NEUROSCI, V7, P511, DOI 10.1111/j.1460-9568.1995.tb00347.x; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; GOW A, 1994, J NEUROSCI RES, V37, P574, DOI 10.1002/jnr.490370504; HARTUNG HP, 1988, BRAIN, V111, P1039, DOI 10.1093/brain/111.5.1039; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; HAYASAKA K, 1993, BIOCHEM BIOPH RES CO, V194, P1317, DOI 10.1006/bbrc.1993.1968; HAYASAKA K, 1993, NAT GENET, V5, P266, DOI 10.1038/ng1193-266; HAYASAKA K, 1993, HUM MOL GENET, V2, P1369, DOI 10.1093/hmg/2.9.1369; HIMORO M, 1993, BIOCHEM MOL BIOL INT, V31, P169; HOOGENDIJK JE, 1995, J NEUROL, V242, P149; HUSMANN K, 1992, J CELL BIOL, V116, P1475, DOI 10.1083/jcb.116.6.1475; KIRSCHNER DA, 1994, J NEUROSCI RES, V39, P63, DOI 10.1002/jnr.490390109; KULKENS T, 1993, NAT GENET, V5, P35, DOI 10.1038/ng0993-35; Landon D.N, 1976, PERIPHERAL NERVE, P1; MARTINI R, 1990, J NEUROCYTOL, V19, P601, DOI 10.1007/BF01257247; MARTINI R, J NEUROSCI, V15, P4488; MITCHELL LS, 1990, J NEUROSCI RES, V27, P125, DOI 10.1002/jnr.490270202; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; NAVE KA, 1994, J NEUROSCI RES, V38, P607, DOI 10.1002/jnr.490380602; NELIS E, 1994, J MED GENET, V31, P811, DOI 10.1136/jmg.31.10.811; OUVRIER RA, 1987, BRAIN, V110, P121, DOI 10.1093/brain/110.1.121; RAUTENSTRAUSS B, 1994, HUM MOL GENET, V3, P1701, DOI 10.1093/hmg/3.9.1701; REYNOLDS RJ, 1994, J NEUROCYTOL, V23, P555, DOI 10.1007/BF01262056; SHINE HD, 1992, J NEUROCHEM, V58, P342, DOI 10.1111/j.1471-4159.1992.tb09316.x; SU Y, 1993, P NATL ACAD SCI USA, V90, P10856, DOI 10.1073/pnas.90.22.10856; SUTER U, 1993, TRENDS NEUROSCI, V16, P50, DOI 10.1016/0166-2236(93)90015-E; TACHI N, 1984, BRAIN DEV-JPN, V6, P560, DOI 10.1016/S0387-7604(84)80101-1; UCHIDA Y, 1985, J NEUROCHEM, V46, P1376	31	268	268	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					281	286		10.1038/ng1195-281	http://dx.doi.org/10.1038/ng1195-281			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581451				2022-12-17	WOS:A1995TC63900016
J	GRUIS, NA; VANDERVELDEN, PA; SANDKUIJL, LA; PRINS, DE; WEAVERFELDHAUS, J; KAMB, A; BERGMAN, W; FRANTS, RR				GRUIS, NA; VANDERVELDEN, PA; SANDKUIJL, LA; PRINS, DE; WEAVERFELDHAUS, J; KAMB, A; BERGMAN, W; FRANTS, RR			HOMOZYGOTES FOR CDKN2 (P16) GERMLINE MUTATION IN DUTCH FAMILIAL MELANOMA KINDREDS	NATURE GENETICS			English	Letter							DNA		LEIDEN UNIV,MGC DEPT HUMAN GENET,LEIDEN,NETHERLANDS; UNIV LEIDEN HOSP,DEPT DERMATOL,LEIDEN,NETHERLANDS; MYRIAD GENET INC,SALT LAKE CITY,UT	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Myriad Genetics, Inc				van der Velden, Pieter/0000-0002-5710-9256; Gruis, Nelleke/0000-0002-5210-9150; Orr, Harry/0000-0001-6118-741X				BERGMAN W, 1994, J INVEST DERMATOL, V103, pS122; BERGMAN W, 1992, CYTOGENET CELL GENET, V59, P161, DOI 10.1159/000133232; CANNONALBRIGHT LA, 1992, SCIENCE, V258, P1148, DOI 10.1126/science.1439824; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; GRULS NA, 1993, MELANOMA RES, V3, P271; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; KAMB A, 1994, NAT GENET, V8, P22, DOI 10.1038/ng0994-22; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Maniatis T, 1989, DECONTAMINATION DILU; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0	17	268	273	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1995	10	3					351	353		10.1038/ng0795-351	http://dx.doi.org/10.1038/ng0795-351			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG386	7670475				2022-12-17	WOS:A1995RG38600021
J	PHILLIPS, HA; SCHEFFER, IE; BERKOVIC, SF; HOLLWAY, GE; SUTHERLAND, GR; MULLEY, JC				PHILLIPS, HA; SCHEFFER, IE; BERKOVIC, SF; HOLLWAY, GE; SUTHERLAND, GR; MULLEY, JC			LOCALIZATION OF A GENE FOR AUTOSOMAL-DOMINANT NOCTURNAL FRONTAL-LOBE EPILEPSY TO CHROMOSOME 20Q13.2	NATURE GENETICS			English	Letter							FAMILIAL NEONATAL CONVULSIONS; JUVENILE MYOCLONIC EPILEPSY; LINKAGE; HETEROGENEITY; LOCUS		WOMENS & CHILDRENS HOSP,CTR MED GENET,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA; UNIV ADELAIDE,DEPT PAEDIAT,ADELAIDE,SA,AUSTRALIA; AUSTIN HOSP HEIDELBERG,DEPT NEUROL,MELBOURNE,VIC,AUSTRALIA; UNIV MELBOURNE,DEPT NEUROL,MELBOURNE,VIC,AUSTRALIA; ROYAL CHILDRENS HOSP,DEPT NEUROL,MELBOURNE,VIC,AUSTRALIA	Womens & Childrens Hospital Australia; University of Adelaide; University of Melbourne; Royal Children's Hospital Melbourne			jiang, yu/HGU-0029-2022; Sutherland, Grant Robert/D-2606-2012; Scheffer, Ingrid E/G-1668-2013; Hollway, Georgina E/E-6764-2010	Scheffer, Ingrid E/0000-0002-2311-2174; Berkovic, Samuel/0000-0003-4580-841X				ANAND R, 1992, GENOMICS, V13, P962, DOI 10.1016/0888-7543(92)90008-G; [Anonymous], 1989, EPILEPSIA, V30, P389; Beck C, 1994, Neurobiol Dis, V1, P95, DOI 10.1006/nbdi.1994.0012; BERKOVIC SF, 1994, ARCH NEUROL-CHICAGO, V51, P1125, DOI 10.1001/archneur.1994.00540230063014; BERKOVIC SF, 1995, EPILEPTIC SEIZURES S, P259; GANTZ I, 1993, GENOMICS, V18, P166, DOI 10.1006/geno.1993.1448; GREENBERG DA, 1988, AM J MED GENET, V31, P185, DOI 10.1002/ajmg.1320310125; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; LAURENT P, 1994, GENOME, V5, P303; LEHESJOKI AE, 1991, P NATL ACAD SCI USA, V88, P3696, DOI 10.1073/pnas.88.9.3696; LEPPERT M, 1989, NATURE, V337, P647, DOI 10.1038/337647a0; LEWIS TB, 1993, AM J HUM GENET, V53, P670; MALAFOSSE A, 1992, HUM GENET, V89, P54, DOI 10.1007/BF00207042; Plouin P., 1994, IDIOPATHIC GEN EPILE, P39; RISE ML, 1991, SCIENCE, V251, P669; ROMEO G, 1994, NAT GENET, V7, P451, DOI 10.1038/ng0894-451; SCHEFFER IE, 1995, BRAIN, V118, P61, DOI 10.1093/brain/118.1.61; SCHEFFER IE, 1994, LANCET, V343, P515, DOI 10.1016/S0140-6736(94)91463-X; SCHEFFER IE, 1994, PEDIATR NEUROL, V11, P95; STEINLEIN O, 1992, GENOMICS, V12, P69, DOI 10.1016/0888-7543(92)90408-K; STEINLEIN O, 1994, GENOMICS, V22, P493, DOI 10.1006/geno.1994.1420; TAHVANAINEN E, 1994, P NATL ACAD SCI USA, V91, P7267, DOI 10.1073/pnas.91.15.7267; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WHITEHOUSE WP, 1993, AM J HUM GENET, V53, P652	24	268	281	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1995	10	1					117	118		10.1038/ng0595-117	http://dx.doi.org/10.1038/ng0595-117			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	7647781				2022-12-17	WOS:A1995QX57300027
J	MATSUO, T; OSUMIYAMASHITA, N; NOJI, S; OHUCHI, H; KOYAMA, E; MYOKAI, F; MATSUO, N; TANIGUCHI, S; DOI, H; ISEKI, S; NINOMIYA, Y; FUJIWARA, M; WATANABE, T; ETO, K				MATSUO, T; OSUMIYAMASHITA, N; NOJI, S; OHUCHI, H; KOYAMA, E; MYOKAI, F; MATSUO, N; TANIGUCHI, S; DOI, H; ISEKI, S; NINOMIYA, Y; FUJIWARA, M; WATANABE, T; ETO, K			A MUTATION IN THE PAX-6 GENE IN RAT SMALL-EYE IS ASSOCIATED WITH IMPAIRED MIGRATION OF MIDBRAIN CREST CELLS	NATURE GENETICS			English	Article							BETA-GLOBIN GENE; POINT MUTATION; SPLICE JUNCTION; NEURAL-TUBE; DEFECT; SITE; THALASSEMIA; DEFICIENCY; DELETION; DISEASE	The rat small eye strain (rSey) lacks eyes and nose in the homozygote, an is similar the mouse Sey strain with mutations in the Pax-6 gene. We isolated Pax-6 cDNA clones from an rSey homozygote library, and found an internal deletion of about 600 basepairs in the serine/threonine-rich domain. At the genomic level, a single base (G) insertion in an exon generates an abnormal 5' donor splice site, thereby producing the truncated mRNA. Anterior midbrain crest cells in the homozygous rSey embryos reached the eye rudiments but did not migrate any further to the nasal rudiments, suggesting that the Pax-6 gene is involved in conducting migration of neural crest cells from the anterior midbrain.	OKAYAMA UNIV,SCH MED,DEPT OPHTHALMOL,OKAYAMA 700,JAPAN; OKAYAMA UNIV,SCH DENT,DEPT BIOCHEM,OKAYAMA 700,JAPAN; TOKYO MED & DENT UNIV,GRAD SCH DENT,DEPT DEV BIOL,DIV LIFE SCI MAXILLOFACIAL SYST,TOKYO 113,JAPAN; UNIV TOKUSHIMA,FAC ENGN,DEPT BIOL SCI & TECHNOL,TOKUSHIMA 770,JAPAN; FUJITSU LABS LTD,IIAS,BIOL INFORMAT SECT,CHIBA 261,JAPAN; YAMANOUCHI PHARMACEUT CO LTD,SAFETY RES LABS,TOKYO 174,JAPAN	Okayama University; Okayama University; Tokyo Medical & Dental University (TMDU); Tokushima University; Fujitsu Ltd; Fujitsu Laboratories Ltd; Astellas Pharmaceuticals			Osumi, Noriko/T-2823-2019	Osumi, Noriko/0000-0003-0548-6452; Ninomiya, Youichirou/0000-0003-3572-2532				ATWEH GF, 1987, BLOOD, V70, P147; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; DOBKIN C, 1983, P NATL ACAD SCI-BIOL, V80, P1184, DOI 10.1073/pnas.80.5.1184; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; FUKIISHI Y, 1992, CELL TISSUE RES, V268, P1, DOI 10.1007/BF00338048; GLASER T, 1990, SCIENCE, V250, P823, DOI 10.1126/science.2173141; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; GRUSS P, 1992, CELL, V69, P719, DOI 10.1016/0092-8674(92)90281-G; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HOGAN BLM, 1988, DEVELOPMENT, V103, P115; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; MOASE CE, 1991, DEVELOPMENT, V113, P1049; MYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P3955, DOI 10.1073/pnas.85.11.3955; NAKAJIMA H, 1990, J BIOL CHEM, V265, P9392; NAKANO T, 1989, J BIOL CHEM, V264, P5155; NELSON C, 1992, J BIOL CHEM, V267, P3351; NOJI S, 1989, FEBS LETT, V257, P93, DOI 10.1016/0014-5793(89)81794-6; OSUMIYAMASHITA N, 1992, CRANIOFAC GENET DEV, V12, P130; PARKINSON DB, 1992, NAT GENET, V1, P149, DOI 10.1038/ng0592-149; REES DJG, 1985, NATURE, V316, P643, DOI 10.1038/316643a0; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SERBEDZIJA GN, 1992, DEVELOPMENT, V116, P297; SU TS, 1990, J BIOL CHEM, V265, P19716; TAKEUCHI T, 1990, ENDOCRINOLOGY, V126, P31, DOI 10.1210/endo-126-1-31; TAN SS, 1986, J EMBRYOL EXP MORPH, V98, P21; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TON CCT, 1991, CELL, V67, P1089; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; WALTHER C, 1991, GENOMICS, V11, P424, DOI 10.1016/0888-7543(91)90151-4; WALTHER C, 1991, DEVELOPMENT, V113, P1435	34	268	271	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1993	3	4					299	304		10.1038/ng0493-299	http://dx.doi.org/10.1038/ng0493-299			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KW257	7981749				2022-12-17	WOS:A1993KW25700009
J	Wittkopp, PJ; Haerum, BK; Clark, AG				Wittkopp, Patricia J.; Haerum, Belinda K.; Clark, Andrew G.			Regulatory changes underlying expression differences within and between Drosophila species	NATURE GENETICS			English	Article							GENE-EXPRESSION; INTERSPECIFIC HYBRIDS; MELANOGASTER; EVOLUTION; CIS; TRANS	Differences in gene expression are an important source of phenotypic variation, and can be caused by changes in cis and/or trans regulation. cis-regulatory variants alter allele-specific expression, whereas trans-regulatory variants influence expression of both alleles in a diploid cell. Because of this difference, we hypothesize that natural selection may favor one type of change over the other. Here, we investigate contributions of cis- and trans-regulatory changes to variable intra- and interspecific gene expression using four strains of Drosophila melanogaster, three strains of D. simulans and a total of 78 genes. We show that cis- regulatory changes account for a greater proportion of the expression differences observed between rather than within species. These data are inconsistent with a neutral model assuming equal probabilities of fixation for cis- and trans-regulatory polymorphisms, suggesting that natural selection influences the molecular mechanisms underlying divergent gene expression. Specifically, cis- regulatory changes seem to accumulate preferentially over time.	[Wittkopp, Patricia J.; Haerum, Belinda K.; Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Wittkopp, Patricia J.; Haerum, Belinda K.] Univ Michigan, Dept Mol Cellular & Dev Biol, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	Cornell University; University of Michigan System; University of Michigan	Wittkopp, PJ (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	wittkopp@umich.edu		Clark, Andrew/0000-0001-7159-8511				Akritas MG, 1996, ASTROPHYS J, V470, P706, DOI 10.1086/177901; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Gibson G, 2004, GENETICS, V167, P1791, DOI 10.1534/genetics.104.026583; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Landry CR, 2005, GENETICS, V171, P1813, DOI 10.1534/genetics.105.047449; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Meiklejohn CD, 2003, P NATL ACAD SCI USA, V100, P9894, DOI 10.1073/pnas.1630690100; Michalak P, 2003, MOL BIOL EVOL, V20, P1070, DOI 10.1093/molbev/msg119; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Osada N, 2006, MOL BIOL EVOL, V23, P1585, DOI 10.1093/molbev/msl023; Powell J.R., 1997, PROGR PROSPECTS EVOL; Ranz JM, 2004, GENOME RES, V14, P373, DOI 10.1101/gr.2019804; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; Wittkopp PJ, 2006, GENETICS, V173, P1817, DOI 10.1534/genetics.105.054684; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wittkopp PJ, 2005, CELL MOL LIFE SCI, V62, P1779, DOI 10.1007/s00018-005-5064-9; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	24	267	270	0	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2008	40	3					346	350		10.1038/ng.77	http://dx.doi.org/10.1038/ng.77			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18278046				2022-12-17	WOS:000253548400027
J	Simpson, MA; Cross, H; Proukakis, C; Priestman, DA; Neville, DCA; Reinkensmeier, G; Wang, H; Wiznitzer, M; Gurtz, K; Verganelaki, A; Pryde, A; Patton, MA; Dwek, RA; Butters, TD; Platt, FM; Crosby, AH				Simpson, MA; Cross, H; Proukakis, C; Priestman, DA; Neville, DCA; Reinkensmeier, G; Wang, H; Wiznitzer, M; Gurtz, K; Verganelaki, A; Pryde, A; Patton, MA; Dwek, RA; Butters, TD; Platt, FM; Crosby, AH			Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase	NATURE GENETICS			English	Article							HUMAN SERUM; GANGLIOSIDES; GLYCOSPHINGOLIPIDS; BIOSYNTHESIS; COMPLEX	We identified an autosomal recessive infantile-onset symptomatic epilepsy syndrome associated with developmental stagnation and blindness. Assuming a founder effect in a large Old Order Amish pedigree, we carried out a genome-wide screen for linkage and identified a single region of homozygosity on chromosome 2p12-p11.2 spanning 5.1 cM (maximum lod score of 6.84). We sequenced genes in the region and identified a nonsense mutation in SIAT9, which is predicted to result in the premature termination of the GM3 synthase enzyme (also called lactosylceramide alpha-2,3 sialyltransferase). GM3 synthase is a member of the sialyltransferase family and catalyzes the initial step in the biosynthesis of most complex gangliosides from lactosylceramide. Biochemical analysis of plasma glycosphingolipids confirmed that affected individuals lack GM3 synthase activity, as marked by a complete lack of GM3 ganglioside and its biosynthetic derivatives and an increase in lactosylceramide and its alternative derivatives. Although the relationship between defects in ganglioside catabolism and a range of lysosomal storage diseases is well documented, this is the first report, to our knowledge, of a disruption of ganglioside biosynthesis associated with human disease.	Univ London St Georges Hosp, Sch Med, Dept Med Genet, London SW17 0RE, England; Univ Arizona, Sch Med, Dept Ophthalmol, Tucson, AZ USA; Univ Oxford, Dept Biochem, Glycobiol Inst, Oxford OX1 3QU, England; Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; Windows Hope Genet Studies, Kimmeridge Trail, OH 44065 USA	St Georges University London; University of Arizona; University of Oxford; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Crosby, AH (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Med Genet, Cranmer Terrace, London SW17 0RE, England.	acrosby@sghms.ac.uk	Proukakis, Christos/G-4548-2013; proukakis, christos/ABE-3447-2020; Platt, Frances/G-1004-2010; Crosby, Andrew H/E-2218-2015; Simpson, Michael/F-4737-2011	proukakis, christos/0000-0001-6423-6539; Crosby, Andrew H/0000-0003-3667-9054; Simpson, Michael/0000-0002-8539-8753; Neville, David/0000-0003-2385-8993; Verganelaki, Argyro/0000-0001-8748-1078; Platt, Frances/0000-0001-7614-0403				Datta AK, 2001, J BIOL CHEM, V276, P15200, DOI 10.1074/jbc.M010542200; Gardiner RM, 2000, J NEUROL, V247, P327, DOI 10.1007/s004150050598; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P627, DOI 10.1023/A:1011086929064; Inoue M, 2002, J BIOL CHEM, V277, P29881, DOI 10.1074/jbc.M201631200; IZUMI T, 1993, PEDIATR NEUROL, V9, P293, DOI 10.1016/0887-8994(93)90066-L; Kawai H, 2001, J BIOL CHEM, V276, P6885, DOI 10.1074/jbc.C000847200; Kobayashi T, 2000, GLYCOCONJUGATE J, V17, P163, DOI 10.1023/A:1026528921085; KUNDU SK, 1985, ARCH BIOCHEM BIOPHYS, V238, P388, DOI 10.1016/0003-9861(85)90179-1; MAX SR, 1974, NEW ENGL J MED, V291, P929, DOI 10.1056/NEJM197410312911802; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Negroni E, 1996, GLYCOCONJUGATE J, V13, P347, DOI 10.1007/BF00731466; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Proia RL, 2003, PHILOS T R SOC B, V358, P879, DOI 10.1098/rstb.2003.1268; Sandhoff K, 2003, PHILOS T R SOC B, V358, P847, DOI 10.1098/rstb.2003.1265; Schapiro FB, 1998, AM J PHYSIOL-CELL PH, V274, pC319, DOI 10.1152/ajpcell.1998.274.2.C319; SENN HJ, 1992, ATHEROSCLEROSIS, V94, P109, DOI 10.1016/0021-9150(92)90235-9; Wraith J E, 2002, Semin Neonatol, V7, P75, DOI 10.1053/siny.2001.0088; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yu R K, 1975, Trans Am Neurol Assoc, V100, P261; YU RK, 1987, YALE J BIOL MED, V60, P107; ZEBDA N, 1995, FEBS LETT, V362, P161, DOI 10.1016/0014-5793(95)00234-Z; ZELLER CB, 1992, AM J PHYSIOL, V262, pC1341, DOI 10.1152/ajpcell.1992.262.6.C1341	22	267	279	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11					1225	1229		10.1038/ng1460	http://dx.doi.org/10.1038/ng1460			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	15502825	Bronze			2022-12-17	WOS:000224832800028
J	Marini, AM; Matassi, G; Raynal, V; Andre, B; Cartron, JP; Cherif-Zahar, B				Marini, AM; Matassi, G; Raynal, V; Andre, B; Cartron, JP; Cherif-Zahar, B			The human Rhesus-associated RhAG protein and a kidney homologue promote ammonium transport in yeast	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; GENE FAMILY; PERMEASE; EXPRESSION; EVOLUTION; CLONING; RH50	The Rhesus blood-group antigens are defined by a complex association of membrane polypeptides that includes the nonglycosylated Rh proteins (RhD and RhCE) and the RHag glycoprotein, which is strictly required for cell surface expression of these antigens', RhAG and the Rh polypeptides are erythroid-specific transmembrane proteins belonging to the same family (36% identity)(2,3). Despite their importance in transfusion medicine, the function of RhAG and Rh proteins remains unknown, except that their absence in Rh-null individuals leads to morphological and functional abnormalities of erythrocytes, known as the Rh-deficiency syndrome. We recently found significant sequence similarity between the Rh family proteins, especially RhAG, and Mep/Amt ammonium transporters(4,5). We show here that RhAG and also RhGK, a new human homologue expressed in kidney cells only, function as ammonium transport proteins when expressed in yeast. Both specifically complement the growth defect of a yeast mutant deficient in ammonium uptake. Moreover, ammonium efflux assays and growth tests in the presence of toxic concentrations of the analogue methylammonium indicate that RhAG and RhGK also promote ammonium export. Our results provide the first experimental evidence for a direct role of RhAG and RhGK in ammonium transport. These findings are of high interest, because no specific ammonium transport system has been characterized so far in human.	Free Univ Brussels, Lab Physiol Cellularie, Inst Biol & Med Mol, Gosselies, Belgium; Inst Natl Transfus Sanguine, Unite INSERM U76, F-75015 Paris, France; Stn Zool Anton Dohrn, Lab Evoluz Mol, Naples, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); Stazione Zoologica Anton Dohrn di Napoli	Andre, B (corresponding author), Free Univ Brussels, Lab Physiol Cellularie, Inst Biol & Med Mol, Gosselies, Belgium.		André, Bruno/D-1725-2010; Matassi, Giorgio/G-6301-2014	Matassi, Giorgio/0000-0003-4923-226X; Cherif-Zahar, Baya/0000-0002-4965-7252				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Avent ND, 2000, BLOOD, V95, P375, DOI 10.1182/blood.V95.2.375; Cartron JP, 1999, BEST PRACT RES CL HA, V12, P655, DOI 10.1053/beha.1999.0047; CherifZahar B, 1996, NAT GENET, V12, P168, DOI 10.1038/ng0296-168; DEJONG CH, 1996, J GASTROENTEROL S, V218, P61; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; GOOD DW, 1985, AM J PHYSIOL, V248, pF459, DOI 10.1152/ajprenal.1985.248.4.F459; HUIZENGA JR, 1994, ANN CLIN BIOCHEM, V31, P529, DOI 10.1177/000456329403100602; Iraqui I, 1999, MOL CELL BIOL, V19, P989; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JACOBS P, 1980, J MOL BIOL, V139, P691, DOI 10.1016/0022-2836(80)90055-8; Kitano T, 1998, BIOCHEM BIOPH RES CO, V249, P78, DOI 10.1006/bbrc.1998.9074; KNEPPER MA, 1989, PHYSIOL REV, V69, P179, DOI 10.1152/physrev.1989.69.1.179; KO CH, 1991, MOL CELL BIOL, V11, P4266, DOI 10.1128/MCB.11.8.4266; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Matassi G, 1999, J MOL EVOL, V48, P151, DOI 10.1007/PL00006453; Matassi G, 1998, GENOMICS, V47, P286, DOI 10.1006/geno.1997.5112; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nakamura RL, 1997, J BIOL CHEM, V272, P1011, DOI 10.1074/jbc.272.2.1011; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Palkova Z, 1997, NATURE, V390, P532, DOI 10.1038/37398; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Seack J, 1997, IMMUNOGENETICS, V46, P493, DOI 10.1007/s002510050310	26	267	272	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					341	344		10.1038/81656	http://dx.doi.org/10.1038/81656			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062476				2022-12-17	WOS:000165176500025
J	Reilly, KM; Loisel, DA; Bronson, RT; McLaughlin, ME; Jacks, T				Reilly, KM; Loisel, DA; Bronson, RT; McLaughlin, ME; Jacks, T			Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects	NATURE GENETICS			English	Article							NF1 TUMOR-SUPPRESSOR; NEUROFIBROMATOSIS TYPE-1; VONRECKLINGHAUSEN NEUROFIBROMATOSIS; MOLECULAR ANALYSIS; TRANSGENIC MICE; P53 MUTATIONS; BRAIN-TUMORS; PROGRESSION; PATHWAYS; CELLS	Astrocytomas are the leading cause of brain cancer in humans. Because these tumours are highly infiltrative, current treatments that rely on targeting the tumour mass are often ineffective. A mouse model for astrocytoma would be a powerful tool for dissecting tumour progression and testing therapeutics. Mouse models of astrocytoma have been designed to express oncogenic proteins in astrocytes, but have had limited success due to low tumour penetrance or limited tumour progression(1-3). We present here a mouse model of astrocytomas involving mutation of two tumour-suppressor genes, Nf1 and Trp53. Humans with mutations in NF1 develop neurofibromatosis type I (NF1) and have increased risk of optic gliomas, astrocytomas and glioblastomas(4,5). The TP53 tumour suppressor is often mutated in a subset of astrocytomas that develop at a young age and progress slowly to glioblastoma (termed secondary glioblastomas, in contrast to primary glioblastomas that develop rapidly de novo(6-10)). This mouse model shows a range of astrocytoma stages, from low-grade astrocytoma to glioblastoma multiforme, and may accurately model human secondary glioblastoma involving TP53 loss. This is the first reported mouse model of astrocytoma initiated by loss of tumour suppressors, rather than overexpression of transgenic oncogenes.	MIT, Dept Biol, Cambridge, England; MIT, Ctr Canc Res, Cambridge, England; Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; Tufts Univ, Sch Vet Med, Dept Pathol, Boston, MA 02111 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; MIT, Howard Hughes Med Inst, Cambridge, MA USA	Tufts University; Tufts University; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Jacks, T (corresponding author), MIT, Dept Biol, Cambridge, England.		Reilly, Karlyne/V-4475-2019; Loisel, Dagan/A-6671-2010	Reilly, Karlyne/0000-0001-9109-4409; 				Bonner RF, 1997, SCIENCE, V278, P1481, DOI 10.1126/science.278.5342.1481; Brugarolas J, 1998, J CELL BIOL, V141, P503, DOI 10.1083/jcb.141.2.503; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; DANKS RA, 1995, CANCER RES, V55, P4302; EASTGATE AR, 1993, J ANAL ATOM SPECTROM, V8, P305, DOI 10.1039/ja9930800305; GOULD VE, 1986, HUM PATHOL, V17, P979, DOI 10.1016/S0046-8177(86)80080-6; Gutmann DH, 1999, ONCOGENE, V18, P4450, DOI 10.1038/sj.onc.1202829; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Huson SHR, 1994, NEUROFIBROMATOSES PA; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x; Kleihues P., 1997, PATHOLOGY GENETICS T; LANG FF, 1994, J NEUROSURG, V81, P427, DOI 10.3171/jns.1994.81.3.0427; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; MARSDEN HB, 1983, INT J CANCER, V31, P439, DOI 10.1002/ijc.2910310408; MENON AG, 1990, P NATL ACAD SCI USA, V87, P5435, DOI 10.1073/pnas.87.14.5435; RASHEED BKA, 1994, CANCER RES, V54, P1324; Rizvi TA, 1999, BRAIN RES, V816, P111, DOI 10.1016/S0006-8993(98)01133-0; Scherer HJ, 1940, BRAIN, V63, P1, DOI 10.1093/brain/63.1.1; SORENSEN SA, 1986, NEW ENGL J MED, V314, P1010, DOI 10.1056/NEJM198604173141603; TISCHLER AS, 1995, ENDOCR PATHOL, V6, P323, DOI 10.1007/BF02738732; VANMEYEL DJ, 1994, JNCI-J NATL CANCER I, V86, P1011, DOI 10.1093/jnci/86.13.1011; Vogel KS, 1999, SCIENCE, V286, P2176, DOI 10.1126/science.286.5447.2176; Watanabe K, 1997, CLIN CANCER RES, V3, P523; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Weissenberger J, 1997, ONCOGENE, V14, P2005, DOI 10.1038/sj.onc.1201168	27	267	278	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					109	113		10.1038/79075	http://dx.doi.org/10.1038/79075			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	10973261				2022-12-17	WOS:000089078000030
J	Stickens, D; Clines, G; Burbee, D; Ramos, P; Thomas, S; Hogue, D; Hecht, JT; Lovett, M; Evans, GA				Stickens, D; Clines, G; Burbee, D; Ramos, P; Thomas, S; Hogue, D; Hecht, JT; Lovett, M; Evans, GA			The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes	NATURE GENETICS			English	Article							DIRECT SELECTION; COMPLEX GENOMES; CHROMOSOME-11; MAP; MARKERS; LOCUS; HUMAN-CHROMOSOME-11; HETEROZYGOSITY; LOCALIZATION	Hereditary multiple exostoses (EXT) is an autosomal dominant condition characterized by short stature and the development of bony protuberances at the ends of all the long bones. Three genetic loci have been identified by genetic linkage analysis at chromosomes 8q24.1, 11p11-13 and 19p. The EXT1 gene on chromosome 8 was recently identified and characterized. Here, we report the isolation and characterization of the EXT2 gene. This gene shows striking sequence similarity to the EXT1 gene, and we have identified a four base deletion segregating with the phenotype. Both EXT1 and EXT2 show significant homology with one additional expressed sequence tag, defining a new multigene family of proteins with potential tumour suppressor activity.	UNIV TEXAS, SW MED CTR, MCDERMOTT CTR HUMAN GROWTH & DEV, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, DEPT INTERNAL MED, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, DEPT BIOCHEM, DALLAS, TX 75235 USA; UNIV TEXAS, SCH MED, DEPT PEDIAT, HOUSTON, TX 77225 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System					NHGRI NIH HHS [HG00202, HG00368] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000368] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AHN J, 1995, NAT GENET, V11, P137, DOI 10.1038/ng1095-137; ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; Altschul SF, 1990, J MOL BIOL, V215, P403; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; COOK A, 1993, AM J HUM GENET, V53, P71; DELMASTRO RG, 1995, GENOME RES, V5, P185, DOI 10.1101/gr.5.2.185; EVANS GA, 1989, P NATL ACAD SCI USA, V86, P5030, DOI 10.1073/pnas.86.13.5030; EVANS GA, IN PRESS GENOME ANAL; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; HECHT JT, 1995, AM J HUM GENET, V56, P1125; HENNEKAM RCM, 1991, J MED GENET, V28, P262, DOI 10.1136/jmg.28.4.262; JAMES MR, 1994, NAT GENET, V8, P70, DOI 10.1038/ng0994-70; KOOTH R, 1961, AM J HUM GENET, V13, P340; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LEMERRER M, 1994, HUM MOL GENET, V3, P717, DOI 10.1093/hmg/3.5.717; LENNON G, IN PRESS GENOMICS; LEONE NC, 1987, J HERED, V78, P171, DOI 10.1093/oxfordjournals.jhered.a110351; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; LONGMIRE J, 1993, GENET ANAL TECH APPL, V10, P49; LOVETT M, 1994, TRENDS GENET, V10, P352, DOI 10.1016/0168-9525(94)90131-7; LOVETT M, 1991, P NATL ACAD SCI USA, V88, P9628, DOI 10.1073/pnas.88.21.9628; LUDECKE HJ, 1995, HUM MOL GENET, V4, P31, DOI 10.1093/hmg/4.1.31; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; QIN S, 1993, GENOMICS, V16, P580, DOI 10.1006/geno.1993.1233; QUACKENBUSH J, 1995, GENOMICS, V29, P512, DOI 10.1006/geno.1995.9974; RASKIND WH, 1995, AM J HUM GENET, V56, P1132; SCHMALE GA, 1994, J BONE JOINT SURG AM, V76A, P986, DOI 10.2106/00004623-199407000-00005; SMITH MW, 1994, NAT GENET, V7, P40, DOI 10.1038/ng0594-40; SMITH MW, 1993, GENOMICS, V17, P699, DOI 10.1006/geno.1993.1392; SOLOMON L, 1961, J BONE JOINT SURG BR, V43, P700, DOI 10.1302/0301-620X.43B4.700; WICKLUND CL, 1995, AM J MED GENET, V55, P43, DOI 10.1002/ajmg.1320550113; WU YQ, 1994, HUM MOL GENET, V3, P167, DOI 10.1093/hmg/3.1.167; WUYTS W, 1995, AM J HUM GENET, V57, P382	33	267	288	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1996	14	1					25	32		10.1038/ng0996-25	http://dx.doi.org/10.1038/ng0996-25			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VF611	8782816				2022-12-17	WOS:A1996VF61100017
J	Piazza, R; Valletta, S; Winkelmann, N; Redaelli, S; Spinelli, R; Pirola, A; Antolini, L; Mologni, L; Donadoni, C; Papaemmanuil, E; Schnittger, S; Kim, DW; Boultwood, J; Rossi, F; Gaipa, G; De Martini, GP; Di Celle, PF; Jang, HG; Fantin, V; Bignell, GR; Magistroni, V; Haferlach, T; Pogliani, EM; Campbell, PJ; Chase, AJ; Tapper, WJ; Cross, NCP; Gambacorti-Passerini, C				Piazza, Rocco; Valletta, Simona; Winkelmann, Nils; Redaelli, Sara; Spinelli, Roberta; Pirola, Alessandra; Antolini, Laura; Mologni, Luca; Donadoni, Carla; Papaemmanuil, Elli; Schnittger, Susanne; Kim, Dong-Wook; Boultwood, Jacqueline; Rossi, Fabio; Gaipa, Giuseppe; De Martini, Greta P.; Di Celle, Paola Francia; Jang, Hyun Gyung; Fantin, Valeria; Bignell, Graham R.; Magistroni, Vera; Haferlach, Torsten; Pogliani, Enrico Maria; Campbell, Peter J.; Chase, Andrew J.; Tapper, William J.; Cross, Nicholas C. P.; Gambacorti-Passerini, Carlo			Recurrent SETBP1 mutations in atypical chronic myeloid leukemia	NATURE GENETICS			English	Article							SCHINZEL-GIEDION SYNDROME; MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS; DIFFERENTIAL EXPRESSION; RNA-SEQ; TUMOR-SUPPRESSOR; SELF-RENEWAL; GENOME; PROTEIN; FUSION; DISORDERS	Atypical chronic myeloid leukemia (aCML) shares clinical and laboratory features with CML, but it lacks the BCR-ABL1 fusion. We performed exome sequencing of eight aCMLs and identified somatic alterations of SETBP1 (encoding a p.Gly870Ser alteration) in two cases. Targeted resequencing of 70 aCMLs, 574 diverse hematological malignancies and 344 cancer cell lines identified SETBP1 mutations in 24 cases, including 17 of 70 aCMLs (24.3%; 95% confidence interval (CI) = 16-35%). Most mutations (92%) were located between codons 858 and 871 and were identical to changes seen in individuals with Schinzel-Giedion syndrome. Individuals with mutations had higher white blood cell counts (P = 0.008) and worse prognosis (P = 0.01). The p.Gly870Ser alteration abrogated a site for ubiquitination, and cells exogenously expressing this mutant exhibited higher amounts of SETBP1 and SET protein, lower PP2A activity and higher proliferation rates relative to those expressing the wild-type protein. In summary, mutated SETBP1 represents a newly discovered oncogene present in aCML and closely related diseases.	[Piazza, Rocco; Valletta, Simona; Redaelli, Sara; Spinelli, Roberta; Pirola, Alessandra; Antolini, Laura; Mologni, Luca; Donadoni, Carla; De Martini, Greta P.; Magistroni, Vera; Pogliani, Enrico Maria; Gambacorti-Passerini, Carlo] Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy; [Winkelmann, Nils; Chase, Andrew J.; Tapper, William J.; Cross, Nicholas C. P.] Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury, Wilts, England; [Winkelmann, Nils] Univ Klinikum Jena, Klin Innere Med 2, Jena, Germany; [Papaemmanuil, Elli; Bignell, Graham R.; Campbell, Peter J.] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge, England; [Schnittger, Susanne; Haferlach, Torsten] MLL, Munich, Germany; [Kim, Dong-Wook] Catholic Univ, Dept Hematol, Seoul, South Korea; [Boultwood, Jacqueline] John Radcliffe Hosp, Leukaemia & Lymphoma Res Mol Hematol Unit, Oxford OX3 9DU, England; [Rossi, Fabio] San Gerardo Hosp, Immunotransfus Unit, Monza, Italy; [Gaipa, Giuseppe] Univ Milano Bicocca, Pediat Clin, M Tettamanti Res Ctr, Monza, Italy; [Di Celle, Paola Francia] Azienda Ospeda San Giovanni Battista Torino, Lab Oncol Mol, Ctr Ric Med Sperimentale CeRMS, Turin, Italy; [Jang, Hyun Gyung; Fantin, Valeria] Agios Pharmaceut, Cambridge, MA USA; [Pogliani, Enrico Maria] San Gerardo Hosp, Hematol Unit, Monza, Italy; [Chase, Andrew J.; Tapper, William J.; Cross, Nicholas C. P.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Gambacorti-Passerini, Carlo] San Gerardo Hosp, Hematol & Clin Res Unit, Monza, Italy	University of Milano-Bicocca; Salisbury District Hospital; Friedrich Schiller University of Jena; University of Cambridge; Wellcome Trust Sanger Institute; MLL Munich Leukemia Laboratory; Catholic University of Korea; University of Oxford; San Gerardo Hospital; University of Milano-Bicocca; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; Agios Pharmaceuticals; San Gerardo Hospital; University of Southampton; San Gerardo Hospital	Gambacorti-Passerini, C (corresponding author), Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy.	carlo.gambacorti@unimib.it	高, 雨莉/HGU-8187-2022; Mologni, Luca/AAC-1065-2022; redaelli, sara/I-5146-2012; Antolini, Laura/C-6115-2018; Cross, Nicholas/B-4817-2009; Magistroni, Vera/AAA-5582-2020	Mologni, Luca/0000-0002-6365-5149; redaelli, sara/0000-0003-0166-1188; Cross, Nicholas/0000-0001-5481-2555; Magistroni, Vera/0000-0002-7334-9401; Gaipa, Giuseppe/0000-0002-1006-5946; Tapper, William/0000-0002-5896-1889; Boultwood, Jacqueline/0000-0002-4330-2928; Rocco, Piazza/0000-0003-4198-9620; Valletta, Simona/0000-0002-3524-4991; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X; Chase, Andrew/0000-0001-6617-9953	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG-10092]; Programmi di ricerca di Rilevante Interesse Nazionale (PRIN) program [20084XBENM_004]; Fondazione Cariplo [2009-2667]; Lombardy Region [ID-16871, ID14546A]; Lombardy Region (FSE Dote Ricercatori) [16-AR]; Leukaemia and Lymphoma Research (UK); Korea Research Foundation [R21-2007-000-10041-0]; Mildred Scheel Stiftung fuer Krebsforschung (Deutsche Krebshilfe, Germany) [109590]	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Programmi di ricerca di Rilevante Interesse Nazionale (PRIN) program(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariplo(Fondazione Cariplo); Lombardy Region(Regione Lombardia); Lombardy Region (FSE Dote Ricercatori); Leukaemia and Lymphoma Research (UK); Korea Research Foundation(National Research Foundation of Korea); Mildred Scheel Stiftung fuer Krebsforschung (Deutsche Krebshilfe, Germany)	We kindly acknowledge the contributions of S. Mori in the preparation of this manuscript, M. Viltadi for technical help, G. Cazzaniga (Tettamanti Foundation, San Gerardo Hospital) for the MIGR1-EGFP plasmid and C. Cecchetti, Z. Sortino and C. Rizzo for clinical sample management. We thank M. Vogel for her critical reading of the manuscript. This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) 2010 (IG-10092 to C. G.-P.); Programmi di ricerca di Rilevante Interesse Nazionale (PRIN) program (20084XBENM_004 to R. P.); Fondazione Cariplo (2009-2667 to C. G.-P.); the Lombardy Region (ID-16871 and ID14546A to C. G.-P. and FSE Dote Ricercatori 16-AR to S. R.); Leukaemia and Lymphoma Research (UK) grants (to N.C.P.C. and J.B.); the Basic Research Program of the Korea Research Foundation (R21-2007-000-10041-0 to D.-W.K.) (2007); and Mildred Scheel Stiftung fuer Krebsforschung (Deutsche Krebshilfe, Germany, grant 109590 to N.W.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Cristobal I, 2010, BLOOD, V115, P615, DOI 10.1182/blood-2009-06-227363; Cross NCP, 2012, ONCOTARGET, V3, P3; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Ernst T, 2010, HAEMATOL-HEMATOL J, V95, P1473, DOI 10.3324/haematol.2010.021808; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Gambacorti-Passerini C, 2011, JNCI-J NATL CANCER I, V103, P553, DOI 10.1093/jnci/djr060; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Godley LA, 2012, NEW ENGL J MED, V366, P1152, DOI 10.1056/NEJMe1200409; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goldman JM, 2010, SEMIN HEMATOL, V47, P302, DOI 10.1053/j.seminhematol.2010.07.001; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kurzrock R, 2001, J CLIN ONCOL, V19, P2915, DOI 10.1200/JCO.2001.19.11.2915; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; le Coutre P, 1999, J NATL CANCER I, V91, P163, DOI 10.1093/jnci/91.2.163; Lehman AM, 2008, AM J MED GENET A, V146A, P1299, DOI 10.1002/ajmg.a.32277; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XD, 2001, CYTOKINE GROWTH F R, V12, P1, DOI 10.1016/S1359-6101(00)00031-9; Longo DL, 2012, NEW ENGL J MED, V366, P956, DOI 10.1056/NEJMe1200656; Manfredini R, 2005, STEM CELLS, V23, P496, DOI 10.1634/stemcells.2004-0265; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Marubini E, 1995, ANAL SURVIVAL DATA C; Minakuchi M, 2001, EUR J BIOCHEM, V268, P1340, DOI 10.1046/j.1432-1327.2001.02000.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MUNDY GR, 1991, CIBA F SYMP, V157, P137; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; NOWELL PC, 1960, SCIENCE, V132, P1497; Oakley K, 2012, BLOOD, V119, P6099, DOI 10.1182/blood-2011-10-388710; Panagopoulos I, 2007, BRIT J HAEMATOL, V136, P294, DOI 10.1111/j.1365-2141.2006.06410.x; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Piazza R, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks394; Randles R, 1979, INTRO THEORY NONPARA; Rebora P, 2010, AM J EPIDEMIOL, V172, P1028, DOI 10.1093/aje/kwq262; Reiter A, 2009, HAEMATOL-HEMATOL J, V94, P1634, DOI 10.3324/haematol.2009.014001; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Score J, 2012, BLOOD, V119, P1208, DOI 10.1182/blood-2011-07-367243; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Xu GR, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-2	52	266	271	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2013	45	1					18	U41		10.1038/ng.2495	http://dx.doi.org/10.1038/ng.2495			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	061HJ	23222956	Green Accepted			2022-12-17	WOS:000312838800008
J	Bonnefond, A; Clement, N; Fawcett, K; Yengo, L; Vaillant, E; Guillaume, JL; Dechaume, A; Payne, F; Roussel, R; Czernichow, S; Hercberg, S; Hadjadj, S; Balkau, B; Marre, M; Lantieri, O; Langenberg, C; Bouatia-Naji, N; Charpentier, G; Vaxillaire, M; Rocheleau, G; Wareham, NJ; Sladek, R; McCarthy, MI; Dina, C; Barroso, I; Jockers, R; Froguel, P				Bonnefond, Amelie; Clement, Nathalie; Fawcett, Katherine; Yengo, Loic; Vaillant, Emmanuel; Guillaume, Jean-Luc; Dechaume, Aurelie; Payne, Felicity; Roussel, Ronan; Czernichow, Sebastien; Hercberg, Serge; Hadjadj, Samy; Balkau, Beverley; Marre, Michel; Lantieri, Olivier; Langenberg, Claudia; Bouatia-Naji, Nabila; Charpentier, Guillaume; Vaxillaire, Martine; Rocheleau, Ghislain; Wareham, Nicholas J.; Sladek, Robert; McCarthy, Mark I.; Dina, Christian; Barroso, Ines; Jockers, Ralf; Froguel, Philippe		Meta-Anal Glucose Insulin-Related	Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; FASTING PLASMA-GLUCOSE; GENERAL-POPULATION; RISK; DISEASES; EXCESS; LOCI	Genome-wide association studies have revealed that common noncoding variants in MTNR1B (encoding melatonin receptor 1B, also known as MT2) increase type 2 diabetes (T2D) risk(1,2). Although the strongest association signal was highly significant (P < 1 x 10(-20)), its contribution to T2D risk was modest (odds ratio (OR) of similar to 1.10-1.15)(1-3). We performed large-scale exon resequencing in 7,632 Europeans, including 2,186 individuals with T2D, and identified 40 nonsynonymous variants, including 36 very rare variants (minor allele frequency (MAF) < 0.1%), associated with T2D (OR = 3.31, 95% confidence interval (CI) = 1.78-6.18; P = 1.64 x 10(-4)). A four-tiered functional investigation of all 40 mutants revealed that 14 were nonfunctional and rare (MAF < 1%), and 4 were very rare with complete loss of melatonin binding and signaling capabilities. Among the very rare variants, the partial-or total-loss-of-function variants but not the neutral ones contributed to T2D (OR = 5.67, CI = 2.17-14.82; P = 4.09 x 10(-4)). Genotyping the four complete loss-of-function variants in 11,854 additional individuals revealed their association with T2D risk (8,153 individuals with T2D and 10,100 controls; OR = 3.88, CI = 1.49-10.07; P = 5.37 x 10(-3)). This study establishes a firm functional link between MTNR1B and T2D risk.	[Bonnefond, Amelie; Yengo, Loic; Vaillant, Emmanuel; Dechaume, Aurelie; Bouatia-Naji, Nabila; Vaxillaire, Martine; Froguel, Philippe] Lille Pasteur Inst, CNRS, Unite Mixte Rech UMR 8199, Lille, France; [Bonnefond, Amelie; Yengo, Loic; Vaillant, Emmanuel; Dechaume, Aurelie; Bouatia-Naji, Nabila; Vaxillaire, Martine; Froguel, Philippe] Lille Nord France Univ, Ecole Doctorale Biol Sante, Lille, France; [Guillaume, Jean-Luc; Jockers, Ralf] Inst Cochin, INSERM, U1016, Paris, France; [Clement, Nathalie; Guillaume, Jean-Luc; Jockers, Ralf] CNRS, UMR 8104, Paris, France; [Clement, Nathalie; Guillaume, Jean-Luc; Jockers, Ralf] Paris Descartes Univ, Dept Med, Paris, France; [Fawcett, Katherine; Payne, Felicity; Barroso, Ines] Wellcome Trust Sanger Inst, Cambridge, England; [Roussel, Ronan; Marre, Michel] Bichat Claude Bernard Univ Hosp, AP HP, Dept Endocrinol Diabetol & Nutr, Paris, France; [Roussel, Ronan; Marre, Michel] Univ Paris 07, INSERM, U695, Paris, France; [Czernichow, Sebastien] Ambroise Pare Hosp, AP HP, Dept Nutr, Boulogne, France; [Czernichow, Sebastien] Univ Versailles Saint Quentin, Unite Format & Rech UFR Sci Sante, Boulogne, France; [Hercberg, Serge] Univ Paris 13, Ctr Rech Nutr Humaine, Inst Natl Rech Agron, INSERM,U557,U1125, Bobigny, France; [Hercberg, Serge] Avicenne Hosp, AP HP, Dept Publ Hlth, Bobigny, France; [Hadjadj, Samy] Ctr Hosp Univ Poitiers, Dept Endocrinol & Diabetol, Poitiers, France; [Hadjadj, Samy] Clin Invest Ctr Poitiers Biotheque CIC0802, INSERM, U927, Poitiers, France; [Balkau, Beverley] Ctr Res Epidemiol & Populat Hlth, INSERM, U780, Villejuif, France; [Balkau, Beverley] Univ Paris 11, Orsay, France; [Lantieri, Olivier] Inst Interreg Sante IRSA, La Riche, France; [Langenberg, Claudia] Univ Cambridge, MRC, Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Charpentier, Guillaume] Corbeil Essonnes Hosp, Dept Endocrinol & Diabetol, Essonnes, France; [Rocheleau, Ghislain] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada; [Rocheleau, Ghislain] Prognomix, Montreal, PQ, Canada; [Sladek, Robert] McGill Univ, Fac Med, Dept Human Genet, Montreal, PQ, Canada; [Sladek, Robert] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Dina, Christian] Inst Thorax, INSERM, U915, Nantes, France; [Dina, Christian] CNRS, Equipe Rech Labellisee 3147, Nantes, France; [Dina, Christian] Univ Nantes, Dept Biol Med & Hlth, Nantes, France; [Barroso, Ines] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 2QQ, England; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, Sch Publ Hlth, Hammersmith Hosp, London, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Sanofi-Aventis; Sanofi France; UDICE-French Research Universities; Universite Paris Cite; Wellcome Trust Sanger Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; CHU Poitiers; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Cambridge; Centre Hospitalier Sud Francilien; Universite de Montreal; McGill University; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Nantes Universite; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Imperial College London	Froguel, P (corresponding author), Lille Pasteur Inst, CNRS, Unite Mixte Rech UMR 8199, Lille, France.	ralf.jockers@inserm.fr; p.froguel@imperial.ac.uk	Serge, Hercberg/F-3038-2017; Payne, Felicity/GKF-2573-2022; Bonnefond, Amélie/O-2784-2017; Jockers, Ralf/Q-2100-2019; BOUATIA-NAJI, NABILA/D-5863-2013; HERCBERG, Serge/B-4429-2008; Dina, Christian R/D-3535-2015; Yengo, Loic/D-2692-2017; Langenberg, Claudia/ABG-9067-2021; Jockers, Ralf/P-2272-2017; Sladek, Robert/R-2391-2019; Bouatia-Naji, Nabila/AGF-1400-2022; FROGUEL, Philippe/O-6799-2017; McCarthy, Mark/M-3763-2015	Serge, Hercberg/0000-0002-3168-1350; Payne, Felicity/0000-0003-4228-581X; Bonnefond, Amélie/0000-0001-9976-3005; Jockers, Ralf/0000-0002-4354-1750; HERCBERG, Serge/0000-0002-3168-1350; Dina, Christian R/0000-0002-7722-7348; Yengo, Loic/0000-0002-4272-9305; Langenberg, Claudia/0000-0002-5017-7344; Jockers, Ralf/0000-0002-4354-1750; Sladek, Robert/0000-0002-2730-1204; Bouatia-Naji, Nabila/0000-0001-5424-2134; FROGUEL, Philippe/0000-0003-2972-0784; McCarthy, Mark/0000-0002-4393-0510; Barroso, Ines/0000-0001-5800-4520; Fawcett, Katherine/0000-0002-6675-2112; Marre, Michel/0000-0002-3071-1837	French Agence Nationale de la Recherche [ANR-08-GENOPAT, ANR-11-blanc 'MLT2D', ANR-11-META 'MELA-BETES']; Contrat de Projects Etat-Region Nord-Pas-De-Calais (CPER); Societe Francophone du Diabete; Fondation Recherche Medicale; Inserm; CNRS; Wellcome Trust [077016/Z/05/Z]; UK National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre; MRC Centre for Obesity and Related Metabolic Diseases; Medical Research Council [G0600717B, MC_U106179471] Funding Source: researchfish	French Agence Nationale de la Recherche(French National Research Agency (ANR)); Contrat de Projects Etat-Region Nord-Pas-De-Calais (CPER)(Region Hauts-de-France); Societe Francophone du Diabete; Fondation Recherche Medicale; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Wellcome Trust(Wellcome Trust); UK National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre; MRC Centre for Obesity and Related Metabolic Diseases(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are sincerely indebted to all participants in the genetic study. We thank M. Deweirder and F. Allegaert for their technical assistance and their invaluable management of DNA samples and B. Gardiola-Lemaitre for her invaluable advice. This study was supported by the French Agence Nationale de la Recherche (ANR-08-GENOPAT to P. F. and ANR-11-blanc 'MLT2D' and ANR-11-META 'MELA-BETES' to R. J. and P. F.), the Contrat de Projects Etat-Region Nord-Pas-De-Calais (CPER 2007-2013 'Axe Cardio-Diabete' to P. F.), the Societe Francophone du Diabete (to A. B.), the Fondation Recherche Medicale ('Equipe FRM' to R. J.), Inserm and CNRS. I. B. acknowledges funding from the Wellcome Trust (077016/Z/05/Z) and from the UK National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre and the MRC Centre for Obesity and Related Metabolic Diseases.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Andersson EA, 2010, DIABETES, V59, P1539, DOI 10.2337/db09-1757; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Downes K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012646; Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; Dubovsky SL, 2009, EXPERT OPIN INV DRUG, V18, P1533, DOI 10.1517/13543780903292634; Hadjadj S, 2008, DIABETES CARE, V31, P1847, DOI 10.2337/dc07-2079; Hercberg S, 1998, CONTROL CLIN TRIALS, V19, P336, DOI 10.1016/S0197-2456(98)00015-4; Jockers R, 2008, BRIT J PHARMACOL, V154, P1182, DOI 10.1038/bjp.2008.184; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Meyre D, 2004, DIABETES, V53, P803, DOI 10.2337/diabetes.53.3.803; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Peschke E, 2010, BEST PRACT RES CL EN, V24, P829, DOI 10.1016/j.beem.2010.09.001; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Syddall HE, 2005, INT J EPIDEMIOL, V34, P1234, DOI 10.1093/ije/dyi127; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; WILLIAMS DRR, 1995, DIABETIC MED, V12, P30, DOI 10.1111/j.1464-5491.1995.tb02058.x	29	266	269	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2012	44	3					297	U98		10.1038/ng.1053	http://dx.doi.org/10.1038/ng.1053			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22286214	Green Accepted			2022-12-17	WOS:000300843600015
J	Kilpivaara, O; Mukherjee, S; Schram, AM; Wadleigh, M; Mullally, A; Ebert, BL; Bass, A; Marubayashi, S; Heguy, A; Garcia-Manero, G; Kantarjian, H; Offit, K; Stone, RM; Gilliland, DG; Klein, RJ; Levine, RL				Kilpivaara, Outi; Mukherjee, Semanti; Schram, Alison M.; Wadleigh, Martha; Mullally, Ann; Ebert, Benjamin L.; Bass, Adam; Marubayashi, Sachie; Heguy, Adriana; Garcia-Manero, Guillermo; Kantarjian, Hagop; Offit, Kenneth; Stone, Richard M.; Gilliland, D. Gary; Klein, Robert J.; Levine, Ross L.			A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; SUSCEPTIBILITY LOCI; ACTIVATING MUTATION; FAMILIAL RISKS; DISORDERS; CLONALITY; DISEASE	Polycythemia vera, essential thrombocythemia and primary myelofibrosis are myeloproliferative neoplasms (MPN) characterized by multilineage clonal hematopoiesis(1-5). Given that the identical somatic activating mutation in the JAK2 tyrosine kinase gene (JAK2(V617F)) is observed in most individuals with polycythemia vera, essential thrombocythemia and primary myelofibrosis(6-10), there likely are additional genetic events that contribute to the pathogenesis of these phenotypically distinct disorders. Moreover, family members of individuals with MPN are at higher risk for the development of MPN, consistent with the existence of MPN predisposition loci(11). We hypothesized that germline variation contributes to MPN predisposition and phenotypic pleiotropy. Genome-wide analysis identified an allele in the JAK2 locus (rs10974944) that predisposes to the development of JAK2(V617F)-positive MPN, as well as three previously unknown MPN modifier loci. We found that JAK2(V617F) is preferentially acquired in cis with the predisposition allele. These data suggest that germline variation is an important contributor to MPN phenotype and predisposition.	[Mukherjee, Semanti; Klein, Robert J.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Kilpivaara, Outi; Schram, Alison M.; Marubayashi, Sachie; Heguy, Adriana; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Mukherjee, Semanti] Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY USA; [Wadleigh, Martha; Mullally, Ann; Bass, Adam; Stone, Richard M.; Gilliland, D. Gary] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Mullally, Ann; Ebert, Benjamin L.; Gilliland, D. Gary] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; [Ebert, Benjamin L.; Bass, Adam; Gilliland, D. Gary] Harvard Univ, Broad Inst, Cambridge, MA 02138 USA; [Ebert, Benjamin L.; Bass, Adam; Gilliland, D. Gary] MIT, Cambridge, MA 02139 USA; [Garcia-Manero, Guillermo; Kantarjian, Hagop] Univ Texas Houston, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, New York, NY 10021 USA; [Gilliland, D. Gary] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Gilliland, D. Gary] Harvard Univ, Stem Cell Inst, Boston, MA 02115 USA; [Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Memorial Sloan Kettering Cancer Center	Klein, RJ (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	kleinr@mskcc.org; leviner@mskcc.org	Heguy, Adriana/GPP-3907-2022; levine, ross/AAE-7658-2019; Klein, Robert/K-1888-2013	Klein, Robert/0000-0003-3539-5391; Schram, Alison/0000-0002-6070-2413	Wellcome Trust [076113]; National Institutes of Health; Starr Cancer Consortium; Myeloproliferative Disorders Foundation; Howard Hughes Medical Institute; Doris Duke Charitable Foundation; Kristen Amico Sesselman Leukemia Research Fund; Academy of Finland; US National Institutes of Health [P30 CA008748]; Geoffrey Beene Junior Chair at Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016672, K08CA134931, P30CA008748] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; Myeloproliferative Disorders Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Kristen Amico Sesselman Leukemia Research Fund; Academy of Finland(Academy of Finland); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geoffrey Beene Junior Chair at Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to acknowledge the subjects who have contributed to our understanding of these disorders. We thank S. Thomas, I. Dolgalev and T. Landers for assistance with high-throughput resequencing, A. Viale for assistance with JAK2 expression analysis, and T. Kirchhoff for advice and suggestions. This study makes use of data generated by the Wellcome Trust Case-Control Consortium; a full list of the investigators who contributed to the generation of the data are available from http://www.wtccc.org.uk and funding was provided by the Wellcome Trust under award 076113. This work was supported by grants from the National Institutes of Health, the Starr Cancer Consortium, the Myeloproliferative Disorders Foundation, the Howard Hughes Medical Institute, the Doris Duke Charitable Foundation and the Kristen Amico Sesselman Leukemia Research Fund. O.K. is supported by a grant from the Academy of Finland. D.G.G. is an Investigator of the Howard Hughes Medical Institute and is a Doris Duke Charitable Foundation Distinguished Clinical Scientist. Work in the laboratory of R.J.K. is supported by Memorial Sloan Kettering Cancer Center through US National Institutes of Health grant P30 CA008748. R. L. L. is an Early Career Award recipient of the Howard Hughes Medical Institute and a Clinical Scientist Development Award recipient of the Doris Duke Charitable Foundation and is the Geoffrey Beene Junior Chair at Memorial Sloan Kettering Cancer Center.	ADAMSON JW, 1976, NEW ENGL J MED, V295, P913, DOI 10.1056/NEJM197610212951702; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bellanne-Chantelot C, 2006, BLOOD, V108, P346, DOI 10.1182/blood-2005-12-4852; Bercovich D, 2008, LANCET, V372, P1484, DOI 10.1016/S0140-6736(08)61341-0; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cario H, 2005, BRIT J HAEMATOL, V130, P800, DOI 10.1111/j.1365-2141.2005.05683.x; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; El Kassar Nahed, 1995, British Journal of Haematology, V90, P131; GILLILAND DG, 1991, P NATL ACAD SCI USA, V88, P6848, DOI 10.1073/pnas.88.15.6848; Hemminki K, 2008, INT J CANCER, V123, P1726, DOI 10.1002/ijc.23702; Hemminki K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002504; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jamieson CHM, 2006, P NATL ACAD SCI USA, V103, P6224, DOI 10.1073/pnas.0601462103; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; Landgren O, 2008, BLOOD, V112, P2199, DOI 10.1182/blood-2008-03-143602; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2006, BLOOD, V107, P4139, DOI 10.1182/blood-2005-09-3900; Mercher T, 2006, BLOOD, V108, P2770, DOI 10.1182/blood-2006-04-014712; Pardanani A, 2008, BLOOD, V111, P2785, DOI 10.1182/blood-2007-06-095703; Pietra D, 2008, BLOOD, V111, P1686, DOI 10.1182/blood-2007-07-101576; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Scott LM, 2006, BLOOD, V108, P2435, DOI 10.1182/blood-2006-04-018259; TSUKAMOTO N, 1994, BRIT J HAEMATOL, V86, P253, DOI 10.1111/j.1365-2141.1994.tb04723.x; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	28	266	272	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2009	41	4					455	459		10.1038/ng.342	http://dx.doi.org/10.1038/ng.342			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19287384	Green Accepted			2022-12-17	WOS:000264659000020
J	Hashimshony, T; Zhang, JM; Keshet, I; Bustin, M; Cedar, H				Hashimshony, T; Zhang, JM; Keshet, I; Bustin, M; Cedar, H			The role of DNA methylation in setting up chromatin structure during development	NATURE GENETICS			English	Article							H3 LYSINE-4 METHYLATION; MOUSE EMBRYO; HISTONE H1; BINDING; TRANSCRIPTION; COMPLEX	DNA methylation inhibits gene expression in animal cells, probably by affecting chromatin structure. Biochemical studies suggest that this process may be mediated by methyl-specific binding proteins that recruit enzymatic machinery capable of locally altering histone modification(1). To test whether DNA methylation actually has a role in the assembly of chromatin during normal development, we used cell transfection and a transgene construct genetically programmed to be either methylated or unmethylated in all cell types of the mouse(2). Chromatin immunoprecipitation (ChIP) analysis shows that the presence of DNA methylation brings about the deacetylation of histone H4 and methylation of Lys9 of histone H3 (H3 Lys9) and prevents methylation of Lys4 of histone H3 (H3 Lys4), thus generating a structure identical to that of methylated sequences in the genome. These results indicate that the methylation pattern established in early embryogenesis is profoundly important in setting up the structural profile of the genome.	Hebrew Univ Jerusalem, Dept Cellular Biochem & Human Genet, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Expt Med & Canc Res, IL-91120 Jerusalem, Israel; NCI, Prot Sect, Mol Carcinogenesis Lab, Div Basic Sci,NIH, Bethesda, MD 20892 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cedar, H (corresponding author), Hebrew Univ Jerusalem, Dept Cellular Biochem & Human Genet, POB 12272, IL-91120 Jerusalem, Israel.	cedar@md2.huji.ac.il	Bustin, Michael/G-6155-2015	Bustin, Michael/0000-0002-5147-7242	NATIONAL CANCER INSTITUTE [ZIABC004496, Z01BC004496] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; BUSTIN M, 1989, METHOD ENZYMOL, V170, P214; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; FUKS F, 2002, J BIOL CHEM; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Jones BE, 1998, EXTREMOPHILES, V2, P191, DOI 10.1007/s007920050060; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; MONK M, 1987, DEVELOPMENT, V99, P371; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; RENZ M, 1975, P NATL ACAD SCI USA, V72, P733, DOI 10.1073/pnas.72.2.733; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wolffe AP, 1997, INT J BIOCHEM CELL B, V29, P1463, DOI 10.1016/S1357-2725(97)00026-5; Wolffe AP, 1997, BIOESSAYS, V19, P249, DOI 10.1002/bies.950190311; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200	24	266	276	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2003	34	2					187	192		10.1038/ng1158	http://dx.doi.org/10.1038/ng1158			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12740577				2022-12-17	WOS:000183200500025
J	Matsuo, K; Owens, JM; Tonko, M; Elliott, C; Chambers, TJ; Wagner, EF				Matsuo, K; Owens, JM; Tonko, M; Elliott, C; Chambers, TJ; Wagner, EF			Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation	NATURE GENETICS			English	Article							TERMINAL TRANSACTIVATION DOMAIN; ACTIVATION DOMAINS; BINDING PROTEIN; CELL-GROWTH; FRA-1 GENE; TRANSFORMATION; LIGAND; CYTOKINE; REQUIRES; MOUSE	Osteoclasts are bone-resorbing cells derived from haematopoietic precursors of the monocyte-macrophage lineage. Mice lacking Fos (encoding c-Fos) develop osteopetrosis due to an early differentiation block in the osteoclast lineage(1-3), c-Fos is a component of the dimeric transcription factor activator protein-1 (Ap-1), which is composed mainly of Fos (c-Fos, FosB, Fra-1 and Fra-2) and Jun proteins (c-Jun, JunB and JunD). Unlike Fra-1 (encoded by Fos/1), c-Fos contains transactivation domains required for oncogenesis and cellular transformation(4-6). The mechanism by which c-Fos exerts its specific function in osteoclast differentiation is not understood. Here we show by retroviral-gene transfer that all four Fos proteins, hut not the Jun proteins, rescue the differentiation block in vitro. Structure-function analysis demonstrated that the major carboxy-terminal transactivation domains of c-Fos and FosB are dispensable and that Fra-1 (which lacks transactivation domains(4,7)) has the highest rescue activity. Moreover, a transgene expressing Fra-1 rescues the osteopetrosis of c-fos-mutant mice in vivo. The osteoclast differentiation factor Rankl (also known as TRANCE, CUE and OPGL; refs 8-11) induces transcription of Fos/1 in a c-fos-dependent manner, thereby establishing a link between Rank signalling and the expression of Ap-1 proteins in osteoclast differentiation.	Res Inst Mol Pathol, A-1030 Vienna, Austria; St George Hosp, Sch Med, Dept Histopathol, London, England	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); St Georges University London	Wagner, EF (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Matsuo, Koichi/K-5695-2012; Elliott, Candace/F-1860-2011	Matsuo, Koichi/0000-0002-1490-8955; Elliott, Candace/0000-0002-9174-0244; Wagner, Erwin F/0000-0001-7872-0196				Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; BERGERS G, 1995, MOL CELL BIOL, V15, P3748; BROWN HJ, 1995, EMBO J, V14, P124, DOI 10.1002/j.1460-2075.1995.tb06982.x; CHAMBERS TJ, 1993, P NATL ACAD SCI USA, V90, P5578, DOI 10.1073/pnas.90.12.5578; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Funk M, 1997, MOL CELL BIOL, V17, P537, DOI 10.1128/MCB.17.2.537; GIUS D, 1990, MOL CELL BIOL, V10, P4243, DOI 10.1128/MCB.10.8.4243; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; JOOSS KU, 1994, EMBO J, V13, P1467, DOI 10.1002/j.1460-2075.1994.tb06401.x; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kustikova O, 1998, MOL CELL BIOL, V18, P7095, DOI 10.1128/MCB.18.12.7095; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; LIVAK KJ, 1995, PCR METH APPL, V4, P357; METZ R, 1994, MOL CELL BIOL, V14, P6021, DOI 10.1128/MCB.14.9.6021; METZ R, 1994, EMBO J, V13, P3832, DOI 10.1002/j.1460-2075.1994.tb06694.x; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; OLIVIERO S, 1992, GENE DEV, V6, P1799, DOI 10.1101/gad.6.9.1799; Owens JM, 1999, J CELL PHYSIOL, V179, P170, DOI 10.1002/(SICI)1097-4652(199905)179:2<170::AID-JCP7>3.0.CO;2-K; Russell RGG, 1999, BONE, V25, P97, DOI 10.1016/S8756-3282(99)00116-7; Schreiber M, 1997, ONCOGENE, V15, P1171, DOI 10.1038/sj.onc.1201460; SUTHERLAND JA, 1992, GENE DEV, V6, P1810, DOI 10.1101/gad.6.9.1810; WANG SJ, 1992, J OPT SOC AM B, V9, P360, DOI 10.1364/JOSAB.9.000360; WISDOM R, 1992, GENE DEV, V6, P667, DOI 10.1101/gad.6.4.667; WISDOM R, 1993, MOL CELL BIOL, V13, P7429, DOI 10.1128/MCB.13.12.7429; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; WRIGHTON C, 1993, MOL CELL BIOL, V13, P4657, DOI 10.1128/MCB.13.8.4657; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	30	266	276	0	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2000	24	2					184	187		10.1038/72855	http://dx.doi.org/10.1038/72855			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	280LQ	10655067				2022-12-17	WOS:000085104600022
J	Wright, AF; Carothers, AD; Pirastu, M				Wright, AF; Carothers, AD; Pirastu, M			Population choice in mapping genes for complex diseases	NATURE GENETICS			English	Editorial Material							DEPENDENT DIABETES-MELLITUS; HUMAN LIPOPROTEIN-LIPASE; LINKAGE DISEQUILIBRIUM; DEMOGRAPHIC HISTORY; APOLIPOPROTEIN-E; GENOME; SUSCEPTIBILITY; TRAITS; LOCI; IDENTIFICATION	The difficulty of identifying susceptibility genes for common diseases has polarized geneticists' views on what disease models are appropriate and how best to proceed once high-density genome maps become available. Different disease models have different implications for using linkage or linkage-disequilibrium-based approaches for mapping complex disease genes. We argue that the choice of study population is a critical factor when designing a study, and that genetically simplified isolates are more useful than diverse continental populations under most assumptions.	Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; CNR, Inst Genet Mol, Alghero, Sardinia, Italy	University of Edinburgh; Consiglio Nazionale delle Ricerche (CNR)	Wright, AF (corresponding author), Western Gen Hosp, MRC, Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.							BAIRD PA, 1988, AM J HUM GENET, V42, P677; Balciuniene J, 1998, AM J HUM GENET, V63, P786, DOI 10.1086/302012; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; BEAR JC, 1988, AM J MED GENET, V29, P649, DOI 10.1002/ajmg.1320290324; BELL JI, 1992, GENETIC BASIS COMMON; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; Bickeboller H, 1997, AM J HUM GENET, V60, P439; Camp NJ, 1997, AM J HUM GENET, V61, P1424, DOI 10.1086/301648; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; ELLIS WS, 1978, AM J HUM GENET, V30, P366; Falconer D.S., 1986, INTRO QUANTITATIVE G; Genin E, 1996, AM J HUM GENET, V58, P861; Graham J, 1998, AM J HUM GENET, V63, P1517, DOI 10.1086/302102; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; Harding RM, 1997, AM J HUM GENET, V60, P772; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Hartl DL, 1997, PRINCIPLES POPULATIO; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Jarvik GP, 1997, ANN EPIDEMIOL, V7, P357, DOI 10.1016/S1047-2797(97)00028-8; JORDE LB, 1994, AM J HUM GENET, V54, P884; JORDE LB, 1995, AM J HUM GENET, V56, P11; Kainulainen K, 1999, HYPERTENSION, V33, P844, DOI 10.1161/01.HYP.33.3.844; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; KIMURA M, 1969, GENETICS, V61, P893; Kruglyak L, 1997, AM J HUM GENET, V61, P810, DOI 10.1086/514893; KRUGLYAK L, 1995, AM J HUM GENET, V56, P1212; KRUGLYAK L, 1999, PROSPECTS WHOLEGENOM, V22, P139; Kruglyak S, 1998, P NATL ACAD SCI USA, V95, P10774, DOI 10.1073/pnas.95.18.10774; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Mackay TFC, 1996, BIOESSAYS, V18, P113, DOI 10.1002/bies.950180207; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; MCKUSICK VA, 1974, GENETIC POLYMORPHISM; MOUTULSKY AG, 1992, GENETIC BASIS COMMON; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; PETERSON AC, 1995, HUM MOL GENET, V4, P887, DOI 10.1093/hmg/4.5.887; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Risch N, 1997, SCIENCE, V275, P1329; RISCH N, 1990, AM J HUM GENET, V46, P222; RISCH N, 1993, AM J HUM GENET, V53, P702; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; Schaid DJ, 1998, AM J HUM GENET, V63, P935, DOI 10.1086/302077; Scott WK, 1997, SCIENCE, V275, P1327, DOI 10.1126/science.275.5304.1327; Service SK, 1999, AM J HUM GENET, V64, P1728, DOI 10.1086/302398; SING CF, 1996, GENETIC ARCHITECTURE, P211; Soubrier F, 1995, Curr Opin Nephrol Hypertens, V4, P177, DOI 10.1097/00041552-199503000-00011; SUAREZ BK, 1994, PROBLEMS REPLICATING; Sullivan LS, 1996, MOL MED TODAY, V2, P380, DOI 10.1016/S1357-4310(96)10037-X; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; Teng J, 1997, AM J HUM GENET, V60, P979; Terwilliger JD, 1997, AM J HUM GENET, V61, P430, DOI 10.1086/514855; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Terwilliger JD, 1998, HUM HERED, V48, P138, DOI 10.1159/000022794; Thompson EA, 1997, AM J HUM GENET, V60, P197; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; Tu IP, 1999, AM J HUM GENET, V64, P641, DOI 10.1086/302253; VanCamp G, 1997, AM J HUM GENET, V60, P758; VOGELSTEIN B, 1998, HUMAN CANC; vonHaeseler A, 1996, NAT GENET, V14, P135, DOI 10.1038/ng1096-135; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; WEISS KM, 1993, PRINCIPLES EVOLUTION; WORKMAN PL, 1975, AM J PHYS ANTHROPOL, V43, P165, DOI 10.1002/ajpa.1330430204; Zerba KE, 1998, HUM GENET, V103, P346, DOI 10.1007/s004390050828	74	266	271	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1999	23	4					397	404		10.1038/70501	http://dx.doi.org/10.1038/70501			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	261RZ	10581024				2022-12-17	WOS:000084023900013
J	D'Adamo, P; Menegon, A; Lo Nigro, C; Grasso, M; Gulisano, M; Tamanini, F; Bienvenu, T; Gedeon, AK; Oostra, B; Wu, SK; Tandon, A; Valtorta, F; Balch, WE; Chelly, J; Toniolo, D				D'Adamo, P; Menegon, A; Lo Nigro, C; Grasso, M; Gulisano, M; Tamanini, F; Bienvenu, T; Gedeon, AK; Oostra, B; Wu, SK; Tandon, A; Valtorta, F; Balch, WE; Chelly, J; Toniolo, D			Mutations in GDI1 are responsible for X-linked non-specific mental retardation	NATURE GENETICS			English	Article							GDP-DISSOCIATION INHIBITOR; GTP-BINDING PROTEIN; HIPPOCAMPAL-NEURONS; SYNAPTIC VESICLES; RAB PROTEINS; GENE; EXOCYTOSIS; XQ28; IDENTIFICATION; EXPRESSION	Rab GDP-dissociation inhibitors (GDI) are evolutionarily conserved proteins that play an essential role in the recycling of Rab GTPases required for vesicular transport through the secretory pathway We have found mutations in the GDI1 gene (which encodes alpha GDI) in two families affected with X-linked non-specific mental retardation. One of the mutations caused a non-conservative substitution (L92P) which reduced binding and recycling of RAB3A, the second was a null mutation. Our results show that both functional and developmental alterations in the neuron may account for the severe impairment of learning abilities as a consequence of mutations in GDI1, emphasizing its critical role in development of human intellectual and learning abilities.	CNR, Inst Genet Biochem & Evolut, I-27100 Pavia, Italy; Galliera Hosp, Lab Human Genet, Genoa, Italy; HSR, DIBIT, Milan, Italy; Inst Cochin Genet Mol, F-75014 Paris, France; Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Adelaide, SA, Australia; Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Scripps Res Inst, Dept Mol & Cell Biol, La Jolla, CA USA; Univ Milan, Dept Med Pharmacol, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Ente Ospedaliero Ospedali Galliera; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Womens & Childrens Hospital Australia; Erasmus University Rotterdam; Scripps Research Institute; University of Milan	Toniolo, D (corresponding author), CNR, Inst Genet Biochem & Evolut, I-27100 Pavia, Italy.	Toniola@igbe.pv.cnr.it	Chelly, Jamel/J-7528-2015; Flavia, Valtorta/F-3450-2012; Gedeon, Agi/G-7890-2011; Gulisano, Massimo/F-6609-2012; Toniolo, Daniela/AAE-2969-2019; D'Adamo, Patrizia/AAN-3919-2020; menegon, andrea/AAN-3736-2020; Grasso, Marina/AAC-8722-2019	Chelly, Jamel/0000-0002-0939-8719; Flavia, Valtorta/0000-0001-9556-4746; Gulisano, Massimo/0000-0001-8654-1745; Toniolo, Daniela/0000-0001-9545-6032; D'Adamo, Patrizia/0000-0002-0312-5541; menegon, andrea/0000-0002-2396-756X; s, hema/0000-0002-3440-9475; Grasso, Marina/0000-0001-5682-1789	NEI NIH HHS [EY11606] Funding Source: Medline; NIGMS NIH HHS [GM33301] Funding Source: Medline; Telethon [E.0297] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033301] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Telethon(Fondazione Telethon); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACHNER D, 1995, HUM MOL GENET, V4, P701, DOI 10.1093/hmg/4.4.701; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BARTLETT WP, 1984, J NEUROSCI, V4, P1954; BEAN JA, 1997, NEURON, V19, P751; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; BIONE S, 1993, P NATL ACAD SCI USA, V90, P10977, DOI 10.1073/pnas.90.23.10977; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; BURGAYA F, 1995, EUR J NEUROSCI, V7, P1810, DOI 10.1111/j.1460-9568.1995.tb00700.x; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Chen EY, 1996, HUM MOL GENET, V5, P659, DOI 10.1093/hmg/5.5.659; Claes S, 1997, CLIN GENET, V52, P155; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; DASCHER C, 1994, J BIOL CHEM, V269, P1437; DEKKER LV, 1991, J NEUROCHEM, V56, P1146, DOI 10.1111/j.1471-4159.1991.tb11404.x; desPortes V, 1997, AM J HUM GENET, V60, P903; GARRETT MD, 1994, EMBO J, V13, P1718, DOI 10.1002/j.1460-2075.1994.tb06436.x; Gecz J, 1996, NAT GENET, V13, P105, DOI 10.1038/ng0596-105; Gedeon AK, 1996, AM J MED GENET, V64, P158, DOI 10.1002/(SICI)1096-8628(19960712)64:1<158::AID-AJMG26>3.3.CO;2-V; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Gulisano M, 1996, EUR J NEUROSCI, V8, P1037, DOI 10.1111/j.1460-9568.1996.tb01590.x; Hamel BCJ, 1996, AM J MED GENET, V64, P131, DOI 10.1002/(SICI)1096-8628(19960712)64:1<131::AID-AJMG22>3.0.CO;2-N; Lubs HA, 1996, AM J MED GENET, V64, P147, DOI 10.1002/(SICI)1096-8628(19960712)64:1<147::AID-AJMG25>3.0.CO;2-M; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; NUOFFER C, 1995, METHOD ENZYMOL, V257, P3; PFEFFER SR, 1995, J BIOL CHEM, V270, P17057, DOI 10.1074/jbc.270.29.17057; SASAKI T, 1990, J BIOL CHEM, V265, P2333; Schalk I, 1996, NATURE, V381, P42, DOI 10.1038/381042a0; SEABRA MC, 1993, SCIENCE, V259, P377, DOI 10.1126/science.8380507; SEDLACEK Z, 1994, MAMM GENOME, V5, P633, DOI 10.1007/BF00411459; SPINARDI L, 1991, NUCLEIC ACIDS RES, V19, P4009, DOI 10.1093/nar/19.14.4009; SUEDHOF TC, 1997, NEURON, V18, P519; Takai Y, 1996, GENES CELLS, V1, P615, DOI 10.1046/j.1365-2443.1996.00257.x; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VONMOLLARD GF, 1994, J BIOL CHEM, V269, P10971; VONMOLLARD GF, 1994, TRENDS BIOCHEM SCI, V19, P164, DOI 10.1016/0968-0004(94)90278-X; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wu SK, 1996, TRENDS BIOCHEM SCI, V21, P472, DOI 10.1016/S0968-0004(96)10062-1	42	266	274	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1998	19	2					134	139		10.1038/487	http://dx.doi.org/10.1038/487			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620768				2022-12-17	WOS:000073865100019
J	duSart, D; Cancilla, MR; Earle, E; Mao, JI; Saffery, R; Tainton, KM; Kalitsis, P; Martyn, J; Barry, AE; Choo, KHA				duSart, D; Cancilla, MR; Earle, E; Mao, JI; Saffery, R; Tainton, KM; Kalitsis, P; Martyn, J; Barry, AE; Choo, KHA			A functional neo-centromere formed through activation of a latent human centromere and consisting of non-alpha-satellite DNA	NATURE GENETICS			English	Article							SUPERNUMERARY MARKER CHROMOSOMES; PROTEIN CENP-C; ANTICENTROMERE ANTIBODIES; SACCHAROMYCES-CEREVISIAE; KINETOCHORE CENTROMERE; INSITU HYBRIDIZATION; HUMAN AUTOANTIBODIES; MAMMALIAN-CELLS; FISSION YEAST; PHYSICAL MAP	We recently described a human marker chromosome containing a functional neo-centromere that binds anticentromere antibodies, but is devoid of centromeric alpha-satellite repeats and derived from a hitherto non-centromeric: region of chromosome 10q25. Chromosome walking using cloned single-copy DNA from this region enabled us to identify the antibody-binding domain of this centromere. Extensive restriction mapping indicates that this domain has an identical genomic organization to the corresponding normal chromosomal region, suggesting a mechanism for the origin of this centromere through the activation of a latent centromere that exists within 10q25.	ROYAL CHILDRENS HOSP,MURDOCH INST RES BIRTH DEFECTS,PARKVILLE,VIC 3052,AUSTRALIA; GENOME THERAPEUT CORP,COLLABORAT RES DIV,WALTHAM,MA 02154	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne			Saffery, Richard/GLS-1976-2022; Kalitsis, Paul/C-1916-2015	Saffery, Richard/0000-0002-9510-4181; Kalitsis, Paul/0000-0001-5569-0609; Barry, Alyssa/0000-0002-1189-2310				ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ALEIXANDRE C, 1987, HUM GENET, V77, P46; ARCHIDIACONO N, 1994, SITU HYBRIDIZATION P, P1; BALDINI A, 1993, HUM GENET, V90, P577; BALDINI A, 1991, CYTOGENET CELL GENET, V58, P1868; BERNAT RL, 1990, J CELL BIOL, V111, P1519, DOI 10.1083/jcb.111.4.1519; BISCHOFF FR, 1990, P NATL ACAD SCI USA, V87, P8617, DOI 10.1073/pnas.87.21.8617; BLENNOW E, 1994, AM J HUM GENET, V54, P877; BRENNER S, 1981, J CELL BIOL, V91, P95, DOI 10.1083/jcb.91.1.95; BROWN KE, 1994, HUM MOL GENET, V3, P1227, DOI 10.1093/hmg/3.8.1227; BROWN MT, 1993, J CELL BIOL, V123, P387, DOI 10.1083/jcb.123.2.387; BROWN MT, 1995, GENE, V160, P111, DOI 10.1016/0378-1119(95)00163-Z; BROWN W, 1995, TRENDS GENET, V11, P337, DOI 10.1016/S0168-9525(00)89100-3; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; CALLEN DF, 1992, AM J MED GENET, V43, P709, DOI 10.1002/ajmg.1320430412; CHOO KHA, IN PRESS CENTROMERE; CLARKE L, 1985, ANNU REV GENET, V19, P29, DOI 10.1146/annurev.genet.19.1.29; CROLLA JA, 1992, J MED GENET, V29, P699, DOI 10.1136/jmg.29.10.699; DASSO M, 1993, TRENDS BIOCHEM SCI, V18, P96, DOI 10.1016/0968-0004(93)90161-F; DUTRILLAUX B, 1979, HUM GENET, V48, P251, DOI 10.1007/BF00272830; EARNSHAW WC, 1989, CHROMOSOMA, V98, P1, DOI 10.1007/BF00293329; EARNSHAW WC, 1994, FASEB J, V8, P947, DOI 10.1096/fasebj.8.12.8088460; EARNSHAW WC, 1985, CHROMOSOMA, V92, P290, DOI 10.1007/BF00329812; FARR CJ, 1995, EMBO J, V14, P5444, DOI 10.1002/j.1460-2075.1995.tb00228.x; FRITZLER MJ, 1980, AM J MED, V69, P520, DOI 10.1016/0002-9343(80)90462-3; GRADY DL, 1992, P NATL ACAD SCI USA, V89, P1695, DOI 10.1073/pnas.89.5.1695; HAAF T, 1994, HUM MOL GENET, V3, P697, DOI 10.1093/hmg/3.5.697; HAAF T, 1992, CELL, V70, P681, DOI 10.1016/0092-8674(92)90436-G; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; HEARTLEIN MW, 1988, MOL CELL BIOL, V8, P3611, DOI 10.1128/MCB.8.9.3611; Heller R, 1996, P NATL ACAD SCI USA, V93, P7125, DOI 10.1073/pnas.93.14.7125; JEPPESEN P, 1992, CHROMOSOMA, V101, P322, DOI 10.1007/BF00346011; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; KINGWELL B, 1987, CHROMOSOMA, V95, P403, DOI 10.1007/BF00333991; LARIN Z, 1994, HUM MOL GENET, V3, P689, DOI 10.1093/hmg/3.5.689; MAGNANI I, 1993, CLIN GENET, V43, P180; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; MOIR DT, 1994, GENOMICS, V22, P1, DOI 10.1006/geno.1994.1338; MOROI Y, 1981, J CELL BIOL, V90, P254, DOI 10.1083/jcb.90.1.254; Moschonas N. K., 1996, Cytogenetics and Cell Genetics, V72, P99, DOI 10.1159/000134172; MURPHY TD, 1995, CELL, V82, P599, DOI 10.1016/0092-8674(95)90032-2; NELSON M, 1991, NUCLEIC ACIDS RES, V19, P2045, DOI 10.1093/nar/19.suppl.2045; OHASHI H, 1994, AM J HUM GENET, V55, P1202; PAGE SL, 1995, HUM MOL GENET, V4, P289, DOI 10.1093/hmg/4.2.289; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; PALMER DK, 1985, MOL CELL BIOL, V5, P173, DOI 10.1128/MCB.5.1.173; PLUTA AF, 1990, TRENDS BIOCHEM SCI, V15, P181, DOI 10.1016/0968-0004(90)90158-8; PLUTA AF, 1995, SCIENCE, V270, P1591, DOI 10.1126/science.270.5242.1591; RAUCH A, 1992, CLIN GENET, V42, P84; SEARLE AG, 1989, ANN HUM GENET, V53, P89, DOI 10.1111/j.1469-1809.1989.tb01777.x; STEINER NC, 1994, CELL, V79, P865, DOI 10.1016/0092-8674(94)90075-2; STEINER NC, 1993, MOL CELL BIOL, V13, P4578, DOI 10.1128/MCB.13.8.4578; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; TOMKIEL J, 1994, J CELL BIOL, V125, P531, DOI 10.1083/jcb.125.3.531; TROWELL HE, 1993, HUM MOL GENET, V2, P1639, DOI 10.1093/hmg/2.10.1639; TYLERSMITH C, 1993, NAT GENET, V5, P368, DOI 10.1038/ng1293-368; VERMA RS, 1992, GENOMICS, V14, P113, DOI 10.1016/S0888-7543(05)80291-5; VOULLAIRE LE, 1993, AM J HUM GENET, V52, P1153; WEVRICK R, 1989, P NATL ACAD SCI USA, V86, P9394, DOI 10.1073/pnas.86.23.9394; WEVRICK R, 1991, NUCLEIC ACIDS RES, V19, P2295, DOI 10.1093/nar/19.9.2295; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; Yang CH, 1996, MOL CELL BIOL, V16, P3576; ZHENG CJ, 1994, GENOMICS, V22, P55, DOI 10.1006/geno.1994.1345	65	266	278	1	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1997	16	2					144	153						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XB543	9171825				2022-12-17	WOS:A1997XB54300014
J	ADLKOFER, K; MARTINI, R; AGUZZI, A; ZIELASEK, J; TOYKA, KV; SUTER, U				ADLKOFER, K; MARTINI, R; AGUZZI, A; ZIELASEK, J; TOYKA, KV; SUTER, U			HYPERMYELINATION AND DEMYELINATING PERIPHERAL NEUROPATHY IN PMP22-DEFICIENT MICE	NATURE GENETICS			English	Article							TOOTH DISEASE TYPE-1A; TREMBLER-J MOUSE; ARREST-SPECIFIC GENE; MYELIN PROTEIN; POINT MUTATION; SCHWANN-CELLS; HEREDITARY NEUROPATHY; PRESSURE PALSIES; NERVOUS-SYSTEM; PMP22 GENE	Peripheral myelin protein PMP22 has been suggested to have a role in peripheral nerve myelination and cell proliferation. Defects at the PMP22 locus are associated with peripheral neuropathies such as Charcot-Marie-Tooth disease type 1A. We now demonstrate that mice devoid of Pmp22 are retarded in the onset of myelination and develop abundant sausage-like hypermyelination structures (tomacula) at a young age followed by severe demyelination, axonal loss and functional impairment. Mice carrying one functional copy of Pmp22 are less affected but they also exhibit focal tomacula comparable to the morphological features in hereditary neuropathy with liability to pressure palsies (HNPP). We conclude that Pmp22 is required for the correct development of peripheral nerves, the maintenance of axons and the determination of myelin thickness and stability.	ETH HONGGERBERG,DEPT CELL BIOL,CH-8093 ZURICH,SWITZERLAND; ETH HONGGERBERG,DEPT NEUROBIOL,CH-8093 ZURICH,SWITZERLAND; UNIV ZURICH HOSP,INST NEUROPATHOL,CH-8091 ZURICH,SWITZERLAND; UNIV WURZBURG,DEPT NEUROL,D-97080 WURZBURG,GERMANY	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; University of Wurzburg			Aguzzi, Adriano/A-3351-2008; Suter, Ueli/A-1624-2010	Martini, Rudolf/0000-0002-5463-5592; Aguzzi, Adriano/0000-0002-0344-6708				AGUAYO AJ, 1977, NATURE, V265, P73, DOI 10.1038/265073a0; BAECHER D, IN PRESS J NEUROSCI; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; CHANCE PF, 1994, HUM MOL GENET, V3, P323; COLLELO RJ, 1994, J NEUROSCI, V14, P2594; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Dyck P.J, 1993, PNP, P1094; DYCK PJ, 1984, PERIPHERAL NEUROPATH, P760; ELLIS D, 1994, NAT GENET, V6, P333, DOI 10.1038/ng0494-333; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; HENRY EW, 1983, J NEUROPATH EXP NEUR, V42, P688, DOI 10.1097/00005072-198311000-00008; LOW PA, 1977, J NEUROL NEUROSUR PS, V40, P434, DOI 10.1136/jnnp.40.5.434; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MANFIOLETTI G, 1990, MOL CELL BIOL, V10, P2924, DOI 10.1128/MCB.10.6.2924; MARTINI R, 1995, NAT GENET, V11, P281, DOI 10.1038/ng1195-281; MARTINI R, 1995, J NEUROSCI, V15, P4488; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; MEIER C, 1982, J NEUROL, V228, P73, DOI 10.1007/BF00313754; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; NAVE KA, 1994, J NEUROSCI RES, V38, P607, DOI 10.1002/jnr.490380602; NICHOLSON GA, 1994, NAT GENET, V6, P263, DOI 10.1038/ng0394-263; PAREEK S, 1993, J BIOL CHEM, V268, P10372; PARMANTIER E, 1995, EUR J NEUROSCI, V7, P1080, DOI 10.1111/j.1460-9568.1995.tb01095.x; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Peters A., 1991, FINE STRUCTURE NERVO, P212; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; ROA BB, 1993, NAT GENET, V5, P269, DOI 10.1038/ng1193-269; RUFFNER H, 1993, P NATL ACAD SCI USA, V90, P11503, DOI 10.1073/pnas.90.24.11503; SHINE HD, 1992, J NEUROCHEM, V58, P342, DOI 10.1111/j.1471-4159.1992.tb09316.x; SKRE H, 1974, CLIN GENET, V6, P98; SNIPES GJ, 1995, J ANAT, V186, P483; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; SPREYER P, 1991, EMBO J, V10, P3661, DOI 10.1002/j.1460-2075.1991.tb04933.x; SUTER U, 1993, TRENDS NEUROSCI, V16, P50, DOI 10.1016/0166-2236(93)90015-E; SUTER U, 1992, P NATL ACAD SCI USA, V89, P4382, DOI 10.1073/pnas.89.10.4382; SUTER U, 1995, ANNU REV NEUROSCI, V18, P45, DOI 10.1146/annurev.ne.18.030195.000401; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; SUTER U, 1995, J NEUROSCI RES, V40, P145, DOI 10.1002/jnr.490400202; SUTER U, 1994, J BIOL CHEM, V269, P25795; TAYLOR V, IN PRESS J BIOL CHEM; THOMAS FP, 1994, ACTA NEUROPATHOL, V87, P91; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; UNCINI A, 1995, MUSCLE NERVE, V18, P628, DOI 10.1002/mus.880180610; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; VALENTIJN LJ, 1995, HUM MUTAT, V5, P76, DOI 10.1002/humu.1380050110; WELCHER AA, 1991, P NATL ACAD SCI USA, V88, P7195, DOI 10.1073/pnas.88.16.7195; Windebank A, 1993, PERIPHERAL NEUROPATH, V2, P1137; ZOIDL G, 1995, EMBO J, V14, P1122, DOI 10.1002/j.1460-2075.1995.tb07095.x	53	266	270	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					274	280		10.1038/ng1195-274	http://dx.doi.org/10.1038/ng1195-274			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581450				2022-12-17	WOS:A1995TC63900015
J	HATADA, I; MUKAI, T				HATADA, I; MUKAI, T			GENOMIC IMPRINTING OF P57(KIP2), CYCLIN-DEPENDENT KINASE INHIBITOR, IN MOUSE	NATURE GENETICS			English	Letter							GENE; METHYLATION; ALLELES				HATADA, I (corresponding author), NATL CARDIOVASC CTR,RES INST,5-7-1 FUJISHIRO DAI,SUITA,OSAKA 565,JAPAN.							BARLOW DP, 1994, TRENDS GENET, V10, P194, DOI 10.1016/0168-9525(94)90255-0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; EFSTRATIADIS A, 1994, CURR OPIN GENET DEV, V4, P265, DOI 10.1016/S0959-437X(05)80054-1; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; HATADA I, 1995, NUCLEIC ACIDS RES, V23, P36, DOI 10.1093/nar/23.1.36; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; LUBINSKY M, 1974, LANCET, V1, P932; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; MCLAUGHLIN KJ, IN PRESS GENES DEV; MONGHONG L, 1995, GENE DEV, V9, P639; NEUMANN B, 1995, NAT GENET, V9, P12, DOI 10.1038/ng0195-12; NICHOLLS RD, 1994, AM J HUM GENET, V54, P733; OHLSSON R, 1994, TRENDS GENET, V10, P415, DOI 10.1016/0168-9525(94)90100-7; PAL N, 1990, ONCOGENE, V5, P1665; RAZIN A, 1994, CELL, V77, P473, DOI 10.1016/0092-8674(94)90208-9; SCHROEDER WT, 1987, AM J HUM GENET, V40, P413; SCRABLE H, 1989, P NATL ACAD SCI USA, V86, P7480, DOI 10.1073/pnas.86.19.7480; SEARLE AG, 1990, GENET RES, V56, P237, DOI 10.1017/S0016672300035333; SEIZINGER BR, 1991, CYTOGENET CELL GENET, V58, P1080, DOI 10.1159/000133722; SOLTER D, 1988, ANNU REV GENET, V22, P127; VERES G, 1987, SCIENCE, V237, P415, DOI 10.1126/science.3603027; ZEMEL S, 1992, NAT GENET, V2, P259	28	266	269	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1995	11	2					204	206		10.1038/ng1095-204	http://dx.doi.org/10.1038/ng1095-204			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RX806	7550351				2022-12-17	WOS:A1995RX80600025
J	LAMB, BT; SISODIA, SS; LAWLER, AM; SLUNT, HH; KITT, CA; KEARNS, WG; PEARSON, PL; PRICE, DL; GEARHART, JD				LAMB, BT; SISODIA, SS; LAWLER, AM; SLUNT, HH; KITT, CA; KEARNS, WG; PEARSON, PL; PRICE, DL; GEARHART, JD			INTRODUCTION AND EXPRESSION OF THE 400 KILOBASE PRECURSOR AMYLOID PROTEIN GENE IN TRANSGENIC MICE	NATURE GENETICS			English	Article							HEREDITARY CEREBRAL-HEMORRHAGE; FAMILIAL ALZHEIMERS-DISEASE; AGE-ASSOCIATED INCLUSIONS; BETA-PROTEIN; NEUROFIBRILLARY TANGLES; GEL-ELECTROPHORESIS; TERMINAL FRAGMENT; DOWNS-SYNDROME; CLEAVAGE SITE; MOUSE-BRAIN	Overexpression of the gene encoding the beta-amyloid precursor protein (APP) may have a key role in the pathogenesis of both Alzheimer's disease (AD) and Down Syndrome (DS). We have therefore introduced a 650 kilobase (kb) yeast artificial chromosome (YAC) that contains the entire, unrearranged 400 kb human APP gene into mouse embryonic stem (ES) cells by lipid-mediated transfection. ES lines were generated that contain a stably integrated, unrearranged human APP gene. Moreover, we demonstrate germ line transmission of the APP YAC in transgenic mice and expression of human APP mRNA and protein at levels comparable to endogenous APP. This transgenic strategy may prove invaluable for the development of mouse models for AD and DS.	JOHNS HOPKINS UNIV, SCH MED,DEPT GYNECOL & OBSTET,DEV GENET LAB, 205 PHYSIOL BLDG,725 N WOLFE ST, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT PATHOL, NEUROPATHOL LAB, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, CTR MED GENET, DEPT MED, BALTIMORE, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University			Kearns, William/AAE-7699-2020					ANAND R, 1989, NUCLEIC ACIDS RES, V17, P3425, DOI 10.1093/nar/17.9.3425; ANDERSON JP, 1991, NEUROSCI LETT, V128, P126, DOI 10.1016/0304-3940(91)90775-O; BRADLEY A, 1987, TERATOCARCINOMAS EMB, P113; BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CHOI TK, 1993, NAT GENET, V4, P117, DOI 10.1038/ng0693-117; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; CONNELLY C, 1991, GENOMICS, V10, P10, DOI 10.1016/0888-7543(91)90477-V; Davis R W, 1980, Methods Enzymol, V65, P404; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GARDINER K, 1986, SOMAT CELL MOLEC GEN, V12, P185, DOI 10.1007/BF01560665; GIACCONE G, 1989, NEUROSCI LETT, V97, P232, DOI 10.1016/0304-3940(89)90169-9; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDE TE, 1990, NEURON, V4, P253, DOI 10.1016/0896-6273(90)90100-T; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; HIETER P, 1990, GENOME ANAL, V1, P83; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JAKOBOVITS A, 1993, NATURE, V362, P255, DOI 10.1038/362255a0; JUCKER M, 1992, SCIENCE, V255, P1443, DOI 10.1126/science.1542796; KAMMESHEIDT A, 1992, P NATL ACAD SCI USA, V89, P10857, DOI 10.1073/pnas.89.22.10857; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KAWABATA S, 1991, NATURE, V354, P476, DOI 10.1038/354476a0; KAWABATA S, 1992, NATURE, V356, P23, DOI 10.1038/356023b0; Kemper T., 1984, CLIN NEUROLOGY AGING, P9; Lamb Bruce T., 1991, Gene Expression, V1, P185; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; LINNEY E, 1983, CELL, V35, P693, DOI 10.1016/0092-8674(83)90102-2; MANN DMA, 1989, J NEUROL SCI, V89, P169, DOI 10.1016/0022-510X(89)90019-1; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; PRICE DL, 1992, AM J PATHOL, V141, P767; QUON D, 1991, NATURE, V352, P239, DOI 10.1038/352239a0; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; SCHEDL A, 1993, NATURE, V362, P258, DOI 10.1038/362258a0; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SELKOE DJ, 1987, SCIENCE, V235, P873, DOI 10.1126/science.3544219; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Sisodia S S, 1992, Curr Opin Neurobiol, V2, P648, DOI 10.1016/0959-4388(92)90033-H; SISODIA SS, 1987, MOL CELL BIOL, V7, P3602, DOI 10.1128/MCB.7.10.3602; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STRAUSS WM, 1993, SCIENCE, V259, P1904, DOI 10.1126/science.8096090; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TASSONE F, 1992, AM J HUM GENET, V51, P1251; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; WANG R, 1991, J BIOL CHEM, V266, P16960; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; WIRAK D, 1992, SCIENCE, V255, P1445, DOI 10.1126/science.255.5050.1445; WIRAK DO, 1991, EMBO J, V10, P289, DOI 10.1002/j.1460-2075.1991.tb07949.x; WIRAK DO, 1991, SCIENCE, V253, P323, DOI 10.1126/science.1857970; YOSHIKAI S, 1990, GENE, V87, P257, DOI 10.1016/0378-1119(90)90310-N; YOSHIKAI S, 1991, GENE, V102, P291, DOI 10.1016/0378-1119(91)90093-Q	67	266	311	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1993	5	1					22	29		10.1038/ng0993-22	http://dx.doi.org/10.1038/ng0993-22			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	8220418				2022-12-17	WOS:A1993LV56500010
J	GEORGE, AL; CRACKOWER, MA; ABDALLA, JA; HUDSON, AJ; EBERS, GC				GEORGE, AL; CRACKOWER, MA; ABDALLA, JA; HUDSON, AJ; EBERS, GC			MOLECULAR-BASIS OF THOMSEN DISEASE (AUTOSOMAL DOMINANT MYOTONIA-CONGENITA)	NATURE GENETICS			English	Article							HYPERKALEMIC PERIODIC PARALYSIS; RECESSIVE GENERALIZED MYOTONIA; AROMATIC CARBOXYLIC-ACIDS; MUSCLE CHLORIDE CHANNEL; CONDUCTANCE; MUTATION; EXPRESSION; FIBERS; DNA	Thomsen's disease (autosomal dominant myotonia congenita) has recently been linked to chromosome 7q35 in the region of the human skeletal muscle chloride channel gene (HUMCLC). Single strand conformation polymorphism analysis (SSCP) was used to screen DNA from members of four unrelated pedigrees with this disorder for mutations in HUMCLC. Abnormal bands were detected in all affected, but no unaffected individuals in three of the families. Direct sequencing revealed a G to A transition that results in the substitution of a glutamic acid for a glycine residue located between the third and fourth predicted membrane spanning segments. This glycine residue is conserved in all known members of this class of chloride channel proteins. These findings establish HUMCLC as the Thomsen's disease gene.	VANDERBILT UNIV,MED CTR,SCH MED,DEPT PHARMACOL,NASHVILLE,TN 37232; UNIV WESTERN ONTARIO,UNIV HOSP,RICHARD IVEY CTR MOLEC BIOL,LONDON N6A 5A5,ONTARIO,CANADA; UNIV WESTERN ONTARIO,UNIV HOSP,DEPT CLIN NEUROL SCI,LONDON N6A 5A5,ONTARIO,CANADA	Vanderbilt University; Western University (University of Western Ontario); Western University (University of Western Ontario)	GEORGE, AL (corresponding author), VANDERBILT UNIV,MED CTR,SCH MED,DEPT MED,NASHVILLE,TN 37232, USA.			Ebers, George/0000-0003-4771-4177				ABADALLA JA, 1992, AM J HUM GENET, V51, P579; ADRIAN RH, 1974, J PHYSIOL-LONDON, V240, P505, DOI 10.1113/jphysiol.1974.sp010620; BARCHI RL, 1975, ARCH NEUROL-CHICAGO, V32, P175, DOI 10.1001/archneur.1975.00490450055007; BARCHI RL, 1982, MUSCLE NERVE, V5, P360; BECKER PE, 1979, HUM GENET, V46, P325, DOI 10.1007/BF00273316; BECKER PE, 1977, PATHOGENESIS HUMAN M, P699; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BRETAG AH, 1973, NEW DEV ELECTROMYOGR, P464; Bryant S H, 1979, Ann N Y Acad Sci, V317, P314, DOI 10.1111/j.1749-6632.1979.tb56540.x; BRYANT SH, 1977, PATHOGENESIS HUMAN M, P715; BRYANT SH, 1971, J PHYSIOL-LONDON, V219, P361; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; FRANKE C, 1991, MUSCLE NERVE, V14, P762, DOI 10.1002/mus.880140811; FURMAN RE, 1978, ANN NEUROL, V4, P357, DOI 10.1002/ana.410040411; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Iaizzo P A, 1991, Neuromuscul Disord, V1, P47, DOI 10.1016/0960-8966(91)90042-Q; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; Lipicky R.J., 1973, NEW DEV ELECTROMYOGR, P451; LIPICKY RJ, 1979, HDB CLIN NEUROLOGY, P533; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MCCLATCHEY AI, 1992, CELL, V68, P769, DOI 10.1016/0092-8674(92)90151-2; MEHRKE G, 1988, MUSCLE NERVE, V11, P440, DOI 10.1002/mus.880110505; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; OTT J, 1985, ANAL HUMAN GENETIC L; PALADE PT, 1977, J GEN PHYSIOL, V69, P325, DOI 10.1085/jgp.69.3.325; PALADE PT, 1977, J GEN PHYSIOL, V69, P879, DOI 10.1085/jgp.69.6.879; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1992, NEURON, V8, P891; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; RUDEL R, 1985, PHYSIOL REV, V65, P310, DOI 10.1152/physrev.1985.65.2.310; Sambrook J., 1989, MOL CLONING LAB MANU; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; STREIB EW, 1987, MUSCLE NERVE, V10, P603, DOI 10.1002/mus.880100704; Thomsen, 1876, ARCH PSYCHIAT NERVEN, V6, P702, DOI DOI 10.1007/BF02164912; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615	38	266	271	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1993	3	4					305	310		10.1038/ng0493-305	http://dx.doi.org/10.1038/ng0493-305			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KW257	7981750				2022-12-17	WOS:A1993KW25700010
J	STIFANI, S; BLAUMUELLER, CM; REDHEAD, NJ; HILL, RE; ARTAVANISTSAKONAS, S				STIFANI, S; BLAUMUELLER, CM; REDHEAD, NJ; HILL, RE; ARTAVANISTSAKONAS, S			HUMAN HOMOLOGS OF A DROSOPHILA ENHANCER OF SPLIT GENE-PRODUCT DEFINE A NOVEL FAMILY OF NUCLEAR PROTEINS	NATURE GENETICS			English	Article							CASEIN KINASE-II; SV40 T-ANTIGEN; NEUROGENIC LOCUS; SACCHAROMYCES-CEREVISIAE; NOTCH LOCUS; TRANSMEMBRANE PROTEIN; GLUCOSE REPRESSION; SERRATE ENCODES; BINDING-PROTEIN; SHOWS HOMOLOGY	Notch and the m9/10 gene (groucho) of the Enhancer of split (E(spl)) complex are members of the "Notch group" of genes, which is required for a variety of cell fate choices in Drosophila. We have characterized human cDNA clones encoding a family of proteins, designated TLE, that are homologous to the E(spl) m9/10 gene product, as well as a novel Notch-related protein. The TLE genes are differentially expressed and encode nuclear proteins, consistent with the presence of sequence motifs associated with nuclear functions. The structural redundancy implied by the existence of more than one TLE and Notch-homologous gene may be a feature of the human counterparts of the developmentally important Drosophila Notch group genes.	YALE UNIV,SCH MED,HOWARD HUGHES MED INST,BOYER CTR MOLEC MED,DEPT CELL BIOL,NEW HAVEN,CT 06536; YALE UNIV,SCH MED,DEPT BIOL,NEW HAVEN,CT 06536; WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND	Howard Hughes Medical Institute; Yale University; Yale University; University of Edinburgh				Stifani, Stefano/0000-0002-2376-7701				ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ARTAVANISTSAKONAS S, 1991, TRENDS GENET, V7, P403, DOI 10.1016/0168-9525(91)90264-Q; AVES SJ, 1985, EMBO J, V4, P457, DOI 10.1002/j.1460-2075.1985.tb03651.x; BISCHOFF JR, 1990, P NATL ACAD SCI USA, V87, P4766, DOI 10.1073/pnas.87.12.4766; BREEDEN L, 1987, NATURE, V329, P651, DOI 10.1038/329651a0; COFFMAN C, 1990, SCIENCE, V249, P1438, DOI 10.1126/science.2402639; DALRYMPLE MA, 1989, CELL, V58, P811, DOI 10.1016/0092-8674(89)90930-6; DANG CV, 1988, MOL CELL BIOL, V8, P4048, DOI 10.1128/MCB.8.10.4048; DELIDAKIS C, 1991, GENETICS, V129, P803; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; FEHON RG, 1991, J CELL BIOL, V113, P657, DOI 10.1083/jcb.113.3.657; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; FLEMING RJ, 1990, GENE DEV, V4, P2188, DOI 10.1101/gad.4.12a.2188; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; GRASSER FA, 1988, VIROLOGY, V165, P13, DOI 10.1016/0042-6822(88)90653-8; GUILLEMOT F, 1989, P NATL ACAD SCI USA, V86, P4594, DOI 10.1073/pnas.86.12.4594; HARTLEY DA, 1988, CELL, V55, P785, DOI 10.1016/0092-8674(88)90134-1; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; JANS DA, 1991, J CELL BIOL, V115, P1203, DOI 10.1083/jcb.115.5.1203; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; KALDERON D, 1984, NATURE, V311, P499; KIDD S, 1986, MOL CELL BIOL, V6, P3094, DOI 10.1128/MCB.6.9.3094; KLAMBT C, 1989, EMBO J, V8, P203, DOI 10.1002/j.1460-2075.1989.tb03365.x; KNUST E, 1987, EMBO J, V6, P4113, DOI 10.1002/j.1460-2075.1987.tb02757.x; LAMARCO K, 1991, SCIENCE, V253, P789, DOI 10.1126/science.1876836; LUSCHER B, 1989, EMBO J, V8, P1111, DOI 10.1002/j.1460-2075.1989.tb03481.x; LUSCHER B, 1990, NATURE, V344, P517, DOI 10.1038/344517a0; MCVEY D, 1989, NATURE, V341, P503, DOI 10.1038/341503a0; MEEK DW, 1990, EMBO J, V9, P3253, DOI 10.1002/j.1460-2075.1990.tb07524.x; Meisner H, 1991, CURR OPIN CELL BIOL, V3, P474, DOI 10.1016/0955-0674(91)90076-B; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; NOMURA N, 1988, NUCLEIC ACIDS RES, V16, P11075, DOI 10.1093/nar/16.23.11075; PREISS A, 1988, EMBO J, V7, P3917, DOI 10.1002/j.1460-2075.1988.tb03278.x; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; RIHS HP, 1991, EMBO J, V10, P633, DOI 10.1002/j.1460-2075.1991.tb07991.x; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; RUGGIERI R, 1989, P NATL ACAD SCI USA, V86, P8778, DOI 10.1073/pnas.86.22.8778; SAMBROOK J, 1989, MOL CLINING LABORATO; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMOLLER D, 1990, GENE DEV, V4, P1688, DOI 10.1101/gad.4.10.1688; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; STIFANI S, 1988, BIOCHEM J, V250, P467, DOI 10.1042/bj2500467; THOMAS U, 1991, DEVELOPMENT, V111, P749; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; VAESSIN H, 1985, J NEUROGENET, V2, P291; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; WILLIAMS FE, 1990, MOL CELL BIOL, V10, P6500, DOI 10.1128/MCB.10.12.6500; WILLIAMS FE, 1991, MOL CELL BIOL, V11, P3307, DOI 10.1128/MCB.11.6.3307; XU T, 1990, GENE DEV, V4, P464, DOI 10.1101/gad.4.3.464; XU T, 1991, GENETICS, V126, P665; YOCHEM J, 1987, J MOL BIOL, V195, P233, DOI 10.1016/0022-2836(87)90646-2	55	266	282	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1992	2	2					119	127		10.1038/ng1092-119	http://dx.doi.org/10.1038/ng1092-119			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JR084	1303260				2022-12-17	WOS:A1992JR08400010
J	LIFTON, RP; DLUHY, RG; POWERS, M; RICH, GM; GUTKIN, M; FALLO, F; GILL, JR; FELD, L; GANGULY, A; LAIDLAW, JC; MURNAGHAN, DJ; KAUFMAN, C; STOCKIGT, JR; ULICK, S; LALOUEL, JM				LIFTON, RP; DLUHY, RG; POWERS, M; RICH, GM; GUTKIN, M; FALLO, F; GILL, JR; FELD, L; GANGULY, A; LAIDLAW, JC; MURNAGHAN, DJ; KAUFMAN, C; STOCKIGT, JR; ULICK, S; LALOUEL, JM			HEREDITARY HYPERTENSION CAUSED BY CHIMERIC GENE DUPLICATIONS AND ECTOPIC EXPRESSION OF ALDOSTERONE SYNTHASE	NATURE GENETICS			English	Article							POLYMERASE CHAIN-REACTION; GLUCOCORTICOID-SUPPRESSIBLE ALDOSTERONISM; HYPER-ALDOSTERONISM; DNA; CLONING; IDENTIFICATION; 18-OXOCORTISOL; POLYMORPHISMS; LOCALIZATION; FRAGMENTS	Patients with glucocorticoid-remediable aldosteronism (GRA) from 12 kindreds possess chimaeric gene duplications arising from unequal crossing-over, fusing regulatory sequences of steroid 11-beta-hydroxylase to coding sequences of aldosterone synthase. These chimaeric genes are specific for GRA and explain the biochemistry, physiology and genetics of this form of hypertension. Sites of crossing over range from intron 2 to intron 4. Most mutations have arisen independently from either sister or non-sister chromatid exchange between these genes, which are only 45 kilobases apart. The possibility of a susceptibility allele for GRA of Irish origin is suggested. These findings indicate the utility of a direct genetic test for this disorder.	UNIV UTAH,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; BRIGHAM & WOMENS HOSP,DIV ENDOCRINE HYPERTENS,BOSTON,MA 02115; HYPERTENS RENAL GRP,LIVINGSTON,NJ 07039; UNIV PADUA,INST SEMEIOT MED,I-35100 PADUA,ITALY; NHLBI,BETHESDA,MD 20892; CHILDRENS HOSP,DIV NEPHROL,BUFFALO,NY 14222; UNIV S FLORIDA,COLL MED,DEPT MED,TAMPA,FL 33620; CANADIAN CANC SOC,TORONTO M4V 3B1,ONTARIO,CANADA; REG HOSP CORK,DEPT MED,CORK,IRELAND; UNIV OKLAHOMA,HLTH SCI CTR,NEPHROL SECT,OKLAHOMA CITY,OK 73112; ALFRED HOSP,EWEN DOWNIE METAB UNIT,MELBOURNE,VIC 3181,AUSTRALIA; VET AFFAIRS HOSP,BRONX,NY 10468	Utah System of Higher Education; University of Utah; Harvard University; Brigham & Women's Hospital; University of Padua; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University System of Florida; University of South Florida; Canadian Cancer Society (CCS); University of Oklahoma System; University of Oklahoma Health Sciences Center; Florey Institute of Neuroscience & Mental Health	LIFTON, RP (corresponding author), UNIV UTAH,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112, USA.			FALLO, FRANCESCO/0000-0002-7511-0226				BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; CHU MD, 1982, J BIOL CHEM, V257, P2218; CHUA SC, 1987, P NATL ACAD SCI USA, V84, P7193, DOI 10.1073/pnas.84.20.7193; FALLO F, CLIN ENDOCRINOL, V22, P777; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GARDINER K, 1986, SOMAT CELL MOLEC GEN, V12, P185, DOI 10.1007/BF01560665; GIEBINK GS, 1973, J CLIN ENDOCR METAB, V36, P715, DOI 10.1210/jcem-36-4-715; GILLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725, DOI 10.1073/pnas.87.7.2725; GOMEZSANCHEZ CE, 1984, J CLIN ENDOCR METAB, V59, P1022, DOI 10.1210/jcem-59-5-1022; GRIM CE, 1980, PEDIATRICS, V65, P597; HAHN RA, 1990, JAMA-J AM MED ASSOC, V264, P2654, DOI 10.1001/jama.264.20.2654; KAWAMOTO T, 1990, BIOCHEM BIOPH RES CO, V173, P309, DOI 10.1016/S0006-291X(05)81058-7; KAZAZIAN HH, 1990, SEMIN HEMATOL, V27, P209; LIFTON RP, 1990, GENOMICS, V7, P131, DOI 10.1016/0888-7543(90)90530-8; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; MORNET E, 1989, J BIOL CHEM, V264, P20961; NATHANS J, 1987, ANNU REV NEUROSCI, V10, P163; NEW MI, 1967, J CLIN ENDOCR METAB, V27, P300, DOI 10.1210/jcem-27-2-300; OGISHIMA T, 1991, J BIOL CHEM, V266, P10731; OMAHONY S, 1989, J HUM HYPERTENS, V3, P255; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; RICH GM, 1992, ANN INTERN MED, V116, P813, DOI 10.7326/0003-4819-116-10-813; SCHOWALTER DB, 1989, ANAL BIOCHEM, V177, P90, DOI 10.1016/0003-2697(89)90019-5; SIMPSON ER, 1988, ANNU REV PHYSIOL, V50, P427, DOI 10.1146/annurev.ph.50.030188.002235; STOCKIGT JR, 1987, J CLIN ENDOCR METAB, V64, P22, DOI 10.1210/jcem-64-1-22; SUTHERLAND DJ, 1966, CAN MED ASSOC J, V95, P1109; ULICK S, 1990, J CLIN ENDOCR METAB, V71, P1151, DOI 10.1210/jcem-71-5-1151; ULICK S, 1983, J BIOL CHEM, V258, P5498; WARD R, 1990, DIAGNOSIS MANAGEMENT, P81; WEIR BS, 1990, GENETIC DATA ANAL, P102; WHITE PC, 1991, J CLIN INVEST, V87, P1664, DOI 10.1172/JCI115182; YABU M, 1991, HISTOCHEMISTRY, V96, P391, DOI 10.1007/BF00315995	32	266	275	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					66	74		10.1038/ng0992-66	http://dx.doi.org/10.1038/ng0992-66			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	1303253	Green Published			2022-12-17	WOS:A1992JM64600019
J	Bhandari, V; Hoey, C; Liu, LY; Lalonde, E; Ray, J; Livingstone, J; Lesurf, R; Shiah, YJ; Vujcic, T; Huang, XY; Espiritu, SMG; Heisler, LE; Yousif, F; Huang, V; Yamaguchi, TN; Yao, CQ; Sabelnykova, VY; Fraser, M; Chua, MLK; van der Kwast, T; Liu, SK; Boutros, PC; Bristow, RG				Bhandari, Vinayak; Hoey, Christianne; Liu, Lydia Y.; Lalonde, Emilie; Ray, Jessica; Livingstone, Julie; Lesurf, Robert; Shiah, Yu-Jia; Vujcic, Tina; Huang, Xiaoyong; Espiritu, Shadrielle M. G.; Heisler, Lawrence E.; Yousif, Fouad; Huang, Vincent; Yamaguchi, Takafumi N.; Yao, Cindy Q.; Sabelnykova, Veronica Y.; Fraser, Michael; Chua, Melvin L. K.; van der Kwast, Theodorus; Liu, Stanley K.; Boutros, Paul C.; Bristow, Robert G.			Molecular landmarks of tumor hypoxia across cancer types	NATURE GENETICS			English	Article							PROTEOGENOMIC CHARACTERIZATION; SOMATIC MUTATIONS; PROSTATE-CANCER; GENE-EXPRESSION; BREAST-TUMORS; NECK-CANCER; RADIOTHERAPY; OXYGENATION; DISCOVERY; HEAD	Many primary-tumor subregions have low levels of molecular oxygen, termed hypoxia. Hypoxic tumors are at elevated risk for local failure and distant metastasis, but the molecular hallmarks of tumor hypoxia remain poorly defined. To fill this gap, we quantified hypoxia in 8,006 tumors across 19 tumor types. In ten tumor types, hypoxia was associated with elevated genomic instability. In all 19 tumor types, hypoxic tumors exhibited characteristic driver-mutation signatures. We observed widespread hypoxia-associated dysregulation of microRNAs (miRNAs) across cancers and functionally validated miR-133a-3p as a hypoxia-modulated miRNA. In localized prostate cancer, hypoxia was associated with elevated rates of chromothripsis, allelic loss of PTEN and shorter telomeres. These associations are particularly enriched in polyclonal tumors, representing a constellation of features resembling tumor nimbosus, an aggressive cellular phenotype. Overall, this work establishes that tumor hypoxia may drive aggressive molecular features across cancers and shape the clinical trajectory of individual tumors.	[Bhandari, Vinayak; Hoey, Christianne; Liu, Lydia Y.; Lalonde, Emilie; Ray, Jessica; Liu, Stanley K.; Boutros, Paul C.; Bristow, Robert G.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Bhandari, Vinayak; Liu, Lydia Y.; Lalonde, Emilie; Livingstone, Julie; Lesurf, Robert; Shiah, Yu-Jia; Espiritu, Shadrielle M. G.; Heisler, Lawrence E.; Yousif, Fouad; Huang, Vincent; Yamaguchi, Takafumi N.; Yao, Cindy Q.; Sabelnykova, Veronica Y.; Fraser, Michael; Boutros, Paul C.] Ontario Inst Canc Res, Informat & Biocomp Program, Toronto, ON, Canada; [Ray, Jessica; Vujcic, Tina; Huang, Xiaoyong; Liu, Stanley K.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON, Canada; [Chua, Melvin L. K.] Natl Canc Ctr Singapore, Div Radiat Oncol, Singapore, Singapore; [Chua, Melvin L. K.] Duke NUS Grad Med Sch, Singapore, Singapore; [van der Kwast, Theodorus] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada; [Liu, Stanley K.; Bristow, Robert G.] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Boutros, Paul C.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Boutros, Paul C.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Boutros, Paul C.] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA 90095 USA; [Boutros, Paul C.] Univ Calif Los Angeles, Johnsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Boutros, Paul C.] Univ Calif Los Angeles, Inst Precis Hlth, Los Angeles, CA 90095 USA; [Bristow, Robert G.] Univ Hlth Network, Princess Margaret Hosp, Toronto, ON, Canada; [Bristow, Robert G.] Univ Manchester, Fac Biol Hlth & Med, Div Canc Sci, Manchester, Lancs, England; [Bristow, Robert G.] Christie NHS Fdn Trust, Manchester, Lancs, England; [Bristow, Robert G.] CRUK Manchester Inst, Manchester, Lancs, England; [Bristow, Robert G.] Manchester Canc Res Ctr, Manchester, Lancs, England	University of Toronto; Ontario Institute for Cancer Research; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; National Cancer Centre Singapore (NCCS); National University of Singapore; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Manchester; Christie NHS Foundation Trust; University of Manchester	Boutros, PC; Bristow, RG (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.; Boutros, PC (corresponding author), Ontario Inst Canc Res, Informat & Biocomp Program, Toronto, ON, Canada.; Bristow, RG (corresponding author), Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada.; Boutros, PC (corresponding author), Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada.; Boutros, PC (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA.; Boutros, PC (corresponding author), Univ Calif Los Angeles, Dept Urol, Los Angeles, CA 90095 USA.; Boutros, PC (corresponding author), Univ Calif Los Angeles, Johnsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.; Boutros, PC (corresponding author), Univ Calif Los Angeles, Inst Precis Hlth, Los Angeles, CA 90095 USA.; Bristow, RG (corresponding author), Univ Hlth Network, Princess Margaret Hosp, Toronto, ON, Canada.; Bristow, RG (corresponding author), Univ Manchester, Fac Biol Hlth & Med, Div Canc Sci, Manchester, Lancs, England.; Bristow, RG (corresponding author), Christie NHS Fdn Trust, Manchester, Lancs, England.; Bristow, RG (corresponding author), CRUK Manchester Inst, Manchester, Lancs, England.; Bristow, RG (corresponding author), Manchester Canc Res Ctr, Manchester, Lancs, England.	pboutros@mednet.ucla.edu; robert.bristow@manchester.ac.uk	Chua, Melvin LK/ABG-6045-2020	Chua, Melvin LK/0000-0002-1648-1473; Bristow, Robert/0000-0002-8553-9544; Hoey, Christianne/0000-0002-9054-4049; Yamaguchi, Takafumi/0000-0003-1082-3871; Wright, Jessica/0000-0002-5413-4739; Liu, Stanley/0000-0001-6851-0857; Lesurf, Robert/0000-0001-7095-1491; Lalonde, Emilie/0000-0002-8573-1966; Bhandari, Vinayak/0000-0003-0265-0835; Boutros, Paul/0000-0003-0553-7520	Movember funds through Prostate Cancer Canada; Ontario Institute for Cancer Research; Movember Foundation [RS2014-01]; Terry Fox Research Institute New Investigator Award; Prostate Cancer Canada Rising Star Fellowship; Canadian Institutes of Health Research (CIHR) New Investigator Award; Ontario government; Movember Rising Star award - Movember Foundation [RS2014-03, D2015-12, D2017-1811]; Telus Motorcycle Ride For Dad; Ministry of Research and Innovation Early Researcher Award; Princess Margaret Cancer Centre Foundation; Terry Fox Research Institute Program Project Grant; Canadian Cancer Society Research Scientist Award; CRUK Manchester Institute through Cancer Research UK; Government of Ontario; Prostate Cancer Canada; CIHR; Radiation Medicine Program Academic Enrichment Fund	Movember funds through Prostate Cancer Canada; Ontario Institute for Cancer Research; Movember Foundation; Terry Fox Research Institute New Investigator Award; Prostate Cancer Canada Rising Star Fellowship; Canadian Institutes of Health Research (CIHR) New Investigator Award(Canadian Institutes of Health Research (CIHR)); Ontario government; Movember Rising Star award - Movember Foundation; Telus Motorcycle Ride For Dad; Ministry of Research and Innovation Early Researcher Award(Ministry of Research and Innovation, Ontario); Princess Margaret Cancer Centre Foundation(University of Toronto); Terry Fox Research Institute Program Project Grant; Canadian Cancer Society Research Scientist Award; CRUK Manchester Institute through Cancer Research UK; Government of Ontario; Prostate Cancer Canada; CIHR(Canadian Institutes of Health Research (CIHR)); Radiation Medicine Program Academic Enrichment Fund	This study was conducted with the support of Movember funds through Prostate Cancer Canada, and with the additional support of the Ontario Institute for Cancer Research, funded by the Government of Ontario. This work was supported by Prostate Cancer Canada and is funded by the Movember Foundation (grant RS2014-01). P.C.B. was supported by a Terry Fox Research Institute New Investigator Award, a Prostate Cancer Canada Rising Star Fellowship, and a Canadian Institutes of Health Research (CIHR) New Investigator Award. This work has been funded by Fellowships from the CIHR and the Ontario government to V.B. and E.L. S.K.L. is supported as a Movember Rising Star award recipient funded by the Movember Foundation (grants RS2014-03, D2015-12 and D2017-1811), the Telus Motorcycle Ride For Dad (Huronia Branch) and a Ministry of Research and Innovation Early Researcher Award. The authors thank the Princess Margaret Cancer Centre Foundation and Radiation Medicine Program Academic Enrichment Fund for support (to R.G.B.). This work was supported by a Terry Fox Research Institute Program Project Grant. R.G.B. is supported as a recipient of a Canadian Cancer Society Research Scientist Award. Laboratory work for R.G.B is supported by the CRUK Manchester Institute through Cancer Research UK. The authors thank all members of the Boutros and Bristow laboratoriess for helpful suggestions.	Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Bindra RS, 2004, MOL CELL BIOL, V24, P8504, DOI 10.1128/MCB.24.19.8504-8518.2004; Blagosklonny MV, 2004, CANCER CELL, V5, P13, DOI 10.1016/S1535-6108(03)00336-2; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Brizel DM, 1999, RADIOTHER ONCOL, V53, P113, DOI 10.1016/S0167-8140(99)00102-4; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Buffa FM, 2010, BRIT J CANCER, V102, P428, DOI 10.1038/sj.bjc.6605450; Chua M. L. K, 2017, EUR UROL, V71, P183; Chua MLK, 2017, EUR UROL, V72, P496, DOI 10.1016/j.eururo.2017.04.004; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Deshwar AG, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0602-8; Dhani N, 2015, SEMIN NUCL MED, V45, P110, DOI 10.1053/j.semnuclmed.2014.11.002; Ding ZH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku181; EDWARDS YH, 1995, GENOMICS, V30, P350, DOI 10.1006/geno.1995.9866; Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Espiritu SMG, 2018, CELL, V173, P1003, DOI 10.1016/j.cell.2018.03.029; Eustace A, 2013, CLIN CANCER RES, V19, P4879, DOI 10.1158/1078-0432.CCR-13-0542; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Fraser M, 2017, NATURE, V541, P359, DOI 10.1038/nature20788; Gerstung M, 2017, PREPRINT; Gilkes DM, 2013, FUTURE ONCOL, V9, P1623, DOI [10.2217/fon.13.92, 10.2217/FON.13.92]; Govind SK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-78; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Ha G, 2014, GENOME RES, V24, P1881, DOI 10.1101/gr.180281.114; Haider S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0999-8; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hieronymus H, 2014, P NATL ACAD SCI USA, V111, P11139, DOI 10.1073/pnas.1411446111; Hong MKH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7605; Hopkins JF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00377-y; Hoskin PJ, 2010, J CLIN ONCOL, V28, P4912, DOI 10.1200/JCO.2010.28.4950; Hoskin PJ, 1997, BRIT J CANCER, V76, P260, DOI 10.1038/bjc.1997.372; Hu ZY, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-9; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson WC, 2018, EUR UROL, V74, P413, DOI 10.1016/j.eururo.2017.12.023; Janssens GO, 2012, J CLIN ONCOL, V30, P1777, DOI 10.1200/JCO.2011.35.9315; Koshiji M, 2005, MOL CELL, V17, P793, DOI 10.1016/j.molcel.2005.02.015; Lalonde E, 2017, EUR UROL, V72, P22, DOI 10.1016/j.eururo.2016.10.013; Lalonde E, 2014, LANCET ONCOL, V15, P1521, DOI 10.1016/S1470-2045(14)71021-6; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li CH, 2018, CANCER RES, V78, P5527, DOI 10.1158/0008-5472.CAN-18-0362; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin PY, 2008, J ORAL PATHOL MED, V37, P18, DOI 10.1111/j.1600-0714.2007.0057.x; Luoto Kaisa R, 2013, Genome Integr, V4, P5, DOI 10.1186/2041-9414-4-5; Masella AP, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1162-y; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Mihaylova VT, 2003, MOL CELL BIOL, V23, P3265, DOI 10.1128/MCB.23.9.3265-3273.2003; Milholland B, 2015, ONCOTARGET, V6, P24627, DOI 10.18632/oncotarget.5685; Milosevic M, 2012, CLIN CANCER RES, V18, P2108, DOI 10.1158/1078-0432.CCR-11-2711; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Mucaj V, 2012, INT J HEMATOL, V95, P464, DOI 10.1007/s12185-012-1070-5; Noman MZ, 2015, AM J PHYSIOL-CELL PH, V309, pC569, DOI 10.1152/ajpcell.00207.2015; Nordsmark M, 2004, ACTA ONCOL, V43, P396, DOI 10.1080/02841860410026189; P'ng C, 2017, PREPRINT; Parker C, 2004, INT J RADIAT ONCOL, V58, P750, DOI 10.1016/S0360-3016(03)01621-3; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Ragnum HB, 2015, BRIT J CANCER, V112, P382, DOI 10.1038/bjc.2014.604; Rankin EB, 2016, SCIENCE, V352, P175, DOI 10.1126/science.aaf4405; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; Seigneuric R, 2007, RADIOTHER ONCOL, V83, P374, DOI 10.1016/j.radonc.2007.05.002; Semenza GL, 2000, CRIT REV BIOCHEM MOL, V35, P71, DOI 10.1080/10409230091169186; Sorensen BS, 2010, ACTA ONCOL, V49, P895, DOI 10.3109/02841861003614343; Tan EY, 2009, BRIT J CANCER, V100, P405, DOI 10.1038/sj.bjc.6604844; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Vaupel P, 2001, MED ONCOL, V18, P243, DOI 10.1385/MO:18:4:243; Vollan HKM, 2015, MOL ONCOL, V9, P115, DOI 10.1016/j.molonc.2014.07.019; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weber CE, 2012, SURG ONCOL, V21, P172, DOI 10.1016/j.suronc.2011.09.001; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Winter SC, 2007, CANCER RES, V67, P3441, DOI 10.1158/0008-5472.CAN-06-3322; Yuan Y, 2016, CANCER CELL, V29, P711, DOI 10.1016/j.ccell.2016.04.001; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zannella VE, 2013, CLIN CANCER RES, V19, P6741, DOI 10.1158/1078-0432.CCR-13-1787; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Zhang H, 2016, CELL, V166, P755, DOI 10.1016/j.cell.2016.05.069; Zhong H, 1999, CANCER RES, V59, P5830; Zundel W, 2000, GENE DEV, V14, P391	84	265	271	18	129	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2019	51	2					308	+		10.1038/s41588-018-0318-2	http://dx.doi.org/10.1038/s41588-018-0318-2			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HJ6PM	30643250				2022-12-17	WOS:000457314300017
J	Wang, YP; Lu, Y; Zhang, Y; Ning, ZM; Li, Y; Zhao, Q; Lu, HY; Huang, R; Xia, XQ; Feng, Q; Liang, XF; Liu, KY; Zhang, L; Lu, TT; Huang, T; Fan, DL; Weng, QJ; Zhu, CR; Lu, YQ; Li, WJ; Wen, ZR; Zhou, CC; Tian, QL; Kang, XJ; Shi, MJ; Zhang, WT; Jang, SH; Du, FK; He, S; Liao, LJ; Li, YM; Gui, B; He, HH; Ning, Z; Yang, C; He, LB; Luo, LF; Yang, R; Luo, Q; Liu, XC; Li, SS; Huang, W; Xiao, L; Lin, HR; Han, B; Zhu, ZY				Wang, Yaping; Lu, Ying; Zhang, Yong; Ning, Zemin; Li, Yan; Zhao, Qiang; Lu, Hengyun; Huang, Rong; Xia, Xiaoqin; Feng, Qi; Liang, Xufang; Liu, Kunyan; Zhang, Lei; Lu, Tingting; Huang, Tao; Fan, Danlin; Weng, Qijun; Zhu, Chuanrang; Lu, Yiqi; Li, Wenjun; Wen, Ziruo; Zhou, Congcong; Tian, Qilin; Kang, Xiaojun; Shi, Mijuan; Zhang, Wanting; Jang, Songhun; Du, Fukuan; He, Shan; Liao, Lanjie; Li, Yongming; Gui, Bin; He, Huihui; Ning, Zhen; Yang, Cheng; He, Libo; Luo, Lifei; Yang, Rui; Luo, Qiong; Liu, Xiaochun; Li, Shuisheng; Huang, Wen; Xiao, Ling; Lin, Haoran; Han, Bin; Zhu, Zuoyan			The draft genome of the grass carp (Ctenopharyngodon idellus) provides insights into its evolution and vegetarian adaptation	NATURE GENETICS			English	Article							MOLECULAR CHARACTERIZATION; EXPRESSION ANALYSIS; ORGAN SIZE; GENE; ZEBRAFISH; IDENTIFICATION; FISH; DUPLICATION; DISCOVERY; SEQUENCE	The grass carp is an important farmed fish, accounting for similar to 16% of global freshwater aquaculture, and has a vegetarian diet. Here we report a 0.9-Gb draft genome of a gynogenetic female adult and a 1.07-Gb genome of a wild male adult. Genome annotation identified 27,263 protein-coding gene models in the female genome. A total of 114 scaffolds consisting of 573 Mb are anchored on 24 linkage groups. Divergence between grass carp and zebrafish is estimated to have occurred 49-54 million years ago. We identify a chromosome fusion in grass carp relative to zebrafish and report frequent crossovers between the grass carp X and Y chromosomes. We find that transcriptional activation of the mevalonate pathway and steroid biosynthesis in liver is associated with the grass carp's adaptation from a carnivorous to an herbivorous diet. We believe that the grass carp genome could serve as an initial platform for breeding better-quality fish using a genomic approach.	[Wang, Yaping; Huang, Rong; Xia, Xiaoqin; Kang, Xiaojun; Shi, Mijuan; Zhang, Wanting; Jang, Songhun; Du, Fukuan; Liao, Lanjie; Li, Yongming; Gui, Bin; He, Huihui; Ning, Zhen; Yang, Cheng; He, Libo; Luo, Lifei; Zhu, Zuoyan] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Lu, Ying; Li, Yan; Zhao, Qiang; Lu, Hengyun; Feng, Qi; Liu, Kunyan; Zhang, Lei; Lu, Tingting; Huang, Tao; Fan, Danlin; Weng, Qijun; Zhu, Chuanrang; Lu, Yiqi; Li, Wenjun; Wen, Ziruo; Zhou, Congcong; Tian, Qilin; Han, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Natl Ctr Gene Res, Shanghai, Peoples R China; [Zhang, Yong; Liu, Xiaochun; Li, Shuisheng; Huang, Wen; Xiao, Ling; Lin, Haoran] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Yong; Liu, Xiaochun; Li, Shuisheng; Huang, Wen; Xiao, Ling; Lin, Haoran] Sun Yat Sen Univ, Sch Life Sci, Guangdong Prov Key Lab Aquat Econ Anim, Guangzhou 510275, Guangdong, Peoples R China; [Ning, Zemin] Wellcome Trust Sanger Inst, Hinxton, England; [Liang, Xufang; He, Shan] Huazhong Agr Univ, Coll Fisheries, Minist Agr, Key Lab Freshwater Anim Breeding, Wuhan, Peoples R China; [Liang, Xufang] Huazhong Agr Univ, Coll Fisheries, Freshwater Aquaculture Collaborat Innovat Ctr Hu, Wuhan, Peoples R China; [Kang, Xiaojun; Yang, Cheng] China Univ Geosci, Sch Comp Sci, Wuhan 430074, Peoples R China; [Jang, Songhun] Kim Illinois Sung Univ, Coll Life Sci, Pyongyang, North Korea; [Yang, Rui; Luo, Qiong] Yunnan Agr Univ, Coll Plant Protect, Kunming, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Sun Yat Sen University; Sun Yat Sen University; Wellcome Trust Sanger Institute; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University; China University of Geosciences; Yunnan Agricultural University	Wang, YP (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	wangyp@ihb.ac.cn; lsslhr@mail.sysu.edu.cn; bhan@ncgr.ac.cn; zyzhu@ihb.ac.cn	Ning, Zemin/D-2411-2013; lin, haoran/GXH-3030-2022	Lu, Ying/0000-0002-2509-9209; xia, xiao qin/0000-0002-8034-1096; Ning, Zemin/0000-0003-4359-776X	National High-Technology Research and Development Program (863 Program) [2011AA100403]; National Natural Science Foundation of China [31130055]; Strategic Pilot Science and Technology Projects (A) Category, Chinese Academy of Science [XDA08030203]; Guangdong Provincial Science and Technology Program [20123090500008]; State Key Laboratory of Freshwater Ecology and Biotechnology [2011FBZ18]	National High-Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Pilot Science and Technology Projects (A) Category, Chinese Academy of Science; Guangdong Provincial Science and Technology Program; State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences)	We thank S. Liu (Hunan Normal University) for providing a gynogenetic female individual. We thank Y. Xue and J. Torrance for their help in English-language editing of the manuscript. This work is supported by the National High-Technology Research and Development Program (863 Program, 2011AA100403), the National Natural Science Foundation of China (31130055), the Strategic Pilot Science and Technology Projects (A) Category, Chinese Academy of Science (XDA08030203), the Guangdong Provincial Science and Technology Program (20123090500008) and the State Key Laboratory of Freshwater Ecology and Biotechnology (2011FBZ18).	Akira S, 2003, BIOCHEM SOC T, V31, P637, DOI 10.1042/BST0310637; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braasch I., 2012, POLYPLOIDY GENOME EV, V1, P341, DOI [10.1007/978-3-642-31442-1_17, DOI 10.1007/978-3-642-31442-1_17, 10.1007/978-3-642-31442-1_17/FIGURES/7, DOI 10.1007/978]; Chen J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-108; Chen Y, 2014, FISH PHYSIOL BIOCHEM, V40, P45, DOI 10.1007/s10695-013-9822-6; CHILTON EW, 1992, REV FISH BIOL FISHER, V2, P283, DOI 10.1007/BF00043520; Crow KD, 2006, MOL BIOL EVOL, V23, P121, DOI 10.1093/molbev/msj020; CUI YB, 1993, AQUACULTURE, V113, P57, DOI 10.1016/0044-8486(93)90340-5; Danen EHJ, 2001, J CELL PHYSIOL, V189, P1, DOI 10.1002/jcp.1137; DEMPSEY ME, 1974, ANNU REV BIOCHEM, V43, P967, DOI 10.1146/annurev.bi.43.070174.004535; Feng K, 2013, J EXP ZOOL PART A, V319A, P202, DOI 10.1002/jez.1784; Flores MV, 2007, GENE EXPR PATTERNS, V7, P535, DOI 10.1016/j.modgep.2007.02.001; Goodman BE, 2010, ADV PHYSIOL EDUC, V34, P44, DOI 10.1152/advan.00094.2009; Guo T, 2013, FISH SHELLFISH IMMUN, V35, P1624, DOI 10.1016/j.fsi.2013.09.012; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jang SH, 2010, MAR BIOTECHNOL, V12, P261, DOI 10.1007/s10126-010-9268-0; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kumar S, 2011, BIOINFORMATICS, V27, P2023, DOI 10.1093/bioinformatics/btr315; Kurosawa G, 2006, GENE, V370, P75, DOI 10.1016/j.gene.2005.11.015; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nocusa S., 1960, MEM HYOGO U AGR, V3, P1; Palacin M, 2005, PHYSIOLOGY, V20, P112, DOI 10.1152/physiol.00051.2004; Peng ZH, 2013, NAT GENET, V45, P456, DOI 10.1038/ng.2569; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; STANLEY JG, 1976, J FISH RES BOARD CAN, V33, P1372, DOI 10.1139/f76-175; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Statistics and Information Service Fisheries and Aquaculture Department Food and Agriculture Organization of the United Nations, 2013, FAO YB FISH AQ STAT; Tan Y, 2008, J NEUROGENET, V22, P149, DOI 10.1080/01677060802049738; Traut W, 2001, CHROMOSOME RES, V9, P659, DOI 10.1023/A:1012956324417; Wang TT, 2013, FISH SHELLFISH IMMUN, V35, P1421, DOI 10.1016/j.fsi.2013.08.006; Wegner M, 2010, INT J BIOCHEM CELL B, V42, P381, DOI 10.1016/j.biocel.2009.07.006; Xia JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-135; Xu B, 2010, ANIM BIOTECHNOL, V21, P217, DOI 10.1080/10495398.2010.505843; Yu EM, 2014, J ANIM PHYSIOL AN N, V98, P755, DOI 10.1111/jpn.12132; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zhong SS, 2013, GEN COMP ENDOCR, V185, P19, DOI 10.1016/j.ygcen.2013.01.016; Zhou Y, 2013, AQUACULTURE, V416, P1, DOI 10.1016/j.aquaculture.2013.08.023	45	265	303	7	136	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					625	631		10.1038/ng.3280	http://dx.doi.org/10.1038/ng.3280			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25938946	hybrid			2022-12-17	WOS:000355386500013
J	Pharoah, PDP; Tsai, YY; Ramus, SJ; Phelan, CM; Goode, EL; Lawrenson, K; Buckley, M; Fridley, BL; Tyrer, JP; Shen, H; Weber, R; Karevan, R; Larson, MC; Song, HL; Tessier, DC; Bacot, F; Vincent, D; Cunningham, JM; Dennis, J; Dicks, E; Katja, KA; Anton-Culver, H; Antonenkova, N; Armasu, SM; Baglietto, L; Bandera, EV; Beckmann, MW; Birrer, MJ; Bloom, G; Bogdanova, N; Brenton, JD; Brinton, LA; Brooks-Wilson, A; Brown, R; Butzow, R; Campbell, I; Carney, ME; Carvalho, RS; Chang-Claude, J; Chen, YA; Chen, ZH; Chow, WH; Cicek, MS; Coetzee, G; Cook, LS; Cramer, DW; Cybulski, C; Dansonka-Mieszkowska, A; Despierre, E; Doherty, JA; Doerk, T; du Bois, A; Duerst, M; Eccles, D; Edwards, R; Ekici, AB; Fasching, PA; Fenstermacher, D; Flanagan, J; Gao, YT; Garcia-Closas, M; Gentry-Maharaj, A; Giles, G; Gjyshi, A; Gore, M; Gronwald, J; Guo, Q; Halle, MK; Harter, P; Hein, A; Heitz, F; Hillemanns, P; Hoatlin, M; Hogdall, E; Hogdall, CK; Hosono, S; Jakubowska, A; Jensen, A; Kalli, KR; Karlan, BY; Kelemen, LE; Kiemeney, LA; Kjaer, SK; Konecny, GE; Krakstad, C; Kupryjanczyk, J; Lambrechts, D; Lambrechts, S; Le, ND; Lee, N; Lee, J; Leminen, A; Lim, BK; Lissowska, J; Lubinski, J; Lundvall, L; Lurie, G; Massuger, LFAG; Matsuo, K; McGuire, V; McLaughlin, JR; Menon, U; Modugno, F; Moysich, KB; Nakanishi, T; Narod, SA; Ness, RB; Nevanlinna, H; Nickels, S; Noushmehr, H; Odunsi, K; Olson, S; Orlow, I; Paul, J; Pejovic, T; Pelttari, LM; Permuth-Wey, J; Pike, MC; Poole, EM; Qu, XT; Risch, HA; Rodriguez-Rodriguez, L; Rossing, MA; Rudolph, A; Runnebaum, I; Rzepecka, IK; Salvesen, HB; Schwaab, I; Severi, G; Shen, H; Shridhar, V; Shu, XO; Sieh, W; Southey, MC; Spellman, P; Tajima, K; Teo, SH; Terry, KL; Thompson, PJ; Timorek, A; Tworoger, SS; van Altena, AM; van den Berg, D; Vergote, I; Vierkant, RA; Vitonis, AF; Wang-Gohrke, S; Wentzensen, N; Whittemore, AS; Wik, E; Winterhoff, B; Woo, YL; Wu, AH; Yang, HP; Zheng, W; Ziogas, A; Zulkifli, F; Goodman, MT; Hall, P; Easton, DF; Pearce, CL; Berchuck, A; Chenevix-Trench, G; Iversen, E; Monteiro, ANA; Gayther, SA; Schildkraut, JM; Sellers, TA				Pharoah, Paul D. P.; Tsai, Ya-Yu; Ramus, Susan J.; Phelan, Catherine M.; Goode, Ellen L.; Lawrenson, Kate; Buckley, Melissa; Fridley, Brooke L.; Tyrer, Jonathan P.; Shen, Howard; Weber, Rachel; Karevan, Rod; Larson, Melissa C.; Song, Honglin; Tessier, Daniel C.; Bacot, Francois; Vincent, Daniel; Cunningham, Julie M.; Dennis, Joe; Dicks, Ed; Aben, Katja K.; Anton-Culver, Hoda; Antonenkova, Natalia; Armasu, Sebastian M.; Baglietto, Laura; Bandera, Elisa V.; Beckmann, Matthias W.; Birrer, Michael J.; Bloom, Greg; Bogdanova, Natalia; Brenton, James D.; Brinton, Louise A.; Brooks-Wilson, Angela; Brown, Robert; Butzow, Ralf; Campbell, Ian; Carney, Michael E.; Carvalho, Renato S.; Chang-Claude, Jenny; Chen, Y. Anne; Chen, Zhihua; Chow, Wong-Ho; Cicek, Mine S.; Coetzee, Gerhard; Cook, Linda S.; Cramer, Daniel W.; Cybulski, Cezary; Dansonka-Mieszkowska, Agnieszka; Despierre, Evelyn; Doherty, Jennifer A.; Doerk, Thilo; du Bois, Andreas; Duerst, Matthias; Eccles, Diana; Edwards, Robert; Ekici, Arif B.; Fasching, Peter A.; Fenstermacher, David; Flanagan, James; Gao, Yu-Tang; Garcia-Closas, Montserrat; Gentry-Maharaj, Aleksandra; Giles, Graham; Gjyshi, Anxhela; Gore, Martin; Gronwald, Jacek; Guo, Qi; Halle, Mari K.; Harter, Philipp; Hein, Alexander; Heitz, Florian; Hillemanns, Peter; Hoatlin, Maureen; Hogdall, Estrid; Hogdall, Claus K.; Hosono, Satoyo; Jakubowska, Anna; Jensen, Allan; Kalli, Kimberly R.; Karlan, Beth Y.; Kelemen, Linda E.; Kiemeney, Lambertus A.; Kjaer, Susanne Kruger; Konecny, Gottfried E.; Krakstad, Camilla; Kupryjanczyk, Jolanta; Lambrechts, Diether; Lambrechts, Sandrina; Le, Nhu D.; Lee, Nathan; Lee, Janet; Leminen, Arto; Lim, Boon Kiong; Lissowska, Jolanta; Lubinski, Jan; Lundvall, Lene; Lurie, Galina; Massuger, Leon F. A. G.; Matsuo, Keitaro; McGuire, Valerie; McLaughlin, John R.; Menon, Usha; Modugno, Francesmary; Moysich, Kirsten B.; Nakanishi, Toru; Narod, Steven A.; Ness, Roberta B.; Nevanlinna, Heli; Nickels, Stefan; Noushmehr, Houtan; Odunsi, Kunle; Olson, Sara; Orlow, Irene; Paul, James; Pejovic, Tanja; Pelttari, Liisa M.; Permuth-Wey, Jenny; Pike, Malcolm C.; Poole, Elizabeth M.; Qu, Xiaotao; Risch, Harvey A.; Rodriguez-Rodriguez, Lorna; Rossing, Mary Anne; Rudolph, Anja; Runnebaum, Ingo; Rzepecka, Iwona K.; Salvesen, Helga B.; Schwaab, Ira; Severi, Gianluca; Shen, Hui; Shridhar, Vijayalakshmi; Shu, Xiao-Ou; Sieh, Weiva; Southey, Melissa C.; Spellman, Paul; Tajima, Kazuo; Teo, Soo-Hwang; Terry, Kathryn L.; Thompson, Pamela J.; Timorek, Agnieszka; Tworoger, Shelley S.; van Altena, Anne M.; van den Berg, David; Vergote, Ignace; Vierkant, Robert A.; Vitonis, Allison F.; Wang-Gohrke, Shan; Wentzensen, Nicolas; Whittemore, Alice S.; Wik, Elisabeth; Winterhoff, Boris; Woo, Yin Ling; Wu, Anna H.; Yang, Hannah P.; Zheng, Wei; Ziogas, Argyrios; Zulkifli, Famida; Goodman, Marc T.; Hall, Per; Easton, Douglas F.; Pearce, Celeste L.; Berchuck, Andrew; Chenevix-Trench, Georgia; Iversen, Edwin; Monteiro, Alvaro N. A.; Gayther, Simon A.; Schildkraut, Joellen M.; Sellers, Thomas A.		Australian Canc Study; Australian Ovarian Canc Study Grp	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RISK; EXPRESSION; GENE; NEBULETTE; CARCINOMA; 19P13; MYC	Genome-wide association studies (GWAS) have identified four susceptibility loci for epithelial ovarian cancer (EOC), with another two suggestive loci reaching near genome-wide significance. We pooled data from a GWAS conducted in North America with another GWAS from the UK. We selected the top 24,551 SNPs for inclusion on the iCOGS custom genotyping array. We performed follow-up genotyping in 18,174 individuals with EOC (cases) and 26,134 controls from 43 studies from the Ovarian Cancer Association Consortium. We validated the two loci at 3q25 and 17q21 that were previously found to have associations close to genome-wide significance and identified three loci newly associated with risk: two loci associated with all EOC subtypes at 8q21 (rs11782652, P = 5.5 x 10(-9)) and 10p12 (rs1243180, P = 1.8 x 10(-8)) and another locus specific to the serous subtype at 17q12 (rs757210, P = 8.1 x 10(-10)). An integrated molecular analysis of genes and regulatory regions at these loci provided evidence for functional mechanisms underlying susceptibility and implicated CHMP4C in the pathogenesis of ovarian cancer.	[Pharoah, Paul D. P.; Tyrer, Jonathan P.; Song, Honglin; Dicks, Ed; Guo, Qi; Easton, Douglas F.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Pharoah, Paul D. P.; Dennis, Joe; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Tsai, Ya-Yu; Phelan, Catherine M.; Buckley, Melissa; Bloom, Greg; Chen, Y. Anne; Chen, Zhihua; Fenstermacher, David; Gjyshi, Anxhela; Permuth-Wey, Jenny; Qu, Xiaotao; Monteiro, Alvaro N. A.; Sellers, Thomas A.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Canc Epidemiol, Div Populat Sci, Tampa, FL 33682 USA; [Ramus, Susan J.; Lawrenson, Kate; Shen, Howard; Karevan, Rod; Lee, Nathan; Lee, Janet; Pike, Malcolm C.; van den Berg, David; Wu, Anna H.; Pearce, Celeste L.; Gayther, Simon A.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Goode, Ellen L.; Fridley, Brooke L.; Cicek, Mine S.; Vierkant, Robert A.] Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA; [Weber, Rachel; Schildkraut, Joellen M.] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA; [Larson, Melissa C.; Armasu, Sebastian M.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA; [Tessier, Daniel C.; Bacot, Francois; Vincent, Daniel] McGill Univ, Ctr Technol, Montreal, PQ, Canada; [Tessier, Daniel C.; Bacot, Francois; Vincent, Daniel] McGill Univ, Montreal, PQ, Canada; [Tessier, Daniel C.; Bacot, Francois; Vincent, Daniel] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Cunningham, Julie M.; Shridhar, Vijayalakshmi] Mayo Clin, Dept Lab Med & Pathol, Div Anat Pathol, Rochester, MN USA; [Aben, Katja K.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [Aben, Katja K.; Kiemeney, Lambertus A.] Comprehens Canc Ctr Netherlands, Utrecht, Netherlands; [Anton-Culver, Hoda; Ziogas, Argyrios] Univ Calif Irvine, Sch Med, Dept Epidemiol, Ctr Canc Genet Res & Prevent, Irvine, CA 92717 USA; [Antonenkova, Natalia] NN Aleksandrov Byelorussian Inst Oncol & Med Radi, Minsk, BELARUS; [Baglietto, Laura; Giles, Graham; Severi, Gianluca] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Baglietto, Laura; Giles, Graham; Severi, Gianluca] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Bandera, Elisa V.; Rodriguez-Rodriguez, Lorna] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, New Brunswick, NJ USA; [Beckmann, Matthias W.; Fasching, Peter A.; Hein, Alexander] Univ Erlangen Nurnberg, Dept Gynecol & Obstet, Univ Hosp Erlangen, Ctr Comprehens Canc, D-91054 Erlangen, Germany; [Birrer, Michael J.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Birrer, Michael J.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Bogdanova, Natalia; Doerk, Thilo] Hannover Med Sch, Gynaecol Res Unit, Hannover, Germany; [Brenton, James D.] Li Ka Shing Ctr, Cambridge Res Inst, Cambridge, England; [Brinton, Louise A.; Wentzensen, Nicolas; Yang, Hannah P.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Brooks-Wilson, Angela] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Brown, Robert; Flanagan, James] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Butzow, Ralf] Univ Helsinki, Cent Hosp, Dept Pathol, Helsinki, Finland; [Butzow, Ralf; Leminen, Arto; Nevanlinna, Heli; Pelttari, Liisa M.] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland; [Campbell, Ian] Peter MacCallum Canc Ctr, Div Res, Canc Genet Lab, Melbourne, Vic, Australia; [Campbell, Ian] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Carney, Michael E.; Lurie, Galina; Thompson, Pamela J.; Goodman, Marc T.] Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA; [Chang-Claude, Jenny; Nickels, Stefan; Rudolph, Anja] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Chow, Wong-Ho] NCI, Div Canc Etiol & Genet, Bethesda, MD 20892 USA; [Coetzee, Gerhard; Noushmehr, Houtan] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Microbiol & Prevent Med, Los Angeles, CA 90033 USA; [Cook, Linda S.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Cramer, Daniel W.; Terry, Kathryn L.; Vitonis, Allison F.] Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; [Cramer, Daniel W.; Terry, Kathryn L.; Vitonis, Allison F.] Harvard Univ, Sch Med, Boston, MA USA; [Cramer, Daniel W.; Poole, Elizabeth M.; Terry, Kathryn L.; Tworoger, Shelley S.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Cybulski, Cezary; Gronwald, Jacek; Jakubowska, Anna; Lubinski, Jan] Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Szczecin, Poland; [Dansonka-Mieszkowska, Agnieszka; Kupryjanczyk, Jolanta; Rzepecka, Iwona K.] Maria Sklodowska Curie Mem Canc Ctr, Dept Mol Pathol, Warsaw, Poland; [Dansonka-Mieszkowska, Agnieszka; Kupryjanczyk, Jolanta; Rzepecka, Iwona K.] Inst Oncol, Warsaw, Poland; [Despierre, Evelyn; Lambrechts, Sandrina; Vergote, Ignace] Leuven Canc Inst, Dept Obstet & Gynaecol, Div Gynecol Oncol, Louvain, Belgium; [Doherty, Jennifer A.] Geisel Sch Med Dartmouth, Sect Biostat & Epidemiol, Lebanon, NH USA; [du Bois, Andreas; Harter, Philipp; Heitz, Florian] Dr Horst Schmidt Kliniken Wiesbaden, Dept Gynecol & Gynecol Oncol, Wiesbaden, Germany; [du Bois, Andreas; Harter, Philipp; Heitz, Florian] Kliniken Essen Mitte Evang Huyssens Stiftung Knap, Dept Gynecol & Gynecol Oncol, Essen, Germany; [Duerst, Matthias; Runnebaum, Ingo] Jena Univ Hosp, Dept Gynecol, Jena, Germany; [Eccles, Diana] Univ Southampton, Fac Med, Southampton Univ Hosp, Southampton SO9 5NH, Hants, England; [Edwards, Robert; Modugno, Francesmary] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Edwards, Robert] Magee Womens Res Inst, Womens Canc Program, Pittsburgh, PA USA; [Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, Erlangen, Germany; [Fasching, Peter A.; Konecny, Gottfried E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Garcia-Closas, Montserrat] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England; [Garcia-Closas, Montserrat] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London, England; [Gentry-Maharaj, Aleksandra; Menon, Usha] UCL, Elizabeth Garrett Anderson Inst Womens Hlth, Gynaecol Canc Res Ctr, London, England; [Giles, Graham] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Gore, Martin] Royal Marsden Hosp, Gynecol Oncol Unit, London SW3 6JJ, England; [Halle, Mari K.; Krakstad, Camilla; Salvesen, Helga B.; Wik, Elisabeth] Haukeland Hosp, Dept Gynecol & Obstet, N-5021 Bergen, Norway; [Halle, Mari K.; Krakstad, Camilla; Salvesen, Helga B.; Wik, Elisabeth] Univ Bergen, Dept Clin Med, Bergen, Norway; [Hillemanns, Peter] Hannover Med Sch, Clin Obstet, Hannover, Germany; [Hillemanns, Peter] Hannover Med Sch, Clin Gynaecol, Hannover, Germany; [Hoatlin, Maureen] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; [Hogdall, Estrid; Jensen, Allan; Kjaer, Susanne Kruger] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Hogdall, Estrid] Univ Copenhagen, Herlev Hosp, Dept Pathol, Mol Unit, Copenhagen, Denmark; [Hogdall, Claus K.; Kjaer, Susanne Kruger; Lundvall, Lene] Rigshosp, Dept Obstet & Gynecol, Juliane Marie Ctr, DK-2100 Copenhagen, Denmark; [Hosono, Satoyo; Matsuo, Keitaro; Tajima, Kazuo] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Kalli, Kimberly R.] Mayo Clin, Dept Med Oncol, Rochester, MN USA; [Karlan, Beth Y.] Cedars Sinai Med Ctr, Womens Canc Program, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Kelemen, Linda E.] Alberta Hlth Serv Canc Care, Dept Populat Hlth Res, Calgary, AB, Canada; [Kelemen, Linda E.] Univ Calgary, Dept Med Genet, Calgary, AB, Canada; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Lambrechts, Diether] Katholieke Univ Leuven, Vesalius Res Ctr, Louvain, Belgium; [Le, Nhu D.] BC Canc Agcy, Canc Control Res, Vancouver, BC, Canada; [Lim, Boon Kiong; Woo, Yin Ling] Univ Malaya, Med Ctr, Dept Obstet & Gynaecol, Kuala Lumpur, Malaysia; [Lissowska, Jolanta] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland; [Massuger, Leon F. A. G.; van Altena, Anne M.] Radboud Univ Nijmegen, Med Ctr, Dept Gynaecol, NL-6525 ED Nijmegen, Netherlands; [McGuire, Valerie; Sieh, Weiva; Whittemore, Alice S.] Stanford Univ, Sch Med, Dept Hlth Res & Policy Epidemiol, Stanford, CA 94305 USA; [McLaughlin, John R.] Univ Toronto, Fac Med, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [McLaughlin, John R.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Modugno, Francesmary] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Moysich, Kirsten B.; Odunsi, Kunle] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Nakanishi, Toru] Aichi Canc Ctr Cent Hosp, Dept Gynecol Oncol, Nagoya, Aichi, Japan; [Narod, Steven A.] Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada; [Ness, Roberta B.] Univ Texas Sch Publ Hlth, Houston, TX USA; [Noushmehr, Houtan; Shen, Hui] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Epigenome Ctr, Los Angeles, CA 90033 USA; [Olson, Sara; Orlow, Irene; Pike, Malcolm C.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Paul, James] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Pejovic, Tanja] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Pejovic, Tanja] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Poole, Elizabeth M.; Tworoger, Shelley S.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Risch, Harvey A.] Yale Univ, Dept Epidemiol & Publ Hlth, Sch Publ Hlth, New Haven, CT 06520 USA; [Risch, Harvey A.] Yale Univ, Sch Med, New Haven, CT USA; [Rossing, Mary Anne] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Rossing, Mary Anne] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Epidemiol, Seattle, WA 98104 USA; [Schwaab, Ira] Inst Human Genet & Anthropol, Wiesbaden, Germany; [Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Melbourne, Vic, Australia; [Spellman, Paul] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Teo, Soo-Hwang; Zulkifli, Famida] Canc Res Initiat Fdn, Sime Darby Med Ctr, Subang Jaya, Malaysia; [Teo, Soo-Hwang; Zulkifli, Famida] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia; [Timorek, Agnieszka] Warsaw Med Univ, Fac Med 2, Dept Obstet Gynecol & Oncol, Warsaw, Poland; [Timorek, Agnieszka] Brodnowski Hosp, Dept Obstet & Gynaecol, Warsaw, Poland; [Wang-Gohrke, Shan] Univ Ulm, Dept Obstet & Gynaecol, D-89069 Ulm, Germany; [Winterhoff, Boris] Mayo Clin, Dept Obstet & Gynaecol, Rochester, MN USA; [Hall, Per] Karolinska Istitutet, Dept Epidemiol & Biostat, Stockholm, Sweden; [Berchuck, Andrew] Duke Univ, Med Ctr, Dept Obstet & Gynaecol, Durham, NC USA; [Chenevix-Trench, Georgia] Queensland Inst Med Res, Canc Div, Herston, Qld 4006, Australia; [Iversen, Edwin] Duke Univ, Dept Stat, Durham, NC USA; [Schildkraut, Joellen M.] Duke Canc Inst, Canc Prevent Detect & Control Res Program, Durham, NC USA	University of Cambridge; University of Cambridge; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Southern California; Mayo Clinic; Duke University; Mayo Clinic; McGill University; McGill University; Mayo Clinic; Radboud University Nijmegen; University of California System; University of California Irvine; Cancer Council Victoria; University of Melbourne; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; University of Erlangen Nuremberg; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Hannover Medical School; CRUK Cambridge Institute; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); British Columbia Cancer Agency; Imperial College London; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Peter Maccallum Cancer Center; University of Melbourne; Cancer Research Center of Hawaii; University of Hawaii System; Helmholtz Association; German Cancer Research Center (DKFZ); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Southern California; University of New Mexico; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Pomeranian Medical University; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Dartmouth College; Kliniken Essen-Mitte; Friedrich Schiller University of Jena; University of Southampton; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; University of Erlangen Nuremberg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Shanghai Jiao Tong University; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; University College London; Monash University; Royal Marsden NHS Foundation Trust; University of Bergen; Haukeland University Hospital; University of Bergen; Hannover Medical School; Hannover Medical School; Oregon Health & Science University; Danish Cancer Society; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Aichi Cancer Center; Mayo Clinic; Cedars Sinai Medical Center; Alberta Health Services (AHS); University of Calgary; University of Calgary; Radboud University Nijmegen; KU Leuven; British Columbia Cancer Agency; Universiti Malaya; Maria Sklodowska-Curie National Research Institute of Oncology; Radboud University Nijmegen; Stanford University; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Roswell Park Cancer Institute; Aichi Cancer Center; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Southern California; Memorial Sloan Kettering Cancer Center; Beatson Oncology Centre; Oregon Health & Science University; Oregon Health & Science University; Harvard University; Brigham & Women's Hospital; Yale University; Yale University; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Vanderbilt University; Vanderbilt University; University of Melbourne; Oregon Health & Science University; Universiti Malaya; Medical University of Warsaw; Ulm University; Mayo Clinic; Karolinska Institutet; Duke University; QIMR Berghofer Medical Research Institute; Duke University; Duke University	Pharoah, PDP (corresponding author), Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England.	paul.pharoah@medschl.cam.ac.uk	Lambrechts, Diether/AAJ-3167-2020; Kiemeney, Lambertus A./D-3357-2009; Brooks-Wilson, Angela/E-9399-2012; Hein, Alexander/F-6999-2010; Carvalho, Renato/AAK-3890-2020; Verdrengh, Evelien/H-4571-2012; Pharoah, Paul/V-6658-2019; Baglietto, Laura/AAB-9051-2019; Rzepecka, Iwona K/AFO-1670-2022; Modugno, Francesmary/AIB-6722-2022; Van Den Berg, David J/G-8598-2017; jones, Rob j/N-9379-2017; Brinton, Louise A/G-7486-2015; Garcia-Closas, Montserrat/F-3871-2015; Aben, Katja KH/G-9686-2016; Jakubowska, Anna/O-8050-2014; Woo, Yin Ling/B-5198-2010; Menon, Usha/C-4716-2008; Teo, Soo-hwang/H-2353-2014; Dörk, Thilo/J-8620-2012; Fasching, Peter A/ABH-9912-2020; coetzee, Gerhard/AAT-6203-2020; Whittemore, Alice S/F-9925-2014; Ekici, Arif B/C-3971-2013; Woo, Yin Ling/GPX-0086-2022; Gronwald, Jacek/A-4576-2017; N, Houtan/C-9692-2013; Ramus, Susan/AAG-8352-2019; Wentzensen, Nicolas/AAG-8522-2019; salvesen, Helga B/C-1187-2017; Massuger, Leon F.A.G./H-8072-2014; campbell, Ian G/F-6006-2011; Bogdanova, Natalia V./Y-2205-2019; Shen, Hui/AAO-4387-2020; Matsuo, Keitaro/H-6758-2019; Eccles, Diana/K-6327-2019; Bowtell, David/H-1007-2016; Krakstad, Camilla/AAB-5138-2020; gao, yi/HCI-8298-2022; Chenevix-Trench, Georgia/AAV-2014-2020; Fridley, Brooke L/D-8315-2015; Severi, Gianluca/H-3774-2018; Coetzee, Gerhard/AAG-8439-2019; Halle, Mari K/AAT-4856-2020; Brenton, James D/B-3174-2008; Monteiro, Alvaro N. A./A-7566-2009; Severi, Gianluca/Q-1824-2019; Vierkant, Robert/AAP-4927-2020; Gao, Yu/HGE-1937-2022; Zheng, Wei/O-3351-2013; McLaughlin, John R/E-4577-2013; Narod, Steven A/AAA-6112-2022; Wik, E./AAA-9105-2020; Gao, Y./GWZ-3665-2022; zhang, weihua/GXV-1334-2022; Garcia-Closas, Montserrat/AAZ-6930-2021; Bandera, Elisa V/M-4169-2014; van Altena, Anne M/B-9824-2016; Lissowska, Jolanta/AAH-3252-2020	Lambrechts, Diether/0000-0002-3429-302X; Kiemeney, Lambertus A./0000-0002-2368-1326; Brooks-Wilson, Angela/0000-0003-1009-6408; Hein, Alexander/0000-0003-2601-3398; Pharoah, Paul/0000-0001-8494-732X; Van Den Berg, David J/0000-0002-5404-5218; Brinton, Louise A/0000-0003-3853-8562; Garcia-Closas, Montserrat/0000-0003-1033-2650; Aben, Katja KH/0000-0002-0214-2147; Jakubowska, Anna/0000-0002-5650-0501; Woo, Yin Ling/0000-0003-1742-1066; Menon, Usha/0000-0003-3708-1732; Dörk, Thilo/0000-0002-9458-0282; Fasching, Peter A/0000-0003-4885-8471; Ekici, Arif B/0000-0001-6099-7066; Woo, Yin Ling/0000-0003-1742-1066; Gronwald, Jacek/0000-0002-3643-2871; N, Houtan/0000-0003-4051-8114; Ramus, Susan/0000-0003-0005-7798; salvesen, Helga B/0000-0002-4438-8831; Matsuo, Keitaro/0000-0003-1761-6314; Eccles, Diana/0000-0002-9935-3169; Bowtell, David/0000-0001-9089-7525; Krakstad, Camilla/0000-0002-0174-8139; Chenevix-Trench, Georgia/0000-0002-1878-2587; Fridley, Brooke L/0000-0001-7739-7956; Severi, Gianluca/0000-0001-7157-419X; Brenton, James D/0000-0002-5738-6683; Monteiro, Alvaro N. A./0000-0002-8448-4801; Severi, Gianluca/0000-0001-7157-419X; Vierkant, Robert/0000-0001-6242-5221; Zheng, Wei/0000-0003-1226-070X; Garcia-Closas, Montserrat/0000-0003-1033-2650; Bandera, Elisa V/0000-0002-8789-2755; Lissowska, Jolanta/0000-0003-2695-5799; Jensen, Allan/0000-0001-8124-4880; Flanagan, James/0000-0003-4955-1383; Brown, Robert/0000-0001-7960-5755; Halle, Mari K/0000-0002-2660-8271; Pelttari, Liisa/0000-0001-8091-9751; Goodman, Marc/0000-0002-4839-3021; Southey, Melissa/0000-0002-6313-9005; Lawrenson, Kate/0000-0002-6469-2515; Coetzee, Gerhard/0000-0001-8820-8364; Dansonka-Mieszkowska, Agnieszka/0000-0002-2482-6523; Hogdall, Claus/0000-0002-5959-8874; Heitz, Florian/0000-0002-2412-0352; Rzepecka, Iwona Krystyna/0000-0001-7305-6687; Orlow, Irene/0000-0001-6234-6961; Giles, Graham/0000-0003-4946-9099; Hogdall, Estrid/0000-0003-4689-5658; Rudolph, Anja/0000-0001-7520-2035; Nevanlinna, Heli/0000-0002-0916-2976; Weber, Rachel/0000-0001-7119-7734; Lubinski, Jan/0000-0003-2931-3003; Kupryjanczyk, Jolanta/0000-0001-5820-0214; Paul, James/0000-0001-7367-5816; Campbell, Ian/0000-0002-7773-4155; Olson, Sara/0000-0003-0182-2754; Shen, Hui/0000-0001-9767-4084; Kjaer, Susanne/0000-0002-8347-1398; Tworoger, Shelley/0000-0002-6986-7046; Baglietto, Laura/0000-0002-8193-7529; Dennis, Joe/0000-0003-4591-1214	European Commission's Seventh Framework Programme [223175, HEALTH-F22009-223175]; Ovarian Cancer Research Fund; Genetic Associations and Mechanisms in Oncology (GAME-ON); National Cancer Institute Cancer Post-GWAS Initiative [U19-CA148112]; Wellcome Trust [076113]; NATIONAL CANCER INSTITUTE [R01CA083918, U19CA148112, ZIACP010126, P30CA072720, R01CA112523, R01CA122443, R37CA070867, P30CA016672, P30CA076292, P50CA136393, R01CA149429, R01CA087538, P30CA008748] Funding Source: NIH RePORTER; Cancer Research UK [11022, 16561, 15601, 10118, 15960, 13086] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; National Breast Cancer Foundation [IF-12-06] Funding Source: researchfish	European Commission's Seventh Framework Programme(European Commission); Ovarian Cancer Research Fund; Genetic Associations and Mechanisms in Oncology (GAME-ON); National Cancer Institute Cancer Post-GWAS Initiative; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); The Francis Crick Institute; National Breast Cancer Foundation	We thank all the individuals who took part in this study and all the researchers, clinicians and technical and administrative staff who made possible the many studies contributing to this work (a full list is provided in the Supplementary Note). The COGS project is funded through a European Commission's Seventh Framework Programme grant (agreement number 223175 - HEALTH-F22009-223175). The Ovarian Cancer Association Consortium is supported by a grant from the Ovarian Cancer Research Fund thanks to donations by the family and friends of Kathryn Sladek Smith (PPD/RPCI.07). The scientific development and funding for this project were supported in part by the Genetic Associations and Mechanisms in Oncology (GAME-ON) and a National Cancer Institute Cancer Post-GWAS Initiative (U19-CA148112). Details of the funding of individual investigators and studies are provided in the Supplementary Note. This study made use of data generated by the Wellcome Trust Case Control consortium; funding for the project was provided by the Wellcome Trust under award 076113. A full list of the investigators who contributed to the generation of the data is available from the website (see URLs). The results published here are based in part on data generated by The Cancer Genome Atlas Pilot Project established by the National Cancer Institute and National Human Genome Research Institute; information about The Cancer Genome Atlas (TCGA) and the investigators and institutions who constitute the TCGA research network can be found on the website (see URLs).	Antoniou Antonis C, 2006, Future Oncol, V2, P257, DOI 10.2217/14796694.2.2.257; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180; Caudell D, 2008, LEUKEMIA, V22, P678, DOI 10.1038/sj.leu.2405074; Coser VM, 2010, CANCER GENET CYTOGEN, V198, P151, DOI 10.1016/j.cancergencyto.2009.12.013; Elliott KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010858; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Hindorff L.A., 2013, CATALOGUE PUBLISHED; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Kato N, 2006, MODERN PATHOL, V19, P83, DOI 10.1038/modpathol.3800492; Kato N, 2009, HISTOL HISTOPATHOL, V24, P1479, DOI 10.14670/HH-24.1479; Kim MJ, 2011, CLIN PHARMACOL THER, V89, P571, DOI 10.1038/clpt.2010.353; Lawrenson K, 2010, NEOPLASIA, V12, P317, DOI 10.1593/neo.91948; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; McCullough J, 2008, P NATL ACAD SCI USA, V105, P7687, DOI 10.1073/pnas.0801567105; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Nikolova DN, 2009, MOL MED REP, V2, P365, DOI 10.3892/mmr_00000109; Ram R, 2010, J AM COLL CARDIOL, V56, P1503, DOI 10.1016/j.jacc.2010.06.031; Salzman J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001156; Shen H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2629; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Spurdle AB, 2011, NAT GENET, V43, P451, DOI 10.1038/ng.812; Stratton JF, 1998, BRIT J OBSTET GYNAEC, V105, P493, DOI 10.1111/j.1471-0528.1998.tb10148.x; Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Yu X, 2009, FEBS J, V276, P2201, DOI 10.1111/j.1742-4658.2009.06949.x	31	265	273	0	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2013	45	4					362	370		10.1038/ng.2564	http://dx.doi.org/10.1038/ng.2564			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115VS	23535730	Green Submitted, Green Accepted			2022-12-17	WOS:000316840600006
J	Mathieson, I; McVean, G				Mathieson, Iain; McVean, Gil			Differential confounding of rare and common variants in spatially structured populations	NATURE GENETICS			English	Article							GENOMIC CONTROL; GENETIC ASSOCIATION; HDL CHOLESTEROL; DISEASES; STRATIFICATION; SCALE; BIAS	Well-powered genome-wide association studies, now made possible through advances in technology and large-scale collaborative projects, promise to characterize the contribution of rare variants to complex traits and disease. However, while population structure is a known confounder of association studies, it remains unknown whether methods developed to control stratification are equally effective for rare variants. Here, we demonstrate that rare variants can show a stratification that is systematically different from, and typically stronger than, common variants, and this is not necessarily corrected by existing methods. We show that the same process leads to inflation for load-based tests and can obscure signals at truly associated variants. Furthermore, we show that populations can display spatial structure in rare variants, even when Wright's fixation index F-ST is low, but that allele frequency-dependent metrics of allele sharing can reveal localized stratification. These results underscore the importance of collecting and integrating spatial information in the genetic analysis of complex traits.	[Mathieson, Iain; McVean, Gil] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [McVean, Gil] Univ Oxford, Dept Stat, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Mathieson, I (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	mathii@well.ox.ac.uk		McVean, Gil/0000-0002-5012-4162	Wellcome Trust [089250/Z/09/Z, 086084/Z/08/Z, 090532/Z/09/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors thank M. Pirinen, C. Spencer, Z. Iqbal and C. Lindgren for discussion and M. Pirinen for providing software to fit the linear mixed models used in this analysis. This work was supported by grants from the Wellcome Trust (089250/Z/09/Z to I. M., 086084/Z/08/Z to G. M. and 090532/Z/09/Z to the Wellcome Trust Centre for Human Genetics).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; COPELAND KT, 1977, AM J EPIDEMIOL, V105, P488, DOI 10.1093/oxfordjournals.aje.a112408; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Mukhopadhyay I, 2010, GENET EPIDEMIOL, V34, P213, DOI 10.1002/gepi.20451; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Wang J, 2000, ARTERIOSCL THROM VAS, V20, P1983, DOI 10.1161/01.ATV.20.8.1983	28	265	266	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2012	44	3					243	U29		10.1038/ng.1074	http://dx.doi.org/10.1038/ng.1074			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22306651	Green Accepted			2022-12-17	WOS:000300843600005
J	Turnbull, C; Rapley, EA; Seal, S; Pernet, D; Renwick, A; Hughes, D; Ricketts, M; Linger, R; Nsengimana, J; Deloukas, P; Huddart, RA; Bishop, DT; Easton, DF; Stratton, MR; Rahman, N				Turnbull, Clare; Rapley, Elizabeth A.; Seal, Sheila; Pernet, David; Renwick, Anthony; Hughes, Deborah; Ricketts, Michelle; Linger, Rachel; Nsengimana, Jeremie; Deloukas, Panagiotis; Huddart, Robert A.; Bishop, D. Timothy; Easton, Douglas F.; Stratton, Michael R.; Rahman, Nazneen		UK Testicular Canc Collaboration	Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LUNG-CANCER; TELOMERE DYSFUNCTION; SUSCEPTIBILITY LOCI; SEX REVERSAL; 5P15.33; TUMORS; RISK; GENE; INSTABILITY	We conducted a genome-wide association study for testicular germ cell tumor, genotyping 298,782 SNPs in 979 affected individuals and 4,947 controls from the UK and replicating associations in a further 664 cases and 3,456 controls. We identified three new susceptibility loci, two of which include genes that are involved in telomere regulation. We identified two independent signals within the TERT-CLPTM1L locus on chromosome 5, which has previously been associated with multiple other cancers (rs4635969, OR = 1.54, P = 1.14 x 10(-23); rs2736100, OR = 1.33, P = 7.55 x 10(-15)). We also identified a locus on chromosome 12 (rs2900333, OR = 1.27, P = 6.16 x 10(-10)) that contains ATF7IP, a regulator of TERT expression. Finally, we identified a locus on chromosome 9 (rs755383, OR = 1.37, P = 1.12 x 10(-23)), containing the sex determination gene DMRT1, which has been linked to teratoma susceptibility in mice.	[Turnbull, Clare; Rapley, Elizabeth A.; Seal, Sheila; Pernet, David; Renwick, Anthony; Hughes, Deborah; Ricketts, Michelle; Linger, Rachel; Stratton, Michael R.; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Surrey, England; [Nsengimana, Jeremie; Bishop, D. Timothy] Leeds Inst Mol Med, Epidemiol & Biostat Sect, Leeds, W Yorkshire, England; [Deloukas, Panagiotis; Stratton, Michael R.] Wellcome Trust Sanger Inst, Hinxton, England; [Huddart, Robert A.] Inst Canc Res, Acad Radiotherapy Unit, Sutton, Surrey, England; [Easton, Douglas F.] Strangeways Res Lab, Genet Epidemiol Unit, Canc Res UK, Cambridge CB1 4RN, England	University of London; Institute of Cancer Research - UK; University of Leeds; Wellcome Trust Sanger Institute; University of London; Institute of Cancer Research - UK; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Turnbull, C (corresponding author), Inst Canc Res, Sect Canc Genet, Surrey, England.	clare.turnbull@icr.ac.uk	Deloukas, Panos/B-2922-2013; Turnbull, Clare/AAA-6596-2019; Nsengimana, Jeremie/AGK-5625-2022; Rahman, Nazneen/B-8890-2012; Nsengimana, Jeremie/AAP-3185-2020; Rahman, Nazneen/D-2802-2013	Deloukas, Panos/0000-0001-9251-070X; Turnbull, Clare/0000-0002-1734-5772; Bishop, Tim/0000-0002-8752-8785; huddart, robert/0000-0003-3604-1990; Rahman, Nazneen/0000-0003-4376-0440	National Health Service; Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02]; Institute of Cancer Research; Cancer Research UK; MRC [G0700491, G0000934] Funding Source: UKRI; Cancer Research UK [10589, 10118, 11022] Funding Source: researchfish; Medical Research Council [G0700491] Funding Source: researchfish	National Health Service; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Institute of Cancer Research; Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank subjects with TGCT and the clinicians involved in their care for participation in this study. We also thank D. Dudakia, J. Pugh, H. McDonald and J. Marke for recruitment of subjects and database entry for the TGCT collections. We acknowledge National Health Service funding to the National Institute for Health Research Biomedical Research Centre. We acknowledge use of DNA from the British 1958 Birth Cohort DNA collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. C.T. is a Medical Research Council Clinical Research Fellow. D.F.E. is a Principal Research Fellow of Cancer Research UK. The study was supported by the Institute of Cancer Research, Cancer Research UK and the Wellcome Trust.	Barbaro M, 2009, EUR J HUM GENET, V17, P1439, DOI 10.1038/ejhg.2009.70; Feldser DM, 2003, NAT REV CANCER, V3, P623, DOI 10.1038/nrc1142; FERLAY J, 2002, IARC CANCERBASE, V5; Fernandez-Garcia I, 2008, J THORAC ONCOL, V3, P1085, DOI 10.1097/JTO.0b013e3181886713; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; Hemminki K, 2004, BRIT J CANCER, V90, P1765, DOI 10.1038/sj.bjc.6601714; Horvath A, 2009, CANCER RES, V69, P5301, DOI 10.1158/0008-5472.CAN-09-0884; Horwich A, 2006, LANCET, V367, P754, DOI 10.1016/S0140-6736(06)68305-0; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Kang JU, 2008, CANCER GENET CYTOGEN, V182, P1, DOI 10.1016/j.cancergencyto.2007.12.004; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Liu LF, 2009, J BIOL CHEM, V284, P5165, DOI 10.1074/jbc.M807098200; Livadas S, 2003, CANCER GENET CYTOGEN, V143, P174, DOI 10.1016/S0165-4608(02)00849-X; Masters JRW, 2003, NAT REV CANCER, V3, P517, DOI 10.1038/nrc1120; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nathanson KL, 2005, AM J HUM GENET, V77, P1034, DOI 10.1086/498455; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Rashid HH, 2004, UROL ONCOL-SEMIN ORI, V22, P285, DOI 10.1016/S1078-1439(03)00177-7; Schrader M, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-32; Schrader M, 2002, ONCOL REP, V9, P1097; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Smith CA, 1999, NATURE, V402, P601, DOI 10.1038/45130; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; Zhang A, 2002, INT J CANCER, V101, P427, DOI 10.1002/ijc.10627	30	265	273	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2010	42	7					604	U178		10.1038/ng.607	http://dx.doi.org/10.1038/ng.607			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	616WO	20543847	Green Accepted			2022-12-17	WOS:000279242400013
J	Martinez-Estrada, OM; Lettice, LA; Essafi, A; Guadix, JA; Slight, J; Velecela, V; Hall, E; Reichmann, J; Devenney, PS; Hohenstein, P; Hosen, N; Hill, RE; Munoz-Chapuli, R; Hastie, ND				Martinez-Estrada, Ofelia M.; Lettice, Laura A.; Essafi, Abdelkader; Antonio Guadix, Juan; Slight, Joan; Velecela, Victor; Hall, Emma; Reichmann, Judith; Devenney, Paul S.; Hohenstein, Peter; Hosen, Naoki; Hill, Robert E.; Munoz-Chapuli, Ramon; Hastie, Nicholas D.			Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin	NATURE GENETICS			English	Article							WILMS-TUMOR GENE; STEM-CELLS; EXPRESSION; MOUSE; ACTIVATION; EPICARDIUM; RECEPTOR; BIOLOGY; PROTEIN; TOOL	The epicardial epithelial-mesenchymal transition (EMT) is hypothesized to generate cardiovascular progenitor cells that differentiate into various cell types, including coronary smooth muscle and endothelial cells, perivascular and cardiac interstitial fibroblasts and cardiomyocytes. Here we show that an epicardial-specific knockout of the gene encoding Wilms' tumor-1 (Wt1) leads to a reduction in mesenchymal progenitor cells and their derivatives. We show that Wt1 is essential for repression of the epithelial phenotype in epicardial cells and during embryonic stem cell differentiation through direct transcriptional regulation of the genes encoding Snail (Snai1) and E-cadherin (Cdh1), two of the major mediators of EMT. Some mesodermal lineages do not form in Wt1-null embryoid bodies, but this effect is rescued by the expression of Snai1, underscoring the importance of EMT in generating these differentiated cells. These new insights into the molecular mechanisms regulating cardiovascular progenitor cells and EMT will shed light on the pathogenesis of heart diseases and may help the development of cell-based therapies.	[Martinez-Estrada, Ofelia M.; Lettice, Laura A.; Essafi, Abdelkader; Slight, Joan; Velecela, Victor; Hall, Emma; Reichmann, Judith; Devenney, Paul S.; Hohenstein, Peter; Hill, Robert E.; Hastie, Nicholas D.] MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Martinez-Estrada, Ofelia M.; Lettice, Laura A.; Essafi, Abdelkader; Slight, Joan; Velecela, Victor; Hall, Emma; Reichmann, Judith; Devenney, Paul S.; Hohenstein, Peter; Hill, Robert E.; Hastie, Nicholas D.] Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Antonio Guadix, Juan; Munoz-Chapuli, Ramon] Univ Malaga, Dept Anim Biol, Fac Sci, E-29071 Malaga, Spain; [Hosen, Naoki] Osaka Univ, Grad Sch Med, Dept Canc Stem Cell Biol, Osaka, Japan	University of Edinburgh; Universidad de Malaga; Osaka University	Hastie, ND (corresponding author), MRC Human Genet Unit, Edinburgh, Midlothian, Scotland.	n.hastie@hgu.mrc.ac.uk	Martinez-Estrada, Ofelia M/V-4733-2017; Munoz-Chapuli, Ramon/K-7306-2014; Hohenstein, Peter/Y-2428-2018	Martinez-Estrada, Ofelia M/0000-0002-1814-1974; Munoz-Chapuli, Ramon/0000-0001-6392-6802; Reichmann, Judith/0000-0003-3288-2856; Hall, Emma/0000-0002-6944-6719; Hohenstein, Peter/0000-0001-8548-4734	MRC [MC_U127584494, MC_U127527180] Funding Source: UKRI; Medical Research Council [MC_U127584494, U.1275.03.013.00001.01, MC_U127527180] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Hohenstein P, 2006, HUM MOL GENET, V15, pR196, DOI 10.1093/hmg/ddl196; Hosen N, 2007, LEUKEMIA, V21, P1783, DOI 10.1038/sj.leu.2404752; Hosono S, 2000, J BIOL CHEM, V275, P10943, DOI 10.1074/jbc.275.15.10943; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Lettice LA, 1999, P NATL ACAD SCI USA, V96, P9695, DOI 10.1073/pnas.96.17.9695; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Mitiku N, 2007, DEV CELL, V13, P897, DOI 10.1016/j.devcel.2007.10.004; Miyoshi Y, 2002, CLIN CANCER RES, V8, P1167; Moore AW, 1999, DEVELOPMENT, V126, P1845; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Niksic M, 2004, HUM MOL GENET, V13, P463, DOI 10.1093/hmg/ddh040; Nishikawa SI, 2007, NAT REV MOL CELL BIO, V8, P502, DOI 10.1038/nrm2189; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Spencer HL, 2007, MOL BIOL CELL, V18, P2838, DOI 10.1091/mbc.E06-09-0875; Spraggon L, 2007, ONCOGENE, V26, P1484, DOI 10.1038/sj.onc.1209922; Wagner KD, 2002, FASEB J, V16, P1117, DOI 10.1096/fj.01-0986fje; Wagner N, 2005, GENE DEV, V19, P2631, DOI 10.1101/gad.346405; Wessels A, 2004, ANAT REC PART A, V276A, P43, DOI 10.1002/ar.a.10129	23	265	276	0	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					89	U112		10.1038/ng.494	http://dx.doi.org/10.1038/ng.494			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA	20023660	Bronze, Green Accepted			2022-12-17	WOS:000273055100022
J	Taft, RJ; Glazov, EA; Cloonan, N; Simons, C; Stephen, S; Faulkner, GJ; Lassmann, T; Forrest, ARR; Grimmond, SM; Schroder, K; Irvine, K; Arakawa, T; Nakamura, M; Kubosaki, A; Hayashida, K; Kawazu, C; Murata, M; Nishiyori, H; Fukuda, S; Kawai, J; Daub, CO; Hume, DA; Suzuki, H; Orlando, V; Carninci, P; Hayashizaki, Y; Mattick, JS				Taft, Ryan J.; Glazov, Evgeny A.; Cloonan, Nicole; Simons, Cas; Stephen, Stuart; Faulkner, Geoffrey J.; Lassmann, Timo; Forrest, Alistair R. R.; Grimmond, Sean M.; Schroder, Kate; Irvine, Katharine; Arakawa, Takahiro; Nakamura, Mari; Kubosaki, Atsutaka; Hayashida, Kengo; Kawazu, Chika; Murata, Mitsuyoshi; Nishiyori, Hiromi; Fukuda, Shiro; Kawai, Jun; Daub, Carsten O.; Hume, David A.; Suzuki, Harukazu; Orlando, Valerio; Carninci, Piero; Hayashizaki, Yoshihide; Mattick, John S.			Tiny RNAs associated with transcription start sites in animals	NATURE GENETICS			English	Article							ANALYSIS GENE-EXPRESSION; POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; DNA METHYLATION; FACTOR TFIIS; HUMAN-CELLS; GENOME; INITIATION; CLEAVAGE	It has been reported that relatively short RNAs of heterogeneous sizes are derived from sequences near the promoters of eukaryotic genes. In conjunction with the FANTOM4 project, we have identified tiny RNAs with a modal length of 18 nt that map within -60 to +120 nt of transcription start sites (TSSs) in human, chicken and Drosophila. These transcription initiation RNAs (tiRNAs) are derived from sequences on the same strand as the TSS and are preferentially associated with G+C-rich promoters. The 5' ends of tiRNAs show peak density 10-30 nt downstream of TSSs, indicating that they are processed. tiRNAs are generally, although not exclusively, associated with highly expressed transcripts and sites of RNA polymerase II binding. We suggest that tiRNAs may be a general feature of transcription in metazoa and possibly all eukaryotes.	[Lassmann, Timo; Forrest, Alistair R. R.; Arakawa, Takahiro; Nakamura, Mari; Kubosaki, Atsutaka; Hayashida, Kengo; Kawazu, Chika; Murata, Mitsuyoshi; Nishiyori, Hiromi; Fukuda, Shiro; Kawai, Jun; Daub, Carsten O.; Suzuki, Harukazu; Carninci, Piero; Hayashizaki, Yoshihide] RIKEN, Yokohama Inst, Omics Sci Ctr, Kanagawa, Japan; [Taft, Ryan J.; Cloonan, Nicole; Simons, Cas; Stephen, Stuart; Faulkner, Geoffrey J.; Grimmond, Sean M.; Schroder, Kate; Irvine, Katharine; Hume, David A.; Mattick, John S.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Glazov, Evgeny A.] Univ Queensland, Diamantina Inst Canc Immunol & Metab Med, Princess Alexandra Hosp, Woolloongabba, Qld, Australia; [Forrest, Alistair R. R.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [Hume, David A.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Orlando, Valerio] IRCCS Santa Lucia EBRI, Dulbecco Telethon Inst, Rome, Italy; [Orlando, Valerio] IGB CNR, Dulbecco Telethon Inst, Naples, Italy	RIKEN; University of Queensland; University of Queensland; Griffith University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Fondazione Telethon; Dulbecco Telethon Institute (DTI)	Hayashizaki, Y (corresponding author), RIKEN, Yokohama Inst, Omics Sci Ctr, Kanagawa, Japan.	yosihide@gsc.riken.jp; j.mattick@imb.uq.edu.au	Forrest, Alistair/A-6597-2008; Lassmann, Timo/A-8271-2008; Simons, Cas/A-7905-2011; Mattick, John S/I-7789-2012; Faulkner, Geoffrey J/M-3168-2014; Irvine, Katharine M/A-5559-2011; Kawai, Jun/A-6451-2016; Taft, Ryan/B-2945-2010; Hayashizaki, Yoshihide/N-6590-2015; Lassmann, Timo/HCH-4313-2022; Schroder, Kate/C-6132-2008; Grimmond, Sean M/J-5304-2016; Cloonan, Nicole/B-5272-2008; Glazov, Evgeny A/F-9951-2010; Hume, David A/C-7695-2013; Stuart, Stephen/I-3380-2012; Mattick, John/ABH-6130-2020; Daub, Carsten O/A-7436-2010; Suzuki, Harukazu/N-9553-2015; Carninci, Piero/K-1568-2014; Grimmond, Sean/K-3246-2019	Forrest, Alistair/0000-0003-4543-1675; Lassmann, Timo/0000-0002-0138-2691; Simons, Cas/0000-0003-3147-8042; Mattick, John S/0000-0002-7680-7527; Faulkner, Geoffrey J/0000-0001-5769-4494; Irvine, Katharine M/0000-0002-6716-1605; Lassmann, Timo/0000-0002-0138-2691; Schroder, Kate/0000-0001-9261-3805; Grimmond, Sean M/0000-0002-8102-7998; Cloonan, Nicole/0000-0001-7802-6647; Stuart, Stephen/0000-0001-5141-640X; Mattick, John/0000-0002-7680-7527; Daub, Carsten O/0000-0002-3295-8729; Suzuki, Harukazu/0000-0002-8087-0836; Carninci, Piero/0000-0001-7202-7243; Grimmond, Sean/0000-0002-8102-7998; Fukuda, Shiro/0000-0002-0065-662X; Hume, David/0000-0002-2615-1478	US National Science Foundation Graduate Research Fellowship; University of Queensland Postdoctoral Research Fellowship; Australian National Health and Medical Research Council [ID 428261]; Australian NHMRC Fellowship [455857]; Telethon [TCP00094]; Associazione Italiana Riecrca sul Cancro (AIRC); Compagnia San Paolo; Australian Research Council Federation Fellowship [ID FF0561986]; University of Queensland and the Queensland State Government; Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government; RIKEN Frontier Research System, Functional RNA Research Program; Medical Research Council [G9900991B] Funding Source: researchfish	US National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); University of Queensland Postdoctoral Research Fellowship(University of Queensland); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian NHMRC Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Telethon(Fondazione Telethon); Associazione Italiana Riecrca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Compagnia San Paolo(Compagnia di San Paolo); Australian Research Council Federation Fellowship(Australian Research Council); University of Queensland and the Queensland State Government; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN Frontier Research System, Functional RNA Research Program; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Hasegawa, F. Hori, H. Sano for technical assistance. R. J. T. is supported by a US National Science Foundation Graduate Research Fellowship. N. C. is supported by a University of Queensland Postdoctoral Research Fellowship. A. R. R. F. is supported by a CJ Martin Fellowship from the Australian National Health and Medical Research Council (ID 428261). S. M. G. is supported by Australian NH&MRC Fellowship grant no. 455857. V.O. is supported by Telethon TCP00094, Associazione Italiana Riecrca sul Cancro (AIRC), Compagnia San Paolo. J. S. M. is supported by an Australian Research Council Federation Fellowship (ID FF0561986), the University of Queensland and the Queensland State Government. This work was also supported by grants for the Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Y.H.), and Research Grant for the RIKEN Genome Exploration Research Project from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government, the RIKEN Frontier Research System, Functional RNA Research Program (Y.H.). We thank the reviewers for their insights and suggestions.	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Carninci P, 1996, GENOMICS, V37, P327, DOI 10.1006/geno.1996.0567; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Chekanova JA, 2007, CELL, V131, P1340, DOI 10.1016/j.cell.2007.10.056; Chu CY, 2007, J CELL PHYSIOL, V213, P412, DOI 10.1002/jcp.21230; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; de Hoon M, 2008, BIOTECHNIQUES, V44, P627, DOI 10.2144/000112802; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Faulkner GJ, 2008, GENOMICS, V91, P281, DOI 10.1016/j.ygeno.2007.11.003; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; FROMONTRACINE M, 1993, NUCLEIC ACIDS RES, V21, P1683, DOI 10.1093/nar/21.7.1683; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Janowski BA, 2005, NAT CHEM BIOL, V1, P216, DOI 10.1038/nchembio725; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kadonaga JT, 2002, EXP MOL MED, V34, P259, DOI 10.1038/emm.2002.36; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Lagonigro MS, 2004, PIGM CELL RES, V17, P312; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mellor J, 2008, CURR OPIN GENET DEV, V18, P116, DOI 10.1016/j.gde.2007.12.005; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Pal M, 2001, MOL CELL BIOL, V21, P5815, DOI 10.1128/MCB.21.17.5815-5825.2001; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Prather DA, 2005, MOL CELL BIOL, V25, P2650, DOI 10.1128/MCB.25.7.2650-2659.2005; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Schwartz JC, 2008, NAT STRUCT MOL BIOL, V15, P842, DOI 10.1038/nsmb.1444; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tews B, 2007, ONCOGENE, V26, P5010, DOI 10.1038/sj.onc.1210297; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Weilbaecher RG, 2003, J BIOL CHEM, V278, P24189, DOI 10.1074/jbc.M211197200; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang CF, 2003, J BIOL CHEM, V278, P50101, DOI 10.1074/jbc.M307590200	47	265	294	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					572	578		10.1038/ng.312	http://dx.doi.org/10.1038/ng.312			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19377478				2022-12-17	WOS:000265575600018
J	Lee, C; Iafrate, AJ; Brothman, AR				Lee, Charles; Iafrate, A. John; Brothman, Arthur R.			Copy number variations and clinical cytogenetic diagnosis of constitutional disorders	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; SEGMENTAL ANEUPLOIDY; WHOLE-GENOME; REARRANGEMENTS; GENE; MICROARRAY; DELETION; POLYMORPHISM; RETARDATION; IMBALANCE	The recent appreciation of widespread copy number variation in the genomes of healthy human beings has presented a significant challenge to clinical cytogeneticists who wish to use genome-wide array comparative genomic hybridization (CGH) assays for clinical diagnostic purposes. Clinical cytogeneticists need to differentiate between copy number variants (CNVs) that are likely to be pathogenic and CNVs that are less likely to contribute to an affected individual's clinical presentation. Unfortunately, our knowledge of the phenotypic effects of most CNVs is minimal, leading to the classification of many CNVs as genomic imbalances of unknown clinical significance. This has caused many laboratories to resist the use of higher-resolution genome-wide array CGH assays for clinical purposes. Ironically, the accumulation and annotation of such array CGH data can lead to the rapid identification of pathogenic CNVs and the definition of new genomic syndromes that, in turn, are useful for accurate clinical genetic diagnoses.	[Lee, Charles; Iafrate, A. John] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lee, Charles; Iafrate, A. John] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Brothman, Arthur R.] Univ Utah, Dept Pediat, Salt Lake City, UT 84132 USA; [Brothman, Arthur R.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84132 USA; [Brothman, Arthur R.] Univ Utah, Dept Pathol, Salt Lake City, UT 84132 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Lee, C (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	clee@rics.bwh.harvard.edu						Bejjani BA, 2006, J MOL DIAGN, V8, P528, DOI 10.2353/jmoldx.2006.060029; Brewer C, 1999, AM J HUM GENET, V64, P1702, DOI 10.1086/302410; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; DELACHAPELLE A, 1974, AM J HUM GENET, V26, P746; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Flint J, 2003, CURR OPIN GENET DEV, V13, P310, DOI 10.1016/S0959-437X(03)00049-2; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Friedman JM, 2006, AM J HUM GENET, V79, P500, DOI 10.1086/507471; Hansson K, 2007, AM J MED GENET A, V143A, P1354, DOI 10.1002/ajmg.a.31783; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Knight SJL, 2000, AM J HUM GENET, V67, P320, DOI 10.1086/302998; Knight SJL, 1999, LANCET, V354, P1676, DOI 10.1016/S0140-6736(99)03070-6; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; LINDSLEY DL, 1972, GENETICS, V71, P157; Martin CL, 2002, J MED GENET, V39, P734, DOI 10.1136/jmg.39.10.734; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Menten B, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039453; Ning Y, 1996, NAT GENET, V14, P86, DOI 10.1038/ng0996-86; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Ravnan JB, 2006, J MED GENET, V43, P478, DOI 10.1136/jmg.2005.036350; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Saunier S, 1997, HUM MOL GENET, V6, P2317, DOI 10.1093/hmg/6.13.2317; SCHAFFER LG, 2005, ISCN 2005 INT SYSTEM, pCH7; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Veltman JA, 2006, J MOL DIAGN, V8, P534, DOI 10.2353/jmoldx.2006.060131; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; WANG Y, 2005, NUCLEIC ACIDS RES, V38, P183, DOI DOI 10.1039/NAR/GNI177	37	265	292	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39			7			S48	S54		10.1038/ng2092	http://dx.doi.org/10.1038/ng2092			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	274AO	17597782				2022-12-17	WOS:000253974400009
J	Scherer, SW; Lee, C; Birney, E; Altshuler, DM; Eichler, EE; Carter, NP; Hurles, ME; Feuk, L				Scherer, Stephen W.; Lee, Charles; Birney, Ewan; Altshuler, David M.; Eichler, Evan E.; Carter, Nigel P.; Hurles, Matthew E.; Feuk, Lars			Challenges and standards in integrating surveys of structural variation	NATURE GENETICS			English	Article							COPY-NUMBER VARIATION; COMPARATIVE GENOMIC HYBRIDIZATION; HUMAN GENETIC-VARIATION; SEGMENTAL DUPLICATIONS; HOMOLOGOUS RECOMBINATION; OLIGONUCLEOTIDE ARRAYS; LINKAGE DISEQUILIBRIUM; EXPRESSION PROFILES; NORMAL INDIVIDUALS; WIDE DETECTION	There has been an explosion of data describing newly recognized structural variants in the human genome. In the flurry of reporting, there has been no standard approach to collecting the data, assessing its quality or describing identified features. This risks becoming a rampant problem, in particular with respect to surveys of copy number variation and their application to disease studies. Here, we consider the challenges in characterizing and documenting genomic structural variants. From this, we derive recommendations for standards to be adopted, with the aim of ensuring the accurate presentation of this form of genetic variation to facilitate ongoing research.	[Scherer, Stephen W.; Feuk, Lars] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada; [Scherer, Stephen W.; Feuk, Lars] Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1L7, Canada; [Scherer, Stephen W.] Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1L7, Canada; [Lee, Charles] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lee, Charles] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Birney, Ewan] European Bioinformat Inst, Cambridge CB10 1SA, England; [Carter, Nigel P.; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Altshuler, David M.] Harvard Univ, Board Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Altshuler, David M.] Harvard Univ, MIT, Cambridge, MA 02142 USA; [Eichler, Evan E.] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Scherer, SW (corresponding author), Hosp Sick Children, Ctr Appl Genom, 14th Floor,Toronoto Med Discovery Tower,MaRS Disc, Toronto, ON M5G 1L7, Canada.	steve@genet.sickkids.on.ca	Altshuler, David M/A-4476-2009; Scherer, Stephen W./B-3785-2013	Altshuler, David M/0000-0002-7250-4107; Scherer, Stephen W./0000-0002-8326-1999; Birney, Ewan/0000-0001-8314-8497	Wellcome Trust [077014, 077008] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett ST, 2005, PHARMACOGENOMICS, V6, P373, DOI 10.1517/14622416.6.4.373; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Budarf ML, 1997, HUM MOL GENET, V6, P1657, DOI 10.1093/hmg/6.10.1657; Burgoon LD, 2006, NAT BIOTECHNOL, V24, P1369, DOI 10.1038/nbt1106-1369; Carson Andrew R., 2006, Human Genomics, V2, P403; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2007, NAT GENET, V39, pS30, DOI 10.1038/ng2042; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Eichler EE, 2006, NAT GENET, V38, P9, DOI 10.1038/ng0106-9; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Heim S, 1996, PEDIATR HEMAT ONCOL, V13, pR3, DOI 10.3109/08880019609030800; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ikeo K, 2003, CR BIOL, V326, P1079, DOI 10.1016/j.crvi.2003.09.034; *ISCN, 1985, BIRTH DEFECTS ORIG A, V21, P1; Istrail S, 2004, P NATL ACAD SCI USA, V101, P1916, DOI 10.1073/pnas.0307971100; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lee C, 2007, NAT GENET, V39, pS48, DOI 10.1038/ng2092; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Locke DP, 2004, J MED GENET, V41, P175, DOI 10.1136/jmg.2003.013813; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Mullikin JC, 2000, NATURE, V407, P516, DOI 10.1038/35035089; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; RISIN S, 1992, CANCER GENET CYTOGEN, V60, P164, DOI 10.1016/0165-4608(92)90010-6; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Small K, 1997, NAT GENET, V16, P96, DOI 10.1038/ng0597-96; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Urban AE, 2006, P NATL ACAD SCI USA, V103, P4534, DOI 10.1073/pnas.0511340103; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	73	265	279	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39			7			S7	S15		10.1038/ng2093	http://dx.doi.org/10.1038/ng2093			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	274AO	17597783	Green Accepted			2022-12-17	WOS:000253974400003
J	Segal, E; Friedman, N; Kaminski, N; Regev, A; Koller, D				Segal, E; Friedman, N; Kaminski, N; Regev, A; Koller, D			From signatures to models: understanding cancer using microarrays	NATURE GENETICS			English	Article							HUMAN BREAST-CANCER; GENE-EXPRESSION; CELL-CYCLE; REGULATORY NETWORKS; TRANSCRIPTION FACTORS; LUNG ADENOCARCINOMA; BINDING-SITES; C-MYC; GENOME; PATTERNS	Genomics has the potential to revolutionize the diagnosis and management of cancer by offering an unprecedented comprehensive view of the molecular underpinnings of pathology. Computational analysis is essential to transform the masses of generated data into a mechanistic understanding of disease. Here we review current research aimed at uncovering the modular organization and function of transcriptional networks and responses in cancer. We first describe how methods that analyze biological processes in terms of higher-level modules can identify robust signatures of disease mechanisms. We then discuss methods that aim to identify the regulatory mechanisms underlying these modules and processes. Finally, we show how comparative analysis, combining human data with model organisms, can lead to more robust findings. We conclude by discussing the challenges of generalizing these methods from cells to tissues and the opportunities they offer to improve cancer diagnosis and management.	Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA; Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA; Univ Pittsburgh, Pittsburgh, PA 15260 USA; Hebrew Univ Jerusalem, Sch Engn & Comp Sci, Jerusalem, Israel	Rockefeller University; Stanford University; Harvard University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Hebrew University of Jerusalem	Segal, E (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10021 USA.	koller@cs.stanford.edu	Friedman, Nir/H-9692-2012; Segal, Eran/AAF-4855-2019	Friedman, Nir/0000-0002-9678-3550; Segal, Eran/0000-0002-6859-1164; Kaminski, Naftali/0000-0001-5917-4601				Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Behrens J, 2004, INT J DEV BIOL, V48, P477, DOI 10.1387/ijdb.041815jb; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Caetano MS, 2002, FASEB J, V16, P1940, DOI 10.1096/fj.02-0282fje; Chang CF, 2004, NUCLEIC ACIDS RES, V32, P1798, DOI 10.1093/nar/gkh507; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Desai KV, 2002, P NATL ACAD SCI USA, V99, P6967, DOI 10.1073/pnas.102172399; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Fuller AP, 2003, J MAMMARY GLAND BIOL, V8, P335, DOI 10.1023/B:JOMG.0000010033.49464.0c; Garber K, 2004, SCIENCE, V303, P1754, DOI 10.1126/science.303.5665.1754; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hartemink Alexander J, 2002, Pac Symp Biocomput, P437; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; Hulboy DL, 2001, MOL CELL BIOL, V21, P5478, DOI 10.1128/MCB.21.16.5478-5487.2001; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Kalir S, 2004, CELL, V117, P713, DOI 10.1016/j.cell.2004.05.010; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Khan J, 1999, ELECTROPHORESIS, V20, P223, DOI 10.1002/(SICI)1522-2683(19990201)20:2<223::AID-ELPS223>3.0.CO;2-A; Kobayashi K, 2004, ONCOGENE, V23, P3089, DOI 10.1038/sj.onc.1207433; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lander ES, 1999, NAT GENET, V21, P3, DOI 10.1038/4427; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lossos IS, 2002, P NATL ACAD SCI USA, V99, P8886, DOI 10.1073/pnas.132253599; Lu P, 2003, P NATL ACAD SCI USA, V100, P10370, DOI 10.1073/pnas.1832361100; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; Mecham BH, 2004, PHYSIOL GENOMICS, V18, P308, DOI 10.1152/physiolgenomics.00066.2004; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nachman I, 2004, BIOINFORMATICS, V20, P248, DOI 10.1093/bioinformatics/bth941; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pe'er Dana, 2002, Bioinformatics, V18 Suppl 1, pS258; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Pritsker M, 2004, GENOME RES, V14, P99; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; Rostomily RC, 1997, CANCER RES, V57, P3526; Schroeder MD, 2004, PLOS BIOL, V2, P1396, DOI 10.1371/journal.pbio.0020271; Segal E, 2003, BIOINFORMATICS, V19, pi273, DOI 10.1093/bioinformatics/btg1038; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; SEGAL E, 2004, RECOMB 2004 P 8 ANN, P141; SEGAL E, 2002, P 6 INT C RES COMP M, P263; SEGAL E, 2004, THESIS STANFORD U; Sharan R, 2004, NUCLEIC ACIDS RES, V32, pW253, DOI 10.1093/nar/gkh385; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sinha S, 2003, BIOINFORMATICS, V19, pi292, DOI 10.1093/bioinformatics/btg1040; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Stuart RO, 2004, P NATL ACAD SCI USA, V101, P615, DOI 10.1073/pnas.2536479100; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431	69	265	289	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37			S			S38	S45		10.1038/ng1561	http://dx.doi.org/10.1038/ng1561			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	932YF	15920529	Bronze			2022-12-17	WOS:000229590000008
J	McKay, JD; Hung, RJ; Han, Y; Zong, XC; Carreras-Torres, R; Christiani, DC; Caporaso, NE; Johansson, M; Xiao, XJ; Li, YF; Byun, J; Dunning, A; Pooley, KA; Qian, DC; Ji, XM; Liu, G; Timofeeva, MN; Bojesen, SE; Wu, XF; Le Marchand, L; Albanes, D; Bickeboller, H; Aldrich, MC; Bush, WS; Tardon, A; Rennert, G; Teare, MD; Field, JK; Kiemeney, LA; Lazarus, P; Haugen, A; Lam, S; Schabath, MB; Andrew, AS; Shen, HB; Hong, YC; Yuan, JM; Bertazzi, PA; Pesatori, AC; Ye, YQ; Diao, N; Su, L; Zhang, RY; Brhane, Y; Leighl, N; Johansen, JS; Mellemgaard, A; Saliba, W; Haiman, CA; Wilkens, LR; Fernandez-Somoano, A; Fernandez-Tardon, G; van der Heijden, HFM; Kim, JH; Dai, JC; Hu, ZB; Davies, MPA; Marcus, MW; Brunnstrom, H; Manjer, J; Melander, O; Muller, DC; Overvad, K; Trichopoulou, A; Tumino, R; Doherty, JA; Barnett, MP; Chen, C; Goodman, GE; Cox, A; Taylor, F; Woll, P; Bruske, I; Wichmann, HE; Manz, J; Muley, TR; Risch, A; Rosenberger, A; Grankvist, K; Johansson, M; Shepherd, FA; Tsao, MS; Arnold, SM; Haura, EB; Bolca, C; Holcatova, I; Janout, V; Kontic, M; Lissowska, J; Mukeria, A; Ognjanovic, S; Orlowski, TM; Scelo, G; Swiatkowska, B; Zaridze, D; Bakke, P; Skaug, V; Zienolddiny, S; Duell, EJ; Butler, LM; Koh, WP; Gao, YT; Houlston, RS; McLaughlin, J; Stevens, VL; Joubert, P; Lamontagne, M; Nickle, DC; Obeidat, M; Timens, W; Zhu, B; Song, L; Kachuri, L; Artigas, MS; Tobin, MD; Wain, LV; Rafnar, T; Thorgeirsson, TE; Reginsson, GW; Stefansson, K; Hancock, DB; Bierut, LJ; Spitz, MR; Gaddis, NC; Lutz, SM; Gu, FY; Johnson, EO; Kamal, A; Pikielny, C; Zhu, DK; Lindstroem, S; Jiang, X; Tyndale, RF; Chenevix-Trench, G; Beesley, J; Bosse, Y; Chanock, S; Brennan, P; Landi, MT; Amos, CI				McKay, James D.; Hung, Rayjean J.; Han, Younghun; Zong, Xuchen; Carreras-Torres, Robert; Christiani, David C.; Caporaso, Neil E.; Johansson, Mattias; Xiao, Xiangjun; Li, Yafang; Byun, Jinyoung; Dunning, Alison; Pooley, Karen A.; Qian, David C.; Ji, Xuemei; Liu, Geoffrey; Timofeeva, Maria N.; Bojesen, Stig E.; Wu, Xifeng; Le Marchand, Loic; Albanes, Demetrios; Bickeboeller, Heike; Aldrich, Melinda C.; Bush, William S.; Tardon, Adonina; Rennert, Gad; Teare, M. Dawn; Field, John K.; Kiemeney, Lambertus A.; Lazarus, Philip; Haugen, Aage; Lam, Stephen; Schabath, Matthew B.; Andrew, Angeline S.; Shen, Hongbing; Hong, Yun-Chul; Yuan, Jian-Min; Bertazzi, Pier Alberto; Pesatori, Angela C.; Ye, Yuanqing; Diao, Nancy; Su, Li; Zhang, Ruyang; Brhane, Yonathan; Leighl, Natasha; Johansen, Jakob S.; Mellemgaard, Anders; Saliba, Walid; Haiman, Christopher A.; Wilkens, Lynne R.; Fernandez-Somoano, Ana; Fernandez-Tardon, Guillermo; van der Heijden, Henricus F. M.; Kim, Jin Hee; Dai, Juncheng; Hu, Zhibin; Davies, Michael P. A.; Marcus, Michael W.; Brunnstrom, Hans; Manjer, Jonas; Melander, Olle; Muller, David C.; Overvad, Kim; Trichopoulou, Antonia; Tumino, Rosario; Doherty, Jennifer A.; Barnett, Matt P.; Chen, Chu; Goodman, Gary E.; Cox, Angela; Taylor, Fiona; Woll, Penella; Brueske, Irene; Wichmann, H-Erich; Manz, Judith; Muley, Thomas R.; Risch, Angela; Rosenberger, Albert; Grankvist, Kjell; Johansson, Mikael; Shepherd, Frances A.; Tsao, Ming-Sound; Arnold, Susanne M.; Haura, Eric B.; Bolca, Ciprian; Holcatova, Ivana; Janout, Vladimir; Kontic, Milica; Lissowska, Jolanta; Mukeria, Anush; Ognjanovic, Simona; Orlowski, Tadeusz M.; Scelo, Ghislaine; Swiatkowska, Beata; Zaridze, David; Bakke, Per; Skaug, Vidar; Zienolddiny, Shanbeh; Duell, Eric J.; Butler, Lesley M.; Koh, Woon-Puay; Gao, Yu-Tang; Houlston, Richard S.; McLaughlin, John; Stevens, Victoria L.; Joubert, Philippe; Lamontagne, Maxime; Nickle, David C.; Obeidat, Ma'en; Timens, Wim; Zhu, Bin; Song, Lei; Kachuri, Linda; Artigas, Maria Soler; Tobin, Martin D.; Wain, Louise V.; Rafnar, Thorunn; Thorgeirsson, Thorgeir E.; Reginsson, Gunnar W.; Stefansson, Kari; Hancock, Dana B.; Bierut, Laura J.; Spitz, Margaret R.; Gaddis, Nathan C.; Lutz, Sharon M.; Gu, Fangyi; Johnson, Eric O.; Kamal, Ahsan; Pikielny, Claudio; Zhu, Dakai; Lindstroem, Sara; Jiang, Xia; Tyndale, Rachel F.; Chenevix-Trench, Georgia; Beesley, Jonathan; Bosse, Yohan; Chanock, Stephen; Brennan, Paul; Landi, Maria Teresa; Amos, Christopher I.		SpiroMeta Consortium	Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TELOMERE LENGTH; CROHNS-DISEASE; RISK; VARIANTS; ARCHITECTURE; METAANALYSIS; IMPUTATION; COMPONENT	Although several lung cancer susceptibility loci have been identified, much of the heritability for lung cancer remains unexplained. Here 14,803 cases and 12,262 controls of European descent were genotyped on the OncoArray and combined with existing data for an aggregated genomewide association study (GWAS) analysis of lung cancer in 29,266 cases and 56,450 controls. We identified 18 susceptibility loci achieving genome-wide significance, including 10 new loci. The new loci highlight the striking heterogeneity in genetic susceptibility across the histological subtypes of lung cancer, with four loci associated with lung cancer overall and six loci associated with lung adenocarcinoma. Gene expression quantitative trait locus (eQTL) analysis in 1,425 normal lung tissue samples highlights RNASET2, SECISBP2L and NRG1 as candidate genes. Other loci include genes such as a cholinergic nicotinic receptor, CHRNA2, and the telomere-related genes OFBC1 and RTEL1. Further exploration of the target genes will continue to provide new insights into the etiology of lung cancer.	[McKay, James D.; Carreras-Torres, Robert; Johansson, Mattias; Timofeeva, Maria N.; Scelo, Ghislaine; Brennan, Paul] WHO, Int Agcy Res Canc, Lyon, France; [Hung, Rayjean J.; Zong, Xuchen; Liu, Geoffrey; Brhane, Yonathan; Kachuri, Linda] Univ Toronto, Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Han, Younghun; Xiao, Xiangjun; Li, Yafang; Byun, Jinyoung; Qian, David C.; Ji, Xuemei; Kamal, Ahsan; Pikielny, Claudio; Zhu, Dakai; Amos, Christopher I.] Geisel Sch Med Dartmouth, Biomed Data Sci, Hanover, NH USA; [Christiani, David C.; Haugen, Aage; Diao, Nancy; Su, Li; Zhang, Ruyang] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Christiani, David C.; Diao, Nancy; Su, Li; Zhang, Ruyang] Harvard Med Sch, Massachusetts Gen Hospital, Boston, MA USA; [Caporaso, Neil E.; Albanes, Demetrios; Zhu, Bin; Song, Lei; Gu, Fangyi; Chanock, Stephen; Landi, Maria Teresa] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Dunning, Alison; Pooley, Karen A.] Univ Cambridge, Ctr Canc Genet Epidemiol, Cambridge, England; [Bojesen, Stig E.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Bojesen, Stig E.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Bojesen, Stig E.] Herlev & Gentofte Hosp, Copenhagen Gen Populat Study, Copenhagen, Denmark; [Wu, Xifeng; Ye, Yuanqing] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Le Marchand, Loic; Wilkens, Lynne R.] Univ Hawaii, Canc Ctr, Epidemiol Program, Honolulu, HI 96822 USA; [Bickeboeller, Heike; Rosenberger, Albert] Georg August Univ Gottingen, Univ Med Ctr, Dept Genet Epidemiol, Gottingen, Germany; [Aldrich, Melinda C.] Vanderbilt Univ, Med Ctr, Div Epidemiol, Dept Thorac Surg, Nashville, TN USA; [Bush, William S.] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Tardon, Adonina; Fernandez-Somoano, Ana; Fernandez-Tardon, Guillermo] Univ Oviedo, Oviedo, Spain; [Tardon, Adonina; Fernandez-Somoano, Ana; Fernandez-Tardon, Guillermo] CIBERESP, Fac Med, Oviedo, Spain; [Rennert, Gad; Saliba, Walid] Clalit Natl Canc Control Ctr, Carmel Med Ctr, Haifa, Israel; [Rennert, Gad; Saliba, Walid] Techn Fac Med, Haifa, Israel; [Teare, M. Dawn] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Field, John K.; Davies, Michael P. A.; Marcus, Michael W.] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England; [Kiemeney, Lambertus A.; van der Heijden, Henricus F. M.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands; [Kiemeney, Lambertus A.; van der Heijden, Henricus F. M.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, Nijmegen, Netherlands; [Lazarus, Philip] Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, Spokane, WA USA; [Haugen, Aage; Skaug, Vidar; Zienolddiny, Shanbeh] Nat Inst Occupat Hlth, Oslo, Norway; [Lam, Stephen] British Columbia Canc Agcy, Vancouver, BC, Canada; [Schabath, Matthew B.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA; [Andrew, Angeline S.; Doherty, Jennifer A.] Geisel Sch Med, Dept Epidemiol, Hanover, NH USA; [Shen, Hongbing; Dai, Juncheng; Hu, Zhibin] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat,Collaborat Innovat Ctr C, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China; [Hong, Yun-Chul] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Yuan, Jian-Min; Butler, Lesley M.] Univ Pittsburgh, Canc Inst, Pittsburgh, PA USA; [Bertazzi, Pier Alberto] IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dept Prevent Med, Milan, Italy; [Bertazzi, Pier Alberto; Pesatori, Angela C.] Univ Milan, Dept Clin Sci & Community Health DISCCO, Milan, Italy; [Leighl, Natasha; Shepherd, Frances A.; Tsao, Ming-Sound] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Johansen, Jakob S.; Mellemgaard, Anders] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Oncol, Copenhagen, Denmark; [Haiman, Christopher A.] Univ Southern Calif, Norris Comprehens Canc Ctr, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA; [Kim, Jin Hee] Sejong Univ, Dep Integrat Biosci & Biotechnol, Seoul, South Korea; [Brunnstrom, Hans] Lund Univ, Dept Pathol, Lund, Sweden; [Manjer, Jonas; Melander, Olle] Lund Univ, Fac Med, Lund, Sweden; [Muller, David C.] Imperial Coll London, Sch Publ Hlth, St Marys Campus, London, England; [Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Sect Epidemiol, Aarhus, Denmark; [Trichopoulou, Antonia] Hellen Hlth Fdn, Athens, Greece; [Tumino, Rosario] Sci Inst Tuscany, CSPO Canc Res & Prevent Ctr, Mol & Nutr Epidemiol Unit, Florence, Italy; [Doherty, Jennifer A.; Barnett, Matt P.; Chen, Chu] Fred Hutchinson Canc Res Ctr, Program Epidemiol, Seattle, WA 98104 USA; [Doherty, Jennifer A.] Huntsman Canc Inst, Salt Lake City, UT USA; [Doherty, Jennifer A.] Univ Utah, Huntsman Canc Inst, Dept Populat Hlth Sci, Salt Lake City, UT USA; [Goodman, Gary E.] Swedish Med Grp, Seattle, WA USA; [Cox, Angela; Taylor, Fiona; Woll, Penella] Univ Sheffield, Dept Oncol, Sheffield, S Yorkshire, England; [Brueske, Irene; Wichmann, H-Erich] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Epidemiol 2, Neuherberg, Germany; [Wichmann, H-Erich] Ludwig Maximilians Univ Munchen, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H-Erich] Tech Univ Munich, Inst Med Stat & Epidemiol, Munich, Germany; [Manz, Judith; Risch, Angela] Helmholtz Zentrum Munchen German Res Ctr Environm, Res Unit Mol Epidemiol, Neuherberg, Germany; [Muley, Thomas R.; Risch, Angela] Univ Hosp Heidelberg, Thoraxklin, Heidelberg, Germany; [Muley, Thomas R.; Risch, Angela] TLRC H, Heidelberg, Germany; [Risch, Angela] German Ctr Lung Res DZL, Heidelberg, Germany; [Risch, Angela] Univ Salzburg, Salzburg, Austria; [Risch, Angela] Canc Cluster Salzburg, Salzburg, Austria; [Grankvist, Kjell] Umea Univ, Dept Med Biosci, Umea, Sweden; [Johansson, Mikael] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Arnold, Susanne M.] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA; [Haura, Eric B.] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL USA; [Bolca, Ciprian] Inst Pneumol Marius Nasta, Bucharest, Romania; [Holcatova, Ivana] Charles Univ Prague, Fac Med 2, Prague, Czech Republic; [Janout, Vladimir] Univ Ostrava, Fac Med, Ostrava, Czech Republic; [Kontic, Milica] Clin Ctr Serbia, Belgrade, Serbia; [Kontic, Milica] Univ Belgrade, Sch Med, Belgrade, Serbia; [Lissowska, Jolanta] Inst Oncol, M Sklodowska Curie Canc Ctr, Warsaw, Poland; [Mukeria, Anush; Zaridze, David] Russian NN Blokhin Canc Res Ctr, Dept Epidemiol & Prevent, Moscow, Russia; [Ognjanovic, Simona] Int Org Canc Prevent & Res, Belgrade, Serbia; [Orlowski, Tadeusz M.] Natl TB & Lung Dis Res Inst, Dept Surg, Warsaw, Poland; [Swiatkowska, Beata] Nofer Inst Occupat Med, Dept Environm Epidemiol, Lodz, Poland; [Bakke, Per] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Duell, Eric J.] Catalan Inst Oncol ICO IDIBELL, Unit Nutr & Canc, Barcelona, Spain; [Koh, Woon-Puay] Duke Natl Univ Singapore, Med Sch, Singapore, Singapore; [Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Houlston, Richard S.] Inst Canc Res, London, England; [McLaughlin, John] Publ Hlth Ontario, Toronto, ON, Canada; [Stevens, Victoria L.] Amer Canc Soc, Atlanta, GA 30329 USA; [Joubert, Philippe; Lamontagne, Maxime; Bosse, Yohan] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Nickle, David C.] Merck Res Labs Genet & Pharmacogen, Boston, MA USA; [Obeidat, Ma'en] Univ British Columbia, St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC, Canada; [Timens, Wim] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, GRIAC Res Inst, Groningen, Netherlands; [Artigas, Maria Soler; Tobin, Martin D.; Wain, Louise V.] Univ Leicester, Dept Hlth Sci, Genet Epidemiol Grp, Leicester, Leics, England; [Artigas, Maria Soler; Tobin, Martin D.; Wain, Louise V.] Glenfield Hosp, NIHR, Leicester Resp Biomed Res Unit, Leicester, Leics, England; [Rafnar, Thorunn; Thorgeirsson, Thorgeir E.; Reginsson, Gunnar W.; Stefansson, Kari] Amgen Inc, deCODE Genet, Reykjavik, Iceland; [Hancock, Dana B.] RTI Int, Behav & Urban Hlth Program, Behav Hlth & Criminal Justice Div, Res Triangle Pk, NC USA; [Bierut, Laura J.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Spitz, Margaret R.] Baylor Coll Med, Duncan Canc Ctr, Houston, TX 77030 USA; [Gaddis, Nathan C.] RTI Int, Res Comp Div, Res Triangle Pk, NC USA; [Lutz, Sharon M.] Univ Colorado, Dept Biostatist & Informat, Anschutz Med Campus, Aurora, CO USA; [Johnson, Eric O.] RTI Int, Fellow Program & Behav Hlth & Criminal Justice Di, Res Triangle Pk, NC USA; [Lindstroem, Sara] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Jiang, Xia] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Tyndale, Rachel F.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Tyndale, Rachel F.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Tyndale, Rachel F.] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada; [Chenevix-Trench, Georgia; Beesley, Jonathan] QIMR Berghofer Med Res Inst, Canc Div, Brisbane, Qld, Australia; [Bosse, Yohan] Univ Laval, Dept Mol Med, Quebec City, PQ, Canada	World Health Organization; International Agency for Research on Cancer (IARC); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Dartmouth College; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Cambridge; University of Copenhagen; University of Copenhagen; University of Texas System; UTMD Anderson Cancer Center; Cancer Research Center of Hawaii; University of Hawaii System; University of Gottingen; Vanderbilt University; Case Western Reserve University; University of Oviedo; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Sheffield; University of Liverpool; Radboud University Nijmegen; Radboud University Nijmegen; Washington State University; British Columbia Cancer Agency; H Lee Moffitt Cancer Center & Research Institute; Dartmouth College; Nanjing Medical University; Seoul National University (SNU); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Copenhagen; University of Southern California; Sejong University; Lund University; Lund University; Imperial College London; Aarhus University; Fred Hutchinson Cancer Center; Huntsman Cancer Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Swedish Medical Center; University of Sheffield; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg; Salzburg University; Umea University; Umea University; University of Kentucky; H Lee Moffitt Cancer Center & Research Institute; "Marius Nasta" Pneumophtisiology Institute; Charles University Prague; University of Ostrava; Clinical Centre of Serbia; University of Belgrade; Maria Sklodowska-Curie National Research Institute of Oncology; N.N. Blokhin Russian Cancer Research Center; Nofer Institute of Occupational Medicine; University of Bergen; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); National University of Singapore; Shanghai Jiao Tong University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; American Cancer Society; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of Groningen; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Research Triangle Institute; Washington University (WUSTL); Baylor College of Medicine; Research Triangle Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; Research Triangle Institute; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; QIMR Berghofer Medical Research Institute; Laval University	Amos, CI (corresponding author), Geisel Sch Med Dartmouth, Biomed Data Sci, Hanover, NH USA.	christopher.i.amos@dartmouth.edu	Gao, Y./GWZ-3665-2022; Kiemeney, Lambertus A./D-3357-2009; Johansson, Mattias/ABF-3365-2020; Kim, Jin Hee/AET-7817-2022; Nickle, David/ABF-2727-2020; Muller, David C/V-8207-2017; Hong, Yun-Chul/J-5725-2012; Field, John K./AAD-5674-2020; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Bush, William/N-1369-2019; Davies, Michael/GWV-2527-2022; Arnold, S./L-4176-2015; Song, Lei/F-6946-2018; xiao, xiang/GWU-6035-2022; Gaddis, Nathan/GXG-6395-2022; Tsao, Ming-Sound/M-3503-2017; Bierut, Laura Jean/W-6806-2019; Timens, Wim/K-5570-2013; Fernandez-Tardon, Guillermo/AAC-1832-2022; Lissowska, Jolanta/AAH-3252-2020; Gaddis, Nathan/GXG-6447-2022; Chenevix-Trench, Georgia/AAV-2014-2020; Scelo, Ghislaine/CAF-8077-2022; Brunnström, Hans/AAZ-6803-2020; Carreras-Torres, Robert/E-3887-2019; TARDON, ADONINA/B-6563-2014; Tsao, Ming Sound/AFQ-7332-2022; Schabath, Matthew B./J-3763-2016; gao, yi/HCI-8298-2022; Risch, Angela/H-2669-2013; Fernández-Somoano, Ana/E-5489-2017; Wichmann, Heinz Erich/AAA-5695-2022; Gao, Yu/HGE-1937-2022; Ciprian, Bolca/C-2345-2014; van der Heijden, Erik H.F.M/D-3774-2009; Stefansson, Kari/AAE-7187-2019; Muley, Thomas/AAY-9200-2020; Bickeböller, Heike/V-2318-2018; Hung, Rayjean J/A-7439-2013; Soler Artigas, Maria/L-6529-2013; Ji, Xuemei/B-9774-2015	Kiemeney, Lambertus A./0000-0002-2368-1326; Muller, David C/0000-0002-2350-0417; Field, John K./0000-0003-3951-6365; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Bush, William/0000-0002-9729-6519; Bierut, Laura Jean/0000-0002-9952-4810; Timens, Wim/0000-0002-4146-6363; Fernandez-Tardon, Guillermo/0000-0002-7680-158X; Lissowska, Jolanta/0000-0003-2695-5799; Chenevix-Trench, Georgia/0000-0002-1878-2587; Brunnström, Hans/0000-0001-7402-138X; Carreras-Torres, Robert/0000-0002-2925-734X; TARDON, ADONINA/0000-0001-5150-1209; Tsao, Ming Sound/0000-0002-9160-5405; Schabath, Matthew B./0000-0003-3241-3216; Risch, Angela/0000-0002-8026-5505; Fernández-Somoano, Ana/0000-0002-8135-9079; Ciprian, Bolca/0000-0001-5480-4459; van der Heijden, Erik H.F.M/0000-0003-3596-518X; Bickeböller, Heike/0000-0002-3361-5488; Woll, Penella/0000-0002-1118-0831; Zienolddiny, Shan/0000-0001-9747-9625; Tyndale, Rachel/0000-0003-1297-2053; Grankvist, Kjell/0000-0003-4289-2097; Overvad, Kim/0000-0001-6429-7921; Wilkens, Lynne/0000-0001-8408-4536; Soler Artigas, Maria/0000-0002-3213-1107; Hung, Rayjean/0000-0002-4486-7496; Ji, Xuemei/0000-0001-7416-9122; Joubert, Philippe/0000-0001-7784-6387; Kontic Jovanovic, Milica/0000-0003-1285-3812; Arnold, Susanne/0000-0001-6542-9551; KIM, JIN HEE/0000-0003-1204-7079; tumino, rosario/0000-0003-2666-414X; Johnson, Eric Otto/0000-0002-8870-1949; Hancock, Dana/0000-0003-2240-3604; Davies, Michael Peter Alan/0000-0002-7609-4977; Rennert, Gad/0000-0002-8512-068X; Teare, Marion Dawn/0000-0003-3994-0051; Liu, Geoffrey/0000-0002-2603-7296; Cox, Angela/0000-0002-5138-1099; Beesley, Jonathan/0000-0003-1942-325X; Timofeeva, Maria/0000-0002-2503-4253; Shen, Hongbing/0000-0002-2581-5906; Swiatkowska, Beata/0000-0003-3757-3868; Wain, Louise/0000-0003-4951-1867; Bojesen, Stig/0000-0002-4061-4133; Lamontagne, Maxime/0000-0001-6674-4983; Thorgeirsson, Thorgeir/0000-0002-5149-7040; Melander, Olle/0000-0002-2581-484X; Johansson, Mattias/0000-0002-3116-5081; Tobin, Martin/0000-0002-3596-7874	Centre for Inherited Disease Research [26820120008i-0-26800068-1]; Fondation de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec; Respiratory Health Network of the FRQS; Canadian Institutes of Health Research [MOP-123369];  [U19-CA148127];  [CA148127S1]; MRC [G0902313, MR/N011317/1] Funding Source: UKRI; Cancer Research UK [20622] Funding Source: researchfish; Medical Research Council [MR/N011317/1, G0902313] Funding Source: researchfish; Novo Nordisk Fonden [NNF17OC0026936, NNF14OC0009819] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA023108, U01CA164973, P30CA016672, ZIACP010195, P50CA119997, R35CA197449, P30CA076292, R01CA151989, K07CA172294, U19CA148127, P30CA071789, UM1CA167462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035825] Funding Source: NIH RePORTER	Centre for Inherited Disease Research; Fondation de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec; Respiratory Health Network of the FRQS; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Transdisciplinary Research for Cancer in Lung (TRICL) of the International Lung Cancer Consortium (ILCCO) was supported by grants U19-CA148127 and CA148127S1. ILCCO data harmonization is supported by the Cancer Care Ontario Research Chair of Population Studies to R.J.H. and the Lunenfeld-Tanenbaum Research Institute, Sinai Health System. Additional funding information is provided in the Supplementary Note.; The TRICL-ILCCO OncoArray was supported by in-kind genotyping by the Centre for Inherited Disease Research (26820120008i-0-26800068-1).; The authors would like to thank the staff at the Respiratory Health Network Tissue Bank of the FRQS for their valuable assistance with the lung eQTL data set at Laval University. The lung eQTL study at Laval University was supported by the Fondation de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec, the Respiratory Health Network of the FRQS and the Canadian Institutes of Health Research (MOP-123369). Y. Bosse holds a Canada Research Chair in Genomics of Heart and Lung Diseases.	Amos CI, 2017, CANCER EPIDEM BIOMAR, V26, P126, DOI 10.1158/1055-9965.EPI-16-0106; Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Artigas MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9658; Bahcall OG, 2013, NAT GENET, V45, P343, DOI 10.1038/ng.2592; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Brenner DR, 2013, HUM GENET, V132, P579, DOI 10.1007/s00439-013-1270-y; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Durham AL, 2015, LUNG CANCER, V90, P121, DOI 10.1016/j.lungcan.2015.08.017; Fehringer G, 2016, CANCER RES, V76, P5103, DOI 10.1158/0008-5472.CAN-15-2980; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Fernandez-Cuesta L, 2014, CANCER DISCOV, V4, P415, DOI 10.1158/2159-8290.CD-13-0633; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Hao K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003029; Hemminki K, 2005, MUTAT RES-FUND MOL M, V592, P6, DOI 10.1016/j.mrfmmm.2005.05.008; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Lan Q, 2012, NAT GENET, V44, P1330, DOI 10.1038/ng.2456; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li YF, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0965-1; Lindelof B, 2001, LANCET, V358, P1696, DOI 10.1016/S0140-6736(01)06721-6; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; Moulton EA, 2014, ADDICT BIOL, V19, P317, DOI 10.1111/adb.12101; Mucci LA, 2016, JAMA-J AM MED ASSOC, V315, P68, DOI 10.1001/jama.2015.17703; Pooley KA, 2010, CANCER RES, V70, P3170, DOI 10.1158/0008-5472.CAN-09-4595; Shi JX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4365; Timofeeva MN, 2012, HUM MOL GENET, V21, P4980, DOI 10.1093/hmg/dds334; Truong T, 2010, JNCI-J NATL CANCER I, V102, P959, DOI 10.1093/jnci/djq178; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Walsh KM, 2015, ONCOTARGET, V6, P42468, DOI 10.18632/oncotarget.6468; Walsh KM, 2014, NAT GENET, V46, P731, DOI 10.1038/ng.3004; Wang YF, 2015, EUR J HUM GENET, V23, P1723, DOI 10.1038/ejhg.2015.48; Wang YF, 2014, NAT GENET, V46, P736, DOI 10.1038/ng.3002; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang SK, 2014, GUT, V63, P80, DOI 10.1136/gutjnl-2013-305193; Yu CTR, 2011, J THORAC ONCOL, V6, P988, DOI 10.1097/JTO.0b013e318212692e; Yuan H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34234; Zhang CA, 2015, HUM MOL GENET, V24, P5356, DOI 10.1093/hmg/ddv252	43	264	269	6	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2017	49	7					1126	+		10.1038/ng.3892	http://dx.doi.org/10.1038/ng.3892			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EY8OB	28604730	Green Submitted, Green Accepted			2022-12-17	WOS:000404253300024
J	De Iaco, A; Planet, E; Coluccio, A; Verp, S; Duc, J; Trono, D				De Iaco, Alberto; Planet, Evarist; Coluccio, Andrea; Verp, Sonia; Duc, Julien; Trono, Didier			DUX-family transcription factors regulate zygotic genome activation in placental mammals	NATURE GENETICS			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; GENE-EXPRESSION; PREIMPLANTATION EMBRYOS; ANALYSIS TOOLS; CELLS; DROSOPHILA; CHROMATIN; ZELDA; D4Z4; REPLICATION	In animal embryos, transcription is mostly silent for several cell divisions, until the release of the first major wave of embryonic transcripts through so-called zygotic genome activation (ZGA)(1). Maternally provided ZGA-triggering factors have been identified in Drosophila melanogaster and Danio rerio(2,3), but their mammalian homologs are still undefined. Here, we provide evidence that the DUX family of transcription factors(4,5) is essential to this process in mice and potentially in humans. First, human DUX4 and mouse Dux are both expressed before ZGA in their respective species. Second, both orthologous proteins bind the promoters of ZGA-associated genes and activate their transcription. Third, Dux knockout in mouse embryonic stem cells (mESCs) prevents the cells from cycling through a 2-cell-like state. Finally, zygotic depletion of Dux leads to impaired early embryonic development and defective ZGA. We conclude that DUX-family proteins are key inducers of zygotic genome activation in placental mammals.	[De Iaco, Alberto; Planet, Evarist; Coluccio, Andrea; Verp, Sonia; Duc, Julien; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Trono, D (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland.	didier.trono@epfl.ch	De Iaco, Alberto/AAN-4116-2021	De Iaco, Alberto/0000-0001-8388-4304; Duc, Julien/0000-0001-8195-804X	Swiss National Science Foundation; Gebert-Ruf Foundation; INGENIUM grant (FP7 MC-ITN INGENIUM) [290123]; European Research Council [ERC 268721, ERC 694658]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gebert-Ruf Foundation; INGENIUM grant (FP7 MC-ITN INGENIUM); European Research Council(European Research Council (ERC)European Commission)	We thank T. Macfarlan (NIH) and M.E. Torres-Padilla (Helmholtz Zentrum Munchen) for sharing reagents and for helpful discussions, and we thank the Transgenic and Gene Expression Core Facility (EPFL) and S. Offner for technical assistance. This work was financed through grants from the Swiss National Science Foundation, the Gebert-Ruf Foundation, an INGENIUM grant (FP7 MC-ITN INGENIUM 290123), and the European Research Council (ERC 268721 and ERC 694658) to D.T.	Choi SH, 2016, NUCLEIC ACIDS RES, V44, P5161, DOI 10.1093/nar/gkw141; Clapp J, 2007, AM J HUM GENET, V81, P264, DOI 10.1086/519311; De Iaco A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-11; De Iaco A, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-20; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Ecco G, 2016, DEV CELL, V36, P611, DOI 10.1016/j.devcel.2016.02.024; Eckersley-Maslin MA, 2016, CELL REP, V17, P179, DOI 10.1016/j.celrep.2016.08.087; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Ishiuchi T, 2015, NAT STRUCT MOL BIOL, V22, P662, DOI 10.1038/nsmb.3066; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Lee MT, 2013, NATURE, V503, P360, DOI 10.1038/nature12632; Leidenroth A, 2012, CHROMOSOMA, V121, P489, DOI 10.1007/s00412-012-0380-y; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Lu FL, 2014, GENE DEV, V28, P2103, DOI 10.1101/gad.248005.114; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; Maksakova IA, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-15; Perrod S, 2003, CELL MOL LIFE SCI, V60, P2303, DOI 10.1007/s00018-003-3246-x; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Schoorlemmer J, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00014; Schulz KN, 2015, GENOME RES, V25, P1715, DOI 10.1101/gr.192682.115; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sun YJ, 2015, GENOME RES, V25, P1703, DOI 10.1101/gr.192542.115; Thomas-Chollier M, 2008, NUCLEIC ACIDS RES, V36, pW119, DOI 10.1093/nar/gkn304; Tohonen V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9207; van der Maarel SM, 2011, TRENDS MOL MED, V17, P252, DOI 10.1016/j.molmed.2011.01.001; Vassena R, 2011, DEVELOPMENT, V138, P3699, DOI 10.1242/dev.064741; Walter M, 2016, ELIFE, V5, DOI 10.7554/eLife.11418; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Young JM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003947; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	43	264	267	6	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2017	49	6					941	+		10.1038/ng.3858	http://dx.doi.org/10.1038/ng.3858			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV8VM	28459456	Green Submitted, Green Accepted			2022-12-17	WOS:000402062300019
J	Jia, GQ; Huang, XH; Zhi, H; Zhao, Y; Zhao, Q; Li, WJ; Chai, Y; Yang, LF; Liu, KY; Lu, HY; Zhu, CR; Lu, YQ; Zhou, CC; Fan, DL; Weng, QJ; Guo, YL; Huang, T; Zhang, L; Lu, TT; Feng, Q; Hao, HF; Liu, HK; Lu, P; Zhang, N; Li, YH; Guo, EH; Wang, SJ; Wang, SY; Liu, JR; Zhang, WF; Chen, GQ; Zhang, BJ; Li, W; Wang, YF; Li, HQ; Zhao, BH; Li, JY; Diao, XM; Han, B				Jia, Guanqing; Huang, Xuehui; Zhi, Hui; Zhao, Yan; Zhao, Qiang; Li, Wenjun; Chai, Yang; Yang, Lifang; Liu, Kunyan; Lu, Hengyun; Zhu, Chuanrang; Lu, Yiqi; Zhou, Congcong; Fan, Danlin; Weng, Qijun; Guo, Yunli; Huang, Tao; Zhang, Lei; Lu, Tingting; Feng, Qi; Hao, Hangfei; Liu, Hongkuan; Lu, Ping; Zhang, Ning; Li, Yuhui; Guo, Erhu; Wang, Shujun; Wang, Suying; Liu, Jinrong; Zhang, Wenfei; Chen, Guoqiu; Zhang, Baojin; Li, Wei; Wang, Yongfang; Li, Haiquan; Zhao, Baohua; Li, Jiayang; Diao, Xianmin; Han, Bin			A haplotype map of genomic variations and genome-wide association studies of agronomic traits in foxtail millet (Setaria italica)	NATURE GENETICS			English	Article							ARABIDOPSIS-THALIANA; CULTIVATED RICE; FLOWERING TIME; OPEN SOFTWARE; MODEL; DOMESTICATION; SEQUENCE; MAIZE; LOCUS; PHENOTYPES	Foxtail millet (Setaria italica) is an important grain crop that is grown in arid regions. Here we sequenced 916 diverse foxtail millet varieties, identified 2.58 million SNPs and used 0.8 million common SNPs to construct a haplotype map of the foxtail millet genome. We classified the foxtail millet varieties into two divergent groups that are strongly correlated with early and late flowering times. We phenotyped the 916 varieties under five different environments and identified 512 loci associated with 47 agronomic traits by genome-wide association studies. We performed a de novo assembly of deeply sequenced genomes of a Setaria viridis accession (the wild progenitor of S. italica) and an S. italica variety and identified complex interspecies and intraspecies variants. We also identified 36 selective sweeps that seem to have occurred during modern breeding. This study provides fundamental resources for genetics research and genetic improvement in foxtail millet.	[Jia, Guanqing; Zhi, Hui; Chai, Yang; Yang, Lifang; Hao, Hangfei; Liu, Hongkuan; Lu, Ping; Diao, Xianmin] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China; [Huang, Xuehui; Zhao, Yan; Zhao, Qiang; Li, Wenjun; Liu, Kunyan; Lu, Hengyun; Zhu, Chuanrang; Lu, Yiqi; Zhou, Congcong; Fan, Danlin; Weng, Qijun; Guo, Yunli; Huang, Tao; Zhang, Lei; Lu, Tingting; Feng, Qi; Han, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Ctr Gene Res, Shanghai, Peoples R China; [Zhang, Ning; Li, Jiayang] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China; [Zhang, Ning; Li, Jiayang] Chinese Acad Sci, Natl Ctr Plant Gene Res Beijing, Inst Genet & Dev Biol, Beijing, Peoples R China; [Li, Yuhui; Guo, Erhu] Shanxi Acad Agr Sci, Inst Millet Crops, Changzhi, Shanxi, Peoples R China; [Wang, Shujun; Wang, Suying; Liu, Jinrong] Anyang Acad Agr Sci, Inst Millet Crops, Anyang, Henan, Peoples R China; [Zhang, Wenfei; Chen, Guoqiu; Zhang, Baojin] Liaoning Acad Agr Sci, Inst Soil & Water Conservat, Chaoyang, Liaoning, Peoples R China; [Li, Wei; Wang, Yongfang; Li, Haiquan; Diao, Xianmin] Hebei Acad Agr & Forestry Sci, Inst Millet Crops, Shijiazhuang, Hebei, Peoples R China; [Zhao, Baohua; Diao, Xianmin] Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Hebei, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Shanxi Agricultural University; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Hebei Academy of Agricultural & Forestry Sciences; Hebei Normal University	Han, B (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Ctr Gene Res, Shanghai, Peoples R China.	jyli@genetics.ac.cn; diaoxianmin@caas.cn; bhan@ncgr.ac.cn	Li, Jiayang/AAG-4377-2020; BAOHUA, ZHAO/W-4718-2019	Han, Bin/0000-0001-8695-0274	China Agricultural Research System [CARS07-12.5-A02]; National Natural Science Foundation of China [31171560, 30630045, 31121063]; National High Technology Research and Development Program of China (863 Program) [2013AA102603]; National Fund for Genetically Modified Organisms of China [2009ZX08009-093B]; Ministry of Agriculture of China [2011ZX08009-002]; Chinese Academy of Sciences	China Agricultural Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Fund for Genetically Modified Organisms of China; Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank J. Chen from the Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, for discussion about the manuscript. We thank Z. Ning for assistance with sequence alignment. This work was supported by the China Agricultural Research System (CARS07-12.5-A02), the National Natural Science Foundation of China (31171560, 30630045 and 31121063), the National High Technology Research and Development Program of China (863 Program) (2013AA102603), the National Fund for Genetically Modified Organisms of China (2009ZX08009-093B), the Ministry of Agriculture of China (2011ZX08009-002) and the Chinese Academy of Sciences.	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barton L, 2009, P NATL ACAD SCI USA, V106, P5523, DOI 10.1073/pnas.0809960106; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bettinger RL, 2010, EVOL ANTHROPOL, V19, P9, DOI 10.1002/evan.20236; Brutnell TP, 2010, PLANT CELL, V22, P2537, DOI 10.1105/tpc.110.075309; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; CHURCHILL GA, 1994, GENETICS, V138, P963; de la Bastide Melissa, 2007, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1104s17; Doust AN, 2005, GENETICS, V169, P1659, DOI 10.1534/genetics.104.035543; Doust AN, 2004, P NATL ACAD SCI USA, V101, P9045, DOI 10.1073/pnas.0402892101; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Goudet J., 2001, CLADISTICS; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/NMETH.1311, 10.1038/nmeth.1311]; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; Lin ZW, 2012, NAT GENET, V44, P720, DOI 10.1038/ng.2281; Meuwissen THE, 2001, GENETICS, V157, P1819; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; RADICELLA JP, 1991, PLANT MOL BIOL, V17, P127, DOI 10.1007/BF00036813; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Saitoh K, 2004, GENETICS, V168, P997, DOI 10.1534/genetics.103.018390; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Singh M, 2003, PLANT CELL, V15, P874, DOI 10.1105/tpc.010249; Wang CF, 2012, G3-GENES GENOM GENET, V2, P769, DOI 10.1534/g3.112.002907; Wang CF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-90; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195	39	264	331	7	166	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2013	45	8					957	U167		10.1038/ng.2673	http://dx.doi.org/10.1038/ng.2673			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	190WW	23793027				2022-12-17	WOS:000322374900024
J	Anttila, V; Stefansson, H; Kallela, M; Todt, U; Terwindt, GM; Calafato, MS; Nyholt, DR; Dimas, AS; Freilinger, T; Muller-Myhsok, B; Artto, V; Inouye, M; Alakurtti, K; Kaunisto, MA; Hamalainen, E; de Vries, B; Stam, AH; Weller, CM; Heinze, A; Heinze-Kuhn, K; Goebel, I; Borck, G; Gobel, H; Steinberg, S; Wolf, C; Bjornsson, A; Gudmundsson, G; Kirchmann, M; Hauge, A; Werge, T; Schoenen, J; Eriksson, JG; Hagen, K; Stovner, L; Wichmann, E; Meitinger, T; Alexander, M; Moebus, S; Schreiber, S; Aulchenko, YS; Breteler, MMB; Uitterlinden, AG; Hofman, A; van Duijn, CM; Tikka-Kleemola, P; Vepsalainen; Lucae, S; Tozzi, F; Muglia, P; Barrett, J; Kaprio, J; Farkkila, M; Peltonen, L; Stefansson, K; Zwart, JA; Ferrari, MD; Olesen, J; Daly, M; Wessman, M; van den Maagdenberg, AMJM; Dichgans, M; Kubisch, C; Dermitzakis, ET; Frants, RR; Palotie, A				Anttila, Verneri; Stefansson, Hreinn; Kallela, Mikko; Todt, Unda; Terwindt, Gisela M.; Calafato, M. Stella; Nyholt, Dale R.; Dimas, Antigone S.; Freilinger, Tobias; Mueller-Myhsok, Bertram; Artto, Ville; Inouye, Michael; Alakurtti, Kirsi; Kaunisto, Mari A.; Haemaelaeinen, Eija; de Vries, Boukje; Stam, Anine H.; Weller, Claudia M.; Heinze, Axel; Heinze-Kuhn, Katja; Goebel, Ingrid; Borck, Guntram; Goebel, Hartmut; Steinberg, Stacy; Wolf, Christiane; Bjoernsson, Asgeir; Gudmundsson, Gretar; Kirchmann, Malene; Hauge, Anne; Werge, Thomas; Schoenen, Jean; Eriksson, Johan G.; Hagen, Knut; Stovner, Lars; Wichmann, Erich; Meitinger, Thomas; Alexander, Michael; Moebus, Susanne; Schreiber, Stefan; Aulchenko, Yurii S.; Breteler, Monique M. B.; Uitterlinden, Andre G.; Hofman, Albert; van Duijn, Cornelia M.; Tikka-Kleemola, Paevi; Vepsaelaeinen, Salli; Lucae, Susanne; Tozzi, Federica; Muglia, Pierandrea; Barrett, Jeffrey; Kaprio, Jaakko; Faerkkilae, Markus; Peltonen, Leena; Stefansson, Kari; Zwart, John-Anker; Ferrari, Michel D.; Olesen, Jes; Daly, Mark; Wessman, Maija; van den Maagdenberg, Arn M. J. M.; Dichgans, Martin; Kubisch, Christian; Dermitzakis, Emmanouil T.; Frants, Rune R.; Palotie, Aarno		Int Headache Genetics Consortium	Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1	NATURE GENETICS			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; LYMPHOBLASTOID CELL-LINES; EPISODIC ATAXIA; SPREADING DEPRESSION; GENE-EXPRESSION; CONFERS RISK; GLUTAMATE; MUTATION; INVOLVEMENT; MECHANISMS	Migraine is a common episodic neurological disorder, typically presenting with recurrent attacks of severe headache and autonomic dysfunction. Apart from rare monogenic subtypes, no genetic or molecular markers for migraine have been convincingly established. We identified the minor allele of rs1835740 on chromosome 8q22.1 to be associated with migraine (P = 5.38 x 10(-9), odds ratio = 1.23, 95% CI 1.150-1.324) in a genome-wide association study of 2,731 migraine cases ascertained from three European headache clinics and 10,747 population-matched controls. The association was replicated in 3,202 cases and 40,062 controls for an overall meta-analysis P value of 1.69 x 10(-11) (odds ratio = 1.18, 95% CI 1.127-1.244). rs1835740 is located between MTDH (astrocyte elevated gene 1, also known as AEG-1) and PGCP (encoding plasma glutamate carboxypeptidase). In an expression quantitative trait study in lymphoblastoid cell lines, transcript levels of the MTDH were found to have a significant correlation to rs1835740 (P = 3.96 x 10(-5), permuted threshold for genome-wide significance 7.7 x 10(-5)). To our knowledge, our data establish rs1835740 as the first genetic risk factor for migraine.	[Anttila, Verneri; Inouye, Michael; Alakurtti, Kirsi; Barrett, Jeffrey] Wellcome Trust Sanger Inst, Cambridge, England; [Anttila, Verneri; Alakurtti, Kirsi; Kaunisto, Mari A.; Haemaelaeinen, Eija; Kaprio, Jaakko; Peltonen, Leena; Wessman, Maija; Palotie, Aarno] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Stefansson, Hreinn; Steinberg, Stacy; Bjoernsson, Asgeir; Stefansson, Kari] DeCODE genet, Dept Populat Genom, Reykjavik, Iceland; [Kallela, Mikko; Artto, Ville; Vepsaelaeinen, Salli; Faerkkilae, Markus] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; [Goebel, Ingrid; Borck, Guntram] Univ Cologne, Inst Human Genet, Cologne, Germany; [Todt, Unda; Goebel, Ingrid; Borck, Guntram] Univ Cologne, Inst Genet, D-5000 Cologne, Germany; [Todt, Unda; Goebel, Ingrid; Borck, Guntram] Univ Cologne, Ctr Mol Med Cologne, D-5000 Cologne, Germany; [Terwindt, Gisela M.; Stam, Anine H.; Ferrari, Michel D.; van den Maagdenberg, Arn M. J. M.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Calafato, M. Stella] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Cambridge Biomed Res Ctr, Nat Inst Hlth Res, Cambridge, England; [Nyholt, Dale R.] Queensland Inst Med Res, Neurogenet Lab, Brisbane, Qld 4006, Australia; [Dimas, Antigone S.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Dimas, Antigone S.; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, Geneva, Switzerland; [Freilinger, Tobias] Univ Munich, Dept Neurol, Klinikum Grosshadern, Munich, Germany; [Freilinger, Tobias; Dichgans, Martin] Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Mueller-Myhsok, Bertram; Wolf, Christiane; Lucae, Susanne] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Inouye, Michael; de Vries, Boukje; Weller, Claudia M.; van den Maagdenberg, Arn M. J. M.; Frants, Rune R.] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Kaunisto, Mari A.] Folkhalsan Res Ctr, Helsinki, Finland; [Heinze, Axel; Heinze-Kuhn, Katja; Goebel, Hartmut] Kiel Pain & Headache Ctr, Kiel, Germany; [Gudmundsson, Gretar] Landspitali Univ Hosp, Dept Neurol, Reykjavik, Iceland; [Kirchmann, Malene; Hauge, Anne; Olesen, Jes] Danish Headache Ctr, Glostrup, Denmark; [Kirchmann, Malene; Hauge, Anne] Glostrup Cty Hosp, Dept Neurol, Glostrup, Denmark; [Werge, Thomas] Univ Copenhagen, Research Inst Biol Psychiat, Roskilde, Denmark; [Schoenen, Jean] Univ Liege, Headache Res Unit, Dept Neurol, B-4000 Liege, Belgium; [Schoenen, Jean] Univ Liege, GIGA, B-4000 Liege, Belgium; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Dept Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Cent Hosp, Vaasa, Finland; [Eriksson, Johan G.; Kaprio, Jaakko] Nat Inst Hlth & Welf, Helsinki, Finland; [Hagen, Knut; Stovner, Lars; Zwart, John-Anker] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Wichmann, Erich] Inst Epidemiol, Helmholtz Ctr Munich, Neuherberg, Germany; [Wichmann, Erich] Univ Munich, Inst Med Informationsverarbeitung, Munich, Germany; [Meitinger, Thomas] Inst Human Genet, Helmholtz Ctr Munich, Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, Klinikum Rechts Isar, Munich, Germany; [Alexander, Michael] Univ Bonn, Dept Genom, Life & Brain Ctr, D-5300 Bonn, Germany; [Alexander, Michael] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; [Moebus, Susanne] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Schreiber, Stefan] Univ Kiel, Dept Clin Mol Biol, Kiel, Germany; [Schreiber, Stefan] Univ Kiel, Dept Internal Med 1, Kiel, Germany; [Aulchenko, Yurii S.; Breteler, Monique M. B.; Hofman, Albert; van Duijn, Cornelia M.] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Tikka-Kleemola, Paevi] Univ Helsinki, Res Program Mol Med, Helsinki, Finland; [Tozzi, Federica; Muglia, Pierandrea] GlaxoSmithKline Res & Dev Ltd, Verona, Italy; [Muglia, Pierandrea] Univ Toronto, Dept Psychiat, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Peltonen, Leena; Palotie, Aarno] Broad Inst & Harvard, Boston, MA USA; [Zwart, John-Anker] Oslo Univ Hosp & Univ, Dept Neurol, Oslo, Norway; [Kubisch, Christian] Univ Cologne, Cologne Excellence Cluster Cellular Stress Resp, Cologne, Germany; [Kubisch, Christian] Univ Ulm, Inst Human Genet, Ulm, Germany; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Palotie, Aarno] Univ Helsinki, Cent Hosp, Dept Med Genet, Helsinki, Finland	Wellcome Trust Sanger Institute; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Cologne; University of Cologne; University of Cologne; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Cambridge; QIMR Berghofer Medical Research Institute; University of Oxford; Wellcome Centre for Human Genetics; University of Geneva; University of Munich; University of Munich; Max Planck Society; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Folkhalsan Research Center; Landspitali National University Hospital; University of Copenhagen; University of Copenhagen; University of Liege; University of Liege; University of Helsinki; Helsinki University Central Hospital; Vaasa Central Hospital; Norwegian University of Science & Technology (NTNU); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Bonn; University of Bonn; University of Duisburg Essen; University of Kiel; University of Kiel; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Helsinki; GlaxoSmithKline; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Cologne; Ulm University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Anttila, V (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	verneri.anttila@sanger.ac.uk; aarno.palotie@sanger.ac.uk	Meitinger, Thomas/O-1318-2015; Müller-Myhsok, Bertram/A-3289-2013; Borck, Guntram/F-1868-2015; Nyholt, Dale Robert/J-3174-2017; Ferrari, Michel D./ABE-3758-2021; van den Maagdenberg, Arn M.J.M./AAE-9052-2019; Werge, Thomas/G-7263-2012; Dermitzakis, Emmanouil/B-7687-2013; Tozzi, Federica/AAP-5462-2021; Muglia, Pierandrea/ABD-9235-2020; Daly, Mark J/B-2453-2017; Kubisch, Christian/F-1893-2011; Kaprio, Jaakko/A-1820-2008; Aulchenko, Yurii/M-8270-2013; Breteler, Monique M.B./J-5058-2014; Dichgans, Martin/HCH-3247-2022; Stefansson, Kari/AAE-7187-2019; Göbel, Hartmut/AAE-4719-2020; Stovner, Lars Jacob/D-5025-2014	Nyholt, Dale Robert/0000-0001-7159-3040; Ferrari, Michel D./0000-0001-9691-9449; Tozzi, Federica/0000-0002-3536-2920; Muglia, Pierandrea/0000-0002-3973-8606; Daly, Mark J/0000-0002-0949-8752; Kubisch, Christian/0000-0003-4220-0978; Kaprio, Jaakko/0000-0002-3716-2455; Aulchenko, Yurii/0000-0002-7899-1575; Breteler, Monique M.B./0000-0002-0626-9305; Dichgans, Martin/0000-0002-0654-387X; Meitinger, Thomas/0000-0002-8838-8403; Anttila, Verneri/0000-0002-0073-4675; Palotie, Aarno/0000-0002-2527-5874; Van Duijn, Cornelia/0000-0002-2374-9204; Kaunisto, Mari/0000-0002-6946-9195; Eriksson, Johan/0000-0002-2516-2060; Inouye, Michael/0000-0001-9413-6520; Olesen, Jes/0000-0002-6712-2702; Stefansson, Hreinn/0000-0002-9331-6666; Moebus, Susanne/0000-0002-0072-5410	Wellcome Trust [WT089062]; Academy of Finland [200923, 00213]; Helsinki University Central Hospital; Academy of Finland Center of Excellence for Complex Disease Genetics; EuroHead project [LSM-CT-2004-504837]; Helsinki Biomedical Graduate School; Finnish Cultural Foundation; Finnish Neurology Foundation; Biomedicum Helsinki Foundation; Cambridge Biomedical Research Centre; Australian National Health and Medical Research Council [339462, 613674]; Australian Research Council [FT0991022]; German Federal Ministry of Education and Research (BMBF) [01GS08121]; German National Genome Research Network; Center for Molecular Medicine Cologne; Heinz Nixdorf Foundation; Netherlands Organization for the Health Research and Development [90700217]; Netherlands Organisation for Scientific Research (NWO) [918.56.602]; Spinoza; Center for Medical Systems Biology (CMSB) [050-060-409, 050-060-810, 175.010.2005.011, 911-03-012]; National Center for Research Resources (US); Helmholtz Center Munich; German Federal Ministry of Education and Research; State of Bavaria; Munich Center of Health Sciences (MC Health); Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Deutsche Forschungsgemeinschaft	Wellcome Trust(Wellcome Trust); Academy of Finland(Academy of Finland); Helsinki University Central Hospital; Academy of Finland Center of Excellence for Complex Disease Genetics(Academy of Finland); EuroHead project(European Commission); Helsinki Biomedical Graduate School; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Neurology Foundation; Biomedicum Helsinki Foundation; Cambridge Biomedical Research Centre(General Electric); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network; Center for Molecular Medicine Cologne; Heinz Nixdorf Foundation; Netherlands Organization for the Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Spinoza; Center for Medical Systems Biology (CMSB); National Center for Research Resources (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Helmholtz Center Munich(Helmholtz Association); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); State of Bavaria; Munich Center of Health Sciences (MC Health); Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We wish to thank all individuals in the respective cohorts for their generous participation. This work was supported by the Wellcome Trust (grant number WT089062) and, among others, by the Academy of Finland (200923 to AP, 00213 to M. W.); the Helsinki University Central Hospital (to M. Kallela., M. F., V. Artto and S. V.); the Academy of Finland Center of Excellence for Complex Disease Genetics; the EuroHead project (LSM-CT-2004-504837); the Helsinki Biomedical Graduate School (to V. Anttila, P. T.-K.); the Finnish Cultural Foundation (to V. Anttila); the Finnish Neurology Foundation, Biomedicum Helsinki Foundation (to V. Anttila, P. T.-K. and V. Artto); the Cambridge Biomedical Research Centre (to S. C.); the Australian National Health and Medical Research Council Fellowship (339462 and 613674) and the Australian Research Council Future Fellowship (FT0991022) schemes (to D. R. N.); the German Federal Ministry of Education and Research (BMBF) (grant 01GS08121 to M. Dichgans, along with support to H. E. W. in the context of the German National Genome Research Network (NGFN-2 and NGFN-plus) for the Heinz Nixdorf Recall study, and to C. K. (EMINet -01GS08120) for the National Genome Research Network (Germany; NGFN-1 and NGFN-Plus)); the Center for Molecular Medicine Cologne (to C. K.); the Heinz Nixdorf Foundation for the Heinz Nixdorf Recall study, Deutsche Forschungsgemeinschaft (DFG; to C. K. and H. G.); the Netherlands Organization for the Health Research and Development (ZonMw) no. 90700217 (to G. M. T.) and to the Rotterdam Study (RIDE1 and RIDE2); the Netherlands Organisation for Scientific Research (NWO) VICI (918.56.602) and Spinoza (2009) grants (to M. D. F.); and the Center for Medical Systems Biology (CMSB) established by the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NGI/NWO), project no. 050-060-409 (to C. M. v. D., R. R. F., M. D. F. and A. M. J. M. v. d. M.) and project nos. 050-060-810 and 175.010.2005.011, 911-03-012 (to the Rotterdam Study). We thank the Health 2000 study for providing Finnish control genotypes. The Broad Institute Center for Genotyping and Analysis is supported by a grant from the National Center for Research Resources (US). The KORA research platform was initiated and financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria and is supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII) and the Municipality of Rotterdam. We wish to thank S. Hunt, R. Gwillian, P. Whittaker, S. Potter and A. Tashakkori-Ghanbarian, as well as P. Marin-Garcia, for their invaluable help with this study. Finally, we wish to collectively thank everyone who has contributed to the collection, genotyping and analysis of the individual cohorts.	Boycott HE, 2008, GLIA, V56, P998, DOI 10.1002/glia.20673; Burstein R, 2000, BRAIN, V123, P1703, DOI 10.1093/brain/123.8.1703; Dallas M, 2007, J NEUROSCI, V27, P3946, DOI 10.1523/JNEUROSCI.5030-06.2007; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; de Vries B, 2009, HUM GENET, V126, P115, DOI 10.1007/s00439-009-0684-z; de Vries B, 2009, ARCH NEUROL-CHICAGO, V66, P97, DOI 10.1001/archneurol.2008.535; Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Emdad L, 2009, P NATL ACAD SCI USA, V106, P21300, DOI 10.1073/pnas.0910936106; Frankel WN, 2009, TRENDS GENET, V25, P361, DOI 10.1016/j.tig.2009.07.001; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goadsby PJ, 2009, NEUROSCIENCE, V161, P327, DOI 10.1016/j.neuroscience.2009.03.019; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hanna MG, 2006, NAT CLIN PRACT NEURO, V2, P252, DOI 10.1038/ncpneuro0178; Hindorff LA, CATALOG PUBLISHED GE; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hu VW, 2009, AUTISM RES, V2, P78, DOI 10.1002/aur.73; Jen JC, 2005, NEUROLOGY, V65, P529, DOI 10.1212/01.WNL.0000172638.58172.5a; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Martin MV, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-62; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Noch E, 2009, CANCER BIOL THER, V8, P1791, DOI 10.4161/cbt.8.19.9762; Nyholt DR, 2008, HUM MOL GENET, V17, P3318, DOI 10.1093/hmg/ddn227; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Pietrobon D, 2007, NEUROTHERAPEUTICS, V4, P274, DOI 10.1016/j.nurt.2007.01.008; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Stovner LJ, 2006, EUR J NEUROL, V13, P333, DOI 10.1111/j.1468-1331.2006.01184.x; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Tottene A, 2009, NEURON, V61, P762, DOI 10.1016/j.neuron.2009.01.027	39	264	270	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2010	42	10					869	+		10.1038/ng.652	http://dx.doi.org/10.1038/ng.652			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	655UO	20802479	Green Accepted			2022-12-17	WOS:000282276600017
J	Zhou, DW; Liu, KM; Sun, CW; Pawlik, KM; Townes, TM				Zhou, Dewang; Liu, Kaimao; Sun, Chiao-Wang; Pawlik, Kevin M.; Townes, Tim M.			KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching	NATURE GENETICS			English	Article							KRUPPEL-LIKE FACTOR; TRANSGENIC MICE; FACTOR EKLF; REGION	We show that knockdown of KLF1 in human and mouse adult erythroid progenitors markedly reduces BCL11A levels and increases human. gamma-globin/beta-globin expression ratios. These results suggest that KLF1 controls globin gene switching by directly activating beta-globin and indirectly repressing gamma-globin gene expression. Controlled knockdown of KLF1 in adult erythroid progenitors may provide a method to activate fetal hemoglobin expression in individuals with. beta-thalassemia or sickle cell disease.	[Townes, Tim M.] Univ Alabama, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; Univ Alabama, Sch Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; Univ Alabama, Sch Med, Stem Cell Inst, Birmingham, AL USA; Univ Alabama, Sch Dent, Stem Cell Inst, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Townes, TM (corresponding author), Univ Alabama, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA.	ttownes@uab.edu			US National Institutes of Health [1R01 DK073391]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073391] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank L. Lamb for purification of CD34+ cells from mobilized peripheral blood mononuclear cells, T. Ley for the human beta-globin BAC and S. McConnell for help with qRT-PCR. This work was supported by a grant from the US National Institutes of Health (1R01 DK073391).	BEHRINGER RR, 1990, GENE DEV, V4, P380, DOI 10.1101/gad.4.3.380; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; DONZE D, 1995, J BIOL CHEM, V270, P1955, DOI 10.1074/jbc.270.4.1955; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; ENVER T, 1990, NATURE, V344, P309, DOI 10.1038/344309a0; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Perkins AC, 1996, P NATL ACAD SCI USA, V93, P12267, DOI 10.1073/pnas.93.22.12267; Ryan TM, 2000, NUCLEIC ACIDS RES, V28, P2736, DOI 10.1093/nar/28.14.2736; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Tewari R, 1998, EMBO J, V17, P2334, DOI 10.1093/emboj/17.8.2334; TOWNES TM, 1990, TRENDS GENET, V6, P219, DOI 10.1016/0168-9525(90)90182-6; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Xue L, 2004, BLOOD, V103, P4078, DOI 10.1182/blood-2003-09-3231; Zhou DW, 2006, J BIOL CHEM, V281, P16052, DOI 10.1074/jbc.M601182200	15	264	276	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					742	744		10.1038/ng.637	http://dx.doi.org/10.1038/ng.637			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20676097				2022-12-17	WOS:000281388400006
J	Gudmundsson, J; Sulem, P; Gudbjartsson, DF; Blondal, T; Gylfason, A; Agnarsson, BA; Benediktsdottir, KR; Magnusdottir, DN; Orlygsdottir, G; Jakobsdottir, M; Stacey, SN; Sigurdsson, A; Wahlfors, T; Tammela, T; Breyer, JP; McReynolds, KM; Bradley, KM; Saez, B; Godino, J; Navarrete, S; Fuertes, F; Murillo, L; Polo, E; Aben, KK; van Oort, IM; Suarez, BK; Helfand, BT; Kan, DH; Zanon, C; Frigge, ML; Kristjansson, K; Gulcher, JR; Einarsson, GV; Jonsson, E; Catalona, WJ; Mayordomo, JI; Kiemeney, LA; Smith, JR; Schleutker, J; Barkardottir, RB; Kong, A; Thorsteinsdottir, U; Rafnar, T; Stefansson, K				Gudmundsson, Julius; Sulem, Patrick; Gudbjartsson, Daniel F.; Blondal, Thorarinn; Gylfason, Arnaldur; Agnarsson, Bjarni A.; Benediktsdottir, Kristrun R.; Magnusdottir, Droplaug N.; Orlygsdottir, Gudbjorg; Jakobsdottir, Margret; Stacey, Simon N.; Sigurdsson, Asgeir; Wahlfors, Tiina; Tammela, Teuvo; Breyer, Joan P.; McReynolds, Kate M.; Bradley, Kevin M.; Saez, Berta; Godino, Javier; Navarrete, Sebastian; Fuertes, Fernando; Murillo, Laura; Polo, Eduardo; Aben, Katja K.; van Oort, Inge M.; Suarez, Brian K.; Helfand, Brian T.; Kan, Donghui; Zanon, Carlo; Frigge, Michael L.; Kristjansson, Kristleifur; Gulcher, Jeffrey R.; Einarsson, Gudmundur V.; Jonsson, Eirikur; Catalona, William J.; Mayordomo, Jose I.; Kiemeney, Lambertus A.; Smith, Jeffrey R.; Schleutker, Johanna; Barkardottir, Rosa B.; Kong, Augustine; Thorsteinsdottir, Unnur; Rafnar, Thorunn; Stefansson, Kari			Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility	NATURE GENETICS			English	Article							SEQUENCE VARIANTS; COLORECTAL-CANCER; MULTIPLE LOCI; RISK; GENE; 8Q24; SCAN	We report a prostate cancer genome-wide association follow-on study. We discovered four variants associated with susceptibility to prostate cancer in several European populations: rs10934853[A] (OR = 1.12, P = 2.9 x 10(-10)) on 3q21.3; two moderately correlated (r(2) = 0.07) variants, rs16902094[G] (OR = 1.21, P = 6.2 x 10(-15)) and rs445114[T] (OR = 1.14, P = 4.7 x 10(-1)0), on 8q24.21; and rs8102476[C] (OR = 1.12, P = 1.6 x 10(-11)) on 19q13.2. We also refined a previous association signal on 11q13 with the SNP rs11228565[A] (OR = 1.23, P = 6.7 x 10(-12)). In a multivariate analysis using 22 prostate cancer risk variants typed in the Icelandic population, we estimated that carriers in the top 1.3% of the risk distribution are at a 2.5 times greater risk of developing the disease than members of the general population.	[Gudmundsson, Julius; Sulem, Patrick; Gudbjartsson, Daniel F.; Blondal, Thorarinn; Gylfason, Arnaldur; Magnusdottir, Droplaug N.; Orlygsdottir, Gudbjorg; Jakobsdottir, Margret; Stacey, Simon N.; Sigurdsson, Asgeir; Zanon, Carlo; Frigge, Michael L.; Kristjansson, Kristleifur; Gulcher, Jeffrey R.; Kong, Augustine; Thorsteinsdottir, Unnur; Rafnar, Thorunn; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Agnarsson, Bjarni A.; Benediktsdottir, Kristrun R.; Barkardottir, Rosa B.] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; [Agnarsson, Bjarni A.; Benediktsdottir, Kristrun R.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Wahlfors, Tiina; Schleutker, Johanna] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Wahlfors, Tiina; Schleutker, Johanna] Tampere Univ Hosp, Tampere, Finland; [Tammela, Teuvo] Univ Tampere, Dept Urol, Tampere Univ Hosp, FIN-33101 Tampere, Finland; [Breyer, Joan P.; McReynolds, Kate M.; Bradley, Kevin M.; Smith, Jeffrey R.] Vanderbilt Univ, Sch Med, Dept Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Saez, Berta; Godino, Javier; Mayordomo, Jose I.] Hlth Sci Inst Aragon, Zaragoza, Spain; [Saez, Berta; Mayordomo, Jose I.] Nanotechnol Inst Aragon, Zaragoza, Spain; [Navarrete, Sebastian; Fuertes, Fernando] Univ Zaragoza, Div Radiat Oncol, Lozano Blesa Univ Hosp, Zaragoza, Spain; [Murillo, Laura] Reina Sofia Hosp, Div Med Oncol, Tudela, Spain; [Polo, Eduardo] Ernest Lluch Hosp, Div Med Oncol, Calatayud, Spain; [Aben, Katja K.; Kiemeney, Lambertus A.] Comprehens Canc Ctr E, Nijmegen, Netherlands; [Aben, Katja K.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Epidemiol Biostat & Hlth Technol Assessment, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [van Oort, Inge M.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Urol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Suarez, Brian K.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Helfand, Brian T.; Kan, Donghui; Catalona, William J.] Northwestern Univ, Dept Urol, Feinberg Sch Med, Chicago, IL 60611 USA; [Zanon, Carlo] Univ Turin, Mol Genet Lab, Inst Canc Res & Treatment, Sch Med, Candiolo, Italy; [Einarsson, Gudmundur V.; Jonsson, Eirikur] Landspitali Univ Hosp, Dept Urol, Reykjavik, Iceland; [Mayordomo, Jose I.] Univ Zaragoza, Div Med Oncol, Univ Hosp, Zaragoza, Spain; [Smith, Jeffrey R.] Vet Affairs Tennessee Valley Healthcare Syst, Med Res Serv, Nashville, TN USA	Landspitali National University Hospital; University of Iceland; Tampere University; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Vanderbilt University; Lozano Blesa University Clinical Hospital; University of Zaragoza; Servicio Navarro de Salud - Osasunbidea; Radboud University Nijmegen; Radboud University Nijmegen; Washington University (WUSTL); Northwestern University; Feinberg School of Medicine; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; Landspitali National University Hospital; Miguel Servet University Hospital; University of Zaragoza; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Stefansson, K (corresponding author), deCODE Genet, Reykjavik, Iceland.	julius@decode.is; kstefans@decode.is	Godino, Javier/M-3753-2018; van Oort, Inge/AAD-1197-2020; van Oort, Inge/L-4554-2015; Aben, Katja KH/G-9686-2016; Smith, Jeff/C-3484-2012; Mayordomo, Jose/K-3453-2013; Kiemeney, Lambertus A./D-3357-2009; Stefansson, Kari/AAE-7187-2019; Wahlfors, Tiina/U-7635-2018	Godino, Javier/0000-0002-5653-2722; van Oort, Inge/0000-0002-8002-1869; van Oort, Inge/0000-0002-8002-1869; Aben, Katja KH/0000-0002-0214-2147; Kiemeney, Lambertus A./0000-0002-2368-1326; Smith, Jeffrey/0000-0001-8424-910X; Schleutker, Johanna/0000-0002-1863-0305; Saez, Berta/0000-0003-0753-1165; Gudbjartsson, Daniel/0000-0002-5222-9857; Kong, Augustine/0000-0001-8193-5438; Wahlfors, Tiina/0000-0002-3910-796X; Zanon, Carlo/0000-0003-2539-7238	European Union [202059, 218071]; V Foundation; US Department of Veterans Affairs; Academy of Finland; Sigrid Juselius Foundation; Pirkanmaa Hospital District, Tampere University Hospital; NATIONAL CANCER INSTITUTE [P50CA090386] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER	European Union(European Commission); V Foundation; US Department of Veterans Affairs(US Department of Veterans Affairs); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Pirkanmaa Hospital District, Tampere University Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the individuals who participated in the study and whose contribution made this work possible. This project was funded in part by contract number 202059 PROMARK) from the Seventh Framework Program of the European Union to deCODE Genetics T. R. and L. A. K.), in part by FP7-MC-IAPP Grant agreement no. 218071 CancerGene) to deCODE Genetics, in part by a V Foundation award and US Department of Veterans Affairs grants to J. R. S., and in part by Academy of Finland, Sigrid Juselius Foundation, Finnish Cancer Organisations and the Competitive Research Funding of the Pirkanmaa Hospital District, Tampere University Hospital, to J. S.	Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kote-Jarai Z, 2008, CANCER EPIDEM BIOMAR, V17, P2052, DOI 10.1158/1055-9965.EPI-08-0317; KOTEJARAI Z, 2008, CANCER EPIDEM BIOMAR, V17, P2901; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; MANTEL N, 1959, J NATL CANCER I, V22, P719; Nicolae DL, 2006, GENET EPIDEMIOL, V30, P718, DOI 10.1002/gepi.20182; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Sun J, 2008, NAT GENET, V40, P1153, DOI 10.1038/ng.214; Sun JL, 2009, CANCER RES, V69, P10, DOI 10.1158/0008-5472.CAN-08-3464; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zaitlen N, 2007, AM J HUM GENET, V80, P683, DOI 10.1086/513109; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	31	264	284	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1122	U104		10.1038/ng.448	http://dx.doi.org/10.1038/ng.448			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19767754	Green Accepted			2022-12-17	WOS:000270330400017
J	Giorgini, F; Guidetti, P; Nguyen, QV; Bennett, SC; Muchowski, PJ				Giorgini, F; Guidetti, P; Nguyen, QV; Bennett, SC; Muchowski, PJ			A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease	NATURE GENETICS			English	Article							INCLUSION-BODY FORMATION; MUTANT HUNTINGTIN; POLYGLUTAMINE AGGREGATION; QUINOLINIC ACID; IN-VIVO; TOXICITY; MODEL; BRAIN; INHIBITION; EXPANSIONS	Huntington disease is a fatal neurodegenerative disorder caused by expansion of a polyglutamine tract in the protein huntingtin (Htt)(1), which leads to its aggregation in nuclear and cytoplasmic inclusion bodies(2). We recently identified 52 loss-of-function mutations in yeast genes that enhance the toxicity of a mutant Htt fragment(3). Here we report the results from a genome-wide loss-of-function suppressor screen in which we identified 28 gene deletions that suppress toxicity of a mutant Htt fragment. The suppressors are known or predicted to have roles in vesicle transport, vacuolar degradation, transcription and prion-like aggregation. Among the most potent suppressors was Bna4 ( kynurenine 3-monooxygenase), an enzyme in the kynurenine pathway of tryptophan degradation that has been linked directly to the pathophysiology of Huntington disease in humans by a mechanism that may involve reactive oxygen species(4). This finding is suggestive of a conserved mechanism of polyglutamine toxicity from yeast to humans and identifies new candidate therapeutic targets for the treatment of Huntington disease.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Catonsville, MD 21228 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; Univ Washington, Ctr Neurogenet & Neurotherapeut, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Muchowski, PJ (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	mucho@u.washington.edu		Giorgini, Flaviano/0000-0001-7881-9508	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047237] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS047237] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Goda K, 1999, ADV EXP MED BIOL, V467, P397; Guidetti P, 2000, NEUROSCI LETT, V283, P233, DOI 10.1016/S0304-3940(00)00956-3; Guidetti P, 2004, NEUROBIOL DIS, V17, P455, DOI 10.1016/j.nbd.2004.07.006; Guidetti P, 1999, EUR J NEUROSCI, V11, P3857, DOI 10.1046/j.1460-9568.1999.00806.x; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mallory MJ, 2003, J BIOL CHEM, V278, P44727, DOI 10.1074/jbc.M308632200; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Moroni F, 1999, ADV EXP MED BIOL, V467, P199; Muchowski PJ, 2002, P NATL ACAD SCI USA, V99, P727, DOI 10.1073/pnas.022628699; Perez-Severiano F, 2004, NEUROCHEM RES, V29, P729, DOI 10.1023/B:NERE.0000018843.83770.4b; Qin ZH, 2003, HUM MOL GENET, V12, P3231, DOI 10.1093/hmg/ddg346; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Richter A, 2003, EUR J PHARMACOL, V478, P47, DOI 10.1016/j.ejphar.2003.08.038; Rover S, 1997, J MED CHEM, V40, P4378, DOI 10.1021/jm970467t; Ryu JK, 2004, EXP NEUROL, V187, P150, DOI 10.1016/j.expneurol.2004.01.006; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006; Schwarcz R, 2002, J PHARMACOL EXP THER, V303, P1, DOI 10.1124/jpet.102.034439; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	30	264	273	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2005	37	5					526	531		10.1038/ng1542	http://dx.doi.org/10.1038/ng1542			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	15806102	Green Accepted			2022-12-17	WOS:000228862300023
J	Lin, YP; Ma, WL; Benchimol, S				Lin, YP; Ma, WL; Benchimol, S			Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis	NATURE GENETICS			English	Article							TRANSCRIPTIONAL ACTIVATION; GROWTH SUPPRESSION; ADAPTER MOLECULE; CELL-DEATH; INTERACTS; TRANSFORMATION; IDENTIFICATION; INHIBITION; MOTIF; RIP	The p53 tumour suppressor promotes cell-cycle arrest or apoptosis in response to cellular stress, such as DNA damage and oncogenesis. This role of p53 is important for its tumour-suppression function(1) and depends, at least in part, on its ability to bind to specific DNA sequences and activate the transcription of target genes(2-4). The pathway through which p53 promotes apoptosis is not fully understood. Here we describe a new gene regulated by p53 that encodes a predicted protein of 915 amino acids in mice (910 amino acids in humans), which we have named Pidd. The mouse Pidd cDNA contains a p53 consensus DNA binding sequence upstream of the Pidd-coding region. This sequence element bound to p53 and conferred p53-dependent inducibility on a heterologous reporter gene. Moreover, Pidd RNA was induced by ionizing radiation in a p53-dependent manner and the basal level of Pidd RNA was dependent on Trp53 status. Overexpression of Pidd inhibited cell growth in a p53-like manner by inducing apoptosis. Antisense inhibition of Pidd expression attenuated p53-mediated apoptosis. Our data suggest that Pidd is an effector of p53-dependent apoptosis.	Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, Toronto, ON, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Benchimol, S (corresponding author), Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, 500 Sherbourne St, Toronto, ON, Canada.			Benchimol, Samuel/0000-0003-3433-890X				Ahmad M, 1997, CANCER RES, V57, P615; BARRY ELR, 1993, BIOTECHNIQUES, V15, P1018; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CROOK T, 1994, CELL, V79, P817, DOI 10.1016/0092-8674(94)90071-X; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FU L, 1966, EMBO J, V15, P4392; JOHNSON P, 1993, MOL CELL BIOL, V13, P1456, DOI 10.1128/MCB.13.3.1456; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LIN YP, 1995, MOL CELL BIOL, V15, P6045; Mathews DH, 1999, RNA, V5, P1458, DOI 10.1017/S1355838299991148; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; PIETENPOL JA, 1994, P NATL ACAD SCI USA, V91, P1998, DOI 10.1073/pnas.91.6.1998; Resnick-Silverman L, 1998, GENE DEV, V12, P2102, DOI 10.1101/gad.12.14.2102; SLINGERLAND JM, 1993, EMBO J, V12, P1029, DOI 10.1002/j.1460-2075.1993.tb05744.x; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1	26	264	275	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					122	125		10.1038/79102	http://dx.doi.org/10.1038/79102			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	10973264				2022-12-17	WOS:000089078000033
J	Ewing, B; Green, P				Ewing, B; Green, P			Analysis of expressed sequence tags indicates 35,000 human genes	NATURE GENETICS			English	Article							HUMAN GENOME; CPG ISLANDS	The number of protein-coding genes in an organism provides a useful first measure of its molecular complexity. Single-celled prokaryotes and eukaryotes typically have a few thousand genes; for example. Escherichia coli(1) has 4,300 and Saccharomyces cerevisiae(2) has 6.000. Evolution of multicellularity appears to have been accompanied by a several-fold increase in gene number, the invertebrates Caenorhabditis elegans(3) and Drosophila melanogaster(4) having 19,000 and 13,600 genes, respectively. Here we estimate the number of human genes by comparing a set of human expressed sequence tag (EST) contigs with human chromosome 22 and with a non-redundant set of mRNA sequences. The two comparisons give mutually consistent estimates of approximately 35,000 genes, substantially lower than most previous estimates. Evolution of the increased physiological complexity of vertebrates may therefore have depended more on the combinatorial diversification of regulatory networks or alternative splicing than on a substantial increase in gene number.	Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Green, P (corresponding author), Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA.	phg@u.washington.edu						Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Bernardi G, 1995, ANNU REV GENET, V29, P445, DOI 10.1146/annurev.ge.29.120195.002305; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Dickson D, 1999, NATURE, V401, P311, DOI 10.1038/43722; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FIELDS C, 1994, NAT GENET, V7, P345, DOI 10.1038/ng0794-345; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; GREEN P, 1993, SCIENCE, V259, P1711, DOI 10.1126/science.8456298; Hillier L, 1996, GENOME RES, V6, P807, DOI 10.1101/gr.6.9.807; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; LEWIN B, 1990, GENES, V4, P466; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; WATERSTON R, 1992, NAT GENET, V1, P114, DOI 10.1038/ng0592-114; Wolfsberg TG, 1997, NUCLEIC ACIDS RES, V25, P1626, DOI 10.1093/nar/25.8.1626	19	264	298	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2000	25	2					232	234		10.1038/76115	http://dx.doi.org/10.1038/76115			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	321ML	10835644				2022-12-17	WOS:000087459200028
J	Lim, KC; Lakshmanan, G; Crawford, SE; Gu, Y; Grosveld, F; Engel, JD				Lim, KC; Lakshmanan, G; Crawford, SE; Gu, Y; Grosveld, F; Engel, JD			Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system	NATURE GENETICS			English	Article							TYROSINE-HYDROXYLASE GENE; MOUSE FETAL DEVELOPMENT; REGULATORY ELEMENTS; TARGETED DISRUPTION; EXPRESSION; TRANSCRIPTION; MICE; DIFFERENTIATION; LOCUS; PROMOTER	Mouse embryos deficient in Gata3 die by 11 days post coitum (d.p.c) from pathology of undetermined origin(1). We recently showed that Gata3-directed lacZ expression of a 625-kb Gata3 YAC transgene in mice mimics endogenous Gata3 expression, except in thymus and the sympathoadrenal system(2). As this transgene failed to overcome embryonic lethality (unpublished data and ref. 3) in Gata3(-/-) mice, we hypothesized that a neuroendocrine deficiency in the sympathetic nervous system (SNS) might cause embryonic lethality in these mutants. We find here that null mutation of Gata3 leads to reduced accumulation of Th (encoding tyrosine hydroxylase, Th) and Dbh (dopamine beta-hydroxylase. Dbh) mRNA. whereas several other SNS genes are unaffected. We show that Th and Dbh deficiencies lead to reduced noradrenaline in the SNS, and that noradrenaline deficiency is a proximal cause of death in mutants by feeding catechol intermediates to pregnant dams, thereby partially averting Gata3 mutation-induced lethality. These older, pharmacologically rescued mutants revealed abnormalities that previously could not be detected in untreated mutants. These late embryonic defects include renal hypoplasia and developmental defects in structures derived from cephalic neural crest cells. Thus we have shown that Gata3 has a role in the differentiation of multiple cell lineages during embryogenesis.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Northwestern Univ, Sch Med, Childrens Mem Inst Educ & Res, Dept Pathol, Evanston, IL 60208 USA; Erasmus Univ, Dept Cell Biol & Genet, Rotterdam, Netherlands	Northwestern University; Northwestern University; Erasmus University Rotterdam	Engel, JD (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.				NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028896] Funding Source: NIH RePORTER; NCI NIH HHS [CA60553] Funding Source: Medline; NIGMS NIH HHS [GM28896] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; DRESSLER GR, 1992, P NATL ACAD SCI USA, V89, P1179, DOI 10.1073/pnas.89.4.1179; Esler M, 1997, AM J CARDIOL, V80, pL7, DOI 10.1016/S0002-9149(97)00844-8; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; GROVES AK, 1995, DEVELOPMENT, V121, P887; Hirsch MR, 1998, DEVELOPMENT, V125, P599; HOYLE GW, 1994, J NEUROSCI, V14, P2455; Joh T H, 1998, Adv Pharmacol, V42, P33; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; KOBAYASHI K, 1995, J BIOL CHEM, V270, P27235, DOI 10.1074/jbc.270.45.27235; Lakshmanan G, 1998, DEV BIOL, V204, P451, DOI 10.1006/dbio.1998.8991; Lakshmanan G, 1999, MOL CELL BIOL, V19, P1558; LEONARD MW, 1993, DEVELOPMENT, V119, P519; Lieuw KH, 1997, DEV BIOL, V188, P1, DOI 10.1006/dbio.1997.8575; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; Nardelli J, 1999, DEV BIOL, V210, P305, DOI 10.1006/dbio.1999.9278; Onodera K, 2000, EMBO J, V19, P1335, DOI 10.1093/emboj/19.6.1335; OOSTERWEGEL M, 1992, DEV IMMUNOL, V3, P1, DOI 10.1155/1992/27903; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; RAHMAN MK, 1981, BIOCHEM PHARMACOL, V30, P645, DOI 10.1016/0006-2952(81)90139-8; ten Berge D, 1998, DEVELOPMENT, V125, P3831; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; Tiveron MC, 1996, J NEUROSCI, V16, P7649; Vainio S, 1997, CELL, V90, P975, DOI 10.1016/S0092-8674(00)80363-3; Yang CY, 1998, J NEUROCHEM, V71, P1358; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0	27	264	267	1	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2000	25	2					209	212		10.1038/76080	http://dx.doi.org/10.1038/76080			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	321ML	10835639				2022-12-17	WOS:000087459200023
J	Richard, G; Smith, LE; Bailey, RA; Itin, P; Hohl, D; Epstein, EH; DiGiovanna, JJ; Compton, JG; Bale, SJ				Richard, G; Smith, LE; Bailey, RA; Itin, P; Hohl, D; Epstein, EH; DiGiovanna, JJ; Compton, JG; Bale, SJ			Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis	NATURE GENETICS			English	Article							GAP JUNCTION PROTEINS; MOLECULAR-CLONING; EXPRESSION; SKIN; EPIDERMIS; DEAFNESS; FAMILY; MODULATION; LINKAGE	Erythrokeratodermia variabilis (EKV, OMIM 133200) is an autosomal dominant genodermatosis with considerable intra- and interfamilial variability(1). It has a disfiguring phenotype characterized by the independent occurrence of two morphologic features: transient figurate red patches and localized or generalized hyperkeratosis (Fig. 1). Both features can be triggered by external factors such as trauma to the skin. After initial linkage to the RH locus on 1p (refs 2,3). EKV was mapped to an an interval of 2.6 cM on 1p34-p35. and a candidate gene (GJA4) encoding the gap junction protein alpha-4 (connexin 31. Cx31) was excluded by sequence analysis(4). Evidence in mouse suggesting that the EKV region harbours a cluster of epidermally expressed connexin genes(5,6) led us to characterize the human homologues of GJB3 (encoding Cx31) and GJB5 (encoding Cx31.1). GJB3, GJB5 and GJA4 were localized to a 1.1-Mb YAC in the candidate interval. We detected heterozygous missense mutations in GJB3 in four EKV families leading to substitution of a conserved glycine by charged residues (G12R and G12D). or change of a cysteine (C865). These mutations are predicted to interfere with normal Cx31 structure and function, possibly due to a dominant inhibitory effect. Our results implicate Cx31 in the pathogenesis of EKV, and provide evidence that intercellular communication mediated by Cx31 is crucial for epidermal differentiation and response to external factors.	NIAMSD, Genet Studies Sect, Skin Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Basel, Dept Dermatol, Basel, Switzerland; Beaumont Hosp, Dept Dermatol, Lausanne, Switzerland; Univ Calif San Francisco, San Francisco Gen Hosp, Dept Dermatol, San Francisco, CA 94143 USA; Brown Univ, Rhode Isl Hosp, Dept Dermatol, Div Dermatopharmacol, Providence, RI 02903 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Basel; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Bale, SJ (corresponding author), NIAMSD, Genet Studies Sect, Skin Biol Lab, NIH, Bethesda, MD 20892 USA.			DiGiovanna, John J./0000-0002-2750-2313				BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; BRISSETTE JL, 1994, P NATL ACAD SCI USA, V91, P6453, DOI 10.1073/pnas.91.14.6453; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; BUTTERWECK A, 1994, EUR J CELL BIOL, V65, P152; DACOSTA SM, 1925, ACTA DERM-VENEREOL, V6, P255; Denoyelle F, 1997, HUM MOL GENET, V6, P2173, DOI 10.1093/hmg/6.12.2173; Deschenes SM, 1997, J NEUROSCI, V17, P9077; GOLIGER JA, 1994, DEV DYNAM, V200, P1, DOI 10.1002/aja.1002000102; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; GUO HM, 1992, J INVEST DERMATOL, V99, P460, DOI 10.1111/1523-1747.ep12616154; HAEFLIGER JA, 1992, J BIOL CHEM, V267, P2057; HENNEMANN H, 1992, EUR J CELL BIOL, V57, P51; HENNEMANN H, 1992, J BIOL CHEM, V267, P17225; HOH JH, 1991, J BIOL CHEM, V266, P6524; ITIN P, 1992, HAUTARZT, V43, P500; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Krawczak M, 1997, TRENDS GENET, V13, P121, DOI 10.1016/S0168-9525(97)01068-8; Larson DM, 1997, AM J PHYSIOL-CELL PH, V272, pC405, DOI 10.1152/ajpcell.1997.272.2.C405; MasgrauPeya E, 1997, J HISTOCHEM CYTOCHEM, V45, P1207, DOI 10.1177/002215549704500904; REED KE, 1993, J CLIN INVEST, V91, P997, DOI 10.1172/JCI116321; Richard G, 1997, J INVEST DERMATOL, V109, P666, DOI 10.1111/1523-1747.ep12337713; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; RISEK B, 1992, DEVELOPMENT, V116, P639; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; SUCHYNA TM, 1993, NATURE, V365, P847, DOI 10.1038/365847a0; VANDERSCHROEFF JG, 1988, HUM GENET, V80, P97, DOI 10.1007/BF00451466; VANDERSCHROEFF JG, 1984, HUM GENET, V68, P165, DOI 10.1007/BF00279308; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; Yeager M, 1996, CURR OPIN STRUC BIOL, V6, P183, DOI 10.1016/S0959-440X(96)80073-X; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605	30	264	284	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1998	20	4					366	369		10.1038/3840	http://dx.doi.org/10.1038/3840			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	9843209				2022-12-17	WOS:000077199600024
J	Kas, K; Voz, ML; Roijer, E; Astrom, AK; Meyen, E; Stenman, G; VandeVen, WJM				Kas, K; Voz, ML; Roijer, E; Astrom, AK; Meyen, E; Stenman, G; VandeVen, WJM			Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations	NATURE GENETICS			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ENCODING GENE; FUSION; TUMOR; LYMPHOMA; LIBRARY; LAZ3	Pleiomorphic adenoma of the salivary glands is a benign epithelial tumour occurring primarily in the major and minor salivary glands(1). It is by far the most common type of salivary gland tumour. Microscopically, pleiomorphic adenomas show a marked histological diversity with epithelial, myoepithelial and mesenchymal components in a variety of patterns. In addition to a cytogenetic subgroup with normal karyotypes, pleiomorphic adenomas are characterized by recurrent chromosome rearrangements, particularly reciprocal translocations, with breakpoints at 8q12, 3p21, and 12q13-15, in that order of frequency(2,3). The most common abnormality is a reciprocal t(3;8)(p21;q12). We here demonstrate that the t(3;8)(p21;q12) results in promoter swapping between PLAG1, a novel, developmentally regulated zinc finger gene at 8q12, and the constitutively expressed gene for beta-catenin (CTNNB1), a protein interface functioning in the WG/WNT signalling pathway and specification of cell fate during embryogenesis(4). Fusions occur in the 5'-non-coding regions of both genes, exchanging regulatory control elements while preserving the coding sequences. Due to the t(3;8)(p21;q12), PLAG1 is activated and expression levels of CTNNB1 are reduced. Activation of PLAG1 was also observed in an adenoma with a variant translocation t(8;15)(q12;q14). Our results indicate that PLAG1 activation due to promoter swapping is a crucial event in salivary gland tumourigenesis.	CATHOLIC UNIV LEUVEN,CTR HUMAN GENET,MOL ONCOL LAB,B-3000 LOUVAIN,BELGIUM; FLANDERS INTERUNIV INST BIOTECHNOL,B-3000 LOUVAIN,BELGIUM; GOTHENBURG UNIV,SAHLGRENS HOSP,DEPT PATHOL,CANC GENET LAB,S-41345 GOTHENBURG,SWEDEN	KU Leuven; Sahlgrenska University Hospital; University of Gothenburg								ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ALTSCHUL SF, 1990, J MOL BIOL, V17, P166; APLAN PD, 1992, BLOOD, V79, P1327; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; BULLERDIEK J, 1993, CANCER GENET CYTOGEN, V65, P27, DOI 10.1016/0165-4608(93)90054-P; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; DALLERY E, 1995, ONCOGENE, V10, P2171; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Galieque-Zouitina S, 1996, LEUKEMIA, V10, P579; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HABER DA, 1990, CELL, V61, P1257, DOI 10.1016/0092-8674(90)90690-G; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; KRAUS C, 1994, GENOMICS, V23, P272, DOI 10.1006/geno.1994.1493; LADANYI M, 1994, CANCER RES, V54, P2837; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Nollet F, 1996, GENOMICS, V32, P413, DOI 10.1006/geno.1996.0136; ROIJER E, IN PRESS GENES CHROM; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; Sambrook J, 1989, MOL CLONING LAB MANU; SANDROS J, 1990, CANCER GENET CYTOGEN, V44, P153, DOI 10.1016/0165-4608(90)90042-9; SCHOENMAKERS EFPM, 1994, GENOMICS, V20, P210, DOI 10.1006/geno.1994.1155; SCHOENMAKERS EFPM, 1995, NAT GENET, V10, P436, DOI 10.1038/ng0895-436; Waldron CA., 1991, SURG PATHOLOGY SALIV, P165; WOOD S, 1992, CYTOGENET CELL GENET, V59, P243, DOI 10.1159/000133260; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; [No title captured]	28	264	273	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					170	174		10.1038/ng0297-170	http://dx.doi.org/10.1038/ng0297-170			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020842				2022-12-17	WOS:A1997WF08700016
J	RISINGER, JI; BERCHUCK, A; KOHLER, MF; BOYD, J				RISINGER, JI; BERCHUCK, A; KOHLER, MF; BOYD, J			MUTATIONS OF THE E-CADHERIN GENE IN HUMAN GYNECOLOGIC CANCERS	NATURE GENETICS			English	Article							CELL-ADHESION MOLECULE; TUMOR SUPPRESSOR GENE; PROSTATE-CANCER; EXPRESSION; CARCINOMA; CHROMOSOME-16; UVOMORULIN; ADENOCARCINOMA; PROGRESSION; ALLELOTYPE	Expression of the E-cadherin cell adhesion molecule is reduced in several types of human carcinomas, and the protein serves as an invasion suppressor in vitro. To determine if mutations of the E-cadherin gene (on chromosome 16q22) contribute to epithelial tumorigenesis, 135 carcinomas of the endometrium and ovary were examined for alterations in the E-cadherin coding region. Four mutations were identified: one somatic nonsense and one somatic missense mutation, both with retention of the wildtype alleles, and two missense mutations with somatic loss of heterozygosity in the tumour tissue. These data support the classification of E-cadherin as a human tumour suppressor gene.	NIEHS,GYNECOL PATHOBIOL GRP,MOLEC CARCINOGENESIS LAB,RES TRIANGLE PK,NC 27709; DUKE UNIV,MED CTR,DEPT OBSTET & GYNECOL,DURHAM,NC 27710	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University				Boyd, Jeff/0000-0002-3517-7637				BEHRENS J, 1989, J CELL BIOL, V108, P2435, DOI 10.1083/jcb.108.6.2435; BERGERHEIM USR, 1991, GENE CHROMOSOME CANC, V3, P215, DOI 10.1002/gcc.2870030308; BRABANT G, 1993, CANCER RES, V53, P4987; BRINGUIER PP, 1993, CANCER RES, V53, P3241; BUSSEMAKERS MJG, 1993, MOL BIOL REP, V17, P123, DOI 10.1007/BF00996219; BUSSEMAKERS MJG, 1992, CANCER RES, V52, P2916; CARTER BS, 1990, P NATL ACAD SCI USA, V87, P8751, DOI 10.1073/pnas.87.22.8751; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DEVILEE P, 1991, ONCOGENE, V6, P1705; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; EDELMAN GM, 1988, BIOCHEMISTRY-US, V27, P3533, DOI 10.1021/bi00410a001; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; GAO X, 1993, CANCER RES, V53, P2723; HOFFMAN S, 1983, P NATL ACAD SCI-BIOL, V80, P5762, DOI 10.1073/pnas.80.18.5762; HOHNE MW, 1992, CANCER RES, V52, P2616; INOUE M, 1992, AM J CLIN PATHOL, V98, P76, DOI 10.1093/ajcp/98.1.76; KUNIMI K, 1991, GENOMICS, V11, P530, DOI 10.1016/0888-7543(91)90059-N; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; MANSOURI A, 1988, DIFFERENTIATION, V38, P67, DOI 10.1111/j.1432-0436.1988.tb00593.x; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; NATT E, 1989, CYTOGENET CELL GENET, V50, P145, DOI 10.1159/000132745; ODA T, 1994, P NATL ACAD SCI USA, V91, P1858, DOI 10.1073/pnas.91.5.1858; SASAKI H, 1993, CANCER RES, V53, P1906; SATO T, 1991, CANCER RES, V51, P5118; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; SHIMOYAMA Y, 1991, CANCER RES, V51, P2185; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.bi.59.070190.001321; TSUDA H, 1990, P NATL ACAD SCI USA, V87, P6791, DOI 10.1073/pnas.87.17.6791; UMBAS R, 1992, CANCER RES, V52, P5104; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M	31	264	270	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1994	7	1					98	102		10.1038/ng0594-98	http://dx.doi.org/10.1038/ng0594-98			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	8075649				2022-12-17	WOS:A1994NJ84200021
J	TATSUMI, K; MIYAI, K; NOTOMI, T; KAIBE, K; AMINO, N; MIZUNO, Y; KOHNO, H				TATSUMI, K; MIYAI, K; NOTOMI, T; KAIBE, K; AMINO, N; MIZUNO, Y; KOHNO, H			CRETINISM WITH COMBINED HORMONE DEFICIENCY CAUSED BY A MUTATION IN THE PIT1 GENE	NATURE GENETICS			English	Article							THYROID-HORMONE; TRANSCRIPTION FACTOR; BETA-SUBUNIT; DNA-BINDING; POU-DOMAIN; RESISTANCE; RECEPTOR; REGION; SRY	Cretinism is marked by irreversible mental and growth retardation. We describe here an entirely new case of cretinism showing combined pituitary hormone deficiencies of thyrotropin, growth hormone and prolactin that appears to be caused by homozygosity for a nonsense mutation in the gene for the pituitary specific transcription activator, Pit-1/GHF-1 (designated PIT1 in humans for pituitary specific factor 1). This is the first report in humans of a defect in a transcription activator causing deficiency of multiple target genes.	FUKUOKA HIGASHI NATL HOSP,FUKUOKA,JAPAN; FUKUOKA CHILDRENS HOSP,FUKUOKA,JAPAN		TATSUMI, K (corresponding author), OSAKA UNIV,SCH MED,DEPT LAB MED,SUITA,OSAKA 565,JAPAN.							ASHIDA N, IN PRESS SCREENING, V1; BACHMANN B, 1990, NUCLEIC ACIDS RES, V18, P1309, DOI 10.1093/nar/18.5.1309; BALLING R, 1988, CELL, V55, P531, DOI 10.1016/0092-8674(88)90039-6; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; BRAVERMAN LD, 1991, WERNER INGBARS THYRO; CHALEPAKIS G, 1991, CELL, V66, P873, DOI 10.1016/0092-8674(91)90434-Z; CHATTERJEE VKK, 1991, J CLIN INVEST, V87, P1977; CHISAKA O, 1992, NATURE, V355, P516, DOI 10.1038/355516a0; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; DACOUVOUTETAKIS C, 1990, AM J HUM GENET, V46, P988; DeGroot LJ, 1989, ENDOCRINOLOGY; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; Green MC., 1989, GENETIC VARIANTS STR, P12; HATA N, 1985, CLIN CHEM, V31, P750; HAYASHIZAKI Y, 1990, J CLIN ENDOCR METAB, V71, P792, DOI 10.1210/jcem-71-4-792; HAYASHIZAKI Y, 1989, EMBO J, V8, P2291, DOI 10.1002/j.1460-2075.1989.tb08355.x; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; IEIRI T, 1991, J CLIN INVEST, V88, P1901, DOI 10.1172/JCI115513; INGRAHAM HA, 1990, CELL, V61, P1021, DOI 10.1016/0092-8674(90)90067-O; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; JAGER RJ, 1990, NATURE, V348, P452, DOI 10.1038/348452a0; KOHNO H, 1980, ARCH DIS CHILD, V55, P725, DOI 10.1136/adc.55.9.725; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; MIYAI K, 1971, NEW ENGL J MED, V285, P1043, DOI 10.1056/NEJM197111042851902; MIYAI K, 1988, PROGR ENDOCRINOLOGY, P545; MORI R, 1991, JPN J HUM GENET, V36, P313, DOI 10.1007/BF01883604; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; NOGUCHI T, 1988, PROG NEUROBIOL, V31, P149, DOI 10.1016/0301-0082(88)90030-5; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; RUVKUN G, 1991, CELL, V64, P475, DOI 10.1016/0092-8674(91)90227-P; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAKURAI A, 1990, MOL ENDOCRINOL, V4, P1988, DOI 10.1210/mend-4-12-1988; SAKURAI A, 1989, P NATL ACAD SCI USA, V86, P8977, DOI 10.1073/pnas.86.22.8977; TAKEDA K, 1991, J CLIN INVEST, V87, P496, DOI 10.1172/JCI115023; TATSUMI K, 1992, BIOCHIM BIOPHYS ACTA, V1129, P231, DOI 10.1016/0167-4781(92)90494-K; THEILL LE, 1989, NATURE, V342, P945, DOI 10.1038/342945a0; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; USALA SJ, 1990, BIOCHEM BIOPH RES CO, V171, P575, DOI 10.1016/0006-291X(90)91185-U; USALA SJ, 1991, J CLIN ENDOCR METAB, V72, P32, DOI 10.1210/jcem-72-1-32; USALA SJ, 1991, MOL ENDOCRINOL, V5, P327, DOI 10.1210/mend-5-3-327; USALA SJ, 1990, J CLIN INVEST, V85, P93, DOI 10.1172/JCI114438; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0	46	264	271	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1992	1	1					56	58		10.1038/ng0492-56	http://dx.doi.org/10.1038/ng0492-56			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC978	1302000				2022-12-17	WOS:A1992JC97800013
J	Canela-Xandri, O; Rawlik, K; Tenesa, A				Canela-Xandri, Oriol; Rawlik, Konrad; Tenesa, Albert			An atlas of genetic associations in UK Biobank	NATURE GENETICS			English	Article							MIXED-MODEL; TOOL	Genome-wide association studies (GWAS) have identified many loci contributing to variation in complex traits, yet the majority of loci that contribute to the heritability of complex traits remain elusive. Large study populations with sufficient statistical power are required to detect the small effect sizes of the yet unidentified genetic variants. However, the analysis of huge cohorts, like UK Biobank, is challenging. Here, we present an atlas of genetic associations for 118 non-binary and 660 binary traits of 452,264 UK Biobank participants of European ancestry. Results are compiled in a publicly accessible database that allows querying genome-wide association results for 9,113,133 genetic variants, as well as downloading GWAS summary statistics for over 30 million imputed genetic variants (>23 billion phenotype-genotype pairs). Our atlas of associations (GeneATLAS, http://geneatls.roslin.ed.ac.uk) will help researchers to query UK Biobank results in an easy and uniform way without the need to incur high computational costs.	[Canela-Xandri, Oriol; Rawlik, Konrad; Tenesa, Albert] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Edinburgh, Midlothian, Scotland; [Canela-Xandri, Oriol; Tenesa, Albert] Univ Edinburgh, Western Gen Hosp, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Tenesa, A (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Edinburgh, Midlothian, Scotland.; Tenesa, A (corresponding author), Univ Edinburgh, Western Gen Hosp, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland.	albert.tenesa@ed.ac.uk			UK Biobank Resource [788]; Roslin Institute Strategic Programme Grant from the BBSRC [BB/P013732/1]; MRC [MR/N003179/1, MR/R025851/1]; Medical Research Council; MRC [MR/P015514/1] Funding Source: UKRI	UK Biobank Resource; Roslin Institute Strategic Programme Grant from the BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research has been conducted using the UK Biobank Resource under project 788. The work was funded by the Roslin Institute Strategic Programme Grant from the BBSRC (BB/P013732/1) and MRC grant (MR/N003179/1) granted to A.T. A.T. also acknowledges funding from the Medical Research Council and O.C.-X. from MRC fellowship MR/R025851/1. Analyses were performed using the ARCHER UK National Supercomputing Service.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Bycroft C., 2017, BIORXIV, DOI [DOI 10.1101/16629824, DOI 10.1101/166298]; Canela-Xandri O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166755; Canela-Xandri O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10162; Chahal HS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12510; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; Falconer DS, 1996, INTRO QUANTITATIVE G; Loh PR, 2018, NAT GENET, V50, P906, DOI 10.1038/s41588-018-0144-6; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Meuwissen THE, 2001, GENETICS, V157, P1819; Palmer C, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006916; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ransohoff KJ, 2017, ONCOTARGET, V8, P17586, DOI 10.18632/oncotarget.15230; STRAM DO, 1994, BIOMETRICS, V50, P1171, DOI 10.2307/2533455; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Visscher PM, 2006, TWIN RES HUM GENET, V9, P490, DOI 10.1375/twin.9.4.490; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	21	263	264	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2018	50	11					1593	+		10.1038/s41588-018-0248-z	http://dx.doi.org/10.1038/s41588-018-0248-z			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GY2UB		Green Accepted, Green Submitted			2022-12-17	WOS:000448398000015
J	Liu, JZ; Hov, JR; Folseraas, T; Ellinghaus, E; Rushbrook, SM; Doncheva, NT; Andreassen, OA; Weersma, RK; Weismuller, TJ; Eksteen, B; Invernizzi, P; Hirschfield, GM; Gotthardt, DN; Pares, A; Ellinghaus, D; Shah, T; Juran, BD; Milkiewicz, P; Rust, C; Schramm, C; Muller, T; Srivastava, B; Dalekos, G; Nothen, MM; Herms, S; Winkelmann, J; Mitrovic, M; Braun, F; Ponsioen, CY; Croucher, PJP; Sterneck, M; Teufel, A; Mason, AL; Saarela, J; Leppa, V; Dorfman, R; Alvaro, D; Floreani, A; Onengut-Gumuscu, S; Rich, SS; Thompson, WK; Schork, AJ; Naess, S; Thomsen, I; Mayr, G; Konig, IR; Hveem, K; Cleynen, I; Gutierrez-Achury, J; Ricano-Ponce, I; van Heel, D; Bjornsson, E; Sandford, RN; Durie, PR; Melum, E; Vatn, MH; Silverberg, MS; Duerr, RH; Padyukov, L; Brand, S; Sans, M; Annese, V; Achkar, JP; Boberg, KM; Marschall, HU; Chazouilleres, O; Bowlus, CL; Wijmenga, C; Schrumpf, E; Vermeire, S; Albrecht, M; Rioux, JD; Alexander, G; Bergquist, A; Cho, J; Schreiber, S; Manns, MP; Farkkila, M; Dale, AM; Chapman, RW; Lazaridis, KN; Franke, A; Anderson, CA; Karlsen, TH				Liu, Jimmy Z.; Hov, Johannes Roksund; Folseraas, Trine; Ellinghaus, Eva; Rushbrook, Simon M.; Doncheva, Nadezhda T.; Andreassen, Ole A.; Weersma, Rinse K.; Weismueller, Tobias J.; Eksteen, Bertus; Invernizzi, Pietro; Hirschfield, Gideon M.; Gotthardt, Daniel Nils; Pares, Albert; Ellinghaus, David; Shah, Tejas; Juran, Brian D.; Milkiewicz, Piotr; Rust, Christian; Schramm, Christoph; Mueller, Tobias; Srivastava, Brijesh; Dalekos, Georgios; Noethen, Markus M.; Herms, Stefan; Winkelmann, Juliane; Mitrovic, Mitja; Braun, Felix; Ponsioen, Cyriel Y.; Croucher, Peter J. P.; Sterneck, Martina; Teufel, Andreas; Mason, Andrew L.; Saarela, Janna; Leppa, Virpi; Dorfman, Ruslan; Alvaro, Domenico; Floreani, Annarosa; Onengut-Gumuscu, Suna; Rich, Stephen S.; Thompson, Wesley K.; Schork, Andrew J.; Naess, Sigrid; Thomsen, Ingo; Mayr, Gabriele; Koenig, Inke R.; Hveem, Kristian; Cleynen, Isabelle; Gutierrez-Achury, Javier; Ricano-Ponce, Isis; van Heel, David; Bjoernsson, Einar; Sandford, Richard N.; Durie, Peter R.; Melum, Espen; Vatn, Morten H.; Silverberg, Mark S.; Duerr, Richard H.; Padyukov, Leonid; Brand, Stephan; Sans, Miquel; Annese, Vito; Achkar, Jean-Paul; Boberg, Kirsten Muri; Marschall, Hanns-Ulrich; Chazouilleres, Olivier; Bowlus, Christopher L.; Wijmenga, Cisca; Schrumpf, Erik; Vermeire, Severine; Albrecht, Mario; Rioux, John D.; Alexander, Graeme; Bergquist, Annika; Cho, Judy; Schreiber, Stefan; Manns, Michael P.; Farkkila, Martti; Dale, Anders M.; Chapman, Roger W.; Lazaridis, Konstantinos N.; Franke, Andre; Anderson, Carl A.; Karlsen, Tom H.		UK-PSCSC Consortium; Int IBD Genetics Consortium; Int PSCSC Study Grp	Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; FALSE DISCOVERY RATE; HISTONE DEACETYLASE; SUSCEPTIBILITY LOCI; ULCERATIVE-COLITIS; NATURAL-HISTORY; BOWEL-DISEASE; GENETIC RISK; MIXED-MODEL; HLA	Primary sclerosing cholangitis (PSC) is a severe liver disease of unknown etiology leading to fibrotic destruction of the bile ducts and ultimately to the need for liver transplantation(1-3). We compared 3,789 PSC cases of European ancestry to 25,079 population controls across 130,422 SNPs genotyped using the Immunochip(4). We identified 12 genome-wide significant associations outside the human leukocyte antigen (HLA) complex, 9 of which were new, increasing the number of known PSC risk loci to 16. Despite comorbidity with inflammatory bowel disease (IBD) in 72% of the cases, 6 of the 12 loci showed significantly stronger association with PSC than with IBD, suggesting overlapping yet distinct genetic architectures for these two diseases. We incorporated association statistics from 7 diseases clinically occurring with PSC in the analysis and found suggestive evidence for 33 additional pleiotropic PSC risk loci. Together with network analyses, these findings add to the genetic risk map of PSC and expand on the relationship between PSC and other immune-mediated diseases.	[Liu, Jimmy Z.; Shah, Tejas; Cleynen, Isabelle; Anderson, Carl A.] Wellcome Trust Sanger Inst, Cambridge, England; [Hov, Johannes Roksund; Folseraas, Trine; Naess, Sigrid; Melum, Espen; Boberg, Kirsten Muri; Schrumpf, Erik; Karlsen, Tom H.] Oslo Univ Hosp, Rikshosp, Div Canc Med Surg & Transplantat, Norwegian PSC Res Ctr,Dept Transplantat Med, Oslo, Norway; [Hov, Johannes Roksund; Folseraas, Trine; Naess, Sigrid; Melum, Espen; Karlsen, Tom H.] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, KG Jebsen Inflammat Res Ctr, Oslo, Norway; [Hov, Johannes Roksund; Folseraas, Trine; Andreassen, Ole A.; Naess, Sigrid; Melum, Espen; Vatn, Morten H.; Boberg, Kirsten Muri; Schrumpf, Erik] Univ Oslo, Inst Clin Med, Oslo, Norway; [Hov, Johannes Roksund; Vatn, Morten H.; Boberg, Kirsten Muri; Schrumpf, Erik; Karlsen, Tom H.] Oslo Univ Hosp, Rikshosp, Div Canc Med Surg & Transplantat, Sect Gastroenterol,Dept Transplantat Med, Oslo, Norway; [Ellinghaus, Eva; Ellinghaus, David; Thomsen, Ingo; Schreiber, Stefan; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Rushbrook, Simon M.] Dept Gastroenterol & Hepatol, Norfolk, VA USA; [Rushbrook, Simon M.] Univ Hosp Natl Hlth Serv NHS Trust, Norwich, Norfolk, England; [Doncheva, Nadezhda T.; Mayr, Gabriele; Albrecht, Mario] Max Planck Inst Informat, D-66123 Saarbrucken, Germany; [Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, KG Jebsen Ctr Psychosis Res, Oslo, Norway; [Weersma, Rinse K.] Univ Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Weersma, Rinse K.; Mitrovic, Mitja; Gutierrez-Achury, Javier; Ricano-Ponce, Isis; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Weismueller, Tobias J.; Manns, Michael P.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Weismueller, Tobias J.; Manns, Michael P.] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, Hannover, Germany; [Eksteen, Bertus] Univ Calgary, Dept Med, Snyder Inst Chron Dis, Calgary, AB, Canada; [Invernizzi, Pietro] Humanitas Clin & Res Ctr, Ctr Autoimmune Liver Dis, Rozzano, Italy; [Hirschfield, Gideon M.] Univ Toronto, Dept Med, Div Gastroenterol, Toronto, ON, Canada; [Hirschfield, Gideon M.] NIHR, Liver Res Ctr, Biomed Res Unit, Birmingham, W Midlands, England; [Gotthardt, Daniel Nils] Univ Heidelberg Hosp, Dept Med, Heidelberg, Germany; [Pares, Albert] Univ Barcelona, IDIBAPS, CIBERehd, Liver Unit,Hosp Clin, Barcelona, Spain; [Juran, Brian D.; Lazaridis, Konstantinos N.] Mayo Clin, Coll Med, Ctr Basic Res Digest Dis, Div Gastroenterol & Hepatol, Rochester, MN USA; [Milkiewicz, Piotr] Pomeranian Med Univ, Liver Unit, Szczecin, Poland; [Milkiewicz, Piotr] Pomeranian Med Univ, Liver Res Labs, Szczecin, Poland; [Rust, Christian] Univ Munich, Dept Med 2, Munich, Germany; [Schramm, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [Mueller, Tobias] Charite, Dept Internal Med Hepatol & Gastroenterol, D-13353 Berlin, Germany; [Srivastava, Brijesh; Sandford, Richard N.] Univ Cambridge, Acad Dept Med Genet, Cambridge, England; [Dalekos, Georgios] Univ Thessaly, Sch Med, Dept Med, Larisa, Greece; [Dalekos, Georgios] Univ Thessaly, Sch Med, Larisa, Greece; [Noethen, Markus M.; Herms, Stefan] Univ Bonn, Inst Human Genet, Bonn, Germany; [Noethen, Markus M.; Herms, Stefan] Univ Bonn, Dept Genom, Life & Brain Ctr, Bonn, Germany; [Winkelmann, Juliane] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Winkelmann, Juliane] Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany; [Winkelmann, Juliane] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Mitrovic, Mitja; Gutierrez-Achury, Javier; Ricano-Ponce, Isis; Wijmenga, Cisca] Univ Groningen, Dept Genet, Groningen, Netherlands; [Braun, Felix] Univ Med Ctr Schleswig Holstein, Dept Gen Visceral Thorac Transplantat & Pediat Su, Kiel, Germany; [Ponsioen, Cyriel Y.] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands; [Croucher, Peter J. P.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Sterneck, Martina] Univ Med Ctr Hamburg Eppendorf, Dept Hepatobiliary Surg & Transplantat, Hamburg, Germany; [Teufel, Andreas] Johannes Gutenberg Univ Mainz, Dept Med 1, Mainz, Germany; [Mason, Andrew L.] Univ Alberta, Div Gastroenterol & Hepatol, Edmonton, AB, Canada; [Saarela, Janna] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Leppa, Virpi] Univ Helsinki, FIMM, Publ Hlth Genom Unit, Helsinki, Finland; [Leppa, Virpi] Natl Inst Hlth & Welf, Helsinki, Finland; [Dorfman, Ruslan] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Alvaro, Domenico] Univ Roma La Sapienza, Dept Clin Med, Div Gastroenterol, Rome, Italy; [Floreani, Annarosa] Univ Padua, Dept Surg Oncol & Gastroenterol Sci, Padua, Italy; [Onengut-Gumuscu, Suna] Univ Virginia, Div Endocrinol & Metab, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Onengut-Gumuscu, Suna] Univ Virginia, Dept Internal Med, Div Endocrinol & Metab, Charlottesville, VA USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Rich, Stephen S.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Thompson, Wesley K.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Schork, Andrew J.] Univ Calif San Diego, Grad Program Cognit Sci, La Jolla, CA 92093 USA; [Koenig, Inke R.] Med Univ Lubeck, Inst Med Biometry & Stat, D-23538 Lubeck, Germany; [Hveem, Kristian] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth, N-7034 Trondheim, Norway; [Cleynen, Isabelle; Vermeire, Severine] Katholieke Univ Leuven, Dept Clin & Expt Med, Louvain, Belgium; [van Heel, David] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England; [Bjoernsson, Einar] Landspitali Univ Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Reykjavik, Iceland; [Durie, Peter R.] Hosp Sick Children, Physiol & Expt Med Res Inst, Toronto, ON M5G 1X8, Canada; [Vatn, Morten H.] Akershus Univ Hosp, EpiGen, Nordbyhagen, Norway; [Silverberg, Mark S.] Mt Sinai Hosp, Inflammatory Bowel Dis IBD Grp, Zane Cohen Ctr Digest Dis, Toronto, ON M5G 1X5, Canada; [Duerr, Richard H.] Univ Pittsburgh, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA; [Duerr, Richard H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Padyukov, Leonid] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Padyukov, Leonid] Karolinska Univ Hosp Solna, Stockholm, Sweden; [Brand, Stephan] Univ Munich, Univ Hosp Munich Grosshadern, Dept Med 2, Munich, Germany; [Sans, Miquel] Ctr Med Teknon, Dept Digest Dis, Barcelona, Spain; [Annese, Vito] Casa Sollievodella Sofferenza Hosp, Ist Ricovero & Cura Carattere Sci, Div Gastroenterol, San Giovanni Rotondo, Italy; [Annese, Vito] Azienda Osped Univ Careggi, Unit Gastroenterol SOD2, Florence, Italy; [Achkar, Jean-Paul] Cleveland Clin, Dept Gastroenterol & Hepatol, Inst Digest Dis, Cleveland, OH 44106 USA; [Achkar, Jean-Paul] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44106 USA; [Marschall, Hanns-Ulrich] Sahlgrens Acad, Inst Med, Dept Internal Med, Gothenburg, Sweden; [Marschall, Hanns-Ulrich] Univ Hosp, Gothenburg, Sweden; [Chazouilleres, Olivier] Univ Paris 06, Hop St Antoine, AP HP, Dept Hepatol, Paris, France; [Bowlus, Christopher L.] Univ Calif Davis, Div Gastroenterol & Hepatol, Davis, CA 95616 USA; [Vermeire, Severine] Katholieke Univ Leuven Hosp, Dept Gastroenterol, Louvain, Belgium; [Albrecht, Mario] Univ Med Greifswald, Dept Bioinformat, Inst Biometr & Med Informat, Greifswald, Germany; [Rioux, John D.] Univ Montreal, Res Ctr, Montreal, PQ, Canada; [Rioux, John D.] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Alexander, Graeme] Univ Cambridge, Dept Med, Div Hepatol, Cambridge CB2 2QQ, England; [Bergquist, Annika] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Gastroenterol & Hepatol, Stockholm, Sweden; [Cho, Judy] Yale Univ, Dept Med, Sect Digest Dis, New Haven, CT 06520 USA; [Schreiber, Stefan] Univ Kiel, Dept Gen Internal Med, Kiel, Germany; [Schreiber, Stefan] Univ Kiel, Univ Hosp Schleswig Holstein, PopGen Biobank, Kiel, Germany; [Farkkila, Martti] Helsinki Univ Hosp, Dept Med, Div Gastroenterol, Helsinki, Finland; [Dale, Anders M.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Chapman, Roger W.] John Radcliffe Univ Hosp NHS Trust, Dept Hepatol, Oxford, England; [Karlsen, Tom H.] Univ Bergen, Dept Clin Med, Div Gastroenterol, Bergen, Norway	Wellcome Trust Sanger Institute; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; National Hospital Norway; University of Kiel; Max Planck Society; University of Oslo; University of Groningen; University of Groningen; Hannover Medical School; Hannover Medical School; University of Calgary; IRCCS Humanitas Research Hospital; University of Toronto; University of Birmingham; Ruprecht Karls University Heidelberg; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Mayo Clinic; Pomeranian Medical University; Pomeranian Medical University; University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cambridge; University of Thessaly; University of Thessaly; University of Bonn; University of Bonn; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Groningen; University of Kiel; Schleswig Holstein University Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of California System; University of California Berkeley; University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz; University of Alberta; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Sapienza University Rome; University of Padua; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Lubeck; Norwegian University of Science & Technology (NTNU); KU Leuven; University of London; Queen Mary University London; Landspitali National University Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Munich; IRCCS Casa Sollievo Della Sofferenza; University of Florence; Azienda Ospedaliero Universitaria Careggi; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Gothenburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California Davis; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Greifswald Medical School; Universite de Montreal; Universite de Montreal; University of Cambridge; Karolinska Institutet; Karolinska University Hospital; Yale University; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Helsinki; Helsinki University Central Hospital; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Bergen	Karlsen, TH (corresponding author), Oslo Univ Hosp, Rikshosp, Div Canc Med Surg & Transplantat, Norwegian PSC Res Ctr,Dept Transplantat Med, Oslo, Norway.	t.h.karlsen@medisin.uio.no	Ellinghaus, David/ABC-3610-2020; Silverberg, Mark/B-4183-2008; Färkkilä, Martti/AAG-6970-2021; Weersma, Rinse/ABE-3807-2021; ALVARO, Domenico/J-8600-2018; Hveem, Kristian/AFV-4683-2022; Zeissig, Sebastian/B-6297-2012; Duerr, Richard H/B-4188-2009; Invernizzi, Pietro/AAB-8367-2022; Ellinghaus, Eva/E-6490-2012; Rioux, John D/A-9599-2015; Braun, Felix/AAK-8329-2021; Saarela, Janna S/E-5369-2014; Albrecht, Mario/B-6694-2008; Wijmenga, Cisca/D-2173-2009; Andreassen, Ole A./AAY-7531-2020; Marschall, Hanns-Ulrich/K-8842-2017; Franke, Andre/B-2151-2010; Teufel, Andreas/ABD-8000-2021; Pares, Albert/M-6268-2019; D'Amato, Mauro/F-2450-2010; Palmieri, Orazio/J-7697-2012; D'Amato, Mauro/B-5050-2019; Ricaño-Ponce, Isis/ABC-5454-2020; Gearry, Richard B/H-3959-2019; König, Inke R/A-4544-2009; Ellinghaus, David/G-4467-2012; Wijmenga, Cisca/AAE-7719-2019; Bowlus, Christopher/N-9276-2016; Herms, Stefan/J-1949-2014; Weismüller, Tobias J./I-1879-2019; Hov, Johannes R/J-1480-2019; Pares, Albert/G-1328-2011; Annese, Vito/AGW-4200-2022; Hirschfield, Gideon M/M-2143-2015; Andersen, Vibeke/I-7932-2012; Padyukov, Leonid/A-4890-2009; Mason, Andrew/D-2938-2013	Ellinghaus, David/0000-0002-4332-6110; Färkkilä, Martti/0000-0002-0250-8559; ALVARO, Domenico/0000-0003-3771-9644; Zeissig, Sebastian/0000-0001-5124-0897; Duerr, Richard H/0000-0001-6586-3905; Invernizzi, Pietro/0000-0003-3262-1998; Ellinghaus, Eva/0000-0003-2914-3382; Rioux, John D/0000-0001-7560-8326; Braun, Felix/0000-0002-5296-2020; Albrecht, Mario/0000-0002-3103-9624; Marschall, Hanns-Ulrich/0000-0001-7347-3085; Franke, Andre/0000-0003-1530-5811; Pares, Albert/0000-0002-5413-9687; D'Amato, Mauro/0000-0003-2743-5197; Palmieri, Orazio/0000-0002-0019-7929; D'Amato, Mauro/0000-0003-2743-5197; Ricaño-Ponce, Isis/0000-0002-7530-9526; Gearry, Richard B/0000-0002-2298-5141; König, Inke R/0000-0003-0504-6465; Wijmenga, Cisca/0000-0002-5635-1614; Bowlus, Christopher/0000-0002-3906-6811; Herms, Stefan/0000-0002-2786-8200; Weismüller, Tobias J./0000-0001-9736-1483; Hov, Johannes R/0000-0002-5900-8096; Pares, Albert/0000-0002-5413-9687; Annese, Vito/0000-0002-0082-892X; Hirschfield, Gideon M/0000-0002-6736-2255; Andersen, Vibeke/0000-0002-0127-2863; Schramm, Christoph/0000-0002-4264-1928; Georges, Michel/0000-0003-4124-2375; Padyukov, Leonid/0000-0003-2950-5670; Mitrovic, Mitja/0000-0002-7648-7674; van Heel, David/0000-0002-0637-2265; Winkelmann, Juliane/0000-0003-2667-9691; Leppa, Virpi/0000-0003-2942-2656; Mueller, Tobias/0000-0003-3426-5421; Andreassen, Ole A./0000-0002-4461-3568; Milkiewicz, Piotr/0000-0002-1817-0724; Nothen, Markus/0000-0002-8770-2464; Newman, William/0000-0002-6382-4678; Lees, Charlie/0000-0002-0732-8215; Dorfman, Ruslan/0000-0002-3421-5582; Mason, Andrew/0000-0002-0470-9522; Vermeire, Severine/0000-0001-9942-3019; Anderson, Carl/0000-0003-1719-7009; Doncheva, Nadezhda T./0000-0002-8806-6850; Gutierrez-Achury, Javier/0000-0002-4971-1474; Saarela, Janna/0000-0002-0853-6219; Bergquist, Annika/0000-0002-3858-6241; Laukens, Debby/0000-0002-1984-5850; Rich, Stephen/0000-0003-3872-7793	Norwegian PSC Research Center; German Ministry of Education and Research through the National Genome Research Network [01GS0809-GP7]; Deutsche Forschungsgemeinschaft [FR 2821/2-1]; EU Seventh Framework Programme FP7 ESGI [262055]; Integrated Research and Treatment Center-Transplantation [01EO0802]; PopGen Biobank; Wellcome Trust [098051]; Medical Research Council [G0600329, G0601816, G0800675, 1202121, G0800759] Funding Source: researchfish; Chief Scientist Office [CZB/4/540, ETM/137, ETM/75] Funding Source: researchfish; MRC [G0800675, G0601816, G0600329, G0800759] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA141743] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062420] Funding Source: NIH RePORTER	Norwegian PSC Research Center; German Ministry of Education and Research through the National Genome Research Network; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU Seventh Framework Programme FP7 ESGI; Integrated Research and Treatment Center-Transplantation; PopGen Biobank; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by The Norwegian PSC Research Center (see URLs), by the German Ministry of Education and Research through the National Genome Research Network (01GS0809-GP7), by the Deutsche Forschungsgemeinschaft (FR 2821/2-1), by the EU Seventh Framework Programme FP7/2007-2013 (262055) ESGI, by the Integrated Research and Treatment Center-Transplantation (01EO0802) and by the PopGen Biobank (see URLs). J.Z.L., T.S. and C.A.A. are supported by a grant from the Wellcome Trust (098051). Additional financial support of the study and the coauthors is listed in the Supplementary Note.	AADLAND E, 1987, SCAND J GASTROENTERO, V22, P655, DOI 10.3109/00365528709011139; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bellenguez C, 2012, BIOINFORMATICS, V28, P134, DOI 10.1093/bioinformatics/btr599; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergquist A, 2008, CLIN GASTROENTEROL H, V6, P939, DOI 10.1016/j.cgh.2008.03.016; Broome U, 1996, GUT, V38, P610, DOI 10.1136/gut.38.4.610; Broome U, 2006, SEMIN LIVER DIS, V26, P31, DOI 10.1055/s-2006-933561; Clark K, 2012, P NATL ACAD SCI USA, V109, P16986, DOI 10.1073/pnas.1215450109; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Dequiedt F, 2003, IMMUNITY, V18, P687, DOI 10.1016/S1074-7613(03)00109-2; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Efron B, 2008, ANN APPL STAT, V2, P197, DOI 10.1214/07-AOAS141; Efron B, 2007, ANN STAT, V35, P1351, DOI 10.1214/009053606000001460; Ellinghaus D, 2013, HEPATOLOGY, V58, P1074, DOI 10.1002/hep.25977; FARRANT JM, 1991, GASTROENTEROLOGY, V100, P1710, DOI 10.1016/0016-5085(91)90673-9; Folseraas T, 2012, J HEPATOL, V57, P366, DOI 10.1016/j.jhep.2012.03.031; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hov JR, 2011, HEPATOLOGY, V53, P1967, DOI 10.1002/hep.24299; Hovhannisyan Z, 2008, NATURE, V456, P534, DOI 10.1038/nature07524; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Karlsen TH, 2011, SEMIN LIVER DIS, V31, P188, DOI 10.1055/s-0031-1276647; Karlsen TH, 2010, DIGEST LIVER DIS, V42, P390, DOI 10.1016/j.dld.2010.01.011; Karlsen TH, 2010, GASTROENTEROLOGY, V138, P1102, DOI 10.1053/j.gastro.2009.11.046; Kasler HG, 2011, J IMMUNOL, V186, P4782, DOI 10.4049/jimmunol.1001179; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; Liu JZ, 2012, NAT GENET, V44, P1137, DOI 10.1038/ng.2395; Melum E, 2011, NAT GENET, V43, P17, DOI 10.1038/ng.728; Morris JA, 2010, BIOINFORMATICS, V26, P1786, DOI 10.1093/bioinformatics/btq280; Okada Y, 2011, GASTROENTEROLOGY, V141, P864, DOI 10.1053/j.gastro.2011.05.048; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Pirinen M, 2013, ANN APPL STAT, V7, P369, DOI 10.1214/12-AOAS586; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Saarinen S, 2000, AM J GASTROENTEROL, V95, P3195; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Schlicker A, 2010, NUCLEIC ACIDS RES, V38, pD244, DOI 10.1093/nar/gkp979; SCHRUMPF E, 1982, SCAND J GASTROENTERO, V17, P187, DOI 10.3109/00365528209182038; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Spurkland A, 1999, TISSUE ANTIGENS, V53, P459, DOI 10.1034/j.1399-0039.1999.530502.x; Srivastava B, 2012, SCAND J GASTROENTERO, V47, P820, DOI 10.3109/00365521.2012.682090; Stokkers PCF, 1999, GUT, V45, P395, DOI 10.1136/gut.45.3.395; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Sun L, 2006, GENET EPIDEMIOL, V30, P519, DOI 10.1002/gepi.20164; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Yoo Yun Joo, 2009, BMC Proc, V3 Suppl 7, pS103; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	58	263	266	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2013	45	6					670	+		10.1038/ng.2616	http://dx.doi.org/10.1038/ng.2616			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	152XA	23603763	Green Published, Green Submitted, Green Accepted			2022-12-17	WOS:000319563900015
J	Lynch, VJ; Leclerc, RD; May, G; Wagner, GP				Lynch, Vincent J.; Leclerc, Robert D.; May, Gemma; Wagner, Guenter P.			Transposon-mediated rewiring of gene regulatory networks contributed to the evolution of pregnancy in mammals	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR; HUMAN ENDOMETRIUM; HUMAN GENOME; CYCLIC-AMP; ELEMENTS; INSULATOR; BINDING; CELLS; DECIDUALIZATION; METHYLATIONS	A fundamental challenge in biology is explaining the origin of novel phenotypic characters such as new cell types(1-4); the molecular mechanisms that give rise to novelties are unclear(5-7). We explored the gene regulatory landscape of mammalian endometrial cells using comparative RNA-Seq and found that 1,532 genes were recruited into endometrial expression in placental mammals, indicating that the evolution of pregnancy was associated with a large-scale rewiring of the gene regulatory network. About 13% of recruited genes are within 200 kb of a Eutherian-specific transposable element (MER20). These transposons have the epigenetic signatures of enhancers, insulators and repressors, directly bind transcription factors essential for pregnancy and coordinately regulate gene expression in response to progesterone and cAMP. We conclude that the transposable element, MER20, contributed to the origin of a novel gene regulatory network dedicated to pregnancy in placental mammals, particularly by recruiting the cAMP signaling pathway into endometrial stromal cells.	[Lynch, Vincent J.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; Yale Univ, Yale Syst Biol Inst, New Haven, CT USA	Yale University; Yale University	Lynch, VJ (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	vincent.j.lynch@yale.edu		Lynch, Vincent/0000-0001-5311-3824; Wagner, Gunter/0000-0002-3097-002X	John Templeton Foundation [12793]	John Templeton Foundation	The authors would like to thank A. Pyle and the three anonymous reviewers for comments on an earlier version of this manuscript. We would also like to thank R.W. Truman (National Hansen's Disease Program/US National Institutes of Allergy and Infectious Diseases IAA-2646) and K. Smith for the generous gifts of pregnant armadillo and opossum uterus and R. Bjornson and N. Carriero for assistance with RNA-Seq read mapping. This work was funded by a grant from the John Templeton Foundation, no. 12793, Genetics and the Origin of Organismal Complexity; results presented here do not necessarily reflect the views of the John Templeton Foundation. The funders had no role in study design, data collection and analysis, decision to publish or manuscript preparation.	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Adamska M, 2007, CURR BIOL, V17, pR836, DOI 10.1016/j.cub.2007.08.010; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Buzzio OL, 2006, ENDOCRINOLOGY, V147, P3870, DOI 10.1210/en.2006-0167; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Christian M, 2002, J BIOL CHEM, V277, P20825, DOI 10.1074/jbc.M201018200; DARWIN CD, 1883, ORIGIN SPECIES; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Gerlo S, 2006, BIOESSAYS, V28, P1051, DOI 10.1002/bies.20468; HARTI D, 2010, ESSENTIAL GENETICS G; HSIEHLI HM, 1995, DEVELOPMENT, V121, P1373; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Kim J, 2003, HUM MOL GENET, V12, P233, DOI 10.1093/hmg/ddg028; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lynch VJ, 2008, P NATL ACAD SCI USA, V105, P14928, DOI 10.1073/pnas.0802355105; Mantena SR, 2006, P NATL ACAD SCI USA, V103, P1870, DOI 10.1073/pnas.0507261103; Mayr E., 1960, EVOLUTION DARWIN, P349; MCCLINTOCK B, 1965, COMPONENTS ACTION RE, V64, P527; Mess A, 2006, J EXP ZOOL PART B, V306B, P140, DOI 10.1002/jez.b.21079; Mivart St. George, 1871, GENESIS SPECIES; MULLER GB, 1991, ANNU REV ECOL SYST, V22, P229, DOI 10.1146/annurev.es.22.110191.001305; Oliver KR, 2009, BIOESSAYS, V31, P703, DOI 10.1002/bies.200800219; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Sasaki T, 2008, P NATL ACAD SCI USA, V105, P4220, DOI 10.1073/pnas.0709398105; Thornburg BG, 2006, GENE, V365, P104, DOI 10.1016/j.gene.2005.09.036; van de Lagemaat LN, 2003, TRENDS GENET, V19, P530, DOI 10.1016/j.tig.2003.08.004; Wagner GP, 2005, J EXP ZOOL PART B, V304B, P580, DOI 10.1002/jez.b.21074; Wagner GP, 2010, CURR BIOL, V20, pR48, DOI 10.1016/j.cub.2009.11.010; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wei W, 2001, MOL CELL BIOL, V21, P7714, DOI 10.1128/MCB.21.22.7714-7720.2001; Wildman DE, 2006, P NATL ACAD SCI USA, V103, P3203, DOI 10.1073/pnas.0511344103	38	263	269	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2011	43	11					1154	U158		10.1038/ng.917	http://dx.doi.org/10.1038/ng.917			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	21946353				2022-12-17	WOS:000296584000023
J	Thye, T; Vannberg, FO; Wong, SH; Owusu-Dabo, E; Osei, I; Gyapong, J; Sirugo, G; Sisay-Joof, F; Enimil, A; Chinbuah, MA; Floyd, S; Warndorff, DK; Sichali, L; Malema, S; Crampin, AC; Ngwira, B; Teo, YY; Small, K; Rockett, K; Kwiatkowski, D; Fine, PE; Hill, PC; Newport, M; Lienhardt, C; Adegbola, RA; Corrah, T; Ziegler, A; Morris, AP; Meyer, CG; Horstmann, RD; Hill, AVS				Thye, Thorsten; Vannberg, Fredrik O.; Wong, Sunny H.; Owusu-Dabo, Ellis; Osei, Ivy; Gyapong, John; Sirugo, Giorgio; Sisay-Joof, Fatou; Enimil, Anthony; Chinbuah, Margaret A.; Floyd, Sian; Warndorff, David K.; Sichali, Lifted; Malema, Simon; Crampin, Amelia C.; Ngwira, Bagrey; Teo, Yik Y.; Small, Kerrin; Rockett, Kirk; Kwiatkowski, Dominic; Fine, Paul E.; Hill, Philip C.; Newport, Melanie; Lienhardt, Christian; Adegbola, Richard A.; Corrah, Tumani; Ziegler, Andreas; Morris, Andrew P.; Meyer, Christian G.; Horstmann, Rolf D.; Hill, Adrian V. S.		African TB Genetics Consortium; Wellcome Trust Case Control Consor	Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2	NATURE GENETICS			English	Article								We combined two tuberculosis genome-wide association studies from Ghana and The Gambia with subsequent replication in a combined 11,425 individuals. rs4331426, located in a gene-poor region on chromosome 18q11.2, was associated with disease (combined P = 6.8 x 10(-9), odds ratio = 1.19, 95% CI = 1.13-1.27). Our study demonstrates that genome-wide association studies can identify new susceptibility loci for infectious diseases, even in African populations, in which levels of linkage disequilibrium are particularly low.	[Thye, Thorsten; Meyer, Christian G.; Horstmann, Rolf D.] Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany; [Thye, Thorsten; Ziegler, Andreas] Univ Hosp Schleswig Holstein, Inst Med Biometry & Stat, Lubeck, Germany; [Vannberg, Fredrik O.; Wong, Sunny H.; Teo, Yik Y.; Small, Kerrin; Rockett, Kirk; Kwiatkowski, Dominic; Morris, Andrew P.; Hill, Adrian V. S.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Owusu-Dabo, Ellis; Enimil, Anthony] Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Owusu-Dabo, Ellis] Kwame Nkrumah Univ Sci & Technol, Coll Hlth Sci, Dept Community Hlth, Kumasi, Ghana; [Osei, Ivy; Gyapong, John; Chinbuah, Margaret A.] Ghana Hlth Serv, Hlth Res Unit, Accra, Ghana; [Sirugo, Giorgio; Sisay-Joof, Fatou; Hill, Philip C.; Newport, Melanie; Lienhardt, Christian; Adegbola, Richard A.; Corrah, Tumani] Med Res Ctr Labs, Banjul, Gambia; [Enimil, Anthony] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Floyd, Sian; Crampin, Amelia C.; Fine, Paul E.] London Sch Hyg & Trop Med, London WC1, England; [Warndorff, David K.; Sichali, Lifted; Malema, Simon; Ngwira, Bagrey; Fine, Paul E.] Karonga Prevent Study, Chilumba, Karonga Dist, Malawi	Bernhard Nocht Institut fur Tropenmedizin; University of Kiel; Schleswig Holstein University Hospital; University of Oxford; Wellcome Centre for Human Genetics; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; Ghana Health Service; Kwame Nkrumah University Science & Technology; University of London; London School of Hygiene & Tropical Medicine; Malawi Epidemiology and Intervention Research Unit	Horstmann, RD (corresponding author), Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany.	horstmann@bnitm.de; adrian.hill@well.ox.ac.uk	Wong, Sunny H/N-3754-2015; Clark, Taane G./AAM-2570-2020; Sirugo, Giorgio/L-1628-2016; Lienhardt, Christian/AAU-4969-2021; Enimil, Anthony/AAV-2595-2021; Sirugo, Giorgio/N-9056-2019; Ziegler, Andreas/G-4246-2012	Wong, Sunny H/0000-0002-3354-9310; Clark, Taane G./0000-0001-8985-9265; Lienhardt, Christian/0000-0003-0233-893X; Newport, Melanie/0000-0002-8946-7525; Small, Kerrin/0000-0003-4566-0005; Ziegler, Andreas/0000-0002-8386-5397; Kwiatkowski, Dominic/0000-0002-5023-0176; Crampin, Amelia/0000-0002-1513-4330; Gyapong, John/0000-0002-8415-1468	MRC [MC_U190071468, G19/9] Funding Source: UKRI; Medical Research Council [G0600718B] Funding Source: researchfish; Medical Research Council [MC_U190071468, G19/9] Funding Source: Medline; Wellcome Trust [076438, 084818, 079828] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		[Anonymous], 2003, Wkly Epidemiol Rec, V78, P122; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fitness J, 2004, AM J TROP MED HYG, V71, P341, DOI 10.4269/ajtmh.2004.71.341; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Lienhardt C, 2002, AM J EPIDEMIOL, V155, P1066, DOI 10.1093/aje/155.11.1066; STEAD WW, 1990, NEW ENGL J MED, V322, P422, DOI 10.1056/NEJM199002153220702; Thye T, 2009, HUM MOL GENET, V18, P381, DOI 10.1093/hmg/ddn352; *WHO, 2009, LANCET, V373, P1145; Ziegler A, 2009, GENET EPIDEMIOL, V33, pS45, DOI 10.1002/gepi.20472	13	263	274	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					739	741		10.1038/ng.639	http://dx.doi.org/10.1038/ng.639			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20694014	Green Accepted, Green Submitted			2022-12-17	WOS:000281388400005
J	Rosendahl, J; Witt, H; Szmola, R; Bhatia, E; Ozsvari, B; Landt, O; Schulz, HU; Gress, TM; Pfuetzer, R; Loehr, M; Kovacs, P; Blueher, M; Stumvoll, M; Choudhuri, G; Hegyi, P; Morsche, RHT; Drenth, JP; Truninger, K; Macek, M; Puhl, G; Witt, U; Schmidt, H; Buening, C; Ockenga, J; Kage, A; Groneberg, DA; Nickel, R; Berg, T; Wiedenmann, B; Boedeker, H; Keim, V; Moessner, J; Teich, N; Sahin-Toth, M				Rosendahl, Jonas; Witt, Heiko; Szmola, Richard; Bhatia, Eesh; Ozsvari, Bela; Landt, Olfert; Schulz, Hans-Ulrich; Gress, Thomas M.; Pfuetzer, Roland; Loehr, Matthias; Kovacs, Peter; Blueher, Matthias; Stumvoll, Michael; Choudhuri, Gourdas; Hegyi, Peter; Morsche, Rene Hm te; Drenth, Joost P. H.; Truninger, Kaspar; Macek, Milan, Jr.; Puhl, Gero; Witt, Ulrike; Schmidt, Hartmut; Buening, Carsten; Ockenga, Johann; Kage, Andreas; Groneberg, David Alexander; Nickel, Renate; Berg, Thomas; Wiedenmann, Bertram; Boedeker, Hans; Keim, Volker; Moessner, Joachim; Teich, Niels; Sahin-Toth, Miklos			Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis	NATURE GENETICS			English	Article							CATIONIC TRYPSINOGEN GENE; TROPICAL CALCIFIC PANCREATITIS; HEREDITARY PANCREATITIS; MISSENSE MUTATIONS; INHIBITOR GENE; DEGRADATION; PRSS1	Chronic pancreatitis is a persistent inflammatory disease of the pancreas, in which the digestive protease trypsin has a fundamental pathogenetic role. Here we have analyzed the gene encoding the trypsin-degrading enzyme chymotrypsin C (CTRC) in German subjects with idiopathic or hereditary chronic pancreatitis. Two alterations in this gene, p.R254W and p.K247_R254del, were significantly overrepresented in the pancreatitis group, being present in 30 of 901 (3.3%) affected individuals but only 21 of 2,804 (0.7%) controls ( odds ratio (OR)=4.6; confidence interval (CI)=2.6 - 8.0; P=1.3x10(-7)). A replication study identified these two variants in 10 of 348 (2.9%) individuals with alcoholic chronic pancreatitis but only 3 of 432 ( 0.7%) subjects with alcoholic liver disease (OR=4.2; CI=1.2 - 15.5; P=0.02). CTRC variants were also found in 10 of 71 (14.1%) Indian subjects with tropical pancreatitis but only 1 of 84 (1.2%) healthy controls (OR=13.6; CI=1.7 - 109.2; P=0.0028). Functional analysis of the CTRC variants showed impaired activity and/or reduced secretion. The results indicate that loss-of-function alterations in CTRC predispose to pancreatitis by diminishing its protective trypsin-degrading activity.	[Szmola, Richard; Ozsvari, Bela; Sahin-Toth, Miklos] Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Rosendahl, Jonas; Boedeker, Hans; Keim, Volker; Moessner, Joachim; Teich, Niels] Univ Leipzig, Dept Gastroenterol & Hepatol, D-04103 Leipzig, Germany; [Witt, Heiko; Berg, Thomas; Boedeker, Hans] Charite Univ Med Berlin, Dept Hepatol & Gastroenterol, D-13353 Berlin, Germany; [Bhatia, Eesh] Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrinol, Lucknow 226014, Uttar Pradesh, India; [Ozsvari, Bela; Hegyi, Peter] Univ Szeged, Dept Med 1, H-6720 Szeged, Hungary; [Landt, Olfert] TIB MOLBIOL, D-12103 Berlin, Germany; [Schulz, Hans-Ulrich] Otto VonGuericke Univ Magdegurg, Dept Surg, D-39120 Magdeburg, Germany; [Gress, Thomas M.] Univ Marburg, Fac Med, Dept Gastroenterol Endocrinol & Metab, D-35043 Marburg, Germany; [Pfuetzer, Roland] Univ Heidelberg, Med Fac Mannheim, Dept Med 2 Gastroenterol Hepatol Infect Dis, D-68167 Mannheim, Germany; [Loehr, Matthias] Karoliniska Univ Hosp, Karolinska Inst, Dept Clin Sci Intervent & Technol, SE-14186 Stockholm, Sweden; [Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res Leipzig, D-04103 Leipzig, Germany; [Blueher, Matthias; Stumvoll, Michael] Univ Leipzig, Dept Endocrinol, D-04103 Leipzig, Germany; [Choudhuri, Gourdas] Sanjay Gandhi Postgrad Inst Med Sci, Dept Gastroenterol, Lucknow 226014, Uttar Pradesh, India; [Morsche, Rene Hm te; Drenth, Joost P. H.] Univ Nijmegen, Med Ctr, Div Gastroenterol & Hepatol, Dept Med, NL-6500 HB Nijmegen, Netherlands; [Truninger, Kaspar] Inselspital Bern, Gastroenterol Clin, CH-3010 Bern, Switzerland; [Macek, Milan, Jr.] Charles Univ Prague, Sch Med 2, CZ-15006 Prague 5, Czech Republic; [Macek, Milan, Jr.] Univ Hosp Motol, Inst Biol & Med Genet Cyst, CZ-15006 Prague 5, Czech Republic; [Puhl, Gero] Dept Surg Charie, Campus Virchow Klinikum, D-13353 Berlin, Germany; [Schmidt, Hartmut] Univ Hosp Munster, D-48149 Munster, Germany; [Buening, Carsten; Ockenga, Johann] Charite Univ Med Berlin, Dept Gastroenterol Hepatol Endocrinol, D-10008 Berlin, Germany; [Kage, Andreas] Charite Univ Med Berlin, Inst Lab Med & Pathobiochem, D-13353 Berlin, Germany; [Groneberg, David Alexander] Charite Univ Med Berlin, Inst Occupat Med, D-12207 Berlin, Germany; [Nickel, Renate] Charite Univ Med Berlin, Dept Pediat, D-13353 Berlin, Germany	Boston University; Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Szeged University; Otto von Guericke University; Philipps University Marburg; Ruprecht Karls University Heidelberg; Karolinska Institutet; Karolinska University Hospital; Leipzig University; Leipzig University; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Radboud University Nijmegen; University of Bern; University Hospital of Bern; Charles University Prague; Motol University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Sahin-Toth, M (corresponding author), Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, 715 Albany St,Evans St, Boston, MA 02118 USA.	miklos@bu.edu	Stumvoll, Michael/ABE-1121-2021; Groneberg, David/A-5132-2018; Drenth, J.P.H./H-8025-2014; te Morsche, R/P-9143-2015; Teich, Niels/AAF-5104-2019; Drenth, Joost/V-7436-2019; Löhr, Matthias/A-3692-2012	Stumvoll, Michael/0000-0001-6225-8240; Groneberg, David/0000-0001-8551-6556; Löhr, Matthias/0000-0002-7647-198X; Gress, Thomas/0000-0002-9333-5461; Kovacs, Peter/0000-0002-0290-5423; Berg, Thomas/0000-0003-0003-6241; Wiedenmann, Bertram/0000-0002-7890-2552; Sahin-Toth, Miklos/0000-0003-4513-9922	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058088] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK058088-07, R01 DK058088-06, R01 DK058088] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bhatia E, 2002, GASTROENTEROLOGY, V123, P1020, DOI 10.1053/gast.2002.36028; Boulling A, 2007, EUR J HUM GENET, V15, P936, DOI 10.1038/sj.ejhg.5201873; Chandak GR, 2002, J MED GENET, V39, P347, DOI 10.1136/jmg.39.5.347; Gorry MC, 1997, GASTROENTEROLOGY, V113, P1063, DOI 10.1053/gast.1997.v113.pm9322498; JESSOP NW, 1980, IN VITRO CELL DEV B, V16, P212; Kiraly O, 2007, GUT, V56, P1433, DOI 10.1136/gut.2006.115725; Le Marechal C, 2006, NAT GENET, V38, P1372, DOI 10.1038/ng1904; Pfutzer RH, 2000, GASTROENTEROLOGY, V119, P615, DOI 10.1053/gast.2000.18017; Sahin-Toth M, 2006, ENDOCRIN METAB CLIN, V35, P303, DOI 10.1016/j.ecl.2006.02.002; Schneider A, 2002, GASTROENTEROLOGY, V123, P1026, DOI 10.1053/gast.2002.36059; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; Teich N, 1998, HUM MUTAT, V12, P39, DOI 10.1002/(SICI)1098-1004(1998)12:1<39::AID-HUMU6>3.0.CO;2-P; Teich N, 2006, HUM MUTAT, V27, P721, DOI 10.1002/humu.20343; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witt H, 2001, JAMA-J AM MED ASSOC, V285, P2716, DOI 10.1001/jama.285.21.2716-a; Witt H, 1999, GASTROENTEROLOGY, V117, P7, DOI 10.1016/S0016-5085(99)70543-3; Witt H, 2006, NAT GENET, V38, P668, DOI 10.1038/ng1797	18	263	275	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2008	40	1					78	82		10.1038/ng.2007.44	http://dx.doi.org/10.1038/ng.2007.44			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18059268	Green Accepted			2022-12-17	WOS:000252118600021
J	Bienengraeber, M; Olson, TM; Selivanov, VA; Kathmann, EC; O'Cochlain, F; Gao, F; Karger, AB; Ballew, JD; Hodgson, DM; Zingman, LV; Pang, YP; Alekseev, AE; Terzic, A				Bienengraeber, M; Olson, TM; Selivanov, VA; Kathmann, EC; O'Cochlain, F; Gao, F; Karger, AB; Ballew, JD; Hodgson, DM; Zingman, LV; Pang, YP; Alekseev, AE; Terzic, A			ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic K-ATP channel gating	NATURE GENETICS			English	Article							SULFONYLUREA RECEPTOR; HEART-FAILURE; KIR6.2; TRAFFICKING; GENE; SUR1	Stress tolerance of the heart requires high-fidelity metabolic sensing by ATP-sensitive potassium (K-ATP) channels that adjust membrane potential dependent functions to match cellular energetic demand. Scanning of genomic DNA from individuals with heart failure and rhythm disturbances due to idiopathic dilated cardiomyopathy identified two mutations in ABCC9, which encodes the regulatory SUR2A subunit of the cardiac K-ATP channel. These missense and frameshift mutations mapped to evolutionarily conserved domains adjacent to the catalytic ATPase pocket within SUR2A. Mutant SUR2A proteins showed aberrant redistribution of conformations in the intrinsic ATP hydrolytic cycle, translating into abnormal K-ATP channel phenotypes with compromised metabolic signal decoding. Defective catalysis-mediated pore regulation is thus a mechanism for channel dysfunction and susceptibility to dilated cardiomyopathy.	Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Dept Med, Coll Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Mol Pharmacol & Expt Therapeut, Coll Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Pediat Cardiol, Dept Pediat & Adolescent Med, Coll Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Terzic, A (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Dept Med, Coll Med, 200 1st St SW, Rochester, MN 55905 USA.	terzic.andre@mayo.edu	Zingman, Leonid V/GXG-0136-2022; Alekseev, Alexey/I-5346-2013	Zingman, Leonid V/0000-0002-7566-4616; Pang, Yuan-Ping/0000-0003-0838-2560; Olson, Timothy/0000-0003-2716-9423; Selivanov, Vitaly/0000-0002-7937-9249; Karger, Amy/0000-0002-2781-3824	NHLBI NIH HHS [R01 HL071225-01, R01 HL071225, R01 HL071225-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071225] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abraham MR, 2002, J BIOL CHEM, V277, P24427, DOI 10.1074/jbc.M201777200; Bienengraeber M, 2000, FASEB J, V14, P1943, DOI 10.1096/fj.00-0027com; Cartier EA, 2001, P NATL ACAD SCI USA, V98, P2882, DOI 10.1073/pnas.051499698; Chien KR, 2003, NAT MED, V9, P508, DOI 10.1038/nm0503-508; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Gaudet R, 2001, EMBO J, V20, P4964, DOI 10.1093/emboj/20.17.4964; Hodgson DM, 2003, EMBO J, V22, P1732, DOI 10.1093/emboj/cdg192; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Matsuo M, 2000, J BIOL CHEM, V275, P28757, DOI 10.1074/jbc.M004818200; Matsushita K, 2002, CIRC RES, V90, P554, DOI 10.1161/01.RES.0000012666.42782.30; Nestorowicz A, 1997, DIABETES, V46, P1743, DOI 10.2337/diabetes.46.11.1743; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; OROURKE B, 1994, SCIENCE, V265, P962, DOI 10.1126/science.8052856; Pang YP, 2001, PROTEINS, V45, P183, DOI 10.1002/prot.1138; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Sharma N, 1999, J BIOL CHEM, V274, P20628, DOI 10.1074/jbc.274.29.20628; Towbin JA, 2002, NATURE, V415, P227, DOI 10.1038/415227a; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WEISS JN, 1987, SCIENCE, V238, P67, DOI 10.1126/science.2443972; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199; Zingman LV, 2002, J BIOL CHEM, V277, P14206, DOI 10.1074/jbc.M109452200; Zingman LV, 2001, NEURON, V31, P233, DOI 10.1016/S0896-6273(01)00356-7	29	263	273	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					382	387		10.1038/ng1329	http://dx.doi.org/10.1038/ng1329			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	15034580	Green Accepted, Bronze			2022-12-17	WOS:000220647200022
J	Liu, G; Parant, JM; Lang, G; Chau, P; Chavez-Reyes, A; El-Naggar, AK; Multani, A; Chang, S; Lozano, G				Liu, G; Parant, JM; Lang, G; Chau, P; Chavez-Reyes, A; El-Naggar, AK; Multani, A; Chang, S; Lozano, G			Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice	NATURE GENETICS			English	Article							P53-DEPENDENT APOPTOSIS; GENETIC INSTABILITY; GENOMIC INSTABILITY; V(D)J RECOMBINATION; P53-DEFICIENT MICE; IN-VIVO; P53; ACTIVATION; GROWTH; RADIATION	The p53 protein integrates multiple upstream signals and functions as a tumor suppressor by activating distinct downstream genes(1-3). At the cellular level, p53 induces apoptosis, cell cycle arrest and senescence. A rare mutant form of p53 with the amino acid substitution R175P, found in human tumors, is completely defective in initiating apoptosis but still induces cell cycle arrest(4,5). To decipher the functional importance of these pathways in spontaneous tumorigenesis, we used homologous recombination to generate mice with mutant p53-R172P ( the mouse equivalent of R175P in humans). Mice inheriting two copies of this mutation (Trp53(515C/515C)) escape the early onset of thymic lymphomas that characterize Trp53-null mice. At 7 months of age, 90% of Trp53-null mice had died, but 85% of Trp53(515C/515C) mice were alive and tumor-free, indicating that p53-dependent apoptosis was not required for suppression of early onset of spontaneous tumors. The lymphomas and sarcomas that eventually developed in Trp53(515C/515C) mice retained a diploid chromosome number, in sharp contrast to aneuploidy observed in tumors and cells from Trp53 null mice. The ability of mutant p53-R172P to induce a partial cell cycle arrest and retain chromosome stability are crucial for suppression of early onset tumorigenesis.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Sect Canc Genet, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Liu, G (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Sect Canc Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.		Chavez-Reyes, Arturo/ABG-1231-2020	Chavez-Reyes, Arturo/0000-0002-6655-815X; Chau, Gilda/0000-0002-7907-3290				CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Donehower LA, 1997, CANCER SURV, V29, P329; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; HARVEY M, 1993, ONCOGENE, V8, P2457; Hundley JE, 1997, MOL CELL BIOL, V17, P723, DOI 10.1128/MCB.17.2.723; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kapoor M, 1998, P NATL ACAD SCI USA, V95, P2834, DOI 10.1073/pnas.95.6.2834; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Lee Y, 2001, J NEUROSCI, V21, P6687, DOI 10.1523/JNEUROSCI.21-17-06687.2001; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liao MJ, 1998, MOL CELL BIOL, V18, P3495, DOI 10.1128/MCB.18.6.3495; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; Ludwig RL, 1996, MOL CELL BIOL, V16, P4952; Nacht M, 1998, CELL GROWTH DIFFER, V9, P131; Rowan S, 1996, EMBO J, V15, P827, DOI 10.1002/j.1460-2075.1996.tb00418.x; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; SYMONDS H, 1994, CELL, V78, P703, DOI 10.1016/0092-8674(94)90534-7; Tarapore P, 2002, ONCOGENE, V21, P6234, DOI 10.1038/sj.onc.1205707; Tarapore P, 2001, ONCOGENE, V20, P3173, DOI 10.1038/sj.onc.1204424; Tlsty TD, 1996, CANCER SURV, V28, P217; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675	30	263	266	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2004	36	1					63	68		10.1038/ng1282	http://dx.doi.org/10.1038/ng1282			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	14702042	Bronze			2022-12-17	WOS:000187666800015
J	Schubeler, D; Scalzo, D; Kooperberg, C; van Steensel, B; Delrow, J; Groudine, M				Schubeler, D; Scalzo, D; Kooperberg, C; van Steensel, B; Delrow, J; Groudine, M			Genome-wide DNA replication profile for Drosophila melanogaster: a link between transcription and replication timing	NATURE GENETICS			English	Article							MAMMALIAN-CELLS; GENE-EXPRESSION; HETEROCHROMATIN; ORGANIZATION; ASSOCIATION; REGION; LOCUS	Replication of the genome before mitotic cell division is a highly regulated process that ensures the fidelity of DNA duplication. DNA replication initiates at specific locations, termed origins of replication, and progresses in a defined temporal order during the S phase of the cell cycle. The relationship between replication timing and gene expression has been the subject of some speculation(1). A recent genome-wide analysis in Saccharomyces cerevisiae showed no association between replication timing and gene expression(2). In higher eukaryotes, the limited number of genomic loci analyzed has not permitted a firm conclusion regarding this association. To explore the relationship between DNA replication and gene expression in higher eukaryotes, we developed a strategy to measure the timing of DNA replication for thousands of genes in a single DNA array hybridization experiment. Using this approach, we generated a genome-wide map of replication timing for Drosophila melanogaster. Moreover, by surveying over 40% of all D. melanogaster genes, we found a strong correlation between DNA replication early in S phase and transcriptional activity. As this correlation does not exist in S. cerevisiae, this interplay between DNA replication and transcription may be a unique characteristic of higher eukaryotes.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; Netherlands Canc Inst, Amsterdam, Netherlands; Fred Hutchinson Canc Res Ctr, DNA Array Facil, Seattle, WA 98104 USA; Univ Washington, Dept Radiat Oncol, Seattle, WA USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Netherlands Cancer Institute; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Schubeler, D (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.							Ahmad K, 2001, J CELL BIOL, V153, P101, DOI 10.1083/jcb.153.1.101; CAIZZI R, 1993, GENETICS, V133, P335; Cimbora DM, 2001, CELL, V104, P643, DOI 10.1016/S0092-8674(01)00260-4; Cimbora DM, 2000, MOL CELL BIOL, V20, P5581, DOI 10.1128/MCB.20.15.5581-5591.2000; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; DePamphilis ML, 1999, BIOESSAYS, V21, P5, DOI 10.1002/(SICI)1521-1878(199901)21:1<5::AID-BIES2>3.0.CO;2-6; DOLFINI S, 1970, EXPERIENTIA, V26, P1020, DOI 10.1007/BF02114171; EBERL DF, 1993, GENETICS, V134, P277; Fan J., 1996, LOCAL POLYNOMIAL MOD; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; HANSEN RS, 1995, HUM MOL GENET, V4, P813; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; HATTON KS, 1988, MOL CELL BIOL, V8, P2149, DOI 10.1128/MCB.8.5.2149; JAKUBCZAK JL, 1992, GENETICS, V131, P129; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Kooperberg C, 2002, J COMPUT BIOL, V9, P55, DOI 10.1089/10665270252833190; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Pritchard CC, 2001, P NATL ACAD SCI USA, V98, P13266, DOI 10.1073/pnas.221465998; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Smith ZE, 1999, HUM MOL GENET, V8, P1373, DOI 10.1093/hmg/8.8.1373; Sullivan B, 2001, J CELL BIOL, V154, P683, DOI 10.1083/jcb.200103001; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; WAKIMOTO BT, 1990, GENETICS, V125, P141; Yang YH, 2001, MICROARRAYS OPTICAL	25	263	272	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					438	442		10.1038/ng1005	http://dx.doi.org/10.1038/ng1005			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12355067				2022-12-17	WOS:000179034800023
J	Wong, KK; Chang, S; Weiler, SR; Ganesan, S; Chaudhuri, J; Zhu, CM; Artandi, SE; Rudolph, KL; Gottlieb, GJ; Chin, L; Alt, FW; DePinho, RA				Wong, KK; Chang, S; Weiler, SR; Ganesan, S; Chaudhuri, J; Zhu, CM; Artandi, SE; Rudolph, KL; Gottlieb, GJ; Chin, L; Alt, FW; DePinho, RA			Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation	NATURE GENETICS			English	Article							STRAND BREAK REPAIR; V(D)J RECOMBINATION; MAMMALIAN-CELLS; LIGASE-IV; CHROMOSOME BREAKAGE; STEM-CELLS; MICE; KU; IDENTIFICATION; PROTEINS	Telomeres are specialized nucleoprotein complexes that serve as protective caps of linear eukaryotic chromosomes. Loss of telomere function is associated with rampant genetic instability and loss of cellular viability and renewal potential. The telomere also participates in processes of chromosomal repair, as evidenced by the 'capture' or de novo synthesis of telomere repeats at double-stranded breaks(1-4) and by the capacity of yeast telomeres to serve as repositories of essential components of the DNA repair machinery, particularly those involved in non-homologous end-joining(5-7) (NHEJ). Here we used the telomerase-deficient mouse. null for the essential telomerase RNA gene (Terc). to assess the role of telomerase and telomere function on the cellular and organismal response to ionizing radiation. Although the loss of telomerase activity per se had no discernable impact on the response to ionizing radiation, the emergence of telomere dysfunction in late-generation Terc(-/-) mice imparted a radiosensitivity syndrome associated with accelerated mortality. On the cellular level, the gastrointestinal crypt stem cells and primary thymocytes showed increased rates of apoptosis, and mouse embryonic fibroblasts (MEFs) showed diminished dose-dependent clonogenic survival. The radiosensitivity of telomere dysfunctional cells correlated with delayed DNA break repair kinetics, persistent chromosomal breaks and cytogenetic profiles characterized by complex chromosomal aberrations and massive fragmentation. Our findings establish a intimate relationship between functionally intact telomeres and the genomic. cellular and organismal response to ionizing radiation.	Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet & Med, Boston, MA 02115 USA; Quest Diagnost Inc, Anat Pathol, Teterboro, NJ USA; Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	DePinho, RA (corresponding author), Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA.			Rudolph, Karl Lenhard/0000-0002-4839-2862; DePinho, Ronald/0000-0002-5625-577X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028317, R01HD034880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR002104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG001019] Funding Source: NIH RePORTER; NIAMS NIH HHS [K08AR02104-01] Funding Source: Medline; NIA NIH HHS [K08 AG001019] Funding Source: Medline; NICHD NIH HHS [R01HD28317, R01HD 34880] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Grawunder U, 1998, MOL CELL, V2, P477, DOI 10.1016/S1097-2765(00)80147-1; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Haber JE, 1999, CELL, V97, P829, DOI 10.1016/S0092-8674(00)80795-3; Hall E.J., 2019, RADIOBIOLOGY RADIOLO, Veighth; HESSE JE, 1987, CELL, V49, P775, DOI 10.1016/0092-8674(87)90615-5; Jeggo PA, 1998, RADIAT RES, V150, pS80, DOI 10.2307/3579810; Kiltie AE, 1997, NUCLEIC ACIDS RES, V25, P2945, DOI 10.1093/nar/25.14.2945; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; MELTZER PS, 1993, NAT GENET, V4, P252, DOI 10.1038/ng0793-252; Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2; MURNANE JP, 1993, MOL CELL BIOL, V13, P977, DOI 10.1128/MCB.13.2.977; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; SAVAGE JRK, 1975, J MED GENET, V12, P103; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Slijepcevic P, 1998, MUTAGENESIS, V13, P45; Sprung CN, 1999, P NATL ACAD SCI USA, V96, P6781, DOI 10.1073/pnas.96.12.6781; Sturzbecher HW, 1996, EMBO J, V15, P1992, DOI 10.1002/j.1460-2075.1996.tb00550.x; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; Weaver DT, 1996, CRIT REV EUKAR GENE, V6, P345, DOI 10.1615/CritRevEukarGeneExpr.v6.i4.20	30	263	282	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					85	88		10.1038/79232	http://dx.doi.org/10.1038/79232			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	10973255				2022-12-17	WOS:000089078000024
J	Xiao, S; Nalabolu, SR; Aster, JC; Ma, JL; Abruzzo, L; Jaffe, ES; Stone, R; Weissman, SM; Hudson, TJ; Fletcher, JA				Xiao, S; Nalabolu, SR; Aster, JC; Ma, JL; Abruzzo, L; Jaffe, ES; Stone, R; Weissman, SM; Hudson, TJ; Fletcher, JA			FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome	NATURE GENETICS			English	Article							FIBROBLAST GROWTH-FACTOR; T-CELL; CHROMOSOMAL TRANSLOCATIONS; LYMPHOBLASTIC LYMPHOMA; RECEPTOR; EOSINOPHILIA; ABERRATIONS; MALIGNANCY; ACTIVATION; MUTATIONS	Various histological subtypes of leukaemia and lymphoma are associated with diagnostic chromosome translocations(1-4), and substantial strides have been made in determining the specific oncogenes targetted by those translocations. We report the cloning of a novel fusion oncogene associated with a unique leukaemia/lymphoma syndrome. Patients afflicted with this syndrome present with lymphoblastic lymphoma and a myeloproliferative disorder, often accompanied by pronounced peripheral eosinophilia and/or prominent eosinophilic infiltrates in the affected bone marrow, which generally progress to full-blown acute myelogenous leukaemia within a year of diagnosis(5-9). A specific chromosome translocation, t(8;13)(p11;q11-12), is found in both lymphoma and myeloid leukaemia cells from these patients, supporting bi-lineage differentiation from a transformed stem cell(6-8). We find that the 8p11 translocation breakpoints, in each of four patients, interrupt intron 8 of the fibroblast growth factor receptor 1 gene (FGFR1). These translocations are associated with aberrant transcripts in which four predicted zinc-finger domains, contributed by a novel and widely expressed chromosome-13 gene (ZNF198), are fused to the FGFR1 tyrosine-kinase domain. Transient expression studies show that the ZNF198-FGFR1 fusion transcript directs the synthesis of an approximately 87-kD polypeptide, localizing predominantly to the cytoplasm. Our studies demonstrate an FGFR1 oncogenic role and suggest a tumorigenic mechanism in which ZNF198-FGFR1 activation results from ZNF198 zinc-finger-mediated homodimerization.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Yale Univ, Sch Med, New Haven, CT 06536 USA; MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02142 USA; Univ Maryland, Med Ctr, Dept Pathol, Baltimore, MD 21201 USA; NCI, Hematopathol Sect, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Yale University; Massachusetts Institute of Technology (MIT); Whitehead Institute; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital	Xiao, S (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.		Jaffe, Elaine S/G-8984-2014	Jaffe, Elaine S/0000-0003-4632-0301	NATIONAL CANCER INSTITUTE [R01CA072791] Funding Source: NIH RePORTER; NCI NIH HHS [CA72791] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRUZZO LV, 1992, AM J SURG PATHOL, V16, P236, DOI 10.1097/00000478-199203000-00003; Aster JC, 1997, J BIOL CHEM, V272, P11336; AVRAHAM H, 1994, BLOOD, V83, P2126; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Carroll M, 1996, P NATL ACAD SCI USA, V93, P14845, DOI 10.1073/pnas.93.25.14845; CROCE CM, 1993, SEMIN ONCOL, V20, P31; DIB A, 1995, ONCOGENE, V10, P995; FAGAN K, 1993, CANCER GENET CYTOGEN, V65, P71, DOI 10.1016/0165-4608(93)90062-Q; FLETCHER JA, 1991, NEW ENGL J MED, V324, P436, DOI 10.1056/NEJM199102143240702; GABBIANELLI M, 1990, SCIENCE, V249, P1561, DOI 10.1126/science.2218497; GABRILOVE JL, 1994, BLOOD, V83, P907; INHORN RC, 1995, BLOOD, V85, P1881, DOI 10.1182/blood.V85.7.1881.bloodjournal8571881; ITOH N, 1990, BIOCHEM BIOPH RES CO, V169, P680, DOI 10.1016/0006-291X(90)90384-Y; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MACDONALD D, 1995, LEUKEMIA, V9, P1628; NAEEM R, 1995, GENE CHROMOSOME CANC, V12, P148, DOI 10.1002/gcc.2870120210; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; OFFIT K, 1991, HEMATOL ONCOL CLIN N, V5, P853, DOI 10.1016/S0889-8588(18)30389-7; PARIMOO S, 1993, NUCLEIC ACIDS RES, V21, P4422, DOI 10.1093/nar/21.18.4422; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; RODRIGUES GA, 1993, MOL CELL BIOL, V13, P6711, DOI 10.1128/MCB.13.11.6711; ROWLEY JD, 1990, CANCER RES, V50, P3816; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Tong Q, 1997, J BIOL CHEM, V272, P9043; vanderMaarel SM, 1996, HUM MOL GENET, V5, P887, DOI 10.1093/hmg/5.7.887; Verdier AS, 1997, GENOMICS, V40, P151, DOI 10.1006/geno.1996.4492; WILSON EL, 1991, BLOOD, V77, P954; XIAO S, 1995, AM J PATHOL, V147, P896	30	263	279	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					84	87		10.1038/ng0198-84	http://dx.doi.org/10.1038/ng0198-84			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425908				2022-12-17	WOS:000071259600029
J	Lee, MP; Hu, RJ; Johnson, LA; Feinberg, AP				Lee, MP; Hu, RJ; Johnson, LA; Feinberg, AP			Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements	NATURE GENETICS			English	Article							FACTOR-II GENE; WILMS-TUMOR; IGF2; H19; RELAXATION; EXPRESSION; DNA	Genomic imprinting is an epigenetic chromosomal modification in the gamete or zygote causing preferential expression of a specific parental allele in somatic cells of the offspring. We and others have identified three imprinted human genes on 11p15.5, IGF2 (refs 1-4), H19 (refs 1,5), and p57(KIP2) (ref. 6), although the latter gene is separated by 700 kb from the other two, and it is unclear whether there are other imprinted genes within this large interval. We previously mapped an embryonal tumour suppressor gene to this region(7), as well as five balanced germline chromosomal rearrangement breakpoints from patients with Beckwith-Wiedemann syndrome (BWS)(8), a condition characterized by prenatal overgrowth and cancer. We isolated the upstream exons of the previously identified gene KVLQT1, which causes the familial cardiac defect long-QT (LQT) syndrome. We found that KVLQT1 spans much of the interval between p57(KIP2) and IGF2, and that it is also imprinted. We demonstrated that the gene is disrupted by chromosomal chromosomal translocation in an embryonal rhabdoid tumour. Furthermore, the lack of parent-of-origin effect in LQT syndrome appears to be due to relative lack of imprinting in the affected tissue, cardiac muscle, representing a novel mechanism for variable penetrance of a human disease gene.	JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MOL BIOL & GENET,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT ONCOL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University			Feinberg, Andrew/AAY-7666-2020	Feinberg, Andrew/0000-0002-8364-1991	NATIONAL CANCER INSTITUTE [R01CA054358, R37CA054358] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA054358, CA54358] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BURN TC, 1995, GENE, V161, P183, DOI 10.1016/0378-1119(95)00223-S; Chung WY, 1996, HUM MOL GENET, V5, P1101, DOI 10.1093/hmg/5.8.1101; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; FEINBERG AP, 1994, J CELL SCI S, V18, P7; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; HATADA H, 1996, NAT GENET, V14, P171; Hoovers JMN, 1995, P NATL ACAD SCI USA, V92, P12456, DOI 10.1073/pnas.92.26.12456; KOI M, 1993, SCIENCE, V260, P361, DOI 10.1126/science.8469989; Mannens M., 1994, European Journal of Human Genetics, V2, P3; Matsuoka S, 1996, P NATL ACAD SCI USA, V93, P3026, DOI 10.1073/pnas.93.7.3026; MOULTON T, 1994, NAT GENET, V7, P440, DOI 10.1038/ng0794-440; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; OHLSSON R, 1993, NAT GENET, V4, P94, DOI 10.1038/ng0593-94; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; REIK W, 1994, HUM MOL GENET, V3, P1297, DOI 10.1093/hmg/3.8.1297; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SCHROEDER WT, 1987, AM J HUM GENET, V40, P413; SCRABLE H, 1989, P NATL ACAD SCI USA, V86, P7480, DOI 10.1073/pnas.86.19.7480; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; THOMPSON JS, IN PRESS CANC RES; VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	28	263	282	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					181	185		10.1038/ng0297-181	http://dx.doi.org/10.1038/ng0297-181			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020845				2022-12-17	WOS:A1997WF08700019
J	Zeng, YX; Somasundaram, K; ElDeiry, WS				Zeng, YX; Somasundaram, K; ElDeiry, WS			AP2 inhibits cancer cell growth and activates p21(WAF1)/(CIP1) expression	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR AP-2; INDUCIBLE ENHANCER; LEUKEMIA-CELLS; GENE; DIFFERENTIATION; INDUCTION; CARCINOMA; CHROMOSOME-6; PATHWAY; KINASES	The 52-kD Activator Protein (AP2) is a DNA-binding transcription factor(1-3) implicated in signalling terminal differentiation(2-4). Profound developmental abnormalities have been recently observed in AP2-null mice(5-6). The molecular events by which AP2 promotes differentiation or development are, however, unknown. Increased expression of the universal cell cycle inhibitor p21(WAF1/CIP1) occurs in growth-arrested terminally differentiating cells(7-12). In a search for cellular factors that could activate p21 during phorbol ester (TPA)-induced differentiation, we identified AP2 as a regulator of p21 expression. Mutagenesis of an AP2 DNA-binding site within a p21 promoter-luciferase reporter inhibited its activation by either AP2 transfection or TPA stimulation. Endogenous p21 protein levels were elevated and DNA synthesis was inhibited in AP2 versus control vector-transfected cells. Overexpression of AP2 in HepG2 human hepatoblastoma and SW480 human colon adenocarcinoma cells inhibited cell division and stable colony formation. These results link the differentiation-associated factor AP2 to negative cell cycle and growth control, possibly through p21 activation.	UNIV PENN,SCH MED,HOWARD HUGHES MED INST,DEPT MED & GENET,LAB MOL ONCOL & CELL CYCLE REGULAT,PHILADELPHIA,PA 19104	Howard Hughes Medical Institute; University of Pennsylvania								BOSHER JM, 1995, P NATL ACAD SCI USA, V92, P744, DOI 10.1073/pnas.92.3.744; BUETTNER R, 1993, MOL CELL BIOL, V13, P4174, DOI 10.1128/MCB.13.7.4174; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; DUAN CM, 1995, J BIOL CHEM, V270, P24844, DOI 10.1074/jbc.270.42.24844; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELDEIRY WS, 1995, CANCER RES, V55, P2910; FOULKES WD, 1993, BRIT J CANCER, V67, P551, DOI 10.1038/bjc.1993.101; GAYNOR RB, 1991, GENOMICS, V10, P1100, DOI 10.1016/0888-7543(91)90209-W; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; HYMAN SE, 1989, MOL CELL BIOL, V9, P321, DOI 10.1128/MCB.9.1.321; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; KANNAN F, 1994, GENE DEV, V8, P1258, DOI 10.1101/gad.8.11.1258; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KHARBANDA S, 1994, J BIOL CHEM, V269, P872; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; LUSCHER B, 1989, GENE DEV, V3, P1507, DOI 10.1101/gad.3.10.1507; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; MICHIELI P, 1994, CANCER RES, V54, P3391; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; NAWROZ H, 1994, CANCER RES, V54, P1152; Robertson GP, 1996, CANCER RES, V56, P1635; SATO EF, 1995, BBA-MOL CELL RES, V1266, P23, DOI 10.1016/0167-4889(94)00238-A; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Somasundaram K, 1996, P NATL ACAD SCI USA, V93, P3088, DOI 10.1073/pnas.93.7.3088; STEINMAN RA, 1994, ONCOGENE, V9, P389; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; TRENT JM, 1990, SCIENCE, V247, P568, DOI 10.1126/science.2300817; WILL, 1991, WILLIAMS T, V5, P671; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; Zeng YX, 1996, ONCOGENE, V12, P1557; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0	32	263	267	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					78	82		10.1038/ng0197-78	http://dx.doi.org/10.1038/ng0197-78			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988173				2022-12-17	WOS:A1997WA37300025
J	Reiter, LT; Murakami, T; Koeuth, T; Pentao, L; Muzny, DM; Gibbs, RA; Lupski, JR				Reiter, LT; Murakami, T; Koeuth, T; Pentao, L; Muzny, DM; Gibbs, RA; Lupski, JR			A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element	NATURE GENETICS			English	Article							TOOTH DISEASE TYPE-1A; HUMAN X-CHROMOSOME; DISTAL SHORT ARM; DROSOPHILA-MELANOGASTER; REPETITIVE ELEMENTS; FREQUENT DELETIONS; DNA DUPLICATION; GENE; MUTATION; FAMILIES	The Charcot-Marie Tooth disease type 1A (CMT1A) duplication and hereditary neuropathy with liability to pressure palsies (HNPP) deletion are reciprocal products of an unequal crossing-over event between misaligned flanking CMT1A-REP repeats. The molecular aetiology of this apparently homologous recombination event was examined by sequencing the crossover region. Through the detection of novel junction fragments from the recombinant CMT1A-REPs in both CMT1A and HNPP patients, a 1.7-kb recombination hotspot within the similar to 30-kb CMT1A-REPs was identified. This hotspot is 98% identical between CMT1A-REPs indicating that sequence identity is not likely the sole factor involved in promoting crossover events. Sequence analysis revealed a mariner transposon-like element (MITE) near the hotspot which we hypothesize could mediate strand exchange events via cleavage by a transposase at or near the 3' end of the element.	BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030; BAYLOR COLL MED,CELL & MOLEC BIOL PROGRAM,HOUSTON,TX 77030; BAYLOR COLL MED,DEV BIOL PROGRAM,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine			Reiter, Lawrence/H-4161-2019	Reiter, Lawrence/0000-0002-4100-2630; Murakami, Tatsufumi/0000-0001-7851-6822	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027042] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00210] Funding Source: Medline; NINDS NIH HHS [NS27042] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSSON B, 1994, ANAL BIOCHEM, V218, P300, DOI 10.1006/abio.1994.1182; BALLABIO A, 1990, GENOMICS, V8, P263, DOI 10.1016/0888-7543(90)90281-X; CAPY P, 1992, GENETICA, V86, P37, DOI 10.1007/BF00133709; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; DAVIES DM, 1954, LANCET, V2, P266; De Jong J, 1947, PSYCHIAT NEUROL BL A, V50, P60; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; GARZA D, 1991, GENETICS, V128, P303; HERTZ JM, 1994, CLIN GENET, V46, P291; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; IONASESCU VV, 1993, MUSCLE NERVE, V16, P1232, DOI 10.1002/mus.880161114; JACOBSON JW, 1986, P NATL ACAD SCI USA, V83, P8684, DOI 10.1073/pnas.83.22.8684; JURKA J, 1990, NUCLEIC ACIDS RES, V18, P137, DOI 10.1093/nar/18.1.137; JURKA J, IN PRESS COMP CHEM; KAKU DA, 1993, NEUROLOGY, V43, P1806, DOI 10.1212/WNL.43.9.1806; KALLIONIEMI OP, 1994, GENOMICS, V20, P125, DOI 10.1006/geno.1994.1138; KIYOSAWA H, 1995, HUM MOL GENET, V4, P2327, DOI 10.1093/hmg/4.12.2327; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; LEGUERN E, 1995, HUM MOL GENET, V4, P1673, DOI 10.1093/hmg/4.9.1673; LI XM, 1992, NUCLEIC ACIDS RES, V20, P1117, DOI 10.1093/nar/20.5.1117; LIDHOLM DA, 1993, GENETICS, V134, P859; LOHE AR, 1995, MOL BIOL EVOL, V12, P62, DOI 10.1093/oxfordjournals.molbev.a040191; LOHE AR, 1995, GENETICS, V140, P183; LORENZETTI D, 1995, AM J HUM GENET, V56, P91; LUPSKI JR, 1993, JAMA-J AM MED ASSOC, V270, P2326, DOI 10.1001/jama.270.19.2326; Lupski JR, 1996, AM J HUM GENET, V58, P21; LUPSKI JR, 1993, AM J MED GENET, V45, P92, DOI 10.1002/ajmg.1320450122; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUPSKI JR, 1991, CURRENT NEUROLOGY, P1; MARUYAMA K, 1991, J MOL EVOL, V33, P514, DOI 10.1007/BF02102804; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; MAZNY DM, 1994, AUTOMATED DNA SEQUEN, P182; MCCARRON M, 1994, GENETICS, V136, P1013; Mckusick V.A., 1994, MENDELIAN INHERITANC; METZENBERG AB, 1991, GENETICS, V128, P143; NELIS E, IN PRESS EUR J HUM G; OOSUMI T, 1995, NATURE, V378, P672, DOI 10.1038/378672a0; PALAU F, 1993, HUM MOL GENET, V2, P2031, DOI 10.1093/hmg/2.12.2031; PATEL PI, 1994, TRENDS GENET, V10, P128, DOI 10.1016/0168-9525(94)90214-3; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PENTAO L, 1992, NAT GENET, V2, P92; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; REISECKER F, 1994, NEUROLOGY, V44, P753, DOI 10.1212/WNL.44.4.753; ROA BB, 1994, ADV HUM GENET, V22, P117; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; ROA BB, 1995, LAB MED INT, V12, P22; Robertson H.M., 1993, Insect Molecular Biology, V2, P125, DOI 10.1111/j.1365-2583.1993.tb00132.x; ROBERTSON HM, 1993, NATURE, V362, P241, DOI 10.1038/362241a0; ROSSITER JP, 1994, HUM MOL GENET, V3, P1035, DOI 10.1093/hmg/3.7.1035; Sambrook J, 1989, MOL CLONING LAB MANU; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; SMIT AFA, IN PRESS P NATL ACAD; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timmerman V, 1996, HUM GENET, V97, P26, DOI 10.1007/BF00218828; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; WAHLS WP, 1990, CELL, V60, P95, DOI 10.1016/0092-8674(90)90719-U; WISE CA, 1993, AM J HUM GENET, V53, P853; WORLEY KC, 1995, GENOME RES, V5, P173, DOI 10.1101/gr.5.2.173; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q	65	263	267	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1996	12	3					288	297		10.1038/ng0396-288	http://dx.doi.org/10.1038/ng0396-288			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589720				2022-12-17	WOS:A1996TY18300018
J	Gaulton, KJ; Ferreira, T; Lee, Y; Raimondo, A; Maegi, R; Reschen, ME; Mahajan, A; Locke, A; Rayner, NW; Robertson, N; Scott, RA; Prokopenko, I; Scott, LJ; Green, T; Sparso, T; Thuillier, D; Yengo, L; Grallert, H; Wahl, S; Franberg, M; Strawbridge, RJ; Kestler, H; Chheda, H; Eisele, L; Gustafsson, S; Steinthorsdottir, V; Thorleifsson, G; Qi, L; Karssen, LC; van Leeuwen, EM; Willems, SM; Li, M; Chen, H; Fuchsberger, C; Kwan, P; Ma, C; Linderman, M; Lu, YC; Thomsen, SK; Rundle, JK; Beer, NL; van de Bunt, M; Chalisey, A; Kang, HM; Voight, BF; Abecasis, GR; Almgren, P; Baldassarre, D; Balkau, B; Benediktsson, R; Bluher, M; Boeing, H; Bonnycastle, LL; Bottinger, EP; Burtt, NP; Carey, J; Charpentier, G; Chines, PS; Cornelis, MC; Couper, DJ; Crenshaw, AT; van Dam, RM; Doney, ASF; Dorkhan, M; Edkins, S; Eriksson, JG; Esko, T; Eury, E; Fadista, J; Flannick, J; Fontanillas, P; Fox, C; Franks, PW; Gertow, K; Gieger, C; Gigante, B; Gottesman, O; Grant, GB; Grarup, N; Groves, CJ; Hassinen, M; Have, CT; Herder, C; Holmen, OL; Hreidarsson, AB; Humphries, SE; Hunter, DJ; Jackson, AU; Jonsson, A; Jorgensen, ME; Jorgensen, T; Kao, WHL; Kerrison, ND; Kinnunen, L; Klopp, N; Kong, A; Kovacs, P; Kraft, P; Kravic, J; Langford, C; Leander, K; Liang, L; Lichtner, P; Lindgren, CM; Lindholm, E; Linneberg, A; Liu, CT; Lobbens, S; Luan, J; Lyssenko, V; Mannisto, S; McLeod, O; Meyer, J; Mihailov, E; Mirza, G; Muhleisen, TW; Muller-Nurasyid, M; Navarro, C; Nothen, MM; Oskolkov, NN; Owen, KR; Palli, D; Pechlivanis, S; Peltonen, L; Perry, JRB; Platou, CGP; Roden, M; Ruderfer, D; Rybin, D; van der Schouw, YT; Sennblad, B; Sigurdsson, G; Stancakova, A; Steinbach, G; Storm, P; Strauch, K; Stringham, HM; Sun, Q; Thorand, B; Tikkanen, E; Tonjes, A; Trakalo, J; Tremoli, E; Tuomi, T; Wennauer, R; Wiltshire, S; Wood, AR; Zeggini, E; Dunham, I; Birney, E; Pasquali, L; Ferrer, J; Loos, RJF; Dupuis, J; Florez, JC; Boerwinkle, E; Pankow, JS; van Duijn, C; Sijbrands, E; Meigs, JB; Hu, FB; Thorsteinsdottir, U; Stefansson, K; Lakka, TA; Rauramaa, R; Stumvoll, M; Pedersen, NL; Lind, L; Keinanen-Kiukaanniemi, SM; Korpi-Hyovalti, E; Saaristo, TE; Saltevo, J; Kuusisto, J; Laakso, M; Metspalu, A; Erbel, R; Jocke, KH; Moebus, S; Ripatti, S; Salomaa, V; Ingelsson, E; Boehm, BO; Bergman, RN; Collins, FS; Mohlke, KL; Koistinen, H; Tuomilehto, J; Hveem, K; Njolstad, I; Deloukas, P; Donnelly, PJ; Frayling, TM; Hattersley, AT; de Faire, U; Hamsten, A; Illig, T; Peters, A; Cauchi, S; Sladek, R; Froguel, P; Hansen, T; Pedersen, O; Morris, AD; Palmer, CNA; Kathiresan, S; Melander, O; Nilsson, PM; Groop, LC; Barroso, I; Langenberg, C; Wareham, NJ; O'Callaghan, CA; Gloyn, AL; Altshuler, D; Boehnke, M; Teslovich, TM; McCarthy, MI; Morris, AP				Gaulton, Kyle J.; Ferreira, Teresa; Lee, Yeji; Raimondo, Anne; Maegi, Reedik; Reschen, Michael E.; Mahajan, Anubha; Locke, Adam; Rayner, N. William; Robertson, Neil; Scott, Robert A.; Prokopenko, Inga; Scott, Laura J.; Green, Todd; Sparso, Thomas; Thuillier, Dorothee; Yengo, Loic; Grallert, Harald; Wahl, Simone; Franberg, Mattias; Strawbridge, Rona J.; Kestler, Hans; Chheda, Himanshu; Eisele, Lewin; Gustafsson, Stefan; Steinthorsdottir, Valgerdur; Thorleifsson, Gudmar; Qi, Lu; Karssen, Lennart C.; van Leeuwen, Elisabeth M.; Willems, Sara M.; Li, Man; Chen, Han; Fuchsberger, Christian; Kwan, Phoenix; Ma, Clement; Linderman, Michael; Lu, Yingchang; Thomsen, Soren K.; Rundle, Jana K.; Beer, Nicola L.; van de Bunt, Martijn; Chalisey, Anil; Kang, Hyun Min; Voight, Benjamin F.; Abecasis, Goncalo R.; Almgren, Peter; Baldassarre, Damiano; Balkau, Beverley; Benediktsson, Rafn; Blueher, Matthias; Boeing, Heiner; Bonnycastle, Lori L.; Bottinger, Erwin P.; Burtt, Noel P.; Carey, Jason; Charpentier, Guillaume; Chines, Peter S.; Cornelis, Marilyn C.; Couper, David J.; Crenshaw, Andrew T.; van Dam, Rob M.; Doney, Alex S. F.; Dorkhan, Mozhgan; Edkins, Sarah; Eriksson, Johan G.; Esko, Tonu; Eury, Elodie; Fadista, Joao; Flannick, Jason; Fontanillas, Pierre; Fox, Caroline; Franks, Paul W.; Gertow, Karl; Gieger, Christian; Gigante, Bruna; Gottesman, Omri; Grant, George B.; Grarup, Niels; Groves, Christopher J.; Hassinen, Maija; Have, Christian T.; Herder, Christian; Holmen, Oddgeir L.; Hreidarsson, Astradur B.; Humphries, Steve E.; Hunter, David J.; Jackson, Anne U.; Jonsson, Anna; Jorgensen, Marit E.; Jorgensen, Torben; Kao, Wen-Hong L.; Kerrison, Nicola D.; Kinnunen, Leena; Klopp, Norman; Kong, Augustine; Kovacs, Peter; Kraft, Peter; Kravic, Jasmina; Langford, Cordelia; Leander, Karin; Liang, Liming; Lichtner, Peter; Lindgren, Cecilia M.; Lindholm, Eero; Linneberg, Allan; Liu, Ching-Ti; Lobbens, Stephane; Luan, Jian'an; Lyssenko, Valeriya; Mannisto, Satu; McLeod, Olga; Meyer, Julia; Mihailov, Evelin; Mirza, Ghazala; Muehleisen, Thomas W.; Mueller-Nurasyid, Martina; Navarro, Carmen; Noethen, Markus M.; Oskolkov, Nikolay N.; Owen, Katharine R.; Palli, Domenico; Pechlivanis, Sonali; Peltonen, Leena; Perry, John R. B.; Platou, Carl G. P.; Roden, Michael; Ruderfer, Douglas; Rybin, Denis; van der Schouw, Yvonne T.; Sennblad, Bengt; Sigurdsson, Gunnar; Stancakova, Alena; Steinbach, Gerald; Storm, Petter; Strauch, Konstantin; Stringham, Heather M.; Sun, Qi; Thorand, Barbara; Tikkanen, Emmi; Tonjes, Anke; Trakalo, Joseph; Tremoli, Elena; Tuomi, Tiinamaija; Wennauer, Roman; Wiltshire, Steven; Wood, Andrew R.; Zeggini, Eleftheria; Dunham, Ian; Birney, Ewan; Pasquali, Lorenzo; Ferrer, Jorge; Loos, Ruth J. F.; Dupuis, Josee; Florez, Jose C.; Boerwinkle, Eric; Pankow, James S.; van Duijn, Cornelia; Sijbrands, Eric; Meigs, James B.; Hu, Frank B.; Thorsteinsdottir, Unnur; Stefansson, Kari; Lakka, Timo A.; Rauramaa, Rainer; Stumvoll, Michael; Pedersen, Nancy L.; Lind, Lars; Keinanen-Kiukaanniemi, Sirkka M.; Korpi-Hyovalti, Eeva; Saaristo, Timo E.; Saltevo, Juha; Kuusisto, Johanna; Laakso, Markku; Metspalu, Andres; Erbel, Raimund; Joecke, Karl-Heinz; Moebus, Susanne; Ripatti, Samuli; Salomaa, Veikko; Ingelsson, Erik; Boehm, Bernhard O.; Bergman, Richard N.; Collins, Francis S.; Mohlke, Karen L.; Koistinen, Heikki; Tuomilehto, Jaakko; Hveem, Kristian; Njolstad, Inger; Deloukas, Panagiotis; Donnelly, Peter J.; Frayling, Timothy M.; Hattersley, Andrew T.; de Faire, Ulf; Hamsten, Anders; Illig, Thomas; Peters, Annette; Cauchi, Stephane; Sladek, Rob; Froguel, Philippe; Hansen, Torben; Pedersen, Oluf; Morris, Andrew D.; Palmer, Collin N. A.; Kathiresan, Sekar; Melander, Olle; Nilsson, Peter M.; Groop, Leif C.; Barroso, Ines; Langenberg, Claudia; Wareham, Nicholas J.; O'Callaghan, Christopher A.; Gloyn, Anna L.; Altshuler, David; Boehnke, Michael; Teslovich, Tanya M.; McCarthy, Mark I.; Morris, Andrew P.		DIAbet Genetics Replication Meta-A	Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci	NATURE GENETICS			English	Article							LARGE-SCALE ASSOCIATION; WIDE ASSOCIATION; GLUCOSE-HOMEOSTASIS; GENOTYPE IMPUTATION; COMMON VARIANTS; GLYCEMIC TRAITS; ALPHA-GENE; RISK LOCI; MUTATIONS; CHROMATIN	We performed fine mapping of 39 established type 2 diabetes (T2D) loci in 27,206 cases and 57,574 controls of European ancestry. We identified 49 distinct association signals at these loci, including five mapping in or near KCNQ1. 'Credible sets' of the variants most likely to drive each distinct signal mapped predominantly to noncoding sequence, implying that association with T2D is mediated through gene regulation. Credible set variants were enriched for overlap with FOXA2 chromatin immunoprecipitation binding sites in human islet and liver cells, including at MTNR1B, where fine mapping implicated rs10830963 as driving T2D association. We confirmed that the T2D risk allele for this SNP increases FOXA2-bound enhancer activity in islet- and liver-derived cells. We observed allele-specific differences in NEUROD1 binding in islet-derived cells, consistent with evidence that the T2D risk allele increases islet MTNR1B expression. Our study demonstrates how integration of genetic and genomic information can define molecular mechanisms through which variants underlying association signals exert their effects on disease.	[Gaulton, Kyle J.; Ferreira, Teresa; Mahajan, Anubha; Rayner, N. William; Robertson, Neil; Beer, Nicola L.; van de Bunt, Martijn; Lindgren, Cecilia M.; Steinbach, Gerald; Trakalo, Joseph; Wiltshire, Steven; Ingelsson, Erik; Donnelly, Peter J.; Gloyn, Anna L.; McCarthy, Mark I.; Morris, Andrew P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Gaulton, Kyle J.; Tikkanen, Emmi; Ripatti, Samuli] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Lee, Yeji; Locke, Adam; Scott, Laura J.; Fuchsberger, Christian; Kwan, Phoenix; Ma, Clement; Kang, Hyun Min; Abecasis, Goncalo R.; Jackson, Anne U.; Stringham, Heather M.; Tuomi, Tiinamaija; Boehnke, Michael; Teslovich, Tanya M.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Raimondo, Anne; Rayner, N. William; Robertson, Neil; Thomsen, Soren K.; Rundle, Jana K.; Beer, Nicola L.; van de Bunt, Martijn; Groves, Christopher J.; Owen, Katharine R.; Tuomi, Tiinamaija; Collins, Francis S.; Gloyn, Anna L.; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Maegi, Reedik; Esko, Tonu; Mihailov, Evelin; Wennauer, Roman; Sijbrands, Eric; Metspalu, Andres; Koistinen, Heikki; Morris, Andrew P.] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Reschen, Michael E.; Chalisey, Anil; Wood, Andrew R.; Frayling, Timothy M.; O'Callaghan, Christopher A.] Univ Oxford, Nuffield Dept Med, Ctr Cellular & Mol Physiol, Oxford, England; [Rayner, N. William; Edkins, Sarah; Langford, Cordelia; Peltonen, Leena; Zeggini, Eleftheria; Dunham, Ian; Birney, Ewan; Ripatti, Samuli; Deloukas, Panagiotis; Barroso, Ines] Wellcome Trust Sanger Inst, Hinxton, England; [Scott, Robert A.; Willems, Sara M.; Kerrison, Nicola D.; Luan, Jian'an; Perry, John R. B.; Pasquali, Lorenzo; Loos, Ruth J. F.; Langenberg, Claudia; Wareham, Nicholas J.] Univ Cambridge, Sch Clin Med, Inst Metab Sci, Med Res Council MRC Epidemiol Unit, Cambridge, England; [Prokopenko, Inga; Pasquali, Lorenzo; Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Genom Common Dis, London, England; [Green, Todd; Burtt, Noel P.; Carey, Jason; Crenshaw, Andrew T.; Flannick, Jason; Fontanillas, Pierre; Grant, George B.; Lindgren, Cecilia M.; Kathiresan, Sekar; Altshuler, David] Broad Inst Harvard & MIT, Cambridge, MA USA; [Sparso, Thomas; Grarup, Niels; Have, Christian T.; Hansen, Torben; Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Thuillier, Dorothee; Yengo, Loic; Cauchi, Stephane] European Genom Inst Diabet, Lille Inst Biol, Lille, France; [Grallert, Harald; Wahl, Simone; Gieger, Christian; Klopp, Norman; Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Grallert, Harald; Wahl, Simone; Gieger, Christian; Thorand, Barbara; Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Grallert, Harald; Wahl, Simone; Thorand, Barbara; Peters, Annette] German Ctr Diabet Res, Neuherberg, Germany; [Franberg, Mattias; Strawbridge, Rona J.; Gertow, Karl; McLeod, Olga; Sennblad, Bengt; Hamsten, Anders] Karolinska Inst, Dept Med Solna, Atherosclerosis Res Unit, Stockholm, Sweden; [Franberg, Mattias; Sennblad, Bengt] Sci Life Lab, Stockholm, Sweden; [Franberg, Mattias] Stockholm Univ, Dept Numer Anal & Comp Sci, S-10691 Stockholm, Sweden; [Kestler, Hans] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Kestler, Hans] Univ Ulm, Med Syst Biol, D-89069 Ulm, Germany; [Chheda, Himanshu; Tikkanen, Emmi; Tuomi, Tiinamaija; Ripatti, Samuli; Groop, Leif C.] Finnish Inst Mol Med, Helsinki, Finland; [Eisele, Lewin; Pechlivanis, Sonali; Moebus, Susanne] Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Gustafsson, Stefan; Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Steinthorsdottir, Valgerdur; Thorleifsson, Gudmar; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet Amgen Inc, Reykjavik, Iceland; [Qi, Lu; Hunter, David J.; Kraft, Peter; Liang, Liming; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Qi, Lu; van Dam, Rob M.; Franks, Paul W.; Hunter, David J.; Sun, Qi; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Qi, Lu; Hunter, David J.; Sun, Qi; Hu, Frank B.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Qi, Lu; Hunter, David J.; Sun, Qi; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Qi, Lu] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Karssen, Lennart C.; van Leeuwen, Elisabeth M.; Willems, Sara M.; van Duijn, Cornelia] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Li, Man; Kao, Wen-Hong L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Chen, Han; Liu, Ching-Ti; Dupuis, Josee] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Chen, Han; Kraft, Peter; Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Linderman, Michael] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Lu, Yingchang; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, New York, NY 10029 USA; [Voight, Benjamin F.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Almgren, Peter; Fadista, Joao; Franks, Paul W.; Jonsson, Anna; Kravic, Jasmina; Lindholm, Eero; Lyssenko, Valeriya; Oskolkov, Nikolay N.; Storm, Petter; Melander, Olle; Nilsson, Peter M.; Groop, Leif C.] Lund Univ, Scania Univ Hosp, Dept Clin Sci Malmo, Ctr Diabet, Malmo, Sweden; [Baldassarre, Damiano; Tremoli, Elena] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Baldassarre, Damiano; Tremoli, Elena] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Balkau, Beverley] Ctr Rech Epidemiol & Sante Populat CESP, INSERM, U1018, Villejuif, France; [Balkau, Beverley] Univ Paris 11, UMRS 1018, Villejuif, France; [Benediktsson, Rafn; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Benediktsson, Rafn; Hreidarsson, Astradur B.; Sigurdsson, Gunnar] Landspitali Univ Hosp, Reykjavik, Iceland; [Blueher, Matthias; Kovacs, Peter; Tonjes, Anke; Stumvoll, Michael] Univ Leipzig, Integrated Treatment & Res IFB Ctr Adipos Dis, D-04109 Leipzig, Germany; [Blueher, Matthias; Kovacs, Peter; Tonjes, Anke; Stumvoll, Michael] Univ Leipzig, Dept Med, D-04109 Leipzig, Germany; [Boeing, Heiner] German Inst Human Nutr, Potsdam, Germany; [Bonnycastle, Lori L.; Chines, Peter S.; Collins, Francis S.] NHGRI, US NIH, Bethesda, MD 20892 USA; [Bottinger, Erwin P.; Gottesman, Omri; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Charpentier, Guillaume] Corbeil Essonnes Hosp, Endocrinol Diabetol Unit, Corbeil Essonnes, France; [Cornelis, Marilyn C.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Couper, David J.] Univ N Carolina, Dept Biostat, Collaborat Studies Coordinating Ctr, Chapel Hill, NC USA; [van Dam, Rob M.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Doney, Alex S. F.; Palmer, Collin N. A.] Univ Dundee, Ninewells Hosp, Biomed Res Inst, Ctr Diabet Res, Dundee, Scotland; [Doney, Alex S. F.; Palmer, Collin N. A.] Univ Dundee, Ninewells Hosp, Biomed Res Inst, Pharmacogen Ctr, Dundee, Scotland; [Dorkhan, Mozhgan] Lund Univ, Ctr Diabet, Dept Clin Sci Malmo, Novo Nordisk Scandinavia, Malmo, Sweden; [Eriksson, Johan G.; Kinnunen, Leena; Mannisto, Satu; Peltonen, Leena; Salomaa, Veikko; Koistinen, Heikki; Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.; Tuomi, Tiinamaija] Folkhalsan Res Ctr, Helsinki, Finland; [Esko, Tonu] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Esko, Tonu; Florez, Jose C.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Eury, Elodie; Lobbens, Stephane; Froguel, Philippe] CNRS, UMR 8199, Inst Biol, Lille, France; [Eury, Elodie; Lobbens, Stephane; Froguel, Philippe] Univ Lille 2, Inst Pasteur, Lille, France; [Fox, Caroline; Dupuis, Josee] NHLBI, Framingham Heart Study, Framingham, MA USA; [Fox, Caroline] Brigham & Womens Hosp, Div Endocrinol & Metab, Boston, MA 02115 USA; [Fox, Caroline] Harvard Univ, Sch Med, Boston, MA USA; [Franks, Paul W.] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Franks, Paul W.] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Gigante, Bruna; Leander, Karin; de Faire, Ulf] Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, S-10401 Stockholm, Sweden; [Hassinen, Maija; Lakka, Timo A.; Rauramaa, Rainer] Kuopio Res Inst Exercise Med, Kuopio, Finland; [Herder, Christian; Roden, Michael] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Herder, Christian; Roden, Michael] Partner Site Dusseldorf, German Ctr Diabet Res, Dusseldorf, Germany; [Holmen, Oddgeir L.; Platou, Carl G. P.; Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Nord Trondelag Hlth Study HUNT Res Ctr, Levanger, Norway; [Humphries, Steve E.] UCL, Inst Cardiovasc Sci, British Heart Fdn BHF Labs, Cardiovasc Genet, London, England; [Hunter, David J.; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA; [Jorgensen, Marit E.; Lyssenko, Valeriya] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Jorgensen, Torben; Linneberg, Allan] Capital Reg Denmark, Res Ctr Prevent & Hlth, Copenhagen, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Jorgensen, Torben] Aalborg Univ, Fac Med, Aalborg, Denmark; [Klopp, Norman; Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, Hannover, Germany; [Lichtner, Peter] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Linneberg, Allan] Rigshosp, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Meyer, Julia; Mueller-Nurasyid, Martina; Strauch, Konstantin] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Mirza, Ghazala] Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, Guys & St Thomas Hosp, Genom Core Facil, Biomed Res Ctr, London, England; [Muehleisen, Thomas W.; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Muehleisen, Thomas W.; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Muehleisen, Thomas W.] Res Ctr Julich, Inst Neurosci & Med INM 1, Julich, Germany; [Mueller-Nurasyid, Martina] Univ Munich, Univ Hosp Grosshadern, Dept Med 1, Munich, Germany; [Mueller-Nurasyid, Martina; Strauch, Konstantin] Univ Munich, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Neuherberg, Germany; [Mueller-Nurasyid, Martina; Peters, Annette] Partner Site Munich Heart Alliance, DZHK German Ctr Cardiovasc Res, Munich, Germany; [Navarro, Carmen] Inst Murciano Invest Biosanitaria Virgen de la Ar, Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain; [Navarro, Carmen] CIBERESP, Madrid, Spain; [Navarro, Carmen] Univ Murcia, Dept Hlth & Social Sci, Murcia, Spain; [Owen, Katharine R.; Gloyn, Anna L.; McCarthy, Mark I.] Churchill Hosp, Biomed Res Ctr, Oxford Natl Inst Hlth Res, Oxford OX3 7LJ, England; [Palli, Domenico] Canc Res & Prevent Inst ISPO, Florence, Italy; [Platou, Carl G. P.] Nord Trondelag Hlth Trust, Levanger Hosp, Dept Internal Med, Levanger, Norway; [Roden, Michael] Univ Hosp Dusseldorf, Dept Endocrinol & Diabetol, Dusseldorf, Germany; [Ruderfer, Douglas] Icahn Sch Med Mt Sinai, Dept Psychiat, Div Psychiat Genom, New York, NY 10029 USA; [Rybin, Denis] Boston Univ, Data Coordinating Ctr, Boston, MA 02215 USA; [van der Schouw, Yvonne T.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Sigurdsson, Gunnar] Iceland Heart Assoc, Kopavogur, Iceland; [Stancakova, Alena; Kuusisto, Johanna; Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio, Finland; [Stancakova, Alena; Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Steinbach, Gerald] Univ Ulm, Dept Clin Chem & Cent Lab, D-89069 Ulm, Germany; [Tikkanen, Emmi; Ripatti, Samuli] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Tuomi, Tiinamaija] Helsinki Univ Hosp, Abdominal Ctr, Dept Endocrinol, Helsinki, Finland; [Tuomi, Tiinamaija] Univ Helsinki, Res Program Diabet & Obes, Helsinki, Finland; [Wennauer, Roman; Sijbrands, Eric] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Wood, Andrew R.; Frayling, Timothy M.] Univ Exeter, Sch Med, Genet Complex Traits, Exeter, Devon, England; [Dunham, Ian; Birney, Ewan] European Mol Biol Lab, EBI, Hinxton, England; [Pasquali, Lorenzo] Germans Trias & Pujol Univ Hosp & Res Inst, Div Endocrinol, Badalona, Spain; [Pasquali, Lorenzo] Josep Carreras Leukaemia Res Inst, Badalona, Spain; [Pasquali, Lorenzo] CIBERDEM, Barcelona, Spain; [Ferrer, Jorge] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Ferrer, Jorge] Inst Invest Biomed August Pi & Sunyer, Ctr Esther Koplowitz, Barcelona, Spain; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Florez, Jose C.; Kathiresan, Sekar; Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Florez, Jose C.; Altshuler, David] Massachusetts Gen Hosp, Diabet Res Ctr, Boston, MA 02114 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Houston, TX 77030 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Pankow, James S.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [van Duijn, Cornelia] Netherlands Consortium Hlth Ageing, Netherlands Genom Initiat, Rotterdam, Netherlands; [van Duijn, Cornelia] Ctr Med Syst Biol, Rotterdam, Netherlands; [Meigs, James B.] Massachusetts Gen Hosp, Gen Med Div, Boston, MA 02114 USA; [Lakka, Timo A.; Joecke, Karl-Heinz] Univ Eastern Finland, Inst Biomed Physiol, Kuopio, Finland; [Lakka, Timo A.; Rauramaa, Rainer] Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, SF-70210 Kuopio, Finland; [Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Lind, Lars] Univ Uppsala Hosp, Dept Med Sci, Uppsala, Sweden; [Keinanen-Kiukaanniemi, Sirkka M.] Univ Oulu, Inst Hlth Sci, Fac Med, Oulu, Finland; [Keinanen-Kiukaanniemi, Sirkka M.] Oulu Univ Hosp, Unit Gen Practice, Oulu, Finland; [Korpi-Hyovalti, Eeva] South Ostrobothnia Cent Hosp, Seinajoki, Finland; [Saaristo, Timo E.] Finnish Diabet Assoc, Tampere, Finland; [Saaristo, Timo E.] Pirkanmaa Dist Hosp, Tampere, Finland; [Saltevo, Juha] Cent Finland Cent Hosp, Dept Med, Jyvaskyla, Finland; [Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Erbel, Raimund] Univ Duisdurg Essen, Univ Hosp Essen, West German Heart Ctr, Clin Cardiol, Essen, Germany; [Ripatti, Samuli] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Helsinki, Finland; [Boehm, Bernhard O.] Univ Med Ctr Ulm, Dept Internal Med, Div Endocrinol & Diabet, Ulm, Germany; [Boehm, Bernhard O.] Univ London Imperial Coll Sci Technol & Med, Lee Kong Chian Sch Med, London SW7 2AZ, England; [Boehm, Bernhard O.] Nanyang Technol Univ, Singapore 639798, Singapore; [Bergman, Richard N.] Cedars Sinai Med Ctr, Diabet & Obes Res Inst, Los Angeles, CA 90048 USA; [Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Koistinen, Heikki] Univ Helsinki, Cent Hosp, Dept Med, Div Endocrinol, Helsinki, Finland; [Koistinen, Heikki] Minerva Fdn, Helsinki, Finland; [Tuomilehto, Jaakko] Hosp Univ La Paz, Inst Invest Sanitaria, Madrid, Spain; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] King Abdulaziz Univ, Diabet Res Grp, Jeddah 21413, Saudi Arabia; [Njolstad, Inger] Univ Tromso, Fac Hlth Sci, Dept Community Med, Tromso, Norway; [Deloukas, Panagiotis] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Donnelly, Peter J.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Hattersley, Andrew T.] Univ Exeter, Sch Med, Inst Biomed & Clin Sci, Exeter, Devon, England; [Sladek, Rob] Ctr Hosp Univ Montreal, Ctr Rech, Montreal Diabet Res Ctr, Montreal, PQ, Canada; [Sladek, Rob] McGill Univ, Montreal, PQ, Canada; [Sladek, Rob] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark; [Morris, Andrew D.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Barroso, Ines] Univ Cambridge, Metab Res Labs, Wellcome Trust MRC Inst Metab Sci, Cambridge, England; [Barroso, Ines] Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Cambridge, England; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Mol Biol, Boston, MA USA; Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Morris, Andrew P.] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England	University of Oxford; Wellcome Centre for Human Genetics; Stanford University; University of Michigan System; University of Michigan; University of Oxford; University of Tartu; University of Oxford; Wellcome Trust Sanger Institute; University of Cambridge; Imperial College London; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Novo Nordisk Foundation; University of Copenhagen; Universite de Lille - ISITE; Universite de Lille; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Karolinska Institutet; Stockholm University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Ulm University; University of Duisburg Essen; Uppsala University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Tulane University; Erasmus University Rotterdam; Erasmus MC; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Pennsylvania; Pennsylvania Medicine; Lund University; IRCCS Centro Cardiologico Monzino; University of Milan; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Iceland; Landspitali National University Hospital; Leipzig University; Leipzig University; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Icahn School of Medicine at Mount Sinai; Centre Hospitalier Sud Francilien; Northwestern University; Feinberg School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; National University of Singapore; University of Dundee; University of Dundee; Lund University; Novo Nordisk; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Lund University; Umea University; Karolinska Institutet; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Norwegian University of Science & Technology (NTNU); University of London; University College London; Harvard University; Harvard T.H. Chan School of Public Health; Steno Diabetes Center; University of Copenhagen; Aalborg University; Hannover Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Rigshospitalet; University of Copenhagen; University of Copenhagen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Guy's & St Thomas' NHS Foundation Trust; University of Bonn; University of Bonn; Helmholtz Association; Research Center Julich; University of Munich; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Murcia Regional Health Council; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Murcia; University of Oxford; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Icahn School of Medicine at Mount Sinai; Boston University; Utrecht University; Utrecht University Medical Center; Icelandic Heart Association; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Ulm University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Erasmus University Rotterdam; Erasmus MC; University of Exeter; European Molecular Biology Laboratory (EMBL); Institut de Recerca Contra la Leucemia Josep Carreras (IJC); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Imperial College London; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Icahn School of Medicine at Mount Sinai; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Massachusetts General Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Karolinska Institutet; Uppsala University; Uppsala University Hospital; University of Oulu; University of Oulu; Pirkanmaa Hospital District; Central Finland Central Hospital; University of Tartu; University of Duisburg Essen; Finland National Institute for Health & Welfare; Ulm University; Imperial College London; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Cedars Sinai Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of Helsinki; Helsinki University Central Hospital; Hospital Universitario La Paz; Danube University Krems; King Abdulaziz University; UiT The Arctic University of Tromso; University of London; Queen Mary University London; University of Oxford; University of Exeter; Universite de Montreal; McGill University; University of Southern Denmark; University of Edinburgh; Harvard University; Massachusetts General Hospital; University of Cambridge; University of Cambridge; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Liverpool; University of Liverpool	Gaulton, KJ (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	kgaulton@gmail.com; mark.mccarthy@drl.ox.ac.uk; apmorris@liverpool.ac.uk	Stancakova, Alena/AAN-6723-2020; Khan, Hassan/D-6267-2013; Grallert, Harald/B-3424-2013; Doney, Alexander SF/P-7437-2017; Sijbrands, Eric/A-1065-2009; Pedersen, Oluf/AAG-8015-2020; Mägi, Reedik/AAJ-9679-2021; Fadista, Joao/AAM-4870-2020; Altshuler, David M/A-4476-2009; van Leeuwen, Elisabeth/G-3382-2017; Kestler, Hans A./D-5799-2012; Meigs, James/P-3927-2019; Deloukas, Panos/B-2922-2013; Roden, Michael/AAD-3843-2019; van Dam, Rob M/F-9674-2010; Stumvoll, Michael/ABE-1121-2021; Johnson, Andrew D/G-6520-2013; Hveem, Kristian/AFV-4683-2022; Prokopenko, Inga/H-3241-2014; Kinnunen, Leena/B-7059-2012; Ruderfer, Douglas M/M-5795-2016; Loos, Ruth/GON-5877-2022; van der Schouw, Yvonne T./F-8327-2014; Kraft, Peter/GQH-8448-2022; Fuchsberger, Christian/ABD-7127-2021; Strawbridge, Rona/H-5422-2012; Ferrer, Jorge/A-3176-2012; Jørgensen, Torben/Z-1335-2018; Locke, Adam/K-2000-2019; Stefansson, Kari/AAE-7187-2019; Oskolkov, Nikolay/AAH-2349-2019; FROGUEL, Philippe/O-6799-2017; Palmer, Colin NA/C-7053-2008; Franks, Paul/AAA-3300-2020; Benediktsson, Rafn/R-2457-2018; Sladek, Robert/R-2391-2019; Gigante, Bruna/I-9252-2012; Veglia, Fabrizio/K-1958-2016; Prokopenko, Inga/AAU-9895-2020; Pasquali, Lorenzo/B-6239-2008; Njolstad, Inger/X-3784-2019; Loos, Ruth J F/Q-2862-2016; Boehm, Bernhard Otto/F-8750-2015; Leander, Karin/C-7261-2017; Study, GoDARTS/K-9448-2016; Thorand, Barbara/B-5349-2014; Kanoni, Stavroula/AAN-7161-2021; Müller-Nurasyid, Martina/I-8735-2018; Yengo, Loic/D-2692-2017; Pedersen, Oluf/Z-1731-2019; Peters, Annette/A-6117-2011; Wood, Andrew R/AAB-3807-2019; Li, Man/AAX-3400-2020; Grarup, Niels/K-2807-2015; Langenberg, Claudia/ABG-9067-2021; TREMOLI, ELENA/I-8126-2018; Rudan, Igor/I-1467-2012; Koistinen, Heikki/J-7313-2016; Baldassarre, Damiano/J-3295-2016; McCarthy, Mark/M-3763-2015	Stancakova, Alena/0000-0002-1375-0252; Khan, Hassan/0000-0003-1468-8654; Doney, Alexander SF/0000-0002-6210-5620; Sijbrands, Eric/0000-0001-8857-7389; Fadista, Joao/0000-0003-2539-634X; Altshuler, David M/0000-0002-7250-4107; Kestler, Hans A./0000-0002-4759-5254; Meigs, James/0000-0002-2439-2657; Deloukas, Panos/0000-0001-9251-070X; van Dam, Rob M/0000-0002-7354-8734; Stumvoll, Michael/0000-0001-6225-8240; Johnson, Andrew D/0000-0001-6369-5178; Prokopenko, Inga/0000-0003-1624-7457; Kinnunen, Leena/0000-0001-8739-4812; Ruderfer, Douglas M/0000-0002-2365-386X; van der Schouw, Yvonne T./0000-0002-4605-435X; Fuchsberger, Christian/0000-0002-5918-8947; Strawbridge, Rona/0000-0001-8506-3585; Ferrer, Jorge/0000-0002-5959-5729; Locke, Adam/0000-0001-6227-198X; FROGUEL, Philippe/0000-0003-2972-0784; Palmer, Colin NA/0000-0002-6415-6560; Benediktsson, Rafn/0000-0002-2954-9801; Sladek, Robert/0000-0002-2730-1204; Veglia, Fabrizio/0000-0002-9378-8874; Pasquali, Lorenzo/0000-0003-2423-1826; Loos, Ruth J F/0000-0002-8532-5087; Leander, Karin/0000-0002-1404-9222; Thorand, Barbara/0000-0002-8416-6440; Kanoni, Stavroula/0000-0002-1691-9615; Müller-Nurasyid, Martina/0000-0003-3793-5910; Yengo, Loic/0000-0002-4272-9305; Pedersen, Oluf/0000-0002-3321-3972; Peters, Annette/0000-0001-6645-0985; Wood, Andrew R/0000-0003-1726-948X; Li, Man/0000-0002-3839-0281; Grarup, Niels/0000-0001-5526-1070; Langenberg, Claudia/0000-0002-5017-7344; Pankow, James/0000-0001-7076-483X; Voight, Benjamin/0000-0002-6205-9994; Storm, Petter/0000-0002-7655-3731; Barroso, Ines/0000-0001-5800-4520; Magi, Reedik/0000-0002-2964-6011; Edkins, Sarah/0000-0003-0717-1972; Lindgren, Cecilia/0000-0002-4903-9374; Eriksson, Johan/0000-0002-2516-2060; Dunham, Ian/0000-0003-2525-5598; Dina, Christian/0000-0002-7722-7348; TREMOLI, ELENA/0000-0002-0929-6106; Kovacs, Peter/0000-0002-0290-5423; PALLI, Domenico/0000-0002-5558-2437; Couper, David/0000-0002-4313-9235; Dorkhan, Mozhgan/0000-0002-2478-1409; Mannisto, Satu/0000-0002-8668-3046; van de Bunt, Martijn/0000-0002-6744-6125; Emilsson, Valur/0000-0001-9982-0524; Jorgensen, Torben/0000-0001-9453-2830; Gieger, Christian/0000-0001-6986-9554; Have, Christian Theil/0000-0002-8634-4781; Thomsen, Soren Krogsgaard/0000-0001-8894-2868; Lakka, Timo/0000-0002-9199-2871; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Mahajan, Anubha/0000-0001-5585-3420; Kerrison, Nicola/0000-0002-1471-953X; Forouhi, Nita/0000-0002-5041-248X; Rudan, Igor/0000-0001-6993-6884; Nothen, Markus/0000-0002-8770-2464; Kong, Augustine/0000-0001-8193-5438; Gigante, Bruna/0000-0003-4508-7990; Rybin, Denis/0000-0002-3657-4829; Hattersley, Andrew/0000-0001-5620-473X; Melander, Olle/0000-0002-2581-484X; Van Duijn, Cornelia/0000-0002-2374-9204; Karssen, Lennart C./0000-0002-1959-342X; Moebus, Susanne/0000-0002-0072-5410; Jonsson, Anna/0000-0003-1252-8673; Gloyn, Anna/0000-0003-1205-1844; Dupuis, Josee/0000-0003-2871-3603; Liu, Ching-Ti/0000-0002-0703-0742; Gaulton, Kyle/0000-0003-1318-7161; Koistinen, Heikki/0000-0001-7870-070X; Hansen, Torben/0000-0001-8748-3831; Price, Jackie/0000-0003-3251-3970; Navarro, Carmen/0000-0001-8896-7483; Birney, Ewan/0000-0001-8314-8497; tumino, rosario/0000-0003-2666-414X; Tuomi, Tiinamaija/0000-0002-8306-6202; Bergman, Richard/0000-0003-1539-4471; Linneberg, Allan/0000-0002-0994-0184; Chen, Han/0000-0002-9510-4923; Jorgensen, Marit Eika/0000-0001-8356-5565; Baldassarre, Damiano/0000-0002-2766-8882; Humphries, Stephen E/0000-0002-8221-6547; Lindholm, Eero/0000-0002-8869-681X; McCarthy, Mark/0000-0002-4393-0510; Pechlivanis, Sonali/0000-0002-6181-7044; Franks, Paul/0000-0002-0520-7604	Academy of Finland [77299, 102318, 10493, 118065, 123885, 124243, 129293, 129680, 136895, 139635, 211119, 213506, 251217, 263836]; Agence National de la Recherche; Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques; Association Diabeete Risque Vasculaire; Association Francaise des Diabetiques; Association of Danish Pharmacies; Augustinus Foundation; Becket Foundation; British Diabetes Association (BDA) Research; British Heart Foundation; Central Norway Health Authority; Central Finland Hospital District; Center for Inherited Disease Research (CIDR); City of Kuopio; City of Leutkirch; Copenhagen County; Danish Centre for Evaluation and Health Technology Assessment; Danish Council for Independent Research; Danish Heart Foundation; Danish Research Councils; Deutsche Forschungsgemeinschaft [ER 155/6-2]; Diabetes Research Foundation; Diabetes UK; Doris Duke Charitable Foundation; Erasmus Medical Center; Erasmus University; Estonian government [SF0180142s08]; European Commission [ENGAGE HEALTH-F4-2007-201413, FP7-201413, FP7-245536, EXGENESIS LSHM-CT-2004-005272, FP6 LSHM_CT_2006_037197, LSHM-CT-2007-037273, C-Public Health 2004310]; European Regional Development Fund; Federal Ministry of Education and Research, Germany [FKZ 01GI1128, FKZ 01EO1001]; Federal Ministry of Health, Germany; Finnish Diabetes Association; Finnish Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Finnish Medical Society; Folkhalsan Research Foundation; Foundation for Life and Health in Finland; Foundation for Old Servants; Fredrick och Ingrid Thuring Foundation; French region of Nord-Pas-de-Calais (Contrat de Projets Etat-Region); German Center for Diabetes Research; German Research Council [GRK1041]; German National Genome Research Network; Groupe d'Etude des Maladies Metaboliques et Systemiques; Health Care Centers in Vasa, Narpes and Korsholm, Finland; Health Foundation; Heinz Nixdorf Foundation; Helmholtz Zentrum Munchen; Helsinki University Central Hospital Research Foundation; Hospital District of Southwest Finland; Ib Henriksens Foundation; IngaBritt and Arne Lundberg's Research Foundation [359]; Karolinska Institutet; Knut and Alice Wallenberg Foundation [KAW 2009.0243]; Kuopio University Hospital; Lundbeck Foundation; Magnus Bergvall Foundation; Medical Faculty of University Duisburg-Essen; Medical Research Council, UK [G0000649, G0601261]; Ministry for Health, Welfare and Sports, the Netherlands; Ministry of Education and Culture, Finland [722, 627]; Ministry of Education, Culture and Science, the Netherlands; Ministry of Health and Prevention, Denmark; Ministry of Social Affairs and Health, Finland; Ministry of Innovation, Science, Research and Technology of North Rhine-Westphalia, Germany; Munich Center of Health Sciences; Municipal Health Care Center and Hospital in Jakobstad, Finland; municipality of Rotterdam, the Netherlands; Narpes Health Care Foundation; National Health Screening Service of Norway; National Heart, Lung, and Blood Institute, USA [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, N01HC25195, N02HL64278, R01HL087641, R01HL59367, R01HL086694]; National Human Genome Research Institute, USA [U01HG004402, N01HG65403]; National Institute for Diabetes and Digestive and Kidney Diseases, USA [R01DK078616, U01DK085526, K24DK080140, R01DK073490]; National Institute for Health and Welfare, Finland; National Institutes of Health, USA [HHSN268200625226C, UL1RR025005, R01DK062370, R01DK072193, 1Z01HG000024, AG028555, AG08724, AG04563, AG10175, AG08861, U01HG004399, DK58845, CA055075, DK085545, DK098032]; Netherlands Genomics Initiative; Netherlands Organisation for Health Research and Development; Netherlands Organisation of Scientific Research NOW Investments [175.010.2005.011, 911-03-012, 050-060-810]; Nord-Trondelag County Council; Nordic Center of Excellence in Disease Genetics; Norwegian Institute of Public Health; Norwegian Research Council; Novo Nordisk Foundation; Ollquist Foundation; Oxford National Institute for Health Research (NIHR) Biomedical Research Centre; Paavo Nurmi Foundation; Paivikki and Sakari Sohlberg Foundation; Perklen Foundation; Pirkanmaa Hospital District, Finland; Programme Hospitalier de Recherche Clinique; Programme National de Recherche sur la Diabete; Research Institute for Diseases in the Elderly [014-93-015]; Robert Dawson Evans Endowment, Department of Medicine, Boston University School of Medicine and Boston Medical Center; Royal Swedish Academy of Sciences; Sarstedt, Germany; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Slottery Machine Association, Finland; Social Insurance Institution of Finland; South OstroBothnia Hospital District; state of Baden-Wurttemberg, Germany; Stockholm County Council [560183]; Swedish Cultural Foundation, Finland; Swedish Diabetes Foundation; Swedish e-science Research Center; Swedish Foundation for Strategic Research; Swedish Heart-Lung Foundation; Swedish Research Council [SFO EXODIAB 2009-1039, 521-2010-3490, 521-2007-4037, 521-2008-2974, ANDIS 825-2010-5983, LUDC 349-2008-6589, 8691]; Swedish Society of Medicine; Tore Nilsson Foundation; Torsten and Ragnar Soderbergs Stiftelser [MT33/09]; University Hospital Essen; University of Tromso; University College London NIHR Biomedical Research Centre; UK NIHR Cambridge Biomedical Research Centre; Uppsala University; Uppsala University Hospital; Vaasa Hospital District; Velux Foundation; Wellcome Trust [GR072960, 076113, 083948, 090367, 090532, 083270, 086596, 098017, 095101, 098051, 098381]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA055075] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086694, R01HL087641, R01HL059367, R01HL064278] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402, N01HG065403, Z01HG000024, ZIAHG000024, U01HG004399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062370, R01DK093757, R01DK101478, R01DK062370, R01DK058845, R01DK073490, U01DK078616, R01DK078616, R01DK072193, R01DK098032, P30DK020572, U01DK085526, U01DK085545, K24DK080140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028555, R01AG010175, R37AG008861, R01AG008861, R01AG008724, R01AG004563] Funding Source: NIH RePORTER; British Heart Foundation [RG/08/008/25291, RG/14/5/30893, PG/11/4/28645] Funding Source: researchfish; Medical Research Council [1362320, MC_U106179472, MC_UU_12015/2, MC_UU_12015/1, MC_PC_13046, MC_U106179471, G116/165, G0601261] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10219, NF-SI-0512-10135, NF-SI-0611-10099] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0016416, NNF11OC1014855, NNF13OC0005781, NNF12OC1016167] Funding Source: researchfish; MRC [G0601261, MC_U106179472, MR/L02036X/1, MC_UU_12015/1, MC_UU_12015/2, G116/165] Funding Source: UKRI	Academy of Finland(Academy of Finland); Agence National de la Recherche(French National Research Agency (ANR)); Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques; Association Diabeete Risque Vasculaire; Association Francaise des Diabetiques; Association of Danish Pharmacies; Augustinus Foundation; Becket Foundation; British Diabetes Association (BDA) Research; British Heart Foundation(British Heart Foundation); Central Norway Health Authority; Central Finland Hospital District; Center for Inherited Disease Research (CIDR); City of Kuopio; City of Leutkirch; Copenhagen County; Danish Centre for Evaluation and Health Technology Assessment; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Danish Heart Foundation; Danish Research Councils(Det Frie Forskningsrad (DFF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Diabetes Research Foundation; Diabetes UK(Diabetes UK); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Erasmus Medical Center; Erasmus University; Estonian government; European Commission(European CommissionEuropean Commission Joint Research Centre); European Regional Development Fund(European Commission); Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Federal Ministry of Health, Germany; Finnish Diabetes Association; Finnish Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Finnish Medical Society; Folkhalsan Research Foundation; Foundation for Life and Health in Finland; Foundation for Old Servants; Fredrick och Ingrid Thuring Foundation; French region of Nord-Pas-de-Calais (Contrat de Projets Etat-Region)(Region Hauts-de-France); German Center for Diabetes Research; German Research Council(German Research Foundation (DFG)); German National Genome Research Network; Groupe d'Etude des Maladies Metaboliques et Systemiques; Health Care Centers in Vasa, Narpes and Korsholm, Finland; Health Foundation; Heinz Nixdorf Foundation; Helmholtz Zentrum Munchen(Helmholtz Association); Helsinki University Central Hospital Research Foundation; Hospital District of Southwest Finland; Ib Henriksens Foundation; IngaBritt and Arne Lundberg's Research Foundation; Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Kuopio University Hospital; Lundbeck Foundation(Lundbeckfonden); Magnus Bergvall Foundation; Medical Faculty of University Duisburg-Essen; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry for Health, Welfare and Sports, the Netherlands(Netherlands Government); Ministry of Education and Culture, Finland; Ministry of Education, Culture and Science, the Netherlands(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Netherlands Government); Ministry of Health and Prevention, Denmark; Ministry of Social Affairs and Health, Finland; Ministry of Innovation, Science, Research and Technology of North Rhine-Westphalia, Germany; Munich Center of Health Sciences; Municipal Health Care Center and Hospital in Jakobstad, Finland; municipality of Rotterdam, the Netherlands(Netherlands Government); Narpes Health Care Foundation; National Health Screening Service of Norway; National Heart, Lung, and Blood Institute, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute for Diabetes and Digestive and Kidney Diseases, USA; National Institute for Health and Welfare, Finland; National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Genomics Initiative; Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organisation of Scientific Research NOW Investments; Nord-Trondelag County Council; Nordic Center of Excellence in Disease Genetics; Norwegian Institute of Public Health; Norwegian Research Council(Research Council of NorwayEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Ollquist Foundation; Oxford National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); Paavo Nurmi Foundation; Paivikki and Sakari Sohlberg Foundation; Perklen Foundation; Pirkanmaa Hospital District, Finland; Programme Hospitalier de Recherche Clinique; Programme National de Recherche sur la Diabete; Research Institute for Diseases in the Elderly; Robert Dawson Evans Endowment, Department of Medicine, Boston University School of Medicine and Boston Medical Center; Royal Swedish Academy of Sciences; Sarstedt, Germany; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Slottery Machine Association, Finland; Social Insurance Institution of Finland; South OstroBothnia Hospital District; state of Baden-Wurttemberg, Germany; Stockholm County Council(Stockholm County Council); Swedish Cultural Foundation, Finland; Swedish Diabetes Foundation; Swedish e-science Research Center; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Tore Nilsson Foundation; Torsten and Ragnar Soderbergs Stiftelser; University Hospital Essen; University of Tromso; University College London NIHR Biomedical Research Centre; UK NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Uppsala University; Uppsala University Hospital; Vaasa Hospital District; Velux Foundation(Velux Fonden); Wellcome Trust(Wellcome TrustEuropean Commission); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for the research undertaken in this study has been received from the Academy of Finland (including grants 77299, 102318, 10493, 118065, 123885, 124243, 129293, 129680, 136895, 139635, 211119, 213506, 251217 and 263836); Agence National de la Recherche; Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques; Association Diabeete Risque Vasculaire; Association Francaise des Diabetiques; the Association of Danish Pharmacies; the Augustinus Foundation; the Becket Foundation; the British Diabetes Association (BDA) Research; the British Heart Foundation; the Central Norway Health Authority; the Central Finland Hospital District; the Center for Inherited Disease Research (CIDR); the City of Kuopio; the City of Leutkirch; Copenhagen County; the Danish Centre for Evaluation and Health Technology Assessment; the Danish Council for Independent Research; the Danish Heart Foundation; the Danish Research Councils; Deutsche Forschungsgemeinschaft (including project ER 155/6-2); the Diabetes Research Foundation; Diabetes UK; the Doris Duke Charitable Foundation; Erasmus Medical Center; Erasmus University; the Estonian government (SF0180142s08); the European Commission (including ENGAGE HEALTH-F4-2007-201413, FP7-201413, FP7-245536, EXGENESIS LSHM-CT-2004-005272, FP6 LSHM_CT_2006_037197, LSHM-CT-2007-037273, Directorate C-Public Health 2004310, DG XII); the European Regional Development Fund; the Federal Ministry of Education and Research, Germany (including FKZ 01GI1128 and FKZ 01EO1001); the Federal Ministry of Health, Germany; the Finnish Diabetes Association; the Finnish Diabetes Research Foundation; the Finnish Foundation for Cardiovascular Research; the Finnish Medical Society; the Folkhalsan Research Foundation; the Foundation for Life and Health in Finland; the Foundation for Old Servants; the Fredrick och Ingrid Thuring Foundation; the French region of Nord-Pas-de-Calais (Contrat de Projets Etat-Region); the German Center for Diabetes Research; the German Research Council (including grant GRK1041); the German National Genome Research Network; Groupe d'Etude des Maladies Metaboliques et Systemiques; the Health Care Centers in Vasa, Narpes and Korsholm, Finland; the Health Foundation; the Heinz Nixdorf Foundation; Helmholtz Zentrum Munchen; the Helsinki University Central Hospital Research Foundation; the Hospital District of Southwest Finland; the Ib Henriksens Foundation; IngaBritt and Arne Lundberg's Research Foundation (including grant 359); Karolinska Institutet; the Knut and Alice Wallenberg Foundation (including grant KAW 2009.; 0243); Kuopio University Hospital; the Lundbeck Foundation; the Magnus Bergvall Foundation; the Medical Faculty of University Duisburg-Essen; the Medical Research Council, UK (including grants G0000649 and G0601261); the Ministry for Health, Welfare and Sports, the Netherlands; the Ministry of Education and Culture, Finland (including grants 722 and 627; 2004-2011); the Ministry of Education, Culture and Science, the Netherlands; the Ministry of Health and Prevention, Denmark; the Ministry of Social Affairs and Health, Finland; the Ministry of Innovation, Science, Research and Technology of North Rhine-Westphalia, Germany; the Munich Center of Health Sciences; the Municipal Health Care Center and Hospital in Jakobstad, Finland; the municipality of Rotterdam, the Netherlands; the Narpes Health Care Foundation; the National Health Screening Service of Norway; the National Heart, Lung, and Blood Institute, USA (including grant numbers/contracts HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, N01HC25195, N02HL64278, R01HL087641, R01HL59367 and R01HL086694); the National Human Genome Research Institute, USA (including grant numbers/contracts U01HG004402 and N01HG65403); the National Institute for Diabetes and Digestive and Kidney Diseases, USA (including grants R01DK078616, U01DK085526, K24DK080140 and R01DK073490); the National Institute for Health and Welfare, Finland; the National Institutes of Health, USA (including grant numbers/contracts HHSN268200625226C, UL1RR025005, R01DK062370, R01DK072193, 1Z01HG000024, AG028555, AG08724, AG04563, AG10175, AG08861, U01HG004399, DK58845, CA055075, DK085545 and DK098032); the Netherlands Genomics Initiative; the Netherlands Organisation for Health Research and Development; the Netherlands Organisation of Scientific Research NOW Investments (including grants 175.010.2005.; 011, 911-03-012 and 050-060-810); the Nord-Trondelag County Council; the Nordic Center of Excellence in Disease Genetics; the Norwegian Institute of Public Health; the Norwegian Research Council; the Novo Nordisk Foundation; the Ollquist Foundation; the Oxford National Institute for Health Research (NIHR) Biomedical Research Centre; the Paavo Nurmi Foundation; the Paivikki and Sakari Sohlberg Foundation; the Perklen Foundation; the Pirkanmaa Hospital District, Finland; Programme Hospitalier de Recherche Clinique; Programme National de Recherche sur la Diabete; the Research Institute for Diseases in the Elderly (including grant 014-93-015); the Robert Dawson Evans Endowment, Department of Medicine, Boston University School of Medicine and Boston Medical Center; the Royal Swedish Academy of Sciences; Sarstedt, Germany; the Signe and Ane Gyllenberg Foundation; the Sigrid Juselius Foundation; the Slottery Machine Association, Finland; the Social Insurance Institution of Finland; the South OstroBothnia Hospital District; the state of Baden-Wurttemberg, Germany; the Stockholm County Council (including grant 560183); the Swedish Cultural Foundation, Finland; the Swedish Diabetes Foundation; the Swedish e-science Research Center; the Swedish Foundation for Strategic Research; the Swedish Heart-Lung Foundation; the Swedish Research Council (including grants SFO EXODIAB 2009-1039, 521-2010-3490, 521-2007-4037, 521-2008-2974, ANDIS 825-2010-5983, LUDC 349-2008-6589 and 8691); the Swedish Society of Medicine; the Tore Nilsson Foundation; the Torsten and Ragnar Soderbergs Stiftelser (including grant MT33/09); University Hospital Essen; University of Tromso; the University College London NIHR Biomedical Research Centre; the UK NIHR Cambridge Biomedical Research Centre; Uppsala University; Uppsala University Hospital; the Vaasa Hospital District; the Velux Foundation; and the Wellcome Trust (including the Biomedical Collections Grant GR072960 and grants 076113, 083948, 090367, 090532, 083270, 086596, 098017, 095101, 098051 and 098381). We are grateful to R. Scharfmann (INSERM U1016, Cochin Institute Paris) for the gift of EndoC beta H1 cells and for providing technical support with their maintenance. We thank P. Johnson and the Oxford NIHR Biomedical Research Centre-funded Islet Isolation facility for providing human islets for this study. Detailed acknowledgments are provided in the Supplementary Note.	Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dimas AS, 2014, DIABETES, V63, P2158, DOI 10.2337/db13-0949; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Elbein SC, 2012, AM J HUM GENET, V91, P466, DOI 10.1016/j.ajhg.2012.08.002; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Fadista J, 2014, P NATL ACAD SCI USA, V111, P13924, DOI 10.1073/pnas.1402665111; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Florez JC, 2004, DIABETES, V53, P1360, DOI 10.2337/diabetes.53.5.1360; Fogarty MP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004633; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gao N, 2010, MOL ENDOCRINOL, V24, P1594, DOI 10.1210/me.2009-0513; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Hamming KSC, 2009, DIABETES, V58, P2419, DOI 10.2337/db09-0143; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Holmkvist J, 2006, DIABETOLOGIA, V49, P2882, DOI 10.1007/s00125-006-0450-x; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jafar-Mohammadi B, 2011, DIABETOLOGIA, V54, P111, DOI 10.1007/s00125-010-1916-4; Johnson ME, 2014, J CLIN ENDOCR METAB, V99, pE1580, DOI 10.1210/jc.2013-4503; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Moran I, 2012, CELL METAB, V16, P435, DOI 10.1016/j.cmet.2012.08.010; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; PUGH CW, 1991, P NATL ACAD SCI USA, V88, P10553, DOI 10.1073/pnas.88.23.10553; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Shea J, 2011, NAT GENET, V43, P801, DOI 10.1038/ng.871; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Soccio RE, 2011, MOL ENDOCRINOL, V25, P694, DOI 10.1210/me.2010-0454; Tabassum R, 2008, J HUM GENET, V53, P957, DOI 10.1007/s10038-008-0335-6; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhou YD, 2014, HUM MOL GENET, V23, P6419, DOI 10.1093/hmg/ddu359	74	262	266	2	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1415	+		10.1038/ng.3437	http://dx.doi.org/10.1038/ng.3437			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	26551672	Green Accepted, Green Submitted			2022-12-17	WOS:000365813200013
J	Anttila, V; Winsvold, BS; Gormley, P; Kurth, T; Bettella, F; McMahon, G; Kallela, M; Malik, R; de Vries, B; Terwindt, G; Medland, SE; Todt, U; McArdle, WL; Quaye, L; Koiranen, M; Ikram, MA; Lehtimaki, T; Stam, AH; Ligthart, L; Wedenoja, J; Dunham, I; Neale, BM; Palta, P; Hamalainen, E; Schurks, M; Rose, LM; Buring, JE; Ridker, PM; Steinberg, S; Stefansson, H; Jakobsson, F; Lawlor, DA; Evans, DM; Ring, SM; Farkkila, M; Artto, V; Kaunisto, MA; Freilinger, T; Schoenen, J; Frants, RR; Pelzer, N; Weller, CM; Zielman, R; Heath, AC; Madden, PAF; Montgomery, GW; Martin, NG; Borck, G; Gobel, H; Heinze, A; Heinze-Kuhn, K; Williams, FMK; Hartikainen, AL; Pouta, A; van den Ende, J; Uitterlinden, AG; Hofman, A; Amin, N; Hottenga, JJ; Vink, JM; Heikkila, K; Alexander, M; Muller-Myhsok, B; Schreiber, S; Meitinger, T; Wichmann, HE; Aromaa, A; Eriksson, JG; Traynor, BJ; Trabzuni, D; Rossin, E; Lage, K; Jacobs, SBR; Gibbs, JR; Birney, E; Kaprio, J; Penninx, BW; Boomsma, DI; van Duijn, C; Raitakari, O; Jarvelin, MR; Zwart, JA; Cherkas, L; Strachan, DP; Kubisch, C; Ferrari, MD; van den Maagdenberg, AMJM; Dichgans, M; Wessman, M; Smith, GD; Stefansson, K; Daly, MJ; Nyholt, DR; Chasman, DI; Palotie, A				Anttila, Verneri; Winsvold, Bendik S.; Gormley, Padhraig; Kurth, Tobias; Bettella, Francesco; McMahon, George; Kallela, Mikko; Malik, Rainer; de Vries, Boukje; Terwindt, Gisela; Medland, Sarah E.; Todt, Unda; McArdle, Wendy L.; Quaye, Lydia; Koiranen, Markku; Ikram, M. Arfan; Lehtimaki, Terho; Stam, Anine H.; Ligthart, Lannie; Wedenoja, Juho; Dunham, Ian; Neale, Benjamin M.; Palta, Priit; Hamalainen, Eija; Schuerks, Markus; Rose, Lynda M.; Buring, Julie E.; Ridker, Paul M.; Steinberg, Stacy; Stefansson, Hreinn; Jakobsson, Finnbogi; Lawlor, Debbie A.; Evans, David M.; Ring, Susan M.; Farkkila, Markus; Artto, Ville; Kaunisto, Mari A.; Freilinger, Tobias; Schoenen, Jean; Frants, Rune R.; Pelzer, Nadine; Weller, Claudia M.; Zielman, Ronald; Heath, Andrew C.; Madden, Pamela A. F.; Montgomery, Grant W.; Martin, Nicholas G.; Borck, Guntram; Goebel, Hartmut; Heinze, Axel; Heinze-Kuhn, Katja; Williams, Frances M. K.; Hartikainen, Anna-Liisa; Pouta, Anneli; van den Ende, Joyce; Uitterlinden, Andre G.; Hofman, Albert; Amin, Najaf; Hottenga, Jouke-Jan; Vink, Jacqueline M.; Heikkila, Kauko; Alexander, Michael; Muller-Myhsok, Bertram; Schreiber, Stefan; Meitinger, Thomas; Wichmann, Heinz Erich; Aromaa, Arpo; Eriksson, Johan G.; Traynor, Bryan J.; Trabzuni, Daniah; Rossin, Elizabeth; Lage, Kasper; Jacobs, Suzanne B. R.; Gibbs, J. Raphael; Birney, Ewan; Kaprio, Jaakko; Penninx, Brenda W.; Boomsma, Dorret I.; van Duijn, Cornelia; Raitakari, Olli; Jarvelin, Marjo-Riitta; Zwart, John-Anker; Cherkas, Lynn; Strachan, David P.; Kubisch, Christian; Ferrari, Michel D.; van den Maagdenberg, Arn M. J. M.; Dichgans, Martin; Wessman, Maija; Smith, George Davey; Stefansson, Kari; Daly, Mark J.; Nyholt, Dale R.; Chasman, Daniel I.; Palotie, Aarno		North Amer Brain Expression; UK Brain Expression Consortium; Int Headache Genetics Consortium	Genome-wide meta-analysis identifies new susceptibility loci for migraine	NATURE GENETICS			English	Article							TRANSFORMING-GROWTH-FACTOR; DOWN-REGULATION; ASSOCIATION; EXPRESSION; PROTEIN; FAMILY; MUTATIONS; LEWIS(X); GENES	Migraine is the most common brain disorder, affecting approximately 14% of the adult population, but its molecular mechanisms are poorly understood. We report the results of a meta-analysis across 29 genome-wide association studies, including a total of 23,285 individuals with migraine (cases) and 95,425 population-matched controls. We identified 12 loci associated with migraine susceptibility (P < 5 x 10(-8)). Five loci are new: near AJAP1 at 1p36, near TSPAN2 at 1p13, within FHL5 at 6q16, within C7orf10 at 7p14 and near MMP16 at 8q21. Three of these loci were identified in disease subgroup analyses. Brain tissue expression quantitative trait locus analysis suggests potential functional candidate genes at four loci: APOA1BP, TBC1D7, FUT9, STAT6 and ATP5B.	[Anttila, Verneri; Winsvold, Bendik S.; Gormley, Padhraig; Palta, Priit; Hamalainen, Eija; Palotie, Aarno] Wellcome Trust Sanger Inst, Cambridge, England; [Anttila, Verneri; Palta, Priit; Hamalainen, Eija; Kaunisto, Mari A.; Kaprio, Jaakko; Wessman, Maija; Palotie, Aarno] Univ Helsinki, FIMM, Helsinki, Finland; [Anttila, Verneri; Neale, Benjamin M.; Rossin, Elizabeth; Lage, Kasper; Daly, Mark J.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Anttila, Verneri; Kurth, Tobias; Neale, Benjamin M.; Rose, Lynda M.; Buring, Julie E.; Ridker, Paul M.; Rossin, Elizabeth; Lage, Kasper; Daly, Mark J.; Chasman, Daniel I.] Harvard Univ, Sch Med, Boston, MA USA; [Anttila, Verneri; Neale, Benjamin M.; Rossin, Elizabeth; Lage, Kasper; Jacobs, Suzanne B. R.; Daly, Mark J.; Palotie, Aarno] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Winsvold, Bendik S.; Zwart, John-Anker] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Winsvold, Bendik S.; Zwart, John-Anker] Univ Oslo, Oslo, Norway; [Kurth, Tobias] INSERM, Neuroepidemiol U708, Bordeaux, France; [Kurth, Tobias] Univ Bordeaux, Bordeaux, France; [Kurth, Tobias; Rose, Lynda M.; Buring, Julie E.; Ridker, Paul M.; Chasman, Daniel I.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; [Bettella, Francesco; Steinberg, Stacy; Stefansson, Hreinn; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [McMahon, George; McArdle, Wendy L.; Lawlor, Debbie A.; Evans, David M.; Ring, Susan M.; Smith, George Davey] Univ Bristol, Univ Bristol Med Res Council MRC Integrat Epidemi, Bristol, Avon, England; [Kallela, Mikko; Farkkila, Markus; Artto, Ville] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; [Malik, Rainer; Freilinger, Tobias; Dichgans, Martin] Univ Munich, Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [de Vries, Boukje; Frants, Rune R.; Weller, Claudia M.; van den Maagdenberg, Arn M. J. M.] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Terwindt, Gisela; Stam, Anine H.; Pelzer, Nadine; Zielman, Ronald; Ferrari, Michel D.; van den Maagdenberg, Arn M. J. M.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Medland, Sarah E.; Montgomery, Grant W.; Martin, Nicholas G.; Nyholt, Dale R.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Todt, Unda; Borck, Guntram; Kubisch, Christian] Univ Ulm, Inst Human Genet, D-89069 Ulm, Germany; [Quaye, Lydia; Williams, Frances M. K.; Cherkas, Lynn] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Koiranen, Markku; Pouta, Anneli; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Koiranen, Markku; Pouta, Anneli; Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Ikram, M. Arfan; van den Ende, Joyce; Hofman, Albert; Amin, Najaf; van Duijn, Cornelia] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus Univ, Med Ctr, Dept Radiol, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Lehtimaki, Terho] Fimlab Labs, Dept Clin Chem, Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Ligthart, Lannie; Hottenga, Jouke-Jan; Vink, Jacqueline M.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Ligthart, Lannie; Penninx, Brenda W.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Wedenoja, Juho; Heikkila, Kauko; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Dunham, Ian; Birney, Ewan] European Mol Biol Lab, European Bioinformat Inst, Cambridge, England; [Schuerks, Markus] Univ Hosp Essen, Dept Neurol, Essen, Germany; [Ridker, Paul M.] Harvard Univ, Sch Med, Dept Epidemiol, Boston, MA USA; [Jakobsson, Finnbogi] Landspitali Univ Hosp, Dept Neurol, Reykjavik, Iceland; [Kaunisto, Mari A.; Eriksson, Johan G.; Wessman, Maija] Folkhalsan Res Ctr, Helsinki, Finland; [Freilinger, Tobias] Klinikum Univ Munchen, Dept Neurol, Munich, Germany; [Schoenen, Jean] Univ Liege, Dept Neurol, Headache Res Unit, Liege, Belgium; [Schoenen, Jean] Univ Liege, GIGA Neurosci, Liege, Belgium; [Heath, Andrew C.; Madden, Pamela A. F.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Goebel, Hartmut; Heinze, Axel; Heinze-Kuhn, Katja] Kiel Pain & Headache Ctr, Kiel, Germany; [Hartikainen, Anna-Liisa; Pouta, Anneli] Univ Hosp Oulu, Dept Clin Sci Obstet & Gynecol, Oulu, Finland; [Hartikainen, Anna-Liisa; Pouta, Anneli] Univ Oulu, Med Res Ctr, Oulu, Finland; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Children Young People & Families, Helsinki, Finland; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Alexander, Michael] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Alexander, Michael] Univ Bonn, Inst Human Genet, Bonn, Germany; [Muller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Muller-Myhsok, Bertram; Dichgans, Martin] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Schreiber, Stefan] Univ Kiel, Dept Internal Med 1, Kiel, Germany; [Meitinger, Thomas] Helmholtz Ctr Munich, Inst Human Genet, Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-80290 Munich, Germany; [Wichmann, Heinz Erich] Univ Munich, Inst Med Informat Verarbeitung Biometrie & Epidem, Munich, Germany; [Wichmann, Heinz Erich] Helmholtz Ctr Munich, Inst Epidemiol 1, Neuherberg, Germany; [Wichmann, Heinz Erich] Univ Munich, Klinikum Grosshadern, D-80539 Munich, Germany; [Aromaa, Arpo; Eriksson, Johan G.] Natl Inst Hlth & Welf, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Dept Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Vaasa Cent Hosp, Vaasa, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Traynor, Bryan J.; Gibbs, J. Raphael] NIA, Neurogenet Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Trabzuni, Daniah; Gibbs, J. Raphael] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Trabzuni, Daniah] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Rossin, Elizabeth] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Lage, Kasper] Massachusetts Gen Hosp, Massachusetts Gen Hosp Children, Pediat Surg Res Labs, Boston, MA 02114 USA; [Lage, Kasper] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Lage, Kasper] Univ Copenhagen, Ctr Prot Res, Copenhagen, Denmark; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Dept Mental Hlth & Alcohol Res, Helsinki, Finland; [Penninx, Brenda W.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Penninx, Brenda W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands; [Penninx, Brenda W.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Raitakari, Olli] Univ Turku, Turku Univ Hosp, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FIN-20520 Turku, Finland; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Hlth Protect Agcy HPA Ctr Environm & Hlth, Sch Publ Hlth,Dept Epidemiol & Biostat, London, England; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Strachan, David P.] Univ London, Div Populat Hlth Sci & Educ, London, England; [Stefansson, Kari] Univ Iceland, Sch Med, Reykjavik, Iceland	Wellcome Trust Sanger Institute; University of Helsinki; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Oslo; University of Oslo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Harvard University; Brigham & Women's Hospital; University of Bristol; University of Helsinki; Helsinki University Central Hospital; University of Munich; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; QIMR Berghofer Medical Research Institute; Ulm University; University of London; King's College London; University of Oulu; University of Oulu; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Tampere University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Helsinki; European Molecular Biology Laboratory (EMBL); University of Duisburg Essen; Harvard University; Harvard Medical School; Landspitali National University Hospital; Folkhalsan Research Center; University of Munich; University of Liege; University of Liege; Washington University (WUSTL); University of Oulu; Finland National Institute for Health & Welfare; Erasmus University Rotterdam; Erasmus MC; University of Bonn; University of Bonn; Max Planck Society; University of Munich; University of Kiel; University of Kiel; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; Vaasa Central Hospital; University of Helsinki; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London; King Faisal Specialist Hospital & Research Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Technical University of Denmark; University of Copenhagen; Finland National Institute for Health & Welfare; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; Vrije Universiteit Amsterdam; University of Turku; University of Turku; Imperial College London; University of Oulu; University of London; University of Iceland	Palotie, A (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	anttila@atgu.mgh.harvard.edu; ap8@sanger.ac.uk	Trabzuni, Daniah/AAI-2037-2021; Medland, Sarah/AAT-7595-2020; Wedenoja, Juho/AAX-7008-2020; Kubisch, Christian/F-1893-2011; Lehtimäki, Terho/AAD-1094-2022; Boomsma, Dorret I/AAX-4470-2020; Dichgans, Martin/HCH-3247-2022; Davey Smith, George/A-7407-2013; Gormley, Padhraig/L-1949-2018; Meitinger, Thomas/O-1318-2015; Göbel, Hartmut/AAE-4719-2020; Ferrari, Michel D./ABE-3758-2021; Trabzuni, Daniah M/C-4034-2012; Penninx, Brenda WJH/S-7627-2017; Singleton, Andrew B/C-3010-2009; Ikram, M. Arfan/AAM-5225-2021; Weale, Michael E/F-2587-2010; Ryten, Mina/Q-8419-2016; Palta, Priit/W-2477-2019; Martin, Nicholas/R-9235-2019; Borck, Guntram/F-1868-2015; Heikkilä, Kauko/E-5578-2019; Medland, Sarah E/C-7630-2013; Winsvold, Bendik/ABF-7839-2021; Traynor, Bryan J/G-5690-2010; Stefansson, Kari/AAE-7187-2019; van den Maagdenberg, Arn M.J.M./AAE-9052-2019; Nyholt, Dale Robert/J-3174-2017; Wichmann, Heinz Erich/AAA-5695-2022; Daly, Mark J/B-2453-2017; Montgomery, Grant W/B-7148-2008; Hardy, John/C-2451-2009; Evans, David M/H-6325-2013; Gibbs, J. Raphael/A-3984-2010; Raitakari, Olli/AAQ-7389-2021; Kurth, Tobias/A-9243-2012; Kaprio, Jaakko/A-1820-2008	Trabzuni, Daniah/0000-0003-4826-9570; Medland, Sarah/0000-0003-1382-380X; Wedenoja, Juho/0000-0002-6155-0378; Kubisch, Christian/0000-0003-4220-0978; Lehtimäki, Terho/0000-0002-2555-4427; Dichgans, Martin/0000-0002-0654-387X; Davey Smith, George/0000-0002-1407-8314; Gormley, Padhraig/0000-0002-8908-6968; Ferrari, Michel D./0000-0001-9691-9449; Trabzuni, Daniah M/0000-0003-4826-9570; Penninx, Brenda WJH/0000-0001-7779-9672; Weale, Michael E/0000-0003-4593-1186; Palta, Priit/0000-0001-9320-7008; Martin, Nicholas/0000-0003-4069-8020; Heikkilä, Kauko/0000-0002-9256-8028; Medland, Sarah E/0000-0003-1382-380X; Winsvold, Bendik/0000-0003-4171-8919; Nyholt, Dale Robert/0000-0001-7159-3040; Daly, Mark J/0000-0002-0949-8752; Montgomery, Grant W/0000-0002-4140-8139; Hardy, John/0000-0002-3122-0423; Evans, David M/0000-0003-0663-4621; Gibbs, J. Raphael/0000-0002-6985-0658; Kurth, Tobias/0000-0001-7169-2620; Kaprio, Jaakko/0000-0002-3716-2455; Van Duijn, Cornelia/0000-0002-2374-9204; Williams, Frances/0000-0002-2998-2744; Birney, Ewan/0000-0001-8314-8497; Dunham, Ian/0000-0003-2525-5598; Palotie, Aarno/0000-0002-2527-5874; Lawlor, Debbie A/0000-0002-6793-2262; Meitinger, Thomas/0000-0002-8838-8403; s, hema/0000-0002-3440-9475; Eriksson, Johan/0000-0002-2516-2060; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Stefansson, Hreinn/0000-0002-9331-6666; Ikram, Mohammad Arfan/0000-0003-0372-8585; Jacobs, Suzanne/0000-0002-8103-1700; Ligthart, Lannie/0000-0002-6570-3319; Malik, Rainer/0000-0001-9212-2520; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Kaunisto, Mari/0000-0002-6946-9195; Amin, Najaf/0000-0002-8944-1771; Anttila, Verneri/0000-0002-0073-4675	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA017688] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AG000949-02] Funding Source: Medline; Medical Research Council [MC_UU_12013/4, G9815508, G1001799, MC_UU_12013/1, MC_UU_12013/5, G0802462] Funding Source: Medline; NIAAA NIH HHS [K05 AA017688] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline; Wellcome Trust [089062, 092731] Funding Source: Medline; MRC [G0802462, MC_UU_12013/4, MC_UU_12013/1, MC_UU_12013/5, G1001799] Funding Source: UKRI; Medical Research Council [G0801056B] Funding Source: researchfish	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Allen PB, 2004, P NATL ACAD SCI USA, V101, P7187, DOI 10.1073/pnas.0401673101; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Anttila V, 2010, NAT GENET, V42, P869, DOI 10.1038/ng.652; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biros E, 2012, ATHEROSCLEROSIS, V221, P383, DOI 10.1016/j.atherosclerosis.2012.01.004; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borrie SC, 2012, CELL TISSUE RES, V349, P105, DOI 10.1007/s00441-012-1332-9; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Chasman DI, 2011, NAT GENET, V43, P695, DOI 10.1038/ng.856; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Diniz LP, 2012, J BIOL CHEM, V287, P41432, DOI 10.1074/jbc.M112.380824; Ferraro GB, 2011, J BIOL CHEM, V286, P31418, DOI 10.1074/jbc.M111.249169; Fimia GM, 2000, MOL CELL BIOL, V20, P8613, DOI 10.1128/MCB.20.22.8613-8622.2000; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freilinger T, 2012, NAT GENET, V44, P777, DOI 10.1038/ng.2307; Gouveia R, 2012, BBA-GEN SUBJECTS, V1820, P2007, DOI 10.1016/j.bbagen.2012.09.004; Han JM, 2011, FEBS LETT, V585, P973, DOI 10.1016/j.febslet.2011.02.001; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jha KN, 2008, ENDOCRINOLOGY, V149, P2108, DOI 10.1210/en.2007-0582; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Lafleur MA, 2009, MOL BIOL CELL, V20, P2030, DOI 10.1091/mbc.E08-11-1149; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lieberoth A, 2009, J NEUROSCI, V29, P6677, DOI 10.1523/JNEUROSCI.4361-08.2009; Ligthart L, 2011, EUR J HUM GENET, V19, P901, DOI 10.1038/ejhg.2011.48; Magi R, 2010, GENET EPIDEMIOL, V34, P846, DOI 10.1002/gepi.20540; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Nishihara S, 2003, GLYCOBIOLOGY, V13, P445, DOI 10.1093/glycob/cwg048; Park SJ, 2012, J IMMUNOL, V188, P5132, DOI 10.4049/jimmunol.1101600; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Rozanov DV, 2004, J BIOL CHEM, V279, P4260, DOI 10.1074/jbc.M311569200; RUSSELL MB, 1995, BRIT MED J, V311, P541, DOI 10.1136/bmj.311.7004.541; Schreiner A, 2007, MOL BIOL CELL, V18, P1272, DOI 10.1091/mbc.E06-07-0637; Schurks M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3914; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Sherman EA, 2008, AM J HUM GENET, V83, P604, DOI 10.1016/j.ajhg.2008.09.018; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Terada N, 2002, GLIA, V40, P350, DOI 10.1002/glia.10134; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tsuzuki K, 2004, J NEUROSCI, V24, P762, DOI 10.1523/JNEUROSCI.4658-03.2004; Wilson PM, 2010, J NEUROSCI, V30, P8529, DOI 10.1523/JNEUROSCI.0032-10.2010	52	262	264	2	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2013	45	8					912	U255		10.1038/ng.2676	http://dx.doi.org/10.1038/ng.2676			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	190WW	23793025	Green Published, Green Accepted, Green Submitted			2022-12-17	WOS:000322374900015
J	Rafnar, T; Gudbjartsson, DF; Sulem, P; Jonasdottir, A; Sigurdsson, A; Jonasdottir, A; Besenbacher, S; Lundin, P; Stacey, SN; Gudmundsson, J; Magnusson, OT; le Roux, L; Orlygsdottir, G; Helgadottir, HT; Johannsdottir, H; Gylfason, A; Tryggvadottir, L; Jonasson, JG; de Juan, A; Ortega, E; Ramon-Cajal, JM; Garcia-Prats, MD; Mayordomo, C; Panadero, A; Rivera, F; Aben, KKH; van Altena, AM; Massuger, LFAG; Aavikko, M; Kujala, PM; Staff, S; Aaltonen, LA; Olafsdottir, K; Bjornsson, J; Kong, A; Salvarsdottir, A; Saemundsson, H; Olafsson, K; Benediktsdottir, KR; Gulcher, J; Masson, G; Kiemeney, LA; Mayordomo, JI; Thorsteinsdottir, U; Stefansson, K				Rafnar, Thorunn; Gudbjartsson, Daniel F.; Sulem, Patrick; Jonasdottir, Aslaug; Sigurdsson, Asgeir; Jonasdottir, Adalbjorg; Besenbacher, Soren; Lundin, Par; Stacey, Simon N.; Gudmundsson, Julius; Magnusson, Olafur T.; le Roux, Louise; Orlygsdottir, Gudbjorg; Helgadottir, Hafdis T.; Johannsdottir, Hrefna; Gylfason, Arnaldur; Tryggvadottir, Laufey; Jonasson, Jon G.; de Juan, Ana; Ortega, Eugenia; Ramon-Cajal, Jose M.; Garcia-Prats, Maria D.; Mayordomo, Carlos; Panadero, Angeles; Rivera, Fernando; Aben, Katja K. H.; van Altena, Anne M.; Massuger, Leon F. A. G.; Aavikko, Mervi; Kujala, Paula M.; Staff, Synnove; Aaltonen, Lauri A.; Olafsdottir, Kristrun; Bjornsson, Johannes; Kong, Augustine; Salvarsdottir, Anna; Saemundsson, Hafsteinn; Olafsson, Karl; Benediktsdottir, Kristrun R.; Gulcher, Jeffrey; Masson, Gisli; Kiemeney, Lambertus A.; Mayordomo, Jose I.; Thorsteinsdottir, Unnur; Stefansson, Kari			Mutations in BRIP1 confer high risk of ovarian cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BREAST-CANCER; FAMILY-HISTORY; HELICASE BRIP1; BRCA2; GENE; SUSCEPTIBILITY; BACH1; RECOMBINATION; POPULATION	Ovarian cancer causes more deaths than any other gynecologic malignancy in developed countries. Sixteen million sequence variants, identified through whole-genome sequencing of 457 Icelanders, were imputed to 41,675 Icelanders genotyped using SNP chips, as well as to their relatives. Sequence variants were tested for association with ovarian cancer (N of affected individuals = 656). We discovered a rare (0.41% allelic frequency) frameshift mutation, c.2040_2041insTT, in the BRIP1 (FANCJ) gene that confers an increase in ovarian cancer risk (odds ratio (OR) = 8.13, P = 2.8 x 10(-14)). The mutation was also associated with increased risk of cancer in general and reduced lifespan by 3.6 years. In a Spanish population, another frameshift mutation in BRIP1, c.1702_1703del, was seen in 2 out of 144 subjects with ovarian cancer and 1 out of 1,780 control subjects (P = 0.016). This allele was also associated with breast cancer (seen in 6/927 cases; P = 0.0079). Ovarian tumors from heterozygous carriers of the Icelandic mutation show loss of the wild-type allele, indicating that BRIP1 behaves like a classical tumor suppressor gene in ovarian cancer.	[Rafnar, Thorunn; Gudbjartsson, Daniel F.; Sulem, Patrick; Jonasdottir, Aslaug; Sigurdsson, Asgeir; Jonasdottir, Adalbjorg; Besenbacher, Soren; Lundin, Par; Stacey, Simon N.; Gudmundsson, Julius; Magnusson, Olafur T.; le Roux, Louise; Orlygsdottir, Gudbjorg; Helgadottir, Hafdis T.; Johannsdottir, Hrefna; Gylfason, Arnaldur; Kong, Augustine; Gulcher, Jeffrey; Masson, Gisli; Thorsteinsdottir, Unnur; Stefansson, Kari] DeCODE Genet, Reykjavik, Iceland; [Tryggvadottir, Laufey; Jonasson, Jon G.] Iceland Canc Registry, Reykjavik, Iceland; [Tryggvadottir, Laufey; Jonasson, Jon G.; Benediktsdottir, Kristrun R.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [de Juan, Ana; Rivera, Fernando] Marques de Valdecilla Univ Hosp, Div Med Oncol, Santander, Spain; [Ortega, Eugenia] Arnau de Vilanova Univ Hosp, Div Med Oncol, Lerida, Spain; [Ramon-Cajal, Jose M.] San Jorge Gen Hosp, Div Gynecol, Huesca, Spain; [Garcia-Prats, Maria D.] San Jorge Gen Hosp, Div Pathol, Huesca, Spain; [Mayordomo, Carlos] Univ Zaragoza, Sch Med, Zaragoza, Spain; [Panadero, Angeles] Ciudad Coria Hosp, Div Med Oncol, Coria, Spain; [Aben, Katja K. H.; Kiemeney, Lambertus A.] Comprehens Canc Ctr Netherlands, Nijmegen, Netherlands; [Aben, Katja K. H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assesment, NL-6525 ED Nijmegen, Netherlands; [van Altena, Anne M.; Massuger, Leon F. A. G.] Radboud Univ Nijmegen, Med Ctr, Dept Gynaecol, NL-6525 ED Nijmegen, Netherlands; [Aavikko, Mervi; Aaltonen, Lauri A.] Univ Helsinki, Dept Med Genet, Genome Scale Biol Res Program, Helsinki, Finland; [Kujala, Paula M.] Univ Tampere, Dept Pathol, Ctr Lab Med, FIN-33101 Tampere, Finland; [Staff, Synnove] Tampere Univ Hosp, Dept Obstet & Gynecol, Tampere, Finland; [Staff, Synnove] Univ Tampere, Inst Biomed Technol, Canc Biol Lab, FIN-33101 Tampere, Finland; [Olafsdottir, Kristrun; Bjornsson, Johannes; Benediktsdottir, Kristrun R.] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; [Salvarsdottir, Anna; Saemundsson, Hafsteinn; Olafsson, Karl] Landspitali Univ Hosp, Dept Obstet & Gynecol, Reykjavik, Iceland; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Mayordomo, Jose I.] Univ Hosp, Div Med Oncol, Zaragoza, Spain	University of Iceland; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universidad San Jorge; Hospital Universidad San Jorge; University of Zaragoza; Radboud University Nijmegen; Radboud University Nijmegen; University of Helsinki; Tampere University; Tampere University; Tampere University Hospital; Tampere University; Landspitali National University Hospital; Landspitali National University Hospital; Radboud University Nijmegen; Miguel Servet University Hospital	Rafnar, T (corresponding author), DeCODE Genet, Reykjavik, Iceland.	thorunn.rafnar@decode.is; kstefans@decode.is	Massuger, Leon F.A.G./H-8072-2014; Kiemeney, Lambertus A./D-3357-2009; Mayordomo, Jose/K-3453-2013; Aben, Katja KH/G-9686-2016; Stefansson, Kari/AAE-7187-2019; van Altena, Anne M/B-9824-2016; Aaltonen, Lauri/A-5375-2010	Kiemeney, Lambertus A./0000-0002-2368-1326; Aben, Katja KH/0000-0002-0214-2147; Aaltonen, Lauri/0000-0001-6839-4286; Tryggvadottir, Laufey/0000-0001-8067-9030; Gudbjartsson, Daniel/0000-0002-5222-9857; Helgadottir, Hafdis/0000-0003-4352-152X; Jonasson, Jon G./0000-0002-2635-5032; le Roux, Louise/0000-0002-9491-9653; Besenbacher, Soren/0000-0003-1455-1738; Kong, Augustine/0000-0001-8193-5438; Staff, Synnove/0000-0001-7280-1673	European Commission [218071]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was partly funded by the European Commission 7<SUP>th</SUP> Framework Programme FP7-MC-IAPP (grant agreement no. 218071 CancerGene).	Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cantor SB, 2011, FUTURE ONCOL, V7, P253, DOI [10.2217/fon.10.191, 10.2217/FON.10.191]; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GODWIN AK, 1994, AM J HUM GENET, V55, P666; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kumaraswamy E, 2007, MOL CELL BIOL, V27, P6733, DOI 10.1128/MCB.00961-07; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Malander S, 2006, GYNECOL ONCOL, V101, P238, DOI 10.1016/j.ygyno.2005.10.029; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Rafnar T, 2004, EUR J CANCER, V40, P2788, DOI 10.1016/j.ejca.2004.09.008; Ramus SJ, 2009, MOL ONCOL, V3, P138, DOI 10.1016/j.molonc.2009.02.001; Rubin SC, 1998, AM J OBSTET GYNECOL, V178, P670, DOI 10.1016/S0002-9378(98)70476-4; Sarantaus L, 2000, EUR J HUM GENET, V8, P757, DOI 10.1038/sj.ejhg.5200529; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Stratton JF, 1998, BRIT J OBSTET GYNAEC, V105, P493, DOI 10.1111/j.1471-0528.1998.tb10148.x; Sulem P., NAT GENET IN PRESS; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	29	262	265	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2011	43	11					1104	U91		10.1038/ng.955	http://dx.doi.org/10.1038/ng.955			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	21964575				2022-12-17	WOS:000296584000014
J	Zenatti, PP; Ribeiro, D; Li, WQ; Zuurbier, L; Silva, MC; Paganin, M; Tritapoe, J; Hixon, JA; Silveira, AB; Cardoso, BA; Sarmento, LM; Correia, N; Toribio, ML; Kobarg, J; Horstmann, M; Pieters, R; Brandalise, SR; Ferrando, AA; Meijerink, JP; Durum, SK; Yunes, JA; Barata, JT				Zenatti, Priscila P.; Ribeiro, Daniel; Li, Wenqing; Zuurbier, Linda; Silva, Milene C.; Paganin, Maddalena; Tritapoe, Julia; Hixon, Julie A.; Silveira, Andre B.; Cardoso, Bruno A.; Sarmento, Leonor M.; Correia, Nadia; Toribio, Maria L.; Kobarg, Joerg; Horstmann, Martin; Pieters, Rob; Brandalise, Silvia R.; Ferrando, Adolfo A.; Meijerink, Jules P.; Durum, Scott K.; Yunes, J. Andres; Barata, Joao T.			Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia	NATURE GENETICS			English	Article							INTERLEUKIN-7 RECEPTOR; GENE-EXPRESSION; PRECURSOR-B; ACTIVATION; NOTCH1; PTEN; IL-7; PROLIFERATION; ABNORMALITIES; RESISTANCE	Interleukin 7 (IL-7) and its receptor, formed by IL-7R alpha (encoded by IL7R) and gamma c, are essential for normal T-cell development and homeostasis. Here we show that IL7R is an oncogene mutated in T-cell acute lymphoblastic leukemia (T-ALL). We find that 9% of individuals with T-ALL have somatic gain-of-function IL7R exon 6 mutations. In most cases, these IL7R mutations introduce an unpaired cysteine in the extracellular juxtamembrane-transmembrane region and promote de novo formation of intermolecular disulfide bonds between mutant IL-7Ra subunits, thereby driving constitutive signaling via JAK1 and independently of IL-7, gamma c or JAK3. IL7R mutations induce a gene expression profile partially resembling that provoked by IL-7 and are enriched in the T-ALL subgroup comprising TLX3 rearranged and HOXA deregulated cases. Notably, IL7R mutations promote cell transformation and tumor formation. Overall, our findings indicate that IL7R mutational activation is involved in human T-cell leukemogenesis, paving the way for therapeutic targeting of IL-7R-mediated signaling in T-ALL.	[Ribeiro, Daniel; Silva, Milene C.; Cardoso, Bruno A.; Sarmento, Leonor M.; Correia, Nadia; Barata, Joao T.] Univ Lisbon, Fac Med, Inst Med Mol, Canc Biol Unit, P-1699 Lisbon, Portugal; [Zenatti, Priscila P.; Silveira, Andre B.; Brandalise, Silvia R.; Yunes, J. Andres] Ctr Infantil Boldrini, Lab Biol Mol, Campinas, SP, Brazil; [Li, Wenqing; Tritapoe, Julia; Hixon, Julie A.; Durum, Scott K.] NCI, Immunol Cytokine Grp, Mol Immunoregulat Lab, Ctr Canc Res, Frederick, MD 21701 USA; [Zuurbier, Linda; Meijerink, Jules P.] Erasmus Med Ctr MC Sophia Childrens Hosp, Dept Pediat Oncol Hematol, Rotterdam, Netherlands; [Paganin, Maddalena; Ferrando, Adolfo A.] Columbia Univ Med Ctr, Inst Canc Genet, New York, NY USA; [Toribio, Maria L.] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Madrid, Spain; [Kobarg, Joerg] CNPEM, LNBio, Campinas, SP, Brazil; [Horstmann, Martin] German Cooperat Study Grp Childhood Acute Lymphob, Hamburg, Germany; [Horstmann, Martin] Univ Med Ctr Hamburg Eppendorf, Clin Pediat Hematol & Oncol, Childrens Canc Ctr Hamburg, Res Inst, Hamburg, Germany; [Brandalise, Silvia R.] Univ Estadual Campinas, Serv Hematol Oncol Pediat, Campinas, SP, Brazil; [Ferrando, Adolfo A.] Columbia Univ Med Ctr, Dept Pathol, New York, NY USA; [Yunes, J. Andres] Univ Estadual Campinas, Fac Ciencias Med, Dept Genet Med, Campinas, SP, Brazil	Universidade de Lisboa; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Columbia University; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University of Hamburg; University Medical Center Hamburg-Eppendorf; Universidade Estadual de Campinas; Columbia University; Universidade Estadual de Campinas	Barata, JT (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Canc Biol Unit, P-1699 Lisbon, Portugal.	joao_barata@fm.ul.pt	Meijerink, Jules P/D-4393-2017; Kobarg, Jörg/T-4736-2019; Barata, João T./D-9181-2015; Brandalise, Silvia Regina/ABG-9609-2021; da Silva, Milene Costa/V-1976-2018; Bortolini Silveira, Andre/I-8859-2012; Toribio, Maria L/C-2039-2017	Meijerink, Jules P/0000-0002-6860-798X; Kobarg, Jörg/0000-0002-9419-0145; Barata, João T./0000-0002-4826-8976; da Silva, Milene Costa/0000-0001-6951-2504; durum, scott/0000-0003-1307-9582; Bortolini Silveira, Andre/0000-0003-3375-1081; Cardoso, Bruno/0000-0002-6521-7257; Zuurbier, Linda/0000-0002-8473-1147; Yunes, Jose Andres/0000-0002-1316-3525; Pini Zenatti, Priscila/0000-0002-8662-7458; Sarmento, Leonor/0000-0002-3692-0592; Toribio, Maria L/0000-0002-8637-0373; Ribeiro, Daniel/0000-0003-3660-9646	Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/SAU-OBD/104816/2008]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [08/10034-1]; National Cancer Institute, US National Institutes of Health (NIH); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Bolsa de Investigacao (BI); FCT; foundation Children Cancer-Free (Stichting Kinderen Kankervrij; KiKa) [2007-012]; NATIONAL CANCER INSTITUTE [ZIABC009287] Funding Source: NIH RePORTER	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Cancer Institute, US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Bolsa de Investigacao (BI); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); foundation Children Cancer-Free (Stichting Kinderen Kankervrij; KiKa); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to the subjects and their families for providing the specimens for this study. We thank S. Walsh (University of Maryland) for helpful discussions on the IL7R transmembrane domain; K. Czarra and M. Karwan for animal technical assistance; A. Silva, I. Antunes, A. Melao and J. Buijs-Gladdines for experimental support; P. Vandenabeele for kindly providing the WEHI3B cell line; and J. O'Shea for providing Jak3<SUP>-/-</SUP> bone marrow and CP-690550. This work was supported by grants from Fundacao para a Ciencia e a Tecnologia (FCT; PTDC/SAU-OBD/104816/2008, J. T. B.), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; 08/10034-1, J.A.Y.) and the intramural program of the National Cancer Institute, US National Institutes of Health (NIH) (S. K. D.). P.P.Z. and A. B. S. have Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) PhD scholarships. L. M. S. has a postdoctoral fellowship; D. R., B. A. C. and N.C. have PhD scholarships, and M. C. S. had a Bolsa de Investigacao (BI) fellowship, all from the FCT. L.Z. was supported by a grant (2007-012) from the foundation Children Cancer-Free (Stichting Kinderen Kankervrij; KiKa).	Abraham N, 2005, ONCOGENE, V24, P5252, DOI 10.1038/sj.onc.1208726; Al-Rawi MAA, 2003, HISTOL HISTOPATHOL, V18, P911, DOI 10.14670/HH-18.911; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Barata JT, 2004, HAEMATOLOGICA, V89, P1459; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Barata JT, 2001, BLOOD, V98, P1524, DOI 10.1182/blood.V98.5.1524; BENE MC, 1995, LEUKEMIA, V9, P1783; Burke CL, 1998, MOL CELL BIOL, V18, P5371, DOI 10.1128/MCB.18.9.5371; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Gonzalez-Garcia S, 2009, J EXP MED, V206, P779, DOI 10.1084/jem.20081922; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Izon DJ, 1998, BLOOD, V92, P383, DOI 10.1182/blood.V92.2.383.414k41_383_393; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Jeong EG, 2008, CLIN CANCER RES, V14, P3716, DOI 10.1158/1078-0432.CCR-07-4839; Jiang Q, 2005, CYTOKINE GROWTH F R, V16, P513, DOI 10.1016/j.cytogfr.2005.05.004; Jotta PY, 2010, LEUKEMIA, V24, P239, DOI 10.1038/leu.2009.209; Kim K, 2003, J IMMUNOL METHODS, V274, P177, DOI 10.1016/S0022-1759(02)00513-6; Kjaer S, 2006, ONCOGENE, V25, P7086, DOI 10.1038/sj.onc.1209698; Kleppe M, 2010, NAT GENET, V42, P530, DOI 10.1038/ng.587; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Kovanen PE, 2003, J BIOL CHEM, V278, P5205, DOI 10.1074/jbc.M209015200; Laouar Y, 2004, BLOOD, V103, P1985, DOI 10.1182/blood-2003-06-2126; Liu XB, 2010, NAT MED, V16, P191, DOI 10.1038/nm.2077; Lu XH, 2006, J BIOL CHEM, V281, P7002, DOI 10.1074/jbc.M512638200; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; RICH BE, 1993, J EXP MED, V177, P305, DOI 10.1084/jem.177.2.305; Ridder A, 2005, J MOL BIOL, V354, P894, DOI 10.1016/j.jmb.2005.09.084; Roifman CM, 2000, BLOOD, V96, P2803; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Shochat C, 2011, J EXP MED, V208, P901, DOI 10.1084/jem.20110580; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; van Grotel M, 2008, LEUKEMIA, V22, P124, DOI 10.1038/sj.leu.2404957; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yoda A, 2010, P NATL ACAD SCI USA, V107, P252, DOI 10.1073/pnas.0911726107; Zuurbier L, 2010, LEUKEMIA, V24, P2014, DOI 10.1038/leu.2010.204	51	262	279	3	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2011	43	10					932	U31		10.1038/ng.924	http://dx.doi.org/10.1038/ng.924			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	21892159	Green Accepted			2022-12-17	WOS:000295316200006
J	Limaye, N; Wouters, V; Uebelhoer, M; Tuominen, M; Wirkkala, R; Mulliken, JB; Eklund, L; Boon, LM; Vikkula, M				Limaye, Nisha; Wouters, Vinciane; Uebelhoer, Melanie; Tuominen, Marjut; Wirkkala, Riikka; Mulliken, John B.; Eklund, Lauri; Boon, Laurence M.; Vikkula, Miikka			Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations	NATURE GENETICS			English	Article							TYROSINE KINASES; VASCULAR DEVELOPMENT; ACTIVATION LOOP; TIE2 RECEPTOR; CELL-CELL; ANGIOGENESIS; EXPRESSION; CONTACTS; PROTEIN; EMBRYO	Germline substitutions in the endothelial cell tyrosine kinase receptor TIE2 (encoded by TEK) cause a rare, inherited form of venous anomaly known as a mucocutaneous venous malformation (VMCM; refs. 1-3 and V. W., N.L., M. U., A. Irrthum, L. M. B. et al., unpublished data). We identified a somatic 'second hit' causing loss of function of TIE2 in a resected VMCM and assessed whether such localized, tissue-specific events have a role in the etiology of sporadic venous malformations, which are far more common. We identified eight somatic TEK mutations in lesions from 28 of 57 individuals (49.1%) with sporadic venous malformations; the mutations were absent from the individuals' blood and control tissues. The somatic mutations included one causing a frequent L914F substitution and several double mutations in cis, all of which resulted in ligand-independent TIE2 hyperphosphorylation in vitro. When overexpressed in human umbilical vein endothelial cells, the L914F mutant was abnormally localized and responded to ligand, in contrast to wild-type TIE2 and the common, inherited R849W mutant, suggesting that the mutations have distinct effects. The presence of the same mutations in multifocal sporadic venous malformations in two individuals suggests a common origin for the abnormal endothelial cells at the distant sites. These data show that a sporadic disease may be explained by somatic changes in a gene causing rare, inherited forms and pinpoint TIE2 pathways as potential therapeutic targets for venous malformations.	[Limaye, Nisha; Wouters, Vinciane; Uebelhoer, Melanie; Boon, Laurence M.; Vikkula, Miikka] Univ Catholique Louvain, Duve Inst, B-1200 Brussels, Belgium; [Tuominen, Marjut; Wirkkala, Riikka; Eklund, Lauri] Univ Oulu, Bioctr, Oulu Ctr Cell Matrix Res, FI-90014 Oulu, Finland; [Tuominen, Marjut; Wirkkala, Riikka; Eklund, Lauri] Univ Oulu, Dept Med Biochem & Mol Biol, FI-90014 Oulu, Finland; [Mulliken, John B.] Childrens Hosp, Dept Plast Surg, Boston, MA 02115 USA; [Mulliken, John B.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Boon, Laurence M.] Univ Catholique Louvain, Clin Univ St Luc, Div Plast Surg, Ctr Vasc Anomalies, B-1200 Brussels, Belgium	Universite Catholique Louvain; University of Oulu; University of Oulu; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Vikkula, M (corresponding author), Univ Catholique Louvain, Duve Inst, Ave Hippocrate 74 5,Bp 75-39, B-1200 Brussels, Belgium.	miikka.vikkula@uclouvain.be	Boon, Laurence/HCI-3629-2022; Vikkula, Miikka/Q-1038-2018	Vikkula, Miikka/0000-0002-6236-338X	Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy [5/25, 6/05]; Belgian French Community Ministry [02/07/276, 7/12-005]; National Institutes of Health [P01 AR048564-01A1]; EU FW6 Integrated Project LYMPHANGIOGENOMICS [LSHG-CT2004-503573]; FNRS; UCL; Academy of Finland [116138]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR048564] Funding Source: NIH RePORTER	Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy(Belgian Federal Science Policy Office); Belgian French Community Ministry; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU FW6 Integrated Project LYMPHANGIOGENOMICS(European Commission); FNRS(Fonds de la Recherche Scientifique - FNRS); UCL; Academy of Finland(Academy of Finland); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the patients for their invaluable contributions; A. Mendola, A. Van Egeren and J. Traskelin for expert technical assistance; C. Godfraind for immunohistochemistry; and L. Niculescu for secretarial help. These studies were partially supported by the Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy (network 5/25 and 6/05), Concerted Research Actions (ARC) Conventions no. 02/07/276 and 7/12-005 of the Belgian French Community Ministry, National Institutes of Health program project P01 AR048564-01A1, EU FW6 Integrated Project LYMPHANGIOGENOMICS (LSHG-CT2004-503573), the Fonds national de la recherche scientifique (to M. V., a 'Maitre de recherches du FNRS'); a fellowship from Fonds pour la formation a la recherche dans l'industrie et dans l'agriculture (to V. W.), the Patrimoine UCL and the Academy of Finland (116138 to L. E. and M. T.).	Boon LM, 2004, ARCH DERMATOL, V140, P971, DOI 10.1001/archderm.140.8.971; BOON LM, 1994, HUM MOL GENET, V3, P1583, DOI 10.1093/hmg/3.9.1583; Calvert JT, 1999, HUM MOL GENET, V8, P1279, DOI 10.1093/hmg/8.7.1279; Chen Z, 2008, ONCOGENE, V27, P4336, DOI 10.1038/onc.2008.71; Colmone A, 2008, TRANSL RES, V151, P1, DOI 10.1016/j.trsl.2007.09.003; DUMONT DJ, 1992, ONCOGENE, V7, P1471; DUMONT DJ, 1995, DEV DYNAM, V203, P80, DOI 10.1002/aja.1002030109; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Eklund L, 2006, EXP CELL RES, V312, P630, DOI 10.1016/j.yexcr.2005.09.002; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Jones N, 2001, NAT REV MOL CELL BIO, V2, P257, DOI 10.1038/35067005; Lievens PMJ, 2004, J BIOL CHEM, V279, P43254, DOI 10.1074/jbc.M405247200; Loughna S, 2001, MATRIX BIOL, V20, P319, DOI 10.1016/S0945-053X(01)00149-4; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Nobuhara Y, 2006, SURG TODAY, V36, P283, DOI 10.1007/s00595-005-3138-9; Partanen J, 1999, CURR TOP MICROBIOL, V237, P159; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; SATO TN, 1993, P NATL ACAD SCI USA, V90, P9355, DOI 10.1073/pnas.90.20.9355; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schmidt-Arras DE, 2005, MOL CELL BIOL, V25, P3690, DOI 10.1128/MCB.25.9.3690-3703.2005; SCHNURCH H, 1993, DEVELOPMENT, V119, P957; Shewchuk LM, 2000, STRUCTURE, V8, P1105, DOI 10.1016/S0969-2126(00)00516-5; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tabone-Eglinger S, 2008, CLIN CANCER RES, V14, P2285, DOI 10.1158/1078-0432.CCR-07-4102; Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0; WOUTERS V, 2007, INBORN ERRORS DEV	27	262	272	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					118	124		10.1038/ng.272	http://dx.doi.org/10.1038/ng.272			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19079259	Green Accepted			2022-12-17	WOS:000262085300026
J	Sulem, P; Gudbjartsson, DF; Stacey, SN; Helgason, A; Rafnar, T; Jakobsdottir, M; Steinberg, S; Gudjonsson, SA; Palsson, A; Thorleifsson, G; Palsson, S; Sigurgeirsson, B; Thorisdottir, K; Ragnarsson, R; Benediktsdottir, KR; Aben, KK; Vermeulen, SH; Goldstein, AM; Tucker, MA; Kiemeney, LA; Olafsson, JH; Gulcher, J; Kong, A; Thorsteinsdottir, U; Stefansson, K				Sulem, Patrick; Gudbjartsson, Daniel F.; Stacey, Simon N.; Helgason, Agnar; Rafnar, Thorunn; Jakobsdottir, Margret; Steinberg, Stacy; Gudjonsson, Sigurjon A.; Palsson, Arnar; Thorleifsson, Gudmar; Palsson, Snaebjoern; Sigurgeirsson, Bardur; Thorisdottir, Kristin; Ragnarsson, Rafn; Benediktsdottir, Kristrun R.; Aben, Katja K.; Vermeulen, Sita H.; Goldstein, Alisa M.; Tucker, Margaret A.; Kiemeney, Lambertus A.; Olafsson, Jon H.; Gulcher, Jeffrey; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari			Two newly identified genetic determinants of pigmentation in Europeans	NATURE GENETICS			English	Article							TYRP1 GENE; POLYMORPHISM; AGOUTI; SKIN; POPULATION; SEQUENCE; ALBINISM; MELANOMA; HUMANS	We present results from a genome-wide association study for variants associated with human pigmentation characteristics among 5,130 Icelanders, with follow-up analyses in 2,116 Icelanders and 1,214 Dutch individuals. Two coding variants in TPCN2 are associated with hair color, and a variant at the ASIP locus shows strong association with skin sensitivity to sun, freckling and red hair, phenotypic characteristics similar to those affected by well-known mutations in MC1R.	[Sulem, Patrick; Gudbjartsson, Daniel F.; Stacey, Simon N.; Helgason, Agnar; Rafnar, Thorunn; Jakobsdottir, Margret; Steinberg, Stacy; Gudjonsson, Sigurjon A.; Palsson, Arnar; Thorleifsson, Gudmar; Palsson, Snaebjoern; Gulcher, Jeffrey; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE genet, IS-101 Reykjavik, Iceland; [Sigurgeirsson, Bardur; Thorisdottir, Kristin; Benediktsdottir, Kristrun R.; Olafsson, Jon H.] Landspitali Univ Hosp, Dept Dermatol, IS-101 Reykjavik, Iceland; [Sigurgeirsson, Bardur; Benediktsdottir, Kristrun R.; Olafsson, Jon H.] Landspitali Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; [Thorisdottir, Kristin; Ragnarsson, Rafn] Landspitali Univ Hosp, Dept Plast Surg, IS-101 Reykjavik, Iceland; [Aben, Katja K.; Kiemeney, Lambertus A.] Ctr Comprehens Canc, NL-6501 BG Nijmegen, Netherlands; [Aben, Katja K.; Vermeulen, Sita H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; [Goldstein, Alisa M.; Tucker, Margaret A.] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Services, Bethesda, MD 20892 USA; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Urol, NL-6500 HB Nijmegen, Netherlands	Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; Radboud University Nijmegen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Radboud University Nijmegen	Gudbjartsson, DF (corresponding author), deCODE genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	daniel.gudbjartsson@decode.is; kstefans@decode.is	Kiemeney, Lambertus A./D-3357-2009; Aben, Katja KH/G-9686-2016; Palsson, Arnar/M-2742-2015; Tucker, Margaret A/B-4297-2015; Palsson, Snaebjorn/J-9113-2012; Stefansson, Kari/AAE-7187-2019; Vermeulen, Sita H./L-4716-2015; Sigurgeirsson, Bardur/AAP-7755-2020; Sigurgeirsson, Bárður/B-6130-2011; Helgason, Agnar/K-1522-2015	Kiemeney, Lambertus A./0000-0002-2368-1326; Aben, Katja KH/0000-0002-0214-2147; Palsson, Arnar/0000-0002-6525-8112; Vermeulen, Sita H./0000-0003-4913-8601; Kong, Augustine/0000-0001-8193-5438; Helgason, Agnar/0000-0002-8545-3767; Gudbjartsson, Daniel/0000-0002-5222-9857; Sigurgeirsson, Bardur/0000-0002-9733-9742; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Palsson, Snaebjorn/0000-0002-4297-3500	NATIONAL CANCER INSTITUTE [Z01CP005803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000732] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Box NF, 1998, MAMM GENOME, V9, P50, DOI 10.1007/s003359900678; Frudakis T, 2003, GENETICS, V165, P2071; FUKAI K, 1995, NAT GENET, V9, P92, DOI 10.1038/ng0195-92; Kanetsky PA, 2002, AM J HUM GENET, V70, P770, DOI 10.1086/339076; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Landi MT, 2005, J NATL CANCER I, V97, P998, DOI 10.1093/jnci/dji176; Manga P, 1997, AM J HUM GENET, V61, P1095, DOI 10.1086/301603; Meziani R, 2005, J DERMATOL SCI, V40, P133, DOI 10.1016/j.jdermsci.2005.08.001; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Schmutz SM, 2007, J HERED, V98, P351, DOI 10.1093/jhered/esm036; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Voisey J, 2002, PIGM CELL RES, V15, P10, DOI 10.1034/j.1600-0749.2002.00039.x	14	262	269	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					835	837		10.1038/ng.160	http://dx.doi.org/10.1038/ng.160			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18488028				2022-12-17	WOS:000257166500016
J	Myung, K; Datta, A; Chen, C; Kolodner, RD				Myung, K; Datta, A; Chen, C; Kolodner, RD			SGS1, the Saccharomyces cerevisiae homologue of BLM and WRN, suppresses genome instability and homeologous recombination	NATURE GENETICS			English	Article							WERNERS-SYNDROME GENES; DNA HELICASE; BLOOMS-SYNDROME; REPLICATION; INTERACTS; PROTEINS; PRODUCT	The Escherichia coli gene recQ was identified as a RecF recombination pathway gene(1). The gene SGS1, encoding the only RecQ-like DNA helicase in Saccharomyces cerevisiae, was identified by mutations that suppress the top3 slow-growth phenotype(2,3). Relatively little is known about the function of Sgs1p because single mutations in SCSI do not generally cause strong phenotypes. Mutations in genes encoding RecQ-like DNA helicases such as the Bloom and Werner syndrome genes, BLM and WRN, have been suggested to cause increased genome instability(4,5). But the exact DNA metabolic defect that might underlie such genome instability has remained unclear. To better understand the cellular role of the RecQ-like DNA helicases, sgs1 mutations were analyzed for their effect on genome rearrangements(6,7). Mutations in SGS1 increased the rate of accumulating gross chromosomal rearrangements (GCRs), including translocations and deletions containing extended regions of imperfect homology at their breakpoints. sgs1 mutations also increased the rate of recombination between DNA sequences that had 91% sequence homology. Epistasis analysis showed that Sgs1p is redundant with DNA mismatch repair (MMR) for suppressing GCRs and for suppressing recombination between divergent DNA sequences. This suggests that defects in the suppression of rearrangements involving divergent, repeated sequences may underlie the genome instability seen in BLM and WRN patients and in cancer cases associated with defects in these genes.	Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA.		Chen, Clark C/C-8714-2013	Chen, Clark C/0000-0001-6258-9277	NIGMS NIH HHS [GM50006, GM26017] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026017, R37GM026017, R01GM050006] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bennett RJ, 1998, J BIOL CHEM, V273, P9644, DOI 10.1074/jbc.273.16.9644; Blander G, 1999, J BIOL CHEM, V274, P29463, DOI 10.1074/jbc.274.41.29463; Calin G, 1998, CANCER RES, V58, P3777; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Chen YL, 1998, T NONFERR METAL SOC, V8, P5; Datta A, 1996, MOL CELL BIOL, V16, P1085; Davey S, 1998, MOL CELL BIOL, V18, P2721, DOI 10.1128/MCB.18.5.2721; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Frei C, 2000, GENE DEV, V14, P81; FUKUCHI K, 1990, HUM GENET, V84, P249; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; German J, 1998, GENETIC BASIS HUMAN, P301; Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239; Hanada K, 1997, P NATL ACAD SCI USA, V94, P3860, DOI 10.1073/pnas.94.8.3860; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; LANGLOIS RG, 1989, P NATL ACAD SCI USA, V86, P670, DOI 10.1073/pnas.86.2.670; MATIC I, 1995, CELL, V80, P507, DOI 10.1016/0092-8674(95)90501-4; MONNAT RJ, 1992, GENOMICS, V13, P777, DOI 10.1016/0888-7543(92)90153-J; Moser MJ, 1999, HUM MUTAT, V13, P271, DOI 10.1002/(SICI)1098-1004(1999)13:4<271::AID-HUMU2>3.0.CO;2-Q; NAKAYAMA H, 1984, MOL GEN GENET, V195, P475; Ng SW, 1999, NUCLEIC ACIDS RES, V27, P993, DOI 10.1093/nar/27.4.993; Nicholson A, 2000, GENETICS, V154, P133; SALK D, 1985, ADV EXP MED BIOL, V190, P541; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; SHIRAISHI Y, 1983, CANCER GENET CYTOGEN, V9, P129, DOI 10.1016/0165-4608(83)90033-X; Watt PM, 1996, GENETICS, V144, P935; Yamagata K, 1998, P NATL ACAD SCI USA, V95, P8733, DOI 10.1073/pnas.95.15.8733; Yan H, 1998, NAT GENET, V19, P375, DOI 10.1038/1263; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	30	262	266	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2001	27	1					113	116		10.1038/83673	http://dx.doi.org/10.1038/83673			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11138010				2022-12-17	WOS:000166187900027
J	Sun, C; Sklaetsky, H; Birren, B; Devon, K; Tang, ZL; Silber, S; Oates, R; Page, DC				Sun, C; Sklaetsky, H; Birren, B; Devon, K; Tang, ZL; Silber, S; Oates, R; Page, DC			An azoospermic man with a de novo point mutation in the Y-chromosomal gene USP9Y	NATURE GENETICS			English	Article							POLYMERASE CHAIN-REACTION; HUMAN DNA; LONG ARM; CLONES; MICRODELETIONS; POLYMORPHISMS; LOCALIZATION; EXPRESSION; SEQUENCES; DELETIONS	In humans, deletion of any one of three Y-chromosomal regions-AZFa. AZFb or AZFc-disrupts spermatogenesis, causing infertility in otherwise healthy men(1-5). Although candidate genes have been identified in all three regions(3,6-8), no case of spermatogenic failure has been traced to a point mutation in a Y-linked gene, or to a deletion of a single Y-linked gene. We sequenced the AZFa region of the Y chromosome and identified two functional genes previously described: USP9Y(also known as DFFRY) and DBY (refs 7,8). Screening of the two genes in 576 infertile and 96 fertile men revealed several sequence variants, most of which appear to be heritable and of little functional consequence. We found one de novo mutation in USP9Y: a 4-bp deletion in a splice-donor site, causing an exon to be skipped and protein truncation. This mutation was present in a man with nonobstructive azoospermia (that is, no sperm was detected in semen), but absent in his fertile brother, suggesting that the USP9Y mutation caused spermatogenic failure. We also identified a single-gene deletion associated with spermatogenic failure, again involving USP9Y, by re-analysing a published study.	MIT, Whitehead Inst Biomed Res, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA USA; MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02139 USA; St Lukes Hosp, Infertil Ctr St Louis, St Louis, MO USA; Boston Univ, Sch Med, Dept Urol, Boston, MA 02118 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Saint Luke's Hospital - Missouri; Boston University	Page, DC (corresponding author), MIT, Whitehead Inst Biomed Res, Howard Hughes Med Inst, Cambridge, MA 02139 USA.			Oates, Robert/0000-0003-2330-6697				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AndreuttiZaugg C, 1997, CANCER RES, V57, P3288; Brown GM, 1998, HUM MOL GENET, V7, P97, DOI 10.1093/hmg/7.1.97; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Elliott DJ, 1997, P NATL ACAD SCI USA, V94, P3848, DOI 10.1073/pnas.94.8.3848; Grimaldi P, 1998, MOL HUM REPROD, V4, P1116, DOI 10.1093/molehr/4.12.1116; JONES MH, 1994, GENOMICS, V24, P266, DOI 10.1006/geno.1994.1615; Jones MH, 1996, HUM MOL GENET, V5, P1695, DOI 10.1093/hmg/5.11.1695; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; LAHN BT, SCIENCE, V286, P99; MA K, 1992, HUM MOL GENET, V1, P29, DOI 10.1093/hmg/1.1.29; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; NELSON DL, 1991, P NATL ACAD SCI USA, V88, P6157, DOI 10.1073/pnas.88.14.6157; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Pryor JL, 1997, NEW ENGL J MED, V336, P534, DOI 10.1056/NEJM199702203360802; QURESHI SJ, 1996, MOL HUM REPROD, V2, P275; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Sargent CA, 1999, J MED GENET, V36, P670; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; VOLLRATH D, 1992, SCIENCE, V258, P52, DOI 10.1126/science.1439769	24	262	283	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1999	23	4					429	432		10.1038/70539	http://dx.doi.org/10.1038/70539			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	261RZ	10581029				2022-12-17	WOS:000084023900018
J	Kon, A; Shih, LY; Minamino, M; Sanada, M; Shiraishi, Y; Nagata, Y; Yoshida, K; Okuno, Y; Bando, M; Nakato, R; Ishikawa, S; Sato-Otsubo, A; Nagae, G; Nishimoto, A; Haferlach, C; Nowak, D; Sato, Y; Alpermann, T; Nagasaki, M; Shimamura, T; Tanaka, H; Chiba, K; Yamamoto, R; Yamaguchi, T; Otsu, M; Obara, N; Sakata-Yanagimoto, M; Nakamaki, T; Ishiyama, K; Nolte, F; Hofmann, WK; Miyawaki, S; Chiba, S; Mori, H; Nakauchi, H; Koeffler, HP; Aburatani, H; Haferlach, T; Shirahige, K; Miyano, S; Ogawa, S				Kon, Ayana; Shih, Lee-Yung; Minamino, Masashi; Sanada, Masashi; Shiraishi, Yuichi; Nagata, Yasunobu; Yoshida, Kenichi; Okuno, Yusuke; Bando, Masashige; Nakato, Ryuichiro; Ishikawa, Shumpei; Sato-Otsubo, Aiko; Nagae, Genta; Nishimoto, Aiko; Haferlach, Claudia; Nowak, Daniel; Sato, Yusuke; Alpermann, Tamara; Nagasaki, Masao; Shimamura, Teppei; Tanaka, Hiroko; Chiba, Kenichi; Yamamoto, Ryo; Yamaguchi, Tomoyuki; Otsu, Makoto; Obara, Naoshi; Sakata-Yanagimoto, Mamiko; Nakamaki, Tsuyoshi; Ishiyama, Ken; Nolte, Florian; Hofmann, Wolf-Karsten; Miyawaki, Shuichi; Chiba, Shigeru; Mori, Hiraku; Nakauchi, Hiromitsu; Koeffler, H. Phillip; Aburatani, Hiroyuki; Haferlach, Torsten; Shirahige, Katsuhiko; Miyano, Satoru; Ogawa, Seishi			Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms	NATURE GENETICS			English	Article							GENE-EXPRESSION; DNA; LEUKEMIA; RESISTANT; EVOLUTION	Cohesin is a multimeric protein complex that is involved in the cohesion of sister chromatids, post-replicative DNA repair and transcriptional regulation. Here we report recurrent mutations and deletions involving multiple components of the cohesin complex, including STAG2, RAD21, SMC1A and SMC3, in different myeloid neoplasms. These mutations and deletions were mostly mutually exclusive and occurred in 12.1% (19/157) of acute myeloid leukemia, 8.0% (18/224) of myelodysplastic syndromes, 10.2% (9/88) of chronic myelomonocytic leukemia, 6.3% (4/64) of chronic myelogenous leukemia and 1.3% (1/77) of classical myeloproliferative neoplasms. Cohesin-mutated leukemic cells showed reduced amounts of chromatin-bound cohesin components, suggesting a substantial loss of cohesin binding sites on chromatin. The growth of leukemic cell lines harboring a mutation in RAD21 (Kasumi-1 cells) or having severely reduced expression of RAD21 and STAG2 (MOLM-13 cells) was suppressed by forced expression of wild-type RAD21 and wild-type RAD21 and STAG2, respectively. These findings suggest a role for compromised cohesin functions in myeloid leukemogenesis.	[Kon, Ayana; Sanada, Masashi; Nagata, Yasunobu; Yoshida, Kenichi; Okuno, Yusuke; Sato-Otsubo, Aiko; Sato, Yusuke; Ogawa, Seishi] Univ Tokyo, Grad Sch Med, Canc Genom Project, Bunkyo Ku, Tokyo, Japan; [Shih, Lee-Yung] Chang Gung Univ, Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Taipei, Taiwan; [Minamino, Masashi; Bando, Masashige; Nakato, Ryuichiro; Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Bunkyo Ku, Tokyo, Japan; [Sanada, Masashi; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Sakyo Ku, Kyoto, Japan; [Shiraishi, Yuichi; Shimamura, Teppei; Chiba, Kenichi; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Lab DNA Informat Anal, Minato Ku, Tokyo, Japan; [Ishikawa, Shumpei; Nishimoto, Aiko] Univ Tokyo, Dept Pathol, Bunkyo Ku, Tokyo, Japan; [Ishikawa, Shumpei] Tokyo Med & Dent Univ, Med Res Inst, Dept Genom Pathol, Bunkyo Ku, Tokyo, Japan; [Nagae, Genta; Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Meguro Ku, Tokyo, Japan; [Haferlach, Claudia; Alpermann, Tamara; Haferlach, Torsten] Munich Leukemia Lab, Munich, Germany; [Nowak, Daniel; Nolte, Florian; Hofmann, Wolf-Karsten] Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany; [Nagasaki, Masao] Tohoku Univ, Tohoku Med Megabank Org, Dept Integrat Genom, Div Biomed Informat Anal,Aoba Ku, Sendai, Miyagi 980, Japan; [Tanaka, Hiroko] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Sequence Data Anal,Minato Ku, Tokyo, Japan; [Yamamoto, Ryo; Yamaguchi, Tomoyuki; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Minato Ku, Tokyo, Japan; [Yamaguchi, Tomoyuki; Nakauchi, Hiromitsu] Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO, Stem Cell & Organ Regenerat Project, Chiyoda Ku, Tokyo, Japan; [Otsu, Makoto] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Stem Cell Bank,Minato Ku, Tokyo, Japan; [Obara, Naoshi; Sakata-Yanagimoto, Mamiko; Chiba, Shigeru] Univ Tsukuba, Fac Med, Dept Hematol, Tsukuba, Ibaraki, Japan; [Nakamaki, Tsuyoshi; Mori, Hiraku] Showa Univ, Sch Med, Dept Med, Div Hematol,Shinagawa Ku, Tokyo 142, Japan; [Ishiyama, Ken; Miyawaki, Shuichi] Tokyo Metropolitan Otsuka Hosp, Div Hematol, Toshima Ku, Tokyo, Japan; [Koeffler, H. Phillip] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore	University of Tokyo; Chang Gung Memorial Hospital; Chang Gung University; University of Tokyo; Kyoto University; University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU); University of Tokyo; MLL Munich Leukemia Laboratory; Ruprecht Karls University Heidelberg; Tohoku University; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; University of Tsukuba; Showa University; Cedars Sinai Medical Center; National University of Singapore	Ogawa, S (corresponding author), Univ Tokyo, Grad Sch Med, Canc Genom Project, Bunkyo Ku, Tokyo, Japan.	sogawa-tky@umin.ac.jp	Nagae, Genta/H-6579-2019; Nagae, Genta/AAN-1167-2021; Nakato, Ryuichiro/AAV-6405-2020; Ogawa, Seishi/AAE-7088-2019; Okuno, Yusuke/C-9082-2009; Mamiko, Sakata-yanagimoto/AAP-3298-2020	Nagae, Genta/0000-0002-2929-7990; Nakato, Ryuichiro/0000-0003-3019-5817; Okuno, Yusuke/0000-0003-3139-9272; Otsu, Makoto/0000-0002-9769-0217; Yoshida, Kenichi/0000-0003-4612-2778; Nowak, Daniel/0000-0001-7130-7921; Miyano, Satoru/0000-0002-1753-6616; xing zhi, shi zhi/0000-0003-3289-5681; Nagasaki, Masao/0000-0002-4292-8785; Shirahige, Katsuhiko/0000-0002-7862-1144; Shimamura, Teppei/0000-0003-2994-872X	Ministry of Health, Labor and Welfare of Japan; KAKENHI [23249052, 22134006, 21790907]; New Energy and Industrial Technology Development Organization (NEDO) [08C46598a]; project for development of innovative research on cancer therapies; Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology, initiated by the Council for Science and Technology Policy (CSTP);  [NHRI-EX100-10003NI]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); project for development of innovative research on cancer therapies; Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology, initiated by the Council for Science and Technology Policy (CSTP); 	This work was supported by Grants-in-Aid from the Ministry of Health, Labor and Welfare of Japan and KAKENHI (23249052, 22134006 and 21790907; S.O.), the Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization (NEDO; S.O.) (08C46598a), NHRI-EX100-10003NI Taiwan (L.-Y.S.), the project for development of innovative research on cancer therapies (p-direct; S.O.) and the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology, initiated by the Council for Science and Technology Policy (CSTP; S.O.). We thank Y. Hayashi (Gunma Children's Medical Centre), R. C. Mulligan (Harvard Medical School), S. Sugano (The University of Tokyo), M. Onodera (National Center for Child Health and Development, Japan) and L. Strom (Karolinska Institute) for providing materials. We thank Y. Yamazaki for cell sorting. We also thank Y. Mori, M. Nakamura, N. Mizota and S. Ichimura for their technical assistance and M. Ueda for encouragement.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agarwal S, 2006, P NATL ACAD SCI USA, V103, P15933, DOI 10.1073/pnas.0602674103; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Beckouet F, 2010, MOL CELL, V39, P689, DOI 10.1016/j.molcel.2010.08.008; Bejar R, 2011, J CLIN ONCOL, V29, P504, DOI 10.1200/JCO.2010.31.1175; Bose T, 2010, J CELL BIOL, V189, P201, DOI 10.1083/jcb.200912129; Chan DA, 2011, NAT REV DRUG DISCOV, V10, P351, DOI 10.1038/nrd3374; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Deardorff MA, 2012, AM J HUM GENET, V90, P1014, DOI 10.1016/j.ajhg.2012.04.019; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dorsett D, 2005, DEVELOPMENT, V132, P4743, DOI 10.1242/dev.02064; Dorsett D, 2009, CHROMOSOME RES, V17, P185, DOI 10.1007/s10577-009-9022-5; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Heidinger-Pauli JM, 2010, CURR BIOL, V20, P957, DOI 10.1016/j.cub.2010.04.018; Horsfield JA, 2007, DEVELOPMENT, V134, P2639, DOI 10.1242/dev.002485; Hosoya N, 2006, GENE CHROMOSOME CANC, V45, P482, DOI 10.1002/gcc.20303; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu JL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000119; Liu JL, 2010, NUCLEIC ACIDS RES, V38, P5657, DOI 10.1093/nar/gkq346; Marcucci G, 2011, J CLIN ONCOL, V29, P475, DOI 10.1200/JCO.2010.30.2554; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nabekura T, 2006, MOL THER, V13, P301, DOI 10.1016/j.ymthe.2005.09.021; Nagae G, 2011, HUM MOL GENET, V20, P2710, DOI 10.1093/hmg/ddr170; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Qin J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn518; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Schaaf CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006202; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shih LY, 2013, LEUKEMIA RES, V37, P43, DOI 10.1016/j.leukres.2012.09.012; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Walter MJ, 2013, LEUKEMIA, V27, P1275, DOI 10.1038/leu.2013.58; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Watrin E, 2009, EMBO J, V28, P2625, DOI 10.1038/emboj.2009.202; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496	50	261	265	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2013	45	10			SI		1232	U187		10.1038/ng.2731	http://dx.doi.org/10.1038/ng.2731			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	225UQ	23955599				2022-12-17	WOS:000324989600021
J	Klein, CJ; Botuyan, MV; Wu, YH; Ward, CJ; Nicholson, GA; Hammans, S; Hojo, K; Yamanishi, H; Karpf, AR; Wallace, DC; Simon, M; Lander, C; Boardman, LA; Cunningham, JM; Smith, GE; Litchy, WJ; Boes, B; Atkinson, EJ; Middha, S; Dyck, PJB; Parisi, JE; Mer, G; Smith, DI; Dyck, PJ				Klein, Christopher J.; Botuyan, Maria-Victoria; Wu, Yanhong; Ward, Christopher J.; Nicholson, Garth A.; Hammans, Simon; Hojo, Kaori; Yamanishi, Hiromitch; Karpf, Adam R.; Wallace, Douglas C.; Simon, Mariella; Lander, Cecilie; Boardman, Lisa A.; Cunningham, Julie M.; Smith, Glenn E.; Litchy, William J.; Boes, Benjamin; Atkinson, Elizabeth J.; Middha, Sumit; Dyck, P. James B.; Parisi, Joseph E.; Mer, Georges; Smith, David I.; Dyck, Peter J.			Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss	NATURE GENETICS			English	Article							DNA METHYLTRANSFERASE GENE; SERINE PALMITOYLTRANSFERASE; METHYLATION; DEAFNESS; HYPOMETHYLATION; REPLICATION; INSTABILITY; ACTIVATION; NEURONS; BINDING	DNA methyltransferase 1 (DNMT1) is crucial for maintenance of methylation, gene regulation and chromatin stability(1-3). DNA mismatch repair, cell cycle regulation in post-mitotic neurons(4,5) and neurogenesis(6) are influenced by DNA methylation. Here we show that mutations in DNMT1 cause both central and peripheral neurodegeneration in one form of hereditary sensory and autonomic neuropathy with dementia and hearing loss(7,8). Exome sequencing led to the identification of DNMT1 mutation c.1484A>G (p.Tyr495Cys) in two American kindreds and one Japanese kindred and a triple nucleotide change, c.1470-1472TCC>ATA (p.Asp490Glu-Pro491Tyr), in one European kindred. All mutations are within the targeting-sequence domain of DNMT1. These mutations cause premature degradation of mutant proteins, reduced methyltransferase activity and impaired heterochromatin binding during the G2 cell cycle phase leading to global hypomethylation and site-specific hypermethylation. Our study shows that DNMT1 mutations cause the aberrant methylation implicated in complex pathogenesis. The discovered DNMT1 mutations provide a new framework for the study of neurodegenerative diseases.	[Klein, Christopher J.; Litchy, William J.; Dyck, P. James B.; Dyck, Peter J.] Mayo Clin, Dept Neurol, Div Peripheral Nerve Dis, Rochester, MN 55905 USA; [Nicholson, Garth A.] Univ Sydney, Mol Med Lab, Sydney, NSW 2006, Australia; [Hammans, Simon] Southampton Univ Hosp Natl Hlth Serv NHS Trust, Dept Neurol, Southampton, Hants, England; [Yamanishi, Hiromitch] Harima Sanat, Div Psychiat, Hyogo, Japan; [Karpf, Adam R.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Wallace, Douglas C.; Simon, Mariella] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA USA; [Lander, Cecilie] Univ Queensland, Royal Brisbane Hosp, Herston, Qld, Australia; [Boardman, Lisa A.] Mayo Clin, Div Gastroenterol, Rochester, MN USA; [Smith, Glenn E.] Mayo Clin, Div Psychol, Rochester, MN USA; [Boes, Benjamin] Roche Appl Sci Genom Sequencing, Indianapolis, IN USA; [Parisi, Joseph E.] Mayo Clin, Div Neuropathol, Rochester, MN USA	Mayo Clinic; University of Sydney; Roswell Park Cancer Institute; University of California System; University of California Irvine; Royal Brisbane & Women's Hospital; University of Queensland; Mayo Clinic; Mayo Clinic; Mayo Clinic	Klein, CJ (corresponding author), Mayo Clin, Dept Neurol, Div Peripheral Nerve Dis, Rochester, MN 55905 USA.	klein.christopher@mayo.edu	Mer, Georges/AAT-4946-2021; Cecilie, Lander/F-8223-2014	Mer, Georges/0000-0002-1900-1578; Smith, Glenn/0000-0003-1506-9484; Nicholson, Garth/0000-0001-9694-066X; Middha, Sumit/0000-0003-4135-6268; Karpf, Adam/0000-0002-0866-0666; Lander, Cecilie/0000-0002-3548-9550; Klein, Christopher/0000-0002-4012-8856; Simon, Mariella/0000-0002-8200-3277	National Institute of Neurologic Disorders and Strokes (NINDS) [K08 (NS065007)]; NINDS [R01 (NS36797)]; Muscular Dystrophy Association; NIH [UL1 RR024150]; Clinical Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology [P30DK084567]; US National Institutes of Health [NS21328, NS070298]; NATIONAL CANCER INSTITUTE [R01CA132878] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036797, K08NS065007, R01NS021328, R01NS070298] Funding Source: NIH RePORTER	National Institute of Neurologic Disorders and Strokes (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Muscular Dystrophy Association(Muscular Dystrophy Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institute of Neurologic Disorders and Strokes (NINDS) K08 (NS065007), NINDS R01 (NS36797) and a previous grant from the Muscular Dystrophy Association. The authors wish to thank the Mayo Center for Translational Science Activities (supported by NIH UL1 RR024150) and the Mayo Clinic Bioinformatics Core and Sequencing Core for their excellent assistance. We would also like to thank the support from the Clinical Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology (P30DK084567). D. C. W. and M. S. would like to acknowledge the outstanding clinical contributions of J. Platt. Their portion of this work was supported by US National Institutes of Health grants NS21328 and NS070298.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Brooks PJ, 1996, J NEUROSCI, V16, P939; Brown KD, 2007, NAT GENET, V39, P289, DOI 10.1038/ng0307-289; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cardoso MC, 1999, J CELL BIOL, V147, P25, DOI 10.1083/jcb.147.1.25; Chen TP, 2007, NAT GENET, V39, P391, DOI 10.1038/ng1982; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Dawkins JL, 2001, NAT GENET, V27, P309, DOI 10.1038/85879; Easwaran HP, 2004, EMBO REP, V5, P1181, DOI 10.1038/sj.embor.7400295; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Fellinger K, 2009, J CELL BIOCHEM, V106, P521, DOI 10.1002/jcb.22071; Feng J, 2009, INT REV NEUROBIOL, V89, P67, DOI 10.1016/S0074-7742(09)89004-1; Golshani Peyman, 2005, Thalamus & Related Systems, V3, P227, DOI 10.1017/S1472928807000222; Guelly C, 2011, AM J HUM GENET, V88, P99, DOI 10.1016/j.ajhg.2010.12.003; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hojo K, 1999, EUR J NEUROL, V6, P357, DOI 10.1046/j.1468-1331.1999.630357.x; Hojo K, 2004, NEUROSCI LETT, V367, P340, DOI 10.1016/j.neulet.2004.06.030; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Klein CJ, 2005, PERIPHERAL NEUROPATH, V2, P1809; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Margot JB, 2000, J MOL BIOL, V297, P293, DOI 10.1006/jmbi.2000.3588; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rotthier A, 2010, AM J HUM GENET, V87, P513, DOI 10.1016/j.ajhg.2010.09.010; Song LG, 2005, ANAL CHEM, V77, P504, DOI 10.1021/ac0489420; Spada F, 2007, J CELL BIOL, V176, P565, DOI 10.1083/jcb.200610062; Spada F, 2006, ADV ENZYME REGUL, V46, P224, DOI 10.1016/j.advenzreg.2006.01.011; TAWA R, 1990, DIFFERENTIATION, V45, P44, DOI 10.1111/j.1432-0436.1990.tb00455.x; Tohgi H, 1999, MOL BRAIN RES, V70, P288, DOI 10.1016/S0169-328X(99)00163-1; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Wijsman EM, 2004, AM J HUM GENET, V75, P398, DOI 10.1086/423393; WRIGHT A, 1995, NEUROLOGY, V45, P560, DOI 10.1212/WNL.45.3.560; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052	35	261	280	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2011	43	6					595	U140		10.1038/ng.830	http://dx.doi.org/10.1038/ng.830			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21532572	Green Accepted			2022-12-17	WOS:000291017000020
J	van Es, MA; Veldink, JH; Saris, CGJ; Blauw, HM; van Vught, PWJ; Birve, A; Lemmens, R; Schelhaas, HJ; Groen, EJN; Huisman, MHB; van der Kooi, AJ; de Visser, M; Dahlberg, C; Estrada, K; Rivadeneira, F; Hofman, A; Zwarts, MJ; van Doormaal, PTC; Rujescu, D; Strengman, E; Giegling, I; Muglia, P; Tomik, B; Slowik, A; Uitterlinden, AG; Hendrich, C; Waibel, S; Meyer, T; Ludolph, AC; Glass, JD; Purcell, S; Cichon, S; Nothen, MM; Wichmann, HE; Schreiber, S; Vermeulen, SHHM; Kiemeney, LA; Wokke, JHJ; Cronin, S; McLaughlin, RL; Hardiman, O; Fumoto, K; Pasterkamp, RJ; Meininger, V; Melki, J; Leigh, PN; Shaw, CE; Landers, JE; Al-Chalabi, A; Brown, RH; Robberecht, W; Andersen, PM; Ophoff, RA; van den Berg, LH				van Es, Michael A.; Veldink, Jan H.; Saris, Christiaan G. J.; Blauw, Hylke M.; van Vught, Paul W. J.; Birve, Anna; Lemmens, Robin; Schelhaas, Helenius J.; Groen, Ewout J. N.; Huisman, Mark H. B.; van der Kooi, Anneke J.; de Visser, Marianne; Dahlberg, Caroline; Estrada, Karol; Rivadeneira, Fernando; Hofman, Albert; Zwarts, Machiel J.; van Doormaal, Perry T. C.; Rujescu, Dan; Strengman, Eric; Giegling, Ina; Muglia, Pierandrea; Tomik, Barbara; Slowik, Agnieszka; Uitterlinden, Andre G.; Hendrich, Corinna; Waibel, Stefan; Meyer, Thomas; Ludolph, Albert C.; Glass, Jonathan D.; Purcell, Shaun; Cichon, Sven; Noethen, Markus M.; Wichmann, H-Erich; Schreiber, Stefan; Vermeulen, Sita H. H. M.; Kiemeney, Lambertus A.; Wokke, John H. J.; Cronin, Simon; McLaughlin, Russell L.; Hardiman, Orla; Fumoto, Katsumi; Pasterkamp, R. Jeroen; Meininger, Vincent; Melki, Judith; Leigh, P. Nigel; Shaw, Christopher E.; Landers, John E.; Al-Chalabi, Ammar; Brown, Robert H., Jr.; Robberecht, Wim; Andersen, Peter M.; Ophoff, Roel A.; van den Berg, Leonard H.			Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis	NATURE GENETICS			English	Article							FRONTOTEMPORAL DEMENTIA; CONFERS SUSCEPTIBILITY; CHROMOSOME 9P; POPULATION; DISEASE; VARIANTS; RELEASE; LINKAGE; HAPMAP; DESIGN	We conducted a genome-wide association study among 2,323 individuals with sporadic amyotrophic lateral sclerosis (ALS) and 9,013 control subjects and evaluated all SNPs with P < 1.0 x 10(-4) in a second, independent cohort of 2,532 affected individuals and 5,940 controls. Analysis of the genome-wide data revealed genome-wide significance for one SNP, rs12608932, with P = 1.30 x 10(-9). This SNP showed robust replication in the second cohort (P = 1.86 x 10(-6)), and a combined analysis over the two stages yielded P = 2.53 x 10(-14). The rs12608932 SNP is located at 19p13.3 and maps to a haplotype block within the boundaries of UNC13A, which regulates the release of neurotransmitters such as glutamate at neuromuscular synapses. Follow-up of additional SNPs showed genome-wide significance for two further SNPs (rs2814707, with P = 7.45 x 10(-9), and rs3849942, with P = 1.01 x 10(-8)) in the combined analysis of both stages. These SNPs are located at chromosome 9p21.2, in a linkage region for familial ALS with frontotemporal dementia found previously in several large pedigrees.	[Wokke, John H. J.; van den Berg, Leonard H.] Univ Med Ctr Utrecht, Dept Neurol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Birve, Anna; Dahlberg, Caroline; Andersen, Peter M.] Umea Univ Hosp, Inst Clin Neurosci, S-90185 Umea, Sweden; [Lemmens, Robin; Robberecht, Wim] Katholieke Univ Leuven VIB, Vesalius Res Ctr, Leuven, Belgium; [Lemmens, Robin; Robberecht, Wim] Univ Leuven, Dept Neurol, Univ Hosp Leuven, Louvain, Belgium; [Schelhaas, Helenius J.; Zwarts, Machiel J.] Radboud Univ Nijmegen, Dept Neurology Clin Neurophysiol, Donders Inst Brain Cognit & Behav, Ctr Neurosci,Med Ctr, NL-6525 ED Nijmegen, Netherlands; [van der Kooi, Anneke J.; de Visser, Marianne] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [Estrada, Karol; Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Genet Lab, Rotterdam, Netherlands; [Rivadeneira, Fernando; Hofman, Albert; Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Rujescu, Dan; Giegling, Ina] Univ Munich, Dept Psychiat, Div Mol & Clin Neurobiol, D-8000 Munich, Germany; [Strengman, Eric; Ophoff, Roel A.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Strengman, Eric; Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst, Utrecht, Netherlands; [Muglia, Pierandrea] GlaxoSmithKline R&D, Med Genet, Verona, Italy; [Tomik, Barbara; Slowik, Agnieszka] Jagiellonian Univ, Dept Neurol, Krakow, Poland; [Hendrich, Corinna; Waibel, Stefan; Ludolph, Albert C.] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany; [Meyer, Thomas] Humboldt Univ, Dept Neurol, Charite Univ Hosp, Berlin, Germany; [Glass, Jonathan D.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Purcell, Shaun] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Cichon, Sven; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; [Cichon, Sven; Noethen, Markus M.] Univ Bonn, Dept Genom, Life & Brain Ctr, D-5300 Bonn, Germany; [Wichmann, H-Erich] German Res Ctr Environm Hlth, Inst Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Epidemiol, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Schreiber, Stefan] Univ Kiel, Dept Gen Internal Med, Kiel, Germany; [Vermeulen, Sita H. H. M.] Radboud Univ Nijmegen, Dept Epidemiol Biostat & HTA, Dept Human Genet, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Urol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Comprehens Canc Ctr E, Nijmegen, Netherlands; [Cronin, Simon] Royal Coll Surgeons Ireland, Dept Clin Neurol Sci, Dublin 2, Ireland; [Cronin, Simon; McLaughlin, Russell L.; Hardiman, Orla] Beaumont Hosp, Dept Neurol, Dublin 9, Ireland; [McLaughlin, Russell L.; Hardiman, Orla] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [Fumoto, Katsumi; Pasterkamp, R. Jeroen] Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Meininger, Vincent] Hop La Pitie Salpetriere, Dept Neurol, AP HP, Paris, France; [Melki, Judith] Hadassah Univ Hosp, Dept Human Genet, IL-91120 Jerusalem, Israel; [Leigh, P. Nigel; Shaw, Christopher E.; Al-Chalabi, Ammar] Kings Coll London, Dept Clin Neurosci, MRC, Ctr Neurodegenerat Res,Inst Psychiat, London WC2R 2LS, England; [Landers, John E.; Brown, Robert H., Jr.] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Landers, John E.; Brown, Robert H., Jr.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA; [Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA	Utrecht University; Utrecht University Medical Center; Umea University; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Munich; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; GlaxoSmithKline; Jagiellonian University; Ulm University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Emory University; Harvard University; Massachusetts General Hospital; University of Bonn; University of Bonn; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Kiel; University of Kiel; Radboud University Nijmegen; Radboud University Nijmegen; Royal College of Surgeons - Ireland; Trinity College Dublin; Utrecht University; Utrecht University Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Hebrew University of Jerusalem; University of London; King's College London; Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California Los Angeles	van den Berg, LH (corresponding author), Univ Med Ctr Utrecht, Dept Neurol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	R.A.Ophoff@umcutrecht.nl; L.H.vandenBerg@umcutrecht.nl	Wichmann, Heinz Erich/AAA-5695-2022; Vermeulen, Sita H./L-4716-2015; Leigh, Peter/AAD-5638-2019; Giegling, Ina/ABA-3677-2021; Muglia, Pierandrea/ABD-9235-2020; Al-Chalabi, Ammar/E-5361-2010; Rujescu, Dan/GRS-3875-2022; Schelhaas, Helenius Jurgen/E-2815-2010; Nöthen, Markus/B-2027-2009; Groen, Ewout JN/L-5081-2016; Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020; Hardiman, Orla/Y-3441-2019; Cichon, Sven/B-9618-2014; Rivadeneira, Fernando/O-5385-2015; Cichon, Sven/H-8803-2013; Saris, C.G.J./L-4623-2015; van+Es, Michael/AAC-5772-2021; Kiemeney, Lambertus A./D-3357-2009	Vermeulen, Sita H./0000-0003-4913-8601; Muglia, Pierandrea/0000-0002-3973-8606; Al-Chalabi, Ammar/0000-0002-4924-7712; Nöthen, Markus/0000-0002-8770-2464; Groen, Ewout JN/0000-0002-2330-9444; Hardiman, Orla/0000-0003-2610-1291; Cichon, Sven/0000-0002-9475-086X; Rivadeneira, Fernando/0000-0001-9435-9441; Cichon, Sven/0000-0002-9475-086X; Kiemeney, Lambertus A./0000-0002-2368-1326; Pasterkamp, Jeroen/0000-0003-1631-6440; Veldink, Jan/0000-0001-5572-9657; McLaughlin, Russell/0000-0003-3915-2135; Lemmens, Robin/0000-0002-4948-5956; Landers, John/0000-0001-8084-5043; van Es, Michael/0000-0002-7709-5883; van der Kooi, Anneke/0000-0002-5261-5512; Shaw, Christopher/0000-0003-0251-0146; Meyer, Thomas/0000-0002-2736-7350; Ingre, Caroline/0000-0001-5327-7204	Prinses Beatrix Fonds; VSB fonds; Kersten Foundation; Netherlands ALS Foundation; Adessium Foundation; Brain Foundation of The Netherlands; Netherlands Organisation for Scientific Research (NWO) investments [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly [014-93015]; Netherlands Genomics Initiative/NWO [050-060-810]; National Institute for Mental Health (R.A.O.); Erasmus Medical Center; Erasmus University, Rotterdam; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission; Municipality of Rotterdam; Muscular Dystrophy Association USA; Health Research Board of Ireland; Irish Motor Neuron Disease Research Foundation; Swedish Brain Research Foundation; Hallstens Research Foundation; Swedish Medical Society; Bjorklund Foundation for ALS Research; Swedish Association for the Neurologically; Belgian Federal Science Policy Office; Polish Ministry of Science and Higher Education [N N402 083934, N402 092 32/3216]; Association pour la Recherche sur la SLA; Association Reseau SLA Ile de France; Motor Neurone Disease Association of Great Britain and Ireland; Medical Research Council (UK); Wellcome Trust; Psychiatry Research Trust; ALS Therapy Alliance; Angel Fund; ALS Research Foundation; Al-Athel ALS Research Foundation; ALS Family Charitable Foundation; National Institute of Neurological Disorders and Stroke [NS050557]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050557] Funding Source: NIH RePORTER; MRC [G0600974, G0500289, G0900688] Funding Source: UKRI; Medical Research Council [G0900688, G0600974, G0500289B, G0500289] Funding Source: researchfish	Prinses Beatrix Fonds; VSB fonds; Kersten Foundation; Netherlands ALS Foundation; Adessium Foundation; Brain Foundation of The Netherlands; Netherlands Organisation for Scientific Research (NWO) investments(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative/NWO(Netherlands Organization for Scientific Research (NWO)); National Institute for Mental Health (R.A.O.)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Erasmus Medical Center; Erasmus University, Rotterdam; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Muscular Dystrophy Association USA(Muscular Dystrophy Association); Health Research Board of Ireland; Irish Motor Neuron Disease Research Foundation; Swedish Brain Research Foundation; Hallstens Research Foundation; Swedish Medical Society; Bjorklund Foundation for ALS Research; Swedish Association for the Neurologically; Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Association pour la Recherche sur la SLA; Association Reseau SLA Ile de France; Motor Neurone Disease Association of Great Britain and Ireland; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Psychiatry Research Trust; ALS Therapy Alliance; Angel Fund; ALS Research Foundation; Al-Athel ALS Research Foundation; ALS Family Charitable Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the individuals and their families who participated in this project; the study staff, general practitioners and pharmacists; P. Arp, M. Jhamai, M. Moorhouse, M. Verkerk and S. Bervoets for their help in creating the GWAS database; D. B. Goldstein for his contribution to the genotyping and analysis of the control sample from the German schizophrenia study; and N. Freimer for critical comments and reading of the manuscript. This project was supported by the Prinses Beatrix Fonds, VSB fonds, H. Kersten and M. Kersten (Kersten Foundation), The Netherlands ALS Foundation, and J. R. van Dijk and the Adessium Foundation (L.H.v.d.B.). J. H. V. was supported by the Brain Foundation of The Netherlands. The generation and management of GWAS genotype data for the Rotterdam Study was supported by The Netherlands Organisation for Scientific Research (NWO) investments (no. 175.010.2005.011, 911-03-012), the Research Institute for Diseases in the Elderly (RIDE; 014-93015)and the Netherlands Genomics Initiative/NWO (project no. 050-060-810). The controls from the Dutch schizophrenia GWAS were genotyped with the support of the National Institute for Mental Health (R.A.O.). The Rotterdam study was funded by Erasmus Medical Center and Erasmus University, Rotterdam; the Netherlands Organization for Health Research and Development; RIDE; the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. The Irish studies were funded by the Muscular Dystrophy Association USA (S. C., O.H.), the Health Research Board of Ireland (O.H.) and the Irish Motor Neuron Disease Research Foundation. In Sweden, this project was supported by the Swedish Brain Research Foundation, the Hallstens Research Foundation, the Swedish Medical Society, the Bjorklund Foundation for ALS Research and the Swedish Association for the Neurologically Disabled (P. M. A.). W. R. was supported through the E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders and by the Interuniversity Attraction Poles program P6/43 of the Belgian Federal Science Policy Office. The Polish study was partially funded by the Polish Ministry of Science and Higher Education (nos. N N402 083934 and N402 092 32/3216). In France, this study was funded by the Association pour la Recherche sur la SLA and the Association Reseau SLA Ile de France. We thank the Motor Neurone Disease Association of Great Britain and Ireland, the Medical Research Council (UK), the Wellcome Trust and the Psychiatry Research Trust (Tim Perkins Fund and Charcot Fund). Support was also provided by the ALS Therapy Alliance, Project ALS, the Angel Fund, the Pierre L. de Bourgknecht ALS Research Foundation, the Al-Athel ALS Research Foundation, the ALS Family Charitable Foundation and the National Institute of Neurological Disorders and Stroke (NS050557). R. H. B. is a cofounder of AviTx, which targets development of therapies.	Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Chio A, 2009, HUM MOL GENET, V18, P1524, DOI 10.1093/hmg/ddp059; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Dunckley T, 2007, NEW ENGL J MED, V357, P775, DOI 10.1056/NEJMoa070174; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Graham AJ, 1997, J NEUROL NEUROSUR PS, V62, P562, DOI 10.1136/jnnp.62.6.562; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Landers JE, 2009, P NATL ACAD SCI USA, V106, P9004, DOI 10.1073/pnas.0812937106; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Mitchell JD, 2007, LANCET, V369, P2031, DOI 10.1016/S0140-6736(07)60944-1; Morita M, 2006, NEUROLOGY, V66, P839, DOI 10.1212/01.wnl.0000200048.53766.b4; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Phukan J, 2007, LANCET NEUROL, V6, P994, DOI 10.1016/S1474-4422(07)70265-X; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raaphorst J, 2009, AMYOTROPH LATERAL SC, V29, P1, DOI DOI 10.1080/17482960802645008; Schmermund A, 2002, AM HEART J, V144, P212, DOI 10.1067/mhj.2002.123579; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Valdmanis PN, 2007, ARCH NEUROL-CHICAGO, V64, P240, DOI 10.1001/archneur.64.2.240; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; van Es MA, 2007, LANCET NEUROL, V6, P869, DOI 10.1016/S1474-4422(07)70222-3; Vance C, 2006, BRAIN, V129, P868, DOI 10.1093/brain/awl030; Varoqueaux F, 2005, MOL CELL BIOL, V25, P5973, DOI 10.1128/MCB.25.14.5973-5984.2005; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226	33	261	267	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1083	U53		10.1038/ng.442	http://dx.doi.org/10.1038/ng.442			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19734901				2022-12-17	WOS:000270330400010
J	Calvo, S; Jain, M; Xie, XH; Sheth, SA; Chang, B; Goldberger, OA; Spinazzola, A; Zeviani, M; Carr, SA; Mootha, VK				Calvo, S; Jain, M; Xie, XH; Sheth, SA; Chang, B; Goldberger, OA; Spinazzola, A; Zeviani, M; Carr, SA; Mootha, VK			Systematic identification of human mitochondrial disease genes through integrative genomics	NATURE GENETICS			English	Article							RESPIRATORY-CHAIN DISORDERS; HETEROGENEITY; PROTEINS; SEQUENCE; LOCUS; PROTEOME; DATABASE; MUSCLE; MOUSE	The majority of inherited mitochondrial disorders are due to mutations not in the mitochondrial genome ( mtDNA) but rather in the nuclear genes encoding proteins targeted to this organelle. Elucidation of the molecular basis for these disorders is limited because only half(1,2) of the estimated 1,500 mitochondrial proteins(3) have been identified. To systematically expand this catalog, we experimentally and computationally generated eight genome-scale data sets, each designed to provide clues as to mitochondrial localization: targeting sequence prediction, protein domain enrichment, presence of cis-regulatory motifs, yeast homology, ancestry, tandem-mass spectrometry, coexpression and transcriptional induction during mitochondrial biogenesis. Through an integrated analysis we expand the collection to 1,080 genes, which includes 368 novel predictions with a 10% estimated false prediction rate. By combining this expanded inventory with genetic intervals linked to disease, we have identified candidate genes for eight mitochondrial disorders, leading to the discovery of mutations in MPV17 that result in hepatic mtDNA depletion syndrome(4). The integrative approach promises to better define the role of mitochondria in both rare and common human diseases.	MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02446 USA; Natl Neurol Inst C Besta, Unite Mol Neurogenet, I-20126 Milan, Italy	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; IRCCS Istituto Neurologico Besta	Mootha, VK (corresponding author), MIT, Broad Inst, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	vamsi@hms.harvard.edu	Spinazzola, Antonella/P-5791-2019; Zeviani, Massimo/AAU-2632-2021; Spinazzola, Antonella/P-5298-2017; Zeviani, Massimo/K-2891-2014; Carr, Steven A./AAH-8366-2019	Spinazzola, Antonella/0000-0003-4242-8091; Zeviani, Massimo/0000-0002-9067-5508; Spinazzola, Antonella/0000-0003-4242-8091; Xie, Xiaohui/0000-0002-5479-6345				Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Andreoli C, 2004, NUCLEIC ACIDS RES, V32, pD459, DOI 10.1093/nar/gkh137; Basel-Vanagaite L, 2004, NEUROLOGY, V62, P87, DOI 10.1212/01.WNL.0000101680.49036.69; Christodoulou K, 2001, NEUROGENETICS, V3, P127, DOI 10.1007/s100480100112; Cotter D, 2004, NUCLEIC ACIDS RES, V32, pD463, DOI 10.1093/nar/gkh048; El-Shanti H, 2000, AM J HUM GENET, V66, P1229, DOI 10.1086/302858; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x; Guda C, 2004, BIOINFORMATICS, V20, P1785, DOI 10.1093/bioinformatics/bth171; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Kerrison JB, 1999, ARCH OPHTHALMOL-CHIC, V117, P805; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lopez MF, 2000, ELECTROPHORESIS, V21, P3427, DOI 10.1002/1522-2683(20001001)21:16<3427::AID-ELPS3427>3.0.CO;2-L; MARIMAN ECM, 1995, HUM GENET, V95, P56, DOI 10.1007/BF00225075; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Prokisch H, 2004, PLOS BIOL, V2, P795, DOI 10.1371/journal.pbio.0020160; Rotig A, 2003, J AM SOC NEPHROL, V14, P2995, DOI 10.1097/01.ASN.0000095481.24091.C9; Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718; Seyda A, 2001, AM J HUM GENET, V68, P386, DOI 10.1086/318196; Shoubridge EA, 2001, SEMIN NEUROL, V21, P261, DOI 10.1055/s-2001-17943; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Steinmuller R, 1998, EUR J HUM GENET, V6, P201, DOI 10.1038/sj.ejhg.5200180; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55; Zeviani Massimo, 2004, Suppl Clin Neurophysiol, V57, P304; ZWACKA RM, 1994, EMBO J, V13, P5129, DOI 10.1002/j.1460-2075.1994.tb06842.x	30	261	269	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2006	38	5					576	582		10.1038/ng1776	http://dx.doi.org/10.1038/ng1776			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	16582907				2022-12-17	WOS:000237147500021
J	Sheen, VL; Ganesh, VS; Topcu, M; Sebire, G; Bodell, A; Hill, RS; Grant, PE; Shugart, YY; Imitola, J; Khoury, SJ; Guerrini, R; Walsh, CA				Sheen, VL; Ganesh, VS; Topcu, M; Sebire, G; Bodell, A; Hill, RS; Grant, PE; Shugart, YY; Imitola, J; Khoury, SJ; Guerrini, R; Walsh, CA			Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex	NATURE GENETICS			English	Article							NUCLEOTIDE-EXCHANGE PROTEINS; ADP-RIBOSYLATION FACTORS; TRANS-GOLGI NETWORK; BREFELDIN-A; PERIVENTRICULAR HETEROTOPIA; NEURONAL MIGRATION; CORTICAL SIZE; CELL-ADHESION; GROWTH; BIG2	Disruption of human neural precursor proliferation can give rise to a small brain ( microcephaly), and failure of neurons to migrate properly can lead to an abnormal arrest of cerebral cortical neurons in proliferative zones near the lateral ventricles (periventricular heterotopia). Here we show that an autosomal recessive condition characterized by microcephaly and periventricular heterotopia 1 maps to chromosome 20 and is caused by mutations in the gene ADP-ribosylation factor guanine nucleotide-exchange factor-2 (ARFGEF2). By northern-blot analysis, we found that mouse Arfgef2 mRNA levels are highest during embryonic periods of ongoing neuronal proliferation and migration, and by in situ hybridization, we found that the mRNA is widely distributed throughout the embryonic central nervous system (CNS). ARFGEF2 encodes the large (>200 kDa) brefeldin A (BFA)-inhibited GEF2 protein (BIG2), which is required for vesicle and membrane trafficking from the trans-Golgi network (TGN). Inhibition of BIG2 by BFA, or by a dominant negative ARFGEF2 cDNA, decreases cell proliferation in vitro, suggesting a cell-autonomous regulation of neural expansion. Inhibition of BIG2 also disturbed the intracellular localization of such molecules as E-cadherin and beta-catenin by preventing their transport from the Golgi apparatus to the cell surface. Our findings show that vesicle trafficking is an important regulator of proliferation and migration during human cerebral cortical development.	Harvard Univ, Sch Med, Div Neurogenet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurol,Beth Israel Diaconess Med Ctr, Boston, MA 02115 USA; Hacettepe Univ, Fac Med, Ihsan Dogramaci Childrens Hosp, Dept Pediat Neurol, TR-06100 Ankara, Turkey; Univ Sherbrooke, CHU Fleurimont, Dept Pediat Neurol, Sherbrooke, PQ J1H 5N4, Canada; Harvard Univ, Sch Med, Athinoula A Marinos Ctr Biomed Imaging, Massachusetts Gen Hosp,Dept Pediat Neuroradiol, Boston, MA 02114 USA; Johns Hopkins Med Sch, Dept Pediat Epidemiol, Baltimore, MD 21205 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis,Dept Neurol, Boston, MA 02115 USA; Univ Pisa, Div Child Neurol & Psychiat, Epilepsy Neurophysiol & Neurogenet Unit, I-56018 Pisa, Italy; IRCCS Fdn Stella Maris, I-56018 Pisa, Italy; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Hacettepe University; University of Sherbrooke; Harvard University; Harvard Medical School; Massachusetts General Hospital; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Pisa; IRCCS Fondazione Stella Maris; Harvard University; Harvard Medical School	Walsh, CA (corresponding author), Harvard Univ, Sch Med, Div Neurogenet, Boston, MA 02115 USA.			YAO, YIN/0000-0003-3053-8429; Walsh, Christopher/0000-0002-0156-2238; Grant, Patricia/0000-0003-1005-4013; khoury, samia/0000-0003-3198-6063; Guerrini, Renzo/0000-0002-7272-7079	NIMH NIH HHS [K08 MH063886] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH063886] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Berger UV, 2001, J COMP NEUROL, V433, P101, DOI 10.1002/cne.1128; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Bonifacino JS, 2003, CELL, V112, P141, DOI 10.1016/S0092-8674(03)00038-2; Borghesani PR, 2002, DEVELOPMENT, V129, P1435; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Jareb M, 1997, J NEUROSCI, V17, P8955; KLYMKOWSKY MW, 1995, CELL, V83, P5, DOI 10.1016/0092-8674(95)90226-0; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Pacheco-Rodriguez G, 2002, METHOD ENZYMOL, V345, P397; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Poon PP, 2001, J CELL BIOL, V155, P1239, DOI 10.1083/jcb.200108075; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roberts E, 2002, J MED GENET, V39, P718, DOI 10.1136/jmg.39.10.718; Ruthel G, 1999, J NEUROBIOL, V39, P97, DOI 10.1002/(SICI)1097-4695(199904)39:1<97::AID-NEU8>3.0.CO;2-Z; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; SHEEN VL, 1994, EXP NEUROL, V130, P67, DOI 10.1006/exnr.1994.1186; Sheen VL, 2003, NEUROLOGY, V60, P1108, DOI 10.1212/01.WNL.0000055898.00349.02; Sheen VL, 2002, HUM MOL GENET, V11, P2845, DOI 10.1093/hmg/11.23.2845; Sheen VL, 1999, EXP NEUROL, V158, P47, DOI 10.1006/exnr.1999.7104; Sheen Volney L, 2003, Curr Neurol Neurosci Rep, V3, P433, DOI 10.1007/s11910-003-0027-8; SHEVELL DE, 1994, CELL, V77, P1051, DOI 10.1016/0092-8674(94)90444-8; Shinotsuka C, 2002, BIOCHEM BIOPH RES CO, V294, P254, DOI 10.1016/S0006-291X(02)00456-4; Shinotsuka C, 2002, J BIOL CHEM, V277, P9468, DOI 10.1074/jbc.M112427200; Togawa A, 1999, J BIOL CHEM, V274, P12308, DOI 10.1074/jbc.274.18.12308; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Yamaji R, 2000, P NATL ACAD SCI USA, V97, P2567, DOI 10.1073/pnas.97.6.2567	30	261	270	0	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2004	36	1					69	76		10.1038/ng1276	http://dx.doi.org/10.1038/ng1276			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	14647276	Bronze			2022-12-17	WOS:000187666800016
J	Hu, W; Yan, Q; Shen, DK; Liu, F; Zhu, ZD; Song, HD; Xu, XR; Wang, ZJ; Rong, YP; Zeng, LC; Wu, J; Zhang, X; Wang, JJ; Xu, XN; Wang, SY; Fu, G; Zhang, XL; Wang, ZQ; Brindley, PJ; McManus, DP; Xue, CL; Feng, Z; Chen, Z; Han, ZG				Hu, W; Yan, Q; Shen, DK; Liu, F; Zhu, ZD; Song, HD; Xu, XR; Wang, ZJ; Rong, YP; Zeng, LC; Wu, J; Zhang, X; Wang, JJ; Xu, XN; Wang, SY; Fu, G; Zhang, XL; Wang, ZQ; Brindley, PJ; McManus, DP; Xue, CL; Feng, Z; Chen, Z; Han, ZG			Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resource	NATURE GENETICS			English	Article							COMPARATIVE GENOMICS; SEX DETERMINATION; SEQUENCE; EXPRESSION; MANSONI; PROTEIN; CLONING; HOST	Schistosoma japonicum causes schistosomiasis in humans and livestock in the Asia-Pacific region. Knowledge of the genome of this parasite should improve understanding of schistosome-host interactions, biomedical aspects of schistosomiasis and invertebrate evolution. We assigned 43,707 expressed sequence tags ( ESTs) derived from adult S. japonicum and their eggs to 13,131 gene clusters. Of these, 35% shared no similarity with known genes and 75% had not been reported previously in schistosomes. Notably, S. japonicum encoded mammalian-like receptors for insulin, progesterone, cytokines and neuropeptides, suggesting that host hormones, or endogenous parasite homologs, could orchestrate schistosome development and maturation and that schistosomes modulate anti-parasite immune responses through inhibitors, molecular mimicry and other evasion strategies.	Chinese Natl Human Genome Ctr Shanghai, Shanghai 201203, Peoples R China; Chinese Ctr Dis Control & Prevent, Inst Parasit Dis, Shanghai 200025, Peoples R China; Shanghai Med Univ 2, Dept Parasitol, Shanghai 200025, Peoples R China; Shanghai Med Univ 2, Rui Jin Hosp, State Key Lab Med Genom, Shanghai 200025, Peoples R China; Tulane Univ, Hlth Sci Ctr, Dept Trop Med, New Orleans, LA 70112 USA; Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Australian Ctr Int Hlth & Nutr, Brisbane, Qld 4029, Australia	Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Tulane University; QIMR Berghofer Medical Research Institute	Han, ZG (corresponding author), Chinese Natl Human Genome Ctr Shanghai, 351 Guo Shou Jing Rd, Shanghai 201203, Peoples R China.	hanzg@chgc.sh.cn	HU, Wei/F-1004-2012; Wang, Zhaojun/GKS-9141-2022; McManus, Donald P./G-2678-2013; McManus, Don/AAC-5394-2020; Song, Huai-Dong/G-8961-2011	Wang, Zhaojun/0000-0003-2853-1850; McManus, Don/0000-0001-6443-1449; Brindley, Paul J./0000-0003-1765-0002; Han, Ze-Guang/0000-0002-1018-1752				Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; AMIRI P, 1992, NATURE, V356, P604, DOI 10.1038/356604a0; Ashburner M, 2001, GENOME RES, V11, P1425; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Blair JE, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-7; Boag PR, 2001, ADV PARASIT, V50, P153, DOI 10.1016/S0065-308X(01)50031-7; Bostic JR, 1996, MOL BIOCHEM PARASIT, V79, P79, DOI 10.1016/0166-6851(96)02640-0; Brindley PJ, 1997, MOL BIOCHEM PARASIT, V89, P1, DOI 10.1016/S0166-6851(97)00098-4; BUEDING E, 1982, J PARASITOL, V68, P208, DOI 10.2307/3281177; CAMACHO M, 1995, J PARASITOL, V81, P637, DOI 10.2307/3283866; Dacks JB, 2001, CELL, V107, P419, DOI 10.1016/S0092-8674(01)00584-0; Davies SJ, 2001, SCIENCE, V294, P1358, DOI 10.1126/science.1064462; de Mendonca RL, 2000, PARASITOL TODAY, V16, P233, DOI 10.1016/S0169-4758(00)01641-0; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GORMAN M, 1993, CELL, V72, P39, DOI 10.1016/0092-8674(93)90048-U; Halton DW, 1997, INT J PARASITOL, V27, P693, DOI 10.1016/S0020-7519(97)00011-8; Hoffmann KF, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-8-research0041; Holland PWH, 1999, NATURE, V402, pC41, DOI 10.1038/35011536; Imase A, 2001, PARASITOLOGY, V123, P163, DOI 10.1017/S0031182001008198; Johnston DA, 1999, BIOESSAYS, V21, P131, DOI 10.1002/(SICI)1521-1878(199902)21:2<131::AID-BIES7>3.0.CO;2-I; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Kuwabara PE, 1998, DEV BIOL, V204, P251, DOI 10.1006/dbio.1998.9062; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le TH, 2002, TRENDS PARASITOL, V18, P206, DOI 10.1016/S1471-4922(02)02252-3; Li L, 2003, GENOME RES, V13, P443, DOI 10.1101/gr.693203; Li WH, 2001, NATURE, V409, P847, DOI 10.1038/35057039; Lipman DJ, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-20; Lum DH, 2000, GENE DEV, V14, P3153; Mei HP, 1997, EXP PARASITOL, V86, P69, DOI 10.1006/expr.1997.4150; Morand S, 2000, PARASITOLOGY, V120, P45, DOI 10.1017/S0031182099005235; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; PULTZ MA, 1995, DEVELOPMENT, V121, P99; Ravindran B, 2001, TRENDS PARASITOL, V17, P70, DOI 10.1016/S1471-4922(00)01835-3; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Ross AGP, 2001, CLIN MICROBIOL REV, V14, P270, DOI 10.1128/CMR.14.2.270-295.2001; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Salzet M, 2000, PARASITOL TODAY, V16, P536, DOI 10.1016/S0169-4758(00)01787-7; Santos TM, 1999, MOL BIOCHEM PARASIT, V103, P79, DOI 10.1016/S0166-6851(99)00100-0; Skelly PJ, 1996, P NATL ACAD SCI USA, V93, P3642, DOI 10.1073/pnas.93.8.3642; SKELLY PJ, 1994, J BIOL CHEM, V269, P4247; Sokol SB, 2000, GENE DEV, V14, P901; Thornton JW, 2000, ANNU REV GENOM HUM G, V1, P41, DOI 10.1146/annurev.genom.1.1.41; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Xu XR, 2001, P NATL ACAD SCI USA, V98, P15089, DOI 10.1073/pnas.241522398	46	261	298	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2003	35	2					139	147		10.1038/ng1236	http://dx.doi.org/10.1038/ng1236			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726WV	12973349				2022-12-17	WOS:000185625300010
J	Cuesta, A; Pedrola, L; Sevilla, T; Garcia-Planells, J; Chumillas, MJ; Mayordomo, F; LeGuern, E; Marin, I; Vilchez, JJ; Palau, F				Cuesta, A; Pedrola, L; Sevilla, T; Garcia-Planells, J; Chumillas, MJ; Mayordomo, F; LeGuern, E; Marin, I; Vilchez, JJ; Palau, F			The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease	NATURE GENETICS			English	Article							CMT4A LOCUS; TRANSFERASES	We identified three distinct mutations and six mutant alleles in GDAP1 in three families with axonal Charcot-Marie-Tooth (CMT) neuropathy and vocal cord paresis, which were previously linked to the CMT4A locus on chromosome 8q21.1. These results establish the molecular etiology of CMT4A (MIM 214400) and suggest that it may be associated with both axonal and demyelinating phenotypes.	CSIC, Inst Biomed, Lab Genet & Mol Med, E-46010 Valencia, Spain; Univ Valencia, Hosp La Fe, Dept Neurol, E-46100 Valencia, Spain; Univ Valencia, Hosp La Fe, Dept Clin Neurophysiol, E-46100 Valencia, Spain; Univ Valencia, Hosp La Fe, Dept Pathol, E-46100 Valencia, Spain; Hop La Pitie Salpetriere, INSERM, U289, F-75651 Paris, France; Hop La Pitie Salpetriere, Dept Genet Cytogenet & Foetopathol, F-75651 Paris, France; Univ Valencia, Dept Genet, E-46100 Valencia, Spain; Univ Valencia, Inst Cavanilles Biodivers & Biol Evolut, E-46100 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Hospital Universitari i Politecnic La Fe; University of Valencia; Hospital Universitari i Politecnic La Fe; University of Valencia; Hospital Universitari i Politecnic La Fe; University of Valencia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Valencia; University of Valencia	Palau, F (corresponding author), CSIC, Inst Biomed, Lab Genet & Mol Med, Jaime Roig 11, E-46010 Valencia, Spain.	fpalau@ibv.csic.es	Marin, Ignacio/A-9524-2009; Sevilla, Teresa/L-3292-2017; Palau, Francesc/A-9391-2014	Marin, Ignacio/0000-0002-1315-8961; Palau, Francesc/0000-0002-8635-5421; Pedrola, Laia/0000-0002-3031-6124; Vilchez, Juan J/0000-0002-0532-2872; Garcia-Planells, Javier/0000-0002-3224-2966; Sevilla, Teresa/0000-0003-4716-2667				Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Baxter RV, 2002, NAT GENET, V30, P21, DOI 10.1038/ng796; Ben Othmane K, 1998, NEUROGENETICS, V2, P18, DOI 10.1007/s100480050047; BENOTHMANE K, 1995, GENOMICS, V28, P286, DOI 10.1006/geno.1995.1143; Dyck P.J, 1993, PNP, P1094; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; HENTATI F, 2001, ACTA MYOL, V20, P25; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Lewis RA, 2000, MUSCLE NERVE, V23, P1472, DOI 10.1002/1097-4598(200010)23:10<1472::AID-MUS3>3.0.CO;2-#; Liu H, 1999, J NEUROCHEM, V72, P1781, DOI 10.1046/j.1471-4159.1999.0721781.x; Lupski JR, 2001, METABOLIC MOL BASES, P5759; OTHMANE KB, 1993, HUM MOL GENET, V2, P1625, DOI 10.1093/hmg/2.10.1625; Salinas AE, 1999, CURR MED CHEM, V6, P279; SEVILLA T, 2001, ACTA MYOL, V20, P49	14	261	269	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2002	30	1					22	25		10.1038/ng798	http://dx.doi.org/10.1038/ng798			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11743580				2022-12-17	WOS:000173105600007
J	Morahan, G; Huang, DX; Ymer, SI; Cancilla, MR; Stephen, K; Dabadghao, P; Werther, G; Tait, BD; Harrison, LC; Colman, PG				Morahan, G; Huang, DX; Ymer, SI; Cancilla, MR; Stephen, K; Dabadghao, P; Werther, G; Tait, BD; Harrison, LC; Colman, PG			Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele	NATURE GENETICS			English	Article							DISTAL CHROMOSOME 2Q; GENETIC SUSCEPTIBILITY; INSULIN; CELLS; CYTOKINE; MELLITUS; IDDM; TH2	Type 1 diabetes (T1D; or insulin-dependent diabetes mellitus, IDDM) is an autoimmune disease with both genetic and environmental components. In addition to the human leukocyte antigen (HLA) complex, the single major genetic contributor of susceptibility(1), an unknown number of other unidentified genes are required to mediate disease. Although many loci conferring susceptibility to T1D have been mapped(2), their identification has proven problematic(3) due to the complex nature of this disease. Our strategy for finding T1D susceptibility genes has been to test for human homologues of loci implicated in diabetes-prone NOD (non-obese diabetic) mice, together with application of biologically relevant stratification methods(4). We report here a new susceptibility locus, IDDM18 located near the interleukin-12 (IL-12)p40 gene, IL12B. Significant bias in transmission of IL12B alleles was observed in affected sibpairs and was confirmed in an independent cohort of simplex families. A single base change in the 3' UTR showed strong linkage disequilibrium with the T1D susceptibility locus. The IL12B 3' UTR alleles showed different levers of expression in cell lines. Variation in IL-12p40 production may influence T-cell responses crucial for either mediating or protecting against this and other autoimmune diseases.	Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; Royal Childrens Hosp, Dept Endocrinol, Melbourne, Vic, Australia; Royal Melbourne Hosp, Australian Red Cross Blood Serv, Victorian Transplantat & Immunogenet Serv, Rotary Bone Marrow Res Ctr, Melbourne, Vic, Australia	Walter & Eliza Hall Institute; Royal Children's Hospital Melbourne; Australian Red Cross Blood Service; Royal Melbourne Hospital	Morahan, G (corresponding author), Walter & Eliza Hall Inst Med Res, PO Royal Melbourne Hosp, Parkville, Vic, Australia.	morahan@wehi.edu.au	Werther, George/B-3784-2012; Morahan, Grant/T-7501-2019	Colman, Peter/0000-0001-8718-6175				Adorini L, 1996, ANN NY ACAD SCI, V795, P208, DOI 10.1111/j.1749-6632.1996.tb52670.x; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; DEGLIESPOSTI MA, 1993, HUM IMMUNOL, V38, P3, DOI 10.1016/0198-8859(93)90514-2; Fu J, 1998, DIABETOLOGIA, V41, P228, DOI 10.1007/s001250050894; GERMANN T, 1993, EUR J IMMUNOL, V23, P1762, DOI 10.1002/eji.1830230805; GUBLER U, 1991, P NATL ACAD SCI USA, V88, P4143, DOI 10.1073/pnas.88.10.4143; HOLMANS P, 1993, AM J HUM GENET, V52, P362; HUANG D, IN PRESS GENES IMMUN; JOHNSON KJ, 1992, GENOMICS, V14, P745, DOI 10.1016/S0888-7543(05)80178-8; KATZ JD, 1995, SCIENCE, V268, P1185, DOI 10.1126/science.7761837; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Larsen ZM, 1999, AUTOIMMUNITY, V31, P35, DOI 10.3109/08916939908993857; LECAM A, 1995, EUR J BIOCHEM, V231, P620; Lernmark A, 1998, NAT GENET, V19, P213, DOI 10.1038/881; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; Morahan G, 1996, SCIENCE, V272, P1811, DOI 10.1126/science.272.5269.1811; ROBINSON WP, 1993, GENET EPIDEMIOL, V10, P273, DOI 10.1002/gepi.1370100502; Sambrook J., 1989, MOL CLONING; She JX, 1998, CURR OPIN IMMUNOL, V10, P682, DOI 10.1016/S0952-7915(98)80089-7; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Szelachowska M, 1997, HORM METAB RES, V29, P168, DOI 10.1055/s-2007-979014; Trembleau S, 1997, EUR J IMMUNOL, V27, P2330, DOI 10.1002/eji.1830270930; TREMBLEAU S, 1995, J EXP MED, V181, P817, DOI 10.1084/jem.181.2.817; WARRINGTON JA, 1994, GENOMICS, V24, P395, DOI 10.1006/geno.1994.1636; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WOLF SF, 1991, J IMMUNOL, V146, P3074; YOUNES RN, 1994, SHOCK S, V1, P2; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	29	261	271	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2001	27	2					218	221		10.1038/84872	http://dx.doi.org/10.1038/84872			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175794				2022-12-17	WOS:000166839200027
J	Burch, GH; Gong, Y; Liu, WH; Dettman, RW; Curry, CJ; Smith, L; Miller, WL; Bristow, J				Burch, GH; Gong, Y; Liu, WH; Dettman, RW; Curry, CJ; Smith, L; Miller, WL; Bristow, J			Tenascin-X deficiency is associated with Ehlers-Danlos syndrome	NATURE GENETICS			English	Letter							EXTRACELLULAR-MATRIX PROTEIN; STEROID 21-HYDROXYLASE DEFICIENCY; CLASS-III REGION; PRO-ALPHA-2(I) CHAIN; FIBRONECTIN; GENE; REPEATS; TISSUE; FIBRINOGEN; HAPLOTYPES	The tenascins are a family of large extracellular matrix proteins with at least three members: tenascin-X (TNX)(1-3), tenascin-C (TNC, or cytotactin)(4-6) and tenascin-R (TN-R, or restrictin)(7,8). Although the tenascins have been implicated in a number of important cellular processes, no function has been clearly established for any tenascin(9). We describe a new contiguous-gene syndrome, involving the CYP21B and TNX genes, that results in 21-hydroxylase deficiency and a connective-tissue disorder consisting of skin and joint hyperextensibility, vascular fragility and poor wound healing. The connective tissue findings are typical of the Ehlers-Danlos syndrome (EDS)(10). The abundant expression of TNX in connective tissues(2,11-13) is consistent with a role in EDS, and our patient's skin fibroblasts do not synthesize TNX protein in vitro or in vivo. His paternal allele carries a novel deletion arising from recombination between TNX and its partial duplicate gene, XA(14), which precludes TNX synthesis. Absence of TNX mRNA and protein in the proband, mapping of the TNX gene and HLA typing of this family suggest recessive inheritance of TNX deficiency and connective-tissue disease. Although the precise role of TNX in the pathogenesis of EDS is uncertain, this patient's findings suggest a unique and essential role for TNX in connective-tissue structure and function.	UNIV CALIF SAN FRANCISCO, DEPT PEDIAT, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, CARDIOVASC RES INST, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, METAB RES UNIT, SAN FRANCISCO, CA 94143 USA; VALLEY CHILDRENS HOSP, DEPT MED GENET, FRESNO, CA 93703 USA; UNIV WASHINGTON, SCH MED, DEPT MED, SEATTLE, WA 98195 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle			Miller, Walter L/J-3696-2012	Dettman, Robert/0000-0002-3074-5922	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL002695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037922] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL02695] Funding Source: Medline; NIDDK NIH HHS [DK37922] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRISTOW J, 1993, J BIOL CHEM, V268, P12919; BRISTOW J, 1993, J CELL BIOL, V122, P265, DOI 10.1083/jcb.122.1.265; BURCH GH, 1995, DEV DYNAM, V203, P491, DOI 10.1002/aja.1002030411; BYERS PH, 1994, J INVEST DERMATOL, V103, pS47, DOI 10.1038/jid.1994.9; CHIQUETEHRISMANN R, 1986, CELL, V47, P131, DOI 10.1016/0092-8674(86)90374-0; COLLIER S, 1989, EMBO J, V8, P1393, DOI 10.1002/j.1460-2075.1989.tb03520.x; DePaepe A, 1997, AM J HUM GENET, V60, P547; Erickson HP, 1993, CURR OPIN CELL BIOL, V5, P869, DOI 10.1016/0955-0674(93)90037-Q; ERICKSON HP, 1984, NATURE, V311, P267, DOI 10.1038/311267a0; EYRE DR, 1985, J BIOL CHEM, V260, P1322; Forsberg E, 1996, P NATL ACAD SCI USA, V93, P6594, DOI 10.1073/pnas.93.13.6594; FUSS B, 1993, J CELL BIOL, V120, P1237, DOI 10.1083/jcb.120.5.1237; GEFFROTIN C, 1995, EUR J BIOCHEM, V231, P83, DOI 10.1111/j.1432-1033.1995.0083f.x; GITELMAN SE, 1992, MOL CELL BIOL, V12, P2124, DOI 10.1128/MCB.12.5.2124; HAUSSER I, 1994, HUM GENET, V93, P394; JONES FS, 1988, P NATL ACAD SCI USA, V85, P2186, DOI 10.1073/pnas.85.7.2186; MATSUMOTO K, 1992, IMMUNOGENETICS, V36, P400; MATSUMOTO K, 1994, J CELL BIOL, V125, P483, DOI 10.1083/jcb.125.2.483; MATSUMOTO K, 1992, GENOMICS, V12, P485, DOI 10.1016/0888-7543(92)90438-X; MOREL Y, 1989, P NATL ACAD SCI USA, V86, P6582, DOI 10.1073/pnas.86.17.6582; MOREL Y, 1989, J CLIN INVEST, V83, P527, DOI 10.1172/JCI113914; NORENBERG U, 1992, NEURON, V8, P849, DOI 10.1016/0896-6273(92)90199-N; PINNELL SR, 1972, NEW ENGL J MED, V286, P1013, DOI 10.1056/NEJM197205112861901; SAGA Y, 1992, GENE DEV, V6, P1821, DOI 10.1101/gad.6.10.1821; SINNOTT P, 1990, P NATL ACAD SCI USA, V87, P2107, DOI 10.1073/pnas.87.6.2107; SMITH LT, 1992, AM J HUM GENET, V51, P235; Smith LT, 1997, J INVEST DERMATOL, V108, P241, DOI 10.1111/1523-1747.ep12286441; Toriello HV, 1996, NAT GENET, V13, P361, DOI 10.1038/ng0796-361; Wenstrup RJ, 1996, HUM MOL GENET, V5, P1733, DOI 10.1093/hmg/5.11.1733; WHITE PC, 1988, P NATL ACAD SCI USA, V85, P4436, DOI 10.1073/pnas.85.12.4436; WIRTZ MK, 1987, J BIOL CHEM, V262, P16376	31	261	265	1	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1997	17	1					104	108		10.1038/ng0997-104	http://dx.doi.org/10.1038/ng0997-104			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288108				2022-12-17	WOS:A1997XU72400028
J	Gauguier, D; Froguel, P; Parent, V; Bernard, C; Bihoreau, MT; Portha, B; James, MR; Penicaud, L; Lathrop, M; Ktorza, A				Gauguier, D; Froguel, P; Parent, V; Bernard, C; Bihoreau, MT; Portha, B; James, MR; Penicaud, L; Lathrop, M; Ktorza, A			Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes in the GK rat	NATURE GENETICS			English	Article							SPONTANEOUSLY HYPERTENSIVE RAT; BLOOD-PRESSURE; MELLITUS; ENDOCRINE; ETIOLOGY; LINKAGE; TWINS; MAP	Goto-Kakizaki (GK) rats are a well characterized model for non-insulin dependent diabetes mellitus (NIDDM). We have used a combination of physiological and genetic studies to identify quantitative trait loci (QTLs) responsible for the control of glucose homeostasis and insulin secretion in a F-2 cohort bred from spontaneously diabetic GK rats. The genetic dissection of NIDDM allowed us to map up to six independently segregating loci predisposing to hyperglycaemia, glucose intolerance or altered insulin secretion, and a seventh locus implicated in body weight. QTLs implicated in glucose tolerance and adiposity map to the same region of rat chromosome 1, and may indicate the influence of a single locus. Our study demonstrates that distinct combinations of genetic loci are responsible for different physiological characteristics associated with the diabetic phenotype in the GK rat, and it constitutes an important step for directing the search for the genetic factors involved in human NIDDM.	ST LOUIS HOSP,INSERM,U358,F-75010 PARIS,FRANCE; INST PASTEUR,CNRS,EP 10,F-59019 LILLE,FRANCE; UNIV PARIS 07,PHYSIOPATHOL NUTR LAB,CNRS,URA 307,F-75005 PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Gauguier, D (corresponding author), WELLCOME TRUST CTR HUMAN GENET,WINDMILL RD,OXFORD OX3 7BN,ENGLAND.		FROGUEL, Philippe/O-6799-2017; Gauguier, Dominique/G-2190-2016; Portha, Bernard/AAW-3021-2021	FROGUEL, Philippe/0000-0003-2972-0784; Gauguier, Dominique/0000-0001-6156-9530; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABDELHALIM SM, 1994, DIABETES, V43, P2811; AKABAYASHI A, 1994, MOL BRAIN RES, V21, P55, DOI 10.1016/0169-328X(94)90377-8; ANDERSSON L, 1994, SCIENCE, V263, P1771, DOI 10.1126/science.8134840; BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; BARNETT AH, 1981, DIABETOLOGIA, V20, P87, DOI 10.1007/BF00262007; COOK DL, 1992, INT TXB DIABETES MEL, P89; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; DENG YL, 1992, NAT GENET, V1, P267, DOI 10.1038/ng0792-267; DUBAY C, 1993, NAT GENET, V3, P354, DOI 10.1038/ng0493-354; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; GAUGUIER D, 1994, DIABETES, V43, P220, DOI 10.2337/diabetes.43.2.220; GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; GLASER B, 1994, NAT GENET, V7, P185, DOI 10.1038/ng0694-185; GOTO Y, 1975, P JPN ACAD, V51, P80, DOI 10.2183/pjab1945.51.80; GOTO Y, 1988, LESSONS ANIMAL DIABE, V2, P490; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; JACOB HJ, 1992, NAT GENET, V2, P56, DOI 10.1038/ng0992-56; KING H, 1988, BAILLIERE CLIN ENDOC, V2, P291, DOI 10.1016/S0950-351X(88)80033-8; LEIBOWITZ SF, 1991, BRAIN RES BULL, V27, P333, DOI 10.1016/0361-9230(91)90121-Y; LINDPAINTNER K, 1993, J HYPERTENS, V11, P19, DOI 10.1097/00004872-199301000-00004; NEWMAN B, 1987, DIABETOLOGIA, V30, P763; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; PORTHA B, 1991, DIABETES, V40, P486, DOI 10.2337/diabetes.40.4.486; RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315; ROSEN KM, 1993, ENDOCRINOLOGY, V133, P168; SAMANI NJ, 1993, J CLIN INVEST, V92, P1099, DOI 10.1172/JCI116616; SERIKAWA T, 1992, GENETICS, V131, P701; SHEIKH SP, 1988, AM J PHYSIOL, V255, pG46, DOI 10.1152/ajpgi.1988.255.1.G46; STEINER DF, 1990, DIABETES CARE, V13, P600, DOI 10.2337/diacare.13.6.600; TAYLOR R, 1989, BRIT MED BULL, V45, P73, DOI 10.1093/oxfordjournals.bmb.a072322; TAYLOR SI, 1991, J CLIN ENDOCR METAB, V73, P1158, DOI 10.1210/jcem-73-6-1158; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Wallum BJ, 1992, INT TXB DIABETES MEL, P285; WEST DB, 1994, J CLIN INVEST, V94, P1410, DOI 10.1172/JCI117477	35	261	266	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1996	12	1					38	43		10.1038/ng0196-38	http://dx.doi.org/10.1038/ng0196-38			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	8528248				2022-12-17	WOS:A1996TM55500012
J	RUBINSZTEIN, DC; AMOS, W; LEGGO, J; GOODBURN, S; JAIN, S; LI, SH; MARGOLIS, RL; ROSS, CA; FERGUSONSMITH, MA				RUBINSZTEIN, DC; AMOS, W; LEGGO, J; GOODBURN, S; JAIN, S; LI, SH; MARGOLIS, RL; ROSS, CA; FERGUSONSMITH, MA			MICROSATELLITE EVOLUTION - EVIDENCE FOR DIRECTIONALITY AND VARIATION IN RATE BETWEEN SPECIES	NATURE GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISMS; TRINUCLEOTIDE CAG REPEAT; HUNTINGTONS-DISEASE; LOCUS; EXPANSION; LENGTH; GENE; MUTATION; ONSET; AGE	Microsatellite DNA sequences are rapidly becoming the dominant source of nuclear genetic markers for a wide range of applications, from genome mapping to forensic testing to population studies. If misinterpretation is to be avoided, it is vital that we understand fully the way in which microsatellite sequences evolve. We have therefore compared allele length distributions for 42 microsatellites in humans with their homologues in a range of related primates. We find a highly significant trend for the loci to be longer in humans, showing that microsatellites can evolve directionally and at different rates in closely related species.	UNIV CAMBRIDGE,DEPT GENET,CAMBRIDGE CB2 2QQ,ENGLAND; ADDENBROOKES HOSP,DEPT CLIN GENET,CAMBRIDGE CB2 2QQ,ENGLAND; JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,MOLEC NEUROBIOL LAB,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE CB2 1QP,ENGLAND	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Johns Hopkins University; Johns Hopkins University; University of Cambridge	RUBINSZTEIN, DC (corresponding author), ADDENBROOKES NHS TRUST,GENET MOLEC LAB,E ANGLIAN REG GENET SERV,BOX 158,HILLS RD,CAMBRIDGE CB2 2QQ,ENGLAND.		Rubinsztein, David C/C-3472-2011		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050763] Funding Source: NIH RePORTER; NIMH NIH HHS [MH50763] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; BANCHS I, 1994, HUM MUTAT, V3, P365, DOI 10.1002/humu.1380030407; BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BRUNNER HG, 1993, AM J HUM GENET, V53, P1016; BUARD J, 1994, EMBO J, V13, P3203, DOI 10.1002/j.1460-2075.1994.tb06619.x; CLEMENS PR, 1991, AM J HUM GENET, V49, P951; COLEMAN MP, 1991, GENOMICS, V11, P991, DOI 10.1016/0888-7543(91)90024-9; DEKA R, 1994, GENOMICS, V22, P226, DOI 10.1006/geno.1994.1369; DOVER GA, 1993, CURR OPIN GENET DEV, V3, P902, DOI 10.1016/0959-437X(93)90012-E; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FARRER LA, 1992, AM J HUM GENET, V50, P528; FU YH, CELL, V67, P1047; GRAY IC, 1991, P ROY SOC B-BIOL SCI, V243, P241, DOI 10.1098/rspb.1991.0038; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDWICK LJ, 1993, HUM MOL GENET, V2, P1755, DOI 10.1093/hmg/2.10.1755; HUGNOT JP, 1991, NUCLEIC ACIDS RES, V19, P3159, DOI 10.1093/nar/19.11.3159; JANSEN G, 1994, AM J HUM GENET, V54, P575; JANSEN G, 1992, GENOMICS, V13, P509, DOI 10.1016/0888-7543(92)90118-C; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; JODICE C, 1994, AM J HUM GENET, V54, P959; Jones Michael H., 1992, Human Molecular Genetics, V1, P131, DOI 10.1093/hmg/1.2.131; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KOLDE R, 1994, NAT GENET, V6, P9; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P220; LI SH, 1993, GENOMICS, V16, P572, DOI 10.1006/geno.1993.1232; MOORE BJ, 1991, NUCLEIC ACIDS RES, V20, P929; NAPLER JR, 1967, HDB LIVING PRIMATES; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; OUDET C, 1992, J MED GENET, V30, P300; PASCHEN W, 1994, GENOMICS, V20, P435, DOI 10.1006/geno.1994.1198; PORTER CJ, 1992, NUCLEIC ACIDS RES, V20, P1429, DOI 10.1093/nar/20.6.1429; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; RICHARDS RI, 1994, NAT GENET, V6, P114, DOI 10.1038/ng0294-114; ROUX AF, 1993, HUM MOL GENET, V2, P821, DOI 10.1093/hmg/2.6.821-a; RUBINSZTEIN DC, 1994, BRIT J PSYCHIAT, V164, P851, DOI 10.1192/bjp.164.6.851; RUBLNSZTEIN DC, 1994, NAT GENET, V7, P525; SLIERENDREGT BL, 1993, TISSUE ANTIGENS, V42, P55, DOI 10.1111/j.1399-0039.1993.tb02167.x; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; STANIER P, 1991, NUCLEIC ACIDS RES, V19, P4793, DOI 10.1093/nar/19.17.4793; TAUTZ D, 1994, CURR OPIN GENET DEV, V4, P832, DOI 10.1016/0959-437X(94)90067-1; TSAI YC, 1995, J UROLOGY, V153, P1697, DOI 10.1016/S0022-5347(01)67507-4; VALDES AM, 1993, GENETICS, V133, P737; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4037, DOI 10.1093/nar/18.13.4037; WEBER JL, 1993, HUM MOL GENET, V8, P1123; WILLEMS PJ, 1994, NAT GENET, V8, P213, DOI 10.1038/ng1194-213	46	261	265	0	24	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1995	10	3					337	343		10.1038/ng0795-337	http://dx.doi.org/10.1038/ng0795-337			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG386	7670473				2022-12-17	WOS:A1995RG38600019
J	Edger, PP; Poorten, T; VanBuren, R; Hardigan, MA; Colle, M; McKain, MR; Smith, RD; Teresi, S; Nelson, ADL; Wai, CM; Alger, EI; Bird, KA; Yocca, AE; Pumplin, N; Ou, SJ; Ben-Zvi, G; Brode, A; Baruch, K; Swale, T; Shiue, L; Acharya, CB; Cole, GS; Mower, JP; Childs, KL; Jiang, N; Lyons, E; Freeling, M; Puzey, JR; Knapp, SJ				Edger, Patrick P.; Poorten, Thomasj; VanBuren, Robert; Hardigan, Michael A.; Colle, Marivi; McKain, Michael R.; Smith, Ronald D.; Teresi, Scottj; Nelson, Andrew D. L.; Wai, Ching Man; Alger, Elizabeth, I; Bird, Kevin A.; Yocca, Alan E.; Pumplin, Nathan; Ou, Shujun; Ben-Zvi, Gil; Brode, Avital; Baruch, Kobi; Swale, Thomas; Shiue, Lily; Acharya, Charlotte B.; Cole, Glenn S.; Mower, Jeffrey P.; Childs, Kevin L.; Jiang, Ning; Lyons, Eric; Freeling, Michael; Puzey, Joshua R.; Knapp, Steven J.			Origin and evolution of the octoploid strawberry genome	NATURE GENETICS			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GENE-EXPRESSION; CONFERRING RESISTANCE; TRANSPOSABLE ELEMENTS; PHYLOGENETIC ANALYSIS; SUBGENOME DOMINANCE; METABOLIC NETWORK; ENCODING GENES; LARGE-SCALE; FRAGARIA	Cultivated strawberry emerged from the hybridization of two wild octoploid species, both descendants from the merger of four diploid progenitor species into a single nucleus more than 1 million years ago. Here we report a near-complete chromosomescale assembly for cultivated octoploid strawberry (Fragaria x ananassa) and uncovered the origin and evolutionary processes that shaped this complex allopolyploid. We identified the extant relatives of each diploid progenitor species and provide support for the North American origin of octoploid strawberry. We examined the dynamics among the four subgenomes in octoploid strawberry and uncovered the presence of a single dominant subgenome with significantly greater gene content, gene expression abundance, and biased exchanges between homoeologous chromosomes, as compared with the other subgenomes. Pathway analysis showed that certain metabolomic and disease-resistance traits are largely controlled by the dominant subgenome. These findings and the reference genome should serve as a powerful platform for future evolutionary studies and enable molecular breeding in strawberry.	[Edger, Patrick P.; VanBuren, Robert; Colle, Marivi; Wai, Ching Man; Alger, Elizabeth, I; Bird, Kevin A.; Yocca, Alan E.; Ou, Shujun; Jiang, Ning] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Edger, Patrick P.; Bird, Kevin A.; Ou, Shujun; Jiang, Ning] Michigan State Univ, Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA; [Poorten, Thomasj; Hardigan, Michael A.; Pumplin, Nathan; Acharya, Charlotte B.; Cole, Glenn S.; Knapp, Steven J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [VanBuren, Robert] Michigan State Univ, Plant Resilience Inst, E Lansing, MI 48824 USA; [McKain, Michael R.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA; [Smith, Ronald D.; Teresi, Scottj] Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA; [Nelson, Andrew D. L.; Lyons, Eric; Puzey, Joshua R.] Univ Arizona, Sch Plant Sci, Tucson, AZ USA; [Ben-Zvi, Gil; Brode, Avital; Baruch, Kobi] NRGene, Ness Ziona, Israel; [Swale, Thomas; Shiue, Lily] Dovetail Genom, Santa Cruz, CA USA; [Mower, Jeffrey P.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE USA; [Childs, Kevin L.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Childs, Kevin L.] Michigan State Univ, Ctr Genom Enabled Plant Sci, E Lansing, MI 48824 USA; [Freeling, Michael] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	Michigan State University; Michigan State University; University of California System; University of California Davis; Michigan State University; University of Alabama System; University of Alabama Tuscaloosa; William & Mary; University of Arizona; University of Nebraska System; University of Nebraska Lincoln; Michigan State University; Michigan State University; University of California System; University of California Berkeley	Edger, PP (corresponding author), Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA.; Edger, PP (corresponding author), Michigan State Univ, Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA.; Knapp, SJ (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	edgerpat@msu.edu; sjknapp@ucdavis.edu	Mower, Jeff/P-5893-2019; Edger, Patrick/AAP-3846-2021; Mower, Jeff/B-7875-2008; Edger, Patrick/ABE-6442-2020; Childs, Kevin/C-9513-2014	Mower, Jeff/0000-0002-1501-5809; Mower, Jeff/0000-0002-1501-5809; Lyons, Eric/0000-0002-3348-8845; Puzey, Joshua/0000-0001-8019-9993; Bird, Kevin/0000-0002-3174-3646; Teresi, Scott/0000-0003-1356-7543; Nelson, Andrew/0000-0001-9896-1739; Smith, Ronald/0000-0003-2736-0092; Childs, Kevin/0000-0002-3680-062X	Michigan State University AgBioResearch; NSF-DBI [1757043, 1737898]; USDA-NIFA SCRI [2017-51181-26833]; California Strawberry Commission; University of California; USDA-NIFA HATCH [1009804]	Michigan State University AgBioResearch; NSF-DBI(National Science Foundation (NSF)); USDA-NIFA SCRI; California Strawberry Commission; University of California(University of California System); USDA-NIFA HATCH	This work was supported by Michigan State University AgBioResearch to P.P.E., USDA-NIFA HATCH 1009804 to P.P.E., NSF-DEB 1737898 to P.P.E., S.J.T as a participant in the Plant Genomics at MSU REU program funded by NSF-DBI 1757043, USDA-NIFA SCRI 2017-51181-26833 to S.J.K., the California Strawberry Commission to S.J.K., and the University of California to S.J.K.	Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Avni R, 2017, SCIENCE, V357, P93, DOI 10.1126/science.aan0032; Bao L., 2017, BZIOINFORMATICS AQUA, V8, P86; Bekaert M, 2011, PLANT CELL, V23, P1719, DOI 10.1105/tpc.110.081281; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birchler JA, 2001, DEV BIOL, V234, P275, DOI 10.1006/dbio.2001.0262; Bird KA, 2018, NEW PHYTOL, V220, P87, DOI 10.1111/nph.15256; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bottani S, 2018, TRENDS PLANT SCI, V23, P393, DOI 10.1016/j.tplants.2018.01.002; BRINGHURST RS, 1963, AM J BOT, V50, P658, DOI 10.2307/2440042; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Campbell MS, 2014, PLANT PHYSIOL, V164, P513, DOI 10.1104/pp.113.230144; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Cheng F, 2016, NEW PHYTOL, V211, P288, DOI 10.1111/nph.13884; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Dal'Molin CGD, 2010, PLANT PHYSIOL, V152, P579, DOI 10.1104/pp.109.148817; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Davik J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137746; Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51; Douglas GM, 2015, P NATL ACAD SCI USA, V112, P2806, DOI 10.1073/pnas.1412277112; Doyle JJ, 2008, ANNU REV GENET, V42, P443, DOI 10.1146/annurev.genet.42.110807.091524; Duchesne Antoine-Nicolas, 1766, HIST NATURELLE FRAIS; Eckardt NA, 2014, PLANT CELL, V26, P1834, DOI 10.1105/tpc.114.127183; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edger PP, 2018, CURR OPIN PLANT BIOL, V42, P76, DOI 10.1016/j.pbi.2018.03.006; Edger PP, 2017, GIGASCIENCE, V7, DOI 10.1093/gigascience/gix124; Edger PP, 2017, PLANT CELL, V29, P2150, DOI 10.1105/tpc.17.00010; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; FEDOROVA N. J., 1946, Doklady Akademii nauk SSSR, V52, P545; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Folta KM., 2009, GENETICS GENOMICS RO; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Freeling M, 2012, CURR OPIN PLANT BIOL, V15, P131, DOI 10.1016/j.pbi.2012.01.015; Gaeta RT, 2010, NEW PHYTOL, V186, P18, DOI 10.1111/j.1469-8137.2009.03089.x; Garsmeur O, 2014, MOL BIOL EVOL, V31, P448, DOI 10.1093/molbev/mst230; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo H, 2014, GENETICS, V197, P1153, DOI 10.1534/genetics.114.166124; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Han YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq862; Hanada K, 2008, PLANT PHYSIOL, V148, P993, DOI 10.1104/pp.108.122457; He ZS, 2017, PLANT BIOTECHNOL J, V15, P594, DOI 10.1111/pbi.12657; Hirakawa H, 2014, DNA RES, V21, P169, DOI 10.1093/dnares/dst049; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Johnson AL, 2014, BOT J LINN SOC, V176, P99, DOI 10.1111/boj.12190; Kalvari I, 2018, NUCLEIC ACIDS RES, V46, pD335, DOI 10.1093/nar/gkx1038; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kroj T, 2016, NEW PHYTOL, V210, P618, DOI 10.1111/nph.13869; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laricchia KM, 2017, MOL BIOL EVOL, V34, P2187, DOI 10.1093/molbev/msx155; Lefort V, 2015, MOL BIOL EVOL, V32, P2798, DOI 10.1093/molbev/msv150; Leggett Richard M., 2013, Frontiers in Genetics, V4, P288, DOI 10.3389/fgene.2013.00288; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liston A, 2014, AM J BOT, V101, P1686, DOI 10.3732/ajb.1400140; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lundberg M., 2011, THESIS; Luo MC, 2017, NATURE, V551, P498, DOI 10.1038/nature24486; Lyons E., 2008, Tropical Plant Biology, V1, P181, DOI 10.1007/s12042-008-9017-y; Lysak MA, 2007, PLANT PHYSIOL, V145, P402, DOI 10.1104/pp.107.104380; Mangandi J, 2017, G3-GENES GENOM GENET, V7, P1707, DOI 10.1534/g3.117.042119; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; McKain MR, 2017, BIOINFORMATICS, V33, P130, DOI 10.1093/bioinformatics/btw583; McKain MR, 2016, GENOME BIOL EVOL, V8, P1150, DOI 10.1093/gbe/evw060; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Milne RI, 2008, MOL ECOL, V17, P1108, DOI 10.1111/j.1365-294X.2007.03643.x; Nelson ADL, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00052; Njuguna W, 2013, MOL PHYLOGENET EVOL, V66, P17, DOI 10.1016/j.ympev.2012.08.026; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Osborn TC, 2004, PHYSIOL PLANTARUM, V121, P531, DOI 10.1111/j.1399-3054.2004.00360.x; Ou SJ, 2018, PLANT PHYSIOL, V176, P1410, DOI 10.1104/pp.17.01310; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parkin IAP, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r77; Paterson AH, 2015, NAT BIOTECHNOL, V33, P491, DOI 10.1038/nbt.3217; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pincot DDA, 2018, G3-GENES GENOM GENET, V8, P1817, DOI 10.1534/g3.118.200129; Potter D, 2000, SYST BOT, V25, P337, DOI 10.2307/2666646; Putnam NH, 2016, GENOME RES, V26, P342, DOI 10.1101/gr.193474.115; Qian LH, 2017, G3-GENES GENOM GENET, V7, P1577, DOI 10.1534/g3.117.040485; Renny-Byfield S, 2017, MOL BIOL EVOL, V34, P1825, DOI 10.1093/molbev/msx121; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Roach JA, 2016, THEOR APPL GENET, V129, P1191, DOI 10.1007/s00122-016-2695-1; Sankoff D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S8; Sarris PF, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0228-7; Schnable JC, 2011, P NATL ACAD SCI USA, V108, P4069, DOI 10.1073/pnas.1101368108; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Soltis PS, 2005, NEW PHYTOL, V166, P5, DOI 10.1111/j.1469-8137.2005.01379.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; STAUDT G., 1962, CANADIAN JOUR BOT, V40, P869, DOI 10.1139/b62-081; STEBBINS GL, 1947, ADV GENET, V1, P403, DOI 10.1016/S0065-2660(08)60490-3; Sun HH, 2017, MOL PLANT, V10, P1293, DOI 10.1016/j.molp.2017.09.003; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tang HB, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-102; Tarailo-Graovac Maja, 2009, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s25; Tennessen JA, 2014, GENOME BIOL EVOL, V6, P3295, DOI 10.1093/gbe/evu261; Thomas BC, 2006, GENOME RES, V16, P934, DOI 10.1101/gr.4708406; Ulrich D, 2013, J APPL BOT FOOD QUAL, V86, P37, DOI 10.5073/JABFQ.2013.086.006; Van De Peer Y, 2017, NAT REV GENET, V18, P411, DOI 10.1038/nrg.2017.26; VanBuren R, 2015, NATURE, V527, P508, DOI 10.1038/nature15714; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wendel JF, 2018, CURR OPIN GENET DEV, V49, P1, DOI 10.1016/j.gde.2018.01.004; Woodhouse MR, 2014, P NATL ACAD SCI USA, V111, P5283, DOI 10.1073/pnas.1402475111; Xiong ZY, 2011, P NATL ACAD SCI USA, V108, P7908, DOI 10.1073/pnas.1014138108; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang JH, 2016, NAT GENET, V48, P1225, DOI 10.1038/ng.3657; Yang YL, 2017, GENOME BIOL EVOL, V9, P3433, DOI 10.1093/gbe/evx214; ZHANG HB, 1995, PLANT J, V7, P175, DOI 10.1046/j.1365-313X.1995.07010175.x; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhao MX, 2017, PLANT CELL, V29, P2974, DOI 10.1105/tpc.17.00595	129	260	268	25	139	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2019	51	3					541	+		10.1038/s41588-019-0356-4	http://dx.doi.org/10.1038/s41588-019-0356-4			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HN1KZ	30804557	hybrid, Green Published			2022-12-17	WOS:000459947200021
J	Zhang, JS; Zhang, XT; Tang, HB; Zhang, Q; Hua, XT; Ma, XK; Zhu, F; Jones, T; Zhu, XG; Bowers, J; Wai, CM; Zheng, CF; Shil, Y; Chen, S; Xu, XM; Yue, JJ; Nelsons, DR; Huang, LX; Li, Z; Xu, HM; Zhou, D; Wang, YJ; Hu, WC; Lin, JS; Deng, YJ; Pandey, N; Mancini, M; Zerpa, D; Nguyen, JK; Wang, LM; Yu, L; Xin, YH; Ge, LF; Arro, J; Han, JO; Chakrabarty, S; Pushko, M; Zhang, WP; Ma, YH; Ma, PP; Lv, MJ; Chen, FM; Zheng, GY; Xu, JS; Yang, ZH; Deng, F; Chen, XQ; Liao, ZY; Zhang, XX; Lin, ZC; Lin, H; Yan, HS; Kuang, Z; Zhong, WM; Liang, PP; Wang, GF; Yuan, Y; Shi, JX; Hou, JX; Lin, JX; Jin, JJ; Cao, PJ; Shen, QC; Jiang, Q; Zhou, P; Ma, YY; Zhang, XD; Xu, RR; Liu, J; Zhou, YM; Jia, HF; Ma, Q; Qi, R; Zhang, ZL; Fang, JP; Fang, HK; Song, JJ; Wang, MJ; Dong, GR; Wang, G; Chen, Z; Ma, T; Liu, H; Dhungana, SR; Huss, SE; Yang, XP; Sharma, A; Trujillo, JH; Martinez, MC; Hudson, M; Riascos, JJ; Schuler, M; Chen, LQ; Braun, DM; Li, L; Yu, QY; Wang, JP; Wang, K; Schatz, MC; Heckerman, D; Van Sluys, MA; Souza, GM; Moore, PH; Sankoff, D; VanBuren, R; Paterson, AH; Nagai, C; Ming, R				Zhang, Jisen; Zhang, Xingtan; Tang, Haibao; Zhang, Qing; Hua, Xiuting; Ma, Xiaokai; Zhu, Fan; Jones, Tyler; Zhu, Xinguang; Bowers, John; Wai, Ching Man; Zheng, Chunfang; Shil, Yan; Chen, Shuai; Xu, Xiuming; Yue, Jingjing; Nelsons, David R.; Huang, Lixian; Li, Zhen; Xu, Huimin; Zhou, Dong; Wang, Yongjun; Hu, Weichang; Lin, Jishan; Deng, Youjin; Pandey, Neha; Mancini, Melina; Zerpa, Dessiree; Nguyen, Julie K.; Wang, Liming; Yu, Liang; Xin, Yinghui; Ge, Liangfa; Arro, Jie; Han, Jennifer O.; Chakrabarty, Setu; Pushko, Marija; Zhang, Wenping; Ma, Yanhong; Ma, Panpan; Lv, Mingju; Chen, Faming; Zheng, Guangyong; Xu, Jingsheng; Yang, Zhenhui; Deng, Fang; Chen, Xuequn; Liao, Zhenyang; Zhang, Xunxiao; Lin, Zhicong; Lin, Hai; Yan, Hansong; Kuang, Zheng; Zhong, Weimin; Liang, Pingping; Wang, Guofeng; Yuan, Yuan; Shi, Jiaxian; Hou, Jinxiang; Lin, Jingxian; Jin, Jingjing; Cao, Peijian; Shen, Qiaochu; Jiang, Qing; Zhou, Ping; Ma, Yaying; Zhang, Xiaodan; Xu, Rongrong; Liu, Juan; Zhou, Yongmei; Jia, Haifeng; Ma, Qing; Qi, Rui; Zhang, Zhiliang; Fang, Jingping; Fang, Hongkun; Song, Jinjin; Wang, Mengjuan; Dong, Guangrui; Wang, Gang; Chen, Zheng; Ma, Teng; Liu, Hong; Dhungana, Singha R.; Huss, Sarah E.; Yang, Xiping; Sharma, Anupma; Trujillo, Jhon H.; Martinez, Maria C.; Hudson, Matthew; Riascos, John J.; Schuler, Mary; Chen, Li-Qing; Braun, David M.; Li, Lei; Yu, Qingyi; Wang, Jianping; Wang, Kai; Schatz, Michael C.; Heckerman, David; Van Sluys, Marie-Anne; Souza, Glaucia Mendes; Moore, Paul H.; Sankoff, David; VanBuren, Robert; Paterson, Andrew H.; Nagai, Chifumi; Ming, Ray			Allele-defined genome of the autopolyploid sugarcane Saccharum spontaneum L.	NATURE GENETICS			English	Article							DE-NOVO IDENTIFICATION; GENE-EXPRESSION; READ ALIGNMENT; SEQUENCE; EVOLUTION; PROGRAM; TOOL; DIVERSITY; ACCURATE; RNA	Modern sugarcanes are polyploid interspecific hybrids, combining high sugar content from Saccharum officinarum with hardiness, disease resistance and ratooning of Saccharum spontaneum. Sequencing of a haploid S. spontaneum, AP85-441, facilitated the assembly of 32 pseudo-chromosomes comprising 8 homologous groups of 4 members each, bearing 35,525 genes with alleles defined. The reduction of basic chromosome number from 10 to 8 in S. spontaneum was caused by fissions of 2 ancestral chromosomes followed by translocations to 4 chromosomes. Surprisingly, 80% of nucleotide binding site-encoding genes associated with disease resistance are located in 4 rearranged chromosomes and 51% of those in rearranged regions. Resequencing of 64 S. spontaneum genomes identified balancing selection in rearranged regions, maintaining their diversity. Introgressed S. spontaneum chromosomes in modern sugarcanes are randomly distributed in AP85-441 genome, indicating random recombination among homologs in different S. spontaneum accessions. The allele-defined Saccharum genome offers new knowledge and resources to accelerate sugarcane improvement.	[Zhang, Jisen; Zhang, Xingtan; Tang, Haibao; Zhang, Qing; Hua, Xiuting; Ma, Xiaokai; Shil, Yan; Chen, Shuai; Xu, Xiuming; Yue, Jingjing; Huang, Lixian; Li, Zhen; Xu, Huimin; Zhou, Dong; Wang, Yongjun; Hu, Weichang; Lin, Jishan; Deng, Youjin; Wang, Liming; Zhang, Wenping; Ma, Yanhong; Ma, Panpan; Xu, Jingsheng; Yang, Zhenhui; Deng, Fang; Chen, Xuequn; Liao, Zhenyang; Zhang, Xunxiao; Lin, Zhicong; Lin, Hai; Yan, Hansong; Kuang, Zheng; Zhong, Weimin; Liang, Pingping; Wang, Guofeng; Yuan, Yuan; Shi, Jiaxian; Hou, Jinxiang; Lin, Jingxian; Shen, Qiaochu; Jiang, Qing; Zhou, Ping; Ma, Yaying; Zhang, Xiaodan; Xu, Rongrong; Liu, Juan; Zhou, Yongmei; Jia, Haifeng; Ma, Qing; Qi, Rui; Zhang, Zhiliang; Fang, Jingping; Fang, Hongkun; Song, Jinjin; Wang, Mengjuan; Dong, Guangrui; Wang, Gang; Chen, Zheng; Ma, Teng; Liu, Hong; Li, Lei; Wang, Jianping; Wang, Kai; Ming, Ray] Fujian Agr & Forestry Univ, Minist Educ,Fujian Prov Key Lab Haixia Appl Plant, Key Lab Genet Breeding & Multiple Utilizat Corps, Natl Sugarcane Engn Technol Res Ctr,Fujian Agr &, Fuzhou, Fujian, Peoples R China; [Zhu, Fan; Pandey, Neha; Mancini, Melina; Zerpa, Dessiree; Nguyen, Julie K.; Yu, Liang; Xin, Yinghui; Ge, Liangfa; Arro, Jie; Han, Jennifer O.; Chakrabarty, Setu; Pushko, Marija; Huss, Sarah E.; Schuler, Mary; Chen, Li-Qing; Ming, Ray] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Jones, Tyler; Moore, Paul H.; Nagai, Chifumi] Hawaii Agr Res Ctr, Kunia, HI 96759 USA; [Zhu, Xinguang; Lv, Mingju] Chinese Acad Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Bowers, John; Paterson, Andrew H.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Wai, Ching Man; VanBuren, Robert] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Zheng, Chunfang; Sankoff, David] Univ Ottawa, Dept Math & Stat, Ottawa, ON, Canada; [Nelsons, David R.] Univ Tennessee HSC, Dept Microbiol Immunol & Biochem, Memphis, TN USA; [Chen, Faming; Zheng, Guangyong] Chinese Acad Sci, Chinese Acad Sci Max Planck Gesell Partner Inst C, Shanghai, Peoples R China; [Jin, Jingjing; Cao, Peijian] CNTC, Zhengzhou Tobacco Res Inst, China Tobacco Gene Res Ctr, Zhengzhou, Henan, Peoples R China; [Dhungana, Singha R.; Braun, David M.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Yang, Xiping; Wang, Jianping] Univ Florida, Dept Agron, Gainesville, FL 32611 USA; [Sharma, Anupma; Yu, Qingyi] Texas A&M Univ Syst, Texas A&M AgriLife Res, Dallas, TX USA; [Trujillo, Jhon H.; Martinez, Maria C.; Riascos, John J.] Ctr Invest Cana Azucar Colombia Cenicana, Cali, Colombia; [Hudson, Matthew] Univ Illinois, Dept Crop Sci, Urbana, IL USA; [Schatz, Michael C.] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Schatz, Michael C.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Heckerman, David] Microsoft Res, Redmond, WA USA; [Van Sluys, Marie-Anne] Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, Brazil; [Souza, Glaucia Mendes] Univ Sao Paulo, Dept Bioquim, Inst Quim, Sao Paulo, Brazil	Fujian Agriculture & Forestry University; University of Illinois System; University of Illinois Urbana-Champaign; Chinese Academy of Sciences; University System of Georgia; University of Georgia; Michigan State University; University of Ottawa; University of Tennessee System; University of Tennessee Health Science Center; Chinese Academy of Sciences; Max Planck Society; Zhengzhou Tobacco Research Institute of CNTC; University of Missouri System; University of Missouri Columbia; State University System of Florida; University of Florida; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; University of Illinois System; University of Illinois Urbana-Champaign; Johns Hopkins University; Johns Hopkins University; Microsoft; Universidade de Sao Paulo; Universidade de Sao Paulo	Zhang, JS; Ming, R (corresponding author), Fujian Agr & Forestry Univ, Minist Educ,Fujian Prov Key Lab Haixia Appl Plant, Key Lab Genet Breeding & Multiple Utilizat Corps, Natl Sugarcane Engn Technol Res Ctr,Fujian Agr &, Fuzhou, Fujian, Peoples R China.; Ming, R (corresponding author), Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA.; Nagai, C (corresponding author), Hawaii Agr Res Ctr, Kunia, HI 96759 USA.	zjisen@fafu.edu.cn; cnagai@harc-hspa.com; rayming@illinois.edu	Van Sluys, Marie-Anne/A-8483-2012; Schatz, Michael/L-2690-2019; Tang, Haibao/A-6715-2011; Cao, Peijian/U-6776-2019; MA, YAN/HHN-2912-2022; Bowers, John/AAD-7601-2019; Ge, Liangfa/K-2371-2017; Qi, Ruomei/AAA-2835-2021; Wang, Kai/A-2143-2011; Hudson, Matthew E/A-4438-2008; qi, rui/HGU-2541-2022; Yu, Qingyi/E-8899-2019; Souza, Glaucia/E-6780-2012	Van Sluys, Marie-Anne/0000-0002-6506-2734; Schatz, Michael/0000-0002-4118-4446; Tang, Haibao/0000-0002-3460-8570; Ge, Liangfa/0000-0002-4831-4637; Wang, Kai/0000-0002-1074-0438; Hudson, Matthew E/0000-0002-4737-0936; Yu, Qingyi/0000-0001-5393-5764; pandey, neha/0000-0002-9373-9597; Arro, Jie/0000-0003-4179-4559; Bowers, John/0000-0001-5693-2796; Zhang, Xingtan/0000-0002-5207-0882; Yu, Li'ang/0000-0002-9556-011X; Dhungana, Singha/0000-0003-2113-0093; Yang, Xiping/0000-0002-3452-211X; Souza, Glaucia/0000-0001-6903-9913	Fujian Agriculture and Forestry University; International Consortium for Sugarcane Biotechnology [35]; US Department of Energy (DOE) [DE-SC0010686]; European Bioinformatics Institute [BP2012OO2J17]; US National Science Foundation Plant Genome Research Program [IOS-1025976]; 863 program [2013AA102604]; Natural Science Foundation of China [31201260]; Program for New Century Excellent Talents in Fujian Province; Sao Paulo Research Foundation [2008/52146-0, 2012/51062-3, 2014/50921-8, 2008/52074-8]; DOE Center for Advanced Bioenergy and Bioproducts Innovation (US DOE, Office of Science, Office of Biological and Environmental Research) [DE-SC 18420]	Fujian Agriculture and Forestry University; International Consortium for Sugarcane Biotechnology; US Department of Energy (DOE)(United States Department of Energy (DOE)); European Bioinformatics Institute; US National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); 863 program(National High Technology Research and Development Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in Fujian Province(Program for New Century Excellent Talents in University (NCET)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); DOE Center for Advanced Bioenergy and Bioproducts Innovation (US DOE, Office of Science, Office of Biological and Environmental Research)(United States Department of Energy (DOE))	We thank L. McHale for reviewing and commenting on the section on disease resistance genes. This project was supported by a startup fund from Fujian Agriculture and Forestry University to R.M., the International Consortium for Sugarcane Biotechnology (project #35, R.M.), the US Department of Energy (DOE; DE-SC0010686 to R.M.), the European Bioinformatics Institute (BP2012OO2J17 to R.M.), the US National Science Foundation Plant Genome Research Program (grant IOS-1025976 to D.M.B.), the 863 program (2013AA102604 to J.Z.), the Natural Science Foundation of China (31201260 to J.Z.), the Program for New Century Excellent Talents in Fujian Province (J.Z.), and the Sao Paulo Research Foundation (FAPESP; grants 2008/52146-0, 2012/51062-3 and 2014/50921-8 to G.M.S. and 2008/52074-8 to M.-A.V.S.). This work was funded in part by the DOE Center for Advanced Bioenergy and Bioproducts Innovation (US DOE, Office of Science, Office of Biological and Environmental Research under Award Number DE-SC 18420 to M.H. and L.-Q.C.).	Abrusan G, 2009, BIOINFORMATICS, V25, P1329, DOI 10.1093/bioinformatics/btp084; Andrews S., 2010, FASTQC QUALITY CONTR; Avni R, 2017, SCIENCE, V357, P93, DOI 10.1126/science.aan0032; Baker RF, 2016, PLANT PHYSIOL, V172, P1876, DOI 10.1104/pp.16.00884; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Berjak P, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00478, 10.3389/fpls.2013.00177]; Bihmidine S, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2015.1117721; Bihmidine S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0572-8; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BRANDES E. W., 1936, Yearbook of the United States Department of Agriculture, P561; Bredeson JV, 2016, NAT BIOTECHNOL, V34, P562, DOI 10.1038/nbt.3535; Buels R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0924-1; Burton JN, 2013, NAT BIOTECHNOL, V31, P1119, DOI 10.1038/nbt.2727; Casu RE, 2015, PLANT MOL BIOL, V89, P607, DOI 10.1007/s11103-015-0388-9; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Cheng XA, 2010, GENET MOL BIOL, V33, P292, DOI 10.1590/S1415-47572010005000036; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; DHont A, 1996, MOL GEN GENET, V250, P405, DOI [10.1007/BF02174028, 10.1007/s004380050092]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; Eom JS, 2015, CURR OPIN PLANT BIOL, V25, P53, DOI 10.1016/j.pbi.2015.04.005; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fitch M. M. M., 1989, P INT SOC SUGAR CANE, V20, P599; Garsmeur O, 2011, NEW PHYTOL, V189, P629, DOI 10.1111/j.1469-8137.2010.03497.x; Ghurye J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3879-z; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Goudet J., 2001, CLADISTICS; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hardigan MA, 2017, P NATL ACAD SCI USA, V114, pE9999, DOI 10.1073/pnas.1714380114; HATCH MD, 1966, BIOCHEM J, V101, P103, DOI 10.1042/bj1010103; Hoang NV, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3757-8; Julius BT, 2017, PLANT CELL PHYSIOL, V58, P1442, DOI 10.1093/pcp/pcx090; Jung B, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2014.1, 10.1038/NPLANTS.2014.1]; Kim C, 2014, PLANT CELL, V26, P2420, DOI 10.1105/tpc.114.125583; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; KORTSCHAK HP, 1965, PLANT PHYSIOL, V40, P209, DOI 10.1104/pp.40.2.209; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mascher M, 2017, NATURE, V544, P426, DOI 10.1038/nature22043; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ming R, 2001, THEOR APPL GENET, V102, P892, DOI 10.1007/s001220000448; Mintz Sidney W., 1986, SWEETNESS POWER; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Nattestad M, 2016, BIOINFORMATICS, V32, P3021, DOI 10.1093/bioinformatics/btw369; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Ou SJ, 2018, PLANT PHYSIOL, V176, P1410, DOI 10.1104/pp.17.01310; PANJE R. R., 1960, CYTOLOGIA, V25, P152, DOI 10.1508/cytologia.25.152; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Patrick JW, 2013, PLANT BIOTECHNOL J, V11, P142, DOI 10.1111/pbi.12002; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ren Y, 2018, PLANT PHYSIOL, V176, P836, DOI 10.1104/pp.17.01290; Roach BT, 1972, P INT SOC SUGAR CANE, V14, P206; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Said JI, 2015, MOL GENET GENOMICS, V290, P1615, DOI [10.1007/s00438-015-1021-y, 10.1007/s00438-014-0963-9]; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Slewinski TL, 2010, PLANT SCI, V178, P341, DOI 10.1016/j.plantsci.2010.01.010; Smit A, REPEATMASKER OPEN 4; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Swaminathan K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-142; VanBuren R, 2015, NATURE, V527, P508, DOI 10.1038/nature15714; Wang LP, 2008, CROP SCI, V48, P951, DOI 10.2135/cropsci2007.10.0555; Wang L, 2014, NAT BIOTECHNOL, V32, P1158, DOI 10.1038/nbt.3019; Wang XY, 2011, PLANT CELL, V23, P27, DOI 10.1105/tpc.110.080622; Wang YP, 2012, NUCLEIC ACIDS RES, V40, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; Watson Andrew, 2008, AGR INNOVATION EARLY; Williams LE, 2000, TRENDS PLANT SCI, V5, P283, DOI 10.1016/S1360-1385(00)01681-2; Wu GA, 2018, NATURE, V554, P311, DOI 10.1038/nature25447; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xie T, 2015, MOL PLANT, V8, P489, DOI 10.1016/j.molp.2014.12.015; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang JH, 2016, NAT GENET, V48, P1225, DOI 10.1038/ng.3657; Zhang JS, 2012, EUPHYTICA, V185, P511, DOI 10.1007/s10681-012-0664-6	95	260	290	22	111	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2018	50	11					1565	+		10.1038/s41588-018-0237-2	http://dx.doi.org/10.1038/s41588-018-0237-2			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GY2UB	30297971	hybrid, Green Submitted			2022-12-17	WOS:000448398000012
J	Nagel, M; Jansen, PR; Stringer, S; Watanabe, K; de Leeuw, CA; Bryois, J; Savage, JE; Hammerschlag, AR; Skene, NG; Munoz-Manchado, AB; White, T; Tiemeier, H; Linnarsson, S; Hjerling-Leffler, J; Polderman, TJC; Sullivan, PF; van der Sluis, S; Posthuma, D				Nagel, Mats; Jansen, Philip R.; Stringer, Sven; Watanabe, Kyoko; de Leeuw, Christiaan A.; Bryois, Julien; Savage, Jeanne E.; Hammerschlag, Anke R.; Skene, Nathan G.; Munoz-Manchado, Ana B.; White, Tonya; Tiemeier, Henning; Linnarsson, Sten; Hjerling-Leffler, Jens; Polderman, Tinca J. C.; Sullivan, Patrick F.; van der Sluis, Sophie; Posthuma, Danielle		23andMe Res Team	Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways	NATURE GENETICS			English	Article							MAJOR DEPRESSION; RISK; ANNOTATION; EFFICIENT; PLINK; SET	Neuroticism is an important risk factor for psychiatric traits, including depression(1), anxiety(2,3), and schizophrenia(4-6). At the time of analysis, previous genome-wide association studies(7-12) (GWAS) reported 16 genomic loci associated to neuroticism10-12. Here we conducted a large GWAS meta-analysis (n = 449,484) of neuroticism and identified 136 independent genome-wide significant loci (124 new at the time of analysis), which implicate 599 genes. Functional follow- up analyses showed enrichment in several brain regions and involvement of specific cell types, including dopaminergic neuroblasts (P = 3.49 x 10(-8)), medium spiny neurons (P = 4.23 x 10(-8)), and serotonergic neurons (P = 1.37 x 10(-7)). Gene set analyses implicated three specific pathways: neurogenesis (P = 4.43 x 10(-9)), behavioral response to cocaine processes (P = 1.84 x 10(-7)), and axon part (P = 5.26 x 10(-8)). We show that neuroticism's genetic signal partly originates in two genetically distinguishable subclusters(13) ('depressed affect' and 'worry'), suggesting distinct causal mechanisms for subtypes of individuals. Mendelian randomization analysis showed unidirectional and bidirectional effects between neuroticism and multiple psychiatric traits. These results enhance neurobiological understanding of neuroticism and provide specific leads for functional follow-up experiments.	[Nagel, Mats; Jansen, Philip R.; Stringer, Sven; Watanabe, Kyoko; de Leeuw, Christiaan A.; Savage, Jeanne E.; Hammerschlag, Anke R.; Polderman, Tinca J. C.; van der Sluis, Sophie; Posthuma, Danielle] Vrije Univ Amsterdam, Dept Complex Trait Genet, Ctr Neurogen & Cognit Res, Amsterdam Neurosci, Amsterdam, Netherlands; [Nagel, Mats; van der Sluis, Sophie; Posthuma, Danielle] Vrije Univ Amsterdam Med Ctr, Amsterdam Neurosci, Sect Complex Trait Genet, Dept Clin Genet, Amsterdam, Netherlands; [Jansen, Philip R.; White, Tonya; Tiemeier, Henning] Erasmus Univ, Dept Child & Adolescent Psychiat, Med Ctr, Rotterdam, Netherlands; [Bryois, Julien; Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Skene, Nathan G.; Munoz-Manchado, Ana B.; Linnarsson, Sten; Hjerling-Leffler, Jens] Karolinska Inst, Dept Med Biochem & Biophys, Lab Mol Neurobiol, Stockholm, Sweden; [Tiemeier, Henning] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; [Hjerling-Leffler, Jens] UCL Inst Neurol, Queen Sq, London, England; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27515 USA	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Erasmus University Rotterdam; Erasmus MC; Karolinska Institutet; Karolinska Institutet; Harvard University; Harvard T.H. Chan School of Public Health; University of London; University College London; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Posthuma, D (corresponding author), Vrije Univ Amsterdam, Dept Complex Trait Genet, Ctr Neurogen & Cognit Res, Amsterdam Neurosci, Amsterdam, Netherlands.; Posthuma, D (corresponding author), Vrije Univ Amsterdam Med Ctr, Amsterdam Neurosci, Sect Complex Trait Genet, Dept Clin Genet, Amsterdam, Netherlands.	d.posthuma@vu.nl	Linnarsson, Sten/HCH-3909-2022; Tiemeier, Henning/H-6534-2019; White, Tonya/AAU-2226-2021; Manchado, Ana Munoz/AAB-6399-2019; Hjerling Leffler, Jens/E-3775-2012	Tiemeier, Henning/0000-0002-4395-1397; White, Tonya/0000-0003-0271-1896; Skene, Nathan/0000-0002-6807-3180; Savage, Jeanne/0000-0002-2034-8341; Watanabe, Kyoko/0000-0002-3303-8860; Posthuma, Danielle/0000-0001-7582-2365; Jansen, Philip/0000-0003-1550-2444; Alipanahi, Babak/0000-0001-8216-7178; van der Sluis, Sophie/0000-0001-9958-7216; Polderman, Tinca/0000-0001-5564-301X; Munoz Manchado, Ana/0000-0002-1121-6072; Hjerling Leffler, Jens/0000-0002-4539-1776; de Leeuw, Christiaan/0000-0003-1076-9828	Netherlands Organization for Scientific Research [433-09-228, VIDI 452-12-014, NWO VICI 435-13-005, 645-000-003]; Sophia Foundation for Scientific Research (SSWO) [S14-27]; Swedish Research Council (Vetenskapsradet) [2014-3863]; Wellcome Trust [108726/Z/15/Z]; Swedish Brain Foundation (Hjarnfonden); Swiss National Science Foundation; NWO-VICI grant (NWO-ZonMW) [016.VICI.170.200]; Netherlands Scientific Organization (NWO) [480-05-003]; VU University (Amsterdam, The Netherlands); Dutch Brain Foundation	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Sophia Foundation for Scientific Research (SSWO); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Brain Foundation (Hjarnfonden); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NWO-VICI grant (NWO-ZonMW); Netherlands Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); VU University (Amsterdam, The Netherlands)(Netherlands Government); Dutch Brain Foundation	We would like to thank the participants, including the 23andMe customers who consented to participate in research, and the researchers who collected and contributed to the data. This work was funded by the Netherlands Organization for Scientific Research through the following grants: NWO Brain and Cognition 433-09-228 (D.P.), NWO MagW VIDI 452-12-014 (S.v.d.S.), NWO VICI 435-13-005 (D.P.) and 645-000-003) (D.P.). P.R.J. was funded by the Sophia Foundation for Scientific Research (SSWO, grant no. S14-27). J.H.-L. was funded by the Swedish Research Council (Vetenskapsradet, award 2014-3863), StratNeuro, the Wellcome Trust (108726/Z/15/Z), and the Swedish Brain Foundation (Hjarnfonden). N.G.S. was supported by the Wellcome Trust (108726/Z/15/Z). J.B. was funded by the Swiss National Science Foundation. The work of H.T. was supported by a NWO-VICI grant (NWO-ZonMW 016.VICI.170.200). Analyses were carried out on the Genetic Cluster computer, which is financed by the Netherlands Scientific Organization (NWO award 480-05-003 to D.P.), VU University (Amsterdam, The Netherlands), and the Dutch Brain Foundation and is hosted by the Dutch National Computing and Networking Services, SurfSARA. This research has been conducted using the UK Biobank resource (application 16406).	Abraham G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093766; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Bycroft C., 2017, BIORXIV, DOI [DOI 10.1101/16629824, DOI 10.1101/166298]; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Coleman JRI, 2019, MOL PSYCHIATR, V24, P182, DOI 10.1038/s41380-018-0040-6; Costa P. T., 1992, PSYCHOL ASSESSMENT R; Cotto Kelsy C, 2018, Nucleic Acids Res, V46, pD1068, DOI 10.1093/nar/gkx1143; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; de Moor MHM, 2012, MOL PSYCHIATR, V17, P337, DOI 10.1038/mp.2010.128; de Moor MHM, 2015, JAMA PSYCHIAT, V72, P642, DOI 10.1001/jamapsychiatry.2015.0554; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; EYSENCK SBG, 1985, PERS INDIV DIFFER, V6, P21, DOI 10.1016/0191-8869(85)90026-1; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Griffith M, 2013, NAT METHODS, V10, P1209, DOI [10.1038/NMETH.2689, 10.1038/nmeth.2689]; Hayes JF, 2017, JAMA PSYCHIAT, V74, P703, DOI 10.1001/jamapsychiatry.2017.0583; Hettema JM, 2006, AM J PSYCHIAT, V163, P857, DOI 10.1176/appi.ajp.163.5.857; Hyde CL, 2016, NAT GENET, V48, P1031, DOI 10.1038/ng.3623; John O.P., 1999, HDB PERSONALITY THEO, V2, P102; Kendler KS, 2010, PSYCHOL MED, V40, P801, DOI 10.1017/S0033291709991140; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lo MT, 2017, NAT GENET, V49, P152, DOI 10.1038/ng.3736; Luciano M, 2018, NAT GENET, V50, P6, DOI 10.1038/s41588-017-0013-8; Middeldorp C., 2006, BIOL PERS INDIV DIFF, V12, P251; Nagel M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03242-8; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Skene NG, 2018, NAT GENET, V50, P825, DOI 10.1038/s41588-018-0129-5; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smeland OB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02346-3; Smith D. J., 2016, MOL PSYCHIATR, V21, P1; Soto CJ, 2009, J RES PERS, V43, P84, DOI 10.1016/j.jrp.2008.10.002; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Terracciano A, 2010, MOL PSYCHIATR, V15, P647, DOI 10.1038/mp.2008.113; Van Os J, 2001, PSYCHOL MED, V31, P1129, DOI 10.1017/S0033291701004044; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; Webb BT, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00030; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Zhu ZH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02317-2	50	260	262	5	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2018	50	7					920	+		10.1038/s41588-018-0151-7	http://dx.doi.org/10.1038/s41588-018-0151-7			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GL5QU	29942085	Green Published, Green Submitted			2022-12-17	WOS:000437224400006
J	Prickett, TD; Agrawal, NS; Wei, XM; Yates, KE; Lin, JC; Wunderlich, JR; Cronin, JC; Cruz, P; Rosenberg, SA; Samuels, Y				Prickett, Todd D.; Agrawal, Neena S.; Wei, Xiaomu; Yates, Kristin E.; Lin, Jimmy C.; Wunderlich, John R.; Cronin, Julia C.; Cruz, Pedro; Rosenberg, Steven A.; Samuels, Yardena		NISC Comparative Sequencing Progra	Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4	NATURE GENETICS			English	Article							GROWTH-FACTOR RECEPTOR; SOMATIC MUTATIONS; CANCER; INHIBITOR; KINASES; BREAST; ACTIVATION; RESISTANCE; LAPATINIB; PATHWAYS	Tyrosine phosphorylation is important in signaling pathways underlying tumorigenesis. We performed a mutational analysis of the protein tyrosine kinase (PTK) gene family in cutaneous metastatic melanoma. We identified 30 somatic mutations affecting the kinase domains of 19 PTKs and subsequently evaluated the entire coding regions of the genes encoding these 19 PTKs for somatic mutations in 79 melanoma samples. We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas. We examined seven missense mutations in the most commonly altered PTK gene, ERBB4, and found that they resulted in increased kinase activity and transformation ability. Melanoma cells expressing mutant ERBB4 had reduced cell growth after shRNA-mediated knockdown of ERBB4 or treatment with the ERBB inhibitor lapatinib. These studies could lead to personalized therapeutics specifically targeting the kinases that are mutationally altered in individual melanomas.	[Prickett, Todd D.; Agrawal, Neena S.; Wei, Xiaomu; Yates, Kristin E.; Cronin, Julia C.; Samuels, Yardena] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Lin, Jimmy C.] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD USA; [Wunderlich, John R.; Rosenberg, Steven A.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA; [Cruz, Pedro] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [NISC Comparative Sequencing Progra] NHGRI, NIH, Intramural Sequencing Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Samuels, Y (corresponding author), NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA.	samuelsy@mail.nih.gov		Samuels, Yardena/0000-0002-3349-7266	National Human Genome Research Institute; National Cancer Institute; National Institutes of Health, USA; NATIONAL CANCER INSTITUTE [ZIABC010984, ZICBC010905] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200337, ZIBHG000196] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank B. Vogelstein, T. Waldman, D. Bell, P. Meltzer, L. Brody, G. Merlino, S. Gutkind and I. Cardenas-Navia for their helpful comments on the manuscript; members of the NISC Comparative Sequencing Program for generating the sequence data analyzed here; and S. Anderson and M. Kirby for assistance with FACS analysis. This work supported by the Intramural Research Programs of the National Human Genome Research Institute and National Cancer Institute, National Institutes of Health, USA.	Allen LF, 2003, SEMIN ONCOL, V30, P65, DOI 10.1053/j.seminoncol.2003.08.009; Bhangale TR, 2006, NAT GENET, V38, P1457, DOI 10.1038/ng1925; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Chappell DB, 1999, CANCER RES, V59, P59; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Frey MR, 2009, GASTROENTEROLOGY, V136, P217, DOI 10.1053/j.gastro.2008.09.023; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Godin-Heymann N, 2007, CANCER RES, V67, P7319, DOI 10.1158/0008-5472.CAN-06-4625; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grant S, 2002, FRONT BIOSCI-LANDMRK, V7, pD376, DOI 10.2741/grant; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heymach JV, 2006, CLIN CANCER RES, V12, p4441S, DOI 10.1158/1078-0432.CCR-06-0286; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; McHugh LA, 2009, INT J ONCOL, V34, P1155, DOI 10.3892/ijo_00000244; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Riese DJ, 2007, BIOESSAYS, V29, P558, DOI 10.1002/bies.20582; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shih LY, 2004, CLIN CANCER RES, V10, P1326, DOI 10.1158/1078-0432.CCR-0835-03; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solomon DA, 2008, CANCER RES, V68, P10300, DOI 10.1158/0008-5472.CAN-08-3272; Soung YH, 2006, INT J CANCER, V118, P1426, DOI 10.1002/ijc.21507; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Xia WL, 2005, ONCOGENE, V24, P6213, DOI 10.1038/sj.onc.1208774	30	260	271	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1127	U112		10.1038/ng.438	http://dx.doi.org/10.1038/ng.438			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19718025	Green Accepted			2022-12-17	WOS:000270330400018
J	He, CY; Kraft, P; Chen, C; Buring, JE; Pare, G; Hankinson, SE; Chanock, SJ; Ridker, PM; Hunter, DJ; Chasman, DI				He, Chunyan; Kraft, Peter; Chen, Constance; Buring, Julie E.; Pare, Guillaume; Hankinson, Susan E.; Chanock, Stephen J.; Ridker, Paul M.; Hunter, David J.; Chasman, Daniel I.			Genome-wide association studies identify loci associated with age at menarche and age at natural menopause	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; REPRODUCTIVE FACTORS; LINKAGE ANALYSIS; BREAST-CANCER; SCAN; RISK; REPLICATION; PROTEIN; GENES; TWIN	Age at menarche and age at natural menopause are associated with causes of substantial morbidity and mortality such as breast cancer and cardiovascular disease. We conducted a joint analysis of two genome-wide association studies of these two traits in a total of 17,438 women from the Nurses' Health Study (NHS, N = 2,287) and the Women's Genome Health Study (WGHS, N = 15,151). For age at menarche, we identified ten associated SNPs (P = 1 x 10(-7)-3 x 10(-13)) clustered at 6q21 (in or near the gene LIN28B) and 9q31.2 (in an intergenic region). For age at natural menopause, we identified 13 associated SNPs (P = 1 x 10(-7)-1 x 10(-21)) clustered at 20p12.3 (in the gene MCM8), 19q13.42 (in or near the gene BRSK1), 5q35.2 (in or near genes UIMC1 and HK3) and 6p24.2 (in the gene SYCP2L). These newly identified loci might expand understanding of the biological pathways regulating these two traits.	[He, Chunyan; Kraft, Peter; Chen, Constance; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [He, Chunyan; Kraft, Peter; Chen, Constance; Buring, Julie E.; Hankinson, Susan E.; Ridker, Paul M.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Buring, Julie E.; Pare, Guillaume; Ridker, Paul M.; Chasman, Daniel I.] Harvard Univ, Sch Med, Donald W Reynolds Ctr Cardiovasc Res, Boston, MA 02115 USA; [Buring, Julie E.; Pare, Guillaume; Ridker, Paul M.; Chasman, Daniel I.] Harvard Univ, Sch Med, Div Prevent Med, Boston, MA 02115 USA; [Pare, Guillaume; Ridker, Paul M.; Chasman, Daniel I.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; [Hankinson, Susan E.; Hunter, David J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA 02115 USA; [Chanock, Stephen J.; Hunter, David J.] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Hunter, David J.] Harvard & MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	He, CY (corresponding author), Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, 665 Huntington Ave, Boston, MA 02115 USA.	che@hsph.harvard.edu	Pare, Guillaume/T-9631-2018	Pare, Guillaume/0000-0002-6795-4760; Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Heart, Lung, and Blood Institute [HL 043851, HL69757]; National Cancer Institute [CA 047988, CA 40356, U01-CA98233]; Donald W. Reynolds Foundation; Fondation Leducq; NATIONAL CANCER INSTITUTE [R01CA040356, U01CA098233, R37CA040356, R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851, U19HL069757, U01HL069757] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Donald W. Reynolds Foundation; Fondation Leducq(Leducq Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Miletich and A. Parker as well as the technical staff at Amgen for their collaboration and scientific support in performing the genotyping for the WGHS. The NHS GWAS was performed as part of the Cancer Genetic Markers of Susceptibility initiative of the NCI. We particularly acknowledge the contributions of R. Hoover, A. Hutchinson, K. Jacobs and G. Thomas. We thank J. Chen for discussion of gene functions. We thank H. Ranu and P. Soule for assistance. The WGHS is supported by HL 043851 and HL69757 from the National Heart, Lung, and Blood Institute and CA 047988 from the National Cancer Institute, the Donald W. Reynolds Foundation and the Fondation Leducq, with collaborative scientific support and funding for genotyping provided by Amgen. The NHS is supported by CA 40356 and U01-CA98233 from the National Cancer Institute. We acknowledge the study participants in the NHS and the WGHS for their contribution in making this study possible.	Anderson CA, 2008, J CLIN ENDOCR METAB, V93, P3965, DOI 10.1210/jc.2007-2568; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Cui R, 2006, J EPIDEMIOL, V16, P177, DOI 10.2188/jea.16.177; de Bruin JP, 2001, HUM REPROD, V16, P2014, DOI 10.1093/humrep/16.9.2014; Guo Y, 2006, J CLIN ENDOCR METAB, V91, P1009, DOI 10.1210/jc.2005-2179; He LN, 2007, J GENET, V86, P269, DOI 10.1007/s12041-007-0034-7; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hooft L, 2008, CLIN ENDOCRINOL, V68, P252, DOI 10.1111/j.1365-2265.2007.03031.x; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; Kinoshita Y, 2008, MICROSC RES TECHNIQ, V71, P288, DOI 10.1002/jemt.20553; KVALE G, 1992, ACTA ONCOL, V31, P187, DOI 10.3109/02841869209088901; MEYER JM, 1991, AM J MED GENET, V39, P148, DOI 10.1002/ajmg.1320390207; Murabito JM, 2005, FERTIL STERIL, V84, P1674, DOI 10.1016/j.fertnstert.2005.05.046; Murabito JM, 2005, J CLIN ENDOCR METAB, V90, P3427, DOI 10.1210/jc.2005-0181; Paganini-Hill A, 2005, J WOMENS HEALTH, V14, P808, DOI 10.1089/jwh.2005.14.808; Pan F, 2008, HUM GENET, V123, P419, DOI 10.1007/s00439-008-0490-z; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Rothenbuhler A, 2006, J CLIN ENDOCR METAB, V91, P3534, DOI 10.1210/jc.2006-0150; Sharma K, 2002, AM J PHYS ANTHROPOL, V117, P327, DOI 10.1002/ajpa.10055; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Snieder H, 1998, J CLIN ENDOCR METAB, V83, P1875, DOI 10.1210/jc.83.6.1875; van Asselt KM, 2004, AM J HUM GENET, V74, P444, DOI 10.1086/382136; Velde ERT, 2002, HUM REPROD UPDATE, V8, P141, DOI 10.1093/humupd/8.2.141; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Yang F, 2006, J CELL BIOL, V173, P497, DOI 10.1083/jcb.200603063	30	260	271	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					724	728		10.1038/ng.385	http://dx.doi.org/10.1038/ng.385			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19448621	Green Published, Green Accepted			2022-12-17	WOS:000266411700023
J	Dieterich, C; Clifton, SW; Schuster, LN; Chinwalla, A; Delehaunty, K; Dinkelacker, I; Fulton, L; Fulton, R; Godfrey, J; Minx, P; Mitreva, M; Roeseler, W; Tian, H; Witte, H; Yang, SP; Wilson, RK; Sommer, RJ				Dieterich, Christoph; Clifton, Sandra W.; Schuster, Lisa N.; Chinwalla, Asif; Delehaunty, Kimberly; Dinkelacker, Iris; Fulton, Lucinda; Fulton, Robert; Godfrey, Jennifer; Minx, Pat; Mitreva, Makedonka; Roeseler, Waltraud; Tian, Huiyu; Witte, Hanh; Yang, Shiaw-Pyng; Wilson, Richard K.; Sommer, Ralf J.			The Pristionchus pacificus genome provides a unique perspective on nematode lifestyle and parasitism	NATURE GENETICS			English	Article							SEQUENCE; GENE; EVOLUTION; CELLULASES; ORTHOLOGS; FAMILIES; BEETLE	Here we present a draft genome sequence of the nematode Pristionchus pacificus, a species that is associated with beetles and is used as a model system in evolutionary biology. With 169 Mb and 23,500 predicted protein-coding genes, the P. pacificus genome is larger than those of Caenorhabditis elegans and the human parasite Brugia malayi. Compared to C. elegans, the P. pacificus genome has more genes encoding cytochrome P450 enzymes, glucosyltransferases, sulfotransferases and ABC transporters, many of which were experimentally validated. The P. pacificus genome contains genes encoding cellulase and diapausin, and cellulase activity is found in P. pacificus secretions, indicating that cellulases can be found in nematodes beyond plant parasites. The relatively higher number of detoxification and degradation enzymes in P. pacificus is consistent with its necromenic lifestyle and might represent a preadaptation for parasitism. Thus, comparative genomics analysis of three ecologically distinct nematodes offers a unique opportunity to investigate the association between genome structure and lifestyle.	[Clifton, Sandra W.; Chinwalla, Asif; Delehaunty, Kimberly; Fulton, Lucinda; Fulton, Robert; Godfrey, Jennifer; Minx, Pat; Mitreva, Makedonka; Yang, Shiaw-Pyng; Wilson, Richard K.] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; [Dieterich, Christoph; Schuster, Lisa N.; Dinkelacker, Iris; Roeseler, Waltraud; Tian, Huiyu; Witte, Hanh; Sommer, Ralf J.] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany	Washington University (WUSTL); Max Planck Society	Wilson, RK (corresponding author), Washington Univ, Sch Med, Genome Sequencing Ctr, Campus Box 8501,Forest Pk Blvd, St Louis, MO 63108 USA.	rwilson@wustl.edu; ralf.sommer@tuebingen.mpg.de	Dieterich, Christoph/ABF-8459-2021; Wilson, Richard K./AAF-4139-2019	Wilson, Richard K./0000-0002-1992-1358; Chinwalla, Asif/0000-0001-7831-3996; Mitreva, Makedonka/0000-0001-9572-3436	NHGRI NIH HHS [U54 HG003079] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; Allen JE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s9; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; Blaxter M, 2007, CELL HOST MICROBE, V2, P211, DOI 10.1016/j.chom.2007.09.008; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Herrmann M, 2007, ZOOL SCI, V24, P883, DOI 10.2108/zsj.24.883; Hong RL, 2006, BIOESSAYS, V28, P651, DOI 10.1002/bies.20404; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Huang XQ, 2006, NUCLEIC ACIDS RES, V34, P201, DOI 10.1093/nar/gkj419; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Keen NT, 1998, P NATL ACAD SCI USA, V95, P4789, DOI 10.1073/pnas.95.9.4789; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; Kiontke Karin, 2005, P1; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Mayer WE, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-104; Oesch F, 1999, TOXICOLOGY, P83; Poulin R., 2007, EVOL ECOL, DOI 10.1515/9781400840809; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Schlager B, 2006, CURR BIOL, V16, P1386, DOI 10.1016/j.cub.2006.06.058; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Smant G, 1998, P NATL ACAD SCI USA, V95, P4906, DOI 10.1073/pnas.95.9.4906; Sommer RJ, 1996, FUND APPL NEMATOL, V19, P511; Srinivasan J, 2002, GENETICS, V162, P129; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Tanaka H, 2003, PEPTIDES, V24, P1327, DOI 10.1016/j.peptides.2003.07.021; Tian H, 2008, CURR BIOL, V18, P142, DOI 10.1016/j.cub.2007.12.048; Weischer B, 2000, INTRO NEMATODES; Yi BQ, 2007, DEVELOPMENT, V134, P3111, DOI 10.1242/dev.008375; Zheng M, 2005, NAT GENET, V37, P300, DOI 10.1038/ng1512	37	260	265	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2008	40	10					1193	1198		10.1038/ng.227	http://dx.doi.org/10.1038/ng.227			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18806794	Green Accepted			2022-12-17	WOS:000259651000018
J	Jones, B; Jones, EL; Bonney, SA; Patel, HN; Mensenkamp, AR; Eichenbaum-Voline, S; Rudling, M; Myrdal, U; Annesi, G; Naik, S; Meadovvs, N; Quattrone, A; Islam, SA; Naoumova, RP; Angelin, B; Infante, R; Levy, E; Roy, CC; Freemont, PS; Scott, J; Shoulders, CC				Jones, B; Jones, EL; Bonney, SA; Patel, HN; Mensenkamp, AR; Eichenbaum-Voline, S; Rudling, M; Myrdal, U; Annesi, G; Naik, S; Meadovvs, N; Quattrone, A; Islam, SA; Naoumova, RP; Angelin, B; Infante, R; Levy, E; Roy, CC; Freemont, PS; Scott, J; Shoulders, CC			Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders	NATURE GENETICS			English	Article							CHYLOMICRON RETENTION DISEASE; ENDOPLASMIC-RETICULUM; ANDERSONS-DISEASE; APOPROTEIN-B; TRANSPORT; PROTEINS; COAT; BINDING; EXPORT	Dietary fat is an important source of nutrition. Here we identify eight mutations in SARA2 that are associated with three severe disorders of fat malabsorption. The Sar1 family of proteins initiates the intracellular transport of proteins in COPII (coat protein)-coated vesicles. Our data suggest that chylomicrons, which vastly exceed the size of typical COPII vesicles, are selectively recruited by the COPII machinery for transport through the secretory pathways of the cell.	Univ London Imperial Coll Sci Technol & Med, Genom & Mol Med Grp, MRC, Ctr Clin Sci, London, England; Huddinge Univ Hosp, Ctr Metab & Endocrinol, Karolinska Inst, Stockholm, Sweden; Huddinge Univ Hosp, Ctr Nutr & Toxicol, Karolinska Inst, Stockholm, Sweden; Cent Hosp Vasteras, Dept Paediat, Vasteras, Sweden; CNR, Inst Neurol Sci, Piano Lago Of Mangone, Consenza, Italy; Barts & London, Dept Adult & Paediat Gastroenterol, Queen Marys Sch Med & Dent, London, England; Univ London Imperial Coll Sci Technol & Med, Struct Bioinformat Grp, London, England; INSERM, Ctr Rech, Paris 12, France; Univ Montreal, Ctr Rech, Hop St Justine, Montreal, PQ H3C 3J7, Canada; Univ London Imperial Coll Sci Technol & Med, Ctr Struct Biol, Dept Sci Biol, London, England; Univ London Imperial Coll Sci Technol & Med, Genet & Genom Res Inst, London, England	Imperial College London; Karolinska Institutet; Karolinska Institutet; Vasteras Central Hospital; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Neurologiche (ISN-CNR); University of London; Queen Mary University London; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montreal; Imperial College London; University of London; Institute of Cancer Research - UK; Imperial College London	Scott, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Genom & Mol Med Grp, MRC, Ctr Clin Sci, London, England.		Annesi, Grazia/AAX-5732-2020; Mensenkamp, Arjen/L-4520-2015; QUATTRONE, Aldo/A-6734-2016	Mensenkamp, Arjen/0000-0003-3805-877X; QUATTRONE, Aldo/0000-0003-2001-957X; Freemont, Paul/0000-0002-5658-8486				Aguglia U, 2000, ANN NEUROL, V47, P260, DOI 10.1002/1531-8249(200002)47:2<260::AID-ANA21>3.3.CO;2-M; Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; BOUMA ME, 1986, J CLIN INVEST, V78, P398, DOI 10.1172/JCI112590; Dannoura AH, 1999, ARTERIOSCL THROM VAS, V19, P2494, DOI 10.1161/01.ATV.19.10.2494; Huang MD, 2001, J CELL BIOL, V155, P937, DOI 10.1083/jcb.200106039; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; NEMETH A, 1995, EUR J CLIN INVEST, V25, P271, DOI 10.1111/j.1365-2362.1995.tb01559.x; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; ROY CC, 1987, GASTROENTEROLOGY, V92, P390, DOI 10.1016/0016-5085(87)90133-8; Saito Y, 1998, J BIOCHEM-TOKYO, V124, P816, DOI 10.1093/oxfordjournals.jbchem.a022185; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153	15	260	266	2	21	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2003	34	1					29	31		10.1038/ng1145	http://dx.doi.org/10.1038/ng1145			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12692552				2022-12-17	WOS:000182667900012
J	Kikuchi, S; Hata, M; Fukumoto, K; Yamane, Y; Matsui, T; Tamura, A; Yonemura, S; Yamagishi, H; Keppler, D; Tsukita, S; Tsukita, S				Kikuchi, S; Hata, M; Fukumoto, K; Yamane, Y; Matsui, T; Tamura, A; Yonemura, S; Yamagishi, H; Keppler, D; Tsukita, S; Tsukita, S			Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes	NATURE GENETICS			English	Article							MULTIDRUG-RESISTANCE PROTEIN; DUBIN-JOHNSON-SYNDROME; EZRIN/RADIXIN/MOESIN ERM PROTEINS; EXPORT PUMP; CELL-ADHESION; DRUG-RESISTANCE; CDNA CLONING; GENE; MOESIN; FAMILY	The ezrin-radixin-moesin (ERM) family of proteins crosslink actin filaments and integral membrane proteins(1-3). Radixin (encoded by Rdx) is the dominant ERM protein in the liver of wildtype mice(4,5) and is concentrated at bile canalicular membranes (BCMs)(5). Here we show that Rdx(-/-) mice are normal at birth, but their serum concentrations of conjugated bilirubin begin to increase gradually around 4 weeks, and they show mild liver injury after 8 weeks. This phenotype is similar to human conjugated hyperbilirubinemia in Dubin-Johnson syndrome(6,7), which is caused by mutations in the multidrug resistance protein 2 (MRP2, gene symbol ABCC2)(8-11), although this syndrome is not associated with overt liver injury. In wildtype mice, Mrp2 concentrates at BCMs to secrete conjugated bilirubin into bile(8,11,12). In the BCMs of Rdx(-/-) mice, Mrp2 is decreased compared with other BCM proteins such as dipeptidyl peptidase IV (CD26) and P-glycoproteins. In vitro binding studies show that radixin associates directly with the carboxy-terminal cytoplasmic domain of human MRP2. These findings indicate that radixin is required for secretion of conjugated bilirubin through its support of Mrp2 localization at BCMs.	Kyoto Univ, Fac Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Prefectural Univ Med, Dept Surg, Kamigyo Ku, Kyoto 6028566, Japan; KAN Res Inst, Shimogyo Ku, Kyoto 6008815, Japan; RIKEN, Ctr Dev Biol, Lab Cellular Morphogenesis, Chuo Ku, Kobe, Hyogo 6500047, Japan; Deutsch Krebsforschungszentrum, Div Tumor Biochem, D-69120 Heidelberg, Germany; Kyoto Univ, Coll Med Technol, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University; Kyoto Prefectural University of Medicine; KAN Research Institute; RIKEN; Helmholtz Association; German Cancer Research Center (DKFZ); Kyoto University	Tsukita, S (corresponding author), Kyoto Univ, Fac Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan.	atsukita@mfour.med.kyoto-u.ac.jp	Keppler, Dietrich/A-5528-2013	Keppler, Dietrich/0000-0003-2964-2333; Kikuchi, Shojiro/0000-0002-6217-8352				Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Buchler M, 1996, J BIOL CHEM, V271, P15091; CHILDS S, 1995, CANCER RES, V55, P2029; Cui YH, 1999, MOL PHARMACOL, V55, P929; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Doi Y, 1999, J BIOL CHEM, V274, P2315, DOI 10.1074/jbc.274.4.2315; DUBIN IN, 1954, MEDICINE, V33, P155, DOI 10.1097/00005792-195409000-00001; Fouassier L, 2001, HEPATOLOGY, V33, P166, DOI 10.1053/jhep.2001.21143; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; ITOH M, 1993, J CELL BIOL, V121, P491, DOI 10.1083/jcb.121.3.491; Kartenbeck J, 1996, HEPATOLOGY, V23, P1061; Keitel V, 2000, HEPATOLOGY, V32, P1317, DOI 10.1053/jhep.2000.19791; Kocher O, 1999, LAB INVEST, V79, P1161; Kondo T, 1997, J CELL BIOL, V139, P749, DOI 10.1083/jcb.139.3.749; Konig J, 1999, BBA-BIOMEMBRANES, V1461, P377, DOI 10.1016/S0005-2736(99)00169-8; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Nies AT, 2002, EUR J BIOCHEM, V269, P1866, DOI 10.1046/j.1432-1033.2002.02832.x; Nies AT, 1998, HEPATOLOGY, V28, P1332, DOI 10.1002/hep.510280523; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Paulusma CC, 1997, HEPATOLOGY, V25, P1539, DOI 10.1002/hep.510250635; Paulusma CC, 1996, SCIENCE, V271, P1126, DOI 10.1126/science.271.5252.1126; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; SATO N, 1992, J CELL SCI, V103, P131; SPRINZ H, 1954, ANN INTERN MED, V41, P952, DOI 10.7326/0003-4819-41-5-952; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885	30	260	269	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2002	31	3					320	325		10.1038/ng905	http://dx.doi.org/10.1038/ng905			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12068294				2022-12-17	WOS:000176494100024
J	Pailhoux, E; Vigier, B; Chaffaux, S; Servel, N; Taourit, S; Furet, JP; Fellous, M; Grosclaude, F; Cribiu, EP; Cotinot, C; Vaiman, D				Pailhoux, E; Vigier, B; Chaffaux, S; Servel, N; Taourit, S; Furet, JP; Fellous, M; Grosclaude, F; Cribiu, EP; Cotinot, C; Vaiman, D			A 11.7-kb deletion triggers intersexuality and polledness in goats	NATURE GENETICS			English	Article							MAMMALIAN SEX DETERMINATION; SRY; BLEPHAROPHIMOSIS; PTOSIS; REGION; MAP; IDENTIFICATION; TRANSLOCATION; DEFINITION; REVERSAL	Mammalian sex determination is governed by the presence of the sex determining region Y gene (SRY) on the Y chromosome(1). Familial cases of SRY-negative XX sex reversal are rare in humans, often hampering the discovery of new sex-determining genes(2,3). The mouse model is also insufficient to correctly apprehend the sex-determination cascade, as the human pathway is much more sensitive to gene dosage(4-6). Other species might therefore be considered in this respect(7). In goats, the polled intersex syndrome (PIS) mutation associates polledness and intersexuality(8,9). The sex reversal affects exclusively the XX individuals in a recessive manner, whereas the absence of horns is dominant in both sexes. The syndrome is caused by an autosomal gene located at chromosome band 1q43 (ref. 9), shown to be homologous to human chromosome band 3q23 (ref. 10). Through a positional cloning approach, we demonstrate that the mutation underlying PIS is the deletion of a critical 11.7-kb DNA element containing mainly repetitive sequences. This deletion affects the transcription of at least two genes: PISRT1, encoding a 1.5-kb mRNA devoid of open reading frame (ORF), and FOXL2, recently shown to be responsible for blepharophimosis ptosis epicanthus inversus syndrome (BPES) in humans(11). These two genes are located 20 and 200 kb telomeric from the deletion, respectively.	INRA, Ctr Rech, Lab Genet Biochim & Cytogenet, Dept Genet Anim, F-78352 Jouy En Josas, France; INRA, Ctr Rech, Dept Anim Physiol, Lab Biol Dev & Biotechnol, F-78352 Jouy En Josas, France; Inst Pasteur, Human Immunogenet Lab, F-75015 Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Vaiman, D (corresponding author), INRA, Ctr Rech, Lab Genet Biochim & Cytogenet, Dept Genet Anim, F-78352 Jouy En Josas, France.		Vaiman, Daniel/O-6030-2015	Vaiman, Daniel/0000-0002-1915-0717; Servel, Nathalie/0000-0001-6925-6256				AASEN E, 1990, BIO-TECHNOL, V8, P1279, DOI 10.1038/nbt1290-1279; Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; Asdell S. A., 1944, SCIENCE, V99, P124, DOI 10.1126/science.99.2563.124; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; De Baere E, 2000, GENOMICS, V68, P296, DOI 10.1006/geno.2000.6304; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GIESE K, 1994, P NATL ACAD SCI USA, V91, P3368, DOI 10.1073/pnas.91.8.3368; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Koopman P, 1999, CELL MOL LIFE SCI, V55, P839; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; KROB G, 1994, EUR J PEDIATR, V153, P2, DOI 10.1007/s004310050077; LAWSON CT, 1995, HUM MOL GENET, V4, P963, DOI 10.1093/hmg/4.5.963; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; MCELREAVEY K, 1993, P NATL ACAD SCI USA, V90, P3368, DOI 10.1073/pnas.90.8.3368; Praphanphoj V, 2000, GENOMICS, V65, P67, DOI 10.1006/geno.2000.6157; Schibler L, 2000, GENOME RES, V10, P311, DOI 10.1101/gr.10.3.311; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Vaiman D, 2000, TRENDS GENET, V16, P488, DOI 10.1016/S0168-9525(00)02126-0; Vaiman D, 1996, MAMM GENOME, V7, P133, DOI 10.1007/s003359900033; Vaiman D, 1996, GENETICS, V144, P279; Vaiman D, 1999, GENOMICS, V56, P31, DOI 10.1006/geno.1998.5691	22	260	270	0	29	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					453	458		10.1038/ng769	http://dx.doi.org/10.1038/ng769			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11726932				2022-12-17	WOS:000172507500022
J	Nanda, I; Shan, ZH; Schartl, M; Burt, DW; Koehler, M; Nothwang, HG; Grutzner, F; Paton, IR; Windsor, D; Dunn, I; Engel, W; Staeheli, P; Mizuno, S; Haaf, T; Schmid, M				Nanda, I; Shan, ZH; Schartl, M; Burt, DW; Koehler, M; Nothwang, HG; Grutzner, F; Paton, IR; Windsor, D; Dunn, I; Engel, W; Staeheli, P; Mizuno, S; Haaf, T; Schmid, M			300 million years of conserved synteny between chicken Z and human chromosome 9	NATURE GENETICS			English	Letter							MAMMALS; GENE		Univ Wurzburg, Bioctr, Dept Human Genet, D-97074 Wurzburg, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Univ Wurzburg, Dept Physiol Chem 1, Bioctr, Wurzburg, Germany; Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; Univ Gottingen, Dept Human Genet, D-3400 Gottingen, Germany; Univ Freiburg, Dept Virol, D-79008 Freiburg, Germany; Tohoku Univ, Dept Appl Biol Chem, Sendai, Miyagi 981, Japan	University of Wurzburg; Max Planck Society; University of Wurzburg; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Gottingen; University of Freiburg; Tohoku University	Nanda, I (corresponding author), Univ Wurzburg, Bioctr, Dept Human Genet, D-97074 Wurzburg, Germany.		Burt, David W/C-7802-2013; Nothwang, Hans G/C-5847-2011; Grutzner, Frank/ABB-2820-2021; Grutzner, Frank/AAD-5834-2020; Dunn, Ian/C-7689-2013	Burt, David W/0000-0002-9991-1028; Grutzner, Frank/0000-0002-3088-7314; Nothwang, Hans Gerd/0000-0001-7695-6437; Dunn, Ian/0000-0003-3630-0120; Schartl, Manfred/0000-0001-9882-5948				Andersson L, 1996, MAMM GENOME, V7, P717, DOI 10.1007/s003359900222; BUJO H, 1995, P NATL ACAD SCI USA, V92, P9905, DOI 10.1073/pnas.92.21.9905; Bull J.J., 1983, EVOLUTION SEX DETERM; BURT DW, 1995, TRENDS GENET, V11, P190, DOI 10.1016/S0168-9525(00)89042-3; Flejter WL, 1998, AM J HUM GENET, V63, P794, DOI 10.1086/302016; Fridolfsson AK, 1998, P NATL ACAD SCI USA, V95, P8147, DOI 10.1073/pnas.95.14.8147; GOODFELLOW PN, 1993, ANNU REV GENET, V27, P71, DOI 10.1146/annurev.ge.27.120193.000443; Guioli S, 1998, AM J HUM GENET, V63, P905, DOI 10.1086/302017; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kunita R, 1997, DIFFERENTIATION, V62, P63, DOI 10.1046/j.1432-0436.1997.6220063.x; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990; Nanda I, 1998, CHROMOSOMA, V107, P204, DOI 10.1007/s004120050298; OBRIEN SJ, 1993, NAT GENET, V3, P103, DOI 10.1038/ng0293-103; Ohno S., 1967, SEX CHROMOSOMES SEX; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618	15	260	290	2	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1999	21	3					258	259		10.1038/6769	http://dx.doi.org/10.1038/6769			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173JR	10080173				2022-12-17	WOS:000078977900014
J	de Winter, JP; Waisfisz, Q; Rooimans, MA; van Berkel, CGM; Bosnoyan-Collins, L; Alon, N; Carreau, M; Bender, O; Demuth, I; Schindler, D; Pronk, JC; Arwert, F; Hoehn, H; Digweed, M; Buchwald, M; Joenje, H				de Winter, JP; Waisfisz, Q; Rooimans, MA; van Berkel, CGM; Bosnoyan-Collins, L; Alon, N; Carreau, M; Bender, O; Demuth, I; Schindler, D; Pronk, JC; Arwert, F; Hoehn, H; Digweed, M; Buchwald, M; Joenje, H			The Fanconi anaemia group G gene FANCG is identical with XRCC9	NATURE GENETICS			English	Article							CHROMOSOMAL INSTABILITY; ANEMIA GENES; COMPLEMENTATION; SUSCEPTIBILITY; SENSITIVITY; UV40; MICE; FAA	Fanconi anemia (FA) is an autosomal recessive disease with diverse clinical symptoms including developmental anomalies, bone marrow failure and early occurrence of malignancies'. In addition to spontaneous chromosome instability, FA cells exhibit cell cycle disturbances and hypersensitivity to crosslinking agents(1). Eight complementation groups (A-H) have been distinguished(2), each group possibly representing a distinct FA gene(3). The genes mutated in patients of complementation groups A (FANCA; refs 4,5) and C (FANCC; ref. 6) have been identified, and FANCD has been mapped to chromosome band 3p22-26 (ref. 7). An additional FA gene has recently been mapped to chromosome 9p (ref. 8). Here we report the identification of the gene mutated in group G, FANCG, on the basis of complementation of an FA-G cell line and the presence of pathogenic mutations in four FA-C patients. We identified the gene as human XRCC9, a gene which has been shown to complement the MMC-sensitive Chinese hamster mutant UV40, and is suspected to be involved in DNA post-replication repair or cell cycle checkpoint control(9,10). The gene is localized to chromosome band 9p13 (ref. 9), corresponding with a known localization of an FA gene.	Free Univ Amsterdam, Dept Human Genet, NL-1081 BT Amsterdam, Netherlands; Hosp Sick Children, Program Genet & Genomic Biol, Res Inst, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Humboldt Univ, Inst Human Genet, D-13353 Berlin, Germany; Univ Wurzburg, Inst Human Genet, D-8700 Wurzburg, Germany	Vrije Universiteit Amsterdam; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Humboldt University of Berlin; University of Wurzburg	Joenje, H (corresponding author), Free Univ Amsterdam, Dept Human Genet, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	h.joenje.humgen@med.vu.nl	Demuth, Ilja/ABD-5352-2021	Demuth, Ilja/0000-0002-4340-2523; Carreau, Madeleine/0000-0002-0582-6114; Waisfisz, Quinten/0000-0002-7384-9182	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050131] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL50131] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Apostolou S, 1996, NAT GENET, V14, P324, DOI 10.1038/ng1196-324; AUERBACH AD, 1998, GENETIC BASIS HUMAN, P317; Auerbach Arleen D., 1997, Current Opinion in Pediatrics, V9, P600, DOI 10.1097/00008480-199712000-00010; BUCHWALD M, 1995, NAT GENET, V11, P228, DOI 10.1038/ng1195-228; Busch DB, 1996, MUTAT RES-DNA REPAIR, V363, P209, DOI 10.1016/0921-8777(96)00014-6; Carreau M, 1998, MOL MED TODAY, V4, P201, DOI 10.1016/S1357-4310(98)01243-X; Chen M, 1996, NAT GENET, V12, P448, DOI 10.1038/ng0496-448; Hoatlin ME, 1998, BLOOD, V91, P1418, DOI 10.1182/blood.V91.4.1418; ISHIDA R, 1982, CANCER RES, V42, P4000; JOENJE H, 1995, BLOOD, V86, P2156, DOI 10.1182/blood.V86.6.2156.bloodjournal8662156; Joenje H, 1997, AM J HUM GENET, V61, P940, DOI 10.1086/514881; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Kupfer GM, 1997, NAT GENET, V17, P487, DOI 10.1038/ng1297-487; Levran O, 1997, P NATL ACAD SCI USA, V94, P13051, DOI 10.1073/pnas.94.24.13051; Liu N, 1997, P NATL ACAD SCI USA, V94, P9232, DOI 10.1073/pnas.94.17.9232; LoTenFoe JR, 1996, NAT GENET, V14, P320, DOI 10.1038/ng1196-320; MOSHELL AN, 1981, IN VITRO CELL DEV B, V17, P299; Saar K, 1998, EUR J HUM GENET, V6, P501, DOI 10.1038/sj.ejhg.5200241; SAVOV A, 1992, NUCLEIC ACIDS RES, V20, P6741, DOI 10.1093/nar/20.24.6741; SCHINDLER D, 1988, AM J HUM GENET, V43, P429; SEYSCHAB H, 1995, BLOOD, V85, P2233, DOI 10.1182/blood.V85.8.2233.bloodjournal8582233; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; WHITNEY M, 1995, NAT GENET, V11, P341, DOI 10.1038/ng1195-341; Whitney MA, 1996, BLOOD, V88, P49	25	260	265	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1998	20	3					281	283		10.1038/3093	http://dx.doi.org/10.1038/3093			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	9806548				2022-12-17	WOS:000076698100023
J	Belin, V; Cusin, V; Viot, G; Girlich, D; Toutain, A; Moncla, A; Vekemans, M; Le Merrer, M; Munnich, A; Cormier-Daire, V				Belin, V; Cusin, V; Viot, G; Girlich, D; Toutain, A; Moncla, A; Vekemans, M; Le Merrer, M; Munnich, A; Cormier-Daire, V			SHOX mutations in dyschondrosteosis (Leri-Weill syndrome)	NATURE GENETICS			English	Article							LOCI; MAP	Dyschondrosteosis(1) (DCS) is an autosomal dominant(2) form of mesomelic dysplasia with deformity of the forearm (Madelung deformity; ref. 3). Based on the observation of XY translocations (p22,q12; refs 4-6) in DCS patients, we tested the pseudoautosomal region in eight families with DCS and showed linkage of the DCS gene to a microsatellite DNA marker at the DXYS233 locus (Zmax=6.26 at theta=0). The short stature homeobox-containing gene(7,8) (SHOX), involved in idiopathic growth retardation and possibly Turner short stature, maps to this region and was therefore regarded as a strong candidate gene in DCS. Here, we report large-scale deletions tin seven families) and a nonsense mutation tin one family) of SHOX in patients with DCS and show that Langer mesomelic dwarfism(9) results from homozygous mutations at the DCS locus.	Hop Enfants Malad, INSERM U393, Dept Genet, Paris, France; Hop Enfants Malad, INSERM U393, Unite Rech Handicaps Genet Enfant, Paris, France; Hop Clocheville, Serv Genet, Tours, France; Hop Enfants La Timone, Dept Genet, Marseille, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Munnich, A (corresponding author), Hop Enfants Malad, INSERM U393, Dept Genet, Paris, France.		cormier-daire, valerie/H-6520-2017	cormier-daire, valerie/0000-0002-2839-9856; Girlich, Delphine/0000-0002-7698-2798; Toutain, Annick/0000-0002-5999-5300				BALLABIO A, 1989, P NATL ACAD SCI USA, V86, P10001, DOI 10.1073/pnas.86.24.10001; CASTILLO S, 1985, CYTOGENET CELL GENET, V40, P601; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Ellison JW, 1997, HUM MOL GENET, V6, P1341, DOI 10.1093/hmg/6.8.1341; ESPERITU C, 1975, AM J DIS CHILD, V129, P375; Guichet A, 1997, CLIN DYSMORPHOL, V6, P341, DOI 10.1097/00019605-199710000-00007; LERI A, 1929, B MEM SOC MED HOP P, V35, P1491; LICHTENSTEIN JR, 1980, J MED GENET, V17, P41, DOI 10.1136/jmg.17.1.41; Madelung V, 1878, ARCH KLIN CHIR, V23, P395; OGATA T, 1992, J MED GENET, V29, P624, DOI 10.1136/jmg.29.9.624; PFEIFFER RA, 1980, CYTOGENET CELL GENET, V26, P150, DOI 10.1159/000131436; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; TOUTAIN A, 1991, ANN PEDIATR-PARIS, V38, P37	14	260	267	2	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1998	19	1					67	69		10.1038/ng0198-67	http://dx.doi.org/10.1038/ng0198-67			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590292				2022-12-17	WOS:000073346700020
J	Bullido, MJ; Artiga, MJ; Recuero, M; Sastre, I; Garcia, MA; Aldudo, J; Lendon, C; Han, SW; Morris, JC; Frank, A; Vazquez, J; Goate, A; Valdivieso, F				Bullido, MJ; Artiga, MJ; Recuero, M; Sastre, I; Garcia, MA; Aldudo, J; Lendon, C; Han, SW; Morris, JC; Frank, A; Vazquez, J; Goate, A; Valdivieso, F			A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia	NATURE GENETICS			English	Article							APOLIPOPROTEIN-E; TYPE-4 ALLELE; DISEASE; FREQUENCY; RNA	The epsilon 4 allele of the apolipoprotein E gene (APOE) has been associated with an increased risk of developing Alzheimer's disease (AD; refs 1,2). However, it is apparent that the APOE epsilon 4 allele alone is neither necessary nor sufficient to cause the disease(3-5). We have recently found three new polymorphisms within the APOE transcriptional regulatory region (M.J.A. et al., manuscript submitted) and now establish an association between one of these polymorphisms (-491A/T) and dementia as observed in Cases Alzheimer's disease, in two independent clinical populations. The results suggest that homozygosity of a common variant (-491A) is associated with increased risk for AD, and that this association is independent of APOE epsilon 4 status. In vitro studies suggest that the -491A/T polymorphism may increase risk for AD by altering the level of ApoE protein expression.	Univ Autonoma Madrid, Dept Biol Mol, E-28049 Madrid, Spain; Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol & Genet, St Louis, MO 63110 USA; Univ Autonoma Madrid, Hosp La Paz, Serv Neurol, Madrid 28034, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Washington University (WUSTL); Washington University (WUSTL); Autonomous University of Madrid; Hospital Universitario La Paz	Valdivieso, F (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, E-28049 Madrid, Spain.	fvaldivieso@cbm.uam.es	Morris, John C/A-1686-2012; Vazquez, Jesus/B-7697-2015; García, Ana Frank/I-5159-2015; Bullido, maria j/C-8509-2014	Vazquez, Jesus/0000-0003-1461-5092; García, Ana Frank/0000-0003-3858-9116; Bullido, maria j/0000-0002-6477-1117; Aldudo, Jesus/0000-0002-7098-4709; Goate, Alison/0000-0002-0576-2472	NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER; NIA NIH HHS [AG05681, AG00634] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BENNETT C, 1995, AM J MED GENET, V60, P1, DOI 10.1002/ajmg.1320600102; Berg Leonard, 1994, P9; Blesa R, 1996, ANN NEUROL, V39, P548, DOI 10.1002/ana.410390419; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Garcia MA, 1996, J NEUROSCI, V16, P7550; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HIXSON JE, 1990, J LIPID RES, V31, P545; Lambert JC, 1997, HUM MOL GENET, V6, P2151, DOI 10.1093/hmg/6.12.2151; Lendon CL, 1997, NEUROSCI LETT, V222, P187, DOI 10.1016/S0304-3940(97)13381-X; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; MORRIS JA, 1988, BRIT MED J, V296, P1313, DOI 10.1136/bmj.296.6632.1313; Muros M, 1996, ATHEROSCLEROSIS, V121, P13, DOI 10.1016/0021-9150(95)06643-8; PAYAMI H, 1993, LANCET, V342, P738; Relkin NR, 1996, LANCET, V347, P1091, DOI 10.1016/S0140-6736(96)90284-6; SANTANA MA, 1996, J NEUROL S2, V243, P591; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Taddei K, 1997, NEUROSCI LETT, V223, P29, DOI 10.1016/S0304-3940(97)13394-8; YAMADA T, 1995, J NEUROL SCI, V129, P56, DOI 10.1016/0022-510X(94)00249-N	20	260	268	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1998	18	1					69	71		10.1038/ng0198-69	http://dx.doi.org/10.1038/ng0198-69			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425904				2022-12-17	WOS:000071259600025
J	Gao, RL; Davis, A; McDonald, TO; Sei, E; Shi, XQ; Wang, Y; Tsai, PC; Casasent, A; Waters, J; Zhang, H; Meric-Bernstam, F; Michor, F; Navin, NE				Gao, Ruli; Davis, Alexander; McDonald, Thomas O.; Sei, Emi; Shi, Xiuqing; Wang, Yong; Tsai, Pei-Ching; Casasent, Anna; Waters, Jill; Zhang, Hong; Meric-Bernstam, Funda; Michor, Franziska; Navin, Nicholas E.			Punctuated copy number evolution and clonal stasis in triple-negative breast cancer	NATURE GENETICS			English	Article							TUMOR EVOLUTION; SINGLE; REARRANGEMENT; CHEMOTHERAPY; INSTABILITY; MODEL	Aneuploidy is a hallmark of breast cancer; however, knowledge of how these complex genomic rearrangements evolve during tumorigenesis is limited. In this study, we developed a highly multiplexed single-nucleus sequencing method to investigate copy number evolution in patients with triple-negative breast cancer. We sequenced 1,000 single cells from tumors in 12 patients and identified 1-3 major clonal subpopulations in each tumor that shared a common evolutionary lineage. For each tumor, we also identified a minor subpopulation of non-clonal cells that were classified as metastable, pseudodiploid or chromazemic. Phylogenetic analysis and mathematical modeling suggest that these data are unlikely to be explained by the gradual accumulation of copy number events over time. In contrast, our data challenge the paradigm of gradual evolution, showing. that the majority of copy number aberrations are acquired at the earliest stages of tumor evolution, in short punctuated bursts, followed by stable clonal expansions that form the tumor mass.	[Gao, Ruli; Davis, Alexander; Sei, Emi; Wang, Yong; Tsai, Pei-Ching; Casasent, Anna; Waters, Jill; Navin, Nicholas E.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Davis, Alexander; Casasent, Anna; Navin, Nicholas E.] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [McDonald, Thomas O.; Michor, Franziska] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [McDonald, Thomas O.; Michor, Franziska] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Shi, Xiuqing] Chinese Acad Med Sci, Peking Union Med Coll, Dept Med Oncol, Canc Hosp & Inst, Beijing, Peoples R China; [Zhang, Hong] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Meric-Bernstam, Funda] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Navin, Nicholas E.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Navin, NE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.; Navin, NE (corresponding author), Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA.; Navin, NE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA.	nnavin@mdanderson.org		Casasent, Anna/0000-0002-7857-179X; Davis, Alexander/0000-0002-1797-2303; Gao, Ruli/0000-0002-1137-4564	Lefkofsky Family Foundation; NCI [1RO1CA169244-01]; American Cancer Society [129098-RSG-16-092-01-TBG]; Moonshot Knowledge Gap Award; Center for Genetics and Genomics; NIH [CA016672, UL1TR000371]; Rosalie B. Hite Fellowship; Center for Genetics and Genomics Postdoctoral Fellowship; Nellie B. Connally Breast Cancer Research Endowment; Susan Komen [SAC10006]; CPRIT [RP110584]; M.D. Anderson Cancer Center Support grant (NIH/NCI) [P30CA016672]; Dana-Farber Cancer Institute Physical Science Oncology Center [U54CA193461-01]; NATIONAL CANCER INSTITUTE [U54CA193461, R21CA174397, P30CA016672, R01CA169244] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	Lefkofsky Family Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Moonshot Knowledge Gap Award; Center for Genetics and Genomics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosalie B. Hite Fellowship; Center for Genetics and Genomics Postdoctoral Fellowship; Nellie B. Connally Breast Cancer Research Endowment; Susan Komen(Susan G. Komen Breast Cancer Foundation); CPRIT; M.D. Anderson Cancer Center Support grant (NIH/NCI); Dana-Farber Cancer Institute Physical Science Oncology Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank M. Edgerton, J. Kendall, M. Wigler and J. Hicks for their support and discussions. We are also very grateful to the patients with breast cancer at M.D. Anderson for generously donating their tumor tissues to our research studies. This work was supported by a grant from the Lefkofsky Family Foundation. N.E.N. is a Nadia's Gift Foundation Damon Runyon-Rachleff Innovator (DRR-25-13). This work is also supported by grants to N.E.N. from the NCI (1RO1CA169244-01) and the American Cancer Society (129098-RSG-16-092-01-TBG). N.E.N. is a T.C. Hsu Endowed Scholar, an AAAS Wachtel Scholar and an Andrew Sabin Family Fellow. The study is also supported by the Moonshot Knowledge Gap Award and the Center for Genetics and Genomics. This study was supported by the M.D. Anderson Sequencing Core Facility grant (CA016672) and the Flow Cytometry Facility grant (CA016672) from the NIH. Additional funding support includes the Rosalie B. Hite Fellowship (A.C.); a Center for Genetics and Genomics Postdoctoral Fellowship (R.G.); NIH UL1TR000371 (F.M.-B.); the Nellie B. Connally Breast Cancer Research Endowment (F.M.-B.), Susan Komen SAC10006 (F.M.-B.), CPRIT RP110584 (F.M.-B.) and the M.D. Anderson Cancer Center Support grant (NIH/NCI P30CA016672). F.M. gratefully acknowledges support from the Dana-Farber Cancer Institute Physical Science Oncology Center (U54CA193461-01).	Almendro V, 2014, CELL REP, V6, P514, DOI 10.1016/j.celrep.2013.12.041; Artandi SE, 2000, CURR OPIN GENET DEV, V10, P39, DOI 10.1016/S0959-437X(99)00047-7; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Bakhoum SF, 2012, J CLIN INVEST, V122, P1138, DOI 10.1172/JCI59954; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Bushati N, 2011, NUCLEIC ACIDS RES, V39, P7380, DOI 10.1093/nar/gkr462; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; DePinho RA, 2004, NAT GENET, V36, P932, DOI 10.1038/ng0904-932; Eldredge N., 1972, P82; EXCOFFIER L, 1992, GENETICS, V131, P479; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Foo J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004350; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; GOULD SJ, 1993, NATURE, V366, P223, DOI 10.1038/366223a0; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Hoglund M, 2002, CANCER RES, V62, P2675; Knouse KA, 2014, P NATL ACAD SCI USA, V111, P13409, DOI 10.1073/pnas.1415287111; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Leber B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000915; Ling SP, 2015, P NATL ACAD SCI USA, V112, pE6496, DOI 10.1073/pnas.1519556112; Lips EH, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0642-8; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Navin NE, 2010, MOL ONCOL, V4, P267, DOI 10.1016/j.molonc.2010.04.010; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Reynolds AP., 2006, J MATH MODEL ALGORIT, V5, P475, DOI [DOI 10.1007/S10852-005-9022-1, 10.1007/s10852-005-9022-1]; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Williams MJ, 2016, NAT GENET, V48, P238, DOI 10.1038/ng.3489; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886	38	259	265	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1119	1130		10.1038/ng.3641	http://dx.doi.org/10.1038/ng.3641			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27526321	Green Submitted, Green Accepted			2022-12-17	WOS:000384391600007
J	Molenaar, JJ; Domingo-Fernandez, R; Ebus, ME; Lindner, S; Koster, J; Drabek, K; Mestdagh, P; van Sluis, P; Valentijn, LJ; van Nes, J; Broekmans, M; Haneveld, F; Volckmann, R; Bray, I; Heukamp, L; Sprussel, A; Thor, T; Kieckbusch, K; Klein-Hitpass, L; Fischer, M; Vandesompele, J; Schramm, A; van Noesel, MM; Varesio, L; Speleman, F; Eggert, A; Stallings, RL; Caron, HN; Versteeg, R; Schulte, JH				Molenaar, Jan J.; Domingo-Fernandez, Raquel; Ebus, Marli E.; Lindner, Sven; Koster, Jan; Drabek, Ksenija; Mestdagh, Pieter; van Sluis, Peter; Valentijn, Linda J.; van Nes, Johan; Broekmans, Marloes; Haneveld, Franciska; Volckmann, Richard; Bray, Isabella; Heukamp, Lukas; Spruessel, Annika; Thor, Theresa; Kieckbusch, Kristina; Klein-Hitpass, Ludger; Fischer, Matthias; Vandesompele, Jo; Schramm, Alexander; van Noesel, Max M.; Varesio, Luigi; Speleman, Frank; Eggert, Angelika; Stallings, Raymond L.; Caron, Huib N.; Versteeg, Rogier; Schulte, Johannes H.			LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression	NATURE GENETICS			English	Article							COPY NUMBER DEFECTS; TUMOR-SUPPRESSOR; CELL-PROLIFERATION; PROMOTES TRANSFORMATION; RISK STRATIFICATION; MIRNA EXPRESSION; MESSENGER-RNA; IN-VIVO; N-MYC; MICRORNA	LIN28B regulates developmental processes by modulating microRNAs (miRNAs) of the let-7 family. A role for LIN28B in cancer has been proposed but has not been established in vivo. Here, we report that LIN28B showed genomic aberrations and extensive overexpression in high-risk neuroblastoma compared to several other tumor entities and normal tissues. High LIN28B expression was an independent risk factor for adverse outcome in neuroblastoma. LIN28B signaled through repression of the let-7 miRNAs and consequently resulted in elevated MYCN protein expression in neuroblastoma cells. LIN28B-let-7-MYCN signaling blocked differentiation of normal neuroblasts and neuroblastoma cells. These findings were fully recapitulated in a mouse model in which LIN28B expression in the sympathetic adrenergic lineage induced development of neuroblastomas marked by low let-7 miRNA levels and high MYCN protein expression. Interference with this pathway might offer therapeutic perspectives.	[Molenaar, Jan J.; Ebus, Marli E.; Koster, Jan; Drabek, Ksenija; van Sluis, Peter; Valentijn, Linda J.; van Nes, Johan; Broekmans, Marloes; Haneveld, Franciska; Volckmann, Richard; Caron, Huib N.; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands; [Domingo-Fernandez, Raquel; Bray, Isabella; Stallings, Raymond L.] Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, Dublin 2, Ireland; [Domingo-Fernandez, Raquel; Bray, Isabella; Stallings, Raymond L.] Natl Childrens Res Ctr, Dublin, Ireland; [Lindner, Sven; Spruessel, Annika; Thor, Theresa; Kieckbusch, Kristina; Schramm, Alexander; Eggert, Angelika; Schulte, Johannes H.] Childrens Hosp Essen, Dept Pediat Oncol & Haematol, Essen, Germany; [Mestdagh, Pieter; Vandesompele, Jo; Speleman, Frank] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Heukamp, Lukas] Univ Hosp Cologne, Inst Pathol, Cologne, Germany; [Klein-Hitpass, Ludger] Univ Hosp Essen, Inst Cell Biol, Essen, Germany; [Fischer, Matthias] Univ Cologne, Childrens Hosp, Dept Pediat Oncol & Hematol, D-50931 Cologne, Germany; [van Noesel, Max M.] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Pediat Oncol Hematol, Rotterdam, Netherlands; [Varesio, Luigi] Gaslini Inst, Mol Biol Lab, Genoa, Italy	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Royal College of Surgeons - Ireland; National Children's Research Centre (NCRC); Trinity College Dublin; Ghent University; University of Cologne; University of Duisburg Essen; University of Cologne; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; University of Genoa; IRCCS Istituto Giannina Gaslini	Molenaar, JJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Oncogen, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.j.molenaar@amc.uva.nl	Versteeg, Rogier/AAQ-1765-2020; Vandesompele, Jo/W-3411-2018; Schulte, Johannes H./V-2474-2018; varesio, luigi/J-8261-2016; Heukamp, Lukas C/A-8338-2013; Koster, Jan/C-5934-2008; Schramm, Alexander/G-5688-2010; Schulte, Johannes H/G-3981-2010; Eggert, Angelika/AAE-6907-2022; Stallings, Raymond/A-7213-2008; speleman, frank/AAR-5184-2020; Heukamp, Lukas/G-9967-2012	Vandesompele, Jo/0000-0001-6274-0184; varesio, luigi/0000-0001-5659-2218; Koster, Jan/0000-0002-0890-7585; Schramm, Alexander/0000-0001-7670-7529; Eggert, Angelika/0000-0003-3476-8184; speleman, frank/0000-0002-6628-8559; Versteeg, Rogier/0000-0001-7172-0388; Heukamp, Lukas/0000-0002-3388-3482; Mestdagh, Pieter/0000-0001-7821-9684; Schulte, Johannes Hubertus/0000-0003-0671-1201; van Nes, Johan/0000-0001-7691-1431	Villa Joep Foundation; Kinderen Kankervrij (KiKa); Toni Voute Fund; Netherlands Cancer Foundation; Science Foundation Ireland [07/IN.1/B1776]; Children's Medical and Research Foundation; US National Institutes of Health [5R01CA127496]; European Union (ENCCA: EU Seventh Framework Programme, Network of Excellence) [261474]; European Union (ASSET: EU Seventh Framework Programme) [CP 259348]; National Genome Research Network (NGFNplus (Germany)) [PKN-01GS0894-6]; German Cancer Aid [108941]; NATIONAL CANCER INSTITUTE [R01CA127496] Funding Source: NIH RePORTER	Villa Joep Foundation; Kinderen Kankervrij (KiKa); Toni Voute Fund; Netherlands Cancer Foundation; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Children's Medical and Research Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union (ENCCA: EU Seventh Framework Programme, Network of Excellence); European Union (ASSET: EU Seventh Framework Programme); National Genome Research Network (NGFNplus (Germany)); German Cancer Aid(Deutsche Krebshilfe); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We kindly thank A. Odersky, L. Schild, I. van der Ploeg, E. Dolman, T Eleveld and L. Bate Eya for excellent technical assistance. The research reported in this Manuscript was supported by grants from the Villa Joep Foundation, Kinderen Kankervrij (KiKa), the Toni Voute Fund and the Netherlands Cancer Foundation. R.L.S. was a recipient of grants from the Science Foundation Ireland (07/IN.1/B1776), the Children's Medical and Research Foundation and the US National Institutes of Health (5R01CA127496). A.E. is funded by the European Union (ENCCA: EU Seventh Framework Programme, Network of Excellence 261474; ASSET: EU Seventh Framework Programme, CP 259348). Support was also provided by the National Genome Research Network (NGFNplus (Germany); PKN-01GS0894-6 to J.H.S., A.E. and A.S.) and the German Cancer Aid (grant 108941 to J.H.S. and A.E.).	Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Bray I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007850; Buechner J, 2011, BRIT J CANCER, V105, P296, DOI 10.1038/bjc.2011.220; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Cotterman R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005799; De Preter K, 2011, CLIN CANCER RES, V17, P7684, DOI 10.1158/1078-0432.CCR-11-0610; Eda A, 2009, BIOCHEM BIOPH RES CO, V388, P648, DOI 10.1016/j.bbrc.2009.08.040; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Helland A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018064; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Loven J, 2010, P NATL ACAD SCI USA, V107, P1553, DOI 10.1073/pnas.0913517107; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Molenaar JJ, 2012, GENE CHROMOSOME CANC, V51, P10, DOI 10.1002/gcc.20926; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Olsson-Carter K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001054; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Ora I, 2011, SEMIN CANCER BIOL, V21, P217, DOI 10.1016/j.semcancer.2011.07.002; Permuth-Wey J, 2011, CANCER RES, V71, P3896, DOI 10.1158/0008-5472.CAN-10-4167; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schulte JH, 2013, ONCOGENE, V32, P1059, DOI 10.1038/onc.2012.106; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Shohet JM, 2011, CANCER RES, V71, P3841, DOI 10.1158/0008-5472.CAN-10-4391; Stanke M, 2006, DEVELOPMENT, V133, P141, DOI 10.1242/dev.02189; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tivnan A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-33; Valentijn LJ, 2005, CANCER RES, V65, P3136, DOI 10.1158/0008-5472.CAN-04-2469; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang J, 2012, STEM CELLS DEV, V21, P1524, DOI 10.1089/scd.2011.0350; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	56	259	265	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1199	1206		10.1038/ng.2436	http://dx.doi.org/10.1038/ng.2436			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23042116				2022-12-17	WOS:000310495800010
J	Okoro, CK; Kingsley, RA; Connor, TR; Harris, SR; Parry, CM; Al-Mashhadani, MN; Kariuki, S; Msefula, CL; Gordon, MA; de Pinna, E; Wain, J; Heyderman, RS; Obaro, S; Alonso, PL; Mandomando, I; MacLennan, CA; Tapia, MD; Levine, MM; Tennant, SM; Parkhill, J; Dougan, G				Okoro, Chinyere K.; Kingsley, Robert A.; Connor, Thomas R.; Harris, Simon R.; Parry, Christopher M.; Al-Mashhadani, Manar N.; Kariuki, Samuel; Msefula, Chisomo L.; Gordon, Melita A.; de Pinna, Elizabeth; Wain, John; Heyderman, Robert S.; Obaro, Stephen; Alonso, Pedro L.; Mandomando, Inacio; MacLennan, Calman A.; Tapia, Milagritos D.; Levine, Myron M.; Tennant, Sharon M.; Parkhill, Julian; Dougan, Gordon			Intracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan Africa	NATURE GENETICS			English	Article							NON-TYPHOIDAL SALMONELLA; NONTYPHOIDAL SALMONELLA; POPULATION-GENETICS; INFECTION; CHILDREN; BACTEREMIA; EVOLUTION; SEROVARS; HIV-1; ADULTS	A highly invasive form of non-typhoidal Salmonella (iNTS) disease has recently been documented in many countries in sub-Saharan Africa. The most common Salmonella enterica serovar causing this disease is Typhimurium (Salmonella Typhimurium). We applied whole-genome sequence-based phylogenetic methods to define the population structure of sub-Saharan African invasive Salmonella Typhimurium isolates and compared these to global Salmonella Typhimurium populations. Notably, the vast majority of sub-Saharan invasive Salmonella Typhimurium isolates fell within two closely related, highly clustered phylogenetic lineages that we estimate emerged independently similar to 52 and similar to 35 years ago in close temporal association with the current HIV pandemic. Clonal replacement of isolates from lineage I by those from lineage II was potentially influenced by the use of chloramphenicol for the treatment of iNTS disease. Our analysis suggests that iNTS disease is in part an epidemic in sub-Saharan Africa caused by highly related Salmonella Typhimurium lineages that may have occupied new niches associated with a compromised human population and antibiotic treatment.	[Okoro, Chinyere K.; Kingsley, Robert A.; Connor, Thomas R.; Harris, Simon R.; Parkhill, Julian; Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge, England; [Parry, Christopher M.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Parry, Christopher M.; Al-Mashhadani, Manar N.] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England; [Kariuki, Samuel] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Msefula, Chisomo L.; Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Program, Blantyre, Malawi; [Msefula, Chisomo L.] Univ Malawi, Coll Med, Dept Microbiol, Blantyre, Malawi; [Gordon, Melita A.] Univ Liverpool, Inst Translat Med, Dept Gastroenterol, Liverpool L69 3BX, Merseyside, England; [de Pinna, Elizabeth; Wain, John] Ctr Infect, Lab Gastrointestinal Infect, Hlth Protect Agcy, London, England; [Wain, John] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Heyderman, Robert S.] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England; [Obaro, Stephen] Michigan State Univ, Dept Paediat & Human Dev, Div Paediat Infect Dis, E Lansing, MI 48824 USA; [Obaro, Stephen] Natl Hosp Abuja, Dept Pediat, Garki Abuja, Nigeria; [Alonso, Pedro L.] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Alonso, Pedro L.; Mandomando, Inacio] CISM, Manhica, Mozambique; [Mandomando, Inacio] Minist Saude, Inst Nacl Saude, Maputo, Mozambique; [MacLennan, Calman A.] Novartis Vaccines Inst Global Hlth NVGH, Siena, Italy; [MacLennan, Calman A.] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Ctr Immune Regulat,MRC, Birmingham, W Midlands, England; [Tapia, Milagritos D.; Levine, Myron M.] Univ Maryland, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Levine, Myron M.; Tennant, Sharon M.] Univ Maryland, Dept Med, Baltimore, MD 21201 USA	Wellcome Trust Sanger Institute; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Liverpool; Kenya Medical Research Institute; University of Malawi; University of Malawi; University of Liverpool; Health Protection Agency; University of East Anglia; University of Bristol; Michigan State University; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; University of Birmingham; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Dougan, G (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	gd1@sanger.ac.uk	Harris, Simon R/K-1318-2013; Wain, John/B-3446-2013; Connor, Thomas/ABE-5989-2020; Parkhill, Julian/G-4703-2011; MacLennan, Calman A/L-9343-2014; Alonso, Pedro L/AAZ-3645-2020; Msefula, Chisomo/AAY-9107-2020; Connor, Thomas/ABD-6533-2021; Mandomando, Inacio/ABD-8007-2020; Gordon, Melita/F-5563-2012	Harris, Simon R/0000-0003-1512-6194; Wain, John/0000-0002-1257-1148; Connor, Thomas/0000-0003-2394-6504; Parkhill, Julian/0000-0002-7069-5958; MacLennan, Calman A/0000-0001-9694-0846; Alonso, Pedro L/0000-0003-3292-3443; Mandomando, Inacio/0000-0002-1078-2187; Heyderman, Robert/0000-0003-4573-449X; Gordon, Melita/0000-0002-0629-0884; Kingsley, Robert/0000-0002-0194-6485; Okoro, Chinyere/0000-0002-2466-304X; Msefula, Chisomo/0000-0003-2304-886X	Wellcome Trust [098051]; Wellcome Trust; GlaxoSmithKline; Medical Research Council [G9818340B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); GlaxoSmithKline(GlaxoSmithKline); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Cheesborough for providing the DRC isolates, M. Okong, N. French and the Medical Research Council, Uganda, for providing the Uganda isolates, S. Nair for providing the Health Protection Agency (HPA) isolates, L. Barquist for modeling the pre-1990 HIV prevalence data and the Sequencing team at the Wellcome Trust Sanger Institute. This work was funded by a Wellcome Trust grant (098051). C.A.M. was supported by a Tropical Research Fellowship from the Wellcome Trust and a Clinical Research Fellowship from GlaxoSmithKline.	BELTRAN P, 1991, J GEN MICROBIOL, V137, P601, DOI 10.1099/00221287-137-3-601; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Beyene G, 2011, J INFECT DEV COUNTR, V5, P23, DOI 10.3855/jidc.906; Brent AJ, 2006, PEDIATR INFECT DIS J, V25, P230, DOI 10.1097/01.inf.0000202066.02212.ff; Cheesbrough JS, 1997, PEDIATR INFECT DIS J, V16, P277, DOI 10.1097/00006454-199703000-00005; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; den Bakker HC, 2010, APPL ENVIRON MICROB, V76, P6085, DOI 10.1128/AEM.00447-10; Dione MM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001148; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Endicott P, 2010, J HUM EVOL, V59, P87, DOI 10.1016/j.jhevol.2010.04.005; Fashae K, 2010, J INFECT DEV COUNTR, V4, P484, DOI 10.3855/jidc.909; GANGAROSA EJ, 1972, J INFECT DIS, V126, P215, DOI 10.1093/infdis/126.2.215; Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009; Gordon MA, 2008, J INFECTION, V56, P413, DOI 10.1016/j.jinf.2008.03.012; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Gordon MA, 2010, CLIN INFECT DIS, V50, P953, DOI 10.1086/651080; Graham SM, 2010, CURR OPIN INFECT DIS, V23, P409, DOI 10.1097/QCO.0b013e32833dd25d; Gray RR, 2009, AIDS, V23, pF9, DOI 10.1097/QAD.0b013e32832faf61; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000929; Holt KE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-36; Ikumapayi UN, 2007, J MED MICROBIOL, V56, P1479, DOI 10.1099/jmm.0.47416-0; Kariuki S, 2006, J MED MICROBIOL, V55, P585, DOI 10.1099/jmm.0.46375-0; Keddy KH, 2009, J INFECT DEV COUNTR, V3, P585, DOI 10.3855/jidc.549; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Langridge GC, 2009, J INFECT DIS, V199, P602, DOI 10.1086/596208; Lemey P, 2004, GENETICS, V167, P1059, DOI 10.1534/genetics.104.026666; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; LEVINE WC, 1991, J INFECT DIS, V164, P81, DOI 10.1093/infdis/164.1.81; MacLennan CA, 2010, SCIENCE, V328, P508, DOI 10.1126/science.1180346; Mandomando I, 2009, TROP MED INT HEALTH, V14, P1467, DOI 10.1111/j.1365-3156.2009.02399.x; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; NAHMIAS AJ, 1986, LANCET, V1, P1279; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Popoff MY, 2004, RES MICROBIOL, V155, P568, DOI 10.1016/j.resmic.2004.04.005; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Rosanova Maria Teresa, 2002, International Journal of Infectious Diseases, V6, P187, DOI 10.1016/S1201-9712(02)90109-8; Roux CM, 2010, INFECT IMMUN, V78, P1520, DOI 10.1128/IAI.00887-09; Sharp ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021135; Sibhat B, 2011, ZOONOSES PUBLIC HLTH, V58, P102, DOI 10.1111/j.1863-2378.2009.01305.x; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; SMITH PD, 1985, ANN INTERN MED, V102, P207, DOI 10.7326/0003-4819-102-2-207; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390	51	259	262	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1215	1221		10.1038/ng.2423	http://dx.doi.org/10.1038/ng.2423			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23023330	Green Accepted, Bronze			2022-12-17	WOS:000310495800012
J	Al-Mayouf, SM; Sunker, A; Abdwani, R; Al Abrawi, S; Almurshedi, F; Alhashmi, N; Al Sonbul, A; Sewairi, W; Qari, A; Abdallah, E; Al-Owain, M; Al Motywee, S; Al-Rayes, H; Hashem, M; Khalak, H; Al-Jebali, L; Alkuraya, FS				Al-Mayouf, Sulaiman M.; Sunker, Asma; Abdwani, Reem; Al Abrawi, Safiya; Almurshedi, Fathiya; Alhashmi, Nadia; Al Sonbul, Abdullah; Sewairi, Wafaa; Qari, Aliya; Abdallah, Eiman; Al-Owain, Mohammed; Al Motywee, Saleh; Al-Rayes, Hanan; Hashem, Mais; Khalak, Hanif; Al-Jebali, Latifa; Alkuraya, Fowzan S.			Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus	NATURE GENETICS			English	Article							SUSCEPTIBILITY VARIANTS; DEOXYRIBONUCLEASE I; PXK	Systemic lupus erythematosus (SLE) is a complex autoimmune disease that causes substantial morbidity. As is typical for many other multifactorial disorders, much of the heritability of SLE remains unknown. We identified a rare autosomal recessive form of SLE, in which autozygome analysis revealed a null mutation in the DNASE1L3 gene. The DNASE1L3-related SLE we describe was always pediatric in onset and correlated with a high frequency of lupus nephritis. Our findings confirm the critical role of impaired clearance of degraded DNA in SLE pathogenesis.	[Sunker, Asma; Hashem, Mais; Khalak, Hanif; Al-Jebali, Latifa; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Al-Mayouf, Sulaiman M.; Al Sonbul, Abdullah] King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Rheumatol Sect, Riyadh 11211, Saudi Arabia; [Abdwani, Reem; Abdallah, Eiman] Sultan Qaboos Univ Hosp, Dept Child Hlth, Muscat, Oman; [Al Abrawi, Safiya; Alhashmi, Nadia] Royal Hosp, Dept Child Hlth, Muscat, Oman; [Almurshedi, Fathiya] Sultan Qaboos Univ Hosp, Dept Genet, Muscat, Oman; [Sewairi, Wafaa; Al Motywee, Saleh] King Fahad Natl Guard Hosp, Div Rheumatol, Dept Med, Riyadh, Saudi Arabia; [Sewairi, Wafaa; Al Motywee, Saleh] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Qari, Aliya; Al-Owain, Mohammed] King Faisal Specialist Hosp & Res Ctr, Dept Med Genet, Riyadh, Saudi Arabia; [Al-Owain, Mohammed; Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh, Saudi Arabia; [Al-Rayes, Hanan] Riyadh Mil Hosp, Dept Med, Riyadh, Saudi Arabia; [Alkuraya, Fowzan S.] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia; [Alkuraya, Fowzan S.] King Khalid Univ Hosp, Dept Pediat, Riyadh 11472, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Sultan Qaboos University; The Royal Hospital, Sultanate of Oman; Sultan Qaboos University; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); King Faisal Specialist Hospital & Research Center; Alfaisal University; Prince Sultan Military Medical City; King Saud University; King Saud University; King Khalid University Hospital	Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.	falkuraya@kfshrc.edu.sa	Alkuraya, Fowzan S./A-1542-2009	Alkuraya, Fowzan S./0000-0003-4158-341X; Al-Mayouf, Sulaiman/0000-0003-0142-6698; Abdwani, Reem/0000-0002-1189-1959	Dubai Harvard Foundation for Medical Research	Dubai Harvard Foundation for Medical Research	We would like to thank the families for their participation and the Genotyping and Sequencing Core Facilities at King Faisal Specialist Hospital and Research Center for their technical help. This work is supported by a Dubai Harvard Foundation for Medical Research collaborative grant (FSA).	Alkuraya FS, 2010, GENET MED, V12, P765, DOI 10.1097/GIM.0b013e3181fbfcc4; ALMAYOUF S, RHEUMATOL I IN PRESS; Chen WJ, 2004, PROTEIN SCI, V13, P875, DOI 10.1110/ps.03438204; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; KIM EM, RHEUMATOL I IN PRESS; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Rodriguez AM, 1997, GENOMICS, V42, P507, DOI 10.1006/geno.1997.4748; RUMORE PM, 1990, J CLIN INVEST, V86, P69, DOI 10.1172/JCI114716; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Ueki M, 2009, CLIN CHIM ACTA, V407, P20, DOI 10.1016/j.cca.2009.06.022; Yang W, 2009, GENES IMMUN, V10, P219, DOI 10.1038/gene.2009.1; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Zeng ZZ, 1997, BIOCHEM BIOPH RES CO, V231, P499, DOI 10.1006/bbrc.1996.5923	13	259	270	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2011	43	12					1186	1188		10.1038/ng.975	http://dx.doi.org/10.1038/ng.975			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22019780				2022-12-17	WOS:000297931400009
J	Lieberman, TD; Michel, JB; Aingaran, M; Potter-Bynoe, G; Roux, D; Davis, MR; Skurnik, D; Leiby, N; LiPuma, JJ; Goldberg, JB; McAdam, AJ; Priebe, GP; Kishony, R				Lieberman, Tami D.; Michel, Jean-Baptiste; Aingaran, Mythili; Potter-Bynoe, Gail; Roux, Damien; Davis, Michael R., Jr.; Skurnik, David; Leiby, Nicholas; LiPuma, John J.; Goldberg, Joanna B.; McAdam, Alexander J.; Priebe, Gregory P.; Kishony, Roy			Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes	NATURE GENETICS			English	Article							CYSTIC-FIBROSIS PATIENTS; BURKHOLDERIA-CEPACIA COMPLEX; LONG-TERM EXPERIMENT; FLUOROQUINOLONE RESISTANCE; ESCHERICHIA-COLI; GENOME EVOLUTION; IN-VIVO; MUTATIONS; TRANSMISSION; INFECTIONS	Bacterial pathogens evolve during the infection of their human host(1-8), but separating adaptive and neutral mutations remains challenging(9-11). Here we identify bacterial genes under adaptive evolution by tracking recurrent patterns of mutations in the same pathogenic strain during the infection of multiple individuals. We conducted a retrospective study of a Burkholderia dolosa outbreak among subjects with cystic fibrosis, sequencing the genomes of 112 isolates collected from 14 individuals over 16 years. We find that 17 bacterial genes acquired nonsynonymous mutations in multiple individuals, which indicates parallel adaptive evolution. Mutations in these genes affect important pathogenic phenotypes, including antibiotic resistance and bacterial membrane composition and implicate oxygen-dependent regulation as paramount in lung infections. Several genes have not previously been implicated in pathogenesis and may represent new therapeutic targets. The identification of parallel molecular evolution as a pathogen spreads among multiple individuals points to the key selection forces it experiences within human hosts.	[Lieberman, Tami D.; Michel, Jean-Baptiste; Leiby, Nicholas; Kishony, Roy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02215 USA; [Michel, Jean-Baptiste] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Aingaran, Mythili; Priebe, Gregory P.] Childrens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Roux, Damien; Skurnik, David; Priebe, Gregory P.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Davis, Michael R., Jr.; Goldberg, Joanna B.] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA USA; [LiPuma, John J.] Univ Michigan, Sch Med, Dept Pediat, Ann Arbor, MI USA; [LiPuma, John J.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [McAdam, Alexander J.] Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; [Priebe, Gregory P.] Childrens Hosp, Dept Anesthesia, Div Crit Care Med, Boston, MA 02115 USA; [Kishony, Roy] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; University of Virginia; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University	Kishony, R (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02215 USA.	alexander.mcadam@childrens.harvard.edu; gregory_priebe@childrens.harvard.edu; roy_kishony@hms.harvard.edu	Michel, Jean-Baptiste/AAH-9336-2020; Weinstock, George M/C-6314-2013; Priebe, Gregory/AAG-4027-2021; Roux, Damien/C-5618-2014; Roux, Damien/L-3671-2014	Weinstock, George M/0000-0002-2997-4592; Priebe, Gregory/0000-0001-9831-0354; Roux, Damien/0000-0002-6103-6416; Roux, Damien/0000-0002-6103-6416; Skurnik, David/0000-0002-4205-9639	Foundational Questions in Evolutionary Biology Prize Fellowship; Harvard Medical School; Center for the Critically Ill Child of Children's Hospital Boston; Cystic Fibrosis Foundation; US National Institutes of Health [GM080177, GM081617]; New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (NERCE) [AI057159]; Harvard Catalyst grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, T32AI007046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081617, T32GM080177] Funding Source: NIH RePORTER	Foundational Questions in Evolutionary Biology Prize Fellowship; Harvard Medical School; Center for the Critically Ill Child of Children's Hospital Boston; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (NERCE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Harvard Catalyst grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to M. Caimano, M. Cendron, P. Kokorowski, S. Lory, C. Marx, N. Delany, S. Walker, M. Waldor and R. Ward for insightful discussions and comments, to O. Iartchouk, A. Brown, M. Light and their team at Partners HealthCare Center for Personalized Genetic Medicine (PCPGM) for Illumina sequencing, to J. Deane and L. Williams for technical assistance, to S. Vargas for assistance with IRB protocols and to M. Baym, M. Ernebjerg, A. Palmer, E. Toprak, K. Vetsigian, Z. Yao and all of the Kishony lab members for helpful discussions and general support. J. B. M. was supported by the Foundational Questions in Evolutionary Biology Prize Fellowship and the Systems Biology PhD Program (Harvard Medical School). G. P. P. was supported in part by The Mannion Fund for Research of the Center for the Critically Ill Child of Children's Hospital Boston. J. J. L. was supported by the Cystic Fibrosis Foundation. This work was supported in part by US National Institutes of Health grants (GM080177 to the Systems Biology Department, Harvard Medical School and GM081617 to R. K.), by a grant from the New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (NERCE; AI057159 to R. K.) and by a Harvard Catalyst grant (to R. K., A. J. M. and M. Cendron).	Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Biddick R, 2003, FEMS MICROBIOL LETT, V228, P57, DOI 10.1016/S0378-1097(03)00724-9; Crosson S, 2005, P NATL ACAD SCI USA, V102, P8018, DOI 10.1073/pnas.0503022102; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Goodarzi H, 2009, NAT METHODS, V6, P581, DOI 10.1038/nmeth.1352; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Kalish LA, 2006, AM J RESP CRIT CARE, V173, P421, DOI 10.1164/rccm.200503-344OC; Kennemann L, 2011, P NATL ACAD SCI USA, V108, P5033, DOI 10.1073/pnas.1018444108; LiPuma JJ, 2005, CURR OPIN PULM MED, V11, P528, DOI 10.1097/01.mcp.0000181475.85187.ed; LIPUMA JJ, 1990, LANCET, V336, P1094, DOI 10.1016/0140-6736(90)92571-X; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Marteyn B, 2010, NATURE, V465, P355, DOI 10.1038/nature08970; Morelli G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001036; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Musher DM, 2002, NEW ENGL J MED, V346, P630, DOI 10.1056/NEJM200202213460820; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Ortega X, 2005, J BACTERIOL, V187, P1324, DOI 10.1128/JB.187.4.1324-1333.2005; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; REYNA F, 1995, ANTIMICROB AGENTS CH, V39, P1621, DOI 10.1128/AAC.39.7.1621; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Vermis K, 2004, INT J SYST EVOL MICR, V54, P689, DOI 10.1099/ijs.0.02888-0; Vinion-Dubiel AD, 2003, J ENDOTOXIN RES, V9, P201, DOI 10.1179/096805103225001404; Weigel LM, 1998, ANTIMICROB AGENTS CH, V42, P2661, DOI 10.1128/AAC.42.10.2661; Wilder CN, 2009, INFECT IMMUN, V77, P5631, DOI 10.1128/IAI.00755-09; Wong A, 2011, MICROBIOL-SGM, V157, P937, DOI 10.1099/mic.0.046870-0; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108; Zdziarski J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001078	38	259	262	0	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2011	43	12					1275	U148		10.1038/ng.997	http://dx.doi.org/10.1038/ng.997			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22081229	Green Accepted			2022-12-17	WOS:000297931400027
J	Antoniou, AC; Wang, XS; Fredericksen, ZS; McGuffog, L; Tarrell, R; Sinilnikova, OM; Healey, S; Morrison, J; Kartsonaki, C; Lesnick, T; Ghoussaini, M; Barrowdale, D; Peock, S; Cook, M; Oliver, C; Frost, D; Eccles, D; Evans, DG; Eeles, R; Izatt, L; Chu, C; Douglas, F; Paterson, J; Stoppa-Lyonnet, D; Houdayer, C; Mazoyer, S; Giraud, S; Lasset, C; Remenieras, A; Caron, O; Hardouin, A; Berthet, P; Hogervorst, FBL; Rookus, MA; Jager, A; van den Ouweland, A; Hoogerbrugge, N; van der Luijt, RB; Meijers-Heijboer, H; Garcia, EBG; Devilee, P; Vreeswijk, MPG; Lubinski, J; Jakubowska, A; Gronwald, J; Huzarski, T; Byrski, T; Gorski, B; Cybulski, C; Spurdle, AB; Holland, H; Goldgar, DE; John, EM; Hopper, JL; Southey, M; Buys, SS; Daly, MB; Terry, MB; Schmutzler, RK; Wappenschmidt, B; Engel, C; Meindl, A; Preisler-Adams, S; Arnold, N; Niederacher, D; Sutter, C; Domchek, SM; Nathanson, KL; Rebbeck, T; Blum, JL; Piedmonte, M; Rodriguez, GC; Wakeley, K; Boggess, JF; Basil, J; Blank, SV; Friedman, E; Kaufman, B; Laitman, Y; Milgrom, R; Andrulis, IL; Glendon, G; Ozcelik, H; Kirchhoff, T; Vijai, J; Gaudet, MM; Altshuler, D; Guiducci, C; Loman, N; Harbst, K; Rantala, J; Ehrencrona, H; Gerdes, AM; Thomassen, M; Sunde, L; Peterlongo, P; Manoukian, S; Bonanni, B; Viel, A; Radice, P; Caldes, T; de la Hoya, M; Singer, CF; Fink-Retter, A; Greene, MH; Mai, PL; Loud, JT; Guidugli, L; Lindor, NM; Hansen, TVO; Nielsen, FC; Blanco, I; Lazaro, C; Garber, J; Ramus, SJ; Gayther, SA; Phelan, C; Narod, S; Szabo, CI; Benitez, J; Osorio, A; Nevanlinna, H; Heikkinen, T; Caligo, MA; Beattie, MS; Hamann, U; Godwin, AK; Montagna, M; Casella, C; Neuhausen, SL; Karlan, BY; Tung, N; Toland, AE; Weitzel, J; Olopade, O; Simard, J; Soucy, P; Rubinstein, WS; Arason, A; Rennert, G; Martin, NG; Montgomery, GW; Chang-Claude, J; Flesch-Janys, D; Brauch, H; Severi, G; Baglietto, L; Cox, A; Cross, SS; Miron, P; Gerty, SM; Tapper, W; Yannoukakos, D; Fountzilas, G; Fasching, PA; Beckmann, MW; Silva, IDS; Peto, J; Lambrechts, D; Paridaens, R; Rudiger, T; Forsti, A; Winqvist, R; Pylkaas, K; Diasio, RB; Lee, AM; Eckel-Passow, J; Vachon, C; Blows, F; Driver, K; Dunning, A; Pharoah, PPD; Offit, K; Pankratz, VS; Hakonarson, H; Chenevix-Trench, G; Easton, DF; Couch, FJ				Antoniou, Antonis C.; Wang, Xianshu; Fredericksen, Zachary S.; McGuffog, Lesley; Tarrell, Robert; Sinilnikova, Olga M.; Healey, Sue; Morrison, Jonathan; Kartsonaki, Christiana; Lesnick, Timothy; Ghoussaini, Maya; Barrowdale, Daniel; Peock, Susan; Cook, Margaret; Oliver, Clare; Frost, Debra; Eccles, Diana; Evans, D. Gareth; Eeles, Ros; Izatt, Louise; Chu, Carol; Douglas, Fiona; Paterson, Joan; Stoppa-Lyonnet, Dominique; Houdayer, Claude; Mazoyer, Sylvie; Giraud, Sophie; Lasset, Christine; Remenieras, Audrey; Caron, Olivier; Hardouin, Agnes; Berthet, Pascaline; Hogervorst, Frans B. L.; Rookus, Matti A.; Jager, Agnes; van den Ouweland, Ans; Hoogerbrugge, Nicoline; van der Luijt, Rob B.; Meijers-Heijboer, Hanne; Garcia, Encarna B. Gomez; Devilee, Peter; Vreeswijk, Maaike P. G.; Lubinski, Jan; Jakubowska, Anna; Gronwald, Jacek; Huzarski, Tomasz; Byrski, Tomasz; Gorski, Bohdan; Cybulski, Cezary; Spurdle, Amanda B.; Holland, Helene; Goldgar, David E.; John, Esther M.; Hopper, John L.; Southey, Melissa; Buys, Saundra S.; Daly, Mary B.; Terry, Mary-Beth; Schmutzler, Rita K.; Wappenschmidt, Barbara; Engel, Christoph; Meindl, Alfons; Preisler-Adams, Sabine; Arnold, Norbert; Niederacher, Dieter; Sutter, Christian; Domchek, Susan M.; Nathanson, Katherine L.; Rebbeck, Timothy; Blum, Joanne L.; Piedmonte, Marion; Rodriguez, Gustavo C.; Wakeley, Katie; Boggess, John F.; Basil, Jack; Blank, Stephanie V.; Friedman, Eitan; Kaufman, Bella; Laitman, Yael; Milgrom, Roni; Andrulis, Irene L.; Glendon, Gord; Ozcelik, Hilmi; Kirchhoff, Tomas; Vijai, Joseph; Gaudet, Mia M.; Altshuler, David; Guiducci, Candace; Loman, Niklas; Harbst, Katja; Rantala, Johanna; Ehrencrona, Hans; Gerdes, Anne-Marie; Thomassen, Mads; Sunde, Lone; Peterlongo, Paolo; Manoukian, Siranoush; Bonanni, Bernardo; Viel, Alessandra; Radice, Paolo; Caldes, Trinidad; de la Hoya, Miguel; Singer, Christian F.; Fink-Retter, Anneliese; Greene, Mark H.; Mai, Phuong L.; Loud, Jennifer T.; Guidugli, Lucia; Lindor, Noralane M.; Hansen, Thomas V. O.; Nielsen, Finn C.; Blanco, Ignacio; Lazaro, Conxi; Garber, Judy; Ramus, Susan J.; Gayther, Simon A.; Phelan, Catherine; Narod, Stephen; Szabo, Csilla I.; Benitez, Javier; Osorio, Ana; Nevanlinna, Heli; Heikkinen, Tuomas; Caligo, Maria A.; Beattie, Mary S.; Hamann, Ute; Godwin, Andrew K.; Montagna, Marco; Casella, Cinzia; Neuhausen, Susan L.; Karlan, Beth Y.; Tung, Nadine; Toland, Amanda E.; Weitzel, Jeffrey; Olopade, Olofunmilayo; Simard, Jacques; Soucy, Penny; Rubinstein, Wendy S.; Arason, Adalgeir; Rennert, Gad; Martin, Nicholas G.; Montgomery, Grant W.; Chang-Claude, Jenny; Flesch-Janys, Dieter; Brauch, Hiltrud; Severi, Gianluca; Baglietto, Laura; Cox, Angela; Cross, Simon S.; Miron, Penelope; Gerty, Sue M.; Tapper, William; Yannoukakos, Drakoulis; Fountzilas, George; Fasching, Peter A.; Beckmann, Matthias W.; Silva, Isabel dos Santos; Peto, Julian; Lambrechts, Diether; Paridaens, Robert; Ruediger, Thomas; Foersti, Asta; Winqvist, Robert; Pylkaes, Katri; Diasio, Robert B.; Lee, Adam M.; Eckel-Passow, Jeanette; Vachon, Celine; Blows, Fiona; Driver, Kristy; Dunning, Alison; Pharoah, Paul P. D.; Offit, Kenneth; Pankratz, V. Shane; Hakonarson, Hakon; Chenevix-Trench, Georgia; Easton, Douglas F.; Couch, Fergus J.		EMBRACE; GEMO Study Collaborators; HEBON; KConFab; SWE-BRCA; MOD SQUAD; GENICA	A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; ESTROGEN-RECEPTOR; COMMON VARIANTS; CONFER SUSCEPTIBILITY; OVARIAN-CANCER; NONSENSE; ALLELES; COMPLEX; 2Q35	Germline BRCA1 mutations predispose to breast cancer. To identify genetic modifiers of this risk, we performed a genome-wide association study in 1,193 individuals with BRCA1 mutations who were diagnosed with invasive breast cancer under age 40 and 1,190 BRCA1 carriers without breast cancer diagnosis over age 35. We took forward 96 SNPs for replication in another 5,986 BRCA1 carriers (2,974 individuals with breast cancer and 3,012 unaffected individuals). Five SNPs on 19p13 were associated with breast cancer risk (P-trend = 2.3 x 10(-9) to Ptrend = 3.9 x 10(-7)), two of which showed independent associations (rs8170, hazard ratio (HR) = 1.26, 95% CI 1.17-1.35; rs2363956 HR = 0.84, 95% CI 0.80-0.89). Genotyping these SNPs in 6,800 population-based breast cancer cases and 6,613 controls identified a similar association with estrogen receptor-negative breast cancer (rs2363956 per-allele odds ratio (OR) = 0.83, 95% CI 0.75-0.92, P-trend = 0.0003) and an association with estrogen receptor-positive disease in the opposite direction (OR = 1.07, 95% CI 1.01-1.14, P-trend = 0.016). The five SNPs were also associated with triple-negative breast cancer in a separate study of 2,301 triple-negative cases and 3,949 controls (Ptrend = 1 x 10(-7) to Ptrend = 8 x 10(-5); rs2363956 per-allele OR = 0.80, 95% CI 0.74-0.87, P-trend = 1.1 x 10(-7)).	[Antoniou, Antonis C.; McGuffog, Lesley; Morrison, Jonathan; Kartsonaki, Christiana; Barrowdale, Daniel; Peock, Susan; Cook, Margaret; Oliver, Clare; Frost, Debra; Tung, Nadine; Blows, Fiona; Driver, Kristy; Dunning, Alison; Pharoah, Paul P. D.; Easton, Douglas F.; EMBRACE] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Wang, Xianshu; Guidugli, Lucia; Szabo, Csilla I.; Toland, Amanda E.; Couch, Fergus J.] Dept Lab Med & Pathol, Mayo Clin, Rochester, MN USA; [Fredericksen, Zachary S.; Tarrell, Robert; Lesnick, Timothy; Weitzel, Jeffrey; Eckel-Passow, Jeanette; Vachon, Celine; Pankratz, V. Shane] Dept Hlth Sci Res, Mayo Clin, Rochester, MN USA; [Sinilnikova, Olga M.; Giraud, Sophie; Olopade, Olofunmilayo] Univ Lyon Ctr Leon Berard, Ctr Hosp, Unit Mixte Genet Constitutionnelle Canc Frequents, Lyon, France; [Sinilnikova, Olga M.; Mazoyer, Sylvie; Simard, Jacques] Univ Lyon, Ctr Leon Berard, CNRS, Equipe Labellisee LIGUE 2008, Lyon, France; [Healey, Sue; Ghoussaini, Maya; Spurdle, Amanda B.; Holland, Helene; Simard, Jacques; Chenevix-Trench, Georgia] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Eccles, Diana; Gerty, Sue M.; Tapper, William] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Evans, D. Gareth] Cent Manchester Univ Hosp, Manchester Acad Hlth Sci Ctr, NHSFT, Manchester, Lancs, England; [Eeles, Ros] Inst Canc Res & Royal Marsden NHS Fdn, Oncogenet Team, Sutton, Surrey, England; [Izatt, Louise; Soucy, Penny] Guys & St Thomas NHS Fdn Trust, Clin Genet, London, England; [Chu, Carol] Yorkshire Reg Genet Serv, Leeds, W Yorkshire, England; [Douglas, Fiona] Newcastle Tyne Hosp NHS Trust, Ctr Life, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; Addenbrookes Hosp, Dept Clin Genet, E Anglian Reg Genet Serv, Cambridge, England; [Stoppa-Lyonnet, Dominique; Houdayer, Claude] Univ Paris 05, Inst Curie, INSERM U509, Serv Genet Oncolog, Paris, France; [Lasset, Christine] Univ Lyon 1, CNRS, UMR5558, F-69365 Lyon, France; [Lasset, Christine] Ctr Leon Berard, Unit Prevent & Epidemiol Genet, Lyon, France; [Remenieras, Audrey] Inst Cancerol Gustave Roussy, Dept Genet, Villejuif, France; [Caron, Olivier] Inst Cancerol Gustave Roussy, Dept Med, Consultat Genet, Villejuif, France; [Hardouin, Agnes; Berthet, Pascaline; Miron, Penelope] Ctr Francois Baclesse, F-14021 Caen, France; [GEMO Study Collaborators] Federat Natl Ctr Lutte Contre Canc, Grp Genet & Canc, Canc Genet Network, GEMO Study, Paris, France; [Hogervorst, Frans B. L.] Netherlands Canc Inst, Family Canc Clin, Amsterdam, Netherlands; [Rookus, Matti A.] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands; [Jager, Agnes] Erasmus Univ, Med Ctr, Rotterdam Family Canc Clin, Dept Clin Genet, Rotterdam, Netherlands; [van den Ouweland, Ans] Rotterdam Family Canc Clin, Erasmus Univ Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [van der Luijt, Rob B.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Meijers-Heijboer, Hanne] Vrije Univ Amsterdam, Dept Clin Genet, Amsterdam, Netherlands; [Garcia, Encarna B. Gomez] Maastricht Univ, Med Ctr, Dept Clin Genet, Sch Oncol & Dev Biol, Maastricht, Netherlands; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Vreeswijk, Maaike P. G.] Leiden Univ, Med Ctr, Dept Toxicogenet, Leiden, Netherlands; [Lubinski, Jan; Jakubowska, Anna; Gronwald, Jacek; Huzarski, Tomasz; Byrski, Tomasz; Gorski, Bohdan; Cybulski, Cezary] Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Szczecin, Poland; [KConFab] Peter MacCallum Canc Inst, Kathleen Cuningham Fdn Consortium Res Familial Br, kConFab, Melbourne, Vic 3000, Australia; [Goldgar, David E.] Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT USA; [John, Esther M.] Stanford Univ, Sch Med, Canc Prevent Inst Calif, Stanford, CA USA; [Hopper, John L.; Southey, Melissa] Univ Melbourne, Melbourne, Vic, Australia; [Buys, Saundra S.] Univ Utah, Hlth Sci Ctr, Huntsman Canc Inst, Salt Lake City, UT USA; [Daly, Mary B.; Godwin, Andrew K.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Terry, Mary-Beth] Columbia Univ, New York, NY USA; [Schmutzler, Rita K.; Wappenschmidt, Barbara] Univ Cologne, Dept Obstet & Gynaecol, Ctr Familial Breast & Ovarian Canc, Cologne, Germany; [Schmutzler, Rita K.; Wappenschmidt, Barbara] Univ Cologne, CIO, Cologne, Germany; [Engel, Christoph] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Meindl, Alfons] Tech Univ Munich, Dept Obstet & Gynaecol, Div Tumor Genet, Klinikum Rechts Isar, Munich, Germany; [Preisler-Adams, Sabine] Univ Munster, Inst Human Genet, Munster, Germany; [Arnold, Norbert] Univ Kiel, Univ Hosp Schleswig Holstein, Dept Obstet & Gynaecol, Kiel, Germany; [Niederacher, Dieter] Univ Dusseldorf, Univ Hosp Dusseldorf, Div Mol Genet, Dept Obstet & Gynaecol, Dusseldorf, Germany; [Sutter, Christian] Heidelberg Univ, Div Mol Diagnost, Inst Human Genet, Heidelberg, Germany; [Domchek, Susan M.; Nathanson, Katherine L.; Rebbeck, Timothy] Univ Penn, Philadelphia, PA 19104 USA; [Blum, Joanne L.] Baylor Charles A Sammons Canc Ctr, Dallas, TX USA; [Piedmonte, Marion] Roswell Pk Canc Inst, Gynecol Oncol Grp Stat & Data Ctr, Buffalo, NY 14263 USA; [Rodriguez, Gustavo C.] Northshore Univ Hlth Syst, Evanston NW Healthcare, Evanston, IL USA; [Wakeley, Katie] Tufts Univ, New England Med Ctr, Boston, MA 02111 USA; [Boggess, John F.] Univ N Carolina, Chapel Hill, NC USA; [Basil, Jack] St Elizabeth Hosp, Edgewood, KY USA; [Blank, Stephanie V.] NYU, Sch Med, New York, NY USA; [Friedman, Eitan; Laitman, Yael; Milgrom, Roni] Sheba Med Ctr, Susanne Levy Gertner Oncogenet Unit, Tel Hashomer, Israel; [Kaufman, Bella] Inst Oncol, Sheba Med Ctr, Tel Hashomer, Israel; [Andrulis, Irene L.; Glendon, Gord] Ontario Canc Inst, Ontario Canc Genet Network, Toronto, ON M4X 1K9, Canada; [Ozcelik, Hilmi] Samuel Lunenfeld Res Inst, Fred Litwin Ctr Canc Genet, Toronto, ON, Canada; [Andrulis, Irene L.; Offit, Kenneth] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Kirchhoff, Tomas; Vijai, Joseph] Mem Hosp, Clin Genet Serv, New York, NY USA; [Kirchhoff, Tomas; Vijai, Joseph] Sloan Kettering Inst, Canc Biol & Genet Program, Mem Sloan Kettering Canc Ctr, New York, NY USA; [Gaudet, Mia M.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, New York, NY USA; [Gaudet, Mia M.] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, New York, NY USA; [Altshuler, David; Guiducci, Candace] Broad Inst Harvard, Cambridge, MA USA; [Altshuler, David; Guiducci, Candace] MIT, Cambridge, MA 02139 USA; [Loman, Niklas; Harbst, Katja] Lund Univ, Dept Oncol, Lund, Sweden; [Rantala, Johanna] Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden; [Ehrencrona, Hans] Uppsala Univ, Dept Genet & Pathol Rudbeck Lab, Uppsala, Sweden; [Gerdes, Anne-Marie] Dept Clin Genet, Copenhagen, Denmark; [Thomassen, Mads] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Sunde, Lone] Aalborg & Aarhus Univ, Dept Clin Genet, Aalborg, Denmark; [Peterlongo, Paolo; Radice, Paolo] Fdn Inst Ricovero Cura Carattere Sci, Unit Genet Susceptibil Canc, Dept Expt Oncol & Mol Med, Ist Nazl Tumori, Milan, Italy; [Peterlongo, Paolo; Radice, Paolo] Fdn Ist Fdn Italiana Ricera Cancro FIRC Oncol Mol, IFOM, Milan, Italy; [Manoukian, Siranoush] Fdn IRCCS Ist Nazl Tumori INT, Unit Med Genet, Dept Prevent & Predict Med, Milan, Italy; [Bonanni, Bernardo; de la Hoya, Miguel] Ist Europeo Oncol, Div Canc Prevent & Genet, Milan, Italy; [Viel, Alessandra] Ctr Riferimento Oncol, Div Expt Oncol, IRCCS, I-33081 Aviano, PN, Italy; [Caldes, Trinidad] Hosp Clin San Carlos, Madrid, Spain; [Singer, Christian F.; Fink-Retter, Anneliese] Med Univ Vienna, Dept Obstet Gynecol, Vienna, Austria; [Greene, Mark H.; Mai, Phuong L.; Loud, Jennifer T.] Natl Canc Inst, Div Canc Epidemiol & Genet, Clin Genet Branch, Bethesda, MD USA; [Lindor, Noralane M.] Mayo Clin Rochester, Rochester, MN USA; [Hansen, Thomas V. O.; Nielsen, Finn C.] Copenhagen Univ Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Blanco, Ignacio; Lazaro, Conxi] Gran Via Hosp, Catalan Inst Oncol, Hereditary Canc Program, Barcelona, Spain; [Garber, Judy] Dana Farber Canc Inst, Boston, MA 02115 USA; [Ramus, Susan J.; Gayther, Simon A.] UCL, Dept Gynecol Oncol, EGA, London, England; [Phelan, Catherine] Res Inst, Womens Coll, Toronto, ON, Canada; [Narod, Stephen] H Lee Moffitt Canc Ctr & Res Inst, Dept Epidemiol & Genet, Tampa, FL USA; [Benitez, Javier; Osorio, Ana] Spanish Natl Canc Res Ctr, Human Canc Genet Programme, Madrid, Spain; [Nevanlinna, Heli; Heikkinen, Tuomas] Univ Helsinki, Ctr Hosp, Dept Obstet & Gynecol, Helsinki, Finland; [Caligo, Maria A.] Univ Pisa, Dept Oncol, Div Surg Mol & Ultrastructural Pathol, Pisa, Italy; [Beattie, Mary S.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Beattie, Mary S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Beattie, Mary S.] Univ Calif San Francisco, Canc Risk Program, Helen Diller Family Canc Ctr, San Francisco, CA 94143 USA; [Hamann, Ute; Foersti, Asta] German Canc Res Ctr, Heidelberg, Germany; [Montagna, Marco; Casella, Cinzia] Ist Oncol Veneto IRCCS, Immunol & Mol Oncol Unit, Padua, Italy; [Neuhausen, Susan L.] Beckman Res Inst City Hope, Dept Populat Sci, Duarte, CA USA; [Karlan, Beth Y.] Canc Res Inst, Samuel Oschin Canc Inst, Div Gynecol Oncol, Cedars Sinai Med Ctr, Los Angeles, CA USA; [Karlan, Beth Y.] Univ Calif Los Angeles, Dept Obstet & Gynecol, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Tung, Nadine] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Toland, Amanda E.] Ohio State Univ, Coll Med, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Weitzel, Jeffrey] City Hope Canc Ctr, Div Clin Canc Genet, Duarte, CA USA; [Olopade, Olofunmilayo] Univ Chicago, Med Ctr, Chicago, IL 60637 USA; [Simard, Jacques] Univ Quebec, Ctr Hosp, Canc Genom Lab, Quebec City, PQ, Canada; [Simard, Jacques] Univ Laval, Ctr Rech Ctr Hosp Univ Quebec CHUQ, Quebec City, PQ G1K 7P4, Canada; [Rubinstein, Wendy S.] Northshore Univ Hlth Syst, Evanston, IL USA; [Arason, Adalgeir] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; [Rennert, Gad] Queensland Inst Med Res, QIMR GWAS Collect, Brisbane, Qld 4006, Australia; [Martin, Nicholas G.; Montgomery, Grant W.] B Rappaport Fac Med Techn, Haifa, Israel; [Martin, Nicholas G.; Montgomery, Grant W.] Carmel Hosp, Dept Commun Med & Epidemiol, Clalit Hlth Serv Natl Canc Control Ctr, Haifa, Israel; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Inst Med Biometr & Epidemiol, Hamburg, Germany; [Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany; [Brauch, Hiltrud] Univ Tubingen, Tubingen, Germany; [Severi, Gianluca; Baglietto, Laura] Canc Epidemiol Ctr, MCCS, Melbourne, Australia; [Cox, Angela] Univ Sheffield, Dept Oncol, Fac Med Dent & Hlth, Inst Canc Studies, Sheffield, S Yorkshire, England; [Cross, Simon S.] Univ Sheffield, Dept Neurosci, Acad Unit Pathol, Fac Med Dent & Hlth, Sheffield, S Yorkshire, England; [Miron, Penelope] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Yannoukakos, Drakoulis] Natl Ctr Sci Res Demokritos, Mol Diagnost Lab Inst Radioisotopes & Radiodiagno, Athens, Greece; [Fountzilas, George] Aristotle Univ Thessaloniki, Papageorgiou Hosp, Dept Med Oncol, Thessaloniki, Greece; [Fountzilas, George] Aristotle Univ Thessaloniki, Papageorgiou Hosp, Dept Med Oncol, Thessaloniki, Greece; [Fasching, Peter A.] Calif State Univ Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90032 USA; [Beckmann, Matthias W.] Univers Hosp Erlangen, Dept Gynecol & Obstet, Erlangen, Germany; [Silva, Isabel dos Santos; Peto, Julian] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Cancer Res UK Epidemiol & Genet Grp, London WC1, England; [Lambrechts, Diether] VRC, VIB, Leuven, Belgium; [Paridaens, Robert] Univ Hosp Leuven, Multidisciplinary Breast Ctr, Leuven, Belgium; [Ruediger, Thomas] Inst Pathol, Stadt Klinikum Karlsruhe, Karlsruhe, Germany; [Foersti, Asta] Lund Univ, Ctr Primary Hlth Care Res, Lund, Sweden; [Winqvist, Robert; Pylkaes, Katri] Univ Oulu, Dept Clin Genet & Biocenter Oulu, Canc Genet Lab, Oulu Univ Hosp, Oulu, Finland; [Diasio, Robert B.; Lee, Adam M.] Mayo Clin, Dept Pharmacol, Rochester, MN USA; [Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Gen, Philadelphia, PA 19104 USA	University of Cambridge; Mayo Clinic; Mayo Clinic; CHU Lyon; UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Centre Leon Berard; QIMR Berghofer Medical Research Institute; University of Manchester; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Guy's & St Thomas' NHS Foundation Trust; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; UNICANCER; Centre Leon Berard; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UNICANCER; Centre Francois Baclesse; Netherlands Cancer Institute; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; Maastricht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Pomeranian Medical University; Peter Maccallum Cancer Center; Utah System of Higher Education; University of Utah; Cancer Prevention Institute of California; Stanford University; University of Melbourne; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Fox Chase Cancer Center; Columbia University; University of Cologne; University of Cologne; Leipzig University; Technical University of Munich; University of Munster; University of Kiel; Schleswig Holstein University Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Ruprecht Karls University Heidelberg; University of Pennsylvania; Baylor University Medical Center; Texas Oncology-Baylor Charles A Sammons Cancer Center; Roswell Park Cancer Institute; NorthShore University Health System; Tufts Medical Center; Tufts University; University of North Carolina; University of North Carolina Chapel Hill; New York University; Chaim Sheba Medical Center; Chaim Sheba Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Yeshiva University; Yeshiva University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Lund University; Karolinska Institutet; Karolinska University Hospital; Uppsala University; University of Southern Denmark; Odense University Hospital; Aalborg University; Fondazione IRCCS Istituto Nazionale Tumori Milan; IFOM - FIRC Institute of Molecular Oncology; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS European Institute of Oncology (IEO); IRCCS Aviano (CRO); Hospital Clinico San Carlos; Medical University of Vienna; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; University of Copenhagen; Catalan Institute of Oncology; Harvard University; Dana-Farber Cancer Institute; University of London; University College London; University of Toronto; Women's College Research Institute; H Lee Moffitt Cancer Center & Research Institute; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Helsinki; University of Pisa; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); IRCCS Istituto Oncologico Veneto (IOV); City of Hope; Beckman Research Institute of City of Hope; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Beth Israel Deaconess Medical Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; City of Hope; University of Chicago; University of Chicago Medical Center; Laval University; University of Quebec; Laval University; NorthShore University Health System; Landspitali National University Hospital; QIMR Berghofer Medical Research Institute; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Clalit Health Services; Carmel Medical Center; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; University of Sheffield; University of Sheffield; Harvard University; Dana-Farber Cancer Institute; National Centre of Scientific Research "Demokritos"; Aristotle University of Thessaloniki; Papageorgiou Hospital; Aristotle University of Thessaloniki; Papageorgiou Hospital; California State University System; California State University Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Erlangen Nuremberg; University of London; London School of Hygiene & Tropical Medicine; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Municipal Hospital Karlsruhe; Lund University; University of Oulu; Mayo Clinic; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Couch, FJ (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England.	couch.fergus@mayo.edu	Viel, Alessandra/J-7116-2018; Blanco, Ignacio/AAN-5426-2021; Peterlongo, Paolo/Q-4717-2018; Verdrengh, Evelien/H-4571-2012; Osorio, Ana/I-4324-2014; Mazoyer, Sylvie/N-7559-2017; Sunde, Lone/AAG-7303-2019; GARCIA, CONXI LAZARO/Q-2410-2016; Sunde, Lone/H-7402-2013; Andrulis, Irene L./E-7267-2013; Hansen, Thomas/GWZ-2858-2022; jager, agnes/V-6381-2017; manoukian, siranoush/E-7132-2017; Nielsen, Finn Cilius/AAA-4926-2020; Severi, Gianluca/Q-1824-2019; Evans, D Gareth/AAB-4308-2022; Altshuler, David M/A-4476-2009; Fasching, Peter A/ABH-9912-2020; Gronwald, Jacek/A-4576-2017; Huzarski, Tomasz/AAQ-2161-2021; Spurdle, Amanda B/A-4978-2011; montagna, marco/E-2225-2012; Ehrencrona, Hans/Q-4621-2019; Fink, Rainer H/C-5333-2008; Tobias, Edward/D-4246-2009; Lambrechts, Diether/AAJ-3167-2020; Baglietto, Laura/AAB-9051-2019; DEVILEE, PETER/ABR-2140-2022; Eccles, Diana/K-6327-2019; Chenevix-Trench, Georgia/AAV-2014-2020; Ehrencrona, Hans/M-5619-2014; Jakubowska, Anna/O-8050-2014; Devilee, Peter/GXV-8005-2022; de la Hoya, MIguel/Z-2911-2019; Fountzilas, George/ABF-2139-2020; BYRSKI, Tomasz/I-2844-2014; Joseph, Vijai/J-9158-2013; Ozcelik, Hilmi/A-3952-2011; Pharoah, Paul/V-6658-2019; Bonanni, Bernardo/AAM-7928-2020; Montgomery, Grant W/B-7148-2008; Arnold, Norbert/E-3012-2010; Caligo, Adelaide Maria/K-4289-2018; Toland, Amanda Ewart/E-4202-2011; Ramus, Susan/AAG-8352-2019; Hansen, Thomas v. O./J-9361-2014; Severi, Gianluca/H-3774-2018; Hoogerbrugge, Nicoline/O-1016-2013; Blanco, Ignacio/D-2565-2013; Rebbeck, Timothy/GLU-8348-2022; Radice, Paolo/O-3119-2013	Viel, Alessandra/0000-0003-2804-0840; Blanco, Ignacio/0000-0002-7414-7481; Peterlongo, Paolo/0000-0001-6951-6855; Osorio, Ana/0000-0001-8124-3984; Sunde, Lone/0000-0002-8479-165X; GARCIA, CONXI LAZARO/0000-0002-7198-5906; jager, agnes/0000-0002-7713-1450; manoukian, siranoush/0000-0002-6034-7562; Severi, Gianluca/0000-0001-7157-419X; Evans, D Gareth/0000-0002-8482-5784; Altshuler, David M/0000-0002-7250-4107; Fasching, Peter A/0000-0003-4885-8471; Gronwald, Jacek/0000-0002-3643-2871; Huzarski, Tomasz/0000-0003-3857-4854; Spurdle, Amanda B/0000-0003-1337-7897; montagna, marco/0000-0002-4929-2150; Ehrencrona, Hans/0000-0002-5589-3622; Fink, Rainer H/0000-0002-6896-4266; Tobias, Edward/0000-0003-2649-7695; Lambrechts, Diether/0000-0002-3429-302X; Eccles, Diana/0000-0002-9935-3169; Chenevix-Trench, Georgia/0000-0002-1878-2587; Ehrencrona, Hans/0000-0002-5589-3622; Jakubowska, Anna/0000-0002-5650-0501; BYRSKI, Tomasz/0000-0001-9181-5026; Joseph, Vijai/0000-0002-7933-151X; Pharoah, Paul/0000-0001-8494-732X; Montgomery, Grant W/0000-0002-4140-8139; Arnold, Norbert/0000-0003-4523-8808; Caligo, Adelaide Maria/0000-0003-0589-1829; Ramus, Susan/0000-0003-0005-7798; Hansen, Thomas v. O./0000-0003-4635-2653; Severi, Gianluca/0000-0001-7157-419X; Hoogerbrugge, Nicoline/0000-0003-2393-8141; Blanco, Ignacio/0000-0002-7414-7481; Rebbeck, Timothy/0000-0002-4799-1900; Barrowdale, Daniel/0000-0003-1661-3939; Engel, Christoph/0000-0002-7247-282X; Dunning, Alison Margaret/0000-0001-6651-7166; Terry, Mary Beth/0000-0002-4106-5033; Yannoukakos, Drakoulis/0000-0001-7509-3510; de la Hoya, Miguel/0000-0002-8113-1410; Cox, Angela/0000-0002-5138-1099; Nathanson, Katherine/0000-0002-6740-0901; Houdayer, Claude/0000-0002-5190-0389; dos Santos Silva, Isabel/0000-0002-6596-8798; Thorne, Heather/0000-0003-3610-2511; Pylkas, Katri/0000-0002-2449-0521; Kirchhoff, Tomas/0000-0002-9055-2364; Brauch, Hiltrud/0000-0001-7531-2736; Tapper, William/0000-0002-5896-1889; Mazoyer, Sylvie/0000-0002-2135-0160; Cross, Simon/0000-0003-2044-1754; Martin, Nicholas/0000-0003-4069-8020; Simard, Jacques/0000-0001-6906-3390; Heikkinen, Tuomas/0000-0003-1154-6204; Nevanlinna, Heli/0000-0002-0916-2976; Winqvist, Robert/0000-0003-0932-9104; Rennert, Gad/0000-0002-8512-068X; Radice, Paolo/0000-0001-6298-4111; Southey, Melissa/0000-0002-6313-9005; Durocher, Francine/0000-0001-8012-4641; van der Luijt, Rob/0000-0002-0018-1089; Gomez-Garcia, Encarna/0000-0003-4999-8847; Lubinski, Jan/0000-0003-2931-3003; Eeles, Rosalind/0000-0002-3698-6241; Baglietto, Laura/0000-0002-8193-7529; Gerdes, Anne-Marie/0000-0002-0328-3320	Breast Cancer Research Foundation (BCRF); US National Institutes of Health [CA128978]; Cancer Research UK; MRC [G0801875] Funding Source: UKRI; Cancer Research UK [11174, 10118, 11022] Funding Source: researchfish; Medical Research Council [G0801875] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P50CA089393, U01CA069631, U01CA113916, U01CA069398, U01CA069638, P50CA116201, U01CA069417, RC4CA153828, R01CA122340, R01CA128978, R01CA074415] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000043] Funding Source: NIH RePORTER	Breast Cancer Research Foundation (BCRF); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Financial support for this study was provided by the Breast Cancer Research Foundation (BCRF), Susan G. Komen for the Cure and US National Institutes of Health grant CA128978 to F. J. C. and by Cancer Research UK to D. F. E. and A. C. A. A. C. A. is a Cancer Research UK Senior Cancer Research Fellow and D. F. E. is a Cancer Research UK Principal Research Fellow. The authors thank Cancer Genetic Markers of Susceptability (CGEMS) and Wellcome Trust Case Control Consortium (WTCCC) for provision of genotype data from controls. Study specific acknowledgments listed in Supplementary Note.	Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2008, BRIT J CANCER, V98, P1457, DOI 10.1038/sj.bjc.6604305; Antoniou AC, 2005, GENET EPIDEMIOL, V29, P1, DOI 10.1002/gepi.20074; Antoniou AC, 2008, AM J HUM GENET, V82, P937, DOI 10.1016/j.ajhg.2008.02.008; Antoniou AC, 2007, AM J HUM GENET, V81, P1186, DOI 10.1086/522611; Antoniou AC, 2009, HUM MOL GENET, V18, P4442, DOI 10.1093/hmg/ddp372; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Begg CB, 2008, JAMA-J AM MED ASSOC, V299, P194, DOI 10.1001/jama.2007.55-a; BOOS DD, 1992, AM STAT, V46, P327, DOI 10.2307/2685328; Buisson M, 2006, HUM MUTAT, V27, P1024, DOI 10.1002/humu.20384; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton D, 2007, HUM HERED, V64, P45, DOI 10.1159/000101422; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Lakhani SR, 2005, CLIN CANCER RES, V11, P5175, DOI 10.1158/1078-0432.CCR-04-2424; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Mazoyer S, 1998, AM J HUM GENET, V62, P713, DOI 10.1086/301768; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Milne RL, 2008, CLIN CANCER RES, V14, P2861, DOI 10.1158/1078-0432.CCR-07-4436; Perrin-Vidoz L, 2002, HUM MOL GENET, V11, P2805, DOI 10.1093/hmg/11.23.2805; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Simchoni S, 2006, P NATL ACAD SCI USA, V103, P3770, DOI 10.1073/pnas.0511301103; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Thompson DJ, 2008, CANCER EPIDEM BIOMAR, V17, P3490, DOI 10.1158/1055-9965.EPI-08-0734; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	32	259	265	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2010	42	10					885	+		10.1038/ng.669	http://dx.doi.org/10.1038/ng.669			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	655UO	20852631	Green Accepted, Green Published			2022-12-17	WOS:000282276600020
J	Jaglin, XH; Poirier, K; Saillour, Y; Buhler, E; Tian, GL; Bahi-Buisson, N; Fallet-Bianco, C; Phan-Dinh-Tuy, F; Kong, XP; Bomont, P; Castelnau-Ptakhine, L; Odent, S; Loget, P; Kossorotoff, M; Snoeck, I; Plessis, G; Parent, P; Beldjord, C; Cardoso, C; Represa, A; Flint, J; Keays, DA; Cowan, NJ; Chelly, J				Jaglin, Xavier Hubert; Poirier, Karine; Saillour, Yoann; Buhler, Emmanuelle; Tian, Guoling; Bahi-Buisson, Nadia; Fallet-Bianco, Catherine; Phan-Dinh-Tuy, Francoise; Kong, Xiang Peng; Bomont, Pascale; Castelnau-Ptakhine, Laetitia; Odent, Sylvie; Loget, Philippe; Kossorotoff, Manoelle; Snoeck, Irina; Plessis, Ghislaine; Parent, Philippe; Beldjord, Cherif; Cardoso, Carlos; Represa, Alfonso; Flint, Jonathan; Keays, David Anthony; Cowan, Nicholas Justin; Chelly, Jamel			Mutations in the beta-tubulin gene TUBB2B result in asymmetrical polymicrogyria	NATURE GENETICS			English	Article							ALPHA-TUBULIN; NEURONAL MIGRATION; RNA INTERFERENCE; EXPRESSION; CHAPERONIN; SEQUENCES; SPECTRUM	Polymicrogyria is a relatively common but poorly understood defect of cortical development characterized by numerous small gyri and a thick disorganized cortical plate lacking normal lamination. Here we report de novo mutations in a beta-tubulin gene, TUBB2B, in four individuals and a 27-gestational-week fetus with bilateral asymmetrical polymicrogyria. Neuropathological examination of the fetus revealed an absence of cortical lamination associated with the presence of ectopic neuronal cells in the white matter and in the leptomeningeal spaces due to breaches in the pial basement membrane. In utero RNAi-based inactivation demonstrates that TUBB2B is required for neuronal migration. We also show that two disease-associated mutations lead to impaired formation of tubulin heterodimers. These observations, together with previous data, show that disruption of microtubule-based processes underlies a large spectrum of neuronal migration disorders that includes not only lissencephaly and pachygyria, but also polymicrogyria malformations.	[Tian, Guoling; Kong, Xiang Peng; Cowan, Nicholas Justin] NYU, Dept Biochem, Med Ctr, New York, NY 10016 USA; [Jaglin, Xavier Hubert; Poirier, Karine; Saillour, Yoann; Bahi-Buisson, Nadia; Phan-Dinh-Tuy, Francoise; Castelnau-Ptakhine, Laetitia; Chelly, Jamel] Univ Paris 05, CNRS, Inst Cochin, UMR 8104, Paris, France; [Jaglin, Xavier Hubert; Poirier, Karine; Saillour, Yoann; Bahi-Buisson, Nadia; Phan-Dinh-Tuy, Francoise; Castelnau-Ptakhine, Laetitia; Chelly, Jamel] INSERM, U567, Paris, France; [Buhler, Emmanuelle] INSERM, U901, Plateforme Postgenom INMED, F-13258 Marseille, France; [Bahi-Buisson, Nadia; Kossorotoff, Manoelle] Hop Necker Enfants Malad, Serv Neurol Pediat, Dept Pediat, AP HP, Paris, France; [Fallet-Bianco, Catherine] Hop St Anne, Serv Anat Pathol, F-75674 Paris, France; [Bomont, Pascale; Cardoso, Carlos; Represa, Alfonso] INSERM, Inst Neurobiol Mediterrane, U901, F-13258 Marseille, France; [Odent, Sylvie] Hop Sud, CHU Rennes, Serv Genet Med, Rennes, France; [Loget, Philippe] CHU Pontchaillou, Dept Anat & Cytopathol, Rennes, France; [Snoeck, Irina] Locatie Juliana Kinderziekenhusi Poliklin, The Hague, Netherlands; [Plessis, Ghislaine] CHU Hop Clemenceau, Serv Genet, Caen, France; [Parent, Philippe] CHU Hop Morvan, Dept Pediat & Genet Med, Brest, France; [Beldjord, Cherif] CHU Hop Cochin, Lab Biochim & Genet Mol, Paris, France; [Flint, Jonathan] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Keays, David Anthony] Inst Mol Pathol, A-1030 Vienna, Austria	New York University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes; CHU Rennes; CHU de Caen NORMANDIE; CHU Brest; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Oxford; Wellcome Centre for Human Genetics; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Cowan, NJ (corresponding author), NYU, Dept Biochem, Med Ctr, New York, NY 10016 USA.	nicholas.cowan@med.nyu.edu; jamel.chelly@inserm.fr	Represa, Alfonso/M-7383-2016; Fallet-Bianco, Catherine/AAP-7390-2020; Cardoso, Carlos/M-2767-2019; POIRIER, Karine/N-3009-2018; Bomont, Pascale/GLS-8721-2022; Bomont, Pascale L/Y-5517-2018; Cardoso, Carlos/H-4520-2016; Chelly, Jamel/J-7528-2015	Represa, Alfonso/0000-0002-5096-8939; Cardoso, Carlos/0000-0003-1914-9553; POIRIER, Karine/0000-0002-7928-2906; Bomont, Pascale/0000-0001-7216-3261; Bomont, Pascale L/0000-0001-7216-3261; Cardoso, Carlos/0000-0003-1914-9553; Chelly, Jamel/0000-0002-0939-8719; Saillour, Yoann/0000-0002-5110-9239; Flint, Jonathan/0000-0002-9427-4429; Kong, Xiang-Peng/0000-0001-5773-2681	AP-HP; INSERM; FRM; ANR [A05183KS, ANR-06-NEURO-008-01, RPV06055ASA]; Ministere de l'Enseignement Superieur et de la Recherche,; Universite Paris Descartes; EMBO [ASTF 66.00-2008]	AP-HP; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); FRM(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur et de la Recherche,(Estonian Research CouncilEuropean Commission); Universite Paris Descartes; EMBO(European Molecular Biology Organization (EMBO))	We thank F. Francis for her helpful comments and critical readings of the manuscript, the subjects and their parents who contributed in this study and all the colleagues who provided clinical and imaging information. We thank R. Guerrini for providing us helpful advice. We are grateful to E. Leguern for allowing K. P. to develop this project and all the members of Cochin Institute genomic platform, Cochin Hospital Cell Bank, and Isabelle Souville for their technical assistance. This work was supported by funding from AP-HP, INSERM, FRM ( funding within the frame of the Programme EQUIPEs FRM 2007) and ANR ( ANR Neuro 2005, project A05183KS and ANR-06-NEURO-008-01 contract number RPV06055ASA). X. H. J. is supported by a PhD fellowship of the Ministere de l'Enseignement Superieur et de la Recherche, by a grant for mobility from Universite Paris Descartes and an EMBO short-term fellowship ( ASTF 66.00-2008) for his work in NYU the Medical Center. K. P. is a post-doctoral researcher supported by FRM ( Fondation pour la Recherche Medicale).	Bahi-Buisson N, 2008, J MED GENET, V45, P647, DOI 10.1136/jmg.2008.058073; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; CLEVELAND DW, 1978, CELL, V15, P1021, DOI 10.1016/0092-8674(78)90286-6; Cowan NJ, 2002, ADV PROTEIN CHEM, V59, P73; Dutcher SK, 2001, CURR OPIN CELL BIOL, V13, P49, DOI 10.1016/S0955-0674(00)00173-3; GAO M, 1992, MOL CELL BIOL, V12, P1330, DOI 10.1128/MCB.12.3.1330; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Lewis SA, 1997, TRENDS CELL BIOL, V7, P479, DOI 10.1016/S0962-8924(97)01168-9; Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008; LITTLE M, 1988, COMP BIOCHEM PHYS B, V90, P655, DOI 10.1016/0305-0491(88)90320-3; LUDUENA RF, 1993, MOL BIOL CELL, V4, P445, DOI 10.1091/mbc.4.5.445; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Metin C, 2006, EUR J NEUROSCI, V23, P894, DOI 10.1111/j.1460-9568.2006.04630.x; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Poirier K, 2007, HUM MUTAT, V28, P1055, DOI 10.1002/humu.20572; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SULLIVAN KF, 1986, P NATL ACAD SCI USA, V83, P4327, DOI 10.1073/pnas.83.12.4327; TIAN GL, 1995, J BIOL CHEM, V270, P23910, DOI 10.1074/jbc.270.41.23910; Tian GL, 1997, J CELL BIOL, V138, P821, DOI 10.1083/jcb.138.4.821; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; Tian G, 2008, MOL BIOL CELL, V19, P1152, DOI 10.1091/mbc.E07-09-0861; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499	28	259	265	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					746	752		10.1038/ng.380	http://dx.doi.org/10.1038/ng.380			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19465910	Green Submitted, Green Accepted			2022-12-17	WOS:000266411700027
J	Kornak, U; Reynders, E; Dimopoulou, A; van Reeuwijk, J; Fischer, B; Rajab, A; Budde, B; Nurnberg, P; Foulquier, F; Lefeber, D; Urban, Z; Gruenewald, S; Annaert, W; Brunner, HG; van Bokhoven, H; Wevers, R; Morava, E; Matthijs, G; Van Maldergem, L; Mundlos, S				Kornak, Uwe; Reynders, Ellen; Dimopoulou, Aikaterini; van Reeuwijk, Jeroen; Fischer, Bjoern; Rajab, Anna; Budde, Birgit; Nurnberg, Peter; Foulquier, Francois; Lefeber, Dirk; Urban, Zsolt; Gruenewald, Stephanie; Annaert, Wim; Brunner, Han G.; van Bokhoven, Hans; Wevers, Ron; Morava, Eva; Matthijs, Gert; Van Maldergem, Lionel; Mundlos, Stefan		ARCL Debre-type Study Grp	Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2	NATURE GENETICS			English	Article							CONGENITAL DISORDER; DEFICIENCY REVEALS; COMPLEX-FORMATION; V-ATPASE; DEFECTS; PATHWAY; PH	We identified loss-of-function mutations in ATP6V0A2, encoding the a2 subunit of the V-type H+ ATPase, in several families with autosomal recessive cutis laxa type II or wrinkly skin syndrome. The mutations result in abnormal glycosylation of serum proteins (CDG-II) and cause an impairment of Golgi trafficking in fibroblasts from affected individuals. These results indicate that the a2 subunit of the proton pump has an important role in Golgi function.	[Kornak, Uwe; Dimopoulou, Aikaterini; Fischer, Bjoern; Mundlos, Stefan] Charite Univ Med Berlin, Inst Med Genet, Berlin, Germany; [Kornak, Uwe; Dimopoulou, Aikaterini; Fischer, Bjoern; Mundlos, Stefan] Max Planck Inst Mol Genet, Berlin, Germany; [Reynders, Ellen; Annaert, Wim] Katholieke Univ Leuven, Ctr Human Genet, Lab Membrane Trafficking, B-3000 Louvain, Belgium; [Reynders, Ellen; Annaert, Wim] Katholieke Univ Leuven VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [van Reeuwijk, Jeroen; Brunner, Han G.; van Bokhoven, Hans] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, NL-3525 GA Nijmegen, Netherlands; [Rajab, Anna] Minist Hlth, Directorate Gen Hlth Affairs, Genet Unit, Muscat 113, Oman; [Budde, Birgit; Nurnberg, Peter] Univ Cologne, CCG, D-50674 Cologne, Germany; [Budde, Birgit; Nurnberg, Peter] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Foulquier, Francois; Matthijs, Gert; Mundlos, Stefan] Katholieke Univ Leuven, Ctr Human Genet, Lab Mol Diagnost, B-3000 Louvain, Belgium; [Lefeber, Dirk; Wevers, Ron; Morava, Eva] Univ Med Ctr Nijmegen, Lab Peiat & Neurol, Dept Pediat, NL-6525 GA Nijmegen, Netherlands; [Urban, Zsolt] Washington Univ, Dept Pediat, St Louis, MO 63110 USA; [Urban, Zsolt] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Gruenewald, Stephanie] Great Ormond St Hosp Children Trust NHS, London WC1N 3JH, England; [Van Maldergem, Lionel] Univ Liege, CHU Sart Tilman, Ctr Genet Humaine, B-4000 Liege, Belgium	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Radboud University Nijmegen; University of Cologne; University of Cologne; KU Leuven; Radboud University Nijmegen; Washington University (WUSTL); Washington University (WUSTL); University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Liege	Kornak, U (corresponding author), Charite Univ Med Berlin, Inst Med Genet, Berlin, Germany.	uwe.kornak@charite.de	Fischer-Zirnsak, Björn/D-7487-2013; Morava, E./L-4529-2015; Van Maldergem, Lionel/G-9849-2017; Mundlos, Stefan/ABH-9585-2020; FOULQUIER, FRANCOIS/AAI-1182-2021; van Reeuwijk, Jeroen/P-8665-2015; Bokhoven, J.H.L.M. van van/H-8015-2014; Urban, Zsolt/B-1977-2008; Wevers, Ron A./H-8116-2014; Nanda, Arti/H-8565-2019; lefeber, dirk/G-5063-2012; Urban, Zsolt/A-2018-2013; Lefeber, Dirk DJ/A-2146-2014; van Bokhoven, Hans/D-8764-2012; Van Maldergem, Lionel/O-3242-2019; foulquier, francois/ABE-5886-2020; Brunner, Han/C-9928-2013; Salih, Mustafa/C-1222-2014	Fischer-Zirnsak, Björn/0000-0002-1075-7571; Van Maldergem, Lionel/0000-0001-8880-5214; van Reeuwijk, Jeroen/0000-0002-0658-4399; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Wevers, Ron A./0000-0003-2278-9746; Urban, Zsolt/0000-0003-3890-1843; Van Maldergem, Lionel/0000-0001-8880-5214; foulquier, francois/0000-0002-6551-3240; Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157; Dobyns, William/0000-0002-7681-2844; Mundlos, Stefan/0000-0002-9788-3166; Matthijs, Gert/0000-0001-6710-1912; Quelhas, Dulce/0000-0001-9989-9236; Leao Teles, Elisa/0000-0002-3011-0249; Nanda, Arti/0000-0002-1223-3181; Foulquier, Francois/0000-0001-5084-4015; Budde, Birgit/0000-0001-9385-4168; Salih, Mustafa/0000-0002-4379-2111				Axelsson MAB, 2001, GLYCOBIOLOGY, V11, P633, DOI 10.1093/glycob/11.8.633; Foulquier F, 2006, P NATL ACAD SCI USA, V103, P3764, DOI 10.1073/pnas.0507685103; Foulquier F, 2007, HUM MOL GENET, V16, P717, DOI 10.1093/hmg/ddl476; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Morava E, 2005, EUR J HUM GENET, V13, P414, DOI 10.1038/sj.ejhg.5201361; MORAVA E, IN PRESS EUR J HUM G; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; RAJAB A, IN PRESS AM J MED GE; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041	15	259	268	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2008	40	1					32	34		10.1038/ng.2007.45	http://dx.doi.org/10.1038/ng.2007.45			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18157129				2022-12-17	WOS:000252118600015
J	Zuchner, S; Noureddine, M; Kennerson, M; Verhoeven, K; Claeys, K; De Jonghe, P; Merory, J; Oliveira, SA; Speer, MC; Stenger, JE; Walizada, G; Zhu, DQ; Pericak-Vance, MA; Nicholson, G; Timmerman, V; Vance, JM				Zuchner, S; Noureddine, M; Kennerson, M; Verhoeven, K; Claeys, K; De Jonghe, P; Merory, J; Oliveira, SA; Speer, MC; Stenger, JE; Walizada, G; Zhu, DQ; Pericak-Vance, MA; Nicholson, G; Timmerman, V; Vance, JM			Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease	NATURE GENETICS			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; NEUROPATHY; IDENTIFICATION; LOCALIZATION; MICROTUBULES; MECHANISM; MUTANT; MAPS; FORM	Charcot-Marie-Tooth (CMT) disease is a clinically and genetically heterogeneous group of peripheral neuropathies. Different chromosomal loci have been linked with three autosomal dominant, `intermediate' types of CMT: DI-CMTA(1),DI-CMTB2 and DI-CMTC3. We refined the locus associated with DI-CMTB on chromosome 19p12- 13. 2 to 4.2 Mb in three unrelated families with CMT originating from Australia, Belgium and North America. After screening candidate genes, we identified unique mutations in dynamin 2 (DNM2) in all families. DNM2 belongs to the family of large GTPases and is part of the cellular fusion-fission apparatus(4). In transiently transfected cell lines, mutations of DNM2 substantially diminish binding of DNM2 to membranes by altering the conformation of the beta3/beta4 loop of the pleckstrin homology domain. Additionally, in the Australian and Belgian pedigrees, which carry two different mutations affecting the same amino acid, Lys558, CMT cosegregated with neutropenia, which has not previously been associated with CMT neuropathies.	Duke Univ, Med Ctr, Dept Human Genet, Durham, NC 27710 USA; Rhein Westfal TH Aachen, Univ Hosp, Dept Neuropathol, D-52074 Aachen, Germany; ANZAC Res Inst, Northcott Neurosci Lab, Sydney, NSW, Australia; Concord Hosp, Mol Med Lab, Concord, NSW, Australia; Univ Antwerp VIB, Dept Mol Genet, B-2020 Antwerp, Belgium; Univ Antwerp Hosp, Div Neurol, Antwerp, Belgium; Heidelberg Repatriat Hosp, Dept Neurol, Heidelberg West, Vic 3081, Australia	Duke University; RWTH Aachen University; RWTH Aachen University Hospital; University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp	Zuchner, S (corresponding author), Duke Univ, Med Ctr, Dept Human Genet, Durham, NC 27710 USA.		Oliveira, Sofia/F-3386-2010; Research Institute, ANZAC/CAE-9030-2022	Kennerson, Marina/0000-0003-3332-5074; Vance, Jeffery/0000-0003-3815-8199; Nicholson, Garth/0000-0001-9694-066X; Claeys, Kristl/0000-0001-9937-443X; Oliveira, Sofia A/0000-0001-7919-4191				Achiriloaie M, 1999, MOL CELL BIOL, V19, P1410; Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Jordanova A, 2003, AM J HUM GENET, V73, P1423, DOI 10.1086/379792; Kennerson ML, 2001, AM J HUM GENET, V69, P883, DOI 10.1086/323743; Kozlov MM, 1999, BIOPHYS J, V77, P604, DOI 10.1016/S0006-3495(99)76917-1; Lee A, 1999, CURR BIOL, V9, P261, DOI 10.1016/S0960-9822(99)80115-8; Muhlberg AB, 2000, METHODS, V20, P475, DOI 10.1006/meth.2000.0960; SCAIFE R, 1990, J CELL BIOL, V111, P3023, DOI 10.1083/jcb.111.6.3023; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Speer MC, 2002, NEUROGENETICS, V4, P83, DOI 10.1007/s10048-002-0139-3; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Vance JM, 2000, ARCH NEUROL-CHICAGO, V57, P638, DOI 10.1001/archneur.57.5.638; Verhoeven K, 2001, AM J HUM GENET, V69, P889, DOI 10.1086/323742; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002; Zhu DQ, 2003, NEUROGENETICS, V4, P179, DOI 10.1007/s10048-003-0147-y; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	27	259	270	1	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2005	37	3					289	294		10.1038/ng1514	http://dx.doi.org/10.1038/ng1514			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15731758				2022-12-17	WOS:000227297800020
J	Broeckel, U; Hengstenberg, C; Mayer, B; Holmer, S; Martin, LJ; Comuzzie, AG; Blangero, J; Nurnberg, P; Reis, A; Riegger, GAJ; Jacob, HJ; Schunkert, H				Broeckel, U; Hengstenberg, C; Mayer, B; Holmer, S; Martin, LJ; Comuzzie, AG; Blangero, J; Nurnberg, P; Reis, A; Riegger, GAJ; Jacob, HJ; Schunkert, H			A comprehensive linkage analysis for myocardial infarction and its related risk factors	NATURE GENETICS			English	Article							CORONARY-HEART-DISEASE; SUSCEPTIBILITY LOCUS; GENETIC-LINKAGE; PAIR ANALYSIS; CHROMOSOME; HYPERTENSION; ASSOCIATION; MAPS	Coronary artery disease and myocardial infarction (MI) are leading causes of death in the western world. Numerous studies have shown that risk factors such as diabetes mellitus, arterial hypertension and hypercholesterolemia contribute to the development of the disease. Although each risk factor by itself is partly under genetic control, a positive family history is an independent predictor, which suggests that there are additional susceptibility genes(1). We have scanned the whole genome in 513 families to identify chromosomal regions linked to myocardial infarction and related risk factors that are known to be under genetic control. Here we show, by using variance component analysis and incorporating risk factors, that risk of myocardial infarction maps to a single region on chromosome 14 with a significant lod score of 3.9 (pointwise P=0.00015, genome-wide P<0.05), providing evidence of a principal MI locus. To characterize this locus we analyzed each risk factor by itself. Serum concentrations of lipoprotein (a) show linkage to both the apolipoprotein (a) locus (lod score 26.99) and a new locus on chromosome 1 (lod score 3.8). There is suggestive linkage for diabetes mellitus on chromosome 6 (lod score 2.96), for hypertension on chromosomes 1 and 6, for high-density and low-density lipoprotein cholesterol on chromosomes 1 and 17, and for triglyceride concentrations on chromosome 9. Although some of these risk factors overlap with previously identified loci, none overlaps with the newly identified susceptibility locus for myocardial infarction and coronary artery disease.	Univ Regensburg, Klin & Poliklin Innere Med 2, D-8400 Regensburg, Germany; Med Coll Wisconsin, Dept Cardiovasc Med, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA; Max Delbruck Ctr Mol Med, Zentrum Genkartierung, Berlin, Germany; Univ Erlangen Nurnberg, Inst Humangenet, D-8520 Erlangen, Germany; Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	University of Regensburg; Medical College of Wisconsin; Medical College of Wisconsin; Texas Biomedical Research Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Erlangen Nuremberg; Medical College of Wisconsin	Schunkert, H (corresponding author), Univ Regensburg, Klin & Poliklin Innere Med 2, D-8400 Regensburg, Germany.	jacob@mcw.edu; heribert.schunkert@klinik.uni-regensburg.de	Blangero, John/ABA-7175-2021; Martin, Lisa/E-2425-2016; Hengstenberg, Christian/U-5485-2019; Reis, André/D-2309-2009	Martin, Lisa/0000-0001-8702-9946; Reis, André/0000-0002-6301-6363				Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Blangero J, 2001, ADV GENET, V42, P151, DOI 10.1016/S0065-2660(01)42021-9; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Comuzzie AG, 1999, GENET EPIDEMIOL, V17, pS109; Dahlen GH, 1998, J INTERN MED, V244, P417; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Lee YA, 2000, NAT GENET, V26, P470, DOI 10.1038/82625; LOBEL H, 1993, CIRCULATION, V88, P2524; Mansfield TA, 1997, NAT GENET, V16, P202, DOI 10.1038/ng0697-202; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Pajukanta P, 2000, AM J HUM GENET, V67, P1481, DOI 10.1086/316902; Pajukanta P, 1998, NAT GENET, V18, P369, DOI 10.1038/ng0498-369; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306; Sobel E, 1996, AM J HUM GENET, V58, P1323; Stoll M, 2000, GENOME RES, V10, P473, DOI 10.1101/gr.10.4.473; THOMPSON EA, 1993, 243 U WASH DEP STAT; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5	27	259	274	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2002	30	2					210	214		10.1038/ng827	http://dx.doi.org/10.1038/ng827			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11818963				2022-12-17	WOS:000173708700024
J	Zhao, XP; Alvarado, D; Rainier, S; Lemons, R; Hedera, P; Weber, CH; Tukel, T; Apak, M; Heiman-Patterson, T; Ming, L; Bui, M; Fink, JK				Zhao, XP; Alvarado, D; Rainier, S; Lemons, R; Hedera, P; Weber, CH; Tukel, T; Apak, M; Heiman-Patterson, T; Ming, L; Bui, M; Fink, JK			Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia	NATURE GENETICS			English	Article							GUANYLATE-BINDING PROTEIN-1; DYNAMIN; RECEPTOR; ENDOCYTOSIS; IMPAIRMENT; DATABASE; PROGRAMS; FAMILY	The hereditary spastic paraplegias (HSPs; Strumpell-Lorrain syndrome, MIM number 18260) are a diverse class of disorders characterized by insidiously progressive lower-extremity spastic weakness (reviewed in refs. 1-3). Eight autosomal dominant HSP (ADHSP) loci have been identified, the most frequent of which is that linked to the SPG4 locus on chromosome 2p22 (found in -42%)(1), followed by that linked to the SPG3A locus on chromosome 14q11-q21 (in similar to9%)(1). Only SPG4 has been identified(4) as a causative gene in ADHSP. Its protein (spastin) is predicted to participate in the assembly or function of nuclear protein complexes(4). Here we report the identification of mutations in a newly identified GTPase gene, SPG3A, in ADHSP affected individuals.	Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; Univ Istanbul, Inst Child Hlth, Div Med Genet, Istanbul, Turkey; Med Coll Penn & Hahnemann Univ, Sch Med, Dept Neurol, Philadelphia, PA USA; Ann Arbor Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Istanbul University; Drexel University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Fink, JK (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.			Hedera, Peter/0000-0003-2699-4085	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036177, R01NS033645, R01NS038713] Funding Source: NIH RePORTER; NINDS NIH HHS [R01NS33645, R01NS38713, R01NS36177] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Della Rocca GJ, 1999, J BIOL CHEM, V274, P4749, DOI 10.1074/jbc.274.8.4749; Fink JK, 1996, NEUROLOGY, V46, P1507, DOI 10.1212/WNL.46.6.1507; Fink JK, 1999, SEMIN NEUROL, V19, P301, DOI 10.1055/s-2008-1040846; FINK JK, 2001, IN PRESS EMERY RIMOI, V4; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hedera P, 2000, NEUROLOGY, V55, P1591, DOI 10.1212/WNL.55.10.1591; Hedera P, 2001, PRENATAL DIAG, V21, P202, DOI 10.1002/1097-0223(200103)21:3<202::AID-PD4>3.0.CO;2-U; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; JOUET M, 1994, NAT GENET, V7, P402, DOI 10.1038/ng0794-402; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Nicoziani P, 2000, MOL BIOL CELL, V11, P481, DOI 10.1091/mbc.11.2.481; NODA Y, 1993, NEUROSCIENCE, V55, P113, DOI 10.1016/0306-4522(93)90459-S; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Prakash B, 2000, EMBO J, V19, P4555, DOI 10.1093/emboj/19.17.4555; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; RAINER S, 2001, IN PRESS J MED GENET; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; SCHWEMMLE M, 1995, J BIOL CHEM, V270, P13518, DOI 10.1074/jbc.270.22.13518; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; Vogler O, 1998, J BIOL CHEM, V273, P12155, DOI 10.1074/jbc.273.20.12155; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	30	259	280	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2001	29	3					326	331		10.1038/ng758	http://dx.doi.org/10.1038/ng758			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11685207				2022-12-17	WOS:000171911000021
J	Waikel, RL; Kawachi, Y; Waikel, PA; Wang, XJ; Roop, DR				Waikel, RL; Kawachi, Y; Waikel, PA; Wang, XJ; Roop, DR			Deregulated expression of c-Myc depletes epidermal stem cells	NATURE GENETICS			English	Letter							HUMAN KERATINOCYTE MIGRATION; DIFFERENTIATION; FIBRONECTIN; INTEGRIN; PROLIFERATION; MARKERS; DEATH; MICE	The beta -catenin/TCF signaling pathway is essential for the maintenance of epithelial stem cells in the small intestine(1). c-Myc a downstream target of beta -catenin/TCF (ref. 2), can induce differentiation of epidermal stem cells in vitro(3). To determine the role of c-Myc in epidermal stem cells in vivo, we have targeted expression of human MYC2 to the hair follicles and the basal layer of mouse epidermis using a keratin 14 vector (K14,MYC2), Adult K14,MYC2 mice gradually lose their hair and develop spontaneous ulcerated lesions due to a severe impairment in wound healing; their keratinocytes show impaired migration in response to wounding. The expression of beta1 integrin, which is preferentially expressed in epidermal stem cells(4) is unusually low in the epidermis of K14.MYC2 mice. Label-retaining analysis to identify epidermal stem cells reveals a 75% reduction in the number of stem cells in 3-month-old K14.MYC2 mice, compared with wildtype mice. We conclude that deregulated expression of c-Myc in stem cells reduces beta1 integrin expression, which is essential to both keratinocyte migration and stem cell maintenance.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Dermatol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Roop, DR (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025479] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA052607, R01CA079998] Funding Source: NIH RePORTER; NCI NIH HHS [CA52607, CA09197, CA79998] Funding Source: Medline; NIAMS NIH HHS [AR62228] Funding Source: Medline; NICHD NIH HHS [HD25479] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AMATI B, 1994, CURR OPIN GENET DEV, V4, P102, DOI 10.1016/0959-437X(94)90098-1; Arin MJ, 2001, J CELL BIOL, V152, P645, DOI 10.1083/jcb.152.3.645; ARNOLD I, IN PRESS CURR BIOL; Barr LF, 1998, CANCER RES, V58, P5537; Berton TR, 2000, GENESIS, V26, P160, DOI 10.1002/(SICI)1526-968X(200002)26:2<160::AID-GENE20>3.0.CO;2-#; Bickenbach JR, 1998, EXP CELL RES, V244, P184, DOI 10.1006/excr.1998.4163; BIRO S, 1993, P NATL ACAD SCI USA, V90, P654, DOI 10.1073/pnas.90.2.654; CLARK RAF, 1982, J INVEST DERMATOL, V79, P264, DOI 10.1111/1523-1747.ep12500075; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; GUO M, 1990, J CELL SCI, V96, P197; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Judware R, 1997, ONCOGENE, V14, P1341, DOI 10.1038/sj.onc.1200955; KIM JP, 1992, J CELL PHYSIOL, V151, P443, DOI 10.1002/jcp.1041510303; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; MACKENZIE IC, 1985, CELL TISSUE RES, V242, P551; POTTEN CS, 1982, CELL TISSUE KINET, V15, P305, DOI 10.1111/j.1365-2184.1982.tb01050.x; STANLEY JR, 1983, J CELL BIOL, V96, P1809, DOI 10.1083/jcb.96.6.1809; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Waikel RL, 1999, ONCOGENE, V18, P4870, DOI 10.1038/sj.onc.1203040; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; WANG XT, 1995, J BEHAV DECIS MAKING, V8, P279, DOI 10.1002/bdm.3960080405; Watt FM, 1998, PHILOS T R SOC B, V353, P831, DOI 10.1098/rstb.1998.0247; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427	25	259	275	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2001	28	2					165	168		10.1038/88889	http://dx.doi.org/10.1038/88889			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381265				2022-12-17	WOS:000169011800020
J	Verhoeven, K; Van Laer, L; Kirschhofer, K; Legan, PK; Hughes, DC; Schatteman, I; Verstreken, M; Van Hauwe, P; Coucke, P; Chen, A; Smith, RJH; Somers, T; Offeciers, FE; Van de Heyning, P; Richardson, GP; Wachtler, F; Kimberling, WT; Willems, PJ; Govaerts, PJ; Van Camp, G				Verhoeven, K; Van Laer, L; Kirschhofer, K; Legan, PK; Hughes, DC; Schatteman, I; Verstreken, M; Van Hauwe, P; Coucke, P; Chen, A; Smith, RJH; Somers, T; Offeciers, FE; Van de Heyning, P; Richardson, GP; Wachtler, F; Kimberling, WT; Willems, PJ; Govaerts, PJ; Van Camp, G			Mutations in the human alpha-tectorin gene cause autosomal dominant non-syndromic hearing impairment	NATURE GENETICS			English	Article							TAMM-HORSFALL PROTEIN; MEMBRANE-PROTEIN; SEQUENCE; GRANULE; GP-2; GLYCOPROTEIN; HOMOLOGY; RECEPTOR; PANCREAS	The tectorial membrane is an extracellular matrix of the inner ear that contacts the stereocilia bundles of specialized sensory hair cells. Sound induces movement of these hair cells relative to the tectorial membrane, deflects the stereocilia, and leads to fluctuations in hair-cell membrane potential, transducing sound into electrical signals. alpha-tectorin is one of the major non-collagenous components of the tectorial membrane(1,2). Recently, the gene encoding mouse alpha-tectorin (Tecta) was mapped to a region of mouse chromosome 9, which shows evolutionary conservation with human chromosome 11q (ref. 3), where linkage was found in two families, one Belgian (DFNA12; ref. 4) and the other, Austrian (DFNA8; unpublished data), with autosomal dominant non-syndromic hearing impairment. We determined the complete sequence and the intron-exon structure of the human TECTA gene. In both families, mutation analysis revealed missense mutations which replace conserved amino-acid residues within the zona pellucida domain of TECTA. These findings indicate that mutations in TECTA are responsible for hearing impairment in these families, and implicate a new type of protein in the pathogenesis of hearing impairment.	Univ Instelling Antwerp, Dept Med Genet, B-2610 Wilrijk, Belgium; Univ Instelling Antwerp, Dept Otorhinolaryngol, B-2610 Wilrijk, Belgium; Univ Hosp Vienna, Clin Otorhinol, A-1090 Vienna, Austria; Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England; Univ Nottingham, MRC, Inst Hearing Res, Nottingham NG7 2RD, England; St Augustinus Hosp, Dept Otolaryngol, B-2610 Wilrijk, Belgium; Univ Iowa Hosp & Clin, Dept Otolaryngol, Iowa City, IA 52242 USA; Univ Vienna, Inst Histol & Embryol, A-1090 Vienna, Austria; Boys Town Natl Res Hosp, Omaha, NE 68131 USA	University of Antwerp; University of Antwerp; University Hospital Vienna; University of Sussex; University of Nottingham; University of Iowa; University of Vienna; Boys Town National Research Hospital	Van Camp, G (corresponding author), Univ Instelling Antwerp, Dept Med Genet, Universiteitsplein 1, B-2610 Wilrijk, Belgium.	gvcamp@uia.ua.ac.be	Van Camp, Guy/F-3386-2013; Hughes, David/AAB-9237-2019; Coucke, Paul J/AAO-2954-2020; Heyning, Paul H Vande/I-8278-2017	Van Camp, Guy/0000-0001-5105-9000; Hughes, David/0000-0002-4539-3093; Coucke, Paul J/0000-0001-7119-586X; Heyning, Paul H Vande/0000-0002-8424-3717; Smith, Richard/0000-0003-1201-6731; Legan, P. Kevin/0000-0002-7403-6415				BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; Brown DD, 1996, P NATL ACAD SCI USA, V93, P1924, DOI 10.1073/pnas.93.5.1924; DURKIN ME, 1988, J CELL BIOL, V107, P2749, DOI 10.1083/jcb.107.6.2749; FUKUOKA SI, 1992, P NATL ACAD SCI USA, V89, P1189, DOI 10.1073/pnas.89.4.1189; FUKUOKA SI, 1991, P NATL ACAD SCI USA, V88, P2898, DOI 10.1073/pnas.88.7.2898; GOVAERTS PJ, IN PRESS AM J OTOL; HARDY DM, 1995, J BIOL CHEM, V270, P26025, DOI 10.1074/jbc.270.44.26025; HESSION C, 1987, SCIENCE, V237, P1479, DOI 10.1126/science.3498215; HOOPS TC, 1991, J BIOL CHEM, V266, P4257; Hughes DC, 1998, GENOMICS, V48, P46, DOI 10.1006/geno.1997.5159; KRAWCZAK M, 1992, HUM GENET, V90, P41; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; LERACH H, 1990, GENOME ANAL, V1, P39; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PRASADAN K, 1995, BBA-GENE STRUCT EXPR, V1260, P328, DOI 10.1016/0167-4781(94)00240-4; RICHARDSON GP, 1987, HEARING RES, V25, P45, DOI 10.1016/0378-5955(87)90078-5; SULIK KK, 1995, HEREDITARY HEARING L, pCH4; Verhoeven K, 1997, AM J HUM GENET, V60, P1168; Wong SME, 1996, GENE, V171, P311, DOI 10.1016/0378-1119(96)00065-0; Yu Heron, 1994, Gene Expression, V4, P63	20	259	277	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1998	19	1					60	62		10.1038/ng0598-60	http://dx.doi.org/10.1038/ng0598-60			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590290				2022-12-17	WOS:000073346700018
J	MCLEAN, WHI; RUGG, EL; LUNNY, DP; MORLEY, SM; LANE, EB; SWENSSON, O; DOPPINGHEPENSTAL, PJC; GRIFFITHS, WAD; EADY, RAJ; HIGGINS, C; NAVSARIA, HA; LEIGH, IM; STRACHAN, T; KUNKELER, L; MUNRO, CS				MCLEAN, WHI; RUGG, EL; LUNNY, DP; MORLEY, SM; LANE, EB; SWENSSON, O; DOPPINGHEPENSTAL, PJC; GRIFFITHS, WAD; EADY, RAJ; HIGGINS, C; NAVSARIA, HA; LEIGH, IM; STRACHAN, T; KUNKELER, L; MUNRO, CS			KERATIN-16 AND KERATIN-17 MUTATIONS CAUSE PACHYONYCHIA-CONGENITA	NATURE GENETICS			English	Article							CERVICAL INTRAEPITHELIAL NEOPLASIA; EPIDERMOLYSIS-BULLOSA SIMPLEX; INTERMEDIATE FILAMENTS; HAIR-FOLLICLES; COILED-COIL; EXPRESSION; CELLS; GENES; CYTOKERATIN; PATTERNS	Pachyonychia congenita (PC) is a group of autosomal dominant disorders characterized by dystrophic nails and other ectodermal aberrations. A gene for Jackson-Lawler PC was recently mapped to the type I keratin cluster on 17q. Here, we show that a heterozygous missense mutation in the helix initiation motif of K17 (Asn92Asp) cosegregates with the disease in this kindred. We also show that Jadassohn-Lewandowsky PC is caused by a heterozygous missense mutation in the helix initiation peptide of K16 (Leu130Pro). The known expression patterns of these keratins in epidermal structures correlates with the specific abnormalities observed in each form of PC.	UNITED MED & DENT SCH, ST THOMAS HOSP, ST JOHNS INST DERMATOL, LONDON SE1 7EH, ENGLAND; ROYAL LONDON HOSP, COLL MED, EXPTL DERMATOL LABS, LONDON E1 6BL, ENGLAND; UNIV NEWCASTLE UPON TYNE, DEPT HUMAN GENET, NEWCASTLE UPON TYNE NE1 7RU, TYNE & WEAR, ENGLAND; SO GEN HOSP, DEPT DERMATOL, GLASGOW G51 4TF, LANARK, SCOTLAND	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Barts Health NHS Trust; Royal London Hospital; Newcastle University - UK; University of Glasgow	MCLEAN, WHI (corresponding author), UNIV DUNDEE, INST MED SCI, DEPT ANAT & PHYSIOL, CANC RES CAMPAIGN LABS, CELL STRUCT RES GRP, DUNDEE DD1 4HN, SCOTLAND.		McLean, William HI/C-6352-2009	McLean, William Henry Irwin/0000-0001-5539-5757	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALBERS K, 1987, J CELL BIOL, V105, P791, DOI 10.1083/jcb.105.2.791; ALBERS K, 1989, J CELL BIOL, V108, P1477, DOI 10.1083/jcb.108.4.1477; ALBERTSEN HM, 1994, NAT GENET, V7, P472, DOI 10.1038/ng0894-472; BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; CHENG J, 1992, CELL, V70, P811, DOI 10.1016/0092-8674(92)90314-3; CHIPEV CC, 1992, CELL, V70, P821, DOI 10.1016/0092-8674(92)90315-4; COLLIN C, 1992, EXP CELL RES, V202, P132, DOI 10.1016/0014-4827(92)90412-2; COULOMBE PA, 1990, J CELL BIOL, V111, P153, DOI 10.1083/jcb.111.1.153; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; HATZFELD M, 1990, J CELL BIOL, V110, P1199, DOI 10.1083/jcb.110.4.1199; HEID HW, 1988, DIFFERENTIATION, V37, P215, DOI 10.1111/j.1432-0436.1988.tb00724.x; HOROVITZ A, 1992, J MOL BIOL, V227, P560, DOI 10.1016/0022-2836(92)90907-2; JACKSON ADM, 1951, ANN EUGENIC, V16, P142, DOI 10.1111/j.1469-1809.1951.tb02468.x; JADASSOHN J, 1906, JACOBS IKONOGRAPHIA, V1, P29; KORGE BP, 1992, P NATL ACAD SCI USA, V89, P910, DOI 10.1073/pnas.89.3.910; KREMER H, 1994, J INVEST DERMATOL, V103, P286, DOI 10.1111/1523-1747.ep12394414; LANE EB, 1991, ANN NY ACAD SCI, V642, P197; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; LANE EB, 1994, CURR OPIN GENET DEV, V4, P412, DOI 10.1016/0959-437X(94)90030-2; LANGBEIN L, 1993, DIFFERENTIATION, V55, P57, DOI 10.1111/j.1432-0436.1993.tb00033.x; MCKUSICK VA, 1994, OMIM LINE MENDELIAN; MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118; MCLEAN WHI, 1994, J INVEST DERMATOL, V103, P277, DOI 10.1111/1523-1747.ep12394307; MCLEAN WHI, 1994, J INVEST DERMATOL, V102, P24, DOI 10.1111/1523-1747.ep12371726; MOLL R, 1982, J CELL BIOL, V95, P285, DOI 10.1083/jcb.95.1.285; MOLL R, 1982, DIFFERENTIATION, V23, P170, DOI 10.1111/j.1432-0436.1982.tb01280.x; MUNRO CS, 1994, J MED GENET, V31, P675, DOI 10.1136/jmg.31.9.675; QUINLAN RA, 1994, INTERMEDIATE FILAMEN; REIS A, 1994, NAT GENET, V6, P174, DOI 10.1038/ng0294-174; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; ROMANO V, 1987, CYTOGENET CELL GENET, V46, P683; ROMANO V, 1988, CYTOGENET CELL GENET, V48, P148, DOI 10.1159/000132612; ROSENBERG M, 1988, MOL CELL BIOL, V8, P722, DOI 10.1128/MCB.8.2.722; ROTHNAGEL JA, 1992, SCIENCE, V257, P1128, DOI 10.1126/science.257.5073.1128; ROTHNAGEL JA, 1994, NAT GENET, V7, P485, DOI 10.1038/ng0894-485; SERRANO L, 1992, J MOL BIOL, V227, P544, DOI 10.1016/0022-2836(92)90906-Z; SMEDTS F, 1990, AM J PATHOL, V136, P657; SMEDTS F, 1992, AM J PATHOL, V140, P601; STARK HJ, 1987, DIFFERENTIATION, V35, P236, DOI 10.1111/j.1432-0436.1987.tb00174.x; STEINERT PM, 1990, J BIOL CHEM, V265, P8766; STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161; STOOF TJ, 1994, KERATINOCYTE HDB, P365; TROYANOVSKY SM, 1989, J CELL SCI, V93, P419; TROYANOVSKY SM, 1992, EUR J CELL BIOL, V59, P127; VASSAR R, 1991, CELL, V64, P365, DOI 10.1016/0092-8674(91)90645-F; WEISS RA, 1984, J CELL BIOL, V98, P1397, DOI 10.1083/jcb.98.4.1397; WETZELS RHW, 1991, AM J PATHOL, V138, P751; WILSON CL, 1994, BRIT J DERMATOL, V131, P191	48	259	281	0	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1995	9	3					273	278		10.1038/ng0395-273	http://dx.doi.org/10.1038/ng0395-273			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	7539673				2022-12-17	WOS:A1995QL23200017
J	TENNYSON, CN; KLAMUT, HJ; WORTON, RG				TENNYSON, CN; KLAMUT, HJ; WORTON, RG			THE HUMAN DYSTROPHIN GENE REQUIRES 16 HOURS TO BE TRANSCRIBED AND IS COTRANSCRIPTIONALLY SPLICED	NATURE GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; POLYMERASE CHAIN-REACTION; MESSENGER-RNA; NASCENT TRANSCRIPTS; NONMUSCLE TISSUES; POLY(A) ADDITION; SITE SELECTION; MAJOR PRODUCT; BRAIN; EXPRESSION	The largest known gene is the human dystrophin gene, which has 79 exons spanning at least 2,300 kilobases (kb). Transcript accumulation was monitored from four regions of the gene following induction of expression in muscle cell cultures. Quantitative reverse transcription-polymerase chain reaction (RT-PCR) results indicate that approximately 12 h are required for transcription of 1,770 kb (at an average elongation rate of 2.4 kb min(-1)), extrapolating to a transcription time of 16 h for the complete gene. Accumulation profiles for spliced and total transcript demonstrated that transcripts are spliced at the 5' end before transcription is complete providing strong evidence for cotranscriptional splicing. The rate of transcript accumulation was reduced at the 3' end of the gene relative to the 5' end, perhaps due to premature termination of transcription complexes.	HOSP SICK CHILDREN,RES INST,TORONTO,ON M5G 1X8,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON M5G 1X8,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	TENNYSON, CN (corresponding author), HOSP SICK CHILDREN,DEPT GENET,555 UNIV AVE,TORONTO,ON M5G 1X8,CANADA.							ABEI M, 1987, TRENDS GENET, V3, P102; BAR S, 1990, BIOCHEM J, V272, P557, DOI 10.1042/bj2720557; BAUREN G, 1994, CELL, V76, P183, DOI 10.1016/0092-8674(94)90182-1; BEYER AL, 1988, GENE DEV, V2, P754, DOI 10.1101/gad.2.6.754; BIES RD, 1992, NUCLEIC ACIDS RES, V20, P1725, DOI 10.1093/nar/20.7.1725; BLAU HM, 1985, ADV EXP MED BIOL, V182, P85; BYERS TJ, 1993, NAT GENET, V4, P77, DOI 10.1038/ng0593-77; CHELLY J, 1990, EUR J BIOCHEM, V187, P691, DOI 10.1111/j.1432-1033.1990.tb15355.x; COFFEY AJ, 1992, GENOMICS, V12, P474, DOI 10.1016/0888-7543(92)90437-W; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; FEENER CA, 1989, NATURE, V338, P509, DOI 10.1038/338509a0; FORD JP, 1978, J VIROL, V28, P795, DOI 10.1128/JVI.28.3.795-801.1978; GALLI G, 1988, P NATL ACAD SCI USA, V85, P2439, DOI 10.1073/pnas.85.8.2439; GORECKI DC, 1992, HUM MOL GENET, V1, P505, DOI 10.1093/hmg/1.7.505; HEDLEY ML, 1991, CELL, V65, P579, DOI 10.1016/0092-8674(91)90090-L; HUGNOT JP, 1992, P NATL ACAD SCI USA, V89, P7506, DOI 10.1073/pnas.89.16.7506; KARIM FD, 1991, GENE DEV, V5, P1067, DOI 10.1101/gad.5.6.1067; KLAMUT HJ, 1990, MOL CELL BIOL, V10, P193, DOI 10.1128/MCB.10.1.193; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; LEDERFEIN D, 1993, HUM MOL GENET, V2, P1883, DOI 10.1093/hmg/2.11.1883; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; LEE HS, 1992, GENE DEV, V6, P284, DOI 10.1101/gad.6.2.284; LEMAIRE MF, 1990, MOL CELL BIOL, V10, P6059, DOI 10.1128/MCB.10.11.6059; LEV AA, 1987, J BIOL CHEM, V262, P15817; LONDON L, 1991, MOL CELL BIOL, V11, P4599, DOI 10.1128/MCB.11.9.4599; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; Maniatis T, 1989, DECONTAMINATION DILU; MONACO AP, 1992, GENOMICS, V12, P465, DOI 10.1016/0888-7543(92)90436-V; NEVINS JR, 1978, CELL, V15, P1477, DOI 10.1016/0092-8674(78)90071-5; NUDEL U, 1988, NATURE, V331, P635, DOI 10.1038/331635a0; REED R, 1986, CELL, V46, P681, DOI 10.1016/0092-8674(86)90343-0; ROBERTS RG, 1992, GENOMICS, V13, P942, DOI 10.1016/0888-7543(92)90005-D; SEHGAL PB, 1976, SCIENCE, V194, P431, DOI 10.1126/science.982026; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; SOLNICK D, 1985, CELL, V43, P667, DOI 10.1016/0092-8674(85)90239-9; SPENCER CA, 1990, ONCOGENE, V5, P777; THUMMEL CS, 1990, CELL, V61, P101, DOI 10.1016/0092-8674(90)90218-4; UCKER DS, 1984, J BIOL CHEM, V259, P7416; WANG AM, 1989, P NATL ACAD SCI USA, V86, P9717, DOI 10.1073/pnas.86.24.9717; WEBER J, 1980, J VIROL, V33, P286, DOI 10.1128/JVI.33.1.286-291.1980; ZEEVI M, 1981, CELL, V26, P39, DOI 10.1016/0092-8674(81)90031-3	42	259	273	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1995	9	2					184	190		10.1038/ng0295-184	http://dx.doi.org/10.1038/ng0295-184			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	7719347				2022-12-17	WOS:A1995QE67200021
J	Bonilla, X; Parmentier, L; King, B; Bezrukov, F; Kaya, G; Zoete, V; Seplyarskiy, VB; Sharpe, HJ; McKee, T; Letourneau, A; Ribaux, PG; Popadin, K; Basset-Seguin, N; Ben Chaabene, R; Santoni, FA; Andrianova, MA; Guipponi, M; Garieri, M; Verdan, C; Grosdemange, K; Sumara, O; Eilers, M; Aifantis, I; Michielin, O; de Sauvage, FJ; Antonarakis, SE; Nikolaev, SI				Bonilla, Ximena; Parmentier, Laurent; King, Bryan; Bezrukov, Fedor; Kaya, Gurkan; Zoete, Vincent; Seplyarskiy, Vladimir B.; Sharpe, Hayley J.; McKee, Thomas; Letourneau, Audrey; Ribaux, Pascale G.; Popadin, Konstantin; Basset-Seguin, Nicole; Ben Chaabene, Rouaa; Santoni, Federico A.; Andrianova, Maria A.; Guipponi, Michel; Garieri, Marco; Verdan, Carole; Grosdemange, Kerstin; Sumara, Olga; Eilers, Martin; Aifantis, Iannis; Michielin, Olivier; de Sauvage, Frederic J.; Antonarakis, Stylianos E.; Nikolaev, Sergey I.			Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma	NATURE GENETICS			English	Article							HEDGEHOG SIGNALING PATHWAY; KINETOCHORE GENE KNSTRN; C-MYC; TUMOR-SUPPRESSOR; MUTATIONAL LANDSCAPE; UBIQUITIN LIGASE; POINT MUTATIONS; CANCER; GROWTH; TRANSCRIPTION	Basal cell carcinoma (BCC) of the skin is the most common malignant neoplasm in humans. BCC is primarily driven by the Sonic Hedgehog (Hh) pathway. However, its phenotypic variation remains unexplained. Our genetic profiling of 293 BCCs found the highest mutation rate in cancer (65 mutations/Mb). Eighty-five percent of the BCCs harbored mutations in Hh pathway genes (PTCH1, 73% or SMO, 20% (P = 6.6 x 10(-8)) and SUFU, 8%) and in TP53 (61%). However, 85% of the BCCs also harbored additional driver mutations in other cancer-related genes. We observed recurrent mutations in MYCN (30%), PPP6C (15%), STK19 (10%), LATS1 (8%), ERBB2 (4%), PIK3CA (2%), and NRAS, KRAS or HRAS (2%), and loss-of-function and deleterious missense mutations were present in PTPN14 (23%), RB1 (8%) and FBXW7 (5%). Consistent with the mutational profiles, N-Myc and Hippo-YAP pathway target genes were upregulated. Functional analysis of the mutations in MYCN, PTPN14 and LATS1 suggested their potential relevance in BCC tumorigenesis.	[Bonilla, Ximena; Letourneau, Audrey; Ribaux, Pascale G.; Popadin, Konstantin; Ben Chaabene, Rouaa; Santoni, Federico A.; Garieri, Marco; Antonarakis, Stylianos E.; Nikolaev, Sergey I.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Parmentier, Laurent] Hosp Valais, Dept Dermatol, Sierre, Switzerland; [King, Bryan; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY USA; [Bezrukov, Fedor] Univ Connecticut, Dept Phys, Storrs, CT USA; [Bezrukov, Fedor] Brookhaven Natl Lab, RIKEN BNL Res Ctr, Upton, NY 11973 USA; [Kaya, Gurkan; Grosdemange, Kerstin] Univ Hosp Geneva, Dept Dermatol, Geneva, Switzerland; [Zoete, Vincent; Michielin, Olivier] Swiss Inst Bioinformat, Lausanne, Switzerland; [Seplyarskiy, Vladimir B.; Andrianova, Maria A.] Russian Acad Sci, Inst Informat Transmiss Problems, Moscow, Russia; [Seplyarskiy, Vladimir B.; Andrianova, Maria A.] Pirogov Russian Natl Res Med Univ, Moscow, Russia; [Seplyarskiy, Vladimir B.; Andrianova, Maria A.] Moscow MV Lomonosov State Univ, Moscow, Russia; [Sharpe, Hayley J.; de Sauvage, Frederic J.] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; [McKee, Thomas; Verdan, Carole] Univ Hosp Geneva, Serv Clin Pathol, Geneva, Switzerland; [Basset-Seguin, Nicole] Univ Paris 07, St Louis Hosp, Dept Dermatol, Paris, France; [Santoni, Federico A.; Guipponi, Michel; Antonarakis, Stylianos E.; Nikolaev, Sergey I.] Univ Hosp Geneva, Serv Genet Med, Geneva, Switzerland; [Sumara, Olga; Eilers, Martin] Univ Wurzburg, Dept Biochem & Mol Biol, D-97070 Wurzburg, Germany; [Eilers, Martin] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, D-97070 Wurzburg, Germany; [Michielin, Olivier] Univ Lausanne, Dept Oncol, Lausanne, Switzerland; [Michielin, Olivier] CHU Vaudois, CH-1011 Lausanne, Switzerland; [Antonarakis, Stylianos E.] Inst Genet & Genom Geneva iGE3, Geneva, Switzerland	University of Geneva; New York University; University of Connecticut; RIKEN; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Geneva; Swiss Institute of Bioinformatics; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Pirogov Russian National Research Medical University; Lomonosov Moscow State University; Roche Holding; Genentech; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Geneva; University of Wurzburg; University of Wurzburg; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Antonarakis, SE; Nikolaev, SI (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.; Antonarakis, SE; Nikolaev, SI (corresponding author), Univ Hosp Geneva, Serv Genet Med, Geneva, Switzerland.; Antonarakis, SE (corresponding author), Inst Genet & Genom Geneva iGE3, Geneva, Switzerland.	stylianos.antonarakis@unige.ch; sergey.nikolaev@unige.ch	Bezrukov, Fedor/AAA-3468-2021; Antonarakis, Stylianos E/N-8866-2014; Michielin, Olivier/ABE-7924-2020; Popadin, Konstantin/L-7459-2017; sharpe, Hayley/U-2214-2019; de Sauvage, Frederic/ABE-8400-2020; Andrianova, Maria/G-1786-2015; Bonilla, Ximena/AAI-7910-2021	Bezrukov, Fedor/0000-0003-3601-1003; Antonarakis, Stylianos E/0000-0001-8907-5823; sharpe, Hayley/0000-0002-4723-298X; de Sauvage, Frederic/0000-0002-5275-2584; Andrianova, Maria/0000-0002-4516-5082; Ben Chaabene, Rouaa/0000-0003-1617-6206; Eilers, Martin/0000-0002-0376-6533; Sumara, Olga/0000-0002-0845-3720; Bonilla, Ximena/0000-0002-4950-6825; McKee, Thomas/0000-0002-2147-3136; Santoni, Federico/0000-0002-3258-4747	Swiss Cancer League [LSCC 2939-02-2012]; Dinu Lipatti; Novartis [14B065]	Swiss Cancer League; Dinu Lipatti; Novartis(Novartis)	We thank Z. Modrusan (next-generation sequencing), R. Piskol (computational biology), G. Pau (computational biology), F. Peale (pathology) and S. Jillo (collaboration management) from Genentech, Inc. This work was supported by Swiss Cancer League (LSCC 2939-02-2012), Dinu Lipatti 2014 and Novartis (14B065) research grants to S.I.N.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Atwood SX, 2015, CANCER CELL, V27, P342, DOI 10.1016/j.ccell.2015.02.002; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Basset-Seguin N, 2015, LANCET ONCOL, V16, P729, DOI 10.1016/S1470-2045(15)70198-1; Besaratinia A, 2007, P NATL ACAD SCI USA, V104, P5953, DOI 10.1073/pnas.0610534104; Brash DE, 2015, PHOTOCHEM PHOTOBIOL, V91, P15, DOI 10.1111/php.12377; Brastianos PK, 2013, NAT GENET, V45, P285, DOI 10.1038/ng.2526; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chang ALS, 2012, ARCH DERMATOL, V148, P1324, DOI 10.1001/archdermatol.2012.2354; Chen CL, 2010, GENOME RES, V20, P447, DOI 10.1101/gr.098947.109; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Clark VE, 2013, SCIENCE, V339, P1077, DOI 10.1126/science.1233009; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Almeida ACD, 2015, NAT GENET, V47, P1465, DOI 10.1038/ng.3442; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Dreno B, 2014, ONCOLOGIST, V19, P790, DOI 10.1634/theoncologist.2014-0003; DROBETSKY EA, 1993, MUTAT RES, V289, P131, DOI 10.1016/0027-5107(93)90062-K; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Ellison DW, 2011, ACTA NEUROPATHOL, V121, P381, DOI 10.1007/s00401-011-0800-8; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/cpps.20]; Freier K, 2006, ONCOL REP, V15, P1141; GERDES J, 1992, J PATHOL, V168, P85, DOI 10.1002/path.1711680114; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hammond D, 2013, J CELL SCI, V126, P3429, DOI 10.1242/jcs.128397; HANAWALT PC, 1994, CURR BIOL, V4, P518, DOI 10.1016/S0960-9822(00)00112-3; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iwasaki JK, 2012, J AM ACAD DERMATOL, V66, pE167, DOI 10.1016/j.jaad.2010.06.054; Jaju PD, 2015, J INVEST DERMATOL, V135, P3197, DOI 10.1038/jid.2015.339; Jayaraman SS, 2014, J INVEST DERMATOL, V134, P213, DOI 10.1038/jid.2013.276; KATO GJ, 1992, FASEB J, V6, P3065, DOI 10.1096/fasebj.6.12.1521738; King B, 2013, CELL, V153, P1552, DOI 10.1016/j.cell.2013.05.041; Knoepfler PS, 2006, CELL CYCLE, V5, P47, DOI 10.4161/cc.5.1.2292; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Laurendeau I, 2010, MOL MED, V16, P262, DOI 10.2119/molmed.2010.00005; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee CS, 2014, NAT GENET, V46, P1060, DOI 10.1038/ng.3091; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li LL, 2013, FEBS LETT, V587, P3921, DOI 10.1016/j.febslet.2013.10.042; Lodrini M, 2013, NUCLEIC ACIDS RES, V41, P6018, DOI 10.1093/nar/gkt346; MARIONNET C, 1995, J MOL BIOL, V252, P550, DOI 10.1006/jmbi.1995.0519; McGregor JM, 1999, J INVEST DERMATOL, V112, P317, DOI 10.1046/j.1523-1747.1999.00507.x; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Murphy AJ, 2014, PEDIATR BLOOD CANCER, V61, P198, DOI 10.1002/pbc.24788; Nikolaev S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6690; Nikolaev SI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5654; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Nikolayeva O, 2014, METHODS MOL BIOL, V1150, P45, DOI 10.1007/978-1-4939-0512-6_3; Oue T, 2010, J PEDIATR SURG, V45, P387, DOI 10.1016/j.jpedsurg.2009.10.081; Pfister S, 2009, J CLIN ONCOL, V27, P1627, DOI 10.1200/JCO.2008.17.9432; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Reifenberger J, 2005, BRIT J DERMATOL, V152, P43, DOI 10.1111/J.1365-2133.2005.06353.X; Santos GC, 2007, J CLIN PATHOL, V60, P1, DOI 10.1136/jcp.2005.034389; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Sharpe HJ, 2015, CANCER CELL, V27, P327, DOI 10.1016/j.ccell.2015.02.001; Smith MJ, 2014, J CLIN ONCOL, V32, P4155, DOI 10.1200/JCO.2014.58.2569; Stacey SN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7825; Stefansson B, 2007, CELL CYCLE, V6, P1386, DOI 10.4161/cc.6.11.4276; Strano S, 2007, ONCOGENE, V26, P2212, DOI 10.1038/sj.onc.1210296; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sweeney RT, 2014, NAT GENET, V46, P722, DOI 10.1038/ng.2986; Tate G, 2015, MED MOL MORPHOL, V48, P177, DOI 10.1007/s00795-014-0086-8; Valentijn LJ, 2012, P NATL ACAD SCI USA, V109, P19190, DOI 10.1073/pnas.1208215109; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Wang WQ, 2012, GENE DEV, V26, P1959, DOI 10.1101/gad.192955.112; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Williams RD, 2015, ONCOTARGET, V6, P7232, DOI 10.18632/oncotarget.3377; Wilson KE, 2014, J BIOL CHEM, V289, P23693, DOI 10.1074/jbc.M113.534701; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Xiao WF, 2013, BIOCHEM BIOPH RES CO, V439, P167, DOI 10.1016/j.bbrc.2013.08.071; Xu LS, 2012, MOL CELL BIOCHEM, V364, P235, DOI 10.1007/s11010-011-1222-6; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200	87	258	260	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2016	48	4					398	+		10.1038/ng.3525	http://dx.doi.org/10.1038/ng.3525			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DH6NZ	26950094				2022-12-17	WOS:000372908800011
J	Katainen, R; Dave, K; Pitkanen, E; Palin, K; Kivioja, T; Valimaki, N; Gylfe, AE; Ristolainen, H; Hanninen, UA; Cajuso, T; Kondelin, J; Tanskanen, T; Mecklin, JP; Jarvinen, H; Renkonen-Sinisalo, L; Lepisto, A; Kaasinen, E; Kilpivaara, O; Tuupanen, S; Enge, M; Taipale, J; Aaltonen, LA				Katainen, Riku; Dave, Kashyap; Pitkanen, Esa; Palin, Kimmo; Kivioja, Teemu; Valimaki, Niko; Gylfe, Alexandra E.; Ristolainen, Heikki; Hanninen, Ulrika A.; Cajuso, Tatiana; Kondelin, Johanna; Tanskanen, Tomas; Mecklin, Jukka-Pekka; Jarvinen, Heikki; Renkonen-Sinisalo, Laura; Lepisto, Anna; Kaasinen, Eevi; Kilpivaara, Outi; Tuupanen, Sari; Enge, Martin; Taipale, Jussi; Aaltonen, Lauri A.			CTCF/cohesin-binding sites are frequently mutated in cancer	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR-BINDING; MUTATIONAL PROCESSES; CHROMATIN; COHESIN; GENOME; SIGNATURES; RESOLUTION; CTCF; SPECIFICITIES; DISCOVERY	Cohesin is present in almost all active enhancer regions, where it is associated with transcription factors(1,2). Cohesin frequently colocalizes with CTCF (CCCTC-binding factor), affecting genomic stability, expression and epigenetic homeostasis(3-6). Cohesin subunits are mutated in cancer(7,8), but CTCF/cohesin-binding sites (CBSs) in DNA have not been examined for mutations. Here we report frequent mutations at CBSs in cancers displaying a mutational signature where mutations in A.T base pairs predominate. Integration of whole-genome sequencing data from 213 colorectal cancer (CRC) samples and chromatin immunoprecipitation sequencing (ChIP-exo) data identified frequent point mutations at CBSs. In contrast, CRCs showing an ultramutator phenotype caused by defects in the exonuclease domain of DNA polymerase epsilon (POLE) displayed significantly fewer mutations at and adjacent to CBSs. Analysis of public data showed that multiple cancer types accumulate CBS mutations. CBSs are a major mutational hotspot in the noncoding cancer genome.	[Katainen, Riku; Pitkanen, Esa; Palin, Kimmo; Kivioja, Teemu; Valimaki, Niko; Gylfe, Alexandra E.; Ristolainen, Heikki; Hanninen, Ulrika A.; Cajuso, Tatiana; Kondelin, Johanna; Tanskanen, Tomas; Renkonen-Sinisalo, Laura; Kaasinen, Eevi; Kilpivaara, Outi; Tuupanen, Sari; Taipale, Jussi; Aaltonen, Lauri A.] Univ Helsinki, Res Programs Unit, Genome Scale Biol Res Program, Helsinki, Finland; [Katainen, Riku; Pitkanen, Esa; Palin, Kimmo; Valimaki, Niko; Gylfe, Alexandra E.; Ristolainen, Heikki; Hanninen, Ulrika A.; Cajuso, Tatiana; Kondelin, Johanna; Tanskanen, Tomas; Kaasinen, Eevi; Kilpivaara, Outi; Tuupanen, Sari; Aaltonen, Lauri A.] Univ Helsinki, Dept Med & Clin Genet Med, Helsinki, Finland; [Dave, Kashyap; Enge, Martin; Taipale, Jussi] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Mecklin, Jukka-Pekka] Univ Eastern Finland, Jyvaskyla Cent Hosp, Dept Surg, Jyvaskyla, Finland; [Jarvinen, Heikki; Renkonen-Sinisalo, Laura; Lepisto, Anna] Univ Helsinki, Cent Hosp, Hosp Dist Helsinki & Uusimaa, Dept Surg, Helsinki, Finland	University of Helsinki; University of Helsinki; Karolinska Institutet; Central Finland Central Hospital; University of Eastern Finland; University of Helsinki; Helsinki University Central Hospital	Aaltonen, LA (corresponding author), Univ Helsinki, Res Programs Unit, Genome Scale Biol Res Program, Helsinki, Finland.	jussi.taipale@ki.se; lauri.aaltonen@helsinki.fi	Katainen, Riku/GYR-0921-2022; Mecklin, Jukka-Pekka/AAC-9650-2019; Mecklin, Jukka-Pekka/AAB-5378-2020; Aaltonen, Lauri/A-5375-2010; Enge, Martin/GYQ-5073-2022; Palin, Kimmo/ABG-5710-2020; Pitkanen, Esa/H-2435-2018	Mecklin, Jukka-Pekka/0000-0003-4895-2249; Aaltonen, Lauri/0000-0001-6839-4286; Palin, Kimmo/0000-0002-4621-6128; Kaasinen, Eevi/0000-0002-1333-8049; Pitkanen, Esa/0000-0002-9818-6370; Lepisto, Anna Henriikka/0000-0002-5866-4059; Cajuso, Tatiana/0000-0002-6354-5572; Katainen, Riku/0000-0003-4575-4239; Enge, Martin/0000-0001-8748-8931; Hanninen, Ulrika/0000-0003-1558-0450	Academy of Finland (Finnish Center of Excellence Program) [250345, 137680, 274474]; University of Helsinki; Finnish Cancer Society; European Research Council (ERC) [268648]; Sigrid Juselius Foundation; SYSCOL (a European Union Framework Programme 7 Collaborative Project) [258236]; Nordic Information for Action eScience Center (NIASC); Nordic Center of Excellence - NordForsk [62721]; State Research Funding of Kuopio University Hospital [B1401]; Academy of Finland [271642, 263164]; Ministry of Education and Culture, Finland	Academy of Finland (Finnish Center of Excellence Program); University of Helsinki; Finnish Cancer Society; European Research Council (ERC)(European Research Council (ERC)European Commission); Sigrid Juselius Foundation(Sigrid Juselius Foundation); SYSCOL (a European Union Framework Programme 7 Collaborative Project); Nordic Information for Action eScience Center (NIASC); Nordic Center of Excellence - NordForsk; State Research Funding of Kuopio University Hospital; Academy of Finland(Academy of Finland); Ministry of Education and Culture, Finland	We thank S. Augsten, L. Hu, H. Metsola, S. Nieminen, A. Ollikainen, M. Rajalaakso, S. Soisalo, I.-L. Svedberg, M. Turunen, I. Vuoristo and A. Zetterlund for technical assistance. Further, we thank M. Aavikko, I. Donner, A. Karhu and M. Mehine for additional help with the manuscript. We acknowledge the International Cancer Genome Consortium (ICGC) for the somatic mutation data. This work was supported by grants from the Academy of Finland (Finnish Center of Excellence Program 2012-2017, 250345, personal grants 137680 and 274474 to O.K.), the University of Helsinki (personal grant to S.T.), the Finnish Cancer Society (also a personal grant to K.P.), the European Research Council (ERC; 268648), the Sigrid Juselius Foundation, SYSCOL (a European Union Framework Programme 7 Collaborative Project, 258236), the Nordic Information for Action eScience Center (NIASC), the Nordic Center of Excellence financed by NordForsk (project 62721, personal grant to K.P.) and State Research Funding of Kuopio University Hospital (B1401). We acknowledge the computational resources provided by the ELIXIR node, hosted at the CSC-IT Center for Science, Finland, and funded by the Academy of Finland (grants 271642 and 263164), the Ministry of Education and Culture, Finland.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Chen CL, 2010, GENOME RES, V20, P447, DOI 10.1101/gr.098947.109; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Guillou E, 2010, GENE DEV, V24, P2812, DOI 10.1101/gad.608210; Guo YC, 2010, BIOINFORMATICS, V26, P3028, DOI 10.1093/bioinformatics/btq590; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kon A, 2013, NAT GENET, V45, P1232, DOI 10.1038/ng.2731; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leiserson MDM, 2015, NAT GENET, V47, P106, DOI 10.1038/ng.3168; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Satou K, 2007, FREE RADICAL BIO MED, V42, P1552, DOI 10.1016/j.freeradbiomed.2007.02.024; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034	29	258	263	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					818	+		10.1038/ng.3335	http://dx.doi.org/10.1038/ng.3335			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26053496	Green Accepted			2022-12-17	WOS:000357090300022
J	Farhat, MR; Shapiro, BJ; Kieser, KJ; Sultana, R; Jacobson, KR; Victor, TC; Warren, RM; Streicher, EM; Calver, A; Sloutsky, A; Kaur, D; Posey, JE; Plikaytis, B; Oggioni, MR; Gardy, JL; Johnston, JC; Rodrigues, M; Tang, PKC; Kato-Maeda, M; Borowsky, ML; Muddukrishna, B; Kreiswirth, BN; Kurepina, N; Galagan, J; Gagneux, S; Birren, B; Rubin, EJ; Lander, ES; Sabeti, PC; Murray, M				Farhat, Maha R.; Shapiro, B. Jesse; Kieser, Karen J.; Sultana, Razvan; Jacobson, Karen R.; Victor, Thomas C.; Warren, Robin M.; Streicher, Elizabeth M.; Calver, Alistair; Sloutsky, Alex; Kaur, Devinder; Posey, Jamie E.; Plikaytis, Bonnie; Oggioni, Marco R.; Gardy, Jennifer L.; Johnston, James C.; Rodrigues, Mabel; Tang, Patrick K. C.; Kato-Maeda, Midori; Borowsky, Mark L.; Muddukrishna, Bhavana; Kreiswirth, Barry N.; Kurepina, Natalia; Galagan, James; Gagneux, Sebastien; Birren, Bruce; Rubin, Eric J.; Lander, Eric S.; Sabeti, Pardis C.; Murray, Megan			Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis	NATURE GENETICS			English	Article							INTRINSIC MULTIDRUG-RESISTANCE; COMPENSATORY MUTATIONS; 2-COMPONENT SYSTEM; RIFAMPIN-RESISTANT; ESCHERICHIA-COLI; FITNESS; GENES; SUSCEPTIBILITY; ANTIBIOTICS; EXPRESSION	M. tuberculosis is evolving antibiotic resistance, threatening attempts at tuberculosis epidemic control. Mechanisms of resistance, including genetic changes favored by selection in resistant isolates, are incompletely understood. Using 116 newly sequenced and 7 previously sequenced M. tuberculosis whole genomes, we identified genome-wide signatures of positive selection specific to the 47 drug-resistant strains. By searching for convergent evolution-the independent fixation of mutations in the same nucleotide position or gene-we recovered 100% of a set of known resistance markers. We also found evidence of positive selection in an additional 39 genomic regions in resistant isolates. These regions encode components in cell wall biosynthesis, transcriptional regulation and DNA repair pathways. Mutations in these regions could directly confer resistance or compensate for fitness costs associated with resistance. Functional genetic analysis of mutations in one gene, ponA1, demonstrated an in vitro growth advantage in the presence of the drug rifampicin.	[Farhat, Maha R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Pulm & Crit Care, Boston, MA 02114 USA; [Shapiro, B. Jesse; Galagan, James; Birren, Bruce; Lander, Eric S.; Sabeti, Pardis C.] Eli & Edythe L Broad Inst, Cambridge, MA USA; [Shapiro, B. Jesse; Sabeti, Pardis C.] Harvard Univ, Fac Arts & Sci, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Shapiro, B. Jesse; Sabeti, Pardis C.] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Shapiro, B. Jesse] Univ Montreal, Dept Sci Biol, Montreal, PQ H3C 3J7, Canada; [Kieser, Karen J.; Rubin, Eric J.; Sabeti, Pardis C.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Sultana, Razvan] Dana Farber Canc Inst, Dept Bioinformat & Computat Biol, Boston, MA 02115 USA; [Jacobson, Karen R.] Boston Univ, Sch Med, Infect Dis Sect, Boston, MA 02118 USA; [Jacobson, Karen R.; Victor, Thomas C.; Warren, Robin M.; Streicher, Elizabeth M.] Univ Stellenbosch, Fac Med & Hlth Sci, Ctr Mol & Cellular Biol,Dept Sci & Technol,Div Mo, MRC,Natl Res Fdn Ctr Excellence Biomed IB Res, ZA-7505 Tygerberg, South Africa; [Calver, Alistair] Anglogold Ashanti Hlth West Vaal Hosp, Orkney, South Africa; [Sloutsky, Alex; Kaur, Devinder] Univ Massachusetts, Sch Med, Massachusetts Supranat TB Reference Lab, Boston, MA 02125 USA; [Posey, Jamie E.; Plikaytis, Bonnie] Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Oggioni, Marco R.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Gardy, Jennifer L.] British Columbia Ctr Dis Control, Communicable Dis Prevent & Control Serv, Vancouver, BC, Canada; [Johnston, James C.] British Columbia Ctr Dis Control, Clin Prevent Serv, Vancouver, BC, Canada; [Rodrigues, Mabel; Tang, Patrick K. C.] British Columbia Ctr Dis Control, Prov Hlth Serv Author Labs, Publ Hlth Microbiol & Reference Lab, Mycobacteriol TB Lab, Vancouver, BC, Canada; [Kato-Maeda, Midori] Univ Calif San Francisco, Div Pulm & Crit Care, San Francisco, CA 94143 USA; [Muddukrishna, Bhavana] Massachusetts Gen Hosp, Dept Biol Mol, Boston, MA 02114 USA; [Muddukrishna, Bhavana] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Kreiswirth, Barry N.; Kurepina, Natalia] State Univ New Jersey, Rutgers, Publ Hlth Res Inst TB Ctr, Newark, NJ USA; [Galagan, James] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Galagan, James] Boston Univ, Dept Microbiol, Boston, MA 02215 USA; [Galagan, James] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Gagneux, Sebastien] Univ Basel, Basel, Switzerland; [Murray, Megan] Harvard Univ, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Murray, Megan] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Universite de Montreal; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Boston University; Stellenbosch University; University of Massachusetts System; University of Massachusetts Boston; Centers for Disease Control & Prevention - USA; University of Leicester; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Rutgers State University Newark; Rutgers State University New Brunswick; Boston University; Boston University; Boston University; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health	Farhat, MR (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Pulm & Crit Care, Boston, MA 02114 USA.	mrfarhat@partners.org; mmurray@hsph.harvard.edu	Oggioni, Marco Rinaldo/K-3839-2016; Gagneux, Sebastien/ABE-7909-2020; Streicher, Elizabeth M/I-7780-2018; Jacobson, Karen/AAX-9461-2021; Streicher, Elizabeth/O-9597-2019; Shapiro, B. Jesse/U-9337-2019; Sabeti, Pardis/GQH-8610-2022	Oggioni, Marco Rinaldo/0000-0003-4117-793X; Streicher, Elizabeth M/0000-0003-3901-1981; Streicher, Elizabeth/0000-0003-3901-1981; Shapiro, B. Jesse/0000-0001-6819-8699; Galagan, James/0000-0003-0542-3291; Jacobson, Karen/0000-0003-4239-3685; Warren, Robin/0000-0001-5741-7358; Rubin, Eric/0000-0001-5120-962X; Gagneux, Sebastien/0000-0001-7783-9048; Farhat, Maha/0000-0002-3871-5760; Tang, Patrick/0000-0003-1583-5484	Senior Ellison Foundation Award; National Institute of Allergy and Infectious Diseases [HHSN266200400001C]; Department of Pulmonary and Critical Care at Massachusetts General Hospital; Harvard MIDAS Center for Communicable Disease Dynamics; Packard Foundation; Swiss National Science Foundation [PP0033_119205]; FOGARTY INTERNATIONAL CENTER [K01TW009213] Funding Source: NIH RePORTER	Senior Ellison Foundation Award; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Pulmonary and Critical Care at Massachusetts General Hospital; Harvard MIDAS Center for Communicable Disease Dynamics; Packard Foundation(The David & Lucile Packard Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	We thank the technical staff of the British Columbia Centre for Disease Control Public Health Microbiology and Reference Mycobacteriology Laboratory in Vancouver, M. Bosman from the National Health Laboratory Service in Cape Town and L. Fattorini from the Istituto Superiore di Sanita in Rome. This work was funded by a Senior Ellison Foundation Award (M. M.) and in part by a contact from the National Institute of Allergy and Infectious Diseases (HHSN266200400001C to B. B.), the Department of Pulmonary and Critical Care at Massachusetts General Hospital (M. R. F.), a postdoctoral fellowship from the Harvard MIDAS Center for Communicable Disease Dynamics (B.J.S.) and a Packard Foundation Fellowship (P. C. S.). S. G. was supported by the Swiss National Science Foundation (PP0033_119205).	Agashe D, 2013, MOL BIOL EVOL, V30, P549, DOI 10.1093/molbev/mss273; [Anonymous], 2011, GLOB TUB CONTR 2011; Billman-Jacobe H, 1999, ANTIMICROB AGENTS CH, V43, P3011, DOI 10.1128/AAC.43.12.3011; Bisson GP, 2012, J BACTERIOL, V194, P6441, DOI 10.1128/JB.01013-12; Brandis G, 2012, MOL MICROBIOL, V85, P142, DOI 10.1111/j.1365-2958.2012.08099.x; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Cangelosi GA, 2006, ANTIMICROB AGENTS CH, V50, P461, DOI 10.1128/AAC.50.2.461-468.2006; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Chavadi SS, 2011, J BIOL CHEM, V286, P24616, DOI 10.1074/jbc.M111.247601; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; de Vos M, 2013, ANTIMICROB AGENTS CH, V57, P827, DOI 10.1128/AAC.01541-12; Denamur E, 2006, MOL MICROBIOL, V60, P820, DOI 10.1111/j.1365-2958.2006.05150.x; Dos Vultos T, 2009, FEMS MICROBIOL REV, V33, P471, DOI 10.1111/j.1574-6976.2009.00170.x; Dubey VS, 2002, MOL MICROBIOL, V45, P1451, DOI 10.1046/j.1365-2958.2002.03119.x; Goudet J., 2001, CLADISTICS; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hett EC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001020; Jiang X, 2006, MICROB DRUG RESIST, V12, P231, DOI 10.1089/mdr.2006.12.231; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Matsunaga I, 2004, J EXP MED, V200, P1559, DOI 10.1084/jem.20041429; Matsunaga I, 2012, CHEMOTHERAPY, V58, P341, DOI 10.1159/000343311; Moker N, 2004, MOL MICROBIOL, V54, P420, DOI 10.1111/j.1365-2958.2004.04249.x; Namouchi A, 2012, GENOME RES, V22, P721, DOI 10.1101/gr.129544.111; Nessar R, 2011, J ANTIMICROB CHEMOTH, V66, P1719, DOI 10.1093/jac/dkr209; Nguyen HT, 2010, MOL MICROBIOL, V76, P348, DOI 10.1111/j.1365-2958.2010.07110.x; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Philalay JS, 2004, ANTIMICROB AGENTS CH, V48, P3412, DOI 10.1128/AAC.48.9.3412-3418.2004; Popescu AA, 2012, BIOINFORMATICS, V28, P1536, DOI 10.1093/bioinformatics/bts184; Rokas A, 2008, MOL BIOL EVOL, V25, P1943, DOI 10.1093/molbev/msn143; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Schrag SJ, 1997, P ROY SOC B-BIOL SCI, V264, P1287, DOI 10.1098/rspb.1997.0178; Shapiro BJ, 2009, TRENDS MICROBIOL, V17, P196, DOI 10.1016/j.tim.2009.02.002; Shigemura Katsumi, 2005, Journal of Infection and Chemotherapy, V11, P226, DOI 10.1007/s10156-005-0403-1; Soldini S, 2011, TUBERCULOSIS, V91, P563, DOI 10.1016/j.tube.2011.08.002; Sun G, 2012, J INFECT DIS, V206, P1724, DOI 10.1093/infdis/jis601; Tanabe K, 1999, FEMS MICROBIOL LETT, V176, P191, DOI 10.1016/S0378-1097(99)00227-X; Yang Q, 2011, ARCH BIOCHEM BIOPHYS, V512, P135, DOI 10.1016/j.abb.2011.05.018; Yu J, 2012, INFECT IMMUN, V80, P1381, DOI 10.1128/IAI.06370-11; Zahrt TC, 2000, J BACTERIOL, V182, P3832, DOI 10.1128/JB.182.13.3832-3838.2000	45	258	277	2	115	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2013	45	10			SI		1183	U320		10.1038/ng.2747	http://dx.doi.org/10.1038/ng.2747			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	225UQ	23995135	Green Submitted, Green Accepted			2022-12-17	WOS:000324989600014
J	Karner, CM; Chirumamilla, R; Aoki, S; Igarashi, P; Wallingford, JB; Carroll, TJ				Karner, Courtney M.; Chirumamilla, Rani; Aoki, Shigehisa; Igarashi, Peter; Wallingford, John B.; Carroll, Thomas J.			Wnt9b signaling regulates planar cell polarity and kidney tubule morphogenesis	NATURE GENETICS			English	Article							DROSOPHILA TRACHEAL MORPHOGENESIS; CONVERGENT EXTENSION MOVEMENTS; BETA-CATENIN GENE; TUBE-SIZE CONTROL; CYSTIC KIDNEY; ZEBRAFISH GASTRULATION; TISSUE POLARITY; XENOPUS-LAEVIS; PRIMARY CILIUM; URETERAL BUD	Although many vertebrate organs, such as kidneys, lungs and liver, are composed of epithelial tubules, little is known of the mechanisms that establish the length or diameter of these tubules. In the kidney, defects in the establishment or maintenance of tubule diameter are associated with one of the most common inherited human disorders, polycystic kidney disease. Here we show that attenuation of Wnt9b signaling during kidney morphogenesis affects the planar cell polarity of the epithelium and leads to tubules with significantly increased diameter. Although previous studies showed that polarized cell divisions maintain the diameter of postnatal kidney tubules, we find that cell divisions are randomly oriented during embryonic development. Our data suggest that diameter is established during early morphogenetic stages by convergent extension processes and maintained by polarized cell divisions. Wnt9b, signaling through the non-canonical Rho/Jnk branch of the Wnt pathway, is necessary for both of these processes.	[Karner, Courtney M.; Chirumamilla, Rani; Aoki, Shigehisa; Igarashi, Peter; Carroll, Thomas J.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Nephrol, Dallas, TX 75390 USA; [Karner, Courtney M.; Chirumamilla, Rani; Carroll, Thomas J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Aoki, Shigehisa] Saga Univ, Pathol & Biodef Fac Med, Saga 840, Japan; [Igarashi, Peter] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Wallingford, John B.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Saga University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Austin	Carroll, TJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Nephrol, Dallas, TX 75390 USA.	thomas.carroll@utsouthwestern.edu	Aoki, Shigehisa/AFQ-9927-2022	Aoki, Shigehisa/0000-0002-1778-8944; Igarashi, Peter/0000-0001-8698-1185; Karner, Courtney/0000-0003-0387-4486	American Society for Nephrology; American Heart Association [0730236N]; Polycystic Kidney Disease Research Foundation; UAB ARPKD Center [5P30DK07403802]; US National Institutes of Health [1R01DK080004]; University of Texas Southwestern O'Brien Kidney Research Core Center [NIH P30DK079328]; National Institute for General Medical Sciences; March of Dimes; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079328, R01DK080004, R37DK042921, P30DK074038] Funding Source: NIH RePORTER	American Society for Nephrology; American Heart Association(American Heart Association); Polycystic Kidney Disease Research Foundation; UAB ARPKD Center; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Southwestern O'Brien Kidney Research Core Center; National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); March of Dimes(March of Dimes); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank O. Cleaver for reading and commenting on this manuscript, L. Avery for help with statistical analysis, J. Zhou (Brigham and Women's and Harvard Medical School) for providing us with antibodies to Pc-1 and Pc-2 and the Pkd1 mutant kidneys, M. Taketo (Kyoto University) for providing the beta-catenin exon 3 flox mice, O. Cabello (J. H. Quillen College of Medicine, East Tennessee State University) for providing us with the Invs mutant kidneys, B. Adams, E. Small, J. Shelton and the Molecular Pathology Core for technical assistance and L. James and M. Princena for the urine albumin studies. This work was supported by grants from the American Society for Nephrology, the American Heart Association (0730236N), the Polycystic Kidney Disease Research Foundation, the UAB ARPKD Center (5P30DK07403802) and the US National Institutes of Health (1R01DK080004) to T. J. C. The work was also supported by the University of Texas Southwestern O'Brien Kidney Research Core Center (NIH P30DK079328). J. B. W. was supported by grants from the National Institute for General Medical Sciences, the March of Dimes and the Burroughs Wellcome Fund.	Araujo SJ, 2005, DEV BIOL, V288, P179, DOI 10.1016/j.ydbio.2005.09.031; Baker SA, 2003, J BIOL CHEM, V278, P34211, DOI 10.1074/jbc.M300156200; Benzing T, 2007, J AM SOC NEPHROL, V18, P1389, DOI 10.1681/ASN.2006121355; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Concha ML, 1998, DEVELOPMENT, V125, P983; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; da Silva SM, 2007, DEVELOPMENT, V134, P3049, DOI 10.1242/dev.004911; Djiane A, 2000, DEVELOPMENT, V127, P3091; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Goldstein B, 2006, DEV CELL, V10, P391, DOI 10.1016/j.devcel.2005.12.016; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Goto T, 2005, CURR BIOL, V15, P787, DOI 10.1016/j.cub.2005.03.040; Goto T, 2002, DEV BIOL, V247, P165, DOI 10.1006/dbio.2002.0673; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hemphala J, 2003, DEVELOPMENT, V130, P249, DOI 10.1242/dev.00218; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Ibraghimov-Beskrovnaya O, 2007, CELL CYCLE, V6, P776, DOI 10.4161/cc.6.7.4047; Jayaram SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001964; Jonassen JA, 2008, J CELL BIOL, V183, P377, DOI 10.1083/jcb.200808137; Jung AC, 2006, CURR BIOL, V16, P1224, DOI 10.1016/j.cub.2006.04.048; Karner C, 2006, SEMIN CELL DEV BIOL, V17, P194, DOI 10.1016/j.semcdb.2006.05.003; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Marose TD, 2008, DEV BIOL, V314, P112, DOI 10.1016/j.ydbio.2007.11.016; Menezes LFC, 2004, KIDNEY INT, V66, P1345, DOI 10.1111/j.1523-1755.2004.00844.x; Merkel CE, 2007, PEDIATR NEPHROL, V22, P1825, DOI 10.1007/s00467-007-0504-4; Meyer TN, 2006, DIFFERENTIATION, V74, P638, DOI 10.1111/j.1432-0436.2006.00102.x; Michael L, 2005, KIDNEY INT, V68, P2010, DOI 10.1111/j.1523-1755.2005.00655.x; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nishimura M, 2007, DEVELOPMENT, V134, P4273, DOI 10.1242/dev.010397; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Paul SM, 2007, DEVELOPMENT, V134, P147, DOI 10.1242/dev.02710; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; SHIH J, 1992, DEVELOPMENT, V116, P901; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Tada M, 2000, DEVELOPMENT, V127, P2227; Thomson RB, 1999, AM J PHYSIOL-RENAL, V277, pF146, DOI 10.1152/ajprenal.1999.277.1.F146; Tong X, 2008, DEV BIOL, V317, P225, DOI 10.1016/j.ydbio.2008.02.040; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wallingford JB, 2001, INT J DEV BIOL, V45, P225; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Ward CJ, 2003, HUM MOL GENET, V12, P2703, DOI 10.1093/hmg/ddg274; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wu VM, 2004, CURR OPIN CELL BIOL, V16, P493, DOI 10.1016/j.ceb.2004.07.008; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087; Zeng GF, 2007, BLOOD, V109, P1345, DOI 10.1182/blood-2006-07-037952	71	258	266	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					793	U46		10.1038/ng.400	http://dx.doi.org/10.1038/ng.400			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	19543268	Green Accepted			2022-12-17	WOS:000267786200008
J	Kooner, JS; Chambers, JC; Aguilar-Salinas, CA; Hinds, DA; Hyde, CL; Warnes, GR; Perez, FJG; Frazer, KA; Elliott, P; Scott, J; Milos, PM; Cox, DR; Thompson, JF				Kooner, Jaspal S.; Chambers, John C.; Aguilar-Salinas, Carlos A.; Hinds, David A.; Hyde, Craig L.; Warnes, Gregory R.; Gomez Perez, Francisco J.; Frazer, Kelly A.; Elliott, Paul; Scott, James; Milos, Patrice M.; Cox, David R.; Thompson, John F.			Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides	NATURE GENETICS			English	Article							GENE; OBESITY; CHREBP; HDL	We tested over 267,000 SNPs in 1,005 Northern Europeans and 248,000 in 1,006 Indian Asians for association with triglycerides and HDL cholesterol, with replication in 10,536 subjects. We found association of a nonsynonymous SNP (rs3812316, G771C, Gln241His) in MLXIPL with plasma triglyceride levels (combined P = 1.4 x 10(-10)). MLXIPL coordinates transcriptional regulation of enzymes that channel glycolytic end-products into lipogenesis and energy storage, making MLXIPL a plausible 'thrifty gene'.	[Kooner, Jaspal S.; Scott, James] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Chambers, John C.; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London SW7 2AZ, England; [Aguilar-Salinas, Carlos A.; Gomez Perez, Francisco J.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City 14000, DF, Mexico; [Hinds, David A.; Frazer, Kelly A.; Cox, David R.] Perlegen Sci Inc, Mountain View, CA 94043 USA; [Hyde, Craig L.; Warnes, Gregory R.; Milos, Patrice M.] Pfizer Global Res & Dev, Groton, CT 06340 USA	Imperial College London; Imperial College London; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Pfizer	Scott, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England.	j.scott@imperial.ac.uk	Salinas, Carlos A Aguilar/AAL-4491-2020	Frazer, Kelly/0000-0002-6060-8902; Thompson, John/0000-0001-8568-3311; Elliott, Paul/0000-0002-7511-5684; Hinds, David/0000-0002-4911-803X	Medical Research Council [G0700931, G0601966] Funding Source: Medline; MRC [G0700931, G0601966] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Fisher RA, 1925, STAT METHODS RES WOR; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Li MV, 2006, DIABETES, V55, P1179, DOI 10.2337/db05-0822; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Ordovas JM, 2002, CARDIOVASC DRUG THER, V16, P273, DOI 10.1023/A:1021769523568; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	15	258	266	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2008	40	2					149	151		10.1038/ng.2007.61	http://dx.doi.org/10.1038/ng.2007.61			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18193046				2022-12-17	WOS:000252732900010
J	Nicot, AS; Toussaint, A; Tosch, V; Kretz, C; Wallgren-Pettersson, C; Iwarsson, E; Kingston, H; Garnier, JM; Biancalana, V; Oldfors, A; Mandel, JL; Laporte, J				Nicot, Anne-Sophie; Toussaint, Anne; Tosch, Valerie; Kretz, Christine; Wallgren-Pettersson, Carina; Iwarsson, Erik; Kingston, Helen; Garnier, Jean-Marie; Biancalana, Valerie; Oldfors, Anders; Mandel, Jean-Louis; Laporte, Jocelyn			Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR BIN1; MEMBRANE CURVATURE; SKELETAL-MUSCLE; SH3 DOMAIN; BAR; PHOSPHOINOSITIDES; MYOTUBULARINS; PHOSPHATASE; ENDOCYTOSIS; DOMINANT	Centronuclear myopathies are characterized by muscle weakness and abnormal centralization of nuclei in muscle fibers not secondary to regeneration. The severe neonatal X- linked form ( myotubular myopathy) is due to mutations in the phosphoinositide phosphatase myotubularin ( MTM1)(1), whereas mutations in dynamin 2 ( DNM2) have been found in some autosomal dominant cases(2). By direct sequencing of functional candidate genes, we identified homozygous mutations in amphiphysin 2 ( BIN1) in three families with autosomal recessive inheritance. Two missense mutations affecting the BAR ( Bin1/ amphiphysin/ RVS167) domain disrupt its membrane tubulation properties in transfected cells, and a partial truncation of the C- terminal SH3 domain abrogates the interaction with DNM2 and its recruitment to the membrane tubules. Our results suggest that mutations in BIN1 cause centronuclear myopathy by interfering with remodeling of T tubules and/ or endocytic membranes, and that the functional interaction between BIN1 and DNM2 is necessary for normal muscle function and positioning of nuclei.	IGBMC, Dept Mol Pathol, F-67400 Illkirch Graffenstaden, France; INSERM, U596, F-67400 Illkirch Graffenstaden, France; CNRS, UMR7104, F-67400 Illkirch Graffenstaden, France; Univ Strasbourg 1, F-67000 Strasbourg, France; Coll France, Chaire Genet Humaine, F-67400 Illkirch Graffenstaden, France; Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; Folkhalsan Inst Genet, Biomed, FIN-00014 Helsinki, Finland; Karolinska Univ Hosp, Dept Mol Med & Surg, Clin Genet Unit, S-17176 Stockholm, Sweden; Acad Unit Med Genet, Manchester M13 0JH, Lancs, England; Cent Manchester & Manchester Childrens Univ Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; Univ Strasbourg 1, Fac Med, CHRU, Lab Diagnost Genet, F-67085 Strasbourg, France; Univ Strasbourg 1, Med Genet Lab, EA3949, F-67085 Strasbourg, France; Sahlgrens Univ Hosp, Dept Pathol, SE-41345 Gothenburg, Sweden	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France; University of Helsinki; Karolinska Institutet; Karolinska University Hospital; University of Manchester; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Sahlgrenska University Hospital	Laporte, J (corresponding author), IGBMC, Dept Mol Pathol, F-67400 Illkirch Graffenstaden, France.	mtm@igbmc.u-strasbg.fr	Laporte, Jocelyn/H-6801-2016; laporte, jocelyn/O-4888-2019; laporte, jocelyn/J-7008-2012; Nicot, Anne-Sophie/GSE-6467-2022; Biancalana, Valerie/O-2351-2016; Iwarsson, Erik/J-4677-2019; Mandel, Jean Louis/Q-2668-2016	Iwarsson, Erik/0000-0002-3827-0263; Oldfors, Anders/0000-0002-5758-7397; Mandel, Jean Louis/0000-0002-0535-6589				Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Buj-Bello A, 2002, P NATL ACAD SCI USA, V99, P15060, DOI 10.1073/pnas.212498399; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Dang H, 2004, MOL BIOL CELL, V15, P189, DOI 10.1091/mbc.E03-08-0605; Engel A., 2004, MYOLOGY BASIC CLIN; Ge K, 1999, P NATL ACAD SCI USA, V96, P9689, DOI 10.1073/pnas.96.17.9689; Ge K, 2000, INT J CANCER, V85, P376; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Jeannet PY, 2004, NEUROLOGY, V62, P1484, DOI 10.1212/01.WNL.0000124388.67003.56; Kojima C, 2004, EMBO J, V23, P4413, DOI 10.1038/sj.emboj.7600442; KORSHUNOV A, 2006, ACTA NEUROPATHOL BER; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; MANDEL JL, 2002, STRUCTURAL MOL BASIS, P124; Muller AJ, 2003, MOL CELL BIOL, V23, P4295, DOI 10.1128/MCB.23.12.4295-4306.2003; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pierson CR, 2005, J NEUROPATH EXP NEUR, V64, P555, DOI 10.1097/01.jnen.0000171653.17213.2e; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tosch V, 2006, HUM MOL GENET, V15, P3098, DOI 10.1093/hmg/ddl250; WALLGRENPETTERSSON C, 1995, J MED GENET, V32, P673, DOI 10.1136/jmg.32.9.673; Wechsler-Reya RJ, 1998, MOL CELL BIOL, V18, P566, DOI 10.1128/MCB.18.1.566; WechslerReya R, 1997, J BIOL CHEM, V272, P31453, DOI 10.1074/jbc.272.50.31453	29	258	268	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1134	1139		10.1038/ng2086	http://dx.doi.org/10.1038/ng2086			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17676042				2022-12-17	WOS:000249122400024
J	Julien, SG; Dube, N; Read, M; Penney, J; Paquet, M; Han, YX; Kennedy, BP; Muller, WJ; Tremblay, ML				Julien, Sofi G.; Dube, Nadia; Read, Michelle; Penney, Janice; Paquet, Marilene; Han, Yongxin; Kennedy, Brian P.; Muller, William J.; Tremblay, Michel L.			Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis	NATURE GENETICS			English	Article							HUMAN BREAST-CANCER; TRANSGENIC MICE; NEU ONCOGENE; CYCLIN D1; SIGNALING PATHWAY; EPITHELIAL-CELLS; POINT MUTATION; ERBB RECEPTORS; TRANSFORMATION; KINASE	We investigated the role of protein tyrosine phosphatase 1B (PTP1B) in mammary tumorigenesis using both genetic and pharmacological approaches. It has been previously shown that transgenic mice with a deletion mutation in the region of Erbb2 encoding its extracellular domain (referred to as NDL2 mice, for 'Neu deletion in extracellular domain 2') develop mammary tumors that progress to lung metastasis. However, deletion of PTP1B activity in the NDL2 transgenic mice either by breeding with Ptpn1-deficient mice or by treatment with a specific PTP1B inhibitor results in significant mammary tumor latency and resistance to lung metastasis. In contrast, specific overexpression of PTP1B in the mammary gland leads to spontaneous breast cancer development. The regulation of ErbB2-induced mammary tumorigenesis by PTB1B occurs through the attenuation of both the MAP kinase (MAPK) and Akt pathways. This report provides a rationale for the development of PTP1B as a new therapeutic target in breast cancer.	McGill Univ, Ctr Canc, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Vet Pathol Serv, Montreal, PQ H3G 1Y6, Canada; Merck Frosst Ctr Therapeut Res, Pointe Claire, PQ H9R 4P8, Canada; McGill Univ, Royal Victoria Hosp, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; Merck & Company; McGill University; Royal Victoria Hospital; McGill University	Tremblay, ML (corresponding author), McGill Univ, Ctr Canc, 3655 Sir William Osler Promenade, Montreal, PQ H3G 1Y6, Canada.	michel.tremblay@mcgill.ca	Paquet, Marilene/L-3414-2019	Paquet, Marilene/0000-0002-3562-4636; Julien, Sophie/0000-0003-2694-7211				Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Andrechek ER, 2003, CANCER RES, V63, P4920; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BARGMANN CI, 1988, EMBO J, V7, P2043, DOI 10.1002/j.1460-2075.1988.tb03044.x; Baselga J, 2002, CANCER CELL, V1, P319, DOI 10.1016/S1535-6108(02)00066-1; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Bjorge JD, 2000, J BIOL CHEM, V275, P41439, DOI 10.1074/jbc.M004852200; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; BROWNSHIMER S, 1992, CANCER RES, V52, P478; Cheng A, 2001, J BIOL CHEM, V276, P25848, DOI 10.1074/jbc.M009734200; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Dube N, 2005, CANCER RES, V65, P10088, DOI 10.1158/0008-5472.CAN-05-1353; Dube N, 2004, P NATL ACAD SCI USA, V101, P1834, DOI 10.1073/pnas.0304242101; Dube N, 2004, CELL CYCLE, V3, P550; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Freiss G, 2004, CRIT REV ONCOL HEMAT, V52, P9, DOI 10.1016/j.critrevonc.2004.05.004; Hutchinson JN, 2000, ONCOGENE, V19, P6130, DOI 10.1038/sj.onc.1203970; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kaminski R, 2006, CANCER RES, V66, P5757, DOI 10.1158/0008-5472.CAN-05-3536; Kwong KY, 1998, MOL CARCINOGEN, V23, P62, DOI 10.1002/(SICI)1098-2744(199810)23:2<62::AID-MC2>3.0.CO;2-O; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Lane HA, 2000, MOL CELL BIOL, V20, P3210, DOI 10.1128/MCB.20.9.3210-3223.2000; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; Lenferink AEG, 2001, CANCER RES, V61, P6583; Lin HJ, 2005, BRIT J CANCER, V93, P1372, DOI 10.1038/sj.bjc.6602862; Liu F, 1998, MOL CELL BIOL, V18, P250, DOI 10.1128/MCB.18.1.250; Liu H, 2006, P NATL ACAD SCI USA, V103, P4134, DOI 10.1073/pnas.0511342103; Montalibet J, 2006, J BIOL CHEM, V281, P5258, DOI 10.1074/jbc.M511546200; Muraoka RS, 2002, MOL CELL BIOL, V22, P2204, DOI 10.1128/MCB.22.7.2204-2219.2002; Neve RM, 2000, ONCOGENE, V19, P1647, DOI 10.1038/sj.onc.1203470; Normanno N, 2003, ENDOCR-RELAT CANCER, V10, P1, DOI 10.1677/erc.0.0100001; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Perez-Nadales E, 2004, BREAST CANCER RES, V6, P137, DOI 10.1186/bcr792; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; SIEGEL PM, 1994, MOL CELL BIOL, V14, P7068, DOI 10.1128/MCB.14.11.7068; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2004, ONCOLOGIST, V9, P1, DOI 10.1634/theoncologist.9-suppl_3-1; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tamir I, 2000, IMMUNITY, V12, P347, DOI 10.1016/S1074-7613(00)80187-9; WIENER JR, 1994, AM J OBSTET GYNECOL, V170, P1177, DOI 10.1016/S0002-9378(94)70118-0; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; ZHAI YF, 1993, CANCER RES, V53, P2272; Zhao MM, 2006, MOL CELL BIOL, V26, P2479, DOI 10.1128/MCB.26.7.2479-2489.2006	44	258	270	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2007	39	3					338	346		10.1038/ng1963	http://dx.doi.org/10.1038/ng1963			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17259984				2022-12-17	WOS:000244480000015
J	Dos Santos, C; Essioux, L; Teinturier, C; Tauber, M; Goffin, V; Bougneres, P				Dos Santos, C; Essioux, L; Teinturier, C; Tauber, M; Goffin, V; Bougneres, P			A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone	NATURE GENETICS			English	Article							CRYSTAL-STRUCTURE; EXPRESSION; COMPLEX; DIVERSITY; MUTATION; CHILDREN; ISOFORM; HEIGHT; GH	Growth hormone is used to increase height in short children who are not deficient in growth hormone, but its efficacy varies largely across individuals. The genetic factors responsible for this variation are entirely unknown. In two cohorts of short children treated with growth hormone, we found that an isoform of the growth hormone receptor gene that lacks exon 3 (d3-GHR) was associated with 1.7 to 2 times more growth acceleration induced by growth hormone than the full-length isoform (P < 0.0001). In transfection experiments, the transduction of growth hormone signaling through d3-GHR homo- or heterodimers was similar to 30% higher than through full-length GHR homodimers (P < 0.0001). One-half of Europeans are hetero- or homozygous with respect to the allele encoding the d3-GHR isoform, which is dominant over the full-length isoform. These observations suggest that the polymorphism in exon 3 of GHR is important in growth hormone pharmacogenetics.	Univ Paris 05, St Vincent de Paul Hosp, INSERM, U561, F-75014 Paris, France; Univ Paris 05, St Vincent de Paul Hosp, Dept Pediat Endocrinol, F-75014 Paris, France; Childrens Hosp, Unite Endocrinol, Toulouse, France; Univ Paris 05, INSERM, U584, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bougneres, P (corresponding author), Univ Paris 05, St Vincent de Paul Hosp, INSERM, U561, 82 Ave Denfert Rochereau, F-75014 Paris, France.	bougneres@paris5.inserm.fr	GOFFIN, Vincent/G-3322-2013	GOFFIN, Vincent/0000-0002-8021-3086; DOS SANTOS MENGUY, Christine/0000-0002-6748-5183				BASS SH, 1991, P NATL ACAD SCI USA, V88, P4498, DOI 10.1073/pnas.88.10.4498; Bryant J, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD004440, 10.1002/14651858.CD004440]; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Frank SJ, 2002, ENDOCRINOLOGY, V143, P2, DOI 10.1210/en.143.1.2; Goffin V, 1996, J BIOL CHEM, V271, P16573, DOI 10.1074/jbc.271.28.16573; Hintz RL, 1999, NEW ENGL J MED, V340, P502, DOI 10.1056/NEJM199902183400702; ITHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; KELLY PA, 1993, RECENT PROG HORM RES, V48, P123; LESAGE C, 1991, J PEDIATR-US, V119, P29, DOI 10.1016/S0022-3476(05)81034-0; Ochoa R, 2003, HORM RES, V60, P68, DOI 10.1159/000071873; Pantel J, 2000, J BIOL CHEM, V275, P18664, DOI 10.1074/jbc.M001615200; Pantel J, 2003, J CLIN ENDOCR METAB, V88, P1705, DOI 10.1210/jc.2002-021667; SOBRIER ML, 1993, FEBS LETT, V319, P16, DOI 10.1016/0014-5793(93)80028-S; Sotiropoulos A, 1996, MOL ENDOCRINOL, V10, P998, DOI 10.1210/me.10.8.998; Stead JDH, 2000, HUM MOL GENET, V9, P713, DOI 10.1093/hmg/9.5.713; Sundstrom M, 1996, J BIOL CHEM, V271, P32197, DOI 10.1074/jbc.271.50.32197; URBANEK M, 1993, J BIOL CHEM, V268, P19025	18	258	271	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					720	724		10.1038/ng1379	http://dx.doi.org/10.1038/ng1379			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15208626	Bronze			2022-12-17	WOS:000222354100022
J	Bestor, TH; Tycko, B				Bestor, TH; Tycko, B			Creation of genomic methylation patterns	NATURE GENETICS			English	Article							DNA METHYLATION; GENE-REGULATION; METHYLTRANSFERASE; EVOLUTION	There are two biological properties of genomic methylation patterns that can be regarded as established. First, methylation of 5'-CpG-3' dinucleotides within promoters represses transcription, often to undetectable levels. Second, in most cases methylation patterns are subject to clonal inheritance. These properties suit methylation patterns for a number of biological roles, although none of the current hypotheses can be regarded as proved or disproved. One hypothesis suggests that the activity of parasitic sequence elements is repressed by selective methylation. Features of invasive sequences that might allow their identification and inactivation are discussed in terms of the genome defense hypothesis. Identification of the cues that direct de novo methylation may reveal the biological role (or roles) of genomic methylation patterns.	COLUMBIA UNIV COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10032	Columbia University	Bestor, TH (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,DEPT GENET & DEV,701 W 168TH ST,NEW YORK,NY 10032, USA.				NATIONAL CANCER INSTITUTE [R01CA060765, R01CA060610] Funding Source: NIH RePORTER; NCI NIH HHS [CA60610, CA60765] Funding Source: Medline; NIGMS NIH HHS [GMOO616] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHBURNER M, 1992, DROSOPHILA LAB HDB, V303; ASSAAD FF, 1993, PLANT MOL BIOL, V22, P1067, DOI 10.1007/BF00028978; BARLOW DP, 1993, SCIENCE, V260, P309, DOI 10.1126/science.8469984; BENDER J, 1995, CELL, V83, P725, DOI 10.1016/0092-8674(95)90185-X; BESTOR T, 1987, NUCLEIC ACIDS RES, V15, P3835, DOI 10.1093/nar/15.9.3835; BESTOR TH, 1993, CURR BIOL, V3, P384, DOI 10.1016/0960-9822(93)90209-7; BESTOR TH, 1990, PHILOS T ROY SOC B, V326, P179, DOI 10.1098/rstb.1990.0002; BESTOR TH, 1994, CURR OPIN CELL BIOL, V6, P380, DOI 10.1016/0955-0674(94)90030-2; BESTOR TH, 1995, GENOMIC IMPRINTING C; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; CHALLITA PM, 1994, P NATL ACAD SCI USA, V91, P2567, DOI 10.1073/pnas.91.7.2567; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; CHEN XA, 1995, P NATL ACAD SCI USA, V92, P5199, DOI 10.1073/pnas.92.11.5199; CHESNOKOV IN, 1995, J BIOL CHEM, V270, P18539, DOI 10.1074/jbc.270.31.18539; CLEAVER JE, 1994, CELL, V76, P1, DOI 10.1016/0092-8674(94)90165-1; CRAIG NL, 1995, SCIENCE, V270, P253, DOI 10.1126/science.270.5234.253; DUHL D, 1994, NAT GENET, V7, P220; ENGELS WR, 1994, SCIENCE, V263, P1623, DOI 10.1126/science.8128250; FINNEGAN J, 1994, BIO-TECHNOL, V12, P883, DOI 10.1038/nbt0994-883; FLAVELL RB, 1994, P NATL ACAD SCI USA, V91, P3490, DOI 10.1073/pnas.91.9.3490; GOYON C, 1994, J MOL BIOL, V240, P42, DOI 10.1006/jmbi.1994.1416; HATADA I, 1995, NAT GENET, V11, P204, DOI 10.1038/ng1095-204; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; JAENISCH R, 1985, P NATL ACAD SCI USA, V82, P1451, DOI 10.1073/pnas.82.5.1451; JENTSCH F, 1986, EMBO J, V5, P181; JUE K, 1995, BIOL REPROD, V53, P561, DOI 10.1095/biolreprod53.3.561; KLIMASAUSKAS S, 1995, NUCLEIC ACIDS RES, V23, P1388, DOI 10.1093/nar/23.8.1388; KRICKER MC, 1992, P NATL ACAD SCI USA, V89, P1075, DOI 10.1073/pnas.89.3.1075; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, COLD SPRING HARB SYM, V58, P297, DOI 10.1101/SQB.1993.058.01.035; LU M, 1991, J BIOL CHEM, V266, P2531; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; MATZKE AJM, 1994, MOL GEN GENET, V244, P219, DOI 10.1007/BF00285449; MATZKE MA, 1995, TRENDS GENET, V11, P1, DOI 10.1016/S0168-9525(00)88973-8; MICHAUD EJ, 1994, GENE DEV, V8, P1463, DOI 10.1101/gad.8.12.1463; MOULTON T, 1994, NAT GENET, V7, P440, DOI 10.1038/ng0794-440; MUMMANENI P, 1993, J BIOL CHEM, V268, P552; NEUMANN B, 1994, NAT GENET, V9, P451; PFEIFER GP, 1990, P NATL ACAD SCI USA, V87, P8252, DOI 10.1073/pnas.87.21.8252; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; RUBIN CM, 1994, NUCLEIC ACIDS RES, V22, P5121, DOI 10.1093/nar/22.23.5121; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; TAYLOR JH, 1984, MOL CELL BIOCHEM, V61, P99; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; YANG AS, 1995, NUCLEIC ACIDS RES, V23, P1380, DOI 10.1093/nar/23.8.1380; YOSHIURA K, 1995, P NATL ACAD SCI USA, V92, P7416, DOI 10.1073/pnas.92.16.7416	51	258	266	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1996	12	4					363	367		10.1038/ng0496-363	http://dx.doi.org/10.1038/ng0496-363			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UC553	8630488				2022-12-17	WOS:A1996UC55300013
J	Olbrich, H; Fliegauf, M; Hoefele, J; Kispert, A; Otto, E; Volz, A; Wolf, MT; Sasmaz, G; Trauer, U; Reinhardt, R; Sudbrak, R; Antignac, C; Gretz, N; Walz, G; Schermer, B; Benzing, T; Hildebrandt, F; Omran, H				Olbrich, H; Fliegauf, M; Hoefele, J; Kispert, A; Otto, E; Volz, A; Wolf, MT; Sasmaz, G; Trauer, U; Reinhardt, R; Sudbrak, R; Antignac, C; Gretz, N; Walz, G; Schermer, B; Benzing, T; Hildebrandt, F; Omran, H			Mutations in a novel gene, NPHP3, cause adolescent nephronophthisis, tapeto-retinal degeneration and hepatic fibrosis	NATURE GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; SENIOR-LOKEN-SYNDROME; FAMILIAL NEPHROPATHY; PROTEIN; PROGRESSION; INTERACTS; LOCUS; IDENTIFICATION; NEPHROCYSTIN; P130(CAS)	Nephronophthisis (NPHP), a group of autosomal recessive cystic kidney disorders, is the most common genetic cause of progressive renal failure in children and young adults(1). NPHP may be associated with Leber congenital amaurosis, tapetoretinal degeneration, cerebellar ataxia, cone-shaped epiphyses, congenital oculomotor apraxia and hepatic fibrosis(2-6). Loci associated with an infantile type of NPHP on 9q22-q31 (NPHP2), juvenile types of NPHP on chromosomes 2q12-q13 (NPHP1) and 1p36 (NPHP4) and an adolescent type of NPHP on 3q21-q22 (NPHP3) have been mapped(7-10). NPHP1 and NPHP4 have been identified(11-13), and interaction of the respective encoded proteins nephrocystin and nephrocystin-4 has been shown(13). Here we report the identification of NPHP3, encoding a novel 1,330-amino acid protein that interacts with nephrocystin. We describe mutations in NPHP3 in families with isolated NPHP and in families with NPHP with associated hepatic fibrosis or tapeto-retinal degeneration. We show that the mouse ortholog Nphp3 is expressed in the node, kidney tubules, retina, respiratory epithelium, liver, biliary tract and neural tissues. In addition, we show that a homozygous missense mutation in Nphp3 is probably responsible for the polycystic kidney disease (pcy) mouse phenotype(14). Interventional studies in the pcy mouse have shown beneficial effects by modification of protein intake and administration of methylprednisolone(15-17), suggesting therapeutic strategies for treating individuals with NPHP3.	Univ Hosp Freiburg, Dept Pediat & Adolescent Med, D-79106 Freiburg, Germany; Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Hannover Med Sch, Inst Mol Biol, Hannover, Germany; Max Planck Inst Mol Genet, Berlin, Germany; Univ Paris 05, Necker Hosp, Dept Genet, Paris, France; Heidelberg Univ, Klinikum Mannheim, Med Res Ctr, D-68167 Mannheim, Germany; Univ Hosp Freiburg, Div Renal, D-79106 Freiburg, Germany; Univ Hosp Freiburg, Clin Res Ctr, D-79106 Freiburg, Germany	University of Freiburg; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Hannover Medical School; Max Planck Society; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Ruprecht Karls University Heidelberg; University of Freiburg; University of Freiburg	Omran, H (corresponding author), Univ Hosp Freiburg, Dept Pediat & Adolescent Med, D-79106 Freiburg, Germany.	omran@kikli.ukl.uni-freiburg.de	Volz, Andreas/AAA-6290-2019; Schermer, Bernhard/E-9972-2014; Hoefele, Julia/AAB-6448-2020; Benzing, Thomas/X-5476-2019; ANTIGNAC, Corinne/H-8945-2017	Schermer, Bernhard/0000-0002-5194-9000; Hoefele, Julia/0000-0002-7917-7129; Omran, Heymut/0000-0003-0282-6765; Reinhardt, Richard/0000-0001-9376-2132; ANTIGNAC, Corinne/0000-0002-9934-4940; Otto, Edgar/0000-0002-2387-9973				ANTIGNAC C, 1993, NAT GENET, V3, P342, DOI 10.1038/ng0493-342; AUKEMA HM, 1992, KIDNEY INT, V42, P837, DOI 10.1038/ki.1992.358; Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Betz R, 2000, J PEDIATR-US, V136, P828, DOI 10.1067/mpd.2000.106225; BOICHIS H, 1973, Q J MED, V42, P221; Donaldson JC, 2000, EXP CELL RES, V256, P168, DOI 10.1006/excr.2000.4822; Erck C, 2000, NEUROCHEM RES, V25, P5, DOI 10.1023/A:1007523028834; GATTONE VH, 1995, AM J KIDNEY DIS, V25, P302, DOI 10.1016/0272-6386(95)90013-6; Haider NB, 1998, AM J HUM GENET, V63, P1404, DOI 10.1086/302108; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hildebrandt F, 2001, PEDIATR NEPHROL, V16, P168, DOI 10.1007/s004670000518; LOKEN AC, 1961, ACTA PAEDIATR, V50, P177, DOI 10.1111/j.1651-2227.1961.tb08037.x; MAINZER F, 1970, AM J MED, V49, P556, DOI 10.1016/S0002-9343(70)80051-1; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Omran H, 2002, J AM SOC NEPHROL, V13, P75, DOI 10.1681/ASN.V13175; Omran H, 2000, AM J HUM GENET, V66, P118, DOI 10.1086/302705; Omran H, 2001, NEPHROL DIAL TRANSPL, V16, P755, DOI 10.1093/ndt/16.4.755; Omran H, 2001, J AM SOC NEPHROL, V12, P107, DOI 10.1681/ASN.V121107; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Schuermann MJ, 2002, AM J HUM GENET, V70, P1240, DOI 10.1086/340317; SENIOR B, 1961, AM J OPHTHALMOL, V52, P625, DOI 10.1016/0002-9394(61)90147-7; TAKAHASHI H, 1986, J UROLOGY, V135, P1280, DOI 10.1016/S0022-5347(17)46074-5; Tomobe K, 1998, AM J KIDNEY DIS, V31, P55, DOI 10.1053/ajkd.1998.v31.pm9428452; Volz A, 2002, CYTOGENET GENOME RES, V97, P163, DOI 10.1159/000066617	29	257	271	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2003	34	4					455	459		10.1038/ng1216	http://dx.doi.org/10.1038/ng1216			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	12872122				2022-12-17	WOS:000184470500026
J	Collin, GB; Marshall, JD; Ikeda, A; So, WV; Russell-Eggitt, I; Maffei, P; Beck, S; Boerkoel, CF; Sicolo, N; Martin, M; Nishina, PM; Naggert, JK				Collin, GB; Marshall, JD; Ikeda, A; So, WV; Russell-Eggitt, I; Maffei, P; Beck, S; Boerkoel, CF; Sicolo, N; Martin, M; Nishina, PM; Naggert, JK			Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstrom syndrome	NATURE GENETICS			English	Article							BARDET-BIEDL-SYNDROME; NATURAL-HISTORY; GENE; INHERITANCE; DYSFUNCTION; DISORDER; LINKAGE; FAMILY	Alstrom syndrome is a homogeneous autosomal recessive disorder that is characterized by childhood obesity associated with hyperinsulinemia, chronic hyperglycemia and neurosensory deficits(1,2). The gene involved in Alstrom syndrome probably interacts with genetic modifiers, as subsets of affected individuals present with additional features such as dilated cardiomyopathy(3), hepatic dysfunction(4), hypothyroidism(5), male hypogonadism, short stature and mild to moderate developmental delay, and with secondary complications normally associated with type 2 diabetes, such as hyperlipidemia and atherosclerosis. Our detection of an uncharacterized transcript, KIAA0328, led us to identify the gene ALMS1, which contains sequence variations, including four frameshift mutations and two nonsense mutations, that segregate with Alstrom syndrome in six unrelated families. ALMS1 is ubiquitously expressed at low levels and does not share significant sequence homology with other genes reported so far. The identification of ALMS1 provides an entry point into a new pathway leading toward the understanding of both Alstrom syndrome and the common diseases that characterize it.	Jackson Lab, Bar Harbor, ME 04609 USA; Hoffmann La Roche Inc, Computat Genom & Genet, Nutley, NJ 07110 USA; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; Univ Padua, Ist Semeiot Med, I-35100 Padua, Italy; Inst Nacl Saude, Lisbon, Portugal; Baylor Coll Med, Houston, TX 77030 USA	Jackson Laboratory; Roche Holding; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Padua; Instituto Nacional de Saude Dr. Ricardo Jorge; Baylor College of Medicine	Naggert, JK (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	jkn@jax.org	Boerkoel, Cornelius Franciscus/AFW-4948-2022; Maffei, Pietro/O-1878-2013	Boerkoel, Cornelius Franciscus/0000-0003-3097-241X; Ikeda, Akihiro/0000-0001-8440-3891; Maffei, Pietro/0000-0002-1717-263X				Alstrom CH, 1959, ACTA PSYCHIAT S S129, V34, P1; CHARLES SJ, 1990, J MED GENET, V27, P590, DOI 10.1136/jmg.27.9.590; Collin GB, 1999, HUM GENET, V105, P474, DOI 10.1007/s004390051133; Collin GB, 1996, GENOMICS, V37, P125, DOI 10.1006/geno.1996.0529; Collin GB, 1997, HUM MOL GENET, V6, P213, DOI 10.1093/hmg/6.2.213; CONNOLLY MB, 1991, AM J MED GENET, V40, P421, DOI 10.1002/ajmg.1320400408; Froguel P, 2001, RECENT PROG HORM RES, V56, P91, DOI 10.1210/rp.56.1.91; GOLDSTEIN JL, 1973, MEDICINE, V52, P53, DOI 10.1097/00005792-197301000-00003; Hearn T, 2002, NAT GENET, V31, P79, DOI 10.1038/ng874; Inui A, 1999, TRENDS NEUROSCI, V22, P62, DOI 10.1016/S0166-2236(98)01292-2; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; Macari F, 1998, HUM GENET, V103, P658, DOI 10.1007/s004390050887; Marshall JD, 1997, AM J MED GENET, V73, P150, DOI 10.1002/(SICI)1096-8628(19971212)73:2<150::AID-AJMG9>3.0.CO;2-Y; Michaud JL, 1996, J PEDIATR-US, V128, P225, DOI 10.1016/S0022-3476(96)70394-3; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Naggert J, 1997, CURR OPIN GENET DEV, V7, P398, DOI 10.1016/S0959-437X(97)80155-4; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; Nishina PM, 1998, GENOMICS, V54, P215, DOI 10.1006/geno.1998.5567; Rastogi P A, 2000, Methods Mol Biol, V132, P47; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116	22	257	271	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2002	31	1					74	78		10.1038/ng867	http://dx.doi.org/10.1038/ng867			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11941369				2022-12-17	WOS:000175362500018
J	Zhang, JZ; Zhang, YP; Rosenberg, HF				Zhang, JZ; Zhang, YP; Rosenberg, HF			Adaptive evolution of a duplicated pancreatic ribonuclease gene in a leaf-eating monkey	NATURE GENETICS			English	Article							POSITIVE DARWINIAN SELECTION; RAPID EVOLUTION; SUBSTITUTIONS; FEATURES; PROTEIN; RATES	Although the complete genome sequences of over 50 representative species have revealed the many duplicated genes in all three domains of life(1-4), the roles of gene duplication in organismal adaptation and biodiversity are poorly understood. In addition, the evolutionary forces behind the functional divergence of duplicated genes are often unknown, leading to disagreement on the relative importance of positive Darwinian selection versus relaxation of functional constraints in this process(5-10). The methodology of earlier studies relied largely on DNA sequence analysis but lacked functional assays of duplicated genes, frequently generating contentious results(11,12). Here we use both computational and experimental approaches to address these questions in a study of the pancreatic ribonuclease gene (RNASE1) and its duplicate gene (RNASE1B) in a leaf-eating colobine monkey, douc langur. We show that RNASE1B has evolved rapidly under positive selection for enhanced ribonucleolytic activity in an altered microenvironment, a response to increased demands for the enzyme for digesting bacterial RNA. At the same time, the ability to degrade double-stranded RNA, a non-digestive activity characteristic of primate RNASE1, has been lost in RNASE1B, indicating functional specialization and relaxation of purifying selection. Our findings demonstrate the contribution of gene duplication to organismal adaptation and show the power of combining sequence analysis and functional assays in delineating the molecular basis of adaptive evolution.	NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Chinese Academy of Sciences; Kunming Institute of Zoology	Zhang, JZ (corresponding author), NIAID, Host Def Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.							BARNARD EA, 1969, NATURE, V221, P340, DOI 10.1038/221340a0; BEINTEMA JJ, 1990, MOL BIOL EVOL, V7, P470; BROOKFIELD JFY, 1994, TRENDS GENET, V10, P109, DOI 10.1016/0168-9525(94)90201-1; Charlesworth B, 1999, NATURE, V400, P519, DOI 10.1038/22922; CODE CF, 1968, HDB PHYSL, V3; Delson Eric, 1994, P11; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Futami J, 1997, DNA CELL BIOL, V16, P413, DOI 10.1089/dna.1997.16.413; Gaudieri S, 1999, GENOME RES, V9, P541; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; GOODMAN M, 1975, NATURE, V253, P603, DOI 10.1038/253603a0; Guyton AC, 1996, TXB MED PHYSL, V9th; Hughes A.L., 1999, ADAPTIVE EVOLUTION G; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Kay Robin N. B., 1994, P229; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kimura M., 1983, NEUTRAL THEORY MOL; LI WH, 1983, MOL BIOL EVOL, V1, P94; LI WH, 1997, MOL EVOLUTION, P221; LIBONATI M, 1969, EUR J BIOCHEM, V8, P81, DOI 10.1111/j.1432-1033.1969.tb00498.x; Lynch M, 2000, GENETICS, V154, P459; Makarova KS, 1999, GENOME RES, V9, P608; OHNO S, 1973, NATURE, V244, P259, DOI 10.1038/244259a0; Rooney AP, 1999, MOL BIOL EVOL, V16, P706, DOI 10.1093/oxfordjournals.molbev.a026153; ROSENBERG HF, 1995, J BIOL CHEM, V270, P21539, DOI 10.1074/jbc.270.37.21539; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sorrentino S, 1997, FEBS LETT, V404, P1, DOI 10.1016/S0014-5793(97)00086-0; TAJIMA F, 1993, GENETICS, V135, P599; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Zhang JZ, 1997, J MOL EVOL, V44, pS139, DOI 10.1007/PL00000067; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708; Zhang JZ, 1997, MOL BIOL EVOL, V14, P1335, DOI 10.1093/oxfordjournals.molbev.a025743; Zhang JZ, 2000, J MOL EVOL, V50, P56, DOI 10.1007/s002399910007	33	257	289	1	60	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2002	30	4					411	415		10.1038/ng852	http://dx.doi.org/10.1038/ng852			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	11925567				2022-12-17	WOS:000174682000019
J	Bennett, CB; Lewis, LK; Karthikeyan, G; Lobachev, KS; Jin, YH; Sterling, JF; Snipe, JR; Resnick, MA				Bennett, CB; Lewis, LK; Karthikeyan, G; Lobachev, KS; Jin, YH; Sterling, JF; Snipe, JR; Resnick, MA			Genes required for ionizing radiation resistance in yeast	NATURE GENETICS			English	Article							PUTATIVE RNA HELICASE; SACCHAROMYCES-CEREVISIAE; DNA-DAMAGE; CELL-CYCLE; REPAIR; EXPRESSION; PROTEIN; CHECKPOINT; END; RECOMBINATION	The ability of Saccharomyces cerevisiae to tolerate ionizing radiation damage requires many DNA-repair and checkpoint genes, most having human orthologs. A genome-wide screen of diploid mutants homozygous with respect to deletions of 3,670 nonessential genes revealed 107 new loci that influence gamma -ray sensitivity. Many affect replication, recombination and checkpoint functions. Nearly 90% were sensitive to other agents, and most new genes could be assigned to the following functional groups: chromatin remodeling, chromosome segregation, nuclear pore formation, transcription, Golgi/vacuolar activities, ubiquitin-mediated protein degradation, cytokinesis, mitochondrial activity and cell wall maintenance. Over 50% share homology with human genes, including 17 implicated in cancer, indicating that a large set of newly identified human genes may have related roles in the toleration of radiation damage.	NIEHS, Mol Genet Lab, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Resnick, MA (corresponding author), NIEHS, Mol Genet Lab, POB 12233, Res Triangle Pk, NC 27709 USA.		resnick, Michael/F-1668-2019	resnick, Michael/0000-0002-8473-7506	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES021091] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AGUILERA A, 1988, GENETICS, V119, P779; Alper T, 1977, Adv Exp Med Biol, V84, P139; ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; Bartsch S, 2000, MOL CELL BIOL, V20, P1194, DOI 10.1128/MCB.20.4.1194-1205.2000; BENNETT CB, 1989, RADIAT RES, V120, P102, DOI 10.2307/3577637; Bennett CB, 2001, MOL CELL BIOL, V21, P5359, DOI 10.1128/MCB.21.16.5359-5373.2001; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; Broomfield S, 2001, MUTAT RES-DNA REPAIR, V486, P167, DOI 10.1016/S0921-8777(01)00091-X; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chan TF, 2000, P NATL ACAD SCI USA, V97, P13227, DOI 10.1073/pnas.240444197; COSS RA, 1981, RADIAT RES, V85, P99, DOI 10.2307/3575441; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Fasullo M, 1998, MOL CELL BIOL, V18, P1190, DOI 10.1128/MCB.18.3.1190; Foiani M, 2000, MUTAT RES-FUND MOL M, V451, P187, DOI 10.1016/S0027-5107(00)00049-X; Foury F, 1997, GENE, V195, P1, DOI 10.1016/S0378-1119(97)00140-6; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Galy V, 2000, NATURE, V403, P108, DOI 10.1038/47528; Game JC, 2000, MUTAT RES-FUND MOL M, V451, P277, DOI 10.1016/S0027-5107(00)00055-5; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Hata H, 1998, GENETICS, V148, P571; HENRY NL, 1994, GENE DEV, V8, P2868, DOI 10.1101/gad.8.23.2868; HEUDE M, 1993, GENETICS, V133, P489; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; Kerscher O, 2001, GENETICS, V157, P1543; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8461, DOI 10.1073/pnas.151260698; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lewis LK, 2000, MUTAT RES-FUND MOL M, V451, P71, DOI 10.1016/S0027-5107(00)00041-5; LOVETT ST, 1987, GENETICS, V116, P547; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; MOORE CW, 1982, CANCER RES, V42, P929; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Nakao K, 2000, INTERNAL MED, V39, P412, DOI 10.2169/internalmedicine.39.412; Negritto MC, 2001, MOL CELL BIOL, V21, P2349, DOI 10.1128/MCB.21.7.2349-2358.2001; Paglin S, 2001, CANCER RES, V61, P439; Perkins EL, 1999, P NATL ACAD SCI USA, V96, P2204, DOI 10.1073/pnas.96.5.2204; RAMOTAR D, 1991, MOL CELL BIOL, V11, P4537, DOI 10.1128/MCB.11.9.4537; Resnick MA, 2000, MUTAT RES-FUND MOL M, V451, P1, DOI 10.1016/S0027-5107(00)00036-1; Stevenson LF, 2001, P NATL ACAD SCI USA, V98, P3946, DOI 10.1073/pnas.051013498; THOMAS JH, 1985, GENETICS, V111, P715; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang XQ, 1996, NUCLEIC ACIDS RES, V24, P4791, DOI 10.1093/nar/24.23.4791; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WELCH MD, 1994, MOL BIOL CELL, V5, P617, DOI 10.1091/mbc.5.6.617; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yu Z, 1999, ENVIRON MOL MUTAGEN, V33, P3, DOI 10.1002/(SICI)1098-2280(1999)33:1<3::AID-EM2>3.0.CO;2-L	50	257	264	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					426	434		10.1038/ng778	http://dx.doi.org/10.1038/ng778			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11726929				2022-12-17	WOS:000172507500018
J	MULLAN, M; HOULDEN, H; WINDELSPECHT, M; FIDANI, L; LOMBARDI, C; DIAZ, P; ROSSOR, M; CROOK, R; HARDY, J; DUFF, K; CRAWFORD, F				MULLAN, M; HOULDEN, H; WINDELSPECHT, M; FIDANI, L; LOMBARDI, C; DIAZ, P; ROSSOR, M; CROOK, R; HARDY, J; DUFF, K; CRAWFORD, F			A LOCUS FOR FAMILIAL EARLY-ONSET ALZHEIMERS-DISEASE ON THE LONG ARM OF CHROMOSOME 14, PROXIMAL TO THE ALPHA-1-ANTICHYMOTRYPSIN GENE	NATURE GENETICS			English	Article							PROTEIN; MUTATION	Although mutations in the beta-amyloid precursor protein gene (APP) on chromosome 21 cause some cases of early-onset Alzheimer's disease (AD), most cases evidently do not have mutations in APP. We analysed ten early-onset families for linkage to APP and markers elsewhere in the genome. One family (F172) was consistent with linkage to chromosome 21 and was subsequently found to have an APP Val to Ile mutation. Of the others, all but one were consistent with linkage to markers in the middle long arm of chromosome 14. However, no family showed independent evidence of linkage with two point analysis and only one showed independent evidence of linkage on multipoint analysis. Therefore, we cannot rule out heterogeneity at these loci although tests for heterogeneity were not significant.	ST MARYS HOSP,SCH MED,DEPT BIOCHEM,LONDON W2 1PG,ENGLAND; ST MARYS HOSP,SCH MED,DEPT NEUROL,LONDON W2 1PG,ENGLAND	Imperial College London; Imperial College London	MULLAN, M (corresponding author), UNIV S FLORIDA,CTR PSYCHIAT,ALZHEIMERS DIS RES LABS,3515 E FLETCHER AVE,TAMPA,FL 33613, USA.		Hardy, John/C-2451-2009; Houlden, Henry J/C-1532-2008; Rossor, Martin/C-1598-2008	Hardy, John/0000-0002-3122-0423; Houlden, Henry J/0000-0002-2866-7777; Rossor, Martin/0000-0001-8215-3120; Mullan, Michael/0000-0002-1473-7527; Duff, Karen/0000-0002-6177-868X				ABE K, 1991, NEUROSCI LETT, V125, P169, DOI 10.1016/0304-3940(91)90019-P; ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; COX DW, 1990, CYTOGENET CELL GENET, V55, P183, DOI 10.1159/000133010; FIDANI L, 1992, HUM MOL GENET, V1, P165, DOI 10.1093/hmg/1.3.165; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GLENNER GG, 1989, J NEUROL SCI, V94, P1, DOI 10.1016/0022-510X(89)90214-1; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; HARLIN MCC, 1991, NATURE, V353, P844; Lathrop G. M., 1990, AM J HUM GENET S, V47, pA188; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Ott J., 1991, ANAL HUMAN GENETIC L; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; WANG ZY, 1992, GENOMICS, V13, P532, DOI 10.1016/0888-7543(92)90121-8; WEITKAMP LR, 1983, AM J HUM GENET, V35, P443; WONG CW, 1985, P NATL ACAD SCI USA, V82, P8729, DOI 10.1073/pnas.82.24.8729	20	257	276	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1992	2	4					340	342		10.1038/ng1292-340	http://dx.doi.org/10.1038/ng1292-340			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	1303291				2022-12-17	WOS:A1992KB49500022
J	Choi, J; Goh, G; Walradt, T; Hong, BS; Bunick, CG; Chen, K; Bjornson, RD; Maman, Y; Wang, T; Tordoff, J; Carlson, K; Overton, JD; Liu, KJ; Lewis, JM; Devine, L; Barbarotta, L; Foss, FM; Subtil, A; Vonderheid, EC; Edelson, RL; Schatz, DG; Boggon, TJ; Girardi, M; Lifton, RP				Choi, Jaehyuk; Goh, Gerald; Walradt, Trent; Hong, Bok S.; Bunick, Christopher G.; Chen, Kan; Bjornson, Robert D.; Maman, Yaakov; Wang, Tiffany; Tordoff, Jesse; Carlson, Kacie; Overton, John D.; Liu, Kristina J.; Lewis, Julia M.; Devine, Lesley; Barbarotta, Lisa; Foss, Francine M.; Subtil, Antonio; Vonderheid, Eric C.; Edelson, Richard L.; Schatz, David G.; Boggon, Titus J.; Girardi, Michael; Lifton, Richard P.			Genomic landscape of cutaneous T cell lymphoma	NATURE GENETICS			English	Article							COPY-NUMBER ALTERATION; MUTATIONS; CANCER; IDENTIFICATION; RHOA; GENE; EXPRESSION; PROTEIN; KINASE; CD80	Cutaneous T cell lymphoma (CTCL) is a non-Hodgkin lymphoma of skin-homing T lymphocytes. We performed exome and whole-genome DNA sequencing and RNA sequencing on purified CTCL and matched normal cells. The results implicate mutations in 17 genes in CTCL pathogenesis, including genes involved in T cell activation and apoptosis, NF-kappa B signaling, chromatin remodeling and DNA damage response. CTCL is distinctive in that somatic copy number variants (SCNVs) comprise 92% of all driver mutations (mean of 11.8 pathogenic SCNVs versus 1.0 somatic single-nucleotide variant per CTCL). These findings have implications for new therapeutics.	[Choi, Jaehyuk; Walradt, Trent; Hong, Bok S.; Bunick, Christopher G.; Chen, Kan; Wang, Tiffany; Tordoff, Jesse; Carlson, Kacie; Liu, Kristina J.; Lewis, Julia M.; Foss, Francine M.; Subtil, Antonio; Edelson, Richard L.; Girardi, Michael] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Choi, Jaehyuk] Dept Vet Affairs Connecticut Healthcare, Dept Dermatol, West Haven, CT USA; [Goh, Gerald; Maman, Yaakov; Schatz, David G.; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Goh, Gerald; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Bjornson, Robert D.] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Maman, Yaakov; Schatz, David G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Overton, John D.] Yale Univ, Sch Med, Yale Ctr Genome Anal, New Haven, CT USA; [Devine, Lesley] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Barbarotta, Lisa; Foss, Francine M.] Yale Univ, Sch Med, Dept Med Hematol, New Haven, CT USA; [Vonderheid, Eric C.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sydney Kimmel Canc Ctr, Baltimore, MD 21205 USA; [Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Yale Ctr Mendelian Genom, New Haven, CT USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Johns Hopkins University; Yale University; Yale University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.	richard.lifton@yale.edu	Hong, Bok Sil/GYQ-5150-2022; Edelson, Richard/AAD-4826-2019; Goh, Gerald/N-1684-2015; Bunick, Christopher/AAD-3842-2021; Choi, Jaehyuk/N-6532-2019	Goh, Gerald/0000-0002-3832-6466; Bunick, Christopher/0000-0002-4011-8308; Choi, Jaehyuk/0000-0003-2379-2226; Chen, Kan/0000-0002-5007-0205; Girardi, Michael/0000-0003-1887-9343; Hong, Bok Sil/0000-0002-2710-7727; , Trent/0000-0003-1081-0923	Dermatology Foundation; Yale Specialized Program of Research Excellence (SPORE) in Skin Cancer Career Development Award; Yale SPORE in Skin Cancer [P50 CA121974]; Agency for Science, Technology and Research, Singapore; US National Institutes of Health (NIH) [RO1 CA102703]; NATIONAL CANCER INSTITUTE [P50CA121974, R01CA102703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032524] Funding Source: NIH RePORTER	Dermatology Foundation; Yale Specialized Program of Research Excellence (SPORE) in Skin Cancer Career Development Award; Yale SPORE in Skin Cancer; Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We gratefully acknowledge the participation of the patients who made this research possible. We are grateful to I. Tikhonova and the staff of the Yale Center for Genome Analysis for their expert production of DNA and RNA sequence. Work was supported by the Dermatology Foundation and the Yale Specialized Program of Research Excellence (SPORE) in Skin Cancer Career Development Award (J.C.);. the Yale SPORE in Skin Cancer, P50 CA121974 (T.J.B.); the Agency for Science, Technology and Research, Singapore (G.G.); and US National Institutes of Health (NIH) grant RO1 CA102703 (M.G.). D.G.S. and R.P.L. are investigators of the Howard Hughes Medical Institute.	Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Braun FCM, 2011, LEUKEMIA, V25, P1494, DOI 10.1038/leu.2011.101; Caprini E, 2009, CANCER RES, V69, P8438, DOI 10.1158/0008-5472.CAN-09-2367; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/nmeth.1363, 10.1038/NMETH.1363]; Choi J, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12197; Couronne L, 2012, NEW ENGL J MED, V366, P95, DOI 10.1056/NEJMc1111708; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Di Fiore R, 2013, J CELL PHYSIOL, V228, P1676, DOI 10.1002/jcp.24329; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans EJ, 2005, NAT IMMUNOL, V6, P271, DOI 10.1038/ni1170; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Girardi M, 2004, NEW ENGL J MED, V350, P1978, DOI 10.1056/NEJMra032810; Goh G, 2014, NAT GENET, V46, P613, DOI 10.1038/ng.2956; Gostissa M, 2009, NATURE, V462, P803, DOI 10.1038/nature08633; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gregoire JM, 1999, J BIOL CHEM, V274, P6567, DOI 10.1074/jbc.274.10.6567; Guenova E, 2013, CLIN CANCER RES, V19, P3755, DOI 10.1158/1078-0432.CCR-12-3488; Haddad BR, 2013, AM J PATHOL, V182, P2264, DOI 10.1016/j.ajpath.2013.02.044; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hidaka T, 2008, BLOOD, V112, P383, DOI 10.1182/blood-2008-01-131185; Hill L, 2013, INT J CANCER, V132, P745, DOI 10.1002/ijc.27708; Kakiuchi M, 2014, NAT GENET, V46, P583, DOI 10.1038/ng.2984; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kelly J, 2003, J IMMUNOL, V170, P210, DOI 10.4049/jimmunol.170.1.210; Kim EJ, 2005, J CLIN INVEST, V115, P798, DOI 10.1172/JCI200524826; Kopp KL, 2013, CELL CYCLE, V12, P1939, DOI 10.4161/cc.24987; Kozarewa I, 2011, METHODS MOL BIOL, V733, P257, DOI 10.1007/978-1-61779-089-8_18; Laharanne E, 2010, J INVEST DERMATOL, V130, P1707, DOI 10.1038/jid.2010.8; Larsen CP, 2005, AM J TRANSPLANT, V5, P443, DOI 10.1111/j.1600-6143.2005.00749.x; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Legarda-Addison D, 2007, J IMMUNOL, V178, P7767, DOI 10.4049/jimmunol.178.12.7767; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li J, 2012, BIOINFORMATICS, V28, P1307, DOI 10.1093/bioinformatics/bts146; Lin WM, 2012, J INVEST DERMATOL, V132, P188, DOI 10.1038/jid.2011.254; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Mayer T, 1999, ONCOGENE, V18, P2117, DOI 10.1038/sj.onc.1202537; Mayrhofer M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r24; Merelli I, 2010, NUCLEIC ACIDS RES, V38, pW262, DOI 10.1093/nar/gkq391; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Meyer SC, 2014, CLIN CANCER RES, V20, P2051, DOI 10.1158/1078-0432.CCR-13-0279; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Neri A, 1996, LEUKEMIA LYMPHOMA, V23, P43, DOI 10.3109/10428199609054800; Odorizzi PM, 2012, J IMMUNOL, V188, P2957, DOI 10.4049/jimmunol.1100038; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Papaemmanuil E, 2014, NAT GENET, V46, P116, DOI 10.1038/ng.2874; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Rajala HLM, 2013, BLOOD, V121, P4541, DOI 10.1182/blood-2012-12-474577; Rangwala S, 2012, FUTURE MED CHEM, V4, P471, DOI [10.4155/FMC.12.6, 10.4155/fmc.12.6]; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Sedwick CE, 2004, MOL IMMUNOL, V41, P675, DOI 10.1016/j.molimm.2004.01.007; Slavik JM, 1999, J BIOL CHEM, V274, P3116, DOI 10.1074/jbc.274.5.3116; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vainchenker W, 2013, ONCOGENE, V32, P2601, DOI 10.1038/onc.2012.347; Vaque JP, 2014, BLOOD, V123, P2034, DOI 10.1182/blood-2013-05-504308; Vermeer MH, 2008, CANCER RES, V68, P2689, DOI 10.1158/0008-5472.CAN-07-6398; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; WILLIAMS TM, 1991, SCIENCE, V254, P1791, DOI 10.1126/science.1840704; Wong HK, 2013, DISCOV MED, V16, P71; Wong HK, 2011, BRIT J HAEMATOL, V155, P150, DOI 10.1111/j.1365-2141.2011.08852.x; Wu JN, 2013, CANCER DISCOV, V3, P35, DOI 10.1158/2159-8290.CD-12-0361; Yao S, 2013, NAT REV DRUG DISCOV, V12, P130, DOI 10.1038/nrd3877; Yoo HY, 2014, NAT GENET, V46, P371, DOI 10.1038/ng.2916; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang Q, 2014, J IMMUNOL, V192, P2913, DOI 10.4049/jimmunol.1302951; Zhao SM, 2013, P NATL ACAD SCI USA, V110, P2916, DOI 10.1073/pnas.1222577110; Zinzani PL, 2007, J CLIN ONCOL, V25, P4293, DOI 10.1200/JCO.2007.11.4207	75	256	261	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2015	47	9					1011	+		10.1038/ng.3356	http://dx.doi.org/10.1038/ng.3356			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CQ1XQ	26192916	Green Accepted			2022-12-17	WOS:000360394100011
J	Murga, M; Bunting, S; Montana, MF; Soria, R; Mulero, F; Canamero, M; Lee, Y; McKinnon, PJ; Nussenzweig, A; Fernandez-Capetillo, O				Murga, Matilde; Bunting, Samuel; Montana, Maria F.; Soria, Rebeca; Mulero, Francisca; Canamero, Marta; Lee, Youngsoo; McKinnon, Peter J.; Nussenzweig, Andre; Fernandez-Capetillo, Oscar			A mouse model of ATR-Seckel shows embryonic replicative stress and accelerated aging	NATURE GENETICS			English	Article							HEMATOPOIETIC STEM-CELLS; DNA-DAMAGE RESPONSE; ATAXIA-TELANGIECTASIA; CHROMOSOME INSTABILITY; DEFICIENT MICE; GENE ATR; CHECKPOINT; AGE; LEADS; P53	Although DNA damage is considered a driving force for aging, the nature of the damage that arises endogenously remains unclear. Replicative stress, a source of endogenous DNA damage, is prevented primarily by the ATR kinase. We have developed a mouse model of Seckel syndrome characterized by a severe deficiency in ATR. Seckel mice show high levels of replicative stress during embryogenesis, when proliferation is widespread, but this is reduced to marginal amounts in postnatal life. In spite of this decrease, adult Seckel mice show accelerated aging, which is further aggravated in the absence of p53. Together, these results support a model whereby replicative stress, particularly in utero, contributes to the onset of aging in postnatal life, and this is balanced by the replicative stress-limiting role of the checkpoint proteins ATR and p53.	[Murga, Matilde; Montana, Maria F.; Soria, Rebeca; Fernandez-Capetillo, Oscar] Spanish Natl Canc Res Ctr CNIO, Genom Instabil Grp, Madrid, Spain; [Bunting, Samuel; Nussenzweig, Andre] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Mulero, Francisca] CNIO, Mol Imaging Unit, Madrid, Spain; [Canamero, Marta] CNIO, Comparat Pathol Unit, Madrid, Spain; [Lee, Youngsoo; McKinnon, Peter J.] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA	Centro Nacional de Investigaciones Oncologicas (CNIO); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); St Jude Children's Research Hospital	Murga, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Genom Instabil Grp, Madrid, Spain.	mmurga@cnio.es; ofernandez@cnio.es	Fernandez-Capetillo, Oscar/H-3508-2015; Mulero, Francisca M/M-3289-2014; Mulero, Francisca/R-2387-2019; Murga, Matilde/B-3499-2018; /AAI-3238-2021	Fernandez-Capetillo, Oscar/0000-0002-2690-6885; Mulero, Francisca M/0000-0001-9584-4211; Mulero, Francisca/0000-0001-9584-4211; Lee, Youngsoo/0000-0003-4773-6464	Spanish Ministry of Science [RYC-2003-002731, CSD200700017, SAF2008-01596]; Fondo de Investigaciones Sanitarias [PI080220]; European Molecular Biology Organization Young Investigator Programme; European Research Council [ERC-210520]; Epigenome Network of Excellence; NATIONAL CANCER INSTITUTE [ZICBC009255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037956] Funding Source: NIH RePORTER	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); European Molecular Biology Organization Young Investigator Programme(European Molecular Biology Organization (EMBO)); European Research Council(European Research Council (ERC)European Commission); Epigenome Network of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Serrano and A. Ramiro for critical comments on the manuscript. We also thank S. P. Jackson for his help with the PIKK inhibitors and A. Garcia for cytometry. M. M. is supported by a Ramon y Cajal contract from the Spanish Ministry of Science (RYC-2003-002731) and from a grant from Fondo de Investigaciones Sanitarias (PI080220). Work in O. F.-C.' s laboratory is supported by grants from the Spanish Ministry of Science (RYC-2003-002731, CSD200700017 and SAF2008-01596), European Molecular Biology Organization Young Investigator Programme, European Research Council (ERC-210520) and Epigenome Network of Excellence.	Arnold SR, 1999, PEDIATR DEVEL PATHOL, V2, P180, DOI 10.1007/s100249900107; BARKER DJP, 1995, P ROY SOC B-BIOL SCI, V262, P37, DOI 10.1098/rspb.1995.0173; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; Bobabilla-Morales L, 2003, AM J MED GENET A, V123A, P148, DOI 10.1002/ajmg.a.20341; BOSCHERINI B, 1981, EUR J PEDIATR, V137, P237, DOI 10.1007/BF00441325; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; BUTLER MG, 1987, AM J MED GENET, V27, P645, DOI 10.1002/ajmg.1320270318; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Casper AM, 2004, AM J HUM GENET, V75, P654, DOI 10.1086/422701; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; EL DW, 1993, CELL, V75, P817; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; FATHIZADEH A, 1979, J AM ACAD DERMATOL, V1, P52, DOI 10.1016/S0190-9622(79)70004-1; Fowden AL, 2008, J NEUROENDOCRINOL, V20, P439, DOI 10.1111/j.1365-2826.2008.01663.x; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; Goodship J, 2000, AM J HUM GENET, V67, P498, DOI 10.1086/303023; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Liu QH, 2000, GENE DEV, V14, P1448; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lombardi G, 2005, J Endocrinol Invest, V28, P99; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; MURPHY DP, 1928, SURG GYNECOL OBSTET, V47, P201; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; SCHMIDT SL, 1987, J COMP NEUROL, V264, P193, DOI 10.1002/cne.902640205; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004; SECKEL H, 1960, STUDIES DEV ANTHR IN; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Shanske A, 1997, AM J MED GENET, V70, P155, DOI 10.1002/(SICI)1096-8628(19970516)70:2<155::AID-AJMG10>3.0.CO;2-I; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Syrrou M., 1995, Genetic Counseling, V6, P37; van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Wang QZ, 1996, J NATL CANCER I, V88, P956, DOI 10.1093/jnci/88.14.956; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401	50	256	260	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					891	U46		10.1038/ng.420	http://dx.doi.org/10.1038/ng.420			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19620979	Green Accepted			2022-12-17	WOS:000268432900012
J	Kanetsky, PA; Mitra, N; Vardhanabhuti, S; Li, MY; Vaughn, DJ; Letrero, R; Ciosek, SL; Doody, DR; Smith, LM; Weaver, J; Albano, A; Chen, C; Starr, JR; Rader, DJ; Godwin, AK; Reilly, MP; Hakonarson, H; Schwartz, SM; Nathanson, KL				Kanetsky, Peter A.; Mitra, Nandita; Vardhanabhuti, Saran; Li, Mingyao; Vaughn, David J.; Letrero, Richard; Ciosek, Stephanie L.; Doody, David R.; Smith, Lauren M.; Weaver, JoEllen; Albano, Anthony; Chen, Chu; Starr, Jacqueline R.; Rader, Daniel J.; Godwin, Andrew K.; Reilly, Muredach P.; Hakonarson, Hakon; Schwartz, Stephen M.; Nathanson, Katherine L.			Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TUMOR SUSCEPTIBILITY; FACTOR-RECEPTOR; PROLIFERATION; PIGMENTATION; ACTIVATION; FERTILITY; MIGRATION; ETIOLOGY; HUMANS	Testicular germ cell tumors (TGCT) have been expected to have a strong underlying genetic component. We conducted a genome-wide scan among 277 TGCT cases and 919 controls and found that seven markers at 12p22 within KITLG (c-KIT ligand) reached genome-wide significance (P < 5.0 x 10 (-8) in discovery). In independent replication, TGCT risk was increased threefold per copy of the major allele at rs3782179 and rs4474514 (OR = 3.08, 95% CI = 2.29-4.13; OR = 3.07, 95% CI 2.29-4.13, respectively). We found associations with rs4324715 and rs6897876 at 5q31.3 near SPRY4 (sprouty 4; P < 5.0 x 10(-6) in discovery). In independent replication, risk of TGCT was increased nearly 40% per copy of the major allele (OR = 1.37, 95% CI = 1.14-1.64; OR = 1.39, 95% CI = 1.16-1.66, respectively). All of the genotypes were associated with both seminoma and nonseminoma TGCT subtypes. These results demonstrate that common genetic variants affect TGCT risk and implicate KITLG and SPRY4 as genes involved in TGCT susceptibility.	[Kanetsky, Peter A.; Mitra, Nandita; Vaughn, David J.; Letrero, Richard; Ciosek, Stephanie L.; Nathanson, Katherine L.] Univ Penn, Sch Med, Abramson Canc Ctr, Dept Med, Philadelphia, PA 19104 USA; [Vaughn, David J.] Univ Penn, Sch Med, Div Hematol Oncol, Dept Med, Philadelphia, PA 19104 USA; [Letrero, Richard; Ciosek, Stephanie L.; Smith, Lauren M.; Nathanson, Katherine L.] Univ Penn, Sch Med, Div Med Genet, Dept Med, Philadelphia, PA 19104 USA; [Kanetsky, Peter A.; Mitra, Nandita; Vardhanabhuti, Saran; Li, Mingyao] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Dept Med, Philadelphia, PA 19104 USA; [Doody, David R.; Starr, Jacqueline R.; Schwartz, Stephen M.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Epidemiol, Seattle, WA 98104 USA; [Weaver, JoEllen; Godwin, Andrew K.] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA; [Albano, Anthony; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Albano, Anthony; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Chen, Chu; Starr, Jacqueline R.; Schwartz, Stephen M.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Starr, Jacqueline R.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Rader, Daniel J.; Reilly, Muredach P.] Univ Penn, Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Rader, Daniel J.; Reilly, Muredach P.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Fred Hutchinson Cancer Center; Fox Chase Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Nathanson, KL (corresponding author), Univ Penn, Sch Med, Abramson Canc Ctr, Dept Med, Philadelphia, PA 19104 USA.	knathans@mail.med.upenn.edu		Reilly, Muredach/0000-0002-3035-9386; Nathanson, Katherine/0000-0002-6740-0901; Starr, Jacqueline/0000-0002-3039-2311; Doody, David/0000-0003-2291-6493	NATIONAL CANCER INSTITUTE [P30CA006927, R01CA085914, R01CA114478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA006927-41, R01 CA085914-08, R01 CA085914-05, R01 CA085914-03, R01 CA085914-02S1, R01 CA085914-10, R01 CA114478-01A2, R01 CA085914-06, P30 CA006927, R01 CA114478, R01 CA085914-07, R01 CA085914-09, R01 CA085914-01, R01 CA085914-02, R01 CA085914-04, R01 CA085914] Funding Source: Medline; NIEHS NIH HHS [P30 ES007033-15, P30 ES007033] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Blume-Jensen P, 2000, NAT GENET, V24, P157, DOI 10.1038/72814; Crockford GP, 2006, HUM MOL GENET, V15, P443, DOI 10.1093/hmg/ddi459; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frolov A, 2003, MOL CANCER THER, V2, P699; Heaney JD, 2008, CANCER RES, V68, P5193, DOI 10.1158/0008-5472.CAN-08-0779; Hemminki K, 2004, BRIT J CANCER, V90, P1765, DOI 10.1038/sj.bjc.6601714; Lehrke M, 2007, J AM COLL CARDIOL, V49, P442, DOI 10.1016/j.jacc.2006.09.034; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meyts ERD, 2007, ANN NY ACAD SCI, V1120, P168, DOI 10.1196/annals.1411.013; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Nathanson KL, 2005, AM J HUM GENET, V77, P1034, DOI 10.1086/498455; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rapley EA, 2000, NAT GENET, V24, P197, DOI 10.1038/72877; Richiardi L, 2005, CANCER EPIDEM BIOMAR, V14, P2557, DOI 10.1158/1055-9965.EPI-05-0409; Ries LAG, 2008, SEER CANC STAT REV 1; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Runyan C, 2006, DEVELOPMENT, V133, P4861, DOI 10.1242/dev.02688; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Starr JR, 2005, CANCER EPIDEM BIOMAR, V14, P2183, DOI 10.1158/1055-9965.EPI-04-0749; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Swerdlow AJ, 1997, LANCET, V350, P1723, DOI 10.1016/S0140-6736(97)05526-8; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Zama AM, 2005, BIOL REPROD, V73, P639, DOI 10.1095/biolreprod.105.042846	30	256	262	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					811	U65		10.1038/ng.393	http://dx.doi.org/10.1038/ng.393			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	19483682	Green Accepted			2022-12-17	WOS:000267786200011
J	Fan, YL; Esmail, MA; Ansley, SJ; Blacque, OE; Boroevich, K; Ross, AJ; Moore, SJ; Badano, JL; May-Simera, H; Compton, DS; Green, JS; Lewis, RA; van Haelst, MM; Parfrey, PS; Baillie, DL; Beales, PL; Katsanis, N; Davidson, WS; Leroux, MR				Fan, YL; Esmail, MA; Ansley, SJ; Blacque, OE; Boroevich, K; Ross, AJ; Moore, SJ; Badano, JL; May-Simera, H; Compton, DS; Green, JS; Lewis, RA; van Haelst, MM; Parfrey, PS; Baillie, DL; Beales, PL; Katsanis, N; Davidson, WS; Leroux, MR			Mutations in a member of the Ras superfamily of small GTP-binding proteins causes Bardet-Biedl syndrome	NATURE GENETICS			English	Article							INTRAFLAGELLAR TRANSPORT; FAMILY; IDENTIFICATION; LOCALIZATION; REGION; LOCUS; CYCLE; ARF	RAB, ADP-ribosylation factors (ARFs) and ARF-like (ARL) proteins belong to the Ras superfamily of small GTP-binding proteins and are essential for various membrane-associated intracellular trafficking processes(1,2). None of the similar to50 known members of this family are linked to human disease. Using a bioinformatic screen for ciliary genes in combination with mutational analyses, we identified ARL6 as the gene underlying Bardet-Biedl syndrome type 3, a multisystemic disorder characterized by obesity, blindness, polydactyly, renal abnormalities and cognitive impairment(3,4). We uncovered four different homozygous substitutions in ARL6 in four unrelated families affected with Bardet-Biedl syndrome, two of which disrupt a threonine residue important for GTP binding(5) and function(5-7) of several related small GTP-binding proteins. Analysis of the Caenorhabditis elegans ARL6 homolog indicates that it is specifically expressed in ciliated cells, and that, in addition to the postulated cytoplasmic functions of ARL proteins, it undergoes intraflagellar transport. These findings implicate a small GTP-binding protein in ciliary transport and the pathogenesis of a pleiotropic disorder.	Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; Johns Hopkins Univ, Inst Med Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21205 USA; UCL, Inst Child Hlth, Mol Med Unit, London WC1 1EH, England; Mem Univ Newfoundland, Dept Clin Epidemiol, St John, NF, Canada; Mem Univ Newfoundland, Dept Med Genet, St John, NF, Canada; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands	Simon Fraser University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; University of London; University College London; Memorial University Newfoundland; Memorial University Newfoundland; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Erasmus University Rotterdam	Davidson, WS (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	wdavidso@sfu.ca; leroux@sfu.ca	Blacque, Oliver/AAL-8860-2021; Beales, Philip L/C-7367-2009; Katsanis, Nicholas/E-1837-2012	May-Simera, Helen/0000-0002-9477-4036; Katsanis, Nicholas/0000-0002-2480-0171; Badano, Jose/0000-0002-0706-8652; Blacque, Oliver/0000-0003-1598-2695; Boroevich, Keith/0000-0001-7095-7332				Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Beales PL, 1999, J MED GENET, V36, P437; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Cuvillier A, 2000, J CELL SCI, V113, P2065; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Engel T, 2004, FEBS LETT, V566, P241, DOI 10.1016/j.febslet.2004.04.048; Ghadami M, 2000, AM J MED GENET, V94, P433, DOI 10.1002/1096-8628(20001023)94:5<433::AID-AJMG17>3.0.CO;2-X; Grayson C, 2002, HUM MOL GENET, V11, P3065, DOI 10.1093/hmg/11.24.3065; Haycraft CJ, 2003, EXP CELL RES, V284, P251, DOI 10.1016/S0014-4827(02)00089-7; Hickson GRX, 2003, MOL BIOL CELL, V14, P2908, DOI 10.1091/mbc.E03-03-0160; Huang CF, 2003, MOL BIOL CELL, V14, P3834, DOI 10.1091/mbc.E03-01-0013; Huber H, 1996, PLANT MOL BIOL, V31, P279, DOI 10.1007/BF00021790; Ingley E, 1999, FEBS LETT, V459, P69, DOI 10.1016/S0014-5793(99)01188-6; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 2004, HUM MOL GENET, V13, pR65, DOI 10.1093/hmg/ddh092; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lu L, 2001, J CELL SCI, V114, P4543; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Pasqualato S, 2001, EMBO REP, V2, P234, DOI 10.1093/embo-reports/kve043; Pazour GJ, 2002, TRENDS CELL BIOL, V12, P551, DOI 10.1016/S0962-8924(02)02410-8; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Young TL, 1998, AM J MED GENET, V78, P461, DOI 10.1002/(SICI)1096-8628(19980806)78:5<461::AID-AJMG12>3.0.CO;2-D	28	256	272	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					989	993		10.1038/ng1414	http://dx.doi.org/10.1038/ng1414			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15314642	Bronze			2022-12-17	WOS:000223658100026
J	Stewart, SA; Ben-Porath, I; Carey, VJ; O'Connor, BF; Hahn, WC; Weinberg, RA				Stewart, SA; Ben-Porath, I; Carey, VJ; O'Connor, BF; Hahn, WC; Weinberg, RA			Erosion of the telomeric single-strand overhang at replicative senescence	NATURE GENETICS			English	Article							NORMAL HUMAN-CELLS; HUMAN FIBROBLASTS; LIFE-SPAN; IN-VITRO; HUMAN-CHROMOSOMES; VIVO; END; LOOP	Cultured primary human cells inevitably enter a state of replicative senescence for which the specific molecular trigger is unknown. We show that the single-strand telomeric overhang, a key component of telomere structure, is eroded at senescence. Expression of telomerase prevents overhang loss, suggesting that this enzyme prevents senescence by maintaining proper telomere structure. In contrast, progressive overhang loss occurs in cells that avoid senescence through the inactivation of p53 and Rb, indicating that overhang erosion is the result of continuous cell division and not a consequence of senescence. We thus provide evidence for a specific molecular alteration in telomere structure at senescence and suggest that this change, rather than overall telomere length, serves to trigger this state.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dana Farber Canc Inst,Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dana Farber Canc Inst,Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dana Farber Canc Inst,Channing Lab, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Stewart, Sheila A/C-5213-2012					ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306; ALLSOPP RC, 1995, EXP CELL RES, V219, P130, DOI 10.1006/excr.1995.1213; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Cimino-Reale G, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e35; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1973, AM J MED SCI, V265, P432, DOI 10.1097/00000441-197306000-00001; HENDERSON ER, 1989, MOL CELL BIOL, V9, P345, DOI 10.1128/MCB.9.1.345; Huffman KE, 2000, J BIOL CHEM, V275, P19719, DOI 10.1074/jbc.M002843200; KARSEDER J, 2002, SCIENCE, V295, P2446; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LINGNER J, 1995, SCIENCE, V269, P1533, DOI 10.1126/science.7545310; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; McElligott R, 1997, EMBO J, V16, P3705, DOI 10.1093/emboj/16.12.3705; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; Petersen S, 1998, EXP CELL RES, V239, P152, DOI 10.1006/excr.1997.3893; Rubin H, 2002, NAT BIOTECHNOL, V20, P675, DOI 10.1038/nbt0702-675; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Stansel RM, 2001, EMBO J, V20, P5532; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; Wright WE, 2002, NAT BIOTECHNOL, V20, P682, DOI 10.1038/nbt0702-682; Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723	28	256	268	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					492	496		10.1038/ng1127	http://dx.doi.org/10.1038/ng1127			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12652299	Bronze			2022-12-17	WOS:000181928600020
J	Kutsche, K; Yntema, H; Brandt, A; Jantke, I; Nothwang, HG; Orth, U; Boavida, MG; David, D; Chelly, J; Fryns, JP; Moraine, C; Ropers, HH; Hamel, BCJ; van Bokhoven, H; Gal, A				Kutsche, K; Yntema, H; Brandt, A; Jantke, I; Nothwang, HG; Orth, U; Boavida, MG; David, D; Chelly, J; Fryns, JP; Moraine, C; Ropers, HH; Hamel, BCJ; van Bokhoven, H; Gal, A			Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation	NATURE GENETICS			English	Letter							GENE; FAMILY; IDENTIFICATION; CHROMOSOME; REPEAT; DOMAIN; ACTIN; FMR2	X-linked forms of mental retardation (XLMR) include a variety of different disorders and may account for up to 25% of all inherited cases of mental retardation(1). So far, seven X-chromosomal genes mutated in nonspecific mental retardation (MRX) have been identified: FMR2, GDI1, RPS6KA3, IL1RAPL, TM4SF2, OPHN1 and PAK3 (refs 2-9). The products of the latter two have been implicated in regulation of neural plasticity by controlling the activity of small GTPases of the Rho family. Here we report the identification of a new MRX gene. ARHGEF6 (also known as alpha PIX or Cool-2). encoding a protein with homology to guanine nucleotide exchange factors for Rho GTPases (Rho GEF). Molecular analysis of a reciprocal X/21 translocation in a male with mental retardation showed that this gene in Xq26 was disrupted by the rearrangement. Mutation screening of 119 patients with nonspecific mental retardation revealed a mutation in the first intron of ARHGEF6 (IVS1-11T-->C) in all affected males in a large Dutch family(10). The mutation resulted in preferential skipping of exon 2. predicting a protein lacking 28 amino acids;. ARHGEF6 is the eighth MRX gene identified so far and the third such gene to encode a protein that interacts with Rho GTPases.	Univ Hamburg, Klinikum Eppendorf, Inst Human Genet, Hamburg, Germany; Univ Nijmegen Hosp, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Max Planck Inst Mol Genet, Berlin, Germany; INSA, Dept Human Genet, Lisbon, Portugal; CHU Cochin, INSERM, ICGM, U129, Paris, France; Univ Hosp Leuven, Ctr Human Genet, Louvain, Belgium; CHU Tours, Hop Bretonneau, Serv Genet, Tours, France	University of Hamburg; Radboud University Nijmegen; Max Planck Society; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; KU Leuven; University Hospital Leuven; CHU Tours	Gal, A (corresponding author), Univ Hamburg, Klinikum Eppendorf, Inst Human Genet, Hamburg, Germany.		Nothwang, Hans G/C-5847-2011; Yntema, H.G./L-4771-2015; Chelly, Jamel/J-7528-2015; Bokhoven, J.H.L.M. van van/H-8015-2014; van Bokhoven, Hans/D-8764-2012	Chelly, Jamel/0000-0002-0939-8719; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Nothwang, Hans Gerd/0000-0001-7695-6437; David, Dezso/0000-0003-2293-590X				Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Bala S, 1997, HUM MUTAT, V10, P201; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BUNGE S, 1996, METH MOL G, V8, P26; Carrie A, 1999, NAT GENET, V23, P25, DOI 10.1038/12623; CASTRESANA J, 1995, FEBS LETT, V374, P149, DOI 10.1016/0014-5793(95)01098-Y; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; Gallo G, 1998, CURR BIOL, V8, pR80, DOI 10.1016/S0960-9822(98)70051-X; Gecz J, 1996, NAT GENET, V13, P105, DOI 10.1038/ng0596-105; Gu YH, 1996, NAT GENET, V13, P109, DOI 10.1038/ng0596-109; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HART MJ, 1994, J BIOL CHEM, V269, P62; Katan M, 1999, FEBS LETT, V452, P36, DOI 10.1016/S0014-5793(99)00531-1; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lubs H, 1999, AM J MED GENET, V83, P237, DOI 10.1002/(SICI)1096-8628(19990402)83:4<237::AID-AJMG2>3.3.CO;2-#; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Merienne K, 1999, NAT GENET, V22, P13, DOI 10.1038/8719; Nomura N, 1994, DNA Res, V1, P27, DOI 10.1093/dnares/1.1.27; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; VAN AL, 1997, GENE DEV, V11, P2295; vonBallestrem CL, 1996, CLIN GENET, V49, P156; WEEKS DE, 1995, GENOMICS, V26, P39, DOI 10.1016/0888-7543(95)80080-6; Yntema HG, 1998, J MED GENET, V35, P801, DOI 10.1136/jmg.35.10.801; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829	29	256	261	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					247	250		10.1038/80002	http://dx.doi.org/10.1038/80002			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017088				2022-12-17	WOS:000089638800029
J	KAY, MA; HOLTERMAN, AX; MEUSE, L; GOWN, A; OCHS, HD; LINSLEY, PS; WILSON, CB				KAY, MA; HOLTERMAN, AX; MEUSE, L; GOWN, A; OCHS, HD; LINSLEY, PS; WILSON, CB			LONG-TERM HEPATIC ADENOVIRUS-MEDIATED GENE-EXPRESSION IN MICE FOLLOWING CTLA4LG ADMINISTRATION	NATURE GENETICS			English	Article							CELL ACTIVATION; RECEPTOR; ANTIGEN; CTLA-4; DELIVERY; THERAPY; LIGAND; SYSTEM; CD28	Recombinant adenovirus vectors are efficient at transferring genes into somatic tissues but are limited for use in clinical gene therapy by immunologic factors that result in the vapid loss of gene expression and inhibit secondary gene transfer. This study demonstrates that systemic coadministration of recombinant adenovirus with soluble CTLA41g, which is known to block co-stimulatory signals between T cells and antigen presenting cells, leads to persistent adenoviral gene expression in mice without longterm immunosuppression. This form of immunotherapy greatly enhances the likelihood that recombinant adenovirus vectors will be useful for human gene therapy.	UNIV WASHINGTON,DEPT PEDIAT,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT IMMUNOL,SEATTLE,WA 98195; BRISTOL MYERS SQUIBB PHARMACEUT RES INST,SEATTLE,WA 98121	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Bristol-Myers Squibb	KAY, MA (corresponding author), UNIV WASHINGTON,DEPT MED,DIV MED GENET,BOX 357720,SEATTLE,WA 98195, USA.			Kay, Mark/0000-0002-2799-2615	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017427, R37HD017427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK047754, R01DK049022] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 17427] Funding Source: Medline; NIDDK NIH HHS [DK 47754, DK 49022] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; BARR D, 1995, GENE THER, V2, P151; BLUESTONE JA, 1995, IMMUNITY, V2, P555, DOI 10.1016/1074-7613(95)90000-4; DAI YF, 1995, P NATL ACAD SCI USA, V92, P1401, DOI 10.1073/pnas.92.5.1401; ENGLEHARDT JF, 1994, P NATL ACAD SCI USA, V91, P6196; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; HATHCOCK KS, 1993, SCIENCE, V262, P905, DOI 10.1126/science.7694361; INCK BK, 1994, SCIENCE, V265, P1225; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; KAY MA, 1994, TRENDS GENET, V10, P253, DOI 10.1016/0168-9525(94)90173-2; KAY MA, 1994, P NATL ACAD SCI USA, V91, P2353, DOI 10.1073/pnas.91.6.2353; KAY MA, 1995, HEPATOLOGY, V21, P815, DOI 10.1002/hep.1840210331; KAY MA, 1992, HUM GENE THER, V3, P641, DOI 10.1089/hum.1992.3.6-641; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; KOZARSKY KF, 1994, J BIOL CHEM, V269, P13695; LENSCHOW DJ, SCIENCE, V257, P789; LEWIS DB, 1994, J EXP MED, V173, P89; LI QT, 1993, HUM GENE THER, V4, P403, DOI 10.1089/hum.1993.4.4-403; LIN H, 1993, J EXP MED, V178, P1801, DOI 10.1084/jem.178.5.1801; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; NGUYEN L, 1994, J IMMUNOL, V152, P478; NONOYAMA S, 1993, J EXP MED, V178, P1097, DOI 10.1084/jem.178.3.1097; NONOYAMA S, 1993, J IMMUNOL, V150, P3817; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; PONDER KP, 1991, P NATL ACAD SCI USA, V88, P1217, DOI 10.1073/pnas.88.4.1217; RAWLE FC, 1991, J IMMUNOL, V146, P3977; Rinaldo C R Jr, 1993, Immunodeficiency, V5, P33; SCARIA A, 1995, GENE THER, V2, P295; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SIMMONS A, 1992, J EXP MED, V175, P1337, DOI 10.1084/jem.175.5.1337; SMITH TAG, 1993, NAT GENET, V5, P397, DOI 10.1038/ng1293-397; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; YANG YP, 1994, IMMUNITY, V1, P433, DOI 10.1016/1074-7613(94)90074-4	33	256	262	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1995	11	2					191	197		10.1038/ng1095-191	http://dx.doi.org/10.1038/ng1095-191			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RX806	7550348				2022-12-17	WOS:A1995RX80600022
J	COOK, GP; TOMLINSON, IM; WALTER, G; RIETHMAN, H; CARTER, NP; BULUWELA, L; WINTER, G; RABBITTS, TH				COOK, GP; TOMLINSON, IM; WALTER, G; RIETHMAN, H; CARTER, NP; BULUWELA, L; WINTER, G; RABBITTS, TH			A MAP OF THE HUMAN-IMMUNOGLOBULIN V-H LOCUS COMPLETED BY ANALYSIS OF THE TELOMERIC REGION OF CHROMOSOME 14Q	NATURE GENETICS			English	Article							HEAVY-CHAIN LOCUS; VARIABLE REGION; ANTIBODY REPERTOIRE; V(H) SEGMENTS; PHYSICAL MAP; 5' EXON; GENE; ORGANIZATION; YEAST; CLONING	Analysis of the telomeric region of chromosome 14q has enabled us to complete a map of the immunoglobulin V-H locus which accounts for almost all V-H segments known to rearrange in B-lymphocytes. The human germline V-H repertoire consists of approximately 50 functional V-H segments - the exact number depending on the haplotype - spanning 1,100 kilobases upstream of the J(H) segments. A yeast artificial chromosome used to map these segments was isolated by its ability to provide telomere activity in yeast, suggesting that the V-H locus may be located within a few kilobases of the 14q telomere. The limited structural diversity encoded by the functional V-H segments demonstrates the importance of combinatorial diversity produced by VDJ joining and the association of heavy and light chains in producing the human antibody repertoire.	MRC,MOLEC BIOL LAB,CAMBRIDGE CB2 2QH,ENGLAND; MRC,CTR PROT ENGN,CAMBRIDGE CB2 2QH,CAMBS,ENGLAND; WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104; UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE CB2 1QP,ENGLAND	MRC Laboratory Molecular Biology; University of Cambridge; The Wistar Institute; University of Cambridge			; Rabbitts, Terence/D-6262-2016	Cook, Graham/0000-0003-0223-3652; Rabbitts, Terence/0000-0002-4982-2609				BAER R, 1988, J EXP MED, V167, P2011, DOI 10.1084/jem.167.6.2011; BAER R, 1985, CELL, V43, P705, DOI 10.1016/0092-8674(85)90243-0; BERMAN JE, 1988, EMBO J, V7, P727, DOI 10.1002/j.1460-2075.1988.tb02869.x; BROWN WRA, 1989, NATURE, V338, P774, DOI 10.1038/338774a0; BRUGGEMANN M, 1989, P NATL ACAD SCI USA, V86, P6709, DOI 10.1073/pnas.86.17.6709; BULUWELA L, 1988, EMBO J, V7, P2003, DOI 10.1002/j.1460-2075.1988.tb03039.x; CARTER NP, 1992, J MED GENET, V29, P299, DOI 10.1136/jmg.29.5.299; CHENG JF, 1989, NUCLEIC ACIDS RES, V17, P6109, DOI 10.1093/nar/17.15.6109; CHERIF D, 1990, GENE CHROMOSOME CANC, V2, P103, DOI 10.1002/gcc.2870020205; CHOTHIA C, 1992, J MOL BIOL, V227, P799, DOI 10.1016/0022-2836(92)90224-8; COX DW, 1982, NATURE, V297, P428, DOI 10.1038/297428a0; CROSS SH, 1989, NATURE, V338, P771, DOI 10.1038/338771a0; FISCH P, 1992, EUR J IMMUNOL, V22, P2745, DOI 10.1002/eji.1830221042; HALUSKA FG, 1987, P NATL ACAD SCI USA, V84, P6835, DOI 10.1073/pnas.84.19.6835; KODAIRA M, 1986, J MOL BIOL, V190, P529, DOI 10.1016/0022-2836(86)90239-1; MATSUDA F, 1990, EMBO J, V9, P2501, DOI 10.1002/j.1460-2075.1990.tb07429.x; MATSUDA F, 1988, EMBO J, V7, P1047, DOI 10.1002/j.1460-2075.1988.tb02912.x; MATSUDA F, 1993, NAT GENET, V3, P88, DOI 10.1038/ng0193-88; MCBRIDE OW, 1982, NUCLEIC ACIDS RES, V10, P8155, DOI 10.1093/nar/10.24.8155; MENGLEGAW L, 1988, P NATL ACAD SCI USA, V85, P9171, DOI 10.1073/pnas.85.23.9171; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; PAVAN WJ, 1990, P NATL ACAD SCI USA, V87, P1300, DOI 10.1073/pnas.87.4.1300; REEVES RH, 1992, METHOD ENZYMOL, V216, P584; RIETHMAN HC, 1989, P NATL ACAD SCI USA, V86, P6240, DOI 10.1073/pnas.86.16.6240; SANZ I, 1989, EMBO J, V8, P3741, DOI 10.1002/j.1460-2075.1989.tb08550.x; SASSO EH, 1993, J CLIN INVEST, V91, P2358, DOI 10.1172/JCI116468; SCHROEDER HW, 1987, SCIENCE, V238, P791, DOI 10.1126/science.3118465; SHIN EK, 1991, EMBO J, V10, P3641, DOI 10.1002/j.1460-2075.1991.tb04930.x; TOMLINSON IM, 1994, HUM MOL GENET, V3, P853; TOMLINSON IM, 1992, J MOL BIOL, V227, P776, DOI 10.1016/0022-2836(92)90223-7; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; VANDIJK KW, 1993, EUR J IMMUNOL, V23, P832, DOI 10.1002/eji.1830230410; VANDIJK KW, 1992, P NATL ACAD SCI USA, V89, P10430, DOI 10.1073/pnas.89.21.10430; VANES JH, 1992, J IMMUNOL, V149, P2234; WALTER G, 1993, NUCLEIC ACIDS RES, V21, P4524, DOI 10.1093/nar/21.19.4524; WALTER MA, 1990, EMBO J, V9, P3303, DOI 10.1002/j.1460-2075.1990.tb07530.x; WALTER MA, 1991, J EXP MED, V174, P335, DOI 10.1084/jem.174.2.335; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; ZELENETZ AD, 1992, J EXP MED, V176, P1137, DOI 10.1084/jem.176.4.1137	39	256	264	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1994	7	2					162	168		10.1038/ng0694-162	http://dx.doi.org/10.1038/ng0694-162			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ037	7920635				2022-12-17	WOS:A1994NQ03700016
J	MATTHEWS, CH; BORGATO, S; BECKPECCOZ, P; ADAMS, M; TONE, Y; GAMBINO, G; CASAGRANDE, S; TEDESCHINI, G; BENEDETTI, A; CHATTERJEE, VKK				MATTHEWS, CH; BORGATO, S; BECKPECCOZ, P; ADAMS, M; TONE, Y; GAMBINO, G; CASAGRANDE, S; TEDESCHINI, G; BENEDETTI, A; CHATTERJEE, VKK			PRIMARY AMENORRHEA AND INFERTILITY DUE TO A MUTATION IN THE BETA-SUBUNIT OF FOLLICLE-STIMULATING-HORMONE	NATURE GENETICS			English	Article							GENE; GONADOTROPINS; SUBSTITUTION; HYPOGONADISM; FOLLITROPIN; CELLS; SERUM; FSH	We report a woman with primary amenorrhoea and infertility associated with an isolated deficiency of pituitary follicle-stimulating hormone (FSH), but normal luteinizing hormone (LH) secretion. Ovulation was induced by administration of exogenous FSH and resulted in a successful pregnancy. Sequence analysis of the FSHbeta-subunit gene indicated that she is homozygous for a two nucleotide frameshift deletion in the coding sequence. Her mother and son are heterozygous for this mutation. This deletion results in an alteration of amino acid codons 61-86 followed by a premature termination codon. The predicted truncated beta-subunit peptide lacks regions which are important for association with the alpha subunit and for binding to and activation of the FSH receptor. Abnormalities of FSH structure or function might be an under recognised but treatable cause of infertility.	UNIV MILAN, OSPED MAGGIORE, INST ENDOCRINE SCI, IRCCS, I-20122 MILAN, ITALY; UNIV TRIESTE, CATTINARA HOSP, DEPT ENDOCRINOL, I-34100 TRIESTE, ITALY	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Trieste	CHATTERJEE, VKK (corresponding author), UNIV CAMBRIDGE, ADDENBROOKES HOSP, DEPT MED, CAMBRIDGE CB2 2QQ, ENGLAND.			Chatterjee, Vengalil Krishna/0000-0002-2654-8854	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALANSARI AAK, 1984, FERTIL STERIL, V42, P618; AVRILDUCARNE D, 1990, J GYNECOL OBST BIO R, V19, P881; AZUMA C, 1990, J MOL ENDOCRINOL, V5, P97, DOI 10.1677/jme.0.0050097; BECKPECCOZ P, 1991, J CLIN ENDOCR METAB, V73, P525, DOI 10.1210/jcem-73-3-525; BENEDETTI A, 1991, GIORNALE CLIN MED, V21, P289; CAMPBELL RK, 1991, P NATL ACAD SCI USA, V88, P760, DOI 10.1073/pnas.88.3.760; COLOMA TAS, 1990, J BIOL CHEM, V265, P5037; DACOUVOUTETAKIS C, 1990, AM J HUM GENET, V46, P988; DIAS JA, 1992, TRENDS ENDOCRIN MET, V3, P24, DOI 10.1016/1043-2760(92)90088-I; HAYASHIZAKI Y, 1989, EMBO J, V8, P2291, DOI 10.1002/j.1460-2075.1989.tb08355.x; HSUEH AJW, 1989, RECENT PROG HORM RES, V45, P209; HULTMAN T, 1989, NUCLEIC ACIDS RES, V17, P4937, DOI 10.1093/nar/17.13.4937; JAMESON JL, 1988, MOL ENDOCRINOL, V2, P806, DOI 10.1210/mend-2-9-806; JOCKENHOVEL F, 1989, ACTA ENDOCRINOL-COP, V121, P802, DOI 10.1530/acta.0.1210802; KEENE JL, 1989, J BIOL CHEM, V264, P4769; MARCHBANKS PA, 1989, AM J EPIDEMIOL, V130, P259, DOI 10.1093/oxfordjournals.aje.a115332; MAROULIS GB, 1977, FERTIL STERIL, V28, P818; NIESCHLAG E, 1993, CLIN ENDOCRINOL, V38, P123, DOI 10.1111/j.1365-2265.1993.tb00983.x; PADMANABHAN V, 1987, ENDOCRINOLOGY, V121, P1089, DOI 10.1210/endo-121-3-1089; RABINOWITZ D, 1979, NEW ENGL J MED, V300, P126, DOI 10.1056/NEJM197901183000306; RYAN RJ, 1987, RECENT PROG HORM RES, V43, P383; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; VAKHARIA DD, 1991, ENDOCRINOLOGY, V128, P1797, DOI 10.1210/endo-128-4-1797; VAKHARIA DD, 1992, MOL CELL ENDOCRINOL, V85, P89, DOI 10.1016/0303-7207(92)90128-S; WANG C, 1987, J CLIN ENDOCR METAB, V65, P629, DOI 10.1210/jcem-65-4-629; WATKINS PC, 1987, DNA-J MOLEC CELL BIO, V6, P205, DOI 10.1089/dna.1987.6.205; WEISS J, 1992, NEW ENGL J MED, V326, P179, DOI 10.1056/NEJM199201163260306; WINTERS SJ, 1992, NEW ENGL J MED, V326, P193, DOI 10.1056/NEJM199201163260309	28	256	267	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1993	5	1					83	86		10.1038/ng0993-83	http://dx.doi.org/10.1038/ng0993-83			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	8220432				2022-12-17	WOS:A1993LV56500022
J	Kim, HJ; Raphael, AR; LaDow, ES; McGurk, L; Weber, RA; Trojanowski, JQ; Lee, VMY; Finkbeiner, S; Gitler, AD; Bonini, NM				Kim, Hyung-Jun; Raphael, Alya R.; LaDow, Eva S.; McGurk, Leeanne; Weber, Ross A.; Trojanowski, John Q.; Lee, Virginia M-Y; Finkbeiner, Steven; Gitler, Aaron D.; Bonini, Nancy M.			Therapeutic modulation of eIF2 alpha phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models	NATURE GENETICS			English	Article							TARGETED GENE-EXPRESSION; STRESS GRANULE FORMATION; DNA-BINDING PROTEIN; PRION-LIKE DOMAINS; ALPHA-SYNUCLEIN; MOLECULAR DETERMINANTS; ENDOGENOUS TDP-43; DROSOPHILA MODEL; 43 KDA; RNA	Amyotrophic lateral sclerosis (ALS) is a fatal, late-onset neurodegenerative disease primarily affecting motor neurons. A unifying feature of many proteins associated with ALS, including TDP-43 and ataxin-2, is that they localize to stress granules. Unexpectedly, we found that genes that modulate stress granules are strong modifiers of TDP-43 toxicity in Saccharomyces cerevisiae and Drosophila melanogaster. eIF2 alpha phosphorylation is upregulated by TDP-43 toxicity in flies, and TDP-43 interacts with a central stress granule component, polyA-binding protein (PABP). In human ALS spinal cord neurons, PABP accumulates abnormally, suggesting that prolonged stress granule dysfunction may contribute to pathogenesis. We investigated the efficacy of a small molecule inhibitor of eIF2 alpha phosphorylation in ALS models. Treatment with this inhibitor mitigated TDP-43 toxicity in flies and mammalian neurons. These findings indicate that the dysfunction induced by prolonged stress granule formation might contribute directly to ALS and that compounds that mitigate this process may represent a novel therapeutic approach.	[Kim, Hyung-Jun; McGurk, Leeanne; Weber, Ross A.; Bonini, Nancy M.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Raphael, Alya R.; Gitler, Aaron D.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [LaDow, Eva S.; Finkbeiner, Steven] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Trojanowski, John Q.; Lee, Virginia M-Y] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA	University of Pennsylvania; Stanford University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Pennsylvania; Pennsylvania Medicine	Bonini, NM (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	nbonini@sas.upenn.edu	McGurk, Leeanne/L-6734-2019	McGurk, Leeanne/0000-0002-6493-6751; Gitler, Aaron/0000-0001-8603-1526	Howard Hughes Medical Institute; US National Institutes of Health [R01NS073660]; NIH Director's New Innovator [DP2OD004417]; US NIH grant [R01NS065317, AG10124, AG32953, AG17586, NS53488]; Robert Packard Center for ALS and the Williams H. Adams Foundation; Target ALS; BrightFocus Alzheimer's disease research grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS053488, R01NS073660, R01NS065317, R01NS039074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010124, P01AG032953, P01AG017586] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004417] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Packard Center for ALS and the Williams H. Adams Foundation; Target ALS; BrightFocus Alzheimer's disease research grant(BrightFocus Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank X. Teng and Y. Zhu for technical assistance and W. Motley, A. Berson and other laboratory members for insightful comments. This work was funded by grants from the Howard Hughes Medical Institute (N.M.B.), grant R01NS073660 from the US National Institutes of Health (NIH; A.D.G. and N.M.B.), NIH Director's New Innovator Award DP2OD004417 (A.D.G.) and US NIH grant R01NS065317 (A.D.G.), the Robert Packard Center for ALS and the Williams H. Adams Foundation (S.F.), and US NIH grants AG10124, AG32953, AG17586 and NS53488 (J. Q. T. and V.M.-Y. L.). A.D.G. and S.F. are supported by a grant from Target ALS. A.R.R. is supported by a BrightFocus Alzheimer's disease research grant.	Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2; Armakola M, 2011, METHODS, V53, P238, DOI 10.1016/j.ymeth.2010.11.006; Arrasate M, 2005, P NATL ACAD SCI USA, V102, P3840, DOI 10.1073/pnas.0409777102; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Aulas A, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-54; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Bentmann E, 2013, FEBS J, V280, P4348, DOI 10.1111/febs.12287; Bentmann E, 2012, J BIOL CHEM, V287, P23079, DOI 10.1074/jbc.M111.328757; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRAND S, 1993, NUCLEIC ACIDS RES, V21, P3699, DOI 10.1093/nar/21.16.3699; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Chowdhury A, 2012, RNA, V18, P936, DOI 10.1261/rna.029876.111; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Couthouis J, 2012, HUM MOL GENET, V21, P2899, DOI 10.1093/hmg/dds116; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; Dalton LE, 2012, PROG MOL BIOL TRANSL, V106, P189, DOI 10.1016/B978-0-12-396456-4.00003-1; Dewey CM, 2012, BRAIN RES, V1462, P16, DOI 10.1016/j.brainres.2012.02.032; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Hart MP, 2012, J NEUROSCI, V32, P9133, DOI 10.1523/JNEUROSCI.0996-12.2012; Hekmat-Scafe DS, 2005, GENETICS, V169, P1477, DOI 10.1534/genetics.104.036558; Hofmann S, 2012, MOL BIOL CELL, V23, P3786, DOI 10.1091/mbc.E12-04-0296; Hu XH, 2007, GENETICS, V175, P1479, DOI 10.1534/genetics.106.065292; Jain S, 2013, ADV EXP MED BIOL, V768, P23, DOI 10.1007/978-1-4614-5107-5_3; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Khong A, 2011, J VIROL, V85, P1439, DOI 10.1128/JVI.02220-10; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kozlov G, 2010, J MOL BIOL, V397, P397, DOI 10.1016/j.jmb.2010.01.032; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Parker SJ, 2012, NEUROCHEM INT, V60, P415, DOI 10.1016/j.neuint.2012.01.019; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Ruggieri A, 2012, CELL HOST MICROBE, V12, P71, DOI 10.1016/j.chom.2012.05.013; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Swisher KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010006; Tazen S., 2013, JAMA NEUROL     0819, DOI [10.1001/jamaneurol.2013.443, DOI 10.1001/JAMANEUR0L.2013.443]; Thomas M, 2013, BRAIN, V136, P1345, DOI 10.1093/brain/awt030; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Warraich ST, 2010, INT J BIOCHEM CELL B, V42, P1606, DOI 10.1016/j.biocel.2010.06.016; Wolozin B, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-56; Zoll WL, 2002, J BIOL CHEM, V277, P37079, DOI 10.1074/jbc.M207109200; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	63	255	262	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					152	+		10.1038/ng.2853	http://dx.doi.org/10.1038/ng.2853			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24336168	Green Accepted, Green Submitted			2022-12-17	WOS:000331208300011
J	Ioshikhes, IP; Albert, I; Zanton, SJ; Pugh, BF				Ioshikhes, Ilya P.; Albert, Istvan; Zanton, Sara J.; Pugh, B. Franklin			Nucleosome positions predicted through comparative genomics	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; MULTIPLE ALIGNMENT; PROMOTER REGIONS; DNA PATTERN; YEAST; IDENTIFICATION; SEQUENCES; GENES; SITES; CORE	DNA sequence has long been recognized as an important contributor to nucleosome positioning, which has the potential to regulate access to genes. The extent to which the nucleosomal architecture at promoters is delineated by the underlying sequence is now being worked out. Here we use comparative genomics to report a genome-wide map of nucleosome positioning sequences (NPSs) located in the vicinity of all Saccharomyces cerevisiae genes. We find that the underlying DNA sequence provides a very good predictor of nucleosome locations that have been experimentally mapped to a small fraction of the genome. Notably, distinct classes of genes possess characteristic arrangements of NPSs that may be important for their regulation. In particular, genes that have a relatively compact NPS arrangement over the promoter region tend to have a TATA box buried in an NPS and tend to be highly regulated by chromatin modifying and remodeling factors.	Penn State Univ, Ctr Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; Penn State Univ, Huck Inst Life Sci, Bioinformat Consulting Ctr, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pugh, BF (corresponding author), Penn State Univ, Ctr Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	bfp2@psu.edu	Albert, Istvan/J-3734-2015	Albert, Istvan/0000-0001-8366-984X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059055] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM059055, GM59055] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Bolshoy A, 1996, COMPUT APPL BIOSCI, V12, P383; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Cohanim AB, 2005, J BIOMOL STRUCT DYN, V22, P687, DOI 10.1080/07391102.2005.10507035; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Ioshikhes I, 1996, J MOL BIOL, V262, P129, DOI 10.1006/jmbi.1996.0503; Ioshikhes I, 1999, P NATL ACAD SCI USA, V96, P2891, DOI 10.1073/pnas.96.6.2891; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Lowary PT, 1997, P NATL ACAD SCI USA, V94, P1183, DOI 10.1073/pnas.94.4.1183; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Sabet N, 2004, MOL CELL BIOL, V24, P8823, DOI 10.1128/MCB.24.20.8823-8833.2004; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Widom J, 1996, J MOL BIOL, V259, P579, DOI 10.1006/jmbi.1996.0341; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zanton SJ, 2006, GENE DEV, V20, P2250, DOI 10.1101/gad.1437506; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583	21	255	263	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1210	1215		10.1038/ng1878	http://dx.doi.org/10.1038/ng1878			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16964265				2022-12-17	WOS:000241251100023
J	Kulaga, HM; Leitch, CC; Eichers, ER; Badano, JL; Lesemann, A; Hoskins, BE; Lupski, JR; Beales, PL; Reed, RR; Katsanis, N				Kulaga, HM; Leitch, CC; Eichers, ER; Badano, JL; Lesemann, A; Hoskins, BE; Lupski, JR; Beales, PL; Reed, RR; Katsanis, N			Loss of BBS proteins causes anosmia in humans and defects in olfactory cilia structure and function in the mouse	NATURE GENETICS			English	Article							BARDET-BIEDL-SYNDROME; HUMAN OBESITY SYNDROME; INTRAFLAGELLAR TRANSPORT; ADENYLYL-CYCLASE; DISEASE GENE; IDENTIFICATION; MUTATIONS; HOMOLOG; CLONING	Defects in cilia are associated with several human disorders, including Kartagener syndrome(1), polycystic kidney disease(2,3), nephronophthisis(4) and hydrocephalus(5). We proposed that the pleiotropic phenotype of Bardet-Biedl syndrome (BBS), which encompasses retinal degeneration, truncal obesity, renal and limb malformations and developmental delay, is due to dysfunction of basal bodies and cilia(6,7). Here we show that individuals with BBS have partial or complete anosmia. To test whether this phenotype is caused by ciliary defects of olfactory sensory neurons, we examined mice with deletions of Bbs1 or Bbs4. Loss of function of either BBS protein affected the olfactory, but not the respiratory, epithelium, causing severe reduction of the ciliated border, disorganization of the dendritic microtubule network and trapping of olfactory ciliary proteins in dendrites and cell bodies. Our data indicate that BBS proteins have a role in the microtubule organization of mammalian ciliated cells and that anosmia might be a useful determinant of other pleiotropic disorders with a suspected ciliary involvement.	Johns Hopkins Univ, Inst Med Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; UCL, Inst Child Hlth, Mol Med Unit, London WC1 1EH, England; Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21287 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Baylor College of Medicine; University of London; University College London; Baylor College of Medicine; Baylor College of Medicine; Johns Hopkins University; Johns Hopkins Medicine	Katsanis, N (corresponding author), Johns Hopkins Univ, Inst Med Genet, 533 Broadway St Bldg,733 N Broadway, Baltimore, MD 21205 USA.	katsanis@jhmi.edu	Katsanis, Nicholas/E-1837-2012; Reed, Russell/HGU-0528-2022; Beales, Philip L/C-7367-2009	Badano, Jose/0000-0002-0706-8652; Katsanis, Nicholas/0000-0002-2480-0171				AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Badano JL, 2003, AM J HUM GENET, V72, P650, DOI 10.1086/368204; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; Beales PL, 1999, J MED GENET, V36, P437; Beales PL, 2003, AM J HUM GENET, V72, P1187, DOI 10.1086/375178; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; Gervais FG, 2002, NAT CELL BIOL, V4, P95, DOI 10.1038/ncb735; Goldstein BJ, 2003, JARO-J ASSOC RES OTO, V4, P74, DOI 10.1007/s10162-002-2039-5; GRAZIADEI PPC, 1978, OLFACTORY SYSTEM MOD, P131; Haycraft CJ, 2003, EXP CELL RES, V284, P251, DOI 10.1016/S0014-4827(02)00089-7; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Menco Bert P. M., 1994, Seminars in Cell Biology, V5, P11, DOI 10.1006/scel.1994.1003; Moore AB, 1999, J CLIN EXP NEUROPSYC, V21, P341, DOI 10.1076/jcen.21.3.341.918; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; RUGARLI EI, 1993, NAT GENET, V4, P19, DOI 10.1038/ng0593-19; Signor D, 2000, Essays Biochem, V35, P89; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X	30	255	262	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					994	998		10.1038/ng1418	http://dx.doi.org/10.1038/ng1418			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15322545	Bronze			2022-12-17	WOS:000223658100027
J	Haug, K; Warnstedt, M; Alekov, AK; Sander, T; Ramirez, A; Poser, B; Maljevic, S; Hebeisen, S; Kubisch, C; Rebstock, J; Horvath, S; Hallmann, K; Dullinger, JS; Rau, B; Haverkamp, F; Beyenburg, S; Schulz, H; Janz, D; Giese, B; Muller-Newen, G; Propping, P; Elger, CE; Fahlke, C; Lerche, H; Heils, A				Haug, K; Warnstedt, M; Alekov, AK; Sander, T; Ramirez, A; Poser, B; Maljevic, S; Hebeisen, S; Kubisch, C; Rebstock, J; Horvath, S; Hallmann, K; Dullinger, JS; Rau, B; Haverkamp, F; Beyenburg, S; Schulz, H; Janz, D; Giese, B; Muller-Newen, G; Propping, P; Elger, CE; Fahlke, C; Lerche, H; Heils, A			RETRACTED: Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies (Retracted article. See vol 41, pg. 1043, 2009)	NATURE GENETICS			English	Article; Retracted Publication							POSTSYNAPTIC INHIBITION; ION CHANNELS; NEURONS; GABA; GAMMA-2-SUBUNIT; CONDUCTANCE; HIPPOCAMPUS; POTASSIUM; MOUSE; CELLS	Idiopathic generalized epilepsy (IGE) is an inherited neurological disorder affecting about 0.4% of the world's population. Mutations in ten genes causing distinct forms of idiopathic epilepsy have been identified so far(1-7), but the genetic basis of many IGE subtypes is still unknown. Here we report a gene associated with the four most common IGE subtypes: childhood and juvenile absence epilepsy (CAE and JAE), juvenile myoclonic epilepsy (JME), and epilepsy with grand mal seizures on awakening (EGMA; ref. 8). We identified three different heterozygous mutations in the chloride-channel gene CLCN2 in three unrelated families with IGE. These mutations result in (i) a premature stop codon (M200fsX231), (ii) an atypical splicing (del74-117) and (iii) a single amino-acid substitution (G715E). All mutations produce functional alterations that provide distinct explanations for their pathogenic phenotypes. M200fsX231 and del74-117 cause a loss of function of ClC-2 channels and are expected to lower the transmembrane chloride gradient essential for GABAergic inhibition. G715E alters voltage-dependent gating, which may cause membrane depolarization and hyperexcitability.	Univ Klinikum Bonn, Inst Humangenet, D-53111 Bonn, Germany; Ctr Estudios Cient, Valdivia, Chile; Rhein Westfal TH Aachen, Inst Biochem, D-52057 Aachen, Germany; Univ Klinikum Bonn, Klinikum Padiatrie, D-59113 Bonn, Germany; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Stat, Los Angeles, CA USA; Univ Klinikum Bonn, Klin Epileptol, D-53105 Bonn, Germany; Humboldt Univ, Virchow Klinikum, Klinikum Charite, Arbeitsgrp Epilepsie Genet,Neurol Klin, D-13353 Berlin, Germany; Univ Ulm, Abt Angew Physiol & Neurol, D-89069 Ulm, Germany; Rhein Westfal TH Aachen, Lehr & Forschungsgebeit Physiol, D-52057 Aachen, Germany	University of Bonn; RWTH Aachen University; University of Bonn; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Bonn; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ulm University; RWTH Aachen University	Heils, A (corresponding author), Univ Klinikum Bonn, Inst Humangenet, Wilhelmstr 31, D-53111 Bonn, Germany.	holger.lerche@medizin.uni-ulm.de; armin.heils@ukb.uni-bonn.de	Ramirez, Alfredo/S-5126-2019; Alekov, Alexi/ABE-4170-2020; Fahlke, Christoph/G-3635-2013; Kubisch, Christian/F-1893-2011	Ramirez, Alfredo/0000-0003-4991-763X; Fahlke, Christoph/0000-0001-8602-9952; Kubisch, Christian/0000-0003-4220-0978; Alekov, Alexi/0000-0001-6362-7247; Maljevic, Snezana/0000-0003-1876-5872				[Anonymous], 1989, EPILEPSIA, V30, P389; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; Berkovic SF, 2001, EPILEPSIA, V42, P16, DOI 10.1046/j.1528-1157.2001.0420s5016.x; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; CID LP, 1995, HUM MOL GENET, V4, P407, DOI 10.1093/hmg/4.3.407; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Fahlke C, 1997, J GEN PHYSIOL, V109, P93, DOI 10.1085/jgp.109.1.93; Fahlke C, 1997, NATURE, V390, P529, DOI 10.1038/37391; Kaila K, 1997, J NEUROSCI, V17, P7662; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; Labarca C, 2001, P NATL ACAD SCI USA, V98, P2786, DOI 10.1073/pnas.041582598; Lerche H, 2001, AM J MED GENET, V106, P146, DOI 10.1002/ajmg.1582; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; MISGELD U, 1986, SCIENCE, V232, P1413, DOI 10.1126/science.2424084; Mladinic M, 1999, P ROY SOC B-BIOL SCI, V266, P1207, DOI 10.1098/rspb.1999.0764; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Ross SA, 2000, J NEUROSCI, V20, P6431, DOI 10.1523/JNEUROSCI.20-17-06431.2000; Sander T, 2000, HUM MOL GENET, V9, P1465, DOI 10.1093/hmg/9.10.1465; Serratosa JM, 1999, EPILEPSIA, V40, P12, DOI 10.1111/j.1528-1157.1999.tb00893.x; Sik A, 2000, NEUROSCIENCE, V101, P51, DOI 10.1016/S0306-4522(00)00360-2; STALEY K, 1994, J NEUROPHYSIOL, V72, P273, DOI 10.1152/jn.1994.72.1.273; Staley K, 1996, NEURON, V17, P543, DOI 10.1016/S0896-6273(00)80186-5; Steinlein OK, 2000, CURR OPIN GENET DEV, V10, P286, DOI 10.1016/S0959-437X(00)00079-4; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/88259	30	255	275	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					527	532		10.1038/ng1121	http://dx.doi.org/10.1038/ng1121			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12612585	Bronze			2022-12-17	WOS:000181928600027
J	Wu, LF; Hughes, TR; Davierwala, AP; Robinson, MD; Stoughton, R; Altschuler, SJ				Wu, LF; Hughes, TR; Davierwala, AP; Robinson, MD; Stoughton, R; Altschuler, SJ			Large-scale prediction of Saccharomyces cerevisiae gene function using overlapping transcriptional clusters	NATURE GENETICS			English	Article							CELL NUCLEAR ANTIGEN; EXPRESSION PROFILES; RIBOSOME BIOGENESIS; PROTEIN FUNCTION; GENOME; YEAST; SEQUENCE; DATABASE; IDENTIFICATION; REPLICATION	Genome sequencing has led to the discovery of tens of thousands of potential new genes. Six years after the sequencing of the well-studied yeast Saccharomyces cerevisiae and the discovery that its genome encodes 6,000 predicted proteins, more than 2,000 have not yet been characterized experimentally, and determining their functions seems far from a trivial task. One crucial constraint is the generation of useful hypotheses about protein function. Using a new approach to interpret microarray data, we assign likely cellular functions with confidence values to these new yeast proteins. We perform extensive genome-wide validations of our predictions and offer visualization methods for exploration of the large numbers of functional predictions. We identify potential new members of many existing functional categories including 285 candidate proteins involved in transcription, processing and transport of non-coding RNA molecules. We present experimental validation confirming the involvement of several of these proteins in ribosomal RNA processing. Our methodology can be applied to a variety of genomics data types and organisms.	Rosetta Inpharmat, Kirkland, WA USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada	Merck & Company; University of Toronto	Altschuler, SJ (corresponding author), Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA.	saltschuler@cgr.harvard.edu	Robinson, Mark D/A-6432-2015; Robinson, Mark D./O-2254-2019	Robinson, Mark D/0000-0002-3048-5518; Robinson, Mark D./0000-0002-3048-5518				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ball CA, 2000, NUCLEIC ACIDS RES, V28, P77, DOI 10.1093/nar/28.1.77; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bork P, 1998, J MOL BIOL, V283, P707, DOI 10.1006/jmbi.1998.2144; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chen C, 1999, MOL CELL BIOL, V19, P7801; CHENG Y, 1995, SCIENCE, V267, P1807, DOI 10.1126/science.7534442; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gelperin D, 2001, RNA, V7, P1268, DOI 10.1017/S1355838201013073; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; Goldstein DR, 2002, STAT SINICA, V12, P219; Hartigan J.A., 1975, CLUSTERING ALGORITHM; Hishigaki H, 2001, YEAST, V18, P523, DOI 10.1002/yea.706; Hodges PE, 1999, NUCLEIC ACIDS RES, V27, P69, DOI 10.1093/nar/27.1.69; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/ng0501-21; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; King RD, 2000, YEAST, V17, P283, DOI 10.1002/1097-0061(200012)17:4<283::AID-YEA52>3.0.CO;2-F; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Mewes HW, 1997, NUCLEIC ACIDS RES, V25, P28, DOI 10.1093/nar/25.1.28; Miki R, 2001, P NATL ACAD SCI USA, V98, P2199, DOI 10.1073/pnas.041605498; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Prosperi E, 1997, Prog Cell Cycle Res, V3, P193; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Shatkay H, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P317; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wen XL, 1998, P NATL ACAD SCI USA, V95, P334, DOI 10.1073/pnas.95.1.334; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; 1909, SCIENCE, V282, P2012	41	255	267	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2002	31	3					255	265		10.1038/ng906	http://dx.doi.org/10.1038/ng906			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12089522				2022-12-17	WOS:000176494100012
J	Moon, AM; Capecchi, MR				Moon, AM; Capecchi, MR			Fgf8 is required for outgrowth and patterning of the limbs	NATURE GENETICS			English	Article							APICAL ECTODERMAL RIDGE; VERTEBRATE LIMB; SONIC-HEDGEHOG; TRANSGENIC MICE; FEEDBACK LOOP; STEM-CELLS; GROWTH; GENE; BUD; INITIATION	The expression pattern and activity of fibroblast growth factor-8 (FGF8) in experimental assays indicate that it has important roles in limb development(1-3), but early embryonic lethality resulting from mutation of Fgf8 in the germ line of mice has prevented direct assessment of these roles(4). Here we report that conditional disruption of Fgf8 in the forelimb of developing mice bypasses embryonic lethality and reveals a requirement for Fgf8 in the formation of the stylopod, anterior zeugopod and autopod. Lack of Fgf8 in the apical ectodermal ridge (AER) alters expression of other Fgf genes, Shh and Bmp2.	Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Dept Human Mol Biol & Genet, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Capecchi, MR (corresponding author), Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA.			moon, anne/0000-0002-9090-1093	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD001373] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; Colvin JS, 1999, DEV DYNAM, V216, P72; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; HEIKINHEIMO M, 1994, MECH DEVELOP, V48, P129, DOI 10.1016/0925-4773(94)90022-1; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; MAHMOOD R, 1995, CURR BIOL, V5, P797, DOI 10.1016/S0960-9822(95)00157-6; MENDELSOHN C, 1991, DEVELOPMENT, V113, P723; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Moon AM, 2000, DEVELOPMENT, V127, P989; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; OHUCHI H, 1994, BIOCHEM BIOPH RES CO, V204, P882, DOI 10.1006/bbrc.1994.2542; REYNOLDS K, 1991, MECH DEVELOP, V36, P15, DOI 10.1016/0925-4773(91)90068-H; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROGALA EJ, 1974, J MED GENET, V11, P221, DOI 10.1136/jmg.11.3.221; Ros MA, 1996, DEVELOPMENT, V122, P2319; ROWE DA, 1981, J EMBRYOL EXP MORPH, V65, P309; RUBIN L, 1972, DEV BIOL, V28, P94, DOI 10.1016/0012-1606(72)90129-7; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Tabin CJ, 1998, NATURE, V396, P322, DOI 10.1038/24516; TANAKA A, 1992, P NATL ACAD SCI USA, V89, P8928, DOI 10.1073/pnas.89.19.8928; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Vogel A, 1996, DEVELOPMENT, V122, P1737; Wolpert L, 1975, Ciba Found Symp, V0, P95; Xu XL, 1998, DEVELOPMENT, V125, P753	30	255	262	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					455	459		10.1038/82601	http://dx.doi.org/10.1038/82601			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101845	Green Accepted			2022-12-17	WOS:000165671700020
J	Bech-Hansen, NT; Naylor, MJ; Maybaum, TA; Sparkes, RL; Koop, B; Birch, DG; Bergen, AAB; Prinsen, CFM; Polomeno, RC; Gal, A; Drack, AV; Musarella, MA; Jacobson, SG; Young, RSL; Weleber, RG				Bech-Hansen, NT; Naylor, MJ; Maybaum, TA; Sparkes, RL; Koop, B; Birch, DG; Bergen, AAB; Prinsen, CFM; Polomeno, RC; Gal, A; Drack, AV; Musarella, MA; Jacobson, SG; Young, RSL; Weleber, RG			Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness	NATURE GENETICS			English	Article							RETINITIS-PIGMENTOSA; GENE; LOCALIZATION; REPEAT; SITES; ELECTRORETINOGRAM; IDENTIFICATION; XP11.23; PROTEIN; REGION	During development, visual photoreceptors, bipolar cells and other neurons establish connections within the retina enabling the eye to process visual images over approximately 7 log units of illumination(1). Within the retina, cells that respond to light increment and light decrement are separated into ON- and OFF-pathways. Hereditary diseases are known to disturb these retinal pathways, causing either progressive degeneration or stationary deficits(2). Congenital stationary night blindness (CSNB) is a group of stable retinal disorders that are characterized by abnormal night vision. Genetic subtypes of CSNB have been defined and different disease actions have been postulated(3-5). The molecular bases have been elucidated in several subtypes, providing a better understanding of the disease mechanisms and developmental retinal neurobiology(2). Here we have studied 22 families with 'complete' X-linked CSNB (CSNB1; MIM 310500; ref. 4) in which affected males have night blindness, some photopic vision loss and a defect of the ON-pathway. We have found 14 different mutations, including 1 founder mutation in 7 families from the United States, in a novel candidate gene, NYX. NYX, which encodes a glycosylphosphatidyl (GPI)-anchored protein called nyctalopin, is a new and unique member of the small leucine-rich proteoglycan (SLRP) family(6). The role of other SLRP proteins suggests that mutant nyctalopin disrupts developing retinal interconnections involving the ON-bipolar cells, leading to the visual losses seen in patients with complete CSNB.	Univ Calgary, Fac Med, Dept Med Genet, Calgary, AB, Canada; Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; Univ Victoria, Environm Res Ctr, Victoria, BC, Canada; Retina Fdn SW, Dallas, TX USA; Netherlands Ophthalm Res Inst, NL-1100 AC Amsterdam, Netherlands; Univ Calgary, Dept Physiol & Biophys, Calgary, AB, Canada; Childrens Hosp, Dept Ophthalmol, Montreal, PQ, Canada; McGill Univ, Montreal, PQ, Canada; Univ Hamburg, Klinikum Eppendorf, Inst Humangenet, Hamburg, Germany; Emory Eye Ctr, Dept Ophthalmol, Atlanta, GA USA; Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA; Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA; Texas Tech Univ, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Lubbock, TX 79430 USA; Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA	University of Calgary; University of Victoria; University of Victoria; Retina Foundation of the Southwest; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Calgary; McGill University; McGill University; University of Hamburg; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Pennsylvania; Pennsylvania Medicine; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Oregon Health & Science University	Bech-Hansen, NT (corresponding author), Univ Calgary, Fac Med, Dept Med Genet, Calgary, AB, Canada.	ntbech@ucalgary.ca	Bergen, Arthur/J-3637-2013; Koop, Ben F./A-8151-2008	Koop, Ben F./0000-0003-0045-5200; Bergen, Arthur/0000-0002-6333-9576; Birch, David/0000-0002-6594-2897; Jacobson, Samuel/0000-0003-2122-169X; Drack, Arlene/0000-0002-8195-8426	NEI NIH HHS [EY05235, EY-05627] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Antonarakis SE, 1998, HUM MUTAT, V11, P1; Bech-Hansen NT, 1998, HUM GENET, V103, P124, DOI 10.1007/s004390050794; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; BERGEN AAB, 1995, HUM MOL GENET, V4, P931, DOI 10.1093/hmg/4.5.931; Bergen AAB, 1996, J MED GENET, V33, P869, DOI 10.1136/jmg.33.10.869; Boycott KM, 1998, AM J HUM GENET, V62, P865, DOI 10.1086/301781; Candille SI, 1999, INVEST OPHTH VIS SCI, V40, P2748; Carr R E, 1974, Trans Am Ophthalmol Soc, V72, P448; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; GAL A, 1989, HUM GENET, V81, P315, DOI 10.1007/BF00283682; Hocking AM, 1998, MATRIX BIOL, V17, P1; JACOBSON SG, 1986, OPHTHALMOLOGY, V93, P1604; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; KRANTZ DE, 1990, EMBO J, V9, P1969, DOI 10.1002/j.1460-2075.1990.tb08325.x; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; MIYAKE Y, 1987, JPN J OPHTHALMOL, V31, P81; MUSARELLA MA, 1989, GENOMICS, V5, P727, DOI 10.1016/0888-7543(89)90114-6; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Pellegata NS, 2000, NAT GENET, V25, P91, DOI 10.1038/75664; PLAAS AHK, 1990, J BIOL CHEM, V265, P20634; Prinsen CFM, 2000, J NEUROSCI, V20, P1424; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Rodieck RW., 1998, 1 STEPS SEEING, V1; ROWEN L, 1994, AUTOMATED DNA SEQUEN; SCHUBERT G, 1952, OPHTHALMOLOGICA, V123, P396, DOI 10.1159/000301211; SHARP DM, 1990, CLIN VISION SCI, V5, P217; Shishido E, 1998, SCIENCE, V280, P2118, DOI 10.1126/science.280.5372.2118; Sparkes RL, 2000, GENOMICS, V68, P97, DOI 10.1006/geno.2000.6270; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Vainio S, 1997, CELL, V90, P975, DOI 10.1016/S0092-8674(00)80363-3; YOUNG RSL, 1986, CLIN VISION SCI, V1, P137; YOUNG RSL, 1991, CLIN VISION SCI, V6, P309	33	255	265	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2000	26	3					319	323		10.1038/81619	http://dx.doi.org/10.1038/81619			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062471				2022-12-17	WOS:000165176500020
J	Ali, RR; Sarra, GM; Stephens, C; de Alwis, M; Bainbridge, JWB; Munro, PM; Fauser, S; Reichell, MB; Kinnon, C; Hunt, DM; Bhattacharya, SS; Thrasher, AJ				Ali, RR; Sarra, GM; Stephens, C; de Alwis, M; Bainbridge, JWB; Munro, PM; Fauser, S; Reichell, MB; Kinnon, C; Hunt, DM; Bhattacharya, SS; Thrasher, AJ			Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy	NATURE GENETICS			English	Article							RDS MUTANT MICE; RETINITIS-PIGMENTOSA; RESCUE; MOUSE; AMPLICONS; VECTOR; ROM-1; DEATH	The gene Prph2 encodes a photoreceptor-specific membrane glycoprotein(1), peripherin-2 (also known as peripherin/rds), which is inserted into the rims of photoreceptor outer segment discs in a complex with rom-1 (ref. 2). The complex is necessary for the stabilization of the discs, which are renewed constantly throughout life, and which contain the visual pigments necessary for photon capture(3). Mutations in Prph2 have been shown to result in a variety of photoreceptor dystrophies, including autosomal dominant retinitis pigmentosa and macular dystrophy(4). A common feature of these diseases is the loss of photoreceptor function, also seen in the retinal degeneration slow (rds or prph2(Rd2/Rd2)) mouse, which is homozygous for a null mutation in Prph2. It is characterized by a complete failure to develop photoreceptor discs and outer segments(5), downregulation of rhodopsin(6,7) and apoptotic loss of photoreceptor cells(8,9). The electroretinograms (ERGs) of Prph2(Rd2/Rd2) mice have greatly diminished a-wave and b-wave amplitudes, which decline to virtually undetectable concentrations by two months(10). Subretinal injection of recombinant adeno-associated virus (AAV) encoding a Prph2 transgene results in stable generation of outer segment structures and formation of new stacks of discs containing both perpherin-2 and rhodopsin, which in many cases are morphologically similar to normal outer segments. Moreover, the re-establishment of the structural integrity of the photoreceptor layer also results in electrophysiological correction. These studies demonstrate for the first time that a complex ultrastructural cell defect can be corrected both morphologically and functionally by in vivo gene transfer.	UCL, Inst Ophthalmol, Dept Mol Genet, London, England; UCL, Inst Child Hlth, Mol Immunol Unit, London, England; Univ Tubingen, Hosp Eye, Tubingen, Germany; Univ Leipzig, Hosp Eye, D-7010 Leipzig, Germany	University of London; University College London; University of London; University College London; Eberhard Karls University of Tubingen; Leipzig University	Ali, RR (corresponding author), UCL, Inst Ophthalmol, Dept Mol Genet, Mortimer St, London, England.	r.ali@ucl.ac.uk	Bhattacharya, Shom/N-2926-2016; Hunt, David M/K-6024-2012; Kinnon, Christine/A-1585-2010	Bhattacharya, Shom/0000-0002-1601-6344; Hunt, David M/0000-0002-9264-3948; Bainbridge, James/0000-0003-1318-8201; Ali, Robin/0000-0003-3126-6517				Ali RR, 1996, HUM MOL GENET, V5, P591, DOI 10.1093/hmg/5.5.591; BASCOM RA, 1992, NEURON, V8, P1171, DOI 10.1016/0896-6273(92)90137-3; Boursnell MEG, 1997, J INFECT DIS, V175, P16, DOI 10.1093/infdis/175.1.16; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Gregory-Evans K, 1998, TRENDS GENET, V14, P103, DOI 10.1016/S0168-9525(98)01402-4; HILLENKAMP F, 1975, APPL PHYS, V8, P341, DOI 10.1007/BF00898368; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; MOLDAY RS, 1994, PROG RETIN EYE RES, V13, P271, DOI 10.1016/1350-9462(94)90013-2; NIR I, 1990, EXP EYE RES, V51, P257, DOI 10.1016/0014-4835(90)90022-M; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; REUTER JH, 1984, NEUROSCI LETT, V48, P231, DOI 10.1016/0304-3940(84)90024-7; SANYAL S, 1981, NEUROSCI LETT, V21, P23, DOI 10.1016/0304-3940(81)90051-3; SHALKEN JJ, 1985, BIOCHIM BIOPHYS ACTA, V839, P122; Takahashi M, 1999, J VIROL, V73, P7812, DOI 10.1128/JVI.73.9.7812-7816.1999; TRAVIS GH, 1992, NEURON, V9, P113, DOI 10.1016/0896-6273(92)90226-4; TRAVIS GH, 1989, NATURE, V338, P70, DOI 10.1038/338070a0; Zhang XL, 1999, HUM GENE THER, V10, P2527, DOI 10.1089/10430349950016861; Zhang XL, 1998, J GEN VIROL, V79, P125, DOI 10.1099/0022-1317-79-1-125	18	255	276	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2000	25	3					306	310		10.1038/77068	http://dx.doi.org/10.1038/77068			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	329RD	10888879				2022-12-17	WOS:000087920900019
J	Thomas, JT; Kilpatrick, MW; Lin, K; Erlacher, L; Lembessis, P; Costa, T; Tsipouras, P; Luyten, FP				Thomas, JT; Kilpatrick, MW; Lin, K; Erlacher, L; Lembessis, P; Costa, T; Tsipouras, P; Luyten, FP			Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1	NATURE GENETICS			English	Article							FACTOR-BETA SUPERFAMILY; PROTEINS; MEMBER; CHONDRODYSPLASIA; REGULATORS; MOUSE; BMP-7	Chondrodysplasia Grebe type (CGT) is an autosomal recessive disorder characterized by severe limb shortening and dysmorphogenesis. We have identified a causative point mutation in the gene encoding the bone morphogenetic protein (BMP)-like molecule, cartilage-derived morphogenetic protein-1 (CDMP-1). The mutation substitutes a tyrosine for the first of seven highly conserved cysteine residues in the mature active domain of the protein, We demonstrate that the mutation results in a protein that is not secreted and is inactive in vitro. It produces a dominant negative effect by preventing the secretion of other, related BMP family members. We present evidence that this may occur through the formation of heterodimers. The mutation and its proposed mechanism of action provide the first human genetic indication that composite expression patterns of different BMPs dictate limb and digit morphogenesis.	UNIV CONNECTICUT,CTR HLTH,DEPT PEDIAT,FARMINGTON,CT 06030; HOSP SICK CHILDREN,DEPT GENET,TORONTO,ON M5G 1X8,CANADA	University of Connecticut; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Thomas, JT (corresponding author), NIDR,CRANIOFACIAL & SKELETAL DIS BRANCH,NIH,BETHESDA,MD 20892, USA.		Luyten, Frank/GPS-7793-2022	Lembessis, Panagiotis/0000-0001-8972-3499	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022610] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-22610] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AONO A, 1995, BIOCHEM BIOPH RES CO, V210, P670, DOI 10.1006/bbrc.1995.1712; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Bell J., 1951, TREASURY HUMAN INHER, VVol 1, P1; CHANG SC, 1994, J BIOL CHEM, V269, P28227; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; Dudley AT, 1997, DEV DYNAM, V208, P349; FENG B, 1985, ACTA GENET SIN, V12, P378; FITCH N, 1978, J MED GENET, V16, P36; GARCIACASTRO JM, 1975, J PEDIATR-US, V87, P948, DOI 10.1016/S0022-3476(75)80915-2; GRAY DJ, 1957, AM J ANAT, V101, P169, DOI 10.1002/aja.1001010202; GREBE H, 1952, FOLIA HERED PATHOL, V2, P23; Griffith DL, 1996, P NATL ACAD SCI USA, V93, P878, DOI 10.1073/pnas.93.2.878; Hall B., 1994, BONE, V8, P137; HAWLEY SHB, 1995, GENE DEV, V9, P2923, DOI 10.1101/gad.9.23.2923; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Israel DI, 1996, GROWTH FACTORS, V13, P291, DOI 10.3109/08977199609003229; JONES CM, 1991, DEVELOPMENT, V111, P531; KINGSLEY DM, 1994, TRENDS GENET, V10, P16, DOI 10.1016/0168-9525(94)90014-0; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; KUMAR D, 1984, CLIN GENET, V25, P68; Lin KM, 1996, GENOMICS, V34, P150, DOI 10.1006/geno.1996.0257; LOPEZ AR, 1992, MOL CELL BIOL, V12, P1674, DOI 10.1128/MCB.12.4.1674; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; LUYTEN FP, 1989, J BIOL CHEM, V264, P13377; LYONS KM, 1995, MECH DEVELOP, V50, P71, DOI 10.1016/0925-4773(94)00326-I; MASTROBATTISTA JM, 1995, J MED GENET, V32, P851, DOI 10.1136/jmg.32.11.851; QUELCE-SALGADO A., 1964, ACTA GENET STATIST MED [BASEL], V14, P63; SAMPATH TK, 1990, J BIOL CHEM, V265, P13198; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Storm EE, 1996, DEVELOPMENT, V122, P3969; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; VENKATARAMAN G, 1995, P NATL ACAD SCI USA, V92, P5406, DOI 10.1073/pnas.92.12.5406; VUKKEVIC S, 1994, J HISTOCHEM CYTOCHEM, V42, P869; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	36	255	274	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1997	17	1					58	64		10.1038/ng0997-58	http://dx.doi.org/10.1038/ng0997-58			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288098				2022-12-17	WOS:A1997XU72400018
J	Reddy, S; Smith, DBJ; Rich, MM; Leferovich, JM; Reilly, P; Davis, BM; Tran, K; Rayburn, H; Bronson, R; Cros, D; BaliceGordon, RJ; Housman, D				Reddy, S; Smith, DBJ; Rich, MM; Leferovich, JM; Reilly, P; Davis, BM; Tran, K; Rayburn, H; Bronson, R; Cros, D; BaliceGordon, RJ; Housman, D			Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy	NATURE GENETICS			English	Article							UNSTABLE CTG REPEAT; MYOSIN HEAVY-CHAIN; FRAGILE-X SYNDROME; MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; MDX MOUSE; MESSENGER-RNA; CONTRACTILE PROPERTIES; TRIPLET REPEAT; GENE	Myotonic dystrophy (DM) is an autosomal dominant disorder resulting from the expansion of a CTG repeat in the 3' untranslated region of a putative protein kinase (DMPK). To elucidate the role of DMPK in DM pathogenesis we have developed Dmpk deficient (Dmpk-/-) mice. Dmpk-/- mice develop a late-onset, progressive skeletal myopathy that shares some pathological features with DM. Muscles from mature mice show variation in fibre size, increased fibre degeneration and fibrosis. Adult Dmpk-/- mice show ultrastructural changes in muscle and a 50% decrease in force generation compared to young mice. Our results indicate that DMPK may be necessary for the maintenance of skeletal muscle structure and function and suggest that a decrease in DMPK levels may contribute to DM pathology.	MIT,CTR CANC RES,CAMBRIDGE,MA 02138; UNIV PENN,SCH MED,DEPT NEUROSCI,PHILADELPHIA,PA 19104; TUFTS UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02111; TUFTS UNIV,SCH VET MED,BOSTON,MA 02111; MASSACHUSETTS GEN HOSP,DEPT NEUROL,BOSTON,MA 02214	Massachusetts Institute of Technology (MIT); University of Pennsylvania; Tufts University; Tufts University; Harvard University; Massachusetts General Hospital				Balice-Gordon, Rita/0000-0002-9950-7965	NATIONAL INSTITUTE ON AGING [P01AG013329] Funding Source: NIH RePORTER; NIA NIH HHS [P0IAG 1332901] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALEU FP, 1964, AM J PATHOL, V45, P221; ANDERSON JE, 1987, ANAT REC, V219, P243, DOI 10.1002/ar.1092190305; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P894; Bancroft JD, 1990, THEORY PRACTICE HIST; BEILHARZ MW, 1992, MOL CELL NEUROSCI, V3, P326, DOI 10.1016/1044-7431(92)90029-2; BELANGER AY, 1983, J NEUROL NEUROSUR PS, V46, P625, DOI 10.1136/jnnp.46.7.625; BOUCHER CA, 1995, HUM MOL GENET, V4, P1919, DOI 10.1093/hmg/4.10.1919; BRAUN T, 1989, EMBO J, V8, P3617, DOI 10.1002/j.1460-2075.1989.tb08535.x; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; BURKE JR, 1994, NAT GENET, V7, P521, DOI 10.1038/ng0894-521; BURKE RE, 1994, MYOLOGY, V1, P464; CAMPION DR, 1984, INT REV CYTOL, V87, P225, DOI 10.1016/S0074-7696(08)62444-4; CARANGO P, 1993, GENOMICS, V18, P340, DOI 10.1006/geno.1993.1474; CARNWATH JW, 1987, J NEUROL SCI, V80, P39, DOI 10.1016/0022-510X(87)90219-X; CASANOVA G, 1979, ACTA NEUROPATHOL, V45, P231, DOI 10.1007/BF00702675; CLOSE RI, 1972, PHYSIOL REV, V52, P129, DOI 10.1152/physrev.1972.52.1.129; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DUBOWITZ V, 1985, MUSLCE BIOPSY; DUNNE PW, 1995, CELL MOTILITY CYTOSK, V33; FARDEAU M, 1970, MUSCLE DISEASES, P98; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; FITZSIMONS RB, 1981, J NEUROL SCI, V52, P367, DOI 10.1016/0022-510X(81)90018-6; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; GAMBKE B, 1984, J BIOL CHEM, V259, P2092; GROUNDS MD, 1992, CELL TISSUE RES, V267, P99, DOI 10.1007/BF00318695; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARLEY HG, 1993, AM J HUM GENET, V52, P1164; Harper P.S., 1989, MYOTONIC DYSTROPHY; HOFMANNRADVANYI H, 1993, HUM MOL GENET, V2, P1263, DOI 10.1093/hmg/2.8.1263; Hogan B., 1986, MANIPULATING MOUSE E; HOUSMAN D, 1995, NAT GENET, V10, P3, DOI 10.1038/ng0595-3; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; JANSEN G, 1992, NAT GENET, V1, P261, DOI 10.1038/ng0792-261; JOHNSON AG, 1969, ACTA NEUROPATHOL, V12, P218, DOI 10.1007/BF00687646; JOHNSON AG, 1969, ACTA NEUROPATHOL, V12, P183, DOI 10.1007/BF00692505; KAMPS MP, 1984, NATURE, V310, P589, DOI 10.1038/310589a0; KARSCHMIZRACHI I, 1989, NUCLEIC ACIDS RES, V17, P6167, DOI 10.1093/nar/17.15.6167; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KOGA R, 1994, BIOCHEM BIOPH RES CO, V202, P577, DOI 10.1006/bbrc.1994.1967; KOIDE R, 1994, NATURE GENET, V6; KOLSHI K, 1995, DEV DYNAMICS, V202, P244; KRAHE R, 1995, GENOMICS, V28; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MAEDA M, 1995, J BIOL CHEM, V270, P20246, DOI 10.1074/jbc.270.35.20246; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MAHADEVAN MS, 1993, HUM MOL GENET, V2, P299, DOI 10.1093/hmg/2.3.299; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MCCOMAS AJ, 1971, J NEUROL NEUROSUR PS, V34, P132, DOI 10.1136/jnnp.34.2.132; MORGANHUGHES JA, 1994, MYOLOGY, P1610; MOSS FP, 1971, ANAT REC, V170, P421, DOI 10.1002/ar.1091700405; NANCARROW JK, 1994, SCIENCE, V264, P1938, DOI 10.1126/science.8009225; NOVELLI G, 1993, BIOCHEM MED METAB B, V50, P85, DOI 10.1006/bmmb.1993.1049; OBRIEN TA, 1984, DEV MED CHILD NEUROL, V26, P62; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; RASTINEJAD F, 1993, CELL, V72, P903, DOI 10.1016/0092-8674(93)90579-F; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; SABOURI LA, 1993, NAT GENET, V4, P233, DOI 10.1038/ng0793-233; SACCO P, 1992, CLIN SCI, V82, P227, DOI 10.1042/cs0820227; SALVATORI S, 1994, BIOCHEM BIOPH RES CO, V203, P1365, DOI 10.1006/bbrc.1994.2335; SCHIAFFINO S, 1986, MUSCLE NERVE, V9, P51, DOI 10.1002/mus.880090108; SCHOTLAND DL, 1970, J NEUROPATH EXP NEUR, V29, P241; SHACKLEFORD GM, 1987, CELL, V50, P89, DOI 10.1016/0092-8674(87)90665-9; SHAW DJ, 1993, GENOMICS, V18, P673, DOI 10.1016/S0888-7543(05)80372-6; TAYLOR RG, 1992, ARCH PHYS MED REHAB, V73, P233; TIMCHENKO L, 1995, P NATL ACAD SCI USA, V92, P5366, DOI 10.1073/pnas.92.12.5366; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WANG JZ, 1995, HUM MOL GENET, V4, P599, DOI 10.1093/hmg/4.4.599; WANG YH, 1995, GENOMICS, V25, P570, DOI 10.1016/0888-7543(95)80061-P; WANG YH, 1994, SCIENCE, V265, P1709; WERNIG A, 1986, PROG NEUROBIOL, V27, P251, DOI 10.1016/0301-0082(86)90023-7; 1993, CELL, V72, P971	78	255	264	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1996	13	3					325	335		10.1038/ng0796-325	http://dx.doi.org/10.1038/ng0796-325			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673132				2022-12-17	WOS:A1996UU28300021
J	Bartel, PL; Roecklein, JA; SenGupta, D; Fields, S				Bartel, PL; Roecklein, JA; SenGupta, D; Fields, S			A protein linkage map of Escherichia coli bacteriophage T7	NATURE GENETICS			English	Article							GENE 2.5 PROTEIN; DNA-POLYMERASE; NUCLEOTIDE-SEQUENCE; HELICASE PROTEINS; 2-HYBRID SYSTEM; RNA-POLYMERASE; YEAST; PURIFICATION; REPLICATION; PRIMASE	Genome sequencing projects are predicting large numbers of novel proteins, whose interactions with other proteins must mediate the function of cellular processes. To analyse these networks, we used the yeast two-hybrid system on a genome-wide scale to identify 25 interactions among the proteins of Escherichia coli bacteriophage T7. Among these is a set of six interactions connecting proteins that function in DNA replication and DNA packaging. Remarkably, two genes, arranged such that one entirely overlaps the other and uses a different reading frame, encode interacting proteins. Several of the interactions reflect intramolecular associations of different domains of the same polypeptide, suggesting that the two-hybrid assay may be useful in the analysis of protein folding. This global approach to protein-protein interactions may be applicable to the analysis of more complex genomes whose sequences are becoming available.	UNIV WASHINGTON,MARKEY MOLEC MED CTR,DEPT GENET,SEATTLE,WA 98195; UNIV WASHINGTON,MARKEY MOLEC MED CTR,DEPT MED,SEATTLE,WA 98195; SUNY STONY BROOK,DEPT MOLEC GENET & MICROBIOL,STONY BROOK,NY 11794; SUNY STONY BROOK,GRAD PROGRAM MOLEC & CELLULAR BIOL,STONY BROOK,NY 11794	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook					NATIONAL CANCER INSTITUTE [P01CA028146] Funding Source: NIH RePORTER; NCI NIH HHS [CA28146] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; Bartel PL, 1993, CELLULAR INTERACTION, P153; BENDIXEN C, 1994, NUCLEIC ACIDS RES, V22, P1778, DOI 10.1093/nar/22.9.1778; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; CASJENS S, 1989, VIROLOGY, V171, P588, DOI 10.1016/0042-6822(89)90628-4; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FIELDS S, 1994, TRENDS GENET, V10, P286, DOI 10.1016/0168-9525(90)90012-U; FINLEY RL, 1994, P NATL ACAD SCI USA, V91, P12980, DOI 10.1073/pnas.91.26.12980; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; HALL MN, 1984, CELL, V36, P1057, DOI 10.1016/0092-8674(84)90055-2; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HUANG ZJ, 1995, SCIENCE, V267, P1169, DOI 10.1126/science.7855598; KIM YT, 1992, J BIOL CHEM, V267, P15032; KIM YT, 1992, J BIOL CHEM, V267, P15022; LANCY ED, 1989, J BACTERIOL, V171, P5581, DOI 10.1128/jb.171.10.5581-5586.1989; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; MATSUOKATO H, 1981, VIROLOGY, V109, P157; MOFFATT BA, 1987, CELL, V49, P221, DOI 10.1016/0092-8674(87)90563-0; MOONEY PQ, 1980, NUCLEIC ACIDS RES, V8, P3043, DOI 10.1093/nar/8.13.3043; NAKAI H, 1986, J BIOL CHEM, V261, P5208; NAKAI H, 1988, J BIOL CHEM, V263, P9818; PATEL SS, 1992, J BIOL CHEM, V267, P15013; PATEL SS, 1993, J BIOL CHEM, V268, P10668; PRINTEN JA, 1994, GENETICS, V138, P609; RAHMSDORF HJ, 1974, P NATL ACAD SCI USA, V71, P586, DOI 10.1073/pnas.71.2.586; ROEDER GS, 1977, VIROLOGY, V76, P263, DOI 10.1016/0042-6822(77)90302-6; Schiestl Robert H., 1993, Methods (Orlando), V5, P79, DOI 10.1006/meth.1993.1011; Sherman F., 1986, METHODS YEAST GENETI; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; SPOEREL N, 1979, NATURE, V278, P30, DOI 10.1038/278030a0; Steven A. C., 1986, ELECT MICROSCOPY PRO, P1; STUDIER FW, 1981, J MOL BIOL, V153, P493, DOI 10.1016/0022-2836(81)90404-6	35	255	278	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1996	12	1					72	77		10.1038/ng0196-72	http://dx.doi.org/10.1038/ng0196-72			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	8528255				2022-12-17	WOS:A1996TM55500017
J	RANADE, K; HUSSUSSIAN, CJ; SIKORSKI, RS; VARMUS, HE; GOLDSTEIN, AM; TUCKER, MA; SERRANO, M; HANNON, GJ; BEACH, D; DRACOPOLI, NC				RANADE, K; HUSSUSSIAN, CJ; SIKORSKI, RS; VARMUS, HE; GOLDSTEIN, AM; TUCKER, MA; SERRANO, M; HANNON, GJ; BEACH, D; DRACOPOLI, NC			MUTATIONS ASSOCIATED WITH FAMILIAL MELANOMA IMPAIR P16(INK4) FUNCTION	NATURE GENETICS			English	Letter							DYSPLASTIC NEVUS; LOCUS		WASHINGTON UNIV,SCH MED,DEPT SURG,ST LOUIS,MO 63110; NCI,GENET EPIDEMIOL BRANCH,BETHESDA,MD 20892; COLD SPRING HARBOR LAB,HOWARD HUGHES MED INST,COLD SPRING HARBOR,NY 11724; SEQUANA THERAPEUT INC,LA JOLLA,CA 92037	Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	RANADE, K (corresponding author), NATL CTR HUMAN GENOME RES,9000 ROCKVILLE PIKE,BETHESDA,MD 20892, USA.		Serrano, Manuel/H-2634-2015; Tucker, Margaret A/B-4297-2015; Hannon, Gregory/AAB-3568-2019	Serrano, Manuel/0000-0001-7177-9312; Dracopoli, Nicholas/0000-0003-3962-4059				BALE SJ, 1989, NEW ENGL J MED, V320, P1367, DOI 10.1056/NEJM198905253202102; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; CANNONALBRIGHT LA, 1992, SCIENCE, V258, P1148, DOI 10.1126/science.1439824; CORMACK B, 1991, CURRENT PROTOCOLS MO; GOLDSTEIN AM, 1994, AM J HUM GENET, V54, P489; GOLDSTEIN AM, 1993, AM J HUM GENET, V52, P537; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; KAMB A, 1994, NAT GENET, V8, P22, DOI 10.1038/ng0994-22; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; MACGEOCH C, 1994, HUM MOL GENET, V3, P2195, DOI 10.1093/hmg/3.12.2195; MORI T, 1994, CANCER RES, V54, P3396; NANCARROW DJ, 1993, AM J HUM GENET, V53, P936; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; SERRANO M, 1995, SCIENCE, V267, P249, DOI 10.1126/science.7809631; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0	17	255	267	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1995	10	1					114	116		10.1038/ng0595-114	http://dx.doi.org/10.1038/ng0595-114			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	7647780				2022-12-17	WOS:A1995QX57300026
J	Ehret, GB; Ferreira, T; Chasman, DI; Jackson, AU; Schmidt, EM; Johnson, T; Thorleifsson, G; Luan, J; Donnelly, LA; Kanoni, S; Petersen, AK; Pihurl, V; Strawbridge, RJ; Shungin, D; Hughes, MF; Meirelles, O; Kaakinen, M; Bouatia-Naji, N; Kristiansson, K; Shah, S; Kleber, ME; Guo, XQ; Lyytikainen, LP; Fava, C; Eriksson, N; Nolte, IM; Magnusson, PK; Salfati, EL; Rallidis, LS; Theusch, E; Smith, AJP; Folkersen, L; Witkowska, K; Pers, TH; Joehanes, R; Kim, SK; Lataniotis, L; Jansen, R; Johnson, AD; Warren, H; Kim, YJ; Zhao, W; Wu, Y; Tayo, BO; Bochud, M; Absher, D; Adair, LS; Amin, N; Arkingl, DE; Axelsson, T; Baldassarre, D; Balkau, B; Bandinelli, S; Barnes, MR; Barroso, I; Bevan, S; Bis, JC; Bjornsdottir, G; Boehnke, M; Boerwinkle, E; Bonnycastle, LL; Boomsma, DI; Bornstein, SR; Brown, MJ; Burnier, M; Cabrera, CP; Chambers, JC; Chang, IS; Cheng, CY; Chines, PS; Chung, RH; Collins, FS; Connell, JM; Doring, A; Dallongeville, J; Danesh, J; de Faire, U; Delgado, G; Dominiczak, AF; Doney, ASF; Drenos, F; Edkins, S; Eicher, JD; Elosua, R; Enroth, S; Erdmann, J; Eriksson, P; Esko, T; Evangelou, E; Evans, A; Fai, T; Farra, M; Felixl, JF; Ferrieres, J; Ferrucci, L; Fornage, M; Forrester, T; Franceschinil, N; Franco, OH; Franco-Cereceda, A; Fraser, RM; Ganesh, SK; Gao, H; Gertow, K; Gianfagna, F; Gigante, B; Giulianini, F; Goe, A; Goodall, AH; Goodarzi, M; Gorski, M; Grassler, J; Groves, CJ; Gudnason, V; Gyllensten, U; Hallmans, G; Hartikainen, AL; Hassinen, M; Havulinna, AS; Hayward, C; Hercberg, S; Herzig, KH; Hicks, AA; Hingorani, AD; Hirschhorn, JN; Hofmanl, A; Holmen, J; Holmen, OL; Hottenga, JJ; Howard, P; Hsiung, CA; Hunt, SC; Ikram, MA; Illig, T; Iribarren, C; Jensen, RA; Kahonen, M; Kang, HM; Kathiresan, S; Keating, BJ; Khaw, KT; Kim, YK; Kim, E; Kivimaki, M; Klopp, N; Kolovou, G; Komulainen, P; Kooner, JS; Kosova, G; Krauss, RM; Kuh, D; Kutalik, Z; Kuusisto, J; Kvaloy, K; Lakka, TA; Lee, NR; Lee, IT; Lee, WJ; Levy, D; Li, X; Liang, KW; Lin, H; Lin, L; Lindstrom, J; Lobbens, S; Mannisto, S; Muller, G; Muller-Nurasyid, M; Mach, F; Markus, HS; Marouli, E; McCarthy, MI; McKenzie, CA; Meneton, P; Menni, C; Metspalu, A; Mijatovic, V; Moilanen, L; Montasser, ME; Morris, AD; Morrison, AC; Mulas, A; Nagaraja, R; Narisu, N; Nikus, K; O'Donnell, CJ; O'Reilly, PF; Ong, KK; Paccaud, F; Palmer, CD; Parsa, A; Pedersen, NL; Penninx, BW; Perola, M; Peters, A; Poulter, N; Pramstaller, PP; Psaty, BM; Quertermous, T; Rao, DC; Rasheed, A; Rayner, NW; Renstrom, F; Rettig, R; Rice, KM; Roberts, R; Rose, LM; Rossouw, J; Samani, NJ; Sanna, S; Saramies, J; Schunkert, H; Sebert, S; Sheu, WHH; Shin, YA; Sim, X; Smit, JH; Smith, AV; Sosa, MX; Spector, TD; Stancakova, A; Stanton, AV; Stirrups, KE; Stringham, HM; Sundstrom, J; Swift, AJ; Syvanen, AC; Tai, ES; Tanaka, T; Tarasov, KV; Teumer, A; Thorsteinsdottir, U; Tobin, MD; Tremoli, E; Uitterlinden, AG; Uusitupa, M; Vaez, A; Vaidya, D; van Duijn, CM; van Iperen, EPA; Vasan, RS; Verwoert, GC; Virtamo, J; Vitart, V; Voight, BF; Vollenweider, P; Wagner, A; Wain, LV; Wareham, NJ; Watldns, H; Weder, AB; Westra, HJ; Wilks, R; Wilsgaard, T; Wilson, JF; Wong, TY; Yang, TP; Yao, J; Yengo, L; Zhang, W; Zhao, JH; Zhu, X; Bovet, P; Cooper, RS; Mohlke, KL; Saleheen, D; Lee, JY; Elliott, P; Gierman, HJ; Willer, CJ; Franke, L; Hovingh, GK; Taylor, KD; Dedoussis, G; Sever, P; Wong, A; Lind, L; Assimes, TL; Njolstad, I; Schwarz, PEH; Langenberg, C; Snieder, H; Caulfield, MJ; Melander, E; Laakso, M; Saltevo, J; Rauramaa, R; Tuomilehto, J; Ingelsson, E; Lehtimaki, T; Hveem, K; Palmas, W; Marz, W; Kumar, M; Salomaa, V; Chen, YDI; Rotter, JI; Froguel, P; Jarvelin, MR; Lakatta, EG; Kuulasmaa, K; Franks, PW; Hamsten, A; Wichmann, HE; Palmer, CNA; Stefansson, K; Ridker, PM; Loos, RJF; Chalcravarti, A; Deloukas, P; Morris, AP; Newton-Cheh, C; Munroe, PB				Ehret, Georg B.; Ferreira, Teresa; Chasman, Daniel I.; Jackson, Anne U.; Schmidt, Ellen M.; Johnson, Toby; Thorleifsson, Gudmar; Luan, Jian'an; Donnelly, Louise A.; Kanoni, Stavroula; Petersen, Ann -Kristin; Pihurl, Vasyl; Strawbridge, Rona J.; Shungin, Dmitry; Hughes, Maria F.; Meirelles, Osorio; Kaakinen, Marika; Bouatia-Naji, Nabila; Kristiansson, Kati; Shah, Sonia; Kleber, Marcus E.; Guo, Xiuqing; Lyytikainen, Leo-Pekka; Fava, Cristiano; Eriksson, Nidas; Nolte, Ilja M.; Magnusson, Patrik K.; Salfati, Elias L.; Rallidis, Loukianos S.; Theusch, Elizabeth; Smith, Andrew J. P.; Folkersen, Lasse; Witkowska, Kate; Pers, Tune H.; Joehanes, Roby; Kim, Stuart K.; Lataniotis, Lazaros; Jansen, Rick; Johnson, Andrew D.; Warren, Helen; Kim, Young Jin; Zhao, Wei; Wu, Ying; Tayo, Bamidele O.; Bochud, Murielle; Absher, Devin; Adair, Linda S.; Amin, Najaf; Arkingl, Dan E.; Axelsson, Tomas; Baldassarre, Damian; Balkau, Beverley; Bandinelli, Stefania; Barnes, Michael R.; Barroso, Ines; Bevan, Stephen; Bis, Joshua C.; Bjornsdottir, Gyda; Boehnke, Michael; Boerwinkle, Eric; Bonnycastle, Lori L.; Boomsma, Dorret I.; Bornstein, Stefan R.; Brown, Morris J.; Burnier, Michel; Cabrera, Claudia P.; Chambers, John C.; Chang, I-Shou; Cheng, Ching-Yu; Chines, Peter S.; Chung, Ren-Hua; Collins, Francis S.; Connell, John M.; Doring, Angela; Dallongeville, Jean; Danesh, John; de Faire, Ulf; Delgado, Graciela; Dominiczak, Anna F.; Doney, Alex S. F.; Drenos, Fotios; Edkins, Sarah; Eicher, John D.; Elosua, Roberto; Enroth, Stefan; Erdmann, Jeanette; Eriksson, Per; Esko, Tonu; Evangelou, Evangelos; Evans, Alun; Fai, Tove; Farra, Martin; Felixl, Janine F.; Ferrieres, Jean; Ferrucci, Luigi; Fornage, Myriam; Forrester, Terrence; Franceschinil, Nora; Franco, Oscar H.; Franco-Cereceda, Anders; Fraser, Ross M.; Ganesh, Santhi K.; Gao, He; Gertow, Karl; Gianfagna, Francesco; Gigante, Bruna; Giulianini, Franco; Goe, Anuj; Goodall, Alison H.; Goodarzi, Mark; Gorski, Mathias; Grassler, Jurgen; Groves, Christopher J.; Gudnason, Vilmundur; Gyllensten, Ulf; Hallmans, Goran; Hartikainen, Anna-Liisa; Hassinen, Maija; Havulinna, Aki S.; Hayward, Caroline; Hercberg, Serge; Herzig, Karl-Heinz; Hicks, Andrew A.; Hingorani, Aroon D.; Hirschhorn, Joel N.; Hofmanl, Albert; Holmen, Jostein; Holmen, Oddgeir Lingaas; Hottenga, Jouke-Jan; Howard, Phil; Hsiung, Chao A.; Hunt, Steven C.; Ikram, M. Arfan; Illig, Thomas; Iribarren, Carlos; Jensen, Richard A.; Kahonen, Mika; Kang, Hyun Min; Kathiresan, Sekar; Keating, Brendan J.; Khaw, Kay-Tee; Kim, Yun Kyoung; Kim, Eric; Kivimaki, Mika; Klopp, Norman; Kolovou, Genovefa; Komulainen, Pirjo; Kooner, Jaspal S.; Kosova, Gulum; Krauss, Ronald M.; Kuh, Diana; Kutalik, Zoltan; Kuusisto, Johanna; Kvaloy, Kirsti; Lakka, Timo A.; Lee, Nanette R.; Lee, I-Te; Lee, Wen-Jane; Levy, Daniel; Li, Xiaohui; Liang, Kae-Woei; Lin, Honghuang; Lin, Li; Lindstrom, Jaana; Lobbens, Stephane; Mannisto, Satu; Muller, Gabriele; Muller-Nurasyid, Martina; Mach, Francois; Markus, Hugh S.; Marouli, Eirini; McCarthy, Mark I.; McKenzie, Colin A.; Meneton, Pierre; Menni, Cristina; Metspalu, Andres; Mijatovic, Vladan; Moilanen, Leena; Montasser, May E.; Morris, Andrew D.; Morrison, Alanna C.; Mulas, Antonella; Nagaraja, Ramaiah; Narisu, Narisu; Nikus, Kjell; O'Donnell, Christopher J.; O'Reilly, Paul F.; Ong, Ken K.; Paccaud, Fred; Palmer, Cameron D.; Parsa, Afshin; Pedersen, Nancy L.; Penninx, Brenda W.; Perola, Markus; Peters, Annette; Poulter, Neil; Pramstaller, Peter P.; Psaty, Bruce M.; Quertermous, Thomas; Rao, Dabeeru C.; Rasheed, Asif; Rayner, N. William; Renstrom, Frida; Rettig, Rainer; Rice, Kenneth M.; Roberts, Robert; Rose, Lynda M.; Rossouw, Jacques; Samani, Nilesh J.; Sanna, Serena; Saramies, Jouko; Schunkert, Heribert; Sebert, Sylvain; Sheu, Wayne H-H; Shin, Young-Ah; Sim, Xueling; Smit, Johannes H.; Smith, Albert V.; Sosa, Maria X.; Spector, Tim D.; Stancakova, Alena; Stanton, Alice V.; Stirrups, Kathleen E.; Stringham, Heather M.; Sundstrom, Johan; Swift, Amy J.; Syvanen, Ann-Christine; Tai, E-Shyong; Tanaka, Toshiko; Tarasov, Kirill V.; Teumer, Alexander; Thorsteinsdottir, Unnur; Tobin, Martin D.; Tremoli, Elena; Uitterlinden, Andre G.; Uusitupa, Matti; Vaez, Ahmad; Vaidya, Dhananjay; van Duijn, Cornelia M.; van Iperen, Erik P. A.; Vasan, Ramachandran S.; Verwoert, Germaine C.; Virtamo, Jarmo; Vitart, Veronique; Voight, Benjamin F.; Vollenweider, Peter; Wagner, Aline; Wain, Louise V.; Wareham, Nicholas J.; Watldns, Hugh; Weder, Alan B.; Westra, Harm Jan; Wilks, Rainford; Wilsgaard, Tom; Wilson, James F.; Wong, Tien Y.; Yang, Tsun-Po; Yao, Jie; Yengo, Loic; Zhang, Weihua; Zhao, Jing Hua; Zhu, Xiaofeng; Bovet, Pascal; Cooper, Richard S.; Mohlke, Karen L.; Saleheen, Danish; Lee, Jong-Young; Elliott, Paul; Gierman, Hinco J.; Willer, Cristen J.; Franke, Lude; Hovingh, G. Kees; Taylor, Kent D.; Dedoussis, George; Sever, Peter; Wong, Andrew; Lind, Lars; Assimes, Themistocles L.; Njolstad, Inger; Schwarz, Peter E. H.; Langenberg, Claudia; Snieder, Harold; Caulfield, Mark J.; Melander, E.; Laakso, Markku; Saltevo, Juha; Rauramaa, Rainer; Tuomilehto, Jaakko; Ingelsson, Erik; Lehtimaki, Terho; Hveem, Kristian; Palmas, Walter; Marz, Winfried; Kumar, Meena; Salomaa, Veikko; Chen, Yii-Der I.; Rotter, Jerome I.; Froguel, Philippe; Jarvelin, Marjo-Riitta; Lakatta, Edward G.; Kuulasmaa, Kari; Franks, Paul W.; Hamsten, Anders; Wichmann, H-Erich; Palmer, Colin N. A.; Stefansson, Kari; Ridker, Paul M.; Loos, Ruth J. F.; Chalcravarti, Aravinda; Deloukas, Panos; Morris, Andrew P.; Newton-Cheh, Christopher; Munroe, Patricia B.		CHARGE-EchoGen Consortium; CHARGE-HF Consortium; Wellcome Trust Case Control Consor	The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; LOCI; TRAITS; SUSCEPTIBILITY; HYPERTENSION; METAANALYSIS	To dissect the genetic architecture of blood pressure and assess effects on target organ damage, we analyzed 128,272 SNPs from targeted and genome-wide arrays in 201,529 individuals of European ancestry, and genotypes from an additional 140,886 individuals were used for validation. We identified 66 blood pressure-associated loci, of which 17 were new; 15 harbored multiple distinct association signals. The 66 index SNPs were enriched for cis-regulatory elements, particularly in vascular endothelial cells, consistent with a primary role in blood pressure control through modulation of vascular tone across multiple tissues. The 66 index SNPs combined in a risk score showed comparable effects in 64,421 individuals of non-European descent. The 66-SNP blood pressure risk score was significantly associated with target organ damage in multiple tissues but with minor effects in the kidney. Our findings expand current knowledge of blood pressure-related pathways and highlight tissues beyond the classical renal system in blood pressure regulation.	[Ehret, Georg B.; Pihurl, Vasyl; Arkingl, Dan E.; Sosa, Maria X.; Chalcravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD USA; [Ehret, Georg B.; Lin, Li; Mach, Francois] Univ Hosp Geneva, Dept Med, Cardiol, Geneva, Switzerland; [Ferreira, Teresa; Farra, Martin; Goe, Anuj; McCarthy, Mark I.; Rayner, N. William; Watldns, Hugh; Morris, Andrew P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Chasman, Daniel I.; Giulianini, Franco; Rose, Lynda M.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Chasman, Daniel I.; Ridker, Paul M.] Harvard Med Sch, Boston, MA USA; [Jackson, Anne U.; Boehnke, Michael; Kang, Hyun Min; Sim, Xueling; Stringham, Heather M.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Jackson, Anne U.; Boehnke, Michael; Kang, Hyun Min; Sim, Xueling; Stringham, Heather M.] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Schmidt, Ellen M.; Willer, Cristen J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Johnson, Toby; Witkowska, Kate; Warren, Helen; Cabrera, Claudia P.; Caulfield, Mark J.; Munroe, Patricia B.] Queen Mary Univ London, William Harvey Res Inst, Clin Pharmacol, London, England; [Johnson, Toby] GlaxoSmithKline, Stevenage, Herts, England; [Thorleifsson, Gudmar; Bjornsdottir, Gyda; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet Amgen Inc, Reykjavik, Iceland; [Luan, Jian'an; Ong, Ken K.; Wareham, Nicholas J.; Zhao, Jing Hua; Langenberg, Claudia; Loos, Ruth J. F.] Univ Cambridge, Sch Clin Med, Inst Metab Sci, MRC Epidemiol Unit, Cambridge Biomed Campus, Cambridge, England; [Donnelly, Louise A.; Doney, Alex S. F.; Morris, Andrew D.; Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee, Scotland; [Kanoni, Stavroula; Lataniotis, Lazaros; Barnes, Michael R.; Marouli, Eirini; Stirrups, Kathleen E.; Yang, Tsun-Po; Deloukas, Panos] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Petersen, Ann -Kristin; Muller-Nurasyid, Martina] Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Strawbridge, Rona J.; Folkersen, Lasse; Eriksson, Per; Gertow, Karl; Hamsten, Anders] Karolinska Inst, Dept Med, Cardiovasc Res Unit, Ctr Mol Med, Stockholm, Sweden; [Strawbridge, Rona J.; Gertow, Karl; Sheu, Wayne H-H; Hamsten, Anders] Karolinska Univ Hosp Solna, Ctr Mol Med, Stockholm, Sweden; [Shungin, Dmitry; Hallmans, Goran; Renstrom, Frida; Franks, Paul W.] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Shungin, Dmitry; Renstrom, Frida; Franks, Paul W.] Lund Univ, Genet & Mol Epidemiol Unit, Dept Clin Sci, Malmo, Sweden; [Shungin, Dmitry] Umea Univ, Dept Odontol, Umea, Sweden; [Hughes, Maria F.; Evans, Alun] Queens Univ Belfast, Ctr Excellence Publ Hlth, Belfast, Antrim, North Ireland; [Meirelles, Osorio; Nagaraja, Ramaiah] NIA, Genet Lab, Intramural Res Program, US Natl Inst Hlth, Baltimore, MD 21224 USA; [Kaakinen, Marika] Imperial Coll London, Sch Publ Hlth, Hammersmith Hosp, Dept Genom Common Dis, London, England; [Bouatia-Naji, Nabila] INSERM UMR 970, Paris Cardiovasc Res Ctr PARCC, Paris, France; [Bouatia-Naji, Nabila] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Kristiansson, Kati; Havulinna, Aki S.; Lindstrom, Jaana; Mannisto, Satu; Perola, Markus; Virtamo, Jarmo; Tuomilehto, Jaakko; Salomaa, Veikko; Kuulasmaa, Kari] Natl Inst Hlth & Welf, Helsinki, Finland; [Kristiansson, Kati; Perola, Markus] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Shah, Sonia; Hingorani, Aroon D.; Kivimaki, Mika; Kumar, Meena] UCL, Dept Epidemiol & Publ Hlth, Genet Epidemiol Grp, London, England; [Kleber, Marcus E.; Delgado, Graciela] Heidelberg Univ, Med Fac Mannheim, Dept Med 5, Mannheim, Germany; [Guo, Xiuqing; Kim, Eric; Li, Xiaohui; Yao, Jie; Taylor, Kent D.; Chen, Yii-Der I.; Rotter, Jerome I.] Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Guo, Xiuqing; Kim, Eric; Li, Xiaohui; Yao, Jie; Taylor, Kent D.; Chen, Yii-Der I.; Rotter, Jerome I.] Harbor UCLA Med Ctr, Dept Pediat, Torrance, CA 90509 USA; [Lyytikainen, Leo-Pekka; Lehtimaki, Terho] Fimlab Labs, Dept Clin Chem, Tampere, Finland; [Lyytikainen, Leo-Pekka; Lehtimaki, Terho] Univ Tampere, Dept Clin Chem, Sch Med, Tampere, Finland; [Fava, Cristiano; Melander, E.] Lund Univ, Dept Internal Med, Malmo, Sweden; [Fava, Cristiano] Univ Verona, Dept Med, Verona, Italy; [Eriksson, Nidas] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Nolte, Ilja M.; Vaez, Ahmad; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Magnusson, Patrik K.; Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Salfati, Elias L.; Quertermous, Thomas; Assimes, Themistocles L.; Ingelsson, Erik] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Rallidis, Loukianos S.] Univ Athens, Sch Med, Attikon Hosp, Dept Cardiol 2, Athens, Greece; [Theusch, Elizabeth] Childrens Hosp Oakland Res Inst, Oakland, CA USA; [Smith, Andrew J. P.; Drenos, Fotios; Howard, Phil] UCL, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, London, England; [Witkowska, Kate; Warren, Helen; Barnes, Michael R.; Cabrera, Claudia P.; Caulfield, Mark J.; Munroe, Patricia B.] Queen Mary Univ London, NIHR Barts Cardiovasc Biomed Res Unit, London, England; [Pers, Tune H.; Esko, Tonu; Hirschhorn, Joel N.; Palmer, Cameron D.] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Pers, Tune H.; Hirschhorn, Joel N.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA USA; [Hirschhorn, Joel N.; Palmer, Cameron D.; Newton-Cheh, Christopher] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Pers, Tune H.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Metab Sect, Genet,Fac Hlth & Med Sci, Copenhagen, Denmark; [Pers, Tune H.] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark; [Joehanes, Roby; Johnson, Andrew D.; Eicher, John D.; Levy, Daniel; Lin, Honghuang; O'Donnell, Christopher J.; Vasan, Ramachandran S.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Kim, Stuart K.; Gierman, Hinco J.] Stanford Univ, Med Ctr, Dept Dev Biol & Genet, Stanford, CA 94305 USA; [Jansen, Rick] Vrije Univ Amsterdam, Dept Psychiat, Med Ctr, Amsterdam, Netherlands; [Johnson, Andrew D.; Eicher, John D.] NHLBI, Cardiovasc Epidemiol & Human Genom Branch, Bldg 10, Bethesda, MD 20892 USA; [Kim, Young Jin; Kim, Yun Kyoung; Shin, Young-Ah; Lee, Jong-Young] Natl Inst Hlth, Ctr Genome Sci, Osong Hlth Technol Adm Complex, Chungcheongbuk Do, South Korea; [Zhao, Wei] Univ Penn, Dept Med, Div Translat Med & Human Genet, Philadelphia, PA 19104 USA; [Wu, Ying; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Tayo, Bamidele O.; Cooper, Richard S.] Loyola Univ, Chicago Stritch Sch Med, Dept Publ Hlth Sci, Maywood, IL 60153 USA; [Bochud, Murielle; Bovet, Pascal] CHU Vaudois, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Bochud, Murielle; Bovet, Pascal] Univ Lausanne, Lausanne, Switzerland; [Absher, Devin] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Adair, Linda S.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Amin, Najaf] Erasmus MC, Dept Epidemiol, Genet Epidemiol Unit, Rotterdam, Netherlands; [Axelsson, Tomas; Sundstrom, Johan; Syvanen, Ann-Christine; Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Baldassarre, Damian; Tremoli, Elena] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Baldassarre, Damian; Tremoli, Elena] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Balkau, Beverley] Univ Paris 11, Ctr Res Epidemiol & Populat Hlth, INSERM U1018, URMS 1018, Villejuif, France; [Bandinelli, Stefania] ASF, Geriatr Unit, Florence, Italy; [Barroso, Ines; Danesh, John; Edkins, Sarah; Rayner, N. William] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Barroso, Ines] Univ Cambridge, Inst Metab Sci, Addenbrookes Hosp, Metab Res Labs, Cambridge, England; [Barroso, Ines] Addenbrookes Hosp, NIHR Cambridge Biomed Res Ctr, Inst Metab Sci, Cambridge, England; [Bevan, Stephen] Lincoln Univ, Joseph Banks Labs, Sch Life Sci, Lincoln, England; [Bis, Joshua C.; Jensen, Richard A.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Human Genet Ctr, Houston, TX 77030 USA; [Bonnycastle, Lori L.; Chines, Peter S.; Collins, Francis S.; Narisu, Narisu; Swift, Amy J.] NHGRI, Med Genom & Metab Genet Branch, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Boomsma, Dorret I.; Hottenga, Jouke-Jan] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Bornstein, Stefan R.; Schwarz, Peter E. H.] Univ Dresden, Med Fac Carl Gustav Carus, Dept Med 3, Dresden, Germany; [Brown, Morris J.] Queen Mary Univ London, Barts Heart Ctr, William Harvey Res Inst, London, England; [Burnier, Michel] CHU Vaudois, Nephrol, Lausanne, Switzerland; [Burnier, Michel] Univ Lausanne, Lausanne, Switzerland; [Chambers, John C.; Evangelou, Evangelos; Gao, He; Zhang, Weihua; Elliott, Paul] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Kooner, Jaspal S.; Zhang, Weihua] Ealing Hosp NHS Trust, Dept Cardiol, Southall, Middx, England; [Chambers, John C.; Kooner, Jaspal S.] Imperial Coll Healthcare NHS Trust, London, England; [Chang, I-Shou] Natl Inst Canc Res, Natl Hlth Res Inst, Zhunan Town, Taiwan; [Cheng, Ching-Yu; Wong, Tien Y.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Cheng, Ching-Yu; Tai, E-Shyong; Wong, Tien Y.] Duke NUS Grad Med Sch Singapore, Singapore, Singapore; [Cheng, Ching-Yu; Wong, Tien Y.] Natl Univ Singapore, Dept Ophthalmol, Singapore, Singapore; [Cheng, Ching-Yu; Wong, Tien Y.] Natl Univ Hlth Syst, Singapore, Singapore; [Chung, Ren-Hua; Hsiung, Chao A.] Natl Hlth Res Inst, Div Biostat & Bioinformat, Inst Populat Hlth Sci, Zhunan Town, Taiwan; [Connell, John M.] Univ Dundee, Ninewells Hosp & Med Sch, Dundee, Scotland; [Doring, Angela; Wichmann, H-Erich] Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Doring, Angela; Peters, Annette] Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Dallongeville, Jean] Univ Lille 2, INSERM UMR 1167, Inst Pasteur Lille, Lille, France; [Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, NIHR Blood & Transplant Res Unit Donor Hlth & Gen, Cambridge, England; [de Faire, Ulf; Gigante, Bruna] Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, Stockholm, Sweden; [Dominiczak, Anna F.] Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Drenos, Fotios] Univ Bristol, Sch Social & Community Med, Med Res Council Integrat Epidemiol Unit, Oakfield House, Bristol, Avon, England; [Elosua, Roberto] Inst Hosp Mar Invest Med IMIM, Cardiovasc Epidemiol & Genet, Barcelona, Spain; [Enroth, Stefan; Gyllensten, Ulf] Uppsala Univ, Dept Immunol Genet & Pathol, Biomed Ctr, Uppsala, Sweden; [Enroth, Stefan; Gyllensten, Ulf] Uppsala Univ, Biomed Ctr, Sci Life Lab, Uppsala, Sweden; [Erdmann, Jeanette] Univ Lubeck, Inst Integrat & Expt Genom, Lubeck, Germany; [Erdmann, Jeanette] Deutsch Zentrum Herz Kreislauf Forsch DZHK, Partner Site Hamburg, Kiel, Germany; [Esko, Tonu; Metspalu, Andres; Perola, Markus] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Esko, Tonu; Kosova, Gulum; Newton-Cheh, Christopher] Broad Inst MIT & Harvard, Cambridge, MA USA; [Evangelou, Evangelos] Univ Ioannina, Dept Hyg & Epidemiol, Sch Med, Ioannina, Greece; [Fai, Tove; Ingelsson, Erik] Uppsala Univ, Mol Epidemiol & Sci Life Lab, Dept Med Sci, Uppsala, Sweden; [Farra, Martin; Goe, Anuj; Watldns, Hugh] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England; [Felixl, Janine F.; Franco, Oscar H.; Hofmanl, Albert; Ikram, M. Arfan; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Verwoert, Germaine C.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Epidemiol, Rotterdam, Netherlands; [Ferrieres, Jean] Toulouse Univ, Sch Med, Rangueil Univ Hosp, INSERM UMR 1027, Toulouse, France; [Ferrucci, Luigi; Tanaka, Toshiko] NIA, Translat Gerontol Branch, Baltimore, MD 21224 USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA; [Forrester, Terrence; McKenzie, Colin A.] Univ West Indies, Trop Metab Res Unit, Res Inst Trop Med, Kingston, Jamaica; [Franceschinil, Nora] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Franco-Cereceda, Anders] Karolinska Inst, Dept Mol Med & Surg, Cardiothorac Surg Unit, Stockholm, Sweden; [Fraser, Ross M.; Wilson, James F.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Fraser, Ross M.] Synpromics Ltd, Edinburgh, Midlothian, Scotland; [Ganesh, Santhi K.] Univ Michigan, Sch Med, Dept Cardiol, Ann Arbor, MI 48109 USA; [Gianfagna, Francesco] Univ Insubria, Dept Clin & Expt Med, Epidemiol & Prevent Med EPIMED Res Ctr, Varese, Italy; [Gianfagna, Francesco] IRCCS, Ist Neurol Mediterraneo NEUROMED, Dept Epidemiol & Prevent, Pozzilli, Italy; [Goodall, Alison H.; Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Goodall, Alison H.; Samani, Nilesh J.] Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Goodarzi, Mark] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA; [Gorski, Mathias] Univ Regensburg, Inst Epidemiol & Prevent Med, Dept Genet Epidemiol, Regensburg, Germany; [Gorski, Mathias] Univ Hosp Regensburg, Dept Nephrol, Regensburg, Germany; [Grassler, Jurgen] Tech Univ Dresden, Dept Med 2, Div Pathobiochem, Dresden, Germany; [Groves, Christopher J.; McCarthy, Mark I.; Rayner, N. William] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Gudnason, Vilmundur; Smith, Albert V.; Froguel, Philippe] Iceland Heart Assoc, Kopavogur, Iceland; [Gudnason, Vilmundur; Smith, Albert V.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Hartikainen, Anna-Liisa] Univ Oulu, Inst Clin Med Obstet & Gynaecol, Oulu, Finland; [Hartikainen, Anna-Liisa] Oulu Univ Hosp, Med Res Ctr, Oulu, Finland; [Hassinen, Maija; Komulainen, Pirjo; Lakka, Timo A.; Rauramaa, Rainer] Kuopio Res Inst Exercise Med, Kuopio, Finland; [Hayward, Caroline; Vitart, Veronique; Wilson, James F.] Western Gen Hosp, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Hercberg, Serge] Univ Paris 13, UREN, INSERM U557, INRA U1125,Sorbonne Paris Cite, Bobigny, France; [Herzig, Karl-Heinz] Univ Oulu, Inst Biomed, Med Res Ctr Oulu, Oulu, Finland; [Herzig, Karl-Heinz] Oulu Univ Hosp, Oulu, Finland; [Herzig, Karl-Heinz; Sebert, Sylvain; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Herzig, Karl-Heinz] Poznan Univ Med Sci, Dept Gastroenterol & Metab, Poznan, Poland; [Hicks, Andrew A.; Pramstaller, Peter P.] European Acad Bozen Bolzano EURAC, Ctr Biomed, Bolzano, Italy; [Hicks, Andrew A.; Pramstaller, Peter P.] Univ Lubeck, Inst, Lubeck, Germany; [Hirschhorn, Joel N.] Harvard Med Sch, Dept Genet, Boston, MA USA; [Hofmanl, Albert] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Holmen, Jostein; Holmen, Oddgeir Lingaas; Kvaloy, Kirsti; Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, HUNT Res Ctr, Levanger, Norway; [Holmen, Oddgeir Lingaas] Univ Trondheim Hosp, St Olav Hosp, Trondheim, Norway; [Hunt, Steven C.] Univ Utah, Sch Med, Cardiovasc Genet Div, Salt Lake City, UT USA; [Hunt, Steven C.] Weill Cornell Med Coll Qatar, Dept Genet Med, Doha, Qatar; [Ikram, M. Arfan] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus MC, Univ Med Ctr Rotterdam, Dept Neurol, Rotterdam, Netherlands; [Illig, Thomas; Klopp, Norman] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Klopp, Norman] Hannover Med Sch, Hannover Unified Biobank, Hannover, Germany; [Illig, Thomas] Hannover Med Sch, Inst Human Genet, Hannover, Germany; [Iribarren, Carlos] Kaiser Permanente, Div Res, Oakland, CA USA; [Jensen, Richard A.] Univ Tampere, Sch Med, Dept Clin Physiol, Tampere, Finland; [Kahonen, Mika] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA USA; [Kahonen, Mika; Newton-Cheh, Christopher] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Kathiresan, Sekar; Kosova, Gulum] Harvard Med Sch, Dept Med, Boston, MA USA; [Kosova, Gulum; Newton-Cheh, Christopher] Massachusetts Gen Hosp, Div Cardiol, Dept Med, Boston, MA 02114 USA; [Kathiresan, Sekar] Univ Penn, Dept Surg, Div Transplantat, Philadelphia, PA 19104 USA; [Kathiresan, Sekar; O'Donnell, Christopher J.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Keating, Brendan J.] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Keating, Brendan J.] Onassis Cardiac Surg Ctr, Dept Cardiol 1, Athens, Greece; [Khaw, Kay-Tee] Imperial Coll London, Hammersmith Hosp Campus, Natl Heart & Lung Inst, London, England; [Kolovou, Genovefa; Paccaud, Fred] Childrens Hosp Oakland, Res Inst, Dept Med, Oakland, CA 94609 USA; [Kooner, Jaspal S.] MRC Unit Lifelong Hlth & Ageing UCL, London, England; [Krauss, Ronald M.] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Kuh, Diana; Wong, Andrew] Swiss Inst Bioinformat, Lausanne, Switzerland; [Kutalik, Zoltan] Univ Eastern Finland, Dept Med, Kuopio, Finland; [Kutalik, Zoltan] Kuopio Univ Hosp, Kuopio, Finland; [Kutalik, Zoltan] Univ Eastern Finland, Inst Biomed Physiol, Kuopio, Finland; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, Kuopio, Finland; [Lakka, Timo A.] Off Populat Studies Fdn Inc, Cebu, Philippines; [Lakka, Timo A.; Sebert, Sylvain; Rauramaa, Rainer] Univ San Carlos, Dept Anthropol Sociol & Hist, Cebu, Philippines; [Lee, Nanette R.] Taichung Vet Gen Hosp, Dept Internal Med, Div Endocrine & Metab, Taichung, Taiwan; [Lee, Nanette R.] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Lee, I-Te; Sheu, Wayne H-H] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Lee, I-Te; Sheu, Wayne H-H] NHLBI, Populat Sci Branch, US Natl Inst Hlth, Bldg 10, Bethesda, MD 20892 USA; [Lee, Wen-Jane] Taichung Vet Gen Hosp, Cardiovasc Ctr, Taichung, Taiwan; [Levy, Daniel] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei, Taiwan; [Liang, Kae-Woei] Boston Univ, Sch Med, Sect Computat Biomed, Dept Med, Boston, MA 02215 USA; [Liang, Kae-Woei] EGID, Lille, France; [Lin, Honghuang] Lille Pasteur Inst, CNRS UMR 8199, Lille, France; [Lobbens, Stephane; Yengo, Loic; Froguel, Philippe] Univ Lille 2, Lille, France; [Lobbens, Stephane; Yengo, Loic; Froguel, Philippe] Univ Dresden, Med Fac Carl Gustav Carus, Ctr Evidence Based Healthcare, Dresden, Germany; [Lobbens, Stephane; Yengo, Loic; Froguel, Philippe] Univ Munich, Univ Hosp Grosshadern, Dept Med 1, Munich, Germany; [Muller, Gabriele] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Muller-Nurasyid, Martina] Univ Cambridge, Neurol Unit, Biomed Campus, Cambridge, England; [Muller-Nurasyid, Martina; Wichmann, H-Erich] Harokopio Univ, Dept Dietet Nutr, Athens, Greece; [Markus, Hugh S.] Univ Paris 13, Univ Paris 06, Sorbonne Univ, INSERM U1142,LIMICS,UMRS 1142, Paris, France; [Marouli, Eirini; Dedoussis, George] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Meneton, Pierre] Univ Verona, Dept Life & Reprod Sci, Verona, Italy; [Menni, Cristina; Spector, Tim D.] Kuopio Univ Hosp, Dept Med, Kuopio, Finland; [Mijatovic, Vladan] Oulu Univ Hosp, Unit Gen Practice, Oulu, Finland; [Moilanen, Leena] Univ Maryland, Sch Med, Dept Med, Program Personalized & Genom Med, Baltimore, MD 21201 USA; [Moilanen, Leena] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Montasser, May E.; Parsa, Afshin] Cittadella Univ Monseratto, IRGB, CNR, Cagliari, Italy; [Morrison, Alanna C.] Tampere Univ Hosp, Ctr Heart, Dept Cardiol, Tampere, Finland; [Mulas, Antonella; Sanna, Serena] Univ Tampere, Sch Med, Dept Cardiol, Tampere, Finland; [Nikus, Kjell] NHLBI, Div Cardiovasc Sci, Bldg 10, Bethesda, MD 20892 USA; [Nikus, Kjell] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [O'Donnell, Christopher J.; Rossouw, Jacques] Childrens Hosp Boston, Genet & Program Genom, Boston, MA USA; [O'Reilly, Paul F.] Vrije Univ Amsterdam, Dept Psychiat, EMGO Inst, Med Ctr, Neurosci Campus, Amsterdam, Netherlands; [Palmer, Cameron D.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Penninx, Brenda W.; Smit, Johannes H.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Penninx, Brenda W.] Imperial Coll London, Int Ctr Circulatory Hlth, London, England; [Penninx, Brenda W.] Gen Cent Hosp, Dept Neurol, Bolzano, Italy; [Poulter, Neil; Sever, Peter] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Pramstaller, Peter P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Pramstaller, Peter P.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.; Sheu, Wayne H-H] Grp Hlth Res Inst, Grp Hlth Cooperat, Seattle, WA USA; [Psaty, Bruce M.] Washington Univ, Sch Med, Div Biostat, St Louis, MO USA; [Psaty, Bruce M.] Ctr Noncommunicable Dis, Karachi, Pakistan; [Rao, Dabeeru C.] Umea Univ, Dept Biobank Res, Umea, Sweden; [Rasheed, Asif; Saleheen, Danish] Univ Med Greifswald, Inst Physiol, Greifswald, Germany; [Renstrom, Frida] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Rettig, Rainer] Univ Ottawa, Inst Heart, Cardiovasc Res Methods Ctr Ontario, Ottawa, ON, Canada; [Rice, Kenneth M.] Ruddy Canadian Cardiovasc Genet Ctr, Ottawa, ON, Canada; [Roberts, Robert] South Karelia Cent Hosp, Lappeenranta, Finland; [Roberts, Robert] Deutsch Herzzentrum Munich, Munich, Germany; [Saramies, Jouko] Tech Univ Munich, Munich, Germany; [Schunkert, Heribert] Deutsch Zentrum Herz Kreislauf Forsch DZHK, Munich, Germany; [Schunkert, Heribert] Munich Heart Alliance, Munich, Germany; [Schunkert, Heribert] Univ Oulu, Ctr Lifecourse Hlth Res, Oulu, Finland; [Sebert, Sylvain; Jarvelin, Marjo-Riitta] Natl Def Med Ctr, Coll Med, Taipei, Taiwan; Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; Natl Univ Hlth Syst, Singapore, Singapore; [Sim, Xueling; Tai, E-Shyong] Univ Eastern Finland, Kuopio, Finland; [Sim, Xueling; Tai, E-Shyong] Kuopio Univ Hosp, Kuopio, Finland; [Stancakova, Alena] Royal Coll Surgeons Ireland, Mol & Cellular Therapeut, Dublin, Ireland; [Stanton, Alice V.] Univ Cambridge, Dept Haematol, Cambridge, England; [Stirrups, Kathleen E.] Natl Univ Singapore, Dept Med, Singapore, Singapore; [Stirrups, Kathleen E.] Natl Univ Hlth Syst, Singapore, Singapore; [Tai, E-Shyong] NIA, Intramural Res Program, Lab Cardiovasc Sci, US Natl Inst Hlth, Baltimore, MD 21224 USA; [Tarasov, Kirill V.; Lakatta, Edward G.] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Teumer, Alexander] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Tobin, Martin D.; Wain, Louise V.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Uitterlinden, Andre G.] Univ Eastern Finland, Dept Publ Hlth & Clin Nutr, Kuopio, Finland; [Uusitupa, Matti] Kuopio Univ Hosp, Res Unit, Kuopio, Finland; [Uusitupa, Matti] Isfahan Univ Med Sci, Res Inst Primordial Prevent Noncommunicable Dis, Esfahan, Iran; [Vaez, Ahmad] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Vaidya, Dhananjay] NGI Erasmus Med Ctr, Ctr Med Syst Biol CMSB 12, Rotterdam, Netherlands; [van Duijn, Cornelia M.] Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands; [van Iperen, Erik P. A.] ICIN Netherlands Heart Inst, Durrer Ctr Cardiogenet Res, Utrecht, Netherlands; [van Iperen, Erik P. A.] Boston Univ, Dept Med, Sect Prevent Med, Sch Med, Boston, MA USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Med, Cardiol, Boston, MA 02215 USA; [Vasan, Ramachandran S.] Univ Penn, Perelman Sch Med, Dept Genet, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Voight, Benjamin F.] Univ Lausanne Hosp, Dept Internal Med, Lausanne, Switzerland; [Vollenweider, Peter] Univ Strasbourg, EA3430, Dept Epidemiol & Publ Hlth, Strasbourg, France; [Wagner, Aline] Univ Michigan, Sch Med, Div Cardiovasc Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Weder, Alan B.; Willer, Cristen J.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Westra, Harm Jan] Univ West Indies, Res Inst Trop Med, Epidemiol Res Unit, Kingston, Jamaica; [Wilks, Rainford] Univ Tromso, Dept Community Med, Fac Hlth Sci, Tromso, Norway; [Wilsgaard, Tom; Njolstad, Inger] Univ Tromso, Fac Hlth Sci, Dept Clin Med, Tromso, Norway; [Wilsgaard, Tom; Njolstad, Inger] Univ Cambridge, MRC Canc Unit, Cambridge, England; [Yang, Tsun-Po] Case Western Reserve Univ, Dept Epidemiol & Biostat, Sch Med, Cleveland, OH 44106 USA; [Zhu, Xiaofeng] Minist Hlth, Victoria, Seychelles; [Bovet, Pascal] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Saleheen, Danish] Imperial Coll London, Sch Publ Hlth, MRC PHE Ctr Environm & Hlth, London, England; [Elliott, Paul; Jarvelin, Marjo-Riitta] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Gierman, Hinco J.] Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Schwarz, Peter E. H.] Univ Hosp, Paul Langerhans Inst Dresden, Helmholtz Ctr Munich, Dresden, Germany; [Schwarz, Peter E. H.] Tech Univ Dresden, Fac Med, Dresden, Germany; [Schwarz, Peter E. H.] German Ctr Diabet Res DZD, Neuherberg, Germany; [Saltevo, Juha] Cent Finland Hlth Care Dist, Dept Med, Jyvaskyla, Finland; [Tuomilehto, Jaakko] Dasman Diabet Inst, Dasman, Kuwait; [Tuomilehto, Jaakko] King Abdulaziz Univ, Saudi Diabet Res Grp, Jeddah, Saudi Arabia; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Palmas, Walter] Columbia Univ, Dept Med, New York, NY USA; [Marz, Winfried] Synlab Acad, Synlab Serv, Mannheim, Germany; [Marz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Franks, Paul W.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Wichmann, H-Erich] Tech Univ Munich, Inst Med Stat & Epidemiol, Munich, Germany; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth Dev Inst, New York, NY 10029 USA; [Deloukas, Panos] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah, Saudi Arabia; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England	Johns Hopkins University; University of Geneva; University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of London; Queen Mary University London; GlaxoSmithKline; University of Cambridge; University of Dundee; University of London; Queen Mary University London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Umea University; Lund University; Umea University; Queens University Belfast; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Finland National Institute for Health & Welfare; University of Helsinki; University of London; University College London; Ruprecht Karls University Heidelberg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Tampere University; Lund University; University of Verona; Uppsala University; University of Groningen; Karolinska Institutet; Stanford University; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of London; University College London; University of London; Queen Mary University London; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Novo Nordisk Foundation; University of Copenhagen; Statens Serum Institut; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Stanford University; Vrije Universiteit Amsterdam; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; University of Pennsylvania; University of North Carolina; University of North Carolina Chapel Hill; Loyola University Chicago; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; HudsonAlpha Institute for Biotechnology; University of North Carolina; University of North Carolina Chapel Hill; Erasmus University Rotterdam; Erasmus MC; Uppsala University; University of Milan; IRCCS Centro Cardiologico Monzino; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Lincoln; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Vrije Universiteit Amsterdam; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of London; Queen Mary University London; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Imperial College London; Imperial College London; National Health Research Institutes - Taiwan; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore; National Health Research Institutes - Taiwan; University of Dundee; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Cambridge; University of Cambridge; Karolinska Institutet; University of Glasgow; University of Bristol; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Uppsala University; Uppsala University; University of Lubeck; German Centre for Cardiovascular Research; University of Tartu; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Ioannina; Uppsala University; University of Oxford; Erasmus University Rotterdam; Erasmus MC; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; Universite Federale Toulouse Midi-Pyrenees (ComUE); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Texas System; University of Texas Health Science Center Houston; University West Indies Mona Jamaica; University of North Carolina; University of North Carolina Chapel Hill; Karolinska Institutet; University of Edinburgh; University of Michigan System; University of Michigan; University of Insubria; IRCCS Neuromed; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Cedars Sinai Medical Center; University of Regensburg; University of Regensburg; Technische Universitat Dresden; University of Oxford; Icelandic Heart Association; University of Iceland; University of Oulu; University of Oulu; University of Edinburgh; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; University of Oulu; University of Oulu; University of Oulu; Poznan University of Medical Sciences; European Academy of Bozen-Bolzano; University of Lubeck; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Utah System of Higher Education; University of Utah; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; Hannover Medical School; Kaiser Permanente; Tampere University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Pennsylvania; University of Pennsylvania; University of Cambridge; Onassis Cardiac Surgery Center; Imperial College London; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of London; University College London; University of Lausanne; Swiss Institute of Bioinformatics; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of San Carlos; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Boston University; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Munich; University of Munich; University of Cambridge; Harokopio University Athens; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris 13; University of London; King's College London; University of Verona; Kuopio University Hospital; University of Eastern Finland; University of Oulu; University System of Maryland; University of Maryland Baltimore; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Cagliari; Tampere University; Tampere University Hospital; Tampere University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of London; King's College London; Harvard University; Boston Children's Hospital; Vrije Universiteit Amsterdam; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Imperial College London; Krankenhaus Bozen; University of Lubeck; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Washington University (WUSTL); Umea University; Greifswald Medical School; University of Washington; University of Washington Seattle; University of Ottawa; University of Ottawa Heart Institute; German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Oulu; National Defense Medical Center; National University of Singapore; National University of Singapore; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Royal College of Surgeons - Ireland; University of Cambridge; National University of Singapore; National University of Singapore; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Greifswald Medical School; University of Leicester; Erasmus University Rotterdam; Erasmus MC; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Isfahan University Medical Science; Johns Hopkins University; Johns Hopkins Medicine; University of Amsterdam; Academic Medical Center Amsterdam; Boston University; Boston University; University of Pennsylvania; Pennsylvania Medicine; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Michigan System; University of Michigan; University of Groningen; University West Indies Mona Jamaica; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University of Cambridge; Case Western Reserve University; University of Pennsylvania; Imperial College London; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Central Finland Central Hospital; King Abdulaziz University; Danube University Krems; Columbia University; SYNLAB Group; Medical University of Graz; University of Oulu; Harvard University; Harvard T.H. Chan School of Public Health; Technical University of Munich; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; King Abdulaziz University; University of Liverpool	Munroe, PB (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Clin Pharmacol, London, England.; Munroe, PB (corresponding author), Queen Mary Univ London, NIHR Barts Cardiovasc Biomed Res Unit, London, England.; Newton-Cheh, C (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA.; Newton-Cheh, C (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA USA.; Newton-Cheh, C (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA.	cnewtoncheh@mgh.harvard.edu; p.b.munroe@qmul.ac.uk	Gianfagna, Francesco/K-4561-2016; Kanoni, Stavroula/AAN-7161-2021; Havulinna, Aki/AAM-4769-2021; Vaidya, Dhananjay/AAL-5684-2020; Uusitupa, Matti Ilmari Julius/AAX-4929-2020; sanna, serena/H-3009-2019; Colaus, PsyColaus/K-6607-2013; paccaud, fred/M-7516-2019; Deloukas, Panos/B-2922-2013; Loos, Ruth/GON-5877-2022; Nikus, Kjell/K-7813-2019; Gudnason, Vilmundur/AAE-7126-2019; Wong, Andrew/AAE-6995-2019; Franco, Óscar H/ABE-2305-2020; Lee, Jong-Young/M-6319-2013; Yengo, Loic/D-2692-2017; Lin, Honghuang/A-3269-2019; Bouatia-Naji, Nabila/AGF-1400-2022; Ikram, M. Arfan/AAM-5225-2021; Doney, Alexander SF/P-7437-2017; Hveem, Kristian/AFV-4683-2022; FROGUEL, Philippe/O-6799-2017; Johnson, Andrew D/G-6520-2013; Lehtimäki, Terho/AAD-1094-2022; Levy, Daniel/ABB-2752-2021; Chung, Ren-Hua/AAB-8364-2019; Peters, Annette/A-6117-2011; Njolstad, Inger/X-3784-2019; Loos, Ruth J F/Q-2862-2016; EHRET, Georg B/A-9532-2009; Narisu, Narisu/T-6908-2019; Enroth, Stefan/C-7396-2009; Kivimaki, Mika/B-3607-2012; Zhu, Xiaofeng/O-6874-2019; Meitinger, Thomas/O-1318-2015; Stancakova, Alena/AAN-6723-2020; Franke, Lude/P-7036-2016; Wong, Tien Yin/AAC-9724-2020; bandinelli, stefania/AAL-4570-2020; Kim, Young-jin/GSD-3168-2022; Serge, Hercberg/F-3038-2017; Franks, Paul/AAA-3300-2020; Strawbridge, Rona/H-5422-2012; Fraser, Ross M/J-9519-2012; Sundström, Johan/A-6286-2009; Wilson, James F/A-5704-2009; Vollenweider, Peter/Q-4603-2016; Vaez, Ahmad/B-4336-2018; Bovet, Pascal/F-4477-2011; Lakatta, Edward G/AAL-1447-2020; Kuh, Diana/L-6019-2014; Goodarzi, Mark/AAH-7106-2021; Fava, Cristiano/K-9590-2015; Wong, Andrew/M-8899-2016; Dedoussis, George/AAN-7252-2021; Wichmann, Heinz Erich/AAA-5695-2022; Evangelou, Evangelos/C-3033-2013; Levy, Daniel/ABF-6873-2021; Shah, Sonia/N-7547-2013; Magnusson, Patrik KE/C-4458-2017; Khaw, Kay-Tee/AAZ-3209-2021; HERCBERG, Serge/B-4429-2008; Stanton, Alice V/F-4697-2012; Cheng, Ching-Yu/Y-2229-2019; Teumer, Alexander/S-7438-2019; Müller-Nurasyid, Martina/I-8735-2018; Hicks, Andrew Anthony/E-9518-2017; Ramachandran, Vasan/Y-2527-2019; Dominiczak, Anna F/P-9390-2017; Mulas, Antonella/B-4231-2015; Penninx, Brenda WJH/S-7627-2017; Sundstrom, Johan/R-2139-2019; BOUATIA-NAJI, NABILA/D-5863-2013; Stefansson, Kari/AAE-7187-2019; Erdmann, Jeanette/A-4417-2009; Sim, Xueling/AAZ-6652-2020; Erdmann, Jeanette/P-7513-2014; Langenberg, Claudia/ABG-9067-2021; Gigante, Bruna/I-9252-2012; Boomsma, Dorret I/AAX-4470-2020; Assimes, Themistocles Leonard/D-9696-2015; Meneton, Pierre/T-1216-2019; Palmer, Colin NA/C-7053-2008; Rotter, Jerome/AAY-6598-2021; Smith, Albert Vernon/K-5150-2015; TREMOLI, ELENA/I-8126-2018; McCarthy, Mark/M-3763-2015; Baldassarre, Damiano/J-3295-2016; Ferrieres, Jean/S-7993-2016	Gianfagna, Francesco/0000-0003-4615-0816; Kanoni, Stavroula/0000-0002-1691-9615; Vaidya, Dhananjay/0000-0002-7164-1601; sanna, serena/0000-0002-3768-1749; Deloukas, Panos/0000-0001-9251-070X; Gudnason, Vilmundur/0000-0001-5696-0084; Wong, Andrew/0000-0003-2079-4779; Franco, Óscar H/0000-0002-4606-4929; Lee, Jong-Young/0000-0002-0092-9958; Yengo, Loic/0000-0002-4272-9305; Lin, Honghuang/0000-0003-3043-3942; Bouatia-Naji, Nabila/0000-0001-5424-2134; Doney, Alexander SF/0000-0002-6210-5620; FROGUEL, Philippe/0000-0003-2972-0784; Johnson, Andrew D/0000-0001-6369-5178; Lehtimäki, Terho/0000-0002-2555-4427; Peters, Annette/0000-0001-6645-0985; Loos, Ruth J F/0000-0002-8532-5087; EHRET, Georg B/0000-0002-5730-0675; Enroth, Stefan/0000-0002-5056-9137; Kivimaki, Mika/0000-0002-4699-5627; Stancakova, Alena/0000-0002-1375-0252; Franke, Lude/0000-0002-5159-8802; Wong, Tien Yin/0000-0002-8448-1264; Serge, Hercberg/0000-0002-3168-1350; Strawbridge, Rona/0000-0001-8506-3585; Fraser, Ross M/0000-0003-0488-2592; Sundström, Johan/0000-0003-2247-8454; Wilson, James F/0000-0001-5751-9178; Vollenweider, Peter/0000-0002-0765-896X; Vaez, Ahmad/0000-0001-9048-3795; Bovet, Pascal/0000-0002-0242-4259; Kuh, Diana/0000-0001-7386-2857; Goodarzi, Mark/0000-0001-6364-5103; Fava, Cristiano/0000-0002-8910-7378; Wong, Andrew/0000-0003-2079-4779; Dedoussis, George/0000-0002-7798-6221; Evangelou, Evangelos/0000-0002-5488-2999; Levy, Daniel/0000-0003-1843-8724; Shah, Sonia/0000-0001-5860-4526; Magnusson, Patrik KE/0000-0002-7315-7899; HERCBERG, Serge/0000-0002-3168-1350; Cheng, Ching-Yu/0000-0003-0655-885X; Teumer, Alexander/0000-0002-8309-094X; Müller-Nurasyid, Martina/0000-0003-3793-5910; Hicks, Andrew Anthony/0000-0001-6320-0411; Ramachandran, Vasan/0000-0001-7357-5970; Dominiczak, Anna F/0000-0003-4913-3608; Penninx, Brenda WJH/0000-0001-7779-9672; Sundstrom, Johan/0000-0003-2247-8454; Sim, Xueling/0000-0002-1233-7642; Erdmann, Jeanette/0000-0002-4486-6231; Langenberg, Claudia/0000-0002-5017-7344; Assimes, Themistocles Leonard/0000-0003-2349-0009; Palmer, Colin NA/0000-0002-6415-6560; Bevan, Steve/0000-0003-0490-6830; Bandinelli, Stefania/0000-0002-6491-0850; Folkersen, Lasse/0000-0003-0708-9530; Elliott, Paul/0000-0002-7511-5684; Mulas, Antonella/0000-0002-6856-1483; Goel, Anuj/0000-0003-2307-4021; Lindstrom, Jaana/0000-0001-9255-020X; Munroe, Patricia/0000-0002-4176-2947; Jansen, Rick/0000-0002-3333-6737; Smith, Andrew/0000-0003-1141-2978; Pedersen, Nancy/0000-0001-8057-3543; Pramstaller, Peter P/0000-0002-9831-8302; Tobin, Martin/0000-0002-3596-7874; Kumari, Meena/0000-0001-9716-1035; Graessler, Juergen/0000-0003-3619-8517; Theusch, Elizabeth/0000-0002-5678-759X; Wain, Louise/0000-0003-4951-1867; ELOSUA, ROBERTO/0000-0001-8235-0095; O'Reilly, Paul/0000-0001-7515-0845; Yang, Tsun-Po/0000-0002-9077-4434; Smith, Albert Vernon/0000-0003-1942-5845; TREMOLI, ELENA/0000-0002-0929-6106; Watkins, Hugh/0000-0002-5287-9016; McCarthy, Mark/0000-0002-4393-0510; Barroso, Ines/0000-0001-5800-4520; Eriksson, Per/0000-0002-5635-2692; Kuulasmaa, Kari/0000-0003-2165-1411; Menni, Cristina/0000-0001-9790-0571; Stanton, Alice/0000-0002-4961-165X; Drenos, Fotios/0000-0003-2469-5516; Franks, Paul/0000-0002-0520-7604; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Baldassarre, Damiano/0000-0002-2766-8882; Van Duijn, Cornelia/0000-0002-2374-9204; Melander, Olle/0000-0002-2581-484X; Brown, Morris/0000-0001-8409-1082; Schmidt, Ellen/0000-0003-1198-7536; Caulfield, Mark/0000-0001-9295-3594; Marouli, Eirini/0000-0001-6179-1609; Morrison, Alanna/0000-0001-6381-4296; Jackson, Anne/0000-0002-9672-2547; Tai, E Shyong/0000-0003-2929-8966; Voight, Benjamin/0000-0002-6205-9994; Zhao, Wei/0000-0002-8301-9297; Goodall, Alison/0000-0002-7883-9645; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Hingorani, Aroon/0000-0001-8365-0081; Gigante, Bruna/0000-0003-4508-7990; Lakatta, Edward/0000-0002-4772-0035; Hughes, Maria/0000-0002-2364-7152; Tarasov, Kirill/0000-0001-7799-4670; Zhu, Xiaofeng/0000-0003-0037-411X; Pers, Tune/0000-0003-0207-4831; Kahonen, Mika/0000-0002-4510-7341; Quertermous, Thomas/0000-0002-7645-9067; Ferrieres, Jean/0000-0001-6144-1297; Amin, Najaf/0000-0002-8944-1771; Barnes, Michael/0000-0001-9097-7381; Bjornsdottir, Gyda/0000-0002-8100-0306; Sebert, Sylvain/0000-0001-6681-6983	Arthritis Research UK Funding Source: Medline; British Heart Foundation [RG/13/2/30098, PG/02/128, RG/07/005/23633, SP/08/005/25115, SP/04/002, SP/10/6/28562, RG2008/014, RG/14/5/30893, RG08/008, FS/13/6/29977, RG/10/12/28456] Funding Source: Medline; FIC NIH HHS [R01 TW008288, R01 TW005596, RC1 TW008485] Funding Source: Medline; Medical Research Council [G1002319, MC_PC_U127561128, MR/K006584/1, MR/K013351/1, G0000934, G0601261, MC_UU_12019/1, 85374, G0700931, G0600237, G0500539, MR/L003120/1, G0401527, G1000143, MC_UU_12015/1, G9521010D, MR/L01341X/1, G0600705, G0601966, MR/N003284/1, MR/N015746/1, MC_UU_12013/5] Funding Source: Medline; NCATS NIH HHS [UL1 TR000124] Funding Source: Medline; NCI NIH HHS [UM1 CA182913] Funding Source: Medline; NCRR NIH HHS [M01 RR000052, UL1 RR024156, UL1 RR024975, M01 RR010284, M01 RR000425, UL1 RR033176, P20 RR020649, UL1 RR025774, M01 RR016500, U54 RR020278, UL1 RR025005] Funding Source: Medline; NEI NIH HHS [R01 EY018246, ZIA EY000401, R01 EY014684] Funding Source: Medline; NHGRI NIH HHS [U01 HG007416, N01HG65403, HHSN268200782096C, Z01 HG200362, U01 HG004402, Z01 HG000024] Funding Source: Medline; NHLBI NIH HHS [N01 HC045204, N01HC95164, R21 HL123677, R01 HL087641, HHSN268201100009C, N02HL64278, R01 HL087679, R01 HL087652, RC1 HL100245, R01 HL105756, N01HC95166, HHSN268201100006C, U01 HL072515, R01 HL071025, N01HC85081, R01 HL109946, T32 HL007902, R01 HL036310, U01 HL096917, RC2 HL101834, HHSN268201100010C, N01HC85082, R01 HL098283, U01 HL054497, R01 HL077477, N01 HC055018, R01 HL055673, U01 HL054495, R01 HL113933, N01HC95160, U01 HL054473, U01 HL054509, U01 HL054471, N01 HC035129, N01 HC045205, N01HC95162, R01 HL085251, U01 HL072518, R01 HL075366, R01 HL085144, N01 HC085084, U01 HL084756, R01 HL086694, N01 WH42114, N01HC55016, R01 HL093328, N01 HC045134, N01HC95168, R01 HL074166, U01 HL054496, R01 HL109512, HHSN268201100008C, R01 HL087660, R01 HL103612, R01 HL087698, HHSN268201100011C, N01 HC055015, R01 HL122684, N01 HC055019, HHSN268201200036C, N01 HC005187, N01HC65226, HHSN268201100007C, N01HC95161, N01HC95169, R01 HL088119, U01 HL080295, R01 HL087647, N01 HC048049, N01HC85080, N01 HC048050, N01HC55020, R01 HL120393, N01 HC048048, N01 HC048047, U01 HL054472, N01HC85083, N01 HC045133, R01 HL046380, N01HC95159, N01HC95167, N01HC95163, N01HC85086, N01 HC015103, R01 HL053353, HHSN268201100012C, R01 HL059367, N01 HC095095, R01 HL080295, N01HC85079, N01HC55021, N01HC75150, R01 HL093029, K23 HL080025, N01 HC085085, R01 HL043851, K24 HL004334, N01HC25195, R01 HL080467, U01 HL069757, T32 HL098049, HHSN268201100005C, K99 HL094535, N01HC55222, N01WH32102, N01HC95165, T32 HL007208, R01 HL059684] Funding Source: Medline; NIA NIH HHS [N01 AG062101, R01 AG010175, ZIA AG007380, T32 AG000219, N01 AG062106, R01 AG027058, R01 AG028555, R01 AG032098, R01 AG013196, R01 AG025941, R01 AG020098, R01 AG018728, Z01 AG000513, N01 AG012100, R01 AG015928, R01 AG023629, N01AG12109, R01 AG016592, N01 AG062103, HHSN271201200022C] Funding Source: Medline; NICHD NIH HHS [R03 HD062783, R03 HD061437, P2C HD050924] Funding Source: Medline; NIDDK NIH HHS [P30 DK072488, R01 DK079888, P30 DK020572, R01 DK062370, P30 DK063491, R01 DK078150, R01 DK072193, R01 DK054261, R01 DK093757, R01 DK101478, P60 DK079637, R01 DK084350, P30 DK056350, U01 DK062370] Funding Source: Medline; NIEHS NIH HHS [P30 ES010126, P30 ES007033] Funding Source: Medline; NIGMS NIH HHS [S06 GM008016, U01 GM074518] Funding Source: Medline; NIH HHS [N01 WH42124] Funding Source: Medline; NIMH NIH HHS [RL1 MH083268, RC2 MH089951, R01 MH063706] Funding Source: Medline; NINDS NIH HHS [U01 NS041588, R21 NS064908] Funding Source: Medline; Wellcome Trust [085475/B/08/Z, 081917/Z/07/Z, 084723/Z/08/Z, WT098017, 090532/Z/09/Z, 098051, 068545/Z/02] Funding Source: Medline; Chief Scientist Office Funding Source: Medline; WHI NIH HHS [N01 WH042122, N01WH32100, N01WH32109, N01 WH042111, N01 WH042121, N01 WH032119, N01WH22110, N01 WH042110, N01 WH032105, N01 WH042112, N01 WH042107, N01 WH042115, N01 WH042125, N01 WH042130, N01 WH044221, N01WH42108, N01WH32112, N01WH24152, N01WH42113, N01 WH042120, N01WH32101, N01 WH042126, N01WH32115, N01 WH032118, N01 WH042123, N01 WH042132, N01 WH032122, N01WH32111, N01WH32106, N01 WH042129, N01 WH042118, N01 WH042119, N01 WH042109, N01WH32113, N01 WH042117, N01 WH042131, N01 WH042116, N01WH32108] Funding Source: Medline; MRC [MR/N005813/1, MR/L003120/1, MR/N015746/1, G0601966, MR/K013351/1, G0600705, MR/N003284/1, MC_U106179472, G0700931, MC_UU_12015/1, MC_PC_U127561128, MC_UU_12015/2, G0600237, MC_UU_12019/1, MC_UU_12013/5, G0601261, G1002319, MR/L01341X/1, MC_UU_12013/3] Funding Source: UKRI; Lundbeck Foundation [R190-2014-3904] Funding Source: researchfish; Medical Research Council [MC_U106179472, MC_UU_12015/2, MC_UU_12013/3, MC_CF023241, MR/N005813/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10052, NF-SI-0512-10113, NF-SI-0513-10059, NF-SI-0611-10170, NF-SI-0515-10091, NF-SI-0507-10228, NF-SI-0512-10019, NF-SI-0507-10267, NF-SI-0512-10114, NF-SI-0514-10027] Funding Source: researchfish; NNF Center for Basic Metabolic Research [Pers Group] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC005187, N01HC048048, N01HC045134, N01HC045133, N01HC055018, N01HC035129, N01HC095095, N01HC085085, N01HC055019, N01HC015103, N01HC048050, N01HC085084, N01HC048049, N01HC048047, N01HC055015] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD062783, R03HD061437] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R01TW005596, RC1TW008485, R01TW008288] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [UM1CA182913] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052, UL1RR025005, UL1RR024156, U54RR020278, P20RR020649, UL1RR033176, M01RR010284, UL1RR024975, UL1RR025774, M01RR000425, M01RR016500] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014684, ZIAEY000401, R01EY018246] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL054509, R43HL095160, R01HL059367, U01HL054495, R44HL095169, U01HL054496, RC2HL101834, R01HL036310, T32HL098049, RC1HL100245, ZIAHL006170, R01HL109512, K99HL094535, T32HL007208, K24HL004334, R01HL086694, R01HL085251, R01HL085144, R01HL074166, R01HL120393, U01HL054471, U01HL054497, R01HL109946, R01HL087660, R01HL080295, R01HL105756, R01HL087698, R13HL095166, U01HL084756, R43HL095161, R43HL095169, R01HL087647, R01HL043851, R01HL080467, R01HL087652, R01HL053353, U01HL080295, U01HL072518, R01HL095163, N01WH32102, R01HL071025, R01HL059684, R01HL098283, U01HL069757, R01HL093328, R21HL123677, U01HL072515, R01HL075366, K23HL080025, R01HL055673, R01HL093029, R01HL113933, U01HL054472, U01HL096917, R21HL095165, T32HL007902, R01HL087641, R01HL103612, R01HL065226, R01HL046380, R01HL122684, R01HL085083, R01HL064278, R01HL087679, ZIAHL006001, U01HL054473, R43HL095167, R01HL088119] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000024, U01HG004402, U01HG007416, N01HG065403, Z01HG200362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062370, R01DK072193, P30DK056350, P30DK020572, R01DK079888, P60DK079637, R01DK078150, R01DK101478, R01DK054261, R01DK062370, P30DK063491, R01DK084350, P30DK072488, R01DK093757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, P30ES007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008016, U01GM074518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268, RC2MH089951, R01MH063706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588, R21NS064908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027058, N01AG062106, N01AG062101, R01AG015928, ZIAAG000799, R01AG032098, N01AG062103, R01AG010175, R01AG013196, R01AG028555, R01AG020098, T32AG000219, N01AG012100, R01AG023629, ZIAAG007380, R01AG025941, R01AG016592, R01AG018728, Z01AG000513] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH032118, N01WH042129, N01WH032109, N01WH042112, N01WH042117, N01WH042107, N01WH042125, N01WH042109, N01WH042118, N01WH032111, N01WH042123, N01WH032112, N01WH022110, N01WH042115, N01WH042119, N01WH032105, N01WH032108, N01WH042122, N01WH042113, N01WH042111, N01WH042131, N01WH042108, N01WH032122, N01WH042110, N01WH042130, N01WH032115, N01WH042126, N01WH032100, N01WH032113, N01WH042120, N01WH042132, N01WH032106, N01WH032119, N01WH042121, N01WH032101, N01WH042116] Funding Source: NIH RePORTER	Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust); Chief Scientist Office; WHI NIH HHS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Coffman TM, 2008, HYPERTENSION, V51, P811, DOI 10.1161/HYPERTENSIONAHA.105.063636; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Erdmann J, 2013, NATURE, V504, P432, DOI 10.1038/nature12722; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Franceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010; Ganesh SK, 2014, AM J HUM GENET, V95, P49, DOI 10.1016/j.ajhg.2014.06.002; Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; HIRATA Y, 1995, HYPERTENSION, V25, P790, DOI 10.1161/01.HYP.25.4.790; Johnson T, 2011, AM J HUM GENET, V89, P688, DOI 10.1016/j.ajhg.2011.10.013; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Kimber CH, 2007, DIABETOLOGIA, V50, P1186, DOI 10.1007/s00125-007-0661-9; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lifton RP, 2009, GENETIC DISEASES OF THE KIDNEY, P1; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; MIALL WE, 1963, BRIT MED J, P75; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Simino J, 2014, AM J HUM GENET, V95, P24, DOI 10.1016/j.ajhg.2014.05.010; Stergachis AB, 2014, NATURE, V515, P365, DOI 10.1038/nature13972; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Tragante V, 2014, AM J HUM GENET, V94, P349, DOI 10.1016/j.ajhg.2013.12.016; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Wang Y, 2009, P NATL ACAD SCI USA, V106, P226, DOI 10.1073/pnas.0808358106; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	40	254	258	0	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1171	1184		10.1038/ng.3667	http://dx.doi.org/10.1038/ng.3667			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27618452	Green Submitted, Green Accepted, Green Published			2022-12-17	WOS:000384391600012
J	Kupper, C; Stocks, M; Risse, JE; dos Remedios, N; Farrell, LL; Mcrae, SB; Morgan, TC; Karlionova, N; Pinchuk, P; Verkuil, YI; Kitaysky, AS; Wingfield, JC; Piersma, T; Zeng, K; Slate, J; Blaxter, M; Lank, DB; Burke, T				Kuepper, Clemens; Stocks, Michael; Risse, Judith E.; dos Remedios, Natalie; Farrell, Lindsay L.; Mcrae, Susan B.; Morgan, Tawna C.; Karlionova, Natalia; Pinchuk, Pavel; Verkuil, Yvonne I.; Kitaysky, Alexander S.; Wingfield, John C.; Piersma, Theunis; Zeng, Kai; Slate, Jon; Blaxter, Mark; Lank, David B.; Burke, Terry			A supergene determines highly divergent male reproductive morphs in the ruff	NATURE GENETICS			English	Article							PHILOMACHUS-PUGNAX; LINKAGE MAP; MATING STRATEGIES; EVOLUTION; LEKKING; DISCOVERY; PLUMAGE; MODEL; RECONSTRUCTION; REARRANGEMENTS	Three strikingly different alternative male mating morphs (aggressive 'independents', semicooperative 'satellites' and female-mimic 'faeders') coexist as a balanced polymorphism in the ruff, Philomachus pugnax, a lek-breeding wading bird(1-3). Major differences in body size, ornamentation, and aggressive and mating behaviors are inherited as an autosomal polymorphism(4,5). We show that development into satellites and faeders is determined by a supergene(6-8) consisting of divergent alternative, dominant and non-recombining haplotypes of an inversion on chromosome 11, which contains 125 predicted genes. Independents are homozygous for the ancestral sequence. One breakpoint of the inversion disrupts the essential CENP-N gene (encoding centromere protein N), and pedigree analysis confirms the lethality of homozygosity for the inversion. We describe new differences in behavior, testis size and steroid metabolism among morphs and identify polymorphic genes within the inversion that are likely to contribute to the differences among morphs in reproductive traits.	[Kuepper, Clemens; Stocks, Michael; dos Remedios, Natalie; Farrell, Lindsay L.; Zeng, Kai; Slate, Jon; Burke, Terry] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Kuepper, Clemens] Graz Univ, Inst Zool, A-8010 Graz, Austria; [Risse, Judith E.; Blaxter, Mark] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh Genom, Edinburgh, Midlothian, Scotland; [Farrell, Lindsay L.; Morgan, Tawna C.; Lank, David B.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Mcrae, Susan B.] E Carolina Univ, Dept Biol, Greenville, NC USA; [Morgan, Tawna C.; Kitaysky, Alexander S.] Univ Alaska, Inst Arctic Biol, Dept Biol & Wildlife, Fairbanks, AK 99775 USA; [Karlionova, Natalia; Pinchuk, Pavel] Sci & Pract Ctr Bioresources, Minsk, BELARUS; [Verkuil, Yvonne I.; Piersma, Theunis] Groningen Inst Evolutionary Life Sci, Conservat Ecol Grp, Groningen, Netherlands; [Wingfield, John C.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Piersma, Theunis] Royal Netherlands Inst Sea Res NIOZ, Dept Marine Ecol, Den Burg, Netherlands	University of Sheffield; University of Graz; University of Edinburgh; Simon Fraser University; University of North Carolina; East Carolina University; University of Alaska System; University of Alaska Fairbanks; National Academy of Sciences of Belarus (NASB); Scientific & Practical Center for Bioresources of the National Academy of Sciences of Belarus; University of California System; University of California Davis; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Burke, T (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	mark.blaxter@ed.ac.uk; dlank@sfu.ca; t.a.burke@sheffield.ac.uk	Blaxter, Mark L/B-4113-2010; McRae, Susan/L-7273-2019; Burke, Terry/B-3196-2011; Slate, Jon/D-2925-2012; Blaxter, Mark/O-2535-2019; Verkuil, Yvonne I./ABH-4507-2020; Küpper, Clemens/D-8116-2011; Stocks, Michael/P-5417-2014	Blaxter, Mark L/0000-0003-2861-949X; McRae, Susan/0000-0003-3209-4710; Burke, Terry/0000-0003-3848-1244; Slate, Jon/0000-0003-3356-5123; Verkuil, Yvonne I./0000-0001-7080-3026; Küpper, Clemens/0000-0002-1507-8033; dos Remedios, Natalie/0000-0002-5412-4039; Lank, David/0000-0002-2670-5143; Piersma, Theunis/0000-0001-9668-466X; Stocks, Michael/0000-0003-3344-6036	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J0189371]; Natural Sciences and Engineering Research Council of Canada (NSERC); H.F. Guggenheim Foundation; National Geographic Society; US National Science Foundation (NSF); European Union (EU) Marie Curie fellowship; NSF Experimental Program to Stimulate Competitive Research (EPSCoR) program at the University of Alaska, Fairbanks; BBSRC [BB/J018791/1, BB/J018937/1, BB/K020161/1, BB/G00661X/1] Funding Source: UKRI; MRC [MR/K001744/1, G0900740] Funding Source: UKRI; NERC [NBAF010003, NE/L005328/1, NBAF010001] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K020161/1, BB/G00661X/1, BB/J018791/1, BB/J018937/1] Funding Source: researchfish; Medical Research Council [MR/K001744/1, G0900740] Funding Source: researchfish; Natural Environment Research Council [NBAF010001, NE/L005328/1, NBAF010003] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); H.F. Guggenheim Foundation; National Geographic Society(National Geographic Society); US National Science Foundation (NSF)(National Science Foundation (NSF)); European Union (EU) Marie Curie fellowship; NSF Experimental Program to Stimulate Competitive Research (EPSCoR) program at the University of Alaska, Fairbanks; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the laboratory and bioinformatics staff at Edinburgh Genomics at the University of Edinburgh for Illumina sequencing and the Lausanne Genomic Technology Facility for PacBio sequencing. This work was supported by a grant to T.B., J.S. and M.B. from the UK Biotechnology and Biological Sciences Research Council (BBSRC; BB/J0189371), by grants to D.B.L. from the Natural Sciences and Engineering Research Council of Canada (NSERC), by the H.F. Guggenheim Foundation, the National Geographic Society and the US National Science Foundation (NSF), and by a European Union (EU) Marie Curie fellowship to C.K. The Simon Fraser University Work-Study program facilitated the maintenance of the captive population since 1993. Hormone work was supported by the NSF Experimental Program to Stimulate Competitive Research (EPSCoR) program at the University of Alaska, Fairbanks.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aslam ML, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-647; Atit R, 2003, DEV CELL, V4, P231, DOI 10.1016/S1534-5807(03)00021-2; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bunney TD, 2011, TRENDS BIOCHEM SCI, V36, P88, DOI 10.1016/j.tibs.2010.08.003; Campbell M.S., 2002, CURR PROTOC BIOINFOR, V48; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Chikhi R, 2014, BIOINFORMATICS, V30, P31, DOI 10.1093/bioinformatics/btt310; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Corbett-Detig RB, 2012, GENETICS, V192, P131, DOI 10.1534/genetics.112.141622; Dale J, 2001, AM NAT, V158, P75, DOI 10.1086/320861; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ekblom R, 2012, ECOL EVOL, V2, P2485, DOI 10.1002/ece3.370; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; Farrell LL, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-109; Farrell LL, 2012, CONSERV GENET RESOUR, V4, P763, DOI 10.1007/s12686-012-9639-0; Goymann W, 2004, ANIM BEHAV, V68, P733, DOI 10.1016/j.anbehav.2003.12.012; Groenen MAM, 2000, GENOME RES, V10, P137; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hoelzel A.R., 1998, ANAL POPULATIONS PRA, P287; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; HOGANWAR.AJ, 1966, ARDEA, V54, P109; HOGLUND J, 1989, AUK, V106, P336; Horton BM, 2014, P NATL ACAD SCI USA, V111, P1443, DOI 10.1073/pnas.1317165111; Hugie DM, 1997, BEHAV ECOL, V8, P218, DOI 10.1093/beheco/8.2.218; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Jukema J, 2006, BIOL LETTERS, V2, P161, DOI 10.1098/rsbl.2005.0416; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kawakami T, 2014, MOL ECOL, V23, P4035, DOI 10.1111/mec.12810; Kirkpatrick M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000501; Knapp R, 2007, BIOL LETTERS, V3, P628, DOI 10.1098/rsbl.2007.0379; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Lamichhaney S, 2016, NAT GENET, V48, P84, DOI 10.1038/ng.3430; Lank DB, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0653; Lank DB, 1999, P ROY SOC B-BIOL SCI, V266, P2323, DOI 10.1098/rspb.1999.0926; LANK DB, 1995, NATURE, V378, P59, DOI 10.1038/378059a0; Lank DB, 2002, BEHAV ECOL, V13, P209, DOI 10.1093/beheco/13.2.209; LANK DB, 1987, BEHAV ECOL SOCIOBIOL, V20, P137, DOI 10.1007/BF00572636; Lank DB, 2001, AUK, V118, P759, DOI 10.1642/0004-8038(2001)118[0759:VSFIIT]2.0.CO;2; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Maney DL, 2008, GEN COMP ENDOCR, V157, P275, DOI 10.1016/j.ygcen.2008.03.023; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mindnich R, 2004, MOL CELL ENDOCRINOL, V218, P7, DOI 10.1016/j.mce.2003.12.006; Morgan T, 2006, THESIS; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Oliveira RF, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P1, DOI 10.1017/CBO9780511542602; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pedram A, 2012, MOL BIOL CELL, V23, P188, DOI 10.1091/mbc.E11-07-0638; Piersma T, 2005, ARDEA, V93, P49; Roberts RB, 2009, SCIENCE, V326, P998, DOI 10.1126/science.1174705; Shuster S. M., 2003, MG BEH ECOL; SHUSTER SM, 1991, NATURE, V350, P608, DOI 10.1038/350608a0; Simpson J.T., 2013, EXPLORING GENOME CHA; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Stonor CR, 1937, P ZOOL SOC LOND A-GE, V107, P85; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; van Oers K, 2014, HEREDITY, V112, P307, DOI 10.1038/hdy.2013.107; Van Rhijn J.G., 1991, THE RUFF; van Rhijn J, 2014, ARDEA, V102, P5, DOI 10.5253/078.102.0103; Wang J, 2013, HEREDITY, V111, P165, DOI 10.1038/hdy.2013.34; Wang J, 2013, NATURE, V493, P664, DOI 10.1038/nature11832; Widemo F, 1998, ANIM BEHAV, V56, P329, DOI 10.1006/anbe.1998.0792; WINGFIELD JC, 1975, STEROIDS, V26, P311, DOI 10.1016/0039-128X(75)90077-X	74	254	258	3	144	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2016	48	1					79	+		10.1038/ng.3443	http://dx.doi.org/10.1038/ng.3443			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CZ7BQ	26569125	hybrid, Green Submitted, Green Published, Green Accepted			2022-12-17	WOS:000367255300017
J	Lorenzo, FR; Huff, C; Myllymaki, M; Olenchock, B; Swierczek, S; Tashi, T; Gordeuk, V; Wuren, T; Ri-Li, G; McClain, DA; Khan, TM; Koul, PA; Guchhait, P; Salama, ME; Xing, JC; Semenza, GL; Liberzon, E; Wilson, A; Simonson, TS; Jorde, LB; Kaelin, WG; Koivunen, P; Prchal, JT				Lorenzo, Felipe R.; Huff, Chad; Myllymaki, Mikko; Olenchock, Benjamin; Swierczek, Sabina; Tashi, Tsewang; Gordeuk, Victor; Wuren, Tana; Ri-Li, Ge; McClain, Donald A.; Khan, Tahsin M.; Koul, Parvaiz A.; Guchhait, Prasenjit; Salama, Mohamed E.; Xing, Jinchuan; Semenza, Gregg L.; Liberzon, Ella; Wilson, Andrew; Simonson, Tatum S.; Jorde, Lynn B.; Kaelin, William G., Jr.; Koivunen, Peppi; Prchal, Josef T.			A genetic mechanism for Tibetan high-altitude adaptation	NATURE GENETICS			English	Article							HYPOXIA-INDUCIBLE FACTOR; HYDROXYLASE DOMAIN PROTEIN-2; OXYGEN SENSING PATHWAY; FACTOR-I; PROLYL 4-HYDROXYLASES; ERYTHROCYTOSIS; IDENTIFICATION; POLYCYTHEMIA; HOMEOSTASIS; MUTATION	Tibetans do not exhibit increased hemoglobin concentration at high altitude. We describe a high-frequency missense mutation in the EGLN1 gene, which encodes prolyl hydroxylase 2 (PHD2), that contributes to this adaptive response. We show that a variant in EGLN1, c.[12C>G; 380G>C], contributes functionally to the Tibetan high-altitude phenotype. PHD2 triggers the degradation of hypoxia-inducible factors (HIFs), which mediate many physiological responses to hypoxia, including erythropoiesis. The PHD2 p.[Asp4Glu; Cys127Ser] variant exhibits a lower Km value for oxygen, suggesting that it promotes increased HIF degradation under hypoxic conditions. Whereas hypoxia stimulates the proliferation of wild-type erythroid progenitors, the proliferation of progenitors with the c.[12C>G; 380G>C] mutation in EGLN1 is significantly impaired under hypoxic culture conditions. We show that the c.[12C>G; 380G>C] mutation originated similar to 8,000 years ago on the same haplotype previously associated with adaptation to high altitude. The c.[12C>G; 380G>C] mutation abrogates hypoxia-induced and HIF-mediated augmentation of erythropoiesis, which provides a molecular mechanism for the observed protection of Tibetans from polycythemia at high altitude.	[Lorenzo, Felipe R.; Swierczek, Sabina; Tashi, Tsewang; McClain, Donald A.; Prchal, Josef T.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84112 USA; [Lorenzo, Felipe R.; Swierczek, Sabina; Tashi, Tsewang; McClain, Donald A.; Prchal, Josef T.] Geoger E Wahlin Vet Adm Med Ctr, Salt Lake City, UT USA; [Huff, Chad; Xing, Jinchuan; Simonson, Tatum S.; Jorde, Lynn B.; Prchal, Josef T.] Univ Utah, Sch Med, Eccles Inst Human Genet, Salt Lake City, UT USA; [Huff, Chad] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Myllymaki, Mikko; Koivunen, Peppi] Univ Oulu, Fac Biochem & Mol Med, Oulu Ctr Cell Matrix Res, Bioctr Oulu, Oulu, Finland; [Olenchock, Benjamin] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Cardiovasc Med, Boston, MA USA; [Gordeuk, Victor] Univ Illinois, Sickle Cell Ctr, Chicago, IL USA; [Wuren, Tana; Ri-Li, Ge] Qinghai Univ, Res Ctr High Altitude Med, Xining, Peoples R China; [Khan, Tahsin M.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Koul, Parvaiz A.] Sherikashmir Inst Med Sci, Srinagar, Jammu & Kashmir, India; [Guchhait, Prasenjit] Reg Ctr Biotechnol, Gurgaon, India; [Salama, Mohamed E.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Salama, Mohamed E.] ARUP Labs, Salt Lake City, UT USA; [Xing, Jinchuan] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vascr Program, Baltimore, MD USA; [Liberzon, Ella; Kaelin, William G., Jr.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Liberzon, Ella] Howard Hughes Med Inst, Chevy Chase, MD USA; [Wilson, Andrew] Univ Utah, Sch Med, Dept Family & Prevent Med, Salt Lake City, UT 84112 USA; [Simonson, Tatum S.] Univ Calif San Diego, Sch Med, Div Physiol, La Jolla, CA 92093 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Texas System; UTMD Anderson Cancer Center; University of Oulu; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Qinghai University; Icahn School of Medicine at Mount Sinai; Sher-i-Kashmir Institute of Medical Sciences; Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; Rutgers State University New Brunswick; Johns Hopkins University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; University of California System; University of California San Diego	Prchal, JT (corresponding author), Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84112 USA.	josef.prchal@hsc.utah.edu	Koul, Parvaiz/B-1666-2017; Koul, Parvaiz/AAS-8828-2021; Gordeuk, Victor/AAG-6577-2019; Koul, Parvaiz/AFK-7442-2022	Koul, Parvaiz/0000-0002-1700-9285; Koul, Parvaiz/0000-0002-1700-9285; Koul, Parvaiz/0000-0002-1700-9285; Wilson, Andrew/0000-0003-3679-9232; McClain, Don/0000-0002-3310-2359; Myllymaki, Mikko/0000-0002-8194-7356	Academy of Finland [120156, 140765, 218129]; S. Juselius Foundation; Finnish Cultural Foundation; Finnish Cancer Organizations; US National Institutes of Health (NIH) [HL119355-01, P01CA108671, HL098062]; National Human Genome Research Institute [HG005846]; National Basic Research Program of China [2012CB518200]; Program of International Science and Technology Cooperation of China [2011DFA32720]; University of Utah; Johns Hopkins Institute for Cell Engineering; NATIONAL CANCER INSTITUTE [P01CA108671] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001067] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL119355, R00HL118215, T32HL098062] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K99HG005846, R00HG005846] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001140] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); S. Juselius Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Cancer Organizations; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Basic Research Program of China(National Basic Research Program of China); Program of International Science and Technology Cooperation of China; University of Utah; Johns Hopkins Institute for Cell Engineering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Veterans Affairs(US Department of Veterans Affairs)	P.K. is supported by Academy of Finland grants 120156, 140765 and 218129, the S. Juselius Foundation, the Finnish Cultural Foundation and the Finnish Cancer Organizations. B.O. is supported by US National Institutes of Health (NIH) Mentored Career Development Award HL119355-01. J.X. is supported by the National Human Genome Research Institute (HG005846). G.R.-L. is supported by the National Basic Research Program of China (grant 2012CB518200) and by the Program of International Science and Technology Cooperation of China (grant 2011DFA32720). S.S. is supported by US NIH grant P01CA108671. T.S.S. is supported by the US NIH T32 Postdoctoral Fellowship HL098062. L.B.J. is supported by the University of Utah Seed Grant Program for studies of hypoxic adaptation. G.L.S. is supported by the Johns Hopkins Institute for Cell Engineering. J.T.P. is supported by US NIH grant P01CA108671, a Veterans Affairs Merit Review Award and the University of Utah Seed Grant Program for studies of hypoxic adaptation.	Aggarwal S, 2010, P NATL ACAD SCI USA, V107, P18961, DOI 10.1073/pnas.1006108107; Albiero E, 2012, HAEMATOL-HEMATOL J, V97, P123, DOI 10.3324/haematol.2010.039545; Albiero E, 2011, BRIT J HAEMATOL, V153, P405, DOI 10.1111/j.1365-2141.2010.08551.x; Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Ang SO, 2002, BLOOD CELL MOL DIS, V28, P57, DOI 10.1006/bcmd.2002.0488; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bigham Abigail W., 2009, Human Genomics, V4, P79; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cipolleschi MG, 1997, EXP HEMATOL, V25, P1187; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Ge RL, 2012, MOL GENET METAB, V106, P244, DOI 10.1016/j.ymgme.2012.03.003; Goldstein D. B., 1999, MICROSATELLITES EVOL, V368; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Huff CD, 2012, MOL BIOL EVOL, V29, P101, DOI 10.1093/molbev/msr151; Huff CD, 2011, GENOME RES, V21, P768, DOI 10.1101/gr.115972.110; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Koivunen P, 2006, J BIOL CHEM, V281, P28712, DOI 10.1074/jbc.M604628200; Ladroue C, 2012, HAEMATOL-HEMATOL J, V97, P9, DOI 10.3324/haematol.2011.044644; LOEFFLER M, 1984, BLUT, V49, P427, DOI 10.1007/BF00320485; Lorenzo F.R., 2010, ASH 52 ANN M; Percy MJ, 2007, BLOOD, V110, P2193, DOI 10.1182/blood-2007-04-084434; Percy Melanie J, 2008, Ulster Med J, V77, P86; Percy MJ, 2012, AM J HEMATOL, V87, P439, DOI 10.1002/ajh.23123; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Prabhakar NR, 2012, PHYSIOL REV, V92, P967, DOI 10.1152/physrev.00030.2011; Prchal J.T., 2010, SECONDARY POLYCYTHEM, P823; Prchal J.T., 2010, PRODUCTION ERYTHROCY; Simonson TS, 2012, HUM GENET, V131, P527, DOI 10.1007/s00439-011-1109-3; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Swierczek SI, 2012, BLOOD, V119, pE100, DOI 10.1182/blood-2011-11-390351; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1993, J BIOL CHEM, V268, P21513; Xing JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003634; Xing JC, 2010, GENOMICS, V96, P199, DOI 10.1016/j.ygeno.2010.07.004; Xing JC, 2009, GENOME RES, V19, P815, DOI 10.1101/gr.085589.108; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yoon D, 2006, J BIOL CHEM, V281, P25703, DOI 10.1074/jbc.M602329200; Yoon D, 2011, AM J PHYSIOL-CELL PH, V300, pC1215, DOI 10.1152/ajpcell.00044.2011	42	254	274	3	127	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2014	46	9					951	+		10.1038/ng.3067	http://dx.doi.org/10.1038/ng.3067			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO8CE	25129147	Green Accepted			2022-12-17	WOS:000341579400008
J	Bradfield, JP; Taal, HR; Timpson, NJ; Scherag, A; Lecoeur, C; Warrington, NM; Hypponen, E; Holst, C; Valcarcel, B; Thiering, E; Salem, RM; Schumacher, FR; Cousminer, DL; Sleiman, PMA; Zhao, JH; Berkowitz, RI; Vimaleswaran, KS; Jarick, I; Pennell, CE; Evans, DM; St Pourcain, B; Berry, DJ; Mook-Kanamori, DO; Hofman, A; Rivadeneira, F; Uitterlinden, AG; van Duijn, CM; van der Valk, RJP; de Jongste, JC; Postma, DS; Boomsma, DI; Gauderman, WJ; Hassanein, MT; Lindgren, CM; Magi, R; Boreham, CAG; Neville, CE; Moreno, LA; Elliott, P; Pouta, A; Hartikainen, AL; Li, MY; Raitakari, O; Lehtimaki, T; Eriksson, JG; Palotie, A; Dallongeville, J; Das, S; Deloukas, P; McMahon, G; Ring, SM; Kemp, JP; Buxton, JL; Blakemore, AIF; Bustamante, M; Guxens, M; Hirschhorn, JN; Gillman, MW; Kreiner-Moller, E; Bisgaard, H; Gilliland, FD; Heinrich, J; Wheeler, E; Barroso, I; O'Rahilly, S; Meirhaeghe, A; Sorensen, TIA; Power, C; Palmer, LJ; Hinney, A; Widen, E; Farooqi, IS; McCarthy, MI; Froguel, P; Meyre, D; Hebebrand, J; Jarvelin, MR; Jaddoe, VWV; Smith, GD; Hakonarson, H; Grant, SFA				Bradfield, Jonathan P.; Taal, H. Rob; Timpson, Nicholas J.; Scherag, Andre; Lecoeur, Cecile; Warrington, Nicole M.; Hypponen, Elina; Holst, Claus; Valcarcel, Beatriz; Thiering, Elisabeth; Salem, Rany M.; Schumacher, Fredrick R.; Cousminer, Diana L.; Sleiman, Patrick M. A.; Zhao, Jianhua; Berkowitz, Robert I.; Vimaleswaran, Karani S.; Jarick, Ivonne; Pennell, Craig E.; Evans, David M.; St Pourcain, Beate; Berry, Diane J.; Mook-Kanamori, Dennis O.; Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.; van Duijn, Cornelia M.; van der Valk, Ralf J. P.; de Jongste, Johan C.; Postma, Dirkje S.; Boomsma, Dorret I.; Gauderman, W. James; Hassanein, Mohamed T.; Lindgren, Cecilia M.; Magi, Reedik; Boreham, Colin A. G.; Neville, Charlotte E.; Moreno, Luis A.; Elliott, Paul; Pouta, Anneli; Hartikainen, Anna-Liisa; Li, Mingyao; Raitakari, Olli; Lehtimaki, Terho; Eriksson, Johan G.; Palotie, Aarno; Dallongeville, Jean; Das, Shikta; Deloukas, Panos; McMahon, George; Ring, Susan M.; Kemp, John P.; Buxton, Jessica L.; Blakemore, Alexandra I. F.; Bustamante, Mariona; Guxens, Monica; Hirschhorn, Joel N.; Gillman, Matthew W.; Kreiner-Moller, Eskil; Bisgaard, Hans; Gilliland, Frank D.; Heinrich, Joachim; Wheeler, Eleanor; Barroso, Ines; O'Rahilly, Stephen; Meirhaeghe, Aline; Sorensen, Thorkild I. A.; Power, Chris; Palmer, Lyle J.; Hinney, Anke; Widen, Elisabeth; Farooqi, I. Sadaf; McCarthy, Mark I.; Froguel, Philippe; Meyre, David; Hebebrand, Johannes; Jarvelin, Marjo-Riitta; Jaddoe, Vincent W. V.; Smith, George Davey; Hakonarson, Hakon; Grant, Struan F. A.		Early Growth Genetics EGG Consorti	A genome-wide association meta-analysis identifies new childhood obesity loci	NATURE GENETICS			English	Article							BODY-MASS INDEX; HELICOBACTER-PYLORI; PREVENTION; OVERWEIGHT; BMI	Multiple genetic variants have been associated with adult obesity and a few with severe obesity in childhood; however, less progress has been made in establishing genetic influences on common early-onset obesity. We performed a North American, Australian and European collaborative meta-analysis of 14 studies consisting of 5,530 cases (>= 95th percentile of body mass index (BMI)) and 8,318 controls (<50th percentile of BMI) of European ancestry. Taking forward the eight newly discovered signals yielding association with P < 5 x 10(-6) in nine independent data sets (2,818 cases and 4,083 controls), we observed two loci that yielded genome-wide significant combined P values near OLFM4 at 13q14 (rs9568856; P = 1.82 x 10(-9); odds ratio (OR) = 1.22) and within HOXB5 at 17q21 (rs9299; P = 3.54 x 10(-9); OR = 1.14). Both loci continued to show association when two extreme childhood obesity cohorts were included (2,214 cases and 2,674 controls). These two loci also yielded directionally consistent associations in a previous metaanalysis of adult BMI1.	[Bradfield, Jonathan P.; Sleiman, Patrick M. A.; Hakonarson, Hakon; Grant, Struan F. A.] Childrens Hosp Philadelphia, Ctr Appl Genom, Abramson Res Ctr, Philadelphia, PA 19104 USA; [Taal, H. Rob; Mook-Kanamori, Dennis O.; Hofman, Albert; van der Valk, Ralf J. P.; de Jongste, Johan C.; Jaddoe, Vincent W. V.] Erasmus MC, Generat Study Grp R, Rotterdam, Netherlands; [Taal, H. Rob; Mook-Kanamori, Dennis O.; Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Jaddoe, Vincent W. V.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Taal, H. Rob; Mook-Kanamori, Dennis O.; Jaddoe, Vincent W. V.] Erasmus MC, Dept Pediat, Rotterdam, Netherlands; [Timpson, Nicholas J.; Evans, David M.; St Pourcain, Beate; Kemp, John P.; Smith, George Davey] Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Sch Social & Community Med, Bristol, Avon, England; [Scherag, Andre] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Lecoeur, Cecile; Froguel, Philippe; Meyre, David] Univ Lille Nord France, CNRS 8199, Inst Pasteur, Lille, France; [Warrington, Nicole M.; Pennell, Craig E.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Hypponen, Elina; Vimaleswaran, Karani S.; Berry, Diane J.; Power, Chris] UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, MRC Ctr Epidemiol Child Hlth, London, England; [Holst, Claus; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Valcarcel, Beatriz; Elliott, Paul; Das, Shikta; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC Hlth Protect Agcy HPA, Ctr Environm & Hlth,Sch Publ Hlth,Fac Med, London, England; [Thiering, Elisabeth; Heinrich, Joachim] German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Inst Epidemiol 1, Neuherberg, Germany; [Salem, Rany M.; Hirschhorn, Joel N.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Salem, Rany M.; Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Salem, Rany M.; Hirschhorn, Joel N.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Salem, Rany M.; Hirschhorn, Joel N.] Broad Inst, Metab Program, Cambridge, MA USA; [Salem, Rany M.; Hirschhorn, Joel N.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Salem, Rany M.; Palotie, Aarno; Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Schumacher, Fredrick R.; Gauderman, W. James; Hassanein, Mohamed T.; Gilliland, Frank D.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Cousminer, Diana L.; Palotie, Aarno; Widen, Elisabeth] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Sleiman, Patrick M. A.; Zhao, Jianhua; Hakonarson, Hakon; Grant, Struan F. A.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Sleiman, Patrick M. A.; Hakonarson, Hakon; Grant, Struan F. A.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Berkowitz, Robert I.] Childrens Hosp Philadelphia, Dept Child & Adolescent Psychiat & Behav Sci, Philadelphia, PA 19104 USA; [Berkowitz, Robert I.] Univ Penn, Dept Psychiat, Perelman Sch Med, Ctr Weight & Eating Disorders, Philadelphia, PA 19104 USA; [Jarick, Ivonne] Univ Marburg, Inst Med Biometry & Epidemiol, Marburg, Germany; [Mook-Kanamori, Dennis O.] Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Doha, Qatar; [Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [van der Valk, Ralf J. P.] Univ Groningen, Dept Pediat Pulmonol & Pediat Allergol, Beatrix Childrens Hosp, Univ Med Ctr Groningen,GRIAC,Res Inst, Groningen, Netherlands; [van der Valk, Ralf J. P.; de Jongste, Johan C.] Erasmus Univ, Div Resp Med, Dept Pediat, Med Ctr,Sophia Childrens Hosp, Rotterdam, Netherlands; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Med & TB, GRIAC Res Inst, Groningen, Netherlands; [Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Lindgren, Cecilia M.; Magi, Reedik] Univ Oxford, Genet & Genom Epidemiol Unit, Wellcome Trust Ctr Human Genet, Oxford, England; [Magi, Reedik] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Boreham, Colin A. G.] Univ Coll Dublin, Inst Sport & Hlth, Dublin 2, Ireland; [Neville, Charlotte E.] Queens Univ Belfast, Ctr Publ Hlth, Inst Clin Sci B, Belfast, Antrim, North Ireland; [Moreno, Luis A.] Univ Zaragoza, Growth Exercise Nutr & Dev GENUD Res Grp, Zaragoza, Spain; [Moreno, Luis A.] Univ Zaragoza, Sch Hlth Sci EUCS, Zaragoza, Spain; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Lifecourse & Serv, Oulu, Finland; [Hartikainen, Anna-Liisa] Univ Oulu, Inst Clin Med Obstet & Gynecol, Oulu, Finland; [Li, Mingyao] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol, FIN-20520 Turku, Finland; [Raitakari, Olli] Univ Turku, Turku, Finland; [Lehtimaki, Terho] Tampere Univ Hosp, Dept Clin Chem, Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, FIN-33101 Tampere, Finland; [Eriksson, Johan G.] Natl Inst Hlth & Welf, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Palotie, Aarno; Deloukas, Panos; Wheeler, Eleanor; Barroso, Ines] Wellcome Trust Sanger Inst, Cambridge, England; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Palotie, Aarno] Univ Cent Hosp, Helsinki, Finland; [Dallongeville, Jean; Meirhaeghe, Aline] Univ Lille Nord France, INSERM, U744, Inst Pasteur Lille, Lille, France; [McMahon, George; Ring, Susan M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Buxton, Jessica L.; Blakemore, Alexandra I. F.] Univ London Imperial Coll Sci Technol & Med, Sect Integrat Med, London, England; [Bustamante, Mariona; Guxens, Monica] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Bustamante, Mariona; Guxens, Monica] Hosp Mar Res Inst IMIM, Barcelona, Spain; [Bustamante, Mariona; Guxens, Monica] Consorcio Invest Biomed Red CIBER Epidemiol & Sal, Barcelona, Spain; [Bustamante, Mariona] Ctr Genom Regulat CRG, Genes & Dis Program, Barcelona, Spain; [Bustamante, Mariona] Pompeu Fabra Univ UPF, Barcelona, Spain; [Gillman, Matthew W.] Harvard Univ, Dept Populat Med, Sch Med, Obes Prevent Program, Boston, MA USA; [Gillman, Matthew W.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Kreiner-Moller, Eskil; Bisgaard, Hans] Univ Copenhagen, Gentofte, Denmark; [Kreiner-Moller, Eskil; Bisgaard, Hans] Copenhagen Univ Hosp, Gentofte, Denmark; [Barroso, Ines; O'Rahilly, Stephen; Farooqi, I. Sadaf] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 2QQ, England; [Barroso, Ines; O'Rahilly, Stephen; Farooqi, I. Sadaf] Addenbrookes Hosp, NIHR, Cambridge Biomed Res Ctr, Inst Metab Sci, Cambridge, England; [Sorensen, Thorkild I. A.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, Copenhagen, Denmark; [Palmer, Lyle J.] Ontario Inst Canc Res, Toronto, ON, Canada; [Palmer, Lyle J.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Hinney, Anke; Hebebrand, Johannes] Univ Duisburg Essen, Dept Child & Adolescent Psychiat, Essen, Germany; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, London, England; [Meyre, David] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Hakonarson, Hakon; Grant, Struan F. A.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Bristol; University of Duisburg Essen; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Western Australia; University of London; University College London; University of Copenhagen; Imperial College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of Southern California; University of Helsinki; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Philipps University Marburg; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Erasmus University Rotterdam; Erasmus MC; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; University of Groningen; Vrije Universiteit Amsterdam; University of Oxford; Wellcome Centre for Human Genetics; University of Tartu; University College Dublin; Queens University Belfast; University of Zaragoza; University of Zaragoza; Finland National Institute for Health & Welfare; University of Oulu; University of Pennsylvania; University of Turku; University of Turku; Tampere University; Tampere University Hospital; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Wellcome Trust Sanger Institute; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Bristol; Imperial College London; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Copenhagen; University of Copenhagen; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Novo Nordisk Foundation; University of Copenhagen; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Duisburg Essen; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Imperial College London; McMaster University; University of Oulu; University of Oulu; University of Pennsylvania; Pennsylvania Medicine	Grant, SFA (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Abramson Res Ctr, Philadelphia, PA 19104 USA.	grants@chop.edu	FROGUEL, Philippe/O-6799-2017; Kronow, Joern/B-1054-2011; Raitakari, Olli/AAQ-7389-2021; Palmer, Lyle John/K-3196-2014; Palmer, Lyle John/N-1948-2019; Taal, Hendrik R/B-4847-2018; Boomsma, Dorret I/AAX-4470-2020; Bustamante, Mariona/ABB-9142-2021; Scherag, Andre/B-3805-2014; Study, Raine/K-4517-2013; Evans, David M/H-6325-2013; Fox, Laura J/C-6249-2016; Buxton, Jessica L/I-4033-2014; Price, Thomas S./B-7372-2008; Middeldorp, Christel M/L-7728-2017; Hinney, Anke/D-6953-2011; Holloway, John W/B-5424-2009; Iñiguez, Carmen/AAA-5866-2019; Warrington, Nicole/P-4868-2014; Buxton, Jessica/L-9849-2019; Moreno, Luis/S-1780-2019; Timpson, Nicholas John/O-7548-2015; Deloukas, Panos/B-2922-2013; Prokopenko, Inga/H-3241-2014; Sunyer, Jordi/G-6909-2014; Meyre, David/D-7315-2011; Rivadeneira, Fernando/O-5385-2015; Heinrich, Joachim/N-1720-2013; Guxens, Monica/T-2285-2018; Schumacher, Fredrick/R-6043-2019; Davey Smith, George/A-7407-2013; Farooqi, Ismaa Sadaf/AAZ-3046-2020; Pennell, Craig/ABD-6902-2020; Meirhaeghe, Aline/E-4663-2015; O'Rahilly, Stephen/ABF-6509-2020; Blakemore, Alexandra I F/D-2253-2009; Kemp, John P./R-3091-2018; Mägi, Reedik/AAJ-9679-2021; Bisgaard, Hans/N-4761-2016; Attrill, Lauren/V-1688-2018; Bustamante, Mariona/M-7277-2015; Thiering, Elisabeth/B-3342-2013; Hypponen, Elina/B-2596-2014; Lehtimäki, Terho/AAD-1094-2022; Estivill, Xavier/A-3125-2013; McCarthy, Mark/M-3763-2015	FROGUEL, Philippe/0000-0003-2972-0784; Palmer, Lyle John/0000-0002-1628-3055; Palmer, Lyle John/0000-0002-1628-3055; Bustamante, Mariona/0000-0003-0127-2860; Evans, David M/0000-0003-0663-4621; Buxton, Jessica L/0000-0002-0918-9335; Price, Thomas S./0000-0001-7356-2109; Middeldorp, Christel M/0000-0002-6218-0428; Hinney, Anke/0000-0001-5659-0706; Holloway, John W/0000-0001-9998-0464; Iñiguez, Carmen/0000-0003-3471-4928; Warrington, Nicole/0000-0003-4195-775X; Moreno, Luis/0000-0003-0454-653X; Timpson, Nicholas John/0000-0002-7141-9189; Deloukas, Panos/0000-0001-9251-070X; Prokopenko, Inga/0000-0003-1624-7457; Sunyer, Jordi/0000-0002-2602-4110; Meyre, David/0000-0003-4850-7444; Rivadeneira, Fernando/0000-0001-9435-9441; Heinrich, Joachim/0000-0002-9620-1629; Guxens, Monica/0000-0002-8624-0333; Schumacher, Fredrick/0000-0002-3073-7463; Davey Smith, George/0000-0002-1407-8314; Pennell, Craig/0000-0002-0937-6165; Meirhaeghe, Aline/0000-0001-6983-2364; O'Rahilly, Stephen/0000-0003-2199-4449; Blakemore, Alexandra I F/0000-0003-0661-564X; Kemp, John P./0000-0002-9105-2249; Bisgaard, Hans/0000-0003-4131-7592; Bustamante, Mariona/0000-0003-0127-2860; Hypponen, Elina/0000-0003-3670-9399; Lehtimäki, Terho/0000-0002-2555-4427; Lakka, Timo/0000-0002-9199-2871; Estivill, Xavier/0000-0002-0723-2256; St Pourcain, Beate/0000-0002-4680-3517; Palotie, Aarno/0000-0002-2527-5874; Magi, Reedik/0000-0002-2964-6011; melbye, mads/0000-0001-8264-6785; Thiering, Elisabeth/0000-0002-5429-9584; Hattersley, Andrew/0000-0001-5620-473X; s, hema/0000-0002-3440-9475; Karani, Vimal/0000-0002-8485-8930; McCarthy, Mark/0000-0002-4393-0510; Iniguez, Carmen/0000-0002-5156-0732; Salem, Rany/0000-0001-8816-6862; Van Duijn, Cornelia/0000-0002-2374-9204; Panoutsopoulou, Kalliope/0000-0002-5460-8025; Farooqi, Sadaf/0000-0001-7609-3504; Kreiner, Eskil/0000-0003-1204-2438; Geller, Frank/0000-0002-9238-3269; Grant, Struan/0000-0003-2025-5302; Wheeler, Eleanor/0000-0002-8616-6444; Lindgren, Cecilia/0000-0002-4903-9374; Zeggini, Eleftheria/0000-0003-4238-659X; Barroso, Ines/0000-0001-5800-4520; Lawlor, Debbie A/0000-0002-6793-2262; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Eriksson, Johan/0000-0002-2516-2060; Elliott, Paul/0000-0002-7511-5684; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Scherag, Andre/0000-0002-9406-4704	British Heart Foundation [PG/09/023, PG/1996183/9569, PG/09/023/26806] Funding Source: Medline; CIHR [MOP-82893] Funding Source: Medline; Diabetes UK [08/0003775] Funding Source: Medline; Medical Research Council [G0500539, G0801056, G0800582, MC_UP_A620_1014, G0100103, G0400546, G0601653, G0000934, G0600705, G0900554, 74882] Funding Source: Medline; NHLBI NIH HHS [R01 HL087680, RC2 HL101651, R01 HL076647, 1RC2HL101651, 5R01HL076647, RC2 HL101543, 1RC2HL101543, 5R01HL087680, R01 HL061768, 5R01HL061768, 5R01HL087679-02, R01 HL087679] Funding Source: Medline; NICHD NIH HHS [R01 HD056465-05, R01 HD056465-04, R01 HD056465-01A1, R01 HD056465-02, R01 HD056465-03, R24 HD050924, R01 HD056465] Funding Source: Medline; NIDDK NIH HHS [R01 DK075787, U01 DK062418] Funding Source: Medline; NIEHS NIH HHS [5P01ES009581, P30 ES007048, 5R01ES014447, 5P01ES011627, R01 ES016535, P01 ES011627, 5R03ES014046, 5P30ES007048, 5R01ES014708, R03 ES014046, 5R01ES016535, P01 ES009581, R01 ES014708, R01 ES014447] Funding Source: Medline; NIMH NIH HHS [R01 MH063706, 5R01MH63706:02, RL1 MH083268, 1RL1MH083268-01] Funding Source: Medline; PHS HHS [R826708-01] Funding Source: Medline; Wellcome Trust [098395, GR069224, WT088431MA, 052515/2/97/2, 086596/Z/08/Z, 076467, 083948, 077016/Z/05/Z, 092731, 068545/Z/02, 090532] Funding Source: Medline; Department of Health [PHCS/C4/4/016] Funding Source: Medline; ORD VA [RD831861-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924, R01HD056465] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101651, R01HL087679, R01HL076647, R01HL061768, R01HL087680, RC2HL101543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075787, U01DK062418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014447, P30ES007048, R01ES016535, P01ES011627, P01ES009581, R03ES014046, R01ES014708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268, R01MH063706] Funding Source: NIH RePORTER; Medical Research Council [G0600717B, U1475000001, G0801056B, G0400546B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082, PHCS/C4/4/016] Funding Source: researchfish; MRC [G0400546, G0900554, G0601653, G0000934, G0600705, G0800582, G0100103, G0801056] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); CIHR(Canadian Institutes of Health Research (CIHR)); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome Trust); Department of Health; ORD VA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abdullahi M, 2008, OBES SURG, V18, P1450, DOI 10.1007/s11695-008-9477-z; Arslan E, 2009, EUR J INTERN MED, V20, P695, DOI 10.1016/j.ejim.2009.07.013; Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10; Dankel SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011033; den Hoed M, 2010, DIABETES, V59, P2980, DOI 10.2337/db10-0370; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Flegal KM, 2002, AM J CLIN NUTR, V75, P761, DOI 10.1093/ajcn/75.4.761; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fu M, 2003, DEV DYNAM, V228, P1, DOI 10.1002/dvdy.10350; Keren D, 2009, OBES SURG, V19, P751, DOI 10.1007/s11695-008-9694-5; Liu WL, 2010, P NATL ACAD SCI USA, V107, P11056, DOI 10.1073/pnas.1001269107; Must A, 2003, NUTR REV, V61, P139, DOI 10.1301/nr.2003.apr.139-142; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zhao JH, 2009, OBESITY, V17, P2254, DOI 10.1038/oby.2009.159	16	254	262	1	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2012	44	5					526	+		10.1038/ng.2247	http://dx.doi.org/10.1038/ng.2247			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	934BW	22484627	Green Accepted, Green Submitted			2022-12-17	WOS:000303416300012
J	Davis, EE; Zhang, Q; Liu, Q; Diplas, BH; Davey, LM; Hartley, J; Stoetzel, C; Szymanska, K; Ramaswami, G; Logan, CV; Muzny, DM; Young, AC; Wheeler, DA; Cruz, P; Morgan, M; Lewis, LR; Cherukuri, P; Maskeri, B; Hansen, NF; Mullikin, JC; Blakesley, RW; Bouffard, GG; Gyapay, G; Rieger, S; Tonshoff, B; Kern, I; Soliman, NA; Neuhaus, TJ; Swoboda, KJ; Kayserili, H; Gallagher, TE; Lewis, RA; Bergmann, C; Otto, EA; Saunier, S; Scambler, PJ; Beales, PL; Gleeson, JG; Maher, ER; Attie-Bitach, T; Dollfus, H; Johnson, CA; Green, ED; Gibbs, RA; Hildebrandt, F; Pierce, EA; Katsanis, N				Davis, Erica E.; Zhang, Qi; Liu, Qin; Diplas, Bill H.; Davey, Lisa M.; Hartley, Jane; Stoetzel, Corinne; Szymanska, Katarzyna; Ramaswami, Gokul; Logan, Clare V.; Muzny, Donna M.; Young, Alice C.; Wheeler, David A.; Cruz, Pedro; Morgan, Margaret; Lewis, Lora R.; Cherukuri, Praveen; Maskeri, Baishali; Hansen, Nancy F.; Mullikin, James C.; Blakesley, Robert W.; Bouffard, Gerard G.; Gyapay, Gabor; Rieger, Susanne; Toenshoff, Burkhard; Kern, Ilse; Soliman, Neveen A.; Neuhaus, Thomas J.; Swoboda, Kathryn J.; Kayserili, Hulya; Gallagher, Tomas E.; Lewis, Richard A.; Bergmann, Carsten; Otto, Edgar A.; Saunier, Sophie; Scambler, Peter J.; Beales, Philip L.; Gleeson, Joseph G.; Maher, Eamonn R.; Attie-Bitach, Tania; Dollfus, Helene; Johnson, Colin A.; Green, Eric D.; Gibbs, Richard A.; Hildebrandt, Friedhelm; Pierce, Eric A.; Katsanis, Nicholas		NISC Comparative Sequencing Progra	TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum	NATURE GENETICS			English	Article							BARDET-BIEDL-SYNDROME; RETROGRADE INTRAFLAGELLAR TRANSPORT; JOUBERT-SYNDROME; RETINAL DEGENERATION; CENTROSOMAL PROTEIN; MECKEL-SYNDROME; IN-VIVO; MUTATIONS; GENE; NEPHRONOPHTHISIS	Ciliary dysfunction leads to a broad range of overlapping phenotypes, collectively termed ciliopathies. This grouping is underscored by genetic overlap, where causal genes can also contribute modifier alleles to clinically distinct disorders. Here we show that mutations in TTC21B, which encodes the retrograde intraflagellar transport protein IFT139, cause both isolated nephronophthisis and syndromic Jeune asphyxiating thoracic dystrophy. Moreover, although resequencing of TTC21B in a large, clinically diverse ciliopathy cohort and matched controls showed a similar frequency of rare changes, in vivo and in vitro evaluations showed a significant enrichment of pathogenic alleles in cases (P < 0.003), suggesting that TTC21B contributes pathogenic alleles to similar to 5% of ciliopathy cases. Our data illustrate how genetic lesions can be both causally associated with diverse ciliopathies and interact in trans with other disease-causing genes and highlight how saturated resequencing followed by functional analysis of all variants informs the genetic architecture of inherited disorders.	[Davis, Erica E.; Diplas, Bill H.; Davey, Lisa M.; Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Davis, Erica E.; Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Zhang, Qi; Liu, Qin; Pierce, Eric A.] Univ Penn, Sch Med, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Hartley, Jane; Maher, Eamonn R.] Univ Birmingham, Inst Biomed Res, Dept Med & Mol Genet, Birmingham, W Midlands, England; [Stoetzel, Corinne; Dollfus, Helene] Univ Strasbourg, Avenir INSERM, Lab Genet Med EA3949, Strasbourg, France; [Szymanska, Katarzyna; Logan, Clare V.; Johnson, Colin A.] St James Univ Hosp, Sect Ophthalmol & Neurosci, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Ramaswami, Gokul; Otto, Edgar A.; Hildebrandt, Friedhelm] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Muzny, Donna M.; Wheeler, David A.; Morgan, Margaret; Lewis, Lora R.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Young, Alice C.; Cruz, Pedro; Cherukuri, Praveen; Maskeri, Baishali; Hansen, Nancy F.; Mullikin, James C.; Blakesley, Robert W.; Bouffard, Gerard G.; Green, Eric D.; NISC Comparative Sequencing Progra] NHGRI, NIH, Intramural Sequencing Ctr, Bethesda, MD 20892 USA; [Gyapay, Gabor] Genoscope Ctr Natl Sequencage, Evry, France; [Rieger, Susanne; Toenshoff, Burkhard] Univ Childrens Hosp, Heidelberg, Germany; [Kern, Ilse] Univ Hosp Geneva, Dept Pediat, Geneva, Switzerland; [Soliman, Neveen A.] Cairo Univ, Dept Pediat, Kasralainy Sch Med, Cairo, Egypt; [Neuhaus, Thomas J.] Univ Childrens Hosp Zurich, Div Nephrol, Zurich, Switzerland; [Swoboda, Kathryn J.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Swoboda, Kathryn J.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Kayserili, Hulya] Istanbul Univ, Istanbul Fac Med, Istanbul, Turkey; [Gallagher, Tomas E.] Univ Hawaii Manoa, Honolulu, HI 96822 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Bergmann, Carsten] Bioscientia, Ctr Human Genet, Ingelheim, Germany; [Bergmann, Carsten] Rhein Westfal TH Aachen, Dept Human Genet, Aachen, Germany; [Saunier, Sophie] Univ Paris 05, Hop Necker Enfants Malades, INSERM, U983, Paris, France; [Scambler, Peter J.; Beales, Philip L.] UCL, Mol Med Unit, Inst Child Hlth, London, England; [Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, La Jolla, CA 92093 USA; [Attie-Bitach, Tania] Univ Paris 05, Hop Necker Enfants Malades, INSERM, U781, Paris, France; [Attie-Bitach, Tania] Univ Paris 05, Hop Necker Enfants Malades, Dept Genet, Paris, France; [Hildebrandt, Friedhelm] Howard Hughes Med Inst, Ann Arbor, MI USA; [Hildebrandt, Friedhelm] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Katsanis, Nicholas] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Katsanis, Nicholas] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Duke University; Duke University; University of Pennsylvania; Pennsylvania Medicine; University of Birmingham; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Saint James's University Hospital; University of Leeds; University of Michigan System; University of Michigan; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Geneva; Egyptian Knowledge Bank (EKB); Cairo University; University Children's Hospital Zurich; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Istanbul University; University of Hawaii System; University of Hawaii Manoa; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; RWTH Aachen University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; Howard Hughes Medical Institute; University of California System; University of California San Diego; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Katsanis, N (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27710 USA.	katsanis@cellbio.duke.edu	Katsanis, Nicholas/E-1837-2012; MAHER, EAMONN R/A-9507-2008; Scambler, Peter/AAZ-6026-2020; Kayserili, Hülya/AAA-5593-2021; ATTIE-BITACH, Tania/K-1453-2017; Beales, Philip L/C-7367-2009; Cherukuri, Praveen/AFU-2005-2022; Saunier, Sophie/G-6044-2015; Soliman, Neveen/Y-1583-2019; Soliman, Neveen A/T-2687-2018; Wheeler, David A/M-9740-2018; Scambler, Peter J/C-4998-2008	MAHER, EAMONN R/0000-0002-6226-6918; Scambler, Peter/0000-0002-1487-4628; Kayserili, Hülya/0000-0003-0376-499X; ATTIE-BITACH, Tania/0000-0002-1155-3626; Cherukuri, Praveen/0000-0002-9509-1245; Saunier, Sophie/0000-0002-1069-0047; Soliman, Neveen/0000-0002-8942-1973; Soliman, Neveen A/0000-0002-8942-1973; Wheeler, David A/0000-0002-9056-6299; Scambler, Peter J/0000-0002-1487-4628; Dollfus, Helene/0000-0002-2249-895X; Diplas, Bill/0000-0001-9248-7351; Davis, Erica/0000-0002-2412-8397; Swoboda, Kathryn/0000-0002-4593-6342; Logan, Clare/0000-0003-4323-1602; Pierce, Eric/0000-0002-2354-4102; Katsanis, Nicholas/0000-0002-2480-0171; Johnson, Colin/0000-0002-2979-8234; Otto, Edgar/0000-0002-2387-9973	US National Institutes of Health [R01HD04260]; National Institute of Child Health and Development [R01DK072301, R01DK075972, R01DK068306, R01DK064614, R01DK069274]; National Institute of Diabetes, Digestive and Kidney disorders [F32 DK079541]; National Eye Institute [RO1EY12910]; Macular Vision Research Foundation; Foundation Fighting Blindness; F.M. Kirby Foundation; Rosanne Silbermann Foundation; Polycystic Kidney Disease (PKD) Foundation; German Kidney Foundation; German Research Foundation (DFG) [BE 3910/5-1, SFB/TRR57]; UNADEV; Retina France; Programme Hospitalier de Recherche Clinique; L'Agence nationale de la recherche; Medical Research Council (MRC); National Human Genome Research Institute; NATIONAL EYE INSTITUTE [R01EY012910] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196, ZIAHG200330, U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306, R01DK072301, R01DK075972, R01DK064614, F32DK079541, R01DK069274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453, R01NS052455] Funding Source: NIH RePORTER; British Heart Foundation [RG/10/13/28570] Funding Source: researchfish; Medical Research Council [G0801843, G9901217, G0700073, G0601347] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; MRC [G0601347, G0700073, G9901217, G0801843] Funding Source: UKRI	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Diabetes, Digestive and Kidney disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Macular Vision Research Foundation; Foundation Fighting Blindness(European Commission); F.M. Kirby Foundation; Rosanne Silbermann Foundation; Polycystic Kidney Disease (PKD) Foundation; German Kidney Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); UNADEV; Retina France; Programme Hospitalier de Recherche Clinique; L'Agence nationale de la recherche(French National Research Agency (ANR)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the individuals affected with ciliopathies and their families for their continued participation and enthusiasm. We thank N. Elkhartoufi for technical assistance, P. Parvex for subject recruitment, D. Parker for critical reading of the manuscript and Yorkshire Regional Genetics Service for help in obtaining control DNA samples. This research was supported by funds from the US National Institutes of Health grant R01HD04260 from the National Institute of Child Health and Development (N. K.), R01DK072301, R01DK075972 (N. K.), R01DK068306, R01DK064614, R01DK069274 (F. H.) and National Research Service Award (NRSA) fellowship F32 DK079541 (E. E. D.) from the National Institute of Diabetes, Digestive and Kidney disorders, RO1EY12910 from the National Eye Institute (E. A. P.), the Macular Vision Research Foundation (N. K.) the Foundation Fighting Blindness (N. K., R. A. L., E. A. P. and Q. L.), the F.M. Kirby Foundation (E. A. P.), the Rosanne Silbermann Foundation (E. A. P.), the Polycystic Kidney Disease (PKD) Foundation (C. B.), German Kidney Foundation (C. B.), German Research Foundation (DFG BE 3910/5-1 and SFB/TRR57; C. B.), UNADEV, Retina France, Programme Hospitalier de Recherche Clinique 2007, L'Agence nationale de la recherche 2009 (H. D.) and a Medical Research Council (MRC) research training fellowship (J.H.). This work was also supported in part by the Intramural Research Program of the National Human Genome Research Institute. R. A. L. is a Senior Scientific Investigator of Research to Prevent Blindness, New York, New York. P. L. B. is a Wellcome Trust Senior Research Fellow. F. H. is an Investigator of the Howard Hughes Medical Institute, a Doris Duke Distinguished Clinical Scientist and the Frederick G. L. Huetwell Professor. N. K. is a Distinguished George W. Brumley Professor.	Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Beales PL, 1999, J MED GENET, V36, P437; Bergmann C, 2008, AM J HUM GENET, V82, P959, DOI 10.1016/j.ajhg.2008.02.017; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Gorden NT, 2008, AM J HUM GENET, V83, P559, DOI 10.1016/j.ajhg.2008.10.002; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Hoefele J, 2007, J AM SOC NEPHROL, V18, P2789, DOI 10.1681/ASN.2007020243; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Louie CM, 2010, NAT GENET, V42, P175, DOI 10.1038/ng.519; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Neuhaus TJ, 1997, EUR J PEDIATR, V156, P723, DOI 10.1007/s004310050699; Otto EA, 2009, J MED GENET, V46, P663, DOI 10.1136/jmg.2009.066613; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594; Wolf MTF, 2007, KIDNEY INT, V72, P1520, DOI 10.1038/sj.ki.5002630; Zaghloul NA, 2010, P NATL ACAD SCI USA, V107, P10602, DOI 10.1073/pnas.1000219107; Zaghloul NA, 2010, TRENDS GENET, V26, P168, DOI 10.1016/j.tig.2010.01.006	31	254	270	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2011	43	3					189	U28		10.1038/ng.756	http://dx.doi.org/10.1038/ng.756			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726BR	21258341	Green Accepted			2022-12-17	WOS:000287693800008
J	Ellinghaus, E; Ellinghaus, D; Stuart, PE; Nair, RP; Debrus, S; Raelson, JV; Belouchi, M; Fournier, H; Reinhard, C; Ding, J; Li, Y; Tejasvi, T; Gudjonsson, J; Stoll, SW; Voorhees, JJ; Lambert, S; Weidinger, S; Eberlein, B; Kunz, M; Rahman, P; Gladman, DD; Gieger, C; Wichmann, HE; Karlsen, TH; Mayr, G; Albrecht, M; Kabelitz, D; Mrowietz, U; Abecasis, GR; Elder, JT; Schreiber, S; Weichenthal, M; Franke, A				Ellinghaus, Eva; Ellinghaus, David; Stuart, Philip E.; Nair, Rajan P.; Debrus, Sophie; Raelson, John V.; Belouchi, Majid; Fournier, Helene; Reinhard, Claudia; Ding, Jun; Li, Yun; Tejasvi, Trilokraj; Gudjonsson, Johann; Stoll, Stefan W.; Voorhees, John J.; Lambert, Sylviane; Weidinger, Stephan; Eberlein, Bernadette; Kunz, Manfred; Rahman, Proton; Gladman, Dafna D.; Gieger, Christian; Wichmann, H. Erich; Karlsen, Tom H.; Mayr, Gabriele; Albrecht, Mario; Kabelitz, Dieter; Mrowietz, Ulrich; Abecasis, Goncalo R.; Elder, James T.; Schreiber, Stefan; Weichenthal, Michael; Franke, Andre			Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2	NATURE GENETICS			English	Article							NF-KAPPA-B; T-CELL; POPULATION; GENETICS; GENES; IL12B; IL23R; POLYMORPHISMS; ACTIVATION; AUTOIMMUNE	Psoriasis is a multifactorial skin disease characterized by epidermal hyperproliferation and chronic inflammation, the most common form of which is psoriasis vulgaris (PsV). We present a genome-wide association analysis of 2,339,118 SNPs in 472 PsV cases and 1,146 controls from Germany, with follow-up of the 147 most significant SNPs in 2,746 PsV cases and 4,140 controls from three independent replication panels. We identified an association at TRAF3IP2 on 6q21 and genotyped two SNPs at this locus in two additional replication panels (the combined discovery and replication panels consisted of 6,487 cases and 8,037 controls; combined P = 2.36 x 10(-10) for rs13210247 and combined P = 1.24 x 10(-16) for rs33980500). About 15% of psoriasis cases develop psoriatic arthritis (PsA). A stratified analysis of our datasets including only PsA cases (1,922 cases compared to 8,037 controls, P = 4.57 x 10(-12) for rs33980500) suggested that TRAF3IP2 represents a shared susceptibility for PsV and PsA. TRAF3IP2 encodes a protein involved in IL-17 signaling and which interacts with members of the Rel/NF-kappa B transcription factor family.	[Ellinghaus, Eva; Ellinghaus, David; Schreiber, Stefan; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Stuart, Philip E.; Nair, Rajan P.; Tejasvi, Trilokraj; Gudjonsson, Johann; Stoll, Stefan W.; Voorhees, John J.; Lambert, Sylviane; Elder, James T.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Debrus, Sophie; Raelson, John V.; Belouchi, Majid; Fournier, Helene; Reinhard, Claudia] Genizon BioSci Inc, St Laurent, PQ, Canada; [Ding, Jun; Li, Yun; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Weidinger, Stephan; Eberlein, Bernadette] Tech Univ Munich, Dept Dermatol & Allergy, Munich, Germany; [Weidinger, Stephan; Mrowietz, Ulrich; Weichenthal, Michael] Univ Kiel, Dept Dermatol, Univ Hosp Schleswig Holstein, D-2300 Kiel, Germany; [Kunz, Manfred] Univ Lubeck, Comprehens Ctr Inflammat Med, Lubeck, Germany; [Rahman, Proton] Mem Univ Newfoundland, Dept Med, St John, NF, Canada; [Gladman, Dafna D.] Univ Toronto, Div Rheumatol, Psoriat Arthrit Program, Univ Hlth Network, Toronto, ON, Canada; [Gieger, Christian; Wichmann, H. Erich] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Epidemiol, Neuherberg, Germany; [Wichmann, H. Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H. Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Karlsen, Tom H.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Clin Specialized Med & Surg, N-0027 Oslo, Norway; [Mayr, Gabriele; Albrecht, Mario] Max Planck Inst Informat, Saarbrucken, Germany; [Kabelitz, Dieter] Univ Kiel, Inst Immunol, Univ Hosp Schleswig Holstein, Kiel, Germany; [Elder, James T.] Ann Arbor Vet Affairs Hosp, Ann Arbor, MI USA	University of Kiel; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Technical University of Munich; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; Memorial University Newfoundland; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Oslo; National Hospital Norway; Max Planck Society; University of Kiel; Schleswig Holstein University Hospital	Franke, A (corresponding author), Univ Kiel, Inst Clin Mol Biol, Kiel, Germany.	mweichenthal@dermatology.uni-kiel.de; a.franke@mucosa.de	Ding, Jun/G-3918-2011; Wichmann, Heinz Erich/AAA-5695-2022; Albrecht, Mario/B-6694-2008; Kabelitz, Dieter/AAB-4199-2021; Weidinger, Stephan/C-8461-2011; Kabelitz, Dieter/A-2757-2010; Ellinghaus, Eva/E-6490-2012; Franke, Andre/B-2151-2010; Weichenthal, Michael/A-5692-2009; Voorhees, John/AAM-9966-2020; Ellinghaus, David/ABC-3610-2020; Ellinghaus, David/G-4467-2012; Abecasis, Goncalo R/B-7840-2010	Albrecht, Mario/0000-0002-3103-9624; Weidinger, Stephan/0000-0003-3944-252X; Ellinghaus, Eva/0000-0003-2914-3382; Franke, Andre/0000-0003-1530-5811; Voorhees, John/0000-0003-1856-785X; Ellinghaus, David/0000-0002-4332-6110; Abecasis, Goncalo/0000-0003-1509-1825; Gieger, Christian/0000-0001-6986-9554; Gudjonsson, Sigurjon A./0000-0001-9314-7412	German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN); German Federal Ministry of Education, Science, Research and Technology; State of Bavaria and the Munich Center of Health Sciences (MC Health); US National Institutes of Health [R01-AR42742, R01-AR050511, R01-AR054966]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042742, R01AR050511, R01AR054966] Funding Source: NIH RePORTER	German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education, Science, Research and Technology; State of Bavaria and the Munich Center of Health Sciences (MC Health); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank all individuals with psoriasis who participated in this study, their families and their physicians for their cooperation. We acknowledge the cooperation of Genizon Biosciences. We wish to thank T. Wesse, T. Henke, C. Furstenau, S. Ehlers, M. Davids and R. Vogler for expert technical help. We thank J.R. Hov for helpful discussions. This study was supported by the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN), the PopGen biobank and the KORA (Cooperative Research in the Region of Augsburg) research platform. KORA was initiated and financed by the Helmholtz Zentrum Munchen-National Research Center for Environmental Health, which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria and the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. The project received infrastructure support through the Deutsche Forschungsgemeinschaft (DFG) clusters of excellence 'Multimodal Computing and Interaction' and 'Inflammation at Interfaces'. This research was also supported by grants R01-AR42742, R01-AR050511 and R01-AR054966 from the US National Institutes of Health.	Bhalerao J, 1998, HUM MOL GENET, V7, P1537, DOI 10.1093/hmg/7.10.1537; Bowcock AM, 2003, J AM ACAD DERMATOL, V49, pS51, DOI 10.1016/S0190-9622(03)01135-6; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chang M, 2008, GENES IMMUN, V9, P176, DOI 10.1038/sj.gene.6364451; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Dupont WD, 1997, CONTROL CLIN TRIALS, V18, P274, DOI 10.1016/S0197-2456(97)00074-3; ELDER JT, 1994, ARCH DERMATOL, V130, P216, DOI 10.1001/archderm.130.2.216; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gelfand JM, 2005, J AM ACAD DERMATOL, V53, P573, DOI 10.1016/j.jaad.2005.03.046; Gottlieb AB, 2005, NAT REV DRUG DISCOV, V4, P19, DOI 10.1038/nrd1607; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Hunter CA, 2007, NAT IMMUNOL, V8, P232, DOI 10.1038/ni0307-232; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; MOLL J M H, 1973, Seminars in Arthritis and Rheumatism, V3, P55, DOI 10.1016/0049-0172(73)90035-8; Nair RP, 2008, J INVEST DERMATOL, V128, P1653, DOI 10.1038/sj.jid.5701255; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Oudot T, 2009, J INVEST DERMATOL, V129, P2637, DOI 10.1038/jid.2009.157; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian YC, 2004, IMMUNITY, V21, P575, DOI 10.1016/j.immuni.2004.09.001; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stoll SW, 2010, J INVEST DERMATOL, V130, P2031, DOI 10.1038/jid.2010.98; Stoll SW, 2010, J INVEST DERMATOL, V130, P295, DOI 10.1038/jid.2009.211; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Tsunemi Y, 2002, J DERMATOL SCI, V30, P161, DOI 10.1016/S0923-1811(02)00072-5; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Zaba LC, 2009, J ALLERGY CLIN IMMUN, V124, P1022, DOI 10.1016/j.jaci.2009.08.046; Zhang XJ, 2007, J INVEST DERMATOL, V127, P2544, DOI 10.1038/sj.jid.5700896; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	37	254	266	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					991	U113		10.1038/ng.689	http://dx.doi.org/10.1038/ng.689			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20953188	Green Accepted			2022-12-17	WOS:000283540500017
J	Brault, AC; Huang, CYH; Langevin, SA; Kinney, RM; Bowen, RA; Ramey, WN; Panella, NA; Holmes, EC; Powers, AM; Miller, BR				Brault, Aaron C.; Huang, Claire Y-H; Langevin, Stanley A.; Kinney, Richard M.; Bowen, Richard A.; Ramey, Wanichaya N.; Panella, Nicholas A.; Holmes, Edward C.; Powers, Ann M.; Miller, Barry R.			A single positively selected West Nile viral mutation confers increased virogenesis in American crows	NATURE GENETICS			English	Article							VIRUS-STRAINS; NEW-YORK; VIRULENCE; BIRDS; TRANSMISSION; DISEASE; EUROPE; HOST; EPIDEMIOLOGY; ENCEPHALITIS	West Nile virus ( WNV), first recognized in North America in 1999, has been responsible for the largest arboviral epiornitic and epidemic of human encephalitis in recorded history. Despite the well- described epidemiological patterns of WNV in North America, the basis for the emergence of WNV-associated avian pathology, particularly in the American crow ( AMCR) sentinel species, and the large scale of the North American epidemic and epiornitic is uncertain. We report here that the introduction of a T249P amino acid substitution in the NS3 helicase ( found in North American WNV) in a lowvirulence strain was sufficient to generate a phenotype highly virulent to AMCRs. Furthermore, comparative sequence analyses of full- length WNV genomes demonstrated that the same site ( NS3- 249) was subject to adaptive evolution. These phenotypic and evolutionary results provide compelling evidence for the positive selection of a mutation encoding increased viremia potential and virulence in the AMCR sentinel bird species.	Univ Calif Davis, Ctr Vector Borne Dis, Sch Vet Med, Davis, CA 95616 USA; Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA; US Dept HHS, Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Ft Collins, CO 80522 USA; Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of California System; University of California Davis; University of California System; University of California Davis; Centers for Disease Control & Prevention - USA; Colorado State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Brault, AC (corresponding author), Univ Calif Davis, Ctr Vector Borne Dis, Sch Vet Med, Davis, CA 95616 USA.	acbrault@ucdavis.edu	Holmes, Edward/GVR-9499-2022; Holmes, Edward/Y-2789-2019; Pacific-Southwest, RCE/B-6155-2009	Holmes, Edward/0000-0001-9596-3552; 	NIAID NIH HHS [AI061822, R01 AI061822, U54 AI065359, U54 AI065359-010001, R01 AI061822-01] Funding Source: Medline; NCPDCID CDC HHS [R01 CI000235, CI000235] Funding Source: Medline; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [R01CI000235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359, R01AI061822] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCPDCID CDC HHS; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bakonyi T, 2005, EMERG INFECT DIS, V11, P225, DOI 10.3201/eid1102.041028; Brault AC, 2004, EMERG INFECT DIS, V10, P2161, DOI 10.3201/eid1012.040486; Charrel RN, 2003, VIROLOGY, V315, P381, DOI 10.1016/S0042-6822(03)00536-1; DAY JF, 1983, J PARASITOL, V69, P163, DOI 10.2307/3281292; DAY JF, 1984, COMP BIOCHEM PHYS A, V77, P447, DOI 10.1016/0300-9629(84)90210-X; Deardorff E, 2006, EMERG INFECT DIS, V12, P314, DOI 10.3201/eid1202.050871; Eidson M, 2001, ANN NY ACAD SCI, V951, P38; EWALD PW, 1983, ANNU REV ECOL SYST, V14, P465, DOI 10.1146/annurev.es.14.110183.002341; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Kinney RM, 2006, J GEN VIROL, V87, P3611, DOI 10.1099/vir.0.82299-0; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Kramer LD, 2001, CURR OPIN INFECT DIS, V14, P519, DOI 10.1097/00001432-200110000-00004; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Langevin SA, 2005, AM J TROP MED HYG, V72, P99, DOI 10.4269/ajtmh.2005.72.99; Langevin SA, 2003, AM J TROP MED HYG, V69, P78, DOI 10.4269/ajtmh.2003.69.78; Lipsitch M, 1997, TRENDS MICROBIOL, V5, P31, DOI 10.1016/S0966-842X(97)81772-6; Malkinson M, 2002, CURR TOP MICROBIOL, V267, P309; Miller BR, 2000, AM J TROP MED HYG, V62, P240, DOI 10.4269/ajtmh.2000.62.240; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Reisen WK, 2005, J MED ENTOMOL, V42, P367, DOI 10.1603/0022-2585(2005)042[0367:AHAMDC]2.0.CO;2; Reisen WK, 2006, J MED ENTOMOL, V43, P356, DOI 10.1603/0022-2585(2006)043[0356:ROCIEO]2.0.CO;2; Sejvar JJ, 2004, NEUROLOGY, V63, P206, DOI 10.1212/01.WNL.0000130361.62281.69; Solomon T, 2003, LANCET INFECT DIS, V3, P189, DOI 10.1016/S1473-3099(03)00574-7; Steele KE, 2000, VET PATHOL, V37, P208, DOI 10.1354/vp.37-3-208; SWOFFORD D, 2003, PHYLOGENETICS ANAL U; Weiss D, 2001, EMERG INFECT DIS, V7, P654, DOI 10.3201/eid0704.010409; WORK TH, 1955, AM J TROP MED HYG, V4, P872, DOI 10.4269/ajtmh.1955.4.872; WORK TH, 1953, P SOC EXP BIOL MED, V84, P719, DOI 10.3181/00379727-84-20764	28	254	262	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2007	39	9					1162	1166		10.1038/ng2097	http://dx.doi.org/10.1038/ng2097			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17694056	Green Accepted			2022-12-17	WOS:000249122400029
J	Moreno-Loshuertos, R; Acin-Perez, R; Fernandez-Silva, P; Movilla, N; Perez-Martos, A; de Cordoba, SR; Gallardo, ME; Enriquez, JA				Moreno-Loshuertos, Raquel; Acin-Perez, Rebeca; Fernandez-Silva, Patricio; Movilla, Nieves; Perez-Martos, Acisclo; de Cordoba, Santiago Rodriguez; Gallardo, M. Esther; Enriquez, Jose Antonio			Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants	NATURE GENETICS			English	Article							OXIDATIVE STRESS; RESPIRATORY-FUNCTION; NADH DEHYDROGENASE; MTDNA HAPLOGROUPS; MAMMALIAN-CELLS; MUTATION; GENE; SELECTION; RNA; FIBROBLASTS	Common mitochondrial DNA (mtDNA) haplotypes in humans and mice have been associated with various phenotypes, including learning performance and disease penetrance. Notably, no influence of mtDNA haplotype in cell respiration has been demonstrated. Here, using cell lines carrying four different common mouse mtDNA haplotypes in an identical nuclear background, we show that the similar level of respiration among the cell lines is only apparent and is a consequence of compensatory mechanisms triggered by different production of reactive oxygen species. We observe that the respiration capacity per molecule of mtDNA in cells with the NIH3T3 or NZB mtDNA is lower than in those with the C57BL/6J, CBA/J or BALB/cJ mtDNA. In addition, we have determined the genetic element underlying these differences. Our data provide insight into the molecular basis of the complex phenotypes associated with common mtDNA variants and anticipate a relevant contribution of mtDNA single nucleotide polymorphisms to phenotypic variability in humans.	Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, E-50013 Zaragoza, Spain; CSIC, Ctr Invest Biol, Dept Inmunol, E-28040 Madrid, Spain	University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Enriquez, JA (corresponding author), Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Miguel Servet 177, E-50013 Zaragoza, Spain.	enriquez@unizar.es	Acin-Perez, Rebeca/AAU-4913-2020; de Cordoba, Santiago Rodriguez/K-6727-2014; Gallardo, M. Esther/AFK-7298-2022; Acin-Perez, Rebeca/H-6160-2015; Enríquez, J.A./M-8468-2016; Silva, Patricio Fernandez/U-2256-2017; Moreno-Loshuertos, Raquel/H-4545-2015	Acin-Perez, Rebeca/0000-0001-9553-8337; de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; Gallardo, M. Esther/0000-0002-8699-8734; Acin-Perez, Rebeca/0000-0001-9553-8337; Enríquez, J.A./0000-0002-3671-2961; Silva, Patricio Fernandez/0000-0001-8971-7355; Moreno Loshuertos, Raquel/0000-0002-6600-1618				Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2003, HUM MOL GENET, V12, P329, DOI 10.1093/hmg/ddg021; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Bai YD, 1998, EMBO J, V17, P4848, DOI 10.1093/emboj/17.16.4848; Battersby BJ, 2001, HUM MOL GENET, V10, P2469, DOI 10.1093/hmg/10.22.2469; Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, P5349, DOI 10.1093/nar/gkg739; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8; Carelli V, 2002, BBA-MOL BASIS DIS, V1588, P7, DOI 10.1016/S0925-4439(02)00097-2; CHOMYN A, 1994, AM J HUM GENET, V54, P966; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; DiMauro S, 2004, BBA-BIOENERGETICS, V1659, P107, DOI 10.1016/j.bbabio.2004.08.003; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Enriquez JA, 1996, EUR J BIOCHEM, V237, P601, DOI 10.1111/j.1432-1033.1996.0601p.x; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Gallardo ME, 2006, HUM MUTAT, V27, P575, DOI 10.1002/humu.20338; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Herrnstadt C, 2004, MITOCHONDRION, V4, P791, DOI 10.1016/j.mito.2004.07.041; Hofhaus G, 1996, Methods Enzymol, V264, P476, DOI 10.1016/S0076-6879(96)64043-9; Howell N, 2003, AM J MED GENET A, V119A, P147, DOI 10.1002/ajmg.a.20135; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; Johnson KR, 2001, NAT GENET, V27, P191, DOI 10.1038/84831; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1159/000064724; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Liu CS, 2003, FREE RADICAL RES, V37, P1307, DOI 10.1080/10715760310001621342; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; Montiel-Sosa F, 2006, GENE, V368, P21, DOI 10.1016/j.gene.2005.09.015; Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311; Roubertoux PL, 2003, NAT GENET, V35, P65, DOI 10.1038/ng1230; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Staden R, 2000, Methods Mol Biol, V132, P115; Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8; Tretter L, 2000, J NEUROSCI, V20, P8972; Wallace DC, 2003, COLD SPRING HARB SYM, V68, P479; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133	48	254	262	0	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1261	1268		10.1038/ng1897	http://dx.doi.org/10.1038/ng1897			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17013393				2022-12-17	WOS:000241592700014
J	Chia, R; Achilli, F; Festing, MFW; Fisher, EMC				Chia, R; Achilli, F; Festing, MFW; Fisher, EMC			The origins and uses of mouse outbred stocks	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; INBRED STRAINS; LABORATORY-ANIMALS; SHEEP ERYTHROCYTES; ANTIBODY-SYNTHESIS; GENETIC-ANALYSIS; SWISS MICE; LINES; SKIN; CARCINOGENESIS	Outbred mouse stocks, often used in genetics, toxicology and pharmacology research, have been generated in rather haphazard ways. Understanding the characteristics of these stocks and their advantages and disadvantages is important for experimental design. In many studies these mice are used inappropriately, wasting animals' lives and resources on suboptimal experiments. Recently, however, researchers from the field of complex trait analysis have capitalized on the genetics of outbred stocks to refine the identification of quantitative trait loci. Here we assess the most widely used outbred stocks of mice and present guidelines for their use.	Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England	University of London; University College London; University of Leicester	Fisher, EMC (corresponding author), Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London WC1N 3BG, England.	e.fisher@prion.ucl.ac.uk	Fisher, Elizabeth MC/C-2168-2008	Fisher, Elizabeth MC/0000-0003-2850-9936; Chia, Ruth/0000-0002-4709-7423				Anghileri LJ, 2005, INT J RADIAT BIOL, V81, P205, DOI 10.1080/09553000500076957; BAKER D, 1990, J NEUROIMMUNOL, V28, P261, DOI 10.1016/0165-5728(90)90019-J; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; BENSON LM, 1977, LAB ANIM SCI, V27, P333; BIOZZI G, 1979, IMMUNOLOGY, V36, P427; BOUCHER W, 1990, J MATH BIOL, V28, P293, DOI 10.1007/BF00178778; BOUTWELL RK, 1964, PROG EXP TUMOR RES, V4, P207; Caballero A, 2000, GENET RES, V75, P331, DOI 10.1017/S0016672399004449; CHAPIN RE, 1993, FUND APPL TOXICOL, V21, P8, DOI 10.1006/faat.1993.1065; CRABBE JC, 1994, SCIENCE, V264, P1715, DOI 10.1126/science.8209252; CUI SL, 1993, LAB ANIM, V27, P116, DOI 10.1258/002367793780810397; Darvasi A, 2005, TRENDS GENET, V21, P373, DOI 10.1016/j.tig.2005.05.003; DEFRIES JC, 1989, ALCOHOL CLIN EXP RES, V13, P196, DOI 10.1111/j.1530-0277.1989.tb00310.x; Dell Ralph B, 2002, ILAR J, V43, P207; Demarest K, 2001, BEHAV GENET, V31, P79, DOI 10.1023/A:1010261909853; DiGiovanni J, 1995, Prog Clin Biol Res, V391, P195; Falconer D. S., 1981, INTRO QUANTITATIVE G; FEINGOLD N, 1976, EUR J IMMUNOL, V6, P43, DOI 10.1002/eji.1830060110; FELTON RP, 1989, J TOXICOL ENV HEALTH, V26, P399, DOI 10.1080/15287398909531264; FESTING M, 1972, Z VERSUCHSTIERKD, V14, P215; FESTING M F, 1974, Laboratory Animals (London), V8, P291, DOI 10.1258/002367774780943689; FESTING M F, 1974, Laboratory Animals (London), V8, P265, DOI 10.1258/002367774780943751; Festing MFW, 2003, TRENDS PHARMACOL SCI, V24, P341, DOI 10.1016/S0165-6147(03)00159-7; FESTING MFW, 1995, J NATL CANCER I, V87, P1715, DOI 10.1093/jnci/87.22.1715; Festing MFW, 1999, NEUROBIOL AGING, V20, P237; Festing MFW, 2001, FOOD CHEM TOXICOL, V39, P375, DOI 10.1016/S0278-6915(00)00149-6; FESTING MFW, 1993, INT INDEX LAB ANIMAL; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Garland T, 2002, EVOLUTION, V56, P1267; Grahame NJ, 1999, BEHAV GENET, V29, P47, DOI 10.1023/A:1021489922751; GROEN A, 1979, LAB ANIM, V13, P81, DOI 10.1258/002367779780943387; HASEMAN JK, 1979, J TOXICOL ENV HEALTH, V5, P89, DOI 10.1080/15287397909529728; HAUSCHKA TS, 1973, PERSPECTIVES CANC RE, V25, P319; HAYAKAWA J, 1980, LAB ANIM-UK, V14, P233, DOI 10.1258/002367780780937625; Hennings H, 1997, MOL CARCINOGEN, V20, P143, DOI 10.1002/(SICI)1098-2744(199709)20:1<143::AID-MC16>3.0.CO;2-1; Hitzemann R, 2002, GENES BRAIN BEHAV, V1, P214, DOI 10.1034/j.1601-183X.2002.10403.x; HOGER H, 1992, EXP ANIM TOKYO, V41, P215, DOI 10.1538/expanim1978.41.2_215; Holt M, 2004, MAMM GENOME, V15, P951, DOI 10.1007/s00335-004-3030-8; HORNADY MH, 2001, SCIENCES NEW YORK, V1, P108; Horvat S, 2000, MAMM GENOME, V11, P2, DOI 10.1007/s003350010002; JAY GE, 1955, P SOC EXP BIOL MED, V90, P378; KATOH H, 1990, LAB ANIM SCI, V40, P490; Kirkpatrick BW, 1998, MAMM GENOME, V9, P97, DOI 10.1007/s003359900696; KLUGE R, 1994, J EXP ANIM SCI, V36, P179; Ku SK, 2002, ANAT HISTOL EMBRYOL, V31, P78, DOI 10.1046/j.1439-0264.2002.00362.x; LYNCH CJ, 1969, LAB ANIM CARE, V19, P214; Manenti G, 2003, CARCINOGENESIS, V24, P1143, DOI 10.1093/carcin/bgg065; Mathews CE, 2004, DIABETES, V53, pS125, DOI 10.2337/diabetes.53.2007.S125; MCCLEARN GE, 2005, CONTRIBUTIONS BEHAV, P3; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; NEI M, 1978, GENETICS, V89, P583; NOBUNAGA T, 1973, LAB ANIM SCI, V23, P803; Nomura T, 1996, GENET SEL EVOL, V28, P141, DOI 10.1051/gse:19960202; PADEH B, 1974, BEHAV GENET, V4, P383, DOI 10.1007/BF01066158; PAPAIOANNOU VE, 1980, LAB ANIM, V14, P11, DOI 10.1258/002367780780943015; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Poiley S M, 1972, Lab Anim Sci, V22, P758; RICE MC, 1980, NATURE, V283, P157, DOI 10.1038/283157a0; RUSSELL RJ, 1993, LAB ANIM SCI, V43, P460; SCHLAGER G, 1994, GENETIC HYPERTENSION, P158; Serfilippi LM, 2004, COMPARATIVE MED, V54, P69; Stahl W, 2002, PARASITOL RES, V88, P507, DOI 10.1007/s00436-002-0618-3; Strivens M, 2004, GENETICA, V122, P89, DOI 10.1007/s10709-004-1435-7; Tabakoff B, 2003, J NEUROSCI, V23, P4491; Talbot CJ, 2003, MAMM GENOME, V14, P223, DOI 10.1007/s00335-002-3059-5; Talbot CJ, 1999, NAT GENET, V21, P305, DOI 10.1038/6825; Teppner I, 2004, LAB ANIM-UK, V38, P406, DOI 10.1258/0023677041958882; Tinston DJ, 1981, CTLP547 IMP CHEM IND; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450	69	254	275	2	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1181	1186		10.1038/ng1665	http://dx.doi.org/10.1038/ng1665			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16254564				2022-12-17	WOS:000233045200014
J	de la Serna, IL; Carlson, KA; Imbalzano, AN				de la Serna, IL; Carlson, KA; Imbalzano, AN			Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation	NATURE GENETICS			English	Article							SWI-SNF COMPLEX; RETINOBLASTOMA PROTEIN; GENE-EXPRESSION; CELL-CYCLE; CHROMATIN; TRANSCRIPTION; BINDING; BRG1; FIBROBLASTS; ACETYLATION	Mammalian SWI/SNF complexes are ATP-dependent chromatin remodeling enzymes that have been implicated in the regulation of gene expression, cell-cycle control and oncogenesis(1-4) MyoD is a muscle-specific regulator able to induce myogenesis in numerous cell types(5). To ascertain the requirement for chromatin remodeling enzymes in cellular differentiation processes, we examined MyoD-mediated induction of muscle differentiation in fibroblasts expressing dominant-negative versions of the human brahma-related gene-1 (BRG1) or human brahma (BRM), the ATPase subunits of two distinct SWI/SNF enzymes. We find that induction of the myogenic phenotype is completely abrogated in the presence of the mutant enzymes. We further demonstrate that failure to induce muscle-specific gene expression correlates with inhibition of chromatin remodeling in the promoter region of an endogenous muscle-specific gene. Our results demonstrate that SWI/SNF enzymes promote MyoD-mediated muscle differentiation and indicate that these enzymes function by altering chromatin structure in promoter regions of endogenous, differentiation-specific loci.	Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Imbalzano, AN (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA.				NIGMS NIH HHS [R01 GM056244] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056244] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brown SA, 1997, GENE DEV, V11, P3116, DOI 10.1101/gad.11.23.3116; CHENG TC, 1993, SCIENCE, V261, P215, DOI 10.1126/science.8392225; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; De la Serna IL, 2000, MOL CELL BIOL, V20, P2839, DOI 10.1128/MCB.20.8.2839-2851.2000; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; EDMONDSON DG, 1992, MOL CELL BIOL, V12, P3665, DOI 10.1128/MCB.12.9.3665; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; Imbalzano AN, 1998, CRIT REV EUKAR GENE, V8, P225, DOI 10.1615/CritRevEukarGeneExpr.v8.i3-4.10; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Javed A, 1999, MOL CELL BIOL, V19, P7491; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; KOWALIK TF, 1995, J VIROL, V69, P2491, DOI 10.1128/JVI.69.4.2491-2500.1995; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Muchardt C, 1999, SEMIN CELL DEV BIOL, V10, P189, DOI 10.1006/scdb.1999.0300; Novitch BG, 1996, J CELL BIOL, V135, P441, DOI 10.1083/jcb.135.2.441; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Shanahan F, 1999, MOL CELL BIOL, V19, P1460; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; WEINTRAUB H, 1990, P NATL ACAD SCI USA, V87, P5623, DOI 10.1073/pnas.87.15.5623; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X	30	254	257	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					187	190		10.1038/84826	http://dx.doi.org/10.1038/84826			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175787				2022-12-17	WOS:000166839200020
J	Bamford, RN; Roessler, E; Burdine, RD; Saplakoglu, U; dela Cruz, J; Splitt, M; Towbin, J; Bowers, P; Marino, B; Schier, AF; Shen, MM; Muenke, M; Casey, B				Bamford, RN; Roessler, E; Burdine, RD; Saplakoglu, U; dela Cruz, J; Splitt, M; Towbin, J; Bowers, P; Marino, B; Schier, AF; Shen, MM; Muenke, M; Casey, B			Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects	NATURE GENETICS			English	Article							LEFT-RIGHT AXIS; ONE-EYED PINHEAD; GASTRULATION; ZEBRAFISH; MALFORMATIONS; MESODERM	Ail vertebrates display a characteristic asymmetry of internal organs with the cardiac apex, stomach and spleen towards the left, and the liver and gall bladder on the right(1-3). Left-right (L-R) axis abnormalities or laterality defects are common in humans (1 in 8,500 live births). Several genes (such as Nodal, Ebaf and Pitx2) have been implicated in L-R organ positioning in model organisms(2-4), In humans, relatively few genes have been associated with a small percentage of human situs defects. These include ZIC3 (ref. 5), LEFTB (formerly LEFTY2; ref. 6) and ACVR2B (encoding activin receptor IIB; ref, 7). The EGF-CFC genes(8), mouse Cfc1 (encoding the Cryptic protein; ref. 9) and zebrafish one-eyed pinhead (oep; refs 10,11) are essential for the establishment of the L-R axis(12,13). EGF-CFC proteins act as co-factors for Nodal-related signals(11), which have also been implicated in L-R axis development(4). Here we identify loss-of-function mutations in human CFC1 (encoding the CRYPTIC protein) in patients with heterotaxic phenotypes (randomized organ positioning). The mutant proteins have aberrant cellular localization in transfected cells and are functionally defective in a zebrafish oepmutant rescue assay. Our findings indicate that the essential role of EGF-CFC genes and Nodal signalling in left-right axis formation is conserved from fish to humans. Moreover, our results support a role for environmental and/or genetic modifiers in determining the ultimate phenotype in humans.	NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; NYU, Sch Med, Dept Cell Biol, Skirball Inst Biomol Med,Dev Genet Program, New York, NY 10016 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, Piscataway, NJ 08854 USA; Univ Newcastle Upon Tyne, Dept Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; Bambino Gesu Childrens Hosp, Dept Cardiol, Rome, Italy; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); New York University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Newcastle University - UK; Baylor College of Medicine; Yale University; IRCCS Bambino Gesu; Baylor College of Medicine	Muenke, M (corresponding author), NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA.		Shen, Michael M/C-7546-2009; Towbin, Jeffrey A./J-5595-2019	Shen, Michael M/0000-0002-4042-1657; Towbin, Jeffrey A./0000-0002-6585-714X; Burdine, Rebecca/0000-0001-6620-5015; Muenke, Maximilian/0000-0002-7719-6545; Schier, Alexander Franz/0000-0001-7645-5325				Burdine RD, 2000, GENE DEV, V14, P763; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; COLLIGNON DB, 1996, NATURE, V3881, P155; Gaio U, 1999, CURR BIOL, V9, P1339, DOI 10.1016/S0960-9822(00)80059-7; Gebbia M, 1997, NAT GENET, V17, P305, DOI 10.1038/ng1197-305; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Kane DA, 1996, DEVELOPMENT, V123, P47; Kosaki K, 1998, SEMIN CELL DEV BIOL, V9, P89, DOI 10.1006/scdb.1997.0187; Kosaki K, 1999, AM J HUM GENET, V64, P712, DOI 10.1086/302289; Kosaki R, 1999, AM J MED GENET, V82, P70, DOI 10.1002/(SICI)1096-8628(19990101)82:1<70::AID-AJMG14>3.0.CO;2-Y; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Minchiotti G, 2000, MECH DEVELOP, V90, P133, DOI 10.1016/S0925-4773(99)00235-X; NIIKAWA N, 1983, AM J MED GENET, V16, P43, DOI 10.1002/ajmg.1320160108; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Osada SI, 2000, DEVELOPMENT, V127, P2503; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; Shen MM, 1997, DEVELOPMENT, V124, P429; SolnicaKrezel L, 1996, DEVELOPMENT, V123, P67; Yan YT, 1999, GENE DEV, V13, P2527, DOI 10.1101/gad.13.19.2527; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	22	254	271	1	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					365	369		10.1038/81695	http://dx.doi.org/10.1038/81695			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062482				2022-12-17	WOS:000165176500031
J	Feliubadalo, L; Font, M; Purroy, J; Rousaud, F; Estivill, X; Nunes, V; Golomb, E; Centola, M; Aksentijevich, I; Kreiss, Y; Goldman, B; Pras, M; Kastner, DL; Pras, E; Gasparini, P; Bisceglia, L; Beccia, E; Gallucci, M; de Sanctis, L; Ponzone, A; Rizzoni, GF; Zelante, L; Bassi, MT; George, AL; Manzoni, M; De Grandi, A; Riboni, M; Endsley, JK; Ballabio, A; Borsani, G; Reig, N; Fernandez, E; Estevez, R; Pineda, M; Torrents, D; Camps, M; Lloberas, J; Zorzano, A; Palacin, M				Feliubadalo, L; Font, M; Purroy, J; Rousaud, F; Estivill, X; Nunes, V; Golomb, E; Centola, M; Aksentijevich, I; Kreiss, Y; Goldman, B; Pras, M; Kastner, DL; Pras, E; Gasparini, P; Bisceglia, L; Beccia, E; Gallucci, M; de Sanctis, L; Ponzone, A; Rizzoni, GF; Zelante, L; Bassi, MT; George, AL; Manzoni, M; De Grandi, A; Riboni, M; Endsley, JK; Ballabio, A; Borsani, G; Reig, N; Fernandez, E; Estevez, R; Pineda, M; Torrents, D; Camps, M; Lloberas, J; Zorzano, A; Palacin, M		Int Cystinuria Consortium	Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (b(o,+)AT) of rBAT	NATURE GENETICS			English	Article							AMINO-ACID-TRANSPORT; EXPRESSION CLONING; SLC3A1 GENE; IDENTIFICATION; LOCALIZATION; KIDNEY; SYSTEM	Cystinuria (MIM 220100) is a common recessive disorder of renal reabsorption of cystine and dibasic amino acids. Mutations in SLC3A1, encoding rBAT, cause cystinuria type I (ref. 1), but not other types of cystinuria (ref. 2). A gene whose mutation causes non-type I cystinuria has been mapped by linkage analysis to 19q12-13.1 (refs 3,4). We have identified a new transcript, encoding a protein (b(o,+)AT, for b(o,+) amino acid transporter) belonging to a family of light subunits of amino acid transporters, expressed in kidney, liver, small intestine and placenta, and localized its gene (SLC7A9) to the non-type I cystinuria 19q locus. Co-transfection of b(o,+)AT and rBAT brings the latter to the plasma membrane, and results in the uptake of L-arginine in COS cells. We have found SLC7A9 mutations in Libyan-Jews, North American, Italian and Spanish non-type I cystinuria patients. The Libyan Jewish patients are homozygous for a founder missense mutation (V170M) that abolishes b(o,+)AT amino-acid uptake activity when co-transfected with rBAT in COS cells. We identified four missense mutations (G105R, A182T, G195R and C295R) and two frameshift (520insT and 596delTG) mutations in other patients. Our data establish that mutations in SLC7A9 cause non-type I cystinuria, and suggest that b(o,+)AT is the light subunit of rBAT.	Univ Barcelona, Dept Bioquim & Biol Mol, Fac Biol, E-08028 Barcelona, Spain; Hosp Duran & Reynals, Ctr Genet Med & Mol IRO, E-08907 Barcelona, Spain; Fdn Puigvert, Serv Nefrol IUNA, E-08025 Barcelona, Spain; Tel Aviv Univ, Sackler Sch Med, Dept Pathol, IL-69978 Tel Aviv, Israel; NIAMSD, Arthrit & Rheumatism Branch, Bethesda, MD 20892 USA; Chaim Sheba Med Ctr, Dept Med C, IL-52621 Tel Hashomer, Israel; Chaim Sheba Med Ctr, Inst Human Genet, IL-52621 Tel Hashomer, Israel; Chaim Sheba Med Ctr, Dept Med F, IL-52621 Tel Hashomer, Israel; Chaim Sheba Med Ctr, Heller Inst Med Sci, IL-52621 Tel Hashomer, Israel; IRCCS, Med Genet Serv, Hosp CSS, San Giovanni Rotondo, Italy; IRCCS, Div Urol, Hosp CSS, San Giovanni Rotondo, Italy; Hosp Cristo Re, Div Urol, Rome, Italy; Univ Turin, Dept Pediat, I-10124 Turin, Italy; Hosp Bambino Gesu, Div Pediat Nephrol, Rome, Italy; Telethon Inst Genet & Med, I-20132 Milan, Italy; Vanderbilt Univ, Dept Med, Div Med Genet, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Med, Div Nephrol, Nashville, TN 37232 USA; Univ Barcelona, Dept Fisiol Biol Macrophage, Fac Biol, E-08028 Barcelona, Spain	University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Fundacio Puigvert; Tel Aviv University; Sackler Faculty of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; University of Turin; IRCCS Bambino Gesu; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Vanderbilt University; Vanderbilt University; University of Barcelona	Palacin, M (corresponding author), Univ Barcelona, Dept Bioquim & Biol Mol, Fac Biol, Avda Diagonal 645, E-08028 Barcelona, Spain.		Riu, Marta Pineda/I-1497-2015; Estivill, Xavier/A-3125-2013; Palacín, Manuel/G-9786-2015; Borsani, Giuseppe/B-1709-2010; Aksentijevich, Ivona/AAF-1335-2019; Bisceglia, Luigi/B-8720-2017; De Sanctis, Luisa/AAC-6902-2022; Estivill, Xavier/E-2957-2012; Feliubadalo, Lidia/G-4577-2016; Nunes, Virginia/AAD-1014-2019; Nunes, Virginia/D-4356-2014; Bassi, Maria Teresa T/A-3517-2014; Lloberas, Jorge/D-4303-2014; Wilson, Matthew H/K-3193-2013; Zorzano, Antonio/R-5479-2018; Gasparini, Paolo/B-6173-2014; Torrents, David/G-5785-2015; Gallucci, Michele/K-9600-2016; Estevez, Raul/D-8610-2015; Camps Camprubi, Marta/F-6557-2016	Riu, Marta Pineda/0000-0002-5403-5845; Estivill, Xavier/0000-0002-0723-2256; Borsani, Giuseppe/0000-0003-0110-1148; Bisceglia, Luigi/0000-0001-5367-8518; Feliubadalo, Lidia/0000-0002-1736-0112; Nunes, Virginia/0000-0002-5747-9310; Nunes, Virginia/0000-0002-5747-9310; Bassi, Maria Teresa T/0000-0002-8236-1197; Lloberas, Jorge/0000-0001-7075-4201; BALLABIO, Andrea/0000-0003-1381-4604; Palacin, Manuel/0000-0002-8670-293X; DE SANCTIS, Luisa/0000-0003-2113-6196; Torrents, David/0000-0002-6086-9037; Gallucci, Michele/0000-0002-3637-6531; Estevez, Raul/0000-0003-1579-650X; Camps Camprubi, Marta/0000-0001-5392-1792; Gasparini, Paolo/0000-0002-0859-0856	Telethon [E.0556, TGM06S01, TGM97000] Funding Source: Medline	Telethon(Fondazione Telethon)		ASHWORTH LK, 1995, NAT GENET, V11, P422, DOI 10.1038/ng1295-422; BERTRAN J, 1993, J BIOL CHEM, V268, P14842; Bisceglia L, 1997, AM J HUM GENET, V60, P611; BISCEGLIA L, 1994, HUM MUTAT, V4, P136, DOI 10.1002/humu.1380040208; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Borsani G, 1999, NAT GENET, V21, P297, DOI 10.1038/6815; CALONGE MJ, 1995, P NATL ACAD SCI USA, V92, P9667, DOI 10.1073/pnas.92.21.9667; CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420; FELIUBADALO L, IN PRESS GENOMICS; FURRIOLS M, 1993, J BIOL CHEM, V268, P27060; GOODYER PR, 1993, J PEDIATR-US, V122, P568, DOI 10.1016/S0022-3476(05)83537-1; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Mastroberardino L, 1998, NATURE, V395, P288, DOI 10.1038/26246; Mora C, 1996, J BIOL CHEM, V271, P10569, DOI 10.1074/jbc.271.18.10569; Nakamura E, 1999, J BIOL CHEM, V274, P3009, DOI 10.1074/jbc.274.5.3009; Palacin M, 1998, CURR OPIN CELL BIOL, V10, P455, DOI 10.1016/S0955-0674(98)80058-6; Palacin M, 1996, BIOCHEM SOC T, V24, P856, DOI 10.1042/bst0240856; Pfeiffer R, 1998, FEBS LETT, V439, P157, DOI 10.1016/S0014-5793(98)01359-3; Pfeiffer R, 1999, EMBO J, V18, P49, DOI 10.1093/emboj/18.1.49; PICKEL VM, 1993, P NATL ACAD SCI USA, V90, P7779, DOI 10.1073/pnas.90.16.7779; Pineda M, 1999, J BIOL CHEM, V274, P19738, DOI 10.1074/jbc.274.28.19738; Pras E, 1998, AM J MED GENET, V80, P173, DOI 10.1002/(SICI)1096-8628(19981102)80:2<173::AID-AJMG16>3.0.CO;2-S; PRAS E, IN PRESS GENOMICS; Sambrook J, 1989, MOL CLONING LAB MANU; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; SILBERNAGL S, 1988, PHYSIOL REV, V68, P911, DOI 10.1152/physrev.1988.68.3.911; Torrents D, 1998, J BIOL CHEM, V273, P32437, DOI 10.1074/jbc.273.49.32437; Torrents D, 1999, NAT GENET, V21, P293, DOI 10.1038/6809; Wartenfeld R, 1997, AM J HUM GENET, V60, P617	29	254	259	0	22	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1999	23	1					52	57		10.1038/12652	http://dx.doi.org/10.1038/12652			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	231XU	10471498				2022-12-17	WOS:000082337300015
J	Coffee, B; Zhang, FP; Warren, ST; Reines, D				Coffee, B; Zhang, FP; Warren, ST; Reines, D			Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells	NATURE GENETICS			English	Article							REPRESS TRANSCRIPTION; DNA METHYLATION; GENE; REGION; DEACETYLASE; EXPRESSION; PROMOTER; YEAST; REACTIVATION; NUCLEOSOME	Mutation of FMR1 results in fragile X mental retardation(1). The most common FMR1 mutation is expansion of a CGG repeat tract at the 5' end of FMR1 (refs 2-4), which leads to cytosine methylation and transcriptional silencing(5,6). Both DNA methylation and histone deacetylation have been associated with transcriptional inactivity(7-9). The finding that the methyl cytosine-binding protein MeCP2 binds to histone deacetylases and represses transcription in vivo(10,11) supports a model in which MeCP2 recruits histone deacetylases to methylated DNA, resulting in histone deacetylation, chromatin condensation and transcriptional silencing(12). Here we demonstrate that the 5' end of FMR1 is associated with acetylated histones H3 and H4 in cells from normal individuals, but acetylation is reduced in cells from fragile X patients. Treatment of fragile X cells with 5-aza-2'-deoxycytidine (5-aza-dC) resulted in reassociation of acetylated histones H3 and H4 with FMR1 and transcriptional reactivation, whereas treatment with trichostatin A (TSA) led to almost complete acetylated histone H4 and little acetylated histone H3 reassociation with FMR1, as well as no detectable transcription. Our results represent the first description of loss of histone acetylation at a specific locus in human disease, and advance understanding of the mechanism of FMR1 transcriptional silencing.	Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Howard Hughes Med Inst, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Genet, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA	Emory University; Emory University; Howard Hughes Medical Institute; Emory University; Emory University	Reines, D (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.		excellency, Your/R-2357-2019; Warren, Stephen T/A-2498-2012	excellency, Your/0000-0003-0832-6243; 	NICHD NIH HHS [HD35576] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD035576] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Ammerpohl O, 1998, NUCLEIC ACIDS RES, V26, P5256, DOI 10.1093/nar/26.23.5256; ARTS J, 1995, BIOCHEM J, V310, P171, DOI 10.1042/bj3100171; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; CHEN EY, 1991, GENOMICS, V10, P792, DOI 10.1016/0888-7543(91)90465-Q; Chiurazzi P, 1998, HUM MOL GENET, V7, P109, DOI 10.1093/hmg/7.1.109; Drouin R, 1997, HUM MOL GENET, V6, P2051, DOI 10.1093/hmg/6.12.2051; Eberhart DE, 1996, SOMAT CELL MOLEC GEN, V22, P435, DOI 10.1007/BF02369435; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Imbert G, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P27; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; LIN R, 1989, J CELL BIOL, V108, P1577, DOI 10.1083/jcb.108.5.1577; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Madisen L, 1998, MOL CELL BIOL, V18, P6281, DOI 10.1128/MCB.18.11.6281; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; SASAKI T, 1992, MOL CELL BIOL, V12, P3819, DOI 10.1128/MCB.12.9.3819; Schwemmle S, 1997, AM J HUM GENET, V60, P1354, DOI 10.1086/515456; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; TURNER BM, 1993, CELL, V75, P5, DOI 10.1016/S0092-8674(05)80078-9; VanLint C, 1996, GENE EXPRESSION, V5, P245; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	30	254	258	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1999	22	1					98	101		10.1038/8807	http://dx.doi.org/10.1038/8807			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192TU	10319871				2022-12-17	WOS:000080096300032
J	Silva, AJ; Frankland, PW; Marowitz, Z; Friedman, E; Lazlo, G; Cioffi, D; Jacks, T; Bourtchuladze, R				Silva, AJ; Frankland, PW; Marowitz, Z; Friedman, E; Lazlo, G; Cioffi, D; Jacks, T; Bourtchuladze, R			A mouse model for the learning and memory deficits associated with neurofibromatosis type I	NATURE GENETICS			English	Article							LONG-TERM POTENTIATION; TARGETED MUTATION; MICE; BEHAVIOR; HIPPOCAMPAL; EXPRESSION; NEURONS; BRAIN; FEAR; NF1	Neurofibromatosis type I (NF1) is one of the most commonly inherited neurological disorders in humans, affecting approximately one in 4,000 individuals(1-3). NF1 results in a complex cluster of developmental and tumour syndromes that include benign neurofibromas, hyperpigmentation of melanocytes and hamartomas of the iris. Some NF1 patients may also show neurologic lesions, such as optic pathway gliomas, dural ectasia and aqueduct stenosis(1-3). Importantly, learning disabilities occur in 30% to 45% of patients with NF1, even in the absence of any apparent neural pathology. The learning disabilities may include a depression in mean IQ scores, visuoperceptual problems and impairments in spatial cognitive abilities(4-9). Spatial learning has been assessed with a variety of cognitive tasks and the most consistent spatial learning deficits have been observed with the Judgement of Line Orientation test(4,7,10,11). It is important to note that some of these deficits could be secondary to developmental abnormalities(1) and other neurological problems, such as poor motor coordination and attentional deficits(9). Previous studies have suggested a role for neurofibromin in brain function. First, the expression of the Nf1 gene is largely restricted to neuronal tissues in the adult(12-14). Second, this GTPase activating protein may act as a negative regulator of neurotrophin-mediated signalling(15). Third, immunohistochemical studies suggest that activation of astrocytes may be common in the brain of NF1 patients(13). Here, we show that the Nf1(+/-) mutation also affects learning and memory in mice. As in humans, the learning and memory deficits of the Nf1(+/-) mice are restricted to specific types of learning, they are not fully penetrant, they can be compensated for with extended training, and they do not involve deficits in simple associative learning.	MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA; MIT, HOWARD HUGHES MED INST, CAMBRIDGE, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Silva, AJ (corresponding author), COLD SPRING HARBOR LAB, POB 100, COLD SPRING HARBOR, NY 11724 USA.		Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494				BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; DATSON MM, 1992, NEURON, V8, P415; EASTON DF, 1993, AM J HUM GENET, V53, P305; ELDRIDGE R, 1989, AM J DIS CHILD, V143, P833, DOI 10.1001/archpedi.1989.02150190083027; Eliason M J, 1988, Neurofibromatosis, V1, P17; ELIASON MJ, 1986, J DEV BEHAV PEDIATR, V7, P175; GUTMANN DH, 1992, ANN NEUROL, V31, P555, DOI 10.1002/ana.410310515; HOFMAN KJ, 1994, J PEDIATR-US, V124, pS1, DOI 10.1016/S0022-3476(05)83163-4; HUSON SM, 1994, NEUROFIBROMATOSES PA, P204; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; JOY P, 1995, DEV MED CHILD NEUROL, V37, P906; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; NORDLUND M, 1993, J NEUROSCI, V13, P1588; NORDLUND ML, 1995, J NEUROPATH EXP NEUR, V54, P588, DOI 10.1097/00005072-199507000-00013; NORTH K, 1993, J CHILD NEUROL, V8, P395, DOI 10.1177/088307389300800421; NORTH K, 1995, DEV MED CHILD NEUROL, V37, P427, DOI 10.1111/j.1469-8749.1995.tb12026.x; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; RICCARDI VM, 1992, NEUROFIBROMATOSIS PH, P195; SUTHERLAND RJ, 1982, NEUROSCI LETT, V31, P271, DOI 10.1016/0304-3940(82)90032-5; VARNHAGEN CK, 1988, J DEV BEHAV PEDIATR, V9, P257; VOGEL KS, 1995, CELL, V82, P733, DOI 10.1016/0092-8674(95)90470-0; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; ZHONG Y, 1995, NATURE, V375, P588, DOI 10.1038/375588a0	30	254	260	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					281	284		10.1038/ng0397-281	http://dx.doi.org/10.1038/ng0397-281			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054942				2022-12-17	WOS:A1997WK38600019
J	Mangiarini, L; Sathasivam, K; Mahal, A; Mott, R; Seller, M; Bates, GP				Mangiarini, L; Sathasivam, K; Mahal, A; Mott, R; Seller, M; Bates, GP			Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation	NATURE GENETICS			English	Article							SPINOCEREBELLAR ATAXIA TYPE-1; PALLIDOLUYSIAN ATROPHY DRPLA; ANDROGEN RECEPTOR GENE; TRINUCLEOTIDE REPEAT; ONSET; AGE; EXPANSION; LENGTH; MOSAICISM	Six inherited neurodegenerative diseases are caused by a CAG/polyglutamine expansion, including spinal and bulbar muscular atrophy (SBMA)(1), Huntington's disease (HD)(2), spinocerebellar ataxia type 1 (SCA1)(3), dentatorubral pallidoluysian atrophy (DRPLA)(4,5) Machado-Joseph disease (MJD or SCA3)(6) and SCA2(7-9). Normal and expanded HD allele sizes of 6-39 and 35-121 repeats have been reported(10-13), and the allele distributions for the other diseases are comparable. Intergenerational instability has been described in all cases, and repeats tend to be more unstable on paternal transmission. This may present as larger increases on paternal inheritance as in HD14, or as a tendency to increase on male and decrease on female transmission as in SCA1 (ref.15). Stomatic repeat instability is also appears most pronounced in the CNS16,17. The major exception is the cerebellum, which in HD, DRPLA, SCA1 and MJD has a smaller repeat relative to the other brain regions tested(16-21). Of non-CNS tissues, instability was observed in blood, liver, kidney and colon(16,20,21). A mouse model of CAG repeat instability would be helpful in unravelling its molecular basis although an absence of CAG repeat instability in transgenic mice has so far been reported. These studies include (CAG)(45) in the androgen receptor cDNA(22), (CAG)(44), in the HD cDNA(23), (CAG)(82) in the SCA1 cDNA(24), (CAG)(79) in the SCA3 cDNA and as an isolated (CAC)(79) tract(25).	GUYS HOSP,DIV MED & MOL GENET,LONDON SE1 9RT,ENGLAND; SANGER CTR,HINXTON CB10 1RO,CAMBS,ENGLAND	Guy's & St Thomas' NHS Foundation Trust; Wellcome Trust Sanger Institute			Bates, Gillian P/E-1146-2012; Longo, Kenneth A/A-5631-2010	Bates, Gillian P/0000-0002-4041-6305; Mott, Richard/0000-0002-1022-9330				ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; ARONIN N, 1995, NEURON, V15, P1193, DOI 10.1016/0896-6273(95)90106-X; BARRON LH, 1993, J MED GENET, V30, P1003, DOI 10.1136/jmg.30.12.1003; BINGHAM PM, 1995, NAT GENET, V9, P191, DOI 10.1038/ng0295-191; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; CHONG SS, 1995, NAT GENET, V10, P344, DOI 10.1038/ng0795-344; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FARRER LA, 1992, AM J HUM GENET, V50, P528; Goldberg YP, 1996, HUM MOL GENET, V5, P177, DOI 10.1093/hmg/5.2.177; *HDCRG, 1993, CELL, V72, P971; HOGAN B, 1994, MANIPULATING MOUSE E; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KRAWCZAK M, 1991, AM J HUM GENET, V49, P735; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MANGIARINI L, 1996, CELL, V87, P497; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; RIESS O, 1993, HUM MOL GENET, V2, P637, DOI 10.1093/hmg/2.6.637; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; SAMPEI K, 1996, NAT GENET, V14, P277; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; Takano H, 1996, AM J HUM GENET, V58, P1212; Tanaka F, 1996, J NEUROL SCI, V135, P43, DOI 10.1016/0022-510X(95)00249-2; TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409; UENO S, 1995, HUM MOL GENET, V4, P663, DOI 10.1093/hmg/4.4.663	30	254	264	1	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					197	200		10.1038/ng0297-197	http://dx.doi.org/10.1038/ng0297-197			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020849				2022-12-17	WOS:A1997WF08700023
J	Bellus, GA; Gaudenz, K; Zackai, EH; Clarke, LA; Szabo, J; Francomano, CA; Muenke, M				Bellus, GA; Gaudenz, K; Zackai, EH; Clarke, LA; Szabo, J; Francomano, CA; Muenke, M			Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes	NATURE GENETICS			English	Letter							PFEIFFER-SYNDROME; CROUZON-SYNDROME; ACHONDROPLASIA; DOMAIN		UNIV PENN,SCH MED,CHILDRENS HOSP PHILADELPHIA,DEPT PEDIAT,DIV HUMAN GENET & MOL BIOL,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,CHILDRENS HOSP PHILADELPHIA,DEPT GENET,PHILADELPHIA,PA 19104; NIH,MED GENET BRANCH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892; JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,BALTIMORE,MD 21287; BRITISH COLUMBIS INST CHILD & FAMILY HLTH,DEPT MED GENET,VANCOUVER,BC V5Z 4H4,CANADA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University; Child & Family Research Institute				Muenke, Maximilian/0000-0002-7719-6545; Clarke, Lorne/0000-0003-0512-7281; Bellus, Gary/0000-0001-7492-3324	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD028732, R01HD029862] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD29862, R29 HD28732] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357; COHEN MM, 1993, AM J MED GENET, V45, P300, DOI 10.1002/ajmg.1320450305; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; HOLLWAY GE, 1995, HUM MOL GENET, V4, P681, DOI 10.1093/hmg/4.4.681; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; LAJEUNIE E, 1995, NAT GENET, V9, P108, DOI 10.1038/ng0295-108; LI X, 1995, NAT GENET, V9, P232, DOI 10.1038/ng0395-232; MASON IJ, 1994, CELL, V78, P547, DOI 10.1016/0092-8674(94)90520-7; MCKUSICK VA, 1994, MENDELIAN INHERITANC, P759; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; Meyers GA, 1996, AM J HUM GENET, V58, P491; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; NEILSON KM, 1995, J BIOL CHEM, V270, P26037, DOI 10.1074/jbc.270.44.26037; PETERS K, 1993, DEV BIOL, V155, P423, DOI 10.1006/dbio.1993.1040; ROBIN NH, 1994, HUM MOL GENET, V3, P2153, DOI 10.1093/hmg/3.12.2153; Rousseau F, 1996, HUM MOL GENET, V5, P509, DOI 10.1093/hmg/5.4.509; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; SCHELL U, 1995, HUM MOL GENET, V4, P323, DOI 10.1093/hmg/4.3.323; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; TAVORMINA PL, 1995, HUM MOL GENET, V4, P2175, DOI 10.1093/hmg/4.11.2175; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; vonGernet S, 1996, AM J MED GENET, V63, P177; Webster MK, 1996, EMBO J, V15, P520, DOI 10.1002/j.1460-2075.1996.tb00384.x; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165	27	254	257	0	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1996	14	2					174	176		10.1038/ng1096-174	http://dx.doi.org/10.1038/ng1096-174			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL446	8841188				2022-12-17	WOS:A1996VL44600022
J	ROSENTHAL, A; JOUET, M; KENWRICK, S				ROSENTHAL, A; JOUET, M; KENWRICK, S			ABERRANT SPLICING OF NEURAL CELL-ADHESION MOLECULE L1 MESSENGER-RNA IN A FAMILY WITH X-LINKED HYDROCEPHALUS	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; MASA SYNDROME; OUTGROWTH; GENE	A locus for X-linked hydrocephalus (HSAS), which is characterized by mental retardation and enlarged brain ventricles, maps to the same subchromosomal region (Xq28) as the gene for neural cell adhesion molecule L1. We have found novel L1 mRNA species in cells from affected members of a HSAS family containing deletions and insertions produced by the utilization of alternative 3' splice sites. A point mutation at a potential branch point signal in an intron segregates with the disease and is likely to be responsible for the abnormal RNA processing. These results suggest that HSAS is a disorder of neuronal cell migration due to disruption of L1 protein function.	UNIV CAMBRIDGE,ADDENBROOKES HOSP,DEPT MED,CAMBRIDGE CB2 2QQ,ENGLAND	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	KENWRICK, S (corresponding author), UNIV CAMBRIDGE,ADDENBROOKES HOSP,MRC,MOLEC GENET GRP,CAMBRIDGE CB2 2QQ,ENGLAND.							BACH I, 1992, AM J HUM GENET, V50, P38; Grumet M, 1991, Curr Opin Neurobiol, V1, P370, DOI 10.1016/0959-4388(91)90055-C; HLAVIN ML, 1991, GENOMICS, V11, P416, DOI 10.1016/0888-7543(91)90150-D; KOWITZ A, 1992, EUR J IMMUNOL, V22, P1199, DOI 10.1002/eji.1830220514; KUHN TB, 1991, J CELL BIOL, V115, P1113, DOI 10.1083/jcb.115.4.1113; LANDMESSER L, 1988, DEV BIOL, V130, P645, DOI 10.1016/0012-1606(88)90358-2; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; MCKUSICK VA, 1988, MENDELIAN INHERITANC; POUSTKA A, 1991, P NATL ACAD SCI USA, V88, P8302, DOI 10.1073/pnas.88.19.8302; ROSENTHAL A, 1991, NUCLEIC ACIDS RES, V19, P5395, DOI 10.1093/nar/19.19.5395; ROSENTHAL A, IN PRESS DNA SEQUENC; SCHRANDERSTUMPEL C, 1990, J MED GENET, V27, P688, DOI 10.1136/jmg.27.11.688; SHARP P, 1987, SCIENCE, V235, P767; SMITH SB, 1989, SCIENCE, V243, P203, DOI 10.1126/science.2911733; VANOOST BA, 1992, MAPPING GENES DNA MA, V1; WILLEMS PJ, 1987, AM J MED GENET, V27, P921, DOI 10.1002/ajmg.1320270419; WILLEMS PJ, 1990, GENOMICS, V8, P367, DOI 10.1016/0888-7543(90)90294-5; WILLEMS PJ, 1991, CYTOGENET CELL GENET, V58, P2090; WINTER RM, 1989, HUM GENET, V82, P367	20	254	258	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1992	2	2					107	112		10.1038/ng1092-107	http://dx.doi.org/10.1038/ng1092-107			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JR084	1303258				2022-12-17	WOS:A1992JR08400008
J	Bolger, A; Scossa, F; Bolger, ME; Lanz, C; Maumus, F; Tohge, T; Quesneville, H; Alseekh, S; Sorensen, I; Lichtenstein, G; Fich, EA; Conte, M; Keller, H; Schneeberger, K; Schwacke, R; Ofner, I; Vrebalov, J; Xu, YM; Osorio, S; Aflitos, SA; Schijlen, E; Jimenez-Gomez, JM; Ryngajllo, M; Kimura, S; Kumar, R; Koenig, D; Headland, LR; Maloof, JN; Sinha, N; van Ham, RCHJ; Lankhorst, RK; Mao, LY; Vogel, A; Arsova, B; Panstruga, R; Fei, ZJ; Rose, JKC; Zamir, D; Carrari, F; Giovannoni, JJ; Weigel, D; Usadel, B; Fernie, AR				Bolger, Anthony; Scossa, Federico; Bolger, Marie E.; Lanz, Christa; Maumus, Florian; Tohge, Takayuki; Quesneville, Hadi; Alseekh, Saleh; Sorensen, Iben; Lichtenstein, Gabriel; Fich, Eric A.; Conte, Mariana; Keller, Heike; Schneeberger, Korbinian; Schwacke, Rainer; Ofner, Itai; Vrebalov, Julia; Xu, Yimin; Osorio, Sonia; Aflitos, Saulo Alves; Schijlen, Elio; Jimenez-Gomez, Jose M.; Ryngajllo, Malgorzata; Kimura, Seisuke; Kumar, Ravi; Koenig, Daniel; Headland, Lauren R.; Maloof, Julin N.; Sinha, Neelima; van Ham, Roeland C. H. J.; Lankhorst, Rene Klein; Mao, Linyong; Vogel, Alexander; Arsova, Borjana; Panstruga, Ralph; Fei, Zhangjun; Rose, Jocelyn K. C.; Zamir, Dani; Carrari, Fernando F; Giovannoni, James J.; Weigel, Detlef; Usadel, Bjoern; Fernie, Alisdair R.			The genome of the stress-tolerant wild tomato species Solanum pennellii	NATURE GENETICS			English	Article							INTROGRESSION LINES; GENE-EXPRESSION; FRUIT; QTL; ACCUMULATION; EVOLUTION; TRICHOMES; RESPONSES; PLANTS; TRAITS	Solanum pennellii is a wild tomato species endemic to Andean regions in South America, where it has evolved to thrive in arid habitats. Because of its extreme stress tolerance and unusual morphology, it is an important donor of germplasm for the cultivated tomato Solanum lycopersicum(1). Introgression lines (ILs) in which large genomic regions of S. lycopersicum are replaced with the corresponding segments from S. pennellii can show remarkably superior agronomic performance(2). Here we describe a high-quality genome assembly of the parents of the IL population. By anchoring the S. pennellii genome to the genetic map, we define candidate genes for stress tolerance and provide evidence that transposable elements had a role in the evolution of these traits. Our work paves a path toward further tomato improvement and for deciphering the mechanisms underlying the myriad other agronomic traits that can be improved with S. pennellii germplasm.	[Bolger, Anthony; Bolger, Marie E.; Schwacke, Rainer; Ryngajllo, Malgorzata; Usadel, Bjoern] Max Planck Inst Mol Plant Physiol, Dept Metab Networks, Potsdam Golm, Germany; [Bolger, Anthony; Vogel, Alexander; Usadel, Bjoern] Rhein Westfal TH Aachen, IBMG, Inst Biol 1, Aachen, Germany; [Scossa, Federico; Tohge, Takayuki; Alseekh, Saleh; Osorio, Sonia; Fernie, Alisdair R.] Max Planck Inst Mol Plant Physiol, Dept Mol Physiol, Potsdam Golm, Germany; [Scossa, Federico] Ctr Ric Orticoltura, Consiglio Ric Sperimentaz Agr, Pontecagnano, Italy; [Bolger, Marie E.; Schwacke, Rainer; Usadel, Bjoern] Forschungszentrum Julich, IBG 2, D-52425 Julich, Germany; [Lanz, Christa; Keller, Heike; Schneeberger, Korbinian; Koenig, Daniel; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [Maumus, Florian; Quesneville, Hadi] INRA Versailles Grignon, French Natl Inst Agr Res INRA, Res Unit Genom Info URGI UR1164, Versailles, France; [Sorensen, Iben; Fich, Eric A.; Rose, Jocelyn K. C.] Cornell Univ, Dept Plant Biol, Ithaca, NY USA; [Lichtenstein, Gabriel; Conte, Mariana; Carrari, Fernando F] INTA, CICVyA, Inst Biotecnol, Castelar, Argentina; [Lichtenstein, Gabriel; Conte, Mariana; Carrari, Fernando F] Consejo Nacl Invest Cient & Tecn, Castelar, Argentina; [Schneeberger, Korbinian] Max Planck Inst Plant Breeding Res, Dept Plant Dev Biol, Cologne, Germany; [Ofner, Itai; Zamir, Dani] Hebrew Univ Jerusalem, Fac Agr, IL-76100 Rehovot, Israel; [Vrebalov, Julia; Xu, Yimin; Mao, Linyong; Fei, Zhangjun; Giovannoni, James J.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Osorio, Sonia] Univ Malaga, Inst Hortofruticultura Subtrop & Mediterrane La M, Dept Mol Biol & Biochem, E-29071 Malaga, Spain; [Aflitos, Saulo Alves; Schijlen, Elio; van Ham, Roeland C. H. J.; Lankhorst, Rene Klein] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [Jimenez-Gomez, Jose M.] Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany; [Jimenez-Gomez, Jose M.] INRA, Inst Jean Pierre Bourgin, UMR 1318, F-78026 Versailles, France; [Kimura, Seisuke; Kumar, Ravi; Koenig, Daniel; Headland, Lauren R.; Maloof, Julin N.; Sinha, Neelima] Univ Calif Davis, Dept Plant Biol, Davis, CA USA; [Arsova, Borjana] Univ Dusseldorf, Dusseldorf, Germany; [Panstruga, Ralph] Rhein Westfal TH Aachen, Inst Biol 1, Unit Plant Mol Cell Biol, Aachen, Germany; [Fei, Zhangjun; Giovannoni, James J.] USDA, Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA	Max Planck Society; RWTH Aachen University; Max Planck Society; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Helmholtz Association; Research Center Julich; Max Planck Society; INRAE; Cornell University; Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Max Planck Society; Hebrew University of Jerusalem; Cornell University; Boyce Thompson Institute for Plant Research; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Wageningen University & Research; Max Planck Society; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Davis; Heinrich Heine University Dusseldorf; RWTH Aachen University; United States Department of Agriculture (USDA)	Usadel, B (corresponding author), Max Planck Inst Mol Plant Physiol, Dept Metab Networks, Potsdam Golm, Germany.	usadel@bio1.rwth-aachen.de	Fei, Zhangjun/H-5152-2012; Maumus, Florian/O-5426-2016; Weigel, Detlef/C-1418-2008; Usadel, Björn/E-1932-2011; Aflitos, Saulo/J-8930-2014; Schneeberger, Korbinian/U-6329-2019; Klein Lankhorst, René/HGD-0360-2022; Weigel, Detlef/AAR-3312-2021; Arsova, Borjana/F-4252-2017; Scossa, Federico/ABI-5343-2020; Panstruga, Ralph/F-3340-2011; Weigel, Detlef/GSJ-0799-2022; Arsova, Borjana/AAA-5594-2020; Osorio, Sonia/AAB-1491-2019; Tohge, Takayuki/G-7924-2017; Quesneville, Hadi/AAG-1048-2020; Ryngajłło, Małgorzata/M-2959-2018; Osorio, Sonia/M-2258-2014	Maumus, Florian/0000-0001-7325-0527; Weigel, Detlef/0000-0002-2114-7963; Usadel, Björn/0000-0003-0921-8041; Aflitos, Saulo/0000-0002-9179-5309; Schneeberger, Korbinian/0000-0002-5512-0443; Arsova, Borjana/0000-0002-0566-2009; Scossa, Federico/0000-0002-6233-1679; Panstruga, Ralph/0000-0002-3756-8957; Weigel, Detlef/0000-0002-2114-7963; Osorio, Sonia/0000-0002-0159-6091; Tohge, Takayuki/0000-0001-5555-5650; Quesneville, Hadi/0000-0003-3001-4908; Ryngajłło, Małgorzata/0000-0002-0430-0102; Bolger, Marie/0000-0001-6335-1578; Fich, Eric/0000-0002-8948-7112; Maloof, Julin/0000-0002-9623-2599; Headland, Lauren/0000-0002-3242-0806; Kimura, Seisuke/0000-0002-6796-3675; Fei, Zhangjun/0000-0001-9684-1450; Sorensen, Iben/0000-0002-9768-620X; LICHTENSTEIN, GABRIEL/0000-0002-2974-6717; Jimenez-Gomez, Jose M/0000-0002-5033-7192	Max Planck Society; Deutsche Israeli Project [FE 552/12-1]; Bundesministerium fur Bildung und Forschung (BMBF) [FKZ 0315961]; Deutsche Forschungsgemeinschaft International Research Training Groups (IRTG) [1525]; CRA Young Investigator Program; INTA, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) grant; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYPT) grant; NSF grant [IOS-0820854]; US National Science Foundation [DBI-0606595, DBI-1313887]; Agriculture and Food Research Initiative competitive grant ,USDA National Institute of Food and Agriculture [2011-04197]; US National Science Foundation Plant Genome Program [DBI-0820612, IOS-0923312]; Direct For Biological Sciences [0820854] Funding Source: National Science Foundation	Max Planck Society(Max Planck Society); Deutsche Israeli Project; Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft International Research Training Groups (IRTG); CRA Young Investigator Program; INTA, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) grant; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYPT) grant; NSF grant(National Science Foundation (NSF)); US National Science Foundation(National Science Foundation (NSF)); Agriculture and Food Research Initiative competitive grant ,USDA National Institute of Food and Agriculture; US National Science Foundation Plant Genome Program(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We gratefully acknowledge the support of the Max Planck Society in the form of an exceptional grant to cover the costs of sequencing the tomato species. In addition, work in the laboratories of D.Z. and A.R.F. was funded in the framework of Deutsche Israeli Project FE 552/12-1, which is administered by the Deutsche Forschungsgemeinschaft. B.U. and M.E.B. acknowledge the support of the Bundesministerium fur Bildung und Forschung (BMBF)-funded primary database FKZ 0315961. B.A. thanks the Deutsche Forschungsgemeinschaft International Research Training Groups (IRTG) 1525. F.S. acknowledges the support of the CRA Young Investigator Program. Work in the laboratory of F.C. was funded by INTA, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) and Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYPT) grants. Work in the laboratories of N.S. and J.N.M. was funded by NSF grant IOS-0820854. J.R. was supported by the US National Science Foundation (Plant Genome Program; DBI-0606595 and DBI-1313887) and by Agriculture and Food Research Initiative competitive grant 2011-04197 from the USDA National Institute of Food and Agriculture. Work in the laboratories of J.G. and Z.F. was additionally supported by US National Science Foundation Plant Genome Program grants DBI-0820612 and IOS-0923312. A.B. would like to thank Y. Brotman for preparing the Pseudomonas syringae-infected S. pennellii samples.	Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [DOI 10.1007/BF02672069, 10.1007/BF02672069]; Bemer M, 2012, PLANT CELL, V24, P4437, DOI 10.1105/tpc.112.103283; Bourdenx B, 2011, PLANT PHYSIOL, V156, P29, DOI 10.1104/pp.111.172320; Bui Q.T., 2012, PLANT TRANSPOSABLE E, P273, DOI 10.1007/978-3-642-31842-9_14; Butelli E, 2012, PLANT CELL, V24, P1242, DOI 10.1105/tpc.111.095232; Chitwood DH, 2013, PLANT CELL, V25, P2465, DOI 10.1105/tpc.113.112391; Chung MY, 2010, PLANT J, V64, P936, DOI 10.1111/j.1365-313X.2010.04384.x; Eshed Y, 1992, THEOR APPL GENET, V83, P1027, DOI 10.1007/BF00232968; Filippis I, 2013, PLANT J, V75, P1039, DOI 10.1111/tpj.12250; Frary A, 2011, BIOL PLANTARUM, V55, P461, DOI 10.1007/s10535-011-0111-x; Frary A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-58; Gong PJ, 2010, J EXP BOT, V61, P3563, DOI 10.1093/jxb/erq167; GRUMET R, 1981, PLANT PHYSIOL, V68, P1428, DOI 10.1104/pp.68.6.1428; Gur A, 2004, PLOS BIOL, V2, P1610, DOI 10.1371/journal.pbio.0020245; Gur A, 2011, THEOR APPL GENET, V122, P405, DOI 10.1007/s00122-010-1456-9; Iijima Y, 2013, PHYTOCHEMISTRY, V95, P145, DOI 10.1016/j.phytochem.2013.07.016; Asins MJ, 2013, PLANT CELL ENVIRON, V36, P1171, DOI 10.1111/pce.12051; Kamenetzky L, 2010, PLANT PHYSIOL, V152, P1772, DOI 10.1104/pp.109.150532; Klee HJ, 2013, CURR BIOL, V23, pR520, DOI 10.1016/j.cub.2013.05.010; Kochevenko A, 2011, J EXP BOT, V62, P3895, DOI 10.1093/jxb/err091; Koenig D, 2013, P NATL ACAD SCI USA, V110, pE2655, DOI 10.1073/pnas.1309606110; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Lohse M, 2014, PLANT CELL ENVIRON, V37, P1250, DOI 10.1111/pce.12231; Mageroy MH, 2012, PLANT J, V69, P1043, DOI 10.1111/j.1365-313X.2011.04854.x; Maron LG, 2013, P NATL ACAD SCI USA, V110, P5241, DOI 10.1073/pnas.1220766110; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; Naito K, 2009, NATURE, V461, P1130, DOI 10.1038/nature08479; Nguyen CV, 2014, PLANT CELL, V26, P585, DOI 10.1105/tpc.113.118794; Parsons EP, 2012, PHYSIOL PLANTARUM, V146, P15, DOI 10.1111/j.1399-3054.2012.01592.x; Powell ALT, 2012, SCIENCE, V336, P1711, DOI 10.1126/science.1222218; Quadrana L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5027; RICK CM, 1981, PLANT SYST EVOL, V139, P11, DOI 10.1007/BF00983920; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schauer N, 2006, NAT BIOTECHNOL, V24, P447, DOI 10.1038/nbt1192; Schauer N, 2008, PLANT CELL, V20, P509, DOI 10.1105/tpc.107.056523; Schilmiller AL, 2012, P NATL ACAD SCI USA, V109, P16377, DOI 10.1073/pnas.1207906109; Schilmiller AL, 2009, P NATL ACAD SCI USA, V106, P10865, DOI 10.1073/pnas.0904113106; Tieman D, 2006, P NATL ACAD SCI USA, V103, P8287, DOI 10.1073/pnas.0602469103; Tieman D, 2010, PLANT J, V62, P113, DOI 10.1111/j.1365-313X.2010.04128.x; Uozumi A, 2012, SCI HORTIC-AMSTERDAM, V138, P1, DOI 10.1016/j.scienta.2012.01.036; Vogg G, 2004, J EXP BOT, V55, P1401, DOI 10.1093/jxb/erh149; Yeats TH, 2012, PLANT J, V69, P655, DOI 10.1111/j.1365-313X.2011.04820.x; Zamir D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001595	45	253	264	5	173	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2014	46	9					1034	+		10.1038/ng.3046	http://dx.doi.org/10.1038/ng.3046			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO8CE	25064008	hybrid, Green Published			2022-12-17	WOS:000341579400021
J	Perez-Iratxeta, C; Bork, P; Andrade, MA				Perez-Iratxeta, C; Bork, P; Andrade, MA			Association of genes to genetically inherited diseases using data mining	NATURE GENETICS			English	Article								Although approximately one-quarter of the roughly 4,000 genetically inherited diseases currently recorded in respective databases (LocusLink(1), OMIM2) are already linked to a region of the human genome, about 450 have no known associated gene. Finding disease-related genes requires laborious examination of hundreds of possible candidate genes (sometimes, these are not even annotated; see, for example, refs 3,4). The public availability of the human genome(5) draft sequence has fostered new strategies to map molecular functional features of gene products to complex phenotypic descriptions, such as those of genetically inherited diseases. Owing to recent progress in the systematic annotation of genes using controlled vocabularies 6, we have developed a scoring system for the possible functional relationships of human genes to 455 genetically inherited diseases that have been mapped to chromosomal regions without assignment of a particular gene. In a benchmark of the system with 100 known disease-associated genes, the disease-associated gene was among the 8 best-scoring genes with a 25% chance, and among the best 30 genes with a 50% chance, showing that there is a relationship between the score of a gene and its likelihood of being associated with a particular disease. The scoring also indicates that for some diseases, the chance of identifying the underlying gene is higher.	European Mol Biol Lab, D-69012 Heidelberg, Germany; Max Delbruck Ctr Mol Med, Dept Bioinformat, D-13092 Berlin, Germany	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69012 Heidelberg, Germany.	bork@embl-heidelberg.de	Andrade, Miguel A/B-6565-2008; Bork, Peer/F-1813-2013	Andrade, Miguel A/0000-0001-6650-1711; Bork, Peer/0000-0002-2627-833X				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Hamosh A, 2000, HUM MUTAT, V15, P57, DOI 10.1002/(SICI)1098-1004(200001)15:1<57::AID-HUMU12>3.0.CO;2-G; Hogenesch JB, 2001, CELL, V106, P413, DOI 10.1016/S0092-8674(01)00467-6; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; PLAITAKIS A, 1993, CAN J NEUROL SCI, V20, P5109; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572; Zimmermann H.J., 2001, FUZZY SET THEORY ITS, V4th	11	253	262	0	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2002	31	3					316	319		10.1038/ng895	http://dx.doi.org/10.1038/ng895			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12006977				2022-12-17	WOS:000176494100023
J	Bamforth, SD; Braganca, J; Eloranta, JJ; Murdoch, JN; Marques, FIR; Kranc, KR; Farza, H; Henderson, DJ; Hurst, HC; Bhattacharya, S				Bamforth, SD; Braganca, J; Eloranta, JJ; Murdoch, JN; Marques, FIR; Kranc, KR; Farza, H; Henderson, DJ; Hurst, HC; Bhattacharya, S			Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR AP-2; RUBINSTEIN-TAYBI-SYNDROME; GENE-EXPRESSION; MOUSE EMBRYOGENESIS; BINDING-PROTEIN; MUTATIONS; ERBB3; MRG1; TUBE; CBP	The protein EP300 and its paralog CREBBP (CREB-binding protein) are ubiquitously expressed transcriptional co-activators and histone acetyl transferases'. The gene EP300 is essential for normal cardiac and neural development, whereas CREBBP is essential for neurulation, hematopoietic differentiation, angiogenesis and skeletal and cardiac development(2-5). Mutations in CREBBP cause Rubinstein-Taybi syndrome, which is characterized by mental retardation, skeletal abnormalities and congenital cardiac defects(6,7). The CBP/p300-interacting transactivator with ED-rich tail 2 (CITED2) binds EP300 and CREBBP with high affinity(8) and regulates gene transcription(8-10). Here we show that Cited2(-/-) embryos die with cardiac malformations, adrenal agenesis, abnormal cranial ganglia and exencephaly. The cardiac defects include atrial and ventricular septal defects, overriding aorta, double-outlet right ventricle, persistent truncus arteriosus and right-sided aortic arches. We find increased apoptosis in the midbrain region and a marked reduction in ErbB3-expressing neural crest cells in mid-embryogenesis. We show that CITED2 interacts with and co-activates all isoforms of transcription factor AP-2 (TFAP2). Transactivation by TFAP2 isoforms is defective in Cited2(-/-) embryonic fibroblasts and is rescued by ectopically expressed CITED2. As certain Tfap2 isoforms are essential in neural crest, neural tube and cardiac development(11-13), we propose that abnormal embryogenesis in mice lacking Cited2 results, at least in part, from its role as a Tfap2 co-activator.	Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford OX3 7BN, England; Hammersmith Hosp, Imperial Canc Res Fund, Mol Oncol Unit, London, England; Inst Child Hlth, Neural Dev Unit, London, England	University of Oxford; Wellcome Centre for Human Genetics; Cancer Research UK; Imperial College London; University of London; University College London	Bhattacharya, S (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Roosevelt Dr, Oxford OX3 7BN, England.		Bamforth, Simon David/I-1277-2019; Kranc, Kamil/B-3449-2009; Bhattacharya, Shoumo/F-4127-2010; Braganca, Jose/F-4410-2012	Bamforth, Simon David/0000-0002-5666-4485; Bhattacharya, Shoumo/0000-0002-5571-0478; Braganca, Jose/0000-0001-9566-400X; Henderson, Deborah/0000-0002-2705-5998				Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Bosher JM, 1996, ONCOGENE, V13, P1701; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; Dunwoodie SL, 1998, MECH DEVELOP, V72, P27, DOI 10.1016/S0925-4773(98)00011-2; Erickson SL, 1997, DEVELOPMENT, V124, P4999; Glenn DJ, 1999, J BIOL CHEM, V274, P36159, DOI 10.1074/jbc.274.51.36159; Goodman RH, 2000, GENE DEV, V14, P1553; Haydar TF, 1999, CEREB CORTEX, V9, P621, DOI 10.1093/cercor/9.6.621; Herrera E, 1999, EMBO J, V18, P1172, DOI 10.1093/emboj/18.5.1172; Juriloff DM, 2000, HUM MOL GENET, V9, P993, DOI 10.1093/hmg/9.6.993; Kung AL, 2000, GENE DEV, V14, P272; Le Douarin NM, 1999, NEURAL CREST; LOO DT, 1989, CELL GROWTH CELL DIV, P17; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; Moser M, 1997, DEV DYNAM, V208, P115, DOI 10.1002/(SICI)1097-0177(199701)208:1<115::AID-AJA11>3.0.CO;2-5; Oike Y, 1999, BLOOD, V93, P2771; Oike Y, 1999, HUM MOL GENET, V8, P387, DOI 10.1093/hmg/8.3.387; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Shioda T, 1997, GENE, V204, P235, DOI 10.1016/S0378-1119(97)00551-9; SKINNER A, 1993, ONCOGENE, V8, P3393; STEVENS CA, 1995, AM J MED GENET, V59, P346, DOI 10.1002/ajmg.1320590313; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0	30	253	268	1	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					469	474		10.1038/ng768	http://dx.doi.org/10.1038/ng768			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11694877				2022-12-17	WOS:000172507500025
J	Geller, DS; Rodriguez-Soriano, J; Boado, AV; Schifter, S; Bayer, M; Chang, SS; Lifton, RP				Geller, DS; Rodriguez-Soriano, J; Boado, AV; Schifter, S; Bayer, M; Chang, SS; Lifton, RP			Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I	NATURE GENETICS			English	Article							EPITHELIAL SODIUM-CHANNEL; RNA SPLICE JUNCTIONS; BETA-SUBUNIT; ALDOSTERONE; SALT; CORTICOSTERONE; HYPERTENSION	Pseudohypoaldosteronism type I (PHA1) is characterized by neonatal renal salt wasting with dehydration, hypotension, hyperkalaemia and metabolic acidosis, despite elevated aldosterone levels. Two forms of PHA1 exist. An autosomal recessive form features severe disease with manifestations persisting into adulthood(1). This form is caused by toss-of-function mutations in genes encoding subunits of the amiloride-sensitive epithelial sodium channel (ENaC; refs 2,3). Autosomal dominant or sporadic PHA1 is a milder disease that remits with age. Among six dominant and seven sporadic PHA1 kindreds, we have found no ENaC gene mutations, implicating mutations in other genes. As ENaC activity in the kidney is regulated by the steroid hormone aldosterone acting through the mineralocorticoid receptor(4), we have screened the mineralocorticoid receptor gene (MLR) for variants and have identified heterozygous mutations in one sporadic and four dominant kindreds. These include two frameshift mutations tone a de novo mutation), two premature termination codons and one splice donor mutation. These mutations segregate with PHA1 and are not found in unaffected subjects. These findings demonstrate that heterozygous MLR mutations cause PHA1, underscore the important role of mineralocorticoid receptor function in regulation of salt and blood pressure homeostasis in humans and motivate further study of this gene for a potential role in blood pressure variation.	Yale Univ, Sch Med, Dept Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Genet, New Haven, CT 06510 USA; Hosp Cruces, Dept Pediat, E-48903 Barakaldo, Spain; Glostrup Cty Hosp, Dept Clin Physiol & Nucl Med, DK-2600 Glostrup, Denmark; Charles Univ, Fac Med 1, Dept Pediat, Prague, Czech Republic	Howard Hughes Medical Institute; Yale University; Yale University; Hospital Universitario Cruces; University of Copenhagen; Charles University Prague	Lifton, RP (corresponding author), Yale Univ, Sch Med, Dept Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.							ARAI K, 1995, J CLIN ENDOCR METAB, V80, P814, DOI 10.1210/jc.80.3.814; BAYER M, 1993, ACTA PAEDIATR, V82, P504, DOI 10.1111/j.1651-2227.1993.tb12736.x; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Berger S, 1996, ENDOCR RES, V22, P641, DOI 10.1080/07435809609043758; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; EPPLE HJ, 1995, AM J PHYSIOL-GASTR L, V269, pG42, DOI 10.1152/ajpgi.1995.269.1.G42; GomezSanchez EP, 1996, STEROIDS, V61, P184, DOI 10.1016/0039-128X(96)00010-4; Grunder S, 1997, CURR OPIN NEPHROL HY, V6, P35; HANSSON JH, 1995, P NATL ACAD SCI USA, V92, P11495, DOI 10.1073/pnas.92.25.11495; KOMESAROFF PA, 1994, J CLIN ENDOCR METAB, V79, P27, DOI 10.1210/jc.79.1.27; KOO WWK, 1982, ARCH DIS CHILD, V57, P500, DOI 10.1136/adc.57.7.500; KRAWCZAK M, 1992, HUM GENET, V90, P41; Kuhnle U, 1997, MOL CELL ENDOCRINOL, V133, P77, DOI 10.1016/S0303-7207(97)00149-4; LimTio SS, 1997, ENDOCRINOLOGY, V138, P2537, DOI 10.1210/en.138.6.2537; PASCOE L, 1992, P NATL ACAD SCI USA, V89, P4996, DOI 10.1073/pnas.89.11.4996; PETERSEN S, 1978, ACTA PAEDIATR SCAND, V67, P255, DOI 10.1111/j.1651-2227.1978.tb16314.x; RODRIGUEZSORIANO J, 1990, PEDIATR NEPHROL, V4, P105, DOI 10.1007/BF00858819; ROSLER A, 1984, J CLIN ENDOCR METAB, V59, P689; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; SIPPELL WG, 1980, PEDIATR RES, V14, P39, DOI 10.1203/00006450-198014010-00010; Strautnieks SS, 1996, NAT GENET, V13, P248, DOI 10.1038/ng0696-248; ZENNARO MC, 1995, J BIOL CHEM, V270, P21016, DOI 10.1074/jbc.270.36.21016; ZENNARO MC, 1994, J CLIN ENDOCR METAB, V79, P32, DOI 10.1210/jc.79.1.32	24	253	259	1	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1998	19	3					279	281		10.1038/966	http://dx.doi.org/10.1038/966			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662404				2022-12-17	WOS:000074565900027
J	LAING, NG; WILTON, SD; AKKARI, PA; DOROSZ, S; BOUNDY, K; KNEEBONE, C; BLUMBERGS, P; WHITE, S; WATKINS, H; LOVE, DR; HAAN, E				LAING, NG; WILTON, SD; AKKARI, PA; DOROSZ, S; BOUNDY, K; KNEEBONE, C; BLUMBERGS, P; WHITE, S; WATKINS, H; LOVE, DR; HAAN, E			A MUTATION IN THE ALPHA-TROPOMYOSIN GENE TPM3 ASSOCIATED WITH AUTOSOMAL-DOMINANT NEMALINE MYOPATHY	NATURE GENETICS			English	Article								Nemaline myopathies are diseases characterized by the presence in muscle fibres of pathognomonic rod bodies. These are composed largely of alpha-actinin and actin. We have identified a missense mutation in the alpha-tropomyosin gene, TPM3, which segregates completely with the disease in a family whose autosomal dominant nemaline myopathy we had previously localized to chromosome 1p13-q25. The mutation substitutes an arginine residue for a highly conserved methionine in a putative actin-binding site near the N terminus of the alpha-tropomyosin. The mutation may strengthen tropomyosin - actin binding, leading to rod body formation, by adding a further basic residue to the postulated actin-binding motif.	CURTIN UNIV TECHNOL, SCH BIOMED SCI, BENTLEY, WA 6102, AUSTRALIA; ROYAL ADELAIDE HOSP, DEPT NEUROL, ADELAIDE, SA 5000, AUSTRALIA; INST MED & VET SCI, ADELAIDE, SA 5000, AUSTRALIA; WOMENS & CHILDRENS HOSP, CTR GENET MED, DEPT MED GENET, ADELAIDE, SA 5006, AUSTRALIA; HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02115 USA; UNIV AUCKLAND, SCH BIOL SCI, AUCKLAND, NEW ZEALAND	Curtin University; Royal Adelaide Hospital; Institute Medical & Veterinary Science Australia; Womens & Childrens Hospital Australia; Harvard University; Harvard Medical School; University of Auckland	LAING, NG (corresponding author), UNIV WESTERN AUSTRALIA, AUSTRALIAN NEUROMUSCULAR RES INST, DEPT PATHOL, 4TH FLOOR, A BLOCK, NEDLANDS, WA 6009, AUSTRALIA.			Laing, Nigel/0000-0001-5111-3732; Wilton, Steve/0000-0002-9400-893X; Love, Donald/0000-0003-4669-8769; Watkins, Hugh/0000-0002-5287-9016				AKKARI PA, 1994, CYTOGENET CELL GENET, V65, P265, DOI 10.1159/000133644; BAADER CD, 1993, FEBS LETT, V328, P63, DOI 10.1016/0014-5793(93)80966-X; BEGGS AH, 1992, GENOMICS, V13, P1314, DOI 10.1016/0888-7543(92)90054-V; BODENSTEINER JB, 1994, MUSCLE NERVE, V17, P131, DOI 10.1002/mus.880170202; CHO YJ, 1990, J BIOL CHEM, V265, P538; CLAYTON L, 1988, J MOL BIOL, V201, P507, DOI 10.1016/0022-2836(88)90633-X; CONEN PE, 1963, CAN MED ASSOC J, V89, P983; EYRE H, IN PRESS CYTOGENET C; EYRE HJ, 1993, CYTOGENET CELL GENET, V62, P181, DOI 10.1159/000133467; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; GUNNING P, 1990, DEV BIOL, V138, P443, DOI 10.1016/0012-1606(90)90210-A; GUYER M, 1992, SCIENCE, V258, P67; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDY S, 1992, BIOCHIM BIOPHYS ACTA, V1131, P239, DOI 10.1016/0167-4781(92)90087-G; HARDY S, 1991, EUR J BIOCHEM, V202, P431, DOI 10.1111/j.1432-1033.1991.tb16392.x; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; HELFMAN DM, 1984, J BIOL CHEM, V259, P4136; HITCHCOCKDEGREGORI SE, 1990, J MOL BIOL, V214, P885, DOI 10.1016/0022-2836(90)90343-K; KARLIK CC, 1984, CELL, V37, P469, DOI 10.1016/0092-8674(84)90377-5; LAING NG, 1992, AM J HUM GENET, V50, P576; MACLEOD AR, 1988, MOL CELL BIOL, V8, P433, DOI 10.1128/MCB.8.1.433; MAK AS, 1980, J BIOL CHEM, V255, P3647; MCALPINE PJ, 1993, GENOME PR R, P11; McKusick V.A., 1992, MENDELIAN INHERITANC; MEEDEL TH, 1993, J BIOL CHEM, V268, P6755; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OTT J, 1974, AM J HUM GENET, V26, P588; PRICE HM, 1965, P NATL ACAD SCI USA, V54, P1398, DOI 10.1073/pnas.54.5.1398; RUIZOPAZO N, 1987, J BIOL CHEM, V262, P4755; SHY GM, 1963, BRAIN, V86, P793, DOI 10.1093/brain/86.4.793; TAHVANAINEN E, 1994, J MED GENET, V31, P79, DOI 10.1136/jmg.31.1.79; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; WIDADA JS, 1988, NUCLEIC ACIDS RES, V16, P3109, DOI 10.1093/nar/16.7.3109; WILTON SD, 1995, CYTOGENET CELL GENET, V68, P122, DOI 10.1159/000133905; WILTON SD, 1993, AM J MED GENET, V46, P563, DOI 10.1002/ajmg.1320460521; WOLFE SL, 1993, MOL CELL BIOL, P451; YONEZAWA N, 1989, EUR J BIOCHEM, V183, P235, DOI 10.1111/j.1432-1033.1989.tb14918.x	37	253	257	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1995	9	1					75	79		10.1038/ng0195-75	http://dx.doi.org/10.1038/ng0195-75			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PZ913	7704029				2022-12-17	WOS:A1995PZ91300018
J	Li, ZQ; Chen, JH; Yu, H; He, L; Xu, YF; Zhang, D; Yi, QZ; Li, CG; Li, XW; Shen, JW; Song, ZJ; Ji, WD; Wang, M; Zhou, J; Chen, BY; Liu, YH; Wang, JQ; Wang, P; Yang, P; Wang, QZ; Feng, GY; Liu, BX; Sun, WS; Li, BJ; He, G; Li, WD; Wan, CL; Xu, Q; Li, WJ; Wen, ZJ; Liu, K; Huang, F; Ji, J; Ripke, S; Yue, WH; Sullivan, PF; O'Donovan, MC; Shi, YY				Li, Zhiqiang; Chen, Jianhua; Yu, Hao; He, Lin; Xu, Yifeng; Zhang, Dai; Yi, Qizhong; Li, Changgui; Li, Xingwang; Shen, Jiawei; Song, Zhijian; Ji, Weidong; Wang, Meng; Zhou, Juan; Chen, Boyu; Liu, Yahui; Wang, Jiqiang; Wang, Peng; Yang, Ping; Wang, Qingzhong; Feng, Guoyin; Liu, Benxiu; Sun, Wensheng; Li, Baojie; He, Guang; Li, Weidong; Wan, Chunling; Xu, Qi; Li, Wenjin; Wen, Zujia; Liu, Ke; Huang, Fang; Ji, Jue; Ripke, Stephan; Yue, Weihua; Sullivan, Patrick F.; O'Donovan, Michael C.; Shi, Yongyong			Genome-wide association analysis identifies 30 new susceptibility loci for schizophrenia	NATURE GENETICS			English	Article							COMMON VARIANTS; GENETIC-VARIATION; CONFERRING RISK; HAN CHINESE; DISEASE; METAANALYSIS; 6P22.1; IMMUNE	We conducted a genome-wide association study (GWAS) with replication in 36,180 Chinese individuals and performed further transancestry meta-analyses with data from the Psychiatry Genomics Consortium (PGC2). Approximately 95% of the genome-wide significant (GWS) index alleles (or their proxies) from the PGC2 study were overrepresented in Chinese schizophrenia cases, including similar to 50% that achieved nominal significance and similar to 75% that continued to be GWS in the transancestry analysis. The Chinese-only analysis identified seven GWS loci; three of these also were GWS in the transancestry analyses, which identified 109 GWS loci, thus yielding a total of 113 GWS loci (30 novel) in at least one of these analyses. We observed improvements in the fine-mapping resolution at many susceptibility loci. Our results provide several lines of evidence supporting candidate genes at many loci and highlight some pathways for further research. Together, our findings provide novel insight into the genetic architecture and biological etiology of schizophrenia.	[Li, Zhiqiang; Shi, Yongyong] Qingdao Univ, Affiliated Hosp, Qingdao, Peoples R China; [Li, Zhiqiang; Shi, Yongyong] Qingdao Univ, Biomed Sci Inst, SJTU Bio X Inst, Qingdao Branch, Qingdao, Peoples R China; [Li, Zhiqiang; Chen, Jianhua; He, Lin; Li, Xingwang; Shen, Jiawei; Song, Zhijian; Wang, Meng; Zhou, Juan; Chen, Boyu; Liu, Yahui; Wang, Jiqiang; Wang, Qingzhong; Li, Baojie; He, Guang; Li, Weidong; Wan, Chunling; Li, Wenjin; Wen, Zujia; Liu, Ke; Huang, Fang; Ji, Jue; Shi, Yongyong] Shanghai Jiao Tong Univ, Minist Educ, Collaborat Innovat Ctr Brain Sci, Key Lab Genet Dev & Neuropsychiat Disorders,Bio X, Shanghai, Peoples R China; [Li, Zhiqiang; Shi, Yongyong] Shanghai Jiao Tong Univ, Inst Social Cognit & Behav Sci, Shanghai, Peoples R China; [Li, Zhiqiang; He, Lin; Ji, Weidong; Shi, Yongyong] Shanghai Jiao Tong Univ, Inst Neuropsychiat Sci & Syst Biol Med, Shanghai, Peoples R China; [Chen, Jianhua; Feng, Guoyin] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Shanghai Key Lab Psychot Disorders, Shanghai, Peoples R China; [Yu, Hao; Zhang, Dai; Yue, Weihua] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, Beijing, Peoples R China; [Yu, Hao; Zhang, Dai; Yue, Weihua] Peking Univ, Hosp 6, Inst Mental Hlth, Beijing, Peoples R China; [Yu, Hao] Jining Med Univ, Dept Psychiat, Jining, Peoples R China; [Zhang, Dai] Peking Univ, McGovern Inst Brain Res, Peking Tsinghua Joint Ctr Life Sci, PKU IDG, Beijing, Peoples R China; [Yi, Qizhong; Shi, Yongyong] Xinjiang Med Univ, Teaching Hosp 1, Dept Psychiat, Urumqi, Peoples R China; [Li, Changgui] Qingdao Univ, Shandong Prov Key Lab Metab Dis, Qingdao, Peoples R China; [Li, Changgui] Qingdao Univ, Metab Dis Inst, Qingdao, Peoples R China; [Ji, Weidong; Shi, Yongyong] Changning Mental Hlth Ctr, Shanghai, Peoples R China; [Wang, Peng; Yang, Ping] Wuhu Fourth Peoples Hosp, Wuhu, Peoples R China; [Liu, Benxiu; Sun, Wensheng] Longquan Mt Hosp Guangxi Prov, Liuzhou, Peoples R China; [Xu, Qi] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing, Peoples R China; [Xu, Qi] Peking Union Med Coll, Beijing, Peoples R China; [Ripke, Stephan] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ripke, Stephan] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Ripke, Stephan] Charite, Dept Psychiat & Psychotherapy, Berlin, Germany; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [O'Donovan, Michael C.] Cardiff Univ, Sch Med, MRC Ctr Neuropsychiat Genet & Gen, Div Psychol Med & Clin Neurosci, Cardiff, S Glam, Wales	Qingdao University; Qingdao University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tsinghua University; Peking University; Jining Medical University; Peking University; Xinjiang Medical University; Qingdao University; Qingdao University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Karolinska Institutet; Cardiff University	Shi, YY (corresponding author), Qingdao Univ, Affiliated Hosp, Qingdao, Peoples R China.; Shi, YY (corresponding author), Qingdao Univ, Biomed Sci Inst, SJTU Bio X Inst, Qingdao Branch, Qingdao, Peoples R China.; Shi, YY (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Collaborat Innovat Ctr Brain Sci, Key Lab Genet Dev & Neuropsychiat Disorders,Bio X, Shanghai, Peoples R China.; Shi, YY (corresponding author), Shanghai Jiao Tong Univ, Inst Social Cognit & Behav Sci, Shanghai, Peoples R China.; Shi, YY (corresponding author), Shanghai Jiao Tong Univ, Inst Neuropsychiat Sci & Syst Biol Med, Shanghai, Peoples R China.; Shi, YY (corresponding author), Xinjiang Med Univ, Teaching Hosp 1, Dept Psychiat, Urumqi, Peoples R China.; Shi, YY (corresponding author), Changning Mental Hlth Ctr, Shanghai, Peoples R China.	shiyongyong@gmail.com	Chen, Jianhua/AAS-8417-2020; Xu, Yifeng/AAA-2064-2021; Yu, Hao/GYD-8698-2022; He, Guang/ABF-7381-2021; O'Donovan, Michael C/P-7005-2018; Shi, Yongyong/GSO-1627-2022; Ripke, Stephan/AAK-5486-2021; Li, Zhiqiang/AAI-4003-2021	Xu, Yifeng/0000-0002-0403-1141; Yu, Hao/0000-0002-9785-8489; He, Guang/0000-0002-4911-088X; O'Donovan, Michael C/0000-0001-7073-2379; Shi, Yongyong/0000-0003-1710-1505; Li, Zhiqiang/0000-0002-0174-9254; Li, Weidong/0000-0001-5384-4838; ripke, stephan/0000-0003-3622-835X; Sullivan, Patrick F/0000-0002-6619-873X	973 Program [2015CB559100]; National Key R&D Program of China [2016YFC0903402, 2016YFC1201701]; Natural Science Foundation of China [31325014, 81130022, 81421061, 81701321]; Program of Shanghai Subject Chief Scientist [15XD1502200]; National Program for Support of Top-Notch Young Professionals; Shanghai Key Laboratory of Psychotic Disorders [13dz2260500]; Shanghai Municipal Education Commission; Shanghai Education Development Foundation [12SG17]; China Postdoctoral Science Foundation [2016M590615]; Shandong Postdoctoral Innovation Foundation [201601015]; Qingdao Postdoctoral Application Research Project [2016048]; Shanghai Hospital Development Center [SHDC12016115]; US NIMH; NIDA [U01 MH109528, U01 MH1095320]; Swedish Research Council (Vetenskapsradet) [D0886501]; Medical Research Council [MR/P005748/1, MR/L010305/1] Funding Source: researchfish; MRC [MR/P005748/1] Funding Source: UKRI	973 Program(National Basic Research Program of China); National Key R&D Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Subject Chief Scientist; National Program for Support of Top-Notch Young Professionals; Shanghai Key Laboratory of Psychotic Disorders; Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Development Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shandong Postdoctoral Innovation Foundation; Qingdao Postdoctoral Application Research Project; Shanghai Hospital Development Center; US NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all of the participants in the study and the international Psychiatric GWAS Consortium (PGC) for the large-scale data resources that made this research possible. We also appreciate H. Huang, B. Neale and M. Daly for their valuable suggestions for data analysis and manuscript organization. This work was supported by the 973 Program (2015CB559100 to Y.S.), the National Key R&D Program of China (2016YFC0903402 to Y.S. and Z.L., and 2016YFC1201701 to X.L.), the Natural Science Foundation of China (31325014 to Y.S., 81130022 to Y.S., 81421061 to L.H. and 81701321 to Z.L.), the Program of Shanghai Subject Chief Scientist (15XD1502200 to Y.S.), the National Program for Support of Top-Notch Young Professionals to Y.S., the Shanghai Key Laboratory of Psychotic Disorders (13dz2260500 to Y.X.), the 'Shu Guang' project supported by the Shanghai Municipal Education Commission and Shanghai Education Development Foundation (12SG17 to Y.S.), the China Postdoctoral Science Foundation (2016M590615 to Z.L.), the Shandong Postdoctoral Innovation Foundation (201601015 to Z.L.), the Qingdao Postdoctoral Application Research Project (2016048 to Z.L.), the Shanghai Hospital Development Center (SHDC12016115 to Y.X.), the US NIMH and NIDA (U01 MH109528 to P.F.S. and U01 MH1095320 to P.F.S.), and the Swedish Research Council (Vetenskapsradet, award D0886501 to P.E.S.).	Adkins DE, 2011, MOL PSYCHIATR, V16, P321, DOI 10.1038/mp.2010.14; Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bauss K, 2014, HUM MOL GENET, V23, P3923, DOI 10.1093/hmg/ddu104; Boonen M, 2016, J CELL SCI, V129, P557, DOI 10.1242/jcs.179374; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burmeister M, 2008, NAT REV GENET, V9, P527, DOI 10.1038/nrg2381; Calabrese F, 2016, EXPERT OPIN THER TAR, V20, P1195, DOI 10.1080/14728222.2016.1188080; Catapano LA, 2007, BBA-BIOMEMBRANES, V1768, P976, DOI 10.1016/j.bbamem.2006.09.025; Citrome L, 2004, DIABETES CARE, V27, P2087, DOI 10.2337/diacare.27.8.2087; de Anda FC, 2012, NAT NEUROSCI, V15, P1022, DOI 10.1038/nn.3141; de Candia TR, 2013, AM J HUM GENET, V93, P463, DOI 10.1016/j.ajhg.2013.07.007; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Du CP, 2012, CNS NEUROSCI THER, V18, P754, DOI 10.1111/j.1755-5949.2012.00357.x; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Gaulton KJ, 2015, NAT GENET, V47, P1415, DOI 10.1038/ng.3437; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gottschalk MG, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu019; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Hattori K, 2009, PSYCHIAT RES, V168, P119, DOI 10.1016/j.psychres.2008.04.014; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; Kichaev G, 2015, AM J HUM GENET, V97, P260, DOI 10.1016/j.ajhg.2015.06.007; Knapp M, 2004, SCHIZOPHRENIA BULL, V30, P279, DOI 10.1093/oxfordjournals.schbul.a007078; Koide T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036836; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lee SH, 2012, GENET EPIDEMIOL, V36, P214, DOI 10.1002/gepi.21614; Li Z, 2015, SENSOR ACTUAT B-CHEM, V207, P490, DOI 10.1016/j.snb.2014.10.071; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mitchell AJ, 2013, SCHIZOPHRENIA BULL, V39, P306, DOI 10.1093/schbul/sbr148; Montgomery W, 2013, CLINICOECONOMIC OUTC, V5, P407, DOI 10.2147/CEOR.S44325; Morris DL, 2016, NAT GENET, V48, P940, DOI 10.1038/ng.3603; Nyholt DR, 2014, BIOINFORMATICS, V30, P2086, DOI 10.1093/bioinformatics/btu171; O'Dushlaine C, 2015, NAT NEUROSCI, V18, P199, DOI 10.1038/nn.3922; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pocklington AJ, 2014, EUR J NEUROSCI, V39, P1059, DOI 10.1111/ejn.12489; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Schmidt EM, 2015, BIOINFORMATICS, V31, P2601, DOI 10.1093/bioinformatics/btv201; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steinberg S, 2011, HUM MOL GENET, V20, P4076, DOI 10.1093/hmg/ddr325; Steiner J, 2014, PROG NEURO-PSYCHOPH, V48, P287, DOI 10.1016/j.pnpbp.2012.09.016; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yu H, 2017, MOL PSYCHIATR, V22, P954, DOI 10.1038/mp.2016.212; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	69	252	264	9	157	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2017	49	11					1576	+		10.1038/ng.3973	http://dx.doi.org/10.1038/ng.3973			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FL0OD	28991256	Green Accepted			2022-12-17	WOS:000413909800006
J	Kim, Y; Lach, FP; Desetty, R; Hanenberg, H; Auerbach, AD; Smogorzewska, A				Kim, Yonghwan; Lach, Francis P.; Desetty, Rohini; Hanenberg, Helmut; Auerbach, Arleen D.; Smogorzewska, Agata			Mutations of the SLX4 gene in Fanconi anemia	NATURE GENETICS			English	Article							CANCER SUSCEPTIBILITY GENE; CROSS-LINK REPAIR; HOLLIDAY JUNCTION RESOLVASE; DNA-REPAIR; MONOUBIQUITINATED FANCD2; IDENTIFICATION; BREAST; NUCLEASE; PATHWAY; DAMAGE	Fanconi anemia is a rare recessive disorder characterized by genome instability, congenital malformations, progressive bone marrow failure and predisposition to hematologic malignancies and solid tumors(1). At the cellular level, hypersensitivity to DNA interstrand crosslinks is the defining feature in Fanconi anemia(2). Mutations in thirteen distinct Fanconi anemia genes(3) have been shown to interfere with the DNA-replication-dependent repair of lesions involving crosslinked DNA at stalled replication forks(4). Depletion of SLX4, which interacts with multiple nucleases and has been recently identified as a Holliday junction resolvase(5-7), results in increased sensitivity of the cells to DNA crosslinking agents. Here we report the identification of biallelic SLX4 mutations in two individuals with typical clinical features of Fanconi anemia and show that the cellular defects in these individuals' cells are complemented by wildtype SLX4, demonstrating that biallelic mutations in SLX4 (renamed here as FANCP) cause a new subtype of Fanconi anemia, Fanconi anemia-P.	[Kim, Yonghwan; Lach, Francis P.; Desetty, Rohini; Smogorzewska, Agata] Rockefeller Univ, Lab Genome Maintenance, New York, NY 10021 USA; [Hanenberg, Helmut] Indiana Univ Sch Med, Riley Hosp Children, Herman B Wells Ctr Pediat Res, Div Pediat Hematol Oncol, Indianapolis, IN USA; [Hanenberg, Helmut] Univ Dusseldorf, Dept Otorhinolaryngol, Dusseldorf, Germany	Rockefeller University; Indiana University System; Indiana University Bloomington; James Whitcomb Riley Hospital Children; Heinrich Heine University Dusseldorf	Smogorzewska, A (corresponding author), Rockefeller Univ, Lab Genome Maintenance, 1230 York Ave, New York, NY 10021 USA.	asmogorzewska@rockefeller.edu	Smogorzewska, Agata/B-8891-2011	Auerbach, Arleen/0000-0002-6911-8379; Lach, Francis/0000-0003-3708-7122; Smogorzewska, Agata/0000-0001-6285-1562	Deutsche Forschungsgemeinschaft [SPP1230]; Bundesministerium fur Bildung und Forschung network for Bone Marrow failure Syndrome; FoneFA; Burroughs Wellcome Fund; NATIONAL CANCER INSTITUTE [R01CA155294] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung network for Bone Marrow failure Syndrome; FoneFA; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We are grateful to the affected individuals and their families for their participation in this study. We thank the Harper Lab, Harvard Medical School, Boston, Massachusetts, USA for reagents, E. Foley for advice and J. de Winter for communicating unpublished results. H. H. is supported by the Deutsche Forschungsgemeinschaft SPP1230, the Bundesministerium fur Bildung und Forschung network for Bone Marrow failure Syndrome, and FoneFA. A.S. is supported by the Burroughs Wellcome Fund Career Award for Medical Scientists and is a Rita Allen Foundation and an Irma T. Hirschl Scholar.	AUERBACH AD, 1976, NATURE, V261, P494, DOI 10.1038/261494a0; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942	26	252	256	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2011	43	2					142	U91		10.1038/ng.750	http://dx.doi.org/10.1038/ng.750			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	711XD	21240275	Green Accepted			2022-12-17	WOS:000286623800013
